PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bouchez, CL; Yoboue, ED; Vargas, LDE; Salin, B; Cuvellier, S; Rigoulet, M; Duvezin-Caubet, S; Devin, A				Bouchez, Cyrielle L.; Yoboue, Edgar D.; Vargas, Livier E. de la Rosa; Salin, Benedicte; Cuvellier, Sylvain; Rigoulet, Michel; Duvezin-Caubet, Stephane; Devin, Anne			?Labile? heme critically regulates mitochondrial biogenesis through the transcriptional co-activator Hap4p in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; heme; yeast; oxidation-reduction (redox); bioenergetics; Hap4p; labile heme; mitochondrial biogenesis; oxidative phosphorylation (OXPHOS); transcription factor; yeast; gene regulation; transcription factor; HAP complex	SKELETAL-MUSCLE; EXTINCTION COEFFICIENT; GROWTH-YIELD; CYC1 GENE; YEAST; ACTIVATION; RESPIRATION; COMPLEX; OXYGEN; HSP90	Heme (iron protoporphyrin IX) is a well-known prosthetic group for enzymes involved in metabolic pathways such as oxygen transport and electron transfer through the mitochondrial respiratory chain. However, heme has also been shown to be an important regulatory molecule (as ?labile? heme) for diverse processes such as translation, kinase activity, and transcription in mammals, yeast, and bacteria. Taking advantage of a yeast strain deficient for heme production that enabled controlled modulation and monitoring of labile heme levels, here we investigated the role of labile heme in the regulation of mitochondrial biogenesis. This process is regulated by the HAP complex in yeast. Using several biochemical assays along with EM and epifluorescence microscopy, to the best of our knowledge, we show for the first time that cellular labile heme is critical for the post-translational regulation of HAP complex activity, most likely through the stability of the transcriptional co-activator Hap4p. Consequently, we found that labile heme regulates mitochondrial biogenesis and cell growth. The findings of our work highlight a new mechanism in the regulation of mitochondrial biogenesis by cellular metabolites.	[Bouchez, Cyrielle L.; Yoboue, Edgar D.; Vargas, Livier E. de la Rosa; Salin, Benedicte; Cuvellier, Sylvain; Rigoulet, Michel; Duvezin-Caubet, Stephane; Devin, Anne] CNRS, F-33000 Bordeaux, France; [Bouchez, Cyrielle L.; Yoboue, Edgar D.; Vargas, Livier E. de la Rosa; Salin, Benedicte; Cuvellier, Sylvain; Rigoulet, Michel; Duvezin-Caubet, Stephane; Devin, Anne] Univ Bordeaux, Inst Biochim & Genet Cellulaires, UMR 5095, F-33000 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Devin, A (corresponding author), CNRS, IBGC, Bioenerget & Cell Metab Lab, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	anne.devin@ibgc.cnrs.fr		Duvezin-Caubet, Stephane/0000-0002-0243-2697; Bouchez, Cyrielle L/0000-0002-5318-3547	Ligue contre le Cancer; Agence Nationale de la Recherche; CNRS	Ligue contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Ligue contre le Cancer, the Agence Nationale de la Recherche, and CNRS. The authors declare that they have no conflicts of interest with the contents of this article.	Aquilano K, 2013, ANTIOXID REDOX SIGN, V18, P386, DOI 10.1089/ars.2012.4615; BETINA S, 1995, EUR J BIOCHEM, V229, P651, DOI 10.1111/j.1432-1033.1995.tb20510.x; Bogacka I, 2005, J CLIN ENDOCR METAB, V90, P6650, DOI 10.1210/jc.2005-1024; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Bourens M, 2013, ANTIOXID REDOX SIGN, V19, P1940, DOI 10.1089/ars.2012.4847; BROWN GC, 1992, BIOCHEM J, V284, P1; Buschlen S, 2003, COMP FUNCT GENOM, V4, P37, DOI 10.1002/cfg.254; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chevtzoff C, 2010, J BIOL CHEM, V285, P1733, DOI 10.1074/jbc.M109.019570; Crisp RJ, 2003, J BIOL CHEM, V278, P45499, DOI 10.1074/jbc.M307229200; Dang VD, 1996, J BACTERIOL, V178, P1842, DOI 10.1128/jb.178.7.1842-1849.1996; Dejean L, 2000, BBA-BIOENERGETICS, V1457, P45, DOI 10.1016/S0005-2728(00)00053-0; Dejean L, 2002, BBA-BIOENERGETICS, V1554, P159, DOI 10.1016/S0005-2728(02)00240-2; Devin A, 2007, AM J PHYSIOL-CELL PH, V292, pC52, DOI 10.1152/ajpcell.00208.2006; Devin A, 2006, J BIOL CHEM, V281, P26779, DOI 10.1074/jbc.M604800200; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; FORSBURG SL, 1988, MOL CELL BIOL, V8, P647, DOI 10.1128/MCB.8.2.647; GROEN AK, 1982, J BIOL CHEM, V257, P2754; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; GUARENTE L, 1984, CELL, V36, P503, DOI 10.1016/0092-8674(84)90243-5; HAHN S, 1988, MOL CELL BIOL, V8, P655, DOI 10.1128/MCB.8.2.655; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Hon T, 2005, GENETICS, V169, P1343, DOI 10.1534/genetics.104.037143; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; KIPPERT F, 1995, FEMS MICROBIOL LETT, V128, P201, DOI 10.1016/0378-1097(95)00113-J; Lan CG, 2004, J BIOL CHEM, V279, P27607, DOI 10.1074/jbc.M402777200; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lascaris R, 2003, GENOME BIOL, V4; Lee HC, 2003, MOL CELL BIOL, V23, P5857, DOI 10.1128/MCB.23.16.5857-5866.2003; Lee HC, 2002, J BIOL CHEM, V277, P7430, DOI 10.1074/jbc.M106951200; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; McNabb DS, 2005, EUKARYOT CELL, V4, P1829, DOI 10.1128/EC.4.11.1829-1839.2005; MCNABB DS, 1995, GENE DEV, V9, P47, DOI 10.1101/gad.9.1.47; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Mogensen M, 2006, J PHYSIOL-LONDON, V571, P669, DOI 10.1113/jphysiol.2005.101691; OLESEN J, 1987, CELL, V51, P953, DOI 10.1016/0092-8674(87)90582-4; PINKHAM JL, 1985, MOL CELL BIOL, V5, P3410, DOI 10.1128/MCB.5.12.3410; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Rabol R, 2009, METABOLISM, V58, P1145, DOI 10.1016/j.metabol.2009.03.014; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; SCHNEIDER JC, 1991, MOL CELL BIOL, V11, P4934, DOI 10.1128/MCB.11.10.4934; Smith D. W., 1970, STRUCT BOND, V7, P1, DOI 10.1007/BFb0118898; TAGER JM, 1983, FEBS LETT, V151, P1, DOI 10.1016/0014-5793(83)80330-5; THORSNESS M, 1989, MOL CELL BIOL, V9, P5702, DOI 10.1128/MCB.9.12.5702; TRAWICK JD, 1989, J BIOL CHEM, V264, P7005; VANGELDER BF, 1962, BIOCHIM BIOPHYS ACTA, V58, P593, DOI 10.1016/0006-3002(62)90073-2; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; WANG L, 1995, GENE, V158, P163, DOI 10.1016/0378-1119(95)00126-Q; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoboue Edgar D, 2012, Int J Cell Biol, V2012, P403870, DOI 10.1155/2012/403870; Yoboue ED, 2012, J BIOL CHEM, V287, P14569, DOI 10.1074/jbc.M111.302786; Zhang TT, 2017, J BIOL CHEM, V292, P16942, DOI 10.1074/jbc.M117.790923	58	6	6	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5095	5109		10.1074/jbc.RA120.012739	http://dx.doi.org/10.1074/jbc.RA120.012739			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32075909	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000526887000029
J	Lusnig, L; Radach, R; Mueller, CJ; Hofmann, MJ				Lusnig, Larissa; Radach, Ralph; Mueller, Christina J.; Hofmann, Markus J.			Zen meditation neutralizes emotional evaluation, but not implicit affective processing of words	PLOS ONE			English	Article							FREQUENCY; ATTENTION; INTERFERENCE; DEPENDENCE; RESPONSES; AROUSAL	There is ample evidence that meditation can regulate emotions. It is questionable, however, whether meditation can down-regulate sensitivity to emotional experience in high-level cognitive representations such as words. The present study shows that adept Zen meditators rated the emotional valence of (low-arousal) positive and (high- and low-arousal) negative nouns significantly more neutral after a meditation session, while there was no change of valence ratings after a comparison intervention in the comparison group. Because the Zen group provided greater "openness to experience" and lower,need for achievement and performance" in the "Big Five" personality assessment, we used these scores as covariates for all analyses. We found no differential emotion effects of Zen meditation during lexical decision, but we replicated the slow-down of low-arousal negative words during lexical decision in both groups. Interestingly, Zen meditation elicited a global facilitation of all response times, which we discuss in terms of increased attentional resources after meditation.	[Lusnig, Larissa; Radach, Ralph; Hofmann, Markus J.] Univ Wuppertal, Dept Psychol, Wuppertal, Germany; [Mueller, Christina J.] Int Psychoanalyt Univ, Methods & Evaluat, Berlin, Germany	University of Wuppertal	Lusnig, L (corresponding author), Univ Wuppertal, Dept Psychol, Wuppertal, Germany.	larissa.lusnig@uni-wuppertal.de			Deutsche Forschungsgemeinschaft [HO 5139/2-2]; Evangelisches Studienwerk e.V.	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Evangelisches Studienwerk e.V.	This work was partly supported by a grant of the Deutsche Forschungsgemeinschaft to MH (HO 5139/2-2) and by a doctoral studies grant of the Evangelisches Studienwerk e.V. to LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BALDWIN MW, 1993, PERS SOC PSYCHOL B, V19, P746, DOI 10.1177/0146167293196010; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bielefeldt C., 1988, DOGENS MANUALS ZEN M; Brefczynski-Lewis JA, 2007, P NATL ACAD SCI USA, V104, P11483, DOI 10.1073/pnas.0606552104; Brickenkamp R., 2015, D2 R TEST ATTENTION; Brysbaert M, 2011, EXP PSYCHOL, V58, P412, DOI 10.1027/1618-3169/a000123; Carter OL, 2005, CURR BIOL, V15, pR412, DOI 10.1016/j.cub.2005.05.043; Chan D, 2007, J ALTERN COMPLEM MED, V13, P651, DOI 10.1089/acm.2007.7022; Chau Bolton K H, 2018, Brain Neurosci Adv, V2, p2398212818771822, DOI 10.1177/2398212818771822; Chiesa A, 2011, J CLIN PSYCHOL, V67, P404, DOI 10.1002/jclp.20776; Citron FMM, 2012, BRAIN LANG, V122, P211, DOI 10.1016/j.bandl.2011.12.007; Corcoran KA, 2005, J NEUROSCI, V25, P8978, DOI 10.1523/JNEUROSCI.2246-05.2005; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Desbordes G, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00292; Fox KCR, 2014, NEUROSCI BIOBEHAV R, V43, P48, DOI 10.1016/j.neubiorev.2014.03.016; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Grecucci A, 2015, BIO MED RES; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Hofmann MJ, 2007, BEHAV RES METHODS, V39, P620, DOI 10.3758/BF03193034; Hofmann MJ, 2009, COGN AFFECT BEHAV NE, V9, P389, DOI 10.3758/9.4.389; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Jacobs AM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00714; Kanske P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030086; Kapleau P, 1965, 3 PILLARS ZEN TEACHI; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Kok BE, 2017, MINDFULNESS, V8, P218, DOI 10.1007/s12671-016-0594-9; Kuchinke L, 2007, INT J PSYCHOPHYSIOL, V65, P132, DOI 10.1016/j.ijpsycho.2007.04.004; Kuperman V, 2014, J EXP PSYCHOL GEN, V143, P1065, DOI 10.1037/a0035669; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lehrl S., 2005, MANUAL ZUM MWT B; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; MEYER DE, 1971, J EXP PSYCHOL, V90, P227, DOI 10.1037/h0031564; Mueller CJ, 2016, COGN AFFECT BEHAV NE, V16, P489, DOI 10.3758/s13415-016-0408-5; New B, 2006, PSYCHON B REV, V13, P45, DOI 10.3758/BF03193811; Ortner CNM, 2007, MOTIV EMOTION, V31, P271, DOI 10.1007/s11031-007-9076-7; Pagnoni G, 2007, NEUROBIOL AGING, V28, P1623, DOI 10.1016/j.neurobiolaging.2007.06.008; Pagnoni G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003083; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; RUBENSTEIN H, 1970, J VERB LEARN VERB BE, V9, P487, DOI 10.1016/S0022-5371(70)80091-3; Satow L., 2011, ZENTRUM PSYCHOL INFO; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Schacht A, 2009, COGN AFFECT BEHAV NE, V9, P28, DOI 10.3758/CABN.9.1.28; Siegle GJ, 2002, COGNITIVE THER RES, V26, P73, DOI 10.1023/A:1013893705009; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Sobolewski A, 2011, NEUROSCI RES, V71, P44, DOI 10.1016/j.neures.2011.06.002; Suzuki S., 1970, ZEN MIND BEGINNERS M; Tang YY, 2007, P NATL ACAD SCI USA, V104, P17152, DOI 10.1073/pnas.0707678104; Tang YY, 2015, NAT REV NEUROSCI, V16, P213, DOI 10.1038/nrn3916; Tasioulis S, 2007, UNSERE ERDE FILM; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Waddell N., 1996, ZEN WORDS HEART HAKU	52	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0229310	10.1371/journal.pone.0229310	http://dx.doi.org/10.1371/journal.pone.0229310			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8AS	32074130	gold, Green Published			2022-12-26	WOS:000535220600039
J	Guerraty, MA; Rao, HS; Anjan, VY; Szapary, H; Mankoff, DA; Pryma, DA; Rader, DJ; Dubroff, JG				Guerraty, Marie A.; Rao, H. Shanker; Anjan, Venkatesh Y.; Szapary, Hannah; Mankoff, David A.; Pryma, Daniel A.; Rader, Daniel J.; Dubroff, Jacob G.			The role of resting myocardial blood flow and myocardial blood flow reserve as a predictor of major adverse cardiovascular outcomes	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CORONARY MICROVASCULAR DYSFUNCTION; PROGNOSTIC VALUE; RB-82 PET; HEART-FAILURE; PERFUSION; QUANTIFICATION; ASSOCIATION; ISCHEMIA; DISEASE	Cardiac perfusion PET is increasingly used to assess ischemia and cardiovascular risk and can also provide quantitative myocardial blood flow (MBF) and flow reserve (MBFR) values. These have been shown to be prognostic biomarkers of adverse outcomes, yet MBF and MBFR quantification remains underutilized in clinical settings. We compare MBFR to traditional cardiovascular risk factors in a large and diverse clinical population (60% African-American, 35.3% Caucasian) to rank its relative contribution to cardiovascular outcomes. Major adverse cardiovascular events (MACE), including unstable angina, non-ST and ST-elevation myocardial infarction, stroke, and death, were assessed for consecutive patients who underwent rest-dipyridamole stress 82Rb PET cardiac imaging from 2012-2015 at the Hospital of the University of Pennsylvania (n = 1283, mean follow-up 2.3 years). Resting MBF (1.1 +/- 0.4 ml/min/g) was associated with adverse cardiovascular outcomes. MBFR (2.1 +/- 0.8) was independently and inversely associated with MACE. Furthermore, MBFR was more strongly associated with MACE than both traditional cardiovascular risk factors and the presence of perfusion defects in regression analysis. Decision tree analysis identified MBFR as superior to established cardiovascular risk factors in predicting outcomes. Incorporating resting MBF and MBFR in CAD assessment may improve clinical decision making.	[Guerraty, Marie A.] Univ Penn, Dept Med, Div Cardiovasc Med, Philadelphia, PA 19104 USA; [Rao, H. Shanker; Szapary, Hannah; Rader, Daniel J.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Anjan, Venkatesh Y.] Prairie Cardiovasc, Belleville, IL USA; [Mankoff, David A.; Pryma, Daniel A.; Dubroff, Jacob G.] Univ Penn, Dept Radiol, Div Nucl Med & Mol Imaging, Philadelphia, PA 19104 USA; [Rader, Daniel J.] Univ Penn, Dept Med, Div Translat Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Guerraty, MA (corresponding author), Univ Penn, Dept Med, Div Cardiovasc Med, Philadelphia, PA 19104 USA.	Marie.guerraty@pennmedicine.upenn.edu		Guerraty, Marie/0000-0002-0766-1253	National Institutes of Health [NIH T32HL007843, 1K08HL136890-01]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	MG was supported NIH T32HL007843 and 1K08HL136890-01 from the National Institutes of Health (www.nih.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baller D, 1999, CIRCULATION, V99, P2871, DOI 10.1161/01.CIR.99.22.2871; Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889; Chow BJW, 2014, JACC-CARDIOVASC IMAG, V7, P278, DOI 10.1016/j.jcmg.2013.12.008; Farhad H, 2013, EUR HEART J-CARD IMG, V14, P1203, DOI 10.1093/ehjci/jet068; Frank F., 2016, DATA MINING PRACTICA; Fukushima K, 2011, J NUCL MED, V52, P726, DOI 10.2967/jnumed.110.081828; Gerber BL, 1998, J NUCL MED, V39, P1655; Gibson CM, 1996, CIRCULATION, V93, P879, DOI 10.1161/01.CIR.93.5.879; Grzymala-Busse JW, 2013, ENTROPY-SWITZ, V15, P1486, DOI 10.3390/e15051486; Herzog BA, 2009, J AM COLL CARDIOL, V54, P150, DOI 10.1016/j.jacc.2009.02.069; HOUGHTON JL, 1994, J AM COLL CARDIOL, V23, P1123, DOI 10.1016/0735-1097(94)90600-9; Kajander SA, 2011, CIRC-CARDIOVASC IMAG, V4, P678, DOI 10.1161/CIRCIMAGING.110.960732; Kato S, 2017, J AM COLL CARDIOL, V70, P869, DOI 10.1016/j.jacc.2017.06.028; Kobayashi Y, 2015, JACC-CARDIOVASC INTE, V8, P1433, DOI 10.1016/j.jcin.2015.03.045; Lautamaki R, 2009, EUR J NUCL MED MOL I, V36, P576, DOI 10.1007/s00259-008-0972-1; Lortie M, 2007, EUR J NUCL MED MOL I, V34, P1765, DOI 10.1007/s00259-007-0478-2; Maddahi J, 2014, SEMIN NUCL MED, V44, P333, DOI 10.1053/j.semnuclmed.2014.06.011; Majmudar MD, 2015, EUR HEART J-CARD IMG, V16, P900, DOI 10.1093/ehjci/jev012; Mc Ardle BA, 2012, J AM COLL CARDIOL, V60, P1828, DOI 10.1016/j.jacc.2012.07.038; Merz CNB, 2017, CIRCULATION, V135, P1075, DOI 10.1161/CIRCULATIONAHA.116.024534; Mohammed SF, 2015, CIRCULATION, V131, P550, DOI 10.1161/CIRCULATIONAHA.114.009625; Murthy VL, 2014, J NUCL MED, V55, P1952, DOI 10.2967/jnumed.114.145342; Murthy VL, 2014, CIRCULATION, V129, P2518, DOI 10.1161/CIRCULATIONAHA.113.008507; Murthy VL, 2012, CIRCULATION, V126, P1858, DOI 10.1161/CIRCULATIONAHA.112.120402; Murthy VL, 2011, CIRCULATION, V124, P2215, DOI 10.1161/CIRCULATIONAHA.111.050427; Nesterov SV, 2014, JACC-CARDIOVASC IMAG, V7, P1119, DOI 10.1016/j.jcmg.2014.08.003; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Pan XB, VALIDATION SYNGO PET; Petretta M, 2008, J NUCL CARDIOL, V15, P456, DOI 10.1016/j.nuclcard.2008.03.008; Schiattarella GG, 2019, NATURE, V568, P351, DOI 10.1038/s41586-019-1100-z; Shah NR, 2016, J AM SOC NEPHROL, V27, P1823, DOI 10.1681/ASN.2015030301; Team RC, 2014, R LANG ENV STAT COMP; Therneau T., 2015, PACKAGE SURVIVAL ANA; Valenta I, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-012-0344-0	34	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228931	10.1371/journal.pone.0228931	http://dx.doi.org/10.1371/journal.pone.0228931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053688	Green Published, gold			2022-12-26	WOS:000535198700075
J	Mitobe, J; Nishiumi, F; Yanagihara, I; Yamamoto, S; Ohnishi, M				Mitobe, Jiro; Nishiumi, Fumiko; Yanagihara, Itaru; Yamamoto, Shouji; Ohnishi, Makoto			Superstructure formation by RodZ hexamers of Shigella sonnei maintains the rod shape of bacilli	PLOS ONE			English	Article							ESCHERICHIA-COLI; CELL-SHAPE; GENE-EXPRESSION; MRE-GENES; BACTERIAL; MICROSCOPY; FILAMENTS	The rod shape of bacilli is maintained by bacterial cytoskeletal protein MreB, an actin homolog that acts in concert with the inner membrane protein RodZ. We previously reported RodZ binds RNA to control the posttranscriptional regulation of invE (virB), which controls the type III secretion system essential for the virulence of Shigella. Here, we show that purified RodZ forms "superstructures" of high molecular mass that dissociate into a midsized "basal complex" in the presence of nonionic detergent, or to a monomer in the presence of dithiothreitol. We used mass spectrometry to show that the basal complex was a hexamer. Electrophoresis mobility shift assays combined with gel filtration detected the RNA-binding activity in fractions containing molecules larger than the basal hexamer. The superstructure was consistently detected with MreB in crude cell lysates of S. sonnei that were fractionated using gel filtration. Immunofluorescence microscopy using two different super-resolution settings showed that wild-type RodZ was distributed in cells as separate dots. Consistent with the superstructure comprising homohexamers, majority of the dots distributed among areas of discrete values. In addition, simultaneous immunodetection of MreB provided the first evidence of colocalization with RodZ as larger patch like signals. These findings indicate that native RodZ forms clusters of various sizes, which may correspond to a superstructure comprising multiple hexamers required for the RNA-binding activity.	[Mitobe, Jiro; Yamamoto, Shouji; Ohnishi, Makoto] Natl Inst Infect Dis, Dept Bacteriol 1, Shinjuku Ku, Tokyo, Japan; [Nishiumi, Fumiko; Yanagihara, Itaru] Osaka Womens & Childrens Hosp, Res Inst, Dept Dev Med, Izumi Ku, Osaka, Japan	National Institute of Infectious Diseases (NIID)	Mitobe, J (corresponding author), Natl Inst Infect Dis, Dept Bacteriol 1, Shinjuku Ku, Tokyo, Japan.	jmitobe@nih.go.jp			JSPS KAKENHI - AMED [26440014, 19K07569, 17H04237, 17K10201, JP18fk0108049]; Nakatani Foundation for Advanced of Measuring Technologies in Biomedical Engineering, Japan [JP18jk021007]	JSPS KAKENHI - AMED; Nakatani Foundation for Advanced of Measuring Technologies in Biomedical Engineering, Japan	This research was supported by JSPS KAKENHI (26440014, 19K07569 17H04237, 17K10201), supported by AMED grant number JP18fk0108049 and in part by grant number JP18jk021007, supported by Grant Program for Biomedical Engineering Research from Nakatani Foundation for Advanced of Measuring Technologies in Biomedical Engineering, Japan.	Alyahya SA, 2009, P NATL ACAD SCI USA, V106, P1239, DOI 10.1073/pnas.0810794106; Bendezu FO, 2009, EMBO J, V28, P193, DOI 10.1038/emboj.2008.264; Bich C, 2010, ANAL CHEM, V82, P172, DOI 10.1021/ac901651r; Bratton BP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05186-5; Colavin A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03633-x; Eun YJ, 2015, J BIOL CHEM, V290, P17181, DOI 10.1074/jbc.R115.637876; Fink G, 2016, CELL, V166, P522, DOI 10.1016/j.cell.2016.06.057; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hayashi S, 2015, MOL BIOL CELL, V26, P1743, DOI 10.1091/mbc.E14-08-1287; Ikebe R, 2018, GENES CELLS, V23, P307, DOI 10.1111/gtc.12572; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/NMETH.1324, 10.1038/nmeth.1324]; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Levin PA, 2002, METHOD MICROBIOL, V31, P115, DOI 10.1016/S0580-9517(02)31007-9; MAURELLI AT, 1984, INFECT IMMUN, V43, P195, DOI 10.1128/IAI.43.1.195-201.1984; Mitobe J, 2005, J BACTERIOL, V187, P107, DOI 10.1128/JB.187.1.107-113.2005; Mitobe J, 2008, J BIOL CHEM, V283, P5738, DOI 10.1074/jbc.M710108200; Mitobe J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005728; Mitobe J, 2011, EMBO REP, V12, P911, DOI 10.1038/embor.2011.132; Mitobe J, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-110; MITTAL KL, 1972, J PHARM SCI, V61, P1334, DOI 10.1002/jps.2600610842; PORTER ME, 1994, J BACTERIOL, V176, P4187, DOI 10.1128/JB.176.13.4187-4191.1994; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Shi HD, 2018, CELL, V172, P1294, DOI 10.1016/j.cell.2018.02.050; Shiomi D, 2013, MOL MICROBIOL, V87, P1029, DOI 10.1111/mmi.12148; Shiomi D, 2008, EMBO J, V27, P3081, DOI 10.1038/emboj.2008.234; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Swulius MT, 2011, BIOCHEM BIOPH RES CO, V407, P650, DOI 10.1016/j.bbrc.2011.03.062; van den Beld MJC, 2012, EUR J CLIN MICROBIOL, V31, P899, DOI 10.1007/s10096-011-1395-7; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; WACHI M, 1987, J BACTERIOL, V169, P4935, DOI 10.1128/jb.169.11.4935-4940.1987; WACHI M, 1989, J BACTERIOL, V171, P6511, DOI 10.1128/jb.171.12.6511-6516.1989	33	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228052	10.1371/journal.pone.0228052	http://dx.doi.org/10.1371/journal.pone.0228052			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053625	gold, Green Published			2022-12-26	WOS:000535198700016
J	Antalova, Z; Blesa, D; Martinek, P; Matusinsky, P				Antalova, Zuzana; Blesa, Dominik; Martinek, Petr; Matusinsky, Pavel			Transcriptional analysis of wheat seedlings inoculated with Fusarium culmorum under continual exposure to disease defence inductors	PLOS ONE			English	Article							HEAD BLIGHT RESISTANCE; GIBBERELLA-ZEAE; BARLEY; GENE; INFECTION; SPIKES; SYNTHASE; IODINE; GROWTH; FHB1	A facultative parasite of cereals, Fusarium culmorum is a soil-, air- and seed-borne fungus causing foot and root rot, fusarium seedling blight, and especially Fusarium head blight, a spike disease leading to decreased yield and mycotoxin contamination of grain. In the present study, we tested changes in expression of wheat genes (B2H2, ICS, PAL, and PR2) involved in defence against diseases. We first compared expression of the analysed genes in seedlings of non-inoculated and artificially inoculated wheat (variety Bohemia). The second part of the experiment compared expression of these genes in seedlings grown under various treatment conditions. These treatments were chosen to determine the effects of prochloraz, sodium bicarbonate, ergosterol, aescin and potassium iodide on expression of the analysed defence genes. In addition to the inoculated and non-inoculated cultivar Bohemia, we additionally examined two other varieties of wheat with contrasting resistance to Fusarium sp. infection. These were the blue aleurone layer variety Scorpion that is susceptible to Fusarium sp. infection and variety V2-49-17 with yellow endosperm and partial resistance to Fusarium sp. infection. In this manner, we were able to compare potential effects of inductors upon defence gene expression among three varieties with different susceptibility to infection but also between inoculated and non-inoculated seedlings of a single variety. The lowest infection levels were detected in the sodium bicarbonate treatment. Sodium bicarbonate had not only negative influence on Fusarium growth but also positively affected expression of plant defence genes. Expression of the four marker genes shown to be important in plant defence was significantly affected by the treatments. The greatest upregulation in comparison to the water control was identified under all treatments for the B2H2 gene. Only expression of PAL under the ergosterol and prochloraz treatments were not statistically significant.	[Antalova, Zuzana; Martinek, Petr] Agrotest Fyto Ltd, Dept Plant Breeding & Genet, Kromeriz, Czech Republic; [Antalova, Zuzana] Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Olomouc, Czech Republic; [Blesa, Dominik; Matusinsky, Pavel] Agrotest Fyto Ltd, Dept Plant Pathol, Kromeriz, Czech Republic; [Blesa, Dominik] Masaryk Univ, Fac Sci, Dept Expt Biol, Brno, Czech Republic; [Matusinsky, Pavel] Palacky Univ Olomouc, Fac Sci, Dept Bot, Olomouc, Czech Republic	Agricultural Research Institute Kromeriz, Ltd; Agrotest Fyto; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Agricultural Research Institute Kromeriz, Ltd; Agrotest Fyto; Masaryk University Brno; Palacky University Olomouc	Matusinsky, P (corresponding author), Agrotest Fyto Ltd, Dept Plant Pathol, Kromeriz, Czech Republic.; Matusinsky, P (corresponding author), Palacky Univ Olomouc, Fac Sci, Dept Bot, Olomouc, Czech Republic.	matusinsky@vukrom.cz		Blesa, Dominik/0000-0003-1813-0981; Matusinsky, Pavel/0000-0002-9095-3934	Ministry of Agriculture of the Czech Republic [QK1910343]; MZE [RO1118]; Internal Grant of Palacky University [IGA_PrF_2020_003]; Agrotest Fyto, Ltd	Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic); MZE; Internal Grant of Palacky University; Agrotest Fyto, Ltd	This work and ZA, DB, PeM and PaM have been supported by the Ministry of Agriculture of the Czech Republic (project no. MZE RO1118). PaM have been supported by the Ministry of Agriculture of the Czech Republic (project no. QK1910197) and Internal Grant of Palacky University (project no. IGA_PrF_2020_003). PeM have been supported by the Ministry of Agriculture of the Czech Republic (project no. QK1910343). The funder Agrotest Fyto, Ltd provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Bliffeld M, 1999, THEOR APPL GENET, V98, P1079, DOI 10.1007/s001220051170; Brenchley WE, 1924, ANN APPL BIOL, V11, P86, DOI 10.1111/j.1744-7348.1924.tb05695.x; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Cardoza RE, 2015, APPL ENVIRON MICROB, V81, P6355, DOI 10.1128/AEM.01626-15; Chakraborty N, 2017, PHYSIOL MOL BIOL PLA, V23, P581, DOI 10.1007/s12298-017-0450-y; Cuthbert PA, 2006, THEOR APPL GENET, V112, P1465, DOI 10.1007/s00122-006-0249-7; D'Angelo DL, 2014, PLANT DIS, V98, P1387, DOI 10.1094/PDIS-01-14-0091-RE; Duba A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041138; Duborska E, 2018, ARCH AGRON SOIL SCI, V64, P46, DOI 10.1080/03650340.2017.1328104; Fahmy A. H., 2018, Journal of Applied Biology & Biotechnology, V6, P31, DOI 10.7324/JABB.2018.60206; Gao CS, 2013, PLANT PATHOL, V62, P383, DOI 10.1111/j.1365-3059.2012.02656.x; Hang YD, 2003, LEBENSM-WISS TECHNOL, V36, P803, DOI 10.1016/S0023-6438(03)00095-1; Hao JF, 2018, PLANT SCI, V271, P133, DOI 10.1016/j.plantsci.2018.03.016; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Jorgensen LN, 2012, ACTA AGR SCAND B-S P, V62, P431, DOI 10.1080/09064710.2011.641028; Kage U, 2017, PLANT BIOTECHNOL J, V15, P447, DOI 10.1111/pbi.12641; Kang ZS, 2008, EUR J PLANT PATHOL, V120, P383, DOI 10.1007/s10658-007-9230-9; Khan MR, 2006, PHYTOPATHOLOGY, V96, P386, DOI 10.1094/PHYTO-96-0386; Kong L, 2005, GENOME, V48, P29, DOI 10.1139/G04-097; LI HH, 2011, PLOS ONE, V6, DOI DOI 10.1371/JOURNAL.PONE.0019008; Li WL, 2001, THEOR APPL GENET, V102, P353, DOI 10.1007/s001220051653; Matusinsky P., 2013, Journal of Food, Agriculture & Environment, V11, P1114; Merhej J, 2010, FOOD ADDIT CONTAM A, V27, P710, DOI 10.1080/19440040903514531; Merhej J, 2012, MOL PLANT PATHOL, V13, P363, DOI 10.1111/j.1364-3703.2011.00755.x; Merhej J, 2011, FUNGAL GENET BIOL, V48, P275, DOI 10.1016/j.fgb.2010.11.008; Oldach KH, 2001, MOL PLANT MICROBE IN, V14, P832, DOI 10.1094/MPMI.2001.14.7.832; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Pereyra SA, 2004, PLANT DIS, V88, P724, DOI 10.1094/PDIS.2004.88.7.724; Pritsch C, 2000, MOL PLANT MICROBE IN, V13, P159, DOI 10.1094/MPMI.2000.13.2.159; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Rawat N, 2016, NAT GENET, V48, P1576, DOI 10.1038/ng.3706; Selitrennikoff CP, 2001, APPL ENVIRON MICROB, V67, P2883, DOI 10.1128/AEM.67.7.2883-2894.2001; Shin SY, 2008, J EXP BOT, V59, P2371, DOI 10.1093/jxb/ern103; Sun H, 2014, NEW PHYTOL, V204, P682, DOI 10.1111/nph.12948; Travella S, 2006, PLANT PHYSIOL, V142, P6, DOI 10.1104/pp.106.084517; Tugizimana F, 2012, MOLECULES, V17, P1698, DOI 10.3390/molecules17021698; UMALY RC, 1971, ANN BOT-LONDON, V35, P127, DOI 10.1093/oxfordjournals.aob.a084451; Wagacha JM, 2007, CROP PROT, V26, P877, DOI 10.1016/j.cropro.2006.09.003; Wiesel L, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00655; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; WONG LSL, 1992, CAN J PLANT PATHOL, V14, P233, DOI 10.1080/07060669209500882; Zaker M., 2014, International Journal of Agriculture and Crop Sciences (IJACS), V7, P1352	43	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0224413	10.1371/journal.pone.0224413	http://dx.doi.org/10.1371/journal.pone.0224413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045412	Green Published, Green Submitted, gold			2022-12-26	WOS:000534633200003
J	Liu, XQ; Liang, B; Liu, X; Amaro-Carambot, E; Surman, S; Kwong, PD; Graham, BS; Collins, PL; Munir, S				Liu, Xueqiao; Liang, Bo; Liu, Xiang; Amaro-Carambot, Emerito; Surman, Sonja; Kwong, Peter D.; Graham, Barney S.; Collins, Peter L.; Munir, Shirin			Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates	PLOS ONE			English	Article							HEMAGGLUTININ-NEURAMINIDASE; RSV F; LIVE; GLYCOPROTEIN; ATTENUATION; BOVINE; IMMUNOGENICITY; IMMUNIZATION; CHALLENGE; MUTATIONS	Human respiratory syncytial virus (RSV) and parainfluenza virus type 3 (HPIV3) are among the most common viral causes of childhood bronchiolitis and pneumonia world-wide, and lack effective antiviral drugs or vaccines. Recombinant (r) HPIV3 was modified to express the RSV fusion (F) glycoprotein, the major RSV neutralization and protective antigen, providing a live intranasal bivalent HPIV3/RSV vaccine candidate. This extends previous studies using a chimeric bovine-human PIV3 vector (rB/HPIV3). One advantage is that rHPIV3 expresses all of the HPIV3 antigens compared to only two for rB/HPIV3. In addition, the use of rHPIV3 as vector should avoid excessive attenuation following addition of the modified RSV F gene, which may occur with rB/HPIV3. To enhance its immunogenicity, RSV F was modified (i) to increase the stability of the prefusion (pre-F) conformation and (ii) by replacement of its transmembrane ( TM) and cytoplasmic tail (CT) domains with those of HPIV3 F (H3TMCT) to increase incorporation in the vector virion. RSV F (+/- H3TMCT) was expressed from the first (F/preN) or the second (F/N-P) gene position of rHPIV3. The H3TMCT modification dramatically increased packaging of RSV F into the vector virion and, in hamsters, resulted in significant increases in the titer of high-quality serum RSV-neutralizing antibodies, in addition to the increase conferred by pre-F stabilization. Only F-H3TMCT/preN replication was significantly attenuated in the nasal turbinates by the RSV F insert. F-H3TMCT/preN, F/ N-P, and F-H3TMCT/N-P provided complete protection against wt RSV challenge. F-H3TMCT/N-P exhibited the most stable and highest expression of RSV F, providing impetus for its further development.	[Liu, Xueqiao; Liang, Bo; Liu, Xiang; Amaro-Carambot, Emerito; Surman, Sonja; Collins, Peter L.; Munir, Shirin] NIAID, RNA Viruses Sect, Lab Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Kwong, Peter D.; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Munir, S (corresponding author), NIAID, RNA Viruses Sect, Lab Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	munirs@niaid.nih.gov	Munir, Shirin/AAA-7943-2021	Munir, Shirin/0000-0002-8493-0728; LIU, XUEQIAO/0000-0001-7652-241X	Intramural Research Program of the NIAID/NIH; Sanofi Pasteur Inc. through a Cooperative Research and Development Agreement (CRADA); NIAID	Intramural Research Program of the NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sanofi Pasteur Inc. through a Cooperative Research and Development Agreement (CRADA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the NIAID/NIH and by Sanofi Pasteur Inc. through a Cooperative Research and Development Agreement (CRADA) with NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso CL, 2016, ARCH VIROL, V161, P2351, DOI 10.1007/s00705-016-2880-1; BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; Bernstein DI, 2012, PEDIATR INFECT DIS J, V31, P109, DOI 10.1097/INF.0b013e31823386f1; CLEMENTS ML, 1991, J CLIN MICROBIOL, V29, P1175, DOI 10.1128/JCM.29.6.1175-1182.1991; CLEMONS DJ, 1992, LAB ANIM SCI, V42, P307; COATES HV, 1966, AM J EPIDEMIOL, V83, P299, DOI 10.1093/oxfordjournals.aje.a120586; Collins P.L., 2013, FIELDS VIROLOGY, P1086; Durbin AP, 1997, VIROLOGY, V235, P323, DOI 10.1006/viro.1997.8697; Karron RA, 1996, PEDIATR INFECT DIS J, V15, P650, DOI 10.1097/00006454-199608000-00003; Karron RA, 2013, FIELDS VIROLOGY, P996; Karron RA, 2012, VACCINE, V30, P3975, DOI 10.1016/j.vaccine.2011.12.022; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Liang B, 2019, J VIROL, V93, DOI 10.1128/JVI.02043-18; Liang B, 2017, J VIROL, V91, DOI 10.1128/JVI.00189-17; Liang B, 2016, J VIROL, V90, P10022, DOI 10.1128/JVI.01196-16; Liang B, 2015, J VIROL, V89, P9499, DOI 10.1128/JVI.01373-15; Liang B, 2014, J VIROL, V88, P4237, DOI 10.1128/JVI.03481-13; Liljeroos L, 2013, P NATL ACAD SCI USA, V110, P11133, DOI 10.1073/pnas.1309070110; Liu X, 2017, J VIROL, V91, DOI 10.1128/JVI.01101-17; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mackow N, 2015, J VIROL, V89, P10319, DOI 10.1128/JVI.01380-15; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; MOSCONA A, 1993, J VIROL, V67, P6463, DOI 10.1128/JVI.67.11.6463-6468.1993; Munir S, 2008, J VIROL, V82, P8780, DOI 10.1128/JVI.00630-08; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241; Ottolini MG, 2000, VIRAL IMMUNOL, V13, P231, DOI 10.1089/vim.2000.13.231; Porotto M, 2007, J VIROL, V81, P3216, DOI 10.1128/JVI.02617-06; Skiadopoulos MH, 1999, VIROLOGY, V260, P125, DOI 10.1006/viro.1999.9802; Skiadopoulos MH, 1998, J VIROL, V72, P1762, DOI 10.1128/JVI.72.3.1762-1768.1998; Skiadopoulos MH, 1999, J VIROL, V73, P1374, DOI 10.1128/JVI.73.2.1374-1381.1999; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Tao T, 2000, J VIROL, V74, P6448, DOI 10.1128/JVI.74.14.6448-6458.2000; Whitehead SS, 1998, J VIROL, V72, P4467, DOI 10.1128/JVI.72.5.4467-4471.1998; Yang CF, 2013, VACCINE, V31, P2822, DOI 10.1016/j.vaccine.2013.04.006	36	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228572	10.1371/journal.pone.0228572	http://dx.doi.org/10.1371/journal.pone.0228572			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045432	Green Published, gold, Green Submitted			2022-12-26	WOS:000534633200021
J	Bharadwaj, VS; Knott, BC; Stahlberg, J; Beckham, GT; Crowley, MF				Bharadwaj, Vivek S.; Knott, Brandon C.; Stahlberg, Jerry; Beckham, Gregg T.; Crowley, Michael F.			The hydrolysis mechanism of a GH45 cellulase and its potential relation to lytic transglycosylase and expansin function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; cellulase; molecular dynamics; enzyme mechanism; cellulose; expansins; GH45; lytic transglycosylases; QM; MM; transition path sampling	MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; CELL-WALL; PEPTIDOGLYCAN BINDING; HUMICOLA INSOLENS; ENDOGLUCANASE V; CELLOBIOHYDROLASE; CHARMM; SIMULATIONS; SUBSTRATE	Family 45 glycoside hydrolases (GH45) are endoglucanases that are integral to cellulolytic secretomes, and their ability to break down cellulose has been successfully exploited in textile and detergent industries. In addition to their industrial relevance, understanding the molecular mechanism of GH45-catalyzed hydrolysis is of fundamental importance because of their structural similarity to cell wall?modifying enzymes such as bacterial lytic transglycosylases (LTs) and expansins present in bacteria, plants, and fungi. Our understanding of the catalytic itinerary of GH45s has been incomplete because a crystal structure with substrate spanning the ?1 to +1 subsites is currently lacking. Here we constructed and validated a putative Michaelis complex in silico and used it to elucidate the hydrolytic mechanism in a GH45, Cel45A from the fungus Humicola insolens, via unbiased simulation approaches. These molecular simulations revealed that the solvent-exposed active-site architecture results in lack of coordination for the hydroxymethyl group of the substrate at the ?1 subsite. This lack of coordination imparted mobility to the hydroxymethyl group and enabled a crucial hydrogen bond with the catalytic acid during and after the reaction. This suggests the possibility of a nonhydrolytic reaction mechanism when the catalytic base aspartic acid is missing, as is the case in some LTs (murein transglycosylase A) and expansins. We calculated reaction free energies and demonstrate the thermodynamic feasibility of the hydrolytic and nonhydrolytic reaction mechanisms. Our results provide molecular insights into the hydrolysis mechanism in HiCel45A, with possible implications for elucidating the elusive catalytic mechanism in LTs and expansins.	[Bharadwaj, Vivek S.; Knott, Brandon C.; Crowley, Michael F.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Stahlberg, Jerry] Swedish Univ Agr Sci, Dept Mol Sci, POB 7015, S-75007 Uppsala, Sweden	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Swedish University of Agricultural Sciences	Crowley, MF (corresponding author), Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA.; Beckham, GT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA.	gregg.beckham@nrel.gov; michael.crowley@nrel.gov	; Stahlberg, Jerry/D-4163-2013	Bharadwaj, Vivek/0000-0001-5851-9807; Knott, Brandon/0000-0003-3414-3897; Stahlberg, Jerry/0000-0003-4059-8580; Hart, Gerald/0000-0001-7812-4351	Department of Energy [DE-AC36-08GO28308]; Department of Energy Office of Energy Efficiency and Renewable Energy [DE-AC36-08GO28308]	Department of Energy(United States Department of Energy (DOE)); Department of Energy Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE))	This work was authored in part by the Alliance for Sustainable Energy, LLC, the manager and operator of the National Renewable Energy Laboratory for the Department of Energy under Contract DE-AC36-08GO28308. We are also grateful for access to and use of National Renewable Energy Laboratory Computational Sciences resources (Peregrine and Eagle), supported by the Department of Energy Office of Energy Efficiency and Renewable Energy under Contract DE-AC36-08GO28308.	Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Ardevol A, 2015, J AM CHEM SOC, V137, P7528, DOI 10.1021/jacs.5b01156; Barnett CB, 2011, J AM CHEM SOC, V133, P19474, DOI 10.1021/ja206842j; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Biarnes X, 2011, J AM CHEM SOC, V133, P20301, DOI 10.1021/ja207113e; Blackburn NT, 2002, BIOCHEMISTRY-US, V41, P1001, DOI 10.1021/bi011833k; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Burgin T, 2019, REACT CHEM ENG, V4, P402, DOI 10.1039/c8re00240a; Byun B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22527-y; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Case D., 2017, AMBER 16 AMBERTOOLS1; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Crowley MF, 2009, INT J QUANTUM CHEM, V109, P3767, DOI 10.1002/qua.22372; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 2012, ACCOUNTS CHEM RES, V45, P308, DOI 10.1021/ar2001765; Davies GJ, 1996, ACTA CRYSTALLOGR D, V52, P7, DOI 10.1107/S0907444995009280; Davies GJ, 1995, BIOCHEMISTRY-US, V34, P16210, DOI 10.1021/bi00049a037; Elstner M, 1998, PHYS REV B, V58, P7260, DOI 10.1103/PhysRevB.58.7260; Fibriansah G, 2012, BIOCHEMISTRY-US, V51, P9164, DOI 10.1021/bi300900t; Georgelis N, 2012, P NATL ACAD SCI USA, V109, P14830, DOI 10.1073/pnas.1213200109; Godoy AS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21798-9; Grossfield A., WHAM WEIGHTED HISTOG; Hynninen AP, 2014, J COMPUT CHEM, V35, P406, DOI 10.1002/jcc.23501; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Knott BC, 2014, J AM CHEM SOC, V136, P321, DOI 10.1021/ja410291u; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Kruger T, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1871913; LAIDLER KJ, 1983, J PHYS CHEM-US, V87, P2657, DOI 10.1021/j100238a002; Larsson AM, 2005, BIOCHEMISTRY-US, V44, P12915, DOI 10.1021/bi0506730; Lee M, 2016, ACS CHEM BIOL, V11, P1525, DOI 10.1021/acschembio.6b00194; Mayes HB, 2016, CHEM SCI, V7, P5955, DOI 10.1039/c6sc00571c; Mayes HB, 2014, J AM CHEM SOC, V136, P1008, DOI 10.1021/ja410264d; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; MCQUEENMASON S, 1994, P NATL ACAD SCI USA, V91, P6574, DOI 10.1073/pnas.91.14.6574; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; Nakamura A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500263; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Peters B, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2409924; Peters B, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2748396; Peters B, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2234477; Peters B, 2016, ANNU REV PHYS CHEM, V67, P669, DOI 10.1146/annurev-physchem-040215-112215; Peters B, 2010, MOL SIMULAT, V36, P1265, DOI 10.1080/08927020903536382; Petersen L, 2009, J PHYS CHEM B, V113, P7331, DOI 10.1021/jp811470d; Quay DHX, 2015, BMC STRUCT BIOL, V15, DOI 10.1186/s12900-015-0039-z; Rasmussen G., 1995, EPO Patent, Patent No. [531372B1, 531372]; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Schulein M., 1998, ACS SYM SER, V687, P66, DOI [10.1021/BK-1998-0687.CH006, DOI 10.1021/BK-1998-0687.CH006]; Seabra GD, 2007, J PHYS CHEM A, V111, P5655, DOI 10.1021/jp0700711; Thompson AJ, 2012, ANGEW CHEM INT EDIT, V51, P10997, DOI 10.1002/anie.201205338; van Straaten KE, 2007, J BIOL CHEM, V282, P21197, DOI 10.1074/jbc.M701818200; van Straaten KE, 2005, J MOL BIOL, V352, P1068, DOI 10.1016/j.jmb.2005.07.067; Vlasenko E, 2010, BIORESOURCE TECHNOL, V101, P2405, DOI 10.1016/j.biortech.2009.11.057; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Whitney SEC, 2000, PLANT J, V22, P327, DOI 10.1046/j.1365-313x.2000.00742.x; Williams AH, 2018, J BIOL CHEM, V293, P6000, DOI 10.1074/jbc.RA117.001095; Wu M, 2013, J BIOL CHEM, V288, P33107, DOI 10.1074/jbc.M113.502765; Yennawar NH, 2006, P NATL ACAD SCI USA, V103, P14664, DOI 10.1073/pnas.0605979103	63	11	11	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4477	4487		10.1074/jbc.RA119.011406	http://dx.doi.org/10.1074/jbc.RA119.011406			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32054684	Green Published, hybrid			2022-12-26	WOS:000524499700010
J	Villa, MG; Morch, CD; Palsson, TS; Boudreau, SA				Villa, Maria Galve; Morch, Carsten D.; Palsson, Thorvaldur S.; Boudreau, Shellie A.			Modifiable motion graphics for capturing sensations	PLOS ONE			English	Article							MCGILL PAIN QUESTIONNAIRE; CLINICAL-TRIALS; ANALOG SCALE; DESCRIPTORS; RELIABILITY; PERCEPTION; QUALITY; LEVEL	Objective The purpose of this study was to assess the relationship between an embodied sensory experience and the ability to translate the perception of this experience visually using modifiable motion graphics. Methods A custom-designed software was developed to enable users to modify a motion graphic in real-time. The motion graphics were designed to depict realistic visualizations of pain quality descriptors, such as tingling and burning. Participants (N = 34) received an electrical stimulation protocol known to elicit sensations of tingling. The protocol consisted of eight stimulation intensities ranging from 2-6mA delivered, in a randomized fashion and repeated three times, to the index finger. Immediately after each stimulus, participants drew the area of the evoked sensation on a digital body chart of the hand. Participants then modified the motion graphic of tingling by adjusting two parameters, namely the speed (rate of dots disappearing and re-appearing) and density of these dots in the drawn area. Then, participants rated the perceived intensity and selected the most appropriate pain quality descriptor. Results There was an increase in the area, density, and perceived intensity ratings as the electrical stimulation intensity increased (P<0.001). The density of the motion graphic, but not speed, correlated with perceived intensity ratings (0.69, P<0.001) and electrical stimulation intensities (0.63, P<0.01). The descriptor 'tingling' was predominantly selected in the range of 3-4.5mA and was often followed by 'stabbing' as the electrical intensity increased. Discussion The motion graphic tested was perceived to reflect a tingling sensation, the stimulation protocol elicited a tingling sensation, and participants adjusted one of the two motion graphic features systematically. In conclusion, an embodied sensation, such as tingling, maybe visually represented similarly between individuals. These findings create research, clinical, and commercial opportunities that utilize psychophysics to explore, visualize, and quantify changes in embodied sensory experiences in response to known stimuli.	[Villa, Maria Galve; Morch, Carsten D.; Boudreau, Shellie A.] Aalborg Univ, Fac Med, Ctr Neuroplast & Pain CNAP, Ctr Sensory Motor Interact SMI,Dept Hlth Sci & Te, Aalborg, Denmark; [Palsson, Thorvaldur S.] Aalborg Univ, Ctr Sensory Motor Interact SMI, Dept Hlth Sci & Technol, Lab Musculoskeletal Pain & Motor Control, Aalborg, Denmark	Aalborg University; Aalborg University	Boudreau, SA (corresponding author), Aalborg Univ, Fac Med, Ctr Neuroplast & Pain CNAP, Ctr Sensory Motor Interact SMI,Dept Hlth Sci & Te, Aalborg, Denmark.	sboudreau@hst.aau.dk	Palsson, Thorvaldur/AAL-8527-2020; Boudreau, Shellie A/H-2906-2012; Mørch, Carsten Dahl/J-5639-2019	Palsson, Thorvaldur/0000-0002-4418-0133; Boudreau, Shellie A/0000-0002-8310-2744; Mørch, Carsten Dahl/0000-0001-6693-2028; Galve Villa, Maria/0000-0002-6227-5726	Aalborg University; Tryg Fonden [109647]; Novo Nordisk Fonden [NNF14OC0013577]; Danish National Research Foundation [DNRF121]	Aalborg University; Tryg Fonden; Novo Nordisk Fonden(Novo Nordisk Foundation); Danish National Research Foundation(Danmarks Grundforskningsfond)	SAB received funding from: Aalborg University (Talent Management Programme 2016) www.aau.dk Tryg Fonden (109647) www.trygfonden.dk Novo Nordisk Fonden (NNF14OC0013577) www.novonordiskfonden.dk SAB and CDM are part of Center for Neuroplasticity and Pain (CNAP) which is supported by the Danish National Research Foundation (DNRF121) www.dg.dk The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Baliki MN, 2015, NEURON, V87, P474, DOI 10.1016/j.neuron.2015.06.005; Baron R, 2010, NEUROPATHIC PAIN DIA, DOI [10.1016/S1474-4422(10)70143-5, DOI 10.1016/S1474-4422(10)70143-5]; Bennett M, 2001, PAIN, V92, P147, DOI 10.1016/S0304-3959(00)00482-6; Boudreau SA, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1521-5; Boudreau SA, 2016, CLIN J PAIN, V32, P139, DOI 10.1097/AJP.0000000000000230; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Bouhassira D, 2004, PAIN, V108, P248, DOI 10.1016/j.pain.2003.12.024; BOUREAU F, 1990, PAIN, V42, P145, DOI 10.1016/0304-3959(90)91158-F; Bulloch B, 2009, ACAD EMERG MED, V16, P465, DOI 10.1111/j.1553-2712.2009.00404.x; CARROLL JD, 1970, PSYCHOMETRIKA, V35, P283, DOI 10.1007/BF02310791; Chidambaran V, 2020, J PAIN, V21, P2, DOI 10.1016/j.jpain.2019.05.008; Clark WC, 2010, ATTEN PERCEPT PSYCHO, V72, P548, DOI 10.3758/APP.72.2.548; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Coy J, 2019, PHYS THER, V99, P924, DOI [10.1093/ptj/pzz054, DOI 10.1093/PTJ/PZZ054]; Cruder C, 2018, PAIN PRACT, V18, P53, DOI 10.1111/papr.12581; Dianne Wilson, 2008, PHYSIOTHER RES INT, V4, P56; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Dworkin RH, 2009, PAIN, V144, P35, DOI 10.1016/j.pain.2009.02.007; Fernandez E, 2012, J PAIN, V13, P532, DOI 10.1016/j.jpain.2012.02.006; Fernandez E, 2011, J PAIN, V12, P444, DOI 10.1016/j.jpain.2010.10.011; Ferreira-Valente MA, 2011, PAIN, V152, P2399, DOI 10.1016/j.pain.2011.07.005; Fillingim RB, 2016, J PAIN, V17, pT10, DOI 10.1016/j.jpain.2015.08.010; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Grunnesjo M, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-65; Hasvik E, 2018, EUR J PAIN, V22, P1160, DOI 10.1002/ejp.1204; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Hayashi K, 2015, PAIN PRACT, V15, P300, DOI 10.1111/papr.12173; Holtan A, 2009, J PAIN SYMPTOM MANAG, V38, P208, DOI 10.1016/j.jpainsymman.2008.08.008; Huang P, 2014, SPINE, V39, pE529, DOI 10.1097/BRS.0000000000000240; Janal MN, 1996, PAIN, V64, P373, DOI 10.1016/0304-3959(95)00127-1; JANAL MN, 1991, PERCEPT PSYCHOPHYS, V50, P108, DOI 10.3758/BF03212212; Jensen MP, 2006, J PAIN, V7, P644, DOI 10.1016/j.jpain.2006.02.012; Krause SJ, 2003, CLIN J PAIN, V19, P306, DOI 10.1097/00002508-200309000-00004; Lalloo C, 2014, J MED INTERNET RES, V16, P216, DOI 10.2196/jmir.3292; Lindheimer JB, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13452; Girbes EL, 2016, PHYS THER, V96, P1196, DOI 10.2522/ptj.20150492; Margoles M., 1983, PAIN MEASUREMENT ASS, P215; Matthews M, 2018, PEERJ, V6, DOI 10.7717/peerj.4406; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; MELZACK R, 1983, PAIN MEASUREMENT ASS, P41; Mogyoros I, 2000, MUSCLE NERVE, DOI [10.1002/(SICI)1097-4598(200003)23:3310::AID-MUS23.0.CO;2-A, DOI 10.1002/(SICI)1097-4598(200003)23:3310::AID-MUS23.0.CO;2-A]; MOONEY V, 1976, WESTERN J MED, V124, P370; NORDIN M, 1984, PAIN, V20, P231, DOI 10.1016/0304-3959(84)90013-7; OCHOA JL, 1980, BRAIN, V103, P835, DOI 10.1093/brain/103.4.835; Packiasabapathy S, 2018, J PAIN RES, V11, P2729, DOI 10.2147/JPR.S94650; PALMER H, 1949, NZ MED J; Price Donald D, HDB PAIN ASSESSMENT, P53; Schilder A, 2018, PAIN REP, V3; Sharma S, 2016, J PAIN RES, V9, P1057, DOI 10.2147/JPR.S119212; Sims SEG, 2015, J HAND SURG-AM, V40, P1996, DOI 10.1016/j.jhsa.2015.06.009; Smith SM, 2016, PAIN, V157, P1056, DOI 10.1097/j.pain.0000000000000502; Steenbergen P, 2014, EXP BRAIN RES, V232, P597, DOI 10.1007/s00221-013-3768-x; Tesarz J, 2016, CLIN J PAIN, V32, P580, DOI 10.1097/AJP.0000000000000308; Thakral M, 2016, PAIN, V157, P2834, DOI 10.1097/j.pain.0000000000000719; Thompson T, 2017, AGEING RES REV, V35, P74, DOI 10.1016/j.arr.2017.01.005; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Turton A, 2014, INT J INTEGRATED CAR; van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121; Waterman C, 2010, J PAIN, V11, P273, DOI 10.1016/j.jpain.2009.07.014; Watson JC, 2015, MAYO CLIN PROC, V90, P940, DOI 10.1016/j.mayocp.2015.05.004; Wiech K, 2016, SCIENCE, V354, P584, DOI 10.1126/science.aaf8934; Zamorano AM, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01016	65	0	0	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229139	10.1371/journal.pone.0229139	http://dx.doi.org/10.1371/journal.pone.0229139			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092081	gold, Green Published			2022-12-26	WOS:000535229300025
J	Weng, QY; Chen, MJ; Yang, WB; Li, J; Fan, K; Xu, M; Weng, W; Lv, XL; Fang, SJ; Zheng, LY; Song, JJ; Zhao, ZW; Fan, XX; Ji, JS				Weng, Qiaoyou; Chen, Minjiang; Yang, Weibin; Li, Jie; Fan, Kai; Xu, Min; Weng, Wei; Lv, Xiuling; Fang, Shiji; Zheng, Liyun; Song, Jingjing; Zhao, Zhongwei; Fan, Xiaoxi; Ji, Jiansong			Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma	FASEB JOURNAL			English	Article						hepatocellular carcinoma; MAGI3; miR-34c-3p; Warburg effect	TUMOR-SUPPRESSOR; MICRORNAS; PROGRESSION; EXPRESSION	Activated oncogenes and loss of tumor suppressors contribute to reprogrammed energy metabolism and induce aerobic glycolysis, also known as Warburg effect. MicroRNAs are profoundly implicated in human malignancies by inhibiting translation of multiple mRNA targets. Using hepatocellular carcinoma (HCC) molecular profiles from The Cancer Genome Atlas (TCGA), we identified a handful of dysregulated microRNA in HCC glycolysis, especially miR-34c-3p. Antagonization of miR-34c-3p inhibited the lactate production, glucose consumption, extracellular acidification rate (ECAR), and aggressive proliferation in HCC cells. Hijacking glycolysis by 2-deoxy-d-glucose or galactose largely abrogated the suppressive effects of miR-34c-3p inhibition in HCC. Membrane associated guanylate kinase, WW, and PDZ domain containing 3 (MAGI3) is then identified as a direct functional target of miR-34c-3p in regulating HCC glycolysis and oncogenic activities. Mechanistically, MAGI3 physically interacted with beta-catenin to regulate its transcriptional activity and c-Myc expression, which further facilitates the Warburg effect by increasing expression of glycolytic genes including HK2, PFKL, and LDHA. Moreover, overexpressed miR-34c-3p and reduced MAGI3 predicted poor clinical outcome and was closely associated with the maximum standard uptake value (SUVmax) in HCC patients who received preoperative F-18-FDG PET/CT. Our findings elucidate critical several microRNAs implicated in HCC glycolysis and reveal a novel function of miR-34c-3p/MAGI3 axis in Warburg effect through regulating beta-catenin activity.	[Weng, Qiaoyou; Chen, Minjiang; Yang, Weibin; Li, Jie; Fan, Kai; Xu, Min; Weng, Wei; Lv, Xiuling; Fang, Shiji; Zheng, Liyun; Song, Jingjing; Zhao, Zhongwei; Fan, Xiaoxi; Ji, Jiansong] Zhejiang Univ, Lishui Hosp, Key Lab Imaging Diag & Minimally Invas Intervent, Sch Med, Lishui, Peoples R China; [Weng, Qiaoyou; Chen, Minjiang; Yang, Weibin; Li, Jie; Fan, Kai; Xu, Min; Weng, Wei; Lv, Xiuling; Fang, Shiji; Zheng, Liyun; Song, Jingjing; Zhao, Zhongwei; Fan, Xiaoxi; Ji, Jiansong] Wenzhou Med Univ, Dept Radiol, Affiliated Hosp 5, Wenzhou, Peoples R China; [Weng, Qiaoyou; Chen, Minjiang; Yang, Weibin; Li, Jie; Fan, Kai; Xu, Min; Weng, Wei; Lv, Xiuling; Fang, Shiji; Zheng, Liyun; Song, Jingjing; Zhao, Zhongwei; Fan, Xiaoxi; Ji, Jiansong] Zhejiang Univ, Cent Hosp Zhejiang Lishui, Affiliated Lishui Hosp, Lishui, Peoples R China	Zhejiang University; Wenzhou Medical University; Zhejiang University	Fan, XX; Ji, JS (corresponding author), Zhejiang Univ, Dept Radiol, Affiliated Lishui Hosp, Lishui 323000, Peoples R China.; Fan, XX; Ji, JS (corresponding author), Wenzhou Med Univ, Affiliated Hosp 5, Cent Hosp Zhejiang Lishui, Wenzhou, Peoples R China.	21968108@qq.com; lschrjjs@163.com		, Jiansong/0000-0001-6975-620X	National Key Research and Development projects intergovernmental cooperation in science and technology of China [2018YFE0126900]; National Natural Science Foundation of China [81803778]; Key Research and development Project of Zhejiang Province [2018C03024]; Public Welfare Project of Zhejiang Province [2018KY197, 2018KY932, 2017C33216]	National Key Research and Development projects intergovernmental cooperation in science and technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and development Project of Zhejiang Province; Public Welfare Project of Zhejiang Province	National Key Research and Development projects intergovernmental cooperation in science and technology of China, Grant/Award Number: 2018YFE0126900; National Natural Science Foundation of China, Grant/Award Number: 81803778; The Key Research and development Project of Zhejiang Province, Grant/Award Number: 2018C03024; The Public Welfare Project of Zhejiang Province, Grant/Award Number: 2018KY197, 2018KY932 and 2017C33216	Chang J, 2002, CANCER LETT, V182, P193, DOI 10.1016/S0304-3835(02)00083-6; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; Du WF, 2018, ANTI-CANCER DRUG, V29, P975, DOI 10.1097/CAD.0000000000000674; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gambari R, 2016, INT J ONCOL, V49, P5, DOI 10.3892/ijo.2016.3503; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hua SN, 2018, ONCOGENE, V37, P1624, DOI 10.1038/s41388-017-0057-3; Jiang SH, 2017, GASTROENTEROLOGY, V153, P277, DOI 10.1053/j.gastro.2017.03.008; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Katoh H, 2006, AM J PATHOL, V168, P1375, DOI 10.2353/ajpath.2006.050989; Lee SJ, 2011, GASTROENTEROLOGY, V140, P924, DOI 10.1053/j.gastro.2010.11.054; Li ZM, 2016, ONCOTARGET, V7, P52781, DOI 10.18632/oncotarget.10947; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Liu F, 2015, CELL PROLIFERAT, V48, P582, DOI 10.1111/cpr.12201; Locasale JW, 2011, CELL METAB, V14, P443, DOI 10.1016/j.cmet.2011.07.014; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu JR, 2015, CANCER LETT, V356, P156, DOI 10.1016/j.canlet.2014.04.001; Ma Q, 2015, ONCOTARGET, V6, P35851, DOI 10.18632/oncotarget.5323; Ni TK, 2016, ELIFE, V5, DOI 10.7554/eLife.14730; Pogribny IP, 2014, CANCER LETT, V342, P223, DOI 10.1016/j.canlet.2012.01.038; Song JJ, 2015, INT J CLIN EXP PATHO, V8, P12728; Streba LAM, 2015, WORLD J GASTROENTERO, V21, P4103, DOI 10.3748/wjg.v21.i14.4103; Tang ZF, 2019, NUCLEIC ACIDS RES, V47, pW556, DOI 10.1093/nar/gkz430; Umemura A, 2016, CANCER CELL, V29, P935, DOI 10.1016/j.ccell.2016.04.006; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Wu J, 2017, BIOCHEM BIOPH RES CO, V483, P10, DOI 10.1016/j.bbrc.2017.01.023; Xiao CZ, 2017, J CANCER RES CLIN, V143, P263, DOI 10.1007/s00432-016-2280-7; Zhong XP, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1603-4	31	13	14	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5420	5434		10.1096/fj.201902895R	http://dx.doi.org/10.1096/fj.201902895R		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32080912	hybrid			2022-12-26	WOS:000515257100001
J	Liu, JM; Liu, YP; Chuang, HC; Wu, CT; Su, YL; Hsu, RJ				Liu, Jui-Ming; Liu, Yueh-Ping; Chuang, Heng-Chang; Wu, Chun-Te; Su, Yu-Li; Hsu, Ren-Jun			Androgen deprivation therapy for prostate cancer and the risk of hematologic disorders	PLOS ONE			English	Article							RECEPTOR EXPRESSION; ANEMIA; SURVIVAL; LEUKEMIA; TESTOSTERONE; RADIATION; STEROIDS	Purpose This study aimed to investigate the association between androgen deprivation therapy (ADT) and the risk of subsequently developing hematologic disorders in patients with prostate cancer. Materials and methods This population-based nationwide cohort study utilized data from the Taiwan National Health Insurance Research Database between 1997 and 2013. The patients were divided into three groups-those who received ADT only (ADT-only group), those who had radiotherapy (RT) only (RT-only group), and those treated with radical prostatectomy (RP) only (RP-only group). The study outcome was newly diagnosed hematologic disorder, including anemia and hematologic malignancy. Propensity score-matched, Cox regression, and Kaplan-Meier curve analyses were performed to investigate the risk of subsequently developing hematologic disorders after ADT. Results Of the 17,168 patients with prostate cancer who were included in the study, 13,318 met the inclusion and exclusion criteria. After propensity score matching, 1,797, 1,797, and 1,797 patients treated with ADT only, RT only, and RP only, respectively, who had a median follow-up period of 4.32 years were included in the study cohort. Compared with the patients treated with RP only, those who received ADT and RT were significantly at increased risk of subsequently developing hematologic disorders (ADT: adjusted hazard ratio [aHR]: 1.60, 95% confidence interval [CI]: 1.29-1.97; RT: aHR, 1.98, 95% CI: 1.62-2.42) according to the Cox regression analysis. Based on the Kaplan-Meier curve analysis, patients with bone metastasis who received ADT only had the lowest cumulative probabilities of not developing hematologic disorders. Moreover, a significantly increased risk of hematologic disorders was observed with the increasing duration of ADT (P for trend < .001). Conclusions The use of ADT in patients with prostate cancer may increase the risk of subsequently developing hematologic disorders.	[Liu, Jui-Ming; Chuang, Heng-Chang] Taoyuan Gen Hosp, Div Urol, Dept Surg, Minist Hlth & Welf, Taoyuan, Taiwan; [Liu, Jui-Ming] Natl Yang Ming Univ, Dept Med, Taipei, Taiwan; [Liu, Jui-Ming; Hsu, Ren-Jun] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Liu, Yueh-Ping] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Liu, Yueh-Ping] Minist Hlth & Welf, Dept Med Affairs, Taipei, Taiwan; [Wu, Chun-Te] Chang Gung Mem Hosp, Dept Urol, Keelung, Taiwan; [Su, Yu-Li] Chang Gung Mem Hosp, Div Hematol Oncol, Dept Internal Med, Kaohsiung, Taiwan; [Su, Yu-Li] Chang Gung Mem Hosp, Clin Trial Ctr, Kaohsiung, Taiwan; [Hsu, Ren-Jun] Hualien Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Canc Res Ctr, Hualien, Taiwan; [Hsu, Ren-Jun] Tzu Chi Univ, Coll Med, Hualien, Taiwan	National Yang Ming Chiao Tung University; National Defense Medical Center; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University	Hsu, RJ (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.; Hsu, RJ (corresponding author), Hualien Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Canc Res Ctr, Hualien, Taiwan.; Hsu, RJ (corresponding author), Tzu Chi Univ, Coll Med, Hualien, Taiwan.	hsurnai@gmail.com	Su, Harvey Yu-Li/N-9726-2019; Jui-Ming, Liu/H-3452-2019	Su, Harvey Yu-Li/0000-0002-1289-473X; Jui-Ming, Liu/0000-0003-3868-085X; Wu, Chun-Te/0000-0002-6910-9253	Taoyuan General Hospital, Ministry of Health and Welfare [PYT10702]; Tri-Service General Hospital [TSGH-C105-168, TSGHC104-188]; Ministry of Science and Technology Taiwan; MOST [104-2320B-016-012-MY3]	Taoyuan General Hospital, Ministry of Health and Welfare; Tri-Service General Hospital; Ministry of Science and Technology Taiwan(Ministry of Science and Technology, Taiwan); MOST	This study was supported by the Taoyuan General Hospital, Ministry of Health and Welfare (Grants No. PYT10702), the Tri-Service General Hospital (Grants No. TSGH-C105-168 and TSGHC104-188), and the Ministry of Science and Technology Taiwan (Grants No. MOST 104-2320B-016-012-MY3). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	BLAGOSKLONNY MV, 1993, EUR CYTOKINE NETW, V4, P279; Calado RT, 2009, BLOOD, V114, P2236, DOI 10.1182/blood-2008-09-178871; Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P; D'Amico AV, 2002, CANCER, V95, P275, DOI 10.1002/cncr.10673; DANEL L, 1981, INT J CANCER, V27, P733, DOI 10.1002/ijc.2910270602; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Frakt AB, 2015, JAMA-J AM MED ASSOC, V313, P1091, DOI 10.1001/jama.2015.0544; HAMILTON JB, 1948, RECENT PROG HORM RES, V3, P257; Hicks BM, 2017, EPIDEMIOLOGY, V28, P712, DOI 10.1097/EDE.0000000000000678; Huggins C, 1972, CA Cancer J Clin, V22, P232, DOI 10.3322/canjclin.22.4.232; Levine GN, 2010, CA-CANCER J CLIN, V60, P194, DOI 10.3322/caac.20061; Liu JM, 2019, PROSTATE CANCER P D, V22, P475, DOI 10.1038/s41391-019-0130-9; Liu JM, 2019, PROSTATE CANCER P D, V22, P276, DOI 10.1038/s41391-018-0091-4; Liu JM, 2018, J UROLOGY, V199, pE700; Liu ZJ, 2009, CANCER INVEST, V27, P156, DOI 10.1080/07357900802208590; Mantalaris A, 2001, J PATHOL, V193, P361, DOI 10.1002/1096-9896(0000)9999:9999<::AID-PATH803>3.0.CO;2-W; MORIYAMA Y, 1975, BLOOD, V45, P665; Mossuz P, 1998, LEUKEMIA RES, V22, P1063, DOI 10.1016/S0145-2126(98)00101-5; Mostaghel EA, 2017, EXP HEMATOL, V49, P34, DOI 10.1016/j.exphem.2017.01.001; Nguyen PL, 2015, EUR UROL, V67, P825, DOI 10.1016/j.eururo.2014.07.010; Pigneux A, 2017, J CLIN ONCOL, V35, P387, DOI 10.1200/JCO.2016.67.6213; Preti HA, 1997, ANN INTERN MED, V127, P186, DOI 10.7326/0003-4819-127-3-199708010-00002; SANCHEZMEDAL L, 1969, BLOOD-J HEMATOL, V34, P283, DOI 10.1182/blood.V34.3.283.283; Saylor PJ, 2012, ONCOLOGIST, V17, P212, DOI 10.1634/theoncologist.2011-0321; SHAHIDI NT, 1973, NEW ENGL J MED, V289, P72, DOI 10.1056/NEJM197307122890205; SHAMDAS GJ, 1993, CANCER, V71, P3594, DOI 10.1002/1097-0142(19930601)71:11<3594::AID-CNCR2820711121>3.0.CO;2-O; Smith A, 2010, BRIT J HAEMATOL, V148, P739, DOI 10.1111/j.1365-2141.2009.08010.x; Strum SB, 1997, BRIT J UROL, V79, P933, DOI 10.1046/j.1464-410X.1997.00234.x; Townsley DM, 2016, NEW ENGL J MED, V374, P1922, DOI 10.1056/NEJMoa1515319; Wallis CJD, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i851; Zhang L, 2012, BLOOD, V120, P3783, DOI 10.1182/blood-2012-04-424630	32	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0229263	10.1371/journal.pone.0229263	http://dx.doi.org/10.1371/journal.pone.0229263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074125	gold, Green Published			2022-12-26	WOS:000535220600037
J	Dasgupta, A; Chen, KH; Wu, DC; Hoskin, V; Mewburn, J; Lima, PDA; Parlow, LRG; Hindmarch, CCT; Martin, A; Sykes, EA; Tayade, C; Lightbody, ED; Madarnas, Y; SenGupta, SK; Elliott, BE; Nicol, CJB; Archer, SL				Dasgupta, Asish; Chen, Kuang-Hueih; Wu, Danchen; Hoskin, Victoria; Mewburn, Jeffrey; Lima, Patricia D. A.; Parlow, Leah R. G.; Hindmarch, Charles C. T.; Martin, Ashley; Sykes, Edward A.; Tayade, Chandrakant; Lightbody, Elizabeth D.; Madarnas, Yolanda; SenGupta, Sandip K.; Elliott, Bruce E.; Nicol, Christopher J. B.; Archer, Stephen L.			An epigenetic increase in mitochondrial fission by MiD49 and MiD51 regulates the cell cycle in cancer: Diagnostic and therapeutic implications	FASEB JOURNAL			English	Article						Akt; breast cancer; Hyperion; microRNA-34a-3p; MiD49; MiD51; mitotic mitochondrial fission; non-small cell lung cancer	MITOFUSIN 2; INDUCED DRP1; PHOSPHORYLATION; FUSION; ACTIVATION; PROLIFERATION; INHIBITION; APOPTOSIS; P21(CIP1); SIGNALS	Excessive proliferation and apoptosis-resistance are hallmarks of cancer. Increased dynamin-related protein 1 (Drp1)-mediated mitochondrial fission is one of the mediators of this phenotype. Mitochondrial fission that accompanies the nuclear division is called mitotic fission and occurs when activated Drp1 binds partner proteins on the outer mitochondrial membrane. We examine the role of Drp1-binding partners, mitochondrial dynamics protein of 49 and 51 kDa (MiD49 and MiD51), as drivers of cell proliferation and apoptosis-resistance in non-small cell lung cancer (NSCLC) and invasive breast carcinoma (IBC). We also evaluate whether inhibiting MiDs can be therapeutically exploited to regress cancer. We show that MiD levels are pathologically elevated in NSCLC and IBC by an epigenetic mechanism (decreased microRNA-34a-3p expression). MiDs silencing causes cell cycle arrest through (a) increased expression of cell cycle inhibitors, p27(Kip1) and p21(Waf1), (b) inhibition of Drp1, and (c) inhibition of the Akt-mTOR-p70S6K pathway. Silencing MiDs leads to mitochondrial fusion, cell cycle arrest, increased apoptosis, and tumor regression in a xenotransplant NSCLC model. There are positive correlations between MiD expression and tumor size and grade in breast cancer patients and inverse correlations with survival in NSCLC patients. The microRNA-34a-3p-MiDs axis is important to cancer pathogenesis and constitutes a new therapeutic target.	[Dasgupta, Asish; Chen, Kuang-Hueih; Wu, Danchen; Mewburn, Jeffrey; Parlow, Leah R. G.; Martin, Ashley; Sykes, Edward A.; Archer, Stephen L.] Queens Univ, Dept Med, Etherington Hall,Room 3041,94 Stuart St, Kingston, ON K7L 3N6, Canada; [Hoskin, Victoria; Lightbody, Elizabeth D.; SenGupta, Sandip K.; Elliott, Bruce E.; Nicol, Christopher J. B.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Lima, Patricia D. A.; Hindmarch, Charles C. T.] Queens Univ, Dept Med, Translat Inst Med TIME, Queens Cardiopulm Unit QCPU, Kingston, ON, Canada; [Tayade, Chandrakant; Nicol, Christopher J. B.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Madarnas, Yolanda; SenGupta, Sandip K.] Kingston Hlth Sci Ctr, Kingston, ON, Canada	Queens University - Canada; McMaster University; Queens University - Canada; Queens University - Canada; Queens University - Canada	Archer, SL (corresponding author), Queens Univ, Dept Med, Etherington Hall,Room 3041,94 Stuart St, Kingston, ON K7L 3N6, Canada.	stephen.archer@queensu.ca	Hindmarch, Charles/AAM-3385-2021; Wu, Danchen/W-4727-2019; wu, danchen/Y-8493-2019	Wu, Danchen/0000-0003-3901-5907; 	Breast Cancer Action Kingston; Queen'sCardiopulmonary Unit (QCPU)	Breast Cancer Action Kingston; Queen'sCardiopulmonary Unit (QCPU)	SLAand his researchare supported byQueen'sCardiopulmonary Unit (QCPU). The authors thank Dr Mamoru Ito (Central Institute for Experimental Animals, Kawasaki, Japan), for providing the BALB/c-Rag2-/-IL2R.c-/-mice. The authors also wish to thank Dr Lois Shepherd (CCT Division, Queen's Cancer Research Institute; Kingston, Canada) and Mr Shakeel Virk (Queen's Laboratory for Molecular Pathology, Kingston, Canada) for their valuable contributions of the NSCLC patient data. The authors also wish to thank the Breast Cancer Action Kingston for the funding of the construction of the breast can-cer cohort and TMAs.	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Burman JL, 2017, J CELL BIOL, V216, P3231, DOI 10.1083/jcb.201612106; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cass Jamaica D, 2012, Cancers (Basel), V4, P725, DOI 10.3390/cancers4030725; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chen KH, 2018, CIRCULATION, V138, P287, DOI 10.1161/CIRCULATIONAHA.117.031258; Chen KH, 2014, FASEB J, V28, P382, DOI 10.1096/fj.13-230037; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Cribbs JT, 2009, METHOD ENZYMOL, V457, P231, DOI 10.1016/S0076-6879(09)05013-7; Dasgupta A, 2015, J IMMUNOL, V195, P5780, DOI 10.4049/jimmunol.1501023; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Disatnik MH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000461; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Ghaffari A, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0438-2; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hong ZG, 2013, CIRC RES, V112, P802, DOI 10.1161/CIRCRESAHA.111.300285; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Kim DI, 2016, BBA-MOL CELL RES, V1863, P2820, DOI 10.1016/j.bbamcr.2016.09.003; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Flores JM, 2014, CELL CYCLE, V13, DOI 10.4161/cc.29147; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Munoz-Alonso MJ, 2005, J BIOL CHEM, V280, P18120, DOI 10.1074/jbc.M500758200; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Okada N, 2014, GENE DEV, V28, P438, DOI 10.1101/gad.233585.113; Prieto J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11124; Prins KW, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006195; Ray A, 2009, MOL CELL BIOL, V29, P986, DOI 10.1128/MCB.00898-08; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Shimura T, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.12; Skildum AJ, 2002, J BIOL CHEM, V277, P5145, DOI 10.1074/jbc.M109179200; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tian L, 2017, J MOL MED, V95, P381, DOI 10.1007/s00109-017-1522-8; Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200; Zorzano A, 2015, ANTIOXID REDOX SIGN, V22, P1020, DOI 10.1089/ars.2014.6208	47	7	7	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5106	5127		10.1096/fj.201903117R	http://dx.doi.org/10.1096/fj.201903117R		FEB 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32068312				2022-12-26	WOS:000515251900001
J	Kato, H; Asamitsu, K; Sun, WD; Kitajima, S; Yoshizawa-Sugata, N; Okamoto, T; Masai, H; Poellinger, L				Kato, Hiroyuki; Asamitsu, Kaori; Sun, Wendi; Kitajima, Shojiro; Yoshizawa-Sugata, Naoko; Okamoto, Takashi; Masai, Hisao; Poellinger, Lorenz			Cancer-derived UTX TPR mutations G137V and D336G impair interaction with MLL3/4 complexes and affect UTX subcellular localization	ONCOGENE			English	Article							MAKE-UP SYNDROME; KABUKI-SYNDROME; DEMETHYLASE UTX; PROTEIN; KDM6A; MLL2; GENES; INACTIVATION; RETARDATION; METHYLATION	The ubiquitously transcribed tetratricopeptide repeat on X chromosome (UTX) is a major histone H3 lysine 27 (H3K27) demethylase and the mixed-lineage leukemia (MLL) proteins are the H3K4 methyltransferases. UTX is one of the major components of MLL3- and MLL4-containing (MlLL3/4) complexes and likely has functions within the complexes. Although UTX is frequently mutated in various types of cancer and is thought to play a crucial role as a tumor suppressor, the importance of UTX interaction with MLL3/4 complexes in cancer formation is poorly understood. Here, we analyzed the ability of cancer-derived UTX mutant proteins to interact with ASH2L, which is a common core component of all the MLL complexes, and MLL3/4-specific components PTIP and PA1, and found that several single-amino acid substitution mutations in the tetratricopeptide repeat (TPR) affect UTX interaction with these components. Interaction-compromised mutants G137V and D336G and a TPR-deleted mutant Delta 80-397 were preferentially localized to the cytoplasm, suggesting that UTX is retained in the nucleus by MLL3/4 complexes through their interaction with the TPR. Intriguingly, WT UTX suppressed colony formation in soft agar, whereas G137V failed. This suggests that interaction of UTX with MLL3/4 complex plays a crucial role in their tumor suppressor function. Preferential cytoplasmic localization was also observed for endogenous proteins of G137V and another mutant G137V Delta 138 in HCT116 created by CRISPR-Cas9 gene editing. Interestingly, expression levels of these mutants were low and MG312 stabilized both endogenous as well as exogenous G137V proteins. These results reveal a novel mechanism of UTX regulation and reinforce the importance of UTX interaction with MLL3/4 complexes in cancer formation.	[Kato, Hiroyuki; Sun, Wendi; Kitajima, Shojiro; Poellinger, Lorenz] Natl Univ Singapore, Canc Sci Inst Singapore, 14 Med Dr, Singapore 117599, Singapore; [Kato, Hiroyuki; Yoshizawa-Sugata, Naoko; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Kato, Hiroyuki; Asamitsu, Kaori; Okamoto, Takashi] Nagoya City Univ, Dept Mol & Cellular Biol, Grad Sch Med Sci, Mizuho Ku, Nagoya, Aichi 467860, Japan; [Kitajima, Shojiro] Keio Univ, Inst Adv Biosci, Kakuganji 246-2, Tsuruoka, Yamagata 9970052, Japan; [Poellinger, Lorenz] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	National University of Singapore; Tokyo Metropolitan Institute of Medical Science; Nagoya City University; Keio University; Karolinska Institutet	Kato, H (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, 14 Med Dr, Singapore 117599, Singapore.; Kato, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.; Kato, H (corresponding author), Nagoya City Univ, Dept Mol & Cellular Biol, Grad Sch Med Sci, Mizuho Ku, Nagoya, Aichi 467860, Japan.	csihkato@gmail.com		Yoshizawa-Sugata, Naoko/0000-0001-8792-8669; Masai, Hisao/0000-0003-1268-5302; Asamitsu, Kaori/0000-0001-5333-8011	Singapore National Research Foundation [R-713-005-014-271, R-713-000-162-511]; Singapore Ministry of Education; Singapore Ministry of Health's National Medical Research Council [NMRC/CIRG/1389/2014]; Japan Society for the Promotion of Science KAKENHI [17K08638, 23247031, 26251004]; Takeda Science Foundation	Singapore National Research Foundation(National Research Foundation, Singapore); Singapore Ministry of Education(Ministry of Education, Singapore); Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank all the LP lab members for technical assistance. This work was supported by grants from the Singapore National Research Foundation (R-713-005-014-271 and R-713-000-162-511), the Singapore Ministry of Education under the Research Centres of Excellence Programme, and the Singapore Ministry of Health's National Medical Research Council (Clinician Scientist Individual Research Grant, NMRC/CIRG/1389/2014) to LP, and Japan Society for the Promotion of Science KAKENHI (17K08638) to KA and (Scientific Research A, 23247031 and 26251004) to HM, and the Takeda Science Foundation to HM. In the midst of this project, Prof. Lorenz Poellinger passed away, to whom we dedicate this work.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Ahn J, 2016, ONCOTARGET, V7, P63252, DOI 10.18632/oncotarget.11207; Andricovich J, 2018, CANCER CELL, V33, P512, DOI 10.1016/j.ccell.2018.02.003; Banka S, 2015, CLIN GENET, V87, P252, DOI 10.1111/cge.12363; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bouazzi H, 2015, CLIN CASE REP, V3, P604, DOI 10.1002/ccr3.301; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hannibal MC, 2011, AM J MED GENET A, V155A, P1511, DOI 10.1002/ajmg.a.34074; Hernandez-Ramirez LC, 2016, J CLIN ENDOCR METAB, V101, P3144, DOI 10.1210/jc.2016-1307; Herz HM, 2016, BIOESSAYS, V38, P1003, DOI 10.1002/bies.201600106; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Ijichi O, 1996, ACTA PAEDIATR JAPON, V38, P66; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim J, 2017, ANN CLIN LAB SCI, V47, P229; Kitajima S, 2017, ONCOTARGET, V8, P114481, DOI 10.18632/oncotarget.23010; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lederer D, 2012, AM J HUM GENET, V90, P119, DOI 10.1016/j.ajhg.2011.11.021; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Ler LD, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8312; Leusen JHW, 1996, J EXP MED, V184, P1243, DOI 10.1084/jem.184.4.1243; Lindgren AM, 2013, HUM GENET, V132, P537, DOI 10.1007/s00439-013-1263-x; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Mar BG, 2012, LEUKEMIA, V26, P1881, DOI 10.1038/leu.2012.56; Merks JHM, 2005, AM J MED GENET A, V134A, P132, DOI 10.1002/ajmg.a.30603; Micale L, 2014, HUM MUTAT, V35, P841, DOI 10.1002/humu.22547; Miyake N, 2013, AM J MED GENET A, V161, P2234, DOI 10.1002/ajmg.a.36072; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; NIIKAWA N, 1988, AM J MED GENET, V31, P565, DOI 10.1002/ajmg.1320310312; NIIKAWA N, 1981, J PEDIATR-US, V99, P565, DOI 10.1016/S0022-3476(81)80255-7; Niranjan TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116454; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Scherer S, 2003, AM J MED GENET A, V122A, P76, DOI 10.1002/ajmg.a.20261; Shpargel KB, 2017, P NATL ACAD SCI USA, V114, pE9046, DOI 10.1073/pnas.1705011114; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Sun WD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05685-3; Tumino M, 2010, AM J MED GENET A, V152A, P1536, DOI 10.1002/ajmg.a.33405; Van der Meulen J, 2014, EPIGENETICS-US, V9, P658, DOI 10.4161/epi.28298; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Vandamme J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002647; Walport LJ, 2014, J BIOL CHEM, V289, P18302, DOI 10.1074/jbc.M114.555052; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Wang JK, 2010, GENE DEV, V24, P327, DOI 10.1101/gad.1882610; Wang SP, 2017, MOL CELL, V67, P308, DOI 10.1016/j.molcel.2017.06.028; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Willems AP, 2017, J BIOL CHEM, V292, P12621, DOI 10.1074/jbc.M117.790097; Zhang SY, 2016, NATURE, V533, P260, DOI 10.1038/nature17973	62	9	9	2	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2020	39	16					3322	3335		10.1038/s41388-020-1218-3	http://dx.doi.org/10.1038/s41388-020-1218-3		FEB 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QF9OJ	32071397				2022-12-26	WOS:000514262600001
J	Liu, Y; Chen, X; Choi, YJ; Yang, N; Song, ZY; Snedecor, ER; Liang, W; Leung, ELH; Zhang, LF; Qin, C; Chen, J				Liu, Ying; Chen, Xi; Choi, Yeon Ja; Yang, Ning; Song, Zhongya; Snedecor, Elizabeth R.; Liang, Wei; Leung, Elaine Lai-Han; Zhang, Lianfeng; Qin, Chuan; Chen, Jiang			GORAB promotes embryonic lung maturation through antagonizing AKT phosphorylation, versican expression, and mesenchymal cell migration	FASEB JOURNAL			English	Article						co-culture; fibroblast; morphogenesis; PDGF; signaling; VCAN	SMOOTH-MUSCLE; PDGF-A; TRANSCRIPTIONAL CONTROL; GROWTH; ALPHA; SCYL1BP1; PROTEOGLYCAN; DEGRADATION; APOPTOSIS; MICE	Embryonic development of the alveolar sac of the lung is dependent upon multiple signaling pathways to coordinate cell growth, migration, and the formation of the extracellular matrix. Here, we identify GORAB as a regulator of embryonic alveolar sac formation as genetically disrupting the Gorab gene in mice resulted in fatal saccular maturation defects characterized by a thickened lung mesenchyme. This abnormality is not associated with impairments in cellular proliferation and death, but aberrantly increased protein kinase B (AKT) phosphorylation, elevated Vcan transcription, and enhanced migration of mesenchymal fibroblasts. Genetically augmenting PDGFR alpha, a potent activator of AKT in lung mesenchymal cells, recapitulated the alveolar phenotypes, whereas disrupting PDGFR alpha partially rescued alveolar phenotypes in Gorab-deficient mice. Overexpressing or suppressing Vcan in primary embryonic lung fibroblasts could, respectively, mimic or attenuate alveolar sac-like phenotypes in a co-culture model. These findings suggest a role of GORAB in negatively regulating AKT phosphorylation, the expression of Vcan, and the migration of lung mesenchyme fibroblasts, and suggest that alveolar sac formation resembles a patterning event that is orchestrated by molecular signaling and the extracellular matrix in the mesenchyme.	[Liu, Ying; Liang, Wei; Zhang, Lianfeng; Qin, Chuan; Chen, Jiang] Chinese Acad Med Sci, Inst Lab Anim Sci, Minist Hlth, Beijing, Peoples R China; [Liu, Ying; Liang, Wei; Zhang, Lianfeng; Qin, Chuan; Chen, Jiang] Minist Hlth, Peking Union Med Coll, Comparat Med Ctr, Beijing, Peoples R China; [Liu, Ying; Liang, Wei; Zhang, Lianfeng; Qin, Chuan; Chen, Jiang] Minist Hlth, Key Lab Human Dis Comparat Med, Beijing, Peoples R China; [Chen, Xi; Choi, Yeon Ja; Yang, Ning; Song, Zhongya; Snedecor, Elizabeth R.; Chen, Jiang] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Chen, Xi; Leung, Elaine Lai-Han] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Song, Zhongya] Peking Univ First Hosp, Dept Dermatol, Beijing, Peoples R China; [Chen, Jiang] SUNY Stony Brook, Dept Dermatol, Stony Brook, NY 11794 USA; [Choi, Yeon Ja] Dongguk Univ Gyeongju, Coll Sci & Technol, Dept Biopharmaceut Engn, Gyeongju, South Korea	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Macau University of Science & Technology; Peking University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Dongguk University	Chen, J (corresponding author), SUNY Stony Brook, Renaissance Sch Med, Dept Pathol, Stony Brook, NY 11794 USA.; Qin, C (corresponding author), CAMS, PUMC, Comparat Med Ctr, Inst Lab Anim Sci, Beijing 100021, Peoples R China.	qinchuan@pumc.edu.cn; jiang.chen@stonybrook.edu	Chen, Xi/AAI-1665-2021; qin, chuan/ABG-4508-2020	Chen, Xi/0000-0001-8072-6335; 	Stony Brook University; China Scholarship Council [201706010325]; CAMS initiative for Innovative Medicine [2016-12M-2-006]; Macau Science and Technology Development Fund [0096/2018/A3]; Natural Science Foundation of China [31301928, 81472899, 81773308]; National Institute of Health of the United States of America [AR061485, AR071573]	Stony Brook University; China Scholarship Council(China Scholarship Council); CAMS initiative for Innovative Medicine; Macau Science and Technology Development Fund; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Health of the United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Jason Shieh for discussion and Adam Naqvi for assistance. We would also like to thank Dr. Lorin Olson for sharing the Pdgfr alpha/J mouse models, Dr. Uwe Kornak for sharing the Gorab conditional knockout mouse models, and the flow cytometry core facility of Stony Brook University for support. Zhongya Song was supported by the China Scholarship Council (No. 201706010325). This work was supported by CAMS initiative for Innovative Medicine (2016-12M-2-006), Macau Science and Technology Development Fund (Project No: 0096/2018/A3), and research grants from the Natural Science Foundation of China (31301928, 81472899, and 81773308) and the National Institute of Health of the United States of America (AR061485 and AR071573). The funders had no role in study design, data collection, data analysis, decision to publish, and preparation of the manuscript.	Andersson-Sjoland A, 2015, GLYCOBIOLOGY, V25, P243, DOI 10.1093/glycob/cwu120; Andersson-Sjoland A, 2011, J HEART LUNG TRANSPL, V30, P945, DOI 10.1016/j.healun.2011.04.006; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Benjamin JT, 2009, DEV BIOL, V335, P407, DOI 10.1016/j.ydbio.2009.09.021; Bird AD, 2014, AM J RESP CELL MOL, V50, P419, DOI 10.1165/rcmb.2013-0169OC; Bostrom H, 2002, DEV DYNAM, V223, P155, DOI 10.1002/dvdy.1225.abs; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Chan WL, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007242; Chao CM, 2015, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00027; Chen J, 2015, J INVEST DERMATOL, V135, P701, DOI 10.1038/jid.2014.483; Dieperink HI, 2006, PEDIATR RES, V59, P185, DOI 10.1203/01.pdr.0000196371.85945.3a; Dutt S, 2006, THESCIENTIFICWORLDJO, V6, P1114, DOI 10.1100/tsw.2006.219; Egerer J, 2015, J INVEST DERMATOL, V135, P2368, DOI 10.1038/jid.2015.192; Evanko SP, 2001, ARCH BIOCHEM BIOPHYS, V394, P29, DOI 10.1006/abbi.2001.2507; Faggian J, 2007, AM J PHYSIOL-REG I, V293, pR784, DOI 10.1152/ajpregu.00801.2006; Gouveia L, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.161976; Gouveia L, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13092; Greer RM, 2014, ORGANOGENESIS, V10, P340, DOI 10.4161/org.29198; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Hatano S, 2012, GLYCOBIOLOGY, V22, P1268, DOI 10.1093/glycob/cws095; Henderson DJ, 1998, CIRC RES, V83, P523, DOI 10.1161/01.RES.83.5.523; Hennies HC, 2008, NAT GENET, V40, P1410, DOI 10.1038/ng.252; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Hsu HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14612-5; Hu L, 2012, CARCINOGENESIS, V33, P1581, DOI 10.1093/carcin/bgs162; Kinsella MG, 2004, CRIT REV EUKAR GENE, V14, P203, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i3.40; Kresch MJ, 1998, PEDIATR RES, V43, P426, DOI 10.1203/00006450-199803000-00020; Kruithof BPT, 2007, DEV BIOL, V302, P208, DOI 10.1016/j.ydbio.2006.09.024; Kugler MC, 2017, AM J RESP CELL MOL, V57, P280, DOI 10.1165/rcmb.2016-0268OC; Kugler MC, 2015, AM J RESP CELL MOL, V52, P1, DOI 10.1165/rcmb.2014-0132TR; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; Li J, 2001, DEV BIOL, V239, P338, DOI 10.1006/dbio.2001.0441; Lindahl P, 1997, DEVELOPMENT, V124, P3943; Liu Y, 2016, J INVEST DERMATOL, V136, P378, DOI 10.1016/j.jid.2015.10.067; Liu YH, 2012, MOL BIOL CELL, V23, P4506, DOI 10.1091/mbc.E12-05-0362; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; McCulley D, 2015, CURR OPIN GENET DEV, V32, P98, DOI 10.1016/j.gde.2015.01.011; McGowan SE, 2013, AM J PHYSIOL-LUNG C, V305, P1229, DOI 10.1152/ajplung.00011.2013; McGowan SE, 2008, ANAT REC, V291, P1649, DOI 10.1002/ar.20764; Noskovicova N, 2015, AM J RESP CELL MOL, V52, P263, DOI 10.1165/rcmb.2014-0294TR; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; Osman N, 2014, CELL SIGNAL, V26, P912, DOI 10.1016/j.cellsig.2014.01.019; Rahmani M, 2006, CAN J PHYSIOL PHARM, V84, P77, DOI 10.1139/Y05-154; Rajab A, 2008, AM J MED GENET A, V146A, P965, DOI 10.1002/ajmg.a.32143; Saito S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186615; Sani FV, 2010, EUR J ORAL SCI, V118, P221, DOI 10.1111/j.1600-0722.2010.00732.x; Scavo LM, 1998, AM J RESP CELL MOL, V18, P21, DOI 10.1165/ajrcmb.18.1.2744; Schittny JC, 2017, CELL TISSUE RES, V367, P427, DOI 10.1007/s00441-016-2545-0; Snow HE, 2005, ANAT REC PART A, V282A, P95, DOI 10.1002/ar.a.20151; Snyder JM, 2015, J HISTOCHEM CYTOCHEM, V63, P952, DOI 10.1369/0022155415610383; Sun T, 2000, DEVELOPMENT, V127, P4519; Szabo A, 2016, J CELL BIOL, V213, P543, DOI 10.1083/jcb.201602083; Theocharis AD, 2008, CONNECT TISSUE RES, V49, P230, DOI 10.1080/03008200802147571; Tiedemann K, 1997, MATRIX BIOL, V15, P469, DOI 10.1016/S0945-053X(97)90020-2; Volckaert T, 2015, DEV DYNAM, V244, P342, DOI 10.1002/dvdy.24234; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Xue GD, 2013, JNCI-J NATL CANCER I, V105, P393, DOI 10.1093/jnci/djs648; Yan J, 2010, FEBS LETT, V584, P3275, DOI 10.1016/j.febslet.2010.06.027; Yang ZP, 2014, ASIAN PAC J CANCER P, V15, P7467, DOI 10.7314/APJCP.2014.15.17.7467; Zhang WD, 2016, MOL NEUROBIOL, V53, P6342, DOI 10.1007/s12035-015-9531-5; Zhang YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22597; Zhuo Y, 2006, TRANSGENIC RES, V15, P543, DOI 10.1007/s11248-006-9007-5	64	0	0	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4918	4933		10.1096/fj.201902075R	http://dx.doi.org/10.1096/fj.201902075R		FEB 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32067289	Green Accepted			2022-12-26	WOS:000515251000001
J	Zhao, HL; Liu, ML; Chen, ZF; Mei, KB; Yu, P; Xie, LX				Zhao, Huilei; Liu, Menglu; Chen, Zhifeng; Mei, Kaibo; Yu, Peng; Xie, Lixia			Dose-response analysis between hemoglobin A1c and risk of atrial fibrillation in patients with and without known diabetes	PLOS ONE			English	Article							GLYCATED HEMOGLOBIN; POPULATION; GUIDELINES; DIAGNOSIS; MELLITUS; SOCIETY; HBA1C	Background The relationship between serum hemoglobin A1c (HbA1c) and atrial fibrillation (AF) or postoperative AF (POAF) in coronary artery bypass (CABG) patients is still under debate. It is also unclear whether there is a dose-response relationship between circulating HbA1c and the risk of AF or POAF. Methods and results The Cochrane Library, PubMed, and EMBASE databases were searched. A robust-error meta-regression method was used to summarize the shape of the dose-response relationship. The RR and 95%CI were using a random-effects model. In total, 14 studies were included, totaling 17,914 AF cases among 352,325 participants. The summary RR per 1% increase in HbA1c was 1.16 (95% CI: 1.07-1.27). In the subgroup analysis, the summary RR was 1.13 (95% CI: 1.08-1.19) or 1.12 (95% CI: 1.05-1.20) for patients with diabetes or without known diabetes, respectively. The nonlinear analysis showed a nonlinear (P-nonlinear = 0.04) relationship between HbA1c and AF, with a significantly increased risk of AF if HbA1c was over 6.3%. However, HbA1c (per 1% increase) was not associated with POAF in patients with diabetes (RR: 1.13, P = 0.34) or without known diabetes (RR: 0.91, P = 0.37) among patients undergoing CABG. Conclusion Our results suggest that higher HbA1c was associated with an increased risk of AF, both in diabetes and in without diabetes or with unknown diabetes. However, no association was found between HbA1c and POAF in patients undergoing CABG. Further prospective studies with larger population sizes are needed to explore the association between serum HbA1c level and the risk of POAF.	[Zhao, Huilei] Third Hosp Nanchang, Dept Anesthesiol, Nanchang, Jiangxi, Peoples R China; [Liu, Menglu] Seventh Peoples Hosp, Dept Cardiol, Zhengzhou, Henan, Peoples R China; [Chen, Zhifeng] Fuzhou Univ Int Studies & Trade, Fuzhou, Fujian, Peoples R China; [Mei, Kaibo] Shangrao Peoples Hosp, Dept Anesthesiol, Shangrao, Jiangxi, Peoples R China; [Yu, Peng] Nanchang Univ, Dept Endocrinol, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China; [Xie, Lixia] Nanchang Univ, Dept Resp & Crit Care Med, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University	Xie, LX (corresponding author), Nanchang Univ, Dept Resp & Crit Care Med, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China.	xielixia2030@163.com	Xie, li/HGE-6052-2022	peng, yu/0000-0002-9405-7686				Abbaszadeh Shahin, 2017, Crit Pathw Cardiol, V16, P37, DOI 10.1097/HPC.0000000000000103; Anderson TJ, 2013, CAN J CARDIOL, V29, P151, DOI 10.1016/j.cjca.2012.11.032; Blasco ML, 2014, EUR HEART J-ACUTE CA, V3, P347, DOI 10.1177/2048872614530574; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Cavero-Redondo I, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-015949; Dahlqvist S, 2017, LANCET DIABETES ENDO, V5, P799, DOI 10.1016/S2213-8587(17)30262-0; Dublin S, 2010, J GEN INTERN MED, V25, P853, DOI 10.1007/s11606-010-1340-y; Gillett Melissa J, 2009, Clin Biochem Rev, V30, P197; Gudul NE, 2017, KOREAN J INTERN MED, V32, P286, DOI 10.3904/kjim.2014.380; Halkos ME, 2008, J THORAC CARDIOV SUR, V136, P631, DOI 10.1016/j.jtcvs.2008.02.091; Harati H, 2019, DIABETOLOGIA, V62, P800, DOI 10.1007/s00125-019-4836-y; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hong LF, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-89; Huxley RR, 2012, HEART, V98, P133, DOI 10.1136/heartjnl-2011-300503; Iguchi Y, 2012, INT J CARDIOL, V156, P156, DOI 10.1016/j.ijcard.2010.10.039; Johansen OE, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-28; John WG, 2012, PRACT DIABETES, V29, P12, DOI 10.1002/pdi.1648; Kinoshita T, 2012, EUR J CARDIO-THORAC, V41, P102, DOI 10.1016/j.ejcts.2011.04.011; Latini R, 2013, AM HEART J, V166, P935, DOI 10.1016/j.ahj.2013.08.012; Lee SS, 2017, EUR HEART J, V38, P2599, DOI 10.1093/eurheartj/ehx316; Liu X, 2020, OBES REV, V21, DOI 10.1111/obr.12970; Matsuura K, 2009, ANN THORAC CARDIOVAS, V15, P18; Mcpheeters ML., 2012, NEWCASTLE OTTAWA QUA; Qi Wenwei, 2017, PLoS One, V12, pe0170955, DOI 10.1371/journal.pone.0170955; Sandhu RK, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000916; Santos-Oliveira R, 2011, DIABETOLOGIA, V54, P1327, DOI 10.1007/s00125-011-2078-8; Schoen T, 2012, J AM COLL CARDIOL, V60, P1421, DOI 10.1016/j.jacc.2012.06.030; Surer S, 2016, PAK J MED SCI, V32, P59, DOI 10.12669/pjms.321.8588; Tsuruta R, 2011, J CARDIOL, V57, P181, DOI 10.1016/j.jjcc.2010.11.003; Turgut O, 2013, PLATELETS, V24, P493, DOI 10.3109/09537104.2012.725876; Yang YF, 2015, INT J CLIN EXP MED, V8, P3271	31	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0227262	10.1371/journal.pone.0227262	http://dx.doi.org/10.1371/journal.pone.0227262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7XT	32069297	Green Published, gold			2022-12-26	WOS:000535212900007
J	Bright, T; McCormick, I; Phiri, M; Mulwafu, W; Burton, M; Polack, S; Mactaggart, I; Yip, JLY; Swanepoel, D; Kuper, H				Bright, Tess; McCormick, Ian; Phiri, Mwanaisha; Mulwafu, Wakisa; Burton, Matthew; Polack, Sarah; Mactaggart, Islay; Yip, Jennifer L. Y.; Swanepoel, De Wet; Kuper, Hannah			Rationale and feasibility of a combined rapid assessment of avoidable blindness and hearing loss protocol	PLOS ONE			English	Article							SMARTPHONE THRESHOLD AUDIOMETRY; VISION IMPAIRMENT; PREVALENCE; HEALTH	Purpose This study has two main objectives: 1) to assess the value of combining the rapid assessment of avoidable blindness (RAAB) and the recently developed rapid assessment of hearing loss (RAHL) based on existing population-based data from Cameroon andIndia; 2) to test the feasibility of a combined RAAB-RAHL protocol. Methods A secondary data analysis of population-based disability surveys in India and Cameroon (in 2013-2014) was conducted, focussing on people aged 50+. Hearing impairment (HI) was defined as pure tone average of >= 41dB (better ear). Visual impairment (VI) was defined as presenting visual acuity of <6/18 (better eye). The relationship between HI and VI was examined. The feasibility of a combined RAAB-RAHL survey was assessed within a RAHL conducted among adults aged 50+ in Malawi in 2018. Outcomes included: time taken, costs, number of people examined in a day, and qualitative feedback from participants and field teams. Results The prevalence of combined VI and HI among people aged 50+ was 4.4% (95% confidence interval (CI) 3.0, 6.4) in India and 4.8% (95%CI 3.0, 8.0) in Cameroon. Among participants with VI, approximately a third in India (29.3%) and Cameroon (35.1%) also had HI. A quarter of participants in India (25.4%) and Cameroon (26.9%) who had HI also had VI. In Malawi, the total time taken to complete both RAAB and RAHL assessments was approximately 27 minutes per participant. It was feasible to complete 30 participants per day for a team of four people. The estimated cost of a combined RAAB-RAHL approach in comparison to two separate impairment surveys is up to 37% less depending on the method of combination. Conclusion The substantial overlap between VI and HI supports a combined rapid survey of the two impairments. The pilot study of a combined RAAB-RAHL survey demonstrates feasibility and lower cost compared to conducting two standalone impairment surveys. A combined RAAB-RAHL approach could maximize limited resources to increase prevalence data for both vision and hearing impairment.	[Bright, Tess; Polack, Sarah; Mactaggart, Islay; Yip, Jennifer L. Y.; Kuper, Hannah] London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, Keppel St, London, England; [McCormick, Ian; Burton, Matthew] London Sch Hyg & Trop Med, Int Ctr Eye Hlth, Keppel St, London, England; [Phiri, Mwanaisha] Queen Elizabeth Cent Hosp, Audiol Dept, Blantyre, Malawi; [Mulwafu, Wakisa] Coll Med, Dept Surg, Blantyre, Malawi; [Swanepoel, De Wet] Univ Pretoria, Dept Speech Language Pathol & Audiol, Pretoria, Gauteng, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Malawi; University of Malawi; University of Pretoria	Bright, T (corresponding author), London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, Keppel St, London, England.	tess.bright@lshtm.ac.uk		Swanepoel, De Wet/0000-0001-8313-1636; Burton, Matthew/0000-0003-1872-9169; McCormick, Ian/0000-0002-7360-3844; Mactaggart, Islay/0000-0001-6287-0384	CBM International; Newton Advanced Fellowship Award [NAF\R1\180332]; Wellcome Trust [207472/Z/17/Z]	CBM International; Newton Advanced Fellowship Award; Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by CBM International (SP). Financial support for DWS provided through a Newton Advanced Fellowship Award (NAF\R1\180332). MJB is supported by the Wellcome Trust (Grant Number 207472/Z/17/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Khabori M, 2004, INT J AUDIOL, V43, P486, DOI 10.1080/14992020400050062; Bastawrous A, 2015, JAMA OPHTHALMOL, V133, P930, DOI 10.1001/jamaophthalmol.2015.1468; Billingham SAM, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-104; Bourne RRA, 2017, LANCET GLOB HEALTH, V5, pE888, DOI 10.1016/S2214-109X(17)30293-0; Bright T, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16183405; Bright T, 2019, TROP MED INT HEALTH, V24, P817, DOI 10.1111/tmi.13238; Bright T, 2019, EAR HEARING, V40, P204, DOI 10.1097/AUD.0000000000000599; Campbell V A, 1999, MMWR CDC Surveill Summ, V48, P131; Chia EM, 2007, EAR HEARING, V28, P187, DOI 10.1097/AUD.0b013e31803126b6; Chia EM, 2006, ARCH OPHTHALMOL-CHIC, V124, P1465, DOI 10.1001/archopht.124.10.1465; Crews JE, 2004, AM J PUBLIC HEALTH, V94, P823, DOI 10.2105/AJPH.94.5.823; Dineen B, 2006, OPHTHAL EPIDEMIOL, V13, P31, DOI 10.1080/09286580500473787; Faustman E.M., 2018, HDB LIFE COURSE HLTH, P349, DOI [10.1007/978-3-319-47143-3, DOI 10.1007/978-3-319-47143-3]; Ferrite S, 2017, TROP MED INT HEALTH, V22, P485, DOI 10.1111/tmi.12840; Folkeard P, 2019, INT J AUDIOL, V58, P427, DOI 10.1080/14992027.2019.1594415; IMHE, 2017, GBD COMPARE; Kuper Hannah, 2006, Community Eye Health, V19, P68; Limburg H, 2013, RAAB6 RAPID ASSESSME; Limburg H., 2013, RAPID ASSESSMENT AVO; Lowe J, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/743263; Mactaggart I, 2019, BRIT J OPHTHALMOL, V103, P1549, DOI 10.1136/bjophthalmol-2019-314015; Mactaggart I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164470; Murthy GVS, 2014, ARCH DIS CHILD, V99, P1103, DOI 10.1136/archdischild-2014-305937; National Insitute for Health Research (NIHR), 2019, DEF FEAS VS PIL STUD; Organization WH, 2015, SUMM WORLD REP AG HL; Sandstrom J, 2016, INT J AUDIOL, V55, P232, DOI 10.3109/14992027.2015.1124294; Stevens G, 2013, EUR J PUBLIC HEALTH, V23, P146, DOI 10.1093/eurpub/ckr176; Swenor BK, 2013, JAMA INTERN MED, V173, P312, DOI 10.1001/jamainternmed.2013.1880; Tataryn M, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0948-z; van Tonder J, 2017, J AM ACAD AUDIOL, V28, P200, DOI 10.3766/jaaa.16002; WHO (World Health Organization), 2018, DEAFN HEAR LOSS; World Health Organization, 2019, WORLD REP VIS; World Health Organization, BLINDN VIS IMP; World Health Organization, 2018, ADDR RIS PREV HEAR; World Health Organization, 2018, HEAR FUTURE; World Health Organization, 2012, FACTS DEAFN	36	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0229008	10.1371/journal.pone.0229008	http://dx.doi.org/10.1371/journal.pone.0229008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053650	Green Published, gold, Green Accepted			2022-12-26	WOS:000535198700089
J	Laundre, JW; Papouchis, C				Laundre, John W.; Papouchis, Christopher			The Elephant in the room: What can we learn from California regarding the use of sport hunting of pumas (Puma concolor) as a management tool?	PLOS ONE			English	Article							NORTH-AMERICAN MODEL; WILDLIFE CONSERVATION; UNITED-STATES; COUGAR; MULE; POPULATIONS; LANDSCAPE; SURVIVAL; MOVEMENT	Puma (Puma concolor) management in the western United States is highly contentious, particularly with regard to the use of sport hunting as a management tool. Since the 1970s, puma in ten western states have been managed by state fish and game agencies through the use of a sport hunt. The rationale presented by wildlife managers is that sport hunting, in addition to providing recreational hunting opportunities, also reduces threats to human safety and livestock safety, and increases populations of the puma's ungulate prey, namely deer (Odocoileus sp.) and elk (Cervus elepus). We evaluated these claims using the state of California as a control, which has prohibited sport hunting since 1972, and employing data obtained from state and federal agencies with authority and control over puma management. Specifically, we tested four hypotheses: 1) sport hunting will suppress puma populations, 2) sport hunting will reduce the number of problematic puma-human encounters; 3) sport hunting will reduce puma predation on domestic livestock, and 4) sport hunting will reduce the impact of puma predation on wild ungulate numbers, resulting in increased hunting opportunities for the sport hunt of ungulates. Our results indicated, respectively, that relative to the 10 states where puma are hunted, California had 1) similar puma densities, 2) the 3rd lowest per capita problematic puma-human encounters, 3) similar per capita loss of cattle (P = 0.13) and a significantly lower (t = 5.7, P < 0.001) per capita loss of sheep, and 4) similar average deer densities while changes in annual deer populations correlated with changes in other states (F = 95.4, P < 0.001, R-2 = 0.68). In sum, our analysis of the records obtained from state and federal wildlife agencies found no evidence that sport hunting of pumas has produced the management outcomes sought by wildlife managers aside from providing a sport hunting opportunity. Consequently, and particularly because other research suggests that sport hunting actually exacerbate conflicts between pumas and humans, we recommend that state agencies re-assess the use of sport hunting as a management tool for pumas.	[Laundre, John W.] Western Oregon Univ, Dept Biol, Monmouth, OR 97361 USA; [Papouchis, Christopher] Calif State Univ Sacramento, Dept Environm Studies, Sacramento, CA 95819 USA	Western Oregon University; California State University System; California State University Sacramento	Laundre, JW (corresponding author), Western Oregon Univ, Dept Biol, Monmouth, OR 97361 USA.	launjohn@hotmail.com						Artelle KA, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao0167; Ballard WB, 2001, WILDLIFE SOC B, V29, P99; Beausoleil RA, 2013, WILDLIFE SOC B, V37, P680, DOI 10.1002/wsb.299; Becker SA, 2003, P 7 MOUNT LION WORKS; BEIER P, 1991, WILDLIFE SOC B, V19, P403; BEIER P, 1995, J MAMMAL, V76, P1056, DOI 10.2307/1382599; Benson JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158006; Connolly G.E., 1978, P369; Cooley HS, 2009, ECOLOGY, V90, P2913, DOI 10.1890/08-1805.1; Cougar Management Guidelines Working Group, 2005, COUGAR MANAGEMENT GU; Darimont CT, 2018, CONSERV BIOL, V32, P747, DOI 10.1111/cobi.13065; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Elbroch LM, 2017, CURR ZOOL, V63, P357, DOI 10.1093/cz/zow080; Feldpausch-Parker AM, 2017, CONSERV SOC, V15, P33, DOI 10.4103/0972-4923.201395; Forrester TD, 2013, MAMMAL REV, V43, P292, DOI 10.1111/mam.12002; Gilbert SL, 2017, CONSERV LETT, V10, P431, DOI 10.1111/conl.12280; Gill RB, 2017, COUGAR ECOLOGY CONSE, P5; Hornocker M.G., 1970, WILDLIFE MONOGR, V21, P3; Humane Society of the United States, 2017, STAT MOUNT CALL END; Hurley MA, 2011, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.4; Kertson BN, 2011, ECOL APPL, V21, P2866, DOI 10.1890/11-0947.1; Kolbe J, 2017, P 12 MOUNT LION WORK, P99; Lambert CMS, 2006, J WILDLIFE MANAGE, V70, P246, DOI 10.2193/0022-541X(2006)70[246:CPDAVI]2.0.CO;2; Laundre J, 2003, ANIM CONSERV, V6, P159, DOI 10.1017/S1367943003003202; Laundre JW, 2006, CAN J ZOOL, V84, P1555, DOI 10.1139/Z06-150; Laundre JW, 2007, J WILDLIFE MANAGE, V71, P345, DOI 10.2193/2005-627; Leopold Aldo, 1949, S COUNTY ALMANAC; Logan K.A., 2001, DESERT PUMA EVOLUTIO; Maletzke BT, 2014, ECOL EVOL, V4, P2178, DOI 10.1002/ece3.1089; Mattson D.J., 2014, LARGE CARNIVORE CONS, P29; Mech LD, 1996, WILDLIFE SOC B, V24, P397; Mooney H, 2016, ECOSYSTEMS OF CALIFORNIA, P1; Organ J.F., 2012, N AM MODEL WILDLIFE; Peebles KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079713; Peterson MN, 2017, HUM DIMENS WILDL, V22, P43, DOI 10.1080/10871209.2016.1234009; Robinson H. S, 2011, GARNET RANGE MOUNTAI; Robinson HS, 2008, ECOL APPL, V18, P1028, DOI 10.1890/07-0352.1; Seidensticker JC, 1973, WILDLIFE MONOGR, V35, P3; Teichman KJ, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0098-4; Treves A, 2016, FRONT ECOL ENVIRON, V14, P380, DOI 10.1002/fee.1312; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; U.S Department of the Interior U.S. Fish and Wildlife Service and U.S. Department of Commerce U.S. census Bureau, 2016, 2016 NAT SURV FISH; Unsworth JW, 1999, J WILDLIFE MANAGE, V63, P315, DOI 10.2307/3802515; Vickers TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131490; Vieira M., 2017, P 12 MOUNT LION WORK, P85; Vucetich JA, 2017, J MAMMAL, V98, P53, DOI 10.1093/jmammal/gyw151; Western Association of Fish and Wildlife Agencies, 2016, 2016 BLACK TAIL MUL; Western Association of Fish and Wildlife Agencies, 2013, 2013 BLACK TAIL MUL; White CG, 2010, J WILDLIFE MANAGE, V74, P355, DOI 10.2193/2007-506; Winslow F, 2017, P 12 MOUNT LION WORK, P117; Zar JH, 1999, BIOSTATISTICAL ANAL	51	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0224638	10.1371/journal.pone.0224638	http://dx.doi.org/10.1371/journal.pone.0224638			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053602	Green Published, Green Submitted, gold			2022-12-26	WOS:000535198700008
J	Luna, A; Palma, A; Sanz-Aguilar, A; Tella, JL; Carrete, M				Luna, Alvaro; Palma, Antonio; Sanz-Aguilar, Ana; Tella, Jose L.; Carrete, Martina			Sex, personality and conspecific density influence natal dispersal with lifetime fitness consequences in urban and rural burrowing owls	PLOS ONE			English	Article							BREEDING HABITAT SELECTION; FEMALE-BIASED DISPERSAL; REPRODUCTIVE SUCCESS; INBREEDING AVOIDANCE; SITE FIDELITY; INDIVIDUAL DISPERSAL; DEPENDENT DISPERSAL; NONRANDOM DISPERSAL; PUBLIC INFORMATION; BIRD	There is a growing need to understand how species respond to habitat changes and the potential key role played by natal dispersal in population dynamics, structure and gene flow. However, few studies have explored differences in this process between conspecifics living in natural habitats and those inhabiting landscapes highly transformed by humans, such as cities. Here, we investigate how individual traits and social characteristics can influence the natal dispersal decisions of burrowing owls (Athene cunicularia) living in urban and rural areas, as well as the consequences in terms of reproductive success and apparent survival. We found short dispersal movements among individuals, with differences between urban and rural birds (i.e., the former covering shorter distances than the latter), maybe because of the higher conspecific density of urban compared to rural areas. Moreover, we found that urban and rural females as well as bold individuals (i.e., individuals with shorter flight initiation distance) exhibited longer dispersal distances than their counterparts. These dispersal decisions have effects on individual fitness. Individuals traveling longer distances increased their reproductive prospects (productivity during the first breeding attempt, and long term productivity). However, the apparent survival of females decreased when they dispersed farther from their natal territory. Although further research is needed to properly understand the ecological and evolutionary consequences of dispersal patterns in transformed habitats, our results provide information about the drivers and the consequences of the restricted natal movements of this species, which may explain its population structuring through restricted gene flow between and within urban and rural areas.	[Luna, Alvaro; Palma, Antonio; Tella, Jose L.] CSIC, Estn Biol Donana, Dept Conservat Biol, Seville, Spain; [Luna, Alvaro; Sanz-Aguilar, Ana] CSIC UIB, IMEDEA, Anim Demog & Ecol Unit, Esporles, Spain; [Sanz-Aguilar, Ana] Univ Balearic Isl, Appl Zool & Conservat Grp, Palma De Mallorca, Spain; [Carrete, Martina] Univ Pablo Olavide, Dept Phys Chem & Nat Syst, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona; Universitat de les Illes Balears; Universidad Pablo de Olavide	Luna, A (corresponding author), CSIC, Estn Biol Donana, Dept Conservat Biol, Seville, Spain.; Luna, A (corresponding author), CSIC UIB, IMEDEA, Anim Demog & Ecol Unit, Esporles, Spain.	aluna@ebd.csic.es	Sanz-Aguilar, Ana/D-3778-2014; Carrete, Martina/D-2618-2017; Carrete, Martina/A-6376-2009	Sanz-Aguilar, Ana/0000-0002-4177-9749; Palma, Antonio/0000-0002-9616-3415; Luna, Alvaro/0000-0002-8566-6367; Carrete, Martina/0000-0002-0491-2950	MINECO (Spain) [CGL2012-31888, CGL2015-71378-P]; Fundacion Repsol; La Caixa-Severo Ochoa International PhD Program (2014); La Caixa-Severo Ochoa International PhD Program (2015)	MINECO (Spain)(Spanish Government); Fundacion Repsol; La Caixa-Severo Ochoa International PhD Program (2014); La Caixa-Severo Ochoa International PhD Program (2015)	The project was funded by Projects CGL2012-31888 and CGL2015-71378-P from MINECO (Spain) and Fundacion Repsol (Jose L. Tella and Martina Carrete). Antonio Palma and A lvaro Luna were supported by La Caixa-Severo Ochoa International PhD Program (2014 and 2015 respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson MFJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3330; Baguette M, 2013, BIOL REV, V88, P310, DOI 10.1111/brv.12000; Barbraud C, 2003, J ANIM ECOL, V72, P246, DOI 10.1046/j.1365-2656.2003.00695.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BELETSKY LD, 1991, ECOLOGY, V72, P787, DOI 10.2307/1940581; Bize P, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0236; Bonte D, 2017, OIKOS, V126, P472, DOI 10.1111/oik.03801; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Boulinier T, 2002, J APPL STAT, V29, P509, DOI 10.1080/02664760120108566; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Brown CR, 2000, J ANIM ECOL, V69, P133, DOI 10.1046/j.1365-2656.2000.00382.x; Bubac CM, 2018, BEHAV ECOL SOCIOBIOL, V72, DOI 10.1007/s00265-018-2515-5; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Camacho C, 2015, EVOL ECOL, V29, P873, DOI 10.1007/s10682-015-9793-4; Camacho C, 2013, ECOL EVOL, V3, P4841, DOI 10.1002/ece3.563; Canestrelli D, 2016, TRENDS ECOL EVOL, V31, P35, DOI 10.1016/j.tree.2015.11.004; Carrete M, 2006, OIKOS, V112, P680, DOI 10.1111/j.0030-1299.2006.14528.x; Carrete M, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00054; Carrete M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31060; Carrete M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03524; Carrete M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018859; Carrete M, 2010, BIOL LETTERS, V6, P167, DOI 10.1098/rsbl.2009.0739; Choquet R, 2009, ENVIRON ECOL STAT SE, V3, P845, DOI 10.1007/978-0-387-78151-8_39; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Cote J, 2010, PHILOS T R SOC B, V365, P4065, DOI 10.1098/rstb.2010.0176; Cote J, 2010, P ROY SOC B-BIOL SCI, V277, P1571, DOI 10.1098/rspb.2009.2128; Cox AS, 2012, CONDOR, V114, P341, DOI 10.1525/cond.2012.110070; Dale S, 2001, OIKOS, V92, P344, DOI 10.1034/j.1600-0706.2001.920217.x; Danchin E, 1998, ECOLOGY, V79, P2415, DOI 10.2307/176832; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Davis JM, 2004, TRENDS ECOL EVOL, V19, P411, DOI 10.1016/j.tree.2004.04.006; Diaz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064634; Dingemanse NJ, 2003, P ROY SOC B-BIOL SCI, V270, P741, DOI 10.1098/rspb.2002.2300; Doligez B, 2004, J ANIM ECOL, V73, P75, DOI 10.1111/j.1365-2656.2004.00782.x; Doligez B, 2008, J ANIM ECOL, V77, P1199, DOI 10.1111/j.1365-2656.2008.01446.x; Duckworth RA, 2007, P NATL ACAD SCI USA, V104, P15017, DOI 10.1073/pnas.0706174104; Fogarty S, 2011, AM NAT, V177, P273, DOI 10.1086/658174; Forero MG, 2002, ECOLOGY, V83, P858, DOI 10.2307/3071887; Forero MG, 1999, ECOLOGY, V80, P1298, DOI 10.1890/0012-9658(1999)080[1298:CACOTC]2.0.CO;2; Fraser DF, 2001, AM NAT, V158, P124, DOI 10.1086/321307; Garant D, 2005, NATURE, V433, P60, DOI 10.1038/nature03051; GAVIN TA, 1988, ECOLOGY, V69, P96, DOI 10.2307/1943164; Greenhalgh S, 2007, POPUL DEV REV, V33, P639; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; GREIGSMITH PW, 1982, ORNIS SCAND, V13, P232, DOI 10.2307/3676304; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; HOELZEL AR, 1991, HEREDITY, V66, P191, DOI 10.1038/hdy.1991.24; Jongejans E, 2008, J ECOL, V96, P687, DOI 10.1111/j.1365-2745.2008.01367.x; Kokko H, 2006, SCIENCE, V313, P789, DOI 10.1126/science.1128566; Kubisch A, 2014, OIKOS, V123, P5, DOI 10.1111/j.1600-0706.2013.00706.x; Lebigre C, 2010, MOL ECOL, V19, P1929, DOI 10.1111/j.1365-294X.2010.04614.x; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lemel JY, 1997, EVOL ECOL, V11, P613, DOI 10.1007/s10682-997-1516-z; Luna A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39251-w; Luna A, 2018, PEERJ, V6, DOI 10.7717/peerj.4908; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Moller AP, 2012, OECOLOGIA, V170, P867, DOI 10.1007/s00442-012-2355-3; Moller AP, 2010, BEHAV ECOL, V21, P365, DOI 10.1093/beheco/arp199; Moulton CE, 2004, J FIELD ORNITHOL, V75, P288, DOI 10.1648/0273-8570-75.3.288; Mueller JC, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0206; Nager RG, 1996, OECOLOGIA, V107, P204, DOI 10.1007/BF00327904; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; PART T, 1995, ANIM BEHAV, V49, P1029, DOI 10.1006/anbe.1995.0132; Payo-Payo A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20333-0; Piper WH, 2008, J ANIM ECOL, V77, P205, DOI 10.1111/j.1365-2656.2007.01334.x; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; R Development Core Team, 2008, LANG ENV STAT COMP; Rebolo-Ifran N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03853-z; Rebolo-Ifran N, 2015, SCI REP-UK, V5, DOI 10.1038/srep13723; Roberts L, 2011, SCIENCE, V333, P540, DOI 10.1126/science.333.6042.540; Rodrigues AMM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1226; RODRIGUEZMARTIN.S, 2014, PLOS ONE, V0009; Serrano D, 2003, ECOLOGY, V84, P3044, DOI 10.1890/02-0231; Serrano D, 2012, J ANIM ECOL, V81, P97, DOI 10.1111/j.1365-2656.2011.01878.x; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; Sol D, 2014, ECOL LETT, V17, P942, DOI 10.1111/ele.12297; Spear LB, 1998, J ANIM ECOL, V67, P165, DOI 10.1046/j.1365-2656.1998.00190.x; Sprau P, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00092; Stracey CM, 2012, J AVIAN BIOL, V43, P50, DOI 10.1111/j.1600-048X.2011.05520.x; Szulkin M, 2008, P R SOC B, V275, P703, DOI 10.1098/rspb.2007.0989; Tarwater CE, 2010, ANIM BEHAV, V80, P535, DOI 10.1016/j.anbehav.2010.06.017; Tella JL, 2014, ARDEOLA, V61, P311, DOI 10.13157/arla.61.2.2014.311; Trochet A, 2016, Q REV BIOL, V91, P297, DOI 10.1086/688097; Wiklund CG, 1996, P ROY SOC B-BIOL SCI, V263, P723, DOI 10.1098/rspb.1996.0108	90	7	8	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0226089	10.1371/journal.pone.0226089	http://dx.doi.org/10.1371/journal.pone.0226089			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32049995	Green Published, gold			2022-12-26	WOS:000535192300002
J	Stabach, JA; Cunningham, SA; Connette, G; Mota, JL; Reed, D; Byron, M; Songer, M; Wacher, T; Mertes, K; Brown, JL; Comizzoli, P; Newby, J; Monfort, S; Leimgruber, P				Stabach, Jared A.; Cunningham, Stephanie A.; Connette, Grant; Mota, Joel L.; Reed, Dolores; Byron, Michael; Songer, Melissa; Wacher, Tim; Mertes, Katherine; Brown, Janine L.; Comizzoli, Pierre; Newby, John; Monfort, Steven; Leimgruber, Peter			Short-term effects of GPS collars on the activity, behavior, and adrenal response of scimitar-horned oryx (Oryx dammah)	PLOS ONE			English	Article							PHYSIOLOGICAL STRESS-RESPONSE; RADIO-COLLARS; MOVEMENT; CAPTURE; ACCELEROMETERS; RADIOTELEMETRY; OPPORTUNITIES; REPRODUCTION; ECOLOGY; BIOLOGY	GPS collars have revolutionized the field of animal ecology, providing detailed information on animal movement and the habitats necessary for species survival. GPS collars also have the potential to cause adverse effects ranging from mild irritation to severe tissue damage, reduced fitness, and death. The impact of GPS collars on the behavior, stress, or activity, however, have rarely been tested on study species prior to release. The objective of our study was to provide a comprehensive assessment of the short-term effects of GPS collars fitted on scimitar-horned oryx (Oryx dammah), an extinct-in-the-wild antelope once widely distributed across Sahelian grasslands in North Africa. We conducted behavioral observations, assessed fecal glucocorticoid metabolites (FGM), and evaluated high-resolution data from tri-axial accelerometers. Using a series of datasets and methodologies, we illustrate clear but short-term effects to animals fitted with GPS collars from two separate manufacturers (Advanced Telemetry Systems-G2110E; Vectronic Aerospace-Vertex Plus). Behavioral observations highlighted a significant increase in the amount of headshaking from pretreatment levels, returning below baseline levels during the post-treatment period (>3 days post-collaring). Similarly, FGM concentrations increased after GPS collars were fitted on animals but returned to pre-collaring levels within 5 days of collaring. Lastly, tri-axial accelerometers, collecting data at eight positions per second, indicated a > 480 percent increase in the amount of hourly headshaking immediately after collaring. This post-collaring increase in headshaking was estimated to decline in magnitude within 4 hours after GPS collar fitting. These effects constitute a handling and/or habituation response (model dependent), with animals showing short-term responses in activity, behavior, and stress that dissipated within several hours to several days of being fitted with GPS collars. Importantly, none of our analyses indicated any long-term effects that would have more pressing animal welfare concerns.	[Stabach, Jared A.; Cunningham, Stephanie A.; Connette, Grant; Mota, Joel L.; Reed, Dolores; Byron, Michael; Songer, Melissa; Mertes, Katherine; Brown, Janine L.; Comizzoli, Pierre; Monfort, Steven; Leimgruber, Peter] Smithsonian Natl Zoo & Conservat Biol Inst, Front Royal, VA 22630 USA; [Wacher, Tim] Zool Soc London, London, England; [Newby, John] Sahara Conservat Fund, Bussy St Georges, France; [Cunningham, Stephanie A.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA; [Mota, Joel L.] Univ West Virginia, Davis Coll Agr Nat Resources & Design, Morgantown, WV USA; [Byron, Michael] North Carolina State Univ, Raleigh, NC USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Zoological Society of London; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; University of North Carolina; North Carolina State University	Stabach, JA (corresponding author), Smithsonian Natl Zoo & Conservat Biol Inst, Front Royal, VA 22630 USA.	stabachj@si.edu	Stabach, Jared/AEX-9187-2022; Leimgruber, Peter/O-1304-2015	Stabach, Jared/0000-0002-7896-1237; Leimgruber, Peter/0000-0002-3682-0153; Cunningham, Stephanie/0000-0002-4470-3299; Songer, Melissa/0000-0001-5536-6315	Environment Agency - Abu Dhabi; Smithsonian Conservation Biology Institute; Sahara Conservation Fund	Environment Agency - Abu Dhabi; Smithsonian Conservation Biology Institute(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute); Sahara Conservation Fund	Funding for this project was provided by the Environment Agency - Abu Dhabi, the Sahara Conservation Fund, and the Smithsonian Conservation Biology Institute.	Adamczewski JZ, 1997, J ZOOL, V241, P245, DOI 10.1111/j.1469-7998.1997.tb01956.x; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Becciolini V, 2019, WILDLIFE BIOL, DOI [10.1111/2981/w1b.00499, 10.1111/2981/wlb.00499]; Benson E., 2010, WIRED WILDERNESS TEC; Bidder OR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088609; Bohrer G, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-2; Bom RA, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-6; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brogi R, 2019, WILDLIFE BIOL, DOI 10.2981/wlb.00497; Brown DD, 2013, ANIM BIOTELEM, V1, P20, DOI DOI 10.1186/2050-3385-1-20; Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2155, DOI 10.1098/rstb.2010.0098; Chivers LS, 2016, CONDOR, V118, P159, DOI 10.1650/CONDOR-15-66.1; Cid B, 2013, ZOOLOGIA-CURITIBA, V30, P115, DOI 10.1590/S1984-46702013000100015; Collins GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103189; Creel S, 1997, CONSERV BIOL, V11, P544, DOI 10.1046/j.1523-1739.1997.95476.x; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Creel S, 2013, FUNCT ECOL, V27, P66, DOI 10.1111/j.1365-2435.2012.02029.x; Dantzer B, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou023; Dennis TE, 2012, J APPL ANIM WELF SCI, V15, P189, DOI 10.1080/10888705.2012.683755; Dorsey C, 2010, J ZOO WILDLIFE MED, V41, P616, DOI 10.1638/2009-0162.1; Durnin ME, 2004, J WILDLIFE MANAGE, V68, P987, DOI 10.2193/0022-541X(2004)068[0987:EOROGP]2.0.CO;2; Ellis J., 2015, IUCN RED LIST 2017 2, pe.T63100A48908629; Ezenwa VO, 2016, RECIPROCAL RELATIONS; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Flack A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500931; Frair JL, 2005, LANDSCAPE ECOL, V20, P273, DOI 10.1007/s10980-005-2075-8; Hallworth MT, 2015, SCI REP-UK, V5, DOI 10.1038/srep11069; Hartup BK, 2005, ZOO BIOL, V24, P15, DOI 10.1002/zoo.20033; Hodges Keith, 2010, P447; Hopkins ME, 2016, INT J PRIMATOL, V37, P213, DOI 10.1007/s10764-016-9896-y; Igual JM, 2005, MAR BIOL, V146, P619, DOI 10.1007/s00227-004-1461-0; Jewell Z, 2013, CONSERV BIOL, V27, P501, DOI 10.1111/cobi.12066; Jung TS, 2019, J WILDLIFE MANAGE, V83, P830, DOI 10.1002/jwmg.21640; Kays R, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2478; Kellner K, 2015, JAGSUI WRAPPER RJAGS; Krausman PR, 2004, WILDLIFE SOC B, V32, P987, DOI 10.2193/0091-7648(2004)032[0987:FTFNLI]2.0.CO;2; Legagneux P, 2013, J FIELD ORNITHOL, V84, P201, DOI 10.1111/jofo.12019; MacNulty DR, 2007, J MAMMAL, V88, P595, DOI 10.1644/06-MAMM-A-119R1.1; McClune D.W., 2014, ANIM BIOTELEM, V2, P1, DOI [10.1186/2050-3385-2-5, DOI 10.1186/2050-3385-2-5]; McShea W, 1992, VA J SCI, P43; Mertes K., 2019, FRONT ECOL EVOL, V7, P470, DOI [10.3389/fevo.2019.00470, DOI 10.3389/FEVO.2019.00470]; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Millspaugh JJ, 2003, WILDLIFE SOC B, V31, P399; Millspaugh JJ, 2001, WILDLIFE SOC B, V29, P899; Moll RJ, 2009, J WILDLIFE MANAGE, V73, P609, DOI 10.2193/2008-266; Morales JM, 2005, LANDSCAPE ECOL, V20, P301, DOI 10.1007/s10980-005-0061-9; Morrow CJ, 2000, ANIM REPROD SCI, V59, P71, DOI 10.1016/S0378-4320(00)00067-1; Mueller T, 2011, GLOBAL ECOL BIOGEOGR, V20, P683, DOI 10.1111/j.1466-8238.2010.00638.x; Murray DL, 2000, METH C CONS, P15; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Neumann W, 2011, CAN J ZOOL, V89, P1013, DOI 10.1139/Z11-076; Northrup JM, 2014, J WILDLIFE MANAGE, V78, P731, DOI 10.1002/jwmg.705; Northrup JM, 2013, ECOLOGY, V94, P1456, DOI 10.1890/12-1688.1; Nussberger B, 2006, WILDLIFE BIOL, V12, P339, DOI 10.2981/0909-6396(2006)12[339:EOROBO]2.0.CO;2; Packard JM, 2014, J ZOO AQUAR RES, V2, P82; Pagano AM, 2017, ENDANGER SPECIES RES, V32, P19, DOI 10.3354/esr00779; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Powers DMWD, 2011, J MACH LEARN TECHNOL, V2, P24; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; R Core Team, 2021, R LANGUAGE ENV STAT; Rachlow JL, 2014, WILDLIFE SOC B, V38, P458, DOI 10.1002/wsb.444; Rasiulis AL, 2014, J WILDLIFE MANAGE, V78, P953, DOI 10.1002/jwmg.722; Schwartz Michael K., 2008, P238; Schwarzenberger F., 2007, International Zoo Yearbook, V41, P52, DOI 10.1111/j.1748-1090.2007.00017.x; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Shumway RH., 2017, TIME SERIES ANAL ITS, DOI 10.1007/978-3-319-52452-8; Soltis J, 2016, ENDANGER SPECIES RES, V31, P1, DOI 10.3354/esr00746; Soltis Joseph, 2012, Endangered Species Research, V18, P255, DOI 10.3354/esr00452; Souris AC, 2007, APPL ANIM BEHAV SCI, V107, P307, DOI 10.1016/j.applanim.2006.09.023; Stabach JA, 2015, BIOL CONSERV, V182, P177, DOI 10.1016/j.biocon.2014.12.003; Stewart KM, 2005, OECOLOGIA, V143, P85, DOI 10.1007/s00442-004-1785-y; Teixeira CP, 2007, ANIM BEHAV, V73, P1, DOI 10.1016/j.anbehav.2006.06.002; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; Wang YW, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0030-0; Warner A. C. I., 1981, Nutrition Abstracts and Reviews, B, V51, P789; Wilson RP, 2006, MEASURING DEVICES WI, P147; Withey John C., 2001, P43, DOI 10.1016/B978-012497781-5/50004-9	79	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0221843	10.1371/journal.pone.0221843	http://dx.doi.org/10.1371/journal.pone.0221843			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045413	Green Published, gold, Green Submitted			2022-12-26	WOS:000534633200002
J	Tambella, AM; Omini, L; Attili, AR; Vullo, C; Martin, S				Tambella, Adolfo Maria; Omini, Luca; Attili, Anna Rita; Vullo, Cecilia; Martin, Stefano			Evaluation of cranial tibial translation in dogs: Diagnostic accuracy of radiographic method using a simple device	PLOS ONE			English	Article							PLATEAU LEVELING OSTEOTOMY; ANTERIOR CRUCIATE LIGAMENT; TUBEROSITY ADVANCEMENT; DEFICIENT STIFLE; SCORING SYSTEM; JOINT; SUBLUXATION; RUPTURE; INSTABILITY; DISEASE	A hand-made, radiolucent, custom-designed device having a mobile and a non-mobile platforms was used to objectively quantify the in vivo cranial tibial translation, in order to assess the functional status of cranial-cruciate-ligament (CrCL) in dogs. The hypothesis was that changes in CrCL integrity would result in detectable changes in tibial translation. To validate the diagnostic method, data from injured (PA, n = 32), contralateral (CO, n = 32) and healthy stifles (HE, n = 32) were compared. Normalized tibial translation (Delta(N)) of each stifle was measured in medio-lateral radiographic projection obtained before and during standard thrust force application, in PA (43.59 +/- 12.97%), CO (20.32 +/- 6.69%) and HE (12.22 +/- 3.77%). Comparing PA with HE and CO (Delta(N) cut-off value: 29.73%), diagnosis could be issued with very high probability. Comparing HE with CO (Delta(N) cut-off value: 14.80%), high performance was obtained. The translator device could be a useful tool to objectively quantify the in vivo tibial translation in dogs with CrCL rupture, before surgery and during post-operatory follow-up.	[Tambella, Adolfo Maria; Attili, Anna Rita; Vullo, Cecilia; Martin, Stefano] Univ Camerino, Sch Biosci & Vet Med, Matelica, MC, Italy; [Omini, Luca] Clin Vet Omini Luca, Chiaravalle, AN, Italy	University of Camerino	Tambella, AM (corresponding author), Univ Camerino, Sch Biosci & Vet Med, Matelica, MC, Italy.	adolfomaria.tambella@unicam.it	Vullo, Cecilia/AAS-7702-2020; Tambella, Adolfo Maria/J-2371-2012; Attili, Anna-Rita/AAF-5571-2020	Tambella, Adolfo Maria/0000-0002-6590-1876; Attili, Anna-Rita/0000-0002-9085-7125; Martin, Stefano/0000-0002-5618-8669				Beer P, 2018, TIERAERZTL PRAX K H, V46, P223, DOI 10.15654/TPK-170486; Bielecki MJ, 2014, VET COMP ORTHOPAED, V27, P470, DOI 10.3415/VCOT-14-02-0018; Biskup JJ, 2017, VET SURG, V46, P691, DOI 10.1111/vsu.12653; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Carobbi B, 2009, J SMALL ANIM PRACT, V50, P224, DOI 10.1111/j.1748-5827.2008.00723.x; Castaneda KA, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1599-5; Chuang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106389; Cohen JF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012799; Cook JL, 2010, VET SURG, V39, P315, DOI 10.1111/j.1532-950X.2010.00658.x; de Rooster H, 1999, AM J VET RES, V60, P1567; de Rooster H, 1998, VET REC, V142, P366, DOI 10.1136/vr.142.14.366; FITCH RB, 1995, VET SURG, V24, P148, DOI 10.1111/j.1532-950X.1995.tb01309.x; Fuller MC, 2014, JAVMA-J AM VET MED A, V244, P328, DOI 10.2460/javma.244.3.328; Griffon DJ, 2017, VET SURG, V46, P206, DOI 10.1111/vsu.12593; Griffon DJ, 2010, VET SURG, V39, P399, DOI 10.1111/j.1532-950X.2010.00654.x; Ho-Eckart LK, 2017, VET SURG, V46, P213, DOI 10.1111/vsu.12609; Johnson K, 2011, CAN VET J, V52, P961; Kim SE, 2011, AM J VET RES, V72, P410, DOI 10.2460/ajvr.72.3.410; KORVICK DL, 1994, J BIOMECH, V27, P77, DOI 10.1016/0021-9290(94)90034-5; Lopez MJ, 2004, J ORTHOPAED RES, V22, P949, DOI 10.1016/j.orthres.2003.10.017; Moore KW, 1996, COMP CONT EDUC PRACT, V18, P223; Muir P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025331; Ober CA, 2019, VET SURG, V48, P401, DOI 10.1111/vsu.13177; Plesman R, 2012, VET COMP ORTHOPAED, V25, P478, DOI 10.3415/VCOT-12-02-0017; Rey J, 2014, TIERAERZTL PRAX K H, V42, P151, DOI 10.1055/s-0038-1623760; Sample SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178086; Shahar R, 2006, VET SURG, V35, P144, DOI 10.1111/j.1532-950X.2006.00125.x; Snow LA, 2010, VET SURG, V39, P195, DOI 10.1111/j.1532-950X.2009.00635.x; Srisuwanporn Pinij, 2016, Journal of the Medical Association of Thailand, V99, P394; Thieman KM, 2010, VET SURG, V39, P355, DOI 10.1111/j.1532-950X.2010.00661.x; Tinga S, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1395-2; Wessely M, 2017, VET COMP ORTHOPAED, V30, P377, DOI [10.3415/VCOT-16-09-0134, 10.3415/vcot-16-09-0134]; Xerogeanes JW, 1998, ANN BIOMED ENG, V26, P345, DOI 10.1114/1.91	33	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228621	10.1371/journal.pone.0228621	http://dx.doi.org/10.1371/journal.pone.0228621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045429	Green Published, gold, Green Submitted			2022-12-26	WOS:000534633200024
J	Kennedy, SP; O'Neill, M; Cunningham, D; Morris, PG; Toomey, S; Blanco-Aparicio, C; Martinez, S; Pastor, J; Eustace, AJ; Hennessy, BT				Kennedy, Sean P.; O'Neill, Michael; Cunningham, Darren; Morris, Patrick G.; Toomey, Sinead; Blanco-Aparicio, Carmen; Martinez, Sonia; Pastor, Joaquin; Eustace, Alex J.; Hennessy, Bryan T.			Preclinical evaluation of a novel triple-acting PIM/PI3K/mTOR inhibitor, IBL-302, in breast cancer	ONCOGENE			English	Article							PIM KINASE INHIBITOR; PROTEIN-KINASE; DUAL INHIBITION; PROSTATE-CANCER; THERAPY; PATHWAY; POTENT; CELLS; PHOSPHORYLATION; RESISTANCE	The proviral integration of Moloney virus (PIM) family of protein kinases are overexpressed in many haematological and solid tumours. PIM kinase expression is elevated in PI3K inhibitor-treated breast cancer samples, suggesting a major resistance pathway for PI3K inhibitors in breast cancer, potentially limiting their clinical utility. IBL-302 is a novel molecule that inhibits both PIM and PI3K/AKT/mTOR signalling. We thus evaluated the preclinical activity of IBL-302, in a range of breast cancer models. Our results demonstrate in vitro efficacy of IBL-302 in a range of breast cancer cell lines, including lines with acquired resistance to trastuzumab and lapatinib. IBL-302 demonstrated single-agent, anti-tumour efficacy in suppression of pAKT, pmTOR and pBAD in the SKBR-3, BT-474 and HCC-1954 HER2+/PIK3CA-mutated cell lines. We have also shown the in vivo single-agent efficacy of IBL-302 in the subcutaneous BT-474 and HCC-1954 xenograft model in BALB/c nude mice. The combination of trastuzumab and IBL-302 significantly increased the anti-proliferative effect in HER2+ breast cancer cell line, and matched trastuzumab-resistant line, relative to testing either drug alone. We thus believe that the novel PIM and PI3K/mTOR inhibitor, IBL-302, represents an exciting new potential treatment option for breast cancer, and that it should be considered for clinical investigation.	[Kennedy, Sean P.; Morris, Patrick G.; Toomey, Sinead; Hennessy, Bryan T.] Royal Coll Surgeons Ireland, Dept Mol Med, Med Oncol Grp, Smurfit Bldg Beaumont Hosp, Dublin, Ireland; [O'Neill, Michael; Cunningham, Darren] Inflect Biosci, Anglesea House, Dublin, Ireland; [Morris, Patrick G.; Hennessy, Bryan T.] Beaumont Hosp, Canc Clin Trials & Res Unit, Dublin, Ireland; [Blanco-Aparicio, Carmen; Martinez, Sonia; Pastor, Joaquin] Spanish Natl Canc Res Ctr CNIO, Expt Therapeut Programme, Madrid, Spain; [Eustace, Alex J.] Dublin City Univ, Natl Inst Cellular Biotechnol, Mol Therapeut Canc Ireland, Dublin, Ireland; [Hennessy, Bryan T.] Canc Trials Ireland, Innovat House,Old Finglas Rd, Dublin, Ireland	Royal College of Surgeons - Ireland; Centro Nacional de Investigaciones Oncologicas (CNIO); Dublin City University	Kennedy, SP (corresponding author), Royal Coll Surgeons Ireland, Dept Mol Med, Med Oncol Grp, Smurfit Bldg Beaumont Hosp, Dublin, Ireland.	Seanpkennedy@rcsi.ie	Blanco-Aparicio, Carmen/I-3162-2015; Gonzalez, Sonia Martinez/I-4616-2015; Fernandez, Joaquin Pastor/I-4567-2015	Blanco-Aparicio, Carmen/0000-0002-3249-6595; Gonzalez, Sonia Martinez/0000-0003-2230-7794; Fernandez, Joaquin Pastor/0000-0003-0553-8021; Hennessy, Bryan/0000-0002-7871-6477	North East Cancer Research & Education Trust; Enterprise Ireland [IV-2017-2125]; Fox family; Kerins family	North East Cancer Research & Education Trust; Enterprise Ireland; Fox family; Kerins family	We are very grateful to Stephen Madden for his valuable input and statistical analysis. This research was supported by the North East Cancer Research & Education Trust, Fox and Kerins families and Enterprise Ireland (Voucher ID: IV-2017-2125).	Aziz AUR, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8010007; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Beier UH, 2007, INT J ONCOL, V30, P1381; Bhattacharya N, 2002, CHROMOSOMA, V111, P80, DOI 10.1007/s00412-002-0192-6; Bian CN, 2018, ONCOL LETT, V15, P9655, DOI 10.3892/ol.2018.8587; Braso-Maristany F, 2016, NAT MED, V22, P1303, DOI 10.1038/nm.4198; Burger MT, 2015, J MED CHEM, V58, P8373, DOI 10.1021/acs.jmedchem.5b01275; Cen B, 2014, MOL CELL BIOL, V34, P2517, DOI 10.1128/MCB.00147-14; Cen B, 2013, CANCER RES, V73, P3402, DOI 10.1158/0008-5472.CAN-12-4619; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chapuis N, 2010, CLIN CANCER RES, V16, P5424, DOI 10.1158/1078-0432.CCR-10-1102; Chen LS, 2009, BLOOD, V114, P4150, DOI 10.1182/blood-2009-03-212852; Cobb M, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-524; Cortes J, 2018, BRIT J CANCER, V118, P1425, DOI 10.1038/s41416-018-0082-1; Dakin LA, 2012, BIOORG MED CHEM LETT, V22, P4599, DOI 10.1016/j.bmcl.2012.05.098; Doshi KA, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-5332; Elster N, 2015, BREAST CANCER RES TR, V149, P373, DOI 10.1007/s10549-014-3239-5; Elster N, 2018, THER ADV MED ONCOL, V10, DOI 10.1177/1758835918778297; Eustace AJ, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-53; Garcia PD, 2014, CLIN CANCER RES, V20, P1834, DOI 10.1158/1078-0432.CCR-13-2062; Haddach M, 2012, ACS MED CHEM LETT, V3, P135, DOI 10.1021/ml200259q; Herzog A, 2013, CLIN CANCER RES, V19, P3808, DOI 10.1158/1078-0432.CCR-12-2716; Hogan C, 2008, J BIOL CHEM, V283, P18012, DOI 10.1074/jbc.M709695200; Horiuchi D, 2016, NAT MED, V22, P1321, DOI 10.1038/nm.4213; Hua H, 2018, BIOMED PHARMACOTHER, V101, P115, DOI 10.1016/j.biopha.2018.02.031; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Isaac M, 2011, DRUG RESIST UPDATE, V14, P203, DOI 10.1016/j.drup.2011.04.002; Jin B, 2014, AGING CELL, V13, P879, DOI 10.1111/acel.12249; Keegan NM, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.1036; Keeton EK, 2014, BLOOD, V123, P905, DOI 10.1182/blood-2013-04-495366; Koblish H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199108; Le XN, 2016, CANCER DISCOV, V6, P1134, DOI 10.1158/2159-8290.CD-16-0305; Liu PX, 2011, NAT MED, V17, P1116, DOI 10.1038/nm.2402; Liu WT, 2016, CELL CYCLE, V15, P886, DOI 10.1080/15384101.2016.1152428; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Malinen M, 2013, MOL CELL ENDOCRINOL, V365, P270, DOI 10.1016/j.mce.2012.10.028; Mcdermott MSJ, 2017, INT J ONCOL, V50, P2221, DOI 10.3892/ijo.2017.3976; McDermott MSJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-157; Meja K, 2014, BRIT J HAEMATOL, V167, P69, DOI 10.1111/bjh.13013; Mohlin S, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201810058; Moody SE, 2015, ONCOGENE, V34, P2061, DOI 10.1038/onc.2014.153; Moore G, 2017, J THORAC ONCOL, V12, pS527, DOI 10.1016/j.jtho.2016.11.649; Musiani D, 2014, J PROTEOME RES, V13, P4970, DOI 10.1021/pr500651n; Narlik-Grassow M, 2014, MED RES REV, V34, P136, DOI 10.1002/med.21284; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; Neil M, 2014, CANCER RES, V74, P4524; Paino T, 2017, CLIN CANCER RES, V23, P225, DOI 10.1158/1078-0432.CCR-16-0230; Rampal RK, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.634.634; Rebello Richard J., 2018, Advances in Biological Regulation, V67, P163, DOI 10.1016/j.jbior.2017.10.010; Reidy M, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.5713.5713; Roh M, 2003, CANCER RES, V63, P8079; Simioni C, 2014, ONCOTARGET, V5, P10034, DOI 10.18632/oncotarget.2490; Song JH, 2012, CANCER RES, V72, P294, DOI 10.1158/0008-5472.CAN-11-3240; Sourbier C, 2006, CANCER RES, V66, P5130, DOI 10.1158/0008-5472.CAN-05-1469; Tursynbay Y, 2016, BIOMED REP, V4, P140, DOI 10.3892/br.2015.561; Wang ZP, 2002, BBA-MOL CELL RES, V1593, P45, DOI 10.1016/S0167-4889(02)00347-6; Warfel NA, 2015, PHARMACOL THERAPEUT, V151, P41, DOI 10.1016/j.pharmthera.2015.03.001; White E, 2003, GENE DEV, V17, P1813, DOI 10.1101/gad.1123103; Wong PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9048; Xia ZP, 2009, J MED CHEM, V52, P74, DOI 10.1021/jm800937p; Yang J, 2017, ONCOGENE, V36, P4828, DOI 10.1038/onc.2017.96; Zhang F, 2009, CANCER BIOL THER, V8, P846, DOI 10.4161/cbt.8.9.8210; Zhang RX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16153-3; Zhang YD, 2007, MOL CANCER RES, V5, P909, DOI 10.1158/1541-7786.MCR-06-0388; Zhao B, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0348-9	65	14	14	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	14					3028	3040		10.1038/s41388-020-1202-y	http://dx.doi.org/10.1038/s41388-020-1202-y		FEB 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KZ2VB	32042115	Green Published, hybrid			2022-12-26	WOS:000512528200002
J	Klomp, J; Hyun, J; Klomp, JE; Pajcini, K; Rehman, J; Malik, AB				Klomp, Jeff; Hyun, James; Klomp, Jennifer E.; Pajcini, Kostandin; Rehman, Jalees; Malik, Asrar B.			Comprehensive transcriptomic profiling reveals SOX7 as an early regulator of angiogenesis in hypoxic human endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hypoxia; endothelial cell; angiogenesis; transcriptomics; vascular	LONG NONCODING RNA; GENE-EXPRESSION; INDUCIBLE FACTOR-1; REDUNDANT ROLES; DNA-BINDING; HIF-1-ALPHA; OXYGEN; SPECIFICITY; PROTECTION; CHROMATIN	Endothelial cells (ECs) lining the vasculature of vertebrates respond to low oxygen (hypoxia) by maintaining vascular homeostasis and initiating adaptive growth of new vasculature through angiogenesis. Previous studies have uncovered the molecular underpinnings of the hypoxic response in ECs; however, there is a need for comprehensive temporal analysis of the transcriptome during hypoxia. Here, we sought to investigate the early transcriptional programs of hypoxic ECs by using RNA-Seq of primary cultured human umbilical vein ECs exposed to progressively increasing severity and duration of hypoxia. We observed that hypoxia modulates the expression levels of approximately one-third of the EC transcriptome. Intriguingly, expression of the gene encoding the developmental transcription factor SOX7 (SRY-box transcription factor 7) rapidly and transiently increased during hypoxia. Transcriptomic and functional analyses of ECs following SOX7 depletion established its critical role in regulating hypoxia-induced angiogenesis. We also observed that depletion of the hypoxia-inducible factor (HIF) genes, HIF1A (encoding HIF-1?) and endothelial PAS domain protein 1 (EPAS1 encoding HIF-2?), inhibited both distinct and overlapping transcriptional programs. Our results indicated a role for HIF-1? in down-regulating mitochondrial metabolism while concomitantly up-regulating glycolytic genes, whereas HIF-2? primarily up-regulated the angiogenesis transcriptional program. These results identify the concentration and time dependence of the endothelial transcriptomic response to hypoxia and an early key role for SOX7 in mediating angiogenesis.	[Klomp, Jeff; Hyun, James; Klomp, Jennifer E.; Pajcini, Kostandin; Rehman, Jalees; Malik, Asrar B.] Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave,Mailcode 868, Chicago, IL 60612 USA; [Rehman, Jalees] Univ Illinois, Coll Med, Dept Med, Div Cardiol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Rehman, J; Malik, AB (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave,Mailcode 868, Chicago, IL 60612 USA.	jalees@uic.edu; abmalik@uic.edu	Rehman, Jalees/GVU-1981-2022	Rehman, Jalees/0000-0002-2787-9292; Malik, Asrar/0000-0002-8205-7128; Klomp, Jeffrey/0000-0002-5243-6987; Klomp, Jennifer/0000-0003-1781-648X	National Institutes of Health T32 Training Program in Lung Biology and Pathobiology [5T32HL007829]; National Institutes of Health [R01HL126516, P01HL060678, P01HL077806, R01HL090152, R01HL118068]; Chicago Biomedical Consortium Postdoctoral Research Award [PDR-089]	National Institutes of Health T32 Training Program in Lung Biology and Pathobiology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium Postdoctoral Research Award	This work was supported by Grant 5T32HL007829 from the National Institutes of Health T32 Training Program in Lung Biology and Pathobiology (to J. K., J. H., J. E. K., and A. B. M.) and National Institutes of Health Grants R01HL126516 (to J. R.), P01HL060678 (to A. B. M. and J. R.), P01HL077806 (to A. B. M.), R01HL090152 (to A. B. M. and J. R.), and R01HL118068 (to A. B. M. and J. R.). This work was also supported by Chicago Biomedical Consortium Postdoctoral Research Award PDR-089 (to J. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhtar S, 2015, HYPERTENSION, V66, P1220, DOI 10.1161/HYPERTENSIONAHA.115.05886; Andrews S., 2021, FASTQC; Behrens AN, 2014, STEM CELLS DEV, V23, P2004, DOI 10.1089/scd.2013.0525; Branco-Price C, 2012, CANCER CELL, V21, P52, DOI 10.1016/j.ccr.2011.11.017; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Chakraborty AA, 2019, SCIENCE, V363, P1217, DOI 10.1126/science.aaw1026; Chen DR, 2017, INT J MOL MED, V40, P1529, DOI 10.3892/ijmm.2017.3138; Chen WF, 2016, NATURE, V539, P112, DOI 10.1038/nature19796; Chesney J, 2014, ONCOTARGET, V5, P6670, DOI 10.18632/oncotarget.2213; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Cho H, 2016, NATURE, V539, P107, DOI 10.1038/nature19795; Choudhry H, 2018, CELL METAB, V27, P281, DOI 10.1016/j.cmet.2017.10.005; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Costa G, 2012, DEVELOPMENT, V139, P1587, DOI 10.1242/dev.071282; Cowburn AS, 2016, P NATL ACAD SCI USA, V113, P8801, DOI 10.1073/pnas.1602978113; Cruys B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12240; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Dengler VL, 2014, CRIT REV BIOCHEM MOL, V49, P1, DOI 10.3109/10409238.2013.838205; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Fuhrmann DC, 2017, REDOX BIOL, V12, P208, DOI 10.1016/j.redox.2017.02.012; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerri C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15492; Han J, 2017, SCI REP-UK, V7, P10, DOI 10.1038/s41598-017-04333-0; Hang XY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-126; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Huang YD, 2012, AM J RESP CELL MOL, V46, P224, DOI 10.1165/rcmb.2011-0024OC; Huang Y, 2012, P NATL ACAD SCI USA, V109, P17478, DOI 10.1073/pnas.1209281109; Ivan M, 2017, MOL CELL, V66, P772, DOI 10.1016/j.molcel.2017.06.002; Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642; JANSSENS D, 1995, BIOCHEM PHARMACOL, V50, P991, DOI 10.1016/0006-2952(95)00227-Q; Kapitsinou PP, 2014, J CLIN INVEST, V124, P2396, DOI 10.1172/JCI69073; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Krueger F., 2012, TRIM GALORE; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee CN, 2005, APOPTOSIS, V10, P887, DOI 10.1007/s10495-005-2946-0; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003230; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lilly AJ, 2017, MECH DEVELOP, V146, P31, DOI 10.1016/j.mod.2017.05.004; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Mineo M, 2016, CELL REP, V15, P2500, DOI 10.1016/j.celrep.2016.05.018; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Morgan M, 2016, RSAMTOOLS BINARY ALI; Parra V, 2017, BBA-MOL BASIS DIS, V1863, P2891, DOI 10.1016/j.bbadis.2017.07.018; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Peters K, 2005, MOL CELL BIOCHEM, V270, P157, DOI 10.1007/s11010-005-4504-z; Rafii S, 2016, NATURE, V529, P316, DOI 10.1038/nature17040; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scheurer SB, 2004, PROTEOMICS, V4, P1737, DOI 10.1002/pmic.200300689; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Shih JW, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0358-4; Skuli N, 2009, BLOOD, V114, P469, DOI 10.1182/blood-2008-12-193581; Smythies JA, 2019, EMBO REP, V20, DOI 10.15252/embr.201846401; Sun P, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku201; Tang HY, 2018, AM J PHYSIOL-LUNG C, V314, pL256, DOI 10.1152/ajplung.00096.2017; Tiana M, 2018, NUCLEIC ACIDS RES, V46, P120, DOI 10.1093/nar/gkx951; Voellenkle C, 2012, RNA, V18, P472, DOI 10.1261/rna.027615.111; Wat MJ, 2012, HUM MOL GENET, V21, P4115, DOI 10.1093/hmg/dds241; Wei H, 2012, P NATL ACAD SCI USA, V109, pE841, DOI 10.1073/pnas.1202081109; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Xia XB, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r113; Zhao J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.565; Zhigalova Nadezhda, 2015, F1000Res, V4, P1518, DOI 10.12688/f1000research.7571.1; Zhou YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143650	72	7	7	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4796	4808		10.1074/jbc.RA119.011822	http://dx.doi.org/10.1074/jbc.RA119.011822			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32071080	hybrid, Green Published			2022-12-26	WOS:000526887000005
J	Dutta, S; Chakraborty, S; Goswami, R; Banerjee, H; Majumdar, K; Li, B; Jat, ML				Dutta, Sudarshan; Chakraborty, Somsubhra; Goswami, Rupak; Banerjee, Hirak; Majumdar, Kaushik; Li, Bin; Jat, M. L.			Maize yield in smallholder agriculture system-An approach integrating socioeconomic and crop management factors	PLOS ONE			English	Article							RESOURCE USE EFFICIENCY; SOIL FERTILITY MANAGEMENT; MAYS L. YIELD; INORGANIC FERTILIZERS; IRRIGATED MAIZE; ORGANIC-MATTER; WESTERN KENYA; FAMILY LABOR; RICE YIELD; FARM SIZE	Yield gaps of maize (Zea mays L.) in the smallholder farms of eastern India are outcomes of a complex interplay of climatic variations, soil fertility gradients, socio-economic factors, and differential management intensities. Several machine learning approaches were used in this study to investigate the relative influences of multiple biophysical, socio-economic, and crop management features in determining maize yield variability using several machine learning approaches. Soil fertility status was assessed in 180 farms and paired with the surveyed data on maize yield, socio-economic conditions, and agronomic management. The C&RT relative variable importance plot identified farm size, total labor, soil factors, seed rate, fertilizer, and organic manure as influential factors. Among the three approaches compared for classifying maize yield, the artificial neural network (ANN) yielded the least (25%) misclassification on validation samples. The random forest partial dependence plots revealed a positive association between farm size and maize productivity. Nonlinear support vector machine boundary analysis for the eight top important variables revealed complex interactions underpinning maize yield response. Notably, farm size and total labor synergistically increased maize yield. Future research integrating these algorithms with empirical crop growth models and crop simulation models for ex-ante yield estimations could result in further improvement.	[Dutta, Sudarshan; Majumdar, Kaushik] African Plant Nutr Inst, Benguerir, Morocco; [Chakraborty, Somsubhra] IIT Kharagpur, Agr & Food Engn Dept, Kolkata, India; [Chakraborty, Somsubhra; Goswami, Rupak] RKMVERI, IRDM Fac Ctr, Kolkata, India; [Banerjee, Hirak] BCKV, Reg Res Stn CSZ, Kakdwip, India; [Li, Bin] Louisiana State Univ, Dept Expt Stat, Baton Rouge, LA 70803 USA; [Jat, M. L.] Int Maize & Wheat Improvement Ctr CIMMYT, New Delhi, India	Mohammed VI Polytechnic University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; Bidhan Chandra Agricultural University; Louisiana State University System; Louisiana State University; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Dutta, S (corresponding author), African Plant Nutr Inst, Benguerir, Morocco.	S.DUTTA@apni.net	Jat, ML/O-2824-2019; Goswami, Rupak/E-1030-2013	Jat, ML/0000-0003-0582-1126; Goswami, Rupak/0000-0002-5998-4396; CHAKRABORTY, SOMSUBHRA/0000-0003-1913-3973; MAJUMDAR, KAUSHIK/0000-0001-6931-8170	International Maize and Wheat Improvement Center (CIMMYT) under the Maize CRP Program [A4032.09.11]	International Maize and Wheat Improvement Center (CIMMYT) under the Maize CRP Program(CGIAR)	KM received the fund. Funder: International Maize and Wheat Improvement Center (CIMMYT) under the Maize CRP Program (Grant No. A4032.09.11). Funder did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid M, 2011, PAK J AGR SCI, V48, P75; Acharya N, 2012, IDS BULL-I DEV STUD, V43, P104, DOI 10.1111/j.1759-5436.2012.00352.x; Agriculture Census, 2015, ALL IND REP NUMB AR; Akudugu M. A., 2012, Journal of Biology, Agriculture and Healthcare, V2, P1; Andrea MCD, 2018, AGR SYST, V165, P264, DOI 10.1016/j.agsy.2018.07.004; [Anonymous], 2015, FLOOD CONT PLAN DIS; Assuncao JJ, 2003, ECON LETT, V80, P189, DOI 10.1016/S0165-1765(03)00091-0; Banerjee H, 2014, NJAS-WAGEN J LIFE SC, V70-71, P79, DOI 10.1016/j.njas.2014.08.001; Bhattarai S, 2017, AGR ECOSYST ENVIRON, V243, P132, DOI 10.1016/j.agee.2017.04.016; Biswas CR, 1996, NUTR CYCL AGROECOSYS, V46, P225, DOI 10.1007/BF00420557; Biswas RK, 2011, IMPACTS CONSTRAINTS; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 1984, CLASSIFICATION REGRE, P254; Ceglar A, 2016, AGR FOREST METEOROL, V216, P58, DOI 10.1016/j.agrformet.2015.10.004; Chakraborty S, 2013, APPL OPTICS, V52, pB82, DOI 10.1364/AO.52.000B82; Chang CW, 2001, SOIL SCI SOC AM J, V65, P480, DOI 10.2136/sssaj2001.652480x; Chang J, 2007, AGRON J, V99, P1654, DOI 10.2134/agronj2007.0170; Chatterjee S, 2015, J AGR SCI TECH-IRAN, V17, P1127; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Chowdhury NT, 2016, J INT DEV, V28, P1075, DOI 10.1002/jid.2919; Delmotte S, 2011, EUR J AGRON, V35, P223, DOI 10.1016/j.eja.2011.06.006; Dore T, 2008, AGRON SUSTAIN DEV, V28, P151, DOI 10.1051/agro:2007031; Duflo E, 2008, AM ECON REV, V98, P482, DOI 10.1257/aer.98.2.482; Dutta S. K., 2015, SATSA Mukhaptra Annual Technical Issue, V19, P19; Eastwood R, 2010, HBK ECON, V18, P3323, DOI 10.1016/S1574-0072(09)04065-1; ESWARAN M, 1986, ECON J, V96, P482, DOI 10.2307/2233128; FAO I.F.A.D. UNICEF W.F.P. WHO, 2018, STAT FOOD SEC NUTR W; FEDER G, 1993, TECHNOL FORECAST SOC, V43, P215, DOI 10.1016/0040-1625(93)90053-A; FEDER G, 1985, J DEV ECON, V18, P297, DOI 10.1016/0304-3878(85)90059-8; Feller C, 1997, GEODERMA, V79, P69, DOI 10.1016/S0016-7061(97)00039-6; Fermont AM, 2009, FIELD CROP RES, V112, P24, DOI 10.1016/j.fcr.2009.01.009; Gani B. S., 2009, Journal of Human Ecology, V28, P113; GAUCH HG, 1988, BIOMETRICS, V44, P705, DOI 10.2307/2531585; Gee G.W., 2002, METHODS SOIL ANAL 4, P255, DOI DOI 10.2136/SSSABOOKSER5.4.C12; Ghimire R, 2015, RICE SCI, V22, P35, DOI 10.1016/j.rsci.2015.05.006; Giller KE, 2006, AGR SYST, V88, P8, DOI 10.1016/j.agsy.2005.06.016; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Graeub BE, 2016, WORLD DEV, V87, P1, DOI 10.1016/j.worlddev.2015.05.012; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hou Y, 2012, NUTR CYCL AGROECOSYS, V92, P347, DOI 10.1007/s10705-012-9494-0; Jame YW, 2016, CAN J PLANT SCI, V76, P9; Jiang D, 2006, PEDOSPHERE, V16, P25, DOI 10.1016/S1002-0160(06)60022-2; Joshi PK, 2005, MAIZE INDIA PRODUCTI; Katsura K, 2008, FIELD CROP RES, V107, P1, DOI 10.1016/j.fcr.2007.12.007; Kraaijvanger R, 2015, AGR ECOSYST ENVIRON, V214, P1, DOI 10.1016/j.agee.2015.08.003; Krupnik TJ, 2015, AGR SYST, V139, P166, DOI 10.1016/j.agsy.2015.05.007; Li T, 2015, GLOBAL CHANGE BIOL, V21, P1328, DOI 10.1111/gcb.12758; Liu ZJ, 2016, SCI TOTAL ENVIRON, V541, P756, DOI 10.1016/j.scitotenv.2015.08.145; MacCarthy Dilys S., 2018, South African Journal of Plant and Soil, V35, P137, DOI 10.1080/02571862.2017.1354407; Mason NM, 2011, 58 FOOD SEC RES PROJ; Mucheru-Muna M, 2007, AGROFOREST SYST, V69, P189, DOI 10.1007/s10457-006-9027-4; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Olsen SR, 1994, ESTIMATION AVAILABLE; Opsi F, 2013, J AGR SCI, V1, P1; Park SJ, 2005, AGR SYST, V85, P59, DOI 10.1016/j.agsy.2004.06.021; Porter PM, 1997, J PROD AGRIC, V10, P293, DOI 10.2134/jpa1997.0293; Aryal JP, 2018, J CROP IMPROV, V32, P477, DOI 10.1080/15427528.2018.1457584; Ray K, 2017, EXPT AGR, V52, P434; Ray K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216939; Ripley B. D., 1996, PATTERN RECOGNITION; Rockstrom J, 2017, AMBIO, V46, P4, DOI 10.1007/s13280-016-0793-6; Rossel RAV, 2010, GEODERMA, V158, P46, DOI 10.1016/j.geoderma.2009.12.025; Simmonds MB, 2013, PRECIS AGRIC, V14, P512, DOI 10.1007/s11119-013-9313-x; Snyder KA, 2017, EXP AGR, V53, P445, DOI 10.1017/S0014479716000508; Soil Survey Staff, 2004, SOIL SURV LAB METH M; Stephens William, 2002, P129, DOI 10.1079/9780851995632.0129; Subba Rao A., 1993, METHODS ANAL SOIL PL, P28; SUBBIAH B. V., 1956, CURRENT SCI, V25, P259; Tamene L, 2016, NUTR CYCL AGROECOSYS, V105, P291, DOI 10.1007/s10705-015-9692-7; Tittonell P, 2008, AGR ECOSYST ENVIRON, V123, P137, DOI 10.1016/j.agee.2007.05.005; Tittonell P, 2007, AGR SYST, V94, P376, DOI 10.1016/j.agsy.2006.10.012; Tittonell P, 2005, AGR ECOSYST ENVIRON, V110, P149, DOI 10.1016/j.agee.2005.04.001; Tittonell P, 2005, AGR ECOSYST ENVIRON, V105, P213, DOI 10.1016/j.agee.2004.04.002; Tittonell P., 2011, INNOVATIONS KEY GREE, P747, DOI DOI 10.1007/978-90-481-2543-2_76; Uno Y, 2005, COMPUT ELECTRON AGR, V47, P149, DOI 10.1016/j.compag.2004.11.014; van Wart J, 2013, FIELD CROP RES, V143, P44, DOI 10.1016/j.fcr.2012.11.023; Vanlauwe B, 2015, SOIL-GERMANY, V1, P491, DOI 10.5194/soil-1-491-2015; Wang XL, 2017, AGR WATER MANAGE, V187, P88, DOI 10.1016/j.agwat.2017.03.017; Zhang YL, 2016, SOIL TILL RES, V155, P85, DOI 10.1016/j.still.2015.08.006; Zhao Y, 2016, EUR J AGRON, V77, P10, DOI 10.1016/j.eja.2016.03.006; Zingore S, 2007, AGR ECOSYST ENVIRON, V119, P112, DOI 10.1016/j.agee.2006.06.019	82	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229100	10.1371/journal.pone.0229100	http://dx.doi.org/10.1371/journal.pone.0229100			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8DW	32092077	gold, Green Published			2022-12-26	WOS:000535229300022
J	Antonioli, L; D'Antongiovanni, V; Pellegrini, C; Fornai, M; Benvenuti, L; di Carlo, A; van den Wijngaard, R; Caputi, V; Cerantola, S; Giron, MC; Nemeth, ZH; Hasko, G; Blandizzi, C; Colucci, R				Antonioli, Luca; D'Antongiovanni, Vanessa; Pellegrini, Carolina; Fornai, Matteo; Benvenuti, Laura; di Carlo, Alma; van den Wijngaard, Rene; Caputi, Valentina; Cerantola, Silvia; Giron, Maria Cecilia; Nemeth, Zoltan H.; Hasko, Gyorgy; Blandizzi, Corrado; Colucci, Rocchina			Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia	FASEB JOURNAL			English	Article						colonic motor dysfunction; enteric glia; inflammation; obesity; substance P	GASTROINTESTINAL MOTILITY; GUT MICROBIOTA; S100B PROTEIN; DISORDERS; NEURONS; TRANSIT; DISEASE; CELLS; MOTOR; ACID	The present study was designed to examine the role of enteric glial cells (EGCs) in colonic neuromuscular dysfunctions in a mouse model of high-fat diet (HFD)-induced obesity. C57BL/6J mice were fed with HFD or standard diet (SD) for 1, 2, or 8 weeks. Colonic interleukin (IL)-1 beta, IL-6, and malondialdehyde (MDA) levels were measured. Expression of occludin in colonic tissues was examined by western blot. Substance P (SP), S100 beta, GFAP, and phosphorylated mitogen-activated protein kinase 1 (pERK) were assessed in whole mount specimens of colonic plexus by immunohistochemistry. Colonic tachykininergic contractions, elicited by electrical stimulation or exogenous SP, were recorded in the presence or absence of fluorocitrate (FC). To mimic exposure to HFD, cultured EGCs were incubated with palmitate (PA) and/or lipopolysaccharide (LPS). SP and IL-1 beta levels were assayed in the culture medium by ELISA. HFD mice displayed an increase in colonic IL-1 beta and MDA, and a reduction of occludin at week 2. These changes occurred to a greater extent at week 8. In vitro electrically evoked tachykininergic contractions were enhanced in HFD mice after 2 or 8 weeks, and they were blunted by FC. Colonic IL-6 levels as well as substance P and S100 beta density in myenteric ganglia of HFD mice were increased at week 8, but not at week 1 or 2. In cultured EGCs, co-incubation with palmitate plus LPS led to a significant increase in both SP and IL-1 beta release. HFD-induced obesity is characterized by a hyperactivation of EGCs and is involved in the development of enteric motor disorders through an increase in tachykininergic activity and release of pro-inflammatory mediators.	[Antonioli, Luca; D'Antongiovanni, Vanessa; Fornai, Matteo; Benvenuti, Laura; di Carlo, Alma; Blandizzi, Corrado] Univ Pisa, Dept Clin & Expt Med, Via Roma 55, I-56126 Pisa, Italy; [Pellegrini, Carolina] Univ Pisa, Dept Pharm, Pisa, Italy; [Fornai, Matteo; van den Wijngaard, Rene] Acad Med Ctr, Dept Gastroenterol & Hepatol, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands; [Caputi, Valentina; Cerantola, Silvia; Giron, Maria Cecilia; Colucci, Rocchina] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Caputi, Valentina] Univ Coll Cork, APC Microbiome Ireland, Cork, Ireland; [Nemeth, Zoltan H.; Hasko, Gyorgy] Columbia Univ, Dept Anesthesiol, New York, NY USA; [Nemeth, Zoltan H.] Morristown Med Ctr, Dept Surg, Morristown, NJ USA	University of Pisa; University of Pisa; University of Amsterdam; Academic Medical Center Amsterdam; University of Padua; University College Cork; Columbia University; Atlantic Health System	Fornai, M (corresponding author), Univ Pisa, Dept Clin & Expt Med, Via Roma 55, I-56126 Pisa, Italy.; Fornai, M (corresponding author), Acad Med Ctr, Dept Gastroenterol & Hepatol, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands.	mfornai74@gmail.com	Giron, Maria Cecilia/AAL-4438-2021; Pellegrini, Carolina/ABE-3462-2021	Giron, Maria Cecilia/0000-0002-0825-7965; Pellegrini, Carolina/0000-0003-2644-5430; COLUCCI, ROCCHINA LUCIA/0000-0002-2593-5457; D'ANTONGIOVANNI, Vanessa/0000-0002-3303-0674; FORNAI, MATTEO/0000-0002-0812-3959; BLANDIZZI, CORRADO/0000-0001-9927-5386				Anitha M, 2016, CELL MOL GASTROENTER, V2, P328, DOI 10.1016/j.jcmgh.2015.12.008; Antonioli L, 2019, INT J OBESITY, V43, P331, DOI 10.1038/s41366-018-0166-2; Antonioli L, 2017, PURINERG SIGNAL, V13, P497, DOI 10.1007/s11302-017-9577-0; Barajon I, 2009, J HISTOCHEM CYTOCHEM, V57, P1013, DOI 10.1369/jhc.2009.953539; Bassotti G, 2014, UNITED EUR GASTROENT, V2, P457, DOI 10.1177/2050640614548096; Bassotti G, 2014, WORLD J GASTROENTERO, V20, P37, DOI 10.3748/wjg.v20.i1.37; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Caputi V, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00350; Chandrasekharan B, 2019, GASTROENTEROLOGY, V157, P179, DOI 10.1053/j.gastro.2019.03.045; Chassaing B, 2014, GUT, V63, P1069, DOI 10.1136/gutjnl-2013-304909; Chow AK, 2017, AM J PHYSIOL-GASTR L, V312, pG145, DOI 10.1152/ajpgi.00384.2016; Christofi FL, 2018, CELL MOL GASTROENTER, V6, P354, DOI 10.1016/j.jcmgh.2018.06.011; Cirillo C, 2011, WORLD J GASTROENTERO, V17, P1261, DOI 10.3748/wjg.v17.i10.1261; Cossais F, 2019, J CLIN GASTROENTEROL, V53, P449, DOI 10.1097/MCG.0000000000001011; Dai XJ, 2015, CELL STRESS CHAPERON, V20, P321, DOI 10.1007/s12192-014-0552-1; DAMETO MC, 1991, COMP BIOCHEM PHYS A, V99, P651, DOI 10.1016/0300-9629(91)90145-3; Delgado-Aros S, 2004, AM J GASTROENTEROL, V99, P1801, DOI 10.1111/j.1572-0241.2004.30887.x; Eder K, 2009, INFLAMM RES, V58, P727, DOI 10.1007/s00011-009-0060-4; France M, 2012, NEUROGASTROENT MOTIL, V24, pe450, DOI 10.1111/j.1365-2982.2012.01981.x; Fysekidis M, 2012, OBES SURG, V22, P403, DOI 10.1007/s11695-011-0396-z; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gougeon PY, 2013, J NEUROSCI, V33, P3339, DOI 10.1523/JNEUROSCI.3564-12.2013; Gulbransen BD, 2018, GASTROENTEROLOGY, V155, P245, DOI 10.1053/j.gastro.2018.06.050; Gulbransen BD, 2012, NAT REV GASTRO HEPAT, V9, P625, DOI 10.1038/nrgastro.2012.138; Herder C, 2015, TRENDS ENDOCRIN MET, V26, P551, DOI 10.1016/j.tem.2015.08.001; Ho Wayne, 2008, Gastroenterol Hepatol (N Y), V4, P572; Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x; Jarolimova J., 2013, PRIM CARE COMPANION, V15, P5; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kindt S, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01414.x; Konig J, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.54; Kunisawa J, 2014, J IMMUNOL, V193, P1666, DOI 10.4049/jimmunol.1302944; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Le Pluart D, 2015, ALIMENT PHARM THER, V41, P758, DOI 10.1111/apt.13143; Lomax AE, 2005, NEUROGASTROENT MOTIL, V17, P4, DOI 10.1111/j.1365-2982.2004.00607.x; Marseglia L, 2015, INT J MOL SCI, V16, P378, DOI 10.3390/ijms16010378; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; McMenamin CA, 2018, NEUROSCIENCE, V393, P369, DOI 10.1016/j.neuroscience.2018.09.033; Murakami M, 2009, J NEUROSCI RES, V87, P2095, DOI 10.1002/jnr.22036; Murphy EA, 2015, CURR OPIN CLIN NUTR, V18, P515, DOI 10.1097/MCO.0000000000000209; Nasser Y, 2006, AM J PHYSIOL-GASTR L, V291, pG912, DOI 10.1152/ajpgi.00067.2006; Nezami BG, 2014, GASTROENTEROLOGY, V146, P473, DOI 10.1053/j.gastro.2013.10.053; Nyavor Y, 2019, CELL TISSUE RES, V376, P325, DOI 10.1007/s00441-019-03002-0; Ochoa-Cortes F, 2016, INFLAMM BOWEL DIS, V22, P433, DOI 10.1097/MIB.0000000000000667; Phatak UP, 2014, INT J OBESITY, V38, P1324, DOI 10.1038/ijo.2014.67; Pochard C, 2018, AM J PHYSIOL-GASTR L, V315, pG1, DOI 10.1152/ajpgi.00016.2018; Pochard C, 2016, GASTROENTEROLOGY, V150, P168, DOI 10.1053/j.gastro.2015.09.038; Rajindrajith S, 2014, J NEUROGASTROENTEROL, V20, P414, DOI 10.5056/jnm14067; Rao M, 2017, GASTROENTEROLOGY, V153, P1068, DOI 10.1053/j.gastro.2017.07.002; Raybould HE, 2012, J PHYSIOL-LONDON, V590, P441, DOI 10.1113/jphysiol.2011.222133; Reichardt F, 2017, J PHYSIOL-LONDON, V595, P1831, DOI 10.1113/JP273269; Richter S, 2018, CELL TISSUE RES, V374, P473, DOI 10.1007/s00441-018-2907-x; Ridha M, 2015, HYPERTENSION, V65, P949, DOI 10.1161/HYPERTENSIONAHA.114.04926; Sharkey KA, 2015, J CLIN INVEST, V125, P918, DOI 10.1172/JCI76303; Stenkamp-Strahm C, 2013, AUTON NEUROSCI-BASIC, V177, P199, DOI 10.1016/j.autneu.2013.04.014; Stienstra R, 2012, CELL METAB, V15, P10, DOI 10.1016/j.cmet.2011.10.011; Tambucci R, 2019, J PEDIATR GASTR NUTR, V68, P517, DOI 10.1097/MPG.0000000000002208; Turco F, 2014, GUT, V63, P105, DOI 10.1136/gutjnl-2012-302090; Vasina V, 2006, AUTON NEUROSCI-BASIC, V126, P264, DOI 10.1016/j.autneu.2006.02.025; Voss U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081413; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm2	63	19	19	4	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5512	5524		10.1096/fj.201901844R	http://dx.doi.org/10.1096/fj.201901844R		FEB 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32086846	Bronze, Green Published			2022-12-26	WOS:000515257600001
J	Concilio, SC; Zhekova, HR; Noskov, SY; Russell, SJ				Concilio, Susanna C.; Zhekova, Hristina R.; Noskov, Sergei Y.; Russell, Stephen J.			Inter-species variation in monovalent anion substrate selectivity and inhibitor sensitivity in the sodium iodide symporter (NIS)	PLOS ONE			English	Article							THYROID NA+/I-SYMPORTER; SODIUM/IODIDE SYMPORTER; IN-VITRO; CRYSTAL-STRUCTURE; ACTIVE-TRANSPORT; SALIVARY-GLAND; REPORTER GENE; SEA-WATER; PERCHLORATE; MECHANISM	The sodium iodide symporter (NIS) transports iodide, which is necessary for thyroid hormone production. NIS also transports other monovalent anions such as tetrafluoroborate (BF4-), pertechnetate (TcO4-), and thiocyanate (SCN-), and is competitively inhibited by perchlorate (ClO4-). However, the mechanisms of substrate selectivity and inhibitor sensitivity are poorly understood. Here, a comparative approach was taken to determine whether naturally evolved NIS proteins exhibit variability in their substrate transport properties. The NIS proteins of thirteen animal species were initially assessed, and three species from environments with differing iodide availability, freshwater species Danio rerio (zebrafish), saltwater species Balaenoptera acutorostrata scammoni (minke whale), and non-aquatic mammalian species Homo sapiens (human) were studied in detail. NIS genes from each of these species were lentivirally transduced into HeLa cells, which were then characterized using radioisotope uptake assays, I-125(-) competitive substrate uptake assays, and kinetic assays. Homology models of human, minke whale and zebrafish NIS were used to evaluate sequence-dependent impact on the organization of Na+ and I- binding pockets. Whereas each of the three proteins that were analyzed in detail concentrated iodide to a similar degree, their sensitivity to perchlorate inhibition varied significantly: minke whale NIS was the least impacted by perchlorate inhibition (IC50 = 4.599 mu M), zebrafish NIS was highly sensitive (IC50 = 0.081 mu M), and human NIS showed intermediate sensitivity (IC50 = 1.566 mu M). Further studies with fifteen additional substrates and inhibitors revealed similar patterns of iodide uptake inhibition, though the degree of I-125(-) uptake inhibition varied with each compound. Kinetic analysis revealed whale NIS had the lowest K-m-I and the highest V-max-I. Conversely, zebrafish NIS had the highest K-m and lowest V-max. Again, human NIS was intermediate. Molecular modeling revealed a high degree of conservation in the putative ion binding pockets of NIS proteins from different species, which suggests the residues responsible for the observed differences in substrate selectivity lie elsewhere in the protein. Ongoing studies are focusing on residues in the extracellular loops of NIS as determinants of anion specificity. These data demonstrate significant transport differences between the NIS proteins of different species, which may be influenced by the unique physiological needs of each organism. Our results also identify naturally-existing NIS proteins with significant variability in substrate transport kinetics and inhibitor sensitivity, which suggest that the affinity and selectivity of NIS for certain substrates can be altered for biotechnological and clinical applications. Further examination of interspecies differences may improve understanding of the substrate transport mechanism.	[Concilio, Susanna C.; Russell, Stephen J.] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Concilio, Susanna C.] Mayo Clin, Grad Sch Biomed Sci, Rochester, MN USA; [Zhekova, Hristina R.; Noskov, Sergei Y.] Univ Calgary, Ctr Mol Simulat, Dept Biol Sci, Calgary, AB, Canada	Mayo Clinic; Mayo Clinic	Russell, SJ (corresponding author), Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA.	sjr@mayo.edu		Noskov, Sergei/0000-0001-7769-335X; Russell, Stephen/0000-0002-0799-6432	National Institutes of Health [R44 TR001191, T32 AI132165 01A1]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-315019]; Alberta Innovates Technical Futures Strategic Chair in Bio-Molecular Simulations; Alberta Innovates Health Solution Post-Doctoral Fellowship; West-Grid/Compute Canada clusters	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Technical Futures Strategic Chair in Bio-Molecular Simulations; Alberta Innovates Health Solution Post-Doctoral Fellowship; West-Grid/Compute Canada clusters	This study was supported by National Institutes of Health R44 TR001191 to S.J.R. (https://www.nih.gov); National Institutes of Health T32 AI132165 01A1 to S.C.C. (https://www.nih.gov); Natural Sciences and Engineering Research Council of Canada (NSERC grant No. RGPIN-315019) (https://www.nserc-crsng.gc.ca) and Alberta Innovates Technical Futures Strategic Chair in Bio-Molecular Simulations to S.Y.N. (https://albertainnovates.ca); and Alberta Innovates Health Solution Post-Doctoral Fellowship to H.R.Z. (https://albertainnovates.ca).All calculations were performed on the West-Grid/Compute Canada clusters under Research Allocation Award to S.Y.N. (https://www.westgrid.ca).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BC, 2012, THERANOSTICS, V2, P392, DOI 10.7150/thno.3722; Ajarem J, 2016, BEHAV BRAIN FUNCT, V12, DOI 10.1186/s12993-016-0098-8; Alford RF, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004398; Alfredo K, 2015, J AM WATER WORKS ASS, V107, pE187, DOI 10.5942/jawwa.2015.107.0036; ANBAR M, 1959, NATURE, V183, P1517, DOI 10.1038/1831517a0; Ballmaier D, 2006, TOXICOLOGY, V221, P166, DOI 10.1016/j.tox.2006.01.009; Bisignano P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07700-1; Butler R, 2005, J ENVIRON MONITOR, V7, P999, DOI 10.1039/b505833c; Chung T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142984; Cianchetta S, 2010, TOXICOL APPL PHARM, V243, P372, DOI 10.1016/j.taap.2009.12.004; COBEN LA, 1969, AM J PHYSIOL, V217, P89, DOI 10.1152/ajplegacy.1969.217.1.89; Crompton T. R., 2006, ANAL SEAWATER GUIDE; Cui YS, 2018, TOXICOL LETT, V297, P24, DOI 10.1016/j.toxlet.2018.08.020; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; Darrouzet E, 2014, BBA-BIOMEMBRANES, V1838, P244, DOI 10.1016/j.bbamem.2013.08.013; Dasgupta PK, 2005, ENVIRON SCI TECHNOL, V39, P1569, DOI 10.1021/es048612x; Daus B, 2007, CHEMOSPHERE, V68, P253, DOI 10.1016/j.chemosphere.2007.01.019; Dayem M, 2008, J ENDOCRINOL, V197, P95, DOI 10.1677/JOE-07-0455; De la Vieja A, 2018, ENDOCR-RELAT CANCER, V25, pR225, DOI 10.1530/ERC-17-0515; Di Bernardo J, 2011, ANAL BIOCHEM, V415, P32, DOI 10.1016/j.ab.2011.04.017; Dohan O, 2007, P NATL ACAD SCI USA, V104, P20250, DOI 10.1073/pnas.0707207104; Du J, 2014, CHIN J OCEANOL LIMN, V32, P732, DOI 10.1007/s00343-014-3191-6; Eroglu AE, 1998, J ANAL ATOM SPECTROM, V13, P875, DOI 10.1039/a802414f; Eskandari S, 1997, J BIOL CHEM, V272, P27230, DOI 10.1074/jbc.272.43.27230; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Feng F, 2018, CANCER RES, V78, P6121, DOI 10.1158/0008-5472.CAN-18-1954; Ferrandino G, 2016, P NATL ACAD SCI USA, V113, pE5379, DOI 10.1073/pnas.1607231113; Fischer AJ, 2011, AM J RESP CELL MOL, V45, P874, DOI 10.1165/rcmb.2010-0329OC; Fragoso MA, 2004, J PHYSIOL-LONDON, V561, P183, DOI 10.1113/jphysiol.2004.071548; FUGE R, 1986, ENVIRON GEOCHEM HLTH, V8, P31, DOI 10.1007/BF02311063; Goosen MFA, 2000, WATER MANAGEMENT PUR, V2; GREENHALGH R, 1961, J MAR BIOL ASSOC UK, V41, P175, DOI 10.1017/S0025315400001624; Hallinger DR, 2017, TOXICOL IN VITRO, V40, P66, DOI 10.1016/j.tiv.2016.12.006; Hesselink ENK, 2016, J NUCL MED, V57, P1685, DOI 10.2967/jnumed.115.169888; Holland H.D., 1978, CHEM EVOLUTION ATMOS; Hu S, 2011, MOL IMAGING, V10, P227, DOI 10.2310/7290.2010.00051; Huc-Brandt S, 2011, BBA-BIOMEMBRANES, V1808, P65, DOI 10.1016/j.bbamem.2010.08.013; Hussein AAM, 2012, CAN J PHYSIOL PHARM, V90, P99, DOI [10.1139/Y11-103, 10.1139/y11-103]; Hutzen B, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-508; Ito K, 1997, ANAL CHEM, V69, P3628, DOI 10.1021/ac9700787; Jauregui-Osoro M, 2010, EUR J NUCL MED MOL I, V37, P2108, DOI 10.1007/s00259-010-1523-0; Jiang HL, 2018, THERANOSTICS, V8, P3918, DOI 10.7150/thno.24997; Jiang HL, 2018, BIOORGAN MED CHEM, V26, P225, DOI 10.1016/j.bmc.2017.11.034; Jones PA, 1996, TOXICOL IN VITRO, V10, P149, DOI 10.1016/0887-2333(95)00114-X; JONES SD, 1984, LIMNOL OCEANOGR, V29, P1016, DOI 10.4319/lo.1984.29.5.1016; Khoshnevisan A, 2017, J NUCL MED, V58, P156, DOI 10.2967/jnumed.116.177519; Kim YH, 2015, THERANOSTICS, V5, P86, DOI 10.7150/thno.10062; KLEBANOFF SJ, 1970, GYNECOL OBSTET INVES, V1, P21, DOI 10.1159/000301903; Kotani T, 1998, CLIN IMMUNOL IMMUNOP, V89, P271, DOI 10.1006/clin.1998.4595; Kumar S, 2017, MOL BIOL EVOL, V34, P1812, DOI 10.1093/molbev/msx116; Lacoste C, 2012, CANCER RES, V72, P5505, DOI 10.1158/0008-5472.CAN-12-0516; Levy O, 1997, P NATL ACAD SCI USA, V94, P5568, DOI 10.1073/pnas.94.11.5568; Levy O, 1998, J BIOL CHEM, V273, P22657, DOI 10.1074/jbc.273.35.22657; Levy O, 1998, FEBS LETT, V429, P36, DOI 10.1016/S0014-5793(98)00522-5; Li CC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-89; Lim HH, 2012, ANAL CHIM ACTA, V741, P32, DOI 10.1016/j.aca.2012.06.046; Livingstone D.A., 1963, 440G USGS, P64; MATTHEWS AD, 1970, ANAL CHIM ACTA, V51, P455; Melo F, 2007, PROTEIN SCI, V16, P2412, DOI 10.1110/ps.072895107; Miller A, 2016, EXPERT OPIN BIOL TH, V16, P15, DOI 10.1517/14712598.2016.1100162; Mitrofanova E, 2006, GENE THER, V13, P1052, DOI 10.1038/sj.gt.3302758; Morgenstern KE, 2005, OPHTHAL PLAST RECONS, V21, P337, DOI 10.1097/01.iop.0000179369.75569.a8; Mueller D.K., 1995, 954031 US GEOL SURV, P74; Neal C, 2007, HYDROL EARTH SYST SC, V11, P301, DOI 10.5194/hess-11-301-2007; Nicola JP, 1998, AM J PHYSIOL-CELL PH, V296, pC654; Opyrchal M, 2012, HUM GENE THER, V23, P419, DOI 10.1089/hum.2011.158; Paroder-Belenitsky M, 2011, P NATL ACAD SCI USA, V108, P17933, DOI 10.1073/pnas.1108278108; Petrich T, 2002, EUR J NUCL MED MOL I, V29, P842, DOI 10.1007/s00259-002-0784-7; Pilson M.E.Q., 2013, INTRO CHEM SEA, Vsecond, P248, DOI [10.5670/oceanog.2014.31, DOI 10.5670/OCEANOG.2014.31]; Quinones O, 2007, ENVIRON TOXICOL CHEM, V26, P1349, DOI 10.1897/06-469R.1; Ravera S, 2017, ANNU REV PHYSIOL, V79, P261, DOI 10.1146/annurev-physiol-022516-034125; Riesco-Eizaguirre G, 2014, J CLIN ENDOCR METAB, V99, pE1199, DOI 10.1210/jc.2013-4249; Riese CGU, 2009, EUR J NUCL MED MOL I, V36, P1767, DOI 10.1007/s00259-009-1153-6; Robertson R, 2009, PHYS MED BIOL, V54, pN355, DOI 10.1088/0031-9155/54/16/N01; Rong L, 2005, CHROMATOGRAPHIA, V61, P371, DOI 10.1365/s10337-005-0501-3; Russo D, 2011, ENDOCRINE, V40, P35, DOI 10.1007/s12020-011-9469-y; Schlosser PM, 2016, J APPL TOXICOL, V36, P1531, DOI 10.1002/jat.3337; Selvakumar T, 2018, J NUCL MED, DOI [10.2967/jnumed.118, DOI 10.2967/JNUMED.118]; Shen DHY, 2004, GENE THER, V11, P161, DOI 10.1038/sj.gt.3302147; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Simmons KJ, 2014, EMBO J, V33, P1831, DOI 10.15252/embj.201387557; Sioka C, 2011, FERTIL STERIL, V95, P1552, DOI 10.1016/j.fertnstert.2011.01.017; Spitzweg C, 1998, J CLIN ENDOCR METAB, V83, P1746, DOI 10.1210/jc.83.5.1746; Spitzweg C, 2001, KIDNEY INT, V59, P1013, DOI 10.1046/j.1523-1755.2001.00584.x; Suksanpaisan L, 2013, CANCER GENE THER, V20, P638, DOI 10.1038/cgt.2013.57; Tonacchera M, 2004, THYROID, V14, P1012, DOI 10.1089/thy.2004.14.1012; ULLBERG S, 1964, ACTA RADIOL THER PHY, V2, P24, DOI 10.3109/02841866409134127; Van Leeuwen FX, 1987, CRIT REV TOXICOL, V18, P25; Van Sande J, 2003, ENDOCRINOLOGY, V144, P247, DOI 10.1210/en.2002-220744; Vergara-Jaque A, 2017, J CHEM INF MODEL, V57, P3043, DOI 10.1021/acs.jcim.7b00521; Waltz F, 2010, ANAL BIOCHEM, V396, P91, DOI 10.1016/j.ab.2009.08.038; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WOLFF J, 1963, BIOCHIM BIOPHYS ACTA, V69, P58, DOI 10.1016/0006-3002(63)91225-3; WOLFF J, 1962, BIOCHIM BIOPHYS ACTA, V57, P422, DOI 10.1016/0006-3002(62)91152-6; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; WRIGHT EM, 1974, J PHYSIOL-LONDON, V240, P535, DOI 10.1113/jphysiol.1974.sp010622; WYNGAARDEN JB, 1952, ENDOCRINOLOGY, V50, P537, DOI 10.1210/endo-50-5-537; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yoshida A, 1998, BBA-BIOMEMBRANES, V1414, P231, DOI 10.1016/S0005-2736(98)00169-2; Zeuthen T, 2006, J PHYSIOL-LONDON, V570, P485, DOI 10.1113/jphysiol.2005.100933; Zhang ZX, 2005, J CLIN ENDOCR METAB, V90, P6131, DOI 10.1210/jc.2005-0895	102	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229085	10.1371/journal.pone.0229085	http://dx.doi.org/10.1371/journal.pone.0229085			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084174	gold, Green Published			2022-12-26	WOS:000535227900048
J	Mijalkov, M; Pereira, JB; Volpe, G				Mijalkov, Mite; Pereira, Joana B.; Volpe, Giovanni			Delayed correlations improve the reconstruction of the brain connectome	PLOS ONE			English	Article							RESTING-STATE NETWORKS; FUNCTIONAL CONNECTIVITY; SMALL-WORLD; STRUCTURAL CONNECTIVITY; ORGANIZATION; TOPOLOGY; MODELS; ARCHITECTURE; SPECIFICITY; DISTANCE	The brain works as a large-scale complex network, known as the connectome. The strength of the connections between two brain regions in the connectome is commonly estimated by calculating the correlations between their patterns of activation. This approach relies on the assumption that the activation of connected regions occurs together and at the same time. However, there are delays between the activation of connected regions due to excitatory and inhibitory connections. Here, we propose a method to harvest this additional information and reconstruct the structural brain connectome using delayed correlations. This delayed-correlation method correctly identifies 70% to 80% of connections of simulated brain networks, compared to only 5% to 25% of connections detected by the standard methods; this result is robust against changes in the network parameters (small-worldness, excitatory vs. inhibitory connection ratio, weight distribution) and network activation dynamics. The delayed-correlation method predicts more accurately both the global network properties (characteristic path length, global efficiency, clustering coefficient, transitivity) and the nodal network properties (nodal degree, nodal clustering, nodal global efficiency), particularly at lower network densities. We obtain similar results in networks derived from animal and human data. These results suggest that the use of delayed correlations improves the reconstruction of the structural brain connectome and open new possibilities for the analysis of the brain connectome, as well as for other types of networks.	[Mijalkov, Mite; Pereira, Joana B.] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Volpe, Giovanni] Univ Gothenburg, Dept Phys, Gothenburg, Sweden	Karolinska Institutet; University of Gothenburg	Volpe, G (corresponding author), Univ Gothenburg, Dept Phys, Gothenburg, Sweden.	giovanni.volpe@physics.gu.se	Pereira, Joana/AAR-4466-2020; Pereira, Joana/AAL-9244-2020; Mijalkov, Mite/AHB-3132-2022; Volpe, Giovanni/B-1862-2008	Volpe, Giovanni/0000-0001-5057-1846; Mijalkov, Mite/0000-0002-9844-4413	European Research Council; Swedish Research Council; Swedish Alzheimer Foundation; Swedish Brain Foundation; Strategic Research Programme in Neuroscience at Karolinska Institutet (StratNeuro)	European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Alzheimer Foundation; Swedish Brain Foundation; Strategic Research Programme in Neuroscience at Karolinska Institutet (StratNeuro)	Work at the authors' research centers was supported by the European Research Council, the Swedish Research Council, the Swedish Alzheimer Foundation, the Swedish Brain Foundation and the Strategic Research Programme in Neuroscience at Karolinska Institutet (StratNeuro).	Abdelnour F, 2014, NEUROIMAGE, V90, P335, DOI 10.1016/j.neuroimage.2013.12.039; Adachi Y, 2012, CEREB CORTEX, V22, P1586, DOI 10.1093/cercor/bhr234; Alexander-Bloch AF, 2013, CEREB CORTEX, V23, P127, DOI 10.1093/cercor/bhr388; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Atay FM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.144101; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Betzel RF, 2018, P NATL ACAD SCI USA, V115, pE4880, DOI 10.1073/pnas.1720186115; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Bonita JD, 2014, COGN NEURODYNAMICS, V8, P1, DOI 10.1007/s11571-013-9267-8; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Galan RF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002148; Gallos LK, 2012, P NATL ACAD SCI USA, V109, P2825, DOI 10.1073/pnas.1106612109; Ghosh A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000196; Goni J, 2014, P NATL ACAD SCI USA, V111, P833, DOI 10.1073/pnas.1315529111; Guevara MA, 1996, INT J PSYCHOPHYSIOL, V23, P145, DOI 10.1016/S0167-8760(96)00038-4; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hammond C., 2015, CELLULAR MOL NEUROPH, V4th, P285; Harrison L, 2003, NEUROIMAGE, V19, P1477, DOI 10.1016/S1053-8119(03)00160-5; Hermundstad AM, 2013, P NATL ACAD SCI USA, V110, P6169, DOI 10.1073/pnas.1219562110; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Karamzadeh N, 2013, NEUROIMAGE, V66, P311, DOI 10.1016/j.neuroimage.2012.10.032; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Lahaye PJ, 2003, NEUROIMAGE, V20, P962, DOI 10.1016/S1053-8119(03)00340-9; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Liang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032766; Maier-Hein KH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01285-x; Markov NT, 2014, CEREB CORTEX, V24, P17, DOI 10.1093/cercor/bhs270; Markova NT, 2013, P NATL ACAD SCI USA, V110, P5187, DOI 10.1073/pnas.1218972110; Messe A, 2015, SCI REP-UK, V5, DOI 10.1038/srep07870; Meszlenyi RJ, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00075; Misic B, 2015, NEURON, V86, P1518, DOI 10.1016/j.neuron.2015.05.035; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Nelson SB, 2015, NEURON, V87, P684, DOI 10.1016/j.neuron.2015.07.033; Newman MEJ, 2003, SOC NETWORKS, V25, P83, DOI 10.1016/S0378-8733(02)00039-4; O'Reilly JX, 2013, P NATL ACAD SCI USA, V110, P13982, DOI 10.1073/pnas.1305062110; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Oldham S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220061; Owen Julia P, 2013, Brain Connect, V3, P547, DOI 10.1089/brain.2013.0175; Park CH, 2008, PHYSICA A, V387, P5958, DOI 10.1016/j.physa.2008.06.048; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Pereira JB, 2016, CEREB CORTEX, V26, P3476, DOI 10.1093/cercor/bhw128; Petersen SE, 2015, NEURON, V88, P207, DOI 10.1016/j.neuron.2015.09.027; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Reveley C, 2015, P NATL ACAD SCI USA, V112, pE2820, DOI 10.1073/pnas.1418198112; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2015, P NATL ACAD SCI USA, V112, P10032, DOI 10.1073/pnas.1420315112; Ryali S, 2011, NEUROIMAGE, V54, P807, DOI 10.1016/j.neuroimage.2010.09.052; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; Schmidt C, 2016, PLOS ONE, V11, P1, DOI DOI 10.1371/J0URNAL.P0NE.0147270; Smith SM, 2012, NEUROIMAGE, V62, P1257, DOI 10.1016/j.neuroimage.2012.01.022; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2013, NAT METHODS, V10, P491, DOI 10.1038/nmeth.2485; Stefanescu RA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000219; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Vakorin VA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00096; Valdes-Sosa PA, 2005, PHILOS T R SOC B, V360, P969, DOI 10.1098/rstb.2005.1654; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wang QY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026206; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yeh FC, 2018, NEUROIMAGE, V178, P57, DOI 10.1016/j.neuroimage.2018.05.027	81	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228334	10.1371/journal.pone.0228334	http://dx.doi.org/10.1371/journal.pone.0228334			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074115	Green Published, Green Submitted, gold			2022-12-26	WOS:000535220600012
J	Notohamiprodjo, M; Goepfert, M; Will, S; Lorbeer, R; Schick, F; Rathmann, W; Martirosian, P; Peters, A; Muller-Peltzer, K; Helck, A; Rospleszcz, S; Bamberg, F				Notohamiprodjo, Mike; Goepfert, Martin; Will, Susanne; Lorbeer, Roberto; Schick, Fritz; Rathmann, Wolfgang; Martirosian, Petros; Peters, Annette; Mueller-Peltzer, Katharina; Helck, Andreas; Rospleszcz, Susanne; Bamberg, Fabian			Renal and renal sinus fat volumes as quantified by magnetic resonance imaging in subjects with prediabetes, diabetes, and normal glucose tolerance	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CARDIOVASCULAR-DISEASE; KIDNEY-DISEASE; ADIPOSE-TISSUE; ASSOCIATION; POPULATION; RISK; MRI; INSUFFICIENCY; OUTCOMES	Purpose We hypothesize that MRI-based renal compartment volumes, particularly renal sinus fat as locally and potentially independently acting perivascular fat tissue, increase with glucose intolerance. We therefore analyze the distribution of renal volumes in individuals with normal glucose levels and prediabetic and diabetic individuals and investigate potential associations with other typical cardiometabolic biomarkers. Material and methods The sample comprised N = 366 participants who were either normoglycemic (N = 230), had prediabetes (N = 87) or diabetes (N = 49), as determined by Oral Glucose Tolerance Test. Other covariates were obtained by standardized measurements and interviews. Whole-body MR measurements were performed on a 3 Tesla scanner. For assessment of the kidneys, a coronal T1w dual-echo Dixon and a coronal T2w single shot fast spin echo sequence were employed. Stepwise semi-automated segmentation of the kidneys on the Dixon-sequences was based on thresholding and geometric assumptions generating volumes for the kidneys and sinus fat. Inter- and intra-reader variability were determined on a subset of 40 subjects. Associations between glycemic status and renal volumes were evaluated by linear regression models, adjusted for other potential confounding variables. Furthermore, the association of renal volumes with visceral adipose tissue was assessed by linear regression models and Pearson's correlation coefficient. Results Renal volume, renal sinus volume and renal sinus fat increased gradually from normoglycemic controls to individuals with prediabetes to individuals with diabetes (renal volume: 280.3 +/- 64.7 ml vs 303.7 +/- 67.4 ml vs 320.6 +/- 77.7ml, respectively, p < 0.001). After adjustment for age and sex, prediabetes and diabetes were significantly associated to increased renal volume, sinus volume (e.g. beta(Prediabetes) = 10.1, 95% CI: [6.5, 13.7]; p<0.01, beta(Diabetes) = 11.86, 95% CI: [7.2, 16.5]; p<0.01) and sinus fat (e.g. beta(Prediabetes) = 7.13, 95% CI: [4.5, 9.8]; p<0.001, beta(Diabetes) = 7.34, 95% CI: [4.0, 10.7]; p<0.001). Associations attenuated after adjustment for additional confounders were only significant for prediabetes and sinus volume (beta = 4.0 95% CI [0.4, 7.6]; p<0.05). Hypertension was significantly associated with increased sinus volume (beta = 3.7, 95% CI: [0.4, 7.0; p<0.05]) and absolute sinus fat volume (beta = 3.0, 95% CI: [0.7, 5.3]; p<0.05). GFR and all renal volumes were significantly associated as well as urine creatinine levels and renal sinus volume (beta = 1.6, 95% CI: [0.1, 2.9]; p<0.05). Conclusion Renal volume and particularly renal sinus fat volume already increases significantly in prediabetic subjects and is significantly associated with VAT. This shows, that renal sinus fat is a perivascular adipose tissue, which early undergoes changes in the development of metabolic disease. Our findings underpin that renal sinus fat is a link between metabolic disease and associated chronic kidney disease, making it a potential imaging biomarker when assessing perivascular adipose tissue.	[Notohamiprodjo, Mike; Will, Susanne; Schick, Fritz; Martirosian, Petros] Univ Hosp Tuebingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Notohamiprodjo, Mike] Die Radiol, Munich, Germany; [Goepfert, Martin; Lorbeer, Roberto; Helck, Andreas] Univ Hosp Munich, Dept Radiol, Munich, Germany; [Lorbeer, Roberto] German Ctr Cardiovasc Dis Res, Munich, Germany; [Rathmann, Wolfgang] German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Rathmann, Wolfgang] German Ctr Diabet Res DZD, Munich, Germany; [Peters, Annette; Rospleszcz, Susanne] German Res Ctr Environm Hlth, Inst Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Martirosian, Petros] Ludwig Maximilians Univ Munchen, Chair Epidemiol, Munich, Germany; [Mueller-Peltzer, Katharina; Bamberg, Fabian] Univ Freiburg, Dept Diagnost & Intervent Radiol, Med Ctr, Freiburg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; German Centre for Cardiovascular Research; Deutsches Diabetes-Zentrum (DDZ); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Freiburg	Notohamiprodjo, M (corresponding author), Univ Hosp Tuebingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany.; Notohamiprodjo, M (corresponding author), Die Radiol, Munich, Germany.	mike.notohamiprodjo@uni-tuebingen.de	Rospleszcz, Susanne/AGF-1630-2022; Peters, Annette/A-6117-2011	Rospleszcz, Susanne/0000-0002-4788-2341; Peters, Annette/0000-0001-6645-0985; Goepfert, Martin/0000-0003-4161-7501; Schick, Fritz/0000-0002-4231-3406	Helmholtz Zentrum Munchen German Research Center for Environmental Health; German Federal Ministry of Education and Research (BMBF); State of Bavaria; Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians Universitat, as part of LMU innovativ; German Research Foundation (DFG, Deutsche Forschungsgemeinschaft); German Centre for Cardiovascular Disease Research (DZHK, Berlin, Germany); Centre for Diabetes Research (DZD e.V., Neuherberg, Germany); Siemens Healthcare	Helmholtz Zentrum Munchen German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians Universitat, as part of LMU innovativ; German Research Foundation (DFG, Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Centre for Cardiovascular Disease Research (DZHK, Berlin, Germany); Centre for Diabetes Research (DZD e.V., Neuherberg, Germany); Siemens Healthcare(Siemens AG)	The KORA study was initiated and financed by the Helmholtz Zentrum Munchen German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians Universitat, as part of LMU innovativ. The KORAMRI sub-study received funding by the German Research Foundation (DFG, Deutsche Forschungsgemeinschaft), the German Centre for Cardiovascular Disease Research (DZHK, Berlin, Germany) and the Centre for Diabetes Research (DZD e.V., Neuherberg, Germany). The KORA-MRI sub-study was supported by an unrestricted research grant from Siemens Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attenberger UI, 2008, EUR J RADIOL, V65, P59, DOI 10.1016/j.ejrad.2007.10.005; AVRAM MM, 1989, NEPHRON, V52, P259, DOI 10.1159/000185653; Bak M, 2000, J AM SOC NEPHROL, V11, P1287, DOI 10.1681/ASN.V1171287; Bamberg F, 2017, DIABETES, V66, P158, DOI 10.2337/db16-0630; Bamberg F, 2015, RADIOLOGY, V277, P206, DOI 10.1148/radiol.2015142272; Cheung CM, 2010, NEPHROL DIAL TRANSPL, V25, P1133, DOI 10.1093/ndt/gfp623; Cheung CM, 2006, KIDNEY INT, V69, P715, DOI 10.1038/sj.ki.5000118; Christiansen T, 1997, KIDNEY INT, V51, P50, DOI 10.1038/ki.1997.7; Christiansen T, 1998, EXP NEPHROL, V6, P302; Chughtai HL, 2010, HYPERTENSION, V56, P901, DOI 10.1161/HYPERTENSIONAHA.110.157370; de Vries APJ, 2014, LANCET DIABETES ENDO, V2, P417, DOI 10.1016/S2213-8587(14)70065-8; Drey N, 2003, AM J KIDNEY DIS, V42, P677, DOI 10.1016/S0272-6386(03)00916-8; Gandy SJ, 2007, BRIT J RADIOL, V80, P12, DOI 10.1259/bjr/11148990; Gepner Y, 2018, CIRCULATION, V137, P1143, DOI 10.1161/CIRCULATIONAHA.117.030501; Gregory DD, 2003, AM J CARDIOL, V92, P1300, DOI 10.1016/j.amjcard.2003.08.011; Heber SD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177154; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Hueper K, 2013, INVEST RADIOL, V48, P834, DOI 10.1097/RLI.0b013e31829d0414; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Irazabal MV, 2016, EBIOMEDICINE, V13, P21, DOI 10.1016/j.ebiom.2016.11.002; Jonker JT, 2018, NEPHROL DIAL TRANSPL, V33, P224, DOI 10.1093/ndt/gfx243; Krievina G, 2016, EBIOMEDICINE, V13, P274, DOI 10.1016/j.ebiom.2016.10.020; Laxy M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164704; Lee JJ, 2018, AM J MED, V131, P684, DOI 10.1016/j.amjmed.2018.02.002; Michaely HJ, 2013, INVEST RADIOL, V48, P590, DOI 10.1097/RLI.0b013e318289a70b; MOGENSEN CE, 1975, DIABETOLOGIA, V11, P221, DOI 10.1007/BF00422325; Morrell GR, 2013, RADIOLOGY, V269, P625, DOI 10.1148/radiol.13132179; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Murakami Y, 2016, ATHEROSCLEROSIS, V246, P374, DOI 10.1016/j.atherosclerosis.2015.12.014; Peng XG, 2013, RADIOLOGY, V269, P748, DOI 10.1148/radiol.13122860; Perrett D., 2006, MULT LINEAR REGRES V, V32, P1; Petersen SE, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-46; Roseman DA, 2017, NEPHROL DIAL TRANSPL, V32, P1344, DOI 10.1093/ndt/gfw237; Sarnak MJ, 2003, AM J KIDNEY DIS, V41, pS11, DOI 10.1016/S0272-6386(03)00372-X; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Schlett CL, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0721-0; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Storz C, 2018, INVEST RADIOL, V53, P357, DOI 10.1097/RLI.0000000000000451; Storz C, 2018, EUR HEART J-CARD IMG, V19, P701, DOI 10.1093/ehjci/jex190; Thelwall PE, 2011, DIABETOLOGIA, V54, P2421, DOI 10.1007/s00125-011-2163-z; Wagner R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02210-4; Wagner R, 2012, DIABETOLOGIA, V55, P2054, DOI 10.1007/s00125-012-2551-z; Wang YC, 2018, EUR RADIOL, V28, P3326, DOI 10.1007/s00330-017-5298-6; Will S, 2014, MAGN RESON MATER PHY, V27, P445, DOI 10.1007/s10334-014-0429-4; Winter KS, 2014, INVEST RADIOL; Woodard T, 2014, AM J KIDNEY DIS, DOI [10.1016/S2213-8587(14)70065-8, DOI 10.1016/S2213-8587(14)70065-8]; Zelicha H, 2018, CLIN NUTR, V37, P1145, DOI 10.1016/j.clnu.2017.04.007	47	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0216635	10.1371/journal.pone.0216635	http://dx.doi.org/10.1371/journal.pone.0216635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074103	Green Published, Green Submitted, gold			2022-12-26	WOS:000535220600001
J	Wang, LP; Zhu, QY; Zhao, HY				Wang, Liping; Zhu, Qingyu; Zhao, Hongyang			Optimization design of a novel X-type six-high rolling mill based on maximum roll system stiffness	PLOS ONE			English	Article							DEFORMATION; PARAMETERS	The present investigation devices a novel X-type six-high (X-6h) mill. In addition, parametric models of different roll layouts such as the four-high (4-h), I-type six-high (I-6h), and X-6h mills are established. Three-dimensional (3D) finite element (FE) contact analysis for a strip rolling process is conducted when the mills are subjected to a constant vertical load of 65 kN. Through comparative analysis of von Mises stress, contact stress and elastic deformation displacement in three roll layouts, the rigidity characteristic of each is obtained, and it is found that the proposed X-6h mill has the largest roll gap stiffness. The influence of different roll diameter ratios on the roll gap stiffness of the roll system is investigated, based on which an optimization design model is built. Further, by taking into account the roll gap stiffness of the roll system as the optimization objective, the optimum diameter ratios of backup roll (BUR) to work roll (WR) of the X-6h rolling mill is achieved via the genetic algorithm (GA) optimization method, obtaining the optimum structural parameters of BUR and WR as well. The reliability of the proposed design is verified by manufacturing a prototype mill which produced magnesium alloy and aluminum alloy strips of high quality.	[Wang, Liping] Univ Sci & Technol Liaoning, Sch Mech Engn & Automat, Anshan, Peoples R China; [Zhu, Qingyu] Dalian Univ Technol, Sch Mech Engn, Dalian, Peoples R China; [Zhao, Hongyang] Univ Sci & Technol Liaoning, Sch Met & Mat, Anshan, Peoples R China	University of Science & Technology Liaoning; Dalian University of Technology; University of Science & Technology Liaoning	Zhu, QY (corresponding author), Dalian Univ Technol, Sch Mech Engn, Dalian, Peoples R China.	neuzqy@mail.dlut.edu.cn		Zhu, Qingyu/0000-0001-5879-4163	Liaoning Education Department Project [L2013128]	Liaoning Education Department Project	This work was supported by the Liaoning Education Department Project [Grant No. L2013128].	Aljabri A, 2013, PRICM 8 PAC RIM INT, P3001; Aljabri A, 2014, MATER SCI FORUM, V773-774, P70, DOI 10.4028/www.scientific.net/MSF.773-774.70; Cao JG, 2010, STEEL ROLLING EQUIPM; Cao JG, 2018, J MATER PROCESS TECH, V252, P432, DOI 10.1016/j.jmatprotec.2017.09.038; Cavaliere MA, 2001, COMPUT STRUCT, V79, P2075, DOI 10.1016/S0045-7949(01)00055-4; Dong Q, 2015, J FAIL ANAL PREV, V15, P320, DOI 10.1007/s11668-015-9936-5; HARTLEY P, 1989, INT MATER REV, V34, P19, DOI 10.1179/imr.1989.34.1.19; Huang JL, 2017, J VIBROENG, V19, P4840, DOI 10.21595/jve.2017.18263; Kezhi Linghu, 2014, Advanced Materials Research, V988, P257, DOI 10.4028/www.scientific.net/AMR.988.257; Komori K, 1999, J MATER PROCESS TECH, V93, P450; Ma J, 2014, APPL MECH MATER, V444-445, P986, DOI 10.4028/www.scientific.net/AMM.0.986; Moon YH, 1997, J MATER PROCESS TECH, V70, P194, DOI 10.1016/S0924-0136(97)02917-8; Mosayebi M, 2017, INT J ADV MANUF TECH, V91, P4359, DOI 10.1007/s00170-017-0026-6; PANTON SM, 1994, INT J MECH SCI, V36, P725, DOI 10.1016/0020-7403(94)90088-4; Shi X, 2004, IRON STEEL, V39, P71, DOI [10.1023/B:JOGO.0000006653.60256.f6, DOI 10.1023/B:JOGO.0000006653.60256.F6]; Sui H, 2018, STEEL RES INT, V89, DOI 10.1002/srin.201800179; Sun CG, 1998, METALL MATER TRANS A, V29, P2407, DOI 10.1007/s11661-998-0117-y; Wang DC, 2017, CHIN J MECH ENG-EN, V30, P1248, DOI 10.1007/s10033-017-0163-8; Wang DC, 2012, J IRON STEEL RES INT, V19, P22, DOI 10.1016/S1006-706X(12)60055-7; YASUDA K, 1991, ISIJ INT, V31, P594, DOI 10.2355/isijinternational.31.594	20	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228593	10.1371/journal.pone.0228593	http://dx.doi.org/10.1371/journal.pone.0228593			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074123	Green Published, gold			2022-12-26	WOS:000535220600020
J	Debaveye, S; De Smedt, D; Heirman, B; Kavanagh, S; Dewulf, J				Debaveye, Sam; De Smedt, Delphine; Heirman, Bert; Kavanagh, Shane; Dewulf, Jo			Quantifying the handprint-Footprint balance into a single score: The example of pharmaceuticals	PLOS ONE			English	Article							LIFE-CYCLE ASSESSMENT; SOIL-TRANSMITTED HELMINTHS; HEALTH IMPACT ASSESSMENT; CARBON FOOTPRINT; VALUE CHOICES; SCHIZOPHRENIA; NORMALIZATION; BENEFITS; TRANSPORT; FRAMEWORK	Life Cycle Assessment typically focuses on the footprint of products and services, expressed on three Areas of Protection (AoP): Human Health, Ecosystems and Resources. While the handprint is often expressed qualitatively, quantified handprints have recently been compared directly to the footprint concerning one AoP: Human Health. We propose to take this one step further by simultaneously comparing the quantified handprint and footprint on all AoPs through normalization and weighting of the results towards a single score. We discuss two example cases of a pharmaceutical treatment: mebendazole to treat soiltransmitted helminthiases and paliperidone palmitate to treat schizophrenia. Each time, treatment is compared to `no treatment'. The footprint of health care is compared to the handprint of improved patient health. The handprint and footprint were normalized separately. To include sensitivity in the normalization step we applied four sets of external normalization factors for both handprint (Global Burden of Disease) and footprint (ReCiPe and PROSUITE). At the weighting step we applied 26 sets of panel weighting factors from three sources. We propose the Relative Sustainability Benefit Rate (RSBR) as a new metric to quantify the relative difference in combined handprint and footprint single score between two alternatives. When only considering the footprint, the first case study is associated with an increased single score burden of treatment compared to 'no treatment', while in the second case study treatment reduces the single score burden by 41.1% compared to `no treatment'. Also including the handprint provided new insights for the first case study, now showing a decrease of 56.4% in single score burden for treatment compared to `no treatment'. For the second case study the reduction of single score burden was confirmed as the handprint burden was also decreased because of treatment by 9.9%, reinforcing the findings.	[Debaveye, Sam; Dewulf, Jo] Univ Ghent, Dept Green Chem & Technol, Campus Coupure, Ghent, Belgium; [De Smedt, Delphine] Univ Ghent, Dept Publ Hlth, Campus UZ, Ghent, Belgium; [Heirman, Bert] Janssen Pharmaceut NV, Johnson & Johnson Environm Hlth Safety & Sustaina, Beerse, Belgium; [Kavanagh, Shane] Janssen Pharmaceut NV, Hlth Econ, Beerse, Belgium	Ghent University; Ghent University; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals	Debaveye, S (corresponding author), Univ Ghent, Dept Green Chem & Technol, Campus Coupure, Ghent, Belgium.	samdebaveye@gmail.com			Flemish government (Flemish Innovation and Entrepreneurship, VLAIO); Janssen Pharmaceutica [140249]; VLAIO, Baekeland mandate grant [140249]	Flemish government (Flemish Innovation and Entrepreneurship, VLAIO); Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); VLAIO, Baekeland mandate grant	This work was carried out as part of a PhD program jointly funded by the Flemish government (Flemish Innovation and Entrepreneurship, VLAIO, https://www.vlaio.be/nl/subsidies-financiering/baekeland-mandaten) and Janssen Pharmaceutica as a Baekeland mandate grant (no. 140249) awarded to SD. The Janssen Pharmaceutica Environment, Health, Safety and Sustainability and Health Economics departments have had a role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript. The VLAIO did not have a role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript. The work was jointly funded by previously mentioned entities in the form of a VLAIO, Baekeland mandate grant (no. 140249).	Afrinaldi F, 2017, J IND ECOL, V21, P116, DOI 10.1111/jiec.12415; Almeida CMVB, 2013, J CLEAN PROD, V47, P457, DOI 10.1016/j.jclepro.2012.08.002; Arvidsson R, 2018, INT J LIFE CYCLE ASS, V23, P690, DOI 10.1007/s11367-016-1116-7; Benini L, 2016, INT J LIFE CYCLE ASS, V21, P224, DOI 10.1007/s11367-015-1013-5; Biemer PEJ, 2013, IEEE CONF TECH SUST, P146, DOI 10.1109/SusTech.2013.6617312; Briggs A, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-105; Casey GJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002146; Castellani V, 2017, J CLEAN PROD, V140, P556, DOI 10.1016/j.jclepro.2016.05.078; Castellani V, 2016, INT J LIFE CYCLE ASS, V21, P1159, DOI 10.1007/s11367-016-1079-8; Cobiac LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167859; Cucurachi S, 2017, J IND ECOL, V21, P242, DOI 10.1111/jiec.12549; De Graeve D, 2005, PHARMACOECONOMICS, V23, P35, DOI 10.2165/00019053-200523001-00004; De Schryver AM, 2013, INT J LIFE CYCLE ASS, V18, P698, DOI 10.1007/s11367-012-0504-x; De Schryver AM, 2011, J IND ECOL, V15, P796, DOI 10.1111/j.1530-9290.2011.00371.x; Debaveye S, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4247-2; Debaveye S, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006954; Debaveye S, 2016, ENVIRON RES, V144, P19, DOI 10.1016/j.envres.2015.10.027; Decuypere F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179049; Di Cesare S, 2018, INT J LIFE CYCLE ASS, V23, P406, DOI 10.1007/s11367-016-1169-7; Drielsma JA, 2016, INT J LIFE CYCLE ASS, V21, P85, DOI 10.1007/s11367-015-0991-7; Dyllick T, 2017, J CLEAN PROD, V162, P346, DOI 10.1016/j.jclepro.2017.05.189; EMA, 2017, SUMM PROD CHAR XEPL; European Commission, 2017, EUR PLATF LIF CYCL A; Ezzati M., 2004, GLOBAL REGIONAL BURD; Frischknecht R, 2005, INT J LIFE CYCLE ASS, V10, P3, DOI 10.1065/lca2004.10.181.1; Frischknecht R, 2013, ENV STUDIES, V1330, P254; Gaasbeek A, 2013, PROSUITE HDB NOVEL M; Gilbertson LM, 2014, ENVIRON SCI TECHNOL, V48, P11360, DOI 10.1021/es5006576; Goedkoop M., 1999, ECO INDICATOR 99 DAM, V99; Goedkoop M, 2009, 1 DUTCH MIN HOUS; Gold MR, 2002, ANNU REV PUBL HEALTH, V23, P115, DOI 10.1146/annurev.publhealth.23.100901.140513; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Heijungs R, 2007, INT J LIFE CYCLE ASS, V12, P211, DOI 10.1065/lca2006.07.260; Hellweg S, 2014, SCIENCE, V344, P1109, DOI 10.1126/science.1248361; Hertwich EG, 2009, ENVIRON SCI TECHNOL, V43, P6414, DOI 10.1021/es803496a; Hoang U, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5422; Hofstetter P, 2002, RISK ANAL, V22, P965, DOI 10.1111/1539-6924.00264; Holm AL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001135; Hough D, 2010, SCHIZOPHR RES, V116, P107, DOI 10.1016/j.schres.2009.10.026; Huijbregts MAJ, 2001, INT J LIFE CYCLE ASS, V6, P127, DOI 10.1007/BF02978728; Huijbregts MAJ, 2005, INTEGR ENVIRON ASSES, V1, P181, DOI 10.1897/2004-007R.1; Huppes G., 2011, BACKGROUND REV EXIST, DOI DOI 10.2788/88828; Huppes G, 2011, EVALUATION WEIGHTING; Huysman S, 2015, RESOUR CONSERV RECY, V101, P53, DOI 10.1016/j.resconrec.2015.05.014; ILCD, 2010, AN EX ENV IMP ASS ME; ILCD, 2010, FRAM REQ LIF CYCL IM; ISO, 2006, 140442006 ISO, DOI [10.1136/bmj.332.7550.1107, DOI 10.1016/J.ECOLIND.2011.01.007]; Itsubo N, 2004, INT J LIFE CYCLE ASS, V9, P196, DOI 10.1007/BF02994194; Kwan SC, 2017, J TRANSP HEALTH, V6, P187, DOI 10.1016/j.jth.2017.06.006; LAURENT A, 2013, DELIVERABLE 5 2 NORM; Levecke B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003204; Lorant V, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1434-2; Marcus SC, 2015, J MANAG CARE SPEC PH, V21, P754, DOI 10.18553/jmcp.2015.21.9.754; Marsh K, 2016, INT J TECHNOL ASSESS, V32, P400, DOI 10.1017/S0266462316000581; Marsh K, 2016, VALUE HEALTH, V19, P249, DOI 10.1016/j.jval.2015.11.008; McAlearney AS, 1999, CLIN THER, V21, P1605, DOI 10.1016/S0149-2918(00)80015-6; McMichael A.J., 2003, CLIMATE CHANGE HUMAN; Moldan B, 2012, ECOL INDIC, V17, P4, DOI 10.1016/j.ecolind.2011.04.033; Montresor A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004371; Montresor A, 2015, T ROY SOC TROP MED H, V109, P262, DOI 10.1093/trstmh/tru180; Montresor A, 2013, T ROY SOC TROP MED H, V107, P313, DOI 10.1093/trstmh/trt019; Munda G., 2008, SOCIAL MULTICRITERIA; Murray C.J, 1996, GLOBAL BURDEN DIS CO; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Nguyen Phuong H., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1213; Norris G, 2015, HANDPRINTS PRODUCT I; Norris GA, 2013, HUMAN FOOTPRINT HUMA; Norris GA, 2006, INT J LIFE CYCLE ASS, V11, P97, DOI 10.1065/lca2006.04.017; Ono Y, 2015, INT J LIFE CYCLE ASS, V20, P1456, DOI 10.1007/s11367-015-0928-1; Pandey D, 2011, ENVIRON MONIT ASSESS, V178, P135, DOI 10.1007/s10661-010-1678-y; Papa M, 2013, WATER RES, V47, P3679, DOI 10.1016/j.watres.2013.04.015; Pasricha SR, 2008, AM J TROP MED HYG, V78, P375, DOI 10.4269/ajtmh.2008.78.375; Pilnick AR, 2021, SCI REP-UK, V11, DOI [10.1038/s41598-021-90564-1, 10.1155/2014/139030, 10.18280/isi.270101]; Pizzol M, 2017, INT J LIFE CYCLE ASS, V22, P853, DOI 10.1007/s11367-016-1199-1; Pizzol M, 2015, J CLEAN PROD, V86, P170, DOI 10.1016/j.jclepro.2014.08.007; Prado-Lopez V, 2014, INT J LIFE CYCLE ASS, V19, P405, DOI 10.1007/s11367-013-0641-x; PRUSS-USTUN A., 2016, PREVENTING DIS HLTH; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Rojas-Rueda D, 2013, PREV MED, V57, P573, DOI 10.1016/j.ypmed.2013.07.021; Rosenbaum RK, 2008, INT J LIFE CYCLE ASS, V13, P532, DOI 10.1007/s11367-008-0038-4; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Sala S, 2018, DEV WEIGHTING APPROA, DOI DOI 10.2760/446145; Sala S, 2015, INT J LIFE CYCLE ASS, V20, P1568, DOI 10.1007/s11367-015-0958-8; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; Savitz AJ, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw018; Schaubroeck T, 2017, J IND ECOL, V21, P1464, DOI 10.1111/jiec.12653; Siebert U, 2012, MED DECIS MAKING, V32, P690, DOI 10.1177/0272989X12455463; Statbel, 2015, STERFT LEV 2015; Steen B., 1999, SYSTEMATIC APPROACH; Steen B., 2015, EPS 2015D IMPACT ASS; Stevenson M, 2016, LANCET, V388, P2925, DOI 10.1016/S0140-6736(16)30067-8; Stylianou KS, 2016, INT J LIFE CYCLE ASS, V21, P734, DOI 10.1007/s11367-015-0961-0; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; UNEP, 2016, GLOB GUID LIF CYCL I; United Nations, 2017, SUSTAINABLE DEV GOAL; United Nations, 2002, REP WORLD SUMM SUST; Verones F, 2017, J CLEAN PROD, V161, P957, DOI 10.1016/j.jclepro.2017.05.206; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Weidema B., 2013, OVERVIEW METHODOLOGY; Weidema B, 1998, INT J LIFE CYCLE ASS, V3, P237, DOI 10.1007/BF02977574; Weidema BP, 2008, J IND ECOL, V12, P3, DOI 10.1111/j.1530-9290.2008.00005.x; WHO, 2017, PCT DAT SOIL TRANSM; Woodcock J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051462; World Health Organisation (WHO), 2012, SOIL TRANSMITTED HEL; World Health Organization, 2017, WHO METH DAT SOURC G; World Health Organization, 2017, GUID PREV CHEM CONTR; Xia T, 2015, ENVIRON INT, V74, P281, DOI 10.1016/j.envint.2014.10.004	107	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0229235	10.1371/journal.pone.0229235	http://dx.doi.org/10.1371/journal.pone.0229235			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7XT	32069318	Green Published, gold			2022-12-26	WOS:000535212900029
J	Ai, CE; Steele, M; Lopman, B				Ai, Chin-En; Steele, Molly; Lopman, Benjamin			Disease burden and seasonal impact of improving rotavirus vaccine coverage in the United States: A modeling study	PLOS ONE			English	Article							GASTROENTERITIS; CHILDREN; TRANSMISSION; INFANTS; IMPLEMENTATION; DYNAMICS; FAMILIES; DECREASE; ENGLAND; DECLINE	Background Prior to vaccine introduction in 2006, rotavirus was the leading cause of severe diarrhea in children under five years of age in the U.S. Vaccination of infants has led to major reductions in disease burden, a shift in the seasonal peak and the emergence of a biennial pattern of disease. However, rotavirus vaccine coverage has remained relatively low (70-75%) compared to other infant immunizations in the U.S. Part of the reason for this lower coverage is that children whose care is provided by family practitioners (FP) have considerably lower probability of being vaccinated compared to those seen be pediatricians (PE). We used a dynamic transmission model to assess the impact of improving rotavirus vaccine coverage by FP and/or PE on rotavirus gastroenteritis (RVGE) incidence and seasonal patterns. Methods A deterministic age-structured dynamic model with susceptible, infectious, and recovered compartments (SIRS model) was used to simulate rotavirus transmission and vaccination. We estimated the reduction of RVGE cases by 2 doses of rotavirus vaccine with three vaccination scenarios: (Status Quo: 85% coverage by pediatricians and 45% coverage by family practitioners; Improved FP: 85% coverage by pediatricians and family practitioners; Improved FP+PE: 95% coverage by pediatricians and family practitioners). In addition, we tested the sensitivity of the model to the assumption of random mixing patterns between children visiting pediatricians and children visiting family practitioners. Results In this model, higher vaccine coverage provided by family practitioners and pediatricians leads to lower incidence of severe RVGE cases (23% averted in Improved FP and 57% averted in Improved FP+PE compared to Status Quo) including indirect effects. One critical impact of higher total vaccine coverage is the effect on rotavirus epidemic patterns in the U. S.; the biennial rotavirus epidemic patterns shifted to reduced annual epidemic patterns. Additionally, assortative mixing patterns in children visiting pediatricians and family practitioners amplify the impact of increasing vaccine coverage. Conclusion Other high-income countries that introduced vaccine have not experienced biennial patterns, like the U.S. Our results suggest that increasing overall vaccine coverage to 85% among infants would lead to an overall reduction in incidence with annual epidemic patterns.	[Ai, Chin-En; Steele, Molly] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA; [Lopman, Benjamin] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Emory University; Rollins School Public Health	Ai, CE (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA.	cai4@emory.edu		Steele, Molly/0000-0001-7601-0924	NIH/NIAID [R01-AI112970]; Vaccine Impact Modeling Consortium	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Vaccine Impact Modeling Consortium	This work was supported by NIH/NIAID (R01-AI112970) and the Vaccine Impact Modeling Consortium. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliabadi N, 2015, MMWR-MORBID MORTAL W, V64, P337; [Anonymous], 2017, R LANG ENV STAT COMP; Atchison C, 2010, VACCINE, V28, P3118, DOI 10.1016/j.vaccine.2010.02.060; Atkins KE, 2012, VACCINE, V30, P552, DOI 10.1016/j.vaccine.2011.11.064; Baker JM, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3816-7; Banerjee I, 2008, J MED VIROL, V80, P1858, DOI 10.1002/jmv.21263; Buttery JP, 2011, PEDIATR INFECT DIS J, V30, pS25, DOI 10.1097/INF.0b013e3181fefdee; Centers for Disease Control and Prevention, 2018, NAT PUBL US DAT 2007; Choe S, 2015, THEOR BIOL MED MODEL, V12, DOI 10.1186/s12976-015-0026-x; Chung YM, 2017, MATERN CHILD HLTH J, V21, P2178, DOI 10.1007/s10995-017-2336-6; Cortese Margaret M., 2009, Morbidity and Mortality Weekly Report, V58, P1; de Blasio BF, 2010, VACCINE, V28, P7923, DOI 10.1016/j.vaccine.2010.09.070; Getachew HB, 2018, PEDIATR INFECT DIS J, V37, P943, DOI [10.1097/INF.0000000000001988, 10.1097/inf.0000000000001988]; GRIMWOOD K, 1983, BRIT MED J, V287, P575, DOI 10.1136/bmj.287.6392.575; Hansen LG CS, 2011, TRUVEN HLTH ANAL; HAUG KW, 1978, SCAND J INFECT DIS, V10, P265, DOI 10.3109/inf.1978.10.issue-4.02; Hemming-Harlo M, 2016, PEDIATR INFECT DIS J, V35, P1304, DOI 10.1097/INF.0000000000001305; Heymann DL, 2015, CONTROL COMMUNICABLE, P524; Hill HA, 2017, MMWR-MORBID MORTAL W, V66, P1171, DOI 10.15585/mmwr.mm6643a3; Jayasinghe S, 2013, VACCINE, V31, P967, DOI 10.1016/j.vaccine.2012.11.099; Kempe A, 2009, PEDIATRICS, V124, pE809, DOI 10.1542/peds.2008-3832; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; O'Leary ST, 2013, AM J PREV MED, V44, P56, DOI 10.1016/j.amepre.2012.10.001; Panozzo CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073825; Pindyck T, 2018, EXPERT REV VACCINES, V17, P593, DOI 10.1080/14760584.2018.1489724; Pitzer VE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042320; Pitzer VE, 2011, J R SOC INTERFACE, V8, P1584, DOI 10.1098/rsif.2011.0062; Pitzer VE, 2009, SCIENCE, V325, P290, DOI 10.1126/science.1172330; RODRIGUEZ WJ, 1979, J INFECT DIS, V140, P353, DOI 10.1093/infdis/140.3.353; Sabbe M, 2016, EUROSURVEILLANCE, V21, P19, DOI 10.2807/1560-7917.ES.2016.21.27.30273; Shah MS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207002; Shah MP, 2016, PEDIATR INFECT DIS J, V35, P782, DOI 10.1097/INF.0000000000001175; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; Tate JE, 2013, PEDIATR INFECT DIS J, V32, P741, DOI 10.1097/INF.0b013e31828d639c; Tate JE, 2009, PEDIATRICS, V124, P465, DOI 10.1542/peds.2008-3528; van Effelterre T, 2010, EPIDEMIOL INFECT, V138, P884, DOI 10.1017/S0950268809991245; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Vesikari T, 2007, INT J INFECT DIS, V11, pS29, DOI 10.1016/S1201-9712(07)60019-8; Washington DUSDoHaHS, OFF DIS PREV HLTH PR; Weidemann F, 2014, VACCINE, V32, P5250, DOI 10.1016/j.vaccine.2014.06.090; Zlamy M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-112	42	3	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0228942	10.1371/journal.pone.0228942	http://dx.doi.org/10.1371/journal.pone.0228942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7VI	32059029	Green Published, gold			2022-12-26	WOS:000535206600022
J	Bailes, C; Caldwell, M; Wamsley, EJ; Tucker, MA				Bailes, Carrie; Caldwell, Mary; Wamsley, Erin J.; Tucker, Matthew A.			Does sleep protect memories against interference? A failure to replicate	PLOS ONE			English	Article							SLOW-WAVE SLEEP; DECLARATIVE MEMORY; VERBAL MEMORY; CONSOLIDATION; NEUROSCIENCE; RESISTANCE	Across a broad spectrum of memory tasks, retention is superior following a night of sleep compared to a day of wake. However, this result alone does not clarify whether sleep merely slows the forgetting that would otherwise occur as a result of information processing during wakefulness, or whether sleep actually consolidates memories, protecting them from subsequent retroactive interference. Two influential studies suggested that sleep protects memories against the subsequent retroactive interference that occurs when participants learn new yet overlapping information (interference learning). In these studies, interference learning was much less detrimental to memory following a night of sleep compared to a day of wakefulness, an indication that sleep supports this important aspect of memory consolidation. In the current replication study, we repeated the protocol of and, additionally, we examined the impact of intrinsic motivation on performance in sleep and wake participants. We were unable to replicate the finding that sleep protects memories against retroactive interference, with the detrimental effects of interference learning being essentially the same in wake and sleep participants. We also found that while intrinsic motivation benefitted task acquisition it was not a modulator of sleep-wake differences in memory processing. Although we cannot accept the null hypothesis that sleep has no role to play in reducing the negative impact of interference, the findings draw into question prior evidence for sleep's role in protecting memories against interference. Moreover, the current study highlights the importance of replicating key findings in the study of sleep's impact on memory processing before drawing strong conclusions that set the direction of future research.	[Bailes, Carrie; Caldwell, Mary; Tucker, Matthew A.] Univ South Carolina, Sch Med, Greenville, SC 29607 USA; [Wamsley, Erin J.] Furman Univ, Dept Psychol, Greenville, SC 29613 USA; [Wamsley, Erin J.] Furman Univ, Program Neurosci, Greenville, SC 29613 USA		Tucker, MA (corresponding author), Univ South Carolina, Sch Med, Greenville, SC 29607 USA.	matucker@greenvillemed.sc.edu		Tucker, Matthew/0000-0003-2346-9373	NIMH [1R15MH107891]	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded by grant 1R15MH107891 from NIMH (https://www.nimh.nih.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ackermann S, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-013-0430-8; Alger SE, 2015, CURR TOP BEHAV NEURO, V25, P269, DOI 10.1007/7854_2014_341; Alger SE, 2012, NEUROBIOL LEARN MEM, V98, P188, DOI 10.1016/j.nlm.2012.06.003; BARNES JM, 1959, J EXP PSYCHOL, V58, P97, DOI 10.1037/h0047507; Brawn TP, 2013, PSYCHOL SCI, V24, P439, DOI 10.1177/0956797612457391; Cohen J.E., 1988, STAT POWER ANAL BEHA; Curtin F, 1998, BIOL PSYCHIAT, V44, P775, DOI 10.1016/S0006-3223(98)00043-2; DECI EL, 1994, J PERS, V62, P119, DOI 10.1111/j.1467-6494.1994.tb00797.x; Deliens G, 2013, SLEEP, V36, P1875, DOI 10.5665/sleep.3220; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Dudai Y, 2015, NEURON, V88, P20, DOI 10.1016/j.neuron.2015.09.004; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; Ellenbogen JM, 2006, CURR OPIN NEUROBIOL, V16, P716, DOI 10.1016/j.conb.2006.10.006; Ellenbogen JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004117; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fischer S, 2009, J EXP PSYCHOL LEARN, V35, P1586, DOI 10.1037/a0017256; FRIENDLY M, 1982, BEHAV RES METH INSTR, V14, P375, DOI 10.3758/BF03203275; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Lechner HA, 1999, LEARN MEMORY, V6, P77; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; MCAULEY E, 1989, RES Q EXERCISE SPORT, V60, P48, DOI 10.1080/02701367.1989.10607413; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mednick SC, 2011, TRENDS NEUROSCI, V34, P504, DOI 10.1016/j.tins.2011.06.003; Ramadan W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006697; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Ruch S, 2012, NEUROPSYCHOLOGIA, V50, P2389, DOI 10.1016/j.neuropsychologia.2012.06.008; RYAN RM, 1982, J PERS SOC PSYCHOL, V43, P450, DOI 10.1037/0022-3514.43.3.450; Schmidt C, 2006, J NEUROSCI, V26, P8976, DOI 10.1523/JNEUROSCI.2464-06.2006; Scullin MK, 2013, PSYCHOL AGING, V28, P105, DOI 10.1037/a0028830; Sheth BR, 2012, SLEEP, V35, P985, DOI 10.5665/sleep.1966; Simonsohn U, 2015, PSYCHOL SCI, V26, P559, DOI 10.1177/0956797614567341; Sonni A, 2015, NEUROBIOL AGING, V36, P2272, DOI 10.1016/j.neurobiolaging.2015.03.010; Stickgold R, 2013, CURR OPIN NEUROBIOL, V23, P847, DOI 10.1016/j.conb.2013.04.002; Tucker MA, 2018, NEUROBIOL LEARN MEM, V155, P371, DOI 10.1016/j.nlm.2018.08.017; Tucker MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021737; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555	37	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0220419	10.1371/journal.pone.0220419	http://dx.doi.org/10.1371/journal.pone.0220419			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7SH	32053586	Green Submitted, gold, Green Published			2022-12-26	WOS:000535198700004
J	Prada-Prada, S; Florez-Castillo, J; Farfan-Garcia, A; Guzman, F; Hernandez-Penaranda, I				Prada-Prada, Sergio; Florez-Castillo, Johanna; Farfan-Garcia, Ana; Guzman, Fanny; Hernandez-Penaranda, Indira			Antimicrobial activity of Ib-M peptides against Escherichia coli O157: H7	PLOS ONE			English	Article								The development of new antimicrobial peptides has become an attractive alternative to conventional antibiotics due to the increasing rates of microbial drug resistance. Ib-M corresponds to a family of cationic synthetic peptides, 20 amino acids in length, that have shown inhibitory effect against the non-pathogenic strain Escherichia coli K-12. This work evaluated the antimicrobial potential of Ib-M peptides against the pathogenic E. coli O157: H7 using a reference strain and a clinical isolate. The Ib-M peptides showed antibacterial activity against both strains of E. coli O157: H7; the minimum inhibitory concentration of Ib-M peptides ranged from 1.6 to 12.5 mu M and the minimum bactericidal concentration ranged from 3.7 to 22.9 mu M, being Ib-M1 and Ib-M2 the peptides that presented the highest inhibitory effect. Time-kill kinetics assay showed a reduction of the bacterial population by more than 95% after 4 hours of exposure to 1xMIC of Ib-M1. Low cytotoxicity was observed in VERO cells with 50% cytotoxic concentration in the range from 197.5 to more than 400 mu M. All peptides showed a random structure in hydrophilic environments, except Ib-M1, and all of them transitioned to an alpha-helical structure when the hydrophobicity of the medium was increased. In conclusion, these findings support the in vitro antimicrobial effect of Ib-M peptides against the pathogenic bacteria E. coli O157: H7 and prove to be promising molecules for the development of new therapeutic alternatives.	[Prada-Prada, Sergio] Univ Santander, Fac Ciencias Salud, Grp Invest Ciencias Basicas & Aplicadas Sostenibi, Invest Enfermedades Infecciosas, Bucaramanga, Colombia; [Florez-Castillo, Johanna; Hernandez-Penaranda, Indira] Univ Santander, Fac Ciencias Exactas Nat & Agr, Dept Ciencias Nat, Grp Invest Ciencias Basicas & Aplicadas Sostenibi, Bucaramanga, Colombia; [Farfan-Garcia, Ana] Univ Santander, Fac Ciencias Salud, Programa Bacteriol & Lab Clin, Grp Invest Manejo Clin CLINIUDES, Bucaramanga, Colombia; [Guzman, Fanny] Pontificia Univ Catolica Valparaiso, Lab Sintesis Peptidos, Nucleo Biotecnol Curauma NBC, Valparaiso, Chile	Universidad Industrial de Santander; Universidad Industrial de Santander; Universidad Industrial de Santander; Pontificia Universidad Catolica de Valparaiso	Hernandez-Penaranda, I (corresponding author), Univ Santander, Fac Ciencias Exactas Nat & Agr, Dept Ciencias Nat, Grp Invest Ciencias Basicas & Aplicadas Sostenibi, Bucaramanga, Colombia.	indira.hernandez@udes.edu.co	Flórez-Castillo, Johanna/ABE-1393-2021	Flórez-Castillo, Johanna/0000-0001-5321-553X; Hernandez Penarada, Indira Paola/0000-0002-1305-8100; Farfan Garcia, Ana Elvira/0000-0002-9691-0759	National Financing Fund for Science, Technology and Innovation Francisco Jose de Caldas, COLCIENCIAS [778]; Universidad de Santander-UDES	National Financing Fund for Science, Technology and Innovation Francisco Jose de Caldas, COLCIENCIAS; Universidad de Santander-UDES	This work was supported by the National Financing Fund for Science, Technology and Innovation Francisco Jose de Caldas, COLCIENCIAS (financing contract RC No778 of 2016) and the Universidad de Santander-UDES. Dr J. F. received the funding to accomplish this project. The funders had no role in study, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias M, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8020019; Aslam B, 2018, INFECT DRUG RESIST, V11, P1645, DOI 10.2147/IDR.S173867; Bagla VP, 2014, BMC COMPLEM ALTERN M, V14, P2; Bertrand RL, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00697-18; Boto A, 2018, MOLECULES, V23, DOI 10.3390/molecules23020311; Brudzynski K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120238; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Chen LC, 2015, J PHYS CHEM B, V119, P850, DOI 10.1021/jp505497k; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V32; CLSI, 1998, M26A CLSI; Dong T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-349; Farfan-Garcia AE, 2017, INT J PEDIAT, V2017, P1; Fink RC, 2012, APPL ENVIRON MICROB, V78, P1752, DOI 10.1128/AEM.07454-11; Florez-Castillo JM, 2014, INT J PEPT RES THER, V20, P365, DOI 10.1007/s10989-014-9391-2; Gomez-Duarte OG, 2010, FOODBORNE PATHOG DIS, V7, P199, DOI 10.1089/fpd.2009.0355; Herigstad B, 2001, J MICROBIOL METH, V44, P121, DOI 10.1016/S0167-7012(00)00241-4; Huang YB, 2010, PROTEIN CELL, V1, P143, DOI 10.1007/s13238-010-0004-3; Izadpanah A, 2005, J AM ACAD DERMATOL, V52, P381, DOI 10.1016/j.jaad.2004.08.026; Kang HK, 2017, J MICROBIOL, V55, P1, DOI 10.1007/s12275-017-6452-1; Kang SJ, 2014, EXPERT REV ANTI-INFE, V12, P1477, DOI 10.1586/14787210.2014.976613; Levison ME, 2004, INFECT DIS CLIN N AM, V18, P451, DOI 10.1016/j.idc.2004.04.012; Lyu YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep27258; Majowicz SE, 2014, FOODBORNE PATHOG DIS, V11, P447, DOI 10.1089/fpd.2013.1704; Malanovic N, 2016, BBA-BIOMEMBRANES, V1858, P936, DOI 10.1016/j.bbamem.2015.11.004; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Mir RA, 2019, ZOONOSES PUBLIC HLTH, V66, P1, DOI 10.1111/zph.12533; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Rudilla H, 2018, AIMS MICROBIOL, V4, P522, DOI 10.3934/microbiol.2018.3.522; Sierra JM, 2017, EXPERT OPIN BIOL TH, V17, P663, DOI 10.1080/14712598.2017.1315402; Snoussi M, 2018, ELIFE, V7, DOI 10.7554/eLife.38174; Svenson J, 2010, J PHARMACOL EXP THER, V332, P1032, DOI 10.1124/jpet.109.162826; Téllez Germán Alberto, 2010, Infect., V14, P55; Udekwu KI, 2009, J ANTIMICROB CHEMOTH, V63, P745, DOI 10.1093/jac/dkn554; Vila J, 2016, FEMS MICROBIOL REV, V40, P437, DOI 10.1093/femsre/fuw005; Wang T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010008	36	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0229019	10.1371/journal.pone.0229019	http://dx.doi.org/10.1371/journal.pone.0229019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053687	gold, Green Published			2022-12-26	WOS:000535198700091
J	Arai, T; Yamada, H; Edagawa, T; Yoshida, S; Hikimoto, S; Sougawa, H; Nakachi, K				Arai, Toshio; Yamada, Hiroki; Edagawa, Takeya; Yoshida, Satoshi; Hikimoto, Shigetoshi; Sougawa, Hiromichi; Nakachi, Kenichiro			Association of decreased variation of coefficient R-R interval with ischemic colitis and small bowel obstruction	PLOS ONE			English	Article							DYSFUNCTION; PATTERNS; ILEUS	Background The parasympathetic nervous system exerts and controls intestinal tone. Several studies have suggested that the coefficient of the R-R intervals (CVRR) is useful for evaluating the parasympathetic nervous system. Objectives This study aimed to evaluate the relationship between gastrointestinal emergencies, specifically ischemic colitis (IC) and small bowel obstruction (SBO), and the autonomic nervous system. Methods In this retrospective study, a total of 13 patients with IC or SBO aged >= 65 years were analyzed. CVRR was measured in patients with IC and SBO and controls. Results CVRR averaged to 8.8% +/- 2.5% in controls, 1.4% +/- 0.4% in patients with IC, and 2.4% +/- 1.0% in SBO groups (p < 0.001). CVRR was significantly lower in patients with IC and SBO than that in controls. Conclusion The results of this study demonstrate the possibility that CVRR may serve as a clinical index for assessing the functioning of the parasympathetic nervous system in patients with IC or SBO.	[Arai, Toshio; Yamada, Hiroki; Edagawa, Takeya; Yoshida, Satoshi; Nakachi, Kenichiro] Hashimoto Municipal Hosp, Dept Gastroenterol, Hashimoto, Wakayama, Japan; [Hikimoto, Shigetoshi; Sougawa, Hiromichi] Hashimoto Municipal Hosp, Dept Cardiol, Hashimoto, Wakayama, Japan		Arai, T (corresponding author), Hashimoto Municipal Hosp, Dept Gastroenterol, Hashimoto, Wakayama, Japan.	toshio-a@ever.ocn.ne.jp						Ando A, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/2810914; Assenza M, 2016, G CHIR, V37, P145, DOI 10.11138/gchir/2016.37.4.145; Beckett KR, 2015, RADIOGRAPHICS, V35, P1738, DOI 10.1148/rg.2015150033; Brandt LJ, 2015, AM J GASTROENTEROL, V110, P18, DOI [10.1038/ajg.2014.395, 10.1038/ajg.2014.295]; Browning KN, 2014, COMPR PHYSIOL, V4, P1339, DOI 10.1002/cphy.c130055; Drozdz W, 2012, ARCH SURG-CHICAGO, V147, P175, DOI 10.1001/archsurg.2011.970; Haapaniemi TH, 2001, J NEUROL NEUROSUR PS, V70, P305, DOI 10.1136/jnnp.70.3.305; Heitkemper M, 1998, DIGEST DIS SCI, V43, P2093, DOI 10.1023/A:1018871617483; Iacobellis F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/895248; Ina K, 2003, J GASTROENTEROL, V38, P111, DOI 10.1007/s005350300019; Kinekawa F, 2001, AM J GASTROENTEROL, V96, P2026, DOI 10.1016/S0002-9270(01)02425-X; Koshikawa Y, 2016, INTEST RES, V14, P89, DOI 10.5217/ir.2016.14.1.89; Kudoh A, 1999, NEUROPSYCHOBIOLOGY, V39, P125, DOI 10.1159/000026572; Lin OS, 2014, WORLD J GASTRO ENDOS, V6, P220, DOI 10.4253/wjge.v6.i6.220; Luckey A, 2003, ARCH SURG-CHICAGO, V138, P206, DOI 10.1001/archsurg.138.2.206; Mosele M, 2010, SCAND J GASTROENTERO, V45, P428, DOI 10.3109/00365520903513225; Noddin Laura, 2005, MedGenMed, V7, P17; Suzuki M, 2017, J NEUROL, V264, P333, DOI 10.1007/s00415-016-8348-0; Vilz TO, 2017, DTSCH ARZTEBL INT, V114, P508, DOI 10.3238/arztebl.2017.0508; Yoshinari M, 2001, DIABETES CARE, V24, P1783, DOI 10.2337/diacare.24.10.1783	20	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228117	10.1371/journal.pone.0228117	http://dx.doi.org/10.1371/journal.pone.0228117			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32049965	Green Published, gold			2022-12-26	WOS:000535192300008
J	Berger, PK; Plows, JF; Jones, RB; Alderete, TL; Yonemitsu, C; Poulsen, M; Ryoo, JH; Peterson, BS; Bode, L; Goran, MI				Berger, Paige K.; Plows, Jasmine F.; Jones, Roshonda B.; Alderete, Tanya L.; Yonemitsu, Chloe; Poulsen, Marie; Ryoo, Ji Hoon; Peterson, Bradley S.; Bode, Lars; Goran, Michael I.			Human milk oligosaccharide 2'-fucosyllactose links feedings at 1 month to cognitive development at 24 months in infants of normal and overweight mothers	PLOS ONE			English	Article							OBESITY; ASSOCIATION; 2'-FUCOSYLLACTOSE; INTELLIGENCE; MYELINATION; CHILDHOOD; LEPTIN; COHORT; AGE	Background Infant cognitive development is influenced by maternal factors that range from obesity to early feeding and breast milk composition. Animal studies suggest a role for human milk oligosaccharide (HMO), 2'-fucosyllactose (2'FL), on learning and memory, yet no human studies have examined its impact on infant cognitive development relative to other HMOs and maternal factors. Objective To determine the impact of 2'FL from breast milk feeding on infant cognitive development at 24 months of age relative to maternal obesity and breast milk feeding frequency. Methods and materials Hispanic mother-infant pairs (N = 50) were recruited across the spectrum of pre-pregnancy BMI. Breast milk was collected at 1 and 6 months, and feedings/day were reported. Nineteen HMOs were analyzed using high-performance liquid chromatography, with initial interest in 2'FL. Infant cognitive development score was assessed with the Bayley-III Scale at 24 months. Linear regressions were used for prediction, and bootstrapping to determine mediation by 2'FL. Results Maternal pre-pregnancy BMI was not related to feedings/day or HMOs, but predicted poorer infant cognitive development (beta = -0.31, P = 0.03). Feedings/day (beta = 0.34) and 2'FL (beta = 0.59) at 1 month predicted better infant cognitive development (both P <= 0.01). The association of feedings/day with infant cognitive development was no longer significant after further adjustment for 2'FL (estimated mediation effect = 0.13, P = 0.04). There were no associations of feedings/day and 2'FL at 6 months with infant cognitive development. Conclusions Our findings suggest that maternal factors influence infant cognitive development through multiple means. Though maternal obesity may be a separate negative influence, greater frequency of breast milk feeding at 1 month contributed to infant cognitive development through greater exposure to 2'FL relative to other HMOs. The influence of 2'FL was not significant at 6 months, indicating that early exposure to 2'FL may be a critical temporal window for positively influencing infant cognitive development.	[Berger, Paige K.; Plows, Jasmine F.; Jones, Roshonda B.; Ryoo, Ji Hoon; Peterson, Bradley S.; Goran, Michael I.] Childrens Hosp Los Angeles, Saban Res Inst, Dept Pediat, Los Angeles, CA 90027 USA; [Alderete, Tanya L.] Univ Colorado Boulder, Dept Integrat Physiol, Boulder, CO USA; [Yonemitsu, Chloe; Bode, Lars] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Yonemitsu, Chloe; Bode, Lars] Univ Calif San Diego, Mother Milk Infant Ctr Res Excellence, La Jolla, CA 92093 USA; [Poulsen, Marie] Childrens Hosp Los Angeles, Univ Ctr Excellence Dev Disabil, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles; University of Colorado System; University of Colorado Boulder; University of California System; University of California San Diego; University of California System; University of California San Diego; Children's Hospital Los Angeles	Goran, MI (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Dept Pediat, Los Angeles, CA 90027 USA.	mgoran@chla.usc.edu	Alderete, Tanya L./H-3356-2019	Alderete, Tanya L./0000-0002-7751-9543	National Institute of Diabetes and Digestive and Kidney Diseases; Gerber Foundation [15PN-013]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Gerber Foundation	MIG received funds from the National Institute of Diabetes and Digestive and Kidney Diseases (NIH R01 DK110793) and the Gerber Foundation (15PN-013) to support this research. The URL for the National Institute of Diabetes and Digestive and Kidney Diseases is as follows: https://www.niddk.nih.gov/.The URL for the Gerber Foundation is as follows: https://www.gerberfoundation.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Azad MB, 2018, J NUTR, V148, P1733, DOI 10.1093/jn/nxy175; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bayley N., 2006, J PSYCHOEDUC ASSESS, V25, P180, DOI [10.1177/0734282906297199, DOI 10.1177/0734282906297199]; Belfort MB, 2013, JAMA PEDIATR, V167, P836, DOI 10.1001/jamapediatrics.2013.455; Berger PK, 2019, PEDIATR OBES, V14, DOI 10.1111/ijpo.12560; Bode L, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00385; Camargos ACR, 2017, BEHAV BRAIN RES, V325, P12, DOI 10.1016/j.bbr.2017.02.030; Carlson AL, 2018, BIOL PSYCHIAT, V83, P148, DOI 10.1016/j.biopsych.2017.06.021; Casas M, 2013, INT J EPIDEMIOL, V42, P506, DOI 10.1093/ije/dyt002; COPPA GV, 1993, PEDIATRICS, V91, P637; Croteau-Chonka EC, 2016, NEUROIMAGE, V125, P413, DOI 10.1016/j.neuroimage.2015.10.038; Czosnykowska-Lukacka M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121893; Dadres GS, 2019, OBESITY, V27, P621, DOI 10.1002/oby.22409; Daraki V, 2017, EUR CHILD ADOLES PSY, V26, P703, DOI 10.1007/s00787-016-0934-2; Deoni S, 2018, NEUROIMAGE, V178, P649, DOI 10.1016/j.neuroimage.2017.12.056; Fields DA, 2012, PEDIATR OBES, V7, P304, DOI 10.1111/j.2047-6310.2012.00059.x; Gale CR, 2009, PSYCHOSOM MED, V71, P675, DOI 10.1097/PSY.0b013e3181a63b2e; Goran MI, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020146; Hinkle SN, 2012, INT J OBESITY, V36, P1312, DOI 10.1038/ijo.2012.143; Isganaitis E, 2019, AM J CLIN NUTR, V110, P111, DOI 10.1093/ajcn/nqy334; Kimbro RT, 2007, AM J PUBLIC HEALTH, V97, P298, DOI 10.2105/AJPH.2005.080812; Kuczmarski RJ, 2000, AM J CLIN NUTR, V72, P1074; Leonard SA, 2011, AM J CLIN NUTR, V93, P556, DOI 10.3945/ajcn.110.002352; Li N, 2019, PSYCHONEUROENDOCRINO, V99, P257, DOI 10.1016/j.psyneuen.2018.10.021; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; Martin LT, 2007, INT J EPIDEMIOL, V36, P769, DOI 10.1093/ije/dym063; Moossavi S, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00058; MORROWTLUCAK M, 1988, SOC SCI MED, V26, P635, DOI 10.1016/0277-9536(88)90028-7; Oliveros E, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101519; Oliveros E, 2016, J NUTR BIOCHEM, V31, P20, DOI 10.1016/j.jnutbio.2015.12.014; Ou XW, 2015, OBESITY, V23, P1047, DOI 10.1002/oby.21055; Pugh SJ, 2016, J EPIDEMIOL COMMUN H, V70, P534, DOI 10.1136/jech-2015-206800; Pugh SJ, 2015, J NUTR, V145, P2562, DOI 10.3945/jn.115.215525; Sattler, 2018, ASSESSMENT CHILDREN; Spann MN, 2014, HUM BRAIN MAPP, V35, P4459, DOI 10.1002/hbm.22487; Tanda R, 2013, MATERN CHILD HLTH J, V17, P222, DOI 10.1007/s10995-012-0964-4; ten Bruggencate SJM, 2014, NUTR REV, V72, P377, DOI 10.1111/nure.12106; Vazquez E, 2015, J NUTR BIOCHEM, V26, P455, DOI 10.1016/j.jnutbio.2014.11.016; Victora CG, 2015, LANCET GLOB HEALTH, V3, pE199, DOI 10.1016/S2214-109X(15)70002-1; Wall R, 2014, ADV EXP MED BIOL, V817, P221, DOI 10.1007/978-1-4939-0897-4_10; Wang B, 2012, ADV NUTR, V3, p465S, DOI 10.3945/an.112.001875; Wigg NR, 1998, AUST NZ J PUBL HEAL, V22, P232, DOI 10.1111/j.1467-842X.1998.tb01179.x; Yu ZT, 2013, GLYCOBIOLOGY, V23, P1281, DOI 10.1093/glycob/cwt065	44	50	52	10	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228323	10.1371/journal.pone.0228323	http://dx.doi.org/10.1371/journal.pone.0228323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KQ8VO	32049968	gold, Green Submitted, Green Published			2022-12-26	WOS:000517199700001
J	Jiang, C; Cao, RX; Lao, QB; Chen, FJ; Zhang, SW; Bian, PW				Jiang, Chen; Cao, Ruixue; Lao, Qibin; Chen, Fajin; Zhang, Shuwen; Bian, Peiwang			Typhoon Merbok induced upwelling impact on material transport in the coastal northern South China Sea	PLOS ONE			English	Article							PEARL RIVER ESTUARY; SEDIMENT TRANSPORT; ISOTOPIC EVIDENCE; TROPICAL CYCLONE; NITRATE SOURCES; ORGANIC-MATTER; CHLOROPHYLL; OFFSHORE; NITROGEN; TAIWAN	Typhoons frequently affect the South China Sea (SCS), playing an important role in changing the coastal marine system. To determine which process has the greatest impact on material transport in the coastal marine area during a typhoon, the sea temperature, salinity, concentration of nutrients, chlorophyll-a, total suspended matter, and delta C-13 of particulate organic carbon (delta C-13-POC) in the water column of coastal Northern SCS (NSCS) were measured during two cruises in June 2017, in the pre- and post-typhoon Merbok periods. The results show that all parameters changed significantly between the two periods. During the pre-typhoon period, stratification of nutrients and physicochemical parameters, combined to high nutrient concentrations, high temperature, and low salinity in the water column of the nearshore area, suggests that the nearshore area is influenced by the river diluted water originated in the coastal cities adjacent to our study area. In the offshore area, mineralization may be responsible for the high nutrient concentration in the bottom water. However, during the post-typhoon, the stratification of nutrients is less significant and their distribution more homogenous in the whole water column of the nearshore area. In the upper water, the nutrient concentration increased and the temperature decreased significantly. These results suggest that the enhanced vertical mixing induced by the typhoon was the dominant process in changing the nutrient distribution pattern in the coastal NSCS.	[Jiang, Chen; Cao, Ruixue; Chen, Fajin; Bian, Peiwang] Guangdong Ocean Univ, Coll Ocean & Meteorol, Zhanjiang, Peoples R China; [Jiang, Chen; Cao, Ruixue; Chen, Fajin; Bian, Peiwang] Guangdong Ocean Univ, Guangdong Prov Key Lab Coastal Ocean Variat & Dis, Zhanjiang, Peoples R China; [Lao, Qibin] State Ocean Adm, Marine Environm Monitoring Ctr Beihai, Beihai, Peoples R China; [Zhang, Shuwen] Shantou Univ, Inst Marine Sci, Shantou, Peoples R China	Guangdong Ocean University; Guangdong Ocean University; State Oceanic Administration; Shantou University	Chen, FJ (corresponding author), Guangdong Ocean Univ, Coll Ocean & Meteorol, Zhanjiang, Peoples R China.; Chen, FJ (corresponding author), Guangdong Ocean Univ, Guangdong Prov Key Lab Coastal Ocean Variat & Dis, Zhanjiang, Peoples R China.; Zhang, SW (corresponding author), Shantou Univ, Inst Marine Sci, Shantou, Peoples R China.	fjchen04@163.com; gdouzhangsw@163.com		Chen, Fajin/0000-0002-5775-911X	China National Key Research and Development Plan Project [2016YFC1401403]; International Science and Technology Cooperation Programme [GASI-IPOVAI-04]; National Natural Science Foundation of China [U1901213, 41676008, 40876005]; Guangdong Natural Science Foundation of China [2016A030312004]; Project of Enhancing School with Innovation of Guangdong Ocean University [GDOU2016050260]	China National Key Research and Development Plan Project; International Science and Technology Cooperation Programme; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); Project of Enhancing School with Innovation of Guangdong Ocean University	This work was supported by China National Key Research and Development Plan Project (2016YFC1401403); International Science and Technology Cooperation Programme (GASI-IPOVAI-04); National Natural Science Foundation of China (U1901213, 41676008, 40876005); Guangdong Natural Science Foundation of China (2016A030312004); and Project of Enhancing School with Innovation of Guangdong Ocean University (GDOU2016050260).	Babin SM, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001938; Bai Y, 2015, J SEA RES, V95, P1, DOI 10.1016/j.seares.2014.10.003; BOUTTON T W, 1991, P173; Cai WJ, 2004, CONT SHELF RES, V24, P1301, DOI 10.1016/j.csr.2004.04.005; Chen CTA, 2003, J MARINE SYST, V42, P65, DOI 10.1016/S0924-7963(03)00065-4; Chen FJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209287; Chen FJ, 2009, BIOGEOCHEMISTRY, V94, P163, DOI 10.1007/s10533-009-9316-x; Chen FR, 2008, J MARINE SYST, V74, P372, DOI 10.1016/j.jmarsys.2008.02.004; Chiang TL, 2011, J PHYS OCEANOGR, V41, P221, DOI 10.1175/2010JPO4518.1; Dai M, 2008, BIOGEOSCIENCES, V5, P1227, DOI 10.5194/bg-5-1227-2008; Du C, 2013, BIOGEOSCIENCES, V10, P6419, DOI 10.5194/bg-10-6419-2013; Goff JA, 2010, GEOLOGY, V38, P351, DOI 10.1130/G30632.1; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Guo L, 2017, GEOPHYS RES LETT, V44, P11565, DOI 10.1002/2017GL075336; Ke ZX, 2016, AQUAT ECOSYST HEALTH, V19, P468, DOI 10.1080/14634988.2016.1235456; Lao QB, 2019, MAR POLLUT BULL, V142, P603, DOI 10.1016/j.marpolbul.2019.04.026; Li YH, 2015, INT J REMOTE SENS, V36, P2201, DOI 10.1080/01431161.2015.1035407; Lin II, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007626; Liu JT, 2013, ANNU REV MAR SCI, V5, P47, DOI 10.1146/annurev-marine-121211-172307; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Lu ZM, 2015, DEEP-SEA RES PT II, V117, P86, DOI 10.1016/j.dsr2.2013.12.011; MEYERS PA, 1994, CHEM GEOL, V114, P289, DOI 10.1016/0009-2541(94)90059-0; Milliman JD, 2007, GEOLOGY, V35, P779, DOI 10.1130/G23760A.1; Mok JS, 2019, SCI TOTAL ENVIRON, V691, P858, DOI 10.1016/j.scitotenv.2019.07.031; Nakatsuka T, 1997, DEEP-SEA RES PT I, V44, P1957, DOI 10.1016/S0967-0637(97)00051-4; Nan D.W, 2005, GEOPHYS RES LETT, V32, P109; Oey LY, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025873; PILSKALN CH, 1991, LIMNOL OCEANOGR, V36, P544, DOI 10.4319/lo.1991.36.3.0544; PRICE JF, 1994, J PHYS OCEANOGR, V24, P233, DOI 10.1175/1520-0485(1994)024<0233:FSRTAM>2.0.CO;2; Qiu DJ, 2019, J GEOPHYS RES-BIOGEO, V124, P274, DOI 10.1029/2018JG004672; Rao AD, 2010, ESTUAR COAST SHELF S, V89, P267, DOI 10.1016/j.ecss.2010.07.011; Siswanto E, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028368; Subrahmanyam B, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015892; Tsai Y, 2008, GEOPHYS RES LETT, V35, P137; Wang T, 2016, J COASTAL RES, V32, P323, DOI 10.2112/JCOASTRES-D-15-00006.1; Yang SL, 2019, J HYDROL, V575, P755, DOI 10.1016/j.jhydrol.2019.05.077; Ye F, 2017, J GEOPHYS RES-OCEANS, V122, P6835, DOI 10.1002/2017JC012931; Ye F, 2016, J GEOPHYS RES-OCEANS, V121, P8689, DOI 10.1002/2016JC012066; Ye F, 2015, J GEOPHYS RES-BIOGEO, V120, P661, DOI 10.1002/2014JG002842; Ying M, 2014, J ATMOS OCEAN TECH, V31, P287, DOI 10.1175/JTECH-D-12-00119.1; Zhao H, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2009JC005384; Zheng GM, 2007, MAR ECOL PROG SER, V333, P61, DOI 10.3354/meps333061	42	7	7	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228220	10.1371/journal.pone.0228220	http://dx.doi.org/10.1371/journal.pone.0228220			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045408	Green Published, gold			2022-12-26	WOS:000534633200008
J	Kaufmann, CN; Shen, J; Woods, GN; Lane, NE; Stone, KL; Kado, DM				Kaufmann, Christopher N.; Shen, Jian; Woods, Gina N.; Lane, Nancy E.; Stone, Katie L.; Kado, Deborah M.		Osteoporotic Fractures Men MrOS St	Hyperkyphosis and self-reported and objectively measured sleep quality in older men	PLOS ONE			English	Article							COMMUNITY-DWELLING MEN; OSTEOPOROTIC FRACTURES; PREDICTS MORTALITY; ACTIGRAPHY; POSTURE; WOMEN; PARAMETERS; KYPHOSIS; RISK	Objectives Hyperkyphosis is associated with restricted pulmonary function and posture, potentially contributing to poor sleep. A previous study reported older women with hyperkyphosis had worse self-reported sleep quality, but it is less clear if this association exists in men. We examined the association between hyperkyphosis and subjective and objective sleep quality in a cohort of older men. Design Longitudinal analysis of data from large cohort of older men participating in the Osteoporotic Fractures in Men Study (MrOS). Setting Community. Participants We studied 754 men participants in MrOS who had kyphosis measured during the 3rd clinic visit (2007-2009) and future subjective and objective sleep quality assessed between 2009-2012 (an average of 2.9 years later). Intervention N/A. Measurements To measure kyphosis, 1.7 cm thick wooden blocks were placed under the participant's head to achieve a neutral spine position while lying supine on a DXA table. We collected data on both subjective (Pittsburgh Sleep Quality Index [PSQI], and Epworth Sleepiness Scale [ESS]) and objective (wrist actigraphy: Total Sleep Time [TST], Wake After Sleep Onset [WASO], Sleep Efficiency [SE], Sleep Onset Latency [SOL]; and polysomnography: Apnea Hypopnea Index [AHI]) sleep measurements. Those who required >3 blocks were considered hyperkyphotic (n = 145 or 19.2%). Results In unadjusted and multivariable analyses, men with hyperkyphosis did not report having worse self-reported sleep characteristics based on PSQI and ESS. Similarly, there were no significant associations between hyperkyphosis and objective sleep measures. When examined as a continuous predictor (blocks ranging from 0-8), results were no different. Conclusions Although we hypothesized that poor posture in those with hyperkyphosis would interfere with sleep, in this sample of older men, worse kyphosis was not associated with self-reported or objectively measured poor sleep quality.	[Kaufmann, Christopher N.] Univ Calif San Diego, Sch Med, Dept Med, Div Geriatr & Gerontol, La Jolla, CA 92093 USA; [Kaufmann, Christopher N.; Shen, Jian; Kado, Deborah M.] Univ Calif San Diego, Sch Med, Dept Family Med & Publ Hlth, Div Prevent Med, La Jolla, CA 92093 USA; [Woods, Gina N.] Univ Calif San Diego, Sch Med, Dept Med, Div Endocrinol, La Jolla, CA 92093 USA; [Lane, Nancy E.] Univ Calif Davis, Ctr Musculoskeletal Hlth, Sacramento, CA USA; [Lane, Nancy E.] Univ Calif Davis, Dept Internal Med, Sacramento, CA USA; [Stone, Katie L.] Calif Pacific Med Ctr Res Inst, San Francisco, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Davis; University of California System; University of California Davis; California Pacific Medical Center; California Pacific Medical Center Research Institute	Kaufmann, CN (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Div Geriatr & Gerontol, La Jolla, CA 92093 USA.; Kaufmann, CN (corresponding author), Univ Calif San Diego, Sch Med, Dept Family Med & Publ Hlth, Div Prevent Med, La Jolla, CA 92093 USA.	cnkaufmann@health.ucsd.edu		Kado, Deborah/0000-0002-2582-5573	National Institute on Aging [K01AG061239]; National Institutes of Health; National Institute on Aging (NIA); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Center for Advancing Translational Sciences (NCATS); NIH Roadmap for Medical Research [U01AG027810, U01AG042124, U01AG042139, U01AG042140, U01AG042143, U01AG042145, U01AG042168, U01AR066160, UL1TR000128]; National Heart, Lung, and Blood Institute (NHLBI) [R01HL071194, R01HL070848, R01HL070847, R01HL070842, R01HL070841, R01HL070837, R01HL070838, R01HL070839]; Merck Co.	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Merck Co.(Merck & Company)	Dr. Kaufmann received support from the National Institute on Aging (K01AG061239). The Osteoporotic Fractures in Men (MrOS) Study is supported by National Institutes of Health funding. The following institutes provide support: the National Institute on Aging (NIA), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Center for Advancing Translational Sciences (NCATS), and NIH Roadmap for Medical Research under the following grant numbers: U01AG027810, U01AG042124, U01AG042139, U01AG042140, U01AG042143, U01AG042145, U01AG042168, U01AR066160, and UL1TR000128. The National Heart, Lung, and Blood Institute (NHLBI) provides funding for the MrOS Sleep ancillary study "Outcomes of Sleep Disorders in Older Men" under the following grant numbers: R01HL071194, R01HL070848, R01HL070847, R01HL070842, R01HL070841, R01HL070837, R01HL070838, and R01HL070839.; Dr. Stone has received grant funding from Merck & Co. All other authors report no conflicts of interest. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Blackwell T, 2008, SLEEP, V31, P283, DOI 10.1093/sleep/31.2.283; Blank JB, 2005, CONTEMP CLIN TRIALS, V26, P557, DOI 10.1016/j.cct.2005.05.005; Boyle JJW, 2002, CLIN BIOMECH, V17, P361, DOI 10.1016/S0268-0033(02)00030-X; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Di Bari M, 2004, J AM GERIATR SOC, V52, P909, DOI 10.1111/j.1532-5415.2004.52257.x; Huang MH, 2006, J BONE MINER RES, V21, P419, DOI 10.1359/JBMR.051201; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kado DM, 2009, ANN INTERN MED, V150, P681, DOI 10.7326/0003-4819-150-10-200905190-00005; Kado DM, 2005, J GERONTOL A-BIOL, V60, P633, DOI 10.1093/gerona/60.5.633; Kado DM, 2004, J AM GERIATR SOC, V52, P1662, DOI 10.1111/j.1532-5415.2004.52458.x; Katzman WB, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1862-0; Liu Y, 2018, SLEEP HEALTH, V4, P265, DOI 10.1016/j.sleh.2018.02.002; Mehra R, 2007, J AM GERIATR SOC, V55, P1356, DOI 10.1111/j.1532-5415.2007.01290.x; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Ryan SD, 1997, J AM GERIATR SOC, V45, P1479, DOI 10.1111/j.1532-5415.1997.tb03199.x; Stone KL, 2014, J AM GERIATR SOC, V62, P299, DOI 10.1111/jgs.12649; Takahashi T, 2005, OSTEOPOROSIS INT, V16, P273, DOI 10.1007/s00198-004-1669-3; Vitale JA, 2019, YALE J BIOL MED, V92, P205; Wankie C, 2015, J SLEEP DISORD MANAG, V1, DOI [10.23937/2572-4053.1510004, DOI 10.23937/2572-4053.1510004]; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4	21	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228638	10.1371/journal.pone.0228638	http://dx.doi.org/10.1371/journal.pone.0228638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9KA	32045440	Green Published, gold			2022-12-26	WOS:000534633200025
J	Riley, CB; Gardiner, MM				Riley, Christopher B.; Gardiner, Mary M.			Examining the distributional equity of urban tree canopy cover and ecosystem services across United States cities	PLOS ONE			English	Article							ENVIRONMENTAL JUSTICE; SPATIAL-DISTRIBUTION; HUMAN HEALTH; SOCIOECONOMIC-STATUS; EXPLORATORY ANALYSIS; PLANTING PROGRAMS; POLITICAL-ECONOMY; GROUP IDENTITY; GREEN SPACE; LAND-COVER	Examining the distributional equity of urban tree canopy cover (UTCC) has increasingly become an important interdisciplinary focus of ecologists and social scientists working within the field of environmental justice. However, while UTCC may serve as a useful proxy for the benefits provided by the urban forest, it is ultimately not a direct measure. In this study, we quantified the monetary value of multiple ecosystem services (ESD) provisioned by urban forests across nine U.S. cities. Next, we examined the distributional equity of UTCC and ESD using a number of commonly investigated socioeconomic variables. Based on trends in the literature, we predicted that UTCC and ESD would be positively associated with the variables median income and percent with an undergraduate degree and negatively associated with the variables percent minority, percent poverty, percent without a high school degree, percent renters, median year home built, and population density. We also predicted that there would be differences in the relationships between each response variable (UTCC and ESD) and the suite of socioeconomic predictor variables examined because of differences in how each response variable is derived. We utilized methods promoted within the environmental justice literature, including a multi-city comparative analysis, the incorporation of high-resolution social and environmental datasets, and the use of spatially explicit models. Patterns between the socioeconomic variables and UTCC and ESD did not consistently support our predictions, highlighting that inequities are generally not universal but rather context dependent. Our results also illustrated that although the variables UTCC and ESD had largely similar relationships with the predictor variables, differences did occur between them. Future distributional equity research should move beyond the use of proxies for environmental amenities when possible while making sure to consider that the use of ecosystem service estimates may result in different patterns with socioeconomic variables of interest. Based on our findings, we conclude that understanding and remedying the challenges associated with inequities requires an understanding of the local social-ecological system if larger sustainability goals are to be achieved.	[Riley, Christopher B.; Gardiner, Mary M.] Ohio State Univ, Dept Entomol, 1735 Neil Ave, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Riley, CB (corresponding author), Ohio State Univ, Dept Entomol, 1735 Neil Ave, Columbus, OH 43210 USA.	criley@Bartlett.com	Riley, Christopher/AAN-7218-2020	Riley, Christopher/0000-0003-4274-1563	National Science Foundation Graduate Research Fellowship Program [DGE-1343012]; SEEDS: The CFAES Research Competitive Grants Program; Division of Environmental Biology CAREER Grant [CAREER1253197]; USDA Agricultural Research Program Initiative Foundational Programs Grant [201767013-26595]	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); SEEDS: The CFAES Research Competitive Grants Program; Division of Environmental Biology CAREER Grant; USDA Agricultural Research Program Initiative Foundational Programs Grant	This work was supported by funding from the National Science Foundation Graduate Research Fellowship Program (DGE-1343012) (https://www.nsfgrfp.org/) and SEEDS: The CFAES Research Competitive Grants Program (https://www.oardc.ohio-state.edu/seeds/t08_pageview/Home.htm) to C.B.R. and a Division of Environmental Biology CAREER Grant (CAREER1253197)(https://www.nsf.gov/div/index.jsp?div=DEB) and USDA Agricultural Research Program Initiative Foundational Programs Grant (201767013-26595)(https://nifa.usda.gov/program/afri-foundational-program) to M.M.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2013, COMPREHENSIVE TOXICO, P327, DOI [10.1016/B978-0-12-801238-3.64317-9, DOI 10.1016/B978-0-12-801238-3.64317-9]; Abdi H, 2010, WIRES COMPUT STAT, V2, P97, DOI 10.1002/wics.51; Alvey Alexis A., 2006, Urban Forestry & Urban Greening, V5, P195, DOI 10.1016/j.ufug.2006.09.003; [Anonymous], 2019, R LANG ENV STAT COMP; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Anselin L, 2013, SPATIAL ECONOMETRICS; Anselin L, 2005, EXPLORING SPATIAL DA; Apparicio P, 2016, APPL GEOGR, V76, P128, DOI 10.1016/j.apgeog.2016.09.023; Astell-burt T., 2014, BMC PUBLIC HEALTH, V14, P19, DOI [10. 1186/1471-2458-14-292 24678610, DOI 10.1186/1471-2458-14-29224678610]; Bagstad KJ, 2013, ECOSYST SERV, V5, pE27, DOI 10.1016/j.ecoser.2013.07.004; Berland A, 2015, CITIES ENV, V8; Boone Christopher G., 2010, Urban Ecosystems, V13, P255, DOI 10.1007/s11252-009-0118-7; Boone CG, 2008, ENVIRON JUSTICE, V1, P149, DOI 10.1089/env.2008.0530; Chan AY, 2017, J SUSTAIN WATER BUIL, V3, DOI 10.1061/JSWBAY.0000827; Commission for Environmental Cooperation, 2006, EC REG N AM COMM PER; Conway T, 2007, CAN GEOGR-GEOGR CAN, V51, P43, DOI 10.1111/j.1541-0064.2007.00164.x; Conway TM, 2015, LANDSCAPE URBAN PLAN, V138, P1, DOI 10.1016/j.landurbplan.2015.01.007; Danford R.S., 2014, CITI ENV, V7, P2; Dobbs C, 2014, ECOL INDIC, V43, P44, DOI 10.1016/j.ecolind.2014.02.007; Donovan Geoffrey H., 2014, Arboriculture & Urban Forestry, V40, P70; Downey L, 2007, URBAN STUD, V44, P953, DOI 10.1080/00420980701256013; Duncan Dustin T, 2014, Spat Demogr, V2, P1, DOI 10.1007/BF03354902; Emmanuel R, 1997, ENVIRON PLANN B, V24, P415, DOI 10.1068/b240415; Ernstson H, 2013, LANDSCAPE URBAN PLAN, V109, P7, DOI 10.1016/j.landurbplan.2012.10.005; Escobedo F., 2006, URBAN FOR URBAN GREE, V4, P105, DOI DOI 10.1016/J.UFUG.2005.12.002; Escobedo FJ, 2011, ENVIRON POLLUT, V159, P2078, DOI 10.1016/j.envpol.2011.01.010; Flocks J, 2011, ENVIRON JUSTICE, V4, P125, DOI 10.1089/env.2010.0018; Frey N, 2017, URBAN GEOGR, V38, P1534, DOI 10.1080/02723638.2016.1238686; Gerrish E, 2018, LANDSCAPE URBAN PLAN, V170, P293, DOI 10.1016/j.landurbplan.2017.09.005; Greene CS, 2018, J ENVIRON MANAGE, V208, P24, DOI 10.1016/j.jenvman.2017.12.015; Grove JM, 2006, ECOSYSTEMS, V9, P578, DOI 10.1007/s10021-006-0116-z; Grove JM, 2014, ENVIRON MANAGE, V54, P402, DOI 10.1007/s00267-014-0310-2; Grove JM, 2006, SOC NATUR RESOUR, V19, P117, DOI 10.1080/08941920500394501; Herrmann DL, 2016, BIOSCIENCE, V66, P965, DOI 10.1093/biosci/biw062; Heynen N.C., 2003, PUBLIC WORKS MANAGEM, V8, P33, DOI [10.1177/1087724X03008001004, DOI 10.1177/1087724X03008001004, 10.1177/1087724X03253604]; Heynen N, 2006, URBAN AFF REV, V42, P3, DOI 10.1177/1078087406290729; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Iverson L., 2000, URBAN ECOSYST, V4, P105; Jenerette GD, 2011, ECOL APPL, V21, P2637, DOI 10.1890/10-1493.1; Jennings V, 2017, POPUL ENVIRON, V39, P69, DOI 10.1007/s11111-017-0276-0; Jensen R, 2004, ECOL SOC, V9; Jesdale BM, 2013, ENVIRON HEALTH PERSP, V121, P811, DOI 10.1289/ehp.1205919; Kirkpatrick JB, 2007, LANDSCAPE URBAN PLAN, V79, P314, DOI 10.1016/j.landurbplan.2006.03.006; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Landry SM, 2009, ENVIRON PLANN A, V41, P2651, DOI 10.1068/a41236; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Livesley SJ, 2016, J ENVIRON QUAL, V45, P119, DOI 10.2134/jeq2015.11.0567; Livesley SJ, 2016, FORESTS, V7, DOI 10.3390/f7120291; Lovell ST, 2013, LANDSCAPE ECOL, V28, P1447, DOI 10.1007/s10980-013-9912-y; Lowry JH, 2012, URBAN ECOSYST, V15, P247, DOI 10.1007/s11252-011-0185-4; Lyytimaki J, 2009, URBAN FOR URBAN GREE, V8, P309, DOI 10.1016/j.ufug.2009.09.003; Martin CA, 2004, LANDSCAPE URBAN PLAN, V69, P355, DOI 10.1016/j.landurbplan.2003.10.034; McPherson EG, 2011, LANDSCAPE URBAN PLAN, V99, P40, DOI 10.1016/j.landurbplan.2010.08.011; Mennis J, 2006, PHOTOGRAMM ENG REM S, V72, P911, DOI 10.14358/PERS.72.8.911; Merse CL., 2009, GEOGR BULL, V50, P65; Mohai P, 2007, SOC PROBL, V54, P343, DOI 10.1525/sp.2007.54.3.343; Nassauer JI, 2014, LANDSCAPE URBAN PLAN, V125, P245, DOI 10.1016/j.landurbplan.2013.10.008; Nassauer JI, 2011, LANDSCAPE URBAN PLAN, V100, P321, DOI 10.1016/j.landurbplan.2011.02.022; Nowak DJ, 2016, URBAN ECOSYST, V19, P1455, DOI 10.1007/s11252-013-0326-z; Nowak DJ, 2014, ENVIRON POLLUT, V193, P119, DOI 10.1016/j.envpol.2014.05.028; Nowak David J., 2008, Arboriculture & Urban Forestry, V34, P347; Nowak DJ, 1996, LANDSCAPE URBAN PLAN, V36, P49, DOI 10.1016/S0169-2046(96)00324-6; Nowak DJ, 2007, URBAN COMMUNITY FORE, P25; Ogden LA, 2019, URBAN ECOSYST, V22, P49, DOI 10.1007/s11252-018-0744-z; Ogneva-Himmelberger Y, 2009, APPL GEOGR, V29, P478, DOI 10.1016/j.apgeog.2009.03.001; Ordonez-Barona C, 2017, URBAN FOR URBAN GREE, V26, P65, DOI 10.1016/j.ufug.2017.06.006; Parmehr EG, 2016, URBAN FOR URBAN GREE, V20, P160, DOI 10.1016/j.ufug.2016.08.011; Pataki DE, 2011, FRONT ECOL ENVIRON, V9, P27, DOI 10.1890/090220; Pedlowski M.A., 2002, URBAN ECOSYST, V6, P9, DOI [DOI 10.1023/A:1025910528583, 10.1023/A:1025910528583]; Perkins HA, 2004, CITIES, V21, P291, DOI 10.1016/j.cities.2004.04.002; Pincetl S, 2013, GEOJOURNAL, V78, P475, DOI 10.1007/s10708-012-9446-x; Riley CB, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10072139; Riley CB, 2018, URBAN FOR URBAN GREE, V29, P367, DOI 10.1016/j.ufug.2017.01.004; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Sandifer PA, 2015, ECOSYST SERV, V12, P1, DOI 10.1016/j.ecoser.2014.12.007; Schwarz K, 2018, SUSTAIN CITIES SOC, V41, P816, DOI 10.1016/j.scs.2018.06.026; Schwarz K, 2016, FRONT ECOL ENVIRON, V14, P296, DOI 10.1002/fee.1288; Schwarz K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122051; Silverman RM, 2013, J URBAN AFF, V35, P131, DOI 10.1111/j.1467-9906.2012.00627.x; Soares AL, 2011, URBAN FOR URBAN GREE, V10, P69, DOI 10.1016/j.ufug.2010.12.001; Sorrensen CL, 2015, URBAN GEOGR, V36, P1042, DOI 10.1080/02723638.2015.1039397; Su JG, 2010, GEOJOURNAL, V75, P595, DOI 10.1007/s10708-009-9269-6; TALARCHEK GM, 1990, URBAN GEOGR, V11, P65, DOI 10.2747/0272-3638.11.1.65; Pham TTH, 2012, LANDSCAPE URBAN PLAN, V107, P214, DOI 10.1016/j.landurbplan.2012.06.002; Troy AR, 2007, ENVIRON MANAGE, V40, P394, DOI 10.1007/s00267-006-0112-2; Tyrvainen L., 2005, URBAN FORESTS TREES, P81, DOI [10.1007/3-540-27684-X_5, DOI 10.1007/3-540-27684-X_5]; Tzoulas K, 2007, LANDSCAPE URBAN PLAN, V81, P167, DOI 10.1016/j.landurbplan.2007.02.001; Wen M, 2013, ANN BEHAV MED, V45, pS18, DOI 10.1007/s12160-012-9426-x; Wolch JR, 2014, LANDSCAPE URBAN PLAN, V125, P234, DOI 10.1016/j.landurbplan.2014.01.017; Zhang Y, 2007, ENVIRON BEHAV, V39, P797, DOI 10.1177/0013916506292326	90	31	32	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228499	10.1371/journal.pone.0228499	http://dx.doi.org/10.1371/journal.pone.0228499			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9KA	32045427	gold, Green Published			2022-12-26	WOS:000534633200015
J	Prottengeier, J; Elsner, S; Wehrfritz, A; Moritz, A; Schmidt, J; Meyer, M				Prottengeier, Johannes; Elsner, Stefan; Wehrfritz, Andreas; Moritz, Andreas; Schmidt, Joachim; Meyer, Michael			Nociception testing during fixed-wing ambulance flights. An interventional pilot study on the effects of flight-related environmental changes on the nociception of healthy volunteers	PLOS ONE			English	Article							GERMAN RESEARCH NETWORK; NEUROPATHIC PAIN DFNS; PERCEPTION; PRESSURE	Background The effects of environmental changes on the somato-sensory system during long-distance air ambulance flights need to be further investigated. Changes in nociceptive capacity are conceivable in light of previous studies performed under related environmental settings. We used standardized somato-sensory testing to investigate nociception in healthy volunteers during air-ambulance flights. Methods Twenty-five healthy individuals were submitted to a test compilation analogous to the quantitative sensory testing battery-performed during actual air-ambulance flights. Measurements were paired around the major changes of external factors during take-off/climb and descent/landing. Bland-Altman-Plots were calculated to identify possible systemic effects. Results Bland-Altman-analyses suggest that the thresholds of stimulus detection and pain as well as above-threshold pain along critical waypoints of travel are not subject to systemic effects but instead demonstrate random variations. Conclusions We provide a novel description of a real-life experimental setup and demonstrate the general feasibility of performing somato-sensory testing during ambulance flights. No systematic effects on the nociception of healthy individuals were apparent from our data. Our findings open up the possibility of future investigations into potential effects of ambulance flights on patients suffering acute or chronic pain.	[Prottengeier, Johannes; Wehrfritz, Andreas; Moritz, Andreas; Schmidt, Joachim; Meyer, Michael] Univ Hosp Erlangen, Dept Anesthesiol, Erlangen, Germany; [Prottengeier, Johannes; Elsner, Stefan; Wehrfritz, Andreas; Moritz, Andreas; Schmidt, Joachim; Meyer, Michael] Friedrich Alexander Univ Erlangen Nuremberg, Fac Med, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Prottengeier, J (corresponding author), Univ Hosp Erlangen, Dept Anesthesiol, Erlangen, Germany.; Prottengeier, J (corresponding author), Friedrich Alexander Univ Erlangen Nuremberg, Fac Med, Erlangen, Germany.	johannes.prottengeier@kfa.imed.uni-erlangen.de		Moritz, Andreas/0000-0003-0321-4971; Wehrfritz, Andreas/0000-0002-0399-0535; Prottengeier, Johannes/0000-0002-5744-3297	ADAC Schutzbrief AG	ADAC Schutzbrief AG	This study was funded by a science grant from the ADAC Schutzbrief AG. Open Access publication fees were provided by the Friedrich-Alexander University of Erlangen-Nuremberg. Sponsors did not play any role in study design, data collection, analysis and interpretation or preparation of the manuscript.	[Anonymous], 2018, DEUTL MEHR NOTR AUSL; Averbeck B, 2017, BIOL SEX DIFFER, V8, DOI 10.1186/s13293-017-0147-5; Backonja M, 2013, PAIN, V154, P1807, DOI 10.1016/j.pain.2013.05.047; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Burdack-Freitag A, 2011, J VERBRAUCH LEBENSM, V6, P95, DOI 10.1007/s00003-010-0630-y; IATA, 2018, ANN REV; Jensen TS, 2014, LANCET NEUROL, V13, P924, DOI 10.1016/S1474-4422(14)70102-4; MCMICHAEL AJ, 1976, J OCCUP ENVIRON MED, V18, P165, DOI 10.1097/00043764-197603000-00009; Moore Rhonda J., 2009, P259, DOI 10.1007/978-0-387-78323-9_11; Mucke M, 2016, QUANTITATIVE SENSORY, DOI [10.1007/s00482-015-0093-2, DOI 10.1007/S00482-015-0093-2]; Nielsen PR, 2007, ACTA ANAESTH SCAND, V51, P582, DOI 10.1111/j.1399-6576.2007.01271.x; NoelJorand MC, 1996, EUR J NEUROSCI, V8, P2075, DOI 10.1111/j.1460-9568.1996.tb00728.x; Pfau DB, 2014, PAIN, V155, P1002, DOI 10.1016/j.pain.2014.02.004; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rolke R, 2010, QST INVESTIGATORS BR; Sato J, 2011, NEUROSCI LETT, V503, P152, DOI 10.1016/j.neulet.2011.08.030; Stener-Victorin E, 2002, ANESTH ANALG, V95, P151, DOI 10.1097/00000539-200207000-00027; Tham SW, 2016, PAIN, V157, P2807, DOI 10.1097/j.pain.0000000000000716; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471	19	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0217530	10.1371/journal.pone.0217530	http://dx.doi.org/10.1371/journal.pone.0217530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092064	Green Published, Green Submitted, gold			2022-12-26	WOS:000535229300002
J	Cao, HB; He, Q; von Eyben, R; Bloomstein, J; Nambiar, DK; Viswanathan, V; Aggarwal, S; Kwok, S; Liang, R; Koong, AJ; Lewis, JS; Kong, C; Xiao, N; Le, QT				Cao, Hongbin; He, Qian; von Eyben, Rie; Bloomstein, Joshua; Nambiar, Dhanya K.; Viswanathan, Vignesh; Aggarwal, Sonya; Kwok, Shirley; Liang, Rachel; Koong, Amanda Jeanette; Lewis, James S., Jr.; Kong, Christina; Xiao, Nan; Quynh-Thu Le			The role of Glial cell derived neurotrophic factor in head and neck cancer	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; TYROSINE KINASE; GDNF FAMILY; RECEPTOR; DISEASE; EXPRESSION; CARCINOMA; MIGRATION; SURVIVAL	Glial cell-derived neurotrophic factor (GDNF) is reported to promote the survival of neurons and salivary gland regeneration after radiation damage. This study investigated the effect of GDNF on cell migration, growth, and response to radiation in preclinical models of head and neck squamous cell carcinoma (HNSCC) and correlated GDNF expression to treatment outcomes in HNSCC patients. Our ultimate goal is to determine whether systemic administration of GDNF at high dose is safe for the management of hyposalivation or xerostomia in HNSCC patients. Three HPV-positive and three HPV-negative cell lines were examined for cell migration, growth, and clonogenic survival in vitro and tumor growth assay in vivo. Immunohistochemical staining of GDNF, its receptors GFR alpha 1 and its co-receptor RET was performed on two independent HNSCC tissue microarrays (TMA) and correlated to treatment outcomes. Results showed that GDNF only enhanced cell migration in two HPV-positive cells at supra-physiologic doses, but not in HPV-negative cells. GDNF did not increase cell survival in the tested cell lines post-irradiation. Likewise, GDNF treatment affected neither tumor growth in vitro nor response to radiation in xenografts in two HPV-positive and two HPV-negative HNSCC models. High stromal expression of GDNF protein was associated with worse overall survival in HPV-negative HNSCC on multivariate analysis in a combined cohort of patients from Stanford University (n = 82) and Washington University (n = 189); however, the association between GDNF gene expression and worse survival was not confirmed in a separate group of HPV-negative HNSCC patients identified from the Cancer Genome Atlas (TCGA) database. Based on these data, we do not believe that GNDF is a safe systemic treatment to prevent or treat xerostomia in HNSCC and a local delivery approach such as intraglandular injection needs to be explored.	[Cao, Hongbin; He, Qian; von Eyben, Rie; Bloomstein, Joshua; Nambiar, Dhanya K.; Viswanathan, Vignesh; Aggarwal, Sonya; Quynh-Thu Le] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA; [Kwok, Shirley; Liang, Rachel; Koong, Amanda Jeanette; Kong, Christina] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Lewis, James S., Jr.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Xiao, Nan] Univ Pacific Arthur A Dugoni Sch Dent, Dept Biomed Sci, San Francisco, CA 94103 USA	Stanford University; Stanford University; Vanderbilt University	Le, QT (corresponding author), Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA.; Xiao, N (corresponding author), Univ Pacific Arthur A Dugoni Sch Dent, Dept Biomed Sci, San Francisco, CA 94103 USA.	nxiao@pacific.edu; qle@stanford.edu	nambiar, Dhanya/AAW-2495-2020; viswanathan, vignesh/AAR-6878-2020	nambiar, Dhanya/0000-0002-0648-403X; viswanathan, vignesh/0000-0001-8307-9508; Le, Quynh Thu/0000-0002-3682-1439; Koong, Amanda/0000-0002-2447-4695; Bloomstein, Joshua/0000-0002-7395-1910; Liang, Rachel/0000-0003-0859-2314	NIH [1R01DE025227-01]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grant from the NIH (1R01DE025227-01).	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Baba T, 2015, MOL CARCINOGEN, V54, P608, DOI 10.1002/mc.22127; Chuang JY, 2013, ORAL ONCOL, V49, P1103, DOI 10.1016/j.oraloncology.2013.08.009; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Gao CB, 2014, EXP THER MED, V8, P818, DOI 10.3892/etm.2014.1821; Gillison ML, 2004, SEMIN ONCOL, V31, P744, DOI 10.1053/j.seminoncol.2004.09.011; He SB, 2014, P NATL ACAD SCI USA, V111, pE2008, DOI 10.1073/pnas.1402944111; Huang SM, 2014, ENDOCR-RELAT CANCER, V21, P73, DOI 10.1530/ERC-13-0351; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Kirik D, 2004, NAT NEUROSCI, V7, P105, DOI 10.1038/nn1175; Kong CS, 2009, INT J RADIAT ONCOL, V74, P553, DOI 10.1016/j.ijrobp.2009.02.015; Lee NY, 2008, SEMIN ONCOL, V35, P236, DOI 10.1053/j.seminoncol.2008.03.003; Lin CZ, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1353860; Lin ZX, 2014, HEAD NECK-J SCI SPEC, V36, P709, DOI 10.1002/hed.23362; Lu DY, 2010, BIOCHEM PHARMACOL, V80, P1201, DOI 10.1016/j.bcp.2010.06.046; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Peterson AL, 2008, NEUROTHERAPEUTICS, V5, P270, DOI 10.1016/j.nurt.2008.02.003; Qi H, 2008, BRIT J OPHTHALMOL, V92, P1269, DOI 10.1136/bjo.2007.132431; Roh J, 2015, ORAL ONCOL, V51, P16, DOI 10.1016/j.oraloncology.2014.10.004; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; Straten G, 2009, J ALZHEIMERS DIS, V18, P331, DOI 10.3233/JAD-2009-1146; van Kempen PMW, 2014, EPIGENETICS-US, V9, P194, DOI 10.4161/epi.26881; Xiao N, 2014, J CLIN INVEST, V124, P3364, DOI 10.1172/JCI74096; Xiao N, 2013, CLIN CANCER RES, V19, P4455, DOI 10.1158/1078-0432.CCR-13-0127	28	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229311	10.1371/journal.pone.0229311	http://dx.doi.org/10.1371/journal.pone.0229311			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084217	Green Published, gold			2022-12-26	WOS:000535227900088
J	Fujita, A; Okuno, T; Oda, M; Kato, K				Fujita, Akiko; Okuno, Takaya; Oda, Mika; Kato, Keiko			Urinary volatilome analysis in a mouse model of anxiety and depression	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; MASS-SPECTROMETRY DATA; GAS-CHROMATOGRAPHY; CERAMBYCID BEETLE; ORGANIC-COMPOUNDS; SEX-PHEROMONE; SCENT MARKS; HOUSE MOUSE; IDENTIFICATION; MICE	Psychiatric disorders including depression and anxiety comprise a broad range of conditions with different symptoms. We have developed a mouse model of depression/anxiety in mice deficient in the St3gal4 gene. In this study, we performed a comparative analysis of urinary volatile organic compounds (VOCs) in St3gal4-deficient (St3gal4-KO) and wild-type mice using gas chromatography-mass spectrometry, and we screened 18 putative VOCs. Principal component analysis (PCA) based on these VOCs identified a major group of 11 VOCs, from which two groups were clarified by hierarchical clustering analysis. One group including six VOCs (pentanoic acid, 4-methyl-, ethyl ester; 3-heptanone, 6-methyl; benzaldehyde; 5,9-undecadien-2-ol, 6,10-dimethyl; and unknown compounds RI1291 and RI1237) was correlated with the startle response (r = 0.620), which is related to an unconscious defensive response. The other group including two VOCs (beta-farnesene and alpha-farnesene) comprised pheromones which increased in KO mice. Next, male mice underwent a social behavior test with female mice in the estrus stage, showing reduced access of KO male mice to female mice. Comparative analysis of urinary VOCs before and after encounters revealed that the six VOCs were not changed by these encounters. However, in WT mice, the two farnesenes increased after the encounters, reaching the level observed in KO mice, which was not altered following the encounter. Taken together, these results indicated that St3gal4 was involved in modulating urinary VOCs. Moreover, VOC clusters discovered by comparison of St3gal4-KO mice with WT mice were correlated with differential emotional behaviors.	[Fujita, Akiko; Okuno, Takaya; Oda, Mika; Kato, Keiko] Kyoto Sangyo Univ, Fac Life Sci, Kyoto, Japan	Kyoto Sangyo University	Kato, K (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Kyoto, Japan.	kato@cc.kyoto-su.ac.jp		kato, keiko/0000-0002-7752-8052	Kyoto Sangyo Univ.; JSPS KAKENHI [JP15K07774]; Mizutani Foundation for Glycoscience [208]; PMAC Scholarship Fund for Young Researchers [GK1701]	Kyoto Sangyo Univ.; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mizutani Foundation for Glycoscience; PMAC Scholarship Fund for Young Researchers	This work was supported by Kyoto Sangyo Univ. Research Grant (K.K.), JSPS KAKENHI (JP15K07774) (K.K.), Mizutani Foundation for Glycoscience (NO. 208) (K.K.), PMAC Scholarship Fund for Young Researchers (GK1701) (A.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Arnaiz E, 2014, ANAL LETT, V47, P721, DOI 10.1080/00032719.2013.853182; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Benton HP, 2008, ANAL CHEM, V80, P6382, DOI 10.1021/ac800795f; Boccuto L, 2014, HUM MOL GENET, V23, P418, DOI 10.1093/hmg/ddt434; Bollard ME, 2001, ANAL BIOCHEM, V295, P194, DOI 10.1006/abio.2001.5211; BONSNES RW, 1945, J BIOL CHEM, V158, P581; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Buljubasic F, 2015, FLAVOUR FRAG J, V30, P5, DOI 10.1002/ffj.3219; Burger BV, 2005, TOP CURR CHEM, V240, P231, DOI 10.1007/b98318; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Cavaggioni A, 2008, CHEM SENSES, V33, P655, DOI 10.1093/chemse/bjn035; Chan ECY, 2011, NAT PROTOC, V6, P1483, DOI 10.1038/nprot.2011.375; Demetrius Lloyd, 2005, EMBO Rep, V6 Spec No, pS39; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Eastman Chemical Company, 2005, PROD DAT SHEET TEX C; Edvardson S, 2013, EPILEPSIA, V54, pe24, DOI 10.1111/epi.12050; Fonseca MG, 2010, J CHEM ECOL, V36, P1132, DOI 10.1007/s10886-010-9850-y; Fragaki K, 2013, EUR J HUM GENET, V21, P528, DOI 10.1038/ejhg.2012.202; Fujita A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46373-8; Galpaz N, 2013, ARCH BIOCHEM BIOPHYS, V539, P117, DOI 10.1016/j.abb.2013.08.006; Hakim M, 2012, CHEM REV, V112, P5949, DOI 10.1021/cr300174a; Hanai Y, 2012, BIOSCI BIOTECH BIOCH, V76, P679, DOI 10.1271/bbb.110760; Herculano-Houzel S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017514; HIRAI K, 1982, J CHEM ECOL, V8, P1263, DOI 10.1007/BF00987759; HOLLAND M, 1983, LIFE SCI, V32, P787, DOI 10.1016/0024-3205(83)90314-4; Hu H, 2011, AM J HUM GENET, V89, P407, DOI 10.1016/j.ajhg.2011.08.008; HUFFMAN RF, 1990, BRAIN RES REV, V15, P295, DOI 10.1016/0165-0173(90)90005-9; Hurst JL, 1998, ANIM BEHAV, V55, P1289, DOI 10.1006/anbe.1997.0650; Iwamoto S, 2017, CHEMBIOCHEM, V18, P1376, DOI 10.1002/cbic.201700111; JEMIOLO B, 1989, PHYSIOL BEHAV, V46, P293, DOI 10.1016/0031-9384(89)90270-9; JEMIOLO B, 1991, PHYSIOL BEHAV, V50, P1119, DOI 10.1016/0031-9384(91)90570-E; Kato K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120753; Kato K, 2009, J NEUROCHEM, V110, P509, DOI 10.1111/j.1471-4159.2009.06132.x; Kayali-Sayadi MN, 2003, J CHROMATOGR B, V796, P55, DOI 10.1016/j.jchromb.2003.08.001; KEVETTER GA, 1981, J COMP NEUROL, V197, P99, DOI 10.1002/cne.901970108; Kwak J, 2013, VOLATILE BIOMARKERS: NON-INVASIVE DIAGNOSIS IN PHYSIOLOGY AND MEDICINE, P395, DOI 10.1016/B978-0-44-462613-4.00021-0; Kwak J, 2011, CHEM SENSES, V36, P443, DOI 10.1093/chemse/bjr015; Kwak J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003591; Linstrom P. J., 1997, NIST STANDARD REFERE, V69, DOI [10.18434/T4D303, DOI 10.18434/T4D303]; LUSBY WR, 1991, EXP APPL ACAROL, V13, P143, DOI 10.1007/BF01193665; Matsuhashi H, 2003, J NEUROCHEM, V84, P53, DOI 10.1046/j.1471-4159.2003.01257.x; MIYASHITA K, 1980, MECH AGEING DEV, V13, P177, DOI 10.1016/0047-6374(80)90060-3; Musteata FM, 2007, TRAC-TREND ANAL CHEM, V26, P36, DOI 10.1016/j.trac.2006.11.003; Novotny MV, 1999, CHEM BIOL, V6, P377, DOI 10.1016/S1074-5521(99)80049-0; Novotny MV, 1999, P ROY SOC B-BIOL SCI, V266, P2017, DOI 10.1098/rspb.1999.0880; Osada K, 2008, CHEM SENSES, V33, P815, DOI 10.1093/chemse/bjn045; Pollack MH, 2005, J CLIN PSYCHIAT, V66, P22; RHODES G, 1981, CLIN CHEM, V27, P580; Rock F, 2006, J CHEM ECOL, V32, P1333, DOI 10.1007/s10886-006-9091-2; Rosenthal N, 2007, NAT CELL BIOL, V9, P993, DOI 10.1038/ncb437; Schaefer ML, 2010, CHEM SENSES, V35, P459, DOI 10.1093/chemse/bjq032; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shirasu M, 2011, J BIOCHEM, V150, P257, DOI 10.1093/jb/mvr090; Simerville JA, 2005, AM FAM PHYSICIAN, V71, P1153; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Srimontri P, 2014, J NEUROCHEM, V131, P675, DOI 10.1111/jnc.12838; Tanaka R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.168101; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Timm DE, 2001, PROTEIN SCI, V10, P997, DOI 10.1110/ps.52201; Vickers CE, 2017, CURR OPIN CHEM BIOL, V40, P47, DOI 10.1016/j.cbpa.2017.05.017; Vigo D, 2016, LANCET PSYCHIAT, V3, P171, DOI 10.1016/S2215-0366(15)00505-2; Want EJ, 2013, NAT PROTOC, V8, P17, DOI 10.1038/nprot.2012.135; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Yamazaki K, 2007, ADV GENET, V59, P129, DOI 10.1016/S0065-2660(07)59005-X; Zarbin PHG, 2013, J CHEM ECOL, V39, P358, DOI 10.1007/s10886-013-0252-9	68	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229269	10.1371/journal.pone.0229269	http://dx.doi.org/10.1371/journal.pone.0229269			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084196	Green Published, gold			2022-12-26	WOS:000535227900076
J	Iwakura, T; Fukasawa, H; Kitamura, A; Ishibuchi, K; Yasuda, H; Furuya, R				Iwakura, Takamasa; Fukasawa, Hirotaka; Kitamura, Atsushi; Ishibuchi, Kento; Yasuda, Hideo; Furuya, Ryuichi			Effect of dipeptidyl peptidase-4 inhibitors on cisplatin-induced acute nephrotoxicity in cancer patients with diabetes mellitus: A retrospective study	PLOS ONE			English	Article							DPP-4 INHIBITORS; KIDNEY; INJURY; LINAGLIPTIN; PROTECTION; STATEMENT; THERAPY; DISEASE; STRESS; CELLS	Background Cisplatin is a highly effective chemotherapeutic agent. However, acute kidney injury (AKI) limits its subsequent use, resulting in poor cancer prognosis. Dipeptidyl peptidase-4 (DPP-4) inhibitors have been reported to attenuate cisplatin-induced AKI in animal models, but the effect in human patients remains to be clarified. We hypothesized that DPP-4 inhibitors can prevent cisplatin-induced AKI in diabetic-cancer patients. Methods We retrospectively reviewed all consecutive cancer patients who were treated with a first cycle of cisplatin-containing regimen between January 2011 and October 2019. We analysed data of diabetic-cancer patients treated with high-dose cisplatin (> 50 mg/m(2))-containing regimens. The change of estimated glomerular filtration rate (eGFR) within 2 weeks after cisplatin treatment was compared between the patients treated with DPP-4 inhibitors and those treated without DPP-4 inhibitors. Results A total of 455 patients were treated with cisplatin during the period. Of these, 34 patients were eligible for the analysis. The change of eGFR was significantly less in the patients treated with DPP-4 inhibitors, compared to those without DPP-4 inhibitors [the percentages of eGFR decline (mean +/- SD) was 23.6 +/- 20.3% vs 43.1 +/- 20.1%, respectively; P = 0.010]. Furthermore, the incidence of AKI was significantly less in the patients treated with DPP-4 inhibitors (25% vs 64%, respectively; P = 0.026). Conclusions DPP-4 inhibitors may decrease the risk of cisplatin-induced AKI in diabetic patients.	[Iwakura, Takamasa; Fukasawa, Hirotaka; Kitamura, Atsushi; Ishibuchi, Kento; Furuya, Ryuichi] Iwata City Hosp, Dept Internal Med, Renal Div, Iwata, Japan; [Yasuda, Hideo] Hamamatsu Univ Sch Med, Div Nephrol, Internal Med 1, Hamamatsu, Shizuoka, Japan	Hamamatsu University School of Medicine	Iwakura, T (corresponding author), Iwata City Hosp, Dept Internal Med, Renal Div, Iwata, Japan.	tkms04211980@gmail.com						Atkin SL, 2017, J DIABETES COMPLICAT, V31, P1458, DOI 10.1016/j.jdiacomp.2017.05.016; Baek SH, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0772-4; Bailey T, 2013, AM J MED, V126, pS10, DOI 10.1016/j.amjmed.2013.06.009; Beysel S, 2018, BMC ENDOCR DISORD, V18, DOI 10.1186/s12902-017-0228-9; Bolignano D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178699; Bolisetty S, 2016, AM J PHYSIOL-RENAL, V310, pF385, DOI 10.1152/ajprenal.00335.2015; Cai XS, 2018, INT J BIOL SCI, V14, P1696, DOI 10.7150/ijbs.27774; Chen YT, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-270; Cooper ME, 2015, AM J KIDNEY DIS, V66, P441, DOI 10.1053/j.ajkd.2015.03.024; Coppolino G, 2018, PHARMACOL RES, V129, P274, DOI 10.1016/j.phrs.2017.12.001; Duffy EA, 2018, CLIN J ONCOL NURS, V22, P175, DOI 10.1188/18.CJON.175-183; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Glorie LLF, 2012, AM J PHYSIOL-RENAL, V303, pF681, DOI 10.1152/ajprenal.00075.2012; Hamroun A, 2019, DRUGS, V79, P1567, DOI 10.1007/s40265-019-01182-1; Hattori S, 2011, ENDOCR J, V58, P69, DOI 10.1507/endocrj.K10E-382; Higuchi K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215757; Inamoto T, 2007, CLIN CANCER RES, V13, P4191, DOI 10.1158/1078-0432.CCR-07-0110; Ishitsuka R, 2017, CLIN EXP NEPHROL, V21, P732, DOI 10.1007/s10157-016-1327-z; Iwakura T, 2019, NEPHROL DIAL TRANSPL, V34, P1669, DOI 10.1093/ndt/gfy397; Jang JH, 2015, CLIN EXP METASTAS, V32, P677, DOI 10.1007/s10585-015-9736-z; Katagiri D, 2013, J AM SOC NEPHROL, V24, P2034, DOI 10.1681/ASN.2013020134; Kawasaki I, 2015, J DIABETES, V7, P41, DOI 10.1111/1753-0407.12153; Kim YG, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1423191; Komaki K, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3135-6; Mathe C, 2011, EUR RESPIR J, V37, P888, DOI 10.1183/09031936.00055110; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mori H, 2014, J DIABETES INVEST, V5, P313, DOI 10.1111/jdi.12142; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nistala R, 2014, OBESITY, V22, P2172, DOI 10.1002/oby.20833; Ozkok A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/967826; Razzaque MS, 1999, HISTOCHEM CELL BIOL, V111, P359, DOI 10.1007/s004180050368; Sato T, 2005, CANCER RES, V65, P6950, DOI 10.1158/0008-5472.CAN-05-0647; Schrijnders D, 2016, DIABETES OBES METAB, V18, P973, DOI 10.1111/dom.12700; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Stokman G, 2010, NEPHROL DIAL TRANSPL, V25, P3852, DOI 10.1093/ndt/gfq311; Szturz P, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00086; Ta NN, 2011, J CARDIOVASC PHARM, V58, P157, DOI 10.1097/FJC.0b013e31821e5626; Tanaka Y, 2016, BIOCHEM BIOPH RES CO, V470, P539, DOI 10.1016/j.bbrc.2016.01.109; Tsuprykov O, 2016, KIDNEY INT, V89, P1049, DOI 10.1016/j.kint.2016.01.016; Uchida T, 2017, RENAL FAILURE, V39, P340, DOI 10.1080/0886022X.2017.1279553; Vaghasiya J, 2011, REGUL PEPTIDES, V166, P48, DOI 10.1016/j.regpep.2010.08.007; Williams DM, 2020, DIABETES THER, V11, P369, DOI 10.1007/s13300-019-00747-3; Yamamoto Y, 2016, ANTICANCER RES, V36, P1873	43	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229377	10.1371/journal.pone.0229377	http://dx.doi.org/10.1371/journal.pone.0229377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084231	Green Published, gold			2022-12-26	WOS:000535227900102
J	Laudicella, VA; Beveridge, C; Carboni, S; Franco, SC; Doherty, MK; Long, N; Mitchell, E; Stanley, MS; Whitfield, PD; Hughes, AD				Laudicella, Vincenzo Alessandro; Beveridge, Christine; Carboni, Stefano; Franco, Sofia C.; Doherty, Mary K.; Long, Nina; Mitchell, Elaine; Stanley, Michele S.; Whitfield, Phillip D.; Hughes, Adam D.			Lipidomics analysis of juveniles' blue mussels (Mytilus edulis L. 1758), a key economic and ecological species	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; PERFORMANCE LIQUID-CHROMATOGRAPHY; THERMALLY STRESSED MUSSELS; PECTEN-MAXIMUS L; CRASSOSTREA-GIGAS; ELECTROSPRAY-IONIZATION; PACIFIC OYSTER; BIOCHEMICAL-COMPOSITION; MASS-SPECTROMETRY; ARTIFICIAL DIETS	Blue mussels (Mytilus edulis L. 1758) are important components of coastal ecosystems and in the economy of rural and coastal areas. The understanding of their physiological processes at key life stages is important both within food production systems and in the management of wild populations. Lipids are crucial molecules for bivalve growth, but their diversity and roles have not been fully characterised. In this study, traditional lipid profiling techniques, such as fatty acid (FA) and lipid class analysis, are combined to untargeted lipidomics to elucidate the lipid metabolism in newly settled spat fed on a range of diets. The evaluated diets included single strains treatments (Cylindrotheca fusiformis CCAP 1017/2 - CYL, Isochrysis galbana CCAP 927/1 - ISO, Monodopsis subterranean CCAP 848/1 - MONO, Nannochloropsis oceanica CCAP 849/10 - NANNO) and a commercial algae paste (SP). Spat growth was influenced by the diets, which, according to their efficacy were ranked as follows: ISO> NANNO/CYL>SP> MONO. A higher triacylglycerols (TG) content, ranging from 4.23 +/- 0.82 mu g mg(ashfree Dry weight (DW))(-1) at the beginning of the trial (T0) to 51 +/- 15.3 mu g mg(ashfreeDW)(-1) in ISO, characterised significant growth in the spat, whereas, a reduction of TG (0.3 +/- 0.08 mu g mg(ashfreeDW)(-1) in MONO), mono unsaturated FA-MUFA (from 8.52 +/- 1.02 mu g mgFA(ashfreeDW)(-1) at T0 to 2.81 +/- 1.02 mu g mgFA(ashfreeDW)(-1) in MONO) and polyunsaturated FA-PUFA (from 17.57 +/- 2.24 mu g mgFA(ashfreeDW)(-1) at T0 to 6.19 +/- 2.49 mu g mgFA(ashfreeDW)(-1) in MONO) content characterised poor performing groups. Untargeted lipidomics evidenced how the availability of dietary essential PUFA did not influence only neutral lipids but also the membrane lipids, with changes in lipid molecular species in relation to the essential PUFA provided via the diet. Such changes have the potential to affect spat production cycle and their ability to respond to the surrounding environment. This study evidenced the advantages of coupling different lipid analysis techniques, as each technique disclosed relevant information on nutritional requirements of M. edulis juveniles, expanding the existing knowledge on the physiology of this important species.	[Laudicella, Vincenzo Alessandro; Beveridge, Christine; Franco, Sofia C.; Long, Nina; Mitchell, Elaine; Stanley, Michele S.; Hughes, Adam D.] Dunstaffnage Marine Lab, Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Carboni, Stefano] Univ Stirling, Fac Nat Sci, Inst Aquaculture, Stirling, Scotland; [Doherty, Mary K.; Whitfield, Phillip D.] Univ Highlands & Isl, Ctr Hlth Sci, Div Biomed Sci, Inverness, Scotland	UHI Millennium Institute; University of Stirling; UHI Millennium Institute	Laudicella, VA (corresponding author), Dunstaffnage Marine Lab, Scottish Assoc Marine Sci, Oban, Argyll, Scotland.	alessandro.laudicella@sams.ac.uk	Stanley, Michele S/D-5859-2013	Doherty, Mary/0000-0002-3480-4088; Laudicella, Vincenzo Alessandro/0000-0003-3148-8347; C. Franco, Sofia/0000-0002-6463-0971; Stanley, Michele/0000-0002-2348-3231; Carboni, Stefano/0000-0002-1302-1068	European Social Fund; Scottish Funding Council; European Structural and Investment Fund Programme [UHI_SAMS_DSW_PGR_AY16/17]; Scottish Aquaculture Innovation Centre (SAIC) [MP_2015_02]; NERC [NE/P005349/2] Funding Source: UKRI	European Social Fund(European Social Fund (ESF)); Scottish Funding Council; European Structural and Investment Fund Programme; Scottish Aquaculture Innovation Centre (SAIC); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by the European Social Fund and Scottish Funding Council as part of Developing Scotland's Workforce in the Scotland 2014-2020 European Structural and Investment Fund Programme (Ref: UHI_SAMS_DSW_PGR_AY16/17). The work was also funded through SAICHatch project (MP_2015_02) funded by the Scottish Aquaculture Innovation Centre (SAIC, www.scottishaquaculture.com).	Abreu S, 2017, J CHROMATOGR A, V1514, P54, DOI 10.1016/j.chroma.2017.07.063; Ackman R.G., 1980, ADV FISH SCI TECHNOL, P83; Albentosa M, 1996, COMP BIOCHEM PHYS A, V113, P113, DOI 10.1016/0300-9629(95)02041-1; ALBENTOSA M, 1993, MAR ECOL PROG SER, V97, P261, DOI 10.3354/meps097261; Albentosa M, 1999, J EXP MAR BIOL ECOL, V232, P23, DOI 10.1016/S0022-0981(98)00086-0; Alfaro AC, 2004, AQUACULTURE, V241, P269, DOI 10.1016/j.aquaculture.2004.07.029; [Anonymous], 2004, HATCHERY CULTURE BIV; AOCS, 2007, OFF METH RACC PRACT; Batista IR, 2014, AQUACULT NUTR, V20, P132, DOI 10.1111/anu.12059; BELL MV, 1985, J EXP MAR BIOL ECOL, V87, P31, DOI 10.1016/0022-0981(85)90189-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beukema JJ, 2015, HELGOLAND MAR RES, V69, P327, DOI 10.1007/s10152-015-0440-9; Boselli E, 2012, J AGR FOOD CHEM, V60, P3234, DOI 10.1021/jf205159a; Bresnan E, 2015, J SEA RES, V105, P16, DOI 10.1016/j.seares.2015.06.009; BROUSSEAU DJ, 1979, MAR BIOL, V51, P221, DOI 10.1007/BF00386801; Burge CA, 2016, INTEGR COMP BIOL, V56, P573, DOI 10.1093/icb/icw048; Caers M, 2000, AQUACULTURE, V186, P157, DOI 10.1016/S0044-8486(99)00364-6; Caers M, 1999, AQUACULTURE, V170, P307, DOI 10.1016/S0044-8486(98)00410-4; Caers M, 1998, AQUACULTURE, V162, P287, DOI 10.1016/S0044-8486(98)00221-X; Caers M, 2000, MAR BIOL, V136, P891, DOI 10.1007/s002270000295; Cajka T, 2014, TRAC-TREND ANAL CHEM, V61, P192, DOI 10.1016/j.trac.2014.04.017; Carboni S, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061381; Guedes AC, 2012, AQUACULTURE, P59; Chen S, 2012, ANAL CHIM ACTA, V735, P76, DOI 10.1016/j.aca.2012.05.035; Cigarria J, 2000, AQUACULTURE, V182, P173, DOI 10.1016/S0044-8486(99)00257-4; da Costa F, 2015, LIPIDS, V50, P503, DOI 10.1007/s11745-015-4006-z; Deguchi R, 1996, DEVELOPMENT, V122, P3651; Delaporte M, 2003, J EXP BIOL, V206, P3053, DOI 10.1242/jeb.00518; DELAUNAY F, 1993, J EXP MAR BIOL ECOL, V173, P163, DOI 10.1016/0022-0981(93)90051-O; Donato P, 2018, ANAL BIOANAL CHEM, V410, P3297, DOI 10.1007/s00216-018-1045-3; Dudek J, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00090; Facchini L, 2018, J MASS SPECTROM, V53, P1, DOI 10.1002/jms.4029; Facchini L, 2016, J MASS SPECTROM, V51, P768, DOI 10.1002/jms.3832; Facchini L, 2016, ELECTROPHORESIS, V37, P1823, DOI 10.1002/elps.201500514; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fao, 2018, STATE WORLD FISHERIE; Fernandez-Reiriz MJ, 2006, COMP BIOCHEM PHYS B, V144, P229, DOI 10.1016/j.cbpb.2006.02.015; Fernandez-Reiriz MJ, 2015, MAR ECOL PROG SER, V528, P221, DOI 10.3354/meps11280; Ferreira JG, 2016, AQUACULT INT, V24, P803, DOI 10.1007/s10499-015-9949-9; FIDALGO JP, 1994, J SHELLFISH RES, V13, P67; Flores-Vergara C, 2004, AQUAC RES, V35, P1131, DOI 10.1111/j.1365-2109.2004.01136.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Folke C, 1998, ECOL APPL, V8, pS63, DOI 10.1890/1051-0761(1998)8[S63:TEFCFS]2.0.CO;2; Freites L, 2002, AQUACULTURE, V207, P97, DOI 10.1016/S0044-8486(01)00752-9; Gerits LR, 2013, LWT-FOOD SCI TECHNOL, V53, P426, DOI 10.1016/j.lwt.2013.03.015; Graeve M, 2009, J CHROMATOGR B, V877, P1815, DOI 10.1016/j.jchromb.2009.05.004; Gromski PS, 2015, ANAL CHIM ACTA, V879, P10, DOI 10.1016/j.aca.2015.02.012; Guercia C, 2017, STEROIDS, V123, P67, DOI 10.1016/j.steroids.2017.05.008; Gui Y, 2016, AQUAC RES, V47, P3907, DOI 10.1111/are.12841; Han XL, 2003, J LIPID RES, V44, P1071, DOI 10.1194/jlr.R300004-JLR200; Higgins CB, 2011, J ENV QUALITY, V40; Hoehne-Reitan K, 2007, AQUACULT NUTR, V13, P45, DOI 10.1111/j.1365-2095.2007.00452.x; HOLLAND DL, 1974, J MAR BIOL ASSOC UK, V54, P1007, DOI 10.1017/S0025315400057726; Jacobs P, 2014, J SEA RES, V85, P365, DOI 10.1016/j.seares.2013.07.006; Kamermans P, 2013, WOODHEAD PUBL FOOD S, P339, DOI 10.1533/9780857097460.2.339; Karayucel S., 2001, TURKISH J MARINE SCI, V7, P195; Kariotoglou DM, 2003, COMP BIOCHEM PHYS B, V136, P27, DOI 10.1016/S1096-4959(03)00168-4; Kariotoglou DM, 1998, Z NATURFORSCH C, V53, P888; Knauer J, 1997, AQUACULTURE, V154, P293, DOI 10.1016/S0044-8486(97)00056-2; Kochmann J, 2008, J EXP MAR BIOL ECOL, V364, P1, DOI 10.1016/j.jembe.2008.05.015; Koelmel JP, 2017, BBA-MOL CELL BIOL L, V1862, P766, DOI 10.1016/j.bbalip.2017.02.016; Kraffe E, 2008, LIPIDS, V43, P961, DOI 10.1007/s11745-008-3219-9; Kraffe E, 2005, LIPIDS, V40, P619, DOI 10.1007/s11745-005-1423-z; Kraffe E, 2002, LIPIDS, V37, P507, DOI 10.1007/s11745-002-0925-z; Laing I, 2000, AQUACULTURE, V183, P325, DOI 10.1016/S0044-8486(99)00262-8; Laing I, 1998, AQUACULTURE, V169, P55, DOI 10.1016/S0044-8486(98)00333-0; LANGDON CJ, 1981, J MAR BIOL ASSOC UK, V61, P431, DOI 10.1017/S0025315400047056; Laudicella VA, 2020, REV AQUACULT, V12, P678, DOI 10.1111/raq.12346; Lauzon-Guay JS, 2005, AQUACULTURE, V250, P652, DOI 10.1016/j.aquaculture.2005.03.049; LAWRENCE JM, 1976, AM ZOOL, V16, P747; Lee MC, 2018, AQUAT TOXICOL, V200, P83, DOI 10.1016/j.aquatox.2018.04.016; Liu ZY, 2017, FOOD CHEM, V219, P419, DOI 10.1016/j.foodchem.2016.09.160; Lodeiros CJ, 2017, AQUACULT NUTR, V23, P511, DOI 10.1111/anu.12419; Losito I, 2018, FOOD CHEM, V255, P309, DOI 10.1016/j.foodchem.2018.02.073; Maguire JA, 2007, MANAGEMENT RECOMMEND; Maity S, 2012, J CRUSTACEAN BIOL, V32, P239, DOI 10.1163/193724011X615578; Martinez G, 2004, INVERTEBR REPROD DEV, V46, P27, DOI 10.1080/07924259.2004.9652602; MARTY Y, 1992, J EXP MAR BIOL ECOL, V163, P221, DOI 10.1016/0022-0981(92)90051-B; MATSUBARA T, 1990, BIOCHIM BIOPHYS ACTA, V1042, P280, DOI 10.1016/0005-2760(90)90154-P; Mejia Edgard M., 2014, Cardiovascular & Hematological Disorders - Drug Targets, V14, P98; MENZEL K, 1989, Z NATURFORSCH C, V44, P743; Messina CM, 2014, AQUAT TOXICOL, V157, P94, DOI 10.1016/j.aquatox.2014.10.001; Muniz O, 2019, OCEANOLOGIA, V61, P114, DOI 10.1016/j.oceano.2018.08.001; Nevejan N, 2007, J SHELLFISH RES, V26, P357, DOI 10.2983/0730-8000(2007)26[357:UOAFDF]2.0.CO;2; Numaguchi K, 2000, J SHELLFISH RES, V19, P153; Oksanen J., 2018, PACKAGE VEGAN; Parrish C.C., 2013, ISRN OCEANOGR, V2013, P604045, DOI [10.5402/2013/604045, DOI 10.5402/2013/604045]; Pernet F, 2006, J EXP MAR BIOL ECOL, V329, P265, DOI 10.1016/j.jembe.2005.09.008; Pernet F, 2004, MAR BIOL, V144, P693, DOI 10.1007/s00227-003-1234-1; Pernet F, 2006, J EXP BIOL, V209, P4663, DOI 10.1242/jeb.02581; Retterstol K, 2000, BBA-MOL CELL BIOL L, V1483, P119, DOI 10.1016/S1388-1981(99)00166-3; Rey F, 2015, SCI REP-UK, V5, DOI 10.1038/srep14549; Rittschof D, 2005, MAR POLLUT BULL, V50, P369, DOI 10.1016/j.marpolbul.2005.02.008; Ronquillo JD, 2012, AQUACULTURE, V360, P64, DOI 10.1016/j.aquaculture.2012.07.018; SAJIKI J, 1995, BIOSCI BIOTECH BIOCH, V59, P1113, DOI 10.1271/bbb.59.1113; Saucedo PE, 2013, AQUACULTURE, V392, P113, DOI 10.1016/j.aquaculture.2013.02.001; Shumway SE, 2003, WORLD AQUACULTURE, V34, P16; SOUDANT P, 1995, J CHROMATOGR B, V673, P15, DOI 10.1016/0378-4347(95)00241-A; Soudant P, 1999, COMP BIOCHEM PHYS B, V123, P209, DOI 10.1016/S0305-0491(99)00063-2; Soudant P, 2000, AQUACULTURE, V184, P315, DOI 10.1016/S0044-8486(99)00323-3; STANLEYSAMUELSON DW, 1994, AM ZOOL, V34, P589; Stavrovskaya IG, 2013, J LIPID RES, V54, P2623, DOI 10.1194/jlr.M036285; STECF. Scientific Technical and Economic Committee for Fisheries, 2016, EC REP EU AQ SECT EW; Suplicy FM, 2018, REV AQUACULT, DOI [10.1111/raq.12193, DOI 10.1111/RAQ.12193]; Tamayo D, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2905-z; THOMPSON RJ, 1984, MAR ECOL PROG SER, V16, P249, DOI 10.3354/meps016249; THOMPSON RJ, 1974, MAR BIOL, V27, P317, DOI 10.1007/BF00394367; Venugopal V, 2017, COMPR REV FOOD SCI F, V16, P1219, DOI 10.1111/1541-4337.12312; WALDOCK MJ, 1984, LIPIDS, V19, P332, DOI 10.1007/BF02534783; Wenk MR, 2010, CELL, V143, P888, DOI 10.1016/j.cell.2010.11.033; WHYTE JNC, 1987, J EXP MAR BIOL ECOL, V113, P113, DOI 10.1016/0022-0981(87)90159-6; Wijsman J.W.M., 2019, GOODS SERVICES MARIN, P7, DOI DOI 10.1007/978--3-319-96776-9_2; Wikfors GH, 1996, AQUACULTURE, V143, P411, DOI 10.1016/0044-8486(96)01265-3; Xia J, 2018, METABOANLYSTR R PACK; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yin FW, 2016, FOOD CHEM, V213, P344, DOI 10.1016/j.foodchem.2016.06.094	116	6	6	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0223031	10.1371/journal.pone.0223031	http://dx.doi.org/10.1371/journal.pone.0223031			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084137	Green Published, Green Submitted, gold			2022-12-26	WOS:000535227900003
J	Reddy, AT; Lakshmi, SP; Benno, A; Jadhav, SK; Kadamberi, IP; Kim, SC; Reddy, RC				Reddy, Aravind T.; Lakshmi, Sowmya P.; Benno, Asoka; Jadhav, Shantanu Krishna; Kadamberi, Ishaque Pulikkal; Kim, Seong C.; Reddy, Raju C.			Cigarette smoke downregulates Nur77 to exacerbate inflammation in chronic obstructive pulmonary disease (COPD)	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NF-KAPPA-B; NGFI-B; CELL-DEATH; RECEPTOR; ACTIVATION; EXPRESSION; APOPTOSIS; INDUCTION; BINDING	Cigarette smoke (CS) contains multiple gaseous and particulate materials that can cause lung inflammation, and smoking is the major cause of chronic obstructive pulmonary disease (COPD). We sought to determine the mechanisms of how CS triggers lung inflammation. Nur77, a nuclear hormone receptor belonging to the immediate-early response gene family, controls inflammatory responses, mainly by suppressing the NF-kappa B signaling pathway. Because it is unknown if Nur77's anti-inflammatory role modulates COPD, we assessed if and how Nur77 expression and activity are altered in CS-induced airway inflammation. In lung tissues and bronchial epithelial cells from COPD patients, we found Nur77 was downregulated. In a murine model of CS-induced airway inflammation, CS promoted lung inflammation and also reduced Nur77 activity in wild type (WT) mice, whereas lungs of Nur77-deficient mice showed exaggerated CS-induced inflammatory responses. Our findings in in vitro studies of human airway epithelial cells complemented those in vivo data in mice, together showing that CS induced threonine-phosphorylation of Nur77, which is known to interfere with its anti-inflammatory functions. In summary, our findings point to Nur77 as an important regulator of CS-induced inflammatory responses and support the potential benefits of Nur77 activation for COPD treatment.	[Reddy, Aravind T.; Lakshmi, Sowmya P.; Benno, Asoka; Jadhav, Shantanu Krishna; Kadamberi, Ishaque Pulikkal; Kim, Seong C.; Reddy, Raju C.] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Reddy, Aravind T.; Lakshmi, Sowmya P.; Jadhav, Shantanu Krishna; Kadamberi, Ishaque Pulikkal; Kim, Seong C.; Reddy, Raju C.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15206 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Reddy, RC (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA.; Reddy, RC (corresponding author), Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15206 USA.	reddyrc@upmc.edu	Reddy, Aravind/P-1847-2018; Lakshmi, Sowmya P./P-1851-2018	Reddy, Aravind/0000-0001-8628-3467; Lakshmi, Sowmya P./0000-0003-1708-9462; Reddy, Raju/0000-0001-5136-817X	United States Department of Veterans Affairs; National Institutes of Health [HL137842]	United States Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a merit review award from the United States Department of Veterans Affairs and National Institutes of Health grant HL137842 (to R.C.R). The contents in this article do not represent the views of the United States Department of Veterans Affairs or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghapour M, 2018, AM J RESP CELL MOL, V58, P157, DOI 10.1165/rcmb.2017-0200TR; Banno A, 2019, AM J PATHOL, V189, P482, DOI 10.1016/j.ajpath.2018.10.002; Cheng ZK, 2011, EUR HEART J, V32, P2179, DOI 10.1093/eurheartj/ehq496; DAVIS IJ, 1991, MOL ENDOCRINOL, V5, P854, DOI 10.1210/mend-5-6-854; Di Stefano A, 2002, EUR RESPIR J, V20, P556, DOI 10.1183/09031936.02.00272002; Du CL, 2017, INT J CHRONIC OBSTR, V12, P3341, DOI 10.2147/COPD.S143279; Flaig R, 2005, J BIOL CHEM, V280, P19250, DOI 10.1074/jbc.M413175200; Geng H, 2017, ONCOL LETT, V13, P469, DOI 10.3892/ol.2016.5407; Hamers AAJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2469-9; Harant H, 2004, NUCLEIC ACIDS RES, V32, P5280, DOI 10.1093/nar/gkh856; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; Holmes WF, 2003, ONCOGENE, V22, P6377, DOI 10.1038/sj.onc.1206694; Jiang YJ, 2016, AM J PHYSIOL-LUNG C, V311, pL1023, DOI 10.1152/ajplung.00043.2016; Kode A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-132; Kolluri SK, 2003, MOL CELL BIOL, V23, P8651, DOI 10.1128/MCB.23.23.8651-8667.2003; Kurakula K, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.02400-2018; Kurakula K, 2015, J IMMUNOL, V195, P1388, DOI 10.4049/jimmunol.1401714; Lakshmi SP, 2019, BIOCHEM J, V476, P2757, DOI 10.1042/BCJ20190253; Lakshmi SP, 2018, J IMMUNOL, V201, P1775, DOI 10.4049/jimmunol.1800649; Lakshmi SP, 2017, INT J CHRONIC OBSTR, V12, P2141, DOI 10.2147/COPD.S121416; Lakshmi SP, 2017, BIOCHEM J, V474, P1531, DOI 10.1042/BCJ20160943; Lakshmi SP, 2012, AM J PHYSIOL-LUNG C, V303, pL758, DOI 10.1152/ajplung.00107.2012; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li L, 2015, NAT CHEM BIOL, V11, P339, DOI [10.1038/NCHEMBIO.1788, 10.1038/nchembio.1788]; MacNee W, 2000, CHEST, V117, p303S, DOI 10.1378/chest.117.5_suppl_1.303S-a; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; OHKURA N, 1994, BIOCHEM BIOPH RES CO, V205, P1959, DOI 10.1006/bbrc.1994.2900; Qin HP, 2019, INT J MOL MED, V44, P25, DOI 10.3892/ijmm.2019.4184; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Reddy AT, 2018, ACS CHEM BIOL, V13, P3269, DOI 10.1021/acschembio.8b00584; Reddy AT, 2018, FREE RADICAL BIO MED, V126, P350, DOI 10.1016/j.freeradbiomed.2018.08.014; Reddy AT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153336; Rodriguez-Calvo R, 2017, EXPERT OPIN THER TAR, V21, P291, DOI 10.1080/14728222.2017.1279146; Strom BO, 2012, BIOCHEM BIOPH RES CO, V417, P1292, DOI 10.1016/j.bbrc.2011.12.132; Sun X, 2017, BIOMED PHARMACOTHER, V86, P457, DOI 10.1016/j.biopha.2016.12.022; To SKY, 2012, EXPERT OPIN THER TAR, V16, P573, DOI 10.1517/14728222.2012.680958; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vinayavekhin N, 2011, J AM CHEM SOC, V133, P17168, DOI 10.1021/ja208199h; Vogelmeier CF, 2017, AM J RESP CRIT CARE, V195, P557, DOI 10.1164/rccm.201701-0218PP; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Wu H, 2016, J PATHOL, V238, P457, DOI 10.1002/path.4670; Wu H, 2011, FASEB J, V25, P192, DOI 10.1096/fj.10-166462; You B, 2009, CIRC RES, V104, P742, DOI 10.1161/CIRCRESAHA.108.192286; Yu DX, 2017, ONCOTARGET, V8, P8791, DOI 10.18632/oncotarget.14456; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106; Zhang XK, 2007, EXPERT OPIN THER TAR, V11, P69, DOI 10.1517/14728222.11.1.69	49	7	7	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229256	10.1371/journal.pone.0229256	http://dx.doi.org/10.1371/journal.pone.0229256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084204	Green Published, Green Submitted, gold			2022-12-26	WOS:000535227900075
J	Burn, D; Matthews, S; Caballes, CF; Chandler, JF; Pratchett, MS				Burn, Deborah; Matthews, Samuel; Caballes, Ciemon F.; Chandler, Josie F.; Pratchett, Morgan S.			Biogeographical variation in diurnal behaviour of Acanthaster planci versus Acanthaster cf. solaris	PLOS ONE			English	Article							OF-THORNS STARFISH; GREAT-BARRIER-REEF; CORAL-REEFS; SEA STAR; OUTBREAKS; DESTRUCTION; COMMUNITIES; ASSEMBLAGES; RECRUITMENT; IMPACT	Crown-of-thorns starfish (CoTS; Acanthaster spp.) are among the most extensively studied coral reef taxa, largely owing to their devastating impacts on live coral cover during population outbreaks. Much of this research has however, been conducted in the western Pacific, although it is now apparent that there are several distinct species of Acanthaster spp. across the Indo-Pacific. The purpose of this study was to test for biogeographical variation in behaviour, comparing between Acanthaster planci at Lankanfushi Island in the Maldives and Acanthaster cf. solaris at Rib Reef on Australia's Great Barrier Reef. The extent to which CoTS were exposed (cf. concealed within or beneath coral substrates) was substantially higher (63.14%) for A. planci at Lankanfushi Island, compared to 28.55% for A. cf. solaris at Rib Reef, regardless of time of day. More importantly, only 52% of individuals were exposed at night at Rib Reef compared to > 97% at reefs around Lankanfushi Island. Biogeographic variation in the behaviour of Acanthaster spp. was independent of differences in the size structure of starfish and coral cover at specific study sites, but may be attributable to other environmental factors such as habitat complexity or prey availability. This is the first study to explicitly test for biogeographical differences in the biology and behaviour of Acanthaster spp., potentially linked to species-specific differences in the causes and explanations of population outbreaks. However, we did not find evidence at this stage of differences in behavior among regions, rather behavioural differences observed were most likely products of different environments.	[Burn, Deborah; Matthews, Samuel; Caballes, Ciemon F.; Pratchett, Morgan S.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Caballes, Ciemon F.] Ultra Coral Australia, Paget, Qld, Australia; [Chandler, Josie F.] Gili Lankanfushi Resort, Lankanfushi Isl, North Male Atol, Maldives	James Cook University	Burn, D (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.	deborah.burn1@my.jcu.edu.au	Pratchett, Morgan/AAW-5179-2020	Pratchett, Morgan/0000-0002-1862-8459; Burn, Deborah/0000-0002-9581-2954	NESP Tropical Water Quality Hub [NESP 4.1.1]; ARC Centre of Excellence for Coral Reef Studies [CE140100020]; Gili Lankanfushi Resort	NESP Tropical Water Quality Hub; ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); Gili Lankanfushi Resort	This study was completed with funding awarded to MSP from NESP Tropical Water Quality Hub (NESP 4.1.1) and the ARC Centre of Excellence for Coral Reef Studies (CE140100020). Gili Lankanfushi Resort provided support in the form of salaries for DB and JFC at the time fieldwork was undertaken. The specific roles of these authors are articulated in the 'author contributions' section. Ocean Paradise Dive Centre provided field materials including SCUBA equipment in the Maldives. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Adam MS, 1989, STATUS REPORT SURVEY; [Anonymous], 2014, J APPL ECOL, DOI [DOI 10.1111/1365-2664.12306, DOI 10.1016/S0167-8809(99)00024-9]; Babcock RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169048; Baird AH, 2013, CORAL REEFS, V32, P803, DOI 10.1007/s00338-013-1025-1; Benzie JAH, 1999, EVOLUTION, V53, P1782, DOI 10.1111/j.1558-5646.1999.tb04562.x; BIRKELAND C, 1990, MAJOR MANAGEMENT PRO; Brodie J, 2005, MAR POLLUT BULL, V51, P266, DOI 10.1016/j.marpolbul.2004.10.035; Bruckner A, 2016, CORAL REEF CPR PUBLI, V1, P19; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CHESHER RH, 1969, SCIENCE, V165, P280, DOI 10.1126/science.165.3890.280; Ciarapica Gloria, 1993, Facies, V28, P33, DOI 10.1007/BF02539727; Cowan ZL, 2017, DIVERSITY-BASEL, V9, DOI 10.3390/d9010007; De'ath G, 1998, J EXP MAR BIOL ECOL, V220, P83, DOI 10.1016/S0022-0981(97)00085-3; De'ath G, 1998, J EXP MAR BIOL ECOL, V220, P107, DOI 10.1016/S0022-0981(97)00100-7; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Done TT, P 5 INT COR REEF S T, V198, P315; Haszprunar G, 2017, DIVERSITY-BASEL, V9, DOI 10.3390/d9020022; Haszprunar G, 2014, ZOOTAXA, V3841, P271, DOI 10.11646/zootaxa.3841.2.6; Hughes TP, 2019, NAT CLIM CHANGE, V9, P40, DOI 10.1038/s41558-018-0351-2; JOHNSON C, 1992, AUST J MAR FRESH RES, V43, P611; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; Keesing JK, 1990, THESIS; KENCHINGTON RA, 1977, BIOL CONSERV, V11, P103, DOI 10.1016/0006-3207(77)90032-5; Lane DJW, 2012, J MAR BIOL ASSOC UK, V92, P803, DOI 10.1017/S0025315411000890; Linnaeus C., 1758, IMPENSIS DIRECT, VI; MacNeil MA, 2017, DIVERSITY-BASEL, V9, DOI 10.3390/d9010018; Mendonca VM, 2010, ZOOL STUD, V49, P108; MORAN PJ, 1986, OCEANOGR MAR BIOL, V24, P379; MORAN PJ, 1988, CORAL REEFS, V7, P125, DOI 10.1007/BF00300972; Ormond R.F.G., 1974, Proceedings int Coral Reef Symp, V2, P595; Pearson R. G., 1969, Fish Notes Qd, V3, P27; Perry CT, 2017, SCI REP-UK, V7, DOI 10.1038/srep40581; Pisapia C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44809-9; PORTER JW, 1972, AM NAT, V106, P487, DOI 10.1086/282789; Pratchett MS, 2010, CORAL REEFS, V29, P717, DOI 10.1007/s00338-010-0602-9; Pratchett MS, 2009, MAR ENVIRON RES, V67, P230, DOI 10.1016/j.marenvres.2009.03.001; Pratchett Morgan S., 2019, Australian Zoologist, V40, P13, DOI 10.7882/AZ.2018.021; Pratchett MS, 2017, DIVERSITY-BASEL, V9, DOI 10.3390/d9040041; Pratchett MS, 2014, OCEANOGR MAR BIOL, V52, P133; R Core Team, 2012, R LANG ENV STAT COMP; REICHELT RE, 1990, MATH COMPUT MODEL, V13, P45, DOI 10.1016/0895-7177(90)90008-B; Rivera-posada Jairo, 2014, Journal of Coastal Life Medicine, V2, P187; Roche RC, 2015, MAR BIOL, V162, P1695, DOI 10.1007/s00227-015-2708-7; SANO M, 1987, MAR ECOL PROG SER, V37, P191, DOI 10.3354/meps037191; Saponari L, 2018, ENVIRON MONIT ASSESS, V190, DOI 10.1007/s10661-018-6661-z; Saponari L, 2015, MAR BIODIVERS, V45, P599, DOI 10.1007/s12526-014-0276-6; Sweatman H, 2008, CURR BIOL, V18, pR598, DOI 10.1016/j.cub.2008.05.033; Tokeshi M, 2011, CORAL REEFS, V30, P227, DOI 10.1007/s00338-010-0693-3; Vanhatalo J, 2017, J APPL ECOL, V54, P188, DOI 10.1111/1365-2664.12710; Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4; Vogler C, 2008, BIOL LETTERS, V4, P696, DOI 10.1098/rsbl.2008.0454; Wooldridge SA, 2015, MAR POLLUT BULL, V101, P805, DOI 10.1016/j.marpolbul.2015.08.049; YAMAGUCHI M, 1986, CORAL REEFS, V5, P23, DOI 10.1007/BF00302168; ZANN L, 1990, CORAL REEFS, V9, P135, DOI 10.1007/BF00258225	55	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0228796	10.1371/journal.pone.0228796	http://dx.doi.org/10.1371/journal.pone.0228796			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8CF	32078663	Green Published, Green Accepted, gold			2022-12-26	WOS:000535224600007
J	Van Neer, W; Alhaique, F; Wouters, W; Dierickx, K; Gala, M; Goffette, Q; Mariani, GS; Zerboni, A; di Lernia, S				Van Neer, Wim; Alhaique, Francesca; Wouters, Wim; Dierickx, Katrien; Gala, Monica; Goffette, Quentin; Mariani, Guido S.; Zerboni, Andrea; di Lernia, Savino			Aquatic fauna from the Takarkori rock shelter reveals the Holocene central Saharan climate and palaeohydrography	PLOS ONE			English	Article							NORTHERN CHAD; AFRICA; LIBYA; FLUCTUATIONS; PALEOCLIMATE; ARCHIVE; MONSOON; RECORDS; FEZZAN	The abundant faunal remains from the Takarkori rock shelter in the Tadrart Acacus region of southwestern Libya are described. The material that covers the period between 10,200 to 4650 years cal BP illustrates the more humid environmental conditions in the Central Sahara during early and middle Holocene times. Particular attention is focussed on the aquatic fauna that shows marked diachronic changes related to increasing aridification. This is reflected in the decreasing amount of fish remains compared to mammals and, within the fish fauna, by changes through time in the proportion of the species and by a reduction of fish size. The aquatic fauna can, in addition, be used to formulate hypotheses about the former palaeohydrographical network. This is done by considering the possible location of pre-Holocene relic populations combined with observations on the topography and palaeohydrological settings of the Central Sahara.	[Van Neer, Wim; Wouters, Wim; Goffette, Quentin] Royal Belgian Inst Nat Sci, Operat Direct Earth & Hist Life, Brussels, Belgium; [Van Neer, Wim; Dierickx, Katrien] Univ Leuven, Lab Biodivers & Evolutionary Genom, Leuven, Belgium; [Alhaique, Francesca; Gala, Monica] Museo Civilta, Bioarchaeol Serv, Rome, Italy; [Mariani, Guido S.] Univ Milan, Dipartimento Sci Terrra A Desio, Milan, Italy; [Zerboni, Andrea] Univ Cagliari, Dipartimento Sci Chim & Geol, Monserrato, Italy; [di Lernia, Savino] Sapienza Univ Roma, Dipartimento Sci Antichita, Rome, Italy; [di Lernia, Savino] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa	Royal Belgian Institute of Natural Sciences; KU Leuven; University of Milan; University of Cagliari; Sapienza University Rome; University of Witwatersrand	Van Neer, W (corresponding author), Royal Belgian Inst Nat Sci, Operat Direct Earth & Hist Life, Brussels, Belgium.; Van Neer, W (corresponding author), Univ Leuven, Lab Biodivers & Evolutionary Genom, Leuven, Belgium.; di Lernia, S (corresponding author), Sapienza Univ Roma, Dipartimento Sci Antichita, Rome, Italy.; di Lernia, S (corresponding author), Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa.	wvanneer@naturalsciences.be; savino.dilernia@uniroma1.it	Mariani, Guido Stefano/AAC-1905-2020	Mariani, Guido Stefano/0000-0002-8456-3964; ALHAIQUE, Francesca/0000-0003-4085-1523; Van Neer, Wim/0000-0003-1710-3623; Goffette, Quentin/0000-0003-2845-1746	"Grandi Scavi di Ateneo", Sapienza University of Rome; Italian Ministry of Foreign Affairs, Direzione Generale Sistema Paese (VI); Italian Ministry of Education, University, and Research (MIUR)	"Grandi Scavi di Ateneo", Sapienza University of Rome; Italian Ministry of Foreign Affairs, Direzione Generale Sistema Paese (VI); Italian Ministry of Education, University, and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	Funds were awarded to SDL by the "Grandi Scavi di Ateneo", Sapienza University of Rome) https://www.uniroma1.it/en/paginastrutturale/research), and the Italian Ministry of Foreign Affairs, Direzione Generale Sistema Paese (VI) (https://www.esteri.it/mae/en/politica_estera/cultura/archeologiapatrimonioculturale.html). AZ received funds from the Italian Ministry of Education, University, and Research (MIUR) "Dipartimenti di Eccellenza 2018-2022" (WP4 Risorse del Patrimonio Culturale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, HDB BIRDS WORLD ALIV; Armitage SJ, 2015, P NATL ACAD SCI USA, V112, P8543, DOI 10.1073/pnas.1417655112; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; BARICH BE, 1974, ORIGINI, V8, P7; BARICH BE, 1987, OXFORD BAR INT SERIE, V368; BAYOUMI AR, 1969, MAR BIOL, V4, P255, DOI 10.1007/BF00393903; Biagetti S, 2013, AFR ARCHAEOL REV, V30, P305, DOI 10.1007/s10437-013-9138-z; BOCHENSKI Z, 1993, MIDDLE PALEOLITHIC B, P159; Bour R., 2008, CHELONIAN RES MONOGR, V5; Breeze PS, 2015, QUATERN INT, V382, P98, DOI 10.1016/j.quaint.2015.01.022; Brito JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014734; Brown D. S., 1980, FRESHWATER SNAILS AF; Brown LH, 1982, BIRDS AFRICA, VI; Cancellieri E, 2016, VERTEBR PALEOBIOL PA, P123, DOI 10.1007/978-94-017-7520-5_7; Carboneras C., 2019, HDB BIRDS WORLD ALIV; Cassoli P. F., 1974, ORIGINI, V8, P159; Cherkinsky A, 2013, RADIOCARBON, V55, P771, DOI 10.1017/S0033822200057933; Clouet Michel, 2003, Alauda, V71, P469; Corridi C., 1998, WADI TESHUINAT PALAE, P89; Cremaschi M., 1998, DOCUMENTATIONS TECHN, V7, P243; Cremaschi M., 1998, WADI TESHUINAT PALAE, V7, P243; Cremaschi M., 2013, LIFE DEATH RURAL VIL, V6, P7; Cremaschi M, 2014, QUATERNARY SCI REV, V101, P36, DOI 10.1016/j.quascirev.2014.07.004; Cremaschi M, 2010, LANDSCAPES AND SOCIETIES: SELECTED CASES, P67, DOI 10.1007/978-90-481-9413-1_5; Cremaschi M, 2010, PALAEOGEOGR PALAEOCL, V287, P81, DOI 10.1016/j.palaeo.2010.01.019; Cremaschi M, 2009, CR GEOSCI, V341, P689, DOI 10.1016/j.crte.2009.05.001; Daget J, 1981, SAHARA SAHEL QUATERN, V45, P687; Davidson L., 2000, GEOLOGICAL EXPLORATI, P295, DOI [DOI 10.1016/B978-044450611-5/50016-7, 10.1134/S0016702914060032]; del Hoyo J, 1992, SAHARA ITALIANO 1, V1; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; del Hoyo J, 2013, HDB BIRDS WORLD; Desio A., 1937, ANTIQUITY, P39; di Lernia S., 2013, OXFORD HDB AFRICAN A, P527, DOI DOI 10.1093/OXFORDHB/9780199569885.013.0036; di Lernia S., 2008, MEMORIA ARTE PITTURE; di Lernia S, 2012, CHANGING DESERTS: INTEGRATING PEOPLE AND THEIR ENVIRONMENT, P101; di Lernia S, 2013, J ANTHROPOL ARCHAEOL, V32, P1, DOI 10.1016/j.jaa.2012.07.002; di Lernia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056879; Dierickx K, 2017, CYBIUM, V41, P223; DILERNIA S, 1999, ARID ZONE ARCHAEOLOG, V1; Drake N, 2006, HOLOCENE, V16, P901, DOI 10.1191/0959683606hol981rr; Drake NA, 2018, QUATERNARY SCI REV, V200, P376, DOI 10.1016/j.quascirev.2018.09.042; Drake NA, 2011, P NATL ACAD SCI USA, V108, P458, DOI 10.1073/pnas.1012231108; Dumont H.J., 1982, Palaeoecology of Africa and the Surrounding Islands, V14, P1; Dunne J, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2016.194; Dunne J, 2012, NATURE, V486, P390, DOI 10.1038/nature11186; Elliott A, 2019, HDB BIRDS WORLD ALIV; Elliott A, 2019, 2 S GEOL LIB U AL FA; Elmer KR, 2013, EVOLUTION, V67, P281, DOI 10.1111/j.1558-5646.2012.01755.x; Fischer-Piette E., 1948, Bull Mus Hist nat Paris (2), V20, P180; Fischer-Piette E., 1949, Journal de Conchyliologie, V89, P231; Fischer-Piette E., 1949, ARID ZONE ARCHAEOLOG, V89, P231; Fryer G, 1972, BAR INT SERIES; Fryer G, 1972, CICHLID FISHES GREAT; Gautier A., 1982, ORIGINI, V11, P87; Girod Alberto, 2010, Triton (Rehovot), V22, P27; Hockey P.A.R., 2005, ROBERTSBIRDS SO AFRI, V7th; HUGUENY B, 1994, ENVIRON BIOL FISH, V39, P365, DOI 10.1007/BF00004806; Jarvis A., 2008, THESIS, V89, P93; JOHNSGARD P.A., 1993, CORMORANTS DARTERS P; JUBB RA, 1966, NEWSLETTER LIMNOLOGI, V2, P26; KLEIN RG, 1986, J ARCHAEOL SCI, V13, P515, DOI 10.1016/0305-4403(86)90038-5; LEBERRE M, 1989, FAUNE SAHARA, V1; Lehner B., 2008, EOS T AM GEOPHYS UN, P93, DOI [DOI 10.1029/2008EO100001, 10.1029/2008EO100001]; Leveque C., 1990, Ichthyological Exploration of Freshwaters, V1, P39; Matheu E, 2019, HDB BIRDS WORLD ALIV; Mercuri AM, 2008, J ARID ENVIRON, V72, P1950, DOI 10.1016/j.jaridenv.2008.04.008; Mercuri AM, 2018, NAT PLANTS, V4, P71, DOI 10.1038/s41477-017-0098-1; MlYNARSKI M., 1993, EGYPT LAST INTERGLAC, P157; Mori F., 1965, PELECANIDAE SULIDAE; MORI F, 1965, ARTE RUPESTRE CULTUR; MOUSSA TOHAMY A., 1956, J MORPH, V98, P125, DOI 10.1002/jmor.1050980105; Nicholson S.E., 2011, DRYLAND CLIMATOLOGY; Osborn DJ, 1980, FIELDIANA ZOOLOGY, V5; Pasa, 1962, MEMORIE MUSEO CIVICO, V10, P251; Perego A, 2011, J MAPS, V7, P464, DOI 10.4113/jom.2011.1207; Peters J, 2003, PALAEOECOL AFR, V1, P265; Peters Joris, 2003, Documenta Archaeobiologiae, V1, P265; Petit-Maire N., 1982, DOCUMENTA ARCHAEOBIO; PETITMAIRE N, 1982, LAC PLEISTOCENE FEZZ; Poll M., 1965, Africa Tervuren, V11, P11; Pollath N, 2003, RECENT ADV ARCHAEOZO, V1, P255; Quade J, 2018, QUATERNARY RES, V90, P253, DOI 10.1017/qua.2018.46; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Rotunno R, 2019, J AFR ARCHAEOL, V17, P76, DOI 10.1163/21915784-20190005; Scortecci G., 1937, S HARA ITALIANO, P211; Skonieczny C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9751; Taylor B., 2019, HDB BIRDS WORLD ALIV; Trape S, 2013, CR BIOL, V336, P582, DOI 10.1016/j.crvi.2013.10.001; Traut MW, 1998, GEOL SOC SPEC PUBL, V132, P69, DOI 10.1144/GSL.SP.1998.132.01.03; Van Bocxlaer B, 2011, J QUATERNARY SCI, V26, P433, DOI 10.1002/jqs.1469; Van Damme D., 1984, FRESHWATER MOLLUSCA; van Neer W., 1989, Palaeoecology of Africa and the Surrounding Islands, V20, P1; Van Neer W., 1993, EGYPT LAST INTERGLAC, P144; Van Neer W., 1993, BAR INT SERIES, P144; Van Neer W., 1989, PREHISTORY WADI KUBB, V2, P119; Van Neer Wim, 2004, Documenta Archaeobiologiae, V2, P141; Walther H., 1960, KLIMADIAGRAMM WELTAT; Zerboni A., 2006, REND ONLINE SOC GEOL; ZERBONI A, 2006, THESIS; Zerboni A, 2019, GEOMORPHOLOGY, V331, P22, DOI 10.1016/j.geomorph.2018.10.011; Zerboni A, 2015, J MAPS, V11, P772, DOI 10.1080/17445647.2014.955891; Zerboni A, 2011, GEOMORPHOLOGY, V125, P319, DOI 10.1016/j.geomorph.2010.10.015; Zerboni A, 2008, GEOMORPHOLOGY, V102, P640, DOI 10.1016/j.geomorph.2008.06.010; [No title captured]	104	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228588	10.1371/journal.pone.0228588	http://dx.doi.org/10.1371/journal.pone.0228588			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8AS	32074116	Green Published, Green Submitted, gold			2022-12-26	WOS:000535220600019
J	Huang, KT; Chen, YC; Tseng, CC; Chang, HC; Su, MC; Wang, TY; Lin, YY; Zheng, YX; Chang, JC; Chin, CH; Hsiao, CC; Lin, MC				Huang, Kuo-Tung; Chen, Yung-Che; Tseng, Chia-Cheng; Chang, Huang-Chih; Su, Mao-Chang; Wang, Ting-Ya; Lin, Yong-Yong; Zheng, Yi-Xin; Chang, Jen-Chieh; Chin, Chien-Hung; Hsiao, Chang-Chun; Lin, Meng-Chih			Aberrant DNA methylation of the toll-like receptors 2 and 6 genes in patients with obstructive sleep apnea	PLOS ONE			English	Article							DAYTIME SLEEPINESS; BLOOD-CELLS; ACTIVATION; RESPONSES; HYPOXIA; HEART	Obstructive sleep apnea (OSA) is a syndrome leading to chronic intermittent hypoxia, and the up-regulation of toll-like receptors (TLR) 2 and 6 on peripheral blood cells has been reported. We hypothesized that DNA methylation in TLR2 and TLR6 genes may play a role in the development of OSA and its excessive daytime sleepiness (EDS) phenotype. DNA methylation over 28 cytosine-phosphate- guanine (CpG) sites of the TLR2 promoter region and 3 CpG sites of the TLR6 gene body, and their protein expressions were measured by using pyrosequencing and ELISA methods in 18 heathy subjects (HS) and 58 patients with severe OSA (divided into 18 non-EDS and 40 EDS group). Patients with severe OSA had higher DNA methylation levels over five CpG sites (#1, #2, #3, #25 and #28) and lower DNA methylation levels over CpG site #18 of the TLR2 promoter region, higher DNA methylation levels over two CpG sites (#1 and #3) of the TLR6 gene body, and higher protein expressions of TLR6 than HS. The CpG site #2 of the TLR6 gene body was hypermethylated in severe OSA patients with EDS. Both DNA methylation levels over CpG site #1 of the TLR6 gene body and protein expressions of TLR6 were reduced after more than 6 months of nasal CPAP treatment in seven selected patients. Aberrant DNA methylation of the TLR2 promoter region and TLR6 gene body are associated with the consequence of severe OSA and its EDS phenotype.	[Huang, Kuo-Tung; Chen, Yung-Che; Tseng, Chia-Cheng; Chang, Huang-Chih; Su, Mao-Chang; Wang, Ting-Ya; Lin, Yong-Yong; Zheng, Yi-Xin; Chang, Jen-Chieh; Chin, Chien-Hung; Lin, Meng-Chih] Kaohsiung Chang Gung Mem Hosp, Dept Med, Div Pulm & Crit Care Med, Kaohsiung, Taiwan; [Huang, Kuo-Tung; Chen, Yung-Che; Tseng, Chia-Cheng; Chang, Huang-Chih; Su, Mao-Chang; Wang, Ting-Ya; Lin, Yong-Yong; Zheng, Yi-Xin; Chang, Jen-Chieh; Chin, Chien-Hung; Lin, Meng-Chih] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Huang, Kuo-Tung; Chen, Yung-Che; Tseng, Chia-Cheng; Chang, Huang-Chih; Su, Mao-Chang; Chin, Chien-Hung; Lin, Meng-Chih] Kaohsiung Chang Gung Mem Hosp, Sleep Ctr, Kaohsiung, Taiwan; [Huang, Kuo-Tung; Chen, Yung-Che; Tseng, Chia-Cheng; Chang, Huang-Chih; Hsiao, Chang-Chun] Chang Gung Univ, Div Pulm & Crit Care Med, Grad Inst Clin Med Sci, Kaohsiung Chang Gung Mem Hosp,Coll Med, Kaohsiung, Taiwan; [Huang, Kuo-Tung] Meiho Univ, Dept Nursing, Pingtung, Taiwan; [Su, Mao-Chang; Lin, Meng-Chih] Chang Gung Univ Sci & Technol, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology	Lin, MC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Med, Div Pulm & Crit Care Med, Kaohsiung, Taiwan.; Lin, MC (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Lin, MC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Sleep Ctr, Kaohsiung, Taiwan.; Hsiao, CC (corresponding author), Chang Gung Univ, Div Pulm & Crit Care Med, Grad Inst Clin Med Sci, Kaohsiung Chang Gung Mem Hosp,Coll Med, Kaohsiung, Taiwan.; Lin, MC (corresponding author), Chang Gung Univ Sci & Technol, Chiayi, Taiwan.	cchsiao@mail.cgu.edu.tw; mengchihlin@hotmail.com			Chang Gung Memorial Hospital [CMRPG 8C1181/1182/1183, NMRPG8F6071-6073/105-2314-B-182A092-MY3]; Ministry of Science and Technology, Taiwan	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This research was funded by grants from the Chang Gung Memorial Hospital (CMRPG 8C1181/1182/1183 to M.C. Lin), Taiwan, and by grants (NMRPG8F6071-6073/105-2314-B-182A092-MY3 to M.C. Lin) from the Ministry of Science and Technology, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinnusi M, 2013, SLEEP BREATH, V17, P1009, DOI 10.1007/s11325-012-0791-2; Arnardottir ES, 2009, SLEEP, V32, P447, DOI 10.1093/sleep/32.4.447; Barbe F, 1998, AM J RESP CRIT CARE, V158, P18, DOI 10.1164/ajrccm.158.1.9709135; Boyd SB, 2016, SLEEP, V39, P1961, DOI 10.5665/sleep.6224; Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; Chen NH, 2002, QUAL LIFE RES, V11, P817, DOI 10.1023/A:1020818417949; Chen R, 2011, SLEEP BREATH, V15, P129, DOI 10.1007/s11325-010-0337-4; Chen YC, 2016, SLEEP, V39, P743, DOI 10.5665/sleep.5620; Chen YC, 2015, SLEEP BREATH, V19, P873, DOI 10.1007/s11325-014-1116-4; Chen YC, 2014, J INFECTION, V69, P546, DOI 10.1016/j.jinf.2014.08.014; Douglas RM, 2008, PHYSIOLOGY, V23, P333, DOI 10.1152/physiol.00023.2008; Feng J, 2012, SLEEP BREATH, V16, P31, DOI 10.1007/s11325-011-0481-5; Gami AS, 2005, NEW ENGL J MED, V352, P1206, DOI 10.1056/NEJMoa041832; Garbarino S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166262; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Huang JF, 2016, CLIN RESPIR J, V10, P714, DOI 10.1111/crj.12276; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Karper JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067923; Kim J, 2012, AM J RESP CRIT CARE, V185, P330, DOI 10.1164/rccm.201106-1026OC; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; Kulis M, 2013, BBA-GENE REGUL MECH, V1829, P1161, DOI 10.1016/j.bbagrm.2013.08.001; Lavie L, 2015, SLEEP MED REV, V20, P27, DOI 10.1016/j.smrv.2014.07.003; Lee JS, 2010, MOL CELL, V39, P71, DOI 10.1016/j.molcel.2010.06.008; Li Y, 2016, SLEEP; Liu B, 2013, MOL CELL BIOCHEM, V378, P183, DOI 10.1007/s11010-013-1609-7; Ma QY, 2014, DRUG DISCOV TODAY, V19, P1883, DOI 10.1016/j.drudis.2014.09.010; Manoharan I, 2014, J IMMUNOL, V193, P4203, DOI 10.4049/jimmunol.1400614; Maor GL, 2015, TRENDS GENET, V31, P274, DOI 10.1016/j.tig.2015.03.002; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Nanduri J, 2012, P NATL ACAD SCI USA, V109, P2515, DOI 10.1073/pnas.1120600109; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Polotsky VY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144725; Rechtschaffen A, 1968, BRAIN INF SERV; Tausendschon M, 2011, CYTOKINE, V53, P256, DOI 10.1016/j.cyto.2010.11.002; Verstraeten E, 2004, SLEEP, V27, P685; Wagner NM, 2013, ARTERIOSCL THROM VAS, V33, P1943, DOI 10.1161/ATVBAHA.113.301783; Watson JA, 2010, EPIGENETICS-US, V5, P293, DOI 10.4161/epi.5.4.11684; Wolk R, 2003, CIRCULATION, V108, P9, DOI 10.1161/01.CIR.0000072346.56728.E4; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104	43	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0228958	10.1371/journal.pone.0228958	http://dx.doi.org/10.1371/journal.pone.0228958			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7XT	32069296	Green Published, gold			2022-12-26	WOS:000535212900018
J	Peng, LL; Ming, Y; Zhang, L; Zhou, J; Xiang, W; Zeng, S; He, HP; Chen, LG				Peng, Lilei; Ming, Yang; Zhang, Ling; Zhou, Jie; Xiang, Wei; Zeng, Shan; He, Haiping; Chen, Ligang			MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway	FASEB JOURNAL			English	Article						Akt signaling pathway; colony-formation ability; Ecto-5 '-nucleotidase; glioma stem cells; microRNA-30a; orthotopic tumor growth; proliferation; self-renewal; sphere-formation ability	TUMOR-GROWTH; EXPRESSION; CD73; PROLIFERATION; BIOMARKER; TARGET	Over the past decade, increasing researches have demonstrated the implication of microRNAs (miRNAs or miRs) in tumorigenicity of glioma stem cells (GSCs). The regulatory functions of miRNAs in GSCs have emerged as potential therapeutic candidates for glioma treatment. Herein, we aim to investigate the role of miR-30a in the proliferation and self-renewal of GSCs and the possible mechanism in relation to ecto-5 '-nucleotidase (NT5E)-dependent Akt signaling pathway. RT-qPCR and Western blot analysis were performed to determine the expression of miR-30a and NT5E in glioma tissues and cell lines. GSCs were isolated from glioma cells and identified using flow cytometry. The relationship between miR-30a and NT5E was determined by dual-luciferase reporter gene assay. Gain- and loss-of-function experiments were performed to examine the effects of miR-30a and NT5E on sphere formation, colony formation, and proliferation of GSCs in vitro, as well as orthotopic tumor growth of GSCs in nude mice. Additionally, the Akt signaling pathway was blocked with an Akt inhibitor, LY294002, to investigate its involvement in the regulatory effect of miR30a. miR-30a was poorly expressed in glioma tissues and cell lines as well as GSCs. NT5E, highly expressed in GSCs, was identified as a target of miR-30a. In addition, miR-30a upregulation or NT5E silencing could reduce GSC sphere formation, clone formation, proliferation, and orthotopic tumor growth in nude mice. Moreover, miR-30a inhibited the activation of the Akt signaling pathway by targeting NT5E, and ultimately suppressing the self-renewal and orthotopic tumor growth of GSCs. Our results demonstrate that miR-30a targets NT5E to inhibit the Akt signaling pathway, by which could suppress the self-renewal and orthotopic tumor growth of GSCs. Those findings may provide theoretical basis of miR-30a as a therapeutic target to suppress the glioma progression.	[Peng, Lilei; Ming, Yang; Zhang, Ling; Zhou, Jie; Xiang, Wei; Zeng, Shan; He, Haiping; Chen, Ligang] Southwest Med Univ, Affiliated Hosp, Dept Neurosurg, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China; [Peng, Lilei; Ming, Yang; Zhang, Ling; Zhou, Jie; Xiang, Wei; Zeng, Shan; He, Haiping; Chen, Ligang] Neurosurg Clin Res Ctr Sichuan Prov, Luzhou 646000, Sichuan, Peoples R China	Southwest Medical University	Chen, LG (corresponding author), Southwest Med Univ, Affiliated Hosp, Dept Neurosurg, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China.; Chen, LG (corresponding author), Neurosurg Clin Res Ctr Sichuan Prov, Luzhou 646000, Sichuan, Peoples R China.	ligangchen_lgc@163.com			Science and Technology Department of Sichuan Province [2013SZZ002, 2018JY0404]; Health Commission of Sichuan Province [16PJ557]; government of Luzhou [14ZC0071-LH09, 2016LZXNYD-G03]; Southwest Medical University [2013ZRQN068]; Project Program of Neurosurgical Clinical Research Center of Sichuan Province [17082]	Science and Technology Department of Sichuan Province; Health Commission of Sichuan Province; government of Luzhou; Southwest Medical University; Project Program of Neurosurgical Clinical Research Center of Sichuan Province	This study was supported by the Science and Technology Department of Sichuan Province (grant nos. 2013SZZ002 and 2018JY0404), the Health Commission of Sichuan Province (grant no. 16PJ557), the government of Luzhou (grant nos. 14ZC0071-LH09 and 2016LZXNYD-G03), the Southwest Medical University (grant no. 2013ZRQN068) and the Project Program of Neurosurgical Clinical Research Center of Sichuan Province (grant no. 17082).	Allard B, 2014, INT J CANCER, V134, P1466, DOI 10.1002/ijc.28456; Azambuja JH, 2019, MOL NEUROBIOL, V56, P3260, DOI 10.1007/s12035-018-1240-4; Binello E, 2011, CANCER SCI, V102, P1958, DOI 10.1111/j.1349-7006.2011.02064.x; Cage TA, 2012, NEUROSURG CLIN N AM, V23, P515, DOI 10.1016/j.nec.2012.04.007; Cheng WJ, 2018, LIFE SCI, V208, P96, DOI 10.1016/j.lfs.2018.07.016; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Conti A, 2016, TUMOR BIOL, V37, P14035, DOI 10.1007/s13277-016-5273-x; Egan KM, 2011, J NEURO-ONCOL, V104, P535, DOI 10.1007/s11060-010-0506-0; Gao ZW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/460654; Hong J, 2019, CURR PROB CANCER, V43, P236, DOI 10.1016/j.currproblcancer.2018.07.007; Hua L, 2018, THERANOSTICS, V8, P5088, DOI 10.7150/thno.26225; Huang Z, 2010, PROTEIN CELL, V1, P638, DOI 10.1007/s13238-010-0078-y; Katakowski M, 2013, CANCER LETT, V335, P201, DOI 10.1016/j.canlet.2013.02.019; Katsuta E, 2016, INT J ONCOL, V48, P657, DOI 10.3892/ijo.2015.3299; Kong BH, 2013, CHILD NERV SYST, V29, P217, DOI 10.1007/s00381-012-1964-9; Liu J, 2018, HISTOL HISTOPATHOL, V33, P987, DOI 10.14670/HH-11-995; Liu LM, 2016, HEPATOLOGY, V64, P814, DOI 10.1002/hep.28690; Liu Y, 2018, BIOMED PHARMACOTHER, V108, P845, DOI 10.1016/j.biopha.2018.09.068; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2014, CANCER LETT, V355, P85, DOI 10.1016/j.canlet.2014.09.012; Mahmood A, 2012, STEM CELLS DEV, V21, P3114, DOI 10.1089/scd.2012.0035; Peng D, 2019, IUBMB LIFE, V71, P113, DOI 10.1002/iub.1942; Peruzzi P, 2013, NEURO-ONCOLOGY, V15, P1212, DOI 10.1093/neuonc/not055; Rathod SS, 2014, FEBS OPEN BIO, V4, P485, DOI 10.1016/j.fob.2014.05.002; Relier S, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0277-6; Ruan P, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171027; Singh SV, 2017, BIOCHEM BIOPH RES CO, V491, P946, DOI 10.1016/j.bbrc.2017.07.140; Song L, 2017, ONCOTARGET, V8, P31977, DOI 10.18632/oncotarget.16667; Wang W, 2013, NEOPLASMA, V60, P274, DOI 10.4149/neo_2013_036; Wang Y, 2017, ONCOTARGET, V8, P59417, DOI 10.18632/oncotarget.19727; Wang ZJ, 2018, NANOSCALE, V10, P13106, DOI 10.1039/c8nr02708k; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; Wu F, 2016, ONCOTARGET, V7, P61619, DOI 10.18632/oncotarget.11423; Wu XR, 2012, J SURG ONCOL, V106, P130, DOI 10.1002/jso.23056; Yao YL, 2015, CNS NEUROSCI THER, V21, P40, DOI 10.1111/cns.12321; Yu JG, 2017, IN VITRO CELL DEV-AN, V53, P132, DOI 10.1007/s11626-016-0089-y; Zhang YH, 2017, ONCOL REP, V38, P1156, DOI 10.3892/or.2017.5728; Zhao B, 2014, J CELL PHYSIOL, V229, P1141, DOI 10.1002/jcp.24540; Zhou JB, 2018, BIOMED PHARMACOTHER, V107, P1705, DOI 10.1016/j.biopha.2018.08.157; Zhu JJ, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0591-1; Zhu KP, 2017, ONCOTARGET, V8, P71881, DOI 10.18632/oncotarget.17985	41	8	8	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5128	5143		10.1096/fj.201802629RR	http://dx.doi.org/10.1096/fj.201802629RR		FEB 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32067282				2022-12-26	WOS:000515250300001
J	Castle, PE; Varallo, JE; Bertram, MM; Ratshaa, B; Kitheka, M; Rammipi, K				Castle, Philip E.; Varallo, John E.; Bertram, Margaret Mary; Ratshaa, Bakgaki; Kitheka, Moses; Rammipi, Kereng			High-risk human papillomavirus prevalence in self-collected cervicovaginal specimens from human immunodeficiency virus (HIV)-negative women and women living with HIV living in Botswana	PLOS ONE			English	Article							SQUAMOUS INTRAEPITHELIAL LESIONS; INVASIVE CERVICAL-CANCER; INFECTED WOMEN; GENOTYPES	Background The prevalence of high-risk human papillomavirus (hrHPV) is poorly described overall and in women living with HIV (WLWH) and HIV-negative women living in Botswana, a high HIV and cervical cancer-burden country. We conducted a pilot study of self-collection and high-risk HPV testing for cervical screening, from which data on HPV prevalence was available. Methods From five health facilities in the Kweneng East District, 1,022 women aged 30-49 years were enrolled to self-collect their cervicovaginal specimen for hrHPV testing by the Xpert HPV Test (Cepheid, Sunnyvale, CA, USA). Crude and age group-adjusted hrHPV prevalence by HIV status were calculated, and the relationship of hrHPV risk groups HPV16> HPV18/45> other hrHPV types) to the presence and severity of visible lesions. Results Of the 1,022 women enrolled, 1,019 (99.7%), 570 WLWH and 449 HIV-negative women, had hrHPV testing results. Crude hrHPV prevalences were 25.2% (95%CI = 21.2-29.4%) for HIV-negative women and 40.4% (95%CI = 36.3-44.5%) for WLWH. Age group-adjusted hrHPV prevalences were 23.7% (95%CI = 19.9-27.9%) for HIV-negative women and 41.3% (95%CI = 37.2-45.4%) for WLWH. Age group-adjusted prevalences of HPV16 (p< 0.001), HPV18/45 (p< 0.001), HPV31/33/35/52/58 (p< 0.001), and HPV39/56/66/68 (p = 0.011) were greater among WLWH than HIV-negative women. Riskier hrHPV groups were more likely to have visible abnormalities (p(trend) = 0.004) and visible abnormalities not eligible for cryotherapy (p(trend) = 0.030). Conclusions hrHPV infection was common among all women in the study living in Botswana, to a greater extent in WLWH than their HIV-negative counterparts. Strategies to triage hrHPV-positive women will be needed to avoid over-treating many women with benign hrHPV infections.	[Castle, Philip E.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Varallo, John E.; Bertram, Margaret Mary] Jhpiego USA, Baltimore, MD 21231 USA; [Ratshaa, Bakgaki; Kitheka, Moses] Jhpiego Botswana Gaborone, Gaborone, Botswana; [Rammipi, Kereng] Botswana Minist Hlth & Wellness, Gaborone, Botswana	Yeshiva University; Albert Einstein College of Medicine; Jhpiego	Varallo, JE (corresponding author), Jhpiego USA, Baltimore, MD 21231 USA.	John.Varallo@jhpiego.org		Varallo, John/0000-0002-4745-5489	Jhpiego	Jhpiego	This study was a Jhpiego (https://www.jhpiego.org/) internally funded project to Moses Kitheka. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, NEW GUID SCREEN TREA; Arbyn M, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4823; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Castle PE, 2019, CANCER PREV RES, V12, P159, DOI 10.1158/1940-6207.CAPR-18-0419; Castle PE, 2011, PREV MED, V52, P452, DOI 10.1016/j.ypmed.2011.03.018; Chung MH, 2013, AIDS, V27, P2909, DOI 10.1097/01.aids.0000432472.92120.1b; Cubie HA, 2017, J CLIN VIROL, V87, P1, DOI 10.1016/j.jcv.2016.11.014; Curry SJ, 2018, OBSTET GYNECOL SURV, V73, P689, DOI [10.1001/jama.2018.10897, 10.1097/01.ogx.0000549540.69362.81]; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Elliott T, 2019, INT J STD AIDS, V30, P1169, DOI 10.1177/0956462419868618; Firnhaber C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053494; Hawes SE, 2003, J INFECT DIS, V188, P555, DOI 10.1086/376996; Hu LM, 2019, JNCI-J NATL CANCER I, V111, P923, DOI 10.1093/jnci/djy225; Jeronimo J, 2017, J GLOB ONCOL, V3, P635, DOI 10.1200/JGO.2016.006577; Jeronimo J, 2015, J LOW GENIT TRACT DI, V19, P220, DOI 10.1097/LGT.0000000000000088; Katanga J, 2019, PLOS ONE, V19; Luckett R, 2019, OBSTET GYNECOL, V134, P840, DOI 10.1097/AOG.0000000000003496; MacLeod IJ, 2011, J MED VIROL, V83, P1689, DOI 10.1002/jmv.22178; Mapanga W, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0874-7; McDonald AC, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00048; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Ndizeye Z, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209303; Obiri-Yeboah D, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3682-x; Polman NJ, 2019, LANCET ONCOL, V20, P229, DOI 10.1016/S1470-2045(18)30763-0; Qiao YL, 2014, INT J CANCER, V134, P2891, DOI 10.1002/ijc.28616; Safaeian M, 2008, SEX TRANSM INFECT, V84, P306, DOI 10.1136/sti.2007.027318; Segondy M, 2016, BRIT J CANCER, V115, P425, DOI 10.1038/bjc.2016.207; Sinayobye JD, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-40; Singh DK, 2009, J INFECT DIS, V199, P1851, DOI 10.1086/599123; Toliman PJ, 2018, PAPILLOMAVIRUS RES, V6, P70, DOI 10.1016/j.pvr.2018.10.009; Vallely AJ, 2018, AUST NZ J OBSTET GYN, V58, P576, DOI 10.1111/ajo.12783; van der Marel J, 2014, BJOG, P10; Vyankandondera J, 2019, SEX TRANSM DIS, V46, P532, DOI 10.1097/OLQ.0000000000001029; WHO, 2019, WHO GUIDELINES USE T; WHO, 2014, CHINA MAT CHILD HLTH; World Health Organization, 2018, 026807000 WHO PQDX	37	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0229086	10.1371/journal.pone.0229086	http://dx.doi.org/10.1371/journal.pone.0229086			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053659	Green Published, gold			2022-12-26	WOS:000535198700098
J	Lucas, AR; Bitting, RL; Fanning, J; Isom, S; Rejeski, WJ; Klepin, HD; Kritchevsky, SB				Lucas, Alexander R.; Bitting, Rhonda L.; Fanning, Jason; Isom, Scott; Rejeski, W. Jack; Klepin, Heidi D.; Kritchevsky, Stephen B.			Trajectories in muscular strength and physical function among men with and without prostate cancer in the health aging and body composition study	PLOS ONE			English	Article							QUALITY-OF-LIFE; ANDROGEN-DEPRIVATION THERAPY; OLDER-ADULTS; IMPACT; EXERCISE; OUTCOMES; MUSCLE; DISABILITY; DIAGNOSIS; MORTALITY	Objectives To examine and compare changes in strength and physical function from pre- to post-diagnosis among men with prostate cancer (PC, [cases]) and matched non-cancer controls identified from the Health, Aging and Body Composition (Health ABC) study. Materials and methods We conducted a longitudinal analysis of 2 strength and 3 physical function-based measures among both cases and controls, identified from a large cohort of community living older adults enrolled in the Health ABC study. We plotted trajectories for each measure and compared cases vs. controls from the point of diagnosis onwards using mixed-effects regression models. For cases only, we examined predictors of poor strength or physical function. Results We identified 117 PC cases and 453 matched non-cancer controls (50% African Americans). At baseline, there were no differences between cases and controls in demographic factors, comorbidities or self-reported physical function; however, cases had slightly better grip strength (44.6 kg vs. 41.0 kg, p<0.01), quadriceps strength (360.5 Nm vs. 338.7 Nm, p = 0.02) and Health ABC physical performance battery scores (2.4 vs. 2.3, p = 0.01). All men experienced similar declines in strength and physical function over an equivalent amount of time. The loss of quad strength was most notable, with losses of nearly two-thirds of baseline strength over approximately 7 years of follow up. Conclusions Among both cases and controls, strength and physical function decline with increasing age. The largest declines were seen in lower body strength. Regular assessments should guide lifestyle interventions that can offset age- and treatment-related declines among men with PC.	[Lucas, Alexander R.] Virginia Commonwealth Univ, Dept Hlth Behav & Policy, Richmond, VA 23284 USA; [Lucas, Alexander R.] VCU Pauley Heart Ctr, Dept Internal Med, Div Cardiol, Richmond, VA 23219 USA; [Bitting, Rhonda L.; Klepin, Heidi D.] Wake Forest Baptist Hlth, Dept Internal Med Hematol & Oncol, Winston Salem, NC USA; [Fanning, Jason; Rejeski, W. Jack] Wake Forest Univ, Dept Hlth & Exercise Sci, Winston Salem, NC 27101 USA; [Isom, Scott] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC 27101 USA; [Kritchevsky, Stephen B.] Wake Forest Baptist Hlth, Dept Internal Med, Sticht Ctr Hlth Aging & Alzheimers Prevent, Winston Salem, NC USA	Virginia Commonwealth University; Virginia Commonwealth University; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest Baptist Medical Center	Lucas, AR (corresponding author), Virginia Commonwealth Univ, Dept Hlth Behav & Policy, Richmond, VA 23284 USA.; Lucas, AR (corresponding author), VCU Pauley Heart Ctr, Dept Internal Med, Div Cardiol, Richmond, VA 23219 USA.	Alexander.Lucas@vcuhealth.org	Lucas, Alexander R/AFF-5881-2022	Lucas, Alexander R/0000-0001-7318-3387	National Cancer Institute training grant [R25 CA122061]; Wake Forest University Claude D. Pepper Older Americans Independence Center [P30-AG21332]; National Institute on Aging [5R21AG058249-02, 5P30AG021332-17, 1R01AG059186-01A1]; National Cancer Institute's Cancer Center Support Grant [P30CA012197]; Wake Forest School of Medicine Claude D. Pepper Older Americans Independence Center [P30AG021332]; National Institute on Aging (NIA) [N01AG-6-2101, N01-AG-6-2103, N01-AG-6-2106]; NIA [R01-AG028050]; NINR grant [R01NR012459]; Intramural Research Program of the NIH, National Institute on Aging	National Cancer Institute training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wake Forest University Claude D. Pepper Older Americans Independence Center; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute's Cancer Center Support Grant; Wake Forest School of Medicine Claude D. Pepper Older Americans Independence Center; National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINR grant; Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr. Lucas's work on this project was partly supported by a National Cancer Institute training grant (R25 CA122061). Dr. Klepin received support from Wake Forest University Claude D. Pepper Older Americans Independence Center (P30-AG21332). Dr. Fanning received support from the National Institute on Aging grants, 5R21AG058249-02, 5P30AG021332-17, and 1R01AG059186-01A1. Scott Isom is supported by National Cancer Institute's Cancer Center Support Grant award number P30CA012197 issued to the Wake Forest Baptist Comprehensive Cancer Center. Dr. Kritchevsky received support from Wake Forest School of Medicine Claude D. Pepper Older Americans Independence Center (P30AG021332). This research was supported by National Institute on Aging (NIA) Contracts N01AG-6-2101; N01-AG-6-2103; N01-AG-6-2106; NIA grant R01-AG028050, and NINR grant R01NR012459. This research was funded in part by the Intramural Research Program of the NIH, National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alibhai SMH, 2010, J CLIN ONCOL, V28, P5038, DOI 10.1200/JCO.2010.29.8091; Banerji JS, 2017, UROL ONCOL-SEMIN ORI, V35, P234, DOI 10.1016/j.urolonc.2016.12.015; Bourke L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26682-0; Brawley Otis W., 2012, Journal of the National Cancer Institute Monographs, P152, DOI 10.1093/jncimonographs/lgs035; Brooks JM, 2018, J NUTR HEALTH AGING, V22, P938, DOI 10.1007/s12603-018-1041-5; Brown JC, 2015, BRIT J CANCER, V112, P194, DOI 10.1038/bjc.2014.568; Chambers SK, 2017, PSYCHO-ONCOLOGY, V26, P1576, DOI 10.1002/pon.4342; Cheung AS, 2014, ENDOCR-RELAT CANCER, V21, pR371, DOI 10.1530/ERC-14-0172; Davis MK, 2015, J ONCOL, V2015, DOI 10.1155/2015/820403; Demark-Wahnefried W, 2005, J CLIN ONCOL, V23, P5814, DOI 10.1200/JCO.2005.01.230; Demark-Wahnefried Wendy, 2004, Int J Behav Nutr Phys Act, V1, P16, DOI 10.1186/1479-5868-1-16; Farris MS, 2017, CANCER EPIDEM BIOMAR, V26, P179, DOI [10.1158/1055-9965.EPI-16-0465, 10.1158/1055-9965.epi-16-0465]; Focht BC, 2018, ANN BEHAV MED, V52, P412, DOI 10.1093/abm/kax002; Focht BC, 2014, J COMMUNITY SUPPORT, V12, P278, DOI 10.12788/jcso.0065; Galvao DA, 2009, PROSTATE CANCER P D, V12, P198, DOI 10.1038/pcan.2008.51; Gonzalez BD, 2016, SUPPORT CARE CANCER, V24, P2201, DOI 10.1007/s00520-015-3016-y; Klepin HD, 2010, J AM GERIATR SOC, V58, P76, DOI 10.1111/j.1532-5415.2009.02620.x; Kvael LAH, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016875; Leach CR, 2016, CANCER-AM CANCER SOC, V122, P1946, DOI 10.1002/cncr.29914; Meng MV, 2002, UROLOGY, V60, P7, DOI 10.1016/S0090-4295(02)01560-1; Middleton A, 2013, CURR GERIATR REP, V2, P205, DOI 10.1007/s13670-013-0057-2; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Morey MC, 2009, JAMA-J AM MED ASSOC, V301, P1883, DOI 10.1001/jama.2009.643; Moyad MA, 2016, RES REP UROL, V8, P133, DOI 10.2147/RRU.S107852; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Nilsen TS, 2015, ACTA ONCOL, V54, P1805, DOI 10.3109/0284186X.2015.1037008; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; Pardo Y, 2010, J CLIN ONCOL, V28, P4687, DOI 10.1200/JCO.2009.25.3245; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reeve BB, 2012, CANCER-AM CANCER SOC, V118, P5679, DOI 10.1002/cncr.27578; Rejeski WJ, 2009, J GERONTOL A-BIOL, V64, P462, DOI 10.1093/gerona/gln041; Ruiz JR, 2009, CANCER EPIDEM BIOMAR, V18, P1468, DOI 10.1158/1055-9965.EPI-08-1075; Sammon JD, 2015, EUR UROL, V68, P32, DOI 10.1016/j.eururo.2014.10.018; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Simonsick EM, 2001, J GERONTOL A-BIOL, V56, pM644, DOI 10.1093/gerona/56.10.M644; Watts AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208581; Weaver KE, 2016, J GERONTOL A-BIOL, V71, pS23, DOI 10.1093/gerona/glv073	37	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228773	10.1371/journal.pone.0228773	http://dx.doi.org/10.1371/journal.pone.0228773			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7SH	32053654	Green Published, gold			2022-12-26	WOS:000535198700053
J	Zmajkovicova, K; Bauer, Y; Menyhart, K; Schnoebelen, M; Freti, D; Boucher, M; Renault, B; Studer, R; Birker-Robaczewska, M; Klenk, A; Nayler, O; Gatfield, J				Zmajkovicova, Katarina; Bauer, Yasmina; Menyhart, Katalin; Schnoebelen, Marie; Freti, Diego; Boucher, Maxime; Renault, Berengere; Studer, Rolf; Birker-Robaczewska, Magdalena; Klenk, Axel; Nayler, Oliver; Gatfield, John			GPCR-induced YAP activation sensitizes fibroblasts to profibrotic activity of TGF beta 1	PLOS ONE			English	Article							INDUCED PULMONARY-FIBROSIS; LYSOPHOSPHATIDIC ACID; HIPPO PATHWAY; SPHINGOSINE 1-PHOSPHATE; LUNG FIBROBLASTS; YAP/TAZ; TAZ; ILOPROST; SPHINGOSINE-1-PHOSPHATE; INHIBITION	Tissue fibrosis is a pathological condition characterized by uncontrolled fibroblast activation that ultimately leads to organ failure. The TGF beta 1 pathway, one of the major players in establishment of the disease phenotype, is dependent on the transcriptional co-activators YAP/TAZ. We were interested whether fibroblasts can be sensitized to TGF beta 1 by activation of the GPCR/YAP/TAZ axis and whether this mechanism explains the profibrotic properties of diverse GPCR ligands. We found that LPA, S1P and thrombin cooperate in human dermal fibroblasts with TGF beta 1 to induce extracellular matrix synthesis, myofibroblast marker expression and cytokine secretion. Whole genome expression profiling identified a YAP/TAZ signature behind the synergistic profibrotic effects of LPA and TGF beta 1. LPA, S1P and thrombin stimulation led to activation of the Rho-YAP axis, an increase of nuclear YAP-Smad2 complexes and enhanced expression of profibrotic YAP/Smad2-target genes. More generally, dermal, cardiac and lung fibroblast responses to TGF beta 1 could be enhanced by increasing YAP nuclear levels (with GPCR ligands LPA, S1P, thrombin or Rho activator) and inhibited by decreasing nuclear YAP (with Rho inhibitor, forskolin, latrunculin B or 2-deoxy-glucose). Thus, we present here a conceptually interesting finding that fibroblast responses to TGF beta 1 can be predicted based on the nuclear levels of YAP and modulated by stimuli/treatments that change YAP nuclear levels. Our study contributes to better understanding of fibrosis as a complex interplay of signalling pathways and proposes YAP/TAZ as promising targets in the treatment of fibrosis.	[Zmajkovicova, Katarina; Bauer, Yasmina; Menyhart, Katalin; Schnoebelen, Marie; Freti, Diego; Boucher, Maxime; Renault, Berengere; Studer, Rolf; Birker-Robaczewska, Magdalena; Klenk, Axel; Nayler, Oliver; Gatfield, John] Idorsia Pharmaceut Ltd, Allschwil, Switzerland	Idorsia Pharmaceuticals Ltd	Gatfield, J (corresponding author), Idorsia Pharmaceut Ltd, Allschwil, Switzerland.	john.gatfield@idorsia.com		SCHNOEBELEN, Marie/0000-0001-7571-4698; Birker, Magdalena/0000-0001-7995-9465	Idorsia Pharmaceuticals Ltd.	Idorsia Pharmaceuticals Ltd.	Funding statement: "support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. "The funder Idorsia Pharmaceuticals Ltd. provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	AKTORIES K, 1989, TRENDS PHARMACOL SCI, V10, P415, DOI 10.1016/0165-6147(89)90191-0; Alsafadi HN, 2017, AM J PHYSIOL-LUNG C, V312, pL896, DOI 10.1152/ajplung.00084.2017; Atanelishvili I, SCLERODERMA ASS INTE, pA1055; Aytemur ZA, 2012, REV PORT PNEUMOL, V18, P272, DOI 10.1016/j.rppneu.2012.04.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogatkevich GS, 2011, ARTHRITIS RHEUM-US, V63, P1416, DOI 10.1002/art.30255; Castelino FV, 2011, ARTHRITIS RHEUM-US, V63, P1405, DOI 10.1002/art.30262; Corboz MR, 2018, PULM PHARMACOL THER, V49, P95, DOI 10.1016/j.pupt.2018.01.012; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dhar A, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-018-0789-8; DiMario JX, 2018, AM J PATHOL, V188, P1263, DOI 10.1016/j.ajpath.2018.01.014; Du YE, 2017, THERANOSTICS, V7, P3972, DOI 10.7150/thno.18990; Enzo E, 2015, EMBO J, V34, P1349, DOI 10.15252/embj.201490379; Foti R, 2017, RHEUMATOL INT, V37, P245, DOI 10.1007/s00296-016-3582-4; Fujii M, 2012, J EXP MED, V209, P479, DOI 10.1084/jem.20111653; Futakuchi A, 2018, INVEST OPHTH VIS SCI, V59, P3069, DOI 10.1167/iovs.18-24258; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Gibault F, 2018, CANCERS, V10, DOI 10.3390/cancers10050140; Gokey JJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122490; Gomez-Arroyo J, 2015, EUR RESPIR J, V45, P449, DOI 10.1183/09031936.00188013; Gonzalez-Fernandez B, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00579; Hiemer SE, 2014, J BIOL CHEM, V289, P13461, DOI 10.1074/jbc.M113.529115; Huber PE, 2010, AM J RESP CRIT CARE, V181; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Jorgenson AJ, 2017, AM J PHYSIOL-CELL PH, V312, pC277, DOI 10.1152/ajpcell.00205.2016; Kim T, 2017, EMBO J, V36, P520, DOI 10.15252/embj.201695137; Knight V, 2017, WORLD J GASTROENTERO, V23, P5692, DOI 10.3748/wjg.v23.i31.5692; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Kolb M, 2017, RESP MED, V131, P49, DOI 10.1016/j.rmed.2017.07.062; Kono Y, 2007, AM J RESP CELL MOL, V37, P395, DOI 10.1165/rcmb.2007-0065OC; Kurundkar AR, 2016, FASEB J, V30, P2135, DOI 10.1096/fj.201500173; Kwon D, 2017, HEART, V103, pA122, DOI 10.1136/heartjnl-2017-311726.174; Lambers C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19294-1; Li CY, 2011, J HEPATOL, V54, P1205, DOI 10.1016/j.jhep.2010.08.028; Mallano T, 2016, ANN RHEUM DIS, V75, P586, DOI 10.1136/annrheumdis-2014-206214; Mann DA, 2013, BBA-MOL BASIS DIS, V1832, P905, DOI 10.1016/j.bbadis.2012.09.009; Milara J, 2012, THORAX, V67, P147, DOI 10.1136/thoraxjnl-2011-200026; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mitani A, 2009, AM J RESP CRIT CARE, V180, P326, DOI 10.1164/rccm.200812-1827OC; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morrison K, 2010, J PHARMACOL EXP THER, V335, P249, DOI 10.1124/jpet.110.169748; Murphy AM, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0023-z; Noguchi S, 2017, SCI REP-UK, V7, DOI 10.1038/srep42595; Palmer SM, 2018, CHEST, V154, P1061, DOI 10.1016/j.chest.2018.08.1058; Panciera T, 2017, NAT REV MOL CELL BIO, V18, P758, DOI 10.1038/nrm.2017.87; Pant A, 2018, AM J PHYSIOL-GASTR L, V315, pG171, DOI 10.1152/ajpgi.00402.2017; Pattanaik D, 2010, DISCOV MED, V10, P161; Piersma B, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00059; Plouffe SW, 2018, J BIOL CHEM, V293, P11230, DOI 10.1074/jbc.RA118.002715; Plouffe SW, 2016, MOL CELL, V64, P993, DOI 10.1016/j.molcel.2016.10.034; Pradere JP, 2008, BBA-MOL CELL BIOL L, V1781, P582, DOI 10.1016/j.bbalip.2008.04.001; Qian YM, 2012, J MED CHEM, V55, P7920, DOI 10.1021/jm301022v; Qin ZP, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0232-3; Rodriguez-Pascual F, 2014, LIFE SCI, V118, P156, DOI 10.1016/j.lfs.2013.12.024; Schafer S, 2017, NATURE, V552, P110, DOI 10.1038/nature24676; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Schuliga M, 2018, INT J BIOCHEM CELL B, V97, P108, DOI 10.1016/j.biocel.2018.02.016; Seo E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31931; Shea BS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.86608; Shea Barry S, 2012, Proc Am Thorac Soc, V9, P102, DOI 10.1513/pats.201201-005AW; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sobel K, 2013, J BIOL CHEM, V288, P14839, DOI 10.1074/jbc.M112.426726; Stein C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005465; Stratton R, 2001, J CLIN INVEST, V108, P241, DOI 10.1172/JCI12020; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Toda N, 2018, INFLAMM REGEN, V38, DOI 10.1186/s41232-018-0070-0; Todd NW, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-11; Totaro A, 2018, NAT CELL BIOL, V20, P888, DOI 10.1038/s41556-018-0142-z; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Veerappan A, 2013, DNA CELL BIOL, V32, P206, DOI 10.1089/dna.2013.2005; Wang WQ, 2015, NAT CELL BIOL, V17, P490, DOI 10.1038/ncb3113; Wang XB, 2016, CELL METAB, V24, P848, DOI 10.1016/j.cmet.2016.09.016; Wang Z, 2017, CANCER RES, V77, P2413, DOI 10.1158/0008-5472.CAN-16-3229; Wennmann DO, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.476; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yui OM, 2018, ONCOGENE, V37, P5492, DOI 10.1038/s41388-018-0301-5; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao XG, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041118; Zhou T, 2018, EBIOMEDICINE, V31, P217, DOI 10.1016/j.ebiom.2018.04.023; Zhu YJ, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-34; Zmajkovicova K, 2019, AM J RESP CELL MOL, V60, P578, DOI 10.1165/rcmb.2018-0142OC	91	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228195	10.1371/journal.pone.0228195	http://dx.doi.org/10.1371/journal.pone.0228195			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053631	Green Published, Green Submitted, gold			2022-12-26	WOS:000535198700020
J	Milian, L; Mata, M; Alcacer, J; Oliver, M; Sancho-Tello, M; de Llano, JJM; Camps, C; Galbis, J; Carretero, J; Carda, C				Milian, Lara; Mata, Manuel; Alcacer, Javier; Oliver, Maria; Sancho-Tello, Maria; de Llano, Jose Javier Martin; Camps, Carlos; Galbis, Jose; Carretero, Julian; Carda, Carmen			Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; ENDOCANNABINOID SYSTEM; CB1; METASTASIS; ANANDAMIDE; PROGNOSIS; MIGRATION	Background/Objective Patients with non-small cell lung cancer (NSCLC) develop resistance to antitumor agents by mechanisms that involve the epithelial-to-mesenchymal transition (EMT). This necessitates the development of new complementary drugs, e.g., cannabinoid receptors (CB1 and CB2) agonists including tetrahydrocannabinol (THC) and cannabidiol (CBD). The combined use of THC and CBD confers greater benefits, as CBD enhances the effects of THC and reduces its psychotropic activity. We assessed the relationship between the expression levels of CB1 and CB2 to the clinical features of a cohort of patients with NSCLC, and the effect of THC and CBD (individually and in combination) on proliferation, EMT and migration in vitro in A549, H460 and H1792 lung cancer cell lines. Methods Expression levels of CB1, CB2, EGFR, CDH1, CDH2 and VIM were evaluated by quantitative reverse transcription-polymerase chain reaction. THC and CBD (10-100 mu M), individually or in combination (1:1 ratio), were used for in vitro assays. Cell proliferation was determined by BrdU incorporation assay. Morphological changes in the cells were visualized by phase-contrast and fluorescence microscopy. Migration was studied by scratch recolonization induced by 20 ng/ml epidermal growth factor (EGF). Results The tumor samples were classified according to the level of expression of CB1, CB2, or both. Patients with high expression levels of CB1, CB2, and CB1/CB2 showed increased survival reaching significance for CB1 and CB1/CB2 (p = 0.035 and 0.025, respectively). Both cannabinoid agonists inhibited the proliferation and expression of EGFR in lung cancer cells, and CBD potentiated the effect of THC. THC and CBD alone or in combination restored the epithelial phenotype, as evidenced by increased expression of CDH1 and reduced expression of CDH2 and VIM, as well as by fluorescence analysis of cellular cytoskeleton. Finally, both cannabinoids reduced the in vitro migration of the three lung cancer cells lines used. Conclusions The expression levels of CB1 and CB2 have a potential use as markers of survival in patients with NSCLC. THC and CBD inhibited the proliferation and expression of EGFR in the lung cancer cells studied. Finally, the THC/CBD combination restored the epithelial phenotype in vitro.	[Milian, Lara; Mata, Manuel; Oliver, Maria; Sancho-Tello, Maria; de Llano, Jose Javier Martin; Carda, Carmen] Univ Valencia, Fac Med & Odontol, Dept Pathol, Valencia, Spain; [Milian, Lara; Mata, Manuel; Sancho-Tello, Maria; de Llano, Jose Javier Martin; Carda, Carmen] Res Inst Univ Clin Hosp Valencia & Ncl, Valencia, Spain; [Mata, Manuel] ISCIII, Networking Res Ctr Resp Dis CIBERER, Carretera Soller Bunyola, Mallorca, Illes Balears, Spain; [Alcacer, Javier] Patologika SL, Leg Espanola Sq, Valencia, Spain; [Camps, Carlos] Univ Gen Hosp Valencia, Valencia, Spain; [Galbis, Jose] Alzira Hosp, Carretera Corbera, Valencia, Spain; [Carretero, Julian] Univ Valencia, Fac Med & Odontol, Dept Physiol, Valencia, Spain	University of Valencia; Instituto de Salud Carlos III; University of Valencia	Mata, M (corresponding author), Univ Valencia, Fac Med & Odontol, Dept Pathol, Valencia, Spain.; Mata, M (corresponding author), Res Inst Univ Clin Hosp Valencia & Ncl, Valencia, Spain.; Mata, M (corresponding author), ISCIII, Networking Res Ctr Resp Dis CIBERER, Carretera Soller Bunyola, Mallorca, Illes Balears, Spain.	manuel.mata@uv.es	Carretero, Julian/N-5214-2014; Sancho-Tello, Maria/F-8566-2016; de Llano, José Javier Martín/K-6610-2012; Roig, Manuel Mata/G-4338-2015	Carretero, Julian/0000-0001-7269-8506; Sancho-Tello, Maria/0000-0002-7080-2979; de Llano, José Javier Martín/0000-0001-5933-9592; Roig, Manuel Mata/0000-0002-1506-7983	Ministry of Economy and Competitiveness of the Spanish Government [MAT2016-76039-C4-2-R, PI16-01315]; Instituto de Salud Carlos III; VI National R&D&I Plan 2008-2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions; European Regional Development Fund	Ministry of Economy and Competitiveness of the Spanish Government(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); VI National R&D&I Plan 2008-2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions(Spanish Government); European Regional Development Fund(European Commission)	This work was supported by grants MAT2016-76039-C4-2-R (MST and CC) and PI16-01315 (MM) from the Ministry of Economy and Competitiveness of the Spanish Government and the Instituto de Salud Carlos III. CIBER-BBN and CIBERER are funded by the VI National R&D&I Plan 2008-2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions and the Instituto de Salud Carlos III, with assistance from the European Regional Development Fund.	Alexander A, 2009, CANCER LETT, V285, P6, DOI 10.1016/j.canlet.2009.04.005; Bethune Gillian, 2010, J Thorac Dis, V2, P48; Bifulco M, 2001, FASEB J, V15, P2745, DOI 10.1096/fj.01-0320fje; Bifulco M, 2006, BRIT J PHARMACOL, V148, P123, DOI 10.1038/sj.bjp.0706632; Bisogno T, 2001, BRIT J PHARMACOL, V134, P845, DOI 10.1038/sj.bjp.0704327; Booth JK, 2019, PLANT SCI, V284, P67, DOI 10.1016/j.plantsci.2019.03.022; Chung SC, 2009, EUR J CANCER, V45, P174, DOI 10.1016/j.ejca.2008.10.010; Cipriano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065798; Cooper WA, 2013, J THORAC DIS, V5, pS479, DOI 10.3978/j.issn.2072-1439.2013.08.03; Elbaz M, 2015, MOL ONCOL, V9, P906, DOI 10.1016/j.molonc.2014.12.010; Ellert-Miklaszewska A, 2007, BRAIN RES, V1137, P161, DOI 10.1016/j.brainres.2006.12.060; Fowler CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015205; Franklin WA, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.31520; Guindon J, 2011, BRIT J PHARMACOL, V163, P1447, DOI 10.1111/j.1476-5381.2011.01327.x; Gustafsson SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023003; Hermanson DJ, 2011, CANCER METAST REV, V30, P599, DOI 10.1007/s10555-011-9318-8; Ignatowska-Jankowska BM, 2013, PSYCHOPHARMACOLOGY, V229, P591, DOI 10.1007/s00213-013-3117-6; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung CK, 2013, ONCOL LETT, V5, P870, DOI 10.3892/ol.2012.1081; Kawata M, 2012, J BIOCHEM, V151, P205, DOI 10.1093/jb/mvr136; Kim EJ, 2015, BIOMOL THER, V23, P141, DOI 10.4062/biomolther.2014.117; Kim JH, 2007, J KOREAN MED SCI, V22, P898, DOI 10.3346/jkms.2007.22.5.898; Koyama S, 1997, AM J PHYSIOL-LUNG C, V272, pL830, DOI 10.1152/ajplung.1997.272.5.L830; De Jesus ML, 2010, NEUROCHEM INT, V56, P829, DOI 10.1016/j.neuint.2010.03.007; Marshall AD, 2011, CANCER RES, V71, P7471, DOI 10.1158/0008-5472.CAN-11-0924; Massi P, 2013, BRIT J CLIN PHARMACO, V75, P303, DOI 10.1111/j.1365-2125.2012.04298.x; Mata M, 2005, THORAX, V60, P144, DOI 10.1136/thx.2004.025692; McAllister SD, 2015, J NEUROIMMUNE PHARM, V10, P255, DOI 10.1007/s11481-015-9608-y; Michalski CW, 2008, INT J CANCER, V122, P742, DOI 10.1002/ijc.23114; Mouronte-Roibas C, 2016, CANCER LETT, V382, P240, DOI 10.1016/j.canlet.2016.09.002; Muhl D, 2014, N-S ARCH PHARMACOL, V387, P691, DOI 10.1007/s00210-014-0984-2; Pacher P, 2011, PROG LIPID RES, V50, P193, DOI 10.1016/j.plipres.2011.01.001; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pertwee RG, 2000, ADDICT BIOL, V5, P37, DOI 10.1080/13556210071252; Preet A, 2008, ONCOGENE, V27, P339, DOI 10.1038/sj.onc.1210641; Preet A, 2011, CANCER PREV RES, V4, P65, DOI 10.1158/1940-6207.CAPR-10-0181; Pyszniak M, 2016, ONCOTARGETS THER, V9, P4323, DOI 10.2147/OTT.S106944; Ravi J, 2016, MOL CARCINOGEN, V55, P2063, DOI 10.1002/mc.22451; Ravi J, 2014, ONCOTARGET, V5, P2475, DOI 10.18632/oncotarget.1723; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Sanchez C, 2001, CANCER RES, V61, P5784; Torres S, 2011, MOL CANCER THER, V10, P90, DOI 10.1158/1535-7163.MCT-10-0688; Vaccani A, 2005, BRIT J PHARMACOL, V144, P1032, DOI 10.1038/sj.bjp.0706134; Vann RE, 2008, DRUG ALCOHOL DEPEN, V94, P191, DOI 10.1016/j.drugalcdep.2007.11.017; Velasco G, 2012, NAT REV CANCER, V12, P436, DOI 10.1038/nrc3247; Xian XS, 2016, CELL PHYSIOL BIOCHEM, V39, P2149, DOI 10.1159/000447910; Xu XD, 2006, CANCER GENET CYTOGEN, V171, P31, DOI 10.1016/j.cancergencyto.2006.06.014; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb; Zappa C, 2016, TRANSL LUNG CANCER R, V5, P288, DOI 10.21037/tlcr.2016.06.07; Zettl UK, 2016, THER ADV NEUROL DISO, V9, P9, DOI 10.1177/1756285615612659; Zhang YZ, 2018, ONCOL LETT, V15, P8527, DOI 10.3892/ol.2018.8407	51	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228909	10.1371/journal.pone.0228909	http://dx.doi.org/10.1371/journal.pone.0228909			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32049991	Green Published, gold			2022-12-26	WOS:000535192300034
J	Wu, JK; Wu, H; Ding, YJ; Qin, J; Li, HY; Liu, SW; Zeng, D				Wu, Jinkui; Wu, Hao; Ding, Yongjian; Qin, Jia; Li, Hongyuan; Liu, Shiwei; Zeng, Di			Interannual and seasonal variations in carbon exchanges over an alpine meadow in the northeastern edge of the Qinghai-Tibet Plateau, China	PLOS ONE			English	Article							ECOSYSTEM CO2 EXCHANGE; WATER-VAPOR EXCHANGE; DIOXIDE EXCHANGE; GRASSLAND ECOSYSTEMS; DECIDUOUS FOREST; ANNUAL SUMS; LEAF-AREA; VARIABILITY; CLIMATE; FLUXES	The alpine meadow is highly sensitive to global climate change due to its high elevation and cold environment. To understand the dynamics of ecosystem carbon cycling, CO2 fluxes were measured over the Suli alpine meadow, which is located at the upper reach of the Shule River basin at the northeastern edge of the Qinghai-Tibet Plateau (QTP), China. The measurements were taken from October 2008 to September 2012 using the eddy covariance technique. Obvious seasonal and inter-annual variations were observed in the CO2 flux. The annual net carbon exchange ranged from -195.28 g.CO2.m(-2) to -118.49 g.CO2.m(-2), indicating that the alpine meadow ecosystem in this area played a role as a carbon sink. The inter-annual variability in the net carbon exchange was significantly related to the length of the growing season for the alpine meadow. The results showed that the months of June, July and August were the strongest CO2 absorption periods, while April, May and October were the strongest CO2 release periods. The annual net exchanges of CO2 in the four years were -118.49 g.CO2.m(-2), -130.75 g.CO2.m(-2), -195.83 g.CO2.m(-2) and -160.65 g.CO2.m(-2), and the average value was -151.43 g.CO2.m(-2). On a seasonal scale, the monthly CO2 fluxes were largely controlled by temperature. At the annual scale, there was no dominant factor that influenced the interannual variations in the CO2 flux.	[Wu, Jinkui; Ding, Yongjian; Qin, Jia; Li, Hongyuan; Zeng, Di] Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, Key Lab Ecol Hydrol & Basin Sci, Lanzhou, Peoples R China; [Wu, Jinkui; Ding, Yongjian; Liu, Shiwei] Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, State Key Lab Cryospher Sci, Lanzhou, Peoples R China; [Wu, Hao] Yangzhou Univ, Coll Hydraul Sci & Engn, Yangzhou, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Yangzhou University	Wu, H (corresponding author), Yangzhou Univ, Coll Hydraul Sci & Engn, Yangzhou, Peoples R China.	jkwu@lzb.ac.cn			Strategic Priority Research Program of the Chinese Academy of Sciences [XDA23060702]; National Natural Science Foundation of China [41771084, 41971094]; CRSRI Open Research Program [CKWV2017534/KY]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CRSRI Open Research Program	This work was funded by the Strategic Priority Research Program of the Chinese Academy of Sciences, Grant No. XDA23060702 to YD; the National Natural Science Foundation of China, Grant No. 41771084 to JW, and Grant No. 41971094 to MX; and the CRSRI Open Research Program, Program SN: CKWV2017534/KY to JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1990, NATURE, V348, P711, DOI 10.1038/348711a0; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Barr AG, 2004, AGR FOREST METEOROL, V126, P237, DOI 10.1016/j.agrformet.2004.06.011; Berbigier P, 2001, AGR FOREST METEOROL, V108, P183, DOI 10.1016/S0168-1923(01)00240-4; Churkina G, 2005, GLOBAL CHANGE BIOL, V11, P1777, DOI 10.1111/j.1365-2486.2005.001012.x; Clement RJ, 2012, AGR FOREST METEOROL, V153, P106, DOI 10.1016/j.agrformet.2011.07.012; Desai AR, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001122; Dragoni D, 2011, GLOBAL CHANGE BIOL, V17, P886, DOI 10.1111/j.1365-2486.2010.02281.x; Du Q, 2013, AGR ECOSYST ENVIRON, V173, P1, DOI 10.1016/j.agee.2013.04.009; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Fan JW, 2008, CLIMATIC CHANGE, V86, P375, DOI 10.1007/s10584-007-9316-6; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fu Y, 2009, BIOGEOSCIENCES, V6, P2879, DOI 10.5194/bg-6-2879-2009; Fu YL, 2006, AGR FOREST METEOROL, V137, P234, DOI 10.1016/j.agrformet.2006.02.009; Goulden ML, 1996, SCIENCE, V271, P1576, DOI 10.1126/science.271.5255.1576; Greco S, 1996, GLOBAL CHANGE BIOL, V2, P183, DOI 10.1111/j.1365-2486.1996.tb00071.x; Hirata R, 2013, AGR FOREST METEOROL, V177, P57, DOI 10.1016/j.agrformet.2013.04.007; Hu J, 2010, GLOBAL CHANGE BIOL, V16, P771, DOI 10.1111/j.1365-2486.2009.01967.x; Kato T, 2006, GLOBAL CHANGE BIOL, V12, P1285, DOI 10.1111/j.1365-2486.2006.01153.x; Keenan TF, 2014, NAT CLIM CHANGE, V4, P598, DOI [10.1038/nclimate2253, 10.1038/NCLIMATE2253]; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Law B, 2004, HDB MICROMETEOROLOGY; Law BE, 1999, GLOBAL CHANGE BIOL, V5, P169, DOI 10.1046/j.1365-2486.1999.00214.x; Law BE, 2002, AGR FOREST METEOROL, V113, P97, DOI 10.1016/S0168-1923(02)00104-1; Leuning R, 2005, AGR FOREST METEOROL, V129, P151, DOI 10.1016/j.agrformet.2004.12.004; Li HQ, 2016, AGR FOREST METEOROL, V228, P95, DOI 10.1016/j.agrformet.2016.06.020; Li YN, 2006, SCI CHINA SER D, V49, P174, DOI 10.1007/s11430-006-8174-9; Li YL, 2008, AGR FOREST METEOROL, V148, P51, DOI 10.1016/j.agrformet.2007.09.002; Liu WJ, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035401; Ma SY, 2007, AGR FOREST METEOROL, V147, P157, DOI 10.1016/j.agrformet.2007.07.008; Marcolla B, 2011, AGR FOREST METEOROL, V151, P1233, DOI 10.1016/j.agrformet.2011.04.015; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Ni J, 2002, J ARID ENVIRON, V50, P205, DOI 10.1006/jare.2001.0902; Oren R, 2006, GLOBAL CHANGE BIOL, V12, P883, DOI 10.1111/j.1365-2486.2006.01131.x; Peters W, 2007, P NATL ACAD SCI USA, V104, P18925, DOI 10.1073/pnas.0708986104; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Piao SL, 2011, GLOBAL PLANET CHANGE, V75, P133, DOI 10.1016/j.gloplacha.2010.10.014; Poulter B, 2013, AGR FOREST METEOROL, V178, P31, DOI 10.1016/j.agrformet.2012.12.006; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Reichstein M, 2007, GLOBAL CHANGE BIOL, V13, P634, DOI 10.1111/j.1365-2486.2006.01224.x; Richardson AD, 2010, PHILOS T R SOC B, V365, P3227, DOI 10.1098/rstb.2010.0102; Ruppert J, 2006, AGR FOREST METEOROL, V138, P5, DOI 10.1016/j.agrformet.2006.03.003; Ryan MG, 2005, BIOGEOCHEMISTRY, V73, P3, DOI 10.1007/s10533-004-5167-7; Shen MG, 2015, GLOBAL CHANGE BIOL, V21, P3647, DOI 10.1111/gcb.12961; [盛煜 SHENG Yu], 2010, [中国矿业大学学报. 自然科学版, Journal of China University of Mining & Technology], V39, P32; Stauch VJ, 2006, GLOBAL CHANGE BIOL, V12, P1707, DOI 10.1111/j.1365-2486.2006.01227.x; Street LE, 2007, J ECOL, V95, P139, DOI 10.1111/j.1365-2745.2006.01187.x; Suni T, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002381; Suyker AE, 2003, GLOBAL CHANGE BIOL, V9, P255, DOI 10.1046/j.1365-2486.2003.00567.x; Thornton PE, 2002, AGR FOREST METEOROL, V113, P185, DOI 10.1016/S0168-1923(02)00108-9; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Vargas R, 2012, GLOBAL CHANGE BIOL, V18, P1401, DOI 10.1111/j.1365-2486.2011.02628.x; Vourlitis GL, 2001, FUNCT ECOL, V15, P388, DOI 10.1046/j.1365-2435.2001.00535.x; [王海波 Wang Haibo], 2014, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V28, P50; Wang J, 2015, QINGHAI LACK ALPINE; Wang L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/810124; Wang YF, 2011, SER INF MANAGE SCI, V10, P26; Wohlfahrt G, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009286; Wu CY, 2013, GLOBAL ECOL BIOGEOGR, V22, P994, DOI 10.1111/geb.12044; Wu Li-Bo, 2010, Chinese Journal of Plant Ecology, V34, P770, DOI 10.3773/j.issn.1005-264x.2010.07.002; Xiao JF, 2011, AGR FOREST METEOROL, V151, P60, DOI 10.1016/j.agrformet.2010.09.002; Xie Xia, 2010, Shengtaixue Zazhi, V29, P1420; Xu LK, 2004, AGR FOREST METEOROL, V123, P79, DOI 10.1016/j.agrformet.2003.10.004; Yi CX, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/3/034007; Yi SH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045403; Yu GR., 2010, J RESOUR ECOL, V1, P97, DOI [10.3969/j.issn.1674-764x.2010.02.00, DOI 10.3969/J.ISSN.1674-764X.2010.02.001, DOI 10.3969/J.ISSN.1674-764X.2010.02.00]; Yu GR, 2013, GLOBAL CHANGE BIOL, V19, P798, DOI 10.1111/gcb.12079; Zhang Fa-Wei, 2012, Chinese Journal of Plant Ecology, V36, P187, DOI 10.3724/SR.J.1258.2012.00187; [张海宏 Zhang Haihong], 2017, [冰川冻土, Journal of Glaciology and Geocryology], V39, P54; Zhang X, 1997, CATA GEOGRAPHICA SIN, V52, P361; Zhao L, 2010, BIOGEOSCIENCES DISCU, V6, P9005; Zhao L, 2006, GLOBAL CHANGE BIOL, V12, P1940, DOI 10.1111/j.1365-2486.2006.01197.x; [朱志鹍 Zhu Zhikun], 2015, [高原气象, Plateau Meteorology], V34, P1217; Zhu ZL, 2006, SCI CHINA SER D, V49, P36, DOI 10.1007/s11430-006-8036-5	74	3	3	13	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228470	10.1371/journal.pone.0228470	http://dx.doi.org/10.1371/journal.pone.0228470			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045420	Green Published, gold			2022-12-26	WOS:000534633200014
J	Wu, XW; Huang, J; Shen, C; Liu, YL; He, SJ; Sun, JQ; Yu, BL				Wu, Xunwei; Huang, Jun; Shen, Cong; Liu, Yeling; He, Shengjie; Sun, Junquan; Yu, Bolan			NRF2 deficiency increases obesity susceptibility in a mouse menopausal model	PLOS ONE			English	Article							INSULIN-RESISTANCE; METABOLIC SYNDROME; SEROTONIN; PATHWAY; OVARIAN; MASS	The risk of metabolic abnormalities in menopausal women increases significantly due to the decline in estrogen level. Nuclear factor E2-related factor 2 (NRF2) is an important oxidative stress sensor that plays regulatory role in energy metabolism. Therefore, an ovariectomized menopausal model in Nrf2-knockout (KO) mice was applied to evaluate the effect of Nrf2 deficiency on metabolism in menopausal females. The mice were divided into four groups according to their genotypes and treatments. Blood samples and bodyweights were obtained preoperatively and in the first to ninth postoperative weeks after overnight fasting. Serum levels of triglycerides (TG), total cholesterol (T-CHO), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and glucose (GLU) were measured at postoperative weeks 0, 1, 3, 5, 7, and 9. Neurotransmitter dopamine (DA) and serotonin (5-HT) was analyzed in brain tissues after sacrifice at postoperative week 9. The results demonstrated that, compared with the corresponding wild-type (WT) mice, KO ovariectomized mice had a greater bodyweight gain (P<0.01). Serum analysis showed that the serum GLU, T-CHO, and TG were significantly lower (P<0.05) but LDL was significantly higher (P<0.05) in the KO control mice than that in WT control mice. However, different from the WT counterparts, an increase in blood GLU level (P<0.05), unchanged T-CHO, TG, and HDL levels, and a significant reduction in LDL (P<0.01) was found in the KO ovariectomized mice. In addition, the level of 5-HT was significantly reduced (P<0.05) in the KO mice after ovariectomy. In conclusion, the combination of Nrf2 deletion and a decline in estrogen level induced a significant increase in bodyweight, which may be associated with their altered glucose and LDL metabolism and decreased 5-HT levels. From a clinical perspective, women with antioxidant defense deficiency may have an increased risk of metabolic abnormalities after menopause.	[Wu, Xunwei; Yu, Bolan] Guangzhou Med Univ, Key Lab Major Obstet Dis Guangdong Prov, Affiliated Hosp 3, Guangzhou, Peoples R China; [Wu, Xunwei; Yu, Bolan] Guangzhou Med Univ, Guangdong Engn & Technol Res Ctr Maternal Fetal M, Affiliated Hosp 3, Guangzhou, Peoples R China; [Huang, Jun] Guangzhou Med Univ, Dept Obstet, Affiliated Hosp 3, Guangzhou, Peoples R China; [Shen, Cong; Liu, Yeling; He, Shengjie; Sun, Junquan] Guangzhou Med Univ, Clin Coll 3, Guangzhou, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Yu, BL (corresponding author), Guangzhou Med Univ, Key Lab Major Obstet Dis Guangdong Prov, Affiliated Hosp 3, Guangzhou, Peoples R China.; Yu, BL (corresponding author), Guangzhou Med Univ, Guangdong Engn & Technol Res Ctr Maternal Fetal M, Affiliated Hosp 3, Guangzhou, Peoples R China.	yubolan-q@qq.com			Key Project of Guangzhou Science and Technology Innovation Committee [201804020057]; Guangdong Science and Technology Department Project [2019B030316023]	Key Project of Guangzhou Science and Technology Innovation Committee; Guangdong Science and Technology Department Project	This study was supported by the Key Project of Guangzhou Science and Technology Innovation Committee (grant number 201804020057), Guangdong Science and Technology Department Project (grant number 2019B030316023), and Lin He's Academician Workstation of New Medicine and Clinical Translation at the Third Affiliated Hospital. BY received all the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305; Burke LK, 2015, J NEUROENDOCRINOL, V27, P389, DOI 10.1111/jne.12287; Chartoumpekis DV, 2011, DIABETES, V60, P2465, DOI 10.2337/db11-0112; DAVIS SR, 2015, NAT REV DIS PRIMERS, V1, DOI DOI 10.1038/NRDP.2015.4; Derby CA, 2009, AM J EPIDEMIOL, V169, P1352, DOI 10.1093/aje/kwp043; Donato GB, 2006, MENOPAUSE, V13, P280, DOI 10.1097/01.gme.0000177907.32634.ae; Gu SM, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00253; Leeners B, 2017, HUM REPROD UPDATE, V23, P300, DOI 10.1093/humupd/dmw045; Marseglia L, 2015, INT J MOL SCI, V16, P378, DOI 10.3390/ijms16010378; Martins Rand Randall, 2005, Acta Cir Bras, V20 Suppl 1, P78; Montazeri SA, 2019, FERTIL STERIL, V111, P780, DOI 10.1016/j.fertnstert.2018.12.017; Monteleone P, 2018, NAT REV ENDOCRINOL, V14, P199, DOI 10.1038/nrendo.2017.180; Omotola O, 2019, AM J PHYSIOL-ENDOC M, V317, pE1172, DOI 10.1152/ajpendo.00365.2019; Pi JB, 2010, J BIOL CHEM, V285, P9292, DOI 10.1074/jbc.M109.093955; Reus GZ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8637970; Romero-Aleshire MJ, 2009, AM J PHYSIOL-REG I, V297, pR587, DOI 10.1152/ajpregu.90762.2008; Rui Wenjuan, 2016, J Pharmacol Exp Ther, V358, P14, DOI 10.1124/jpet.115.231316; Seo HA, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/184598; Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07; Slopien R, 2018, MATURITAS, V117, P6, DOI 10.1016/j.maturitas.2018.08.009; Sowers M, 2007, J CLIN ENDOCR METAB, V92, P895, DOI 10.1210/jc.2006-1393; Stefanska A, 2015, ADV CLIN CHEM, V72, P1, DOI 10.1016/bs.acc.2015.07.001; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Tecott LH, 2007, CELL METAB, V6, P352, DOI 10.1016/j.cmet.2007.09.012; Goncalves JTT, 2016, CIENC SAUDE COLETIVA, V21, P1145, DOI 10.1590/1413-81232015214.16552015; Tonelli C, 2018, ANTIOXID REDOX SIGN, V29, P1727, DOI 10.1089/ars.2017.7342; Uruno A, 2015, ARCH BIOCHEM BIOPHYS, V566, P76, DOI 10.1016/j.abb.2014.12.012; Vomhof-DeKrey EE, 2012, J NUTR BIOCHEM, V23, P1201, DOI 10.1016/j.jnutbio.2012.03.005; Wang Q, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1008-8; Wei QS, 2017, SCAND J CLIN LAB INV, V77, P40, DOI 10.1080/00365513.2016.1247983; Xu JL, 2015, OBESITY, V23, P335, DOI 10.1002/oby.20929; Xue P, 2013, DIABETES, V62, P845, DOI 10.2337/db12-0584; Zhang L, 2017, AM J TRANSL RES, V8, P5309; Zhang ZG, 2015, REV ENDOCR METAB DIS, V16, P35, DOI 10.1007/s11154-014-9305-9; Zhao GL, 2019, REPROD TOXICOL, V83, P8, DOI 10.1016/j.reprotox.2018.10.012; Zhu C, 2015, NEUROSCIENCE, V304, P328, DOI 10.1016/j.neuroscience.2015.07.057	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228559	10.1371/journal.pone.0228559	http://dx.doi.org/10.1371/journal.pone.0228559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045430	Green Published, gold			2022-12-26	WOS:000534633200020
J	Majumdar, G; Yadav, G; Hamaide, J; Coussement, L; De Meyer, T; Verhoye, M; Vanden Berghe, W; Van der Linden, A; Balthazart, J				Majumdar, Gaurav; Yadav, Garima; Hamaide, Julie; Coussement, Louis; De Meyer, Tim; Verhoye, Marleen; Vanden Berghe, Wim; Van der Linden, Annemie; Balthazart, Jacques			Molecular correlates of hypothalamic development in songbird ontogeny in comparison with the telencephalon	FASEB JOURNAL			English	Article						hormones; hypothalamus; ontogeny; sexual dimorphism; telencephalon; zebra finch	TESTOSTERONE-METABOLIZING ENZYMES; RECEPTOR MESSENGER-RNA; FEMALE ZEBRA FINCHES; SEXUAL-DIFFERENTIATION; THYROID-HORMONE; GENE-EXPRESSION; BRAIN NUCLEI; AROMATASE; BEHAVIOR; ORGANIZATION	Development of the songbird brain provides an excellent experimental model for understanding the regulation of sex differences in ontogeny. Considering the regulatory role of the hypothalamus in endocrine, in particular reproductive, physiology, we measured the structural (volume) and molecular correlates of hypothalamic development during ontogeny of male and female zebra finches. We quantified by relative quantitative polymerase chain reaction (rqPCR) the expression of 14 genes related to thyroid and steroid hormones actions as well as 12 genes related to brain plasticity at four specific time points during ontogeny and compared these expression patterns with the expression of the same genes as detected by transcriptomics in the telencephalon. These two different methodological approaches detected specific changes with age and demonstrated that in a substantial number of cases changes observed in both brain regions are nearly identical. Other genes however had a tissue-specific developmental pattern. Sex differences or interactions of sex by age were detected in the expression of a subset of genes, more in hypothalamus than telencephalon. These results correlate with multiple known aspects of the developmental and reproductive physiology but also raise a number of new functional questions.	[Majumdar, Gaurav; Yadav, Garima; Hamaide, Julie; Verhoye, Marleen; Van der Linden, Annemie] Univ Antwerp, Dept Biomed Sci, Bioimaging Lab, B-2000 Antwerp, Belgium; [Coussement, Louis; De Meyer, Tim] Univ Ghent, Dept Data Anal & Math Modelling, Biobix Lab Bioinformat & Computat Genom, Ghent, Belgium; [Vanden Berghe, Wim] Univ Antwerp, Dept Biomed Sci, Lab Prot Chem Prote & Epigenet Signaling PPES, Antwerp, Belgium; [Balthazart, Jacques] Univ Liege, GIGA Neurosci, Lab Behav Neuroendocrinol, Liege, Belgium	University of Antwerp; Ghent University; University of Antwerp; University of Liege	Majumdar, G (corresponding author), Univ Antwerp, Dept Biomed Sci, Bioimaging Lab, B-2000 Antwerp, Belgium.	Gaurav.majumdar@uantwerpen.be	Vanden Berghe, Wim/HGE-4696-2022; Berghe, Wim Vanden/S-6425-2018	Berghe, Wim Vanden/0000-0003-0161-7355; majumdar, gaurav/0000-0002-4238-3404	NINDS NIH HHS [RO1NS104008] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abraham U, 2003, CHRONOBIOL INT, V20, P657, DOI 10.1081/CBI-120022414; ADKINSREGAN E, 1994, J NEUROBIOL, V25, P865, DOI 10.1002/neu.480250710; ADKINSREGAN E, 1987, ANIM BEHAV, V35, P1100, DOI 10.1016/S0003-3472(87)80167-7; ADKINSREGAN E, 1990, HORM BEHAV, V24, P114, DOI 10.1016/0018-506X(90)90031-R; Agate RJ, 2003, P NATL ACAD SCI USA, V100, P4873, DOI 10.1073/pnas.0636925100; ARNOLD AP, 1988, FRONT NEUROENDOCRIN, V10, P185; BALTHAZART J, 1992, HORM BEHAV, V26, P179, DOI 10.1016/0018-506X(92)90041-S; BALTHAZART J, 1992, BRAIN RES, V574, P280, DOI 10.1016/0006-8993(92)90828-W; Balthazart J, 2007, FRONT NEUROENDOCRIN, V28, P161, DOI 10.1016/j.yfrne.2007.05.003; Balthazart J, 2017, HORMONES, BRAIN AND BEHAVIOR, VOL 5: DEVELOPMENT OF HORMONE-BEHAVIOR RELATIONSHIPS, 3RD EDITION, P185, DOI 10.1016/B978-0-12-803592-4.00101-2; Balthazart J, 2017, HORM BEHAV, V93, P137, DOI 10.1016/j.yhbeh.2017.05.017; Bardet SM, 2012, J COMP NEUROL, V520, P4226, DOI 10.1002/cne.23153; Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424; BOTTJER SW, 1985, J NEUROSCI, V5, P1556, DOI 10.1523/jneurosci.05-06-01556.1985; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; Breazile James E., 1993, Publications of the Nuttall Ornithological Club, V23, P493; Burbridge S, 2016, COMPR PHYSIOL, V6, P623, DOI 10.1002/cphy.c150023; Cao J, 2002, BRAIN RES, V943, P80, DOI 10.1016/S0006-8993(02)02537-4; Chao A, 2015, DEV NEUROBIOL, V75, P271, DOI 10.1002/dneu.22228; Chen G, 2006, J NEUROBIOL, V66, P537, DOI 10.1002/neu.20247; Cornez G, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0849; de Vries G.J., 2002, HORMONES BRAIN BEHAV, P137, DOI [10.1016/B978, DOI 10.1016/B978-012532104-4/50066-4]; Ernst DK, 2016, J EXP BIOL, V219, P783, DOI 10.1242/jeb.126987; Felling RJ, 2015, EXP NEUROL, V268, P37, DOI 10.1016/j.expneurol.2014.09.017; Gahr M, 2004, ANN NY ACAD SCI, V1016, P684, DOI 10.1196/annals.1298.025; GURNEY ME, 1980, SCIENCE, V208, P1380, DOI 10.1126/science.208.4450.1380; Hamaide J, 2018, NEUROIMAGE, V181, P190, DOI 10.1016/j.neuroimage.2018.07.010; Hayase S, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006537; Hernandez A, 2012, ENDOCRINOLOGY, V153, P2919, DOI 10.1210/en.2011-1905; Islam MM, 2015, BBA-GENE REGUL MECH, V1849, P210, DOI 10.1016/j.bbagrm.2014.06.001; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Johnen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058751; Kim YH, 2004, J COMP NEUROL, V469, P535, DOI 10.1002/cne.11033; Kinne A, 2011, THYROID RES, V4, DOI 10.1186/1756-6614-4-S1-S7; Kokoeva MV, 2007, J COMP NEUROL, V505, P209, DOI 10.1002/cne.21492; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; KUENZEL WJ, 1982, J COMP NEUROL, V206, P293, DOI 10.1002/cne.902060309; Leng G., 2018, HEART BRAIN HYPOTHAL; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; London SE, 2007, J COMP NEUROL, V502, P507, DOI 10.1002/cne.21335; MacDougall-Shackleton SA, 1999, TRENDS NEUROSCI, V22, P432, DOI 10.1016/S0166-2236(99)01434-4; Majumdar G, 2015, MOL CELL ENDOCRINOL, V399, P110, DOI 10.1016/j.mce.2014.09.020; Markakis EA, 2002, FRONT NEUROENDOCRIN, V23, P257, DOI 10.1016/S0091-3022(02)00003-1; MATHEWS GA, 1990, GEN COMP ENDOCR, V80, P48, DOI 10.1016/0016-6480(90)90147-E; McNabb FMA, 2006, GEN COMP ENDOCR, V147, P93, DOI 10.1016/j.ygcen.2005.12.011; Metzdorf R, 1999, J COMP NEUROL, V407, P115; Migaud M, 2010, EUR J NEUROSCI, V32, P2042, DOI 10.1111/j.1460-9568.2010.07521.x; Mishra I, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12627; Mouriec K, 2013, BRAIN RES, V1516, P20, DOI 10.1016/j.brainres.2013.04.034; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; NICHOLLS TJ, 1988, PHYSIOL REV, V68, P133, DOI 10.1152/physrev.1988.68.1.133; NixdorfBergweiler BE, 1996, J COMP NEUROL, V375, P445, DOI 10.1002/(SICI)1096-9861(19961118)375:3<445::AID-CNE7>3.0.CO;2-2; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Nottebohm F, 2004, ANN NY ACAD SCI, V1016, P628, DOI 10.1196/annals.1298.027; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; PALKOVITS M, 1973, BRAIN RES, V59, P449, DOI 10.1016/0006-8993(73)90290-4; Perfito N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034997; Peterson RS, 2005, P ROY SOC B-BIOL SCI, V272, P2089, DOI 10.1098/rspb.2005.3181; Pfaff D.W, 2017, HORMONES BRAIN BEHAV; Plant TM, 2015, KNOBIL NEILLS PHYSL; POHLAPEL G, 1984, Z TIERPSYCHOL, V64, P330; Prove I., 1983, P368; Raymaekers SR, 2017, GEN COMP ENDOCR, V240, P91, DOI 10.1016/j.ygcen.2016.09.016; Rhinn M, 1999, DEVELOPMENT, V126, P4295; Saldanha CJ, 2000, J COMP NEUROL, V423, P619, DOI 10.1002/1096-9861(20000807)423:4<619::AID-CNE7>3.0.CO;2-U; SCHLINGER BA, 1992, ENDOCRINOLOGY, V130, P289, DOI 10.1210/en.130.1.289; Schlinger BA, 2001, TRENDS NEUROSCI, V24, P429, DOI 10.1016/S0166-2236(00)01855-5; Schlinger BA, 2017, HORMONES, BRAIN AND BEHAVIOR, VOL 2: NON-MAMMALIAN HORMONE-BEHAVIOR SYSTEMS, 3RD EDITION, P255, DOI 10.1016/B978-0-12-803592-4.00030-4; Shaughnessy DW, 2019, J COMP NEUROL, V527, P843, DOI 10.1002/cne.24569; SHEN P, 1995, J COMP NEUROL, V360, P172, DOI 10.1002/cne.903600113; Shinkai T, 1999, EXP GERONTOL, V34, P267, DOI 10.1016/S0531-5565(98)00074-6; SIMERLY RB, 1986, J COMP NEUROL, V246, P312, DOI 10.1002/cne.902460304; SIMPSON HB, 1991, J NEUROBIOL, V22, P755, DOI 10.1002/neu.480220710; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Tobet S.A., 1992, HDB BEHAV NEUROBIOLO, V11, P41; Ubuka T, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00038; Van Herck SLJ, 2013, GEN COMP ENDOCR, V190, P96, DOI 10.1016/j.ygcen.2013.05.003; VOCKEL A, 1990, J NEUROBIOL, V21, P808, DOI 10.1002/neu.480210514; VOCKEL A, 1990, BRAIN RES, V511, P291, DOI 10.1016/0006-8993(90)90174-A; WADE J, 1994, BRAIN RES, V639, P347, DOI 10.1016/0006-8993(94)91752-3; Wade J, 1996, P NATL ACAD SCI USA, V93, P5264, DOI 10.1073/pnas.93.11.5264; Williams H, 2004, ANN NY ACAD SCI, V1016, P1, DOI 10.1196/annals.1298.029; Xie YY, 2017, DEVELOPMENT, V144, P1588, DOI 10.1242/dev.139055; Yoshimura T, 2013, FRONT NEUROENDOCRIN, V34, P157, DOI 10.1016/j.yfrne.2013.04.002	84	0	0	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4997	5015		10.1096/fj.201902477R	http://dx.doi.org/10.1096/fj.201902477R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32052887	Green Submitted			2022-12-26	WOS:000530242100014
J	Mihalas, BP; Redgrove, KA; Bernstein, IR; Robertson, MJ; McCluskey, A; Nixon, B; Holt, JE; McLaughlin, EA; Sutherland, JM				Mihalas, Bettina P.; Redgrove, Kate A.; Bernstein, Ilana R.; Robertson, Mark J.; McCluskey, Adam; Nixon, Brett; Holt, Janet E.; McLaughlin, Eileen A.; Sutherland, Jessie M.			Dynamin 2-dependent endocytosis is essential for mouse oocyte development and fertility	FASEB JOURNAL			English	Article						dynamin; endocytosis; folliculogenesis; oocyte; oogenesis	RIBONUCLEIC-ACID EXPRESSION; MAMMALIAN OOCYTES; FOLLICULAR DEVELOPMENT; MECHANISMS; GRANULOSA; ACTIN; MATURATION; GROWTH; ACTIVATION; ISOFORMS	During folliculogenesis, oocytes are dependent on metabolic and molecular support from surrounding somatic cells. Here, we examined the role of the dynamin (DNM) family of mechanoenzymes in mediating endocytotic uptake into growing follicular oocytes. We found DNM1 and DNM2 to be highly expressed in growing follicular oocytes as well as in mature germinal vesicle (GV) and metaphase II (MII) stage oocytes. Moreover, oocyte-specific conditional knockout (cKO) of DNM2 (DNM2 Delta) led to complete sterility, with follicles arresting at the preantral stage of development. In addition, DNM2 Delta ovaries were characterized by disrupted follicular growth as well as oocyte and follicle apoptosis. Further, the loss of DNM activity, either through DNM2 cKO or through pharmacological inhibition (Dyngo 6a) led to the impairment of endocytotic pathways in preantral oocytes as well as in mature GV and MII oocytes, respectively. Loss of DNM activity resulted in the redistribution of endosomes and the misslocalization of clathrin and actin, suggesting dysfunctional endocytosis. Notably, there was no observable effect on the fertility of DNM1 Delta females. Our study has provided new insight into the complex and dynamic nature of oocyte growth during folliculogenesis, suggesting a role for DNM2 in mediating the endocytotic events that are essential for oocyte development.	[Mihalas, Bettina P.; Redgrove, Kate A.; Bernstein, Ilana R.; Robertson, Mark J.; McCluskey, Adam; Nixon, Brett; McLaughlin, Eileen A.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW, Australia; [Mihalas, Bettina P.; Redgrove, Kate A.; Bernstein, Ilana R.; Nixon, Brett; Holt, Janet E.; McLaughlin, Eileen A.; Sutherland, Jessie M.] Univ Newcastle, Prior Res Ctr Reprod Sci, Callaghan, NSW, Australia; [Mihalas, Bettina P.; Redgrove, Kate A.; Bernstein, Ilana R.; Nixon, Brett; McLaughlin, Eileen A.; Sutherland, Jessie M.] Hunter Medial Res Inst, Pregnancy & Reprod Program, New Lambton Hts, NSW, Australia; [Robertson, Mark J.; McCluskey, Adam] Univ Newcastle, Prior Res Ctr Chem Biol, Callaghan, NSW, Australia; [Holt, Janet E.; Sutherland, Jessie M.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia; [McLaughlin, Eileen A.] Western Sydney Univ, Sch Sci, Penrith, NSW, Australia; [McLaughlin, Eileen A.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand	University of Newcastle; University of Newcastle; University of Newcastle; University of Newcastle; Western Sydney University; University of Auckland	Mihalas, BP (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Prior Res Ctr Reprod Sci, Univ Dr, Callaghan, NSW 2308, Australia.	Bettina.Mihalas@uon.edu.au	McLaughlin, Eileen/AAF-5588-2021; Robertson, Mark/E-9173-2014	Robertson, Mark/0000-0002-2140-2717; Mihalas, Bettina/0000-0002-6006-8475; Sutherland, Jessie/0000-0001-9672-2371; McLaughlin, Eileen/0000-0002-5837-3876				Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Palma GA, 2012, SCI WORLD J, DOI 10.1100/2012/938138; Albertini DF, 2001, REPRODUCTION, V121, P647, DOI 10.1530/rep.0.1210647; BAARENDS WM, 1995, ENDOCRINOLOGY, V136, P4951, DOI 10.1210/en.136.11.4951; Bitoun M, 2009, HUM MUTAT, V30, P1419, DOI 10.1002/humu.21086; Camlin NJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170650; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Carabatsos MJ, 2000, DEV BIOL, V226, P167, DOI 10.1006/dbio.2000.9863; COLONNA R, 1983, BIOL REPROD, V28, P797, DOI 10.1095/biolreprod28.4.797; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; DONAHUE RP, 1968, J REPROD FERTIL, V17, P395, DOI 10.1530/jrf.0.0170395; El-Hayek S, 2018, CURR BIOL, V28, P1124, DOI 10.1016/j.cub.2018.02.039; Elkin SR, 2016, WIEN MED WOCHENSCHR, V166, P196, DOI 10.1007/s10354-016-0432-7; EPPIG JJ, 1991, BIOESSAYS, V13, P569, DOI 10.1002/bies.950131105; Eppig JJ, 2018, CURR BIOL, V28, pR354, DOI 10.1016/j.cub.2018.03.005; Fair T, 2003, ANIM REPROD SCI, V78, P203, DOI 10.1016/S0378-4320(03)00091-5; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; Fortune JE, 2003, ANIM REPROD SCI, V78, P135, DOI 10.1016/S0378-4320(03)00088-5; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gittens JEI, 2005, J CELL SCI, V118, P5071, DOI 10.1242/jcs.02624; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; HIROBE S, 1992, ENDOCRINOLOGY, V131, P854, DOI 10.1210/en.131.2.854; Holt JE, 2012, MOL BIOL CELL, V23, P3970, DOI 10.1091/mbc.E12-05-0352; Jimah JR, 2019, TRENDS CELL BIOL, V29, P257, DOI 10.1016/j.tcb.2018.11.003; Kaksonen M, 2018, NAT REV MOL CELL BIO, V19, P313, DOI 10.1038/nrm.2017.132; Kaur G, 2018, ADV EXP MED BIOL, V1074, P335, DOI 10.1007/978-3-319-75402-4_41; LEESE HJ, 1985, J EXP ZOOL, V234, P231, DOI 10.1002/jez.1402340208; Lowther KM, 2011, REPRODUCTION, V141, P737, DOI 10.1530/REP-10-0461; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; McLaughlin EA, 2009, REPRODUCTION, V137, P1, DOI 10.1530/REP-08-0118; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McNiven MA, 2005, NAT GENET, V37, P215, DOI 10.1038/ng0305-215; Mihalas BP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06372-z; Mihalas BP, 2015, REPRODUCTION, V150, P485, DOI 10.1530/REP-14-0585; Monniaux D, 2016, THERIOGENOLOGY, V86, P41, DOI 10.1016/j.theriogenology.2016.04.017; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; NAKATA T, 1991, NEURON, V7, P461, DOI 10.1016/0896-6273(91)90298-E; Nixon B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135605; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Ramachandran R, 2018, CURR BIOL, V28, pR411, DOI 10.1016/j.cub.2017.12.013; Redgrove KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep35084; Reid AT, 2015, FASEB J, V29, P2872, DOI 10.1096/fj.14-265553; Reid AT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.392803; Rimon-Dahari N, 2016, RESULTS PROBL CELL D, V58, P167, DOI 10.1007/978-3-319-31973-5_7; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Sundborger Anna C, 2014, F1000Prime Rep, V6, P85, DOI 10.12703/P6-85; Thomas FH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-19; Vaid KS, 2007, J CELL PHYSIOL, V210, P644, DOI 10.1002/jcp.20855; van den Hurk R, 2005, THERIOGENOLOGY, V63, P1717, DOI 10.1016/j.theriogenology.2004.08.005; Wang QC, 2014, BIOL CELL, V106, P193, DOI 10.1111/boc.201400007; Yeo CX, 2009, BIOL REPROD, V80, P1072, DOI 10.1095/biolreprod.108.073908; Zhang Y, 2014, MOL REPROD DEV, V81, P725, DOI 10.1002/mrd.22341; Zhao M, 2018, NEUROTHERAPEUTICS, V15, P966, DOI 10.1007/s13311-018-00686-0; Zhou W, 2017, MOL HUM REPROD, V23, P657, DOI 10.1093/molehr/gax044	62	3	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5162	5177		10.1096/fj.201902184R	http://dx.doi.org/10.1096/fj.201902184R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32065700	Bronze			2022-12-26	WOS:000530242100024
J	Craig, AD; Khattak, F; Hastie, P; Bedford, MR; Olukosi, OA				Craig, Allison D.; Khattak, Farina; Hastie, Peter; Bedford, Mike R.; Olukosi, Oluyinka A.			The similarity of the effect of carbohydrase or prebiotic supplementation in broilers aged 21 days, fed mixed cereal diets and challenged with coccidiosis infection	PLOS ONE			English	Article							NUTRIENT DIGESTIBILITY; NONSTARCH POLYSACCHARIDES; GROWTH-PERFORMANCE; DIGESTIVE-TRACT; BETA-GLUCANASE; XYLANASE; CHICKENS; WHEAT; MICROBIOTA; FIBER	The aim of this study was to investigate the effect on growth performance and nutrient utilisation when supplementing diets deficient in energy and protein with carbohydrase enzymes or xylo-oligosaccharide in broilers challenged with coccidia. 960 Ross 308 broilers were used in this 21-day study. The treatments were arranged into a 2x4 factorial with 2 challenge states (challenged and non-challenged) and 4 different additive types (control, xylanase alone, xylanase and beta-glucanase mixture and xylo-oligosaccharide). On day 14, the challenged group received 12x the recommended dose of coccidiosis vaccine while the non-challenged group received a sham treatment of water only. The birds and feed were weighed on days 0, 14 and 21. On day 21, two birds per pen were euthanized, the caeca were removed and the contents collected for short chain fatty acid analysis. Six more birds per pen were euthanized and ileal digesta were collected and pooled per pen for nutrient digestibility analysis. Feed intake was greater (P < 0.05) on days 14 and 21 when xylo-oligosaccharide was included in the diet compared to the xylanase and beta-glucanase mixture in birds challenged with coccidiosis. Including xylo-oligosaccharide in the diet improved (P < 0.05) the digestibility of nitrogen and supplementing diets with the xylanase and beta-glucanase mixture improved (P < 0.05) the digestibility of several amino acids. The concentration of arabinose and xylose was (P < 0.001) greater when broiler diets were supplemented with carbohydrase enzymes or xylo-oligosaccharide compared to the control. Although there was an increase in short chain fatty acid production due to the addition of carbohydrase enzymes or xylo-oligosaccharide, there was no additive effect on the %G+C profile of caecal bacteria however there was a negative effect of coccidiosis. In conclusion, the similarity in the response to carbohydrase enzymes or xylo-oligosaccharide supplementation illustrates that the hydrolysis products from carbohydrase activity may have prebiotic like effects.	[Craig, Allison D.; Khattak, Farina; Olukosi, Oluyinka A.] SRUC, Monogastr Sci Res Ctr, Edinburgh, Midlothian, Scotland; [Craig, Allison D.; Hastie, Peter] Univ Glasgow, Sch Vet Med, McCall Bldg, Glasgow, Lanark, Scotland; [Bedford, Mike R.] Woodstock Ctr, AB Vista, Marlborough Business Pk, Marlborough, MA USA; [Olukosi, Oluyinka A.] Univ Georgia, Dept Poultry Sci, Athens, GA 30602 USA	University of Glasgow; University System of Georgia; University of Georgia	Craig, AD (corresponding author), SRUC, Monogastr Sci Res Ctr, Edinburgh, Midlothian, Scotland.; Craig, AD (corresponding author), Univ Glasgow, Sch Vet Med, McCall Bldg, Glasgow, Lanark, Scotland.	allison.craig@sruc.ac.uk		Khattak, Farina/0000-0001-8206-5788; Olukosi, Oluyinka/0000-0002-9137-6745	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M016080/1]; Scottish government (RESAS); World Poultry Science Association (WPSA) UK branch; WPSA; BBSRC [1741959] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish government (RESAS); World Poultry Science Association (WPSA) UK branch; WPSA; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Allison Craig (AC) is a recipient of i-CASE PhD studentship from Biotechnology and Biological Sciences Research Council (BBSRC), Grant Number: BB/M016080/1, https://bbsrc.ukri.org.BBSRC provided support in the form of salaries for authors [AC only], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. SRUC receives funding from the Scottish government (RESAS). SRUC provided support in the form of authors salaries (OO, FK and AC) and provided research materials. This work forms part of AC PhD project with OO and FK as primary supervisors. As such OO, FK and AC had additional roles in study design, data collection and analysis, decision to publish and the preparation of the manuscript. Allison Craig (AC) received a research award from World Poultry Science Association (WPSA) UK branch which was put towards the %G +C profiling work in this paper, http://www.wpsauk.com/.WPSA provided support in the form of a study grant but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders mentioned up to this point had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MR Bedford is an employee of AB Vista, the manufacturer of the enzymes used in this study. AB Vista provided the enzymes used in this work. As one of the authors MB had influence over the study design and analysis, however, MB had a smaller role to play in the decision to publish or preparation of the manuscript.; The authors acknowledge the staff and students at the Monogastric Science Research Centre, Ayr for all of their help and support.; Allison Craig is a recipient of i-CASE PhD studentship from Biotechnology and Biological Sciences Research Council (BBSRC). Allison Craig also received a research award from WPSA. SRUC receives funding from the Scottish government (RESAS).	Apajalahti J, 2004, WORLD POULTRY SCI J, V60, P223, DOI 10.1079/WPS200415; Apajalahti JHA, 1998, APPL ENVIRON MICROB, V64, P4084; Beeson L.A., 2017, THESIS; Bjerrum L, 2006, POULTRY SCI, V85, P1151, DOI 10.1093/ps/85.7.1151; Bozkurt M, 2014, POULTRY SCI, V93, P389, DOI 10.3382/ps.2013-03368; Chand N, 2016, ENVIRON SCI POLLUT R, V23, P14414, DOI 10.1007/s11356-016-6600-x; Choct M, 2004, BRIT J NUTR, V92, P53, DOI 10.1079/BJN20041166; Choct M., 1997, FEED MILLING INT, V191, P13; Cowieson AJ, 2016, ANIM PROD SCI, V56, P2014, DOI 10.1071/AN15199; Cox CM, 2010, POULTRY SCI, V89, P2597, DOI 10.3382/ps.2010-00987; Crittenden R, 2002, J SCI FOOD AGR, V82, P781, DOI 10.1002/jsfa.1095; Elmusharaf MA, 2007, ANIM FEED SCI TECH, V134, P347, DOI 10.1016/j.anifeedsci.2006.11.022; ENGLYST HN, 1994, ANALYST, V119, P1497, DOI 10.1039/an9941901497; Gabriel I, 2006, WORLD POULTRY SCI J, V62, P499, DOI 10.1017/S0043933906001115; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gonzalez-Ortiz G, 2017, POULTRY SCI, V96, P2776, DOI 10.3382/ps/pex092; Hauck R, 2017, AVIAN DIS, V61, P428, DOI 10.1637/11675-051917-review.1; Henningsson A., 2001, Scandinavian Journal of Nutrition/Naringsforskning, V45, P165; Jia W, 2009, CAN J ANIM SCI, V89, P369, DOI 10.4141/CJAS09017; Kiarie E, 2007, J ANIM SCI, V85, P2982, DOI 10.2527/jas.2006-481; Knudsen KEB, 2014, POULTRY SCI, V93, P2380, DOI 10.3382/ps.2014-03902; Lee SA, 2017, ANIM FEED SCI TECH, V234, P29, DOI 10.1016/j.anifeedsci.2017.07.017; Lee S.A., 2017, J WORLDS POULTRY RES, V7, P35; Masey-O'Neill HV, 2014, BRIT POULTRY SCI, V55, P351, DOI 10.1080/00071668.2014.898836; Mathlouthi N, 2002, ANIM RES, V51, P395, DOI 10.1051/animres:2002034; Munyaka PM, 2016, POULTRY SCI, V95, P528, DOI 10.3382/ps/pev333; Olukosi OA, 2015, POULTRY SCI, V94, P2662, DOI 10.3382/ps/pev260; Olukosi OA, 2017, ANIM FEED SCI TECH, V231, P111, DOI 10.1016/j.anifeedsci.2017.06.010; Onrust L, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00075; Peek HW, 2003, AVIAN PATHOL, V32, P391, DOI 10.1080/0307945031000121149; Ribeiro T, 2018, POULTRY SCI, V97, P4330, DOI 10.3382/ps/pey336; Rinttila T, 2013, J APPL POULTRY RES, V22, P647, DOI 10.3382/japr.2013-00742; Ritzi MM, 2016, VET RES, V47, DOI 10.1186/s13567-016-0397-y; Short FJ, 1996, ANIM FEED SCI TECH, V59, P215, DOI 10.1016/0377-8401(95)00916-7; Sumners LH, 2011, EXP PARASITOL, V127, P714, DOI 10.1016/j.exppara.2010.12.002	35	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229281	10.1371/journal.pone.0229281	http://dx.doi.org/10.1371/journal.pone.0229281			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092087	Green Accepted, gold, Green Published			2022-12-26	WOS:000535229300042
J	Mouhajir, A; Poirier, W; Angebault, C; Rahal, E; Bouabid, R; Bougnoux, ME; Kobi, A; Zouhair, R; Bouchara, JP; Giraud, S				Mouhajir, Abdelmounaim; Poirier, Wilfried; Angebault, Cecile; Rahal, Elkahkahi; Bouabid, Rachid; Bougnoux, Marie-Elisabeth; Kobi, Abdessamad; Zouhair, Rachid; Bouchara, Jean-Philippe; Giraud, Sandrine			Scedosporium species in soils from various biomes in Northwestern Morocco	PLOS ONE			English	Article							APIOSPERMUM INFECTION; PSEUDALLESCHERIA; ECOLOGY	Scedosporium species are opportunistic pathogens causing various infections, including disseminated infections in severely immunocompromised patients. Preventive measures aiming to reduce the risk of exposure to these fungi require a better knowledge on their ecology and on the sources of contamination of the patients. In this context, 99 soil samples from the Rabat-Sale-Kenitra and Fez-Meknes regions in Morocco were analyzed. Samples were inoculated on the highly selective Scedo-Select III culture medium, and seven chemical parameters of the soils were measured. Scedosporium species were detected in 48 of the samples, with the highest density in soils from wastewater treatment plants and landfills, followed by those from roadsides and polluted riverbanks, thus confirming the impact of human activities on their ecology. Scedosporium apiospermum was the most common species, followed by S. boydii and S. aurantiacum. Analysis of the chemical parameters of the soils revealed the presence of Scedosporium species was mainly associated with a moderate electrical conductivity, a pH range of 7.0 to 7.6, a nutrient-rich content and a moderate phosphorus amount. Thereby, these results demonstrated the relatively high occurrence of Scedosporium in Morocco and highlighted the impact of phosphorus content on their ecology.	[Mouhajir, Abdelmounaim; Poirier, Wilfried; Zouhair, Rachid; Bouchara, Jean-Philippe; Giraud, Sandrine] UNIV Angers, UNIV Brest, Grp Etud Interact Hote Pathogene EA 3142, Angers, France; [Mouhajir, Abdelmounaim; Rahal, Elkahkahi; Zouhair, Rachid] Univ Moulay Ismail, Fac Sci, Dept Biol, Meknes, Morocco; [Angebault, Cecile; Bougnoux, Marie-Elisabeth] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Serv Microbiol, Paris, France; [Bouabid, Rachid] Ecole Natl Agr Meknes, Dept Soil Sci, Meknes, Morocco; [Kobi, Abdessamad] Univ Angers, Lab Surete Fonctionnement Qualite & Org EA 3858, Angers, France; [Bouchara, Jean-Philippe] CHU, Lab Parasitol Mycol, Angers, France	Universite d'Angers; Universite de Bretagne Occidentale; Moulay Ismail University of Meknes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Moulay Ismail University of Meknes; Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Giraud, S (corresponding author), UNIV Angers, UNIV Brest, Grp Etud Interact Hote Pathogene EA 3142, Angers, France.	sandrine.giraud@univ-angers.fr		Poirier, Wilfried/0000-0002-2687-3032; Mouhajir, Abdelmounaim/0000-0002-3170-4057				Abdallaoui MS, 2007, J MYCOL MED, V17, P58, DOI 10.1016/j.mycmed.2006.12.001; Al-Yasiri MH, 2017, MYCOSES, V60, P477, DOI 10.1111/myc.12612; Alastruey-Izquierdo A, 2007, ANTIMICROB AGENTS CH, V51, P748, DOI 10.1128/AAC.01177-06; Alvarez E, 2016, REV IBEROAM MICOL, V33, P224, DOI 10.1016/j.riam.2016.03.007; [Anonymous], 1983, SOLS IRRIGABLES ETUD; Castiglioni B, 2002, MEDICINE, V81, P333, DOI 10.1097/00005792-200209000-00001; Claussen M, 1998, RES MICROBIOL, V149, P399, DOI 10.1016/S0923-2508(98)80322-7; Cortez KJ, 2008, CLIN MICROBIOL REV, V21, P157, DOI 10.1128/CMR.00039-07; Crous PW, 2016, PERSOONIA, V37, P218, DOI 10.3767/003158516X694499; DAVIES IS, 1973, CAN J MICROBIOL, V19, P81, DOI 10.1139/m73-012; De Hoog G. S., 2000, ATLAS CLIN FUNGI; Elizondo-Zertuche M, 2017, MYCOLOGIA, V109, P874, DOI 10.1080/00275514.2017.1416260; European Commission, 2000, DIRECTIVE 200060EC E, P327; Giraud S, 2014, CURR FUNGAL INFECT R, V8, P211, DOI 10.1007/s12281-014-0192-z; Guarro J, 2006, MED MYCOL, V44, P295, DOI 10.1080/13693780600752507; Hallouti A, 2017, J PHARM PHARMACOL, P5, DOI [10.17265/2328-2150/2017.010.007, DOI 10.17265/2328-2150/2017.010.007]; Harun A, 2010, MED MYCOL, V48, pS70, DOI 10.3109/13693786.2010.515254; Janda-Ulfig K, 2008, ANN AGR ENV MED, V15, P45; Kaltseis J, 2009, MED MYCOL, V47, P398, DOI 10.1080/13693780802585317; Lackner M, 2014, FUNGAL DIVERS, V67, P1, DOI 10.1007/s13225-014-0295-4; Lamas F, 2005, ENG GEOL, V81, P32, DOI 10.1016/j.enggeo.2005.07.005; Luong ML, 2010, CURR OPIN INFECT DIS, V23, P578, DOI 10.1097/QCO.0b013e32833f9f93; Luplertlop N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159869; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Morio F, 2010, J CLIN MICROBIOL, V48, P1978, DOI 10.1128/JCM.01840-09; Nweze EI, 2010, ACTA MICROBIOL IMM H, V57, P209, DOI 10.1556/AMicr.57.2010.3.5; Rainer J, 2008, ANTON LEEUW INT J G, V93, P315, DOI 10.1007/s10482-007-9206-y; Ramirez-Garcia A, 2018, MED MYCOL, V56, pS102, DOI 10.1093/mmy/myx113; Rott E, 2018, SCI TOTAL ENVIRON, V615, P1176, DOI 10.1016/j.scitotenv.2017.09.223; Rougeron A, 2018, MYCOPATHOLOGIA, V183, P185, DOI 10.1007/s11046-017-0200-2; Rougeron A, 2015, ENVIRON MICROBIOL, V17, P1039, DOI 10.1111/1462-2920.12472; Ryan J., 2001, SOIL PLANT ANAL LAB, Vsecond; Sitterle E, 2014, CLIN MICROBIOL INFEC, V20, P929, DOI 10.1111/1469-0691.12574; Skinner K, 2009, APPL ENVIRON MICROB, V75, P5514, DOI 10.1128/AEM.00078-09; Symoens F, 2006, J HEART LUNG TRANSPL, V25, P603, DOI 10.1016/j.healun.2005.12.011; Tigini V, 2014, SCI TOTAL ENVIRON, V487, P335, DOI 10.1016/j.scitotenv.2014.04.026; Pham T, 2015, MED MYCOL, V53, P512, DOI 10.1093/mmy/myv015; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003	38	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0228897	10.1371/journal.pone.0228897	http://dx.doi.org/10.1371/journal.pone.0228897			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092070	Green Published, Green Submitted, gold			2022-12-26	WOS:000535229300017
J	Bienemann, B; Ruschel, NS; Campos, ML; Negreiros, MA; Mograbi, DC				Bienemann, Bheatrix; Ruschel, Nina Stamato; Campos, Maria Luiza; Negreiros, Marco Aurelio; Mograbi, Daniel C.			Self-reported negative outcomes of psilocybin users: A quantitative textual analysis	PLOS ONE			English	Article							CHALLENGING EXPERIENCES; PSYCHEDELICS	Psilocybin, a substance mainly found in mushrooms of the genus psilocybe, has been historically used for ritualistic, recreational and, more recently, medicinal purposes. The scientific literature suggests low toxicity, low risk of addiction, overdose, or other causes of injury commonly caused by substances of abuse, with growing interest in the use of this substance for conditions such as treatment-resistant depression. However, the presence of negative outcomes linked to psilocybin use is not clear yet. The objective of this study is to investigate the negative effects of psilocybin consumption, according to the users' own perception through self-reports extracted from an online platform. 346 reports were analyzed with the assistance of the IRAMUTEQ textual analysis software, adopting the procedures of Descending Hierarchical Classification, Correspondence Factor Analysis and Specificities Analysis. The text segments were grouped in 4 main clusters, describing thinking distortions, emergencies, perceptual alterations and the administration of the substance. Bad trips were more frequent in female users, being associated with thinking distortions. The use of multiple doses of psilocybin in the same session or its combination with other substances was linked to the occurrence of long-term negative outcomes, while the use of mushrooms in single high doses was linked to medical emergencies. These results can be useful for a better understanding of the effects of psilocybin use, guiding harm-reduction initiatives.	[Bienemann, Bheatrix; Ruschel, Nina Stamato; Campos, Maria Luiza; Negreiros, Marco Aurelio; Mograbi, Daniel C.] Pontificia Univ Catolica, Dept Psychol, Sao Paulo, Brazil; [Mograbi, Daniel C.] Kings Coll London, Dept Psychol, Inst Psychiat Psychol & Neurosci, London, England	Pontificia Universidade Catolica de Sao Paulo; University of London; King's College London	Mograbi, DC (corresponding author), Pontificia Univ Catolica, Dept Psychol, Sao Paulo, Brazil.; Mograbi, DC (corresponding author), Kings Coll London, Dept Psychol, Inst Psychiat Psychol & Neurosci, London, England.	daniel.mograbi@kcl.ac.uk	Bienemann, Bheatrix/AAX-2330-2020	Bienemann, Bheatrix/0000-0003-4291-4612; Mograbi, Daniel/0000-0002-4271-2984	National Research Council (CNPq) [312370]; Carlos Chagas Filho Research Support Foundation (FAPERJ) [226501]	National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Research Support Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	D.C.M. acknowledges funding from the National Research Council (CNPq ref 312370) and the Carlos Chagas Filho Research Support Foundation (FAPERJ ref 226501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett FS, 2016, J PSYCHOPHARMACOL, V30, P1279, DOI 10.1177/0269881116678781; BENJAMIN C, 1979, BRIT MED J, V1, P1319, DOI 10.1136/bmj.1.6174.1319; Bogenschutz MP, 2018, CURR TOP BEHAV NEURO, V36, P361, DOI 10.1007/7854_2016_464; Carbonaro TM, 2016, J PSYCHOPHARMACOL, V30, P1268, DOI 10.1177/0269881116662634; Carhart-Harris RL, 2016, LANCET PSYCHIAT, V3, P619, DOI 10.1016/S2215-0366(16)30065-7; dos Santos RG, 2018, EXPERT REV CLIN PHAR, V11, P889, DOI 10.1080/17512433.2018.1511424; dos Santos RG, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2288-z; Edelson E., 2017, THESIS; EMCDDA & EUROPOL, 2019, EMCDDA PAPERS; EROWID, ER EXP VAULTS; FISCHER R, 1969, EXPERIENTIA, V25, P166, DOI 10.1007/BF01899102; GDS, 2019, GLOB DRUG SURV 2019; GDS, 2017, GLOB DRUG SURV 2017; Johansen PO, 2015, J PSYCHOPHARMACOL, V29, P270, DOI 10.1177/0269881114568039; Johnson MW, 2008, J PSYCHOPHARMACOL, V22, P603, DOI 10.1177/0269881108093587; Johnson MW, 2018, NEUROPHARMACOLOGY, V142, P143, DOI 10.1016/j.neuropharm.2018.05.012; Johnson MW, 2017, NEUROTHERAPEUTICS, V14, P734, DOI 10.1007/s13311-017-0542-y; Kim Hae-Young, 2017, Restor Dent Endod, V42, P152, DOI 10.5395/rde.2017.42.2.152; Krebs TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063972; Linszen M, 2018, EUR NEUROPSYCHOPHARM, V28, pS80, DOI 10.1016/j.euroneuro.2017.12.114; Loubere L, DOCUMENTATION IRAMUT; Moreton SG, 2020, PSYCHOPHARMACOLOGY, V237, P21, DOI 10.1007/s00213-019-05391-0; Nour MM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00269; Nutt D, 2019, DIALOGUES CLIN NEURO, V21, P139, DOI 10.31887/DCNS.2019.21.2/dnutt; Oss OT., 1993, PSILOCYBIN MAGIC MUS, V2nd; Ratinaud P., 2012, ACTES 11EME JOURNEES, P835; Rucker JJH, 2016, J PSYCHOPHARMACOL, V30, P1220, DOI 10.1177/0269881116679368; Satora Leszek, 2005, Przegl Lek, V62, P394; Schenberg EE, 2018, FRONT PHARMACOL, V9, P1; Sellers EM, 2017, CLIN PHARMACOL THER, V102, P580, DOI 10.1002/cpt.697; Shalit N, 2019, ADDICT BEHAV, V89, P35, DOI 10.1016/j.addbeh.2018.09.020; Statistics BT, 2019, BOOKLET NO 9 MACHINE, V9, P1, DOI [10.18356/a4dd519a-en, DOI 10.18356/A4DD519A-EN]; Studerus E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030800; Studerus E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012412; Thomas K, 2017, J PSYCHOACTIVE DRUGS, V49, P446, DOI 10.1080/02791072.2017.1320734; van Amsterdam J, 2011, REGUL TOXICOL PHARM, V59, P423, DOI 10.1016/j.yrtph.2011.01.006; Wightman RS, 2017, SUBST USE MISUSE, V52, P1315, DOI 10.1080/10826084.2016.1276600	37	9	9	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229067	10.1371/journal.pone.0229067	http://dx.doi.org/10.1371/journal.pone.0229067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8DJ	32084160	Green Published, gold			2022-12-26	WOS:000535227900046
J	Bradshaw, TM; Blake-Bradshaw, AG; Fournier, AMV; Lancaster, JD; O'Connell, J; Jacques, CN; Eichholz, MW; Hagy, HM				Bradshaw, Therin M.; Blake-Bradshaw, Abigail G.; Fournier, Auriel M., V; Lancaster, Joseph D.; O'Connell, John; Jacques, Christopher N.; Eichholz, Michael W.; Hagy, Heath M.			Marsh bird occupancy of wetlands managed for waterfowl in the Midwestern USA	PLOS ONE			English	Article							HABITAT ASSOCIATIONS; PORZANA-CAROLINA; BREEDING ECOLOGY; SORA; CONSERVATION; COMMUNITIES; INDICATORS; INTEGRITY; ABUNDANCE; RAIL	Marsh birds (rallids, bitterns, and grebes) depend on emergent wetlands, and habitat loss and degradation are the primary suspected causes for population declines among many marsh bird species. We evaluated the effect of natural wetland characteristics, wetland management practices, and surrounding landscape characteristics on marsh bird occupancy in Illinois during late spring and early summer 2015-2017. We conducted call-back surveys following the North American Standardized Marsh Bird Survey Protocol three times annually at all sites (2015 n = 49, 2016 n = 57, 2017 n = 55). Across all species and groups, detection probability declined 7.1% +/- 2.1 each week during the marsh bird survey period. Wetlands managed for waterfowl (ducks, geese, and swans) had greater occupancy than reference wetlands. Marsh bird occupancy increased with greater wetland complexity, intermediate levels of waterfowl management intensity, greater proportions of surface water inundation, and greater proportions of persistent emergent vegetation cover. Wetland management practices that retain surface water during the growing season, encourage perennial emergent plants (e.g., Typha sp.), and increase wetland complexity could be used to provide habitat suitable for waterfowl and marsh birds.	[Bradshaw, Therin M.; Jacques, Christopher N.] Western Illinois Univ, Dept Biol Sci, Macomb, IL 61455 USA; [Blake-Bradshaw, Abigail G.] Univ Illinois, Prairie Res Inst, Havana, IL USA; [Fournier, Auriel M., V; Lancaster, Joseph D.; Hagy, Heath M.] Univ Illinois, Illinois Nat Hist Survey, Stephen A Forbes Biol Stn, Havana, IL 62644 USA; [O'Connell, John; Eichholz, Michael W.] Southern Illinois Univ, Ctr Ecol, Dept Zool, Cooperat Wildlife Res Lab, Carbondale, IL USA; [Blake-Bradshaw, Abigail G.] Tennessee Technol Univ, Cookeville, TN USA; [Lancaster, Joseph D.] Gulf Coast Joint Venture, Lafayette, LA USA; [Hagy, Heath M.] US Fish & Wildlife Serv, Stanton, TN USA	Western Illinois University; University of Illinois System; Illinois Natural History Survey; University of Illinois System; Southern Illinois University System; Southern Illinois University; Tennessee Technological University; United States Department of the Interior; US Fish & Wildlife Service	Fournier, AMV (corresponding author), Univ Illinois, Illinois Nat Hist Survey, Stephen A Forbes Biol Stn, Havana, IL 62644 USA.	auriel@illinois.edu		Fournier, Auriel M.V./0000-0002-8530-9968	U.S Fish and Wildlife Service	U.S Fish and Wildlife Service(US Fish & Wildlife Service)	HH received #F14AP00485 from the U.S Fish and Wildlife Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 2019, WETL ECOL MANAG, V27, P283, DOI 10.1007/s11273-019-09659-2; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], BIRDS N AM; Blake-Bradshaw A. G., 2018, WETLAND SUITABILITY; Bolenbaugh JR, 2011, J FISH WILDL MANAG, V2, P49, DOI 10.3996/012011-JFWM-001; Bowyer MW, 2005, AM MIDL NAT, V154, P331, DOI 10.1674/0003-0031(2005)154[0331:MPSPFW]2.0.CO;2; Bradshaw TM, 2020, MARSH BIRD OCCUPANCY, DOI [10.13012/B2IDB-5152821_V1, DOI 10.13012/B2IDB-5152821_V1]; Brazner JC, 2007, ECOL INDIC, V7, P610, DOI 10.1016/j.ecolind.2006.07.001; BROWN M, 1986, J WILDLIFE MANAGE, V50, P392, DOI 10.2307/3801093; BROWN M, 1988, OECOLOGIA, V75, P426, DOI 10.1007/BF00376947; Burnham KP, 2003, MODEL SELECTION MULT; Conway CJ, 2005, AUK, V122, P26, DOI 10.1642/0004-8038(2005)122[0026:EOCSFM]2.0.CO;2; CONWAY CJ, 1994, WILSON BULL, V106, P466; Conway CJ, 2011, WATERBIRDS, V34, P319, DOI 10.1675/063.034.0307; CRAIG RJ, 1992, WILSON BULL, V104, P295; Craig RJ, 2008, J FIELD ORNITHOL, V79, P269, DOI 10.1111/j.1557-9263.2008.00173.x; CROONQUIST MJ, 1991, ENVIRON MANAGE, V15, P701, DOI 10.1007/BF02589628; Darrah AJ, 2010, WATERBIRDS, V33, P367, DOI 10.1675/063.033.0314; De Steven D, 2012, WETLANDS, V32, P593, DOI 10.1007/s13157-012-0303-y; DeLuca WV, 2004, WETLANDS, V24, P837, DOI 10.1672/0277-5212(2004)024[0837:IOLUOT]2.0.CO;2; Denes FV, 2015, METHODS ECOL EVOL, V6, P543, DOI 10.1111/2041-210X.12333; EDDLEMAN WR, 1988, WILSON BULL, V100, P458; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fournier A. M. V., 2015, WATERBIRDS, V38, P312, DOI DOI 10.1675/063.038.0313; Fournier AMV, 2019, WATERBIRDS, V42, P168, DOI 10.1675/063.042.0203; Fournier Auriel M.V., 2017, Animal Migration, V4, P15; Fournier AMV, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171664; Fredrickson LH, 1982, MANAGEMENT SEASONALL, P3; GIBBS JP, 1991, J FIELD ORNITHOL, V62, P509; Gray MJ, 2013, MANAGEMENT WETLANDS, P121, DOI [10.1007/978-94-007-6907-6_4, DOI 10.1007/978-94-007-6907-6_4]; GROVER AM, 1995, WETLANDS, V15, P108, DOI 10.1007/BF03160664; Harms TM, 2013, WETLANDS, V33, P561, DOI 10.1007/s13157-013-0414-0; Harms TM, 2012, WATERBIRDS, V35, P208, DOI 10.1675/063.035.0203; Havera SP, 1999, ILLINOIS NATURAL HIS; Hill EB, 2015, LINKING WETLAND MANA; Hine CS, 2017, HYDROBIOLOGIA, V804, P59, DOI 10.1007/s10750-016-2893-5; HORAK GJ, 1970, WILSON BULL, V82, P206; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Johnson DH, 2009, WATERBIRDS, V32, P203, DOI 10.1675/063.032.0201; KAUFMANN GW, 1989, CAN FIELD NAT, V103, P270; Kendall WL, 2009, J APPL ECOL, V46, P1182, DOI 10.1111/j.1365-2664.2009.01732.x; Kroll AJ, 2010, J WILDLIFE MANAGE, V74, P1264, DOI 10.2193/2009-429; Lemke HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079209; Lor S, 2002, WILDLIFE SOC B, V30, P1195; Lor S, 2006, WATERBIRDS, V29, P427, DOI 10.1675/1524-4695(2006)29[427:BEANHA]2.0.CO;2; Lyons JE, 2008, J WILDLIFE MANAGE, V72, P1683, DOI 10.2193/2008-141; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McClain SE, 2019, RESTOR ECOL, V27, P168, DOI 10.1111/rec.12818; Muller M. J., 1999, BIRDS N AM, DOI [10.2173/bna.410, DOI 10.2173/BNA.410]; Neyman J, 1934, J R STAT SOC, V97, P558, DOI 10.2307/2342192; Poole AF, 2005, BIRDS N AM ONLINE, DOI [10.2173/bna.3, DOI 10.2173/BNA.3]; Rehm EM, 2007, WILSON J ORNITHOL, V119, P648, DOI 10.1676/06-060.1; Reid FA, 1989, DIFFERENTIAL HABTIAT; SAYRE MW, 1984, J WILDLIFE MANAGE, V48, P599, DOI 10.2307/3801198; Smith LA, 2010, ENVIRON MANAGE, V45, P1040, DOI 10.1007/s00267-010-9475-5; Srivathsa A, 2018, J APPL ECOL, V55, P754, DOI 10.1111/1365-2664.13005; Stafford JD, 2011, J FISH WILDL MANAG, V2, P3, DOI 10.3996/092010-JFWM-034; Stapanian MA, 2004, HYDROBIOLOGIA, V520, P119, DOI 10.1023/B:HYDR.0000027731.16535.53; Theobald DM, 2007, ENVIRON MANAGE, V40, P134, DOI 10.1007/s00267-005-0199-x; Tiner RW, 1984, WETLANDS US CURRENT, P1; Tozer DC, 2018, J ENVIRON MANAGE, V212, P160, DOI 10.1016/j.jenvman.2018.01.055; Weller M.W., 1965, 43 IOW STAT U AM US	62	7	7	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0228980	10.1371/journal.pone.0228980	http://dx.doi.org/10.1371/journal.pone.0228980			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084190	gold, Green Published, Green Submitted			2022-12-26	WOS:000535227900040
J	Cheng, M; Kato, M; Saunders, JA; Tseng, CH				Cheng, Miao; Kato, Masaharu; Saunders, Jeffrey Allen; Tseng, Chia-huei			Paired walkers with better first impression synchronize better	PLOS ONE			English	Article							INTERPERSONAL COORDINATION; MIMICRY; CONVERGENCE; ADOLESCENCE; MECHANISMS; DYNAMICS; IMPACT; TRUST; AGE	This study measured automatic walking synchronization and how it associates with social impression. Previous studies discovered positive social consequence of motor synchrony with ecological paradigms (e.g. body movement synchrony between therapists and patients in clinical sessions, and the synchrony of side-by-side walkers). However, most studies of joint movement with high ecological validity face the same challenge, namely that conversations between participants might be the main or a partial contributor to the observed social benefits, as conversation is well documented to promote understanding and motor synchronization. We addressed this issue by using a novel paradigm to remove the conversation component and examined how synchrony per se interacted with social impression. Participants were paired to walk side by side in silence (i.e. without conversation) and their social impression toward each other was rated before/after the paired walk. Our results showed that walkers' first impression was positively associated with their step synchronization rate in the silent paired walk. Together with past findings, the bi-directional relation between body entrainment and social functions suggests that implicit nonverbal communication plays a significant role in providing a basis for interpersonal interaction.	[Cheng, Miao] NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan; [Cheng, Miao; Saunders, Jeffrey Allen] Univ Hong Kong, Dept Psychol, Hong Kong, Peoples R China; [Kato, Masaharu] Doshisha Univ, Ctr Baby Sci, Kyoto, Japan; [Tseng, Chia-huei] Tohoku Univ, Res Inst Elect Commun, Sendai, Miyagi, Japan	Nippon Telegraph & Telephone Corporation; University of Hong Kong; Doshisha University; Tohoku University	Tseng, CH (corresponding author), Tohoku Univ, Res Inst Elect Commun, Sendai, Miyagi, Japan.	CH_Tseng@alumni.uci.edu	/D-4927-2009	/0000-0003-4694-7526; Cheng, Miao/0000-0003-0611-6170	Cooperative Research Project Program from Research Institute of Electrical Communication at Tohoku University, Tohoku University Center for Gender Equality Promotion (TUMUG) [18H04180]	Cooperative Research Project Program from Research Institute of Electrical Communication at Tohoku University, Tohoku University Center for Gender Equality Promotion (TUMUG)	Tseng is supported by the Cooperative Research Project Program from Research Institute of Electrical Communication at Tohoku University, Tohoku University Center for Gender Equality Promotion (TUMUG), and Grant-in-Aid for Scientific Research on Innovative Areas (No. 18H04180) "Construction of the Face-Body Studies in Transcultural Conditions". These funders do not play any role in the study design, data collection and analysis, decision to publish, preparation of the manuscript, or alter our adherence to PLOS ONE policies on sharing data and materials. NTT corporation provided support in the form of salaries for author MC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Agarwal R, 2000, MIS QUART, V24, P665, DOI 10.2307/3250951; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; Byrne D., 1971, ATTRACTION PARADIGM, V1st ed.; Chartrand TL, 2013, ANNU REV PSYCHOL, V64, P285, DOI 10.1146/annurev-psych-113011-143754; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cheng M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184083; Cornejo C, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01546; Duffy KA, 2015, CURR OPIN BEHAV SCI, V3, P112, DOI 10.1016/j.cobeha.2015.03.002; Eisenberg N, 2005, J RES ADOLESCENCE, V15, P235, DOI 10.1111/j.1532-7795.2005.00095.x; Eisenberg N, 2002, J PERS SOC PSYCHOL, V82, P993, DOI 10.1037//0022-3514.82.6.993; Endedijk HM, 2015, DEV PSYCHOL, V51, P714, DOI 10.1037/a0038980; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; Evans KR, 2000, J ACAD MARKET SCI, V28, P512, DOI 10.1177/0092070300284004; Farley SD, 2014, J NONVERBAL BEHAV, V38, P195, DOI 10.1007/s10919-014-0174-4; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feldman R, 2007, AM J ORTHOPSYCHIAT, V77, P582, DOI 10.1037/0002-9432.77.4.582; Garcia L. J., 1996, CANADIAN J SPEECH LA, V20, P123; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Kashino Makio, 2016, HUMAN HARMONIZED INF, V1, P271, DOI [10.1007/978-4-431-55867-5_10, DOI 10.1007/978-4-431-55867-5_10]; Kato M, 2015, 6 BIANN JOINT ACT M; Kokal I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027272; Koole SL, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00862; Krishnan-Barman S, 2017, NEUROPSYCHOLOGIA, V105, P101, DOI 10.1016/j.neuropsychologia.2017.01.018; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Launay J, 2013, EXP PSYCHOL, V60, P53, DOI 10.1027/1618-3169/a000173; Lopes VP, 2011, SCAND J MED SCI SPOR, V21, P663, DOI 10.1111/j.1600-0838.2009.01027.x; Lubans DR, 2010, SPORTS MED, V40, P1019, DOI 10.2165/11536850-000000000-00000; Lumsden J, 2012, J EXP SOC PSYCHOL, V48, P746, DOI 10.1016/j.jesp.2011.12.007; Manson JH, 2013, EVOL HUM BEHAV, V34, P419, DOI 10.1016/j.evolhumbehav.2013.08.001; Miles LK, 2011, EXP BRAIN RES, V211, P495, DOI 10.1007/s00221-011-2641-z; Miles LK, 2010, EUR J SOC PSYCHOL, V40, P52, DOI 10.1002/ejsp.721; Nessler JA, 2009, HUM MOVEMENT SCI, V28, P772, DOI 10.1016/j.humov.2009.04.007; Park JL, 2016, NEUROIMAGE, V139, P8, DOI 10.1016/j.neuroimage.2016.06.013; Paxton A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01135; Paxton A, 2013, Q J EXP PSYCHOL, V66, P2092, DOI 10.1080/17470218.2013.853089; Ramseyer F, 2011, J CONSULT CLIN PSYCH, V79, P284, DOI 10.1037/a0023419; Reddish P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071182; Reddish P, 2014, RELIG BRAIN BEHAV, V4, P3, DOI 10.1080/2153599X.2013.764545; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Satta E, 2017, NEUROPSYCHOLOGIA, V105, P111, DOI 10.1016/j.neuropsychologia.2017.04.027; Schilbach L, 2013, BEHAV BRAIN SCI, V36, P393, DOI 10.1017/S0140525X12000660; Schmidt RC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00633; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Seitz AR, 2003, NATURE, V422, P36, DOI 10.1038/422036a; Stel M, 2008, EUR J SOC PSYCHOL, V38, P965, DOI 10.1002/ejsp.472; STEVENS CK, 1995, J APPL PSYCHOL, V80, P587, DOI 10.1037/0021-9010.80.5.587; STREET RL, 1984, HUM COMMUN RES, V11, P139, DOI 10.1111/j.1468-2958.1984.tb00043.x; Swider BW, 2011, J APPL PSYCHOL, V96, P1275, DOI 10.1037/a0024005; TRONICK EZ, 1989, CHILD DEV, V60, P85, DOI 10.2307/1131074; Tschacher W, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01323; Valdesolo P, 2011, EMOTION, V11, P262, DOI 10.1037/a0021302; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; van Gaal S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00121; Wrotniak BH, 2006, PEDIATRICS, V118, pE1758, DOI 10.1542/peds.2006-0742; Xavier J, 2018, FRONT PSYCHOL, P9; Zhao Z, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01864; Zhao Z, 2015, HUM MOVEMENT SCI, V41, P240, DOI 10.1016/j.humov.2015.03.012	61	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0227880	10.1371/journal.pone.0227880	http://dx.doi.org/10.1371/journal.pone.0227880			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8DJ	32084136	gold, Green Published			2022-12-26	WOS:000535227900011
J	Mehtala, J; Zong, JH; Vassilev, Z; Brobert, G; Gabarro, MS; Stattin, P; Khanfir, LH				Mehtala, Juha; Zong, Jihong; Vassilev, Zdravko; Brobert, Gunnar; Gabarro, Montse Soriano; Stattin, Par; Khanfir, Houssem L.			Overall survival and second primary malignancies in men with metastatic prostate cancer	PLOS ONE			English	Article							SKELETAL COMPLICATIONS; DOCETAXEL; RADIOTHERAPY; ABIRATERONE; POPULATION; PREDNISONE; TRIALS; COHORT; IMPACT	Background Among prostate cancer (PC) patients, over 90% of distant metastases occur in the bone. PC treatments may be associated with side effects, including second primary malignancies (SPM). There is limited information on the incidence of SPM among men with bone metastatic PC (mPC) and among men with bone metastatic castration-resistant PC (mCRPC). We estimated overall survival and the incidence of SPM in men with mPC and mCRPC. Methods In the Prostate Cancer data Base Sweden, the National Prostate Cancer Register was linked to other national health care registers, 15,953 men with mPC in 1999-2011 were identified. Further, 693 men with mCRPC were identified. Outcomes were evaluated using stratified incidence rates, Kaplan-Meier estimators and Cox models. Results The mean age among men with mPC was 73.9 years and in men with mCRPC 70.0 years. The median respective survivals were 1.5 (13,965 deaths) and 1.14 years (599 deaths), and average times since PC diagnosis 1.8 and 4.7 years. We observed 2,669 SPMs in men with mPC and 100 SPMs in men with mCRPC. The incidence rate of SPM per 1,000 person-years was 81.8 (78.8-85.0) for mPC and 115.6 (95.1-140.7) for mCRPC. High age, prior neoplasms, urinary tract infection, congestive heart failure, diabetes and renal disease were most strongly associated with increased mortality risk. Prior neoplasms and prior use of antineoplastic agents were most strongly associated with increased SPM risk. Several factors associated with increased mortality and SPM risks were more prevalent in the mCRPC cohort. Conclusions Our results on mortality for men with mPC and mCRPC are in line with previous studies from the same time period. Investigation of factors associated with mortality and SPM in men with mPC and mCRPC can help to further understand these outcomes in the era prior to several new treatments have come available.	[Mehtala, Juha; Khanfir, Houssem L.] EPID Res, Espoo, Finland; [Zong, Jihong; Vassilev, Zdravko] Bayer LLC, Whippany, NJ USA; [Brobert, Gunnar] Bayer AB, Stockholm, Sweden; [Gabarro, Montse Soriano] Bayer AG, Berlin, Germany; [Stattin, Par] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden	Bayer AG; Bayer AG; Uppsala University	Mehtala, J (corresponding author), EPID Res, Espoo, Finland.	juha.mehtala@gmail.com			Bayer AG	Bayer AG(Bayer AG)	The study was initiated and funded by Bayer AG. ZV, JZ, GB and MSG are employed by Bayer. JM and HK are employees of EPID Research, a contract research organization that performs commissioned pharmacoepidemiologic studies in collaboration with several pharmaceutical companies. The funder provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Berruti A, 2005, BRIT J CANCER, V93, P633, DOI 10.1038/sj.bjc.6602767; Bournakis E, 2011, ANTICANCER RES, V31, P1475; Brenner DJ, 2006, INT J RADIAT ONCOL, V65, P637, DOI 10.1016/j.ijrobp.2006.02.044; CATALONA WJ, 1994, NEW ENGL J MED, V331, P996; Chin SN, 2010, CURR ONCOL, V17, P24; Dalesio O, 2000, LANCET, V355, P1491; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Engholm G., 2016, NORDCAN CANC INCIDEN; Hall EJ, 2012, RADIOBIOLOGY RADIOLO; Heidenreich A, 2008, EUR UROL, V53, P68, DOI 10.1016/j.eururo.2007.09.002; Hussain M, 2009, J CLIN ONCOL, V27, P2450, DOI 10.1200/JCO.2008.19.9810; Hwang SS, 2004, CANCER INVEST, V22, P849, DOI 10.1081/CNV-200039643; Inoue T, 2009, UROLOGY, V73, P1104, DOI 10.1016/j.urology.2008.07.062; James ND, 2015, EUR UROL, V67, P1028, DOI 10.1016/j.eururo.2014.09.032; Kirby M, 2011, INT J CLIN PRACT, V65, P1180, DOI 10.1111/j.1742-1241.2011.02799.x; Morris MJ, 2003, ONCOLOGIST, V8, P161, DOI 10.1634/theoncologist.8-2-161; Murray L, 2014, RADIOTHER ONCOL, V110, P213, DOI 10.1016/j.radonc.2013.12.012; Neugut AI, 1997, CANCER, V79, P1600, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1600::AID-CNCR24>3.0.CO;2-0; Norgaard M, 2010, J UROLOGY, V184, P162, DOI 10.1016/j.juro.2010.03.034; Oefelein MG, 2004, J UROLOGY, V171, P1525, DOI 10.1097/01.ju.0000118294.88852.cd; Parker C, 2013, NEW ENGL J MED, V369, P213, DOI 10.1056/NEJMoa1213755; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Soerdjbalie-Maikoe V, 2004, EUR J NUCL MED MOL I, V31, P958, DOI 10.1007/s00259-004-1479-z; Tangen Catherine M, 2003, Clin Prostate Cancer, V2, P41, DOI 10.3816/CGC.2003.n.011; TANNOCK I, 1989, J CLIN ONCOL, V7, P590, DOI 10.1200/JCO.1989.7.5.590; Van Hemelrijck M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102596; Van Hemelrijck M, 2013, INT J EPIDEMIOL, V42, P956, DOI 10.1093/ije/dys068; Van Hemelrijck M, 2012, CANCER-AM CANCER SOC, V118, P6207, DOI 10.1002/cncr.27672; Wallis CJD, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i851; Wirth MP, 2007, EUR UROL, V51, P306, DOI 10.1016/j.eururo.2006.08.043	33	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0227552	10.1371/journal.pone.0227552	http://dx.doi.org/10.1371/journal.pone.0227552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084147	Green Published, gold			2022-12-26	WOS:000535227900009
J	Morhayim, J; Ghebes, CA; Erkeland, SJ; ter Borg, MND; Hoogenboezem, RM; Bindels, EMJ; van Alphen, FPJ; Kassem, M; van Wijnen, AJ; Cornelissen, JJ; van Leeuwen, JP; van der Eerden, BCJ; Voermans, C; van de Peppel, J; Braakman, E				Morhayim, Jess; Ghebes, Corina A.; Erkeland, Stefan J.; ter Borg, Mariette N. D.; Hoogenboezem, Remco M.; Bindels, Eric M. J.; van Alphen, Floris P. J.; Kassem, Moustapha; van Wijnen, Andre J.; Cornelissen, Jan J.; van Leeuwen, Johannes P.; van der Eerden, Bram C. J.; Voermans, Carlijn; van de Peppel, Jeroen; Braakman, Eric			Identification of osteolineage cell-derived extracellular vesicle cargo implicated in hematopoietic support	FASEB JOURNAL			English	Article						bone; hematopoietic expansion; hematopoietic niche; intercellular communication	STEM-CELLS; VIVO EXPANSION; SELF-RENEWAL; ENGRAFTMENT; EXPRESSION; DIFFERENTIATION; TRANSPLANTATION; PROGENITORS; MICRORNAS; PROTEINS	Osteolineage cell-derived extracellular vesicles (EVs) play a regulatory role in hematopoiesis and have been shown to promote the ex vivo expansion of human hematopoietic stem and progenitor cells (HSPCs). Here, we demonstrate that EVs from different human osteolineage sources do not have the same HSPC expansion promoting potential. Comparison of stimulatory and non-stimulatory osteolineage EVs by next-generation sequencing and mass spectrometry analyses revealed distinct microRNA and protein signatures identifying EV-derived candidate regulators of ex vivo HSPC expansion. Accordingly, the treatment of umbilical cord blood-derived CD34(+) HSPCs with stimulatory EVs-altered HSPC transcriptome, including genes with known roles in cell proliferation. An integrative bioinformatics approach, which connects the HSPC gene expression data with the candidate cargo in stimulatory EVs, delineated the potentially targeted biological functions and pathways during hematopoietic cell expansion and development. In conclusion, our study gives novel insights into the complex biological role of EVs in osteolineage cell-HSPC crosstalk and promotes the utility of EVs and their cargo as therapeutic agents in regenerative medicine.	[Morhayim, Jess; ter Borg, Mariette N. D.; Hoogenboezem, Remco M.; Bindels, Eric M. J.; Cornelissen, Jan J.; Braakman, Eric] Erasmus MC, Dept Hematol, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands; [Ghebes, Corina A.; van Alphen, Floris P. J.; Voermans, Carlijn] Sanquin Res, Amsterdam, Netherlands; [Erkeland, Stefan J.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Kassem, Moustapha] Odense Univ Hosp, Dept Endocrinol, Odense, Denmark; [van Wijnen, Andre J.] Mayo Clin, Dept Orthped Surg, Rochester, MN USA; [van Leeuwen, Johannes P.; van der Eerden, Bram C. J.; van de Peppel, Jeroen] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Southern Denmark; Odense University Hospital; Mayo Clinic; Erasmus University Rotterdam; Erasmus MC	Braakman, E (corresponding author), Erasmus MC, Dept Hematol, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.	e.braakman@erasmusmc.nl	van Wijnen, Andre J./AAG-3578-2019; van de Peppel, Jeroen/K-6683-2019; van der Eerden, Bram CJ/I-7496-2012; Voermans, Carlijn/GPP-3405-2022; van Leeuwen, Johannes/D-5015-2014	van Wijnen, Andre J./0000-0002-4458-0946; van de Peppel, Jeroen/0000-0002-6524-727X; van der Eerden, Bram CJ/0000-0003-4403-6497; Erkeland, Stefan/0000-0002-1019-7957; van Leeuwen, Johannes/0000-0002-2282-4006; Morhayim, Jess/0000-0001-7610-9342	Erasmus MC; Sanquin [PPOC-16-05]; US National Institutes of Health [R01-AR049069, F32-AR066508]	Erasmus MC; Sanquin; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Erasmus MC, Grant/Award Number: Mrace grant 2015; Sanquin, Grant/Award Number: PPOC-16-05; US National Institutes of Health, Grant/Award Number: R01-AR049069 and F32-AR066508	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Barker JN, 2010, BLOOD, V115, P1843, DOI 10.1182/blood-2009-07-231068; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Bissels U, 2012, HAEMATOL-HEMATOL J, V97, P160, DOI 10.3324/haematol.2011.051730; Brunstein CG, 2010, BLOOD, V116, P4693, DOI 10.1182/blood-2010-05-285304; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; CHIBA H, 1993, CELL STRUCT FUNCT, V18, P419, DOI 10.1247/csf.18.419; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; de Lima M, 2012, NEW ENGL J MED, V367, P2305, DOI 10.1056/NEJMoa1207285; Dudakovic A, 2014, J CELL BIOCHEM, V115, P1816, DOI 10.1002/jcb.24852; Duinhouwer LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119086; Eijken M, 2007, FASEB J, V21, P2949, DOI 10.1096/fj.07-8080com; Ekstrom K, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18389; Emmrich S, 2014, GENE DEV, V28, P858, DOI 10.1101/gad.233791.113; Fei XM, 2007, CYTOTHERAPY, V9, P338, DOI 10.1080/14653240701291638; Goloviznina NA, 2016, J BIOL CHEM, V291, P24607, DOI 10.1074/jbc.M116.745653; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Keerthikumar S, 2016, J MOL BIOL, V428, P688, DOI 10.1016/j.jmb.2015.09.019; Kerkhoff C, 2002, J BIOL CHEM, V277, P41879, DOI 10.1074/jbc.M207990200; Ko KH, 2011, STEM CELLS, V29, P108, DOI 10.1002/stem.551; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Krater M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02352-5; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Labbaye C, 2008, NAT CELL BIOL, V10, P788, DOI 10.1038/ncb1741; Lee YT, 2013, BLOOD, V122, P1034, DOI 10.1182/blood-2012-12-472308; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Morhayim J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32034; Morhayim J, 2014, ARCH BIOCHEM BIOPHYS, V561, P38, DOI 10.1016/j.abb.2014.05.011; Nair R, 2014, STEM CELLS DEV, V23, P1625, DOI 10.1089/scd.2013.0633; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pineault N, 2015, EXP HEMATOL, V43, P498, DOI 10.1016/j.exphem.2015.04.011; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Renstrom J, 2009, CELL STEM CELL, V5, P157, DOI 10.1016/j.stem.2009.05.020; Roden C, 2016, CURR STEM CELL REP, V2, P183, DOI 10.1007/s40778-016-0057-1; Sauvageau G, 2004, ONCOGENE, V23, P7223, DOI 10.1038/sj.onc.1207942; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Starczynowski DT, 2011, EXP HEMATOL, V39, P167, DOI 10.1016/j.exphem.2010.09.011; Stik G, 2017, J CELL BIOL, V216, P2217, DOI 10.1083/jcb.201601109; Su YH, 2015, HUM CELL, V28, P14, DOI 10.1007/s13577-014-0098-7; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; TAICHMAN RS, 1994, J EXP MED, V179, P1677, DOI 10.1084/jem.179.5.1677; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Varnum-Finney B, 2003, BLOOD, V101, P1784, DOI 10.1182/blood-2002-06-1862; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Walenda T, 2011, EXP HEMATOL, V39, P617, DOI 10.1016/j.exphem.2011.02.011; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	56	5	5	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5435	5452		10.1096/fj.201902610R	http://dx.doi.org/10.1096/fj.201902610R		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32086861	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000515259300001
J	Ramaraju, H; Solorio, LD; Bocks, ML; Hollister, SJ				Ramaraju, Harsha; Solorio, Loran D.; Bocks, Martin L.; Hollister, Scott J.			Degradation properties of a biodegradable shape memory elastomer, poly(glycerol dodecanoate), for soft tissue repair	PLOS ONE			English	Article							BIOMATERIALS; POLYMERS	Development of biodegradable shape memory elastomers (SMEs) is driven by the growing need for materials to address soft tissue pathology using a minimally invasive surgical approach. Composition, chain length and crosslinking of biocompatible polymers like PCL and PLA have been investigated to control mechanical properties, shape recovery and degradation rates. Depending on the primary mechanism of degradation, many of these polymers become considerably stiffer or softer resulting in mechanical properties that are inappropriate to support the regeneration of surrounding soft tissues. Additionally, concerns regarding degradation byproducts or residual organic solvents during synthesis accelerated interest in development of materials from bioavailable monomers. We previously developed a biodegradable SME, poly(glycerol dodecanoate) (PGD), using biologically relevant metabolites and controlled synthesis conditions to tune mechanical properties for soft tissue repair. In this study, we investigate the influence of crosslinking density on the mechanical and thermal properties of PGD during in vitro and in vivo degradation. Results suggest polymer degradation in vivo is predominantly driven by surface erosion, with no significant effects of initial crosslinking density on degradation time under the conditions investigated. Importantly, mechanical integrity is maintained during degradation. Additionally, shifts in melt transitions on thermograms indicate a potential shift in shape memory transition temperatures as the polymers degrade. These findings support the use of PGD for soft tissue repair and warrant further investigation towards tuning the molecular and macromolecular properties of the polymer to tailor degradation rates for specific clinical applications.	[Ramaraju, Harsha; Hollister, Scott J.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Solorio, Loran D.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Bocks, Martin L.] Case Western Reserve Univ, Sch Med, UH Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA	University System of Georgia; Georgia Institute of Technology; University of Michigan System; University of Michigan; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Ramaraju, H (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	harsha.ramaraju@gatech.edu	Hollister, Scott/ABH-3463-2021; Bocks, Martin/AAR-4542-2020; Ramaraju, Harsha/HGE-1406-2022	Hollister, Scott/0000-0001-7625-892X; Ramaraju, Harsha/0000-0001-9452-9228	National Institute of Health, Heart Lung and Blood Institute [NIHR21HL126004]; Georgia Institute of Technology	National Institute of Health, Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Georgia Institute of Technology	This study was supported the by National Institute of Health, Heart Lung and Blood Institute (NIHR21HL126004) and Georgia Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported the by National Institute of Health, Heart Lung and Blood Institute (NIHR21HL126004) and Georgia Institute of Technology.	Behl M, 2007, MATER TODAY, V10, P20, DOI 10.1016/S1369-7021(07)70047-0; Chahal J, 2012, ARTHROSCOPY, V28, P1718, DOI 10.1016/j.arthro.2012.03.007; Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003; Deshmukh P, 2017, J POLYM SCI POL CHEM, V55, P3424, DOI 10.1002/pola.28721; Hearon K, 2011, J APPL POLYM SCI, V121, P144, DOI 10.1002/app.33428; Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102; Ma CY, 2018, BIOMATERIALS, V178, P383, DOI 10.1016/j.biomaterials.2018.05.003; Mahdavi A, 2008, P NATL ACAD SCI USA, V105, P2307, DOI 10.1073/pnas.0712117105; Mann DL, 2016, EUR J HEART FAIL, V18, P314, DOI 10.1002/ejhf.449; Migneco F, 2009, BIOMATERIALS, V30, P6479, DOI 10.1016/j.biomaterials.2009.08.021; Pego AP, 2003, J BIOMED MATER RES A, V67A, P1044, DOI 10.1002/jbm.a.10121; Pomerantseva I, 2009, J BIOMED MATER RES A, V91A, P1038, DOI 10.1002/jbm.a.32327; Rai R, 2012, PROG POLYM SCI, V37, P1051, DOI 10.1016/j.progpolymsci.2012.02.001; Solorio LD, 2017, J BIOMED MATER RES A, V105, P1618, DOI 10.1002/jbm.a.35973; Tanzi MC, 2015, SHAPE MEMORY POLYM B, P133, DOI 10.1016/B978-0-85709-698-2.00007-6; Tobushi H, 2015, SHAPE MEMORY POLYM B, DOI [10.1016/B978-0-85709-698-2.00004-0, DOI 10.1016/B978-0-85709-698-2.00004-0]; Tran RT, 2015, ANNU REV MATER RES, V45, P277, DOI 10.1146/annurev-matsci-070214-020815; Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534; Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602; Wang YJ, 2018, ACS BIOMATER SCI ENG, V4, P1397, DOI 10.1021/acsbiomaterials.8b00091; Weinberger F, 2017, CIRC RES, V120, P1487, DOI 10.1161/CIRCRESAHA.117.310738; Woodard LN, 2016, MACROMOL RAPID COMM, V37, P1972, DOI 10.1002/marc.201600414; Yahia L., 2015, SHAPE MEM POLYM BIOM, V30, P3, DOI [10.1016/B978-0-85709-698-2.00001-5, DOI 10.1016/B978-0-85709-698-2.00001-5]; Zhu Y, 2017, BIOMATERIALS, V129, P37, DOI 10.1016/j.biomaterials.2017.02.032	24	8	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229112	10.1371/journal.pone.0229112	http://dx.doi.org/10.1371/journal.pone.0229112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084184	Green Published, gold			2022-12-26	WOS:000535227900054
J	Hoang, TTH; Dang, DA; Pham, TH; Luong, MH; Tran, ND; Nguyen, TH; Nguyen, TT; Nguyen, TT; Inoue, S; Morikawa, S; Okutani, A				Thi Thu Ha Hoang; Duc Anh Dang; Thanh Hai Pham; Minh Hoa Luong; Nhu Duong Tran; Tran Hien Nguyen; Thuy Tram Nguyen; Tran Tuan Nguyen; Inoue, Satoshi; Morikawa, Shigeru; Okutani, Akiko			Epidemiological and comparative genomic analysis of Bacillus anthracis isolated from northern Vietnam	PLOS ONE			English	Article							POLYMORPHISMS	To understand the epidemiological and genetic background of anthrax cases occurring in Vietnam from 2011 to 2015, we surveilled and genetically analyzed Bacillus anthracis isolated in the north of the country. Epidemiological surveillance showed that most human cutaneous anthrax cases occurred in association with animal dissection. Whole-genome sequences were obtained from six B. anthracis strains from human patients with cutaneous anthrax in the endemic area. Comparative genomic analysis showed that the genetic homogeneity among Vietnamese B. anthracis strains was very high. All Vietnamese B. anthracis strains belonged to the canSNP lineage of A.Br.011/009, which mostly consists of strains of the trans-Eurasian (TEA) group, including the most closely related strain, Carbosap. To clarify the genetic diversity of Vietnamese strains and strains belonging to A.Br.011/009 and A. Br.008/011 canSNP lineages, we applied a reference genome-based single-nucleotide polymorphism (SNP) and gene-by-gene genomic analysis (whole-genome MLST) strategy. The phylogeny from core genome SNPs revealed that the Vietnamese strains were positioned close to each other; moreover, several SNPs specific to Vietnamese B. anthracis were identified. Whole-genome MLST analysis revealed the differences in the number of SNPs between Vietnamese strains, which could enable discrimination at the strain level.	[Thi Thu Ha Hoang; Duc Anh Dang; Thanh Hai Pham; Minh Hoa Luong; Nhu Duong Tran; Tran Hien Nguyen; Thuy Tram Nguyen] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Tran Tuan Nguyen] Ha Giang Ctr Dis Control, Ha Giang, Vietnam; [Inoue, Satoshi; Morikawa, Shigeru; Okutani, Akiko] Natl Inst Infect Dis, Dept Vet Sci, Tokyo, Japan	National Institute of Hygiene & Epidemiology (NIHE); National Institute of Infectious Diseases (NIID)	Okutani, A (corresponding author), Natl Inst Infect Dis, Dept Vet Sci, Tokyo, Japan.	okutani@nih.go.jp		Hoang, Thi Thu Ha/0000-0002-3075-1820; MORIKAWA, SHIGERU/0000-0001-6249-6716	Japan Agency for Medical Research and Development (AMED) [18fk0108049]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	AO, SI and SM greatly acknowledge financial support by Japan Agency for Medical Research and Development (AMED; Grant No. 18fk0108049). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Derzelle S, 2016, VET MICROBIOL, V196, P1, DOI 10.1016/j.vetmic.2016.10.014; Derzelle S, 2016, INFECT GENET EVOL, V46, P50, DOI 10.1016/j.meegid.2016.10.019; Derzelle S, 2015, INFECT GENET EVOL, V32, P370, DOI 10.1016/j.meegid.2015.03.030; DRAGON DC, 1995, CAN VET J, V36, P295; Duong TN, 2012, VIET J PREVENT MED, V22, P14; Fasanella A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-167; Girault G., 2014, Advances in Bioscience and Biotechnology, V5, P669, DOI 10.4236/abb.2014.57079; Hanczaruk M, 2014, EMERG INFECT DIS, V20, P322, DOI 10.3201/eid2002.120921; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Okutani A, 2019, INFECT GENET EVOL, V71, P128, DOI 10.1016/j.meegid.2019.03.022; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Pearson T, 2009, INFECT GENET EVOL, V9, P1010, DOI 10.1016/j.meegid.2009.05.014; Pilo P, 2011, INFECT GENET EVOL, V11, P1218, DOI 10.1016/j.meegid.2011.05.013; Ruan Z, 2016, NUCLEIC ACIDS RES, V44, pD682, DOI 10.1093/nar/gkv1004; Sahl JW, 2016, MBIO, V7, DOI [10.1128/mBio.01501-16, 10.1128/mbio.01501-16]; Sambrook J, 2006, COLD SPRING HARB PRO, V2006, P4455, DOI DOI 10.1101/PDB.PR0T4455; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06; Vergnaud G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146216; WHO, 1998, GUIDELINES SURVEILLA	21	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0228116	10.1371/journal.pone.0228116	http://dx.doi.org/10.1371/journal.pone.0228116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084143	Green Published, gold			2022-12-26	WOS:000535227900015
J	Plewes, MR; Hou, XY; Talbott, HA; Zhang, P; Wood, JR; Cupp, AS; Davis, JS				Plewes, Michele R.; Hou, Xiaoying; Talbott, Heather A.; Zhang, Pan; Wood, Jennifer R.; Cupp, Andrea S.; Davis, John S.			Luteinizing hormone regulates the phosphorylation and localization of the mitochondrial effector dynamin-related protein-1 (DRP1) and steroidogenesis in the bovine corpus luteum	FASEB JOURNAL			English	Article						bovine; corpus luteum; dynamin-like protein 1; mitochondria; progesterone; protein kinase A; steroidogenesis	PROGESTERONE PRODUCTION; SPATIAL-DISTRIBUTION; THERAPEUTIC TARGETS; LIPID MICRODOMAINS; FISSION PROTEINS; LATERAL MOBILITY; S-NITROSYLATION; CANCER CELLS; CYCLIC-AMP; FISH-OIL	The corpus luteum is an endocrine gland that synthesizes and secretes progesterone. Luteinizing hormone (LH) activates protein kinase A (PKA) signaling in luteal cells, increasing delivery of substrate to mitochondria for progesterone production. Mitochondria maintain a highly regulated equilibrium between fusion and fission in order to sustain biological function. Dynamin-related protein 1 (DRP1), is a key mediator of mitochondrial fission. The mechanism by which DRP1 is regulated in the ovary is largely unknown. We hypothesize that LH via PKA differentially regulates the phosphorylation of DRP1 on Ser616 and Ser637 in bovine luteal cells. In primary cultures of steroidogenic small luteal cells (SLCs), LH, and forskolin stimulated phosphorylation of DRP1 (Ser 637), and inhibited phosphorylation of DRP1 (Ser 616). Overexpression of a PKA inhibitor blocked the effects of LH and forskolin on DRP1 phosphorylation. In addition, LH decreased the association of DRP1 with the mitochondria. Genetic knockdown of the DRP1 mitochondria receptor, and a small molecule inhibitor of DRP1 increased basal and LH-induced progesterone production. Studies with a general Dynamin inhibitor and siRNA knockdown of DRP1 showed that DRP1 is required for optimal LH-induced progesterone biosynthesis. Taken together, the findings place DRP1 as an important target downstream of PKA in steroidogenic luteal cells.	[Plewes, Michele R.; Hou, Xiaoying; Talbott, Heather A.; Zhang, Pan; Davis, John S.] Univ Nebraska Med Ctr, Olson Ctr Womens Hlth, Dept Obstet & Gynecol, 983255 Nebraska Med Ctr, Omaha, NE 68198 USA; [Plewes, Michele R.; Davis, John S.] Nebraska Western Iowa Vet Hlth Care Syst, Omaha, NE USA; [Wood, Jennifer R.; Cupp, Andrea S.] Univ Nebraska, Dept Anim Sci, Lincoln, NE USA	University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Lincoln	Davis, JS (corresponding author), Univ Nebraska Med Ctr, Olson Ctr Womens Hlth, Dept Obstet & Gynecol, 983255 Nebraska Med Ctr, Omaha, NE 68198 USA.	jsdavis@unmc.edu	Wood, Jennifer R/S-3213-2019	Wood, Jennifer R/0000-0001-9337-5837; Davis, John/0000-0003-3468-4079; Talbott, Heather/0000-0002-6140-9059	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture [2018-67012-29531 MRP, 2017-67015-26450 JSD]; NIH [R01 HD087402, R01HD092263]; Department of Veterans Affairs; Olson Center for Women's Health	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Olson Center for Women's Health	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2018-67012-29531 MRP and 2017-67015-26450 JSD from the USDA National Institute of Food and Agriculture; NIH grants R01 HD087402 and R01HD092263, the Department of Veterans Affairs; and The Olson Center for Women's Health.	ALILA HW, 1988, J REPROD FERTIL, V82, P645, DOI 10.1530/jrf.0.0820645; Arikan S, 2010, REPROD DOMEST ANIM, V45, pe434, DOI 10.1111/j.1439-0531.2010.01596.x; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Bertoldo MJ, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.06.04; Bhatt MP, 2013, DIABETES, V62, P3851, DOI 10.2337/db13-0039; Bordt EA, 2017, DEV CELL, V40, P583, DOI 10.1016/j.devcel.2017.02.020; Bowdridge EC, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.129411; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chang CR, 2007, EMBO REP, V8, P1088, DOI 10.1038/sj.embor.7401118; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chen DB, 1998, ENDOCRINOLOGY, V139, P3876, DOI 10.1210/en.139.9.3876; Chen DB, 2001, ENDOCRINOLOGY, V142, P887, DOI 10.1210/en.142.2.887; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen L, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003012; DAVIS JS, 1987, P NATL ACAD SCI USA, V84, P3728, DOI 10.1073/pnas.84.11.3728; DAVIS JS, 1987, J BIOL CHEM, V262, P8515; DONALDSON L, 1965, J DAIRY SCI, V48, P905, DOI 10.3168/jds.S0022-0302(65)88360-6; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Flynn MP, 2016, J CELL SCI, V129, P2983, DOI 10.1242/jcs.190397; Fukushima NH, 2001, MOL BIOL CELL, V12, P2756, DOI 10.1091/mbc.12.9.2756; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Girard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029042; Hall AR, 2014, BRIT J PHARMACOL, V171, P1890, DOI 10.1111/bph.12516; HANSEL W, 1991, J REPROD FERTIL, P77; HANSEL W, 1987, AUST J BIOL SCI, V40, P331, DOI 10.1071/BI9870331; HARRISON LM, 1987, J REPROD FERTIL, V79, P539, DOI 10.1530/jrf.0.0790539; Hou XY, 2010, ENDOCRINOLOGY, V151, P2846, DOI 10.1210/en.2009-1032; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; JOHNSON KR, 1962, J DAIRY SCI, V45, P633, DOI 10.3168/jds.S0022-0302(62)89463-6; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Law NC, 2016, J BIOL CHEM, V291, P4547, DOI 10.1074/jbc.M115.698761; Lee DG, 2016, TOXICOLOGY, V365, P17, DOI 10.1016/j.tox.2016.07.022; Li D, 2008, DIABETES, V57, P635, DOI 10.2337/db07-0717; Li J, 2015, J MOL CELL CARDIOL, V86, P62, DOI 10.1016/j.yjmcc.2015.07.010; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mao DG, 2013, MOL ENDOCRINOL, V27, P2066, DOI 10.1210/me.2013-1274; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; MARSH JM, 1976, BIOL REPROD, V14, P30, DOI 10.1095/biolreprod14.1.30; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Miller WL, 2017, J STEROID BIOCHEM, V165, P18, DOI 10.1016/j.jsbmb.2016.03.009; Morigi M, 2015, J CLIN INVEST, V125, P715, DOI 10.1172/JCI77632; Nakamura T, 2016, TRENDS PHARMACOL SCI, V37, P73, DOI 10.1016/j.tips.2015.10.002; Nakamura T, 2010, MITOCHONDRION, V10, P573, DOI 10.1016/j.mito.2010.04.007; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Ong SB, 2015, EUR J PHARMACOL, V763, P104, DOI 10.1016/j.ejphar.2015.04.056; Otera Hidenori, 2012, Int J Cell Biol, V2012, P821676, DOI 10.1155/2012/821676; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Park JE, 2019, ENDOCRINOLOGY, V160, P729, DOI 10.1210/en.2019-00029; Park J, 2015, TOXICOLOGY, V337, P39, DOI 10.1016/j.tox.2015.08.009; Pennanen C, 2014, J CELL SCI, V127, P2659, DOI 10.1242/jcs.139394; Plewes MR, 2018, DOMEST ANIM ENDOCRIN, V63, P38, DOI 10.1016/j.domaniend.2017.12.001; Plewes MR, 2017, DOMEST ANIM ENDOCRIN, V60, P9, DOI 10.1016/j.domaniend.2017.02.001; Plewes MR, 2017, DOMEST ANIM ENDOCRIN, V58, P39, DOI 10.1016/j.domaniend.2016.08.001; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Preta G, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0102-1; Ramachandran R, 2018, SEMIN CELL DEV BIOL, V76, P201, DOI 10.1016/j.semcdb.2017.07.039; Roy L, 2009, ENDOCRINOLOGY, V150, P5036, DOI 10.1210/en.2009-0771; Roy M, 2015, CURR OPIN CELL BIOL, V33, P111, DOI 10.1016/j.ceb.2015.02.001; Sarkar D, 2002, P NATL ACAD SCI USA, V99, P10054, DOI 10.1073/pnas.152327199; Schrepfer E, 2016, MOL CELL, V61, P683, DOI 10.1016/j.molcel.2016.02.022; Scott I, 2010, ESSAYS BIOCHEM, V47, P85, DOI [10.1042/BSE0470085, 10.1042/bse0470085]; Sharp WW, 2014, FASEB J, V28, P316, DOI 10.1096/fj.12-226225; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Takao Y, 1997, MOL HUM REPROD, V3, P569, DOI 10.1093/molehr/3.7.569; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; Taurin S, 2008, AM J PHYSIOL-CELL PH, V294, pC1169, DOI 10.1152/ajpcell.00096.2008; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wang QL, 2017, AUTOPHAGY, V13, P404, DOI 10.1080/15548627.2016.1263776; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wikstrom JD, 2013, MOL ENDOCRINOL, V27, P1706, DOI 10.1210/me.2013-1109; WILTBANK MC, 1991, J REPROD FERTIL, P65; Wu Q, 2017, HISTOL HISTOPATHOL, V32, P551, DOI 10.14670/HH-11-841; Xiao L, 2015, J BIOL CHEM, V290, P24961, DOI 10.1074/jbc.M115.673343; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zaja I, 2014, BIOCHEM BIOPH RES CO, V453, P710, DOI 10.1016/j.bbrc.2014.09.144; Zhou J, 2015, AUTOPHAGY, V11, P1259, DOI 10.1080/15548627.2015.1056970	80	9	9	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5299	5316		10.1096/fj.201902958R	http://dx.doi.org/10.1096/fj.201902958R		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32077149	Bronze, Green Accepted			2022-12-26	WOS:000515256400001
J	Miyata, H; Shimada, K; Morohoshi, A; Oura, S; Matsumura, T; Xu, ZL; Oyama, Y; Ikawa, M				Miyata, Haruhiko; Shimada, Keisuke; Morohoshi, Akane; Oura, Seiya; Matsumura, Takafumi; Xu, Zoulan; Oyama, Yuki; Ikawa, Masahito			Testis-enriched kinesin KIF9 is important for progressive motility in mouse spermatozoa	FASEB JOURNAL			English	Article						fertilization; male fertility; sperm motility	CILIARY MOTILITY; PROTEINS; FLAGELLA; DYNEIN; FERTILITY; SHEATH; CELLS; HYDIN	Kinesin is a molecular motor that moves along microtubules. Kinesin family member 9 (KIF9) is evolutionarily conserved and expressed strongly in mouse testis. In the unicellular flagellate Chlamydomonas, KLP1 (ortholog of KIF9) is localized to the central pair microtubules of the axoneme and regulates flagellar motility. In contrast, the function of KIF9 remains unclear in mammals. Here, we mutated KIF9 in mice using the CRISPR/Cas9 system. Kif9 mutated mice exhibit impaired sperm motility and subfertility. Further analysis reveals that the flagella lacking KIF9 showed an asymmetric waveform pattern, which leads to a circular motion of spermatozoa. In spermatozoa that lack the central pair protein HYDIN, KIF9 was not detected by immunofluorescence and immunoblot analysis. These results suggest that KIF9 is associated with the central pair microtubules and regulates flagellar motility in mice.	[Miyata, Haruhiko; Shimada, Keisuke; Morohoshi, Akane; Oura, Seiya; Matsumura, Takafumi; Xu, Zoulan; Ikawa, Masahito] Osaka Univ, Res Inst Microbial Dis, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Morohoshi, Akane; Ikawa, Masahito] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan; [Oura, Seiya; Matsumura, Takafumi; Xu, Zoulan; Ikawa, Masahito] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan; [Oyama, Yuki] Doshisha Univ, Grad Sch Life & Med Sci, Kyotanabe, Japan; [Ikawa, Masahito] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Matsumura, Takafumi] Yokohama City Univ, Inst Mol Med & Life Sci, Assoc Med Sci, Yokohama, Kanagawa, Japan	Osaka University; Osaka University; Osaka University; Doshisha University; University of Tokyo; Yokohama City University	Miyata, H; Ikawa, M (corresponding author), Osaka Univ, Res Inst Microbial Dis, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	hmiya003@biken.osaka-u.ac.jp; ikawa@biken.osaka-u.ac.jp	ikawa, masahito/A-5315-2009; Shimada, Keisuke/N-6112-2019; Shimada, Keisuke/E-8958-2019	ikawa, masahito/0000-0001-9859-6217; Shimada, Keisuke/0000-0003-3739-7163; Shimada, Keisuke/0000-0003-3739-7163; OYAMA, Yuki/0000-0003-4579-5487; Miyata, Haruhiko/0000-0003-4758-5803; Oura, Seiya/0000-0002-7606-732X	MEXT | Japan Society for the Promotion of Science (JSPS) [JP17H04987, JP17K17852, JP19J12450, JP19J21619, JP17H01394]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [JP25112007, JP19H05750]; Takeda Science Foundation; Japan Agency for Medical Research and Development (AMED) [JP19gm5010001]; HHS \ NIH \ Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [P01HD087157, R01HD088412]; Bill and Melinda Gates Foundation [OPP1160866]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); HHS \ NIH \ Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP17H04987, JP17K17852, JP19J12450, JP19J21619 and JP17H01394; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant/Award Number: JP25112007 and JP19H05750; Takeda Science Foundation; Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP19gm5010001; HHS vertical bar NIH vertical bar Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: P01HD087157 and R01HD088412; Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation), Grant/Award Number: OPP1160866	Abbasi F, 2018, J CELL SCI, V131, DOI 10.1242/jcs.221648; BABA SA, 1985, CELL MOTIL CYTOSKEL, V5, P475, DOI 10.1002/cm.970050605; BERNSTEIN M, 1994, J CELL BIOL, V125, P1313, DOI 10.1083/jcb.125.6.1313; Cao WL, 2006, MOL CELL PROTEOMICS, V5, P801, DOI 10.1074/mcp.M500322-MCP200; Castaneda JM, 2017, P NATL ACAD SCI USA, V114, pE5370, DOI 10.1073/pnas.1621279114; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cornfine S, 2011, MOL BIOL CELL, V22, P202, DOI 10.1091/mbc.E10-05-0394; Demonchy R, 2009, J CELL BIOL, V187, P615, DOI 10.1083/jcb.200903139; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; Fujihara Y, 2018, EXP ANIM TOKYO, V67, P91, DOI 10.1538/expanim.17-0153; Fujihara Y, 2013, TRANSGENIC RES, V22, P195, DOI 10.1007/s11248-012-9635-x; Goodson SG, 2011, BIOL REPROD, V84, P1207, DOI 10.1095/biolreprod.110.088989; Gyobu S, 2016, MOL CELL BIOL, V36, P645, DOI 10.1128/MCB.00919-15; Hermann BP, 2018, CELL REP, V25, P1650, DOI 10.1016/j.celrep.2018.10.026; Hirokawa N, 2015, EXP CELL RES, V334, P16, DOI 10.1016/j.yexcr.2015.02.016; HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214; Inaba K, 2011, MOL HUM REPROD, V17, P524, DOI 10.1093/molehr/gar034; Ishijima S, 2002, MOL REPROD DEV, V61, P376, DOI 10.1002/mrd.10017; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P1, DOI 10.1002/mrd.10179; Konjikusic MJ, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007817; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Lechtreck KF, 2007, J CELL BIOL, V176, P473, DOI 10.1083/jcb.200611115; Lehti MS, 2013, MOL CELL ENDOCRINOL, V377, P44, DOI 10.1016/j.mce.2013.06.030; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; McKenzie CW, 2015, MOL BIOL CELL, V26, P3140, DOI 10.1091/mbc.E15-02-0121; Miller MG, 1999, BIOL REPROD, V60, P1047, DOI 10.1095/biolreprod60.4.1047; Miyata H, 2016, P NATL ACAD SCI USA, V113, P7704, DOI 10.1073/pnas.1608458113; Miyata H, 2015, SCIENCE, V350, P442, DOI 10.1126/science.aad0836; Morohoshi A, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008585; Muro Y, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135368; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nakagawa T, 1997, P NATL ACAD SCI USA, V94, P9654, DOI 10.1073/pnas.94.18.9654; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Oji A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31666; Oura S, 2019, EXP ANIM TOKYO, V68, P25, DOI 10.1538/expanim.18-0071; Sapiro R, 2002, MOL CELL BIOL, V22, P6298, DOI 10.1128/MCB.22.17.6298-6305.2002; Sasaki K, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0462-y; Schou KB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14177; Shimada K, 2019, J REPROD DEVELOP, V65, P155, DOI 10.1262/jrd.2018-136; Sironen A, 2011, BIOL REPROD, V85, P690, DOI 10.1095/biolreprod.111.091132; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Yokoyama R, 2004, P NATL ACAD SCI USA, V101, P17398, DOI 10.1073/pnas.0406817101; Zeleznik A.J., 2014, PHYSL REPROD, V1, P99	43	14	14	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5389	5400		10.1096/fj.201902755R	http://dx.doi.org/10.1096/fj.201902755R		FEB 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32072696	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000515254200001
J	Runge, M; Snow, RW; Molteni, F; Thawer, S; Mohamed, A; Mandike, R; Giorgi, E; Macharia, PM; Smith, TA; Lengeler, C; Pothin, E				Runge, Manuela; Snow, Robert W.; Molteni, Fabrizio; Thawer, Sumaiyya; Mohamed, Ally; Mandike, Renata; Giorgi, Emanuele; Macharia, Peter M.; Smith, Thomas A.; Lengeler, Christian; Pothin, Emilie			Simulating the council-specific impact of anti-malaria interventions: A tool to support malaria strategic planning in Tanzania	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; COST-EFFECTIVENESS ANALYSIS; ENTOMOLOGIC INOCULATION RATES; LASTING INSECTICIDAL NETS; CARE RESOURCE-ALLOCATION; VECTOR CONTROL; PREVENT MALARIA; TRANSMISSION; MODEL; ELIMINATION	Introduction The decision-making process for malaria control and elimination strategies has become more challenging. Interventions need to be targeted at council level to allow for changing malaria epidemiology and an increase in the number of possible interventions. Models of malaria dynamics can support this process by simulating potential impacts of multiple interventions in different settings and determining appropriate packages of interventions for meeting specific expected targets. Methods The OpenMalaria model of malaria dynamics was calibrated for all 184 councils in mainland Tanzania using data from malaria indicator surveys, school parasitaemia surveys, entomological surveillance, and vector control deployment data. The simulations were run for different transmission intensities per region and five interventions, currently or potentially included in the National Malaria Strategic Plan, individually and in combination. The simulated prevalences were fitted to council specific prevalences derived from geostatistical models to obtain council specific predictions of the prevalence and number of cases between 2017 and 2020. The predictions were used to evaluate in silico the feasibility of the national target of reaching a prevalence of below 1% by 2020, and to suggest alternative intervention stratifications for the country. Results The historical prevalence trend was fitted for each council with an agreement of 87% in 2016 (95%CI: 0.84-0.90) and an agreement of 90% for the historical trend (2003-2016) (95%CI: 0.87-0.93) The current national malaria strategy was expected to reduce the malaria prevalence between 2016 and 2020 on average by 23.8% (95% CI: 19.7%-27.9%) if current case management levels were maintained, and by 52.1% (95% CI: 48.8%-55.3%) if the case management were improved. Insecticide treated nets and case management were the most cost-effective interventions, expected to reduce the prevalence by 25.0% (95% CI: 19.7%-30.2) and to avert 37 million cases between 2017 and 2020. Mass drug administration was included in most councils in the stratification selected for meeting the national target at minimal costs, expected to reduce the prevalence by 77.5% (95%CI: 70.5%-84.5%) and to avert 102 million cases, with almost twice higher costs than those of the current national strategy. In summary, the model suggested that current interventions are not sufficient to reach the national aim of a prevalence of less than 1% by 2020 and a revised strategic plan needs to consider additional, more effective interventions, especially in high transmission areas and that the targets need to be revisited. Conclusion The methodology reported here is based on intensive interactions with the NMCP and provides a helpful tool for assessing the feasibility of country specific targets and for determining which intervention stratifications at sub-national level will have most impact. This country-led application could support strategic planning of malaria control in many other malaria endemic countries.	[Runge, Manuela; Molteni, Fabrizio; Thawer, Sumaiyya; Smith, Thomas A.; Lengeler, Christian; Pothin, Emilie] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Runge, Manuela; Smith, Thomas A.; Lengeler, Christian; Pothin, Emilie] Univ Basel, Basel, Switzerland; [Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Snow, Robert W.; Macharia, Peter M.] Kenya Govt Med Res Ctr, Populat Hlth Unit, Wellcome Trust Res Programme, Nairobi, Kenya; [Molteni, Fabrizio; Thawer, Sumaiyya; Mohamed, Ally; Mandike, Renata] Natl Malaria Control Programme NMCP, Dar Es Salaam, Tanzania; [Giorgi, Emanuele] Univ Lancaster, Lancaster Med Sch, CHICAS, Lancaster, England; [Pothin, Emilie] Clinton Hlth Access Initiat, Boston, MA USA	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Oxford; Kenya Medical Research Institute; Lancaster University	Runge, M (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Runge, M (corresponding author), Univ Basel, Basel, Switzerland.	manuela.runge@swisstph.ch	Macharia, Peter M/GSJ-0206-2022; Macharia, Peter/I-3496-2019; Smith, Thomas/B-5569-2015; Snow, Robert William/AFR-1436-2022; Macharia, Peter M/E-2255-2015; Runge, Manuela/AAV-5429-2021	Macharia, Peter M/0000-0003-3410-1881; Macharia, Peter/0000-0003-3410-1881; Smith, Thomas/0000-0002-3650-9381; Snow, Robert William/0000-0003-3725-6088; Macharia, Peter M/0000-0003-3410-1881; Giorgi, Emanuele/0000-0003-0640-181X; Runge, Manuela/0000-0001-9918-760X	Global Fund to Fight Aids, Tuberculosis and Malaria; Swiss Agency for Development and Cooperation; Swiss Tropical and Public Health Institute; Bill and Melinda Gates Foundation [OPP1032350]; Wellcome Trust [079080, 103602, 212176]; Medical Research Council [MR/M015297/1]; UK's Department for International Development [203155]; Initiative to Develop African Research Leaders Project [107769]; MRC [MR/M015297/1] Funding Source: UKRI	Global Fund to Fight Aids, Tuberculosis and Malaria; Swiss Agency for Development and Cooperation; Swiss Tropical and Public Health Institute; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK's Department for International Development; Initiative to Develop African Research Leaders Project; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding was received for EP and MR from the Global Fund to Fight Aids, Tuberculosis and Malaria URL: https://www.theglobalfund.org/en/, the NETCELL Project funded by the Swiss Agency for Development and Cooperation URL: https://www.eda.admin.ch/sdc, and the Swiss Tropical and Public Health Institute URL https://www.swisstph.ch.TAS received funding from the Bill and Melinda Gates Foundation, project OPP1032350. RWS is supported as a Wellcome Trust Principal Fellow (#079080, 103602 and 212176) URL: https://wellcome.ac.uk/.EG was supported by an Medical Research Council Strategic Skills Fellowship in Biostatistics (MR/M015297/1) URL: https://mrc.ukri.org/.RWS also acknowledges support from the UK's Department for International Development under a project entitled Strengthening the Use of Data for Malaria Decision Making in Africa (Department for International Development Programme Code #203155) URL: https://www.gov.uk/government/organisations/department-for-internationaldevelopment.PMM acknowledges support for his PhD under the Initiative to Develop African Research Leaders Project (#107769) URL: https://ideal.kemri-wellcome.org/.	Ali AS, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1982-x; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000403; [Anonymous], 2011, MAL RAP DIAGN TEST P; [Anonymous], 2016, TANZ DEM HLTH SURV M; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2013, 2012 POPULATION HOUS; [Anonymous], 2011, TANZ DEM HLTH SURV 2; [Anonymous], 2014, MAL CONTR MAL EL MAN; Arifin SMN, 2016, SPATIAL AGENT BASED; Baidjoe AY, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1362-y; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Bhatt S, 2015, ELIFE, V4, DOI 10.7554/eLife.09672; Brady OJ, 2017, LANCET GLOB HEALTH, V5, pE680, DOI [10.1016/S2214-109X(17)30220-6, 10.1016/s2214-109x(17)30220-6]; Brady OJ, 2016, T ROY SOC TROP MED H, V110, P107, DOI 10.1093/trstmh/trv113; Briet OJT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-401; Briet OJT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-77; Brooks A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032587; Celhay Olivier J, 2019, Wellcome Open Res, V4, P61, DOI 10.12688/wellcomeopenres.14770.2; Chaki PP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-311; Chipeta M. G., 2019, Wellcome Open Research, V4, DOI 10.12688/wellcomeopenres.15193.2; Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0; Chitnis N, 2012, B MATH BIOL, V74, P1098, DOI 10.1007/s11538-011-9710-0; Cibulskis RE, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0151-8; Cohen JM, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2106-3; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Crowell V, 2012, EPIDEMICS-NETH, V4, P1, DOI 10.1016/j.epidem.2011.10.003; DIETZ K, 1974, B WORLD HEALTH ORGAN, V50, P347; Drakeley C, 2003, TROP MED INT HEALTH, V8, P767, DOI 10.1046/j.1365-3156.2003.01100.x; Elbasha EH, 2004, HEALTH ECON, V13, P21, DOI 10.1002/hec.793; Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632; Galactionova K, 2017, VACCINE, V35, P53, DOI 10.1016/j.vaccine.2016.11.042; Galactionova K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127818; Gerardin J, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1903-z; Giorgi E, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2238-0; Goodman CA, 1999, LANCET, V354, P378, DOI 10.1016/S0140-6736(99)02141-8; Govella NJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-124; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Gu WD, 2003, T ROY SOC TROP MED H, V97, P43, DOI 10.1016/S0035-9203(03)90018-6; Haara FO, 2012, MATH ENTHUS, V9; Hamilton M, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1705-3; Hansen KS, 2012, INT HEALTH, V4, P38, DOI 10.1016/j.inhe.2011.10.001; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Jones AE, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-162; Kabula B, 2014, MED VET ENTOMOL, V28, P244, DOI 10.1111/mve.12036; Kabula Bilali, 2011, Tanzan J Health Res, V13, P319; Killeen GF, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000211; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Kim D, 2017, RISK ANAL, V37, P231, DOI 10.1111/risa.12606; Kisinza WN, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2087-2; Korenromp E, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1461-9; KRAMER K, 2017, MALARIA J, V16, DOI DOI 10.1186/S12936-017-192-0; Kramer K, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1902-0; Kramer RA, 2009, HEALTH POLICY, V92, P133, DOI 10.1016/j.healthpol.2009.02.011; Lalji S, 2016, GLOB HEALTH-SCI PRAC, V4, P251, DOI 10.9745/GHSP-D-16-00040; Laska EM, 1999, HEALTH ECON, V8, P171, DOI 10.1002/(SICI)1099-1050(199903)8:2<171::AID-HEC424>3.0.CO;2-E; Le Menach A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00093; Lee BY, 2017, AM J TROP MED HYG, V96, P1430, DOI 10.4269/ajtmh.16-0744; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lindblade KA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0554-1; Lwetoijera DW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-331; Macharia PM, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2489-9; Mandal S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-202; Maude RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037166; Ministry of Health Community Development Gender Elderly and Children (MoHCDGEC) [Tanzania Mainland] Ministry of Health (MoH) [Zanzibar] National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) ICF, 2017, TANZ MAL IND SURV 20; MoHCDGEC (Tanzania), 2017, REP MIDT REV NAT MAL; MOLINEAUX L, 1978, B WORLD HEALTH ORGAN, V56, P565; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Msellemu D, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1340-4; Mwangangi JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-228; National Malaria Control Programme (NMCP), 2014, NAT MAL STRAT PLAN 2; National Malaria Control Programme (Tanzania) WHO Ifakara Health Institute KEMRI-Wellcome Trust (Kenya), 2013, EP PROF MAL ITS CONT, P152; Newby G, 2015, AM J TROP MED HYG, V93, P125, DOI 10.4269/ajtmh.14-0254; Nikolov M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005192; Nkumama IN, 2017, TRENDS PARASITOL, V33, P128, DOI 10.1016/j.pt.2016.11.006; Ochomo EO, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-368; Oduro F, 2012, J MATH RES, V4, P22, DOI DOI 10.5539/JMR.V4N6P22; Oduro FT, 2015, INT J SCI TECHNOLEDG, V3; Okell LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020179; Okosun KO, 2011, BIOSYSTEMS, V106, P136, DOI 10.1016/j.biosystems.2011.07.006; Okosun KO, 2013, BIOSYSTEMS, V111, P83, DOI 10.1016/j.biosystems.2012.09.008; Otieno G, 2016, MATHEMATICS-BASEL, V4, DOI 10.3390/math4010014; Patouillard E, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000176; Pemberton-Ross P, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2010-x; Penny MA, 2016, LANCET, V387, P367, DOI 10.1016/S0140-6736(15)00725-4; Penny MA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0864-3; Plummer M., 2003, P 3 INT WORKSH DISTR; PMI, 2018, MAL OP PLAN FY 2018; Poirot E, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008846.pub2; Protopopoff N, 2018, LANCET, V391, P1577, DOI [10.1016/S0140-6736(18)30427-6, 10.1016/s0140-6736(18)30427-6]; QGIS Development Team, 2016, QGIS GEOGR INF SYST; RBM, 2010, MATH MOD SUPP MAL CO; Renggli S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-85; Reynolds R, 2017, WEATHER, V72, P206, DOI 10.1002/wea.3022; Scott N, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2019-1; Silal SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144990; Silal SP, 2019, WELLCOME OPEN RES, V4, P62, DOI DOI 10.12688/WELLC0ME0PENRES.14771.1; Smith NR, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2442-y; Smith T, 2008, PARASITOLOGY, V135, P1507, DOI 10.1017/S0031182008000371; Smith T, 2006, AM J TROP MED HYG, V75, P56, DOI 10.4269/ajtmh.2006.75.56; Snow RW, 2017, NATURE, V550, P515, DOI 10.1038/nature24059; Snow RW, 1996, PARASITOL TODAY, V12, P455, DOI 10.1016/S0169-4758(96)30032-X; Stelmach R, 2018, AM J TROP MED HYG, V99, P627, DOI 10.4269/ajtmh.17-0537; Stelmach Rachel, 2016, TANZANIA VECTOR CONT; Stuckey EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107700; Stuckey EM, 2013, TRENDS PARASITOL, V29, P477, DOI 10.1016/j.pt.2013.08.001; Stuckey EM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-357; TACAIDS Zanzibar AIDS Commission (ZAC) National Bureau of Statistics (NBS) [Tanzania] MEA- SURE DHS Macro International Inc, 2008, TANZ HIV AIDS MAL IN; TACAIDS Zanzibar AIDS Commission (ZAC) National Bureau of Statistics (NBS) [Tanzania] Office of the Chief Government Statistician (OCGS) ICF International, 2013, TANZ HIV AIDS MAL IN; Tanzania National Bureau of Statistics, TANZ TOT POP DISTR R; Tatem AJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-287; Theiss-Nyland K, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1184-y; Tusting LS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008923.pub2; Walker PGT, 2016, LANCET GLOB HEALTH, V4, pE474, DOI 10.1016/S2214-109X(16)30073-0; WHO, 2019, GUID MAL VECT CONTR, P171; WHO, 2018, WORLD MAL REP 2018; WHO, 2015, GLOB TECHN STRAT MAL; WHO, 2017, COND US LONG LAST IN; WHO World Health Organization, 2019, HIGH BURDEN HIGH IMP; Winskill P, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2755-5; Winskill P, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000090; World Health Organization (WHO), 2011, FOC MAINL TANZ; Yukich JO, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2051-1; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258	124	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228469	10.1371/journal.pone.0228469	http://dx.doi.org/10.1371/journal.pone.0228469			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8AS	32074112	Green Accepted, gold, Green Published			2022-12-26	WOS:000535220600014
J	Aye, LL; Tripathy, JP; Maung, TM; Oo, MM; Nwe, ML; Thu, HMM; Ko, K; Kaung, KK				Aye, Lwin Lwin; Tripathy, Jaya Prasad; Maung, Thae Maung; Oo, Myo Minn; Nwe, Mya Lay; Thu, Hlaing Moh Moh; Ko, Ko; Kaung, Kyaw Kan			Experiences from the pilot implementation of the Package of Essential Non-communicable Disease Interventions (PEN) in Myanmar, 2017-18: A mixed methods study	PLOS ONE			English	Article							FACILITIES; CARE	Background and objectives Myanmar adopted the World Health Organization (WHO) Package for Essential Non-Communicable Disease Interventions (PEN) in 20 pilot townships in 2017. This study was conducted to assess the implementation of PEN, its effectiveness and understand the facilitators and barriers in its implementation. Methods Mixed methods design involving a quantitative component (retrospective study analysing both aggregate and individual patient data from PEN project records; cross-sectional facility survey using a structured checklist) and a descriptive qualitative component. Results A total of 152,446 individuals were screened between May 2017-December 2018 comprising of current smokers (17.5%), tobacco chewers (26.3%), Body Mass Index >= 25 kg/m(2) (30.6%), raised blood pressure i.e. >= 140/90 mmHg (35.2%) and raised blood sugar i.e. Random Blood Sugar > 200 mg/dl, Fasting Blood Sugar > 126 mg/dl (17.1%). Nearly 14.8% of those screened had Cardiovascular Disease (CVD) risk score >= 20%, 34.6% had CVD risk not recorded. Of 663 patients registered with diabetes and/or hypertension in 05 townships, 27 (4.1%) patients made three follow-up visits after the baseline visit, of whom, CVD risk assessment, systolic blood pressure and blood sugar measurement was done in all visits in 89.0%, 100.0% and 78.0% of cases respectively. Health facility assessment showed 64% of the sanctioned posts were filled; 90% of those appointed been trained in PEN; key essential medicines for PEN were available in half of the facilities surveyed. Confidence of the health care staff in managing common NCD and perceived benefits of the project were some of the strengths. Conclusion High loss to follow up, poor recording of CVD risk score, lack of essential medicines and equipments were the key challenges identified that need to be addressed before further expansion of PEN project to other townships.	[Aye, Lwin Lwin; Nwe, Mya Lay; Thu, Hlaing Moh Moh; Kaung, Kyaw Kan] Minist Hlth & Sports, NCD Prevent & Control Div, Dept Publ Hlth, Nay Pyi Taw, Myanmar; [Tripathy, Jaya Prasad] Union South East Asia Off, Int Union TB & Lung Dis, New Delhi, India; [Tripathy, Jaya Prasad] Int Union TB & Lung Dis, Paris, France; [Maung, Thae Maung] Minist Hlth & Sports, Dept Med Res, Nay Pyi Taw, Myanmar; [Oo, Myo Minn] Int Union TB & Lung Dis, Mandalay, Myanmar; [Ko, Ko] Minist Hlth & Sports, Dept Human Resources Hlth, Yangon, Myanmar; [Tripathy, Jaya Prasad] All India Inst Med Sci, Nagpur, Maharashtra, India	All India Institute of Medical Sciences (AIIMS) Nagpur	Aye, LL (corresponding author), Minist Hlth & Sports, NCD Prevent & Control Div, Dept Publ Hlth, Nay Pyi Taw, Myanmar.	llwinaye@googlemail.com	Oo, Myo Minn/P-3720-2018; Maung, Thae Maung/S-2495-2018	Oo, Myo Minn/0000-0003-4089-016X; Maung, Thae Maung/0000-0002-1265-3813				Bintabara D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192942; Creswell J.W., 2011, DESIGNING CONDUCTING; Division of Prevention and Control of NCDs, 2017, TRAIN TRAIN MAN PACK; Hyon Choe Suk, 2017, WHO South East Asia J Public Health, V6, P69, DOI 10.4103/2224-3151.213794; Islam SMS, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0081-9; Katende D, 2015, TROP MED INT HEALTH, V20, P1385, DOI 10.1111/tmi.12560; Kontsevaya A., 2017, IMPLEMENTATION PACKA; Kvale, 2008, DOING INTERVIEWS, DOI 10.4135/9781849208963; Mendis S, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/584041; Ministry of Health Myanmar, NAT WID SERV AV READ; Moh Thit WM, INTEGRATING NCD SERV; Musinguzi G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142312; Myanmar Diabetes Prevention and Control Project, 2014, MYANMAR DIABETES PRE; Nyarko KM, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.supp.2016.25.1.6252; Pakhare A, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1075-x; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Population Department, 2015, 2014 MYANM POP HOUS, V2; Praveen D, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6142-x; Prinja S, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0043-8; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wangchuk Dukpa, 2014, WHO South East Asia J Public Health, V3, P154, DOI 10.4103/2224-3151.206731; World Health Organization, 2014, NONC DIS NCD COUNTR; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization, 2010, PACK ESS NONC PEN DI; World Health Organization, 2008, HLTH ACT CRIS MYANM	27	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0229081	10.1371/journal.pone.0229081	http://dx.doi.org/10.1371/journal.pone.0229081			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7XT	32069323	Green Published, gold			2022-12-26	WOS:000535212900023
J	Khan, R; Raza, SHA; Guo, HF; Wang, XY; Wu, S; Suhail, SM; Rahman, A; Ullah, I; Abd El-Aziz, AH; Manzari, Z; Alshawi, A; Zan, LS				Khan, Rajwali; Raza, Sayed Haidar Abbas; Guo, Hongfang; Wang Xiaoyu; Wu Sen; Suhail, Syed Muhammad; Rahman, Abdur; Ullah, Irfan; Abd El-Aziz, Ayman Hassan; Manzari, Zeinab; Alshawi, Akil; Zan, Linsen			Genetic variants in the TORC2 gene promoter and their association with body measurement and carcass quality traits in Qinchuan cattle	PLOS ONE			English	Article							INSULIN-RESISTANCE; COACTIVATOR TORC2; GLUCOSE; CRTC2; CREB; FAT; TRANSCRIPTION; POLYMORPHISMS; EXPRESSION; PREDICTION	The TORC2 gene is responsible for nutrient metabolism, gluconeogenesis, myogenesis and adipogenesis through the PI3K-Akt, AMPK, glucagon and insulin resistance signaling pathways. Sequencing of PCR amplicons explored three novel SNPs at loci g.16534694G>A, g.16535011C>T, and g.16535044A>T in the promoter region of the TORC2 gene in the Qinchuan breed of cattle. Allelic and genotypic frequencies of these SNPs deviated from Hardy-Weinberg equilibrium (HWE) (P < 0.05). SNP1 genotype GG, SNP2 genotype CT and SNP3 genotype AT showed significantly (P <0.05) larger body measurement and improved carcass quality traits. Haplotype H1 (GCA) showed significantly (p< 0.01) higher transcriptional activity (51.44%) followed by H4 (ATT) (34.13%) in bovine preadipocytes. The diplotypes HI-H3 (GG-CC-AT), H1-H2 (GG-CT-AT) and H3-H4 (GA-CT-TT) showed significant (P< 0.01) associations with body measurement and improved carcass quality traits. Analysis of the relative mRNA expression level of the TORC2 gene in different tissues within two different age groups revealed a significant increase (P< 0.01) in liver, small intestine, muscle and fat tissues with growth from calf stage to adult stage. We can conclude that variants mapped within TORC2 can be used in marker-assisted selection for carcass quality and body measurement traits in breed improvement programs of Qinchuan cattle.	[Khan, Rajwali; Raza, Sayed Haidar Abbas; Guo, Hongfang; Wang Xiaoyu; Wu Sen; Zan, Linsen] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Wu Sen] Qinghai Univ, Qinghai Acad Anim Sci & Vet Med, Xining, Peoples R China; [Suhail, Syed Muhammad; Rahman, Abdur] Univ Agr Peshawar, Dept Livestock Management Breeding & Genet, Peshawar, Pakistan; [Ullah, Irfan] Chongqing Univ, Coll Biomed Engn, Chongqing, Peoples R China; [Abd El-Aziz, Ayman Hassan] Damanhour Univ, Fac Vet Med, Anim Husb & Anim Wealth Dev Dept, Damanhour, Egypt; [Manzari, Zeinab] Univ Tehran, Coll Agr & Nat Resources, Dept Anim Sci, Karaj, Iran; [Alshawi, Akil] Univ Nottingham, Sch Life Sci, Nottingham, England; [Zan, Linsen] Natl Beef Cattle Improvement Res Ctr, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Qinghai University; Chongqing University; Egyptian Knowledge Bank (EKB); Damanhour University; University of Tehran; University of Nottingham	Zan, LS (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.; Zan, LS (corresponding author), Natl Beef Cattle Improvement Res Ctr, Yangling, Shaanxi, Peoples R China.	zanlinsen@163.com	Alshawi, Akil/AAW-2938-2020; Abd El-Aziz, Ayman H./AAG-5126-2019; Khan, Rajwali/N-2609-2019; Raza, Sayed Haidar Abbas/P-8095-2017	Alshawi, Akil/0000-0003-0527-4273; Abd El-Aziz, Ayman H./0000-0002-8306-0011; Khan, Rajwali/0000-0001-5191-3457; Wu, Sen/0000-0001-5244-4293; Raza, Sayed Haidar Abbas/0000-0002-0961-1911	National Science and Technology Support Projects [2015BAD03B04]; National 863 Program of China [2013AA102505]; National Modern Agricultural Industry Special Program [CARS-37]; National Key Research and Development Program of China [2018YFD0501700]; Technical Innovation Engineering Project of Shaanxi Province [2016 KTCL02-15]	National Science and Technology Support Projects; National 863 Program of China(National High Technology Research and Development Program of China); National Modern Agricultural Industry Special Program; National Key Research and Development Program of China; Technical Innovation Engineering Project of Shaanxi Province	The study was supported by the National Science and Technology Support Projects (No. 2015BAD03B04); National 863 Program of China (No.2013AA102505); the National Modern Agricultural Industry Special Program (No. CARS-37); National Key Research and Development Program of China (No. 2018YFD0501700) and Technical Innovation Engineering Project of Shaanxi Province (#2016 KTCL02-15).	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; [Anonymous], 2005, NUTS BOLTS SERIES; [Anonymous], 2006, ANNU REV NUTR, V26, P22; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Canettieri G, 2005, CELL METAB, V2, P331, DOI 10.1016/j.cmet.2005.09.008; Chen JEKaJ, 2004, DIABETES, V53, P8; Choi SH, 2013, J NUTR BIOCHEM, V24, P539, DOI 10.1016/j.jnutbio.2012.01.015; de Roos APW, 2007, J DAIRY SCI, V90, P4821, DOI 10.3168/jds.2007-0158; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Fragomeni BO, 2019, J DAIRY SCI, V102, P10012, DOI 10.3168/jds.2019-16262; Gilbert RB D., 1993, J ANIM SCI, V71, P8; Goodman MN MM, 1981, AM J PHYSIOL, V241, P7; Gui LS, 2017, MOL CELL PROBE, V32, P40, DOI 10.1016/j.mcp.2016.12.002; Gui LSZ Y.R, 2015, INT J MOL SCI, V16, P13; Guillaume F, 2008, GENET SEL EVOL, V40, P91, DOI 10.1051/gse:2007036; Guo H, 2018, GENE, V672, P50, DOI 10.1016/j.gene.2018.06.022; Haldar SM, 2012, P NATL ACAD SCI USA, V109, P6739, DOI 10.1073/pnas.1121060109; Han J LE, 2015, NATURE, V524, P3; He LQ, 2017, J AGR FOOD CHEM, V65, P2287, DOI 10.1021/acs.jafc.7b00324; Herzig FL, 2001, NATURE, V413, P5; Hill MJ, 2016, MOL ENDOCRINOL, V30, P104, DOI 10.1210/me.2015-1237; Hongfang Guo R, 2018, GENE, V659, P6; Khan R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184338; Kim ES, 2015, PLOS ONE, V10; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Le Lay J, 2009, CELL METAB, V10, P55, DOI 10.1016/j.cmet.2009.06.006; Le Zhang YN, 2018, DNA CELL BIOL, V37, P9; Liu SL, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0527-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mei CG, POLYMORPHISMS ADRENE; Meuwissen THE, 2001, GENETICS, V157, P1819; MICAH J, 2016, MOL ENDOCRINOL, V30, P104, DOI DOI 10.1210/ME.2015-1237; MNAAK ROYCHOUDHURY, 1974, GENETICS, V76, P11; Morris MJPJF, 2000, GENE, V254, P13; National Academies of Sciences E and Medicine, 2016, NUTR REQ BEEF CATTL; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Prosdocimo DA, 2015, TRENDS CARDIOVAS MED, V25, P10, DOI [10.1016/j.tcm.2014.09.007, DOI 10.1016/J.TCM.2014.09.007]; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Rahnert JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159181; Raza SHA, 2020, GENOMICS, V112, P423, DOI 10.1016/j.ygeno.2019.03.005; Raza SHA, 2018, GENE, V645, P55, DOI 10.1016/j.gene.2017.12.034; Renaud Dentin SH, 2008, SCIENCE, V319, P4; Saberi M, NOVEL LIVER SPECIFIC; Saberi M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1137, DOI 10.1152/ajpendo.00158.2009; Samarajeewa NU, 2013, HORM CANC, V4, P8; Sambrook J., 2001, MOL CLONING LAB MANU; Schaeffer LR, 2006, J ANIM BREED GENET, V123, P218, DOI 10.1111/j.1439-0388.2006.00595.x; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; Sun PZ R.J, 2011, FEBS J, V278, P7; Tjian BLaR, 2000, GENE DEV, V14, P19; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Wei DW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08384-1; Wei DW, 2018, GENE, V656, P9, DOI 10.1016/j.gene.2018.02.059; Whitington T, 2009, NUCLEIC ACIDS RES, V37, P14, DOI 10.1093/nar/gkn866; Wu S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041035; Wu Z, 2013, DEV BIOL, V373, P8; Xu HC, 2015, GENET MOL RES, V14, P12912, DOI 10.4238/2015.October.21.12; Yeh F.C, 1999, POPGENE VER 1 31; Zhao ZD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19661	65	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0227254	10.1371/journal.pone.0227254	http://dx.doi.org/10.1371/journal.pone.0227254			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7VI	32059009	gold, Green Published			2022-12-26	WOS:000535206600005
J	Anders, N; Eide, I; Lerfall, J; Roth, B; Breen, M				Anders, Neil; Eide, Ida; Lerfall, Jorgen; Roth, Bjorn; Breen, Michael			Physiological and flesh quality consequences of pre-mortem crowding stress in Atlantic mackerel (Scomber scombrus)	PLOS ONE			English	Article							COD GADUS-MORHUA; PERCH PERCA-FLUVIATILIS; CLUPEA-HARENGUS L; PRE-SLAUGHTER; RAINBOW-TROUT; ONCORHYNCHUS-MYKISS; SEASONAL-VARIATIONS; POSTMORTEM CHANGES; KILLING PROCEDURES; SWIMMING SPEEDS	In commercial wild capture pelagic fisheries it is common practice to crowd catches to high densities to allow efficient pumping onboard. Crowding during the final stages of purse seine capture for small pelagic species often results in intense and sustained behavioural escape responses. Such a response may trigger a shift in energy production from aerobic to anaerobic pathways and result in metabolic acid accumulation and exhaustion of intracellular reserves of ATP. Where there is insufficient time or opportunity to recover to physiological equilibrium before death, pre-mortem stress may be an important determinant of fillet quality, as has been shown for a variety of farmed fish species. However, there is currently a lack of knowledge related to the flesh quality implications of capture stress for wild captured species in European waters. Here we show that crowding results in a physiological stress response that has consequences for flesh quality in the wild captured species Atlantic mackerel (Scomber scombrus). Using small schools in tanks and aquaculture net pens in three separate experiments, we found crowding results in physiological changes in mackerel consistent with an acute stress response and anaerobic metabolism. Consequently, we found crowded fish had more acidic pre- and post-mortem muscle pH as well as indications of faster onset and strength of rigor mortis and increased cathepsin B & L activity. We examined fillet flesh quality after two and seven days of ice storage and found reduced green colouration, increased gaping (separation of muscle myotomes) and reduced textural firmness associated with fish which had been crowded. However, the effects on quality were dependant on experiment and/or storage time. These results indicate the potential of crowding capture stress to influence the flesh quality of an economically important species and may have important implications for the wild capture pelagic fishing industry.	[Anders, Neil; Breen, Michael] Inst Marine Res IMR, Fish Capture Div, Bergen, Norway; [Anders, Neil] Univ Bergen, Dept Biol Sci, Bergen, Norway; [Eide, Ida; Lerfall, Jorgen] Norwegian Univ Sci & Technol NTNU, Dept Biotechnol & Food Sci, Trondheim, Norway; [Roth, Bjorn] Nofima, Dept Proc Technol, Stavanger, Norway	Institute of Marine Research - Norway; University of Bergen; Norwegian University of Science & Technology (NTNU); Nofima	Anders, N (corresponding author), Inst Marine Res IMR, Fish Capture Div, Bergen, Norway.; Anders, N (corresponding author), Univ Bergen, Dept Biol Sci, Bergen, Norway.	neil.anders@hi.no		Lerfall, Jorgen/0000-0001-6243-0880	Norwegian Seafood Research Fund (Fiskeri-og Havbruksnaeringens Forskningsfond) [901350]; Norwegian Research Council [203477/O30]	Norwegian Seafood Research Fund (Fiskeri-og Havbruksnaeringens Forskningsfond); Norwegian Research Council(Research Council of NorwayEuropean Commission)	Funding for this work was provided to MB by the Norwegian Seafood Research Fund (Fiskeri-og Havbruksnaeringens Forskningsfond, Project No. 901350). NA was financed by a Norwegian Research Council grant (Project No. 203477/O30) to the Centre for Research-based Innovation in Sustainable Fish Capture and Processing Technology (CRISP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213709; Ando M, 2001, FISHERIES SCI, V67, P744, DOI 10.1046/j.1444-2906.2001.00315.x; [Anonymous], 2009, ATP DERIVED PRODUCTS, DOI DOI 10.1002/9781444322668.CH4; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 1998, ANIMAL WELFARE MEAT; [Anonymous], 2015, FORSKRIFT BRUK DYR I; Aoki T, 1997, FOOD RES INT, V30, P585, DOI 10.1016/S0963-9969(98)00014-3; Bagni M, 2007, AQUACULTURE, V263, P52, DOI 10.1016/j.aquaculture.2006.07.049; Bahuaud D, 2010, FOOD CHEM, V118, P602, DOI 10.1016/j.foodchem.2009.05.028; BARTON BA, 1988, PROG FISH CULT, V50, P16, DOI 10.1577/1548-8640(1988)050&lt;0016:FADCAS&gt;2.3.CO;2; Bito M, 1983, B TOKAI REG FISH RES; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Borderias AJ, 2011, J FOOD SCI, V76, pR1, DOI 10.1111/j.1750-3841.2010.01900.x; Brinkhof J, 2018, FISH RES, V206, P209, DOI 10.1016/j.fishres.2018.05.021; Burt JR, 1970, INT J FOOD SCI TECH, V5, P339, DOI [10.1111/j.1365-2621.1970.tb01578.x, DOI 10.1111/J.1365-2621.1970.TB01578.X]; Cheng JH, 2014, COMPR REV FOOD SCI F, V13, P52, DOI 10.1111/1541-4337.12043; Cheret R, 2007, FOOD CHEM, V101, P1474, DOI 10.1016/j.foodchem.2006.04.023; Cicia AM, 2012, COMP BIOCHEM PHYS A, V162, P130, DOI 10.1016/j.cbpa.2011.06.003; Clark TD, 2011, J FISH BIOL, V79, P1322, DOI 10.1111/j.1095-8649.2011.03118.x; Cooke SJ, 2013, FISHERIES MANAG ECOL, V20, P268, DOI 10.1111/j.1365-2400.2012.00867.x; Crawley EF, 2007, RETHINKING ENGINEERING EDUCATION: THE CDIO APPROACH, P1, DOI 10.1007/978-0-387-38290-6; DANDO PR, 1969, J MAR BIOL ASSOC UK, V49, P209, DOI 10.1017/S002531540004652X; Dickson KA, 1996, COMP BIOCHEM PHYS A, V113, P39, DOI 10.1016/0300-9629(95)02056-X; Digre H, 2016, FISH RES, V176, P65, DOI 10.1016/j.fishres.2015.12.011; Digre H, 2010, FISHERIES SCI, V76, P549, DOI 10.1007/s12562-010-0254-2; Donnelly Trochim, 2015, RES METHODS ESSENTIA; Driedzic WR, 1978, FISH PHYSL 7 LOCOMOT, P503; Duinker A, 2014, 900786 NAT I NUR SEA; DUNAJSKI E, 1980, J TEXTURE STUD, V10, P301, DOI 10.1111/j.1745-4603.1980.tb00862.x; Eldridge WH, 2015, CAN J FISH AQUAT SCI, V72, P1527, DOI 10.1139/cjfas-2014-0350; Erikson U, 2008, J FOOD SCI, V73, pC50, DOI 10.1111/j.1750-3841.2007.00617.x; Farrell AP, 2001, COMP BIOCHEM PHYS A, V128, P551, DOI 10.1016/S1095-6433(00)00335-4; Gezelius SS, 2006, MAR POLICY, V30, P462, DOI 10.1016/j.marpol.2005.06.004; GILLERMAN RG, 1980, J FISH BIOL, V17, P31, DOI 10.1111/j.1095-8649.1980.tb02740.x; Gray IE, 1930, BIOL BULL-US, V58, P217, DOI 10.2307/1537101; Grimsmo L, 2012, QUALITY MANUAL PELAG; Handegard NO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190259; HATTULA T, 1995, FISH RES, V23, P209, DOI 10.1016/0165-7836(94)00358-4; HAUX C, 1985, MAR ENVIRON RES, V15, P77, DOI 10.1016/0141-1136(85)90131-X; HE P, 1988, J FISH BIOL, V33, P255, DOI 10.1111/j.1095-8649.1988.tb05468.x; HOLETON GF, 1982, CAN J ZOOL, V60, P1141, DOI 10.1139/z82-159; Hultmann L, 2012, FOOD CHEM, V134, P1399, DOI 10.1016/j.foodchem.2012.03.038; Huse I, 2010, FISH RES, V106, P54, DOI 10.1016/j.fishres.2010.07.001; Huss H.H., 1988, FRESH FISH QUALITY Q; ICES, 2018, REPORT WORKING GROUP; Jerrett AR, 1996, J FOOD SCI, V61, P527, DOI 10.1111/j.1365-2621.1996.tb13149.x; JOHNSTONE ADF, 1993, J FISH BIOL, V42, P149, DOI 10.1006/jfbi.1993.1014; Kieffer JD, 2000, COMP BIOCHEM PHYS A, V126, P161, DOI 10.1016/S1095-6433(00)00202-6; Kiessling A, 2004, AQUACULTURE, V236, P645, DOI 10.1016/j.aquaculture.2004.02.030; Killen SS, 2013, TRENDS ECOL EVOL, V28, P651, DOI 10.1016/j.tree.2013.05.005; Klefoth T, 2017, EVOL APPL, V10, P994, DOI 10.1111/eva.12504; KORCOCK DE, 1988, J FISH BIOL, V33, P319, DOI 10.1111/j.1095-8649.1988.tb05474.x; LARSSON AL, 1973, GEN COMP ENDOCR, V20, P155, DOI 10.1016/0016-6480(73)90141-X; LEMON DW, 1977, J FISH RES BOARD CAN, V34, P439, DOI 10.1139/f77-073; Lerfall J, 2015, FOOD CHEM, V175, P157, DOI 10.1016/j.foodchem.2014.11.111; LOCKWOOD SJ, 1983, FISH RES, V2, P129, DOI 10.1016/0165-7836(83)90114-5; Marcalo A, 2006, MAR BIOL, V149, P1509, DOI 10.1007/s00227-006-0277-5; Marcalo A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195433; Marcalo A, 2010, ICES J MAR SCI, V67, P334, DOI 10.1093/icesjms/fsp244; Marx H, 1997, Z LEBENSM UNTERS F A, V204, P282, DOI 10.1007/s002170050078; Matos E, 2010, AQUACULTURE, V305, P66, DOI 10.1016/j.aquaculture.2010.04.020; Miyazaki R., 2018, JPN J FOOD CHEM SAF, V25, P139; Mochizuki S, 1996, NIPPON SUISAN GAKK, V62, P453; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; MUKUNDAN MK, 1986, FISH RES, V4, P259, DOI 10.1016/0165-7836(86)90007-X; Ogata Y., 2016, Journal of FisheriesSciences.com, V10, P83; Olsen RE, 2005, AQUACULTURE, V250, P480, DOI 10.1016/j.aquaculture.2005.03.014; Olsen RE, 2012, FISH PHYSIOL BIOCHEM, V26, P211; Olsen SH, 2006, AQUACULTURE, V258, P462, DOI 10.1016/j.aquaculture.2006.04.047; Olsen SH, 2013, FISH RES, V147, P446, DOI 10.1016/j.fishres.2013.03.009; Pawson M.G., 1980, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V177, P439; Plataniotis K., 2013, COLOR IMAGE PROCESSI; Poli BM, 2005, AQUACULT INT, V13, P29, DOI 10.1007/s10499-004-9035-1; Rehbein H., 2009, FISHERY PRODUCTS QUA; Robb DHF, 2000, AQUACULTURE, V182, P261, DOI 10.1016/S0044-8486(99)00273-2; Robergs RA, 2004, AM J PHYSIOL-REG I, V287, pR502, DOI 10.1152/ajpregu.00114.2004; Romotowska PE, 2017, LWT-FOOD SCI TECHNOL, V83, P275, DOI 10.1016/j.lwt.2017.05.024; Rotabakk BT, 2011, FISH RES, V112, P44, DOI 10.1016/j.fishres.2011.08.009; Roth B, 2005, AQUACULTURE, V250, P796, DOI 10.1016/j.aquaculture.2005.03.010; Roth B, 2006, AQUACULTURE, V257, P504, DOI 10.1016/j.aquaculture.2005.10.021; Roth B, 2012, AQUACULTURE, V326, P178, DOI 10.1016/j.aquaculture.2011.11.005; Roth B, 2009, AQUACULTURE, V289, P350, DOI 10.1016/j.aquaculture.2009.01.013; SANDSTROM O, 1983, CAN J ZOOL, V61, P1475, DOI 10.1139/z83-198; Sato K, 2002, J FOOD BIOCHEM, V26, P415, DOI 10.1111/j.1745-4514.2002.tb00763.x; Schreck CB, 2016, FISH PHYSIOL, V35, P1, DOI 10.1016/B978-0-12-802728-8.00001-1; SHIMIZU Y, 1986, B JPN SOC SCI FISH, V52, P1837; Skipnes D, 2007, J FOOD ENG, V80, P1078, DOI 10.1016/j.jfoodeng.2006.08.015; Skjervold PO, 2001, AQUACULTURE, V192, P265, DOI 10.1016/S0044-8486(00)00447-6; Sogn-Grundvag G, 2019, MAR POLICY, V104, P232, DOI 10.1016/j.marpol.2018.06.011; Sone I, 2019, EUR FOOD RES TECHNOL, V245, P775, DOI 10.1007/s00217-018-3222-1; Sopinka NM, 2016, FISH PHYSIOL, V35, P405, DOI 10.1016/B978-0-12-802728-8.00011-4; Stien LH, 2005, AQUAC RES, V36, P1197, DOI 10.1111/j.1365-2109.2005.01339.x; Stoot LJ, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou011; Suvanich V, 1998, J FOOD SCI, V63, P966; Svalheim RA, SIMULATED TRAWLING E, DOI [10.1101/372581, DOI 10.1101/372581]; SWIFT DJ, 1983, COMP BIOCHEM PHYS A, V76, P795, DOI 10.1016/0300-9629(83)90143-3; Takei Y, 2016, FISH PHYSIOL, V35, P207, DOI 10.1016/B978-0-12-802728-8.00006-0; Tamotsu S, 2012, NIPPON SUISAN GAKK, V78, P454, DOI 10.2331/suisan.78.454; Tenningen M, 2012, ICES J MAR SCI, V69, P1523, DOI 10.1093/icesjms/fss114; WARDLE CS, 1988, J FISH BIOL, V32, P471, DOI 10.1111/j.1095-8649.1988.tb05382.x; Wardle CS., 1993, BEHAV TELEOST FISHES, P463, DOI DOI 10.1007/978-1-4684-8261-4_18; WOOD CM, 1983, J FISH BIOL, V22, P189, DOI 10.1111/j.1095-8649.1983.tb04739.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	104	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228454	10.1371/journal.pone.0228454	http://dx.doi.org/10.1371/journal.pone.0228454			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053624	Green Published, Green Submitted, gold			2022-12-26	WOS:000535198700028
J	Nyondo-Mipando, AL; Kinshella, MLW; Bohne, C; Suwedi-Kapesa, LC; Salimu, S; Banda, M; Newberry, L; Njirammadzi, J; Hiwa, T; Chiwaya, B; Chikoti, F; Vidler, M; Dube, Q; Molyneux, E; Mfutso-Bengo, J; Goldfarb, DM; Kawaza, K; Mijovic, H				Nyondo-Mipando, Alinane Linda; Kinshella, Mai-Lei Woo; Bohne, Christine; Suwedi-Kapesa, Leticia Chimwemwe; Salimu, Sangwani; Banda, Mwai; Newberry, Laura; Njirammadzi, Jenala; Hiwa, Tamanda; Chiwaya, Brandina; Chikoti, Felix; Vidler, Marianne; Dube, Queen; Molyneux, Elizabeth; Mfutso-Bengo, Joseph; Goldfarb, David M.; Kawaza, Kondwani; Mijovic, Hana			Barriers and enablers of implementing bubble Continuous Positive Airway Pressure (CPAP): Perspectives of health professionals in Malawi	PLOS ONE			English	Article							RESPIRATORY-DISTRESS; NURSES; COLLABORATION; PHYSICIANS; COUNTRIES; INFANTS	Background Preterm birth complications are the leading cause of neonatal deaths. Malawi has high rates of preterm birth, with 18.1 preterm births per 100 live births. More than 50% of preterm neonates develop respiratory distress which if left untreated, can lead to respiratory failure and death. Term and preterm neonates with respiratory distress can often be effectively managed with Continuous Positive Airway Pressure (CPAP) and this is considered an essential intervention for the management of preterm neonates by the World Health Organization. Bubble CPAP may represent a safe and cost-effective method for delivering CPAP in low-income settings. Objective The study explored the factors that influence the implementation of bubble CPAP among health care professionals in secondary and tertiary hospitals in Malawi. Methods This was a qualitative study conducted in three district hospitals and a tertiary hospital in southern Malawi. We conducted 46 in-depth interviews with nurses, clinicians and clinical supervisors, from June to August 2018. All data were digitally recorded, transcribed verbatim and thematically analyzed. Results Factors that influenced implementation of bubble CPAP occurred in an interconnected manner and included: inadequate healthcare provider training in preparation for use, rigid division of roles and responsibilities among providers, lack of effective communication among providers and between providers and newborn's caregivers, human resource constraints, and inadequate equipment and infrastructure. Conclusion There are provider, caregiver and health system level factors that influence the implementation of bubble CPAP among neonates in Malawian health facilities. Ensuring adequate staffing in the nurseries, combined with ongoing training for providers, team cohesion, improved communication with caregivers, and improved hospital infrastructure would ensure optimal utilization of bubble CPAP and avoid inadvertent harm from inappropriate use.	[Nyondo-Mipando, Alinane Linda; Mfutso-Bengo, Joseph] Univ Malawi, Coll Med, Sch Publ Hlth & Family Med, Dept Hlth Syst & Policy, Blantyre, Malawi; [Nyondo-Mipando, Alinane Linda; Newberry, Laura; Njirammadzi, Jenala; Hiwa, Tamanda; Chiwaya, Brandina; Chikoti, Felix; Dube, Queen; Molyneux, Elizabeth; Mfutso-Bengo, Joseph; Kawaza, Kondwani] Coll Med, IMCHA Project, Blantyre, Malawi; [Kinshella, Mai-Lei Woo; Vidler, Marianne] BC Childrens & Womens Hosp, Dept Obstet & Gynaecol, Vancouver, BC, Canada; [Kinshella, Mai-Lei Woo; Vidler, Marianne; Goldfarb, David M.; Mijovic, Hana] Univ British Columbia, Vancouver, BC, Canada; [Bohne, Christine] Rice Univ, Inst Global Hlth, NEST 360, Houston, TX USA; [Suwedi-Kapesa, Leticia Chimwemwe; Salimu, Sangwani; Banda, Mwai; Newberry, Laura; Njirammadzi, Jenala; Hiwa, Tamanda; Kawaza, Kondwani] Univ Malawi, Coll Med, Dept Pediat & Child Hlth, Blantyre, Malawi; [Dube, Queen; Molyneux, Elizabeth; Kawaza, Kondwani] Queen Elizabeth Cent Hosp, Pediat, Blantyre, Malawi; [Mfutso-Bengo, Joseph] Ctr Bioeth Eastern & Southern Africa CEBESA, Blantyre, Malawi; [Goldfarb, David M.] BC Childrens & Womens Hosp, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Mijovic, Hana] BC Childrens Hosp, Dept Pediat, Vancouver, BC, Canada	University of Malawi; University of Malawi; University of British Columbia; University of British Columbia; Rice University; University of Malawi; University of Malawi; University of British Columbia; BC Childrens Hospital; University of British Columbia	Nyondo-Mipando, AL (corresponding author), Univ Malawi, Coll Med, Sch Publ Hlth & Family Med, Dept Hlth Syst & Policy, Blantyre, Malawi.; Nyondo-Mipando, AL (corresponding author), Coll Med, IMCHA Project, Blantyre, Malawi.	lmipando@medcol.mw	Kinshella, Mai-Lei Woo/AAA-8117-2022; Goldfarb, David/ABD-4623-2021; Nyondo, Alinane/AFN-8844-2022	Kinshella, Mai-Lei Woo/0000-0001-5846-3014; Nyondo, Alinane/0000-0002-3572-3810; Goldfarb, David/0000-0003-0835-9504; Bohne, Christine/0000-0001-8541-1324; Mitchell, Hana/0000-0002-6324-0779; Vidler, Marianne/0000-0002-7633-8812	Canadian International Development Research Centre (IDRC); Global Affairs Canada (GAC); Canadian Institutes for Health Research (CIHR) [108030]	Canadian International Development Research Centre (IDRC); Global Affairs Canada (GAC)(CGIAR); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	ALNM, KK, QD and DG were funded by the Canadian International Development Research Centre (IDRC), Global Affairs Canada (GAC) and the Canadian Institutes for Health Research (CIHR). Project ID is 108030. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S., 2016, MOBILE TECHNOLOGY SU; Ajuwon A, 2018, MALAWI MED J, V30, P120, DOI 10.4314/mmj.v30i2.12; Amudha P., 2018, J NURSING CARE, V7, P1, DOI [10.4172/2167-1168.1000455, DOI 10.4172/2167-1168.1000455]; [Anonymous], 2018, LEVELS TRENDS CHILD; Asibon A, 2020, ACTA PAEDIATR, V109, P705, DOI 10.1111/apa.15025; Atreya MR, 2018, ADV NEONAT CARE, V18, P500, DOI 10.1097/ANC.0000000000000510; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Brown J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053622; Charmaz K, 2008, HDB CONSTRUCTIONIST, V1, P397, DOI DOI 10.1016/J.DESTUD.2004.08.003; Crehan C, 2018, ARCH DIS CHILD, V103, P732, DOI 10.1136/archdischild-2017-313867; Dewez JE, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1311-8; Dewez JE, 2017, TROP DOCT, V47, P19, DOI 10.1177/0049475516630210; Earns J, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0668; Edwards MO, 2013, PAEDIATR RESPIR REV, V14, P29, DOI 10.1016/j.prrv.2012.02.002; Ekhaguere OA, 2019, PAEDIATR RESPIR REV, V29, P31, DOI 10.1016/j.prrv.2018.04.004; Fulton C, 2013, BMJ OPEN QUAL, V2; Gondwe MJ, 2017, MALAWI MED J, V29, P5, DOI 10.4314/mmj.v29i1.2; Hagbaghery Mohsen Adib, 2004, BMC Nurs, V3, P2, DOI 10.1186/1472-6955-3-2; Kallander K, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2130; Kawaza K, 2014, PLOS ONE JAN MALAWI, V299; Lancaster G, 2015, J NURS SCHOLARSHIP, V47, P275, DOI 10.1111/jnu.12130; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Martin S, 2014, ARCH DIS CHILD-FETAL, V99, pF495, DOI 10.1136/archdischild-2013-305519; McAdams RM, 2015, RESP CARE, V60, P437, DOI 10.4187/respcare.03438; McCallin A, 2009, WHAT IS GROUNDED THE; Ministry of Health and Population, 2017, HLTH SECT STRAT PLAN; Myhre J, 2016, J TROP PEDIATRICS, V62, P385, DOI 10.1093/tropej/fmw023; Nahimana E, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0449-x; Ntigurirwa P, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-017-0252-6; O'Regan Stephanie, 2016, Adv Simul (Lond), V1, P4, DOI 10.1186/s41077-015-0004-8; Olayo B, 2019, PAEDIATR INT CHILD H, V39, P193, DOI 10.1080/20469047.2019.1624007; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Pfadenhauer LM, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0552-5; Schmalenberg C, 2009, CRIT CARE NURSE, V29, P74, DOI 10.4037/ccn2009436; Tang CJ, 2013, INT NURS REV, V60, P291, DOI 10.1111/inr.12034; Thukral A, 2016, J PERINATOL, V36, pS21, DOI 10.1038/jp.2016.29; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Van den Heuvel M, 2011, ANN TROP PAEDIATR, V31, P59, DOI 10.1179/1465328110Y.0000000001; Willemse Juliana J., 2015, Curationis, V38, P1, DOI [10.4102/CURATIONIS.v38i2.1512, 10.4102/curationis.v38i2.1512]	40	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228915	10.1371/journal.pone.0228915	http://dx.doi.org/10.1371/journal.pone.0228915			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053649	Green Published, gold			2022-12-26	WOS:000535198700068
J	Varley, TF; Craig, M; Adapa, R; Finoia, P; Williams, G; Allanson, J; Pickard, J; Menon, DK; Stamatakis, EA				Varley, Thomas F.; Craig, Michael; Adapa, Ram; Finoia, Paola; Williams, Guy; Allanson, Judith; Pickard, John; Menon, David K.; Stamatakis, Emmanuel A.			Fractal dimension of cortical functional connectivity networks & severity of disorders of consciousness	PLOS ONE			English	Article							COMPLEXITY-MEASURES; SMALL-WORLD; BRAIN; EEG; ANESTHESIA; DEPTH; INFORMATION; INTEGRATION; ENTROPY; SURFACE	Recent evidence suggests that the quantity and quality of conscious experience may be a function of the complexity of activity in the brain and that consciousness emerges in a critical zone between low and high-entropy states. We propose fractal shapes as a measure of proximity to this critical point, as fractal dimension encodes information about complexity beyond simple entropy or randomness, and fractal structures are known to emerge in systems nearing a critical point. To validate this, we tested several measures of fractal dimension on the brain activity from healthy volunteers and patients with disorders of consciousness of varying severity. We used a Compact Box Burning algorithm to compute the fractal dimension of cortical functional connectivity networks as well as computing the fractal dimension of the associated adjacency matrices using a 2D box-counting algorithm. To test whether brain activity is fractal in time as well as space, we used the Higuchi temporal fractal dimension on BOLD time-series. We found significant decreases in the fractal dimension between healthy volunteers (n = 15), patients in a minimally conscious state (n = 10), and patients in a vegetative state (n = 8), regardless of the mechanism of injury. We also found significant decreases in adjacency matrix fractal dimension and Higuchi temporal fractal dimension, which correlated with decreasing level of consciousness. These results suggest that cortical functional connectivity networks display fractal character and that this is associated with level of consciousness in a clinically relevant population, with higher fractal dimensions (i.e. more complex) networks being associated with higher levels of consciousness. This supports the hypothesis that level of consciousness and system complexity are positively associated, and is consistent with previous EEG, MEG, and fMRI studies.	[Varley, Thomas F.; Craig, Michael; Adapa, Ram; Finoia, Paola; Menon, David K.; Stamatakis, Emmanuel A.] Univ Cambridge, Sch Clin Med, Div Anaesthesia, Cambridge, Cambs, England; [Williams, Guy; Pickard, John; Menon, David K.] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, Cambs, England; [Allanson, Judith] Addenbrookes Hosp, Dept Neurorehabil, Cambridge, Cambs, England; [Pickard, John] Univ Cambridge, Sch Clin Med, Div Neurosurg, Cambridge, Cambs, England; [Varley, Thomas F.; Craig, Michael; Stamatakis, Emmanuel A.] Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge, Cambs, England; [Varley, Thomas F.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA	University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge; Indiana University System; Indiana University Bloomington	Varley, TF (corresponding author), Univ Cambridge, Sch Clin Med, Div Anaesthesia, Cambridge, Cambs, England.; Varley, TF (corresponding author), Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge, Cambs, England.; Varley, TF (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	tvarley@iu.edu	Adapa, Ram/D-7925-2012	Adapa, Ram/0000-0002-9845-8532; Williams, Guy/0000-0001-5223-6654; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601; Menon, David/0000-0002-3228-9692	Wellcome Trust Clinical Research Training Fellowship [083660/Z/07/Z]; UK Medical Research Council [U.1055.01.002.00001.01]; James S. McDonnell Foundation; Evelyn Trust, Cambridge; National Institute for Health Research (NIHR, UK); Cambridge Biomedical Research Centre; NIHR Senior Investigator Awards; Canadian Institute for Advanced Research (CIFAR); Stephen Erskine Fellowship (Queens' College, Cambridge); British Oxygen Professorship of the Royal College of Anaesthetists; Cambridge International Trust; Howard Sidney Sussex Research Studentship; NSF-NRT grant [1735095]; EoE CLAHRC fellowship; NIHR Brain Injury Healthcare Technology Co-operative based at Cambridge University Hospitals NHS Foundation Trust and University of Cambridge	Wellcome Trust Clinical Research Training Fellowship(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); James S. McDonnell Foundation; Evelyn Trust, Cambridge; National Institute for Health Research (NIHR, UK)(National Institute for Health Research (NIHR)); Cambridge Biomedical Research Centre(General Electric); NIHR Senior Investigator Awards; Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Stephen Erskine Fellowship (Queens' College, Cambridge); British Oxygen Professorship of the Royal College of Anaesthetists; Cambridge International Trust; Howard Sidney Sussex Research Studentship; NSF-NRT grant; EoE CLAHRC fellowship; NIHR Brain Injury Healthcare Technology Co-operative based at Cambridge University Hospitals NHS Foundation Trust and University of Cambridge	This work was supported by grants from the Wellcome Trust Clinical Research Training Fellowship to RMA (Contract grant number: 083660/Z/07/Z); the UK Medical Research Council [U.1055.01.002.00001.01 to JDP; the James S. McDonnell Foundation to JDP; the Evelyn Trust, Cambridge to JA, the National Institute for Health Research (NIHR, UK), Cambridge Biomedical Research Centre and NIHR Senior Investigator Awards to JDP and DKM; The Canadian Institute for Advanced Research (CIFAR) to DKM and EAS; the Stephen Erskine Fellowship (Queens' College, Cambridge) to EAS; the British Oxygen Professorship of the Royal College of Anaesthetists to DKM. MC was supported by the Cambridge International Trust and the Howard Sidney Sussex Research Studentship. TFV is supported by NSF-NRT grant 1735095, Interdisciplinary Training in Complex Networks and Systems. This work was also supported by the Evelyn Trust, Cambridge and the EoE CLAHRC fellowship to J.A and the NIHR Brain Injury Healthcare Technology Co-operative based at Cambridge University Hospitals NHS Foundation Trust and University of Cambridge.; This work was supported by grants from the Wellcome Trust Clinical Research Training Fellowship to RMA (Contract grant number: 083660/Z/07/Z); the UK Medical Research Council [U.1055.01.002.00001.01 to JDP; the James S. McDonnell Foundation to JDP; the Evelyn Trust, Cambridge to JA, the National Institute for Health Research (NIHR, UK), Cambridge Biomedical Research Centre and NIHR Senior Investigator Awards to JDP and DKM; The Canadian Institute for Advanced Research (CIFAR) to DKM and EAS; the Stephen Erskine Fellowship (Queens' College, Cambridge) to EAS; the British Oxygen Professorship of the Royal College of Anaesthetists to DKM. MC was supported by the Cambridge International Trust and the Howard Sidney Sussex Research Studentship. TFV is supported by NSF-NRT grant 1735095, Interdisciplinary Training in Complex Networks and Systems. The Evelyn Trust, Cambridge and the EoE CLAHRC fellowship to J.A; this research was also supported by the NIHR Brain Injury Healthcare Technology Co-operative based at Cambridge University Hospitals NHS Foundation Trust and University of Cambridge. We would like to thank Victoria Lupson and the staff in the Wolfson Brain Imaging Centre (WBIC) at Addenbrooke's Hospital for their assistance in scanning. We would like to thank Dian Lu and Andrea Luppi for useful discussions, and all the participants for their contribution to this study.	Adapa RM, 2014, HUM BRAIN MAPP, V35, P2935, DOI 10.1002/hbm.22375; [Anonymous], 2007, REV CUB ALIMENT NU S, V17, pS20; Atasoy S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17546-0; Baianu I. C., 2007, AXIOMATHES, V17, P223, DOI DOI 10.1007/S10516-007-9011-2; Bao FS, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/406391; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Beggs JM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00163; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bornas X, 2013, INT J PSYCHOL, V48, P695, DOI 10.1080/00207594.2012.671945; Carhart-Harris RL, 2018, NEUROPHARMACOLOGY, V142, P167, DOI 10.1016/j.neuropharm.2018.03.010; Carhart-Harris RL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00020; Chen Y, 2016, EQUIVALENT RELATION; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cocchi L, 2017, PROG NEUROBIOL, V158, P132, DOI 10.1016/j.pneurobio.2017.07.002; CORBIT JD, 1995, P ROY SOC B-BIOL SCI, V262, P1, DOI 10.1098/rspb.1995.0168; Di Ieva A, 2015, NEUROSCIENTIST, V21, P30, DOI 10.1177/1073858413513928; Di Ieva A, 2014, NEUROSCIENTIST, V20, P403, DOI 10.1177/1073858413513927; Ferenets R, 2006, IEEE T BIO-MED ENG, V53, P1067, DOI 10.1109/TBME.2006.873543; Gallos LK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00123; Gallos LK, 2012, P NATL ACAD SCI USA, V109, P2825, DOI 10.1073/pnas.1106612109; GERLACH M, 2019, BRIT J ANAESTH, V122, DOI DOI 10.1103/PHYSREVLETT.122.168301; Ha TH, 2005, NEUROSCI LETT, V384, P172, DOI 10.1016/j.neulet.2005.04.078; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; HIGUCHI T, 1988, PHYSICA D, V31, P277, DOI 10.1016/0167-2789(88)90081-4; Ibanez-Molina A, 2014, COMP THEORETICAL EXP; Im K, 2006, HUM BRAIN MAPP, V27, P994, DOI 10.1002/hbm.20238; Jones E., 2001, SCIPY OPEN SOURCE SC; Joosten JJ, 2016, ADV MATH PHYS, V2016, DOI 10.1155/2016/5030593; Kanders K, 2017, CHAOS, V27, DOI 10.1063/1.4978998; Ke DG, 2013, SCI REP-UK, V3, DOI 10.1038/srep01585; Kesic S, 2016, COMPUT METH PROG BIO, V133, P55, DOI 10.1016/j.cmpb.2016.05.014; Kim H, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00042; King RD, 2009, BRAIN IMAGING BEHAV, V3, P154, DOI 10.1007/s11682-008-9057-9; Klonowski W., 2005, SLEEP EEG ANAL USING, P4; Klonowski W, 2010, J PSYCHOPHYSIOL, V24, P131, DOI 10.1027/0269-8803/a000024; Koch C, 2016, NAT REV NEUROSCI, V17, P307, DOI 10.1038/nrn.2016.22; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Liu XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092182; Mitchell M., 2009, COMPLEXITY GUIDED TO; Mustafa N, 2012, NEUROIMAGE, V61, P694, DOI 10.1016/j.neuroimage.2012.03.088; Pappas I, 2019, NEUROIMAGE, V186, P221, DOI 10.1016/j.neuroimage.2018.10.078; Pereda E, 1998, NEUROSCI LETT, V250, P91, DOI 10.1016/S0304-3940(98)00435-2; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; de Miras JR, 2019, COMPUT METH PROG BIO, V175, P129, DOI 10.1016/j.cmpb.2019.04.017; Sarasso S, 2014, CLIN EEG NEUROSCI, V45, P40, DOI 10.1177/1550059413513723; Schaefer A., 2018, BIORXIV, DOI [10.1093/cercor/bhx179, DOI 10.1093/CERCOR/BHX179]; Schartner M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133532; Schartner MM, 2017, NEUROSCI CONSCIOUS, V3, DOI 10.1093/nc/niw022; Schartner MM, 2017, SCI REP-UK, V7, DOI 10.1038/srep46421; Shew WL, 2011, J NEUROSCI, V31, P55, DOI 10.1523/JNEUROSCI.4637-10.2011; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Solhjoo S, 2005, P ANN INT IEEE EMBS, P2041, DOI 10.1109/IEMBS.2005.1616858; Song CM, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/03/P03006; Spasic S, 2011, FRACTALS, V19, P113, DOI 10.1142/S0218348X1100521X; Stamatakis EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014224; Tagliazucchi E, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.1027; Tagliazucchi E, 2014, HUM BRAIN MAPP, V35, P5442, DOI 10.1002/hbm.22562; Timme NM, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00425; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Tononi G, 2008, BIOL BULL-US, V215, P216, DOI 10.2307/25470707; Varley TF, 2019, SEROTONERGIC PSYCHED, P517847; Viol A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06854-0; Voitalov I., 2018, ARXIV181102071; Wang J, 2017, NEUROSCI LETT, V653, P320, DOI 10.1016/j.neulet.2017.05.045; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Yang HD, 2012, J NEUROSCI, V32, P1061, DOI 10.1523/JNEUROSCI.2771-11.2012; Zhang XS, 2001, IEEE T BIO-MED ENG, V48, P1424, DOI 10.1109/10.966601; ZIV J, 1978, IEEE T INFORM THEORY, V24, P530, DOI 10.1109/TIT.1978.1055934; Zmeskal O, 2013, COMPUT MATH APPL, V66, P135, DOI 10.1016/j.camwa.2013.01.017	71	17	17	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0223812	10.1371/journal.pone.0223812	http://dx.doi.org/10.1371/journal.pone.0223812			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KQ8WL	32053587	Green Published, gold			2022-12-26	WOS:000517202100001
J	Kadin, ME; Hamilton, RG; Vonderheid, EC				Kadin, Marshall E.; Hamilton, Robert G.; Vonderheid, Eric C.			Evidence linking atopy and staphylococcal superantigens to the pathogenesis of lymphomatoid papulosis, a recurrent CD30+cutaneous lymphoproliferative disorder	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; MYCOSIS-FUNGOIDES; CD30; PROGRESSION; CHILDREN	Background Primary cutaneous CD30+ lymphoproliferative disorders (CD30CLPD) are the second most common type of cutaneous T cell lymphoma (CTCL) and include lymphomatoid papulosis (LyP) and primary cutaneous anaplastic large cell lymphoma (pcALCL). Case reports and small patient series suggest an association of CD30CLPD with atopic disorders. However, the prevalence of atopy in patients with CD30CLPD in retrospective studies depends on patients' recall which is not always reliable. More objective criteria of atopy include evidence of skin reactivity to allergens (positive prick test) and evidence of allergen-specific IgE in serum. This study was undertaken to test the hypothesis that atopy is prevalent in patients with CD30CLPD using serologic criteria of allergen-specific IgE antibodies to aeroallergens and Staphylococcal aureus enterotoxin superantigens (SSAgs). Methods We tested serum samples of CD30CLPD for common IgE-specific airborne allergens with the Phadiatop test, which if positive, is regarded as serologic evidence of atopy in adults. Sera were also tested for IgE antibodies reactive to three Staphylococcal enterotoxins with superantigenic properties (SSAg-IgE). Control sera were obtained from adult subjects evaluated for rhino-sinusitis and a negative Phadiatop test. Patients' history of an atopic disorder was obtained by retrospective chart review. Findings Nearly 50% of patients with the most common LyP types (A and C) had a positive Phadiatop test for allergic sensitization to common airborne allergens, and total serum IgE (IgE-t) was increased compared to non-atopic controls. At the IgE antibody concentration generally used to define serologic atopy (>= 0.35 kU(A)/L), 8/31 (26%) samples of CD30CLPD and 7/28 (25%) samples of LyP were reactive to at least one SSAg-IgE compared to 3/52 (6%) control specimens (P = 0.016 and P = 0.028, respectively). TSST1-IgE was detected in 7 (23%) specimens of CD30CLPD, often together with SEB-IgE; SEA-IgE >= 0.35 kUA/L was not detected. For control specimens, TSST1-IgE exceeded the 0.35 kU(A)/L threshold in 3 (6%) specimens. Conclusions Patients with LyP types A and C have serologic evidence of atopy against common airborne antigens and SSAgs when compared to control adult subjects who had rhino-sinusitis and a negative Phadiatop test for aero-IgEs. Serologic evidence of atopy exceeded that determined by LyP patients' personal history. The findings support our hypothesis that an atopic diathesis may contribute to the pathogenesis of the most common types of LyP (A and C).	[Kadin, Marshall E.] Boston Univ, Dept Dermatol, Boston, MA 02215 USA; [Kadin, Marshall E.] Lifespan Rhode Isl Hosp, Dept Pathol & Lab Med, Providence, RI 02903 USA; [Kadin, Marshall E.] Roger Williams Med Ctr, Dept Dermatol & Skin Surg, Providence, RI 02908 USA; [Hamilton, Robert G.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Hamilton, Robert G.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Hamilton, Robert G.] Johns Hopkins Dermatol, Allergy & Clin Immunol Reference Lab, Baltimore, MD USA; [Vonderheid, Eric C.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Vonderheid, Eric C.] Johns Hopkins Univ, Sch Med, Sydney Kimmel Canc Ctr, Baltimore, MD USA	Boston University; Lifespan Health Rhode Island; Rhode Island Hospital; Roger Williams Medical Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Kadin, ME (corresponding author), Boston Univ, Dept Dermatol, Boston, MA 02215 USA.; Kadin, ME (corresponding author), Lifespan Rhode Isl Hosp, Dept Pathol & Lab Med, Providence, RI 02903 USA.; Kadin, ME (corresponding author), Roger Williams Med Ctr, Dept Dermatol & Skin Surg, Providence, RI 02908 USA.	mkadin@me.com		Kadin, Marshall/0000-0003-1039-4384	Drs. Martin and Dorothy Spatz Foundation, Sebastopol, CA	Drs. Martin and Dorothy Spatz Foundation, Sebastopol, CA	MEK received a grant from the Drs. Martin and Dorothy Spatz Foundation, Sebastopol, CA, to support this work.	Alexander-Savino CV, 2016, ONCOTARGET, V7, P75954, DOI 10.18632/oncotarget.12488; Bonzheim I, 2004, BLOOD, V104, P3358, DOI 10.1182/blood-2004-03-1037; Chott A, 1996, J INVEST DERMATOL, V106, P696, DOI 10.1111/1523-1747.ep12345532; Davison SC, 2001, BRIT J DERMATOL, V145, P245, DOI 10.1046/j.1365-2133.2001.04341.x; Fletcher CL, 2004, ARCH DERMATOL, V140, P449, DOI 10.1001/archderm.140.4.449; Gergen PJ, 2009, J ALLERGY CLIN IMMUN, V124, P447, DOI 10.1016/j.jaci.2009.06.011; Harlin H, 2002, J IMMUNOL, V169, P2451, DOI 10.4049/jimmunol.169.5.2451; Kadin ME, 2012, J INVEST DERMATOL, V132, P703, DOI 10.1038/jid.2011.351; Kadin ME, 2001, ANN NY ACAD SCI, V941, P59; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kirby B, 2002, J AM ACAD DERMATOL, V47, pS165, DOI 10.1067/mjd.2002.106357; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Laube S, 2005, BRIT J DERMATOL, V152, P1346, DOI 10.1111/j.1365-2133.2005.06548.x; LEUNG DYM, 1995, J CLIN INVEST, V96, P2106, DOI 10.1172/JCI118263; Lindahl LM, 2019, BLOOD, V134, P1072, DOI 10.1182/blood.2018888107; Maggi L, 2017, J ALLERGY CLIN IMMUN, V139, P964, DOI 10.1016/j.jaci.2016.06.032; Miquel J, 2014, BRIT J DERMATOL, V171, P1138, DOI 10.1111/bjd.13061; Muluk NB, 2018, AM J RHINOL ALLERGY, V32, P27, DOI [10.2500/ajra.2018.32.4489, 10.1177/1945892418801083]; Nakamura S, 2011, INDIAN J DERMATOL VE, V77, DOI 10.4103/0378-6323.77496; Nijsten T, 2004, ARCH DERMATOL, V140, P306, DOI 10.1001/archderm.140.3.306; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Schlievert PM, 2019, MBIO, V10, DOI 10.1128/mBio.00214-19; Sigurdardottir SL, 2013, BRIT J DERMATOL, V168, P237, DOI 10.1111/j.1365-2133.2012.11215.x; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, pS9, DOI 10.1016/j.jaci.2011.12.979; Talpur R, 2008, BRIT J DERMATOL, V159, P105, DOI 10.1111/j.1365-2133.2008.08612.x; Vonderheid EC, 2017, CLIN DERMATOL, V2; Vonderheid EC, 2016, J CUTAN PATHOL, V43, P303, DOI 10.1111/cup.12653; WILLEMZE R, 1993, J AM ACAD DERMATOL, V28, P973, DOI 10.1016/0190-9622(93)70140-O; Willemze R, 2019, BLOOD, V133, P1703, DOI 10.1182/blood-2018-11-881268; Willerslev-Olsen A, 2013, TOXINS, V5, P1402, DOI 10.3390/toxins5081402	30	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228751	10.1371/journal.pone.0228751	http://dx.doi.org/10.1371/journal.pone.0228751			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32049976	Green Published, Green Submitted, gold			2022-12-26	WOS:000535192300024
J	Vidal, M; Desantis, A; Madelain, L				Vidal, Manuel; Desantis, Andrea; Madelain, Laurent			Irrelevant auditory and tactile signals, but not visual signals, interact with the target onset and modulate saccade latencies	PLOS ONE			English	Article							FIXATION-POINT OFFSETS; SUPERIOR COLLICULUS; WARNING SIGNALS; MULTISENSORY INTEGRATION; STIMULUS ONSET; MOTOR MAPS; MONKEY; RECALIBRATION; VENTRILOQUISM; DISTRACTORS	Saccadic eye movements bring events of interest to the center of the retina, enabling detailed visual analysis. This study explored whether irrelevant auditory (experiments A, B & F), visual (C & D) or tactile signals (E & F) delivered around the onset of a visual target modulates saccade latency. Participants were instructed to execute a quick saccade toward a target stepping left or right from a fixation position. We observed an interaction between auditory beeps or tactile vibrations and the oculomotor reaction that included two components: a warning effect resulting in faster saccades when the signal and the target were presented simultaneously; and a modulation effect with shorter-or longer-latencies when auditory and tactile signals were delivered before-or after-the target onset. Combining both modalities only increased the modulation effect to a limited extent, pointing to a saturation of the multisensory interaction with the motor control. Interestingly, irrelevant visual stimuli (black background or isoluminant noise strips in peripheral vision, flashed for 10 ms) increased saccade latency whether they were presented just before or after target onset. The lack of latency reduction with visual signals suggests that the modulation observed in the auditory and tactile experiments was not related to priming effects but rather to low-level audio- and tactile-visual integration. The increase in saccade latency observed with irrelevant visual stimuli is discussed in relation to saccadic inhibition. Our results demonstrate that signals conveying no information regarding where and when a visual target would appear modulate saccadic reactivity, much like in multisensory temporal binding, but only when these signals come from a different modality.	[Vidal, Manuel; Madelain, Laurent] Aix Marseille Univ, CNRS, Inst Neurosci la Timone, UMR 7289, Marseille, France; [Vidal, Manuel] Aix Marseille Univ, CNRS, Lab Psychol Cognit, UMR 7290, Marseille, France; [Desantis, Andrea] Off Natl Etud & Rech Aerosp, Dept Traitement Informat & Syst, Salon De Provence, France; [Desantis, Andrea] Univ Paris 05, CNRS, Integrat Neurosci & Cognit Ctr, UMR 8002, Paris, France; [Madelain, Laurent] Univ Lille, CNRS, Sci Cognit & Sci Affect, UMR 9193, Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Lille - ISITE; Universite de Lille	Vidal, M (corresponding author), Aix Marseille Univ, CNRS, Inst Neurosci la Timone, UMR 7289, Marseille, France.; Vidal, M (corresponding author), Aix Marseille Univ, CNRS, Lab Psychol Cognit, UMR 7290, Marseille, France.	manuel.vidal@univ-amu.fr		Vidal, Manuel/0000-0002-8504-1500	Agence Nationale de la Recherche [ANR-18-CE10-0001]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This research was in part funded by the Agence Nationale de la Recherche (grant number ANR-18-CE10-0001) awarded to Andrea Desantis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amlot R, 2006, EXP BRAIN RES, V168, P557, DOI 10.1007/s00221-005-0116-9; Amlot R, 2003, NEUROPSYCHOLOGIA, V41, P1, DOI 10.1016/S0028-3932(02)00139-2; Amlot R, 2011, OXFORD HDB EYE MOVEM; Bompas A, 2015, J VISION, V15, DOI 10.1167/15.6.15; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buonocore A, 2008, EXP BRAIN RES, V191, P117, DOI 10.1007/s00221-008-1558-7; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Carpenter RHS, 1988, MOVEMENTS EYES; Colonius H, 2004, J COGNITIVE NEUROSCI, V16, P1000, DOI 10.1162/0898929041502733; Colonius H, 2001, PERCEPT PSYCHOPHYS, V63, P126, DOI 10.3758/BF03200508; Corneil BD, 1996, J NEUROSCI, V16, P8193; Crevecoeur F, 2016, J NEUROSCI, V36, P8598, DOI 10.1523/JNEUROSCI.0184-16.2016; Desantis A, 2016, SCI REP-UK, V6, DOI 10.1038/srep39086; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fendrich R, 2001, PERCEPT PSYCHOPHYS, V63, P719, DOI 10.3758/BF03194432; FENDRICH R, 1991, PERCEPT PSYCHOPHYS, V50, P383, DOI 10.3758/BF03212231; Findlay JM, 1999, BEHAV BRAIN SCI, V22, P661, DOI 10.1017/S0140525X99002150; FISCHER B, 1993, BEHAV BRAIN SCI, V16, P553, DOI 10.1017/S0140525X00031575; Frens MA, 1998, BRAIN RES BULL, V46, P211, DOI 10.1016/S0361-9230(98)00007-0; FRENS MA, 1995, PERCEPT PSYCHOPHYS, V57, P802, DOI 10.3758/BF03206796; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Guillaume A, 2012, J VISION, V12, DOI 10.1167/12.6.5; Hartcher-O'Brien J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089339; Hartcher-O'Brien J, 2011, J EXP PSYCHOL HUMAN, V37, P1383, DOI 10.1037/a0024234; JAY MF, 1984, NATURE, V309, P345, DOI 10.1038/309345a0; Keetels M, 2012, NEURAL BASEMULTISE; Krauzlis RJ, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0205; LEVYSCHO.A, 1969, ANN PSYCHOL, V69, P373; Maij F, 2009, J NEUROPHYSIOL, V102, P490, DOI 10.1152/jn.91253.2008; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P576, DOI 10.1152/jn.1993.70.2.576; MUNOZ DP, 1995, EXP BRAIN RES, V103, P168; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POPPEL E, 1990, NATURWISSENSCHAFTEN, V77, P89, DOI 10.1007/BF01131783; Reingold EM, 2002, J COGNITIVE NEUROSCI, V14, P371, DOI 10.1162/089892902317361903; REUTERLORENZ PA, 1995, EXP BRAIN RES, V103, P287; REUTERLORENZ PA, 1991, PERCEPT PSYCHOPHYS, V49, P167, DOI 10.3758/BF03205036; Rolfs M, 2007, J VISION, V7, DOI 10.1167/7.10.7; ROSS LE, 1980, PERCEPT PSYCHOPHYS, V27, P251, DOI 10.3758/BF03204262; ROSS SM, 1981, PERCEPT PSYCHOPHYS, V29, P429, DOI 10.3758/BF03207356; SASLOW MG, 1967, J OPT SOC AM, V57, P1024, DOI 10.1364/JOSA.57.001024; Shams L, 2010, TRENDS COGN SCI, V14, P425, DOI 10.1016/j.tics.2010.07.001; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; SPARKS DL, 1988, BRAIN BEHAV EVOLUT, V31, P49, DOI 10.1159/000116575; SPARKS DL, 1987, TRENDS NEUROSCI, V10, P312, DOI 10.1016/0166-2236(87)90085-3; STAMPE DM, 1993, BEHAV RES METH INSTR, V25, P137, DOI 10.3758/BF03204486; STEIN BE, 1993, PROG BRAIN RES, V95, P79, DOI 10.1016/S0079-6123(08)60359-3; STETSON DS, 1992, MUSCLE NERVE, V15, P1095, DOI 10.1002/mus.880151007; Vidal M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172028; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Walker R, 1997, J NEUROPHYSIOL, V78, P1108, DOI 10.1152/jn.1997.78.2.1108; WALLACE MT, 1993, J NEUROPHYSIOL, V69, P1797, DOI 10.1152/jn.1993.69.6.1797; White BJ, 2005, J NEUROPHYSIOL, V93, P3214, DOI 10.1152/jn.01104.2004; WURTZ RH, 1972, J NEUROPHYSIOL, V35, P575, DOI 10.1152/jn.1972.35.4.575	54	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0221192	10.1371/journal.pone.0221192	http://dx.doi.org/10.1371/journal.pone.0221192			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9KA	32045415	Green Published, gold, Green Submitted			2022-12-26	WOS:000534633200001
J	Yang, JZ; Mohamed, ASR; Bahig, H; Ding, Y; Wang, JH; Ng, SP; Lai, S; Miller, A; Hutcheson, KA; Fuller, CD				Yang, Jinzhong; Mohamed, Abdallah S. R.; Bahig, Houda; Ding, Yao; Wang, Jihong; Ng, Sweet Ping; Lai, Stephen; Miller, Austin; Hutcheson, Kate A.; Fuller, Clifton Dave		Joint Head Neck Radiotherapy Mri D	Automatic registration of 2D MR cine images for swallowing motion estimation	PLOS ONE			English	Article							NECK-CANCER; HUMAN-PAPILLOMAVIRUS; HEAD; RADIOTHERAPY; DYSPHAGIA; MARGINS	Purpose To automate the estimation of swallowing motion from 2D MR cine images using deformable registration for future applications of personalized margin reduction in head and neck radiotherapy and outcome assessment of radiation-associated dysphagia. Methods Twenty-one patients with serial 2D FSPGR-MR cine scans of the head and neck conducted through the course of definitive radiotherapy for oropharyngeal cancer. Included patients had at least one cine scan before, during, or after radiotherapy, with a total of 52 cine scans. Contours of 7 swallowing related regions-of-interest (ROIs), including pharyngeal constrictor, epiglottis, base of tongue, geniohyoid, hyoid, soft palate, and larynx, were manually delineated from consecutive frames of the cine scan covering at least one swallowing cycle. We applied a modified thin-plate-spline robust-point-matching algorithm to register the point sets of each ROI automatically over frames. The deformation vector fields from the registration were then used to estimate the motion during swallowing for each ROI. Registration errors were estimated by comparing the deformed contours with the manual contours. Results On average 22 frames of each cine scan were contoured. The registration for one cine scan (7 ROIs over 22 frames) on average took roughly 22 minutes. A number of 8018 registrations were successfully batch processed without human interaction after the contours were drawn. The average registration error for all ROIs and all patients was 0.36 mm (range: 0.06 mm-2.06 mm). Larynx had the average largest motion in superior direction of all structures under consideration (range: 0.0 mm-58.7 mm). Geniohyoid had the smallest overall motion of all ROIs under consideration and the superior-inferior motion was larger than the anterior-posterior motion for all ROIs. Conclusion We developed and validated a deformable registration framework to automate the estimation of swallowing motion from 2D MR cine scans.	[Yang, Jinzhong; Wang, Jihong] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Mohamed, Abdallah S. R.; Bahig, Houda; Ding, Yao; Ng, Sweet Ping; Miller, Austin; Fuller, Clifton Dave] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Lai, Stephen; Hutcheson, Kate A.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Bahig, Houda] Ctr Hosp Univ Montreal, Radiat Oncol Dept, Montreal, PQ, Canada; [Ng, Sweet Ping] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Universite de Montreal; Peter Maccallum Cancer Center	Fuller, CD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.; Hutcheson, KA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA.	KArnold@mdanderson.org; cdfuller@mdanderson.org	Ng, Sweet Ping/L-5289-2019; Fuller, Clifton D./AAB-4012-2019; Mohamed, Abdallah/X-2359-2019	Ng, Sweet Ping/0000-0003-1721-0680; Fuller, Clifton D./0000-0002-5264-3994; Mohamed, Abdallah/0000-0003-2064-7613; Yang, Jinzhong/0000-0002-9254-4501	NIH/NCI Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program [1R01CA218148-01, 1R01CA218148]; Andrew Sabin Family Foundation; Elekta and MD Anderson Cancer Center Institutional Research Grant; National Institutes of Health (NIH)/National Institute for Dental and Craniofacial Research [1R01DE025248-01/R56DE025248-01]; NIH/National Cancer Institute (NCI) Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award [P50CA097007-10]; Pau l Calabresi Clinical Oncology Program Award [K12 CA088084-06]; National Science Foundation (NSF), Division of Mathematical Sciences, Joint NIH/NSF Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD) [NSF 1557679]; NIH Big Data to Knowledge (BD2K) Program of the National Cancer Institute (NCI) Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award [1R01CA214825-01]; Cancer center Support Grant Radiation Oncology/Cancer Imaging Program Seed Grant [5P30CA016672]; Elekta AB; Australian Postgraduate Award; Royal Australian and New Zealand College of Radiologists (RANZCR)	NIH/NCI Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Andrew Sabin Family Foundation; Elekta and MD Anderson Cancer Center Institutional Research Grant; National Institutes of Health (NIH)/National Institute for Dental and Craniofacial Research; NIH/National Cancer Institute (NCI) Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award; Pau l Calabresi Clinical Oncology Program Award; National Science Foundation (NSF), Division of Mathematical Sciences, Joint NIH/NSF Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD); NIH Big Data to Knowledge (BD2K) Program of the National Cancer Institute (NCI) Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award; Cancer center Support Grant Radiation Oncology/Cancer Imaging Program Seed Grant; Elekta AB; Australian Postgraduate Award(Australian Government); Royal Australian and New Zealand College of Radiologists (RANZCR)	This work is directly supported by the NIH/NCI Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program (1R01CA218148) and the Andrew Sabin Family Foundation; Dr. Fuller is a Sabin Family Foundation Fellow. Dr. Yang received funding support from Elekta and MD Anderson Cancer Center Institutional Research Grant. Drs. Mohamed, Lai, Hutcheson, and Fuller receive(d) funding support from the National Institutes of Health (NIH)/National Institute for Dental and Craniofacial Research (1R01DE025248-01/R56DE025248-01) and NIH/NCI Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program (1R01CA218148-01). Dr. Fuller received/receives federal grant and/or salary support from: the NIH/National Cancer Institute (NCI) Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award (P50CA097007-10) and Pau l Calabresi Clinical Oncology Program Award (K12 CA088084-06); a National Science Foundation (NSF), Division of Mathematical Sciences, Joint NIH/NSF Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD) Grant (NSF 1557679); the NIH Big Data to Knowledge (BD2K) Program of the National Cancer Institute (NCI) Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award (1R01CA214825-01); and the Cancer center Support Grant Radiation Oncology/Cancer Imaging Program Seed Grant (5P30CA016672). Dr. Fuller receives(d) industry grant support and speaker travel funding from Elekta AB. Dr. Ng was supported by the Australian Postgraduate Award and the Royal Australian and New Zealand College of Radiologists (RANZCR) research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley JA, 2011, INT J RADIAT ONCOL, V81, pE803, DOI 10.1016/j.ijrobp.2010.12.015; Breyer T, 2009, MAGN RESON IMAGING, V27, P48, DOI 10.1016/j.mri.2008.05.018; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chui HL, 2003, COMPUT VIS IMAGE UND, V89, P114, DOI 10.1016/S1077-3142(03)00009-2; Dale T, 2016, RADIOTHER ONCOL, V118, P304, DOI 10.1016/j.radonc.2016.01.019; Ding Y, 2015, PRACT RADIAT ONCOL, V5, pE299, DOI 10.1016/j.prro.2014.11.003; Gillison ML, 2004, SEMIN ONCOL, V31, P744, DOI 10.1053/j.seminoncol.2004.09.011; Hutcheson KA, 2012, CANCER-AM CANCER SOC, V118, P5793, DOI 10.1002/cncr.27631; Li H, 2016, MED PHYS, V43, P4700, DOI 10.1118/1.4955118; McKenzie A, 2002, RADIOTHER ONCOL, V62, P299, DOI 10.1016/S0167-8140(02)00015-4; Messer JA, 2016, RADIOTHER ONCOL, V118, P315, DOI 10.1016/j.radonc.2016.01.011; Palmer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089126; Rangarajan A, 1997, INFORM PROCESSING ME; Samuels SE, 2016, INT J RADIAT ONCOL, V96, P645, DOI 10.1016/j.ijrobp.2016.06.2456; van der Laan HP, 2013, RADIOTHER ONCOL, V107, P282, DOI 10.1016/j.radonc.2013.05.004; van Herk M, 2004, SEMIN RADIAT ONCOL, V14, P52, DOI 10.1053/j.semradonc.2003.10.003; Wang X, 2019, PHYS MED BIOL, V64, DOI 10.1088/1361-6560/ab1c2b; Wilson JA, 2011, OTOLARYNG HEAD NECK, V145, P767, DOI 10.1177/0194599811414506; Woo J, 2019, J ACOUST SOC AM, V145, pEL423, DOI 10.1121/1.5103191; Yang JZ, 2014, PRACT RADIAT ONCOL, V4, pE53, DOI 10.1016/j.prro.2013.04.005; Yang JZ, 2012, MED PHYS, V39, P5136, DOI 10.1118/1.4737891; Yang JZ, 2011, PATTERN RECOGN LETT, V32, P910, DOI 10.1016/j.patrec.2011.01.015; YUILLE AL, 1994, NEURAL COMPUT, V6, P341, DOI 10.1162/neco.1994.6.3.341	23	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228652	10.1371/journal.pone.0228652	http://dx.doi.org/10.1371/journal.pone.0228652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045464	Green Published, gold			2022-12-26	WOS:000534633200029
J	Srividya, N; Lange, I; Hartmann, M; Li, QR; Mirzaei, M; Lange, BM				Srividya, Narayanan; Lange, Iris; Hartmann, Michael; Li Qunrui; Mirzaei, Maryam; Lange, Bernd Markus			Biochemical characterization of acyl activating enzymes for side chain moieties of Taxol and its analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						terpenoid; plant biochemistry; natural product biosynthesis; metabolism; coenzyme A (CoA); acyl-activating enzyme; CoA ligase; paclitaxel; Taxol; Taxus	COENZYME-A-SYNTHETASE; COA SYNTHETASE; ESCHERICHIA-COLI; ARABIDOPSIS-THALIANA; ANALYSIS REVEALS; BIOSYNTHESIS; ACID; IDENTIFICATION; LIGASES; GROWTH	Taxol (paclitaxel) is a very widely used anticancer drug, but its commercial sources mainly consist of stripped bark or suspension cultures of members of the plant genus Taxus. Taxol accumulates as part of a complex mixture of chemical analogs, termed taxoids, which complicates its production in pure form, highlighting the need for metabolic engineering approaches for high-level Taxol production in cell cultures or microbial hosts. Here, we report on the characterization of acyl-activating enzymes (AAEs) that catalyze the formation of CoA esters of different organic acids relevant for the N-substitution of the 3-phenylisoserine side chain of taxoids. On the basis of similarities to AAE genes of known function from other organisms, we identified candidate genes in publicly available transcriptome data sets obtained with Taxus ? media. We cloned 17 AAE genes, expressed them heterologously in Escherichia coli, purified the corresponding recombinant enzymes, and performed in vitro assays with 27 organic acids as potential substrates. We identified TmAAE1 and TmAAE5 as the most efficient enzymes for the activation of butyric acid (Taxol D side chain), TmAAE13 as the best candidate for generating a CoA ester of tiglic acid (Taxol B side chain), TmAAE3 and TmAAE13 as suitable for the activation of 4-methylbutyric acid (N-debenzoyl-N-(2-methylbutyryl)taxol side chain), TmAAE15 as a highly efficient candidate for hexanoic acid activation (Taxol C side chain), and TmAAE4 as suitable candidate for esterification of benzoic acid with CoA (Taxol side chain). This study lays important groundwork for metabolic engineering efforts aimed at improving Taxol production in cell cultures.	[Srividya, Narayanan; Lange, Iris; Lange, Bernd Markus] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Srividya, Narayanan; Lange, Iris; Hartmann, Michael; Li Qunrui; Mirzaei, Maryam; Lange, Bernd Markus] Washington State Univ, MJ Murdock Metabol Lab, Pullman, WA 99164 USA; [Hartmann, Michael] Univ Dusseldorf, Dept Mol Ecophysiol Plants, Univ Str 1, D-40225 Dusseldorf, Germany; [Li Qunrui] CP Pharmaceut Grp, Jia 3 Yongandongli, Beijing 100022, Peoples R China; [Mirzaei, Maryam] Tarbiat Modares Univ, Tehran 14115111, Iran	Washington State University; Washington State University; Heinrich Heine University Dusseldorf; Tarbiat Modares University	Lange, BM (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	lange-m@wsu.edu	Srividya, Narayanan/AAV-6936-2021	Lange, Mark/0000-0001-6565-9584; Srividya, Narayanan/0000-0001-7934-7987; Hartmann, Michael/0000-0003-4828-958X	National Institutes of Health [RC2GM092561-01, 1R01AT010593-01]; McIntire-Stennis Capacity Grant [WNP 00811]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McIntire-Stennis Capacity Grant	This work was supported by the National Institutes of Health Grants RC2GM092561-01 and 1R01AT010593-01 and McIntire-Stennis Capacity Grant WNP 00811 (to B. M. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2018, BIOTECHNOLOGY NATURA, DOI DOI 10.1007/978-3-319-67903-7_8; Arbuck S G, 1993, J Natl Cancer Inst Monogr, P11; Beuerle T, 2002, ARCH BIOCHEM BIOPHYS, V400, P258, DOI 10.1016/S0003-9861(02)00026-7; Chen H, 2011, PLANT CELL, V23, P2247, DOI 10.1105/tpc.111.086140; Cragg GM, 1998, MED RES REV, V18, P315, DOI 10.1002/(SICI)1098-1128(199809)18:5<315::AID-MED3>3.0.CO;2-W; Cuthbertson DJ, 2013, PHYTOCHEMISTRY, V91, P187, DOI 10.1016/j.phytochem.2013.02.018; Ehlting J, 1999, PLANT J, V19, P9, DOI 10.1046/j.1365-313X.1999.00491.x; Eisenthal R, 2007, TRENDS BIOTECHNOL, V25, P247, DOI 10.1016/j.tibtech.2007.03.010; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fischedick JT, 2015, PHYTOCHEMISTRY, V113, P87, DOI 10.1016/j.phytochem.2014.11.020; Foster J, 2012, PLANT CELL, V24, P1217, DOI 10.1105/tpc.112.096032; Fulda M, 2004, PLANT CELL, V16, P394, DOI 10.1105/tpc.019646; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Holton RA., 1995, TAXOL SCI APPL, P97, DOI DOI 10.1002/CHIN.199552275; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Ketchum REB, 2006, BIOTECH AGR FOREST, V57, P291; Ketchum REB, 2003, PHYTOCHEMISTRY, V62, P901, DOI 10.1016/S0031-9422(02)00711-2; Kingston DGI, 2001, CHEM COMMUN, P867, DOI 10.1039/b100070p; Klempien A, 2012, PLANT CELL, V24, P2015, DOI 10.1105/tpc.112.097519; Kliebenstein DJ, 2007, PLANT J, V51, P1062, DOI 10.1111/j.1365-313X.2007.03205.x; Koetsier MJ, 2011, FEBS LETT, V585, P893, DOI 10.1016/j.febslet.2011.02.018; Koo AJK, 2006, J BIOL CHEM, V281, P33511, DOI 10.1074/jbc.M607854200; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Liu TT, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00004; Loncaric Catherine, 2007, Biotechnology Journal, V2, P266, DOI 10.1002/biot.200600194; McElroy C, 2018, BIOTECHNOLOGY NATURA, P145, DOI DOI 10.1007/978-3-319-67903-7_7; Morgan-Kiss RM, 2004, J BIOL CHEM, V279, P37324, DOI 10.1074/jbc.M405233200; Ramirez-Estrada K, 2016, PLANT BIOTECHNOL J, V14, P85, DOI 10.1111/pbi.12359; RUSSIN WA, 1995, INT J PLANT SCI, V156, P668, DOI 10.1086/297289; Sabater-Jara AB, 2010, PHYTOCHEM REV, V9, P343, DOI 10.1007/s11101-010-9167-z; SCHEPARTZ SA, 1976, CANCER TREAT REP, V60, P975; Schneider K, 2005, J BIOL CHEM, V280, P13962, DOI 10.1074/jbc.M413578200; Shockey JM, 2003, PLANT PHYSIOL, V132, P1065, DOI 10.1104/pp.103.020552; Stout JM, 2012, PLANT J, V71, P353, DOI 10.1111/j.1365-313X.2012.04949.x; Sun GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062865; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Weimar JD, 2002, J BIOL CHEM, V277, P29369, DOI 10.1074/jbc.M107022200; Xu HY, 2013, MOL PLANT, V6, P1301, DOI 10.1093/mp/sst004; Zhao LF, 2010, PLANT J, V64, P1048, DOI 10.1111/j.1365-313X.2010.04396.x; Zhou T, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1645-x	41	9	9	3	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4963	4973		10.1074/jbc.RA120.012663	http://dx.doi.org/10.1074/jbc.RA120.012663			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32086380	hybrid, Green Published			2022-12-26	WOS:000526887000019
J	Zheng, N; Gao, YN; Zhu, WS; Meng, D; Walker, WA				Zheng, Nan; Gao, Yanan; Zhu, Weishu; Meng, Di; Walker, W. Allan			Short chain fatty acids produced by colonizing intestinal commensal bacterial interaction with expressed breast milk are anti-inflammatory in human immature enterocytes	PLOS ONE			English	Article							INFLAMMATION; PREVENTION; EPITHELIUM; PROBIOTICS; MICROBIOTA; NEWBORN	Necrotizing enterocolitis (NEC) is a devastating intestinal emergency that affects ten percent of very low birth weight premature babies and costs society in both expense and heartache. It is probably caused by an inappropriate interaction of colonizing bacteria with an immature intestine. A possible preventative measure is to feed prematures their mother's expressed breast milk in conjunction with a probiotic. This synbiotic prevention reduces the severity and incidence of this condition. This study was designed to determine the mechanism of the synbiotic effect in human and mouse fetal intestine. Breast milk interacting with a NEC preventative probiotic such as Bifidobacterium infantis can produce increased levels of short chain fatty acids (acetate, propionate and butyrate) (SCFAs). SCFAs are known to be anti-inflammatory in mature enterocytes and immunocytes. Very little is known about their role in immature intestine. When exposed to a human fetal cell line, fetal intestinal organoids and fetal mouse intestine, these SCFAs were anti-inflammatory. Their mechanism of anti-inflammation differed from those reported for mature cells by involving the G-protein coupled receptor (GPR 109A) and inhibiting histone deacetylase 4 and 5. These bacterial metabolites may help explain the synbiotic anti-inflammatory effect of breast milk and probiotics given to premature infants at risk for NEC.	[Zheng, Nan; Gao, Yanan] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing, Peoples R China; [Zhu, Weishu; Meng, Di; Walker, W. Allan] Harvard Med Sch, Mucosal Immunol & Biol Res Ctr, Massachusetts Gen Hosp Children, Boston, MA 02115 USA	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Harvard University; Harvard Medical School	Walker, WA (corresponding author), Harvard Med Sch, Mucosal Immunol & Biol Res Ctr, Massachusetts Gen Hosp Children, Boston, MA 02115 USA.	wwalker@mgh.harvard.edu			NIDDK [P01-DK033506]; Family Larsson-Rosenquist Foundation; Beth Israel/Deaconess Medical Center [01027741]	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Family Larsson-Rosenquist Foundation; Beth Israel/Deaconess Medical Center	This study was supported by the following grants. -NIDDK (P01-DK033506) "Barrier function of the GI tract in health and disease" PI W. Allan Walker -Family Larsson-Rosenquist Foundation "The impact of breastmilk microbiome and protective factors on development of human intestinal disease" PI W. Allan Walker -Beth Israel/Deaconess Medical Center (Award #01027741) "Impact of breastmilk in premature intestinal colonization" PI W. Allan Walker	Bridgman SL, 2017, FRONT NUTR, V4, DOI 10.3389/fnut.2017.00011; Claud EC, 2004, P NATL ACAD SCI USA, V101, P7404, DOI 10.1073/pnas.0401710101; Fellows R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02651-5; Ganguli K, 2011, J CLIN GASTROENTEROL, V45, pS133, DOI 10.1097/MCG.0b013e318228b799; Huda-Faujan N, 2010, Open Biochem J, V4, P53, DOI 10.2174/1874091X01004010053; Jiang ZZ, 2016, INT J FOOD SCI NUTR, V67, P632, DOI 10.1080/09637486.2016.1195798; Li M, 2018, EUR J PHARMACOL, V831, P52, DOI 10.1016/j.ejphar.2018.05.003; Licciardi PV, 2011, ISRN ALLERGY; Lin MY, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00554; Macia L, 2012, IMMUNOL REV, V245, P164, DOI 10.1111/j.1600-065X.2011.01080.x; Marchesi JR, 2007, J PROTEOME RES, V6, P546, DOI 10.1021/pr060470d; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Meng D, 2015, PEDIATR RES, V77, P416, DOI 10.1038/pr.2014.207; MEUNIER V, 1995, CELL BIOL TOXICOL, V11, P187, DOI 10.1007/BF00756522; Nanthakumar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017776; Nanthakumar NN, 2005, AM J PHYSIOL-GASTR L, V288, pG85, DOI 10.1152/ajpgi.00169.2004; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; O'Rourke L, 2018, J NUTR SCI, V7, DOI 10.1017/jns.2017.69; Pourcyrous M, 2014, J PEDIATR GASTR NUTR, V59, P725, DOI 10.1097/MPG.0000000000000515; Repa A, 2015, PEDIATR RES, V77, P381, DOI 10.1038/pr.2014.192; Sanderson IR, 1996, P NATL ACAD SCI USA, V93, P7717, DOI 10.1073/pnas.93.15.7717; Senger S, 2018, CELL MOL GASTROENTER, V5, P549, DOI 10.1016/j.jcmgh.2018.01.014; Tan J, 2014, ADV IMMUNOL, V121, P91, DOI 10.1016/B978-0-12-800100-4.00003-9; Tanaka KI, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00344; Vangaveti V, 2010, THER ADV ENDOCRINOL, V1, P165, DOI 10.1177/2042018810381066; Walker WA, 2017, PEDIATR RES, V82, P387, DOI 10.1038/pr.2017.111; Walker WA, 2015, PEDIATR RES, V77, P220, DOI 10.1038/pr.2014.160; Weng MQ, 2014, AM J PHYSIOL-GASTR L, V306, pG779, DOI 10.1152/ajpgi.00183.2013; Yu ZT, 2013, GLYCOBIOLOGY, V23, P1281, DOI 10.1093/glycob/cwt065	30	30	31	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229283	10.1371/journal.pone.0229283	http://dx.doi.org/10.1371/journal.pone.0229283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084202	gold, Green Published, Green Submitted			2022-12-26	WOS:000535227900081
J	Borgomaneri, S; Bolloni, C; Sessa, P; Avenanti, A				Borgomaneri, Sara; Bolloni, Corinna; Sessa, Paola; Avenanti, Alessio			Blocking facial mimicry affects recognition of facial and body expressions	PLOS ONE			English	Article							ACTION OBSERVATION NETWORK; HUMAN MOTOR CORTEX; EMOTIONAL EMPATHY; NEURAL BASES; PERCEPTION; FACE; SIMULATION; STATE; MOVEMENTS; RESPONSES	Facial mimicry is commonly defined as the tendency to imitate-at a sub-threshold level-facial expressions of other individuals. Numerous studies support a role of facial mimicry in recognizing others' emotions. However, the underlying functional mechanism is unclear. A prominent hypothesis considers facial mimicry as based on an action-perception loop, leading to the prediction that facial mimicry should be observed only when processing others' facial expressions. Nevertheless, previous studies have also detected facial mimicry during observation of emotional bodily expressions. An emergent alternative hypothesis is that facial mimicry overtly reflects the simulation of an "emotion", rather than the reproduction of a specific observed motor pattern. In the present study, we tested whether blocking mimicry ("Bite") on the lower face disrupted recognition of happy expressions conveyed by either facial or body expressions. In Experiment 1, we tested participants' ability to identify happy, fearful and neutral expressions in the Bite condition and in two control conditions. In Experiment 2, to ensure that such a manipulation selectively affects emotion recognition, we tested participants' ability to recognize emotional expressions, as well as the actors' gender, under the Bite condition and a control condition. Finally, we investigated the relationship between dispositional empathy and emotion recognition under the condition of blocked mimicry. Our findings demonstrated that blocking mimicry on the lower face hindered recognition of happy facial and body expressions, while the recognition of neutral and fearful expressions was not affected by the mimicry manipulation. The mimicry manipulation did not affect the gender discrimination task. Furthermore, the impairment of happy expression recognition correlated with empathic traits. These results support the role of facial mimicry in emotion recognition and suggest that facial mimicry reflects a global sensorimotor simulation of others' emotions rather than a muscle-specific reproduction of an observed motor expression.	[Borgomaneri, Sara; Bolloni, Corinna; Avenanti, Alessio] Univ Bologna, Alma Mater Studiorum, Ctr Studi & Ric Neurosci Cognit, Dipartimento Psicol, Campus Cesena, Rome, Italy; [Borgomaneri, Sara] IRCCS Fdn Santa Lucia, Rome, Italy; [Sessa, Paola] Univ Padua, Dipartimento Psicol Sviluppo & Socializzaz, Padua, Italy; [Sessa, Paola] PNC, Padua, Italy; [Avenanti, Alessio] Univ Catolica Maule, Ctr Invest Neuropsicol & Neurociencias Cognit, Talca, Chile	University of Bologna; IRCCS Santa Lucia; University of Padua; Universidad Catolica del Maule	Borgomaneri, S; Avenanti, A (corresponding author), Univ Bologna, Alma Mater Studiorum, Ctr Studi & Ric Neurosci Cognit, Dipartimento Psicol, Campus Cesena, Rome, Italy.; Borgomaneri, S (corresponding author), IRCCS Fdn Santa Lucia, Rome, Italy.; Avenanti, A (corresponding author), Univ Catolica Maule, Ctr Invest Neuropsicol & Neurociencias Cognit, Talca, Chile.	sara.borgomaneri@unibo.it; alessio.avenanti@unibo.it	Avenanti, Alessio/K-5250-2012; borgomaneri, sara/J-9873-2016; Sessa, Paola/B-9523-2008	Avenanti, Alessio/0000-0003-1139-9996; borgomaneri, sara/0000-0003-4959-6442; Sessa, Paola/0000-0002-8748-2633	Cogito Foundation [R-117/13, 14e139-R]; Fondazione del Monte di Bologna e Ravenna [339bis/2017]; BIAL foundation [347/18]; Giovani Ricercatori [GR-2018-12365733]	Cogito Foundation; Fondazione del Monte di Bologna e Ravenna(Fondazione del Monte di Bologna e Ravenna); BIAL foundation(Bial Foundation); Giovani Ricercatori	This work was supported by grants from Cogito Foundation [R-117/13 and 14e139-R], Fondazione del Monte di Bologna e Ravenna [339bis/2017] and BIAL foundation [347/18] awarded to A.A., and by grants from the Giovani Ricercatori 2018 grant [GR-2018-12365733] awarded to S.B. www.cogitofoundation.ch www.fondazionedelmonte.it www.bial.com www.salute.gov.it The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaibou A, 2008, NEUROPSYCHOLOGIA, V46, P1104, DOI 10.1016/j.neuropsychologia.2007.10.019; Adolphs R, 2000, J NEUROSCI, V20, P2683; Amoruso L, 2018, NEUROIMAGE, V177, P68, DOI 10.1016/j.neuroimage.2018.05.020; Avenanti A, 2018, CEREB CORTEX, V28, P1282, DOI 10.1093/cercor/bhx041; Avenanti A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00185; Avenanti A, 2013, CEREB CORTEX, V23, P570, DOI 10.1093/cercor/bhs040; Avenanti A, 2009, NEUROIMAGE, V44, P275, DOI 10.1016/j.neuroimage.2008.08.001; Bailenson JN, 2005, PSYCHOL SCI, V16, P814, DOI 10.1111/j.1467-9280.2005.01619.x; Balconi M, 2014, COGNITION EMOTION, V28, P153, DOI 10.1080/02699931.2013.805685; Banissy MJ, 2012, NEUROIMAGE, V62, P2034, DOI 10.1016/j.neuroimage.2012.05.081; Borgomaneri S, 2017, BRAIN STRUCT FUNCT, V222, P3267, DOI 10.1007/s00429-017-1403-5; Borgomaneri S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14122; Borgomaneri S, 2015, CORTEX, V65, P232, DOI 10.1016/j.cortex.2015.01.014; Borgomaneri S, 2015, BRAIN STRUCT FUNCT, V220, P2765, DOI 10.1007/s00429-014-0825-6; Borgomaneri S, 2012, BRAIN STIMUL, V5, P70, DOI 10.1016/j.brs.2012.03.011; Bos PA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167991; Carr EW, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00505; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Cattaneo L, 2013, EXP BRAIN RES, V231, P37, DOI 10.1007/s00221-013-3664-4; Cattaneo L, 2009, J NEUROSCI, V29, P11134, DOI 10.1523/JNEUROSCI.2605-09.2009; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Davis M., 1996, EMPATHY SOCIAL PSYCH; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; de Gelder B, 2010, NEUROSCI BIOBEHAV R, V34, P513, DOI 10.1016/j.neubiorev.2009.10.008; De Stefani E, 2019, GENES BRAIN BEHAV, V18, DOI 10.1111/gbb.12548; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dimberg U, 2000, PSYCHOPHYSIOLOGY, V37, P693, DOI 10.1111/1469-8986.3750693; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; Dimberg U, 2011, J PSYCHOPHYSIOL, V25, P26, DOI 10.1027/0269-8803/a000029; Engelen T, 2015, CORTEX, V73, P195, DOI 10.1016/j.cortex.2015.08.013; Eres R, 2015, NEUROIMAGE, V117, P305, DOI 10.1016/j.neuroimage.2015.05.038; Fadiga L, 2005, CURR OPIN NEUROBIOL, V15, P213, DOI 10.1016/j.conb.2005.03.013; Ferrari C, 2022, SOC COGN AFFECT NEUR, V17, P81, DOI 10.1093/scan/nsz074; Fino E, 2016, BIOL PSYCHOL, V118, P126, DOI 10.1016/j.biopsycho.2016.04.069; Franzen A, 2018, J EXP PSYCHOL GEN, V147, P1950, DOI 10.1037/xge0000422; Goldman AI, 2005, COGNITION, V94, P193, DOI 10.1016/j.cognition.2004.01.005; Goshen-Gottstein Y, 2000, J EXP PSYCHOL LEARN, V26, P1198, DOI 10.1037//0278-7393.26.5.1198; Harrison NA, 2010, SOC NEUROSCI-UK, V5, P393, DOI 10.1080/17470911003656330; Hennenlotter A, 2009, CEREB CORTEX, V19, P537, DOI 10.1093/cercor/bhn104; Hess U, 2014, SOC PERSONAL PSYCHOL, V8, P45, DOI 10.1111/spc3.12083; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Hsu CT, 2018, NEUROPSYCHOLOGIA, V116, P61, DOI 10.1016/j.neuropsychologia.2017.08.018; Hyniewska S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00291; Ipser A., 2015, J VISUAL-JAPAN, V15, P1376, DOI [10.1167/15.12.1376, DOI 10.1167/15.12.1376]; Jacquet PO, 2015, CEREB CORTEX, V25, P598, DOI 10.1093/cercor/bht242; Keysers C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0175; Kilner JM, 2011, TRENDS COGN SCI, V15, P352, DOI 10.1016/j.tics.2011.06.005; Kilts CD, 2003, NEUROIMAGE, V18, P156, DOI 10.1006/nimg.2002.1323; Korb S, 2015, CORTEX, V70, P101, DOI 10.1016/j.cortex.2015.06.025; Korb S, 2010, BIOL PSYCHOL, V85, P347, DOI 10.1016/j.biopsycho.2010.07.012; Kret ME, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00028; Kret ME, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00001; Kret ME, 2011, NEUROPSYCHOLOGIA, V49, P1187, DOI 10.1016/j.neuropsychologia.2011.02.007; Kulesza W, 2014, J LANG SOC PSYCHOL, V33, P183, DOI 10.1177/0261927X13506906; Lakin JL, 2003, J NONVERBAL BEHAV, V27, P145, DOI 10.1023/A:1025389814290; Lamm C, 2019, NEUROSCI LETT, V693, P49, DOI 10.1016/j.neulet.2017.06.054; Lee SY, 2011, ATTEN PERCEPT PSYCHO, V73, P473, DOI 10.3758/s13414-010-0032-3; Lee TW, 2006, SOC COGN AFFECT NEUR, V1, P122, DOI 10.1093/scan/nsl012; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Likowski KU, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00214; Magnee MJCM, 2007, NEUROREPORT, V18, P369, DOI 10.1097/WNR.0b013e32801776e6; Maringer M, 2011, EMOTION, V11, P181, DOI 10.1037/a0022596; Martin D, 2011, Q J EXP PSYCHOL, V64, P217, DOI 10.1080/17470218.2010.541266; Mazzoni N, 2017, J NEUROSCI, V37, P7231, DOI 10.1523/JNEUROSCI.0913-17.2017; Miellet S., 2012, J VISION, V12, P824, DOI DOI 10.1167/12.9.824; Moody EJ, 2007, EMOTION, V7, P447, DOI 10.1037/1528-3542.7.2.447; Moody EJ, 2018, SOC PSYCHOL PERS SCI, V9, P844, DOI 10.1177/1948550617726832; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Neal DT, 2011, SOC PSYCHOL PERS SCI, V2, P673, DOI 10.1177/1948550611406138; Niedenthal PM, 2010, BEHAV BRAIN SCI, V33, P417, DOI 10.1017/S0140525X10000865; Niedenthal PM, 2001, COGNITION EMOTION, V15, P853, DOI 10.1080/02699930143000194; Oberman LM, 2007, SOC NEUROSCI-UK, V2, P167, DOI 10.1080/17470910701391943; Paracampo R, 2018, NEUROPSYCHOLOGIA, V116, P86, DOI 10.1016/j.neuropsychologia.2018.01.043; Paracampo R, 2017, CEREB CORTEX, V27, P5116, DOI 10.1093/cercor/bhw294; Penton T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11578-2; Pitcher D, 2008, J NEUROSCI, V28, P8929, DOI 10.1523/JNEUROSCI.1450-08.2008; Ponari M, 2012, EMOTION, V12, P1398, DOI 10.1037/a0028588; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Prochazkova E, 2017, NEUROSCI BIOBEHAV R, V80, P99, DOI 10.1016/j.neubiorev.2017.05.013; Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x; Rychlowska M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090876; Rymarczyk K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158534; Schilbach L, 2008, SOC NEUROSCI-UK, V3, P37, DOI 10.1080/17470910701563228; Seibt B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01122; Sel A, 2014, J NEUROSCI, V34, P3263, DOI 10.1523/JNEUROSCI.0106-13.2014; Sessa P, 2018, SOC COGN AFFECT NEUR, V13, P1281, DOI 10.1093/scan/nsy095; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Sonnby-Borgstrom M, 2002, SCAND J PSYCHOL, V43, P433, DOI 10.1111/1467-9450.00312; Stel M, 2008, PSYCHOL SCI, V19, P984, DOI 10.1111/j.1467-9280.2008.02188.x; Sweeny TD, 2009, CONSCIOUS COGN, V18, P929, DOI 10.1016/j.concog.2009.07.011; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Trautmann SA, 2009, BRAIN RES, V1284, P100, DOI 10.1016/j.brainres.2009.05.075; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Valchev N, 2015, NEUROPSYCHOLOGIA, V66, P237, DOI 10.1016/j.neuropsychologia.2014.11.030; van der Gaag C, 2007, SOC NEUROSCI-UK, V2, P179, DOI 10.1080/17470910701376878; Varcin KJ, 2019, SOC NEUROSCI-UK, V14, P608, DOI 10.1080/17470919.2018.1564694; Vernon D, 2008, IMAGE VISION COMPUT, V26, P127, DOI 10.1016/j.imavis.2005.08.009; Vicario CM, 2017, NEUROSCI BIOBEHAV R, V80, P185, DOI 10.1016/j.neubiorev.2017.05.008; Vicario CM, 2017, SOC COGN AFFECT NEUR, V12, P352, DOI 10.1093/scan/nsw129; Vitale J, 2014, BIOL INSPIR COGN ARC, V10, P30, DOI 10.1016/j.bica.2014.11.005; Wagenmakers EJ, 2016, PERSPECT PSYCHOL SCI, V11, P917, DOI 10.1177/1745691616674458; Wolf F.M., 1986, METAANALYSIS QUANTIT; Wood A, 2016, TRENDS COGN SCI, V20, P227, DOI 10.1016/j.tics.2015.12.010	106	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0229364	10.1371/journal.pone.0229364	http://dx.doi.org/10.1371/journal.pone.0229364			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8CF	32078668	Green Published, gold			2022-12-26	WOS:000535224600029
J	Jacobsen, BK; Melhus, M; Kvaloy, K; Siri, SRA; Michalsen, VL; Broderstad, AR				Jacobsen, Bjarne K.; Melhus, Marita; Kvaloy, Kirsti; Siri, Susanna R. A.; Michalsen, Vilde Lehne; Broderstad, Ann Ragnhild			A descriptive study of ten-year longitudinal changes in weight and waist circumference in the multi-ethnic rural Northern Norway. The SAMINOR Study, 2003-2014	PLOS ONE			English	Article							BODY-MASS INDEX; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; NORWEGIAN POPULATIONS; OBESITY; HEALTH; ADULTS; MEN; PREVALENCE; HEIGHT	The obesity epidemic is dynamic with varying secular trends and differences between countries and ethnic groups. The objective of this study was to describe the age- and sex-specific longitudinal changes in weight and waist circumference in a rural Norwegian population with a high proportion of the indigenous Sami population. Based on two population-based surveys, SAMINOR 1 (2003-2004) and SAMINOR 2 (2012-2014), we present longitudinal changes in weight and waist circumference according to age at baseline in the SAMINOR 1 Survey and sex during the 10-year period. The analyses included 1538 men and 1958 women aged 36 to 69 at baseline (birth year 1934 to 1967). Forty-one percent of the population were Sami. Both weight and waist circumference were measured. The mean weight increased 0.8 kg (95% confidence interval: 0.5, 1.1) in men and 0.3 kg (95% confidence interval: 0, 0.5) in women. In both men and women, younger individuals gained significantly more weight during the 10-year follow-up than older participants (p < 0.001). The mean weight showed a statistically significant increase in men aged 36-54 and women aged 3649 at baseline and was statistically significantly reduced in men and women aged 60-69. The mean waist circumference increased by 6.3 cm (95% confidence interval: 6.0, 6.6) in men and 8.4 cm (95% confidence interval 8.1, 8.8) in women. The mean waist circumference increased statistically significantly from SAMINOR 1 to SAMINOR 2 in all age groups, and there was an inverse relationship between age at baseline and change in waist circumference (p < 0.001). Waist circumference increased more than can be explained by changes in weight and age during the 10-year period. The inverse relationships between age at baseline in SAMINOR 1 and the 10-year change in weight and waist circumference were found in both Sami and non-Sami participants. The findings underline the need for prevention of obesity, particularly in younger people, as it is difficult to achieve permanent weight loss.	[Jacobsen, Bjarne K.; Melhus, Marita; Kvaloy, Kirsti; Siri, Susanna R. A.; Michalsen, Vilde Lehne; Broderstad, Ann Ragnhild] UiT Arctic Univ Norway, Dept Community Med, Ctr Sami Hlth Res, Tromso, Norway; [Jacobsen, Bjarne K.] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway; [Kvaloy, Kirsti] NTNU Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, HUNT Res Ctr, Trondheim, Norway; [Broderstad, Ann Ragnhild] Univ Hosp North Norway, Div Internal Med, Dept Med, Harstad, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; University Hospital of North Norway	Jacobsen, BK (corresponding author), UiT Arctic Univ Norway, Dept Community Med, Ctr Sami Hlth Res, Tromso, Norway.; Jacobsen, BK (corresponding author), UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway.	bjarne.jacobsen@uit.no		Siri, Susanna Ragnhild Andersdatter/0000-0003-3231-8139	Norwegian Ministry of Health and Care Services; Northern Norway Regional Health Authority; Regional Research Fund of Northern Norway; Sami Parliament; Sami Norwegian National Advisory Unit on Mental Health and Substance Use; Finnmark county council; Troms county council; Nordland county council; UiT The Arctic University of Norway	Norwegian Ministry of Health and Care Services; Northern Norway Regional Health Authority; Regional Research Fund of Northern Norway; Sami Parliament; Sami Norwegian National Advisory Unit on Mental Health and Substance Use; Finnmark county council; Troms county council; Nordland county council; UiT The Arctic University of Norway	The authors received no specific funding for this work. The SAMINOR Study has been supported by The Norwegian Ministry of Health and Care Services, the Northern Norway Regional Health Authority, the Regional Research Fund of Northern Norway, the Sami Parliament, the Sami Norwegian National Advisory Unit on Mental Health and Substance Use, and the Finnmark, Troms, and Nordland county councils. The publication charges for this article have been funded by the publication fund of UiT The Arctic University of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aars Nils Abel, 2016, BMC Obes, V3, P40, DOI 10.1186/s40608-016-0120-6; Anderson I, 2016, LANCET, V388, P131, DOI 10.1016/S0140-6736(16)00345-7; Beaufrere B, 2000, EUR J CLIN NUTR, V54, pS48, DOI 10.1038/sj.ejcn.1601025; Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976; Bokor-Billmann T, 2020, J CLIN EPIDEMIOL, V119, P1, DOI 10.1016/j.jclinepi.2019.11.005; Brandkvist M, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4067; Broderstad AR, 2018, SCAND J PUBLIC HEALT, V46, P638, DOI [10.1177/1403494818773534, DOI 10.1177/1403494818773534]; Chimeddamba Oyun, 2017, BMC Obes, V4, P19, DOI 10.1186/s40608-017-0155-3; da Silva M, 2018, OBESITY FACTS, V11, P381, DOI 10.1159/000492002; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Droyvold WB, 2006, INT J OBESITY, V30, P935, DOI 10.1038/sj.ijo.0803178; Ebrahimi-Mameghani M, 2008, EUR J CLIN NUTR, V62, P1208, DOI 10.1038/sj.ejcn.1602839; El Reda D, 2017, OBESITY, V25, P476, DOI 10.1002/oby.21745; Elobeid MA, 2007, OBESITY, V15, P2380, DOI 10.1038/oby.2007.282; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fildes A, 2015, AM J PUBLIC HEALTH, V105, pE54, DOI 10.2105/AJPH.2015.302773; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Freedman DS, 2015, AM J CLIN NUTR, V101, P425, DOI 10.3945/ajcn.114.094672; Gaski M, 2011, RURAL REMOTE HEALTH, V11; Gearon E, 2018, PREV MED, V111, P378, DOI 10.1016/j.ypmed.2017.11.030; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Grimby G, 2015, SCAND J MED SCI SPOR, V25, P119, DOI 10.1111/sms.12611; Haftenberger M, 2016, EUR J CLIN NUTR, V70, P300, DOI 10.1038/ejcn.2015.179; Jacobsen Bjarne K, 2016, BMC Obes, V3, P41, DOI 10.1186/s40608-016-0121-5; Jacobsen BK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007859; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Jacobsen BK, 2001, ARCH INTERN MED, V161, P466, DOI 10.1001/archinte.161.3.466; JACOBSEN BK, 1988, SCAND J SOC MED, V16, P101, DOI 10.1177/140349488801600207; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Kvamme JM, 2012, J EPIDEMIOL COMMUN H, V66, P611, DOI 10.1136/jech.2010.123232; Langhammer A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-143; Lund E, 2007, INT J CIRCUMPOL HEAL, V66, P113, DOI 10.3402/ijch.v66i2.18241; Haheim LL, 2006, QJM-INT J MED, V99, P665, DOI 10.1093/qjmed/hcl090; Michalsen VL, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027791; Mienna CS, 2019, INT J CIRCUMPOL HEAL, V78, DOI 10.1080/22423982.2019.1638195; Niemi E., 1995, ETHNICITY NATION BUI, P145; Nooyens ACJ, 2009, PUBLIC HEALTH NUTR, V12, P862, DOI 10.1017/S1368980008003091; Nystad T, 2010, SCAND J PUBLIC HEALT, V38, P17, DOI 10.1177/1403494809354791; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Peter RS, 2014, AM J HUM BIOL, V26, P690, DOI 10.1002/ajhb.22582; Pettersen T, 2013, INT J CIRCUMPOL HEAL, V72, P1, DOI 10.3402/ijch.v72i0.21813; Reas DL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-269; Ronn PF, 2017, ATHEROSCLEROSIS, V265, P207, DOI 10.1016/j.atherosclerosis.2017.08.011; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Siri SRA, 2018, SCAND J PUBLIC HEALT, V46, P638, DOI 10.1177/1403494818773534; Siri SRA, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-028939; Solbakk J., 2006, SAMI PEOPLE HDB; Sorkin JD, 1999, EPIDEMIOL REV, V21, P247, DOI 10.1093/oxfordjournals.epirev.a018000; Tanamas SK, 2016, QJM-INT J MED, V109, P443, DOI 10.1093/qjmed/hcv201; Tanamas SK, 2014, OBESITY, V22, P1538, DOI 10.1002/oby.20704; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Tvermosegaard M, 2015, CAN J CARDIOL, V31, P1116, DOI 10.1016/j.cjca.2015.06.002; Verweij LM, 2013, PUBLIC HEALTH NUTR, V16, P281, DOI 10.1017/S1368980012002741; Walls HL, 2011, OBESITY, V19, P216, DOI 10.1038/oby.2010.149; Walter S, 2016, JAMA-J AM MED ASSOC, V316, P63, DOI 10.1001/jama.2016.8729; Whitaker KM, 2016, INT J OBESITY, V40, P1278, DOI 10.1038/ijo.2016.48; World Health Organization (WHO), 2011, WAIST CIRCUMFERENCE; Zamboni M, 2005, INT J OBESITY, V29, P1011, DOI 10.1038/sj.ijo.0803005; Zaninotto P, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025309	60	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0229234	10.1371/journal.pone.0229234	http://dx.doi.org/10.1371/journal.pone.0229234			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8AS	32074126	gold, Green Submitted, Green Published			2022-12-26	WOS:000535220600035
J	Sehadova, H; Guerra, PA; Sauman, I; Reppert, SM				Sehadova, Hana; Guerra, Patrick A.; Sauman, Ivo; Reppert, Steven M.			A re-evaluation of silk measurement by the cecropia caterpillar (Hyalophora cecropia) during cocoon construction reveals use of a silk odometer that is temporally regulated	PLOS ONE			English	Article							SPINNING BEHAVIOR; MUSHROOM BODIES; ANT ODOMETER; SPIDERS	The late 5(th) instar caterpillar of the cecropia silk moth (Hyalophora cecropia) spins a silken cocoon with a distinct, multilayered architecture. The cocoon construction program, first described by the seminal work of Van der Kloot and Williams, consists of a highly ordered sequence of events. We perform behavioral experiments to re-evaluate the original cecropia work, which hypothesized that the length of silk that passes through the spinneret controls the orderly execution of each of the discrete events of cocoon spinning. We confirm and extend by three-dimensional scanning and quantitative measurements of silk weights that if cocoon construction is interrupted, upon re-spinning, the caterpillar continues the cocoon program from where it left off. We also confirm and extend by quantitative measurements of silk weights that cecropia caterpillars will not bypass any of the sections of the cocoon during the construction process, even if presented with a pre-spun section of a cocoon spun by another caterpillar. Blocking silk output inhibits caterpillars from performing normal spinning behaviors used for cocoon construction. Surprisingly, unblocking silk output 24-hr later did not restart the cocoon construction program, suggesting the involvement of a temporally-defined interval timer. We confirm with surgical reductions of the silk glands that it is the length of silk itself that matters, rather than the total amount of silk extracted by individuals. We used scanning electron microscopy to directly show that either mono- or dual-filament silk (i.e., equal silk lengths but which vary in their total amount of silk extracted) can be used to construct equivalent cocoons of normal size and that contain the relevant layers. We propose that our findings, taken together with the results of prior studies, strongly support the hypothesis that the caterpillar uses a silk "odometer" to measure the length of silk extracted during cocoon construction but does so in a temporally regulated manner. We further postulate that our examination of the anatomy of the silk spinning apparatus and ablating spinneret sensory output provides evidence that silk length measurement occurs upstream of output from the spinneret.	[Sehadova, Hana; Sauman, Ivo] Czech Acad Sci, Ctr Biol, Inst Entomol, Ceske Budejovice, Czech Republic; [Sehadova, Hana; Sauman, Ivo] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Guerra, Patrick A.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; [Reppert, Steven M.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University System of Ohio; University of Cincinnati; University of Massachusetts System; University of Massachusetts Worcester	Sauman, I (corresponding author), Czech Acad Sci, Ctr Biol, Inst Entomol, Ceske Budejovice, Czech Republic.; Sauman, I (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.; Guerra, PA (corresponding author), Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA.; Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	guerrapk@ucmail.uc.edu; sauman@entu.cas.cz; steven.reppert@umassmed.edu	Sehadova, Hana/G-9329-2014; Sauman, Ivo/H-2071-2014; Sehadova, Hana/AAD-7738-2022	Sehadova, Hana/0000-0003-2962-0871; Sehadova, Hana/0000-0003-2962-0871; Sauman, Ivo/0000-0002-3576-3222	Higgins Foundation; Czech Science Foundation [17-01003S]; University of Cincinnati	Higgins Foundation; Czech Science Foundation(Grant Agency of the Czech Republic); University of Cincinnati	This work was supported in part by the Higgins Foundation to SMR, Czech Science Foundation Grant 17-01003S to IS, and the University of Cincinnati to PAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkowitz A, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.192054; China Chemical Reporter, 2009, CHINA CHEM REPORTER, V20, P11; Costa JT, 1997, AM SCI, V85, P150; Danks HV, 2004, EUR J ENTOMOL, V101, P433, DOI 10.14411/eje.2004.062; Danks HV, 2002, OIKOS, V99, P10, DOI 10.1034/j.1600-0706.2002.990102.x; Eberhard WG, 2019, BEHAVIOUR, V156, P331, DOI 10.1163/1568539X-00003544; Edgerly JS, 2002, J INSECT BEHAV, V15, P219, DOI 10.1023/A:1015437001089; FITZGERALD TD, 1983, J KANSAS ENTOMOL SOC, V56, P20; GROMYSZ KAZIMIERA, 1960, FOLIA BIOL, V8, P351; Gronenberg W, 2004, ACTA BIOL HUNG, V55, P31, DOI 10.1556/ABiol.55.2004.1-4.5; Guerra PA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174023; Hesselberg T, 2015, CURR ZOOL, V61, P313, DOI 10.1093/czoolo/61.2.313; Hiroi M, 2013, GENES CELLS, V18, P1070, DOI 10.1111/gtc.12094; LAND MF, 1972, J EXP BIOL, V57, P15; LOUNIBOS LP, 1975, ANIM BEHAV, V23, P843, DOI 10.1016/0003-3472(75)90109-8; LOUNIBOS LP, 1976, PHYSIOL ENTOMOL, V1, P195, DOI 10.1111/j.1365-3032.1976.tb00961.x; Martin JR, 1998, LEARN MEMORY, V5, P179; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; MERRILL D, 1965, J EXP ZOOL, V158, P123, DOI 10.1002/jez.1401580111; REED CF, 1969, AM ZOOL, V9, P211; SCARBROUGH A G, 1977, Journal of the Lepidopterists' Society, V31, P153; Skorupski P, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2016.0513; Turner-Evans DB, 2016, CURR BIOL, V26, pR453, DOI 10.1016/j.cub.2016.04.006; Tuskes PM, 1996, WILD SILK MOTHS N AM; VANDERKLOOT WG, 1953, BEHAVIOUR, V5, P157, DOI 10.1163/156853953X00096; VANDERKLOOT WG, 1953, BEHAVIOUR, V5, P141, DOI 10.1163/156853953X00087; VANDERKLOOT WG, 1954, BEHAVIOUR, V6, P233, DOI 10.1163/156853954X00112; WADEPUHL M, 1979, NATURWISSENSCHAFTEN, V66, P320, DOI 10.1007/BF00441284; WALDBAUER GP, 1982, ENTOMOL EXP APPL, V31, P191, DOI 10.1111/j.1570-7458.1982.tb03134.x; Walls ML, 2009, CURR BIOL, V19, P25, DOI 10.1016/j.cub.2008.10.069; Weevers R. de G., 1985, P213; Wittlinger M, 2006, SCIENCE, V312, P1965, DOI 10.1126/science.1126912; Wittlinger M, 2007, J EXP BIOL, V210, P198, DOI 10.1242/jeb.02657; Wolf H, 2011, J EXP BIOL, V214, P1629, DOI 10.1242/jeb.038570; Zacharuk R.Y., 1985, COMPREHENSIVE INSECT, P1	35	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228453	10.1371/journal.pone.0228453	http://dx.doi.org/10.1371/journal.pone.0228453			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KT6HA	32074121	gold, Green Published, Green Submitted			2022-12-26	WOS:000519113800001
J	Esperon-Moldes, U; Ginarte-Val, M; Rodriguez-Pazos, L; Fachal, L; Martin-Santiago, A; Vicente, A; Jimenez-Gallo, D; Guillen-Navarro, E; Sampol, LM; Gonzalez-Ensenat, MA; Vega, A				Esperon-Moldes, Uxia; Ginarte-Val, Manuel; Rodriguez-Pazos, Laura; Fachal, Laura; Martin-Santiago, Ana; Vicente, Asuncion; Jimenez-Gallo, David; Guillen-Navarro, Encarna; Martorell Sampol, Loreto; Antonia Gonzalez-Ensenat, Maria; Vega, Ana			Novel CYP4F22 mutations associated with autosomal recessive congenital ichthyosis (ARCI). Study of the CYP4F22 c.1303C>T founder mutation	PLOS ONE			English	Article							LAMELLAR ICHTHYOSIS; GENE; AGE; CAPTURE; ABCA12	Mutations in CYP4F22 cause autosomal recessive congenital ichthyosis (ARCI). However, less than 10% of all ARCI patients carry a mutation in CYP4F22. In order to identify the molecular basis of ARCI among our patients (a cohort of ninety-two Spanish individuals) we performed a mutational analysis using direct Sanger sequencing in combination with a multi-gene targeted NGS panel. From these, eight ARCI families (three of them with Moroccan origin) were found to carry five different CYP4F22 mutations, of which two were novel. Computational analysis showed that the mutations found were present in highly conserved residues of the protein and may affect its structure and function. Seven of the eight families were carriers of a highly recurrent CYP4F22 variant, c.1303C>T; p.(His435Tyr). A 12Mb haplotype was reconstructed in all c.1303C>T carriers by genotyping ten microsatellite markers flanking the CYP4F22 gene. A prevalent 2.52Mb haplotype was observed among Spanish carrier patients suggesting a recent common ancestor. A smaller core haplotype of 1.2Mb was shared by Spanish and Moroccan families. Different approaches were applied to estimate the time to the most recent common ancestor (TMRCA) of carrier patients with Spanish origin. The age of the mutation was calculated by using DMLE and BDMC2. The algorithms estimated that the c.1303C>T variant arose approximately 2925 to 4925 years ago, while Spanish carrier families derived from a common ancestor who lived in the XIII century. The present study reports five CYP4F22 mutations, two of them novel, increasing the number of CYP4F22 mutations currently listed. Additionally, our results suggest that the recurrent c.1303C>T change has a founder effect in Spanish population and c.1303C>T carrier families originated from a single ancestor with probable African ancestry.	[Esperon-Moldes, Uxia; Fachal, Laura; Vega, Ana] Fdn Publ Galega Med Xenom SERGAS, Grp Med Xenom USC, CIBERER, IDIS, Santiago De Compostela, Spain; [Esperon-Moldes, Uxia] Univ Santiago de Compostela, Dept Ciencias Forenses Anat Patolox Xinecoloxia O, Santiago De Compostela, Spain; [Ginarte-Val, Manuel] Complexo Hosp Univ Santiago, Dermatol Serv, Santiago De Compostela, Spain; [Rodriguez-Pazos, Laura] Complexo Hosp Univ Vigo, Dermatol Serv, Vigo, Spain; [Martin-Santiago, Ana] Hosp Univ Son Espases, Dermatol Serv, Palma De Mallorca, Spain; [Vicente, Asuncion; Antonia Gonzalez-Ensenat, Maria] Hosp St Joan Deu, Dermatol Serv, Barcelona, Spain; [Jimenez-Gallo, David] Hosp Puerta Mar, Dermatol Serv, Cadiz, Spain; [Guillen-Navarro, Encarna] Hosp Clin Univ Virgen de la Arrixaca, Dermatol Serv, Murcia, Spain; [Martorell Sampol, Loreto] Hosp St Joan Deu, Genet Serv, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Vigo; Hospital Universitari Son Espases; University of Barcelona; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Hospital Clinico Universitario Virgen de la Arrixaca; University of Barcelona	Vega, A (corresponding author), Fdn Publ Galega Med Xenom SERGAS, Grp Med Xenom USC, CIBERER, IDIS, Santiago De Compostela, Spain.	ana.vega@usc.es	Fachal, Laura/N-5560-2014; Martín-Santiago, Ana/K-2417-2012; Guillén Navarro, Encarna/AFU-6717-2022	Fachal, Laura/0000-0002-7256-9752; Martín-Santiago, Ana/0000-0002-6318-3313; Guillén Navarro, Encarna/0000-0002-2915-7381; Jimenez-Gallo, David/0000-0003-1161-6698; Martorell, Loreto/0000-0003-0898-7332; Ginarte, Manuel/0000-0002-7030-7484	Ramon Areces Foundation [2013-056]; Spanish Instituto de Salud Carlos III (ISCIII) [INT15/00070, INT16/00154, INT17/00133]; Xunta de Galicia [IN607B]	Ramon Areces Foundation; Spanish Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos III); Xunta de Galicia(Xunta de GaliciaEuropean Commission)	This work was partially supported by Ramon Areces Foundation project (Rare Diseases 2013-056); by Spanish Instituto de Salud Carlos III (ISCIII) (INT15/00070, INT16/00154, INT17/00133) and by Xunta de Galicia (IN607B), given to A.V. U.E was supported by a predoctoral fellowship from Xunta de Galicia.	Akiyama M, 2010, HUM MUTAT, V31, P1090, DOI 10.1002/humu.21326; Bergman A, 2001, EUR J HUM GENET, V9, P787, DOI 10.1038/sj.ejhg.5200704; Buckova H, 2016, BRIT J DERMATOL, V174, P405, DOI 10.1111/bjd.13918; Capelli C, 2009, EUR J HUM GENET, V17, P848, DOI 10.1038/ejhg.2008.258; Cunha DL, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.539; Diociaiuti A, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0384-4; Esperon-Moldes U, 2018, J DERMATOL SCI; Esperon-Moldes U, 2019, ACTA DERM-VENEREOL, V99, P894, DOI 10.2340/00015555-3227; Fachal L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033580; Farasat S, 2009, J MED GENET, V46, P103, DOI 10.1136/jmg.2008.060905; Feng C, 2017, CLIN EXP DERMATOL, V42, P98, DOI 10.1111/ced.12988; Fischer J, 2009, J INVEST DERMATOL, V129, P1319, DOI 10.1038/jid.2009.57; Gandolfo LC, 2014, GENETICS, V197, P1315, DOI 10.1534/genetics.114.164616; Genin E, 2004, J MED GENET, V41, P445, DOI 10.1136/jmg.2003.017962; Grall A, 2012, NAT GENET, V44, P140, DOI 10.1038/ng.1056; Gruber R, 2017, BRIT J DERMATOL, V176, P1068, DOI 10.1111/bjd.14860; Haldane JBS, 1919, J GENET, V8, P299; Heinz L, 2017, AM J HUM GENET, V100, P926, DOI 10.1016/j.ajhg.2017.05.007; Hellstrom Pigg M, 2016, ACTA DERM-VENEREOL, V96, P932, DOI 10.2340/00015555-2418; Hernandez-Martin A, 2012, J AM ACAD DERMATOL, V67, P240, DOI 10.1016/j.jaad.2011.07.033; Hotz A, 2018, HUM MUTAT, V39, P1305, DOI 10.1002/humu.23594; Israeli S, 2013, CLIN EXP DERMATOL, V38, P911, DOI 10.1111/ced.12148; Kirchmeier P, 2017, ACTA DERM-VENEREOL, V97, P102, DOI 10.2340/00015555-2510; Kumar Suresh, 2015, BMC Res Notes, V8, P9, DOI 10.1186/s13104-015-0976-4; Labuda D, 1997, AM J HUM GENET, V61, P768, DOI 10.1016/S0002-9297(07)64341-9; Lefevre C, 2006, HUM MOL GENET, V15, P767, DOI 10.1093/hmg/ddi491; Lefevre C, 2003, HUM MOL GENET, V12, P2369, DOI 10.1093/hmg/ddg235; Lugassy J, 2008, ARCH DERMATOL RES, V300, P81, DOI 10.1007/s00403-007-0815-0; Noguera-Morel L, 2016, PEDIATR DERMATOL, V33, pE48, DOI 10.1111/pde.12740; Ohno Y, 2015, P NATL ACAD SCI USA, V112, P7707, DOI 10.1073/pnas.1503491112; Oji V, 2010, J AM ACAD DERMATOL, V63, P607, DOI 10.1016/j.jaad.2009.11.020; Palamar M, 2015, OPHTHALMIC GENET, V36, P229, DOI 10.3109/13816810.2013.870215; Radner FPW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003536; Reeve JP, 2002, BIOINFORMATICS, V18, P894, DOI 10.1093/bioinformatics/18.6.894; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Rodriguez-Pazos L, 2013, ACTAS DERMO-SIFILOGR, V104, P270, DOI [10.1016/j.adengl.2011.11.021, 10.1016/j.ad.2011.11.015]; Scott CA, 2013, J INVEST DERMATOL, V133, P573, DOI 10.1038/jid.2012.332; Shigehara Y, 2016, HUM MOL GENET, V25, P4484, DOI 10.1093/hmg/ddw277; Simpson A, 2020, J MULTILING MULTICUL, V41, P305, DOI 10.1080/01434632.2019.1618317; Sitek JC, 2018, J EUR ACAD DERMATOL, V32, P1022, DOI 10.1111/jdv.14870; Slatkin M, 1997, AM J HUM GENET, V60, P447; Sugiura K, 2013, J DERMATOL SCI, V72, P193, DOI 10.1016/j.jdermsci.2013.06.008; Terrell G.R., 1999, MATH STAT UNIFIED IN; Vahlquist A, 2018, AM J CLIN DERMATOL, V19, P51, DOI 10.1007/s40257-017-0313-x; Yan D, 2003, HUM GENET, V114, P44, DOI 10.1007/s00439-003-1018-1; Youssefian L, 2018, HUM MUTAT	46	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0229025	10.1371/journal.pone.0229025	http://dx.doi.org/10.1371/journal.pone.0229025			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7XT	32069299	Green Published, gold			2022-12-26	WOS:000535212900019
J	Wang, Y; Liu, Y; Bailey, C; Zhang, HX; He, M; Sun, DX; Zhang, P; Parkin, B; Baer, MR; Zheng, P; Malek, SN; Liu, Y				Wang, Yin; Liu, Yan; Bailey, Christopher; Zhang, Huixia; He, Miao; Sun, Duxin; Zhang, Peng; Parkin, Brian; Baer, Maria R.; Zheng, Pan; Malek, Sami N.; Liu, Yang			Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1 alpha with echinomycin	ONCOGENE			English	Article							MYELODYSPLASTIC SYNDROMES; P53 MUTATIONS; STEM-CELLS; TP53 GENE; SURVIVAL; PERMEABILITY; HIF1-ALPHA	TP53 mutation in acute myeloid leukemia (AML) is associated with poor prognosis. Since no targeted therapy is available to restore p53 function, it is of great interest to test whether other pathways activated by TP53 mutations can be therapeutically targeted. Here, we showed HIF-1 alpha target genes are enriched in TP53-mutated versus TP53-wild-type AML. To determine the role of this activation, we tested efficacy of HIF-1 alpha inhibitor echinomycin in TP53-mutated AML samples in vitro and in vivo. Echinomycin was broadly effective against a panel of primary AML blast cells, with low nanomolar IC(50)s and, based on colony-forming unit assay, was tenfold more effective in eliminating AML stem cells. Echinomycin selectively eliminated CD34(+)CD38(-) AML cells. To test the therapeutic efficacy of echinomycin, we established a xenograft model of TP53-mutated AML. Echinomycin was broadly effective against xenografts from multiple AML samples in vivo, and more effective than cytarabine + daunorubicin chemotherapy. Importantly, while cytarabine + daunorubicin enriched for AML stem cells, echinomycin nearly eliminated this population. Using TP53-mutated AML cell line THP1 and patient-derived AML cells, we tested a new echinomycin formulation with longer half-life and significantly improved therapeutic effect. Our data suggest a novel approach to treat AML with TP53 mutations.	[Wang, Yin; Liu, Yan; Bailey, Christopher; Zhang, Peng; Zheng, Pan; Liu, Yang] Univ Maryland, Sch Med, Dept Surg, Div Immunotherapy,Inst Human Virol, Baltimore, MD 21201 USA; [Wang, Yin; Liu, Yan; Bailey, Christopher; Zhang, Peng; Zheng, Pan; Liu, Yang] Univ Maryland, Sch Med, Ctr Comprehens Canc, Baltimore, MD 21201 USA; [Bailey, Christopher] George Washington Univ, Sch Med, Grad Program Integrated Biomed Res, Washington, DC 20052 USA; [Zhang, Huixia; He, Miao; Sun, Duxin] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA; [Parkin, Brian; Malek, Sami N.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Baer, Maria R.] Univ Maryland, Dept Med, Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA; [Zheng, Pan; Liu, Yang] OncoImmune Inc, Rockville, MD 20853 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; George Washington University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland Baltimore	Wang, Y; Liu, Y (corresponding author), Univ Maryland, Sch Med, Dept Surg, Div Immunotherapy,Inst Human Virol, Baltimore, MD 21201 USA.; Wang, Y; Liu, Y (corresponding author), Univ Maryland, Sch Med, Ctr Comprehens Canc, Baltimore, MD 21201 USA.; Liu, Y (corresponding author), OncoImmune Inc, Rockville, MD 20853 USA.	yin.wang@ihv.umaryland.edu; yaliu@ihv.umaryland.edu	Sun, Duxin/AAA-1774-2022	Zhang, Peng/0000-0002-6218-1885	National Institutes of Health National Cancer Institute [CA171972, CA183030, CA164469]; OncoImmune, Inc.	National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OncoImmune, Inc.	This study was supported by grants from the National Institutes of Health National Cancer Institute [CA171972, CA183030 (YL) and CA164469 (YW)] and a grant from OncoImmune, Inc. Some of the studies were performed when the authors were at the Children's National Medical Center in Washington, DC.	Bally C, 2014, LEUKEMIA RES, V38, P751, DOI 10.1016/j.leukres.2014.03.012; Bejar R, 2014, J CLIN ONCOL, V32, P2691, DOI 10.1200/JCO.2013.52.3381; BenYehuda D, 1996, BLOOD, V88, P4296; Birner P, 2001, CLIN CANCER RES, V7, P1661; Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Cerqueira BBS, 2015, EUR J PHARM BIOPHARM, V97, P140, DOI 10.1016/j.ejpb.2015.10.007; Cheloni G, 2017, BLOOD, V130, P655, DOI 10.1182/blood-2016-10-745588; CORBAZ R, 1957, HELV CHIM ACTA, V40, P199, DOI 10.1002/hlca.19570400124; Haferlach C, 2008, LEUKEMIA, V22, P1539, DOI 10.1038/leu.2008.143; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hou HA, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.59; Huang J, 2009, J CLIN INVEST, V119, P3519, DOI 10.1172/JCI40572; ISOBE M, 1986, NATURE, V320, P84, DOI 10.1038/320084a0; Iyer AK, 2006, DRUG DISCOV TODAY, V11, P812, DOI 10.1016/j.drudis.2006.07.005; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Kumar P, 2012, CRIT REV THER DRUG, V29, P355, DOI 10.1615/CritRevTherDrugCarrierSyst.v29.i5.10; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Ok CY, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0139-z; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Parkin B, 2010, BLOOD, V116, P4958, DOI 10.1182/blood-2010-01-266999; Ruckner FG, 2012, BLOOD, V119, P2114, DOI 10.1182/blood-2011-08-375758; Selivanova G, 1997, NAT MED, V3, P632, DOI 10.1038/nm0697-632; Shih AH, 2013, HAEMATOLOGICA, V98, P908, DOI 10.3324/haematol.2012.076729; Silverman JA, 2013, CANCER CHEMOTH PHARM, V71, P555, DOI 10.1007/s00280-012-2042-4; SUGIMOTO K, 1992, BLOOD, V79, P2378, DOI 10.1182/blood.V79.9.2378.2378; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tyner JW, 2018, NATURE, V562, P526, DOI 10.1038/s41586-018-0623-z; Wang Y, 2014, BLOOD, V124, P1127, DOI 10.1182/blood-2013-12-544221; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; WATTEL E, 1994, BLOOD, V84, P3148, DOI 10.1182/blood.V84.9.3148.3148; Welch JS, 2016, NEW ENGL J MED, V375, P2023, DOI 10.1056/NEJMoa1605949; Zhang HJ, 2012, BLOOD, V119, P2595, DOI 10.1182/blood-2011-10-387381	32	15	16	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	14					3015	3027		10.1038/s41388-020-1201-z	http://dx.doi.org/10.1038/s41388-020-1201-z		FEB 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KZ2VB	32060420	Green Accepted			2022-12-26	WOS:000513384400001
J	Son, MK; Seo, J; Yang, S				Son, Min Kook; Seo, Jeongkuk; Yang, Sung			Association between dyslipidemia and serum uric acid levels in Korean adults: Korea National Health and Nutrition Examination Survey 2016-2017	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR-DISEASE; PREDICTOR; HYPERURICEMIA; HYPERTENSION; INDIVIDUALS; PREVALENCE; PROFILE; RISK	Objectives Despite the growing pieces of evidence linking hyperuricemia with metabolic syndrome and cardiovascular disease, the relationship between dyslipidemia and serum uric acid has not yet been established. This study aimed to investigate the association between individual components of dyslipidemia and serum uric acid by using the nationally representative Korea National Health and Nutrition Examination Survey 2016-2017. Methods A total of 8,722 participants (age >= 19 years) without missing values were analyzed for this study. Serum uric acid levels according to the presence of individual dyslipidemia components were calculated using multivariable-adjusted general linear models (GLM). Odds ratios of individual dyslipidemia components to hyperuricemia were calculated using unadjusted and multivariable-adjusted logistic regression analysis. Results A total of 1,061 participants were identified as having hyperuricemia, with a prevalence of 12.2%. Multivariable-adjusted GLM demonstrated a significant trend between individual dyslipidemia components and serum uric acid levels (P < 0.05). A positive association between the numbers of dyslipidemia components and the increments of serum uric acid levels was also observed (P < 0.001). In multivariable-adjusted logistic regression analysis, odds ratios (OR) and 95% confidence interval (CI) of all dyslipidemia components to hyperuricemia were shown to be statistically significant (P < 0.05). When further adjusted for the combined components themselves, each 10 mg/dL increments of total cholesterol (OR 1.053; 95% CI 1.028-1.079), triglycerides (OR 1.017; 95% CI 1.009-1.026) and HDL-C (OR 0.804; 95% CI 0.729-0.887), retained significant correlation with hyperuricemia. Conclusion Our study demonstrated that the dyslipidemia components of serum total cholesterol, triglycerides and LDL-C levels are positively associated with serum uric acid levels, whereas serum HDL-C levels are inversely related. Further complementary studies regarding other lipid parameters are needed to confirm the accurate association between dyslipidemia and serum uric acid levels.	[Son, Min Kook; Yang, Sung] Gwangju Inst Sci & Technol, Dept Biomed Sci & Engn, Gwangju, South Korea; [Seo, Jeongkuk] Armed Forces Goyang Hosp, Dept Internal Med, Goyang Si, South Korea; [Yang, Sung] Gwangju Inst Sci & Technol, Sch Mech Engn, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Yang, S (corresponding author), Gwangju Inst Sci & Technol, Dept Biomed Sci & Engn, Gwangju, South Korea.; Yang, S (corresponding author), Gwangju Inst Sci & Technol, Sch Mech Engn, Gwangju, South Korea.	syang@gist.ac.kr		Son, Minkook/0000-0002-0047-3102	Radianqbio Inc. [GI06530]	Radianqbio Inc.	This work was supported by the Radianqbio Inc. (2018, GI06530). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders have not served or currently serve on the editorial board. The funders have not acted as an expert witness in relevant legal proceedings. The funders have not sat or currently sit on a committee for an organization that may benefit form publication of the paper.	Ali N, 2019, BMC CARDIOVASC DISOR, V19, DOI 10.1186/s12872-019-1026-2; Ali N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206850; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Bardin T, 2014, CURR OPIN RHEUMATOL, V26, P186, DOI 10.1097/BOR.0000000000000028; Bickel C, 2002, AM J CARDIOL, V89, P12, DOI 10.1016/S0002-9149(01)02155-5; Borghi C, 2015, J HYPERTENS, V33, P1729, DOI 10.1097/HJH.0000000000000701; Cho SK, 2018, ARTHRITIS RHEUMATOL, V70, P1122, DOI 10.1002/art.40472; Choi HK, 2007, AM J MED, V120, P442, DOI 10.1016/j.amjmed.2006.06.040; Cicero AFG, 2019, J HYPERTENS, V37, P728, DOI 10.1097/HJH.0000000000001927; Cicero AFG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29955-w; Cui YD, 2001, ARCH INTERN MED, V161, P1413, DOI 10.1001/archinte.161.11.1413; Derosa G, 2016, DRUGS, V76, P947, DOI 10.1007/s40265-016-0591-2; Hou YL, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1031-6; Jung JY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35175-z; Kallistratos M, 2018, J HYPERTENS, V36, pE138, DOI 10.1097/01.hjh.0000539359.83742.00; Keenan T, 2012, AM J CARDIOL, V110, P1787, DOI 10.1016/j.amjcard.2012.08.012; Kim JW, 2017, RHEUMATOL INT, V37, P1499, DOI 10.1007/s00296-017-3768-4; Kim KI, 2016, KOREAN CIRC J, V46, P275, DOI 10.4070/kcj.2016.46.3.275; Kim Y, 2018, CLIN RHEUMATOL, V37, P2529, DOI 10.1007/s10067-018-4130-2; Korea Center for Disease Control and Prevention, 2019, KOR NAT HLTH NUTR EX; Kuwabara M, 2014, HYPERTENS RES, V37, P785, DOI 10.1038/hr.2014.75; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lehto S, 1998, STROKE, V29, P635, DOI 10.1161/01.STR.29.3.635; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lima WG, 2015, BIOCHIMIE, V116, P17, DOI 10.1016/j.biochi.2015.06.025; Lippi Giuseppe, 2010, Clin Cardiol, V33, pE76, DOI 10.1002/clc.20511; Liu R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/762820; Milionis HJ, 2004, AM HEART J, V148, P635, DOI 10.1016/j.ahj.2004.04.005; Muiesan ML, 2016, EUR CARDIOL REV, V11, P54, DOI 10.15420/ecr.2016:4:2; Peng TC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/127596; ROBERTS WC, 1988, AM J CARDIOL, V62, P345, DOI 10.1016/0002-9149(88)90248-2; Sarmah D, 2013, ASIAN J MED SCI, V4, P8, DOI DOI 10.3126/ajms.v4i2.7893; Stelmach MJ, 2015, IRISH J MED SCI, V184, P463, DOI 10.1007/s11845-014-1146-8; Vekic J, 2009, ATHEROSCLEROSIS, V203, P236, DOI 10.1016/j.atherosclerosis.2008.05.047; Xu J, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-117	35	21	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0228684	10.1371/journal.pone.0228684	http://dx.doi.org/10.1371/journal.pone.0228684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7VI	32059030	Green Published, gold			2022-12-26	WOS:000535206600012
J	Geng, WJ; Qi, YJ; Li, WT; McConville, TH; Hill-Ricciuti, A; Grohs, EC; Saiman, L; Uhlemann, AC				Geng, Wenjing; Qi, Yujie; Li, Wenting; McConville, Thomas H.; Hill-Ricciuti, Alexandra; Grohs, Emily C.; Saiman, Lisa; Uhlemann, Anne-Catrin			Epidemiology of Staphylococcus aureus in neonates on admission to a Chinese neonatal intensive care unit	PLOS ONE			English	Article							SEQUENCE TYPE 398; METHICILLIN-RESISTANT; MOLECULAR CHARACTERISTICS; MRSA STRAINS; SPA TYPES; COLONIZATION; OXACILLIN; COMMUNITY; RISK; INFECTIONS	Purpose Little is known about the molecular epidemiology of Staphylococcus aureus in Chinese neonatal intensive care units (NICUs). We describe the molecular epidemiology of S. aureus isolated from neonates on admission to Beijing Children's Hospital. Methods From May 2015-March 2016, nasal swabs were obtained on admission from 536 neonates. Cultures were also obtained from body sites with suspected infections. S. aureus isolates were characterized by staphylococcal chromosomal cassette (SCCmec) type, staphylococcal protein A (spa) type, multilocus sequence type (MLST), sasX gene, antimicrobial susceptibility and cytotoxicity. Logistic regression assessed risk factors for colonization. Results Overall, 92 (17%) infants were colonized with S. aureus and 20 (3.7%) were diagnosed with culture-positive S. aureus infection. Of the colonized infants, 70% (64/92) harbored methicillin-susceptible S. aureus (MSSA), 30% (28/92) harbored methicillin-resistant S. aureus (MRSA) while 70% (14/20) of infected infants were culture-positive for MRSA, 30% (6/20) were culture-positive for MSSA. Risk factors for colonization included female sex, age 7-28 days, higher birthweight (3270 IQR [2020-3655] grams) and vaginal delivery (p<0.05). The most common MRSA and MSSA clones were community-associated ST59-SCCmecIVat437 (60%) and ST188-t189 (15%), respectively. The sasX gene was not detected. Some MSSA isolates (16%) were penicillin-susceptible and some MRSA isolates (18%) were oxacillin-susceptible. MRSA and MSSA had similar cytotoxicity, but colonizing strains were less cytotoxic than strains associated with infections. Conclusions S. aureus colonization was common in infants admitted to our NICU and two community-associated clones predominated. Several non-modifiable risk factors for S. aureus colonization were identified. These results suggest that screening infants for S. aureus upon admission and targeting decolonization of high-risk infants and/or those colonized with high-risk clones could be useful to prevent transmission.	[Geng, Wenjing; Qi, Yujie] Capital Med Univ, Beijing Childrens Hosp, Neonatal Ctr, Natl Ctr Childrens Hlth, Beijing, Peoples R China; [Li, Wenting] Shandong Univ, Resp Dept, Qilu Childrens Hosp, Jinan, Peoples R China; [McConville, Thomas H.; Uhlemann, Anne-Catrin] Columbia Univ, Dept Med, Div Infect Dis, Med Ctr, New York, NY USA; [Hill-Ricciuti, Alexandra; Grohs, Emily C.; Saiman, Lisa] Columbia Univ, Dept Pediat, Irving Med Ctr, New York, NY 10027 USA; [Saiman, Lisa] NewYork Presbyterian Hosp, Dept Infect Prevent & Control, New York, NY USA	Capital Medical University; Shandong University; Columbia University; Columbia University; NewYork-Presbyterian Hospital; NewYork-Presbyterian Hospital	Geng, WJ (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Neonatal Ctr, Natl Ctr Childrens Hlth, Beijing, Peoples R China.	wenjingsmart@163.com			Innovation Fund of Morgan Stanley Global AlliancePediatric Specialties Initiatives; Beijing Municipal Administration of Hospitals' Youth Programme [QML20161204]	Innovation Fund of Morgan Stanley Global AlliancePediatric Specialties Initiatives; Beijing Municipal Administration of Hospitals' Youth Programme	This work was supported by the Innovation Fund of Morgan Stanley Global AlliancePediatric Specialties Initiatives and the Beijing Municipal Administration of Hospitals' Youth Programme (QML20161204). WJ G received the award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade-Figueiredo M, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0733-4; Asadollahi P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00163; Bhat M, 2009, EMERG INFECT DIS, V15, P285, DOI 10.3201/eid1502.080609; Bignardi GE, 1996, J ANTIMICROB CHEMOTH, V37, P53, DOI 10.1093/jac/37.1.53; Cailes B, 2018, ARCH DIS CHILD-FETAL, V103, pF547, DOI 10.1136/archdischild-2017-313203; Carey AJ, 2010, J PERINATOL, V30, P135, DOI 10.1038/jp.2009.119; Chabot MR, 2015, J ANTIMICROB CHEMOTH, V70, P3353, DOI 10.1093/jac/dkv270; Clinical and Laboratory Standards Institute (CLSI), 2016, M100S25 CLSI; Conceicao T, 2015, J ANTIMICROB CHEMOTH, V70, P3200, DOI 10.1093/jac/dkv261; David MZ, 2013, J CLIN MICROBIOL, V51, P2443, DOI 10.1128/JCM.01057-13; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Geng WJ, 2010, FEMS IMMUNOL MED MIC, V58, P356, DOI [10.1111/j.1574-695X.2009.00648.x, 10.1111/j.1574-695X.2010.00648.x]; Giuffre M, 2015, AM J INFECT CONTROL, V43, P476, DOI 10.1016/j.ajic.2014.12.027; Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2; Hau SJ, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02073-17; Ho CM, 2016, DIAGN MICR INFEC DIS, V86, P405, DOI 10.1016/j.diagmicrobio.2016.08.025; Hornik CP, 2012, EARLY HUM DEV, V88, pS69, DOI 10.1016/S0378-3782(12)70019-1; Huang YC, 2006, PEDIATRICS, V118, P469, DOI 10.1542/peds.2006-0254; James L, 2008, ARCH DIS CHILD-FETAL, V93, pF40, DOI 10.1136/adc.2006.104026; Kong HS, 2018, INFECT DRUG RESIST, V11, P55, DOI 10.2147/IDR.S153399; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Kuo CY, 2014, NEONATOLOGY, V105, P142, DOI 10.1159/000356733; Laabei M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002229; Lehtonen L, 2017, SEMIN FETAL NEONAT M, V22, P153, DOI 10.1016/j.siny.2017.02.006; Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692; Li SP, 2015, APMIS, V123, P28, DOI 10.1111/apm.12304; Li SP, 2014, APMIS, V122, P101, DOI 10.1111/apm.12105; Lin JL, 2018, INFECT DRUG RESIST, V11, P555, DOI 10.2147/IDR.S157522; Loeb MB, 2003, COCHRANE DB SYST REV, V2003, DOI [10.1002/14651858.CD003340, DOI 10.1002/14651858.CD003340]; Macnow T, 2013, PEDIATR INFECT DIS J, V32, pE443, DOI 10.1097/INF.0b013e3182a1d77f; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Miller M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006708; Mitsuda T, 1996, EUR J PEDIATR, V155, P194, DOI 10.1007/BF01953937; Oza S, 2015, B WORLD HEALTH ORGAN, V93, P19, DOI 10.2471/BLT.14.139790; Pournaras S, 2013, FUTURE MICROBIOL, V8, P1365, DOI 10.2217/fmb.13.118; Pu WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088134; Rose HR, 2015, J INFECT DIS, V211, P1862, DOI 10.1093/infdis/jiu554; Song YJ, 2017, J GLOB ANTIMICROB RE, V11, P1, DOI 10.1016/j.jgar.2017.05.009; Top KA, 2010, J CLIN MICROBIOL, V48, P3675, DOI 10.1128/JCM.01129-10; Uhlemann AC, 2017, MBIO, V8, DOI 10.1128/mBio.01375-16; Uhlemann AC, 2013, CLIN INFECT DIS, V57, P700, DOI 10.1093/cid/cit375; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; Wang YA, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0048-7; Washam M, 2017, AM J INFECT CONTROL, V45, P1388, DOI 10.1016/j.ajic.2017.06.021; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Yan X, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.08.022; Zervou FN, 2014, PEDIATRICS, V133, pE1015, DOI 10.1542/peds.2013-3413; Zhao CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038577	48	6	6	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0211845	10.1371/journal.pone.0211845	http://dx.doi.org/10.1371/journal.pone.0211845			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053585	gold, Green Submitted, Green Published			2022-12-26	WOS:000535198700001
J	Leiu, KH; Chin, YS; Sheriff, ZM; Arumugam, M; Chan, YM				Leiu, Kok Hong; Chin, Yit Siew; Sheriff, Zalilah Mohd; Arumugam, Manohar; Chan, Yoke Mun			High body fat percentage and low consumption of dairy products were associated with vitamin D inadequacy among older women in Malaysia	PLOS ONE			English	Article							25-HYDROXYVITAMIN D CONCENTRATIONS; SUN EXPOSURE; D DEFICIENCY; BONE; CALCIUM; CHINESE; IMPEDANCE; DENSITY; HEALTH; MILK	Background Serum vitamin D insufficiency is a public health issue, especially among older women. Sun exposure is fundamental in the production of vitamin D, but older women have less optimal sun exposure. Therefore, factors such as body composition and diet become more essential in sustaining sufficient serum levels of vitamin D. The objective of the current study is to determine factors contributing towards serum vitamin D insufficiency among 214 older women. Methods The respondents had their body weight, height, waist circumference and body fat percentage measured, as well as interviewed for their socio-demographic characteristics, sun exposure and dietary intake. Fasting blood samples were obtained from the respondents to measure their serum 25-hydroxyvitamin D [25(OH)D] concentration. Results There were 82.7% (95% CI: 77.6%, 87.8%) of the respondents that had serum vitamin D insufficiency (< 50 nmol/L) with an average of 37.4 +/- 14.3nmol/L. In stepwise multiple linear regression, high percentage of body fat (beta = -0.211, p < 0.01) and low consumption of milk and dairy products (beta = 0.135, p < 0.05) were the main contributors towards insufficient serum vitamin D levels, but not socio-demographic characteristics, other anthropometric indices, sun exposure and diet quality. Conclusion Older women with high body fat percentage and low dairy product consumption were more likely to have serum vitamin D insufficiency. Older women should ensure their body fat percentage is within a healthy range and consume more milk and dairy products in preventing serum vitamin D insufficiency.	[Leiu, Kok Hong; Chin, Yit Siew; Sheriff, Zalilah Mohd; Chan, Yoke Mun] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Serdang, Selangor, Malaysia; [Chin, Yit Siew; Chan, Yoke Mun] Univ Putra Malaysia, Fac Med & Hlth Sci, Res Ctr Excellence Nutr & Noncommunicable Dis, Serdang, Selangor, Malaysia; [Arumugam, Manohar] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Orthoped, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Chin, YS (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Serdang, Selangor, Malaysia.; Chin, YS (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Res Ctr Excellence Nutr & Noncommunicable Dis, Serdang, Selangor, Malaysia.	chinys@upm.edu.my	Chin, Yit Siew/G-2001-2015	Chin, Yit Siew/0000-0002-7609-1944; Leiu, Kok Hong/0000-0002-1247-1403; Mohd Shariff, Zalilah/0000-0002-5347-4627	Yoke Mun Chan (YMC) One Fundamental Research Grant Scheme Ministry of Higher Education, Malaysia	Yoke Mun Chan (YMC) One Fundamental Research Grant Scheme Ministry of Higher Education, Malaysia	Yoke Mun Chan (YMC) One Fundamental Research Grant Scheme Ministry of Higher Education, Malaysia mohe.gov.my The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas MA, 2017, J STEROID BIOCHEM, V165, P369, DOI 10.1016/j.jsbmb.2016.08.004; Aday LA, 2006, DESIGNING CONDUCTING, V47; Anderson PH, 2012, CLIN BIOCHEM, V45, P880, DOI 10.1016/j.clinbiochem.2012.02.020; [Anonymous], 2000, WHO TECHN REP SER; Araghi SO, 2015, J NUTR HEALTH AGING, V19, P980, DOI [10.1007/s12603-015-0507-y, 10.1007/s12603-015-0657-y]; Barger-Lux MJ, 2002, J CLIN ENDOCR METAB, V87, P4952, DOI 10.1210/jc.2002-020636; Brincat M, 2015, MATURITAS, V80, P329, DOI 10.1016/j.maturitas.2014.12.018; Cashman KD, 2015, J STEROID BIOCHEM, V148, P19, DOI 10.1016/j.jsbmb.2015.01.023; Chee W Ss Jr, 2010, Malays J Nutr, V16, P233; Chee WSS, 2002, ASIA PAC J CLIN NUTR, V11, P142, DOI 10.1046/j.1440-6047.2002.00276.x; Chee WSS, 2003, OSTEOPOROSIS INT, V14, P828, DOI 10.1007/s00198-003-1448-6; Chowdhury R, 2014, BMJ-BRIT MED J, V348, P1; Cole TJ, 1997, DESIGN CONCEPTS NUTR; Darmon N, 2015, NUTR REV, V73, P643, DOI 10.1093/nutrit/nuv027; Delle Monache S, 2019, CLIN NUTR, V38, P829, DOI 10.1016/j.clnu.2018.02.024; Deurenberg P, 2002, ASIA PAC J CLIN NUTR, V11, P1, DOI 10.1046/j.1440-6047.2002.00258.x; Deurenberg P, 2001, EUR J CLIN NUTR, V55, P973, DOI 10.1038/sj.ejcn.1601254; Earthman CP, 2012, INT J OBESITY, V36, P387, DOI 10.1038/ijo.2011.119; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Field A, 2013, DISCOVERING STAT USI; Freeman J, 2015, CLIN BIOCHEM, V48, P1097, DOI 10.1016/j.clinbiochem.2015.05.021; George D., 2010, SPSS WINDOWS STEP ST, V10; Hall LM, 2010, J NUTR, V140, P542, DOI 10.3945/jn.109.115253; Heaney RP, 2009, J AM COLL NUTR, V28, P252, DOI 10.1080/07315724.2009.10719779; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Holick MF., 2002, CURR OPIN ENDOCRINOL, V9, P87, DOI DOI 10.1097/00060793-200202000-00011; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick Michael F, 2014, Adv Exp Med Biol, V810, P1; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Institute for Public Health, 2014, NAT HLTH MORB SURV 2, VI; Institute for Public Health, 2011, MAL FOOD ALB; Institute of Medicine, 2011, DIETARY REFERENCE IN; Isabelle M., 2011, REPORT REGULATORY ST; Kotlarczyk MP, 2017, OSTEOPOROSIS INT, V28, P1347, DOI 10.1007/s00198-016-3877-z; Kruger MC, 2016, EUR J NUTR, V55, P1911, DOI 10.1007/s00394-015-1007-x; Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Laurent RT St., 1994, UNDERSTANDING REGRES; Lee J.-K., 2007, APLAR J RHEUMATOL, V10, P300, DOI [10.1111/j.1479-8077.2007.00314.x, DOI 10.1111/J.1479-8077.2007.00314.X, DOI 10.1111/j.1479-8077.2007.00314.x]; Lee TT, 2011, 26 SCI C NUTR SOC MA; Lips P, 2014, ANN NY ACAD SCI, V1317, P92, DOI 10.1111/nyas.12443; Maclaughlin J., 1986, NUTR CLIN PRACT, V1, P57, DOI [10.1177/088453368600100118, DOI 10.1177/088453368600100118]; Mat S, 2018, INT J RHEUM DIS, V21, P930, DOI 10.1111/1756-185X.13279; McMichael AJ, 2014, INT J HEALTH POLICY, V2, P9, DOI 10.15171/ijhpm.2014.03; Nasabian PJ, 2017, J ENDOCRINOL, V234, pR37, DOI 10.1530/JOE-16-0603; National Coordinating Committee on Food and Nutrition, 2010, MAL DIET GUID; National Coordinating Committee on Food and Nutrition (NCCFN), 2017, REC NUTR INT MAL; Nieman D, 2010, EXERCISE TESTING PRE; Norman AW, 2012, ANN NUTR METAB, V61, P199, DOI 10.1159/000343104; Nurbazlin M, 2013, ASIA PAC J CLIN NUTR, V22, P391, DOI 10.6133/apjcn.2013.22.3.15; PARISI AV, 1994, PHOTOCHEM PHOTOBIOL, V60, P470, DOI 10.1111/j.1751-1097.1994.tb05136.x; Rahman SA, 2004, ASIA PAC J CLIN NUTR, V13, P255; Schwalfenberg G.K., 2015, SCI WORLD J, V2015; Shafinaz IS, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2924-1; St-Onge MP, 2010, NUTRITION, V26, P152, DOI 10.1016/j.nut.2009.07.004; Stewart A., 2011, INT STANDARDS ANTHRO, V137; Tan KML, 2013, J CLIN LAB ANAL, V27, P301, DOI 10.1002/jcla.21602; Tangpricha V, 2003, AM J CLIN NUTR, V77, P1478, DOI 10.1093/ajcn/77.6.1478; Tsiaras WG, 2011, ACTA DERM-VENEREOL, V91, P115, DOI 10.2340/00015555-0980; van Schoor N, 2017, ENDOCRIN METAB CLIN, V46, P845, DOI 10.1016/j.ecl.2017.07.002; Vitezova A, 2017, CLIN NUTR, V36, P585, DOI 10.1016/j.clnu.2016.04.017; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; Wang J, 2017, OSTEOPOROSIS INT, V28, P2645, DOI 10.1007/s00198-017-4081-5; WHO, 2010, WHO GUID DRAW BLOOD; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; World Health Organization, UV MEAS	67	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228803	10.1371/journal.pone.0228803	http://dx.doi.org/10.1371/journal.pone.0228803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053636	gold, Green Published, Green Accepted			2022-12-26	WOS:000535198700058
J	Carr-Markell, MK; Demler, CM; Couvillon, MJ; Schurch, R; Spivak, M				Carr-Markell, Morgan K.; Demler, Cora M.; Couvillon, Margaret J.; Schurch, Roger; Spivak, Marla			Do honey bee (Apis mellifera) foragers recruit their nestmates to native forbs in reconstructed prairie habitats?	PLOS ONE			English	Article							LAND-USE; POLLEN NUTRITION; COLONIES; STRESS; RESTORATIONS; COMMUNITIES; POLLINATION; GRASSLAND; DIVERSITY; SURVIVAL	Honey bee (Apis mellifera) colonies are valued for the pollination services that they provide. However, colony mortality has increased to unsustainable levels in some countries, including the United States. Landscape conversion to monocrop agriculture likely plays a role in this increased mortality by decreasing the food sources available to honey bees. Many land owners and organizations in the Upper Midwest region of the United States would like to restore/reconstruct native prairie habitats. With increasing public awareness of high bee mortality, many landowners and beekeepers have wondered whether these restored prairies could significantly improve honey bee colony nutrition. Conveniently, honey bees have a unique communication signal called a waggle dance, which indicates the locations of the flower patches that foragers perceive as highly profitable food sources. We used these communication signals to answer two main questions: First, is there any part of the season in which the foraging force of a honey bee colony will devote a large proportion of its recruitment efforts (waggle dances) to flower patches within prairies? Second, will honey bee foragers advertise specific taxa of native prairie flowers as profitable pollen sources? We decoded 1528 waggle dances in colonies located near two large, reconstructed prairies. We also collected pollen loads from a subset of waggle-dancing bees, which we then analyzed to determine the flower taxon advertised. Most dances advertised flower patches outside of reconstructed prairies, but the proportion of dances advertising nectar sources within prairies increased significantly in the late summer/fall at one site. Honey bees advertised seven native prairie taxa as profitable pollen sources, although the three most commonly advertised pollen taxa were non-native. Our results suggest that including certain native prairie flower taxa in reconstructed prairies may increase the chances that colonies will use those prairies as major food sources during the period of greatest colony growth and honey production.	[Carr-Markell, Morgan K.; Spivak, Marla] Univ Minnesota, Dept Entomol, Falcon Hts, MN 55455 USA; [Demler, Cora M.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA; [Couvillon, Margaret J.; Schurch, Roger] Virginia Tech, Dept Entomol, Blacksburg, VA USA	University of Minnesota System; Cornell University; Virginia Polytechnic Institute & State University	Carr-Markell, MK (corresponding author), Univ Minnesota, Dept Entomol, Falcon Hts, MN 55455 USA.	carrm163@umn.edu		Carr-Markell, Morgan/0000-0002-7787-9194	Project Apis m-Costco Honey Bee Health Fellowship; North Dakota Department of Agriculture; General Mills; Madhava Sweeteners; NSF [1462347]	Project Apis m-Costco Honey Bee Health Fellowship; North Dakota Department of Agriculture; General Mills; Madhava Sweeteners; NSF(National Science Foundation (NSF))	MCM received funds from a Project Apis m-Costco Honey Bee Health Fellowship, which supported this work. MS received research funds for this work from the North Dakota Department of Agriculture, General Mills, and Madhava Sweeteners.; We thank Belle Kinder for her assistance in maintaining colonies, surveying flowers, and decoding dances at Carleton College and Phoebe Koenig for her help at Belwin Conservancy. We thank Belwin Conservancy and Carleton College's Cowling Arboretum for allowing us to collect data on their land, particularly Mark McKone, Nancy Braker, Ned Phillips, and Tara Kelly for their advice and help with floral surveys. We are very grateful to Martin McGough and Fritz Bogott who generously allowed us to keep our bees near their residences and use their electricity. We thank Ian Lane and Elaine Evans for their assistance with flower identification. We are grateful to two undergraduate technicians who assisted in decoding dances, Brooke Sommerfeldt and Eileen Hickman. We are indebted to Erin Treiber for advice on DNA extraction, marker amplification, and sequencing. We thank Michael Spengler for his help in modifying the R code for analyzing and mapping dances, and John Fieberg for helpful advice on Bayesian statistics. We are very grateful to Gary Reuter for all of his help in caring for the honey bees and creativity in modifying sheds and observation hives for this project. Dan Cariveau, Diane Larson, and Emilie Snell-Rood provided invaluable feedback. We also thank the LacCore Center (funded by NSF grant No. 1462347) for the use of their pollen reference library and microscopes.	Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Attwood SJ, 2008, GLOBAL ECOL BIOGEOGR, V17, P585, DOI 10.1111/j.1466-8238.2008.00399.x; Barron AB, 2007, P NATL ACAD SCI USA, V104, P1703, DOI 10.1073/pnas.0610506104; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Beekman M, 2016, INSECT SOC, V63, P117, DOI 10.1007/s00040-015-0443-1; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Bryant V. M., 2001, PALYNOLOGY, V25, P11, DOI DOI 10.1080/01916122.2001.9989554; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Corby-Harris V., 2019, BEE WORLD, V96, P3, DOI [10.1080/ 0005772x.2018.1535951, DOI 10.1080/0005772X.2018.1535951]; Cornman RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145365; Corrigan CE., 2014, THESIS; Couvillon Margaret J., 2014, Communicative & Integrative Biology, V7, pe28821, DOI 10.4161/cib.28821; Couvillon M, 2015, APIDOLOGIE, V46, P61, DOI 10.1007/s13592-014-0302-5; Couvillon MJ, 2014, CURR BIOL, V24, P1212, DOI 10.1016/j.cub.2014.03.072; Couvillon MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093495; Couvillon MJ, 2012, BIOL OPEN, V1, P467, DOI 10.1242/bio.20121099; DeGrandi-Hoffman G, 2016, APIDOLOGIE, V47, P186, DOI 10.1007/s13592-015-0386-6; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Dolezal AG, 2019, P NATL ACAD SCI USA, V116, P25147, DOI 10.1073/pnas.1912801116; ESRI, 2020, ARCGIS DESKT REL 10; FREE JB, 1963, J ANIM ECOL, V32, P119, DOI 10.2307/2521; Furgala B, 2017, BEEKEEPING NO CLIMAT; Garbuzov M, 2015, AGR ECOSYST ENVIRON, V203, P62, DOI 10.1016/j.agee.2014.12.009; Garbuzov M, 2014, BIOSCIENCE, V64, P1019, DOI 10.1093/biosci/biu150; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Hartel S, 2014, CURR BIOL, V24, pR524, DOI 10.1016/j.cub.2014.04.052; Harmon-Threatt AN, 2015, BASIC APPL ECOL, V16, P64, DOI 10.1016/j.baae.2014.11.001; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Haydak MH, 1962, BEEKEEPING MINNESOTA; Hendrickx F, 2007, J APPL ECOL, V44, P340, DOI 10.1111/j.1365-2664.2006.01270.x; Hernandez DL, 2013, SOIL SCI SOC AM J, V77, P2029, DOI 10.2136/sssaj2012.0403; Hodges D., 1984, POLLEN LOADS HONEY B; Hopwood JL, 2008, BIOL CONSERV, V141, P2632, DOI 10.1016/j.biocon.2008.07.026; Horn J, 2016, OIKOS, V125, P1001, DOI 10.1111/oik.02636; Hovenden MJ, 2008, NEW PHYTOL, V178, P815, DOI 10.1111/j.1469-8137.2008.02419.x; Huang Zachary, 2012, Terrestrial Arthropod Reviews, V5, P175, DOI 10.1163/187498312X639568; Huang Z, 2010, AM BEE J, V150, P773; Hung KLJ, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2140; Jack-McCollough RT, 2015, ANIM BEHAV, V110, P9, DOI 10.1016/j.anbehav.2015.09.003; Jones Gretchen D., 2014, Journal of Pollination Ecology, V13, P203; Jordan W. R., 2011, MAKING NATURE WHOLE; Keller I, 2005, BEE WORLD, V86, P3, DOI 10.1080/0005772X.2005.11099641; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Kulhanek K, 2017, J APICULT RES, V56, P328, DOI 10.1080/00218839.2017.1344496; Langstroth LL., 1853, LANGSTROTH HIVE HONE; Le Feon V, 2010, AGR ECOSYST ENVIRON, V137, P143, DOI 10.1016/j.agee.2010.01.015; Lesica P, 2010, J ARID ENVIRON, V74, P1013, DOI 10.1016/j.jaridenv.2010.02.002; Mallinger RE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189268; Mao W, 2013, P NATL ACAD SCI USA, V110, P8842, DOI 10.1073/pnas.1303884110; MEYER WALTRAUD, 1956, BEE WORLD, V37, P25; MN BWSR, 2017, ID PROGR FUND PARTN; MN DNR, 2011, MINN PRAIR CONS PLAN; Nakamura J, 2006, BEHAV ECOL SOCIOBIOL, V60, P339, DOI 10.1007/s00265-006-0170-8; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Otto CRV, 2016, P NATL ACAD SCI USA, V113, P10430, DOI 10.1073/pnas.1603481113; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ratnieks FLW, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00031; Richardson RT, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1500043; ROBINSON GE, 1984, APIDOLOGIE, V15, P355, DOI 10.1051/apido:19840307; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Scaven VL, 2013, CURR ZOOL, V59, P418, DOI 10.1093/czoolo/59.3.418; Schurch R, 2013, J COMP PHYSIOL A, V199, P1143, DOI 10.1007/s00359-013-0860-4; Scofield HN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121731; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1989, BEHAV ECOL SOCIOBIOL, V24, P181, DOI 10.1007/BF00292101; Seeley TD, 2000, J COMP PHYSIOL A, V186, P813, DOI 10.1007/s003590000134; SEELEY TD, 1994, BEHAV ECOL SOCIOBIOL, V34, P51, DOI 10.1007/BF00175458; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Senapathi D, 2017, FUNCT ECOL, V31, P26, DOI 10.1111/1365-2435.12809; Simone-Finstrom MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034601; Smart MD, 2017, ENVIRON ENTOMOL, V46, P38, DOI 10.1093/ee/nvw159; Smart M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152685; Smart MD, 2016, AGR ECOSYST ENVIRON, V230, P139, DOI 10.1016/j.agee.2016.05.030; Spivak M, 2011, ENVIRON SCI TECHNOL, V45, P34, DOI 10.1021/es101468w; Sponsler Douglas B., 2017, Journal of Urban Ecology, V3, pjuw008, DOI 10.1093/jue/juw008; Steiner J. J., 1999, Trefoil: the science and technology of Lotus. Proceedings of a symposium cosponsored by the American Society of Agronomy and the Crop Science Society of America in St. Louis, MO, USA, 22-24 March 1994., P81; Swenk M. H., 1925, American Museum Novitates, Vno. 186, P1; Tanner D, 2009, APIDOLOGIE, V40, P55, DOI 10.1051/apido:2008074; Tonietto RK, 2017, ECOL APPL, V27, P705, DOI 10.1002/eap.1481; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; von Frisch K., 1967, DANCE LANGUAGE LANGU; WADDINGTON KD, 1994, BEHAV ECOL SOCIOBIOL, V35, P423, DOI 10.1007/BF00165845; Weaver JE., 1954, N AM PRAIRIE; WERNER PA, 1980, CAN J PLANT SCI, V60, P1393, DOI 10.4141/cjps80-194; Wilson JS, 2017, FRONT ECOL ENVIRON, V15, P460, DOI 10.1002/fee.1531; Wood TJ, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00210; Zarchin S, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2394-1	88	19	19	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228169	10.1371/journal.pone.0228169	http://dx.doi.org/10.1371/journal.pone.0228169			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32049993	gold, Green Published			2022-12-26	WOS:000535192300010
J	Dargahi, N; Johnson, J; Apostolopoulos, V				Dargahi, Narges; Johnson, Joshua; Apostolopoulos, Vasso			Streptococcus thermophilus alters the expression of genes associated with innate and adaptive immunity in human peripheral blood mononuclear cells	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; PROBIOTIC MIXTURE VSLNUMBER-3; CYTOKINE PRODUCTION; STRAIN-SPECIFICITY; COMPLEMENT-SYSTEM; ESCHERICHIA-COLI; T-CELLS; LACTOBACILLUS; INDUCTION; GAMMA	Consumption of probiotics contributes to a healthy microbiome of the GIT leading to many health benefits. They also contribute to the modulation of the immune system and are becoming popular for the treatment of a number of immune and inflammatory diseases. The main objective of this study was to evaluate anti-inflammatory and modulatory properties of Streptococcus thermophilus. We used peripheral blood mononuclear cells from healthy donors and assessed modifications in the mRNA expression of their genes related to innate and adaptive immune system. Our results showed strong immune modulatory effects of S. thermophilus 285 to human peripheral blood mononuclear cells with an array of anti-inflammatory properties. S. thermophilus 285 reduced mRNA expression in a number of inflammatory immune mediators and markers, and upregulated a few of immune markers. S. thermophilus is used in the dairy industry, survives during cold storage, tolerates well upon ingesting, and their consumption may have beneficial effects with potential implications in inflammatory and autoimmune disorders.	[Dargahi, Narges; Apostolopoulos, Vasso] Victoria Univ, Inst Hlth & Sport, Melbourne, Vic, Australia; [Johnson, Joshua] Victoria Univ, Inst Sustainable Ind & Liveable Cities, Melbourne, Vic, Australia	Victoria University; Victoria University	Dargahi, N; Apostolopoulos, V (corresponding author), Victoria Univ, Inst Hlth & Sport, Melbourne, Vic, Australia.	Narges.Dargahi@live.vu.edu.au; Vasso.Apostolopoulos@vu.edu.au		Dargahi, Narges/0000-0001-8090-025X	VU Research; Institute for Health and Sport at Victoria University; Institute for Sustainable Industries and Liveable Cities at Victoria University	VU Research; Institute for Health and Sport at Victoria University; Institute for Sustainable Industries and Liveable Cities at Victoria University	All authors were supported by VU Research and in particular, Institute for Health and Sport and the Institute for Sustainable Industries and Liveable Cities at Victoria University.	Abubaker J, 2013, PLOS ONE, V8; Appledorn DM, 2008, GENE THER, V15, P1606, DOI 10.1038/gt.2008.114; Arce C, 2010, COMP IMMUNOL MICROB, V33, P161, DOI 10.1016/j.cimid.2008.08.003; Asarat M, 2016, IMMUNOL INVEST, V45, P205, DOI 10.3109/08820139.2015.1122613; Asarat M, 2015, INT J FOOD SCI NUTR, V66, P755, DOI 10.3109/09637486.2015.1088935; Asarat M, 2015, IMMUNOL INVEST, V44, P678, DOI 10.3109/08820139.2015.1085389; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Balzaretti S, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.02702-16, 10.1128/aem.02702-16]; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Betsou F, 2019, CURR PATHOBIOL REP, V7, P17, DOI 10.1007/s40139-019-00192-8; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; Biasin V, 2017, SCI REPORTS, V7; Bron PA, 2013, CURR OPIN MICROBIOL, V16, P262, DOI 10.1016/j.mib.2013.06.001; Butterworth RF, 2011, NEUROCHEM INT, V59, P830, DOI 10.1016/j.neuint.2011.07.014; Corkum CP, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0113-0; D'Arienzo R, 2009, CYTOKINE, V48, P254, DOI 10.1016/j.cyto.2009.08.003; Dai C, 2013, MOL CELL BIOCHEM, V374, P1, DOI 10.1007/s11010-012-1488-3; Dai YD, 2009, DIABETES, V58, P156, DOI 10.2337/db07-1608; Dargahi N, 2019, MATURITAS, V119, P25, DOI 10.1016/j.maturitas.2018.11.002; Dargahi N, 2018, J FUNCT FOODS, V49, P241, DOI 10.1016/j.jff.2018.08.038; Dargahi N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070078; Di Caro S, 2005, DIGEST LIVER DIS, V37, P320, DOI 10.1016/j.dld.2004.12.008; Djaldetti M, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx014; Dong HL, 2012, BRIT J NUTR, V108, P459, DOI 10.1017/S0007114511005824; Donkor ON, 2007, FOOD AUST, V59, P121; Donkor ON, 2006, INT DAIRY J, V16, P1181, DOI 10.1016/j.idairyj.2005.10.008; Donkor ON, 2012, FOOD CHEM, V135, P950, DOI 10.1016/j.foodchem.2012.05.058; Donkor ON, 2012, CLIN EXP IMMUNOL, V167, P282, DOI 10.1111/j.1365-2249.2011.04496.x; Donkor ON, 2010, INT DAIRY J, V20, P373, DOI 10.1016/j.idairyj.2009.12.017; Donkor ON, 2007, LAIT, V87, P21, DOI 10.1051/lait:2006023; dos Santos GG, 2009, TOXICOL APPL PHARM, V236, P372, DOI 10.1016/j.taap.2009.02.004; Fink LN, 2007, INT IMMUNOL, V19, P1319, DOI 10.1093/intimm/dxm103; Fleischer J, 1996, IMMUNOLOGY, V89, P592, DOI 10.1046/j.1365-2567.1996.d01-785.x; Gaston JD, 2017, J HEALTHC ENG, V2017, DOI 10.1155/2017/5740975; Goad J, 2017, DEV BIOL, V423, P138, DOI 10.1016/j.ydbio.2017.01.015; Goritzka M, 2014, J VIROL, V88, P6128, DOI 10.1128/JVI.00333-14; Green AC, 2019, BONE, V119, P42, DOI 10.1016/j.bone.2017.11.018; Grievink HW, 2016, BIOPRESERV BIOBANK, V14, P410, DOI 10.1089/bio.2015.0104; Hafez M, 2010, INFECT IMMUN, V78, P2153, DOI 10.1128/IAI.01406-09; Hajebi A, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1828-2; Han GK, 2008, J IMMUNOL, V180, P2553; Hols P, 2005, FEMS MICROBIOL REV, V29, P435, DOI 10.1016/j.femsre.2005.04.008; Husson-Kao C, 2000, APPL ENVIRON MICROB, V66, P558, DOI 10.1128/AEM.66.2.558-565.2000; Islam MA, 2013, INNATE IMMUN-LONDON, V19, P631, DOI 10.1177/1753425913477166; Jensen H, 2015, PROBIOTICS ANTIMICRO, V7, P14, DOI 10.1007/s12602-014-9174-2; Kaczorowski KJ, 2017, P NATL ACAD SCI USA, V114, pE6097, DOI 10.1073/pnas.1705065114; Kajikawa A, 2011, APPL ENVIRON MICROB, V77, P6587, DOI 10.1128/AEM.05153-11; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P1192, DOI 10.3748/wjg.14.1192; Kern M, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/2748192; Kondrikov D, 2010, J BIOL CHEM, V285, P4319, DOI 10.1074/jbc.M109.063172; Latvala S, 2008, WORLD J GASTROENTERO, V14, P5570, DOI 10.3748/wjg.14.5570; Lee IC, 2013, PHARMACOL RES, V69, P61, DOI 10.1016/j.phrs.2012.09.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Maassen CBM, 2000, VACCINE, V18, P2613, DOI 10.1016/S0264-410X(99)00378-3; Malashchenko VV, 2018, CELL IMMUNOL, V325, P23, DOI 10.1016/j.cellimm.2018.01.007; Maneechotesuwan K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000076; Mariman R, 2015, J NUTR, V145, P1354, DOI 10.3945/jn.114.199729; Menard S, 2004, GUT, V53, P821, DOI 10.1136/gut.2003.026252; Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008; Meshkibaf S, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0578-2; Michalkiewicz J., 2003, Microbial Ecology in Health and Disease, V15, P185, DOI 10.1080/08910600310022729; Miettinen M, 1998, INFECT IMMUN, V66, P6058, DOI 10.1128/IAI.66.12.6058-6062.1998; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Purwandari U, 2009, INT J DAIRY TECHNOL, V62, P411, DOI 10.1111/j.1471-0307.2009.00501.x; Rus H, 2005, IMMUNOL RES, V33, P103, DOI 10.1385/IR:33:2:103; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Saito S, 2007, MOL ASPECTS MED, V28, P192, DOI 10.1016/j.mam.2007.02.006; Salazar N, 2009, J DAIRY SCI, V92, P4158, DOI 10.3168/jds.2009-2126; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Souza BM, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0548-x; Stagg AJ, 2004, BEST PRACT RES CL GA, V18, P255, DOI 10.1016/j.bpg.2003.10.004; Stagg J, 2011, CANCER RES, V71, P2892, DOI 10.1158/0008-5472.CAN-10-4246; Strzepa A, 2017, CELL IMMUNOL, V317, P1, DOI 10.1016/j.cellimm.2017.05.002; Sugitharini V, 2016, CYTOKINE, V85, P191, DOI 10.1016/j.cyto.2016.06.024; Sugitharini V, 2014, CYTOKINE, V69, P211, DOI 10.1016/j.cyto.2014.06.003; Takanashi N, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-54; Taranu I, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071923; Taranu I, 2015, TOXICON, V97, P53, DOI 10.1016/j.toxicon.2015.01.016; Thayer TC, 2010, ENDOCRIN METAB CLIN, V39, P541, DOI 10.1016/j.ecl.2010.05.001; Uriot O, 2017, J FUNCT FOODS, V37, P74, DOI 10.1016/j.jff.2017.07.038; van Baarlen P, 2013, TRENDS IMMUNOL, V34, P208, DOI 10.1016/j.it.2013.01.005; Vliagoftis H, 2008, ANN ALLERG ASTHMA IM, V101, P570, DOI 10.1016/S1081-1206(10)60219-0; Yang Z, 2015, MOL IMMUNOL, V65, P293, DOI 10.1016/j.molimm.2015.01.019; You JL, 2012, FEMS IMMUNOL MED MIC, V66, P353, DOI 10.1111/j.1574-695X.2012.01014.x; Yu X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07384-7; Zhang T, 2017, INT IMMUNOPHARMACOL, V51, P140, DOI 10.1016/j.intimp.2017.08.008	88	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228531	10.1371/journal.pone.0228531	http://dx.doi.org/10.1371/journal.pone.0228531			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045425	Green Published, Green Accepted, gold			2022-12-26	WOS:000534633200017
J	Kluz, PN; Kolb, R; Xie, Q; Borcherding, N; Liu, Q; Luo, YW; Kim, MC; Wang, LN; Zhang, YN; Li, W; Stipp, C; Gibson-Corley, KN; Zhao, C; Qi, HH; Bellizzi, A; Tao, AW; Sugg, S; Weigel, RJ; Zhou, DH; Shen, X; Zhang, WZ				Kluz, Paige N.; Kolb, Ryan; Xie, Qing; Borcherding, Nicholas; Liu, Qi; Luo, Yuewan; Kim, Myung-Chul; Wang, Linna; Zhang, Yinan; Li, Wei; Stipp, Christopher; Gibson-Corley, Katherine N.; Zhao, Chen; Qi, Hank H.; Bellizzi, Andrew; Tao, Andy W.; Sugg, Sonia; Weigel, Ronald J.; Zhou, Daohong; Shen, Xian; Zhang, Weizhou			Cancer cell-intrinsic function of CD177 in attenuating beta-catenin signaling	ONCOGENE			English	Article							MAMMARY-GLAND HYPERPLASIA; GENE-EXPRESSION; TRANSGENIC MICE; WNT PATHWAY; BREAST; CADHERIN; ACTIVATION; PROMOTES; METASTASIS; SURVIVAL	Aiming to identify immune molecules with a novel function in cancer pathogenesis, we found the cluster of differentiation 177 (CD177), a known neutrophil antigen, to be positively correlated with relapse-free, metastasis-free, or overall survival in breast cancer. In addition, CD177 expression is correlated with good prognosis in several other solid cancers including prostate, cervical, and lung. Focusing on breast cancer, we found that CD177 is expressed in normal breast epithelial cells and is significantly reduced in invasive cancers. Loss of CD177 leads to hyperproliferative mammary epithelium and contributes to breast cancer pathogenesis. Mechanistically, we found that CD177-deficiency is associated with an increase in beta-catenin signaling. Here we identified CD177 as a novel regulator of mammary epithelial proliferation and breast cancer pathogenesis likely via the modulation of Wnt/beta-catenin signaling pathway, a key signaling pathway involved in multiple cancer types.	[Kluz, Paige N.; Xie, Qing; Borcherding, Nicholas; Gibson-Corley, Katherine N.; Zhao, Chen; Bellizzi, Andrew] Univ Iowa, Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Kluz, Paige N.; Luo, Yuewan; Kim, Myung-Chul; Li, Wei] Univ Iowa, Coll Med, Free Rad & Radiat Biol Program, Iowa City, IA 52242 USA; [Kolb, Ryan; Zhang, Weizhou] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; [Borcherding, Nicholas] Univ Iowa, Coll Med, Med Sci Training Program, Iowa City, IA 52242 USA; [Liu, Qi; Qi, Hank H.] Univ Iowa, Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Wang, Linna; Tao, Andy W.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Zhang, Yinan] Nankai Univ, Coll Life Sci, Dept Biol, Tianjin 300071, Peoples R China; [Stipp, Christopher] Univ Iowa, Coll Med, Dept Biol, Iowa City, IA 52242 USA; [Stipp, Christopher; Gibson-Corley, Katherine N.; Bellizzi, Andrew; Sugg, Sonia; Weigel, Ronald J.] Univ Iowa, Coll Med, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA; [Sugg, Sonia; Weigel, Ronald J.] Univ Iowa, Coll Med, Dept Surg, Iowa City, IA 52242 USA; [Zhou, Daohong] Univ Florida, Coll Pharm, Dept Pharmacodynam, Gainesville, FL 32610 USA; [Shen, Xian] Wenzhou Med Univ, Div Gastrointestinal Surg, Affiliated Hosp 2, Wenzhou 325035, Zhejiang, Peoples R China; [Xie, Qing] Xinxiang Med Univ, Sch Basic Med Sci, Tumor Signaling & Transduct Lab, Xinxiang 453000, Henan, Peoples R China	University of Iowa; University of Iowa; State University System of Florida; University of Florida; University of Iowa; University of Iowa; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Nankai University; University of Iowa; University of Iowa; University of Iowa; State University System of Florida; University of Florida; Wenzhou Medical University; Xinxiang Medical University	Zhang, WZ (corresponding author), Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.; Shen, X (corresponding author), Wenzhou Med Univ, Div Gastrointestinal Surg, Affiliated Hosp 2, Wenzhou 325035, Zhejiang, Peoples R China.	13968888872@126.com; zhangw@ufl.edu	Kluz, Paige/AAT-4892-2021	Borcherding, Nicholas/0000-0003-1427-6342; Weigel, Ronald/0000-0002-9249-0793; Luo, Yuewan/0000-0002-8964-5301; Bellizzi, Andrew/0000-0002-8264-6379; Sugg, Sonia/0000-0001-7530-8526	NIH [CA206255, CA200673, CA203834]; V Scholar award; American Cancer Society; Breast Cancer Research Award; Oberley Award (National Cancer Institute Award) from Holden Comprehensive Cancer Center at the University of Iowa, University of Iowa [P30CA086862]; National Natural Science Foundation of China [81502313]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Scholar award; American Cancer Society(American Cancer Society); Breast Cancer Research Award; Oberley Award (National Cancer Institute Award) from Holden Comprehensive Cancer Center at the University of Iowa, University of Iowa; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	W.Z. was supported by NIH grants CA200673 and CA203834, the V Scholar award, American Cancer Society seed grant, Breast Cancer Research Award and Oberley Award (National Cancer Institute Award P30CA086862) from Holden Comprehensive Cancer Center at the University of Iowa, University of Iowa. N.B. was supported by NIH CA206255. Q.X. was supported by the National Natural Science Foundation of China (No. 81502313). We thank Dr. Foekens for sharing the site-specific metastasis information related to GSE2034. We thank Dr. Shay for sharing the human colon epithelial cells.	Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Borcherding N, 2018, AM J PATHOL, V188, P1910, DOI 10.1016/j.ajpath.2018.05.003; Brisken C, 2000, GENE DEV, V14, P650; Bulut G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027243; Caruccio L, 2006, TRANSFUSION, V46, P441, DOI 10.1111/j.1537-2995.2006.00741.x; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen Q, 2014, ONCOTARGET, V5, P9092, DOI 10.18632/oncotarget.2377; Chiurillo MA, 2015, WORLD J EXP MED, V5, P84, DOI [10.5493/wjem.v5.i2.84, DOI 10.5493/wjem.v5.i2.84, DOI 10.5493/WJEM.V5.I2.84]; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Eger A, 2000, J CELL BIOL, V148, P173, DOI 10.1083/jcb.148.1.173; Fagotto F, 1996, J CELL BIOL, V132, P1105, DOI 10.1083/jcb.132.6.1105; Feng Q, 2014, CELL RES, V24, P809, DOI 10.1038/cr.2014.71; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hayes MJ, 2008, CLIN CANCER RES, V14, P4038, DOI 10.1158/1078-0432.CCR-07-4379; HEASMAN J, 1994, DEVELOPMENT, V120, P49; Imbert A, 2001, J CELL BIOL, V153, P555, DOI 10.1083/jcb.153.3.555; Incassati A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2723; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Kissel K, 2001, EUR J IMMUNOL, V31, P1301, DOI 10.1002/1521-4141(200105)31:5<1301::AID-IMMU1301>3.0.CO;2-J; Koesters R, 1999, CANCER RES, V59, P3880; Kuphal F, 2006, EXP CELL RES, V312, P457, DOI 10.1016/j.yexcr.2005.11.007; Kypta RM, 2012, NAT REV UROL, V9, P418, DOI 10.1038/nrurol.2012.116; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nakashima N, 2012, LUNG CANCER, V76, P228, DOI 10.1016/j.lungcan.2011.10.007; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Orsulic S, 1999, J CELL SCI, V112, P1237; Ozaki S, 2005, ONCOL REP, V14, P1437; Passamonti F, 2004, BRIT J HAEMATOL, V126, P650, DOI 10.1111/j.1365-2141.2004.05098.x; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Prasad CP, 2007, ONCOLOGY-BASEL, V73, P112, DOI 10.1159/000120999; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Stockinger A, 2001, J CELL BIOL, V154, P1185, DOI 10.1083/jcb.200104036; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Temerinac S, 2000, BLOOD, V95, P2569; Tepera SB, 2003, J CELL SCI, V116, P1137, DOI 10.1242/jcs.00334; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Toyoda T, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-122; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Xie Q, 2015, PROTEIN CELL, V6, P117, DOI 10.1007/s13238-014-0109-1; Yokoyama NN, 2014, AM J CLIN EXP UROL, V2, P27; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang J, 2010, ONCOGENE, V29, P539, DOI 10.1038/onc.2009.339; Zhang YN, 2014, INT J CLIN EXP PATHO, V7, P3908	63	6	6	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	14					2877	2889		10.1038/s41388-020-1203-x	http://dx.doi.org/10.1038/s41388-020-1203-x		FEB 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KZ2VB	32042113	Green Accepted			2022-12-26	WOS:000512528200001
J	Schneider, M; Trummer, C; Stengl, A; Zhang, P; Szwagierczak, A; Cardoso, MC; Leonhardt, H; Bauer, C; Antes, I				Schneider, Markus; Trummer, Carina; Stengl, Andreas; Zhang, Peng; Szwagierczak, Aleksandra; Cardoso, M. Cristina; Leonhardt, Heinrich; Bauer, Christina; Antes, Iris			Systematic analysis of the binding behaviour of UHRF1 towards different methyl- and carboxylcytosine modification patterns at CpG dyads	PLOS ONE			English	Article							BASE-RESOLUTION ANALYSIS; THYMINE DNA GLYCOSYLASE; SRA DOMAIN; FORCE-FIELD; MULTIDOMAIN PROTEIN; STRUCTURAL BASIS; RECOGNITION; TET; 5-FORMYLCYTOSINE; DYNAMICS	The multi-domain protein UHRF1 is essential for DNA methylation maintenance and binds DNA via a base-flipping mechanism with a preference for hemi-methylated CpG sites. We investigated its binding to hemi- and symmetrically modified DNA containing either 5-methylcytosine (mC), 5-hydroxymethylcytosine (hmC), 5-formylcytosine (fC), or 5-carboxylcytosine (caC). Our experimental results indicate that UHRF1 binds symmetrically carboxylated and hybrid methylated/carboxylated CpG dyads in addition to its previously reported substrates. Complementary molecular dynamics simulations provide a possible mechanistic explanation of how the protein could differentiate between modification patterns. First, we observe different local binding modes in the nucleotide binding pocket as well as the protein's NKR finger. Second, both DNA modification sites are coupled through key residues within the NKR finger, suggesting a communication pathway affecting protein-DNA binding for carboxylcytosine modifications. Our results suggest a possible additional function of the hemi-methylation reader UHRF1 through binding of carboxylated CpG sites. This opens the possibility of new biological roles of UHRF1 beyond DNA methylation maintenance and of oxidised methylcytosine derivates in epigenetic regulation.	[Schneider, Markus; Antes, Iris] Tech Univ Munich, Ctr Integrated Prot Sci Munich, TUM Sch Life Sci, Freising Weihenstephan, Germany; [Trummer, Carina; Stengl, Andreas; Zhang, Peng; Szwagierczak, Aleksandra; Leonhardt, Heinrich; Bauer, Christina] Ludwig Maximilians Univ Munchen, Dept Biol 2, Ctr Integrated Prot Sci Munich, Planegg Martinsried, Germany; [Zhang, Peng; Cardoso, M. Cristina] Tech Univ Darmstadt, Dept Biol, Cell Biol & Epigenet, Darmstadt, Germany; [Bauer, Christina] Univ Basel, Dept Biomed, Basel, Switzerland	Technical University of Munich; University of Munich; Technical University of Darmstadt; University of Basel	Antes, I (corresponding author), Tech Univ Munich, Ctr Integrated Prot Sci Munich, TUM Sch Life Sci, Freising Weihenstephan, Germany.	antes@tum.de	Leonhardt, Heinrich/B-2791-2014; Stengl, Andreas/ABD-2251-2021	Stengl, Andreas/0000-0002-8802-3260; Bauer, Christina/0000-0001-9511-2491	Deutsche Forschungsgemeinschaft [SFB 1035/A10, SFB749/C08, SFB 1064/A17, SFB 1243/A01, CA198/10-1]; TUM International Graduate School of Science and Engineering (IGSSE); International Max Planck Research School for Molecular Life Sciences (IMPRS-LS); graduate school GRK1721 of the Deutsche Forschungsgemeinschaft; Vereinigung von Freunden der Technischen Universitat Darmstadt; Deutsche Forschungsgemeinschaft (CIPSM)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); TUM International Graduate School of Science and Engineering (IGSSE); International Max Planck Research School for Molecular Life Sciences (IMPRS-LS); graduate school GRK1721 of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Vereinigung von Freunden der Technischen Universitat Darmstadt; Deutsche Forschungsgemeinschaft (CIPSM)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 1035/A10 and SFB749/C08 to IA, SFB 1064/A17 and SFB 1243/A01 to HL, CIPSM to IA and HL, CA198/10-1 to MCC). MS was supported by the TUM International Graduate School of Science and Engineering (IGSSE). CB and CT were supported by the International Max Planck Research School for Molecular Life Sciences (IMPRS-LS). AS was trained and supported by the graduate school GRK1721 of the Deutsche Forschungsgemeinschaft. PZ received support from the "Vereinigung von Freunden der Technischen Universitat Darmstadt". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Arita K, 2012, P NATL ACAD SCI USA, V109, P12950, DOI 10.1073/pnas.1203701109; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bianchi C, 2014, BIOPHYS CHEM, V187, P14, DOI 10.1016/j.bpc.2013.12.005; Bianchi C, 2013, BIOPHYS CHEM, V171, P38, DOI 10.1016/j.bpc.2012.10.002; Bochtler M, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600178; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Bronner Christian, 2010, Genet Epigenet, V2009, P29; Case D. A., 2017, AMBER 2017; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Duell ER, 2016, ACS CHEM BIOL, V11, P1082, DOI 10.1021/acschembio.5b00905; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; El Hassan MA, 1998, J MOL BIOL, V282, P331, DOI 10.1006/jmbi.1998.1994; Eleftheriou M, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0117-x; Fang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11197; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021306; Frisch G. W., 2013, GAUSSIAN 09; Gelato KA, 2014, MOL CELL, V54, P905, DOI 10.1016/j.molcel.2014.04.004; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Gowher H, 2018, BIOCHEM SOC T, V46, P1191, DOI 10.1042/BST20170574; Greiner VJ, 2015, BIOCHEMISTRY-US, V54, P6012, DOI 10.1021/acs.biochem.5b00419; Grin I, 2016, NUCLEIC ACIDS RES, V44, P3713, DOI 10.1093/nar/gkw059; Harrison JS, 2016, ELIFE, V5, DOI 10.7554/eLife.17101; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hashimoto H, 2014, GENE DEV, V28, P2304, DOI 10.1101/gad.250746.114; Hashimoto H, 2013, DNA REPAIR, V12, P535, DOI 10.1016/j.dnarep.2013.04.003; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Hashimoto H, 2009, EPIGENETICS-US, V4, P8, DOI 10.4161/epi.4.1.7370; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Helabad MB, 2014, INT J MOL SCI, V15, P11799, DOI 10.3390/ijms150711799; Huang N, 2003, P NATL ACAD SCI USA, V100, P68, DOI 10.1073/pnas.0135427100; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ishiyama S, 2017, MOL CELL, V68, P350, DOI 10.1016/j.molcel.2017.09.037; Ivani I, 2016, NAT METHODS, V13, P55, DOI [10.1038/NMETH.3658, 10.1038/nmeth.3658]; Jin SG, 2016, CELL REP, V14, P493, DOI 10.1016/j.celrep.2015.12.044; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamiya H, 2002, J BIOCHEM, V132, P551, DOI 10.1093/oxfordjournals.jbchem.a003256; Kilin V, 2017, J AM CHEM SOC, V139, P2520, DOI 10.1021/jacs.7b00154; Kim KY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04818-0; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Laget S, 2014, EPIGENETICS-US, V9, P546, DOI 10.4161/epi.27695; Lankas F, 2002, BIOPHYS J, V82, P2592, DOI 10.1016/S0006-3495(02)75601-4; Lu XY, 2015, CELL RES, V25, P386, DOI 10.1038/cr.2015.5; Luo T, 2013, BIOCHEM BIOPH RES CO, V441, P65, DOI 10.1016/j.bbrc.2013.10.018; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Mistry Helena, 2010, Genome Integr, V1, P7, DOI 10.1186/2041-9414-1-7; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Muller U, 2014, NUCLEIC ACIDS RES, V42, P8592, DOI 10.1093/nar/gku552; Nabel CS, 2011, SCIENCE, V333, P1229, DOI 10.1126/science.1211917; Neri F, 2015, CELL REP, V10, P674, DOI 10.1016/j.celrep.2015.01.008; Nishiyama A, 2013, NATURE, V502, P249, DOI 10.1038/nature12488; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pfaffeneder T, 2014, NAT CHEM BIOL, V10, P574, DOI [10.1038/NCHEMBIO.1532, 10.1038/nchembio.1532]; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Pichler G, 2011, J CELL BIOCHEM, V112, P2585, DOI 10.1002/jcb.23185; Qian CM, 2008, J BIOL CHEM, V283, P34490, DOI 10.1074/jbc.C800169200; Qin WH, 2015, CELL RES, V25, P911, DOI 10.1038/cr.2015.72; Rajakumara E, 2016, SCI REP-UK, V6, DOI 10.1038/srep20161; Rajakumara E, 2011, GENE DEV, V25, P137, DOI 10.1101/gad.1980311; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Rottach A, 2010, NUCLEIC ACIDS RES, V38, P1796, DOI 10.1093/nar/gkp1152; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Shibutani T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05220; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Szulik MW, 2015, BIOCHEMISTRY-US, V54, P1294, DOI 10.1021/bi501534x; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tian YY, 2015, CELL REP, V10, P1957, DOI 10.1016/j.celrep.2015.03.038; Vanquelef E, 2011, NUCLEIC ACIDS RES, V39, pW511, DOI 10.1093/nar/gkr288; Vaughan RM, 2018, P NATL ACAD SCI USA, V115, P8775, DOI 10.1073/pnas.1806373115; Verma N, 2018, NAT GENET, V50, P83, DOI 10.1038/s41588-017-0002-y; Wang F., 2013, PYTHON OBJECT ORIENT; Wang LF, 2015, NATURE, V523, P621, DOI 10.1038/nature14482; Weber AR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10806; Xu L, 2014, ANGEW CHEM INT EDIT, V53, P11223, DOI 10.1002/anie.201406220; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zhou T, 2014, MOL CELL, V54, P879, DOI 10.1016/j.molcel.2014.04.003	85	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229144	10.1371/journal.pone.0229144	http://dx.doi.org/10.1371/journal.pone.0229144			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084194	gold, Green Published, Green Submitted			2022-12-26	WOS:000535227900062
J	Muturi, EJ; Selling, GW; Doll, KM; Hay, WT; Ramirez, JL				Muturi, Ephantus J.; Selling, Gordon W.; Doll, Kenneth M.; Hay, William T.; Ramirez, Jose L.			Leptospermum scoparium essential oil is a promising source of mosquito larvicide and its toxicity is enhanced by a biobased emulsifier	PLOS ONE			English	Article							PLANT ESSENTIAL OILS; AEDES-AEGYPTI; MANUKA; VARIABILITY; TRIKETONE; COMPLEX	Synthetic pesticides are the cornerstone of vector-borne disease control, but alternatives are urgently needed to tackle the growing problem of insecticide resistance and concerns over environmental safety. Leptospermum scoparium J.R. Forst and G. Forst (manuka) essential oil and its four fractions were analyzed for chemical composition and toxicity against Aedes aegypti larvae. The use of bio-based amylose-N-1-hexadecylammonium chloride inclusion complexes (Hex-Am) as an emulsifier for L. scoparium essential oil was also investigated. Fraction 1 was inactive, fractions 2 (LC50 = 12.24 ppm) and 3 (LC50 = 20.58 ppm) were more toxic than the whole essential oil (LC50 = 47.97 ppm), and fraction 4 (LC50 = 35.87 ppm) had similar toxicity as the whole essential oil. Twenty-one chemical constituents were detected in L. scoparium essential oil compared to 16, 5, 19 and 25 chemical constituents in fractions, 1, 2, 3 and 4 respectively. The two most dominant chemical constituents were calamenene (17.78%) and leptospermone (11.86%) for L. scoparium essential oil, calamenene (37.73%) and ledene (10.37%) for fraction 1, leptospermone (56.6%) and isoleptospermone (19.73) for fraction 2, cubenol (24.30%) and caryophyllene oxide (12.38%) for fraction 3, and.-gurjunene (21.62%) and isoleptospermone (7.88%) for fraction 4. Alpha-pinene, ledene, and aromandendrene were 2-7 times less toxic than the whole essential sugge(s)ting that the toxicity of L. scoparium essential oil was either due to other chemical constituents that were not tested or due synergist interactions among chemical constituents. Leptospermum scoparium essential oil-Hex-Am emulsion (LC50 = 29.62) was more toxic than the whole essential oil. These findings suggest that L. scoparium essential oil is a promising source of mosquito larvicide and that Hex-Am is an excellent emulsifier for L. scoparium essential oil for use as a larvicide.	[Muturi, Ephantus J.; Ramirez, Jose L.] ARS, USDA, NCAUR, Crop Bioprotect Res Unit, Peoria, IL 61604 USA; [Selling, Gordon W.] ARS, USDA, NCAUR, Plant Polymer Res Unit, Peoria, IL USA; [Doll, Kenneth M.] ARS, USDA, NCAUR, Biooils Res Unit, Peoria, IL USA; [Hay, William T.] ARS, USDA, NCAUR, Mycotoxin Prevent & Appl Microbiol Res Unit, Peoria, IL USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Muturi, EJ (corresponding author), ARS, USDA, NCAUR, Crop Bioprotect Res Unit, Peoria, IL 61604 USA.	Ephantus.Muturi@ars.usda.gov		Hay, William/0000-0001-8784-6591	U.S. Department of Agriculture, Agricultural Research Service	U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by the U.S. Department of Agriculture, Agricultural Research Service. All authors are employed by the USDA. The specific roles of each author are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboukhalid K, 2017, CHEM BIODIVERS, V14, DOI 10.1002/cbdv.201700158; Adam F, 2008, MOSQUITO REPELLENTS, V74, P162; Albuquerque ELD, 2013, ACTA TROP, V127, P181, DOI 10.1016/j.actatropica.2013.04.011; [Anonymous], 2005, GUIDELINES LAB FIELD; Barra A, 2009, NAT PROD COMMUN, V4, P1147; Benelli G, 2018, IND CROP PROD, V112, P668, DOI 10.1016/j.indcrop.2017.12.062; BLACKWELL R, 1991, BR J PHYTOTHER, V2, P26; Brugger BP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44709-y; Camilotti J., 2015, Journal of Medicinal Plants Research, V9, P1021; Cheng SS, 2003, BIORESOURCE TECHNOL, V89, P99, DOI 10.1016/S0960-8524(03)00008-7; Christoph F., 1999, Journal of Essential Oil Research, V11, P705; Dickinson E, 2010, CURR OPIN COLLOID IN, V15, P40, DOI 10.1016/j.cocis.2009.11.001; Douglas MH, 2004, PHYTOCHEMISTRY, V65, P1255, DOI 10.1016/j.phytochem.2004.03.019; Eller FJ, 2018, INT BIODETER BIODEGR, V129, P95, DOI 10.1016/j.ibiod.2018.01.010; FANG F, 2016, PARASITE VECTOR, V9, DOI DOI 10.1186/S13071-016-1889-; Fanta GF, 2013, CARBOHYD POLYM, V98, P555, DOI 10.1016/j.carbpol.2013.06.028; Fanta GF, 2010, CARBOHYD POLYM, V81, P645, DOI 10.1016/j.carbpol.2010.03.026; Fanta GF, 1999, CARBOHYD POLYM, V38, P1, DOI 10.1016/S0144-8617(98)00104-0; George DR, 2009, VET PARASITOL, V161, P276, DOI 10.1016/j.vetpar.2009.01.010; Hanula JL, 2008, ENVIRON ENTOMOL, V37, P1403, DOI 10.1603/0046-225X-37.6.1403; Hay WT, 2019, FOOD HYDROCOLLOID, V90, P490, DOI 10.1016/j.foodhyd.2018.12.038; Hay WT, 2018, CARBOHYD POLYM, V188, P76, DOI 10.1016/j.carbpol.2018.01.088; Hay WT, 2017, CARBOHYD POLYM, V157, P1050, DOI 10.1016/j.carbpol.2016.10.068; Hu W, 2017, J ECON ENTOMOL, V110, P1556, DOI 10.1093/jee/tox120; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Izakmehri K, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.15201; Jeong EY, 2009, PEST MANAG SCI, V65, P327, DOI 10.1002/ps.1684; Kiran SR, 2006, BIORESOURCE TECHNOL, V97, P2481, DOI 10.1016/j.biortech.2005.10.003; Komalamisra Narumon, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1412; Lee HS, 2006, J AM MOSQUITO CONTR, V22, P292, DOI 10.2987/8756-971X(2006)22[292:MLAOAM]2.0.CO;2; Lis-Balchin M, 1997, J ROY SOC HEALTH, V117, P324, DOI 10.1177/146642409711700511; Lis-Balchin M, 2000, PHYTOTHER RES, V14, P623, DOI 10.1002/1099-1573(200012)14:8&lt;623::AID-PTR763&gt;3.0.CO;2-Z; Maes C, 2019, MOLECULES, V24, DOI 10.3390/molecules24142539; Manimaran A., 2012, Advances in Bioscience and Biotechnology, V3, P855; Marinopoulou A, 2016, CARBOHYD POLYM, V141, P106, DOI 10.1016/j.carbpol.2015.12.062; Martin A., 2010, OPEN CHEM ENG, V4, P31, DOI DOI 10.2174/1874123101004010031; McMclements DJ, 2004, FOOD EMULSIONS, P2; Mun SH, 2006, LANGMUIR, V22, P1551, DOI 10.1021/la052575l; Muturi EJ, 2019, INSECTS, V10, DOI 10.3390/insects10100337; Muturi EJ, 2019, PEST MANAG SCI, V75, P2043, DOI 10.1002/ps.5327; Muturi EJ, 2017, J MED ENTOMOL, V54, P1684, DOI 10.1093/jme/tjx168; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Park CG, 2017, MOLECULES, V22, DOI 10.3390/molecules22071050; Pavela R, 2018, IND CROP PROD, V113, P46, DOI 10.1016/j.indcrop.2018.01.021; Porter NG, 1999, PHYTOCHEMISTRY, V50, P407, DOI 10.1016/S0031-9422(98)00548-2; Regnault-Roger C, 2012, ANNU REV ENTOMOL, V57, P405, DOI 10.1146/annurev-ento-120710-100554; Scalerandi E, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01579; Silva IMA, 2018, PEST MANAG SCI, V74, P1001, DOI 10.1002/ps.4801; Tadros T. F., 1983, ENCY EMULSION TECHNO, V1; Tak JH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42432; Tak JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep12690; Tripathi A. K., 2001, Insect Science and its Application, V21, P61	53	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0229076	10.1371/journal.pone.0229076	http://dx.doi.org/10.1371/journal.pone.0229076			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8CF	32078653	gold, Green Published			2022-12-26	WOS:000535224600017
J	Ayral, F; Kodjo, A; Guedon, G; Boue, F; Richomme, C				Ayral, Florence; Kodjo, Angeli; Guedon, Gerald; Boue, Franck; Richomme, Celine			Muskrats are greater carriers of pathogenic Leptospira than coypus in ecosystems with temperate climates	PLOS ONE			English	Article							MYOCASTOR-COYPUS; FRANCE; EPIDEMIOLOGY; OUTBREAK	Knowledge on the possible sources of human leptospirosis, other than rats, is currently lacking. To assess the distribution pattern of exposure and infection by Leptospira serogroups in the two main semi-aquatic rodents of Western France, coypus (Myocastor coypus) and muskrats (Ondatra zibethicus), results of micro-agglutination testing and renal tissue PCR were used. In coypus, the apparent prevalence was 11% (n = 524, CI95% = [9% - 14%]), seroprevalence was 42% (n = 590, CI95% = [38% - 46%]), and the predominant serogroup was Australis (84%). In muskrats, the apparent prevalence was 33% (n = 274, CI95% = [27% - 39%]), seroprevalence was 57% (n = 305, CI95% = [52% - 63%]), and the predominant serogroup was Grippotyphosa (47%). Muskrats should therefore be considered an important source of Grippotyphosa infection in humans and domestic animals exposed in this part of France.	[Ayral, Florence; Kodjo, Angeli] Univ Lyon, INRAE, VetAgro Sup, UsC 1233 RS2GP, Marcy Letoile, France; [Guedon, Gerald] FNLON Natl Federat Pest Control, Angers, France; [Boue, Franck; Richomme, Celine] ANSES, Nancy Lab Rabies & Wildlife, Malzeville, France	INRAE; VetAgro Sup; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Technopole Agricole et Veterinaire	Ayral, F (corresponding author), Univ Lyon, INRAE, VetAgro Sup, UsC 1233 RS2GP, Marcy Letoile, France.	florence.ayral@vetagro-sup.fr			French Ministry of Agriculture	French Ministry of Agriculture	Sampling and analysis were mainly funded by the French Ministry of Agriculture in the framework of the GEDUVER project run by French national federation for pest control (Federation nationale de lutte contre les organismes nuisibles, FNLON). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre-Fontaine G, 2004, B EPIDEMIOLOGIQUE, V12, P11; Andre-Fontaine G, 2015, CURR MICROBIOL, V71, P136, DOI 10.1007/s00284-015-0836-4; Aviat F, 2009, COMP IMMUNOL MICROB, V32, P463, DOI 10.1016/j.cimid.2008.05.004; Ayral F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162549; Ayral F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139604; Ayral FC, 2014, AM J TROP MED HYG, V91, P756, DOI 10.4269/ajtmh.13-0416; Baranton G, 2006, INT J INFECT DIS, V10, P162, DOI 10.1016/j.ijid.2005.02.010; Bourhy P., 2017, Bulletin Epidemiologique Hebdomadaire, P131; Brehm TT, 2018, INFECTION, V46, P847, DOI 10.1007/s15010-018-1181-x; Cameron CE, 2015, CURR TOP MICROBIOL, V387, P21, DOI 10.1007/978-3-662-45059-8_3; Chappel RJ, 2004, J CLIN MICROBIOL, V42, P5484, DOI 10.1128/JCM.42.12.5484-5488.2004; Ellis WA, 2015, CURR TOP MICROBIOL, V387, P99, DOI 10.1007/978-3-662-45059-8_6; Faine S., 1999, MEDISCI; Guillois Y, 2018, EUROSURVEILLANCE, V23, P12, DOI 10.2807/1560-7917.ES.2018.23.48.1700848; Hochedez P, 2013, EUROSURVEILLANCE, V18, P14; Hurd J, 2017, RES VET SCI, V114, P351, DOI 10.1016/j.rvsc.2017.06.015; Levett PN, 2003, CLIN INFECT DIS, V36, P447, DOI 10.1086/346208; Michel V, 2001, EUR J EPIDEMIOL, V17, P111, DOI 10.1023/A:1017931607318; Mori M, 2015, EPIDEMIOL INFECT, V143, P1761, DOI 10.1017/S0950268814002763; Nardone A, 2004, CLIN INFECT DIS, V39, P751, DOI 10.1086/423272; Pages F, 2016, EPIDEMIOL INFECT, V144, P661, DOI 10.1017/S0950268815001740; Perra A, 2002, Euro Surveill, V7, P131; Picardeau M, 2017, CTR NATL REFERENCE L; THIERMANN AB, 1981, J WILDLIFE DIS, V17, P39, DOI 10.7589/0090-3558-17.1.39; Vein J, 2014, EUR J WILDLIFE RES, V60, P125, DOI 10.1007/s10344-013-0758-z; Vincent AT, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007270	26	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228577	10.1371/journal.pone.0228577	http://dx.doi.org/10.1371/journal.pone.0228577			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074117	gold, Green Published			2022-12-26	WOS:000535220600018
J	Pahapill, PA; Chen, G; Arocho-Quinones, EV; Nencka, AS; Li, SJ				Pahapill, Peter A.; Chen, Guangyu; Arocho-Quinones, Elsa V.; Nencka, Andrew S.; Li, Shi-Jiang			Functional connectivity and structural analysis of trial spinal cord stimulation responders in failed back surgery syndrome	PLOS ONE			English	Article							CHRONIC PAIN; PERIAQUEDUCTAL GRAY; STATE; REPRESENTATION; MULTICENTER; ANATOMY; PATIENT; FMRI	Background Chronic pain has been associated with alterations in brain structure and function that appear dependent on pain phenotype. Functional connectivity (FC) data on chronic back pain (CBP) is limited and based on heterogeneous pain populations. We hypothesize that failed back surgery syndrome (FBSS) patients being considered for spinal cord stimulation (SCS) therapy have altered resting state (RS) FC cross-network patterns that 1) specifically involve emotion and reward/aversion functions and 2) are related to pain scores. Methods RS functional MRI (fMRI) scans were obtained for 10 FBSS patients who are being considered for but who have not yet undergone implantation of a permanent SCS device and 12 healthy age-matched controls. Seven RS networks were analyzed including the striatum (STM). The Wilcoxon signed-rank test evaluated differences in cross-network FC strength (FCS). Differences in periaqueductal grey (PAG) FC were assessed with seed-based analysis. Results Cross-network FCS was decreased (p<0.05) between the STM and all other networks in these FBSS patients. There was a negative linear relationship (R-2 = 0.76, p<0.0022) between STMFCS index and pain scores. The PAG showed decreased FC with network elements and amygdala but increased FC with the sensorimotor cortex and cingulate gyrus. Conclusions Decreased FC between STM and other RS networks in FBSS has not been previously reported. This STMFCS index may represent a more objective measure of chronic pain specific to FBSS which may help guide patient selection for SCS and subsequent management.	[Pahapill, Peter A.; Arocho-Quinones, Elsa V.] US Dept Vet Affairs, Med Ctr, Dept Neurosurg, Milwaukee, WI USA; [Pahapill, Peter A.; Arocho-Quinones, Elsa V.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Chen, Guangyu; Li, Shi-Jiang] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Nencka, Andrew S.] Med Coll Wisconsin, Ctr Imaging Res, Milwaukee, WI 53226 USA	US Department of Veterans Affairs; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Arocho-Quinones, EV (corresponding author), US Dept Vet Affairs, Med Ctr, Dept Neurosurg, Milwaukee, WI USA.; Arocho-Quinones, EV (corresponding author), Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA.	elsa.arocho@outlook.com		Arocho-Quinones, Elsa/0000-0002-6000-5503	Daniel M. Soref Charitable Trust	Daniel M. Soref Charitable Trust	Funding Source: The Daniel M. Soref Charitable Trust The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baliki MN, 2015, SCI REP-UK, V5, DOI 10.1038/srep07603; Baliki MN, 2015, NEURON, V87, P474, DOI 10.1016/j.neuron.2015.06.005; Baliki MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106133; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Brier MR, 2012, J NEUROSCI, V32, P8890, DOI 10.1523/JNEUROSCI.5698-11.2012; Brier MR, 2014, NEUROLOGY, V83, P1613, DOI 10.1212/WNL.0000000000000939; Cauda F, 2014, NEUROIMAGE-CLIN, V4, P676, DOI 10.1016/j.nicl.2014.04.007; Chen GY, 2016, J ALZHEIMERS DIS, V54, P983, DOI 10.3233/JAD-160537; Chen GY, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00456; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; De Ridder D, 2016, NEUROMODULATION, V19, P47, DOI 10.1111/ner.12368; Deer TR, 2014, NEUROMODULATION, V17, P515, DOI 10.1111/ner.12208; Deogaonkar M, 2016, NEUROMODULATION, V19, P142, DOI 10.1111/ner.12346; Faria AV, 2012, NEUROIMAGE, V61, P613, DOI 10.1016/j.neuroimage.2012.03.078; Glover GH, 2012, J MAGN RESON IMAGING, V36, P39, DOI 10.1002/jmri.23572; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Harper Daniel E, 2018, J Pain, V19, DOI 10.1016/j.jpain.2018.01.001; Hashmi JA, 2013, BRAIN, V136, P2751, DOI 10.1093/brain/awt211; Hemington KS, 2016, BRAIN STRUCT FUNCT, V221, P4203, DOI 10.1007/s00429-015-1161-1; Kapural L, 2016, NEUROSURGERY, V79, P667, DOI 10.1227/NEU.0000000000001418; Khan SA, 2014, PAIN, V155, P1472, DOI 10.1016/j.pain.2014.04.022; Kong J, 2019, BRAIN IMAGING BEHAV, V13, P482, DOI 10.1007/s11682-018-9875-3; Kucyi A, 2015, TRENDS NEUROSCI, V38, P86, DOI 10.1016/j.tins.2014.11.006; Levy RM, 2013, NEUROMODULATION, V16, P495, DOI 10.1111/ner.12148; Linnman C, 2012, NEUROIMAGE, V60, P505, DOI 10.1016/j.neuroimage.2011.11.095; Loggia ML, 2013, PAIN, V154, P24, DOI 10.1016/j.pain.2012.07.029; Maihofner C, 2004, NEUROLOGY, V63, P693, DOI 10.1212/01.WNL.0000134661.46658.B0; Mainero C, 2011, ANN NEUROL, V70, P838, DOI 10.1002/ana.22537; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mohan A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19683; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Pahapill PA, 2015, NEUROMODULATION, V18, P367, DOI 10.1111/ner.12239; Pahapill PA, 2014, NEUROMODULATION, V17, P22, DOI 10.1111/ner.12033; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Tass PA, 2012, ANN NEUROL, V72, P816, DOI 10.1002/ana.23663; Thomas JB, 2014, JAMA NEUROL, V71, P1111, DOI 10.1001/jamaneurol.2014.1654; Wang L, 2012, ANN NEUROL, V72, P571, DOI 10.1002/ana.23643; Woolf CJ, 2010, NAT MED, V16, P1241, DOI 10.1038/nm.2230; Yu RJ, 2014, NEUROIMAGE-CLIN, V6, P100, DOI 10.1016/j.nicl.2014.08.019	40	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228306	10.1371/journal.pone.0228306	http://dx.doi.org/10.1371/journal.pone.0228306			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074111	Green Published, gold			2022-12-26	WOS:000535220600011
J	Gong, C; Tsoi, H; Mok, KC; Cheung, J; Man, EPS; Fujino, K; Wong, AH; Lam, EWF; Khoo, US				Gong, Chun; Tsoi, Ho; Mok, Ka Chun; Cheung, Jenny; Man, Ellen P. S.; Fujino, Kazunari; Wong, Ashely; Lam, Eric W. F.; Khoo, Ui-Soon			Phosphorylation independent eIF4E translational reprogramming of selective mRNAs determines tamoxifen resistance in breast cancer	ONCOGENE			English	Article							TRANSCRIPTION FACTOR; INITIATION-FACTORS; PROTEIN-SYNTHESIS; ER-ALPHA; THERAPY; EXPRESSION; FOXM1; SENSITIVITY; MECHANISMS; RECEPTOR	Eukaryotic translation initiation factor 4E (eIF4E) selectively promotes translation of mRNAs with atypically long and structured 5 '-UTRs and has been implicated in drug resistance. Through genome-wide transcriptome and translatome analysis we revealed eIF4E overexpression could promote cellular activities mediated by ER alpha and FOXM1 signalling pathways. Whilst eIF4E overexpression could enhance the translation of both ER alpha and FOXM1, it also led to enhanced transcription of FOXM1. Polysome fractionation experiments confirmed eIF4E could modulate the translation of ER alpha and FOXM1 mRNA. The enhancement of FOXM1 transcription was contingent upon the presence of ER alpha, and it was the high levels of FOXM1 that conferred Tamoxifen resistance. Furthermore, tamoxifen resistance was conferred by phosphorylation independent eIF4E overexpression. Immunohistochemistry on 134 estrogen receptor (ER+) primary breast cancer samples confirmed that high eIF4E expression was significantly associated with increased ER alpha and FOXM1, and significantly associated with tamoxifen resistance. Our study uncovers a novel mechanism whereby phosphorylation independent eIF4E translational reprogramming in governing the protein synthesis of ER alpha and FOXM1 contributes to anti-estrogen insensitivity in ER+ breast cancer. In eIF4E overexpressing breast cancer, the increased ER alpha protein expression in turn enhances FOXM1 transcription, which together with its increased translation regulated by eIF4E, contributes to tamoxifen resistance. Coupled with eIF4E translational regulation, our study highlights an important mechanism conferring tamoxifen resistance via both ER alpha dependent and independent pathways.	[Gong, Chun; Tsoi, Ho; Mok, Ka Chun; Cheung, Jenny; Man, Ellen P. S.; Wong, Ashely; Khoo, Ui-Soon] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Gong, Chun; Fujino, Kazunari; Lam, Eric W. F.] Imperial Coll London, Dept Surg & Canc, Hammersmith Hosp Campus, London, England	University of Hong Kong; Imperial College London	Khoo, US (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.; Lam, EWF (corresponding author), Imperial Coll London, Dept Surg & Canc, Hammersmith Hosp Campus, London, England.	eric.lam@imperial.ac.uk; uskhoo@pathology.hku.hk	Khoo, Ui Soon/C-4293-2009; Lam, Eric W-F/AAW-8566-2020	Khoo, Ui Soon/0000-0003-2200-7505; Lam, Eric W-F/0000-0003-1274-3576; tsoi, ho/0000-0003-2037-9575	Committee on Research and Conference Grants from the University of Hong Kong [201109176081, 201209176093, 201711159147]; MRC [MR/N012097/1]; CRUK [A12011]; Breast Cancer Now [2012MayPR070, 2012NovPhD016]; Cancer Research UK Imperial Centre; NIHR Imperial BRC; Imperial ECMC	Committee on Research and Conference Grants from the University of Hong Kong; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); Breast Cancer Now; Cancer Research UK Imperial Centre; NIHR Imperial BRC; Imperial ECMC	The study was supported by grants from the Committee on Research and Conference Grants from the University of Hong Kong Project numbers 201109176081, 201209176093 and 201711159147. We thank Dr Robert Clarke (Georgetown University Medical Center) for providing the cell lines. EW-FL work is supported by MRC (MR/N012097/1), CRUK (A12011), Breast Cancer Now (2012MayPR070; 2012NovPhD016), the Cancer Research UK Imperial Centre, Imperial ECMC and NIHR Imperial BRC.	Bilanges B, 2007, ONCOGENE, V26, P5973, DOI 10.1038/sj.onc.1210431; Burris HA, 2013, CANCER CHEMOTH PHARM, V71, P829, DOI 10.1007/s00280-012-2043-3; Busch S, 2015, CANCER RES, V75, P1457, DOI 10.1158/0008-5472.CAN-14-1583; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012293; Chimge NO, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3073; Chu J, 2016, TRENDS CELL BIOL, V26, P918, DOI 10.1016/j.tcb.2016.06.005; Culjkovic B, 2008, J CELL BIOL, V181, P51, DOI 10.1083/jcb.200707018; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Droog M, 2013, EUR J PHARMACOL, V717, P47, DOI 10.1016/j.ejphar.2012.11.071; DUNCAN R, 1983, J BIOL CHEM, V258, P7228; DUNCAN R, 1987, J BIOL CHEM, V262, P380; Fagan DH, 2017, HORM CANCER-US, V8, P219, DOI 10.1007/s12672-017-0296-3; Ferrari N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15658; Geter PA, 2017, GENE DEV, V31, P2235, DOI 10.1101/gad.305631.117; Gong C, 2018, CLIN CANCER RES, V24, P3681, DOI 10.1158/1078-0432.CCR-17-2259; Halasi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031761; Hassan MK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191377; HORWITZ KB, 1975, SCIENCE, V189, P726, DOI 10.1126/science.168640; Hou Y, 2015, NAT IMMUNOL, V16, P810, DOI 10.1038/ni.3204; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Ito Y, 2015, NAT REV CANCER, V15, P81, DOI 10.1038/nrc3877; Jordan VC, 2008, EUR J CANCER, V44, P30, DOI 10.1016/j.ejca.2007.11.002; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Karadedou CT, 2006, HIPPOKRATIA, V10, P128; Kevil C, 1995, ONCOGENE, V11, P2339; Kevil CG, 1996, INT J CANCER, V65, P785, DOI 10.1002/(SICI)1097-0215(19960315)65:6<785::AID-IJC14>3.0.CO;2-3; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Leppek K, 2018, NAT REV MOL CELL BIO, V19, P158, DOI 10.1038/nrm.2017.103; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Millour J, 2010, ONCOGENE, V29, P2983, DOI 10.1038/onc.2010.47; ROSENWALD IB, 1993, MOL CELL BIOL, V13, P7358, DOI 10.1128/MCB.13.12.7358; Ruggero D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012336; SHANTZ LM, 1994, CANCER RES, V54, P2313; Siddiqui N, 2015, BIOCHEM SOC T, V43, P763, DOI 10.1042/BST20150126; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Uttam S, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00470; Zhang LD, 2013, CANCER RES, V73, P246, DOI 10.1158/0008-5472.CAN-12-2241; Zhu YH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03951-0; Zilli M, 2009, BBA-REV CANCER, V1795, P62, DOI 10.1016/j.bbcan.2008.08.003; Zindy P, 2011, CANCER RES, V71, P4068, DOI 10.1158/0008-5472.CAN-11-0420	42	9	9	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	15					3206	3217		10.1038/s41388-020-1210-y	http://dx.doi.org/10.1038/s41388-020-1210-y		FEB 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LB8NS	32066877	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000514052700005
J	Tian, LT; Yao, K; Liu, K; Han, B; Dong, HG; Zhao, W; Jiang, WB; Qiu, FB; Qu, LL; Wu, ZH; Zhou, B; Zhong, MY; Zhao, JB; Qiu, XF; Zhong, LF; Guo, XF; Shi, TL; Hong, XH; Lu, SC				Tian, Lantian; Yao, Ke; Liu, Kun; Han, Bing; Dong, Hanguang; Zhao, Wei; Jiang, Weibo; Qiu, Fabo; Qu, Linlin; Wu, Zehua; Zhou, Bin; Zhong, Mengya; Zhao, Jiabao; Qiu, Xingfeng; Zhong, Lifeng; Guo, Xiaofeng; Shi, Tianlu; Hong, Xuehui; Lu, Shichun			PLK1/NF-kappa B feedforward circuit antagonizes the mono-ADP-ribosyltransferase activity of PARP10 and facilitates HCC progression	ONCOGENE			English	Article							POLO-LIKE KINASE; HEPATOCELLULAR-CARCINOMA; PLK1; PHOSPHORYLATION; PROLIFERATION; RIBOSYLATION; REPLICATION; ACTIVATION; RESISTANCE	Dysregulation of PARP10 has been implicated in various tumor types and plays a vital role in delaying hepatocellular carcinoma (HCC) progression. However, the mechanisms controlling the expression and activity of PARP10 in HCC remain mostly unknown. The crosstalk between PLK1, PARP10, and NF-kappa B pathway in HCC was determined by performing different in vitro and in vivo assays, including mass spectrometry, kinase, MARylation, chromatin immunoprecipitation, and luciferase reporter measurements. Functional examination was performed by using small chemical drug, cell culture, and mice HCC models. Correlation between PLK1, NF-kappa B, and PARP10 expression was determined by analyzing clinical samples of HCC patients with using immunohistochemistry. PLK1, an important regulator for cell mitosis, directly interacts with and phosphorylates PARP10 at T601. PARP10 phosphorylation at T601 significantly decreases its binding to NEMO and disrupts its inhibition to NEMO ubiquitination, thereby enhancing the transcription activity of NF-kappa B toward multiple target genes and promoting HCC development. In turn, NF-kappa B transcriptionally inhibits the PARP10 promoter activity and leads to its downregulation in HCC. Interestingly, PLK1 is mono-ADP-ribosylated by PARP10 and the MARylation of PLK1 significantly inhibits its kinase activity and oncogenic function in HCC. Clinically, the expression levels of PLK1 and phosphor-p65 show an inverse correlation with PARP10 expression in human HCC tissues. These findings are the first to uncover a PLK1/PARP10/NF-kappa B signaling circuit that underlies tumorigenesis and validate PLK1 inhibitors, alone or with NF-kappa B antagonists, as potential effective therapeutics for PARP10-expressing HCC.	[Tian, Lantian; Han, Bing; Zhao, Wei; Jiang, Weibo; Qiu, Fabo; Qu, Linlin; Wu, Zehua; Zhou, Bin] Qingdao Univ, Affiliated Hosp, Dept Hepatopancreatobiliary Surg, Qingdao, Shandong, Peoples R China; [Tian, Lantian; Lu, Shichun] Chinese Peoples Liberat Army Gen Hosp, Clin Med Ctr 1, Dept Hepatobiliary Surg, Beijing, Peoples R China; [Yao, Ke] Qingdao Univ, Affiliated Hosp, Dept Obstet & Gynaecol, Qingdao, Shandong, Peoples R China; [Liu, Kun] PLA Navy, Hosp 971, Dept Gen Surg, Qingdao, Shandong, Peoples R China; [Dong, Hanguang] Shandong Univ, Dept Gen Surg, Qilu Hosp, Qingdao, Shandong, Peoples R China; [Zhong, Mengya; Zhao, Jiabao; Qiu, Xingfeng; Zhong, Lifeng; Hong, Xuehui] Xiamen Univ, Dept Gastrointestinal Surg, Zhongshan Hosp, Xiamen, Fujian, Peoples R China; [Zhong, Mengya; Zhao, Jiabao; Qiu, Xingfeng; Zhong, Lifeng; Hong, Xuehui] Xiamen Univ, Inst Gastrointestinal Oncol, Sch Med, Xiamen, Fujian, Peoples R China; [Guo, Xiaofeng] Zhongshan Univ, Affiliated Hosp, Dept Hepatopancreatobiliary Surg, Guangzhou, Guangdong, Peoples R China; [Shi, Tianlu] Univ Sci & Technol China, Affiliated Hosp 1, Div Life Sci & Med, Dept Pharm, Hefei, Anhui, Peoples R China	Qingdao University; Chinese People's Liberation Army General Hospital; Qingdao University; Sixth Medical Center of Chinese PLA General Hospital; Shandong University; Xiamen University; Xiamen University; Sun Yat Sen University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Lu, SC (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Clin Med Ctr 1, Dept Hepatobiliary Surg, Beijing, Peoples R China.; Hong, XH (corresponding author), Xiamen Univ, Dept Gastrointestinal Surg, Zhongshan Hosp, Xiamen, Fujian, Peoples R China.; Hong, XH (corresponding author), Xiamen Univ, Inst Gastrointestinal Oncol, Sch Med, Xiamen, Fujian, Peoples R China.; Shi, TL (corresponding author), Univ Sci & Technol China, Affiliated Hosp 1, Div Life Sci & Med, Dept Pharm, Hefei, Anhui, Peoples R China.	tianlu828@163.com; hongxu@xmu.edu.cn; lushichun889@126.com	Zhong, Mengya/AAA-6082-2021		National Natural Science Foundation of China [81602149]; Natural Science Foundation of Fujian Province [2016J01619]; Training Program for Young Talents of Fujian Health System [2016-ZQN-85]; Fujian Provincial Funds for Distinguished Young Scientists [2018D0016]; Affiliated Hospital of Qingdao University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Training Program for Young Talents of Fujian Health System; Fujian Provincial Funds for Distinguished Young Scientists; Affiliated Hospital of Qingdao University	The authors would like to thank the Affiliated Hospital of Qingdao University for providing clinical samples and the contributions and supports of the entire research team. This study was supported by National Natural Science Foundation of China (Grant No. 81602149), Natural Science Foundation of Fujian Province (Grant No. 2016J01619), Training Program for Young Talents of Fujian Health System (Grant No. 2016-ZQN-85), Fujian Provincial Funds for Distinguished Young Scientists (No. 2018D0016).	Almeida LO, 2014, FEBS OPEN BIO, V4, P96, DOI 10.1016/j.fob.2013.12.003; Chen YC, 2010, J BIOL CHEM, V285, P41244, DOI 10.1074/jbc.M110.155242; Chou HYE, 2006, J BIOL CHEM, V281, P15201, DOI 10.1074/jbc.M506745200; de Carcer G, 2011, CELL CYCLE, V10, P2255, DOI 10.4161/cc.10.14.16494; Dietrich P, 2018, ONCOTARGET, V9, P3605, DOI 10.18632/oncotarget.23188; Feijs KLH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-5; Fu Z, 2017, CANCERS, V9, DOI 10.3390/cancers9100131; Gutteridge REA, 2016, MOL CANCER THER, V15, P1427, DOI 10.1158/1535-7163.MCT-15-0897; Hong XH, 2018, ELIFE, V7, DOI 10.7554/eLife.29511; Hong XH, 2014, GUT, V63, P1635, DOI 10.1136/gutjnl-2013-305302; Huang GL, 2010, WORLD J GASTROENTERO, V16, P2046, DOI 10.3748/wjg.v16.i16.2046; Kachaner D, 2012, MOL CELL, V45, P553, DOI 10.1016/j.molcel.2011.12.030; Lasek AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150225; Li XY, 2017, CELL CYCLE, V16, P1933, DOI 10.1080/15384101.2017.1363942; Ling F, 2017, ONCOTARGET, V8, P72773, DOI 10.18632/oncotarget.20347; Liu XQ, 2015, TRANSL ONCOL, V8, P185, DOI 10.1016/j.tranon.2015.03.010; Lo J, 2015, HEPATOLOGY, V62, P534, DOI 10.1002/hep.27859; de Lima CDM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041772; Marton J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0187789; Paone G, 2006, J BIOL CHEM, V281, P17054, DOI 10.1074/jbc.M603042200; Qu C, 2016, J HEPATOL, V64, P1076, DOI 10.1016/j.jhep.2016.01.005; Schleicher EM, 2018, NUCLEIC ACIDS RES, V46, P8908, DOI 10.1093/nar/gky658; Sokolova O, 2017, TOXINS, V9, DOI 10.3390/toxins9040119; Song RP, 2014, HEPATOLOGY, V60, P1659, DOI 10.1002/hep.27312; Studach LL, 2009, HEPATOLOGY, V50, P414, DOI 10.1002/hep.22996; Teloni F, 2016, NUCLEIC ACIDS RES, V44, P993, DOI 10.1093/nar/gkv1383; Varol B, 2014, TUMOR BIOL, V35, P5575, DOI 10.1007/s13277-014-1735-1; Verheugd P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2672; Wang G, 2013, J CELL SCI, V126, P1355, DOI 10.1242/jcs.114918; Wright G, 2017, ACS CHEM BIOL, V12, P1883, DOI 10.1021/acschembio.7b00147; Yau L, 2003, EUR J BIOCHEM, V270, P101, DOI 10.1046/j.1432-1033.2003.03366.x; Zhao YH, 2018, ONCOGENE, V37, P2921, DOI 10.1038/s41388-018-0168-5; Zhu Y., 2018, IEEE J SEL TOP QUANT, V24, P1	33	14	15	6	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	15					3145	3162		10.1038/s41388-020-1205-8	http://dx.doi.org/10.1038/s41388-020-1205-8		FEB 2020	18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LB8NS	32060423				2022-12-26	WOS:000513384600002
J	Khilji, MS; Verstappen, D; Dahlby, T; Prause, MCB; Pihl, C; Bresson, SE; Bryde, TH; Andersen, PAK; Klindt, K; Zivkovic, D; Bousquet-Dubouch, MP; Tyrberg, B; Mandrup-Poulsen, T; Marzec, MT				Khilji, Muhammad Saad; Verstappen, Danielle; Dahlby, Tina; Prause, Michala Cecilie Burstein; Pihl, Celina; Bresson, Sophie Emilie; Bryde, Tenna Holgersen; Andersen, Phillip Alexander Keller; Klindt, Kristian; Zivkovic, Dusan; Bousquet-Dubouch, Marie-Pierre; Tyrberg, Bjorn; Mandrup-Poulsen, Thomas; Marzec, Michal Tomasz			The intermediate proteasome is constitutively expressed in pancreatic beta cells and upregulated by stimulatory, low concentrations of interleukin 1 beta	PLOS ONE			English	Article							COMPLEXES; IMMUNOPROTEASOME; INTERFERON; DYNAMICS; ISLETS; RECOGNITION; INHIBITOR; DIVERSITY; CYTOKINES; SUBTYPES	A central and still open question regarding the pathogenesis of autoimmune diseases, such as type 1 diabetes, concerns the processes that underlie the generation of MHC-presented autoantigenic epitopes that become targets of autoimmune attack. Proteasomal degradation is a key step in processing of proteins for MHC class I presentation. Different types of proteasomes can be expressed in cells dictating the repertoire of peptides presented by the MHC class I complex. Of particular interest for type 1 diabetes is the proteasomal configuration of pancreatic beta cells, as this might facilitate autoantigen presentation by beta cells and thereby their T-cell mediated destruction. Here we investigated whether so-called inducible subunits of the proteasome are constitutively expressed in beta cells, regulated by inflammatory signals and participate in the formation of active intermediate or immuno-proteasomes. We show that inducible proteasomal subunits are constitutively expressed in human and rodent islets and an insulin-secreting cell-line. Moreover, the beta 5i subunit is incorporated into active intermediate proteasomes that are bound to 19S or 11S regulatory particles. Finally, inducible subunit expression along with increase in total proteasome activities are further upregulated by low concentrations of IL-1 beta stimulating proinsulin biosynthesis. These findings suggest that the beta cell proteasomal repertoire is more diverse than assumed previously and may be highly responsive to a local inflammatory islet environment.	[Khilji, Muhammad Saad; Verstappen, Danielle; Dahlby, Tina; Pihl, Celina; Bresson, Sophie Emilie; Bryde, Tenna Holgersen; Andersen, Phillip Alexander Keller; Klindt, Kristian; Mandrup-Poulsen, Thomas; Marzec, Michal Tomasz] Univ Copenhagen, Dept Biomed Sci, Metab & Oxidat Sect, Lab Immunoendocrinol, Copenhagen, Denmark; [Khilji, Muhammad Saad] Univ Vet & Anim Sci, Dept Physiol, Lahore, Punjab, Pakistan; [Verstappen, Danielle] Radboud Univ Nijmegen, Nijmegen, Netherlands; [Prause, Michala Cecilie Burstein] Univ Copenhagen, Dept Biomed Sci, Sect Beta Cell Biol, Copenhagen, Denmark; [Zivkovic, Dusan; Bousquet-Dubouch, Marie-Pierre] Univ Toulouse, CNRS, Inst Pharmacol & Biol Struct, Toulouse, France; [Tyrberg, Bjorn] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden; [Tyrberg, Bjorn] Inst Rech Servier, Cardiovasc & Metab Dis, Suresnes, France	University of Copenhagen; University of Veterinary & Animal Science - Pakistan; Radboud University Nijmegen; University of Copenhagen; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Gothenburg; Servier; Institut de Recherches Internationales Servier	Marzec, MT (corresponding author), Univ Copenhagen, Dept Biomed Sci, Metab & Oxidat Sect, Lab Immunoendocrinol, Copenhagen, Denmark.	Michal@sundk.ku.dk	Pihl, Celina/AAU-6509-2021; Bresson, Sophie Emilie/AAZ-3071-2021; Marzec, Michal/O-6387-2016	Pihl, Celina/0000-0002-0848-9096; Andersen, Phillip/0000-0002-3045-499X; Marzec, Michal/0000-0001-9698-6019; Prause, Michala/0000-0002-5922-0396; ZIVKOVIC, Dusan/0000-0001-5794-4422; Bousquet, Marie-Pierre/0000-0003-2680-8932; Tyrberg, Bjorn/0000-0003-0976-1220; Dahlby, Tina/0000-0003-1656-0814; Bryde, Tenna Holgersen/0000-0003-3422-2122	Punjab Educational Endowment Fund; Department of Biomedical Sciences at the University of Copenhagen; Augustinus Foundation; EFSD/JDRF/Lilly European Programme in Type 1 Diabetes; Vissing Fonden; Bjarne Jensen Fonden; Poul og Erna Sehested Hansens Fond; Eva og Hans Carl Holms Mindelegat	Punjab Educational Endowment Fund; Department of Biomedical Sciences at the University of Copenhagen; Augustinus Foundation; EFSD/JDRF/Lilly European Programme in Type 1 Diabetes; Vissing Fonden; Bjarne Jensen Fonden; Poul og Erna Sehested Hansens Fond; Eva og Hans Carl Holms Mindelegat	This study was funded by The Punjab Educational Endowment Fund https://www.peef.org.pk/(M.S.K), the Department of Biomedical Sciences at the University of Copenhagen https://bmi.ku.dk/(T.D.and M.T.M.); the Augustinus Foundation https://augustinusfonden.dk/(T.D.and M.T.M.); EFSD/JDRF/Lilly European Programme in Type 1 Diabetes http://www.europeandiabetes foundation.org/, Vissing Fonden http://www.vissing fonden.dk/, Bjarne Jensen Fonden http://www.bjarnejensensfond.dk/, Poul og Erna Sehested Hansens Fond, no website, Eva og Hans Carl Holms Mindelegat https://haldguttenberg.dk/1april/(M.T.M).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldeon ME, 1997, DIABETES, V46, P770, DOI 10.2337/diabetes.46.5.770; Bard JAM, 2018, ANNU REV BIOCHEM, V87, P697, DOI 10.1146/annurev-biochem-062917-011931; BENDTZEN K, 1986, SCIENCE, V232, P1545, DOI 10.1126/science.3086977; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Bousquet-Dubouch MP, 2009, MOL CELL PROTEOMICS, V8, P1150, DOI 10.1074/mcp.M800193-MCP200; Brand MD, 2010, DIABETES OBES METAB, V12, P134, DOI 10.1111/j.1463-1326.2010.01264.x; Brooks P, 2000, BIOCHEM J, V346, P155, DOI 10.1042/0264-6021:3460155; Brooks P, 2000, BIOCHEM J, V352, P611, DOI 10.1042/0264-6021:3520611; Cascio P, 2014, BIOMOLECULES, V4, P566, DOI 10.3390/biom4020566; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; de Graaf N, 2011, EUR J IMMUNOL, V41, P926, DOI 10.1002/eji.201041040; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Fabre B., 2014, EUPROT, V4, P82, DOI DOI 10.1016/J.EUPROT.2014.06.001; Fabre B, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145497; Fabre B, 2014, J PROTEOME RES, V13, P3027, DOI 10.1021/pr500193k; Fabre B, 2013, MOL CELL PROTEOMICS, V12, P687, DOI 10.1074/mcp.M112.023317; Ferrington DA, 2012, PROG MOL BIOL TRANSL, V109, P75, DOI 10.1016/B978-0-12-397863-9.00003-1; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Forthofer RN, 2006, BIOSTATISTICS GUIDE, V2nd; FREER DE, 1979, CLIN CHEM, V25, P565; Freudenburg W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052408; Ghiasi SM, 2019, DIABETES, V68, P747, DOI 10.2337/db18-0671; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Guillaume B, 2010, P NATL ACAD SCI USA, V107, P18599, DOI 10.1073/pnas.1009778107; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; Huang XL, 2016, NAT STRUCT MOL BIOL, V23, P778, DOI 10.1038/nsmb.3273; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Ichikawa HT, 2012, ARTHRITIS RHEUM-US, V64, P493, DOI 10.1002/art.33333; James AB, 2006, J NEUROSCI, V26, P1624, DOI 10.1523/JNEUROSCI.4199-05.2006; Kasahara M, 2019, IMMUNOGENETICS, V71, P251, DOI 10.1007/s00251-019-01105-0; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kitiphongspattana K, 2005, J BIOL CHEM, V280, P15727, DOI 10.1074/jbc.M410876200; Klare N, 2007, J MOL BIOL, V373, P1, DOI 10.1016/j.jmb.2007.07.038; Kniepert A, 2014, TRENDS BIOCHEM SCI, V39, P17, DOI 10.1016/j.tibs.2013.10.004; Koizumi S, 2018, P JPN ACAD B-PHYS, V94, P325, DOI 10.2183/pjab.94.021; Kors S, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00048; Krishna S, 2005, P NATL ACAD SCI USA, V102, P4771, DOI 10.1073/pnas.0406415102; Kunjappu MJ, 2014, BBA-MOL CELL RES, V1843, P2, DOI 10.1016/j.bbamcr.2013.03.008; Litwak SA, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/280615; Lundh M, 2017, J ENDOCRINOL, V233, P369, DOI 10.1530/JOE-17-0110; Menneteau T, 2019, MOL CELL PROTEOMICS, V18, P744, DOI 10.1074/mcp.RA118.000958; Morozov AV, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00894; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Noble JA, 2011, CURR DIABETES REP, V11, P533, DOI 10.1007/s11892-011-0223-x; Nowlin SY, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/542698; Opitz E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002233; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pelletier S, 2010, MOL BIOSYST, V6, P1450, DOI 10.1039/c004989a; Rabinovitch A, 2003, REV ENDOCR METAB DIS, V4, P291, DOI 10.1023/A:1025160614313; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; SPINAS GA, 1986, ACTA ENDOCRINOL-COP, V113, P551, DOI 10.1530/acta.0.1130551; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Unger WW, 2011, J AUTOIMMUN, V37, P151, DOI 10.1016/j.jaut.2011.05.012; Unno M, 2002, J BIOCHEM, V131, P171, DOI 10.1093/oxfordjournals.jbchem.a003084; Urizar AI, 2019, MOL CELL ENDOCRINOL, V496, DOI 10.1016/j.mce.2019.110524; Vigneron N, 2014, BIOMOLECULES, V4, P994, DOI 10.3390/biom4040994; Visekruna A, 2009, INFLAMM BOWEL DIS, V15, P526, DOI 10.1002/ibd.20805; Zhou WY, 2019, NATURE, V569, P663, DOI 10.1038/s41586-019-1236-x	65	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0222432	10.1371/journal.pone.0222432	http://dx.doi.org/10.1371/journal.pone.0222432			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053590	Green Published, gold			2022-12-26	WOS:000535198700005
J	Werlenius, K; Fekete, B; Blomstrand, M; Caren, H; Jakola, AS; Rydenhag, B; Smits, A				Werlenius, Katja; Fekete, Boglarka; Blomstrand, Malin; Caren, Helena; Jakola, Asgeir S.; Rydenhag, Bertil; Smits, Anja			Patterns of care and clinical outcome in assumed glioblastoma without tissue diagnosis: A population-based study of 131 consecutive patients	PLOS ONE			English	Article							ELDERLY-PATIENTS; PROGNOSTIC-FACTORS; OLDER PATIENTS; TEMOZOLOMIDE; RADIOTHERAPY; MULTIFORME; SURVIVAL; TOXICITY; TUMORS; BRAIN	Background Elderly patients with glioblastoma and an accumulation of negative prognostic factors have an extremely short survival. There is no consensus on the clinical management of these patients and many may escape histologically verified diagnosis. The primary aim of this study was to characterize this particular subgroup of patients with radiological glioblastoma diagnosis without histological verification. The secondary aim was to evaluate if oncological therapy was of benefit. Methods Between November 2012 and June 2016, all consecutive patients presenting with a suspected glioblastoma in the western region of Sweden were registered in a population-based study. Of the 378 patients, 131 (35%) met the inclusion criteria of the present study by typical radiological features of glioblastoma without histological verification. Results The clinical characteristics of the 131 patients (72 men, 59 women) were: age >= 75 (n = 99, 76%), performance status according to Eastern Cooperative Oncology Group >= 2 (n = 93, 71%), significant comorbidity (n = 65, 50%) and multilobular tumors (n = 90, 69%). The overall median survival rate was 3.6 months. A subgroup of 44 patients (34%) received upfront treatment with temozolomide, with an overall radiological response rate of 34% and a median survival of 6.8 months, compared to 2.7 months for those receiving best supportive care only. Good performance status and temozolomide treatment were statistically significant favorable prognostic factors, while younger age was not. Conclusion Thirty-five percent of patients with a radiological diagnosis of glioblastoma in our region lacked histological diagnosis. Apart from high age and poor performance status, they had more severe comorbidities and extensive tumor spread. Even for this poor prognostic group upfront treatment with temozolomide was shown of benefit in a subgroup of patients. Our data illustrate the need of non-invasive diagnostic methods to guide optimal individualized therapy for patients considered too fragile for neurosurgical biopsy.	[Werlenius, Katja; Fekete, Boglarka; Blomstrand, Malin] Sahlgrens Univ Hosp, Dept Oncol, Gothenburg, Sweden; [Werlenius, Katja; Blomstrand, Malin] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Oncol, Gothenburg, Sweden; [Fekete, Boglarka; Jakola, Asgeir S.; Rydenhag, Bertil; Smits, Anja] Sahlgrens Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden; [Caren, Helena] Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Canc Ctr, Inst Biomed,Dept Lab Med, Gothenburg, Sweden; [Jakola, Asgeir S.; Rydenhag, Bertil] Sahlgrens Univ Hosp, Dept Neurosurg, Gothenburg, Sweden; [Smits, Anja] Sahlgrens Univ Hosp, Dept Neurol, Gothenburg, Sweden; [Smits, Anja] Uppsala Univ, Dept Neurosci, Neurol, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital; Sahlgrenska University Hospital; Uppsala University	Werlenius, K (corresponding author), Sahlgrens Univ Hosp, Dept Oncol, Gothenburg, Sweden.; Werlenius, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Oncol, Gothenburg, Sweden.	katja.werlenius@vgregion.se	Jakola, Asgeir/J-1738-2018	Jakola, Asgeir/0000-0002-2860-9331; Werlenius, Katja/0000-0003-1414-5588; Caren, Helena/0000-0002-8584-555X	Gothenburg Medical Society; Regional FoU [VGFOUREG-750851]; AFA Research Foundation; Swedish government [ALFGBG-717021, ALFGBG- 716671]	Gothenburg Medical Society; Regional FoU; AFA Research Foundation; Swedish government	This work received financial support from the Gothenburg Medical Society (KW), Regional FoU-support; VGFOUREG-750851, BR), AFA Research Foundation (BR) and by grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-717021, AS; ALFGBG- 716671, ASJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asklund T, 2015, ACTA ONCOL, V54, P377, DOI 10.3109/0284186X.2014.975369; Brodbelt A, 2015, EUR J CANCER, V51, P533, DOI 10.1016/j.ejca.2014.12.014; Chaichana KL, 2011, J NEUROSURG, V114, P587, DOI 10.3171/2010.8.JNS1081; Chakrabarti I, 2005, CANCER-AM CANCER SOC, V104, P2798, DOI 10.1002/cncr.21539; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cloney Michael, 2016, World Neurosurg, V89, P362, DOI 10.1016/j.wneu.2015.12.096; Connon FV, 2016, NEUROSURG REV, V39, P55, DOI 10.1007/s10143-015-0652-0; Dressler EV, 2019, NEURO-ONCOL PRACT, V6, P37, DOI 10.1093/nop/npy014; Eriksson M, 2019, ACTA ONCOL, V58, P334, DOI 10.1080/0284186X.2019.1571278; Fekete B, 2016, ACTA NEUROL SCAND, V133, P434, DOI 10.1111/ane.12481; Fekete B., 2019, NEUROL NEUROSURG, V2, DOI [10.15761/NNS.1000123, DOI 10.15761/NNS.1000123]; Glaser SM, 2017, J NEURO-ONCOL, V134, P107, DOI 10.1007/s11060-017-2493-x; Gulati S, 2012, WORLD NEUROSURG, V78, P518, DOI 10.1016/j.wneu.2011.12.008; Gulati S, 2011, WORLD NEUROSURG, V76, P572, DOI 10.1016/j.wneu.2011.06.014; Ho VKY, 2014, EUR J CANCER, V50, P2309, DOI 10.1016/j.ejca.2014.05.019; Iwamoto FM, 2009, CANCER-AM CANCER SOC, V115, P3758, DOI 10.1002/cncr.24413; Keime-Guibert F, 2007, NEW ENGL J MED, V356, P1527, DOI 10.1056/NEJMoa065901; Kita D, 2009, NEUROEPIDEMIOLOGY, V33, P17, DOI 10.1159/000210017; Li J, 2011, INT J RADIAT ONCOL, V81, P623, DOI 10.1016/j.ijrobp.2010.06.012; Li K, 2018, CANCER MED-US, V7, P5281, DOI 10.1002/cam4.1757; Lorimer CF, 2017, CLIN ONCOL-UK, V29, P739, DOI 10.1016/j.clon.2017.05.010; Lorimer CF, 2016, J GERIATR ONCOL, V7, P453, DOI 10.1016/j.jgo.2016.07.005; Lutterbach J, 2003, STRAHLENTHER ONKOL, V179, P8, DOI 10.1007/s00066-003-1004-5; Malmstrom A, 2012, LANCET ONCOL, V13, P916, DOI 10.1016/S1470-2045(12)70265-6; McGirt MJ, 2009, NEUROSURGERY, V65, P167, DOI 10.1227/01.NEU.0000345642.50726.A3; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Perez-Larraya JG, 2011, J CLIN ONCOL, V29, P3050, DOI 10.1200/JCO.2011.34.8086; Perry JR, 2017, NEW ENGL J MED, V376, P1027, DOI 10.1056/NEJMoa1611977; Roa W, 2015, J CLIN ONCOL, V33, P4145, DOI 10.1200/JCO.2015.62.6606; Saenz-Antonanzas A, 2019, CANCERS, V11, DOI 10.3390/cancers11070950; Schneeweiss S, 2003, HEALTH SERV RES, V38, P1103, DOI 10.1111/1475-6773.00165; Sijben AE, 2008, J NEURO-ONCOL, V89, P97, DOI 10.1007/s11060-008-9593-6; Wick W, 2012, LANCET ONCOL, V13, P707, DOI 10.1016/S1470-2045(12)70164-X; Yin AA, 2014, J NEURO-ONCOL, V116, P315, DOI 10.1007/s11060-013-1294-0; Zarnett OJ, 2015, JAMA NEUROL, V72, P589, DOI 10.1001/jamaneurol.2014.3739	36	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228480	10.1371/journal.pone.0228480	http://dx.doi.org/10.1371/journal.pone.0228480			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053655	Green Published, gold			2022-12-26	WOS:000535198700029
J	Yoon, JH; Han, K; Lee, E; Lee, J; Kim, EK; Moon, HJ; Park, VY; Nam, KH; Kwak, JY				Yoon, Jung Hyun; Han, Kyunghwa; Lee, Eunjung; Lee, Jandee; Kim, Eun-Kyung; Moon, Hee Jung; Park, Vivian Youngjean; Nam, Kee Hyun; Kwak, Jin Young			Radiomics in predicting mutation status for thyroid cancer: A preliminary study using radiomics features for predicting BRAF(V600E) mutations in papillary thyroid carcinoma	PLOS ONE			English	Article							BRAF V600E MUTATION; UNITED-STATES; INCREASING INCIDENCE; ASSOCIATION	Purpose To evaluate whether if ultrasonography (US)-based radiomics enables prediction of the presence of BRAF(V600E) mutations among patients diagnosed as papillary thyroid carcninoma (PTC). Methods From December 2015 to May 2017, 527 patients who had been treated surgically for PTC were included (training: 387, validation: 140). All patients had BRAF(V600E) mutation analysis performed on surgical specimen. Feature extraction was performed using preoperative US images of the 527 patients (mean size of PTC: 16.4mm +/- 7.9, range, 10-85 mm). A Radiomics Score was generated by using the least absolute shrinkage and selection operator (LASSO) regression model. Univariable/multivariable logistic regression analysis was performed to evaluate the factors including Radiomics Score in predicting BRAF(V600E) mutation. Subgroup analysis including conventional PTC <20-mm (n = 389) was performed (training: 280, validation: 109). Results Of the 527 patients diagnosed with PTC, 428 (81.2%) were positive and 99 (18.8%) were negative for BRAF(V600E) mutation. In both total 527 cancers and 389 conventional PTC<20-mm, Radiomics Score was the single factor showing significant association to the presence of BRAF(V600E) mutation on multivariable analysis (all P<0.05). C-statistics for the validation set in the total cancers and the conventional PTCs<20-mm were lower than that of the training set: 0.629 (95% CI: 0.516-0.742) to 0.718 (95% CI: 0.650-0.786), and 0.567 (95% CI: 0.434-0.699) to 0.729 (95% CI: 0.632-0.826), respectively. Conclusion Radiomics features extracted from US has limited value as a non-invasive biomarker for predicting the presence of BRAF(V600E) mutation status of PTC regardless of size.	[Yoon, Jung Hyun; Kim, Eun-Kyung; Moon, Hee Jung; Park, Vivian Youngjean; Kwak, Jin Young] Yonsei Univ, Severance Hosp, Coll Med, Res Inst Radiol Sci, Seoul, South Korea; [Han, Kyunghwa] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol, Seoul, South Korea; [Han, Kyunghwa] Yonsei Univ, Coll Med, Ctr Clin Imaging Data Sci, Seoul, South Korea; [Lee, Eunjung] Yonsei Univ, Coll Med, Dept Computat Sci & Engn, Seoul, South Korea; [Lee, Jandee; Nam, Kee Hyun] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kwak, JY (corresponding author), Yonsei Univ, Severance Hosp, Coll Med, Res Inst Radiol Sci, Seoul, South Korea.	docjin@yuhs.ac	; Kim, Eun-Kyung/E-5211-2017	Kwak, Jin Young/0000-0002-6212-1495; Lee, Jandee/0000-0003-4090-0049; Moon, Hee Jung/0000-0002-5643-5885; Nam, Kee-Hyun/0000-0002-6852-1190; Yoon, Jung Hyun/0000-0002-2100-3513; Park, Vivian/0000-0002-5135-4058; Lee, Eunjung/0000-0001-9989-3555; Kim, Eun-Kyung/0000-0002-3368-5013	National Research Foundation of Korea(NRF) - Korea government(MSIT) [2019R1A2C1002375]; CMB-Yuhan research grant of Yonsei University College of Medicine [6-2017-0170]	National Research Foundation of Korea(NRF) - Korea government(MSIT); CMB-Yuhan research grant of Yonsei University College of Medicine	This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIT) (2019R1A2C1002375). This study was also supported by a CMB-Yuhan research grant of Yonsei University College of Medicine (6-2017-0170). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4789; Braman NM, INTRATUMORAL PERITUM; Brown RL, 2011, J CANCER, V2, P193, DOI 10.7150/jca.2.193; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Enewold L, 2009, CANCER EPIDEM BIOMAR, V18, P784, DOI 10.1158/1055-9965.EPI-08-0960; George JR, NOT BRAF MUTATION IN; Gevaert O, PREDICTIVE RADIOGENO; Harrell FE, 2001, REGRESSION MODELING; Kim KH, 2004, YONSEI MED J, V45, P818, DOI 10.3349/ymj.2004.45.5.818; Kim TH, 2012, CANCER-AM CANCER SOC, V118, P1764, DOI 10.1002/cncr.26500; Li C, 2012, J CLIN ENDOCR METAB, V97, P4559, DOI 10.1210/jc.2012-2104; Liu RY, 2017, JAMA ONCOL, V3, P202, DOI 10.1001/jamaoncol.2016.3288; Liu TT, 2019, TECHNOL CANCER RES T, V18, DOI 10.1177/1533033819831713; Loh KC, 1997, J CLIN ENDOCR METAB, V82, P3553, DOI 10.1210/jc.82.11.3553; Magreni A, 2015, JAMA OTOLARYNGOL, V141, P319, DOI 10.1001/jamaoto.2014.3740; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; Melo M, TERT BRAF NRAS PRIMA; Noone AM, 2017, CANCER EPIDEM BIOMAR, V26, P632, DOI 10.1158/1055-9965.EPI-16-0520; Park VY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37748-4; Penna GC, 2016, CYTOGENET GENOME RES, V150, P194, DOI 10.1159/000456576; Xing MZ, 2014, J CLIN ONCOL, V32, P2718, DOI 10.1200/JCO.2014.55.5094; Xing MZ, 2013, JAMA-J AM MED ASSOC, V309, P1493, DOI 10.1001/jama.2013.3190; Yang L, 2018, EUR RADIOL, V28, P2058, DOI 10.1007/s00330-017-5146-8; Yin DT, 2016, CLIN ENDOCRINOL, V85, P299, DOI 10.1111/cen.13017; Zhang B, 2017, CLIN CANCER RES, V23, P4259, DOI 10.1158/1078-0432.CCR-16-2910	26	15	16	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228968	10.1371/journal.pone.0228968	http://dx.doi.org/10.1371/journal.pone.0228968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053670	gold, Green Published			2022-12-26	WOS:000535198700080
J	Wang, PY; Wu, HB; Zhao, GW; He, YH; Kong, WH; Zhang, J; Liu, SM; Liu, ML; Hu, KY; Liu, LF; Xu, YY; Xu, ZH				Wang, Pingyong; Wu, Haibo; Zhao, Guangwei; He, Yuhua; Kong, Weihu; Zhang, Jian; Liu, Shuimiao; Liu, Mengli; Hu, Keyun; Liu, Lifeng; Xu, Yongyang; Xu, Zhihong			Transcriptome analysis clarified genes involved in resistance to Phytophthora capsici in melon	PLOS ONE			English	Article							AGE-RELATED RESISTANCE; DEFENSE; PROTEIN; OVEREXPRESSION; BIOSYNTHESIS; MECHANISMS; INTERACTS; INFESTANS; PATHWAY; ELEMENT	Phytophthora blight caused by Phytophthora capsici is a devastating disease for melon plant. However, the underlying resistance mechanisms are still poorly understood. In this study, the transcriptome differences between the resistant ZQK9 and susceptible E31 at 0, 3, and 5 days post-inoculation (dpi) were identified by RNA-seq. A total of 1,195 and 6,595 differentially expressed genes (DEGs) were identified in ZQK9 and E31, respectively. P. capsici infection triggered massive transcript changes in the inoculated tissues. Genes related to plant defense responses were activated, which was reflected by a lot of up-regulated DEGs involved in pathogenesis-related (PR) genes, hormones biosynthesis and signal transduction, secondary metabolites biosynthesis and cell wall modification in resistant ZQK9. The dataset generated in this study may provide a basis for identifying candidate resistant genes in melon against P. capsici and lay a foundation for further research on the molecular mechanisms.	[Wang, Pingyong; Zhao, Guangwei; He, Yuhua; Kong, Weihu; Zhang, Jian; Liu, Shuimiao; Liu, Mengli; Hu, Keyun; Liu, Lifeng; Xu, Yongyang; Xu, Zhihong] Chinese Acad Agr Sci, Zhengzhou Fruit Res Inst, Zhengzhou, Henan, Peoples R China; [Wu, Haibo] Xinjiang Acad Agr Sci, Hainan Sanya Trial Ctr Crops Breeding, Sanya, Hainan, Peoples R China	Chinese Academy of Agricultural Sciences; Zhengzhou Fruit Research Institute, CAAS	Xu, YY; Xu, ZH (corresponding author), Chinese Acad Agr Sci, Zhengzhou Fruit Res Inst, Zhengzhou, Henan, Peoples R China.	xuyongyong@caas.cn; xuzhihong@caas.cn			National Natural Science Foundation of China [31801888, 31872134]; China Agriculture Research System [CARS-25]; Agricultural Science and Technology Innovation Program (ASTIP) [CAAS-ASTIP-2019-ZFRI]; Central Public-interest Scientific Institution Basal Research Fund [1610192019201]; Modern Agricultural Industry Technology of Henan province [S2014-11-G03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Agricultural Science and Technology Innovation Program (ASTIP); Central Public-interest Scientific Institution Basal Research Fund; Modern Agricultural Industry Technology of Henan province	This work was supported by grants from the National Natural Science Foundation of China (Grant Numbers 31801888 to PW and 31872134 to LL), the China Agriculture Research System (Grant No. CARS-25 to YX), the Agricultural Science and Technology Innovation Program (ASTIP) (Grant No. CAAS-ASTIP-2019-ZFRI to YX), the Central Public-interest Scientific Institution Basal Research Fund (Grant No. 1610192019201 to PW) and the Modern Agricultural Industry Technology of Henan province (Grant No. S2014-11-G03 to ZX).	Aarrouf J, 2008, J PHYTOPATHOL, V156, P338, DOI 10.1111/j.1439-0434.2007.01364.x; Aarts MGM, 1995, PLANT CELL, V7, P2115, DOI 10.1105/tpc.7.12.2115; Acharya K, 2013, MOL BIOTECHNOL, V54, P609, DOI 10.1007/s12033-012-9603-y; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Babadoost M., 2004, URBANA, DOI 10.1094/APSnetFeature-2004-0404; Buttner M, 1997, P NATL ACAD SCI USA, V94, P5961, DOI 10.1073/pnas.94.11.5961; Dempsey D'Maris Amick, 2011, Arabidopsis Book, V9, pe0156, DOI 10.1199/tab.0156; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Donahoo RS, 2013, HORTSCIENCE, V48, P164, DOI 10.21273/HORTSCI.48.2.164; Du HS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01173; Ewas M, 2017, SCI BULL, V62, P476, DOI 10.1016/j.scib.2017.03.018; Fagoaga C, 2001, MOL BREEDING, V7, P175, DOI 10.1023/A:1011358005054; Fernandez-Perez F, 2015, PLANT SCI, V239, P192, DOI 10.1016/j.plantsci.2015.08.001; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Hausbeck M, 2004, VEG GROW NEWS, V38, P28; Herrero ML, 2002, PLANT DIS, V86, DOI 10.1094/PDIS.2002.86.5.558A; Hu TZ, 2013, PLANT MOL BIOL REP, V31, P1141, DOI 10.1007/s11105-013-0581-4; Jain D., 2018, MOL ASPECTS PLANT PA, P265, DOI 10.1007/978-981-10-7371-7; Jetter R, 2006, ANNU PLANT REV, V23, P145; Jia QingLi, 2012, Journal of Agricultural Biotechnology, V20, P1126; Kim MinJeong, 2012, Korean Journal of Crop Science / Hanguk Jakmul Hakhoe Chi, V57, P389, DOI 10.7740/kjcs.2012.57.4.389; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mansfeld BN, 2017, HORTIC RES-ENGLAND, V4, DOI 10.1038/hortres.2017.22; Naveed ZA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123735; Pang ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056513; Pontes ND, 2014, TROP PLANT PATHOL, V39, P74, DOI 10.1590/S1982-56762014000100009; Portieles R, 2010, PLANT BIOTECHNOL J, V8, P678, DOI 10.1111/j.1467-7652.2010.00501.x; Prabhu K, 2011, TURK J BOT, V35, P663, DOI 10.3906/bot-1006-7; Prasannath K., 2017, AGRIEAST, V11, P38, DOI [10.4038/agrieast.v11i1.33, DOI 10.4038/AGRIEAST.V11I1.33]; Shah Sayed Rashad Ali, 2015, Horticultural Plant Journal, V1, P70, DOI 10.16420/j.issn.2095-9885.2015-0019; Shen DY, 2016, PLANT GROWTH REGUL, V80, P59, DOI 10.1007/s10725-016-0163-1; Sholberg PL, 2007, CAN J PLANT PATHOL, V29, P153, DOI 10.1080/07060660709507451; Singh A., 2018, Molecular aspects of plant-pathogen interaction, DOI 10.1007/978-981-10-7371-7; Tompkins CM, 1937, J AGRIC RES, V54, P0933; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Wamaitha MJ, 2012, RICE, V5, DOI 10.1186/1939-8433-5-35; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wei H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071669; Wu LM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00847; Zainal Z., 2009, American Journal of Plant Physiology, V4, P70, DOI 10.3923/ajpp.2009.70.79; Zhang HX, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010048; Zhang ZG, 2006, PLANT PATHOL, V55, P770, DOI 10.1111/j.1365-3059.2006.01442.x; Zhou JM, 1997, EMBO J, V16, P3207, DOI 10.1093/emboj/16.11.3207	47	11	11	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0227284	10.1371/journal.pone.0227284	http://dx.doi.org/10.1371/journal.pone.0227284			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32050262	gold, Green Published			2022-12-26	WOS:000535192300004
J	Dumas, K; Ayachi, C; Gilleron, J; Lacas-Gervais, S; Pastor, F; Favier, FB; Peraldi, P; Vaillant, N; Yvan-Charvet, L; Bonnafous, S; Patouraux, S; Anty, R; Tran, A; Gual, P; Cormont, M; Tanti, JF; Giorgetti-Peraldi, S				Dumas, Karine; Ayachi, Chaima; Gilleron, Jerome; Lacas-Gervais, Sandra; Pastor, Faustine; Favier, Francois B.; Peraldi, Pascal; Vaillant, Nathalie; Yvan-Charvet, Laurent; Bonnafous, Stephanie; Patouraux, Stephanie; Anty, Rodolphe; Tran, Albert; Gual, Philippe; Cormont, Mireille; Tanti, Jean-Francois; Giorgetti-Peraldi, Sophie			REDD1 deficiency protects against nonalcoholic hepatic steatosis induced by high-fat diet	FASEB JOURNAL			English	Article						autophagy; hepatic steatosis; obesity; REDD1	DNA-DAMAGE 1; INSULIN-RESISTANCE; SKELETAL-MUSCLE; ADIPOSE-TISSUE; MAMMALIAN TARGET; FEEDBACK-CONTROL; GENE-EXPRESSION; LIVER-DISEASE; OBESITY; MTORC1	Nonalcoholic fatty liver disease is a chronic liver disease which is associated with obesity and insulin resistance. We investigated the implication of REDD1 (Regulated in development and DNA damage response-1), a stress-induced protein in the development of hepatic steatosis. REDD1 expression was increased in the liver of obese mice and morbidly obese patients, and its expression correlated with hepatic steatosis and insulin resistance in obese patients. REDD1 deficiency protected mice from the development of hepatic steatosis induced by high-fat diet (HFD) without affecting body weight gain and glucose intolerance. This protection was associated with a decrease in the expression of lipogenic genes, SREBP1c, FASN, and SCD-1 in liver of HFD-fed REDD1-KO mice. Healthy mitochondria are crucial for the adequate control of lipid metabolism and failure to remove damaged mitochondria is correlated with liver steatosis. Expression of markers of autophagy and mitophagy, Beclin, LC3-II, Parkin, BNIP3L, was enhanced in liver of HFD-fed REDD1-KO mice. The number of mitochondria showing colocalization between LAMP2 and AIF was increased in liver of HFD-fed REDD1-KO mice. Moreover, mitochondria in liver of REDD1-KO mice were smaller than in WT. These results are correlated with an increase in PGC-1 alpha and CPT-1 expression, involved in fatty acid oxidation. In conclusion, loss of REDD1 protects mice from the development of hepatic steatosis.	[Dumas, Karine; Ayachi, Chaima; Gilleron, Jerome; Pastor, Faustine; Cormont, Mireille; Tanti, Jean-Francois; Giorgetti-Peraldi, Sophie] Univ Cote dAzur, INSERM, Nice, France; [Lacas-Gervais, Sandra] Univ Cote dAzur, Ctr Commun Microscopie Appliquee, CCMA, Nice, France; [Favier, Francois B.] Univ Montpellier, INRA, DMEM, Montpellier, France; [Peraldi, Pascal] Univ Cote dAzur, CNRS, INSERM, IBV, Nice, France; [Vaillant, Nathalie; Yvan-Charvet, Laurent] Univ Cote dAzur, INSERM, C3M Team Haematometabolism Dis, Nice, France; [Bonnafous, Stephanie; Patouraux, Stephanie; Anty, Rodolphe; Tran, Albert; Gual, Philippe] Univ Cote dAzur, Team Chron Liver Dis Associated Steatosis & Alcoh, INSERM, Nice, France; [Bonnafous, Stephanie; Patouraux, Stephanie; Anty, Rodolphe; Tran, Albert] Univ Cote dAzur, CHU, INSERM, C3M Team, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; INRAE; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Giorgetti-Peraldi, S (corresponding author), Univ Cote dAzur, INSERM, Nice, France.	Sophie.GIORGETTI-PERALDI@inserm.fr	Peraldi, Pascal/O-4592-2016; Gual, Philippe/P-9833-2019; Gilleron, Jerome/GRX-8574-2022	Peraldi, Pascal/0000-0003-0205-9252; Gual, Philippe/0000-0001-7393-8356; Gilleron, Jerome/0000-0002-6389-8685; Giorgetti-Peraldi, Sophie/0000-0002-2751-2618; CORMONT, Mireille/0000-0001-6918-2410; Tanti, Jean-Francois/0000-0003-1782-1318; Favier, Francois/0000-0002-9084-4797; Albert, TRAN/0000-0003-0003-5361; patouraux, stephanie/0000-0001-6004-7685; Yvan-Charvet, Laurent/0000-0002-7748-4942; Anty, Rodolphe/0000-0001-8194-9805	INSERM (France); French Government (National Research Agency, ANR) [ANR-15-CE14-0016-01, ANR-18-CE14-0019-02]; "Investments for the Future" LABEX SIGNALIFE [ANR-11-LABX-0028-01]; UCAJEDI Investments in the Future project [ANR-15-IDEX-01]; Societe Francophone du Diabete SFD/ Abbott; Universite Cote d'Azur; Region Provence-Alpes-Cote-d'Azur; Conseil General des Alpes Maritimes; Region Sud-ProvenceAlpes-Cote-d'Azur; GIS-IBiSA and Canceropole Provence-Alpes-Cote d'Azur	INSERM (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Government (National Research Agency, ANR)(French National Research Agency (ANR)); "Investments for the Future" LABEX SIGNALIFE; UCAJEDI Investments in the Future project; Societe Francophone du Diabete SFD/ Abbott; Universite Cote d'Azur; Region Provence-Alpes-Cote-d'Azur(Region Provence-Alpes-Cote d'Azur); Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur); Region Sud-ProvenceAlpes-Cote-d'Azur(Region Auvergne-Rhone-AlpesRegion Bourgogne-Franche-ComteRegion Hauts-de-FranceRegion Nouvelle-Aquitaine); GIS-IBiSA and Canceropole Provence-Alpes-Cote d'Azur	This work was supported by grants from INSERM (France), the French Government (National Research Agency, ANR): #ANR-15-CE14-0016-01, #ANR-18-CE14-0019-02 and through the "Investments for the Future" LABEX SIGNALIFE (#ANR-11-LABX-0028-01) and the UCAJEDI Investments in the Future project (#ANR-15-IDEX-01), Societe Francophone du Diabete SFD/ Abbott, Universite Cote d'Azur, Region Provence-Alpes-Cote-d'Azur, Conseil General des Alpes Maritimes and CCMA electron microscopy equipment have been funded by the Region Sud-ProvenceAlpes-Cote-d'Azur, the Conseil General des Alpes Maritimes, the GIS-IBiSA and Canceropole Provence-Alpes-Cote d'Azur	Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Alvarez-Garcia O, 2017, ARTHRITIS RHEUMATOL, V69, P1418, DOI 10.1002/art.40104; Anty R, 2006, AM J GASTROENTEROL, V101, P1824, DOI 10.1111/j.1572-0241.2006.00724.x; Arab JP, 2018, ANNU REV PATHOL-MECH, V13, P321, DOI 10.1146/annurev-pathol-020117-043617; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Bertola A, 2012, DIABETES, V61, P2238, DOI 10.2337/db11-1274; Britto FA, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0525-4; Chattopadhyay M, 2011, DIABETES, V60, P1483, DOI 10.2337/db10-0869; Cho SS, 2018, FREE RADICAL BIO MED, V124, P221, DOI 10.1016/j.freeradbiomed.2018.06.014; Choi SM, 2008, NUCLEIC ACIDS RES, V36, P6372, DOI 10.1093/nar/gkn620; Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111; Dennis MD, 2015, J BIOL CHEM, V290, P3865, DOI 10.1074/jbc.M114.623058; Dennis MD, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005103; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Dungan CM, 2014, BIOCHEM BIOPH RES CO, V453, P778, DOI 10.1016/j.bbrc.2014.10.032; Elam MB, 2009, OBESITY, V17, P1563, DOI 10.1038/oby.2009.49; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Gelmetti V, 2017, AUTOPHAGY, V13, P654, DOI 10.1080/15548627.2016.1277309; Gordon BS, 2016, AM J PHYSIOL-ENDOC M, V311, pE157, DOI 10.1152/ajpendo.00059.2016; Horak P, 2010, P NATL ACAD SCI USA, V107, P4675, DOI 10.1073/pnas.0907705107; Hu MY, 2017, BIOCHIMIE, V143, P37, DOI 10.1016/j.biochi.2017.10.019; Hulmi JJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE307, DOI 10.1152/ajpendo.00398.2011; Jin HO, 2009, FREE RADICAL BIO MED, V46, P1158, DOI 10.1016/j.freeradbiomed.2009.01.015; Kenerson HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117000; Kenerson HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018075; Kimball SR, 2012, BIOCHEM BIOPH RES CO, V427, P485, DOI 10.1016/j.bbrc.2012.09.074; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kleinert M, 2018, NAT REV ENDOCRINOL, V14, P140, DOI 10.1038/nrendo.2017.161; Lafarge JC, 2014, DIABETOLOGIA, V57, P1674, DOI 10.1007/s00125-014-3280-2; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Lebeaupin C, 2018, J HEPATOL, V69, P927, DOI 10.1016/j.jhep.2018.06.008; Lipina C, 2016, TRENDS ENDOCRIN MET, V27, P868, DOI 10.1016/j.tem.2016.08.005; MCGARRY JD, 1995, BIOCHEM SOC T, V23, P321, DOI 10.1042/bst0230321; Montagner A, 2016, GUT, V65, P1202, DOI 10.1136/gutjnl-2015-310798; Nassir Fatiha, 2015, Gastroenterol Hepatol (N Y), V11, P167; Nassir F, 2014, INT J MOL SCI, V15, P8713, DOI 10.3390/ijms15058713; Neuman MG, 2014, EXP MOL PATHOL, V97, P492, DOI 10.1016/j.yexmp.2014.09.005; Pastor F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07182-z; Patouraux S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.174; Patouraux S, 2017, J HEPATOL, V67, P328, DOI 10.1016/j.jhep.2017.03.003; Patouraux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035612; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Qiao SX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8014; Rabanal-Ruiz Y, 2017, ESSAYS BIOCHEM, V61, P565, DOI 10.1042/EBC20170027; Regazzetti C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052154; Regazzetti C, 2010, J BIOL CHEM, V285, P5157, DOI 10.1074/jbc.M109.047688; Rieusset J, 2017, BBA-MOL CELL RES, V1864, P865, DOI 10.1016/j.bbamcr.2017.01.001; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Scheen AJ, 2002, BEST PRACT RES CL EN, V16, P703, DOI 10.1053/beem.2002.0225; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schupp M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-758; Schuster S, 2018, NAT REV GASTRO HEPAT, V15, P349, DOI 10.1038/s41575-018-0009-6; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Umemura A, 2014, CELL METAB, V20, P133, DOI 10.1016/j.cmet.2014.05.001; Vadysirisack DD, 2011, MOL CELL BIOL, V31, P4356, DOI 10.1128/MCB.05541-11; Wakabayashi T, 2002, J CELL MOL MED, V6, P497, DOI 10.1111/j.1582-4934.2002.tb00452.x; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079; Williamson DL, 2015, AM J PHYSIOL-REG I, V309, pR855, DOI 10.1152/ajpregu.00285.2015; Williamson DL, 2014, J APPL PHYSIOL, V117, P246, DOI 10.1152/japplphysiol.01350.2013; Wolff NC, 2011, MOL CELL BIOL, V31, P1870, DOI 10.1128/MCB.01393-10; Xu MC, 2013, MOL MED REP, V8, P147, DOI 10.3892/mmr.2013.1468; Yamada T, 2018, CELL METAB, V28, P588, DOI 10.1016/j.cmet.2018.06.014; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zeng QH, 2018, CLIN CANCER RES, V24, P445, DOI 10.1158/1078-0432.CCR-17-0419	73	11	13	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5046	5060		10.1096/fj.201901799RR	http://dx.doi.org/10.1096/fj.201901799RR		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32043636	Green Submitted			2022-12-26	WOS:000512671100001
J	Legouhy, A; Commowick, O; Proisy, M; Rousseau, F; Barillot, C				Legouhy, Antoine; Commowick, Olivier; Proisy, Maia; Rousseau, Francois; Barillot, Christian			Regional brain development analysis through registration using anisotropic similarity, a constrained affine transformation	PLOS ONE			English	Article							VOLUMETRIC QUANTIFICATION; CORTICAL THICKNESS; BICAUDATE RATIO; SEX-DIFFERENCES; TEMPORAL-LOBE; SURFACE-AREA; SEGMENTATION; CHILDREN; MRI; SELECTION	We propose a novel method to quantify brain growth in 3 arbitrary orthogonal directions of the brain or its sub-regions through linear registration. This is achieved by introducing a 9 degrees of freedom (dof) transformation called anisotropic similarity which is an affine transformation with constrained scaling directions along arbitrarily chosen orthogonal vectors. This gives the opportunity to extract scaling factors describing brain growth along those directions by registering a database of subjects onto a common reference. This information about directional growth brings insights that are not usually available in longitudinal volumetric analysis. The interest of this method is illustrated by studying the anisotropic regional and global brain development of 308 healthy subjects betwen 0 and 19 years old. A gender comparison of those scaling factors is also performed for four age-intervals. We demonstrate through these applications the stability of the method to the chosen reference and its ability to highlight growth differences accros regions and gender.	[Legouhy, Antoine; Commowick, Olivier; Proisy, Maia; Barillot, Christian] Univ Rennes, Empenn ERL U 1228, IRISA UMR 6074, INSERM,INRIA,CNRS, Rennes, France; [Proisy, Maia] CHU Rennes, Radiol Dept, Rennes, France; [Rousseau, Francois] IMT Atlantique, LaTIM U1101, INSERM, UBL, Brest, France	Centre National de la Recherche Scientifique (CNRS); Inria; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; IMT - Institut Mines-Telecom; IMT Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale	Legouhy, A (corresponding author), Univ Rennes, Empenn ERL U 1228, IRISA UMR 6074, INSERM,INRIA,CNRS, Rennes, France.	antoine.legouhy@irisa.fr	; Rousseau, Francois/B-3338-2008	Legouhy, Antoine/0000-0001-9219-3900; Rousseau, Francois/0000-0001-9837-7487; Commowick, Olivier/0000-0001-7345-6752	ANR MAIA project of the French National Research Agency [ANR-15-CE23-0009]; La Region Bretagne	ANR MAIA project of the French National Research Agency(French National Research Agency (ANR)); La Region Bretagne(Region Bretagne)	The research leading to these results has been supported by the ANR MAIA project, grant ANR-15-CE23-0009 of the French National Research Agency (http://recherche.imt-atlantique.fr/maia) and La Re ' gion Bretagne.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aljabar P, 2009, NEUROIMAGE, V46, P726, DOI 10.1016/j.neuroimage.2009.02.018; Arsigny V, 2006, LOG EUCLIDEAN FRAMEW, P924, DOI 10.1007/11866565_113; Auzias G, 2015, I S BIOMED IMAGING, P1260, DOI 10.1109/ISBI.2015.7164103; AYLWARD EH, 1991, AM J NEURORADIOL, V12, P1217; Ball WS, 2012, CEREB CORTEX, V22, P1, DOI 10.1093/cercor/bhr018; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bermel RA, 2002, ARCH NEUROL-CHICAGO, V59, P275, DOI 10.1001/archneur.59.2.275; Bossa M, 2007, LECT NOTES COMPUT SC, V4791, P667; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Choe MS, 2013, CEREB CORTEX, V23, P2100, DOI 10.1093/cercor/bhs197; Coffey CE, 1998, ARCH NEUROL-CHICAGO, V55, P169, DOI 10.1001/archneur.55.2.169; Collett BR, 2012, CHILD NERV SYST, V28, P1083, DOI 10.1007/s00381-012-1731-y; Commowick O, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P700, DOI 10.1109/ISBI.2012.6235644; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Dubois J, 2019, NEUROIMAGE, V185, P934, DOI 10.1016/j.neuroimage.2018.03.005; Durazzo TC, 2011, ALCOHOL CLIN EXP RES, V35, P1187, DOI 10.1111/j.1530-0277.2011.01452.x; Frisoni GB, 2010, CLIN USE STRUCTURAL; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giorgio A, 2013, J MAGN RESON IMAGING, V37, P1, DOI 10.1002/jmri.23671; Gousias I. S., 2010, 2010 IEEE International Conference on Imaging Systems and Techniques (IST 2010), P290, DOI 10.1109/IST.2010.5548493; Gousias IS, 2008, NEUROIMAGE, V40, P672, DOI 10.1016/j.neuroimage.2007.11.034; Gousias IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059990; Gousias IS, 2012, NEUROIMAGE, V62, P1499, DOI 10.1016/j.neuroimage.2012.05.083; Guimond A, 2000, COMPUT VIS IMAGE UND, V77, P192, DOI 10.1006/cviu.1999.0815; HAMANO K, 1990, NEURORADIOLOGY, V32, P300, DOI 10.1007/BF00593049; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Huppi PS, 1998, ANN NEUROL, V43, P224, DOI 10.1002/ana.410430213; Iwasaki N, 1997, NEURORADIOLOGY, V39, P841, DOI 10.1007/s002340050517; Kim SH, 2016, NEUROIMAGE, V135, P163, DOI 10.1016/j.neuroimage.2016.04.053; Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008; Kuklisova-Murgasova M, 2011, NEUROIMAGE, V54, P2750, DOI 10.1016/j.neuroimage.2010.10.019; LANE TP, 1994, AM STAT, V48, P315, DOI 10.2307/2684843; Lefevre J, 2016, CEREB CORTEX, V26, P3023, DOI 10.1093/cercor/bhv123; Legouhy A, 2019, I S BIOMED IMAGING, P1038, DOI 10.1109/ISBI.2019.8759508; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Makropoulos A, 2016, NEUROIMAGE, V125, P456, DOI 10.1016/j.neuroimage.2015.10.047; Matsumae M, 1996, J NEUROSURG, V84, P982, DOI 10.3171/jns.1996.84.6.0982; Murphy DGM, 1996, ARCH GEN PSYCHIAT, V53, P585; Novak K, 2002, J NEUROSURG, V96, P464, DOI 10.3171/jns.2002.96.3.0464; Ourselin S., 2000, BLOCK MATCHING GEN F, P557, DOI [DOI 10.1002/jmri.23532, DOI 10.1007/978-3-540-40899-4_57]; Pennec X., 1996, ECOLE POLYTECHNIQUE, VX; Peterson M, 2018, J NEUROSURG-PEDIATR, V21, P1; Pfefferbaum A, 1994, QUANTITATIVE MAGNETI; Prima S, 2002, IEEE T MED IMAGING, V21, P122, DOI 10.1109/42.993131; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Seber G., 1989, NONLINEAR REGRESSION; Spiess Andrej-Nikolai, 2010, BMC Pharmacology, V10, P6, DOI 10.1186/1471-2210-10-6; Sylvie NTT, 2011, ARCH PEDIAT ADOL MED, V165, P216, DOI 10.1001/archpediatrics.2011.9; Tosun D, 2015, BJPSYCH OPEN, V1, P129, DOI 10.1192/bjpo.bp.115.001719; Utsunomiya H, 1999, AM J NEURORADIOL, V20, P717; Vercauteren T, 2008, LECT NOTES COMPUT SC, V5241, P754, DOI 10.1007/978-3-540-85988-8_90; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wells W M 3rd, 1996, Med Image Anal, V1, P35; Winkler AM, 2012, NEUROIMAGE, V61, P1428, DOI 10.1016/j.neuroimage.2012.03.026	58	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0214174	10.1371/journal.pone.0214174	http://dx.doi.org/10.1371/journal.pone.0214174			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092061	Green Submitted, Green Published, gold			2022-12-26	WOS:000535229300001
J	Berruyer, C; Porcier, SM; Tafforeau, P				Berruyer, Camille; Porcier, Stephanie M.; Tafforeau, Paul			Synchrotron "virtual archaeozoology" reveals how Ancient Egyptians prepared a decaying crocodile cadaver for mummification	PLOS ONE			English	Article							CUT-MARKS; SPECTROSCOPY	Although Ancient Egyptians mummified millions of animals over the course of one millennium, many details of these mummification protocols remain unknown. Multi-scale propagation phase-contrast X-ray synchrotron microtomography was used to visualise an ancient Egyptian crocodile mummy housed at the Musee des Confluences (Lyon, France). This state-of-the-art non-destructive imaging technique revealed the complete interior anatomy of the mummy in three dimensions. Here, we present detailed insight into the complex postmortem treatment of a decaying crocodile cadaver in preparation for mummification. Except for the head and the extremities of the limbs, everything beneath the skin of the crocodile (i.e. organs, muscles, and even most of the skeleton) was removed to cease further putrefaction. This unexpected finding demonstrates that earlier knowledge obtained from textual and other archaeological sources does not sufficiently reflect the diversity of mummification protocols implemented by Ancient Egyptians.	[Berruyer, Camille; Tafforeau, Paul] European Synchrotron Radiat Facil, Grenoble, France; [Berruyer, Camille] Maison Orient & Mediterranee Jean Pouilloux, ArcheOrient UMR 5133, Lyon, France; [Porcier, Stephanie M.] Univ Paul Valery Montpellier 3, LabEx ARCHIMEDE, Lab CNRS Archeol Soc Mediterraneennes UMR 5140, Montpellier, France; [Porcier, Stephanie M.] Maison Orient & Mediterranee Jean Pouilloux, Lab CNRS HiSoMa UMR 5189, Lyon, France	European Synchrotron Radiation Facility (ESRF); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite Paul-Valery	Berruyer, C (corresponding author), European Synchrotron Radiat Facil, Grenoble, France.; Berruyer, C (corresponding author), Maison Orient & Mediterranee Jean Pouilloux, ArcheOrient UMR 5133, Lyon, France.	camille.berruyer@esrf.fr		Tafforeau, Paul/0000-0002-5962-1683; Berruyer, Camille/0000-0002-0046-2972	Agence Nationale de la Recherche through the "Investissement d'Avenir" program [ESRF-CFR-423, ANR-11-LABX-0032-01]	Agence Nationale de la Recherche through the "Investissement d'Avenir" program(French National Research Agency (ANR))	This research was carried out within the framework of the ESRF (ESRF-CFR-423), and the MAHES Project (Momies Animales et Humaines EgyptienneS) supported by the Agence Nationale de la Recherche through the "Investissement d'Avenir" program ANR-11-LABX-0032-01 LabEx ARCHIMEDE.	Abdel-Maksoud G, 2011, MEDITERR ARCHAEOL AR, V11, P129; Atherton-Woolham S., 2014, CURRENT RES EGYPTOLO, P181; Atherton-Woolham Stephanie D., 2014, Papers on Anthropology University of Tartu, V23, P9; Bondetti M, 2016, CREATURES EARTH WATE; Boschin F, 2012, INT J OSTEOARCHAEOL, V22, P549, DOI 10.1002/oa.1272; Bouchaud C., 2012, WOOD CHARCOAL EVIDEN, P173; Cau A, 2017, NATURE, V552, P395, DOI 10.1038/nature24679; DeGeer C., 1774, MEMOIRES SERVIR HIST, V4; Edwards HGM, 2007, ANAL BIOANAL CHEM, V388, P683, DOI 10.1007/s00216-007-1249-4; Gaillard C., 1912, ARCH MUSEUM HIST NAT, V11, P3; Gaugne R, 2018, P 3 INT C DIG HER NE, P1; Greenfield HJ, 1999, J ARCHAEOL SCI, V26, P797, DOI 10.1006/jasc.1998.0348; Ikram S., 2015, DIVINE CREATURE ANIM; Ikram S., 2010, UCLA ENCY EGYPTOL; Ikram S., 2005, ARCHAEOZOOLOGY NEAR, P240; Ikram S., 2015, EGYPTOLOGY PRESENT E, DOI [10.2307/j.ctvvnbgg, DOI 10.2307/J.CTVVNBGG]; Ikram S, 2017, OXFORD HDB ZOOARCHAE, P452; Ikram Salima, 2015, APPRIVOISER SAUVAGE, P211; Kessler D., 2015, DIVINE CREATURES ANI, P120; Klenner S, 2016, J ANAT, V228, P113, DOI 10.1111/joa.12404; Lewis JE, 2008, J ARCHAEOL SCI, V35, P2001, DOI 10.1016/j.jas.2008.01.016; Lortet L, 1905, ARCH MUSEUM HIST NAT; Lortet L, 1909, ARCH MUSEUM HIST NAT; McKnight LM, 2015, RADIOGRAPHICS, V35, P2109, DOI 10.1148/rg.2015140309; Menager M, 2014, MICROCHEM J, V114, P32, DOI 10.1016/j.microc.2013.11.018; Mirone A, 2014, NUCL INSTRUM METH B, V324, P41, DOI 10.1016/j.nimb.2013.09.030; Nicholson PT, 2015, ANTIQUITY, V89, P645, DOI 10.15184/aqy.2014.53; Nicolotti M, 1994, B CERCLE LYONNAIS EG, V8, P35; Nicolotti Muriel, 1994, Nouvelles Archives du Museum d'Histoire Naturelle de Lyon, V32, P4; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Porcier SM, 2019, J ARCHAEOL SCI, V110, DOI 10.1016/j.jas.2019.105009; Richardin P, 2017, RADIOCARBON, V59, P595, DOI 10.1017/RDC.2016.102; Schroeder H, 2002, FORENSIC SCI INT, V127, P231, DOI 10.1016/S0379-0738(02)00131-7; SHAKER NA, 2015, INT J ANAT RES, V3, P1331, DOI DOI 10.16965/IJAR.2015.206	34	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229140	10.1371/journal.pone.0229140	http://dx.doi.org/10.1371/journal.pone.0229140			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8DJ	32084197	Green Published, gold			2022-12-26	WOS:000535227900059
J	Finoshin, AD; Adameyko, KI; Mikhailov, KV; Kravchuk, OI; Georgiev, AA; Gornostaev, NG; Kosevich, IA; Mikhailov, VS; Gazizova, GR; Shagimardanova, EI; Gusev, OA; Lyupina, YV				Finoshin, Alexander D.; Adameyko, Kim, I; Mikhailov, Kirill, V; Kravchuk, Oksana, I; Georgiev, Anton A.; Gornostaev, Nicolay G.; Kosevich, Igor A.; Mikhailov, Victor S.; Gazizova, Guzel R.; Shagimardanova, Elena, I; Gusev, Oleg A.; Lyupina, Yulia, V			Iron metabolic pathways in the processes of sponge plasticity	PLOS ONE			English	Article							NITRIC-OXIDE; PHOTODYNAMIC THERAPY; HYDROGEN-SULFIDE; CANCER CELLS; EVOLUTION; IDENTIFICATION; TRANSPORTER; HOMEOSTASIS; EXPRESSION; ORIGIN	The ability to regulate oxygen consumption evolved in ancestral animals and is intrinsically linked to iron metabolism. The iron pathways have been intensively studied in mammals, whereas data on distant invertebrates are limited. Sea sponges represent the oldest animal phylum and have unique structural plasticity and capacity to reaggregate after complete dissociation. We studied iron metabolic factors and their expression during reaggregation in the White Sea cold-water sponges Halichondria panicea and Halisarca dujardini. De novo transcriptomes were assembled using RNA-Seq data, and evolutionary trends were analyzed with bioinformatic tools. Differential expression during reaggregation was studied for H. dujardini. Enzymes of the heme biosynthesis pathway and transport globins, neuroglobin (NGB) and androglobin (ADGB), were identified in sponges. The globins mutate at higher evolutionary rates than the heme synthesis enzymes. Highly conserved iron-regulatory protein 1 (IRP1) presumably interacts with the iron-responsive elements (IREs) found in mRNAs of ferritin (FTH1) and a putative transferrin receptor NAALAD2. The reaggregation process is accompanied by increased expression of IRP1, the antiapoptotic factor BCL2, the inflammation factor NF kappa B (p65), FTH1 and NGB, as well as by an increase in mitochondrial density. Our data indicate a complex mechanism of iron regulation in sponge structural plasticity and help to better understand general mechanisms of morphogenetic processes in multicellular species.	[Finoshin, Alexander D.; Adameyko, Kim, I; Kravchuk, Oksana, I; Gornostaev, Nicolay G.; Mikhailov, Victor S.; Lyupina, Yulia, V] Russian Acad Sci, NK Koltzov Inst Dev Biol, Moscow, Russia; [Mikhailov, Kirill, V] Lomonosov Moscow State Univ, AN Belozersky Inst Phys & Chem Biol, Moscow, Russia; [Mikhailov, Kirill, V] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia; [Georgiev, Anton A.; Kosevich, Igor A.] Lomonosov Moscow State Univ, Moscow, Russia; [Gazizova, Guzel R.; Shagimardanova, Elena, I; Gusev, Oleg A.] Kazan Fed Univ, Kazan, Russia; [Gusev, Oleg A.] RIKEN Natl Sci Inst, KFU RIKEN Translat Genom Unit, Yokohama, Kanagawa, Japan	Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; Lomonosov Moscow State University; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Lomonosov Moscow State University; Kazan Federal University	Lyupina, YV (corresponding author), Russian Acad Sci, NK Koltzov Inst Dev Biol, Moscow, Russia.	yulial@bk.ru	Adameyko, Kim/AAH-3736-2019; Shagimardanova, Elena I/H-3699-2012; Gazizova, Guzel/L-6015-2015; Gornostaev, Nikolay/E-6135-2014; Lyupina, Yulia V/B-8365-2014; Kosevich, Igor/K-3369-2015; Kravchuk, Oksana/B-9624-2014; Финошин, Александр/AAM-9346-2020; Gusev, Oleg/D-9383-2011	Adameyko, Kim/0000-0002-5429-3051; Shagimardanova, Elena I/0000-0003-2339-261X; Gazizova, Guzel/0000-0003-4978-8495; Lyupina, Yulia V/0000-0002-9903-3544; Kosevich, Igor/0000-0001-8604-2161; Kravchuk, Oksana/0000-0002-8363-6666; Финошин, Александр/0000-0003-3268-4913; Gusev, Oleg/0000-0002-6203-9758; Mikhailov, Victor/0000-0002-3324-8921; Mikhailov, Kirill/0000-0002-0457-9625; Gornostaev, Nikolay/0000-0002-5331-6709	Russian Foundation for Basic Research [19-34-90019, 19-34-50002]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	EIS, 19-34-50002, Russian Foundation for Basic Research, https://www.rfbr.ru/rffi/eng, no YVL, 19-34-90019, Russian Foundation for Basic Research, https://www.rfbr.ru/rffi/eng, no.	Adebali O, 2015, BIOINFORMATICS, V31, P1475, DOI 10.1093/bioinformatics/btu836; Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Arosio P, 2002, FREE RADICAL BIO MED, V33, P457, DOI 10.1016/S0891-5849(02)00842-0; Ascenzi P, 2016, MOL ASPECTS MED, V52, P1, DOI 10.1016/j.mam.2016.10.004; Bacellar IOL, 2015, INT J MOL SCI, V16, P20523, DOI 10.3390/ijms160920523; Binet M, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0821-8; Blank M, 2012, MOL BIOL EVOL, V29, P3553, DOI 10.1093/molbev/mss164; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boswell-Casteel RC, 2018, AAPS J, V20, DOI 10.1208/s12248-017-0165-6; Bryant DM, 2017, CELL REP, V18, P762, DOI 10.1016/j.celrep.2016.12.063; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Burmester T, 2014, ACTA PHYSIOL, V211, P501, DOI 10.1111/apha.12312; Campillos M, 2010, NUCLEIC ACIDS RES, V38, pW360, DOI 10.1093/nar/gkq371; Camprubi E, 2017, IUBMB LIFE, V69, P373, DOI 10.1002/iub.1632; Cavalier-Smith T, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2015.0476; Cenci U, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0664-6; Corti P, 2016, P NATL ACAD SCI USA, V113, P8538, DOI 10.1073/pnas.1522670113; Davidson NM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0410-6; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Ereskovsky AV, 2013, DEV GENES EVOL, V223, P5, DOI 10.1007/s00427-012-0399-3; Ereskovsky AV, 2000, BIOL BULL, V198, P77, DOI 10.2307/1542805; Exertier C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41780-3; Fahey JM, 2017, NITRIC OXIDE-BIOL CH, V62, P52, DOI 10.1016/j.niox.2016.12.003; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Ganz T, 2018, INT J HEMATOL, V107, P7, DOI 10.1007/s12185-017-2366-2; Garrick MD, 2003, BIOMETALS, V16, P41, DOI 10.1023/A:1020702213099; Gernert C, 2005, MICROB ECOL, V50, P206, DOI 10.1007/s00248-004-0172-x; Girotti AW, 2016, CANCERS, V8, DOI 10.3390/cancers8100096; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graham AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179545; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Guimaraes BG, 2014, ACTA CRYSTALLOGR D, V70, P1005, DOI 10.1107/S1399004714000078; Hagiya Y, 2012, PHOTODIAGN PHOTODYN, V9, P204, DOI 10.1016/j.pdpdt.2011.12.004; Hinchliff CE, 2015, P NATL ACAD SCI USA, V112, P12764, DOI 10.1073/pnas.1423041112; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Ilbert M, 2013, BBA-BIOENERGETICS, V1827, P161, DOI 10.1016/j.bbabio.2012.10.001; Jiang HN, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00191; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; KENNEDY JC, 1990, J PHOTOCH PHOTOBIO B, V6, P143, DOI 10.1016/1011-1344(90)85083-9; Kitajima Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44981-y; Krammer B, 2012, CURR MED CHEM, V19, P793, DOI 10.2174/092986712799034842; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Kumar S, 2012, INT J BIOCHEM CELL B, V44, P189, DOI 10.1016/j.biocel.2011.10.016; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lambert LA, 2007, J MOL EVOL, V64, P113, DOI 10.1007/s00239-006-0137-4; Lavrov AI, 2014, RUSS J DEV BIOL+, V45, P205, DOI 10.1134/S1062360414040067; Lavrov AI, 2018, J EXP ZOOL PART B, V330, P351, DOI [10.1002/jez.b.22830, 10.1002/jezb.22830]; Le Pennec G, 2003, J BIOTECHNOL, V100, P93, DOI 10.1016/S0168-1656(02)00259-6; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lochert C, 2007, VANET'07: PROCEEDINGS OF THE FOURTH ACM INTERNATIONAL WORKSHOP ON VEHICULAR AD HOC NETWORKS, P1; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; MATTHEWS EK, 1989, FEBS LETT, V256, P29, DOI 10.1016/0014-5793(89)81711-9; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Meram AT, 2018, ANTICANCER RES, V38, P3843, DOI 10.21873/anticanres.12668; Michonneau F, 2016, METHODS ECOL EVOL, V7, P1476, DOI 10.1111/2041-210X.12593; Mills DB, 2018, ELIFE, V7, DOI 10.7554/eLife.31176; Mirdita M, 2017, NUCLEIC ACIDS RES, V45, pD170, DOI 10.1093/nar/gkw1081; Mittler R, 2019, ANTIOXID REDOX SIGN, V30, P1083, DOI 10.1089/ars.2018.7502; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; Pisani D, 2015, P NATL ACAD SCI USA, V112, P15402, DOI 10.1073/pnas.1518127112; Puig S, 2017, METALLOMICS, V9, P1483, DOI 10.1039/c7mt00116a; Rapozzi V, 2011, LASER SURG MED, V43, P575, DOI 10.1002/lsm.21095; Raza H, 2011, FEBS J, V278, P4243, DOI 10.1111/j.1742-4658.2011.08358.x; Reeves KJ, 2010, J PHOTOCH PHOTOBIO B, V101, P224, DOI 10.1016/j.jphotobiol.2010.07.007; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roesner A, 2005, MOL BIOL EVOL, V22, P12, DOI 10.1093/molbev/msh258; Rosin FCP, 2018, J CELL BIOCHEM, V119, P3554, DOI 10.1002/jcb.26541; Schroder HC, 2006, APPL ENVIRON MICROB, V72, P4907, DOI 10.1128/AEM.00228-06; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Shawki A, 2015, AM J PHYSIOL-GASTR L, V309, pG635, DOI 10.1152/ajpgi.00160.2015; Sheokand N, 2013, BBA-GEN SUBJECTS, V1830, P3816, DOI 10.1016/j.bbagen.2013.03.019; Shipp LE, 2012, DEV DYNAM, V241, P1111, DOI 10.1002/dvdy.23786; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith-Unna R, 2016, GENOME RES; Sogabe S, 2019, NATURE, V570, P519, DOI 10.1038/s41586-019-1290-4; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; Song L, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0089-y; Strelow J., 2012, J EXP THER ONCOL; Tang XN, 2013, IUBMB LIFE, V65, P863, DOI 10.1002/iub.1211; Tatzel M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00586-5; Vazquez-Limon C, 2012, PLANT SCI, V191, P71, DOI 10.1016/j.plantsci.2012.04.013; Vinogradov SN, 2013, BBA-PROTEINS PROTEOM, V1834, P1789, DOI 10.1016/j.bbapap.2013.03.021; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Waterhouse RM, 2018, MOL BIOL EVOL, V35, P543, DOI 10.1093/molbev/msx319; Weber RE, 2001, PHYSIOL REV, V81, P569, DOI 10.1152/physrev.2001.81.2.569; Weir EK, 2005, NEW ENGL J MED, V353, P2042, DOI 10.1056/NEJMra050002; Yu Y, 2007, CELL CYCLE, V6, P1982, DOI 10.4161/cc.6.16.4603; Zhang CG, 2014, PROTEIN CELL, V5, P750, DOI 10.1007/s13238-014-0083-7	95	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0228722	10.1371/journal.pone.0228722	http://dx.doi.org/10.1371/journal.pone.0228722			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084159	Green Submitted, Green Published, gold			2022-12-26	WOS:000535227900025
J	Mahendran, R; Pathirana, S; Piyatilake, ITS; Perera, SSN; Weerasinghe, MC				Mahendran, Rahini; Pathirana, Sisira; Piyatilake, Ilangamage Thilini Sashika; Perera, Shyam Sanjeewa Nishantha; Weerasinghe, Manuj Chrishantha			Assessment of environmental variability on malaria transmission in a malaria-endemic rural dry zone locality of Sri Lanka: The wavelet approach	PLOS ONE			English	Article							TIME-SERIES; RAINFALL; IMPACT; RISK	Malaria is a global public health concern and its dynamic transmission is still a complex process. Malaria transmission largely depends on various factors, including demography, geography, vector dynamics, parasite reservoir, and climate. The dynamic behaviour of malaria transmission has been explained using various statistical and mathematical methods. Of them, wavelet analysis is a powerful mathematical technique used in analysing rapidly changing time-series to understand disease processes in a more holistic way. The current study is aimed at identifying the pattern of malaria transmission and its variability with environmental factors in Kataragama, a malaria-endemic dry zone locality of Sri Lanka, using a wavelet approach. Monthly environmental data including total rainfall and mean water flow of the "Menik Ganga" river; mean temperature, mean minimum and maximum temperatures and mean relative humidity; and malaria cases in the Kataragama Medical Officer of Health (MOH) area were obtained from the Department of Irrigation, Department of Meteorology and Malaria Research Unit (MRU) of University of Colombo, respectively, for the period 1990 to 2005. Wavelet theory was applied to analyze these monthly time series data. There were two significant periodicities in malaria cases during the period of 1992-1995 and 1999-2000. The cross-wavelet power spectrums revealed an anti-phase correlation of malaria cases with mean temperature, minimum temperature, and water flow of "Menik Ganga" river during the period 1991-1995, while the in-phase correlation with rainfall is noticeable only during 1991-1992. Relative humidity was similarly associated with malaria cases between 1991-1992. It appears that environmental variables have contributed to a higher incidence of malaria cases in Kataragama in different time periods between 1990 and 2005.	[Mahendran, Rahini] Univ Colombo, Fac Med, Colombo, Sri Lanka; [Pathirana, Sisira] Univ Colombo, Fac Med, Dept Parasitol, Malaria Res Unit, Colombo, Sri Lanka; [Piyatilake, Ilangamage Thilini Sashika] Univ Moratuwa, Fac Informat Technol, Dept Computat Math, Moratuwa, Sri Lanka; [Perera, Shyam Sanjeewa Nishantha] Univ Colombo, Fac Sci, Res & Dev Ctr Math Modeling, Colombo, Sri Lanka; [Weerasinghe, Manuj Chrishantha] Univ Colombo, Fac Med, Dept Community Med, Colombo, Sri Lanka; [Mahendran, Rahini] Univ Peradeniya, Fac Dent Sci, Smile Train Cleft Ctr, Peradeniya, Sri Lanka; [Pathirana, Sisira] Univ Colombo, Inst Biochem Mol Biol & Biotechnol, Colombo, Sri Lanka	University of Colombo; University of Colombo; University Moratuwa; University of Colombo; University of Colombo; University of Peradeniya; University of Colombo	Mahendran, R (corresponding author), Univ Colombo, Fac Med, Colombo, Sri Lanka.; Pathirana, S (corresponding author), Univ Colombo, Fac Med, Dept Parasitol, Malaria Res Unit, Colombo, Sri Lanka.; Weerasinghe, MC (corresponding author), Univ Colombo, Fac Med, Dept Community Med, Colombo, Sri Lanka.; Mahendran, R (corresponding author), Univ Peradeniya, Fac Dent Sci, Smile Train Cleft Ctr, Peradeniya, Sri Lanka.; Pathirana, S (corresponding author), Univ Colombo, Inst Biochem Mol Biol & Biotechnol, Colombo, Sri Lanka.	rahini.mahen15@gmail.com; sisira@ibmbb.cmb.ac.lk; manuj@commed.cmb.ac.lk	Mahendran, Rahini/AAP-9382-2021	Mahendran, Rahini/0000-0001-9216-2071	World Bank;  [HETC / QIG / W3 / Medicine - TOR 7]	World Bank(The World Bank India); 	Sisira Pathirana (SP) was funded by the World Bank, (HETC-QIG-W3 project, Faculty of Medicine, University of Colombo, Sri Lanka) for the field work. The grant number is HETC / QIG / W3 / Medicine - TOR 7. The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyasinghe RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043162; Abiodun Gbenga J, 2018, Open Infect Dis J, V10, P88, DOI 10.2174/1874279301810010088; Anokye R, 2018, COGENT SOC SCI, V4, DOI 10.1080/23311886.2018.1461544; Anti-Malaria Campaign Sri Lanka, 2014, NAT MAL STRAT PLAN E; Anwar MY, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1602-1; Briet OJT, 2008, GEOSPATIAL HEALTH, V2, P183, DOI 10.4081/gh.2008.242; BROWN PJ, 1986, SOC SCI MED, V22, P847, DOI 10.1016/0277-9536(86)90239-X; Cazelles B, 2005, PLOS MED, V2, P313, DOI 10.1371/journal.pmed.0020106; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Cazelles B, 2007, J R SOC INTERFACE, V4, P625, DOI 10.1098/rsif.2007.0212; Chirebvu E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0139843; Chui CK, 1992, WAVELETS ANAL ITS AP; Conraria LA, 2011, NIPE WORKING PAPERS; Coulibaly D, 2017, AM J TROP MED HYG, V97, P1761, DOI 10.4269/ajtmh.17-0074; DAS NG, 2015, INFECT ECOL EPIDEMIO, V5, DOI DOI 10.3402/IEE.V525442; Fernando D, 2006, AM J TROP MED HYG, V74, P386, DOI 10.4269/ajtmh.2006.74.386; Fernando P., 2014, J COLL COMMUNITY PHY, V19, P27, DOI DOI 10.4038/JCCPSL.V19I1.7624; GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P77, DOI 10.4269/ajtmh.1991.45.77; Gunawardena DM, 1998, AM J TROP MED HYG, V58, P533, DOI 10.4269/ajtmh.1998.58.533; Guo Cui, 2015, Malar J, V14, P116, DOI 10.1186/s12936-015-0630-6; Karunaweera ND, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-59; Konradsen F, 2004, ACTA TROP, V89, P99, DOI 10.1016/j.actatropica.2003.09.013; Konradsen F, 2000, MALARIA SRI LANKA CU; Koutou O, 2018, ADV DIFF EQU, V220; Krisher LK, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1630-x; Mandal S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-202; MENDIS C, 1990, AM J TROP MED HYG, V42, P298, DOI 10.4269/ajtmh.1990.42.298; Nobre FF, 2001, STAT MED, V20, P3051, DOI 10.1002/sim.963; Ostovar A, 2016, J ARTHROPOD-BORNE DI, V10, P222; Paaijmans KP, 2011, NAT CLIM CHANGE, V1, P349; Patz J.A., 2003, CLIMATE CHANGE HUMAN, V6, P103; Pienaar M., 2016, THESIS; Premaratna R, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-302; Silva K T, 1997, Med Anthropol, V17, P195; van der Hoek W, 1997, ANN TROP MED PARASIT, V91, P945, DOI 10.1080/00034989760347; Wadhwa V, 2010, ADV ASIAN HUM-ENV RE, V1, P1, DOI 10.1007/978-90-481-3358-1-1_1; WHO, 2017, SRI LANK FREE MAL CA; WHO, 2019, WORLD MAL REP 2018; WHO, 2015, WORLD MAL REP 2015; Wickramaarachchil WPTM, 2015, J NATL SCI FOUND SRI, V43, P337, DOI 10.4038/jnsfsr.v43i4.7968; Wickramasinghe M B, 1981, Ceylon Med J, V26, P107; WIJESUNDERA MD, 1988, PARASITOL TODAY, V4, P147, DOI 10.1016/0169-4758(88)90193-7	42	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0228540	10.1371/journal.pone.0228540	http://dx.doi.org/10.1371/journal.pone.0228540			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084156	Green Published, gold			2022-12-26	WOS:000535227900020
J	Rakowski, AG; Velickovic, P; Dall'Ara, E; Lio, P				Rakowski, Alexander G.; Velickovic, Petar; Dall'Ara, Enrico; Lio, Pietro			ChronoMID-Cross-modal neural networks for 3-D temporal medical imaging data	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; CLASSIFICATION; MODELS	ChronoMID-neural networks for temporally-varying, hence Chrono, Medical Imaging Data-makes the novel application of cross-modal convolutional neural networks (X-CNNs) to the medical domain. In this paper, we present multiple approaches for incorporating temporal information into X-CNNs and compare their performance in a case study on the classification of abnormal bone remodelling in mice. Previous work developing medical models has predominantly focused on either spatial or temporal aspects, but rarely both. Our models seek to unify these complementary sources of information and derive insights in a bottom-up, data-driven approach. As with many medical datasets, the case study herein exhibits deep rather than wide data; we apply various techniques, including extensive regularisation, to account for this. After training on a balanced set of approximately 70000 images, two of the models-those using difference maps from known reference points-outperformed a state-of-the-art convolutional neural network baseline by over 30pp (> 99% vs. 68.26%) on an unseen, balanced validation set comprising around 20000 images. These models are expected to perform well with sparse data sets based on both previous findings with X-CNNs and the representations of time used, which permit arbitrarily large and irregular gaps between data points. Our results highlight the importance of identifying a suitable description of time for a problem domain, as unsuitable descriptors may not only fail to improve a model, they may in fact confound it.	[Rakowski, Alexander G.; Velickovic, Petar; Lio, Pietro] Univ Cambridge, Comp Lab, Cambridge, Cambs, England; [Dall'Ara, Enrico] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England	University of Cambridge; University of Sheffield	Dall'Ara, E (corresponding author), Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England.	e.dallara@sheffield.ac.uk	Dall'Ara, Enrico/ABA-5046-2020; P. Lió, Pietro Lio/AAV-3358-2021	Dall'Ara, Enrico/0000-0003-1471-5077; P. Lió, Pietro Lio/0000-0002-0540-5053; Rakowski, Alexander/0000-0002-7512-4169	Engineering and Physical Sciences Research Council (MultiSim project) [EP/K03877X/1]; National Centre for Replacement, Refinement and Reduction of Animals in Research (NC3Rs) [NC/R001073/1]; EPSRC [EP/K03877X/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (MultiSim project)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Centre for Replacement, Refinement and Reduction of Animals in Research (NC3Rs)(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was partially supported by the Engineering and Physical Sciences Research Council (MultiSim project, grant number: EP/K03877X/1; ED; https://www.epsrc.ac.uk/), and the National Centre for Replacement, Refinement and Reduction of Animals in Research (NC3Rs, Grant numbers: NC/R00Y1073/1; ED; https://www.nc3rs.org.uk/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashinsky BG, 2017, J ORTHOP RES, V35, P2243, DOI 10.1002/jor.23519; Ayati BP, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-28; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chen LC, 2018, IEEE T PATTERN ANAL, V40, P834, DOI 10.1109/TPAMI.2017.2699184; Chen T., 2018, ADV NEURAL INF PROCE, V31; Choi E, 2017, J AM MED INFORM ASSN, V24, P361, DOI 10.1093/jamia/ocw112; Corte AD, 2019, J ENG MED; Couderc JP, 2010, J ELECTROCARDIOL, V43, P595, DOI 10.1016/j.jelectrocard.2010.07.015; Cupek Rafal, 2016, Reumatologia (Warsaw), V54, P239, DOI 10.5114/reum.2016.63664; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Glorot Xavier, 2010, P MACHINE LEARNING R, P249; Graham JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063884; Guler NF, 2005, EXPERT SYST APPL, V29, P506, DOI 10.1016/j.eswa.2005.04.011; Hammad M, 2019, FUTURE GENER COMP SY, V101, P180, DOI 10.1016/j.future.2019.06.008; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Huang YX, 2008, STAT MED, V27, P4722, DOI 10.1002/sim.3272; Lu YT, 2017, J MECH BEHAV BIOMED, V75, P244, DOI 10.1016/j.jmbbm.2017.07.034; Lyon A, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0821; Montejo LD, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.7.076002; Nair V., 2010, P 27 INT C INT C MAC, P807; Nasser Y, 2017, I C FIELD PROG LOGIC; Oliviero S, 2018, J MECH BEHAV BIOMED, V86, P172, DOI 10.1016/j.jmbbm.2018.06.022; Oliviero S, 2017, J BIOMECH, V65, P203, DOI 10.1016/j.jbiomech.2017.10.026; Pivonka P, 2010, J THEOR BIOL, V262, P306, DOI 10.1016/j.jtbi.2009.09.021; Rackauckas C., 2019, ARXIV190202376; Roberts BC, 2019, BONE, V127, P260, DOI 10.1016/j.bone.2019.06.024; Rudy SH, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602614; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Tiulpin A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20132-7; Velickovic P, 2016, XCNN CROSS MODAL CON; Vicecontia M, 2019, MECH AGEING DEV, V177, P103, DOI 10.1016/j.mad.2018.07.001; Wetzel, 2016, MACH LEARN HEALTHC C, P253	32	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0228962	10.1371/journal.pone.0228962	http://dx.doi.org/10.1371/journal.pone.0228962			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084166	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000535227900037
J	Lu, YY; Liu, XL; Zhang, E; Kopras, EJ; Smith, EP; Astreinidis, A; Li, CG; Leung, YK; Ho, SM; Yu, JJ				Lu, Yiyang; Liu, Xiaolei; Zhang, Erik; Kopras, Elizabeth J.; Smith, Eric P.; Astreinidis, Aristotelis; Li, Chenggang; Leung, Yuet-Kin; Ho, Shuk-Mei; Yu, Jane J.			Estrogen activates pyruvate kinase M2 and increases the growth of TSC2-deficient cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; PULMONARY LYMPHANGIOLEIOMYOMATOSIS; LUNG METASTASIS; RECEPTOR-BETA; BONE LOSS; TUBERIN; TSC2; PROGESTERONE; ESTRADIOL; CANCER	Lymphangioleiomyomatosis (LAM) is a devastating lung disease caused by inactivating gene mutations in either TSC1 or TSC2 that result in hyperactivation of the mechanistic target of rapamycin complex 1 (mTORC1). As LAM occurs predominantly in women during their reproductive age and is exacerbated by pregnancy, the female hormonal environment, and in particular estrogen, is implicated in LAM pathogenesis and progression. However, detailed underlying molecular mechanisms are not well understood. In this study, utilizing human pulmonary LAM specimens and cell culture models of TSC2-deficient LAM patient-derived and rat uterine leiomyoma-derived cells, we tested the hypothesis that estrogen promotes the growth of mTORC1-hyperactive cells through pyruvate kinase M2 (PKM2). Estrogen increased the phosphorylation of PKM2 at Ser37 and induced the nuclear translocation of phospho-PKM2. The estrogen receptor antagonist Faslodex reversed these effects. Restoration of TSC2 inhibited the phosphorylation of PKM2 in an mTORC1 inhibitor-insensitive manner. Finally, accumulation of phosphorylated PKM2 was evident in pulmonary nodule from LAM patients. Together, our data suggest that female predominance of LAM might be at least in part attributed to estrogen stimulation of PKM2-mediated cellular metabolic alterations. Targeting metabolic regulators of PKM2 might have therapeutic benefits for women with LAM and other female-specific neoplasms.	[Lu, Yiyang; Liu, Xiaolei; Zhang, Erik; Kopras, Elizabeth J.; Smith, Eric P.; Li, Chenggang; Yu, Jane J.] Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH 45221 USA; [Astreinidis, Aristotelis] Univ Tennessee, Hlth Sci Ctr, Div Pediat Nephrol, Dept Pediat,Coll Med, Memphis, TN USA; [Astreinidis, Aristotelis] Le Bonheur Childrens Hosp, Tuberous Sclerosis Complex Ctr Excellence, Memphis, TN USA; [Li, Chenggang] Nankai Univ, State Key Lab Med Chem Biol, Tianjin, Peoples R China; [Li, Chenggang] Nankai Univ, Coll Pharm, Tianjin, Peoples R China; [Leung, Yuet-Kin; Ho, Shuk-Mei] Univ Arkansas Med Sci UAMS, Coll Med, Dept Pharmacol & Toxicol, Little Rock, AR USA	University System of Ohio; University of Cincinnati; University of Tennessee System; University of Tennessee Health Science Center; Nankai University; Nankai University; University of Arkansas System; University of Arkansas Medical Sciences	Yu, JJ (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH 45221 USA.	yuj9@ucmail.uc.edu	Leung, Ricky/H-5958-2019; Astreinidis, Aristotelis/AAK-5137-2020; Astreinidis, Aristotelis/ABA-6715-2021	Leung, Ricky/0000-0003-2063-277X; Kopras, Elizabeth J/0000-0001-5429-2609	LAM Foundation Career Development Fund [AM0140C06-19]; LAM Foundation Bridge Fund [0124B07-17];  [BX000675];  [ES006096];  [RO1HL138481];  [HL098216];  [DK098331]	LAM Foundation Career Development Fund; LAM Foundation Bridge Fund; ; ; ; ; 	The LAM Foundation Career Development Fund AM0140C06-19 to XL; CL was a LAM Foundation Fellow; BX000675 and ES006096 to SMH; RO1HL138481, HL098216, DK098331, and The LAM Foundation Bridge Fund 0124B07-17 to JJY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapro MS, 2004, BREAST, V13, pS29, DOI 10.1016/j.breast.2004.09.005; Alayev A, 2014, CELL CYCLE, V13, P371, DOI 10.4161/cc.27355; Astrinidis A, 2002, ONCOGENE, V21, P8470, DOI 10.1038/sj.onc.1205962; BRENTANI MM, 1984, CHEST, V85, P96, DOI 10.1378/chest.85.1.96; Brunelli A, 1996, INT J GYNECOL OBSTET, V52, P289, DOI 10.1016/0020-7292(95)02619-3; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; El-Chemaly S, 2017, CHEST, V151, P1302, DOI 10.1016/j.chest.2017.01.033; Finlay GA, 2004, J BIOL CHEM, V279, P23114, DOI 10.1074/jbc.M401912200; Finlay GA, 2003, AM J PHYSIOL-CELL PH, V285, pC409, DOI 10.1152/ajpcell.00482.2002; Glasgow CG, 2010, RESP MED, V104, pS45, DOI 10.1016/j.rmed.2010.03.017; Glassberg MK, 2008, J CLIN ENDOCR METAB, V93, P1625, DOI 10.1210/jc.2007-1283; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Goncharova EA, 2011, MOL CELL BIOL, V31, P2484, DOI 10.1128/MCB.01061-10; Gu XX, 2013, P NATL ACAD SCI USA, V110, P14960, DOI 10.1073/pnas.1309110110; Hammes SR, 2013, HORM CANCER-US, V4, P70, DOI 10.1007/s12672-012-0128-4; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henske EP, 2012, J CLIN INVEST, V122, P3807, DOI 10.1172/JCI58709; HOWE SR, 1995, ENDOCRINOLOGY, V136, P4996, DOI 10.1210/en.136.11.4996; HOWE SR, 1995, AM J PATHOL, V146, P1568; Howell A, 2000, CANCER-AM CANCER SOC, V89, P817, DOI 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.0.CO;2-6; HUGHES E, 1987, J REPROD MED, V32, P553; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Johnson S, 1999, THORAX, V54, P254, DOI 10.1136/thx.54.3.254; Johnson SR, 2016, CLIN CHEST MED, V37, P389, DOI 10.1016/j.ccm.2016.04.002; Johnston Stephen R D, 2002, Curr Opin Investig Drugs, V3, P305; Lam HC, 2017, CANCER RES, V77, P3255, DOI 10.1158/0008-5472.CAN-16-2458; Li CG, 2013, AM J RESP CELL MOL, V49, P135, DOI 10.1165/rcmb.2012-0476OC; Lipton A, 2012, CLIN MED INSIGHTS-ON, V6, DOI 10.4137/CMO.S8511; Logginidou H, 2000, CHEST, V117, P25, DOI 10.1378/chest.117.1.25; Manna Subrata, 2016, Sign Transduct Insights, V5, P1; Matsui K, 2000, AM J RESP CRIT CARE, V161, P1002, DOI 10.1164/ajrccm.161.3.9904009; MCCARTY KS, 1980, NEW ENGL J MED, V303, P1461, DOI 10.1056/NEJM198012183032506; McCormack FX, 2016, AM J RESP CRIT CARE, V194, P748, DOI 10.1164/rccm.201607-1384ST; McCormack FX, 2012, AM J RESP CRIT CARE, V186, P1210, DOI 10.1164/rccm.201205-0848OE; McCormack FX, 2011, NEW ENGL J MED, V365, P272; Mitra Subhra, 2004, J Assoc Physicians India, V52, P828; Parkhitko AA, 2014, MOL CANCER RES, V12, P48, DOI 10.1158/1541-7786.MCR-13-0258-T; Prakasam G, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00022; Prizant H, 2016, ENDOCRINOLOGY, V157, P3374, DOI 10.1210/en.2016-1395; Redlich K, 2000, ANN RHEUM DIS, V59, P308, DOI 10.1136/ard.59.4.308; Sullivan EJ, 1998, CHEST, V114, P1689, DOI 10.1378/chest.114.6.1689; Sun Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.204; Sun Y, 2014, HORM CANCER-US, V5, P284, DOI 10.1007/s12672-014-0192-z; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Warner M, 2010, BIOCHEM BIOPH RES CO, V396, P63, DOI 10.1016/j.bbrc.2010.02.144; Yang WW, 2013, CELL CYCLE, V12, P3154, DOI 10.4161/cc.26182; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yu J, 2004, AM J PHYSIOL-LUNG C, V286, pL694, DOI 10.1152/ajplung.00204.2003; Yu JJ, 2009, P NATL ACAD SCI USA, V106, P2635, DOI 10.1073/pnas.0810790106; Zhang YJ, 2011, NAT MED, V17, P79, DOI 10.1038/nm.2280	53	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0228894	10.1371/journal.pone.0228894	http://dx.doi.org/10.1371/journal.pone.0228894			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8CF	32078667	Green Published, gold			2022-12-26	WOS:000535224600008
J	Swier, VJ; White, KA; Meyerholz, DK; Chefdeville, A; Khanna, R; Sieren, JC; Quelle, DE; Weimer, JM				Swier, Vicki J.; White, Katherine A.; Meyerholz, David K.; Chefdeville, Aude; Khanna, Rajesh; Sieren, Jessica C.; Quelle, Dawn E.; Weimer, Jill M.			Validating indicators of CNS disorders in a swine model of neurological disease	PLOS ONE			English	Article							NEUROFIBROMATOSIS TYPE-1; LEARNING-DEFICITS; PRECURSOR CELLS; MOUSE MODEL; MINIPIGS; MICE; EXPRESSION; PROTEIN; BRAIN; NEURODEGENERATION	Genetically modified swine disease models are becoming increasingly important for studying molecular, physiological and pathological characteristics of human disorders. Given the limited history of these model systems, there remains a great need for proven molecular reagents in swine tissue. Here, to provide a resource for neurological models of disease, we validated antibodies by immunohistochemistry for use in examining central nervous system (CNS) markers in a recently developed miniswine model of neurofibromatosis type 1 (NF1). NF1 is an autosomal dominant tumor predisposition disorder stemming from mutations in NF1, a gene that encodes the Ras-GTPase activating protein neurofibromin. Patients classically present with benign neurofibromas throughout their bodies and can also present with neurological associated symptoms such as chronic pain, cognitive impairment, and behavioral abnormalities. As validated antibodies for immunohistochemistry applications are particularly difficult to find for swine models of neurological disease, we present immunostaining validation of antibodies implicated in glial inflammation (CD68), oligodendrocyte development (NG2, O4 and Olig2), and neuron differentiation and neurotransmission (doublecortin, GAD67, and tyrosine hydroxylase) by examining cellular localization and brain region specificity. Additionally, we confirm the utility of anti-GFAP, anti-Iba1, and anti-MBP antibodies, previously validated in swine, by testing their immunoreactivity across multiple brain regions in mutant NF1 samples. These immunostaining protocols for CNS markers provide a useful resource to the scientific community, furthering the utility of genetically modified miniswine for translational and clinical applications.	[Swier, Vicki J.; White, Katherine A.; Weimer, Jill M.] Sanford Res, Pediat & Rare Dis Grp, Sioux Falls, SD 57104 USA; [Meyerholz, David K.; Quelle, Dawn E.] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Chefdeville, Aude; Khanna, Rajesh] Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA; [Khanna, Rajesh] Univ Arizona, Coll Med, Grad Interdisciplinary Program Neurosci, Tucson, AZ USA; [Sieren, Jessica C.] Univ Iowa, Dept Radiol & Biomed Engn, Iowa City, IA USA; [Quelle, Dawn E.] Univ Iowa, Dept Neurosci & Pharmacol, Iowa City, IA USA; [Weimer, Jill M.] Univ South Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD 57105 USA	Sanford Health; University of Iowa; University of Arizona; University of Arizona; University of Iowa; University of Iowa; University of South Dakota	Weimer, JM (corresponding author), Sanford Res, Pediat & Rare Dis Grp, Sioux Falls, SD 57104 USA.; Weimer, JM (corresponding author), Univ South Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD 57105 USA.	Jill.Weimer@sanfordhealth.org	Meyerholz, David/J-8131-2019	Meyerholz, David/0000-0003-1552-3253; Swier, Vicki/0000-0001-7509-9920; Sieren, Jessica/0000-0002-1109-7886; Quelle, Dawn/0000-0001-8776-0122	Synodos for NF1 program at the Children's Tumor Foundation; Children's Tumor Foundation [2015-04-009A]; Sanford Research Histology and Imaging Core [NIH P20GM103620, NIH P20GM103548]	Synodos for NF1 program at the Children's Tumor Foundation; Children's Tumor Foundation; Sanford Research Histology and Imaging Core	This work was supported by funding from the Synodos for NF1 program at the Children's Tumor Foundation to DKM, JCS, DEQ, and JMW, and a research award from the Children's Tumor Foundation (2015-04-009A) to RK and JMW. This work also received support from the Sanford Research Histology and Imaging Core (NIH P20GM103620) and (NIH P20GM103548). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sanford Research did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors [VJS, KAW, JMW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SE, 2000, NEUROBIOL AGING, V21, P913, DOI 10.1016/S0197-4580(00)00173-1; BALESTRAZZI P, 1989, Neurofibromatosis, V2, P322; Beraldi R, 2015, HUM MOL GENET; Bible E, 2004, NEUROBIOL DIS, V16, P346, DOI 10.1016/j.nbd.2004.02.010; Boccazzi Marta, 2016, Stem Cell Investig, V3, P15, DOI 10.21037/sci.2016.05.02; Borsook D, 2012, BRAIN, V135, P320, DOI 10.1093/brain/awr271; Castro-Caldas M, 2009, J MOL NEUROSCI, V38, P114, DOI 10.1007/s12031-008-9141-z; Chieppa MN, 2014, NEURODEGENER DIS, V13, P246, DOI 10.1159/000353472; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Cutting LE, 2002, NEUROLOGY, V59, P1388, DOI 10.1212/01.WNL.0000032370.68306.8A; Dean JM, 2009, NEUROSCIENCE, V160, P606, DOI 10.1016/j.neuroscience.2009.02.071; Diggs-Andrews KA, 2013, ANN NEUROL, V73, P309, DOI 10.1002/ana.23793; DUFFNER PK, 1989, NEUROLOGY, V39, P373, DOI 10.1212/WNL.39.3.373; Galvao RP, 2014, P NATL ACAD SCI USA, V111, pE4214, DOI 10.1073/pnas.1414389111; Geraets RD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176526; Gutmann DH, 2012, J NEUROSCI, V32, P14087, DOI 10.1523/JNEUROSCI.3242-12.2012; Hart AD, 2012, BRAIN BEHAV IMMUN, V26, P754, DOI 10.1016/j.bbi.2011.11.006; Hou J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043556; Isakson SH, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0163-y; Jakobsen JE, 2013, TRANSGENIC RES, V22, P709, DOI 10.1007/s11248-012-9671-6; Jiao Y, 1999, J NEUROSCI METH, V93, P149, DOI 10.1016/S0165-0270(99)00142-9; Kallakuri S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169239; Kragh PM, 2009, TRANSGENIC RES, V18, P545, DOI 10.1007/s11248-009-9245-4; Kreiner G, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00056; LEVINE JM, 1993, GLIA, V7, P307, DOI 10.1002/glia.440070406; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Manohar S, 2012, NEUROSCIENCE, V202, P169, DOI 10.1016/j.neuroscience.2011.12.013; McGonigle P, 2014, BIOCHEM PHARMACOL, V87, P162, DOI 10.1016/j.bcp.2013.08.006; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Meyerholz DK, 2017, J HISTOCHEM CYTOCHEM, V65, P607, DOI 10.1369/0022155417729357; Murphy KPSJ, 2000, J NEUROSCI, V20, P5115; Navarro R, 2012, J NEUROTRAUM, V29, P499, DOI 10.1089/neu.2011.2076; Nelson TE, 1997, J COMP NEUROL, V379, P443, DOI 10.1002/(SICI)1096-9861(19970317)379:3<443::AID-CNE9>3.0.CO;2-3; Nielsen Henrietta M, 2013, Acta Neuropathol Commun, V1, P7, DOI 10.1186/2051-5960-1-7; Okon EA, 2017, J ADV BIOL BIOTECHNO, V16, P1; Parri HR, 2010, EUR J NEUROSCI, V32, P29, DOI 10.1111/j.1460-9568.2010.07281.x; Phatnani H, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020628; Prather RS, 2013, ANNU REV ANIM BIOSCI, V1, P203, DOI 10.1146/annurev-animal-031412-103715; Raore B, 2011, SPINE, V36, pE164, DOI 10.1097/BRS.0b013e3181d77a47; Reynolds R, 1997, J NEUROSCI RES, V47, P455, DOI 10.1002/(SICI)1097-4547(19970301)47:5<455::AID-JNR1>3.0.CO;2-G; Riccardi V M, 1992, Curr Probl Pediatr, V22, P66, DOI 10.1016/0045-9380(92)90053-2; Rice FL, 2017, CEPHALALGIA, V37, P1350, DOI 10.1177/0333102416677051; Robinson AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107649; Rogers CS, 2008, AM J PHYSIOL-LUNG C, V295, pL240, DOI 10.1152/ajplung.90203.2008; ROSENE DL, 1986, J HISTOCHEM CYTOCHEM, V34, P1301, DOI 10.1177/34.10.3745909; Say M, 2007, BRAIN RES, V1152, P17, DOI 10.1016/j.brainres.2007.03.037; Sharaf A, 2015, CELL TISSUE RES, V359, P393, DOI 10.1007/s00441-014-2022-6; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Sieren JC, 2014, J CLIN INVEST, V124, P4052, DOI 10.1172/JCI75447; Sondergaard LV, 2012, TRANSGENIC RES, V21, P1341, DOI 10.1007/s11248-012-9620-4; Steen RG, 2001, AM J NEURORADIOL, V22, P810; Thompson SM, 2013, PROTEOM CLIN APPL, V7, P241, DOI 10.1002/prca.201200086; Tjalkens Ronald B, 2017, Adv Neurobiol, V18, P159, DOI 10.1007/978-3-319-60189-2_8; Tognatta R, 2016, NEUROPHARMACOLOGY, V110, P539, DOI 10.1016/j.neuropharm.2016.04.026; Treuting P. M., 2011, COMP ANATOMY HISTOLO; True LD, 2008, HISTOCHEM CELL BIOL, V130, P473, DOI 10.1007/s00418-008-0481-0; Uchida M, 2001, TRANSGENIC RES, V10, P577, DOI 10.1023/A:1013059917280; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Verkhratsky A, 2014, PERIOD BIOL, V116, P115; Vostrikov V, 2011, SCHIZOPHR RES TREAT, V2011, DOI 10.1155/2011/174689; Walters EM, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-55; Watzlawik JO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128007; Weimer JM, 2009, BRAIN RES, V1266, P93, DOI 10.1016/j.brainres.2009.02.009; White KA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120402; Yang DS, 2010, HUM MOL GENET, V19, P3983, DOI 10.1093/hmg/ddq313; Yang HQ, 2014, CELL RES, V24, P464, DOI 10.1038/cr.2014.25; Yao J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06926; Yu DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077824; Zhou XQ, 2015, CELL MOL LIFE SCI, V72, P1175, DOI 10.1007/s00018-014-1744-7	70	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228222	10.1371/journal.pone.0228222	http://dx.doi.org/10.1371/journal.pone.0228222			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074109	Green Published, Green Submitted, gold			2022-12-26	WOS:000535220600010
J	Campolo, J; Corradi, E; Rizzardi, A; Parolini, M; Dellanoce, C; Di Guglielmo, ML; Tarlarini, P; Cattaneo, M; Trivella, MG; De Maria, R				Campolo, Jonica; Corradi, Ettore; Rizzardi, Alice; Parolini, Marina; Dellanoce, Cinzia; Di Guglielmo, Maria Luisa; Tarlarini, Patrizia; Cattaneo, Marina; Trivella, Maria Giovanna; De Maria, Renata			Irisin and markers of metabolic derangement in non-diabetic Caucasian subjects with stage I-II obesity during early aging	PLOS ONE			English	Article							CIRCULATING IRISIN; RESISTANCE; ADULTS; FAT	Irisin concentrations are decreased in subjects with overt diabetes and upregulated in those with obesity or impaired fasting glucose. However, gender-balanced data in older populations, in whom risk factors commonly culminate in overt cardiovascular disease, are scarce. We assessed in non-diabetic Caucasian subjects with stage I-II obesity in the early aging range (50 to 70 years), the relationship between irisin, body composition and markers of metabolic derangement by gender. In 60 (31 women, 29 men) non-diabetics with a body mass index >= 30 - <= 40 kg/m(2), we measured anthropometrics and body composition (Air Displacement Plethysmography). We assayed lipid and glucose profile by routine methods, plasma irisin by ELISA and measured insulin resistance by the HOMA index. Irisin levels were higher in women than in men (161 [105-198]) vs 83 [33-115] ng/ml, P< 0.001), and correlated directly with HOMA index in both (rho 0.735, P<0.001 M, rho 0.452, P = 0.011 F). Sex differences were maintained across insulin resistance severity stages. In men, irisin concentrations correlated directly with body mass index (rho 0.755, P< 0.001), waist circumference (rho 0.623, P<0.001), fat mass index (rho 0.762, P<0.001), glucose (rho 0.408, P = 0.028), the fatty liver index (rho 0.705, P<0.001) and FINDRISC score (rho 0.536, P = 0.003). Among non-diabetic Caucasian subjects with obesity in the early stages of aging, irisin levels reflect the amount of body fat and insulin resistance severity, independently of between-gender differences in the adipomyokine concentrations and are associated with markers of visceral adiposity in men but not in women.	[Campolo, Jonica; Rizzardi, Alice; Parolini, Marina; Dellanoce, Cinzia; Di Guglielmo, Maria Luisa; Trivella, Maria Giovanna; De Maria, Renata] CNR, CardioThorac & Vasc Dept, Inst Clin Physiol, Milan, Italy; [Corradi, Ettore; Tarlarini, Patrizia; Cattaneo, Marina] ASST Grande Osped Metropolitano Niguarda, Clin Nutr Unit, Med Dept, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	De Maria, R (corresponding author), CNR, CardioThorac & Vasc Dept, Inst Clin Physiol, Milan, Italy.	renata.demaria@ospedaleniguarda.it	Campolo, Jonica/ABC-5841-2020		Regione Lombardia-CNR [19364/RCC]; AMANDA Project	Regione Lombardia-CNR; AMANDA Project	This study was supported by Regione Lombardia-CNR 2016-2018 Framework Agreement, grant 19364/RCC, AMANDA Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daghri NM, 2014, EUR J CLIN INVEST, V44, P119, DOI 10.1111/eci.12196; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Assyov Y, 2016, EXP CLIN ENDOCR DIAB, V124, P22, DOI 10.1055/s-0035-1564130; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Biniaminov N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189254; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Buscemi S, 2018, INT J OBESITY, V42, P398, DOI 10.1038/ijo.2017.255; Crujeiras AB, 2015, CLIN ENDOCRINOL, V82, P467, DOI 10.1111/cen.12627; Crujeiras AB, 2014, AM J HUM BIOL, V26, P198, DOI 10.1002/ajhb.22493; Cuthbertson DJ, 2014, EUR J ENDOCRINOL, V171, P561, DOI 10.1530/EJE-14-0112; Elizondo-Montemayor L, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2628968; Fatouros IG, 2018, CLIN CHEM LAB MED, V56, P525, DOI 10.1515/cclm-2017-0674; Fukushima Y, 2016, OBES SCI PRACT, V2, P203, DOI 10.1002/osp4.43; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Kabasakalis A, 2019, J SPORT SCI, V37, P827, DOI 10.1080/02640414.2018.1530056; Koetsier M, 2010, DIABETES TECHNOL THE, V12, P399, DOI 10.1089/dia.2009.0113; Li Z, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170213; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Pardo M, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/857270; Perakakis N, 2017, NAT REV ENDOCRINOL, V13, P324, DOI 10.1038/nrendo.2016.221; Polyzos SA, 2018, ENDOCRINE, V59, P260, DOI 10.1007/s12020-017-1476-1; Qiu SH, 2016, METABOLISM, V65, P825, DOI 10.1016/j.metabol.2016.02.006; Qiu SH, 2015, SPORTS MED, V45, P1577, DOI 10.1007/s40279-014-0293-4; Rask-Andersen M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08000-4; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Ruan QW, 2019, PEPTIDES, V113, P41, DOI 10.1016/j.peptides.2019.01.004; Sahin-Efe A, 2018, METABOLISM, V79, P24, DOI 10.1016/j.metabol.2017.10.011; Sanchis-Gomar F, 2015, TRENDS ENDOCRIN MET, V26, P335, DOI 10.1016/j.tem.2015.05.004; Siri W., 1961, TECHNIQUES MEASURING, P223; Stirban Alin, 2014, Eur Endocrinol, V10, P106, DOI 10.17925/EE.2014.10.02.106; Martinez-Larrad MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106641; Tibana RA, 2017, J NUTR HEALTH AGING, V21, P241, DOI 10.1007/s12603-016-0748-4; van Waateringe RP, 2016, EUR J CLIN INVEST, V46, P481, DOI 10.1111/eci.12627; Yan B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094235; Zugel M, 2016, ENDOCRINE, V54, P101, DOI 10.1007/s12020-016-0913-x	35	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0229152	10.1371/journal.pone.0229152	http://dx.doi.org/10.1371/journal.pone.0229152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7XT	32069304	Green Published, gold			2022-12-26	WOS:000535212900025
J	Lee, T; Pang, S; Stegger, M; Sahibzada, S; Abraham, S; Daley, D; Coombs, G				Lee, Terence; Pang, Stanley; Stegger, Marc; Sahibzada, Shafi; Abraham, Sam; Daley, Denise; Coombs, Geoffrey		Australian Grp Antimicrobial Resis	A three-year whole genome sequencing perspective of Enterococcus faecium sepsis in Australia	PLOS ONE			English	Article							GLYCOPEPTIDE RESISTANCE; GENE; TOOL	Background Over the last three decades, hospital adapted clonal complex (CC) 17 strains of Enterococcus faecium have acquired and exchanged antimicrobial resistance genes leading to the widespread resistance to clinically important antimicrobials globally. In Australia, a high prevalence of vancomycin resistance has been reported in E. faecium in the last decade. Methods In this study, we determined the phylogenetic relationship and genetic characteristics of E. faecium collected from hospitalized patients with blood stream infections throughout Australia from 2015 to 2017 using high throughput molecular techniques. Results Using single nucleotide polymorphism based phylogenetic inference, three distinct clusters of isolates were observed with additional sub-clustering. One cluster harboured mostly non-CC17 isolates while two clusters were dominant for the vanA and vanB operons. Conclusion The gradual increase in dominance of the respective van operon was observed in both the vanA and vanB dominant clusters suggesting a strain-van operon affinity. The high prevalence of the van operon within isolates of a particular sub-cluster was linked to an increased number of isolates and 30-day all-cause mortality. Different dominant sub-clusters were observed in each region of Australia. Findings from this study can be used to put future surveillance data into a broader perspective including the detection of novel E. faecium strains in Australia as well as the dissemination and evolution of each strain.	[Lee, Terence; Pang, Stanley; Stegger, Marc; Sahibzada, Shafi; Abraham, Sam; Coombs, Geoffrey] Murdoch Univ, Antimicrobial Resistance & Infect Dis Res Lab, Murdoch, WA, Australia; [Stegger, Marc; Coombs, Geoffrey] Statens Serum Inst, Copenhagen, Denmark; [Daley, Denise] Fiona Stanley Hosp, Australian Grp Antimicrobial Resistance AGAR, Murdoch, WA, Australia	Murdoch University; Statens Serum Institut	Coombs, G (corresponding author), Murdoch Univ, Antimicrobial Resistance & Infect Dis Res Lab, Murdoch, WA, Australia.; Coombs, G (corresponding author), Statens Serum Inst, Copenhagen, Denmark.	G.Coombs@murdoch.edu.au		Stegger, Marc/0000-0003-0321-1180; Lee, Terence/0000-0002-5456-3162; Sahibzada, Shafi/0000-0001-7362-8323; Coombs, Geoffrey/0000-0003-1635-6506; Abraham, Sam/0000-0003-0950-2317				Allerberger F, 2008, CLIN MICROBIOL INFEC, V14, P197, DOI 10.1111/j.1469-0691.2007.01929.x; [Anonymous], 2017, CONTROL ECFDPA ANTIM; [Anonymous], 2018, CONTR ECFDPA SURV AN; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen LH, 2016, NUCLEIC ACIDS RES, V44, pD694, DOI 10.1093/nar/gkv1239; Coombs G. W., 2018, Communicable Diseases Intelligence, V42, punpaginated; Coombs GW, 2014, J CLIN MICROBIOL, V52, P897, DOI 10.1128/JCM.03286-13; COOMBS GW, 2014, COMMUN DIS INTELL, V38, pE24; Coombs GW, 2018, AUSTR GROUP ANTIMICR, P42; Didelot X, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004041; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Gould IM, 2013, INT J ANTIMICROB AG, V42, pS17, DOI 10.1016/j.ijantimicag.2013.04.006; GW Coombs DD, 2018, AUSTR ENT SEPS OUTC; Homan WL, 2002, J CLIN MICROBIOL, V40, P1963, DOI 10.1128/JCM.40.6.1963-1971.2002; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Leavis H, 2004, J BACTERIOL, V186, P672, DOI 10.1128/JB.186.3.672-682.2004; Lee T, J GLOBAL ANTIMICROBI, V16, P36; Lester CH, 2006, ANTIMICROB AGENTS CH, V50, P596, DOI 10.1128/AAC.50.2.596-599.2006; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Panesso D, 2010, J CLIN MICROBIOL, V48, P1562, DOI 10.1128/JCM.02526-09; R Core Team, 2018, R LANG ENV STAT COMP; Rice LB, 1998, ANTIMICROB AGENTS CH, V42, P963, DOI 10.1128/AAC.42.4.963; Ruan Z, 2016, NUCLEIC ACIDS RES, V44, pD682, DOI 10.1093/nar/gkv1004; Seemann T, 2017, SNIPPY FAST BACTERIA; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Top J, 2008, FEMS IMMUNOL MED MIC, V52, P297, DOI 10.1111/j.1574-695X.2008.00383.x; van Hal SJ, 2018, J ANTIMICROB CHEMOTH, V73, P1487, DOI 10.1093/jac/dky074; Xu XG, 2010, ANTIMICROB AGENTS CH, V54, P4643, DOI 10.1128/AAC.01710-09; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	32	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0228781	10.1371/journal.pone.0228781	http://dx.doi.org/10.1371/journal.pone.0228781			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7VI	32059020	Green Published, gold			2022-12-26	WOS:000535206600015
J	Hutter, JA; Dion, R; Irace-Cima, A; Fiset, M; Guy, R; Dixon, B; Aguilar, JL; Trepanier, J; Thivierge, K				Hutter, Juliana Ayres; Dion, Rejean; Irace-Cima, Alejandra; Fiset, Marc; Guy, Rebecca; Dixon, Brent; Aguilar, Jeannie Lisette; Trepanier, Julien; Thivierge, Karine			Cryptosporidium spp.: Human incidence, molecular characterization and associated exposures in Quebec, Canada (2016-2017)	PLOS ONE			English	Article							UNITED-STATES; DRINKING-WATER; SURVEILLANCE; EPIDEMIOLOGY; GIARDIA	The aim of this study was to describe the epidemiology of human cryptosporidiosis in Quebec from 2016 to 2017 and to identify possible exposures associated with the disease, and the dominant Cryptosporidium species in circulation. A descriptive analysis was performed on data collected from the provincial notifiable infectious diseases registry and the epidemiological investigation. Fecal sample were sent to the Laboratoire de sante publique du Quebec for molecular characterization. In Quebec, from January 1, 2016 to December 31, 2017, a total of 201 confirmed cases of cryptosporidiosis were notified. A peak in the number of reported cases was observed at the end of the summer. The regional public health department with the highest adjusted incidence rate for sex and age group for both years was that of Nunavik, in the north of Quebec. A higher average annual incidence rate was observed for females between the ages of 20 to 34 years compared to males. Overall, for both males and females the distribution appeared to be bimodal with a first peak in children younger than five years old and a second peak in adults from 20 to 30 years of age. Molecular characterization showed that 23% (11/47) of cases were infected with C. hominis while 74% (35/47) were infected with C. parvum. Meanwhile, subtyping results identified by gp60 sequencing, show that all C. parvum subtypes belonged to the IIa family, whereas the subtypes for C. hominis belonged to the Ia, Ib, and Id families. Finally, the epidemiological investigation showed that diarrhea was the most common reported symptom with 99% (72/73) of investigated cases having experienced it. This first brief epidemiological portrait of cryptosporidiosis in Quebec has allowed for the description, both at the provincial and regional level, of the populations that could be particularly vulnerable to the disease.	[Hutter, Juliana Ayres; Irace-Cima, Alejandra] Inst Natl Sante Publ Quebec, Direct Risques Biol & Sante Travail, Montreal, PQ, Canada; [Dion, Rejean; Aguilar, Jeannie Lisette; Trepanier, Julien; Thivierge, Karine] Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada; [Dion, Rejean] Univ Montreal, Dept Med Sociale & Prevent, Ecole Sante Publ, Montreal, PQ, Canada; [Fiset, Marc] Minist Sante & Serv Sociaux, Direct Vigie Sanit, Quebec City, PQ, Canada; [Guy, Rebecca] Publ Hlth Agcy Canada, Natl Microbiol Lab Guelph, Guelph, ON, Canada; [Dixon, Brent] Hlth Canada, Food Directorate, Bur Microbial Hazards, Ottawa, ON, Canada; [Thivierge, Karine] McGill Univ, Fac Agr & Environm Sci, Inst Parasitol, Macdonald Campus, Ste Anne De Bellevue, PQ, Canada	Institut national de sante publique du Quebec (INSPQ); Institut national de sante publique du Quebec (INSPQ); Universite de Montreal; Public Health Agency of Canada; Health Canada; McGill University	Thivierge, K (corresponding author), Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada.; Thivierge, K (corresponding author), McGill Univ, Fac Agr & Environm Sci, Inst Parasitol, Macdonald Campus, Ste Anne De Bellevue, PQ, Canada.	karine.thivierge@inspq.qc.ca		Trepanier, Julien/0000-0003-0373-087X; Guy, Rebecca/0000-0002-9833-4994	Institut national de sante publique du Quebec	Institut national de sante publique du Quebec	Work related to this study was supported by the Institut national de sante publique du Quebec (KT, JAH).	Benedict KM, 2017, MMWR-MORBID MORTAL W, V66, P1216, DOI 10.15585/mmwr.mm6644a3; Bouzid M, 2013, CLIN MICROBIOL REV, V26, P115, DOI 10.1128/CMR.00076-12; Brankston G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196573; Budu-Amoako E, 2012, ZOONOSES PUBLIC HLTH, V59, P424, DOI 10.1111/j.1863-2378.2012.01474.x; Bureau de surveillance et de vigie Direction de la protection de la sante publique, 2016, VIG SURV MAL DECL OB, P14; Caccio SM, 2016, CLIN MICROBIOL INFEC, V22, P471, DOI 10.1016/j.cmi.2016.04.021; Chalmers RM, 2011, EPIDEMIOL INFECT, V139, P700, DOI 10.1017/S0950268810001688; Chalmers RM, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3354-6; Chartrand A, 2019, SURVEILLANCE MALADIE; CORDELL RL, 1994, PEDIATR INFECT DIS J, V13, P310, DOI 10.1097/00006454-199404000-00012; Long Sharon C., 2006, Journal of Water and Health, V4, P277, DOI 10.2166/wh.2006.016; Heiges M, 2006, NUCLEIC ACIDS RES, V34, pD419, DOI 10.1093/nar/gkj078; Hlavsa MC, 2018, AM J TRANSPLANT, V18, P1815, DOI 10.1111/ajt.14956; Iqbal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031139; Janssen B, 2019, CRYPTOSPORIDIOSIS; Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]; Majowicz SE, 2001, CAN J PUBLIC HEALTH, V92, P62, DOI 10.1007/BF03404847; Nichols RAB, 2003, APPL ENVIRON MICROB, V69, P4183, DOI 10.1128/AEM.69.7.4183-4189.2003; Olson ME, 1997, VET PARASITOL, V68, P375, DOI 10.1016/S0304-4017(96)01072-2; Ong CSL, 2008, EMERG INFECT DIS, V14, P1323, DOI 10.3201/eid1408.080115; Painter JE, 2015, MMWR SURVEILL SUMM, V64, P1; Public Health Agency of Canada, 2009, CAS DEF COMM DIS NAT, p35S2; Public Health Ontario, REP DIS TRENDS ONT; Rose JB, 1997, ANNU REV PUBL HEALTH, V18, P135, DOI 10.1146/annurev.publhealth.18.1.135; Ryan U, 2018, INT J PARASITOL, V48, P1, DOI 10.1016/j.ijpara.2017.09.004; Schuster CJ, 2005, CAN J PUBLIC HEALTH, V96, P254, DOI 10.1007/BF03405157; Semenza J C, 2007, Euro Surveill, V12, pE13; SORVILLO FJ, 1992, AM J PUBLIC HEALTH, V82, P742, DOI 10.2105/AJPH.82.5.742; Stirling R, 2001, Can Commun Dis Rep, V27, P185; Thivierge K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004534; Thomas MK, 2013, FOODBORNE PATHOG DIS, V10, P639, DOI 10.1089/fpd.2012.1389; Vrbova L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-970; Xiao LH, 2007, PARASITOL RES, V100, P701, DOI 10.1007/s00436-006-0337-2; Yoder Jonathan S., 2007, Morbidity and Mortality Weekly Report, V56, P1	34	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228986	10.1371/journal.pone.0228986	http://dx.doi.org/10.1371/journal.pone.0228986			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7SH	32053684	Green Published, gold			2022-12-26	WOS:000535198700082
J	Imakumbili, MLE; Semu, E; Semoka, JMR; Abass, A; Mkamilo, G				Imakumbili, Matema L. E.; Semu, Ernest; Semoka, Johnson M. R.; Abass, Adebayo; Mkamilo, Geoffrey			Plant tissue analysis as a tool for predicting fertiliser needs for low cyanogenic glucoside levels in cassava roots: An assessment of its possible use	PLOS ONE			English	Article							NUTRIENT; POTASSIUM; CULTIVARS; GROWTH; YIELD; SOILS	The use of plant tissue analysis as a tool for attaining low cyanogenic glucoside levels in cassava roots, has hardly been investigated. Just as the quality of crops is improved through the use of plant tissue analysis, the same can probably be done to consistently attain the lowest possible cyanogenic glucoside levels in cassava roots. High levels of cyanogenic glucosides in consumed fresh cassava roots or in their products have the potential of causing cyanide intoxication, hence the need to lower them. An experiment was thus conducted to assess the occurrence of meaningful relationships between plant nutritional status and cyanogenic glucoside production in cassava roots. Total hydrogen cyanide (HCN) levels in cassava roots were used to assess cyanogenic glucoside production. Using NPK fertiliser application to induce changes in plant nutritional status, the main objective of the study was investigated using the following sub-objectives; (1) to determine the effects of increased NPK fertiliser application on cassava root HCN levels; (2) and to show the occurrence of relationships between changes in nutrient levels in plant 'indicator tissue' and HCN levels in cassava roots. The study was a field experiment laid out as a split-plot in a randomized complete block design with three replicates. It was repeated in two consecutive years, with soil nutrient deficiencies only being corrected in the second year. The varieties Salanga, Kalinda, Supa and Kiroba were used in the experiment, while the NPK fertiliser treatments included; a control with no fertiliser applied; a moderate NPK treatment (50 kg N + 10 kg P + 50 kg K/ha); and a high NPK treatment (100 kg N + 25 kg P + 100 kg K/ha). A potassium only treatment (50 kg K/ha) was also included, but mainly for comparison. The root HCN levels of Salanga, Kalinda and Kiroba were significantly influenced by NPK fertiliser application in at least one of the two field experiments, while those of Supa remained uninfluenced. Changes in plant nutritional status in response to fertiliser application were thus shown to influence cyanogenic glucoside production. The results of the multiple linear regression analysis for the first field experiment, generally showed that the root HCN levels of some cassava varieties could have been 'reduced' by decreasing concentrations of nitrogen, potassium and magnesium in plants, or by improving plant calcium concentrations along with NPK fertiliser application. However, in the second field experiment (with corrected soil nutrient deficiencies) the regression analysis generally showed that the root HCN levels of some cassava varieties could have been 'reduced' by improving either one or a combination of the nutrients phosphorous, zinc and potassium in plants along with NPK fertiliser application. Although the results obtained in the two experiments had been contradicting due to slight differences in how they were conducted, the study had nonetheless demonstrated the occurrence of meaningful relationships between plant nutritional status and cyanogenic glucoside production; confirming the possible use of plant tissue analysis in predicting fertiliser needs for the consistent attainment of low cyanogenic glucosides in cassava roots.	[Imakumbili, Matema L. E.; Semu, Ernest; Semoka, Johnson M. R.] Sokoine Univ Agr, Dept Soils & Geol Sci, Morogoro, Tanzania; [Abass, Adebayo] Int Inst Trop Agr, Dar Es Salaam, Tanzania; [Mkamilo, Geoffrey] Naliendele Agr Res Inst, Roots & Tubers Dept, Mtwara, Tanzania	Sokoine University of Agriculture	Imakumbili, MLE (corresponding author), Sokoine Univ Agr, Dept Soils & Geol Sci, Morogoro, Tanzania.	imakumbili@gmail.com	Imakumbili, Matema/W-1755-2019		Alliance for a Green Revolution in Africa (AGRA) through its Soil Health Program (SHP); Sokoine University of Agriculture (AGRA) [2009 SHP 027]; Australian National University (ANU); Bill and Melinda Gates Foundation; AGRA SHP [OPP48790]	Alliance for a Green Revolution in Africa (AGRA) through its Soil Health Program (SHP); Sokoine University of Agriculture (AGRA); Australian National University (ANU)(Australian National University); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); AGRA SHP	This work was made possible with funding from the Alliance for a Green Revolution in Africa (AGRA) (https://agra.org/) through its Soil Health Program (SHP). AGRA had provided MLEI a scholarship to study at Sokoine University of Agriculture (AGRA Grant number 2009 SHP 027). Partial funding had also been given to MLEI for cassava cyanide analysis by Dr J.H. Bradbury from the Australian National University (ANU) (http://www.anu.edu.au/).Funding was also separately provided by the Bill and Melinda Gates Foundation (https://www.gatesfoundation.org/) to cover the cost of publication; on the basis of their support to the AGRA SHP (Grant number OPP48790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekayode F. O., 2013, 11th African Crop Science Proceedings, Sowing innovations for sustainable food and nutrition security in Africa. Entebbe, Uganda, 14-17 October, 2013, P773; Agbede TM, 2018, PERTANIKA J TROP AGR, V41, P1757; Aliyu IA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218969; Alou I.N., 2014, SCH J AGR SCI, V4, P420; Amanullah M. M., 2007, International Journal of Agricultural Sciences, V3, P181; Azucenatopor V, 2008, J NAT SCI, V13, P25; Bennett JG, 1979, MTWARA LINDI REGIONA, V2; Bennett JG, 1979, MTWARA LINDI REGIONA, V1; Bradbury MG, 1999, J SCI FOOD AGR, V79, P593, DOI 10.1002/(SICI)1097-0010(19990315)79:4<593::AID-JSFA222>3.0.CO;2-2; Burns AE, 2012, J AGR FOOD CHEM, V60, P4946, DOI 10.1021/jf2047288; Cadavid LF, 1998, FIELD CROP RES, V57, P45, DOI 10.1016/S0378-4290(97)00114-7; Chotineeranat S., 2006, Kasetsart Journal, Natural Sciences, V40, P694; Cuvaca I. B., 2015, Journal of Agricultural Science (Toronto), V7, P36; De Pauw E, 1984, GCSURT047 FAO UN; Edwards D. G., 1977, Proceedings of the 4th Symposium of the International Society for Tropical Root Crops. CIAT, Cali, Colombia; 1976, P124; Egan SV, 1998, J SCI FOOD AGR, V76, P39, DOI [10.1002/(SICI)1097-0010(199801)76:1<39::AID-JSFA947>3.0.CO;2-M, 10.1002/(SICI)1097-0010(199801)76:1&lt;39::AID-JSFA947&gt;3.0.CO;2-M]; El-Sharkawy MA, 2000, EXP AGR, V36, P323, DOI 10.1017/S0014479700003045; Essers A. A. J., 1994, ACTA HORTIC, V375, P97; Fageria VD, 2001, J PLANT NUTR, V24, P1269, DOI 10.1081/PLN-100106981; George, 2005, LONG TERM FERTILIZER; George J. C.R., 2001, CASSAVAS POTENTIAL A, P279; Gomez K.A., 1984, STAT PROCEDURES AGR; Gransee A, 2013, PLANT SOIL, V368, P5, DOI 10.1007/s11104-012-1567-y; Hochmuth G., 2017, FERTILIZER EXPT DATA; Howeler R., 2014, SUSTAINABLE SOIL CRO, P1; Howeler Reinhardt H., 2001, P115, DOI 10.1079/9780851995243.0115; HOWELER RH, 1990, FERT RES, V26, P61, DOI 10.1007/BF01048744; HOWELER RH, 1982, J PLANT NUTR, V5, P1059, DOI 10.1080/01904168209363038; Howeler RH, 2011, CASS HDB REF MAN BAS; Imakumbili MLE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216708; JARRELL WM, 1981, ADV AGRON, V34, P197, DOI 10.1016/S0065-2113(08)60887-1; Johnston M, 2005, CONTAINER GROWN EXPT; Landon J. R., 2014, ROUTLEDGE; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P369, DOI 10.1016/B978-0-12-384905-2.00015-7; Mkumbira J, 2003, EUPHYTICA, V132, P7, DOI 10.1023/A:1024619327587; Moberg JP, 2001, SOIL ANAL MANUAL; Motsara M., 2008, GUIDE LAB ESTABLISHM; Mowo JG, 1993, REV FERTILIZER REC 2; Nguyen H, 2002, J PLANT NUTR, V25, P425, DOI 10.1081/PLN-120003374; Nur Faezah O., 2013, African Journal of Biotechnology, V12, P2414; O'Neill M., 2010, REGRESSION GEN LINEA; OBIGBESAN GO, 1977, J AGR SCI, V89, P29, DOI 10.1017/S0021859600027167; Okwu D, 2001, J APPL CHEM AGR RES, V7, P112; Phengvichith V., 2006, Tropical and Subtropical Agroecosystems, V6, P177; Plank C. O., 1989, PLANT ANAL HDB GEORG; Pooja A. P., 2018, Trends in Biosciences, V11, P3297; Singleton PW, 1990, NIFTAL; Soil Survey Division Staff, 2017, AGR HDB, V18; Susan John K, 2007, J ROOT CROPS, V33, P20; Tan, 1995, J TROP AGR FOOD SCI, V23, P121; Uyoh EA, 2007, J FOOD AGRIC ENVIRON, V5, P105; Veldkamp WJ, 2001, ZONATION INTEGRATED, VI; WHO, 2011, WHO TECH REP SER, V960, P1	53	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228641	10.1371/journal.pone.0228641	http://dx.doi.org/10.1371/journal.pone.0228641			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053630	Green Published, gold			2022-12-26	WOS:000535198700040
J	Kuzmina, Y; Tikhomirova, T; Lysenkova, I; Malykh, S				Kuzmina, Yulia; Tikhomirova, Tatiana; Lysenkova, Irina; Malykh, Sergey			Domain-general cognitive functions fully explained growth in nonsymbolic magnitude representation but not in symbolic representation in elementary school children	PLOS ONE			English	Article							APPROXIMATE NUMBER SYSTEM; LINE ESTIMATION; NUMERICAL ESTIMATION; WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; PROCESSING SPEED; DEVELOPMENTAL-CHANGE; FLUID INTELLIGENCE; CLASS SIZE; SENSE	In this study, we aimed to compare developmental changes in nonsymbolic and symbolic magnitude representations across the elementary school years. For this aim, we used a four-wave longitudinal study with a one-year interval in schoolchildren in grades 1-4 in Russia and Kyrgyzstan (N = 490, mean age was 7.65 years at grade 1). The results of mixedeffects growth models revealed that growth in the precision of symbolic representation was larger than in the nonsymbolic representation. Moreover, growth in nonsymbolic representation was fully explained by growth in fluid intelligence (FI), visuospatial working memory (VSWM) and processing speed (PS). The analysis demonstrated that growth in nonsymbolic magnitude representation was significant only for pupils with a high level of FI and PS, whereas growth in precision of symbolic representation did not significantly vary across pupils with different levels of FI or VSWM.	[Kuzmina, Yulia; Tikhomirova, Tatiana; Malykh, Sergey] Lomonosov Moscow State Univ, Dept Psychol, Moscow, Russia; [Kuzmina, Yulia; Tikhomirova, Tatiana; Malykh, Sergey] Russian Acad Educ, Psychol Inst, Moscow, Russia; [Lysenkova, Irina] Kyrgyz Russian Slavic Univ, Dept Psychol, Bishkek, Kyrgyzstan	Lomonosov Moscow State University; Psychological Institute, Russian Academy of Education; Kyrgyz-Russian Slavic University	Malykh, S (corresponding author), Lomonosov Moscow State Univ, Dept Psychol, Moscow, Russia.; Malykh, S (corresponding author), Russian Acad Educ, Psychol Inst, Moscow, Russia.	malykhsb@mail.ru	Tikhomirova, Tatiana/N-3016-2014; Kuzmina, Yulia/I-3187-2015; Kuzmina, Julia/N-3636-2019; Malykh, Sergey/I-3697-2013	Tikhomirova, Tatiana/0000-0002-6748-763X; Kuzmina, Yulia/0000-0002-4243-8313; Kuzmina, Julia/0000-0002-4243-8313; Malykh, Sergey/0000-0002-3786-7447	Russian Science Foundation [17-78-30028]	Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported by a grant (No. 17-78-30028) from the Russian Science Foundation to S.Malykh. Russian Science Foundation (http://www.rscf.ru/en/).The funder had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Agrillo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004786; Ashcraft MH, 2012, J EXP CHILD PSYCHOL, V111, P246, DOI 10.1016/j.jecp.2011.08.005; Barth HC, 2011, DEVELOPMENTAL SCI, V14, P125, DOI 10.1111/j.1467-7687.2010.00962.x; Betts JR, 1999, EDUC EVAL POLICY AN, V21, P193, DOI 10.3102/01623737021002193; Blatchford P., 2003, CLASS SIZE DEBATE IS; Booth JL, 2006, DEV PSYCHOL, V42, P189, DOI 10.1037/0012-1649.41.6.189; BOYSEN ST, 1989, J COMP PSYCHOL, V103, P23, DOI 10.1037/0735-7036.103.1.23; Brankaer C, 2013, RES DEV DISABIL, V34, P3361, DOI 10.1016/j.ridd.2013.07.001; Cantlon JF, 2007, PLOS BIOL, V5, P2912, DOI 10.1371/journal.pbio.0050328; Cantlon JF, 2006, PLOS BIOL, V4, P844, DOI 10.1371/journal.pbio.0040125; Castronovo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033832; Coertjens L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182615; Curran PJ, 2010, J COGN DEV, V11, P121, DOI 10.1080/15248371003699969; De Smedt B, 2013, TRENDS NEUROSCI EDUC, V2, P48, DOI 10.1016/j.tine.2013.06.001; Deary IJ, 2001, INTELLIGENCE, V29, P389, DOI 10.1016/S0160-2896(01)00062-9; Dehaene S, 2003, TRENDS COGN SCI, V7, P145, DOI 10.1016/S1364-6613(03)00055-X; Dehaene S, 2001, MIND LANG, V16, P16, DOI 10.1111/1468-0017.00154; Dehaene S., 1995, MATH COGNITION, V1, P83, DOI DOI 10.1155/2014/461647; Dehaene S, 2008, SCIENCE, V320, P1217, DOI 10.1126/science.1156540; DeWind NK, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00068; Dietrich JF, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00295; Duncan TE, 2009, SOC PERSONAL PSYCHOL, V3, P979, DOI 10.1111/j.1751-9004.2009.00224.x; Ebersbach M, 2008, J EXP CHILD PSYCHOL, V99, P1, DOI 10.1016/j.jecp.2007.08.006; Fazio LK, 2014, J EXP CHILD PSYCHOL, V123, P53, DOI 10.1016/j.jecp.2014.01.013; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; FINN JD, 1990, AM EDUC RES J, V27, P557, DOI 10.3102/00028312027003557; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; Friso-van den Bos I, 2015, J EXP CHILD PSYCHOL, V134, P12, DOI 10.1016/j.jecp.2015.02.002; Friso-van Den Bos I, 2014, LEARN INDIVID DIFFER, V33, P23, DOI 10.1016/j.lindif.2014.05.003; Friso-van den Bos I, 2014, J COGN DEV, V15, P325, DOI 10.1080/15248372.2012.742900; Fry AF, 2000, BIOL PSYCHOL, V54, P1, DOI 10.1016/S0301-0511(00)00051-X; Fry AF, 1996, PSYCHOL SCI, V7, P237, DOI 10.1111/j.1467-9280.1996.tb00366.x; Geary DC, 2008, DEV NEUROPSYCHOL, V33, P277, DOI 10.1080/87565640801982361; Geary DC, 2011, DEV PSYCHOL, V47, P1539, DOI 10.1037/a0025510; Gebuis T, 2016, ACTA PSYCHOL, V171, P17, DOI 10.1016/j.actpsy.2016.09.003; Gignac GE, 2015, INTELLIGENCE, V52, P71, DOI 10.1016/j.intell.2015.07.006; Gilmore C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067374; Gilmore CK, 2007, NATURE, V447, P589, DOI 10.1038/nature05850; Goffin C, 2019, MIND BRAIN ED; Guillaume M, 2013, ACTA PSYCHOL, V144, P506, DOI 10.1016/j.actpsy.2013.09.001; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Halberda J, 2012, P NATL ACAD SCI USA, V109, P11116, DOI 10.1073/pnas.1200196109; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P1441, DOI 10.1098/rspb.2003.2414; Honore N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166685; Hornung C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00272; Hox J. J., 2017, MULTILEVEL ANAL TECH; Hyde DC, 2014, COGNITION, V131, P92, DOI 10.1016/j.cognition.2013.12.007; Inglis M, 2014, ACTA PSYCHOL, V145, P147, DOI 10.1016/j.actpsy.2013.11.009; Kucian K, 2011, NEUROIMAGE, V57, P782, DOI 10.1016/j.neuroimage.2011.01.070; Laski EV, 2007, CHILD DEV, V78, P1723, DOI 10.1111/j.1467-8624.2007.01087.x; LeFevre JA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00641; Libertus ME, 2011, DEVELOPMENTAL SCI, V14, P1292, DOI 10.1111/j.1467-7687.2011.01080.x; Lindskog M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00462; Lipton JS, 2005, CHILD DEV, V76, P978, DOI 10.1111/j.1467-8624.2005.00891.x; Lipton JS, 2004, INFANCY, V5, P271, DOI 10.1207/s15327078in0503_2; Lipton JS, 2003, PSYCHOL SCI, V14, P396, DOI 10.1111/1467-9280.01453; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Lukowski SL, 2017, INTELLIGENCE, V65, P67, DOI 10.1016/j.intell.2017.08.005; Lynn R, 2004, INTELLIGENCE, V32, P411, DOI 10.1016/j.intell.2004.06.007; Lyons IM, 2015, J EXP PSYCHOL GEN, V144, P1021, DOI 10.1037/xge0000094; Matejko AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149863; Moeller K, 2009, J EXP CHILD PSYCHOL, V103, P503, DOI 10.1016/j.jecp.2009.02.006; Mundy E, 2009, J EXP CHILD PSYCHOL, V103, P490, DOI 10.1016/j.jecp.2009.02.003; Mussolin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091839; Nys J, 2013, TRENDS NEUROSCI EDUC, V2, P13, DOI 10.1016/j.tine.2013.01.001; Odic D, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12533; Odic D, 2013, DEV PSYCHOL, V49, P1103, DOI 10.1037/a0029472; Pagulayan KF, 2006, J CLIN EXP NEUROPSYC, V28, P1043, DOI 10.1080/13803390500350977; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2013, PSYCHOL SCI, V24, P1037, DOI 10.1177/0956797612464057; Piazza M, 2010, COGNITION, V116, P33, DOI 10.1016/j.cognition.2010.03.012; Praet M, 2014, LEARN INSTR, V33, P19, DOI 10.1016/j.learninstruc.2014.02.003; Price GR, 2017, COGNITIVE DEV, V44, P139, DOI 10.1016/j.cogdev.2017.09.003; Purpura DJ, 2018, COGNITIVE DEV, V45, P31, DOI 10.1016/j.cogdev.2017.11.001; Raven J.C., 1998, ADV PROGR MATRICES; Sasanguie D, 2017, PSYCHOL RES-PSYCH FO, V81, P231, DOI 10.1007/s00426-015-0734-1; Scarf D, 2011, SCIENCE, V334, P1664, DOI 10.1126/science.1213357; Schneider M, 2018, CHILD DEV, V89, P1467, DOI 10.1111/cdev.13068; Sheppard LD, 2008, PERS INDIV DIFFER, V44, P535, DOI 10.1016/j.paid.2007.09.015; Siegler RS, 2004, CHILD DEV, V75, P428, DOI 10.1111/j.1467-8624.2004.00684.x; Siegler RS, 2003, PSYCHOL SCI, V14, P237, DOI 10.1111/1467-9280.02438; Simms V, 2016, J EXP CHILD PSYCHOL, V145, P22, DOI 10.1016/j.jecp.2015.12.004; Starr A, 2017, COGNITION, V168, P222, DOI 10.1016/j.cognition.2017.07.004; StataCorp LP, 2017, STAT STAT SOFTW REL, V15; Tikhomirova T, 2019, DEVELOPMENTAL SCI, V27; Toll SWM, 2015, LEARN INDIVID DIFFER, V38, P10, DOI 10.1016/j.lindif.2014.12.006; Tosto MG, 2014, INTELLIGENCE, V43, P35, DOI 10.1016/j.intell.2013.12.007; Tosto MG, 2017, DEV PSYCHOL, V53, P1924, DOI 10.1037/dev0000331; Tosto MG, 2013, PROCD SOC BEHV, V86, P423, DOI 10.1016/j.sbspro.2013.08.591; van der Ven AHGS, 2000, PERS INDIV DIFFER, V29, P45, DOI 10.1016/S0191-8869(99)00177-4; van't Noordende JE, 2016, PSYCHOL RES-PSYCH FO, V80, P368, DOI 10.1007/s00426-015-0736-z; Whalen J, 1999, PSYCHOL SCI, V10, P130, DOI 10.1111/1467-9280.00120; Wong TTY, 2016, CONTEMP EDUC PSYCHOL, V46, P208, DOI 10.1016/j.cedpsych.2016.06.003; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9; Zebian S, 2012, PSYCHON B REV, V19, P93, DOI 10.3758/s13423-011-0175-9; Zimprich D, 2002, PSYCHOL AGING, V17, P690, DOI 10.1037/0882-7974.17.4.690	97	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228960	10.1371/journal.pone.0228960	http://dx.doi.org/10.1371/journal.pone.0228960			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9KA	32045454	Green Published, gold			2022-12-26	WOS:000534633200049
J	Timme, S; Brand, R				Timme, Sinika; Brand, Ralf			Affect and exertion during incremental physical exercise: Examining changes using automated facial action analysis and experiential self-report	PLOS ONE			English	Article							FROWNING MUSCLE-ACTIVITY; AFFECTIVE RESPONSES; ACTIVITY REFLECTS; EXPRESSIONS; FACE; DISPLEASURE; INTENSITIES; PERCEPTION; TRACKING; PLEASURE	Recent research indicates that affective responses during exercise are an important determinant of future exercise and physical activity. Thus far these responses have been measured with standardized self-report scales, but this study used biometric software for automated facial action analysis to analyze the changes that occur during physical exercise. A sample of 132 young, healthy individuals performed an incremental test on a cycle ergometer. During that test the participants' faces were video-recorded and the changes were algorithmically analyzed at frame rate (30 fps). Perceived exertion and affective valence were measured every two minutes with established psychometric scales. Taking into account anticipated inter-individual variability, multilevel regression analysis was used to model how affective valence and ratings of perceived exertion (RPE) covaried with movement in 20 facial action areas. We found the expected quadratic decline in self-reported affective valence (more negative) as exercise intensity increased. Repeated measures correlation showed that the facial action mouth open was linked to changes in (highly intercorrelated) affective valence and RPE. Multilevel trend analyses were calculated to investigate whether facial actions were typically linked to either affective valence or RPE. These analyses showed that mouth open and jaw drop predicted RPE, whereas (additional) nose wrinkle was indicative for the decline in affective valence. Our results contribute to the view that negative affect, escalating with increasing exercise intensity, may be the body's essential warning signal that physiological overload is imminent. We conclude that automated facial action analysis provides new options for researchers investigating feelings during exercise. In addition, our findings offer physical educators and coaches a new way of monitoring the affective state of exercisers, without interrupting and asking them.	[Timme, Sinika; Brand, Ralf] Univ Potsdam, Sport & Exercise Psychol, Potsdam, Germany	University of Potsdam	Brand, R (corresponding author), Univ Potsdam, Sport & Exercise Psychol, Potsdam, Germany.	ralf.brand@uni-potsdam.de	Brand, Ralf/A-6079-2009	Brand, Ralf/0000-0003-3143-4816; Timme, Sinika/0000-0002-7599-3583				Affectiva, 2018, EM SDK; Alvarez-Alvarado S, 2019, J SPORT EXERCISE PSY, V41, P107, DOI 10.1123/jsep.2018-0336; Bakdash JZ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00456; Barrett LF, 2019, PSYCHOL SCI PUBL INT, V20, P1, DOI 10.1177/1529100619832930; Bennett DS, 2002, INFANCY, V3, P97, DOI 10.1207/S15327078IN0301_5; Borg G., 1998, BORGS PERCEIVED EXER; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brand R, 2018, GER J EXERC SPORT RE, V48, P48, DOI [10.1007/s12662-017-0477-9, 10.1007/s12662-017-0450-7]; Camras LA, 2007, INFANCY, V11, P131, DOI 10.1111/j.1532-7078.2007.tb00219.x; Cohn JF, 1999, PSYCHOPHYSIOLOGY, V36, P35, DOI 10.1017/S0048577299971184; Conroy DE, 2017, EXERC SPORT SCI REV, V45, P230, DOI 10.1249/JES.0000000000000120; de Morree HM, 2012, EUR J APPL PHYSIOL, V112, P1967, DOI 10.1007/s00421-011-2138-2; de Morree HM, 2010, BIOL PSYCHOL, V85, P377, DOI 10.1016/j.biopsycho.2010.08.009; Ekkekakis P, 2003, COGNITION EMOTION, V17, P213, DOI 10.1080/02699930302292; Ekkekakis P, 2008, ANN BEHAV MED, V35, P136, DOI 10.1007/s12160-008-9025-z; Ekkekakis P, 2019, PSYCHOL SPORT EXERC, V42, P130, DOI 10.1016/j.psychsport.2018.12.018; Ekkekakis P, 2011, SPORTS MED, V41, P641, DOI 10.2165/11590680-000000000-00000; EKMAN P, 1980, J PERS SOC PSYCHOL, V39, P1125, DOI 10.1037/h0077722; Ekman P., 2002, MANUAL INVESTIGATORS; Ekman P., 2002, FACIAL ACTION CODING; GANCHROW JR, 1983, INFANT BEHAV DEV, V6, P473, DOI 10.1016/S0163-6383(83)90301-6; HARDY CJ, 1989, J SPORT EXERCISE PSY, V11, P304, DOI 10.1123/jsep.11.3.304; Hartman ME, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.186585; Huang DH, 2014, J SPORT SCI MED, V13, P921; Korte T, 2000, Z KARDIOL, V89, P1019, DOI 10.1007/s003920070154; Kulke L, 2018, PSYARXIV; Kunz M, 2012, PAIN, V153, P350, DOI 10.1016/j.pain.2011.10.027; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lieberman MD, 2007, PSYCHOL SCI, V18, P421, DOI 10.1111/j.1467-9280.2007.01916.x; Lien JJJ, 2000, ROBOT AUTON SYST, V31, P131, DOI 10.1016/S0921-8890(99)00103-7; Long JD, 2012, LONGITUDINAL DATA AN, DOI [10.3389/fpsyg.2017.00456, DOI 10.3389/FPSYG.2017.00456]; McDuff D., 2016, 2016 CHI C EXTENDED, P3723, DOI [DOI 10.1145/2851581.2890247, 10.1145/2851581.2890247]; Miles KH, 2018, J SPORT SCI, V36, P934, DOI 10.1080/02640414.2017.1346275; Overbeek TJM, 2014, BIOL PSYCHOL, V99, P1, DOI 10.1016/j.biopsycho.2014.02.006; Philippen P. B, 2012, J SPORT BEHAV, V34, P337; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; R Core Team R, 2019, LANG ENV STAT COMP; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Rhodes RE, 2015, ANN BEHAV MED, V49, P715, DOI 10.1007/s12160-015-9704-5; Roecker K, 2003, INT J SPORTS MED, V24, P173, DOI 10.1055/s-2003-39087; ROZIN P, 1994, J PERS SOC PSYCHOL, V66, P870, DOI 10.1037//0022-3514.66.5.870; Russell J.A., 2009, OXFORD COMPANION EMO, P104; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Stekelenburg JJ, 2001, PSYCHOPHYSIOLOGY, V38, P629, DOI 10.1111/1469-8986.3840629; Tudor-Locke C, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-60; Uchida MC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208834; Vail A.K., 2016, P 2016 C US MOD AD P, P65, DOI DOI 10.1145/2930238.2930257; van Boxtel A., 2010, 7 METH TECHN BEH RES; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb	50	11	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228739	10.1371/journal.pone.0228739	http://dx.doi.org/10.1371/journal.pone.0228739			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9KA	32045442	Green Published, gold			2022-12-26	WOS:000534633200036
J	Brasier, K; Ward, B; Smith, J; Seago, J; Oakes, J; Balota, M; Davis, P; Fountain, M; Brown-Guedira, G; Sneller, C; Thomason, W; Griffey, C				Brasier, Kyle; Ward, Brian; Smith, Jared; Seago, John; Oakes, Joseph; Balota, Maria; Davis, Paul; Fountain, Myron; Brown-Guedira, Gina; Sneller, Clay; Thomason, Wade; Griffey, Carl			Identification of quantitative trait loci associated with nitrogen use efficiency in winter wheat	PLOS ONE			English	Article							HEAD BLIGHT RESISTANCE; TRITICUM-AESTIVUM L.; GRAIN PROTEIN; GENETIC PROGRESS; HEXAPLOID WHEAT; SPRING WHEAT; MAPPING QTLS; YIELD; SELECTION; REGISTRATION	Maintaining winter wheat (Triticum aestivum L.) productivity with more efficient nitrogen (N) management will enable growers to increase profitability and reduce the negative environmental impacts associated with nitrogen loss. Wheat breeders would therefore benefit greatly from the identification and application of genetic markers associated with nitrogen use efficiency (NUE). To investigate the genetics underlying N response, two bi-parental mapping populations were developed and grown in four site-seasons under low and high N rates. The populations were derived from a cross between previously identified high NUE parents (VA05W-151 and VA09W-52) and a shared common low NUE parent, 'Yorktown.' The Yorktown x VA05W-151 population was comprised of 136 recombinant inbred lines while the Yorktown x VA09W-52 population was comprised of 138 doubled haploids. Phenotypic data was collected on parental lines and their progeny for 11 N-related traits and genotypes were sequenced using a genotyping-by-sequencing platform to detect more than 3,100 high quality single nucleotide polymorphisms in each population. A total of 130 quantitative trait loci (QTL) were detected on 20 chromosomes, six of which were associated with NUE and N-related traits in multiple testing environments. Two of the six QTL for NUE were associated with known photoperiod (Ppd-D1 on chromosome 2D) and disease resistance (FHB-4A) genes, two were reported in previous investigations, and one QTL, QNue.151-1D, was novel. The NUE QTL on 1D, 6A, 7A, and 7D had LOD scores ranging from 2.63 to 8.33 and explained up to 18.1% of the phenotypic variation. The QTL identified in this study have potential for marker-assisted breeding for NUE traits in soft red winter wheat.	[Brasier, Kyle; Seago, John; Balota, Maria; Thomason, Wade; Griffey, Carl] Virginia Tech, Sch Plant & Environm Sci, Blacksburg, VA 24061 USA; [Ward, Brian; Smith, Jared; Brown-Guedira, Gina] USDA ARS, Eastern Reg Small Grains Genotyping Lab, Raleigh, NC 27695 USA; [Oakes, Joseph] Eastern Virginia Agr Res & Extens Ctr, Warsaw, VA USA; [Davis, Paul] Virginia Tech, Extens, New Kent, VA USA; [Fountain, Myron] USDA ARS, Agr Res, Raleigh, NC 27695 USA; [Sneller, Clay] Ohio State Univ, Dept Crops & Hort, Wooster, OH USA; [Brasier, Kyle] Calif State Univ Chico, Coll Agr, Chico, CA 95929 USA	Virginia Polytechnic Institute & State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University System of Ohio; Ohio State University; California State University System; California State University Chico	Brasier, K (corresponding author), Virginia Tech, Sch Plant & Environm Sci, Blacksburg, VA 24061 USA.; Brasier, K (corresponding author), Calif State Univ Chico, Coll Agr, Chico, CA 95929 USA.	brasier1@vt.edu		Ward, Brian/0000-0002-4129-7934; Brasier, Kyle/0000-0002-9944-0983	Virginia Small Grains Board	Virginia Small Grains Board	Funding for this project was provided by the Virginia Small Grains Board (http://www.virginiagrains.com/leadership/va-small-grainsboard/) -KB and CG The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this project was provided by the Virginia Small Grains Board. The authors would like to thank Anthony Christopher, Jon Light, Michelle Lee, Elizabeth Hokanson, Harry Behl and William Myers for assistance collecting field data and Steve Nagle for providing technical assistance in the analysis of tissue N concentration.	An DG, 2006, PLANT SOIL, V284, P73, DOI 10.1007/s11104-006-0030-3; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Balut AL, 2013, CROP SCI, V53, P934, DOI 10.2135/cropsci2012.09.0550; Barraclough PB, 2010, EUR J AGRON, V33, P1, DOI 10.1016/j.eja.2010.01.005; Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Bogard M, 2013, MOL BREEDING, V31, P587, DOI 10.1007/s11032-012-9817-5; Bogard M, 2011, J EXP BOT, V62, P3621, DOI 10.1093/jxb/err061; Bordes J, 2013, THEOR APPL GENET, V126, P805, DOI 10.1007/s00122-012-2019-z; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brasier K., 2019, AGRON J, V111, P1, DOI [10.2134/agronj2018.10.0693, DOI 10.2134/AGR0NJ2018.10.0693]; Brasier KG, 2018, CROP SCI, V58, P2593, DOI 10.2135/cropsci2018.03.0207; Buchi L, 2016, FIELD CROP RES, V191, P111, DOI 10.1016/j.fcr.2016.02.022; Carpenter NR, 2017, CROP SCI, V57, P2991, DOI 10.2135/cropsci2017.03.0143; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chao SM, 2007, CROP SCI, V47, P1018, DOI 10.2135/cropsci2006.06.0434; Chao SM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-727; Cormier F, 2016, PLANT BREEDING, V135, P255, DOI 10.1111/pbr.12371; Cormier F, 2014, THEOR APPL GENET, V127, P2679, DOI 10.1007/s00122-014-2407-7; Cormier F, 2013, THEOR APPL GENET, V126, P3035, DOI 10.1007/s00122-013-2191-9; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cui F, 2016, THEOR APPL GENET, V129, P469, DOI 10.1007/s00122-015-2641-7; Cui F, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-57; DHUGGA KS, 1989, CROP SCI, V29, P1232, DOI 10.2135/cropsci1989.0011183X002900050029x; Doerge RW, 1996, GENETICS, V142, P285; DOVIDIO R, 1995, THEOR APPL GENET, V91, P189, DOI 10.1007/BF00220876; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fontaine JX, 2009, THEOR APPL GENET, V119, P645, DOI 10.1007/s00122-009-1076-4; Frels K, 2018, FIELD CROP RES, V217, P82, DOI 10.1016/j.fcr.2017.12.004; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Garcia-Suarez JV, 2010, CEREAL RES COMMUN, V38, P459, DOI 10.1556/CRC.38.2010.4.2; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Griffey CA, 2003, CROP SCI, V43, P1134, DOI 10.2135/cropsci2003.1134; Guttieri MJ, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1869-5; Habash DZ, 2007, THEOR APPL GENET, V114, P403, DOI 10.1007/s00122-006-0429-5; Hamilton DP, 2016, AQUAT ECOL, V50, P351, DOI 10.1007/s10452-016-9594-z; Han M, 2015, ANNU REV GENET, V49, P269, DOI 10.1146/annurev-genet-112414-055037; Hitz K, 2017, FIELD CROP RES, V200, P1, DOI 10.1016/j.fcr.2016.10.001; Hofer S, 2001, 12107062A LACH INSTR; Hu B, 2015, NAT GENET, V47, P834, DOI 10.1038/ng.3337; Huang M, 2016, THEOR APPL GENET, V129, P1697, DOI 10.1007/s00122-016-2733-z; Hussain W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16006-z; Kariyawasam GK, 2018, MOL BREEDING, V38, DOI 10.1007/s11032-018-0901-3; Knepel K., 2001, SALINE METHODS ANAL, P31; Kolmer JA, 2018, THEOR APPL GENET, V131, P1553, DOI 10.1007/s00122-018-3097-3; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kubota H, 2018, CROP SCI, V58, P1542, DOI 10.2135/cropsci2017.10.0598; Laperche A, 2006, THEOR APPL GENET, V113, P1131, DOI 10.1007/s00122-006-0373-4; Laperche A, 2007, THEOR APPL GENET, V115, P399, DOI 10.1007/s00122-007-0575-4; Latshaw SP, 2016, AGRON J, V108, P2201, DOI 10.2134/agronj2016.02.0070; Le Gouis J, 2000, EUR J AGRON, V12, P163, DOI 10.1016/S1161-0301(00)00045-9; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li XP, 2011, NEW PHYTOL, V189, P449, DOI 10.1111/j.1469-8137.2010.03490.x; LIN CS, 1985, CAN J PLANT SCI, V65, P743, DOI 10.4141/cjps85-094; Liu S., 2019, GLOBAL CHANGE BIOL; Mahjourimajd S, 2016, PLANT SOIL, V399, P247, DOI 10.1007/s11104-015-2694-z; McCartney CA, 2007, MOL BREEDING, V20, P209, DOI 10.1007/s11032-007-9084-z; McKendry AL, 2007, J PLANT REGIST, V1, P21, DOI 10.3198/jpr2006.06.0405crc; Meng L, 2015, CROP J, V3, P269, DOI 10.1016/j.cj.2015.01.001; MOLL RH, 1982, AGRON J, V74, P562, DOI 10.2134/agronj1982.00021962007400030037x; Monostori I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189265; Murphy JP, 2004, CROP SCI, V44, P1479, DOI 10.2135/cropsci2004.1479; OrtizMonasterio JI, 1997, CROP SCI, V37, P898, DOI 10.2135/cropsci1997.0011183X003700030033x; Pavuluri K, 2015, PRECIS AGRIC, V16, P405, DOI 10.1007/s11119-014-9385-2; Petersen S, 2016, CROP SCI, V56, P1473, DOI 10.2135/cropsci2015.05.0312; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pozzo T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204525; Quraishi UM, 2011, PLANT J, V65, P745, DOI 10.1111/j.1365-313X.2010.04461.x; R Core Team, 2013, R LANG ENV STAT COMP; Reynolds M, 2012, PLANT CELL ENVIRON, V35, P1799, DOI 10.1111/j.1365-3040.2012.02588.x; Salameh A, 2011, MOL BREEDING, V28, P485, DOI 10.1007/s11032-010-9498-x; Shiferaw B, 2013, FOOD SECUR, V5, P291, DOI 10.1007/s12571-013-0263-y; Simmonds J, 2016, THEOR APPL GENET, V129, P1099, DOI 10.1007/s00122-016-2686-2; Sinha E, 2017, SCIENCE, V357, P405, DOI 10.1126/science.aan2409; Steiner B, 2017, TROP PLANT PATHOL, V42, P165, DOI 10.1007/s40858-017-0127-7; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Sun JJ, 2013, EUPHYTICA, V191, P317, DOI 10.1007/s10681-012-0834-6; Swaney DP, 2018, SCI TOTAL ENVIRON, V635, P498, DOI 10.1016/j.scitotenv.2018.04.027; Tamang BG, 2017, J PLANT NUTR SOIL SC, V180, P316, DOI 10.1002/jpln.201600312; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Van Deynze A, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006352; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Ward BP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208217; Wilde F, 2007, MOL BREEDING, V19, P357, DOI 10.1007/s11032-006-9067-5; Worland AJ, 1998, THEOR APPL GENET, V96, P1110, DOI 10.1007/s001220050846; Wurschum T, 2018, THEOR APPL GENET, V131, P2071, DOI 10.1007/s00122-018-3133-3; Xu YF, 2014, THEOR APPL GENET, V127, P59, DOI 10.1007/s00122-013-2201-y; You FM, 2016, CROP J, V4, P107, DOI 10.1016/j.cj.2016.01.003; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang MX, 2019, MOL BREEDING, V39, DOI 10.1007/s11032-019-0965-8; Zheng BS, 2010, THEOR APPL GENET, V121, P1501, DOI 10.1007/s00122-010-1406-6	93	12	12	6	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0228775	10.1371/journal.pone.0228775	http://dx.doi.org/10.1371/journal.pone.0228775			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092066	Green Published, gold			2022-12-26	WOS:000535229300013
J	Dolk, H; McCullough, N; Callaghan, S; Casey, F; Craig, B; Given, J; Loane, M; Lagan, BM; Bunting, B; Boyle, B; Dabir, T				Dolk, Helen; McCullough, Nichola; Callaghan, Sinead; Casey, Frank; Craig, Brian; Given, Joanne; Loane, Maria; Lagan, Briege M.; Bunting, Brendan; Boyle, Breidge; Dabir, Tabib			Risk factors for congenital heart disease: The Baby Hearts Study, a population-based case-control study	PLOS ONE			English	Article							BODY-MASS INDEX; FOLIC-ACID SUPPLEMENTATION; MATERNAL SMOKING; BIRTH-DEFECTS; ANTIDEPRESSANT USE; LIFE EVENTS; METAANALYSIS; PREGNANCY; MALFORMATIONS; ASSOCIATION	We investigated the role of maternal environmental factors in the aetiology of congenital heart disease (CHD). A population-based case-control study (242 CHD cases, 966 controls) was conducted using an iPad questionnaire for mother with linkage to maternity and first trimester prescription records. Risk of CHD was associated with low maternal education (OR adjusted for confounders 1.59; 95% confidence interval [CI], 1.02-2.49), pregestational diabetes (OR 4.04; 95% CI 1.00-16.28), self-reported maternal clotting disorders (adjOR 8.55, 95%CI 1.51-48.44), prescriptions for the anticlotting medication enoxaparin (adjOR 3.22, 95%CI 1.01-10.22) and self-reported vaginal infections (adjOR 1.69, 95%CI 1.01-2.80). There was no strong support for the hypothesis that periconceptional folic acid supplements have a protective effect, but there was a protective effect of frequent consumption of folate rich fruits (adjOR 0.64, 95%CI 0.47-0.89). Compared to the most common pre-pregnancy dietary pattern, CHD risk was associated with a poor diet low in fruit and vegetables (adjOR 1.56, 95%CI 1.05-2.34). Mothers of cases reported more pregnancy related stress (adjOR 1.69; 95% CI 1.22-2.34) and multiple stressors (adjOR 1.94, 95%CI 0.83-4.53). We found no supportive evidence for CHD risk being associated with obesity, smoking, depression or antidepressant use in this population. Our findings add to the previous evidence base to show potential for public health approaches to help prevent CHD in future by modifying environmental factors. Independent confirmation should be sought regarding elevated CHD risk associated with maternal blood clotting disorders and their treatment, since we are the first to report this.	[Dolk, Helen; McCullough, Nichola; Given, Joanne; Loane, Maria; Lagan, Briege M.; Boyle, Breidge] Ulster Univ, Inst Nursing & Hlth Res, Newtownabbey, North Ireland; [Callaghan, Sinead; Casey, Frank; Craig, Brian] Royal Belfast Hosp Sick Children, Dept Cardiol, Belfast, Antrim, North Ireland; [Bunting, Brendan] Ulster Univ, Sch Psychol, Coleraine, Londonderry, North Ireland; [Dabir, Tabib] Belfast City Hosp, Dept Genet Med, Belfast, Antrim, North Ireland; [Boyle, Breidge] Queens Univ Belfast, Sch Nursing & Midwifery, Belfast, Antrim, North Ireland	Ulster University; Ulster University; Belfast City Hospital; Queens University Belfast	Dolk, H (corresponding author), Ulster Univ, Inst Nursing & Hlth Res, Newtownabbey, North Ireland.	h.dolk@ulster.ac.uk	casey, frank/GSI-9643-2022; Given, Joanne/J-3484-2017	Dolk, Helen/0000-0001-6639-5904; Given, Joanne/0000-0003-4921-1944; Loane, Maria/0000-0002-1206-3637	Northern Ireland Chest, Heart and Stroke [2013_21, 7C637139180782760415]; Children's Heartbeat Trust	Northern Ireland Chest, Heart and Stroke; Children's Heartbeat Trust	This study was funded by a grant from Northern Ireland Chest, Heart and Stroke 2013_21 https://eur03.safelinks.protection.outlook.com/? url=https%3A%2F%2Fnichs.org.uk%2F&data= 02%7C01%7Ch.dolk%40ulster.ac.uk% 7C6d431106effd4aa65a7208d792b55eb0% 7C6f0b94874fa842a8aeb4bf2e2c22d4e8%7C0% 7C0%7C637139180782760415&sdata=NBc1t1 TBGA5zhrhhnoTCpdDghkmtI82S35zYLDGKCV4% 3D&reserved=0, with additional support from Children's Heartbeat Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha MM, 2011, BIRTH DEFECTS RES A, V91, P1011, DOI 10.1002/bdra.22857; Baardman ME, 2012, HEART, V98, P474, DOI 10.1136/heartjnl-2011-300822; Ban L, 2014, BJOG-INT J OBSTET GY, V121, P1471, DOI 10.1111/1471-0528.12682; Berard A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013372; Botto LD, 2001, EPIDEMIOLOGY, V12, P485, DOI 10.1097/00001648-200109000-00004; Byrne B.M., 2012, STRUCTURAL EQUATION, P3; Carmichael SL, 2007, EPIDEMIOLOGY, V18, P356, DOI 10.1097/01.ede.0000259986.85239.87; Carmichael SL, 2016, BIRTH DEFECTS RES A, V106, P164, DOI 10.1002/bdra.23471; Ford Holly B, 2009, Rev Obstet Gynecol, V2, P76; Gao SY, 2017, BRIT J CLIN PHARMACO, V83, P2134, DOI 10.1111/bcp.13321; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE293, DOI 10.4088/JCP.12r07966; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; Hansen D, 2000, LANCET, V356, P875, DOI 10.1016/S0140-6736(00)02676-3; Helle E, 2017, J PEDIAT, V195, P275; Hobbs CA, 2006, AM J OBSTET GYNECOL, V194, P218, DOI 10.1016/j.ajog.2005.06.016; Houyel L, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-64; Huybrechts KF, 2014, NEW ENGL J MED, V370, P2397, DOI 10.1056/NEJMoa1312828; Jimenez-Solem E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001148; Krauss RS, 2016, CURR TOP DEV BIOL, V116, P569, DOI 10.1016/bs.ctdb.2015.12.010; Lambrot R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3889; Leirgul E, 2015, PAEDIATR PERINAT EP, V29, P391, DOI 10.1111/ppe.12212; Lofvenborg JE, 2016, EUR J ENDOCRINOL, V175, P605, DOI 10.1530/EJE-16-0376; Luteijn JM, 2014, HUM REPROD, V29, P809, DOI 10.1093/humrep/det455; McCullough N, 2019, INT J POPUL DATA SCI, V4, P1; Myles N, 2013, AUST NZ J PSYCHIAT, V47, P1002, DOI 10.1177/0004867413492219; Nembhard WN, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j832; Nettleton JA, 2009, DIABETES CARE, V32, P688, DOI 10.2337/dc08-1799; Northern Irish Statistics and Research Agency, 2010, NO IR MULT DEPR MEAS; Obermann-Borst SA, 2011, BJOG-INT J OBSTET GY, V118, P1205, DOI 10.1111/j.1471-0528.2011.02984.x; Parnell AS, 2017, MATERN CHILD HLTH J, V21, P1105, DOI 10.1007/s10995-016-2209-4; Persson M, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2563; Priest JR, 2015, JAMA PEDIATR, V169, P1112, DOI 10.1001/jamapediatrics.2015.2831; Reef SE, 2006, CLIN INFECT DIS, V43, pS126, DOI 10.1086/505944; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Royal College of Obstetricians and Gynaecologists, 2015, GREEN TOP GUID; Schleich JM, 2013, ARCH CARDIOVASC DIS, V106, P612, DOI 10.1016/j.acvd.2013.07.001; Shaw GM, 2010, BIRTH DEFECTS RES A, V88, P144, DOI 10.1002/bdra.20648; Shlomo M, 2017, DRUG SAFETY, V40, P1147, DOI 10.1007/s40264-017-0573-7; Simeone RM, 2015, AM J PREV MED, V48, P195, DOI 10.1016/j.amepre.2014.09.002; Sotres-Alvarez D, 2013, AM J EPIDEMIOL, V177, P1279, DOI 10.1093/aje/kws349; Sotres-Alvarez D, 2010, J NUTR, V140, P2253, DOI 10.3945/jn.110.124909; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Vrijheid M, 2000, ARCH DIS CHILD, V82, P349, DOI 10.1136/adc.82.5.349; Wemakor A, 2015, EUR J EPIDEMIOL, V30, P1187, DOI 10.1007/s10654-015-0065-y; Wurst KE, 2010, BIRTH DEFECTS RES A, V88, P159, DOI 10.1002/bdra.20627; Xu AP, 2016, INT HEART J, V57, P725, DOI 10.1536/ihj.16-054; Zaidi S, 2017, CIRC RES, V120, P923, DOI 10.1161/CIRCRESAHA.116.309140; Zhang DY, 2017, J MATERN-FETAL NEO M, V30, P645, DOI 10.1080/14767058.2016.1183640; Zhu JL, 2013, PEDIATRICS, V131, pE1225, DOI 10.1542/peds.2012-3024; Zhu Y, 2018, CONGENIT HEART DIS, V13, P271, DOI 10.1111/chd.12567	50	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0227908	10.1371/journal.pone.0227908	http://dx.doi.org/10.1371/journal.pone.0227908			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092068	Green Published, gold			2022-12-26	WOS:000535229300008
J	Graner, M; Pointon, T; Manton, S; Green, M; Dennison, K; Davis, M; Braiotta, G; Craft, J; Edwards, T; Polonsky, B; Fringuello, A; Vollmer, T; Yu, XL				Graner, Michael; Pointon, Tiffany; Manton, Sean; Green, Miyoko; Dennison, Kathryn; Davis, Mollie; Braiotta, Gino; Craft, Julia; Edwards, Taylor; Polonsky, Bailey; Fringuello, Anthony; Vollmer, Timothy; Yu, Xiaoli			Oligoclonal IgG antibodies in multiple sclerosis target patient-specific peptides	PLOS ONE			English	Article							EXPANDED PLASMA-CELLS; CEREBROSPINAL-FLUID; B-CELLS; BANDS; MYELIN; IDENTIFICATION; BRAIN; PATHOGENESIS; PROGNOSIS; DIAGNOSIS	IgG oligoclonal bands (OCBs) are present in the cerebrospinal fluid (CSF) of more than 95% of patients with multiple sclerosis (MS), and are considered to be the immunological hallmark of disease. However, the target specificities of the IgG in MS OCBs have remained undiscovered. Nevertheless, evidence that OCBs are associated with increased levels of disease activity and disability support their probable pathological role in MS. We investigated the antigen specificity of individual MS CSF IgG from 20 OCB-positive patients and identified 40 unique peptides by panning phage-displayed random peptide libraries. Utilizing our unique techniques of phage-mediated real-time Immuno-PCR and phage-probed iso-electric focusing immunoblots, we demonstrated that these peptides were targeted by intrathecal oligoclonal IgG antibodies of IgG1 and IgG3 subclasses. In addition, we showed that these peptides represent epitopes sharing sequence homologies with proteins of viral origin, and proteins involved in cell stress, apoptosis, and inflammatory processes. Although homologous peptides were found within individual patients, no shared peptide sequences were found among any of the 42 MS and 13 inflammatory CSF control specimens. The distinct sets of oligoclonal IgG-reactive peptides identified by individual MS CSF suggest that the elevated intrathecal antibodies may target patient-specific antigens.	[Graner, Michael; Craft, Julia; Fringuello, Anthony; Yu, Xiaoli] Univ Colorado, Dept Neurosurg, Anschutz Med Campus, Aurora, CO 80045 USA; [Pointon, Tiffany; Manton, Sean; Green, Miyoko; Dennison, Kathryn; Davis, Mollie; Braiotta, Gino; Edwards, Taylor; Polonsky, Bailey; Vollmer, Timothy] Univ Colorado, Dept Neurol, Anschutz Med Campus, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Yu, XL (corresponding author), Univ Colorado, Dept Neurosurg, Anschutz Med Campus, Aurora, CO 80045 USA.	Xiaoli.Yu@CUanschutz.edu			National Multiple Sclerosis Society [RG 3934A1/1]	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	Y XY received Research Award (RG 3934A1/1) from National Multiple Sclerosis Society, https://www.nationalmssociety.org/.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avasarala JR, 2001, ARCH NEUROL-CHICAGO, V58, P2044, DOI 10.1001/archneur.58.12.2044; Bankoti J, 2014, ANN NEUROL, V75, P266, DOI 10.1002/ana.24088; Bashford-Rogers RJM, 2018, IMMUNOLOGY, V155, P3, DOI 10.1111/imm.12927; Beseler C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186842; Blauth K, 2015, ACTA NEUROPATHOL, V130, P765, DOI 10.1007/s00401-015-1500-6; Brandle SM, 2016, P NATL ACAD SCI USA, V113, P7864, DOI 10.1073/pnas.1522730113; Breij ECW, 2008, ANN NEUROL, V63, P16, DOI 10.1002/ana.21311; Breij ECW, 2006, J NEUROIMMUNOL, V176, P106, DOI 10.1016/j.jneuroim.2006.03.014; Calabrese M, 2012, BRAIN, V135, P2952, DOI 10.1093/brain/aws246; CAROSCIO JT, 1986, ARCH NEUROL-CHICAGO, V43, P1129, DOI 10.1001/archneur.1986.00520110029009; EWAN PW, 1979, CLIN EXP IMMUNOL, V35, P227; Farina G, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0812-y; Ferreira D, 2014, J NEUROIMMUNOL, V274, P149, DOI 10.1016/j.jneuroim.2014.06.010; Fitzner B, 2015, AUTOIMMUN REV, V14, P903, DOI 10.1016/j.autrev.2015.06.001; Franciotta D, 2008, LANCET NEUROL, V7, P852, DOI 10.1016/S1474-4422(08)70192-3; GARCIAMERINO A, 1986, J NEUROL NEUROSUR PS, V49, P1066, DOI 10.1136/jnnp.49.9.1066; GILDEN D, 1979, J NEUROSCI METH, V1, P133, DOI 10.1016/0165-0270(79)90010-4; GLYNN P, 1982, CLIN EXP IMMUNOL, V48, P102; Greve B, 2001, J NEUROIMMUNOL, V121, P120, DOI 10.1016/S0165-5728(01)00436-2; GRIMALDI LME, 1986, ITAL J NEUROL SCI, V7, P507, DOI 10.1007/BF02342029; Ingram G, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-53; Joseph FG, 2009, J NEUROL NEUROSUR PS, V80, P292, DOI 10.1136/jnnp.2008.150896; Liu YT, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0428-6; LOSY J, 1990, ACTA NEUROL SCAND, V82, P4; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; McLaughlin KA, 2008, ADV IMMUNOL, V98, P121, DOI 10.1016/S0065-2776(08)00404-5; MEHTA PD, 1981, J NEUROL SCI, V49, P91, DOI 10.1016/0022-510X(81)90191-X; Meinl E, 2011, J NEUROL SCI, V311, pS12, DOI 10.1016/S0022-510X(11)70003-X; Navas-Madronal M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175538; Owens GP, 2009, ANN NEUROL, V65, P639, DOI 10.1002/ana.21641; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2; Tintore M, 2008, J NEUROL SCI, V274, P80, DOI 10.1016/j.jns.2008.08.036; Weber MS, 2011, BBA-MOL BASIS DIS, V1812, P239, DOI 10.1016/j.bbadis.2010.06.009; Willis SN, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00600; Yu XL, 2007, J IMMUNOL METHODS, V326, P33, DOI 10.1016/j.jim.2007.07.003; Yu XL, 2006, J IMMUNOL METHODS, V316, P67, DOI 10.1016/j.jim.2006.08.006; Yu XL, 2011, J NEUROIMMUNOL, V240, P129, DOI 10.1016/j.jneuroim.2011.10.009; Yu XL, 2009, J VIROL METHODS, V156, P169, DOI 10.1016/j.jviromet.2008.11.009; Zipoli V, 2009, MULT SCLER J, V15, P472, DOI 10.1177/1352458508100502	40	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0228883	10.1371/journal.pone.0228883	http://dx.doi.org/10.1371/journal.pone.0228883			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084151	Green Published, gold			2022-12-26	WOS:000535227900034
J	Hatami-Marbini, H; Pachenari, M				Hatami-Marbini, Hamed; Pachenari, Mohammad			The contribution of sGAGs to stress-controlled tensile response of posterior porcine sclera	PLOS ONE			English	Article							FORM DEPRIVATION MYOPIA; BIOMECHANICAL PROPERTIES; MECHANICAL-BEHAVIOR; ARTICULAR-CARTILAGE; GLYCOSAMINOGLYCANS; HYDRATION; TENDON; INFLATION; DEGRADATION; DEPLETION	Despite the significant progress in characterizing mechanical functions of individual scleral extracellular matrix (ECM) components, the biomechanical contribution of sulfated glycosaminoglycans (sGAGs) is still poorly understood. The primary purpose of this study was to determine the possible function of sGAGs in scleral mechanical response by characterizing the tensile behavior of normal and sGAG-depleted samples. We used chondroitinase ABC solution to remove sGAGs from scleral samples that were dissected from posterior porcine eyes. We performed biochemical analyses for assessing the efficacy of sGAG removal protocol. Furthermore, we conducted stress-controlled uniaxial tensile tests to characterize the influence of sGAG removal on mechanical properties of sclera. The tensile behavior of scleral strips right after dissection and after being soaked in buffer was also determined. Biochemical analyses confirmed that 18 hour incubation in 0.125 U/ml Chondroitinase ABC solution removed over 90% of chondroitin and dermatan sGAGs. No significant difference was observed in the thickness/hydration of samples because of enzyme- and buffer-treated samples. Furthermore, it was found that sGAG depletion did not significantly alter the tangent modulus, energy dissipation, and peak strain of posterior scleral strips. It was concluded that sGAGs did not influence the stress-controlled viscoelastic tensile response of sclera.	[Hatami-Marbini, Hamed; Pachenari, Mohammad] Univ Illinois, Dept Mech & Ind Engn, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Hatami-Marbini, H (corresponding author), Univ Illinois, Dept Mech & Ind Engn, Chicago, IL 60607 USA.	hatami@uic.edu		Hatami-Marbini, Hamed/0000-0002-6693-2121	National Science Foundation [1351461]; College of Engineering and Mechanical & Industrial Engineering Department at the University of Illinois at Chicago	National Science Foundation(National Science Foundation (NSF)); College of Engineering and Mechanical & Industrial Engineering Department at the University of Illinois at Chicago	The authors would like to acknowledge the support by National Science Foundation: Grant No. 1351461, and the College of Engineering and Mechanical & Industrial Engineering Department at the University of Illinois at Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], [No title captured]; Avetisov E, 1982, METAB PED SYST OPHTH, V7, P183; Boubriak OA, 2003, EXP EYE RES, V76, P701, DOI 10.1016/S0014-4835(03)00053-8; Campbell IC, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026286; Clark SJ, 2011, INVEST OPHTH VIS SCI, V52, P6511, DOI 10.1167/iovs.11-7909; Collins AT, 2019, ANN BIOMED ENG, V47, P190, DOI 10.1007/s10439-018-02143-7; Coudrillier B, 2012, INVEST OPHTH VIS SCI, V53, P1714, DOI 10.1167/iovs.11-8009; Downs JC, 2005, INVEST OPHTH VIS SCI, V46, P540, DOI 10.1167/iovs.04-0114; Elsheikh A, 2005, J R SOC INTERFACE, V2, P177, DOI 10.1098/rsif.2005.0034; Elsheikh A, 2010, EXP EYE RES, V90, P624, DOI 10.1016/j.exer.2010.02.010; Fessel G, 2011, J THEOR BIOL, V268, P77, DOI 10.1016/j.jtbi.2010.10.007; Fessel G, 2009, MATRIX BIOL, V28, P503, DOI 10.1016/j.matbio.2009.08.002; Fukuchi T, 2009, JPN J OPHTHALMOL, V53, P171, DOI 10.1007/s10384-008-0641-8; Geraghty B, 2012, J MECH BEHAV BIOMED, V16, P181, DOI 10.1016/j.jmbbm.2012.10.011; Hatami-Marbini H, 2015, J CATARACT REFR SURG, V41, P644, DOI 10.1016/j.jcrs.2014.07.029; Hatami-Marbini H, 2014, ANN BIOMED ENG, V42, P1740, DOI 10.1007/s10439-014-0996-6; Hatami-Marbini H, 2014, J MECH BEHAV BIOMED, V36, P90, DOI 10.1016/j.jmbbm.2014.03.011; Hatami-Marbini H, 2014, EXP EYE RES, V120, P103, DOI 10.1016/j.exer.2013.11.017; Hatami-Marbini H, 2013, EXP EYE RES, V116, P47, DOI 10.1016/j.exer.2013.07.016; Hatami-Marbini H, 2013, CURR EYE RES, V38, P1124, DOI 10.3109/02713683.2013.809769; Lari DR, 2012, EXP EYE RES, V94, P128, DOI 10.1016/j.exer.2011.11.017; Legerlotz K, 2013, ACTA BIOMATER, V9, P6860, DOI 10.1016/j.actbio.2013.02.028; Lujan TJ, 2007, J ORTHOP RES, V25, P894, DOI 10.1002/jor.20351; Lujan TJ, 2009, J APPL PHYSIOL, V106, P423, DOI 10.1152/japplphysiol.90748.2008; Muir H., 1983, PROTEOGLYCANS ORG IN; Murienne BJ, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0367; Murienne BJ, 2015, ACTA BIOMATER, V12, P195, DOI 10.1016/j.actbio.2014.10.033; Norton Thomas T., 1999, ILAR J, V40, P59; NORTON TT, 1995, VISION RES, V35, P1271, DOI 10.1016/0042-6989(94)00243-F; PHILLIPS JR, 1995, OPHTHAL PHYSL OPT, V15, P357, DOI 10.1016/0275-5408(95)00062-I; Rada JA, 2000, INVEST OPHTH VIS SCI, V41, P2050; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Redaelli A, 2003, J BIOMECH, V36, P1555, DOI 10.1016/S0021-9290(03)00133-7; Rigozzi S, 2013, J BIOMECH, V46, P813, DOI 10.1016/j.jbiomech.2012.11.017; SCHMIDT MB, 1990, J ORTHOPAED RES, V8, P353, DOI 10.1002/jor.1100080307; Schultz DS, 2008, INVEST OPHTH VIS SCI, V49, P4232, DOI 10.1167/iovs.08-1970; Siegwart JT, 1999, VISION RES, V39, P387, DOI 10.1016/S0042-6989(98)00150-3; Svensson RB, 2011, CONNECT TISSUE RES, V52, P415, DOI 10.3109/03008207.2010.551569; Szczesny SE, 2017, J ORTHOP RES, V35, P2127, DOI 10.1002/jor.23517; Tezel G, 1999, ARCH OPHTHALMOL-CHIC, V117, P917; Toyras J, 1999, PHYS MED BIOL, V44, P2723, DOI 10.1088/0031-9155/44/11/303; Trier K., 2005, ADV ORGAN BIOL, V10, P353, DOI DOI 10.1016/S1569-2590(05)10013-5; Wallman J, 2004, NEURON, V43, P447, DOI 10.1016/j.neuron.2004.08.008; Watson PG, 2004, EXP EYE RES, V78, P609, DOI 10.1016/S0014-4835(03)00212-4; Wu JY, 2018, J THEOR BIOL, V437, P202, DOI 10.1016/j.jtbi.2017.10.018; ZHU WB, 1993, J ORTHOPAED RES, V11, P771, DOI 10.1002/jor.1100110602; Zhuola L, 2017, INT J EXPT PATHOLOGY	47	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0227856	10.1371/journal.pone.0227856	http://dx.doi.org/10.1371/journal.pone.0227856			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084141	gold, Green Published			2022-12-26	WOS:000535227900010
J	Mitchell, UH; Bowden, JA; Larson, RE; Belavy, DL; Owen, PJ				Mitchell, Ulrike H.; Bowden, Jennifer A.; Larson, Robert E.; Belavy, Daniel L.; Owen, Patrick J.			Long-term running in middle-aged men and intervertebral disc health, a cross-sectional pilot study	PLOS ONE			English	Article							DIFFUSION; CLASSIFICATION; DEGENERATION; WATER	Purpose To measure intervertebral disc (IVD) health parameters in middle-aged long-term runners compared to matched non-physically active controls. Methods Seventeen males aged 44-62yr were included in the study: 9 runners with a running history of > 10yr, averaging > 50km/week, and eight matched non-physically active controls, the data from one participant had to be excluded. T2-relaxometry, diffusion weighted imaging, T1- and T2-weighted MR scanning, as well as T2 time mapping were performed. Morphological data relating to IVD were extrapolated. Results Compared to controls on average, runners had 20% greater IVD height (p = 0.002) and seven percentage points greater IVD-vertebral body height ratio (p = 0.001). No significant differences were observed between groups for mean(SD) IVD hydration status, as indicated by similar T2-times (runners: 94.4(11.1)ms, controls: 88.6(23.6)ms), or apparent diffusion coefficients (runners: 249.0(175.2)mm(2)/s, controls: 202.3(149.5)mm(2)/s). Average Pfirrmann score for the L5-S1 IVD was 2.2(0.7) for runners and 3.3(1.0) for controls (p = 0.026), average scores for all lumbar levels (L2-S1) were 1.9(0.2) and 2.5(0.7), respectively (p = 0.036). Anterior annulus T2-time and overall average lumbar level Pfirrmann grades were strongly correlated (r = 0.787, p = 0.021 and r = -0.704, p = 0.034, respectively) with greater distances run per week. Average lumbar level Pfirrmann grades were also strongly correlated (r = -0.823, p = 0.006) to total years of running. Conclusion Middle-aged long-term endurance runners exhibit less age-related decline in their lumbar IVDs. In addition, the measures of IVD morphology appeared to be better in those who had been running for a greater number of years, as well as in those who ran a greater distance per week.	[Mitchell, Ulrike H.; Bowden, Jennifer A.; Larson, Robert E.] Brigham Young Univ, Dept Exercise Sci, Provo, UT 84602 USA; [Belavy, Daniel L.; Owen, Patrick J.] Deakin Univ, Sch Exercise & Nutr Sci, Inst Phys Act & Nutr, Geelong, Vic, Australia	Brigham Young University; Deakin University	Mitchell, UH (corresponding author), Brigham Young Univ, Dept Exercise Sci, Provo, UT 84602 USA.	rike_mitchell@byu.edu	Belavy, Daniel/P-4947-2016; Owen, Patrick J/R-3054-2019	Belavy, Daniel/0000-0002-9307-832X; Owen, Patrick J/0000-0003-3924-9375; Bowden, Jennifer/0000-0003-4959-675X; Mitchell, Ulrike/0000-0002-2298-8756				ADAMS MA, 1983, SPINE, V8, P665, DOI 10.1097/00007632-198309000-00013; Beattie PF, 2008, J ORTHOP SPORT PHYS, V38, P42, DOI 10.2519/jospt.2008.2631; Beattie PF, 2009, J ORTHOP SPORT PHYS, V39, P4, DOI 10.2519/jospt.2009.2994; Belavy DL, 2017, SCI REP-UK, V7, DOI 10.1038/srep45975; Belavy DL, 2016, SPORTS MED, V46, P473, DOI 10.1007/s40279-015-0444-2; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; Bowden JA, 2017, J ORTHOP RES; Dimitriadis AT, 2011, J INT MED RES, V39, P569, DOI 10.1177/147323001103900226; Fairbank J C, 1980, Physiotherapy, V66, P271; Fearing BV, 2018, JOR SPINE, V1; Ferguson SJ, 2003, EUR SPINE J, V12, pS97, DOI 10.1007/s00586-003-0621-0; Grunhagen T, 2006, J BONE JOINT SURG AM, V88A, P30, DOI 10.2106/JBJS.E.01290; Guiot BH, 2000, NEUROSURGERY, V47, P1034, DOI 10.1097/00006123-200011000-00003; Gullbrand SE, 2015, SPINE, V40, P1158, DOI 10.1097/BRS.0000000000001012; Hawthorne G, 2007, QUAL LIFE RES, V16, P661, DOI 10.1007/s11136-006-9154-4; Iatridis JC, 2006, J BONE JOINT SURG AM, V88A, P41, DOI 10.2106/JBJS.E.01407; Lou C, 2017, MENOPAUSE; Ma DY, 2013, CLIN INTERV AGING, V8, P1047, DOI 10.2147/CIA.S49698; Marinelli NL, 2009, SPINE, V34, P520, DOI 10.1097/BRS.0b013e318195dd44; Mitchell UH, 2017, MUSCULOSKEL SCI PRAC, V31, P1, DOI 10.1016/j.msksp.2017.06.004; Oh Chang Hyun, 2017, Korean J Spine, V14, P148, DOI 10.14245/kjs.2017.14.4.148; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; PUCHE RC, 1995, BONE, V17, P239, DOI 10.1016/8756-3282(95)00212-V; Teraguchi M, 2014, OSTEOARTHR CARTILAGE, V22, P104, DOI 10.1016/j.joca.2013.10.019; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Videman T, 2010, SPINE J, V10, P26, DOI 10.1016/j.spinee.2009.10.005; Zhang ZP, 2012, MAGN RESON IMAGING, V30, P181, DOI 10.1016/j.mri.2011.09.021	27	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229457	10.1371/journal.pone.0229457	http://dx.doi.org/10.1371/journal.pone.0229457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084224	Green Published, gold			2022-12-26	WOS:000535227900109
J	Nix, DA; Hellwig, S; Conley, C; Thomas, A; Fuertes, CL; Hamil, CL; Bhetariya, PJ; Garrido-Laguna, I; Marth, GT; Bronner, MP; Underhill, HR				Nix, David A.; Hellwig, Sabine; Conley, Christopher; Thomas, Alun; Fuertes, Carrie L.; Hamil, Cindy L.; Bhetariya, Preetida J.; Garrido-Laguna, Ignacio; Marth, Gabor T.; Bronner, Mary P.; Underhill, Hunter R.			The stochastic nature of errors in next-generation sequencing of circulating cell-free DNA	PLOS ONE			English	Article							CLONAL HEMATOPOIESIS; RARE MUTATIONS; CANCER; PLASMA; QUANTIFICATION	Challenges with distinguishing circulating tumor DNA (ctDNA) from next-generation sequencing (NGS) artifacts limits variant searches to established solid tumor mutations. Here we show early and random PCR errors are a principal source of NGS noise that persist despite duplex molecular barcoding, removal of artifacts due to clonal hematopoiesis of indeterminate potential, and suppression of patterned errors. We also demonstrate sample duplicates are necessary to eliminate the stochastic noise associated with NGS. Integration of sample duplicates into NGS analytics may broaden ctDNA applications by removing NGS-related errors that confound identification of true very low frequency variants during searches for ctDNA without a priori knowledge of specific mutations to target.	[Nix, David A.; Conley, Christopher; Garrido-Laguna, Ignacio] Univ Utah, Huntsman Canc Inst, Sch Med, Salt Lake City, UT USA; [Hellwig, Sabine] ARUP Labs, Salt Lake City, UT USA; [Thomas, Alun] Univ Utah, Dept Family & Preventat Med, Div Genet Epidemiol, Salt Lake City, UT USA; [Thomas, Alun] Univ Utah, Dept Family & Preventat Med, Div Publ Hlth, Salt Lake City, UT USA; [Fuertes, Carrie L.; Hamil, Cindy L.; Bronner, Mary P.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Bhetariya, Preetida J.; Marth, Gabor T.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Underhill, Hunter R.] Univ Utah, Dept Pediat, Div Med Genet, Salt Lake City, UT 84132 USA; [Underhill, Hunter R.] Univ Utah, Dept Radiol, Salt Lake City, UT 84132 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Underhill, HR (corresponding author), Univ Utah, Dept Pediat, Div Med Genet, Salt Lake City, UT 84132 USA.; Underhill, HR (corresponding author), Univ Utah, Dept Radiol, Salt Lake City, UT 84132 USA.	Hunter.Underhill@hsc.utah.edu	Garrido-Laguna, Ignacio/ABD-1875-2020	Garrido-Laguna, Ignacio/0000-0003-2273-9028; Hellwig, Sabine/0000-0002-9809-947X	National Cancer Institute of the National Institutes of Health [R37CA246183]; Biorepository and Molecular Pathology Shared Resource; Cancer Biostatistics Shared Resource - Cancer Center Support Grant [P30CA04014]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR001067]	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biorepository and Molecular Pathology Shared Resource; Cancer Biostatistics Shared Resource - Cancer Center Support Grant; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The study received grant support (HRU; R37CA246183) from the National Cancer Institute of the National Institutes of Health (https://www.cancer.gov).This study was conducted with support from the Biorepository and Molecular Pathology Shared Resource and the Cancer Biostatistics Shared Resource supported by the Cancer Center Support Grant awarded to the Huntsman Cancer Institute by the National Cancer Institute (P30CA04014). This study was supported in part with funding for author AT from the National Center for Advancing Translational Sciences of the National Institutes of Health (https://ncats.nih.gov) through Grant UL1TR001067 (formerly UL1TR000105 and UL1RR025764). ARUP Laboratories, a commercial company, provided support in the form of salary for author SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of each author is articulated in the `author contributions' section.	Abbosh C, 2017, NATURE, V545, P446, DOI 10.1038/nature22364; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Head SR, 2014, BIOTECHNIQUES, V56, P61, DOI 10.2144/000114133; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Kennedy SR, 2014, NAT PROTOC, V9, P2586, DOI 10.1038/nprot.2014.170; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kukita Y, 2015, DNA RES, V22, P269, DOI 10.1093/dnares/dsv010; MacConaill LE, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4428-5; Manley Leigh J, 2016, J Biomol Tech, V27, P125; Newman AM, 2016, NAT BIOTECHNOL, V34, P547, DOI 10.1038/nbt.3520; Newman AM, 2016, NAT BIOTECHNOL; Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Siravegna G, 2017, NAT REV CLIN ONCOL, V14, P531, DOI 10.1038/nrclinonc.2017.14; Steensma DP, 2015, BLOOD, V126, P9, DOI 10.1182/blood-2015-03-631747; Sun K, 2015, P NATL ACAD SCI USA, V112, pE5503, DOI 10.1073/pnas.1508736112	19	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229063	10.1371/journal.pone.0229063	http://dx.doi.org/10.1371/journal.pone.0229063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084206	Green Published, Green Submitted, gold			2022-12-26	WOS:000535227900045
J	D'Atanasio, N; de Joannon, AC; Di Sante, L; Mangano, G; Ombrato, R; Vitiello, M; Bartella, C; Magaro, G; Prati, F; Milanese, C; Vignaroli, C; Di Giorgio, FP; Tongiani, S				D'Atanasio, Noemi; de Joannon, Alessandra Capezzone; Di Sante, Laura; Mangano, Giorgina; Ombrato, Rosella; Vitiello, Marco; Bartella, Cristina; Magaro, Gabriele; Prati, Federica; Milanese, Claudio; Vignaroli, Carla; Di Giorgio, Francesco Paolo; Tongiani, Serena			Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors	PLOS ONE			English	Article							IN-VITRO; ESCHERICHIA-COLI; RESISTANCE; GYRASE; NOVOBIOCIN; MECHANISM; SPECTRUM; MUTANTS; ROLES	In this study, a drug discovery programme that sought to identify novel dual bacterial topoisomerase II inhibitors (NBTIs) led to the selection of six optimized compounds. In enzymatic assays, the molecules showed equivalent dual-targeting activity against the DNA gyrase and topoisomerase IV enzymes of Staphylococcus aureus and Escherichia coli. Consistently, the compounds demonstrated potent activity in susceptibility tests against various Gram-positive and Gram-negative reference species, including ciprofloxacin-resistant strains. The activity of the compounds against clinical multidrug-resistant isolates of S. aureus, Clostridium difficile, Acinetobacter baumannii, Neisseria gonorrhoeae, E. coli and vancomycin-resistant Enterococcus spp. was also confirmed. Two compounds (1 and 2) were tested in time-kill and post-antibiotic effect (PAE) assays. Compound 1 was bactericidal against all tested reference strains and showed higher activity than ciprofloxacin, and compound 2 showed a prolonged PAE, even against the ciprofloxacin-resistant S. aureus BAA-1720 strain. Spontaneous development of resistance to both compounds was selected for in S. aureus at frequencies comparable to those obtained for quinolones and other NBTIs. S. aureus BAA-1720 mutants resistant to compounds 1 and 2 had single point mutations in gyrA or gyrB outside of the quinolone resistance-determining region (QRDR), confirming the distinct site of action of these NBTIs compared to that of quinolones. Overall, the very good antibacterial activity of the compounds and their optimizable in vitro safety and physicochemical profile may have relevant implications for the development of new broad-spectrum antibiotics.	[D'Atanasio, Noemi; de Joannon, Alessandra Capezzone; Mangano, Giorgina; Ombrato, Rosella; Vitiello, Marco; Bartella, Cristina; Magaro, Gabriele; Prati, Federica; Milanese, Claudio; Di Giorgio, Francesco Paolo; Tongiani, Serena] Angelini SpA, Angelini RR&D Regulatory Res & Dev, Rome, Italy; [Di Sante, Laura; Vignaroli, Carla] Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy	Marche Polytechnic University	D'Atanasio, N (corresponding author), Angelini SpA, Angelini RR&D Regulatory Res & Dev, Rome, Italy.	noemi.datanasio@angelinipharma.com		Prati, Federica/0000-0002-8483-7646	Angelini S.p.A.; EUREKA project - Angelini S.p.A.; Regione Marche, Universita Politecnica delle Marche (UNIVPM) [740, 812]	Angelini S.p.A.; EUREKA project - Angelini S.p.A.; Regione Marche, Universita Politecnica delle Marche (UNIVPM)	This work was funded by Angelini S.p.A. Angelini S.p.A. provided support in the form of salaries for NDA, ACJ, GM, RO, MV, CB, GM, CM, FPDG and ST. LDS was supported by a grant in the context of the EUREKA project co-funded by Angelini S.p.A. and by Regione Marche, Universita Politecnica delle Marche (UNIVPM -Decreti Rettorali no. 740 July 2013 and no. 812 September 2013). The specific roles of these authors are articulated in the "author contributions" section. The funder had a role in the study design, data collection and analysis, decision to publish and preparation of the manuscript through the provision of expert decision-making input from the preclinical management teams.	Abrams P, 2006, BRIT J PHARMACOL, V148, P565, DOI 10.1038/sj.bjp.0706780; Acar JF, 1997, CLIN INFECT DIS, V24, pS67, DOI 10.1093/clinids/24.Supplement_1.S67; Appelbaum PC, 2000, INT J ANTIMICROB AG, V16, P5, DOI 10.1016/S0924-8579(00)00192-8; Bax BD, 2010, NATURE, V466, P935, DOI 10.1038/nature09197; Biedenbach DJ, 2016, ANTIMICROB AGENTS CH, V60, P1918, DOI 10.1128/AAC.02820-15; Black MT, 2008, ANTIMICROB AGENTS CH, V52, P3339, DOI 10.1128/AAC.00496-08; Bush N. G., 2015, ECOSAL PLUS, V6, DOI [10.1128/ecosalplus.ESP-0010-2014, DOI 10.1128/ECOSALPLUS.ESP-0010-2014]; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Charrier C, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02100-16, 10.1128/aac.02100-16]; Clinical and Laboratory Standards Institute (CLSI), 2015, M07A10 CLIN LAB STAN, V10th; CLSI, 2012, M11A8 CLSI; COX RP, 1959, NEW ENGL J MED, V261, P139, DOI 10.1056/NEJM195907162610307; Danker T, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00203; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Dierks EA, 2001, DRUG METAB DISPOS, V29, P23; Dougherty TJ, 2014, ANTIMICROB AGENTS CH, V58, P2657, DOI 10.1128/AAC.02778-13; Dougherty TJ, 2014, 5463 AACNAP NBTI, V58; Drago L, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-119; Firsov AA, 1997, ANTIMICROB AGENTS CH, V41, P1281, DOI 10.1128/AAC.41.6.1281; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P4474, DOI 10.1073/pnas.73.12.4474; Gootz TD, 1999, ANTIMICROB AGENTS CH, V43, P1845, DOI 10.1128/AAC.43.8.1845; Hooper DC, 1999, DRUGS, V58, P6, DOI 10.2165/00003495-199958002-00002; Hooper DC, 2001, CLIN INFECT DIS, V32, pS9, DOI 10.1086/319370; Huband MD, 2015, ANTIMICROB AGENTS CH, V59, P467, DOI 10.1128/AAC.04124-14; HYNES WL, 1992, FEMS MICROBIOL LETT, V94, P139; ITO H, 1994, ANTIMICROB AGENTS CH, V38, P2014, DOI 10.1128/AAC.38.9.2014; Khodursky AB, 1998, J BIOL CHEM, V273, P27668, DOI 10.1074/jbc.273.42.27668; Knapp C, 1992, CLIN MICROBIOLOGY PR, P14; Lahiri SD, 2015, ANTIMICROB AGENTS CH, V59, P5278, DOI 10.1128/AAC.00571-15; Lautenbach E, 2014, INFECT CONT HOSP EP, V35, P333, DOI 10.1086/675592; Lorian V., 2005, ANTIBIOTICS LAB MED; Magaro G, 2019, J MED CHEM, V62, P7445, DOI 10.1021/acs.jmedchem.9b00394; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mani N, 2006, ANTIMICROB AGENTS CH, V50, P1228, DOI 10.1128/AAC.50.4.1228-1237.2006; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; McGann P, 2016, ANTIMICROB AGENTS CH, V60, P4420, DOI 10.1128/AAC.01103-16; Miles TJ, 2013, BIOORG MED CHEM LETT, V23, P5437, DOI 10.1016/j.bmcl.2013.07.013; MIZUUCHI K, 1980, P NATL ACAD SCI-BIOL, V77, P1847, DOI 10.1073/pnas.77.4.1847; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; ODENHOLTTORNQVIST I, 1993, J ANTIMICROB CHEMOTH, V31, P881, DOI 10.1093/jac/31.6.881; Ombrato R MG, 2017, INVENTORNEW ANTIBACT; Padilla E, 2010, ANTIMICROB AGENTS CH, V54, P177, DOI 10.1128/AAC.00715-09; Park HJ, 2003, BIOSCI BIOTECH BIOCH, V67, P1944, DOI 10.1271/bbb.67.1944; Patel J.B., 2015, PERFORMANCE STANDARD; Perrin D, 1998, BIOCHEM PHARMACOL, V56, P503, DOI 10.1016/S0006-2952(98)00082-3; Reck F, 2012, J MED CHEM, V55, P6916, DOI 10.1021/jm300690s; Redgrave LS, 2014, TRENDS MICROBIOL, V22, P438, DOI 10.1016/j.tim.2014.04.007; Rodriguez-Martinez JM, 2013, J ANTIMICROB CHEMOTH, V68, P68, DOI 10.1093/jac/dks377; Sanchez L, 1997, J BACTERIOL, V179, P6855, DOI 10.1128/jb.179.21.6855-6857.1997; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Spangler SK, 2000, ANTIMICROB AGENTS CH, V44, P186, DOI 10.1128/AAC.44.1.186-189.2000; Tam VH, 2013, ANTIMICROB AGENTS CH, V57, P1062, DOI 10.1128/AAC.01208-12; Tan CM, 2016, ANTIMICROB AGENTS CH, V60, P4830, DOI 10.1128/AAC.00619-16; Unemo M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1029-2; WANDERSMAN C, 1990, P NATL ACAD SCI USA, V87, P4776, DOI 10.1073/pnas.87.12.4776; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; World Health Organization, 2014, ANT RES GLOB REP SUR; Yuan JY, 2012, J ANTIMICROB CHEMOTH, V67, P1655, DOI 10.1093/jac/dks086; ZECHIEDRICH EL, 1995, GENE DEV, V9, P2859, DOI 10.1101/gad.9.22.2859; 2001, AM J INFECT CONTROL, V29, P404, DOI DOI 10.1067/MIC.2001	60	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228509	10.1371/journal.pone.0228509	http://dx.doi.org/10.1371/journal.pone.0228509			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074119	gold, Green Published			2022-12-26	WOS:000535220600017
J	Soboksa, NE; Gari, SR; Hailu, AB; Alemu, BM				Soboksa, Negasa Eshete; Gari, Sirak Robele; Hailu, Abebe Beyene; Alemu, Bezatu Mengistie			Association between microbial water quality, sanitation and hygiene practices and childhood diarrhea in Kersa and Omo Nada districts of Jimma Zone, Ethiopia	PLOS ONE			English	Article							HOUSEHOLD DRINKING-WATER; MIDDLE-INCOME SETTINGS; MICROBIOLOGICAL CONTAMINATION; SAFE STORAGE; CHILDREN; DISEASE; COMMUNITY; COUNTRIES; IMPACT	Introduction Diarrhea is one of the leading causes of child morbidity and mortality in low- and middle-income countries like Ethiopia. The use of safe drinking water and improved sanitation are important practices to prevent diarrhea. However, limited research has been done to link water supply, sanitation and hygiene practices and childhood diarrhea. Therefore, this study aimed at assessing the association between microbial quality of drinking water, sanitation and hygiene practices and childhood diarrhea. Methods Community-based matched case-control study design was applied on 198 paired children from June to July 2019 in Kersa and Omo Nada districts of Jimma Zone, Ethiopia. Cases are children < 5 years of age with diarrhea during the two weeks before the survey. The controls are children without diarrhea during the two weeks before the survey. Twenty-five percent matched pair samples of water were taken from households of cases and controls. Data were collected using structured questionnaire by interviewing mothers/caregivers. A sample of water was collected in nonreactive borosilicate glass bottles and analyzed by the membrane filtration method to count fecal indicator bacteria. A conditional logistic regression model was used; variables with p-value less than 0.05 were considered as significantly associated with childhood diarrhea. Results A total of 396 (each case matched with control) under-five children with their mothers/caregivers were included in this study. In the analysis, variables like presence of under-five child in their home (AOR = 2.76; 95% CI: 1.33-5.71), wealth status (AOR = 5.39; 95% CI: 1.99-14.55), main sources of drinking water (AOR = 4.01; 95% CI: 1.40-11.44), hand washing practice before water collection (AOR = 4.28; 95% CI: 1.46-12.56), treating water at household level (AOR = 1.22; 95% CI: 0.48-3.09), latrine use all the times of the day and night (AOR = 0.22; 95% CI: 0.06-0.78), using pit as method of waste disposal (AOR = 4.91; 95% CI: 1.39-13.29) and use of soap for hand washing (AOR = 2.89; 95% CI: 1.35-6.15) were significantly associated with childhood diarrhea. Moreover, 30% of sampled water from cases and 26% of sampled water from controls families were free from Escherichia coli whereas all sampled water analyzed for Total coliforms were positive. Conclusions We conclude that the main sources of drinking water, hand washing before water drawing from a storage container, domestic waste disposal place and use of soap for hand washing were the most important factors for the prevention of childhood diarrhea.	[Soboksa, Negasa Eshete; Gari, Sirak Robele] Addis Ababa Univ, Ethiopian Inst Water Resources, Addis Ababa, Ethiopia; [Hailu, Abebe Beyene] Jimma Univ, Dept Environm Hlth Sci, Jimma, Ethiopia; [Alemu, Bezatu Mengistie] Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia	Addis Ababa University; Jimma University; Haramaya University	Soboksa, NE (corresponding author), Addis Ababa Univ, Ethiopian Inst Water Resources, Addis Ababa, Ethiopia.	yeroosaa@gmail.com	Soboksa, Negasa Eshete/AAS-8611-2021; Gari, Sirak/AAG-6260-2021	Soboksa, Negasa Eshete/0000-0003-3451-175X; 	Addis Ababa University, Ethiopian Institute of Water Resources	Addis Ababa University, Ethiopian Institute of Water Resources	This work was supported by Addis Ababa University, Ethiopian Institute of Water Resources. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya D, 2018, J INFECT PUBLIC HEAL, V11, P69, DOI 10.1016/j.jiph.2017.04.007; Adane M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181516; Akoachere JTK, 2013, BMC PUBLIC HEALTH, V13, P1; Alebel A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199684; APHA, 2005, STANDARD METHODS EXA, V21st; Azage M, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0052-2; Azry F, 2018, BMC PUBLIC HEALTH, V18, P1; Brown JM, 2008, WATER SCI TECHNOL, V58, P757, DOI 10.2166/wst.2008.439; Centers for Disease Control and Prevention (CDC), 2014, WAT REL DIS CONT PUB; Central Statistical Agency [Ethiopia], 2014, ETH MIN DEM HLTH SUR; Chiller TM, 2006, B WORLD HEALTH ORGAN, V84, P28, DOI 10.2471/BLT.04.016980; Clasen T, 2007, BMJ-BRIT MED J, V334, P782, DOI 10.1136/bmj.39118.489931.BE; Dagnew AB, 2019, BMC INFECT DIS, P3; Degebasa MZ, 2018, PEDIATR HEALTH MED T, V9, P109, DOI 10.2147/PHMT.S159366; Diouf K, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24895; Ejemot-Nwadiaro RI, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004265.pub3; Emina JBO, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001930; Federal Democratic Republic of Ethiopia Ministry of Health, 2012, IMPL PROGR GUID CLTS; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Asfaha KF, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1098-7; Getachew B., 2018, E AFRICAN J HLTH BIO, V2, P26; Godana W., 2013, SC J PUBLIC HLTH, V1, P119, DOI DOI 10.11648/J.SJPH.20130103.12; Graham N., 1998, GUIDELINES DRINKING, V2nd, DOI [10.1016/S1462-0758(00)00006-6, DOI 10.1016/S1462-0758(00)00006-6]; Hashi Abdiwahab, 2017, Prev Med Rep, V6, P361, DOI 10.1016/j.pmedr.2017.04.011; Heitzinger K, 2015, AM J TROP MED HYG, V93, P501, DOI 10.4269/ajtmh.14-0802; Id SY, 2018, TROP MED INFECT DIS, V3, P1; Jimma Zonal Health Office, 2019, DIS PREV CONTR DEP A; Kampf G, 2004, CLIN MICROBIOL REV, V17, P863, DOI 10.1128/CMR.17.4.863-893.2004; Kapwata T, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081665; Kumi-Kyereme A, 2016, J EPIDEMIOL GLOB HEA, V6, P131, DOI 10.1016/j.jegh.2015.05.001; Luby SP, 2015, AM J TROP MED HYG, V93, P904, DOI 10.4269/ajtmh.15-0274; Luby SP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001052; Lule JR, 2005, AM J TROP MED HYG, V73, P926, DOI 10.4269/ajtmh.2005.73.926; Majorin F, 2019, T ROY SOC TROP MED H, V113, P263, DOI 10.1093/trstmh/try142; Mengistie B, 2013, HOUSEHOLD WATER CHLO, V8, P1; Ayalew AM, 2018, J ENVIRON PUBLIC HEA, V2018, DOI 10.1155/2018/4271915; Mohammed A, 2016, SOUTH AFR J INFECT D, V31, P122, DOI 10.1080/23120053.2016.1156876; Oloruntoba EO, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.32; Osumanu IK, 2007, GEOGR TIDSSKR-DEN, V107, P59, DOI 10.1080/00167223.2007.10801375; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Quick RE, 2002, AM J TROP MED HYG, V66, P584, DOI 10.4269/ajtmh.2002.66.584; Soboksa NE, 2019, J HEALTH POPUL NUTR, V38, DOI 10.1186/s41043-019-0205-1; Tambe AB., 2015, CHALLENGES, V6, P229, DOI [DOI 10.3390/CHALLE6020229, 10.3390/challe6020229]; Thiam S, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0323-1; UNICEF Ethiopia, 2018, WAT SAN HYG WASH; Usman MA, 2019, J DEV STUD, V55, P2193, DOI 10.1080/00220388.2018.1493193; WHO, 2014, PREV DIARRH BETT WAT, P1; WHO, 2016, WAT REL DIS; WHO, 2006, GUID DRINK QUAL 1 AD; Wolf J, 2014, TROP MED INT HEALTH, V19, P928, DOI 10.1111/tmi.12331; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x; Yongsi HBN, 2010, J HEALTH POPUL NUTR, V28, P424; Zedie FB., 2018, HLTH ED CARE, V3, P1, DOI DOI 10.15761/HEC.1000144	53	9	9	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0229303	10.1371/journal.pone.0229303	http://dx.doi.org/10.1371/journal.pone.0229303			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074128	Green Published, gold, Green Submitted			2022-12-26	WOS:000535220600038
J	Zhang, GJ; Tang, X; Liang, L; Zhang, WF; Li, DW; Li, XY; Zhao, DC; Zheng, YQ; Chen, YH; Hao, BT; Wang, K; Tang, N; Ding, KY				Zhang, Guiji; Tang, Xia; Liang, Li; Zhang, Wanfeng; Li, Dewei; Li, Xiaoyuan; Zhao, Dachun; Zheng, Yaqiu; Chen, Yanhong; Hao, Bingtao; Wang, Kai; Tang, Ni; Ding, Keyue			DNA and RNA sequencing identified a novel oncogene VPS35 in liver hepatocellular carcinoma	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR-3; RETROMER COMPLEX; RECURRENT MUTATIONS; TRAFFICKING; EXPRESSION; PREVENTION; SECRETION; TARGETS; GENE; RAS	Liver hepatocellular carcinoma (LIHC) is the second leading cause of cancer mortality worldwide. Although cancer driver genes identified so far have been considered to be saturated or nearly saturated, challenges remain in discovering novel genes underlying carcinogenesis due to significant tumor heterogeneity. Here, in a small cohort of hepatitis B virus (HBV)-associated LIHC, we investigated the transcriptional patterns of tumor-mutated alleles using both whole-exome and RNA sequencing data. A graph clustering of the transcribed tumor-mutated alleles characterized overlapped functional clusters, and thus prioritized potentially novel oncogenes. We validated the function of the potentially novel oncogenes in vitro and in vivo. We showed that a component of the retromer complex-the vacuolar protein sorting-associated protein 35 (VPS35)-promoted the proliferation of hepatoma cell through the PI3K/AKT signaling pathway. In VPS35-knockout hepatoma cells, a significantly reduced distribution of membrane fibroblast growth factor receptor 3 (FGFR3) demonstrated the effects of VPS35 on sorting and trafficking of transmembrane receptor. This study provides insight into the roles of the retromer complex on carcinogenesis and has important implications for the development of personalized therapeutic strategies for LIHC.	[Zhang, Guiji; Tang, Xia; Liang, Li; Zheng, Yaqiu; Wang, Kai; Tang, Ni] Chongqing Med Univ, Affiliated Hosp 2, Inst Viral Hepatitis, Key Lab Mol Biol Infect Dis,Minist Educ,Dept Infe, Chongqing, Peoples R China; [Tang, Xia; Zhang, Wanfeng; Ding, Keyue] Chongqing Med Univ, Sch Basic Med, Dept Bioinformat, Chongqing, Peoples R China; [Li, Dewei] Chongqing Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Chongqing, Peoples R China; [Li, Xiaoyuan] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Oncol, Beijing, Peoples R China; [Zhao, Dachun] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Pathol, Beijing, Peoples R China; [Chen, Yanhong; Hao, Bingtao] Henan Univ, Med Genet Inst Henan Prov, Henan Prov Key Lab Genet Dis & Funct Genom, Zhengzhou Univ,Henan Prov Peoples Hosp,Peoples Ho, Zhengzhou, Henan, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Henan University; Zhengzhou University	Wang, K; Tang, N (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Inst Viral Hepatitis, Key Lab Mol Biol Infect Dis,Minist Educ,Dept Infe, Chongqing, Peoples R China.; Ding, KY (corresponding author), Chongqing Med Univ, Sch Basic Med, Dept Bioinformat, Chongqing, Peoples R China.	wangkai@cqmu.edu.cn; nitang@cqmu.edu.cn; ding.keyue@gmail.com	Ding, Keyue/AAH-7228-2019; Wang, Kai/U-3552-2019; Hao, Bingtao/G-6648-2011	Ding, Keyue/0000-0002-3496-6415; Wang, Kai/0000-0002-0137-1247; Hao, Bingtao/0000-0003-1997-9338	China National Natural Science Foundation [81672780, 81872270, 81572683, 81602417]; Major National ST program [2017ZX10202203-004]; Recruitment Program of Global Youth Experts in China; program of Artificial Intelligence in Medicine of CQ CSTC [ZHYX2019004]; Natural Science Foundation Project of CQ CSTC [cstc2018jcyjAX0254]; Program for Innovation Team of Higher Education in Chongqing [CXTDX201601015]; Leading Talent Program of CQ CSTC [CSTCCXLJRC201719]; Talent Development Program of CQMU for Postgraduate [BJRC201728]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Major National ST program; Recruitment Program of Global Youth Experts in China; program of Artificial Intelligence in Medicine of CQ CSTC; Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Program for Innovation Team of Higher Education in Chongqing; Leading Talent Program of CQ CSTC; Talent Development Program of CQMU for Postgraduate	This work was funded by the China National Natural Science Foundation (no. 81672780, KD, nos. 81872270 and 81572683, NT, and 81602417, KW), the Major National S&T program (2017ZX10202203-004 to NT), the Recruitment Program of Global Youth Experts in China (KD), the program of Artificial Intelligence in Medicine of CQ CSTC (ZHYX2019004, KD), Natural Science Foundation Project of CQ CSTC (cstc2018jcyjAX0254 to NT), the Program for Innovation Team of Higher Education in Chongqing (grant no. CXTDX201601015), the Leading Talent Program of CQ CSTC (grant no. CSTCCXLJRC201719 to NT) and Talent Development Program of CQMU for Postgraduate (grant no. BJRC201728).	Ahn SM, 2014, HEPATOLOGY, V60, P1972, DOI 10.1002/hep.27198; Babu SD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-10; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, 2017, Cell, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Caruso S, 2019, GASTROENTEROLOGY, V157, P760, DOI 10.1053/j.gastro.2019.05.001; Chen KE, 2019, TRAFFIC, V20, P465, DOI 10.1111/tra.12649; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Cho JY, 2004, P NATL ACAD SCI USA, V101, P609, DOI 10.1073/pnas.2237184100; Cleary SP, 2013, HEPATOLOGY, V58, P1693, DOI 10.1002/hep.26540; Creixell P, 2015, NAT METHODS, V12, P615, DOI [10.1038/nmeth.3440, 10.1038/NMETH.3440]; Cui Y, 2019, J CELL BIOL, V218, P615, DOI 10.1083/jcb.201806153; Deng H, 2013, MOVEMENT DISORD, V28, P569, DOI 10.1002/mds.25430; DING K, 2015, SCI REP UK, V5; Ding L, 2014, NAT REV GENET, V15, P556, DOI 10.1038/nrg3767; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Farmer T, 2019, MOL BIOL CELL, V30, P1138, DOI 10.1091/mbc.E19-01-0044; Farmer T, 2017, J CELL SCI, V130, P2359, DOI 10.1242/jcs.204537; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Fuse A, 2015, FEBS LETT, V589, P1430, DOI 10.1016/j.febslet.2015.04.040; Gao QZ, 2017, CANCER SCI, V108, P1328, DOI 10.1111/cas.13277; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Haugsten EM, 2005, J CELL SCI, V118, P3869, DOI 10.1242/jcs.02509; Hoshida Y, 2014, J HEPATOL, V61, pS79, DOI 10.1016/j.jhep.2014.07.010; Hsiehchen D, 2018, J HUM GENET, V63, P941, DOI 10.1038/s10038-018-0481-4; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Huang WY, 2015, NUCLEIC ACIDS RES, V43, pD856, DOI 10.1093/nar/gku1151; Javidi-Sharifi N, 2015, CANCER RES, V75, P880, DOI 10.1158/0008-5472.CAN-14-0573; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Kasprzak A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061288; Lee YI, 2000, ONCOGENE, V19, P3717, DOI 10.1038/sj.onc.1203694; Liang L, 2016, ONCOTARGET, V7, P38440, DOI 10.18632/oncotarget.9540; McGough IJ, 2014, CURR BIOL, V24, P1670, DOI 10.1016/j.cub.2014.06.024; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Pan Q, 2016, ONCOTARGET, V7, P38487, DOI 10.18632/oncotarget.9555; Paur J, 2015, HEPATOLOGY, V62, P1767, DOI 10.1002/hep.28023; Qiu WH, 2005, WORLD J GASTROENTERO, V11, P5266, DOI 10.3748/wjg.v11.i34.5266; Rao CV, 2017, CARCINOGENESIS, V38, P2, DOI 10.1093/carcin/bgw118; Schulze K, 2016, J HEPATOL, V65, P1031, DOI 10.1016/j.jhep.2016.05.035; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shibata T, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.6; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Sondka Z, 2018, NAT REV CANCER, V18, P696, DOI 10.1038/s41568-018-0060-1; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; TANG X, 2019, SCI REP UK, V9; Temkin P, 2017, NEURON, V94, P74, DOI 10.1016/j.neuron.2017.03.020; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Wang JX, 2015, IEEE ACM T COMPUT BI, V12, P815, DOI 10.1109/TCBB.2014.2361348; Wang J, 2018, TRAFFIC, V19, P578, DOI 10.1111/tra.12574; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Zaki N, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-163; Zhang J, 2011, DATA DATABASE, V1, P10; Zheng J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200776; Zhou Mo, 2019, Small GTPases, V10, P20, DOI 10.1080/21541248.2016.1263380; Zhou M, 2016, J CELL BIOL, V214, P445, DOI 10.1083/jcb.201604061	61	21	21	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2020	39	16					3229	3244		10.1038/s41388-020-1215-6	http://dx.doi.org/10.1038/s41388-020-1215-6		FEB 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QF9OJ	32071398				2022-12-26	WOS:000514262700002
J	Cerreta, AJ; Cannizzo, SA; Smith, DC; Minter, LJ				Cerreta, Anthony J.; Cannizzo, Sarah A.; Smith, Dustin C.; Minter, Larry J.			Venous hematology, biochemistry, and blood gas analysis of free-ranging Eastern Copperheads (Agkistrodon contortrix) and Eastern Ratsnakes (Pantherophis alleghaniensis)	PLOS ONE			English	Article							LOGGERHEAD SEA-TURTLES; GRACKLES QUISCALUS-MAJOR; DOVES ZENAIDA-MACROURA; NORTH-CAROLINA; PLASMA BIOCHEMISTRY; REFERENCE INTERVALS; CHEMISTRY VALUES; MIST-NET; LACTATE; PARAMETERS	Hematology, plasma biochemistry, and blood gas analysis were performed on venous samples obtained from free-ranging Eastern Copperheads (Agkistrodon contortrix) and Eastern Ratsnakes (Pantherophis alleghaniensis) in central North Carolina during a mark-recapture study conducted from April to October 2015 at the North Carolina Zoo. Blood samples were collected from 31 (15 male and 16 female) free-ranging copperheads and 34 (20 male and 14 female) free-ranging ratsnakes at the beginning and end of restraint. Restraint was performed for morphometric measurements, sex determination, and identification via placement of intracelomic passive integrated transponder (PIT) tags and marking of ventral scutes with a handheld electrocautery unit. Blood gas analytes were measured at the beginning of restraint and compared to analytes measured at the end to evaluate for changes secondary to handling. Total restraint time prior to the first blood sampling was 1.4 +/- 0.4 mins (mean +/- SD) and 1.0 +/- 0.2 mins (mean +/- SD) and restraint time prior to second blood sampling was 12.5 +/- 2.4 mins (mean +/- SD) and 13.5 +/- 3.4 mins (mean +/- SD) for copperheads and ratsnakes, respectively. Blood lactate concentrations at the beginning of restraint were similar for both species. Lactate concentrations increased significantly and pH decreased significantly for both species at the end of restraint when compared to the beginning of restraint. Furthermore, lactate concentrations at the end of restraint were significantly elevated in ratsnakes compared to copperheads. This study provides guidelines for interpretation of venous hematology, plasma biochemistry, and blood gas values for free-ranging copperheads and ratsnakes in central North Carolina and demonstrates the physiological response to venous blood gas analytes secondary to capture and restraint.	[Cerreta, Anthony J.; Minter, Larry J.] North Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27695 USA; [Cannizzo, Sarah A.] Ft Worth Zoo, Ft Worth, TX USA; [Smith, Dustin C.; Minter, Larry J.] North Carolina Zoo, Asheboro, NC 27205 USA; [Cerreta, Anthony J.] Univ Tennessee, Coll Vet Med, Dept Small Anim Clin Sci, Knoxville, TN USA	University of North Carolina; North Carolina State University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Minter, LJ (corresponding author), North Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27695 USA.; Minter, LJ (corresponding author), North Carolina Zoo, Asheboro, NC 27205 USA.	Jb.Minter@nczoo.org		Minter, Larry/0000-0003-3958-3912; Cerreta, Anthony/0000-0001-7567-3451				ALBADRY KS, 1992, J THERM BIOL, V17, P111, DOI 10.1016/0306-4565(92)90007-3; Alleman AR, 1999, AM J VET RES, V60, P507; Allen SE, 2008, J VET EMERG CRIT CAR, V18, P123, DOI 10.1111/j.1476-4431.2008.00286.x; Allender MC, 2006, J WILDLIFE DIS, V42, P107, DOI 10.7589/0090-3558-42.1.107; Anderson ET, 2011, J ZOO WILDLIFE MED, V42, P247, DOI 10.1638/2010-0217.1; [Anonymous], 2019, ZOOL INF MAN SYST ZI; [Anonymous], 2001, C46 NCCLS; Beaupre Steven J., 2007, P334, DOI 10.1017/CBO9780511752438.013; Bennett A.F., 1976, P127; Bernal W, 2002, LANCET, V359, P558, DOI 10.1016/S0140-6736(02)07743-7; Bertelsen MF, 2015, VET ANAESTH ANALG, V42, P386, DOI 10.1111/vaa.12221; Campbell T., 2006, REPTILE MED SURG, P453, DOI 10.1016/B0-72-169327-X/50032-8; CAMPBELL T.W., 2014, CURRENT THERAPY REPT, P70; Campbell T. W., 2006, REPTILE MED SURG, P801; Chittick EJ, 2002, J AM VET MED ASSOC, V221, P1019, DOI 10.2460/javma.2002.221.1019; Christiansen Emily F., 2013, Journal of Herpetological Medicine and Surgery, V23, P83, DOI 10.5818/1529-9651-23.3.83; Dallwig RK, 2011, J ZOO WILDLIFE MED, V42, P205, DOI 10.1638/2008-0202.1; Dantzler W.H., 1976, P447; Dujowich M, 2005, J ZOO WILDLIFE MED, V36, P590, DOI 10.1638/04-111.1; Dutton CJ, 2003, J ZOO WILDLIFE MED, V34, P53, DOI 10.1638/1042-7260(2003)34[0053:ACBPAP]2.0.CO;2; Fowler ME, 2008, RESTRAINT HANDLING W, P423; Friedrichs KR, 2012, VET CLIN PATH, V41, P441, DOI 10.1111/vcp.12006; Funk RS, 2006, REPTILE MED SURG, P49; Geffre A, 2011, VET CLIN PATH, V40, P107, DOI 10.1111/j.1939-165X.2011.00287.x; Geffre A, 2009, VET CLIN PATH, V38, P288, DOI 10.1111/j.1939-165X.2009.00179.x; Harms CA, 2003, J WILDLIFE DIS, V39, P366, DOI 10.7589/0090-3558-39.2.366; Harms CA, 2016, J WILDLIFE DIS, V52, pS54, DOI 10.7589/52.2S.S54; Harms CA, 2012, J ZOO WILDLIFE MED, V43, P77, DOI 10.1638/2011-0114.1; Hess JC, 2007, J HERPETOL MED SURG, V17, P118; HOCHACHKA PW, 1975, SCIENCE, V187, P613, DOI 10.1126/science.163485; Innis C. J., 2009, Proceedings of the Association of Reptilian and Amphibian Veterinarians, 16th Annual Conference, Milwaukee, Wisconsin, USA, 8-15 August, 2009, P51; Innis CJ, 2007, J COMP PHYSIOL B, V177, P623, DOI 10.1007/s00360-007-0160-9; Innis CJ, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou048; JEMISON SC, 1995, J HERPETOL, V29, P129, DOI 10.2307/1565098; Keller JM, 2004, ENVIRON HEALTH PERSP, V112, P1074, DOI 10.1289/ehp.6923; Keller KA, 2012, JAVMA-J AM VET MED A, V240, P317, DOI 10.2460/javma.240.3.317; Kirschbaum B, 2003, CLIN CHIM ACTA, V334, P241, DOI 10.1016/S0009-8981(03)00242-0; KREGER MD, 1993, APPL ANIM BEHAV SCI, V38, P323, DOI 10.1016/0168-1591(93)90030-S; LaGrange SM, 2014, J WILDLIFE DIS, V50, P990, DOI 10.7589/2013-10-267; LEMAHO Y, 1992, AM J PHYSIOL, V263, pR775, DOI 10.1152/ajpregu.1992.263.4.R775; Lewbart GA, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov034; Lewbart GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096487; Lock B, 2008, J EXOT PET MED, V17, P273, DOI 10.1053/j.jepm.2008.07.012; Mader D, 2006, REPTILE MED SURG 2 E, P533, DOI DOI 10.1016/B0-72-169327-X/50035-3; Minter LJ, 2013, HERPETOL CONSERV BIO, V8, P321; Mosley CA, 2004, VET ANAESTH ANALG, V31, P64, DOI 10.1111/j.1467-2995.2004.00135.x; Mosley CAE, 2003, J AM VET MED ASSOC, V222, P1559, DOI 10.2460/javma.2003.222.1559; Pfitzer S, 2014, VET REC, V175, DOI 10.1136/vr.102438; RUSSO EA, 1986, J AM VET MED ASSOC, V189, P1013; Sanchez-Migallon Guzman David, 2011, Journal of Herpetological Medicine and Surgery, V21, P16, DOI 10.5818/1529-9651-21.1.16; Schuett GW, 2000, PHYSIOL BEHAV, V71, P335, DOI 10.1016/S0031-9384(00)00348-6; SECOR SM, 1994, ECOLOGY, V75, P1600, DOI 10.2307/1939621; Shapiro BA, 1994, CLIN APPL BLOOD GASS, P227; SIVE WJ, 1991, AVIAT SPACE ENVIR MD, V62, P831; STABENAU EK, 1993, J EXP BIOL, V180, P311; Stay NI, 2011, CLIN LAB MED, V31, P87, DOI 10.1016/j.cll.2010.10.006; Stockham SL, 2008, FUNDAMENTALS VET CLI, P559; Stoot LJ, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou011; Sykes JM, 2015, CLIN LAB MED, V35, P661, DOI 10.1016/j.cll.2015.05.014; Telford SR, 2009, HEMOPARSITES REPTILI, P199; Travis EK, 2012, J ZOO WILDLIFE MED, V43, P1, DOI 10.1638/2010-0082.1; Wack RF, 2012, J WILDLIFE DIS, V48, P307, DOI 10.7589/0090-3558-48.2.307; Winne Christopher T., 2006, Herpetological Review, V37, P52; Zacher LA, 2010, JAVMA-J AM VET MED A, V236, P892, DOI 10.2460/javma.236.8.892	64	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0229102	10.1371/journal.pone.0229102	http://dx.doi.org/10.1371/journal.pone.0229102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7VI	32059022	Green Published, gold			2022-12-26	WOS:000535206600032
J	Alapati, R; Shuvo, MH; Bhattacharya, D				Alapati, Rahul; Shuvo, Md Hossain; Bhattacharya, Debswapna			SPECS: Integration of side-chain orientation and global distance-based measures for improved evaluation of protein structural models	PLOS ONE			English	Article							PREDICTION; CONFORMATION; SCORE	Significant advancements in the field of protein structure prediction have necessitated the need for objective and robust evaluation of protein structural models by comparing predicted models against the experimentally determined native structures to quantitate their structural similarities. Existing protein model versus native similarity metrics either consider the distances between alpha carbon (C alpha) or side-chain atoms for computing the similarity. However, side-chain orientation of a protein plays a critical role in defining its conformation at the atomic-level. Despite its importance, inclusion of side-chain orientation in structural similarity evaluation has not yet been addressed. Here, we present SPECS, a side-chain-orientation-included protein model-native similarity metric for improved evaluation of protein structural models. SPECS combines side-chain orientation and global distance based measures in an integrated framework using the united-residue model of polypeptide conformation for computing model-native similarity. Experimental results demonstrate that SPECS is a reliable measure for evaluating structural similarity at the global level including and beyond the accuracy of C alpha positioning. Moreover, SPECS delivers superior performance in capturing local quality aspect compared to popular global C alpha positioning-based metrics ranging from models at near-experimental accuracies to models with correct overall folds-making it a robust measure suitable for both high- and moderate-resolution models. Finally, SPECS is sensitive to minute variations in side-chain chi angles even for models with perfect C alpha trace, revealing the power of including side-chain orientation. Collectively, SPECS is a versatile evaluation metric covering a wide spectrum of protein modeling scenarios and simultaneously captures complementary aspects of structural similarities at multiple levels of granularities. SPECS is freely available at http://watson.cse.eng.auburn.edu/SPECS/.	[Alapati, Rahul; Shuvo, Md Hossain; Bhattacharya, Debswapna] Auburn Univ, Dept Comp Sci & Software Engn, Auburn, AL 36849 USA; [Bhattacharya, Debswapna] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Bhattacharya, D (corresponding author), Auburn Univ, Dept Comp Sci & Software Engn, Auburn, AL 36849 USA.; Bhattacharya, D (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	bhattacharyad@auburn.edu	Shuvo, Md Hossain/HHR-9768-2022					Arakaki AK, 2004, BIOINFORMATICS, V20, P1087, DOI 10.1093/bioinformatics/bth044; Boomsma W, 2008, P NATL ACAD SCI USA, V105, P8932, DOI 10.1073/pnas.0801715105; Buczek A, 2011, J PHYS CHEM B, V115, P4295, DOI 10.1021/jp200949t; Cavasotto CN, 2009, DRUG DISCOV TODAY, V14, P676, DOI 10.1016/j.drudis.2009.04.006; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chien YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047951; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Deng HY, 2016, BIOINFORMATICS, V32, P378, DOI 10.1093/bioinformatics/btv601; FRASER RDB, 1955, NATURE, V176, P358, DOI 10.1038/176358a0; Hamelryck T, 2003, BIOINFORMATICS, V19, P2308, DOI 10.1093/bioinformatics/btg299; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Koehl P, 2001, CURR OPIN STRUC BIOL, V11, P348, DOI 10.1016/S0959-440X(00)00214-1; Kopp J, 2007, PROTEINS, V69, P38, DOI 10.1002/prot.21753; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kryshtafovych A, 2014, PROTEINS, V82, P7, DOI 10.1002/prot.24399; Kufareva Irina, 2012, Methods Mol Biol, V857, P231, DOI 10.1007/978-1-61779-588-6_10; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Levitt M, 1998, P NATL ACAD SCI USA, V95, P5913, DOI 10.1073/pnas.95.11.5913; Li JL, 2014, METHODS MOL BIOL, V1137, P29, DOI 10.1007/978-1-4939-0366-5_3; Liwo A, 1997, J COMPUT CHEM, V18, P849, DOI 10.1002/(SICI)1096-987X(199705)18:7<849::AID-JCC1>3.0.CO;2-R; MacCallum JL, 2009, PROTEINS, V77, P66, DOI 10.1002/prot.22538; Mariani V, 2013, BIOINFORMATICS, V29, P2722, DOI 10.1093/bioinformatics/btt473; Miao ZC, 2016, SCI REP-UK, V6, DOI 10.1038/srep37024; Miao ZC, 2011, BIOINFORMATICS, V27, P3117, DOI 10.1093/bioinformatics/btr538; Moult J, 2016, PROTEINS, V84, P4, DOI 10.1002/prot.25064; Olechnovic K, 2013, PROTEINS, V81, P149, DOI 10.1002/prot.24172; Peterson LX, 2014, PROTEINS, V82, P1971, DOI 10.1002/prot.24552; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Siew N, 2000, BIOINFORMATICS, V16, P776, DOI 10.1093/bioinformatics/16.9.776; Wieman H, 2012, MINI-REV MED CHEM, P4; Xu D, 2012, PROTEINS STRUCTURE F; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, CURR OPIN STRUC BIOL, V19, P145, DOI 10.1016/j.sbi.2009.02.005	39	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228245	10.1371/journal.pone.0228245	http://dx.doi.org/10.1371/journal.pone.0228245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053611	Green Published, gold			2022-12-26	WOS:000535198700022
J	Bearden, A; Van Winden, K; Frederick, T; Kono, N; Operskalski, E; Pandian, R; Barton, L; Stek, A; Kovacs, A				Bearden, Allison; Van Winden, Kristi; Frederick, Toni; Kono, Naoko; Operskalski, Eva; Pandian, Raj; Barton, Lorayne; Stek, Alice; Kovacs, Andrea			Low maternal vitamin D is associated with increased risk of congenital and peri/postnatal transmission of Cytomegalovirus in women with HIV	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; DISEASE PROGRESSION; DEFICIENCY; EXPRESSION; PREGNANCY; OUTCOMES; INFANTS; BORN	Background CMV infection of the fetus or neonate can lead to devastating disease, and there are no effective prevention strategies to date. Vitamin D is a potent immunomodulator, supports antiviral immune responses, and plays an important role in placental immunity. Methods Retrospective cohort study to evaluate the impact of low maternal vitamin D on congenital and early postnatal transmission of CMV among HIV-infected, non-breastfeeding women and their HIV exposed but negative infants from an urban HIV clinic. Vitamin D panel was performed on stored maternal plasma obtained near time of delivery. Infant CMV testing at 0-6 months included urine and oral cultures, and/or serum polymerase chain reaction testing. Results Cohort included 340 mother-infant pairs (births 1991-2014). Among 38 infants (11%) with a CMV+ test between 0-6 months, 4.7% (14/300) had congenital CMV transmission (CMV+ test 0-3 weeks), and 7.6% (24/315) had peri/postnatal CMV (CMV+ test > 3 weeks-6 months). Women with lower calcitriol (1,25-dihydroxyvitamin D), the active form of vitamin D, were more likely to have an infant with congenital (OR 12.2 [95% CI 1.61-92.2] P = 0.02) and peri/postnatal (OR 9.84 [95% CI 2.63-36.8] P = 0.0007) infections in multivariate analyses, independent of maternal HIV viral load and CD4 count. Conclusion This study demonstrates an association between inadequate maternal calcitriol during pregnancy and increased congenital and early postnatal acquisition of CMV among non-breastfeeding women with HIV and their HIV negative infants.	[Bearden, Allison; Frederick, Toni; Operskalski, Eva; Kovacs, Andrea] Univ Southern Calif, Dept Pediat, Maternal Child Adolescent Adult Ctr Infect Dis &, Keck Sch Med USC,Div Infect Dis, Los Angeles, CA 90007 USA; [Van Winden, Kristi; Stek, Alice] Univ Southern Calif, Dept Obstet & Gynecol, Div Maternal & Fetal Med, Los Angeles, CA 90007 USA; [Van Winden, Kristi; Stek, Alice] Univ Southern Calif, Keck Sch Med USC, Maternal Child Adolescent Adult Ctr Infect Dis &, Los Angeles, CA 90007 USA; [Kono, Naoko] Univ Southern Calif, Keck Sch Med USC, Dept Prevent Med, Los Angeles, CA 90007 USA; [Pandian, Raj] Pan Labs, Irvine, CA USA; [Barton, Lorayne] Univ Southern Calif, Keck Sch Med USC, Dept Pediat, Div Neonatol, Los Angeles, CA 90007 USA; [Van Winden, Kristi] Kaiser Permanente Northern Calif Reg, Div Maternal Fetal Med, Dept Obstet Gynecol, Oakland, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Kaiser Permanente	Bearden, A (corresponding author), Univ Southern Calif, Dept Pediat, Maternal Child Adolescent Adult Ctr Infect Dis &, Keck Sch Med USC,Div Infect Dis, Los Angeles, CA 90007 USA.	allison.bearden@usc.edu		Van Winden, Kristi/0000-0003-2257-0816; Bearden, Allison/0000-0002-0560-3375	SC CTSI, (NIH/NCRR/NCATS) [UL1TR000130]; Department of Obstetrics and Gynecology at the University of Southern California	SC CTSI, (NIH/NCRR/NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Department of Obstetrics and Gynecology at the University of Southern California	This work was supported by the SC CTSI (https://sc-ctsi.org), (NIH/NCRR/NCATS) through Grant UL1TR000130, awarded to AK and AB. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. This study was funded in part by a seed grant provided by the Department of Obstetrics and Gynecology at the University of Southern California awarded to KV. RP received support in the form of a salary from Pan Laboratories, Irvine, CA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Adeyemi OM, 2011, JAIDS-J ACQ IMM DEF, V57, P197, DOI 10.1097/QAI.0b013e31821ae418; [Anonymous], VITAMIN D PLACENTA E; Antoniucci DM, 2005, SERUM 25 HYDROXYVITA; Bate SL, 2006, CLIN INFECT DIS; Beard JA, 2011, J CLIN VIROL, V50, P194, DOI 10.1016/j.jcv.2010.12.006; Bearden A, 2013, J CLIN ENDOCR METAB, V98, P1726, DOI 10.1210/jc.2012-4031; BENIRSCHKE K, 1974, VIRCHOWS ARCH B, V16, P121, DOI 10.1007/BF02894070; Brannon PM, 2011, ANNU REV NUTR, V31, P89, DOI 10.1146/annurev.nutr.012809.104807; Burton GJ, 1996, J MED VIROL, V50, P237, DOI 10.1002/(SICI)1096-9071(199611)50:3&lt;237::AID-JMV5&gt;3.0.CO;2-A; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002689; Campbell GR, 2011, J BIOL CHEM, V286, P18890, DOI 10.1074/jbc.M110.206110; Chan G, 2002, HUMAN CYTOMEGALOVIRU; Chan SY, 2015, VITAMIN D PROMOTES H; Duryea EL, 2010, PEDIATR INFECT DIS J, V29, P915, DOI 10.1097/INF.0b013e3181e0ce05; Equils O, 2010, J INFECT DIS; Frederick T, 2012, CLIN INFECT DIS, V55, P877, DOI 10.1093/cid/cis535; Gompels UA, 2012, CLIN INFECT DIS, V54, P434, DOI 10.1093/cid/cir837; GRAY TK, 1979, SCIENCE, V204, P1311, DOI 10.1126/science.451538; Guibert G, 2009, CLIN INFECT DIS, V48, P1516, DOI 10.1086/598934; HAUG C, 1994, J INFECT DIS, V169, P889, DOI 10.1093/infdis/169.4.889; Hewison M, 2012, CLIN ENDOCRINOL, V76, P315, DOI 10.1111/j.1365-2265.2011.04261.x; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Kovacs A, 1999, NEW ENGL J MED, V341, P77, DOI 10.1056/NEJM199907083410203; Liu N, 2009, BIOL REPROD, V80, P398, DOI 10.1095/biolreprod.108.073577; Mania A, 2012, J MATERN-FETAL NEO M, V25, P180, DOI 10.3109/14767058.2011.568550; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Mehta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008770; Mehta S, 2009, J INFECT DIS, V200, P1022, DOI 10.1086/605699; Mwaanza N, 2014, CLIN INFECT DIS, V58, P728, DOI 10.1093/cid/cit766; Pass RF, 2014, J PEDIATR INFECT DIS, V3, pS2, DOI 10.1093/jpids/piu069; Pinzone MR, 2013, EUR REV MED PHARMACO, V17, P1938; Rieder FJJ, 2017, J STEROID BIOCHEM, V165, P356, DOI 10.1016/j.jsbmb.2016.08.002; Seiden-Long I, 2007, CLIN CHEM, V53, P1104, DOI 10.1373/clinchem.2006.077560; Teichmann J, 2003, J INFECTION, V46, P221, DOI 10.1053/jinf.2002.1109; Van Winden KR, 2019, AM J PERINATOL  0731; Wagner CL, 2015, DIETARY SUPPLEMENTS; Walker VP, 2011, J CLIN ENDOCR METAB, V96, P1835, DOI 10.1210/jc.2010-1559; Yun CF, 2015, CLIN CHIM ACTA, V448, P22, DOI 10.1016/j.cca.2015.06.007; Zehnder D, 2002, AM J PATHOL, V161, P105, DOI 10.1016/S0002-9440(10)64162-4	40	2	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228900	10.1371/journal.pone.0228900	http://dx.doi.org/10.1371/journal.pone.0228900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053638	gold, Green Published			2022-12-26	WOS:000535198700066
J	Mwamanenge, NA; Assenga, E; Furia, FF				Mwamanenge, Naomi A.; Assenga, Evelyn; Furia, Francis F.			Acute kidney injury among critically ill neonates in a tertiary hospital in Tanzania; Prevalence, risk factors and outcome	PLOS ONE			English	Article								Background Neonatal acute kidney injury contributes to high mortality in developing countries. The burden of neonatal AKI is not known in Tanzania despite having high neonatal mortality. This study was conducted to determine the burden of AKI among critically ill neonates admitted at Muhimbili National Hospital. Methods This was a cross-sectional study conducted in the neonatal ward at the MNH. Eligible critically ill neonates were recruited consecutively between October 2017 and March 2018. Data was collected using a standardized structured questionnaire. Blood specimen was drawn to measure baseline creatinine at admission, 48th hour, 72nd hour and 14th day. Data was analysed using SPSS version 20.0 Univariate analysis was done using chi-square to determine the association between categorical variables and multivariate logistic regression was performed to determine predictors of AKI. Results A total of 378 critically ill neonates were recruited, 31.5% had AKI and independent predictors of AKI were noted to be neonatal sepsis (aOR 2.237, 95%CI 1.3-3.6, P = 0.001), severe pneumonia (aOR3.0, 95%CI 1.0-9.3, P = 0.047) and use of gentamycin (aOR6.8, 95%CI 1.3-9.3, P = 0.02). Complete resolution of renal dysfunction at the fourteenth day was seen in 83.1% of the neonates while 16.9% had persistence of renal dysfunction. Ultrasound scan were performed among 105 participants with AKI revealed increased echogenicity, mild hydronephrosis and ectopic kidneys in 25 (23.8%), 4 (3.8%) and 2 (1.9%) respectively. In-hospital mortality was significantly higher among neonates with AKI (70.6%) as compared to those without (29.4%) p<0.001. Conclusions AKI was noted in a third of critically ill neonates, with neonatal sepsis, severe pneumonia and use of gentamycin as independent predictors of AKI. Neonates who suffered AKI had twice as much mortality as compared to those without.	[Mwamanenge, Naomi A.; Assenga, Evelyn; Furia, Francis F.] Muhimbili Univ Hlth & Allied Sci, Sch Med, Dept Paediat & Child Hlth, Dar Es Salaam, Tanzania	Muhimbili University of Health & Allied Sciences	Furia, FF (corresponding author), Muhimbili Univ Hlth & Allied Sci, Sch Med, Dept Paediat & Child Hlth, Dar Es Salaam, Tanzania.	Fredrick.francis78@gmail.com		Fredrick, Francis/0000-0003-2668-3041				Abdelraheem M, 2014, PERITON DIALYSIS INT, V34, P526, DOI 10.3747/pdi.2013.00082; Ademola AD, 2019, CLIN KIDNEY J, V12, P521, DOI 10.1093/ckj/sfy120; Alaro D, 2014, AFR HEALTH SCI, V14, P982; Annigeri RA, 2017, KIDNEY INT REP, V2, P559, DOI 10.1016/j.ekir.2017.04.006; [Anonymous], 2013, POCKET BOOK HOSP CAR; Caione P, 2011, PEDIATR SURG INT, V27, P1027, DOI 10.1007/s00383-011-2946-9; Ciccia E, 2017, INT J NEPHROLOGY REN, V10; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Esezobor CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051229; Jetton JG, 2017, LANCET CHILD ADOLESC, V1, P184, DOI 10.1016/S2352-4642(17)30069-X; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lee CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187764; Matyanga P K M J, 2013, Cent Afr J Med, V59, P1; Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X; Momtaz HE, 2014, J CLIN NEONATOL, V3, P99, DOI 10.4103/2249-4847.134691; Perico N, 2015, ANN NUTR METAB, V66, P42, DOI 10.1159/000381246; Selewski DT, 2015, PEDIATRICS, V136, pE463, DOI 10.1542/peds.2014-3819; Tambo FFM, 2018, BMC UROL, V18, DOI 10.1186/s12894-018-0364-1; UNICEF WHO UN, UN INT GROUP CHILD M; United Nations, 2015, ESAPWP241 UN; Youssef D, 2015, SAUDI J KIDNEY DIS T, V26, P67, DOI 10.4103/1319-2442.148738	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0229074	10.1371/journal.pone.0229074	http://dx.doi.org/10.1371/journal.pone.0229074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053686	gold, Green Published			2022-12-26	WOS:000535198700097
J	Bernhard, JK; Vidondo, B; Achermann, RL; Rediger, R; Muller, KE; Steiner, A				Bernhard, Johanna Karin; Vidondo, Beatriz; Achermann, Rahel Lisa; Rediger, Rahel; Muller, Kerstin Elisabeth; Steiner, Adrian			Carpal, tarsal, and stifle skin lesion prevalence and potential risk factors in Swiss dairy cows kept in tie stalls: A cross-sectional study	PLOS ONE			English	Article							HOCK LESIONS; LEG LESIONS; LYING TIME; HAIR LOSS; LAMENESS; INJURIES; CATTLE; WELFARE; SYSTEMS; CLEANLINESS	The prevalence of skin lesions at the legs of dairy cows often serves as an indicator for animal welfare and is used as a measurement of adequacy of the present housing conditions. The aim of this study was to assess the prevalence of skin lesions at the carpus, tarsus, and stifle in Swiss dairy cows kept in tie stalls and to describe potential risk factors associated with the different types and severities thereof. Skin lesions and potential risk factors were assessed in 627 cows of 27 tie stall farms in a cross-sectional study. The associations of each outcome and the potential risk factors were assessed by means of logistic regression models using farm as the random factor. One odds ratio was obtained for each biologically relevant risk factor category and the final models were compared between the lesion types and locations. Tarsal lesions were recorded most frequently, with a prevalence of 62.2, 34.4, and 24.0% for moderate to severe hair loss, any severity of ulceration, and moderate to severe swelling, respectively. The prevalence of carpal lesions ranged from 54.4% for hair loss, over 7.7% for ulceration, to 6.1% for swelling, while stifle lesions were recorded less frequently with a prevalence of 18.6, 8.9, 3.4% for hair loss, ulceration, and swelling, respectively. The risk for various skin lesion types and locations significantly increased, when the concrete stall base was covered with a rubber mat and the bedding depth was low. Cows were at the lowest risk to develop skin lesions when they had more than 13 days of outdoor exercise per month. The prevalence of skin lesions in tied Swiss dairy cows is remarkably high and could possibly be reduced by providing the herd more frequent outdoor exercise and a well-cushioned, friction-absorbing and non-abrasive lying surface.	[Bernhard, Johanna Karin; Achermann, Rahel Lisa; Rediger, Rahel; Steiner, Adrian] Univ Bern, Vetsuisse Fac, Clin Ruminants, Bern, Switzerland; [Vidondo, Beatriz] Univ Bern, Vetsuisse Fac, Vet Publ Hlth Inst, Liebefeld, Switzerland; [Muller, Kerstin Elisabeth] Free Univ Berlin, Fac Vet Med, Clin Ruminants & Swine, Berlin, Germany	University of Bern; University of Bern; Free University of Berlin	Bernhard, JK (corresponding author), Univ Bern, Vetsuisse Fac, Clin Ruminants, Bern, Switzerland.	johanna.bernhard@vetsuisse.unibe.ch	Steiner, Adrian/AAD-6814-2022	Steiner, Adrian/0000-0003-2415-3768; Bernhard, Johanna Karin/0000-0003-2104-4021	Swiss tie stall association	Swiss tie stall association	We would like to thank all farmers contributing to this study, the Swiss tie stall association for their support during the recruitment of participants, and the Swiss breeding associations for providing data on longevity. This study was conducted as an independent research project of the Vetsuisse-Faculty Bern and is based on research completed as partial fulfilment for the Ph.D. requirements at the Graduate School for Cellular and Biomedical Science of Bern.	Barrientos AK, 2013, J DAIRY SCI, V96, P3758, DOI 10.3168/jds.2012-6389; Bouffard V, 2017, J DAIRY SCI, V100, P2935, DOI 10.3168/jds.2016-11842; Brenninkmeyer C, 2013, PREV VET MED, V109, P236, DOI 10.1016/j.prevetmed.2012.10.014; Burow E, 2013, ANIMAL, V7, P834, DOI 10.1017/S1751731112002297; Burow E, 2013, ANIMAL, V7, P160, DOI 10.1017/S1751731112001395; Busato A, 2000, J VET MED A, V47, P221, DOI 10.1046/j.1439-0442.2000.00283.x; Canadian Dairy Information Centre, 2018, DAIR BARNS TYP CAN; Charlton GL, 2016, APPL ANIM BEHAV SCI, V175, P14, DOI 10.1016/j.applanim.2015.02.011; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; DFC-NFACC (Dairy Farmers of Canada and the National Farm Animal Care Council), 2011, COW WELF ASS; Dohoo IR, 2001, PREV VET MED, V50, P127, DOI 10.1016/S0167-5877(01)00191-X; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Flower FC, 2006, J DAIRY SCI, V89, P139, DOI 10.3168/jds.S0022-0302(06)72077-X; Fulwider WK, 2007, J DAIRY SCI, V90, P3559, DOI 10.3168/jds.2006-793; Gibbons J, 2012, ANIM WELFARE, V21, P379, DOI 10.7120/09627286.21.3.379; Greenough PR, 1997, LAMENESS CATTLE; Haskell MJ, 2006, J DAIRY SCI, V89, P4259, DOI 10.3168/jds.S0022-0302(06)72472-9; Heyerhoff JCZ, 2014, J DAIRY SCI, V97, P173, DOI 10.3168/jds.2012-6367; HUXLEY J, 2006, LIVESTOCK, V11, P33, DOI DOI 10.1111/j.2044-3870.2006.tb00035.x; Jewell MT, 2019, J DAIRY SCI, V102, P3376, DOI 10.3168/jds.2018-15080; Keil NM, 2006, PREV VET MED, V74, P142, DOI 10.1016/j.prevetmed.2005.11.005; Kester E, 2014, VET J, V202, P222, DOI 10.1016/j.tvjl.2014.07.004; Kielland C, 2009, J DAIRY SCI, V92, P5487, DOI 10.3168/jds.2009-2293; Krebs S, 2001, ACTA AGR SCAND A-AN, V51, P78, DOI 10.1080/090647001316923117; Leach KA, 2009, J DAIRY SCI, V92, P1567, DOI 10.3168/jds.2008-1648; Lim PY, 2015, VET J, V203, P205, DOI 10.1016/j.tvjl.2014.11.005; Livesey CT, 2002, VET REC, V150, P677, DOI 10.1136/vr.150.22.677; Lombard JE, 2010, J DAIRY SCI, V93, P4668, DOI 10.3168/jds.2010-3225; Mattiello S, 2011, J DAIRY SCI, V94, P2403, DOI 10.3168/jds.2010-3606; Murray RD, 1996, VET REC, V138, P586, DOI 10.1136/vr.138.24.586; Nash CGR, 2016, J DAIRY SCI, V99, P6494, DOI 10.3168/jds.2015-10676; Norring M, 2010, J DAIRY SCI, V93, P70, DOI 10.3168/jds.2009-2164; Nuss K, 2013, TIERAERZTL PRAX G N, V41, P234; Nuss K, 2011, SCHWEIZ ARCH TIERH, V153, P520, DOI 10.1024/0036-7281/a000264; Popescu S, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-43; Potterton SL, 2011, J DAIRY SCI, V94, P2952, DOI 10.3168/jds.2010-4084; Regula G, 2004, PREV VET MED, V66, P247, DOI 10.1016/j.prevetmed.2004.09.004; Rutherford KMD, 2008, J DAIRY SCI, V91, P2265, DOI 10.3168/jds.2007-0847; Solano L, 2016, J DAIRY SCI, V99, P2086, DOI 10.3168/jds.2015-10336; Solano L, 2015, J DAIRY SCI, V98, P6978, DOI 10.3168/jds.2015-9652; Spycher B, 2002, SCHWEIZ ARCH TIERH, V144, P519, DOI 10.1024/0036-7281.144.10.519; Swiss Federal Council, 2013, VER DIR LANDW; Swiss Federal Food Safety and Veterinary Office, 2013, FACH TIERSCH VORSCHL; Swiss Federal Statistical Office, 2016, LAND FORSTW, V2016; The Swiss Federal Council, 2008, AN WELF ORD; The Swiss Federal Statistical Office, 2019, LANDW STRUKT 2018; Tucker CB, 2009, J DAIRY SCI, V92, P2684, DOI 10.3168/jds.2008-1926; USDA, 2016, DAIR 2014 DAIR CATTL; Vasseur E, 2015, J DAIRY SCI, V98, P698, DOI 10.3168/jds.2014-8224; Weary DM, 2000, J DAIRY SCI, V83, P697, DOI 10.3168/jds.S0022-0302(00)74931-9; Wechsler B, 2000, APPL ANIM BEHAV SCI, V69, P189, DOI 10.1016/S0168-1591(00)00134-9; Whay HR, 2003, VET REC, V153, P197, DOI 10.1136/vr.153.7.197; Zurbrigg K, 2005, CAN VET J, V46, P902; Zurbrigg K, 2005, J DAIRY SCI, V88, P3201, DOI 10.3168/jds.S0022-0302(05)73003-4	54	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228808	10.1371/journal.pone.0228808	http://dx.doi.org/10.1371/journal.pone.0228808			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32049990	gold, Green Published, Green Submitted			2022-12-26	WOS:000535192300026
J	Cheng, XS; Diao, YN				Cheng, Xiao-Sheng; Diao, Yuanan			The braid index of DNA double crossover polyhedral links	PLOS ONE			English	Article							SEIFERT CIRCLES	In this paper, the authors study the mathematical properties of a class of alternating links called polyhedral links which have been used to model DNA polyhedra. The motivation of such studies is to provide guidance and aid in the research of the properties of certain DNA molecules. For example, such studies can provide characterizations of the structural complexity of DNA molecules. In an earlier work, Cheng and Jin studied the mathematical properties of such polyhedral links and were able to determine the braid index of a double crossover polyhedral link with 4 turn. However, the braid index of a double crossover polyhedral link with 4.5 turn remained an unsolved problem to this date, even though the graphs that admit the double crossover polyhedral links with 4.5 turn have been synthesized. In this paper, we provide a complete formulation of the braid index of a double crossover polyhedral link with an arbitrary turn number. Our approach is more general and it allows us to completely determine the braid indices for a much larger class of links. In the case of the double crossover polyhedral links, our formulation of the braid index is a simple formula based on a simpler graph used as a template to build the double crossover polyhedral links.	[Cheng, Xiao-Sheng] Huizhou Univ, Sch Math & Stat, Huizhou, Guangdong, Peoples R China; [Cheng, Xiao-Sheng; Diao, Yuanan] Univ North Carolina Charlotte, Dept Math & Stat, Charlotte, NC 28223 USA	Huizhou University; University of North Carolina; University of North Carolina Charlotte	Diao, YN (corresponding author), Univ North Carolina Charlotte, Dept Math & Stat, Charlotte, NC 28223 USA.	ydiao@uncc.edu		Diao, Yuanan/0000-0003-4411-3755	Natural Science Foundation of Guangdong Province, China [2016A030313122]; Excellent youth training project of Huizhou University [20160224082617206]; Training Program of the Major Research Plan of Huizhou University [20170327011726271]	Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Excellent youth training project of Huizhou University; Training Program of the Major Research Plan of Huizhou University	Unfunded studies: YD XC: Natural Science Foundation of Guangdong Province, China (No. 2016A030313122) XC: Excellent youth training project of Huizhou University (No. 20160224082617206) XC: Training Program of the Major Research Plan of Huizhou University (No. 20170327011726271).	Alexander JW, 1923, P NATL ACAD SCI USA, V9, P93, DOI 10.1073/pnas.9.3.93; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Cheng XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048968; Cheng XS, 2012, J MATH CHEM, V50, P1386, DOI 10.1007/s10910-012-9976-y; Cox MA, 2008, J MATH CHEM, V43, P874, DOI 10.1007/s10910-007-9323-x; Diao Y., ARXIV190109778; Diao YN, 2020, MATH PROC CAMBRIDGE, V168, P415, DOI 10.1017/S0305004118000907; El-rifai E.-s. A., 1988, THESIS; Erben CM, 2007, J AM CHEM SOC, V129, P6992, DOI 10.1021/ja071493b; FRANKS J, 1987, T AM MATH SOC, V303, P97, DOI 10.2307/2000780; FREYD P, 1985, B AM MATH SOC, V12, P239, DOI 10.1090/S0273-0979-1985-15361-3; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Goodman RP, 2004, CHEM COMMUN, P1372, DOI 10.1039/b402293a; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; He Y, 2010, ANGEW CHEM INT EDIT, V49, P748, DOI 10.1002/anie.200904513; Jones CD, 2019, NAT CHEM, V11, P375, DOI 10.1038/s41557-019-0222-0; Lin C, 2009, BIOCHEMISTRY-US, V48, P1663, DOI 10.1021/bi802324w; MORTON HR, 1986, MATH PROC CAMBRIDGE, V99, P107, DOI 10.1017/S0305004100063982; MORTON HR, 1987, MATH PROC CAMBRIDGE, V101, P267, DOI 10.1017/S0305004100066627; MURASUGI K, 1991, T AM MATH SOC, V326, P237, DOI 10.2307/2001863; Murasugi K, 1993, MEM AM MATH SOC, DOI [10.1090/memo/0508, DOI 10.1090/MEMO/0508]; Nakamura T, 2004, TOPOL APPL, V135, P13, DOI 10.1016/S0166-8641(03)00109-3; Park SH, 2006, ANGEW CHEM INT EDIT, V45, P735, DOI 10.1002/anie.200503797; Przytycki J.H., 1988, KOBE J MATH, V4, P115; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; YAMADA S, 1987, INVENT MATH, V89, P347, DOI 10.1007/BF01389082; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yang GP, 2012, CHEM SOC REV, V41, P6992, DOI 10.1039/c2cs35202h; Zhang C, 2008, P NATL ACAD SCI USA, V105, P10665, DOI 10.1073/pnas.0803841105; Zhang C, 2009, J AM CHEM SOC, V131, P1413, DOI 10.1021/ja809666h; ZHANG YW, 1994, J AM CHEM SOC, V116, P1661, DOI 10.1021/ja00084a006; Zimmermann J, 2008, ANGEW CHEM INT EDIT, V47, P3626, DOI 10.1002/anie.200702682	34	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228855	10.1371/journal.pone.0228855	http://dx.doi.org/10.1371/journal.pone.0228855			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32049974	Green Published, gold			2022-12-26	WOS:000535192300030
J	Ibeto, L; Antonopoulos, A; Grassi, P; Pang, PC; Panico, M; Bobdiwala, S; Al-Memar, M; Davis, P; Davis, M; Taylor, JN; Almeida, P; Johnson, MR; Harvey, R; Bourne, T; Seckl, M; Clark, G; Haslam, SM; Dell, A				Ibeto, Linda; Antonopoulos, Aristotelis; Grassi, Paola; Pang, Poh-Choo; Panico, Maria; Bobdiwala, Shabnam; Al-Memar, Maya; Davis, Paul; Davis, Mark; Taylor, Julian Norman; Almeida, Paula; Johnson, Mark R.; Harvey, Richard; Bourne, Tom; Seckl, Michael; Clark, Gary; Haslam, Stuart M.; Dell, Anne			Insights into the hyperglycosylation of human chorionic gonadotropin revealed by glycomics analysis	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; BETA-SUBUNIT; K562 CELLS; GLYCOSYLATION; HCG; PREGNANCY; GLYCOPROTEIN; GLYCOFORMS; EXPRESSION; CARBOHYDRATE	Human chorionic gonadotropin (hCG) is a glycoprotein hormone that is essential for the maintenance of pregnancy. Glycosylation of hCG is known to be essential for its biological activity. "Hyperglycosylated" variants secreted during early pregnancy have been proposed to be involved in initial implantation of the embryo and as a potential diagnostic marker for gestational diseases. However, what constitutes "hyperglycosylation" is not yet fully understood. In this study, we perform comparative N-glycomic analysis of hCG expressed in the same individuals during early and late pregnancy to help provide new insights into hCG function, reveal new targets for diagnostics and clarify the identity of hyperglycosylated hCG. hCG was isolated in urine collected from women at 7 weeks and 20 weeks' gestation. hCG was also isolated in urine from women diagnosed with gestational trophoblastic disease (GTD). We used glycomics methodologies including matrix assisted laser desorption/ionisation-time of flight (MALDI-TOF) mass spectrometry (MS) and MS/MS methods to characterise the N-glycans associated with hCG purified from the individual samples. The structures identified on the early pregnancy (EP-hCG) and late pregnancy (LP-hCG) samples corresponded to mono-, bi-, tri-, and tetra-antennary N-glycans. A novel finding was the presence of substantial amounts of bisected type N-glycans in pregnancy hCG samples, which were present at much lower levels in GTD samples. A second novel observation was the presence of abundant LewisX antigens on the bisected N-glycans. GTD-hCG had fewer glycoforms which constituted a subset of those found in normal pregnancy. When compared to EP-hCG, GTD-hCG samples had decreased signals for tri- and tetra-antennary N-glycans. In terms of terminal epitopes, GTD-hCG had increased signals for sialylated structures, while Lewis(X) antigens were of very minor abundance. hCG carries the same N-glycans throughout pregnancy but in different proportions. The N-glycan repertoire is more diverse than previously reported. Bisected and Lewis(X) structures are potential targets for diagnostics. hCG isolated from pregnancy urine inhibits NK cell cytotoxicity in vitro at nano-molar levels and bisected type glycans have previously been implicated in the suppression of NK cell cytotoxicity, suggesting that hCG-related bisected type N-glycans may directly suppress NK cell cytotoxicity.	[Ibeto, Linda; Antonopoulos, Aristotelis; Grassi, Paola; Pang, Poh-Choo; Panico, Maria; Haslam, Stuart M.; Dell, Anne] Imperial Coll London, Dept Life Sci, London, England; [Ibeto, Linda; Taylor, Julian Norman; Almeida, Paula; Johnson, Mark R.] Chelsea & Westminster Hosp, Acad Dept Obstet & Gynaecol, London, England; [Bobdiwala, Shabnam; Al-Memar, Maya; Bourne, Tom] Imperial Coll, Queen Charlottes & Chelsea Hosp, Tommys Natl Ctr Miscarriage Res, London, England; [Davis, Paul; Davis, Mark] Mologic LTD, Bedford Technol Pk, Bedford, Beds, England; [Harvey, Richard; Seckl, Michael] Imperial Coll London, Dept Surg & Canc, Div Canc, London, England; [Clark, Gary] Univ Missouri, Dept Obstet Gynaecol & Womens Hlth, Columbia, MO USA	Imperial College London; Imperial College London; Imperial College London; Imperial College London; University of Missouri System; University of Missouri Columbia	Dell, A (corresponding author), Imperial Coll London, Dept Life Sci, London, England.	a.dell@imperial.ac.uk	Bourne, Tom/I-6478-2012	Bourne, Tom/0000-0003-1421-6059	Mologic LTD UK; BBSRC [BB/K016164/1] Funding Source: UKRI	Mologic LTD UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Affiliation with Mologic LTD UK The funder provided support in the form of salaries for authors [PG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section	AMBRUS G, 1994, ENDOCRINOLOGY, V135, P2772, DOI 10.1210/en.135.6.2772; Bansal AS, 2012, EXPERT REV CLIN IMMU, V8, P747, DOI [10.1586/eci.12.77, 10.1586/ECI.12.77]; Bellet D, 1997, CANCER RES, V57, P516; BELLISARIO R, 1973, J BIOL CHEM, V248, P6796; Birken S, 1999, ENDOCRINE, V10, P137, DOI 10.1385/ENDO:10:2:137; Blaschitz A, 2001, Early Pregnancy, V5, P67; CARLSEN RB, 1973, J BIOL CHEM, V248, P6810; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chen QS, 2016, MOL CELL PROTEOMICS, V15, P1857, DOI 10.1074/mcp.M115.055798; Clark GF, 2014, MOL HUM REPROD, V20, P185, DOI 10.1093/molehr/gat064; Clark GF, 1996, HUM REPROD, V11, P467, DOI 10.1093/HUMREP/11.3.467; Cole LA, 2010, PLACENTA, V31, P653, DOI 10.1016/j.placenta.2010.06.005; Cole LA, 1999, CLIN CHEM, V45, P2109; Cole LA, 2014, INT J GYNECOL CANCER, V24, P1709, DOI 10.1097/IGC.0000000000000280; Cole LA, 2012, J REPROD IMMUNOL, V93, P119, DOI 10.1016/j.jri.2012.01.001; Cole LA, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-8; Cui J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01685; de Medeiros SF, 2009, HUM REPROD UPDATE, V15, P69, DOI 10.1093/humupd/dmn036; Dewal MB, 2015, CHEM BIOL, V22, P1301, DOI 10.1016/j.chembiol.2015.09.006; Drake PM, 2001, J EXP MED, V193, P1199, DOI 10.1084/jem.193.10.1199; Elliott MM, 1997, ENDOCRINE, V7, P15, DOI 10.1007/BF02778058; ELOUAGARI K, 1995, J BIOL CHEM, V270, P26970; Erdmann H, 2009, CELL MICROBIOL, V11, P1600, DOI 10.1111/j.1462-5822.2009.01350.x; Fournier T, 2015, PLACENTA, V36, pS60, DOI 10.1016/j.placenta.2015.02.002; Fournier T, 2016, ANN ENDOCRINOL-PARIS, V77, P75, DOI 10.1016/j.ando.2016.04.012; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; HARTREE AS, 1992, BIOCHEM J, V287, P665, DOI 10.1042/bj2870665; Islami D, 2003, MOL HUM REPROD, V9, P395, DOI 10.1093/molehr/gag053; JACOBS I, 1989, HUM REPROD, V4, P1; Jacoby ES, 2000, CLIN CHEM, V46, P1796; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; Keay SD, 2004, BJOG-INT J OBSTET GY, V111, P1218, DOI 10.1111/j.1471-0528.2004.00412.x; Kobata A, 1999, BBA-MOL BASIS DIS, V1455, P315, DOI 10.1016/S0925-4439(99)00060-5; Kolbl AC, 2017, INT J BIOL MARKER, DOI [10.5301/jbm.5000256, DOI 10.5301/JBM.5000256]; Kovalevskaya G, 2002, J ENDOCRINOL, V172, P497, DOI 10.1677/joe.0.1720497; LAIDLER P, 1995, RAPID COMMUN MASS SP, V9, P1021, DOI 10.1002/rcm.1290091110; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; Lee CL, 2011, DIABETES, V60, P909, DOI 10.2337/db10-1186; Li DY, 2015, J BIOL CHEM, V290, P22715, DOI 10.1074/jbc.M115.657072; Liu CL, 1997, J MASS SPECTROM, V32, P33, DOI 10.1002/(SICI)1096-9888(199701)32:1<33::AID-JMS446>3.0.CO;2-X; Lustbader JW, 1998, RECENT PROG HORM RES, V53, P395; MARCILLAC I, 1992, CANCER RES, V52, P3901; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Nemansky M, 1998, J BIOL CHEM, V273, P12068, DOI 10.1074/jbc.273.20.12068; Pang PC, 2006, GLYCOBIOLOGY, V16, P1161; Pang PC, 2011, SCIENCE, V333, P1761, DOI 10.1126/science.1207438; Rao CV, 2007, MOL CELL ENDOCRINOL, V269, P2, DOI 10.1016/j.mce.2006.07.007; Saraswat M, 2016, J PROTEOME RES, V15, P991, DOI 10.1021/acs.jproteome.5b01069; SEGREST JP, 1971, BIOCHEM BIOPH RES CO, V44, P390, DOI 10.1016/0006-291X(71)90612-7; Slattery MM, 2001, BRIT J OBSTET GYNAEC, V108, P704; Stenman UH, 2004, CLIN BIOCHEM, V37, P549, DOI 10.1016/j.clinbiochem.2004.05.008; Stenman UH, 2006, HUM REPROD UPDATE, V12, P769, DOI 10.1093/humupd/dml029; SULKE AN, 1985, J REPROD IMMUNOL, V7, P105, DOI 10.1016/0165-0378(85)90064-6; Sutton-Smith M, 2005, CELL BIOL LAB HDB; Valmu L, 2006, GLYCOBIOLOGY, V16, P1207, DOI 10.1093/glycob/cwl034; WEISSHAAR G, 1991, EUR J BIOCHEM, V195, P257, DOI 10.1111/j.1432-1033.1991.tb15702.x; Wu X, 2018, CELL DEATH DIS, V9, P14, DOI [10.1038/s41419-017-0030-7, DOI 10.1038/S41419-017-0030-7]; Yoshimura M, 1996, CANCER RES, V56, P412	59	3	4	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228507	10.1371/journal.pone.0228507	http://dx.doi.org/10.1371/journal.pone.0228507			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045434	gold, Green Published, Green Submitted			2022-12-26	WOS:000534633200016
J	Shi, SJ; Montalbetti, N; Wang, XQ; Rush, BM; Marciszyn, AL; Baty, CJ; Tan, RJ; Carattino, MD; Kleyman, TR				Shi, Shujie; Montalbetti, Nicolas; Wang, Xueqi; Rush, Brittney M.; Marciszyn, Allison L.; Baty, Catherine J.; Tan, Roderick J.; Carattino, Marcelo D.; Kleyman, Thomas R.			Paraoxonase 3 functions as a chaperone to decrease functional expression of the epithelial sodium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial sodium channel (ENaC); kidney; chaperone; hypertension; aldosterone; degenerin; MEC-6; PON3	IN-SITU HYBRIDIZATION; NA+ CHANNEL; COLLECTING DUCT; ENDOPLASMIC-RETICULUM; LIDDLES SYNDROME; GAMMA-SUBUNIT; BETA-SUBUNIT; ALPHA-ENAC; MOUSE KIDNEY; LOCALIZATION	The paraoxonase (PON) family comprises three highly conserved members: PON1, PON2, and PON3. They are orthologs of Caenorhabditis elegans MEC-6, an endoplasmic reticulum?resident chaperone that has a critical role in proper assembly and surface expression of the touch-sensing degenerin channel in nematodes. We have shown recently that MEC-6 and PON2 negatively regulate functional expression of the epithelial Na+ channel (ENaC), suggesting that the chaperone function is conserved within this family. We hypothesized that other PON family members also modulate ion channel expression. Pon3 is specifically expressed in the aldosterone-sensitive distal tubules in the mouse kidney. We found here that knocking down endogenous Pon3 in mouse cortical collecting duct cells enhanced Na+ transport, which was associated with increased ?ENaC abundance. We further examined Pon3 regulation of ENaC in two heterologous expression systems, Fisher rat thyroid cells and Xenopus oocytes. Pon3 coimmunoprecipitated with each of the three ENaC subunits in Fisher rat thyroid cells. As a result of this interaction, the whole-cell and surface abundance of ENaC ? and ? subunits was reduced by Pon3. When expressed in oocytes, Pon3 inhibited ENaC-mediated amiloride-sensitive Na+ currents, in part by reducing the surface expression of ENaC. In contrast, Pon3 did not alter the response of ENaC to chymotrypsin-mediated proteolytic activation or [2-(trimethylammonium)ethyl]methanethiosulfonate?induced activation of ??(S518C)?, suggesting that Pon3 does not affect channel open probability. Together, our results suggest that PON3 regulates ENaC expression by inhibiting its biogenesis and/or trafficking.	[Shi, Shujie; Montalbetti, Nicolas; Wang, Xueqi; Rush, Brittney M.; Marciszyn, Allison L.; Baty, Catherine J.; Tan, Roderick J.; Carattino, Marcelo D.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, 930 Scaife Hall, Pittsburgh, PA 15261 USA; [Carattino, Marcelo D.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Wang, Xueqi] Cent South Univ, Xiangya Hosp 2, Dept Nephrol, Changsha 410011, Hunan, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University	Shi, SJ (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, 3550 Terrace St, Pittsburgh, PA 15261 USA.	shs117@pitt.edu	Tan, Roderick/AAQ-7678-2021; Montalbetti, Nicolas/T-4212-2019	Tan, Roderick/0000-0003-1012-1722; Montalbetti, Nicolas/0000-0003-2897-9540; , Thomas/0000-0002-2413-5415	NIDDK, National Institutes of Health [DK103834, DK119752, DK038470, DK079307]; NHLBI, National Institutes of Health [HL147818]; National Institutes of Health [S10OD021627]	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by NIDDK, National Institutes of Health Grants DK103834 and DK119752 (to S. S.), DK038470 (to T. R. K.), and DK079307 (to the Pittsburgh Center for Kidney Research); NHLBI, National Institutes of Health Grant HL147818 (to T. R. K.); and National Institutes of Health Grant S10OD021627 (to C. J. B). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Blazer-Yost BL, 1998, AM J PHYSIOL-CELL PH, V274, pC1373, DOI 10.1152/ajpcell.1998.274.5.C1373; Boscardin E, 2018, J AM SOC NEPHROL, V29, P977, DOI [10.1681/ASN.2017030345, 10.1681/asn.2017030345]; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Buck TM, 2018, CURR OPIN NEPHROL HY, V27, P364, DOI 10.1097/MNH.0000000000000438; Buck TM, 2017, BIOCHEM J, V474, P357, DOI 10.1042/BCJ20160760; Buck TM, 2013, J BIOL CHEM, V288, P18366, DOI 10.1074/jbc.M113.469882; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; Chanoux RA, 2013, AM J PHYSIOL-CELL PH, V305, pC776, DOI 10.1152/ajpcell.00059.2013; Chanoux RA, 2012, J BIOL CHEM, V287, P19255, DOI 10.1074/jbc.M112.357756; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; Chen LH, 2017, P NATL ACAD SCI USA, V114, pE9989, DOI 10.1073/pnas.1710964114; Chen YS, 2016, MOL BIOL CELL, V27, P1272, DOI 10.1091/mbc.E15-08-0561; Christensen BM, 2010, J AM SOC NEPHROL, V21, P1942, DOI 10.1681/ASN.2009101077; CORVOL P, 1995, J ENDOCRINOL INVEST, V18, P592; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Denault DL, 1996, AM J PHYSIOL-CELL PH, V271, pC423, DOI 10.1152/ajpcell.1996.271.1.C423; Devarajan A, 2014, ADV EXP MED BIOL, V824, P33, DOI 10.1007/978-3-319-07320-0_5; Donaldson SH, 2007, CHEST, V132, P1631, DOI 10.1378/chest.07-0288; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Draganov DI, 2000, J BIOL CHEM, V275, P33435, DOI 10.1074/jbc.M004543200; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; Fang X, 2002, J GEN PHYSIOL, V119, P199, DOI 10.1085/jgp.119.2.199; Frindt G, 2004, AM J PHYSIOL-RENAL, V286, pF669, DOI 10.1152/ajprenal.00381.2003; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Gamliel-Lazarovich A, 2012, ATHEROSCLEROSIS, V222, P92, DOI 10.1016/j.atherosclerosis.2012.01.047; Giraldez T, 2007, J NEUROCHEM, V102, P1304, DOI 10.1111/j.1471-4159.2007.04622.x; Grifoni SC, 2008, AM J PHYSIOL-HEART C, V294, pH2022, DOI 10.1152/ajpheart.01271.2007; Grimm PR, 2017, J AM SOC NEPHROL, V28, P2598, DOI 10.1681/ASN.2016090948; Grumbach Y, 2014, AM J PHYSIOL-CELL PH, V307, pC701, DOI 10.1152/ajpcell.00134.2014; Grunder S, 1997, CURR OPIN NEPHROL HY, V6, P35; Hadchouel J, 2010, P NATL ACAD SCI USA, V107, P18109, DOI 10.1073/pnas.1006128107; HANSSON JH, 1995, P NATL ACAD SCI USA, V92, P11495, DOI 10.1073/pnas.92.25.11495; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Heidrich E, 2015, J BIOL CHEM, V290, P11569, DOI 10.1074/jbc.M115.640763; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; HUGHEY RP, 1986, BIOCHIM BIOPHYS ACTA, V874, P150, DOI 10.1016/0167-4838(86)90112-3; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; Hummler E, 1999, J STEROID BIOCHEM, V69, P385, DOI 10.1016/S0960-0760(99)00073-4; Joyce-Brady M, 2001, J BIOL CHEM, V276, P9468, DOI 10.1074/jbc.M004352200; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kashlan OB, 2007, J BIOL CHEM, V282, P28149, DOI 10.1074/jbc.M703409200; Kashlan OB, 2018, AM J PHYSIOL-RENAL, V314, pF483, DOI 10.1152/ajprenal.00195.2017; Kellenberger S, 2002, J PHYSIOL-LONDON, V543, P413, DOI 10.1113/jphysiol.2002.022020; Klemens CA, 2017, J BIOL CHEM, V292, P375, DOI 10.1074/jbc.M116.753616; Kleyman TR, 2018, ANNU REV PHYSIOL, V80, P263, DOI 10.1146/annurev-physiol-021317-121143; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Li Q, 2016, HEPATOLOGY, V63, P538, DOI 10.1002/hep.28301; LIFTON RP, 1995, P NATL ACAD SCI USA, V92, P8545, DOI 10.1073/pnas.92.19.8545; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Loffing J, 2001, AM J PHYSIOL-RENAL, V280, pF675, DOI 10.1152/ajprenal.2001.280.4.F675; Loffing J, 2000, AM J PHYSIOL-RENAL, V279, pF252, DOI 10.1152/ajprenal.2000.279.2.F252; Mackness MI, 1996, CURR OPIN LIPIDOL, V7, P69, DOI 10.1097/00041433-199604000-00004; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Mall MA, 2010, J BIOL CHEM, V285, P26945, DOI 10.1074/jbc.M110.151803; Marsillach J, 2008, FREE RADICAL BIO MED, V45, P146, DOI 10.1016/j.freeradbiomed.2008.03.023; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Meyer WK, 2018, SCIENCE, V361, P591, DOI 10.1126/science.aap7714; Mick VE, 2001, MOL ENDOCRINOL, V15, P575, DOI 10.1210/me.15.4.575; Miller RL, 2005, AM J PHYSIOL-CELL PH, V288, pC1134, DOI 10.1152/ajpcell.00084.2004; Mueller GM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M707339200; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Naray-Fejes-Toth A, 2000, KIDNEY INT, V57, P1290, DOI 10.1046/j.1523-1755.2000.00964.x; Nesterov V, 2012, AM J PHYSIOL-RENAL, V303, pF1289, DOI 10.1152/ajprenal.00247.2012; Ng CJ, 2005, FREE RADICAL BIO MED, V38, P153, DOI 10.1016/j.freeradbiomed.2004.09.035; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; Noreng S, 2018, ELIFE, V7, DOI 10.7554/eLife.39340; Passero CJ, 2012, AM J PHYSIOL-RENAL, V302, pF1, DOI 10.1152/ajprenal.00330.2011; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Plotkin MD, 1996, KIDNEY INT, V50, P174, DOI 10.1038/ki.1996.300; Precourt LP, 2011, ATHEROSCLEROSIS, V214, P20, DOI 10.1016/j.atherosclerosis.2010.08.076; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Rengarajan S, 2014, AM J PHYSIOL-RENAL, V306, pF1059, DOI 10.1152/ajprenal.00015.2014; Rotin D, 2001, AM J PHYSIOL-RENAL, V281, pF391, DOI 10.1152/ajprenal.2001.281.3.F391; Rubera I, 2003, J CLIN INVEST, V112, P554, DOI 10.1172/JCI200316956; SCHAFER JA, 1992, KIDNEY INT, V41, P255, DOI 10.1038/ki.1992.37; Schild L, 1996, NEPHROLOGIE, V17, P395; Schild L, 2010, BBA-MOL BASIS DIS, V1802, P1159, DOI 10.1016/j.bbadis.2010.06.014; Shi SJ, 2017, J BIOL CHEM, V292, P15927, DOI 10.1074/jbc.M117.785253; Shi Shujie, 2013, Curr Mol Pharmacol, V6, P28; Shih DM, 2015, FASEB J, V29, P1185, DOI 10.1096/fj.14-260570; Shih DM, 2010, ADV EXP MED BIOL, V660, P73, DOI 10.1007/978-1-60761-350-3_8; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; Strautnieks SS, 1996, HUM MOL GENET, V5, P293, DOI 10.1093/hmg/5.2.293; Strautnieks SS, 1996, NAT GENET, V13, P248, DOI 10.1038/ng0696-248; Su YR, 2001, DRUG METAB DISPOS, V29, P553; TAYLOR AN, 1982, KIDNEY INT, V21, P765, DOI 10.1038/ki.1982.95; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; Wang XP, 2019, J BIOL CHEM, V294, P10182, DOI 10.1074/jbc.RA119.007394; Wiemuth D, 2013, CHANNELS, V7, P38, DOI 10.4161/chan.22406; Wiemuth D, 2012, FASEB J, V26, P4122, DOI 10.1096/fj.12-207043; Yang Y, 2012, FREE RADICAL BIO MED, V53, P437, DOI 10.1016/j.freeradbiomed.2012.05.015; You H, 2017, J CELL SCI, V130, P1027, DOI 10.1242/jcs.198242	106	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4950	4962		10.1074/jbc.RA119.011789	http://dx.doi.org/10.1074/jbc.RA119.011789			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32079677	hybrid, Green Published			2022-12-26	WOS:000526887000018
J	Lu, GJ; Zhang, YS				Lu, Guojie; Zhang, Yaosen			Long non-coding RNA ATB promotes human non-small cell lung cancer proliferation and metastasis by suppressing miR-141-3p	PLOS ONE			English	Article							LNCRNA-ATB; INVASION; MIGRATION; PROGRESSION	Long noncoding RNA activated by transforming growth factor-beta (lncRNA-ATB) plays a critical role in progression of several cancers. In this study, lncRNA-ATB was significantly up-regulated in NSCLC tissues and cell lines, and high lncRNA-ATB expression indicated poor prognosis. Knockdown of lncRNA-ATB suppressed NSCLC cell growth, colony formation, migration, invasion and reversed epithelial-mesenchymal transition. In vivo study showed that silencing lncRNA-ATB inhibited tumor growth. Further mechanism studies demonstrated that lncRNA-ATB was a target of miR-141-3p. MiR-141-3p expression was negatively related to lncRNA-ATB expression in NSCLC tissues. These results suggested that inhibiting lncRNA-ATB might be an approach for NSCLC treatment.	[Lu, Guojie; Zhang, Yaosen] Guangzhou Panyu Cent Hosp, Dept Thorac Surg, Guangzhou, Peoples R China		Zhang, YS (corresponding author), Guangzhou Panyu Cent Hosp, Dept Thorac Surg, Guangzhou, Peoples R China.	13632332051@163.com						Brabletz T, 2018, NAT REV CANCER, V18, P128, DOI 10.1038/nrc.2017.118; Han F, 2017, AM J CANCER RES, V7, P770; Huang S, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0645-7; Jin B., 2018, J CELL PHYSL; Kowal A, 2015, THORAC CANCER, V6, P613, DOI 10.1111/1759-7714.12232; Kuan FC, 2015, BRIT J CANCER, V113, P1519, DOI 10.1038/bjc.2015.356; Lan X., 2018, J CELL MOL MED; Lee SH, 2015, J PATHOL TRANSL MED, V49, P481, DOI 10.4132/jptm.2015.09.14; Li Jun, 2018, Oncotarget, V9, P11948, DOI 10.18632/oncotarget.23946; Li RH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1210-9; Li S., 2018, J PERIODONTAL RES; Li SW, 2018, ONCOTARGET, V9, P1156, DOI 10.18632/oncotarget.23452; Li WS, 2019, BIOCHEM BIOPH RES CO, V509, P647, DOI 10.1016/j.bbrc.2018.12.089; Liang Z, 2019, BIOCHEM BIOPH RES CO, V514, P699, DOI 10.1016/j.bbrc.2019.05.002; Lu Q., 2018, FASEB J; Mott Timothy F, 2018, FP Essent, V464, P27; Ni R, 2015, ONCOTARGETS THER, V8, P2689, DOI [10.2147/OTT.S90998, 10.2147/OTT.S86093]; Owen D, 2018, J THORAC DIS, V10, pS404, DOI 10.21037/jtd.2017.12.93; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qian B., 2018, THORAC CANC; Rathinasamy B, 2018, BIOMED PHARMACOTHER, V102, P242, DOI [10.1016/j.biopha.2018.03.077, DOI 10.1016/J.BI0PHA.2018.03.077]; Tang F., 2019, LNCRNA ATB PROMOTES; Wang N, 2018, ONCOL REP, V39, P747, DOI 10.3892/or.2017.6150; Xiong J, 2016, JPN J CLIN ONCOL, V46, P378, DOI 10.1093/jjco/hyv214; Xu S, 2016, ONCOL REP, V36, P10, DOI 10.3892/or.2016.4791; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Yue B, 2016, J GASTROEN HEPATOL, V31, P595, DOI 10.1111/jgh.13206; Zhu YP, 2019, EXP PHYSIOL, V104, P837, DOI 10.1113/EP087656	28	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229118	10.1371/journal.pone.0229118	http://dx.doi.org/10.1371/journal.pone.0229118			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092085	Green Published, gold			2022-12-26	WOS:000535229300023
J	Leskel, J; Pietiainen, M; Safer, A; Lehto, M; Metso, J; Malle, E; Buggle, F; Becher, H; Sundvall, J; Grau, AJ; Pussinen, PJ; Palm, F				Leskel, Jaakko; Pietiainen, Milla; Safer, Anton; Lehto, Markku; Metso, Jari; Malle, Ernst; Buggle, Florian; Becher, Heiko; Sundvall, Jouko; Grau, Armin J.; Pussinen, Pirkko J.; Palm, Frederick			Serum lipopolysaccharide neutralizing capacity in ischemic stroke	PLOS ONE			English	Article							PHOSPHOLIPID TRANSFER PROTEIN; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PERIODONTAL PATHOGENS; CARDIOVASCULAR-DISEASE; PLASMA-LIPOPROTEINS; ENDOTOXIN ACTIVITY; ASSOCIATION; INFLAMMATION; RELEASE; OBESITY	Introduction Periodontitis is associated with increased serum lipopolysaccharide (LPS) activity, which may be one mechanism linking periodontitis with the risk of cardiovascular diseases. As LPS-carrying proteins including lipoproteins modify LPS-activity, we investigated the determinants of serum LPS-neutralizing capacity (LPS-NC) in ischemic stroke. The association of LPS-NC and Aggregatibacter actinomycetemcomitans, a major microbial biomarker in periodontitis, was also investigated. Materials and methods The assay to measure LPS-NC was set up by spiking serum samples with E. coli LPS. The LPS-NC, LPS-binding protein (LBP), soluble CD14 (sCD14), lipoprotein profiles, apo(lipoprotein) A-I, apoB, and phospholipid transfer protein (PLTP) activity, were determined in 98 ischemic stroke patients and 100 age- and sex-matched controls. Serum and saliva immune response to A. actinomycetemcomitans, its concentration in saliva, and serotype-distribution were examined. Results LPS-NC values ranged between 51-83% in the whole population. Although several of the LPS-NC determinants differed significantly between cases and controls (PLTP, sCD14, apoA-I, HDL-cholesterol), the levels did not (p = 0.056). The main determinants of LPS-NC were i) triglycerides (beta = -0.68, p<0.001), and ii) HDL cholesterol (0.260, <0.001), LDL cholesterol (-0.265, <0.001), PLTP (-0.196, 0.011), and IgG against A. actinomycetemcomitans (0.174, 0.011). Saliva A. actinomycetemcomitans concentration was higher [log mean (95% CI), 4.39 (2.35-8.19) vs. 10.7 (5.45-21) genomes/ml, p = 0.023) and serotype D more frequent (4 vs. 0%, p = 0.043) in cases than controls. Serotypeablity or serotypes did not, however, relate to the LPS-NC. Conclusion Serum LPS-NC comprised low PLTP-activity, triglyceride and LDL cholesterol concentrations, as well as high HDL cholesterol and IgG against A. actinomycetemcomitans. The present findings let us to conclude that LPS-NC did not associate with stroke.	[Leskel, Jaakko; Pietiainen, Milla; Pussinen, Pirkko J.] Univ Helsinki, Oral & Maxillofacial Dis, Helsinki, Finland; [Safer, Anton] Heidelberg Univ, Inst Global Hlth, Heidelberg, Germany; [Lehto, Markku] Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland; [Metso, Jari] Minerva Fdn, Inst Med Res, Helsinki, Finland; [Malle, Ernst] Med Univ Graz, Gottfried Schatz Res Ctr, Div Mol Biol & Biochem, Graz, Austria; [Buggle, Florian; Grau, Armin J.] Klinikum Ludwigshafen, Dept Neurol, Ludwigshafen, Germany; [Becher, Heiko] Univ Med Ctr Hamburg Eppendorf, Inst Med Biometry & Epidemiol, Hamburg, Germany; [Becher, Heiko] Univ Hosp Heidelberg, Inst Global Hlth, Heidelberg, Germany; [Sundvall, Jouko] Natl Inst Hlth & Welf, Helsinki, Finland; [Palm, Frederick] Helios Klinikum Schleswig, Dept Neurol, Schleswig, Germany	University of Helsinki; Ruprecht Karls University Heidelberg; Folkhalsan Research Center; Medical University of Graz; Ludwigshafen Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; Finland National Institute for Health & Welfare; Helios Kliniken	Pussinen, PJ (corresponding author), Univ Helsinki, Oral & Maxillofacial Dis, Helsinki, Finland.	pirkko.pussinen@helsinki.fi	Becher, Heiko/ABI-1234-2020; Leskelä, Jaakko/ABC-5477-2021	Leskelä, Jaakko/0000-0001-9670-339X; Pussinen, Pirkko/0000-0003-3563-1876; Becher, Heiko/0000-0002-8808-6667	Academy of Finland [1266053]; Finnish Dental Society Apollonia; Paulo foundation; Sigrid Juselius foundation	Academy of Finland(Academy of Finland); Finnish Dental Society Apollonia; Paulo foundation; Sigrid Juselius foundation(Sigrid Juselius Foundation)	The study was supported by grants from the Academy of Finland (1266053 for PJP), Finnish Dental Society Apollonia, the Paulo foundation, and the Sigrid Juselius foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Albers JJ, 1996, CURR OPIN LIPIDOL, V7, P88, DOI 10.1097/00041433-199604000-00007; Audo R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193815; Becher H, 2016, STROKE, V47, P173, DOI 10.1161/STROKEAHA.115.011523; Biedzka-Sarek M, 2011, J BIOL CHEM, V286, P38211, DOI 10.1074/jbc.M111.249482; Bousser MG, 2009, CEREBROVASC DIS, V27, P608, DOI 10.1159/000216835; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Champion K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067736; Deckert V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03285-9; Gautier T, 2008, J BIOL CHEM, V283, P18702, DOI 10.1074/jbc.M802802200; Geerts SO, 2002, J PERIODONTOL, V73, P73, DOI 10.1902/jop.2002.73.1.73; Gnauck A, 2016, CRIT REV CL LAB SCI, V53, P197, DOI 10.3109/10408363.2015.1123215; Graham C, 2015, NUTR REV, V73, P376, DOI 10.1093/nutrit/nuv004; Gutsmann T, 2010, INNATE IMMUN-LONDON, V16, P39, DOI 10.1177/1753425909106447; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P533; Haziot A, 1997, SCAND J IMMUNOL, V46, P242, DOI 10.1046/j.1365-3083.1997.d01-124.x; He ZP, 2017, THROMB RES, V154, P19, DOI 10.1016/j.thromres.2017.03.025; Henning MF, 2011, INNATE IMMUN-LONDON, V17, P327, DOI 10.1177/1753425910370709; Hyvarinen K, 2012, ATHEROSCLEROSIS, V223, P478, DOI 10.1016/j.atherosclerosis.2012.05.021; Hyvarinen K, 2009, INNATE IMMUN-LONDON, V15, P195, DOI 10.1177/1753425908101920; Janis MT, 2004, J LIPID RES, V45, P2303, DOI 10.1194/jlr.M400250-JLR200; Jauhiainen M, 2005, METHODS, V36, P97, DOI 10.1016/j.ymeth.2004.11.006; Johansson A, 2005, CEREBROVASC DIS, V20, P226, DOI 10.1159/000087703; Kallio KAE, 2008, INNATE IMMUN-LONDON, V14, P247, DOI 10.1177/1753425908095130; Kallio KAE, 2015, ACTA DIABETOL, V52, P395, DOI 10.1007/s00592-014-0662-3; Kallio KAE, 2013, METABOLISM, V62, P661, DOI 10.1016/j.metabol.2012.09.015; Kitchens RL, 1999, J BIOL CHEM, V274, P34116, DOI 10.1074/jbc.274.48.34116; Kitchens RL, 2003, J ENDOTOXIN RES, V9, P113, DOI 10.1179/096805103125001504; Klimiec E, 2018, ATHEROSCLEROSIS, V269, P138, DOI 10.1016/j.atherosclerosis.2017.12.034; Klimiec E, 2016, J NEUROIMMUNOL, V297, P76, DOI 10.1016/j.jneuroim.2016.05.006; Lakio L, 2003, INFECT IMMUN, V71, P5005, DOI 10.1128/IAI.71.9.5005-5011.2003; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Levels JHM, 2003, CRIT CARE MED, V31, P1647, DOI 10.1097/01.CCM.0000063260.07222.76; Levels JHM, 2001, INFECT IMMUN, V69, P2821, DOI 10.1128/IAI.69.5.2821-2828.2001; Levels JHM, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-34; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Liljestrand JM, 2017, J CLIN PERIODONTOL, V44, P784, DOI 10.1111/jcpe.12751; Mantyla P, 2013, J CLIN PERIODONTOL, V40, P583, DOI 10.1111/jcpe.12098; MASOUD H, 1991, EUR J BIOCHEM, V200, P775, DOI 10.1111/j.1432-1033.1991.tb16244.x; Munford RS, 2016, J LEUKOCYTE BIOL, V100, P687, DOI 10.1189/jlb.3RU0316-151R; Nymark M, 2009, DIABETES CARE, V32, P1689, DOI 10.2337/dc09-0467; PAGE RC, 1991, INFECT IMMUN, V59, P3451, DOI 10.1128/IAI.59.10.3451-3462.1991; Palm F, 2012, CEREBROVASC DIS, V33, P69, DOI 10.1159/000333417; Palm F, 2016, ATHEROSCLEROSIS, V254, P117, DOI 10.1016/j.atherosclerosis.2016.10.008; Palm F, 2014, INNATE IMMUN-LONDON, V20, P511, DOI 10.1177/1753425913501214; Paturel L, 2004, CLIN MICROBIOL INFEC, V10, P98, DOI 10.1111/j.1469-0691.2004.00794.x; PEARSON FC, 1985, J CLIN MICROBIOL, V21, P865, DOI 10.1128/JCM.21.6.865-868.1985; Perry MB, 1996, EUR J BIOCHEM, V242, P682, DOI 10.1111/j.1432-1033.1996.0682r.x; Pietiainen M, 2018, EUR J ORAL SCI, V126, P26, DOI 10.1111/eos.12423; Pietiainen M, 2018, J CLIN PERIODONTOL, V45, P413, DOI 10.1111/jcpe.12873; Pussinen PJ, 2007, ARTERIOSCL THROM VAS, V27, P1433, DOI 10.1161/ATVBAHA.106.138743; Pussinen PJ, 2011, J CLIN PERIODONTOL, V38, P405, DOI 10.1111/j.1600-051X.2011.01703.x; Pussinen PJ, 2011, DIABETES CARE, V34, P392, DOI 10.2337/dc10-1676; Pussinen PJ, 2004, STROKE, V35, P2020, DOI 10.1161/01.STR.0000136148.29490.fe; Pussinen PJ, 2004, J LIPID RES, V45, P139, DOI 10.1194/jlr.M300250-JLR200; Pussinen PJ, 2001, ATHEROSCLEROSIS, V155, P297, DOI 10.1016/S0021-9150(00)00568-2; Pussinen PJ, 2001, BBA-MOL CELL BIOL L, V1533, P153, DOI 10.1016/S1388-1981(01)00153-6; Reich J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040838; Spahr A, 2006, ARCH INTERN MED, V166, P554, DOI 10.1001/archinte.166.5.554; Stoll LL, 2006, CURR PHARM DESIGN, V12, P4229, DOI 10.2174/138161206778743501; Urbaschek R, 2001, ALCOHOL CLIN EXP RES, V25, P261; van Leeuwen HJ, 2003, CRIT CARE MED, V31, P1359, DOI 10.1097/01.CCM.0000059724.08290.51; Verges B, 2014, J CLIN ENDOCR METAB, V99, pE1245, DOI 10.1210/jc.2013-3463; Vesy CJ, 2000, INFECT IMMUN, V68, P2410, DOI 10.1128/IAI.68.5.2410-2417.2000; Wiedermann CJ, 1999, J AM COLL CARDIOL, V34, P1975, DOI 10.1016/S0735-1097(99)00448-9; Yu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20845	66	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0228806	10.1371/journal.pone.0228806	http://dx.doi.org/10.1371/journal.pone.0228806			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084157	Green Published, gold			2022-12-26	WOS:000535227900028
J	Sathyapalan, DT; Padmanabhan, A; Moni, M; P-Prabhu, B; Prasanna, P; Balachandran, S; Trikkur, SP; Jose, S; Edathadathil, F; Anilkumar, JO; Jayaprasad, R; Koramparambil, G; Kamath, RC; Menon, V; Menon, V				Sathyapalan, Dipu T.; Padmanabhan, Athira; Moni, Merlin; P-Prabhu, Binny; Prasanna, Preetha; Balachandran, Sabarish; Trikkur, Sreekrishnan P.; Jose, Soumya; Edathadathil, Fabia; Anilkumar, Jagan O.; Jayaprasad, Rekha; Koramparambil, Gireeshkumar; Kamath, Ravindra C.; Menon, Veena; Menon, Vidya			Efficacy & safety of Carica papaya leaf extract (CPLE) in severe thrombocytopenia (<= 30,000/mu l) in adult dengue - Results of a pilot study	PLOS ONE			English	Article							PLATELET TRANSFUSION; INHIBITION; FEVER	Severe thrombocytopenia in dengue often prompts platelet transfusion primarily to reduce bleeding risk. In India, about 11-43% of dengue patients report receiving platelet transfusions which is considered scarce and expensive especially in resource limited settings. Herein, we evaluated the efficacy and safety of Carica papaya leaf extract (CPLE) in the management of severe thrombocytopenia (<= 30,000/mu L) in dengue infection. 51 laboratory confirmed adult dengue patients with platelet counts <= 30,000/mu L were randomly assigned to either treatment (n = 26) or placebo (n = 24) group. By day 3, CPLE treated patients reported significantly (p = 0.007) increased platelet counts (482%+/- 284) compared to placebo (331%+/- 370) group. In the treatment group, fewer patients received platelet transfusions (1/26 v/s 2/24) and their median time for platelets to recover to >= 50,000/mu L was 2 days (IQR 2-3) compared to 3 days (IQR 2-4) in placebo. Overall, CPLE was safe and well tolerated with no significant decrease in mean hospitalization days. Plasma cytokine profiling revealed that by day 3, mean percent increase in TNF alpha and IFN gamma levels in treatment group was less compared to that observed in placebos; (TNF alpha: 58.6% v/s 127.5%; p = 0.25 and IFN gamma: 1.93% v/s 62.6% for; p = 0.12). While a mean percent increase in IL-6 levels occurred in placebos (15.92%+/- 29.93%) by day 3, a decrease was noted in CPLE group (12.95%+/- 21.75%; p = 0.0232). Inversely, CPLE treated patients reported a mean percent increase compared to placebo by day 3 (143% +/- 115.7% v/s 12.03%+/- 48.4%; p = 0.006). Further, by day 3, a faster clearance kinetics of viral NS1 antigenemia occurred-mean NS1 titers in treatment group decreased to 97.3% compared to 88% in placebos (p = 0.023). This study demonstrates safety and efficacy of CPLE in increasing platelet counts in severe thrombocytopenia in dengue infections. A possible immunomodulatory and antiviral activity may be attributed to CPLE treatment. These findings merit validation in larger prospective studies.	[Sathyapalan, Dipu T.; Moni, Merlin; P-Prabhu, Binny; Menon, Vidya] Amrita Inst Med Sci, Dept Gen Med, Kochi, Kerala, India; [Padmanabhan, Athira; Jose, Soumya; Anilkumar, Jagan O.; Menon, Veena] Amrita Inst Med Sci, Clin Virol Lab, Kochi, Kerala, India; [Prasanna, Preetha; Jayaprasad, Rekha] Amrita Inst Med Sci, Dept Med Adm, Kochi, Kerala, India; [Balachandran, Sabarish; Trikkur, Sreekrishnan P.; Koramparambil, Gireeshkumar] Amrita Inst Med Sci, Dept Emergency Med, Kochi, Kerala, India; [Edathadathil, Fabia] Amrita Inst Med Sci, Dept Allied Hlth Sci, Kochi, Kerala, India; [Kamath, Ravindra C.] Amrita Inst Med Sci, Dept Integrated Holist Med, Kochi, Kerala, India	Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi	Menon, V (corresponding author), Amrita Inst Med Sci, Dept Gen Med, Kochi, Kerala, India.	vidyapmenon@gmail.com	Balachandran, Sabarish/ABE-1732-2020	BALACHANDRAN, SABARISH/0000-0001-6333-4479	Micro Labs Ltd., Bangalore, India	Micro Labs Ltd., Bangalore, India	Funding by Micro Labs Ltd., Bangalore, India. Fund awarded to VM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Nisar, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P330, DOI 10.1016/S2221-1691(11)60055-5; Assir MZK, 2013, TRANSFUS MED HEMOTH, V40, P362, DOI 10.1159/000354837; Azeredo EL, 2001, IMMUNOBIOLOGY, V204, P494, DOI 10.1078/0171-2985-00058; Charan Jaykaran, 2016, Int J Appl Basic Med Res, V6, P249; Chinnappan S, 2016, VIRAL IMMUNOL, V29, P164, DOI 10.1089/vim.2015.0083; de Azeredo EL, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/313842; Eapen CE, 2015, CURR SCI INDIA, V108, P168; Gadhwal Ajeet Kumar, 2016, J Assoc Physicians India, V64, P22; Government of India, 2015, NAT GUID CLIN MAN DE; Hetttige S, 2008, SRI LANKAN FAM PHYS, V29, P17; Jayashree K, 2011, INDIAN J HEMATOL BLO, V27, P127, DOI 10.1007/s12288-011-0075-1; Kasture Prabhu Nagnathappa, 2016, J Assoc Physicians India, V64, P15; Kumar N D, 2000, Indian J Pathol Microbiol, V43, P55; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lee TH, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004576; Lum LCS, 2003, J PEDIATR-US, V143, P682, DOI 10.1067/S0022-3476(03)00503-1; Lye DC, 2017, LANCET, V389, P1611, DOI 10.1016/S0140-6736(17)30269-6; Makroo R N, 2007, Asian J Transfus Sci, V1, P4, DOI 10.4103/0973-6247.28065; Michels M, 2014, THROMB HAEMOSTASIS, V112, P352, DOI 10.1160/TH14-01-0056; Murgue B, 1997, J INFECT DIS, V175, P1497, DOI 10.1086/516486; Okoko Tebekeme, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P449, DOI 10.1016/S2221-1691(12)60074-4; PUTINTSEVA E, 1986, NOUV REV FR HEMATOL, V28, P269; Ranasinghe P, 2012, PHARMACOGN RES, V4, P196, DOI 10.4103/0974-8490.102261; Senthilvel P, 2013, BIOINFORMATION, V9, P889, DOI 10.6026/97320630009889; Sharma N, 2019, ARCH VIROL, V164, P1095, DOI 10.1007/s00705-019-04179-z; Sridharan A, 2013, J VIROL, V87, P11648, DOI 10.1128/JVI.01156-13; Subenthiran S., 2013, EVID-BASED COMPL ALT, V2013, P1, DOI [10.1155/2013/616737, DOI 10.1155/2013/616737]; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Whitehorn J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001716; WHO, 2012, ACC WORK OV GLOB IMP, P13; WHO, 2009, DENG GUID DIAGN TREA; Wong JGX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148579; World Health Organization, 2012, HDB CLIN MAN DENG; World Health Organization, 2009, DENGUE GUIDELINES DI	34	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228699	10.1371/journal.pone.0228699	http://dx.doi.org/10.1371/journal.pone.0228699			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074143	Green Published, gold			2022-12-26	WOS:000535220600025
J	Albright, MBN; Runde, A; Lopez, D; Gans, J; Sevanto, S; Woolf, D; Dunbar, J				Albright, Michaeline B. N.; Runde, Andreas; Lopez, Deanna; Gans, Jason; Sevanto, Sanna; Woolf, Dominic; Dunbar, John			Effects of initial microbial biomass abundance on respiration during pine litter decomposition	PLOS ONE			English	Article							SOIL ORGANIC-CARBON; COMMUNITY STRUCTURE; BACTERIAL ABUNDANCE; FUNGAL; DIVERSITY; MINERALIZATION; METAANALYSIS; TEMPERATURE; DISPERSAL; DILUTION	Microbial biomass is increasingly used to predict respiration in soil organic carbon (SOC) models. Its increased use combined with the difficulty of accurately measuring this variable points a need to directly assess the importance of microbial biomass abundance for carbon (C) cycling. To test the hypothesis that the initial microbial biomass abundance (i.e. biomass abundance on new plant litter) is a strong driver of plant litter C cycling, we manipulated biomass abundance by 10 and 100-fold dilution and composition using 12 source communities on sterile pine litter and measured respiration in microcosms for 30 days. In the first two days of microbial growth on fresh litter, a 100-fold difference in initial biomass abundance caused an average difference in respiration of nearly 300%, but the effect rapidly declined to less than 30% in 10 days and to 14% in 30 days. Parallel simulations with a soil carbon model, SOMIC 1.0, also predicted a 14% difference over 30 days, consistent with the experimental results. Model simulations predicted convergence of cumulative CO2 to within 10% in three months and within 4% in three years. Rapid microbial growth, evidenced by appearance of visible microbial mats on the litter during the first week of incubation, likely attenuates the effects of large initial differences in biomass abundance. In contrast, the persistence of source community as an explanatory factor in driving differences in respiration across microcosms supports the importance of microbial composition in C cycling. Overall, the results suggest that the initial abundance of microbial biomass on litter is a weak driver of C flux from litter decomposition over long timescales (months to years) when litter communities have equal nutrient availability. By extension, slight variation in the timing of microbial dispersal to fresh litter is likely to be a minor factor in long-term C flux. Importance Microbial biomass is one of the most common microbial parameters used in land carbon (C) cycle models, however, it is notoriously difficult to measure accurately. To understand the consequences of mismeasurement, as well as the broader importance of microbial biomass abundance as a direct driver of ecological phenomena, greater quantitative understanding of the role of microbial biomass abundance in environmental processes is needed. Using microcosms, we manipulated the initial biomass of numerous microbial communities across a 100-fold range and measured effects on CO2 production during plant litter decomposition. We found that the effects of initial biomass abundance on CO2 production was largely attenuated within a week, while the effects of community type remained significant over the course of the experiment. Overall, our results suggest that initial microbial biomass abundance in litter decomposition within an ecosystem is a weak driver of long-term C cycling dynamics.	[Albright, Michaeline B. N.; Runde, Andreas; Lopez, Deanna; Gans, Jason; Dunbar, John] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Sevanto, Sanna] Los Alamos Natl Lab, Earth & Environm Sci Div, Los Alamos, NM USA; [Woolf, Dominic] Cornell Univ, Coll Agr & Life Sci, Ithaca, NY USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Cornell University	Albright, MBN (corresponding author), Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA.	malbright@lanl.gov	振轩, 毛/GVT-1623-2022; Sevanto, Sanna/ABE-6310-2020	Sevanto, Sanna/0000-0001-9127-5285; Albright, Michaeline/0000-0002-4528-0312	U.S. Department of Energy, Office of Science, Biological and Environmental Research Division [F260LANL2018]	U.S. Department of Energy, Office of Science, Biological and Environmental Research Division(United States Department of Energy (DOE))	This work was supported by the U.S. Department of Energy, Office of Science, Biological and Environmental Research Division, under award number F260LANL2018 to JD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright MBN, 2018, ISME J, V12, P296, DOI 10.1038/ismej.2017.161; Ali RS, 2018, SOIL BIOL BIOCHEM, V118, P59, DOI 10.1016/j.soilbio.2017.12.007; Allison SD, 2013, ECOLOGY, V94, P714, DOI 10.1890/12-1243.1; Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; ANDERSON JP, 1973, ARCH MIKROBIOL, V93, P113, DOI 10.1007/BF00424942; Anderson M.J., 2008, PERMANOVA PRIMER GUI; ANDERSON TH, 1989, SOIL BIOL BIOCHEM, V21, P471, DOI 10.1016/0038-0717(89)90117-X; [Anonymous], 2017, COMM EC PACK; Bachar A, 2010, MICROB ECOL, V60, P453, DOI 10.1007/s00248-010-9727-1; Baker NR, 2017, SOIL BIOL BIOCHEM, V114, P82, DOI 10.1016/j.soilbio.2017.07.005; Baldrian P, 2013, FUNGAL ECOL, V6, P1, DOI 10.1016/j.funeco.2012.10.002; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Beck T, 1997, SOIL BIOL BIOCHEM, V29, P1023, DOI 10.1016/S0038-0717(97)00030-8; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Birge HE, 2015, SOIL BIOL BIOCHEM, V81, P304, DOI 10.1016/j.soilbio.2014.11.028; Bonan GB, 2013, GLOBAL CHANGE BIOL, V19, P957, DOI 10.1111/gcb.12031; Bradford MA, 2017, NAT ECOL EVOL, V1, P1836, DOI 10.1038/s41559-017-0367-4; Bressan M, 2015, APPL SOIL ECOL, V88, P60, DOI 10.1016/j.apsoil.2014.12.007; Brookes PC, 2017, SOIL BIOL BIOCHEM, V112, P127, DOI 10.1016/j.soilbio.2017.05.003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen J, 2015, SCI REP-UK, V5, DOI 10.1038/srep18032; Colman BP, 2013, SOIL BIOL BIOCHEM, V60, P65, DOI 10.1016/j.soilbio.2013.01.003; Delgado-Baquerizo M, 2016, J ECOL, V104, P936, DOI 10.1111/1365-2745.12585; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Evans S, 2017, ISME J, V11, P176, DOI 10.1038/ismej.2016.96; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Fierer N, 2017, NAT REV MICROBIOL, V15, P579, DOI 10.1038/nrmicro.2017.87; Franklin RB, 2001, APPL ENVIRON MICROB, V67, P702, DOI 10.1128/AEM.67.2.702-712.2001; Frey SD, 2008, SOIL BIOL BIOCHEM, V40, P2904, DOI 10.1016/j.soilbio.2008.07.020; Frossard A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00903; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Glassman SI, 2018, P NATL ACAD SCI USA, V115, P11994, DOI 10.1073/pnas.1811269115; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Golebiewski M, 2019, MICROB ECOL, V77, P56, DOI 10.1007/s00248-018-1209-x; Gonzalez-Quinones V, 2011, SOIL RES, V49, P287, DOI 10.1071/SR10203; HART SC, 1992, CAN J FOREST RES, V22, P306, DOI 10.1139/x92-040; Holden SR, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00163; Hubbell Stephen P., 2001, V32, pi; Johansen R, REVIEW; Kim M, 2014, MICROB ECOL, V67, P837, DOI 10.1007/s00248-014-0380-y; Lee KH, 2003, FOREST ECOL MANAG, V185, P263, DOI 10.1016/S0378-1127(03)00164-6; Matulich KL, 2015, ECOLOGY, V96, P154, DOI 10.1890/14-0357.1; Mille-Lindblom C, 2003, MICROBIAL ECOL, V45, P173, DOI 10.1007/s00248-002-2030-z; Mueller RC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00891; Mueller RC, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv153; Neufeld JD, 2007, NAT PROTOC, V2, P860, DOI 10.1038/nprot.2007.109; Philippot L, 2013, ISME J, V7, P1609, DOI 10.1038/ismej.2013.34; Quinn GP, 2002, EXPT DESIGN DATA ANA, Vxvii; R Core Team, 2013, R LANG ENV STAT COMP; Raeymaekers L, 2000, MOL BIOTECHNOL, V15, P115, DOI 10.1385/MB:15:2:115; Rinkes Zachary L, 2013, Front Microbiol, V4, P260, DOI 10.3389/fmicb.2013.00260; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Serna-Chavez HM, 2013, GLOBAL ECOL BIOGEOGR, V22, P1162, DOI 10.1111/geb.12070; Snajdr J, 2011, FEMS MICROBIOL ECOL, V75, P291, DOI 10.1111/j.1574-6941.2010.00999.x; Strickland MS, 2010, SOIL BIOL BIOCHEM, V42, P1385, DOI 10.1016/j.soilbio.2010.05.007; Taylor JP, 2002, SOIL BIOL BIOCHEM, V34, P387, DOI 10.1016/S0038-0717(01)00199-7; Tenney FG, 1929, SOIL SCI, V28, P55, DOI 10.1097/00010694-192907000-00005; Thiessen S, 2013, SOIL BIOL BIOCHEM, V57, P739, DOI 10.1016/j.soilbio.2012.10.029; Tiunov AV, 2005, ECOL LETT, V8, P618, DOI 10.1111/j.1461-0248.2005.00757.x; Todd-Brown KEO, 2012, BIOGEOCHEMISTRY, V109, P19, DOI 10.1007/s10533-011-9635-6; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Voriskova J, 2013, ISME J, V7, P477, DOI 10.1038/ismej.2012.116; Wang WJ, 2003, SOIL BIOL BIOCHEM, V35, P273, DOI 10.1016/S0038-0717(02)00274-2; WARDLE DA, 1995, SOIL BIOL BIOCHEM, V27, P821, DOI 10.1016/0038-0717(94)00229-T; Waring BG, 2013, ECOL LETT, V16, P887, DOI 10.1111/ele.12125; Wieder WR, 2015, GLOBAL BIOGEOCHEM CY, V29, P1782, DOI 10.1002/2015GB005188; Wieder WR, 2013, NAT CLIM CHANGE, V3, P909, DOI [10.1038/nclimate1951, 10.1038/NCLIMATE1951]; Woolf D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43026-8; Yan Y, 2015, APPL ENVIRON MICROB, V81, P4246, DOI 10.1128/AEM.00958-15; Yuste JC, 2007, GLOBAL CHANGE BIOL, V13, P2018, DOI 10.1111/j.1365-2486.2007.01415.x; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhou JZ, 2013, MBIO, V4, DOI 10.1128/mBio.00584-12	72	4	4	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0224641	10.1371/journal.pone.0224641	http://dx.doi.org/10.1371/journal.pone.0224641			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7VI	32059014	Green Published, Green Submitted, gold			2022-12-26	WOS:000535206600003
J	Liu, L; Wang, HM; Zhang, Y; Niu, JL; Li, ZY; Tang, R				Liu, Lu; Wang, Hongmei; Zhang, Yang; Niu, Jinlei; Li, Zhongyuan; Tang, Rong			Effect of pregravid obesity on perinatal outcomes in singleton pregnancies following in vitro fertilization and the weight-loss goals to reduce the risks of poor pregnancy outcomes: A retrospective cohort study	PLOS ONE			English	Article							BODY-MASS INDEX; MATERNAL OBESITY; PREECLAMPSIA; OVERWEIGHT; EXPRESSION; STILLBIRTH; DIAGNOSIS; COUNTRIES; BIRTH; DEATH	Objective In the present study, we aimed to determine whether pregravid obesity independently predicts increased risks of perinatal complications following in vitro fertilization (IVF) and the weight loss goals to reduce the risk of poor pregnancy outcomes. Design Retrospective cohort study. Population All pregnancies after first the fresh IVF cycle from January 2014 to December 2016 in the Reproductive Center affiliated to Shandong University were reviewed. A total of 3,962 eligible singleton births were stratified into cohorts based on the body mass index (BMI) definitions of the Working Group on Obesity in China (WGOC). Main outcome measures Adverse perinatal outcomes. Results Pregravid overweight and obesity were associated with increased risks of gestational diabetes mellitus (GDM), hypertensive disorders of pregnancy (HDP), including gestational hypertension (GH) and pre-eclampsia (PE), polyhydramnios, preterm premature rupture of the membranes (PPROM), placental abruption, preterm birth (PTB) <37 weeks, caesarean section (CS), fetal macrosomia, large for gestational age (LGA) >90th percentile, neonatal respiratory distress syndrome (NRDS), neonatal intensive care unit (NICU) admission and congenital anomalies as compared with the normal-weight group after adjustment of differences in age, parity, polycystic ovary syndrome (PCOS) and type of controlled ovarian hyperstimulation (COH). The increased risks of PPROM, NRDS and congenital anomalies were eliminated after adjustment of GDM development, whereas the increased risk of NRDS disappeared after adjustment of HDP. Placenta previa was not significantly different between the obese group and reference group (REF). Moreover, the rates of postpartum hemorrhage (PPH), PTB<32 weeks, small for gestational age (SGA) >90th percentile and perinatal mortality were also not significantly different between above-mentioned two groups. For obese women, a 10%-15% reduction in prepregnancy BMI was associated with significantly decreased risks of GH, CS and fetal macrosomia. For overweight women, just a 5% reduction in BMI could significantly reduce the risks of GDM, CS and fetal macrosomia. Conclusions Pregravid obesity could independently predict a higher risk of adverse pregnancy outcomes after adjustment of differences in maternal age, parity, PCOS, and type of COH in IVF pregnancies. The potential mechanism that obesity potentiated the risks of some poor perinantal outcomes might occur through the development of GDM and HDP. A 10%-15% reduction in pregravid BMI for obese women and a 5% reduction for overweight women were associated with a significant reduction of poor perinatal complications.	[Liu, Lu; Zhang, Yang; Niu, Jinlei; Li, Zhongyuan; Tang, Rong] Shandong Univ, Reprod Hosp, Jinan, Peoples R China; [Liu, Lu] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China; [Wang, Hongmei; Tang, Rong] Shandong Univ, Prov Hosp, Dept Obstet & Gynecol, Jinan, Peoples R China; [Niu, Jinlei; Li, Zhongyuan; Tang, Rong] Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Peoples R China; [Niu, Jinlei; Li, Zhongyuan; Tang, Rong] Shandong Univ, Minist Educ, Key Lab Reprod Endocrinol, Jinan, Peoples R China; [Niu, Jinlei; Li, Zhongyuan; Tang, Rong] Shandong Prov Key Lab Reprod Med, Jinan, Peoples R China	Shandong University; Shanghai Jiao Tong University; Shandong University; Shandong University	Tang, R (corresponding author), Shandong Univ, Reprod Hosp, Jinan, Peoples R China.; Tang, R (corresponding author), Shandong Univ, Prov Hosp, Dept Obstet & Gynecol, Jinan, Peoples R China.; Tang, R (corresponding author), Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Peoples R China.; Tang, R (corresponding author), Shandong Univ, Minist Educ, Key Lab Reprod Endocrinol, Jinan, Peoples R China.; Tang, R (corresponding author), Shandong Prov Key Lab Reprod Med, Jinan, Peoples R China.	r.tang.sduivf@hotmail.com			Shandong Province Medical and Health Technology Development Project [2016WS0442]; National Key Research and Development Program of China [2017YFC1001000]	Shandong Province Medical and Health Technology Development Project; National Key Research and Development Program of China	This study was supported by Shandong Province Medical and Health Technology Development Project (2016WS0442) and the National Key Research and Development Program of China (2017YFC1001000).; We are very grateful to our patients and all participants in the data collection. This study was supported by Shandong Province Medical and Health Technology Development Project (2016WS0442) and the National Key Research and Development Program of China (2017YFC1001000).	Al-Zirqi Iqbal, 2009, Am J Obstet Gynecol, V201, DOI 10.1016/j.ajog.2009.06.007; American College of Obstetricians and Gynecologists, 2013, Obstet Gynecol, V121, P213, DOI http://10.1097/01.AOG.0000425667.10377.60; Asseffa NA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213240; Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; Balsells M, 2009, J CLIN ENDOCR METAB, V94, P4284, DOI 10.1210/jc.2009-1231; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Blomberg M, 2013, OBSTET GYNECOL, V122, P50, DOI 10.1097/AOG.0b013e318295657f; Blomberg M, 2011, OBSTET GYNECOL, V118, P561, DOI 10.1097/AOG.0b013e31822a6c59; Butwick AJ, 2018, ANESTHESIOLOGY, V128, P774, DOI 10.1097/ALN.0000000000002082; Carreras-Badosa G, 2017, J CLIN ENDOCR METAB, V102, P2584, DOI 10.1210/jc.2017-00089; Chakraborty C, 2016, MINI-REV MED CHEM, V16, P1258, DOI 10.2174/1389557516666160505115512; Choi SY, 2013, PLACENTA, V34, P799, DOI 10.1016/j.placenta.2013.06.006; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Gilboa SM, 2008, ANN EPIDEMIOL, V18, P196, DOI 10.1016/j.annepidem.2007.09.005; Gollop ND, 2014, J OBSTET GYNAECOL, V34, P373, DOI 10.3109/01443615.2014.896882; HANSON U, 1990, DIABETOLOGIA, V33, P100, DOI 10.1007/BF00401047; Hollowell J, 2013, BJOG, V121, P343; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Kitzmiller JL, 1996, DIABETES CARE, V19, P514, DOI 10.2337/diacare.19.5.514; Koning AMH, 2012, HUM REPROD, V27, P457, DOI 10.1093/humrep/der416; Lagana AS, 2018, J MATERN-FETAL NEO M, V31, P817, DOI 10.1080/14767058.2017.1296426; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; McDonald SD, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3428; National Institute of Health, 1998, NIH PUBLICATION, V98-4083; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ovesen P, 2011, OBSTET GYNECOL, V118, P305, DOI 10.1097/AOG.0b013e3182245d49; Pearson DWM, 2007, BJOG-INT J OBSTET GY, V114, P104, DOI 10.1111/j.1471-0528.2006.01145.x; Peixoto AB, 2018, METHODS MOL BIOL, V1710, P73, DOI 10.1007/978-1-4939-7498-6_6; Persson M, 2009, DIABETES CARE, V32, P2005, DOI 10.2337/dc09-0656; Robinson HE, 2005, OBSTET GYNECOL, V106, P1357, DOI 10.1097/01.AOG.0000188387.88032.41; Schummers L, 2015, OBSTET GYNECOL, V125, P133, DOI 10.1097/AOG.0000000000000591; Thompson D, 2013, CAN J DIABETES, V37, pS168, DOI 10.1016/j.jcjd.2013.01.044; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Van Lieshout RJ, 2013, NUTR REV, V71, pS95, DOI 10.1111/nure.12059; Wolfe KB, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.051; World Health Organization, 2014, GLOB HLTH OBS GHO DA	38	10	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0227766	10.1371/journal.pone.0227766	http://dx.doi.org/10.1371/journal.pone.0227766			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053669	Green Published, gold			2022-12-26	WOS:000535198700014
J	Techatanawat, S; Surarit, R; Chairatvit, K; Khovidhunkit, W; Roytrakul, S; Thanakun, S; Kobayashi, H; Khovidhunkit, SOP; Izumi, Y				Techatanawat, Suteera; Surarit, Rudee; Chairatvit, Kongthawat; Khovidhunkit, Weerapan; Roytrakul, Sittiruk; Thanakun, Supanee; Kobayashi, Hiroaki; Khovidhunkit, Siribang-on Piboonniyom; Izumi, Yuichi			Salivary and serum interleukin-17A and interleukin-18 levels in patients with type 2 diabetes mellitus with and without periodontitis	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; TH17 CELLS; IL-17; HYPERGLYCEMIA; INHIBITION; ACTIVATION; MECHANISMS; BIOMARKERS; RECEPTOR; DISEASE	Objective Interleukin (IL)-17A and IL-18 have been proposed to play important roles in periodontitis and type 2 diabetes mellitus (DM), but human data are conflicting. The present study aimed to investigate the roles of IL-17A and IL-18 in periodontitis and DM by measuring salivary and serum levels, respectively. Materials and methods A total of 49 participants with type 2 DM and 25 control subjects without type 2 DM were recruited. A periodontal screening and recording (PSR) index (0, 1-2, 3, and 4) was used to classify whether these subjects had periodontitis. Salivary and serum IL-17A and IL-18 levels were measured by enzyme-linked immunosorbent assay. Multiple linear regression analyses were used to evaluate the associations between these cytokines and clinical parameters. Results Salivary IL-17A levels were not significantly different between patients with DM and controls, however, the levels were significantly higher in controls with periodontitis than those without periodontitis (p = 0.031). Salivary IL-17A levels were significantly associated with the PSR index (beta = 0.369, p = 0.011). Multiple linear regression analyses revealed the association of salivary IL-18 levels and fasting plasma glucose (beta = 0.270, p = 0.022) whereas serum IL-18 levels were associated with HbA(1C) (beta = 0.293, p = 0.017). No correlation between salivary and serum levels of IL-17A and IL-18 was found. Conclusion Salivary IL-17A was strongly associated with periodontitis, whereas salivary IL-18 was associated with FPG and serum IL-18 was associated with HbA(1C). These results suggest the role of these cytokines in periodontal inflammation and DM.	[Techatanawat, Suteera] Mahidol Univ, Fac Dent, PhD Program Oral Biol, Bangkok, Thailand; [Surarit, Rudee; Chairatvit, Kongthawat] Mahidol Univ, Fac Dent, Dept Oral Biol, Bangkok, Thailand; [Khovidhunkit, Weerapan] Chulalongkorn Univ, Fac Med, Dept Med, Bangkok, Thailand; [Roytrakul, Sittiruk] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Khlong Luang, Pathum Thani, Thailand; [Thanakun, Supanee] Rangsit Univ, Coll Dent Med, Muang Pathum Thani, Pathum Thani, Thailand; [Thanakun, Supanee] Mahidol Univ, Dent Hosp, Fac Dent, Oral Diag & Oral Med Clin, Bangkok, Thailand; [Kobayashi, Hiroaki; Izumi, Yuichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Periodontol, Bunkyo Ku, Tokyo, Japan; [Khovidhunkit, Siribang-on Piboonniyom] Mahidol Univ, Fac Dent, Dept Adv Gen Dent, Bangkok, Thailand; [Izumi, Yuichi] Southern Tohoku Gen Hosp, Oral Care Perio Ctr, Southern Tohoku Res Inst Neurosci, Koriyama, Fukushima, Japan; [Techatanawat, Suteera] Srinakharinwirot Univ, Fac Dent, Dept Gen Dent, Bangkok, Thailand	Mahidol University; Mahidol University; Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University; Tokyo Medical & Dental University (TMDU); Mahidol University; Srinakharinwirot University	Khovidhunkit, SOP (corresponding author), Mahidol Univ, Fac Dent, Dept Adv Gen Dent, Bangkok, Thailand.	siribangon.pib@mahidol.edu		Roytrakul, Sittiruk/0000-0003-3696-8390; Techatanawat, Suteera/0000-0003-4980-2349; Thanakun, Supanee/0000-0002-2570-0658	Thailand Research Fund [PHD/45/2556]; Mahidol University under the National Research Universities Initiative	Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University under the National Research Universities Initiative	This study was supported primarily by a grant to S. Techatanawat and S.P. Khovidhunkit from the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (Grant No. PHD/45/2556), and the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was partially supported by Mahidol University under the National Research Universities Initiative to Rudee Surarit.	Abdel-Moneim A, 2018, BIOMED PHARMACOTHER, V101, P287, DOI 10.1016/j.biopha.2018.02.103; Al-Rubeaan K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02421-9; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Azman R, 2014, INFLAMM RES, V63, P1001, DOI 10.1007/s00011-014-0776-7; Banu S, 2015, J PERIODONTOL, V86, P431, DOI 10.1902/jop.2014.140414; Barros SP, 2016, PERIODONTOL 2000, V70, P53, DOI 10.1111/prd.12107; Beklen A, 2007, J DENT RES, V86, P347, DOI 10.1177/154405910708600409; Bertoldi C, 2017, INT J DENT, V2017, DOI 10.1155/2017/7912158; Cardoso CR, 2009, ORAL MICROBIOL IMMUN, V24, P1, DOI 10.1111/j.1399-302X.2008.00463.x; Cheng WC, 2014, J CLIN PERIODONTOL, V41, P541, DOI 10.1111/jcpe.12238; Corbet EF, 1998, INT DENT J, V48, P268, DOI 10.1111/j.1875-595X.1998.tb00716.x; Correa FOB, 2008, J PERIODONTOL, V79, P2143, DOI 10.1902/jop.2008.080132; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dutzan N, 2016, MUCOSAL IMMUNOL, V9, P1163, DOI 10.1038/mi.2015.136; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Esfahrood Z, 2016, ARRB, V10, P1; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Figueredo CM, 2008, ORAL MICROBIOL IMMUN, V23, P173, DOI 10.1111/j.1399-302X.2007.00408.x; Fujita T, 2012, ACTA DIABETOL, V49, P111, DOI 10.1007/s00592-010-0178-4; Gursoy UK, 2015, J DIABETES, V7, P681, DOI 10.1111/1753-0407.12228; Hughes FJ, 2015, STEM CELL BIOLOGY AND TISSUE ENGINEERING IN DENTAL SCIENCES, P433, DOI 10.1016/B978-0-12-397157-9.00038-2; Jain R, 2008, J EXP MED, V205, P207, DOI 10.1084/jem.20071878; Jha JC, 2014, ADV CHRONIC KIDNEY D, V21, P318, DOI 10.1053/j.ackd.2014.03.008; Lalla E, 2000, PERIODONTOL 2000, V23, P50, DOI 10.1034/j.1600-0757.2000.2230104.x; LOE H, 1993, DIABETES CARE, V16, P329, DOI 10.2337/diacare.16.1.329; Mahajani Monica J, 2017, J Contemp Dent Pract, V18, P1085; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Nakamura A, 2005, DIABETES CARE, V28, P2890, DOI 10.2337/diacare.28.12.2890; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Ozcaka O, 2011, J PERIODONTAL RES, V46, P592, DOI 10.1111/j.1600-0765.2011.01377.x; Pradeep AR, 2009, J PERIODONTOL, V80, P1454, DOI 10.1902/jop.2009.090117; Praditpornsilpa K, 2012, AIDS, V26, P1781, DOI 10.1097/QAD.0b013e328356480d; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Primal KS., 2014, J DENT APP, V1, P8; Roohi A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/718946; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Takahashi K, 2005, J CLIN PERIODONTOL, V32, P369, DOI 10.1111/j.1600-051X.2005.00676.x; Troseid M, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-11; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Williamson S, 2012, NURS RES PRACT, V2012, DOI 10.1155/2012/246178; Wong CK, 2007, CLIN EXP IMMUNOL, V149, P123, DOI 10.1111/j.1365-2249.2007.03389.x; Zaharieva E, 2018, ENDOCR CONNECT, V7, P179, DOI 10.1530/EC-17-0273; Zilverschoon GRC, 2008, INT J OBESITY, V32, P1407, DOI 10.1038/ijo.2008.109; Zizzi A, 2013, J PERIODONTAL RES, V48, P293, DOI 10.1111/jre.12007	44	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228921	10.1371/journal.pone.0228921	http://dx.doi.org/10.1371/journal.pone.0228921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053656	Green Published, gold			2022-12-26	WOS:000535198700071
J	Seidu, AA; Ahinkorah, BO; Agbaglo, E; Darteh, EKM; Ameyaw, EK; Budu, E; Iddrisu, H				Seidu, Abdul-Aziz; Ahinkorah, Bright Opoku; Agbaglo, Ebenezer; Darteh, Eugene Kofuor Maafo; Ameyaw, Edward Kwabena; Budu, Eugene; Iddrisu, Hawa			Are senior high school students in Ghana meeting WHO's recommended level of physical activity? Evidence from the 2012 Global School-based Student Health Survey Data	PLOS ONE			English	Article							ADOLESCENTS; PREVALENCE; CHILDREN; BEHAVIORS; CHOICE; RISK; AGE	Introduction Physical activity (PA) has both short- and long-term importance. In this study we sought to assess the prevalence and correlates of PA among 1,542 Senior High School (SHS) students. Methods A cross-sectional study was conducted in Ghana among SHS students using the 2012 version of the Ghana Global School-based Student Health Survey (GSHS) data, which utilised two-stage cluster sampling technique. The population for the study comprised SHS students. The outcome variable was physical activity. The data were analysed using STATA version 14.2 for Mac OS. Both bivariate and multivariate analyses were employed. At the bivariate level, Pearson chi-square test between each independent variable and PA was conducted and the level of statistical significance was set at 5%. All the significant variables from the chi-square test were selected for the multivariate analysis. In the multivariate analysis, Poisson regression with robust variance was performed to estimate crude and adjusted prevalence ratios (APR). Results It was found that 25.0% (29.0% males and 21.9% females) of SHS students were physically active. Female students (APR = 0.78, 95% CI = 0.65, 0.94), students in SHS 2 (APR = 0.76, 95% CI = 0.577, 0.941) and SHS3 (APR = 0.79, 95% CI = 0.63, 0.93), and those who went hungry (APR = 0.77, 95% CI = 0.65, 0.92) were less likely to be physically active compared to males, those in SHS1 and those who did not go hungry respectively. On the other hand, students who actively commuted to school (APR = 2.40, 95% CI = 1.72, 2.42) and got support from their peers were more likely to be physically active (APR = 1.62, 95% CI = 1.09-2.41). Conclusion Only a quarter of SHS students who participated in the 2012 version of the GSHS met the WHO's recommended level of physical activity. Sex, grade/form and experience of hunger are associated with physical activity. Physical activity is a major component of any health promotion program. Policies and programmes targeting improvement in physical activity among SHS students should take these associated factors into consideration.	[Seidu, Abdul-Aziz; Darteh, Eugene Kofuor Maafo; Budu, Eugene] Univ Cape Coast, Dept Populat & Hlth, Cape Coast, Ghana; [Ahinkorah, Bright Opoku; Ameyaw, Edward Kwabena] Univ Technol Sydney, Fac Hlth, Australian Ctr Publ & Populat Hlth Res ACPPHR, Sydney, NSW, Australia; [Agbaglo, Ebenezer] Univ Cape Coast, Dept English, Cape Coast, Ghana; [Iddrisu, Hawa] Techiman Municipal, Ghana Educ Serv, Techiman, Bono East Regio, Ghana	University of Cape Coast; University of Technology Sydney; University of Cape Coast	Seidu, AA (corresponding author), Univ Cape Coast, Dept Populat & Hlth, Cape Coast, Ghana.	abdul-aziz.seidu@stu.ucc.edu.gh	Darteh, Eugene Kofuor Maafo/H-1670-2015; Seidu, Abdul-Aziz/S-2521-2019; Agbaglo, Ebenezer/AAN-5804-2021	Darteh, Eugene Kofuor Maafo/0000-0003-4689-8891; Seidu, Abdul-Aziz/0000-0001-9734-9054; Ameyaw, Edward Kwabena/0000-0002-6617-237X				Aaron DJ, 2002, ARCH PEDIAT ADOL MED, V156, P1075, DOI 10.1001/archpedi.156.11.1075; Afrifa-Anane E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1546-3; Aguilar-Farias N, 2018, INT J EPIDEMIOL, V47, P976, DOI 10.1093/ije/dyy033; Agyemang C, 2006, J HUM HYPERTENS, V20, P67, DOI 10.1038/sj.jhh.1001923; Al Subhi LK, 2015, J PHYS ACT HEALTH, V12, P257, DOI 10.1123/jpah.2013-0134; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Asante KO., 2019, MENTAL HLTH PREVENTI, V13, P75, DOI [10.1016/j.mhp.2019.01.009, DOI 10.1016/J.MHP.2019.01.009]; Asare M, 2015, CHILD ADOL PSYCH MEN, V9, DOI 10.1186/s13034-015-0043-x; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Corseuil MW, 2011, PREV MED, V53, P289, DOI 10.1016/j.ypmed.2011.07.016; de Farias JC, 2012, REV SAUDE PUBL, V46, P505, DOI 10.1590/S0034-89102012000300013; de Lima TR, 2018, J BODYW MOV THER, V22, P57, DOI 10.1016/j.jbmt.2017.03.022; Dentro KN, 2014, J PHYS ACT HEALTH, V11, pS105, DOI 10.1123/jpah.2014-0184; Dobbins M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651.pub2; Doku D, 2013, PUBLIC HEALTH NUTR, V16, P864, DOI 10.1017/S136898001100276X; Dumith SC, 2010, REV SAUDE PUBL, V44, P457, DOI 10.1590/S0034-89102010000300009; Guthold R, 2020, LANCET CHILD ADOLESC, V4, P23, DOI 10.1016/S2352-4642(19)30323-2; Guthold R, 2010, J PEDIATR-US, V157, P43, DOI 10.1016/j.jpeds.2010.01.019; Haase LJAM, 2017, ASIA PAC J CLIN NUTR, V16, P354; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Kalman M, 2015, CENT EUR J PUBL HEAL, V23, pS78; Karlsson M. K., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P12; Kelishadi R, 2007, B WORLD HEALTH ORGAN, V85, P19, DOI 10.2471/BLT.06.030783; Krol-Zielinska M, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1849715; Kugbey N, 2018, J ADOLESCENCE, V68, P66, DOI 10.1016/j.adolescence.2018.06.013; Lawler M, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4677-x; Li M, 2006, MED SCI SPORT EXER, V38, P2075, DOI 10.1249/01.mss.0000233802.54529.87; de Rezende LFM, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-485, 10.1186/1471-2458-14-333]; Martin SL, 2007, AM J PREV MED, V33, P98, DOI 10.1016/j.amepre.2007.04.024; Micklesfield LK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-40; Oyeyemi AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150142; Peltzer K, 2011, INT J ENV RES PUB HE, V8, P3859, DOI 10.3390/ijerph8103859; Peltzer K, 2011, INT J BEHAV MED, V17, P271, DOI 10.1007/s12529-009-9073-1; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Satija A, 2018, HEALTH EDUC BEHAV, V45, P926, DOI 10.1177/1090198118778332; Seabra AF, 2008, CAD SAUDE PUBLICA, V24, P721, DOI 10.1590/S0102-311X2008000400002; Sharma B, 2018, REV SAUDE PUBL, V52, DOI [10.11606/s1518-8787.2018052000202, 10.11606/S1518-8787.2018052000202]; Silva Diego Augusto Santos, 2015, Rev. paul. pediatr., V33, P167, DOI 10.1016/j.rpped.2014.09.003; Stalsberg R, 2010, SCAND J MED SCI SPOR, V20, P368, DOI 10.1111/j.1600-0838.2009.01047.x; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tamhane AR, 2016, STAT MED, V35, P5730, DOI 10.1002/sim.7059; Terzian M, 2009, PHYS INACTIVITY US A; Tremblay MS, 2014, J PHYS ACT HEALTH, V11, pS113, DOI 10.1123/jpah.2014-0177; Uijtdewilligen L, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-107; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; WHO, 2014, GLOB SCH BAS STUD HL; WHO, 2015, GLOB STRAT DIET PHYS, P3	49	5	5	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0229012	10.1371/journal.pone.0229012	http://dx.doi.org/10.1371/journal.pone.0229012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7PV	32050008	Green Published, gold			2022-12-26	WOS:000535192300040
J	Ghammraoui, B; Badano, A				Ghammraoui, Bahaa; Badano, Aldo			Identification of amyloid plaques in the brain using an x-ray photon-counting strip detector	PLOS ONE			English	Article							SCATTERING FORM-FACTORS; COHERENT SCATTERING; COMPUTED-TOMOGRAPHY; BREAST TISSUES; CT	Brain aggregates of beta amyloid (beta A) protein plaques have been widely recognized as associated with many neurodegenerative diseases, and their identification can assist in the early diagnosis of Alzheimer's disease. We investigate the feasibility of using a spectral x-ray coherent scatter system with a silicon strip photon-counting detector for identifying brain beta A protein plaques. This approach is based on differences in the structure of amyloid, white and grey matter in the brain. We simulated an energy- and angular-dispersive X-ray diffraction system with an x-ray pencil beam and Silicon strip sensor, energy-resolving detectors. The polychromatic beam is geometrically focused toward a region of interest in the brain. First, the open-source MC-GPU code for Monte Carlo transport was modified to accommodate the detector model. Second, brain phantoms with and without beta A were simulated to assess the method and determine the radiation dose required to obtain acceptable statistical power. For beta A targets of 3, 4 and 5 mm sizes in a 15-cm brain model, the required incident exposure was about 0.44 mR from a 60 kVp tungsten spectrum and 3.5 mm of added aluminum filtration. The results suggest that the proposed x-ray coherent scatter technique enables the use of high energy x-ray spectra and therefore has the potential to be used for accurate in vivo detection and quantification of beta A in the brain within acceptable radiation dose levels.	[Ghammraoui, Bahaa; Badano, Aldo] US FDA, Div Imaging Diagnost & Software Reliabil, Off Sci & Engn Labs, CDRH, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Ghammraoui, B (corresponding author), US FDA, Div Imaging Diagnost & Software Reliabil, Off Sci & Engn Labs, CDRH, Silver Spring, MD 20993 USA.	bahaa.ghammraoui@fda.hhs.gov	badano, aldo/G-7786-2012	badano, aldo/0000-0003-3712-6670				Aslund M, 2007, MED PHYS, V34, P1918, DOI 10.1118/1.2731032; Astolfo A, 2016, J SYNCHROTRON RADIAT, V23, P813, DOI 10.1107/S1600577516004045; Badal A, 2009, MED PHYS, V36, P4878, DOI 10.1118/1.3231824; Bornefalk H, 2010, PHYS MED BIOL, V55, P1999, DOI 10.1088/0031-9155/55/7/014; Connor DM, 2009, NEUROIMAGE, V46, P908, DOI 10.1016/j.neuroimage.2009.03.019; Dahal E, 2020, 2020 ALZH ASS INT C; Dahal E, 2018, ALZHEIMERS DEMENT, V14, P834, DOI [10.1016/j.jalz.2018.06.1059, DOI 10.1016/J.JALZ.2018.06.1059]; De Felici M, 2008, PHYS MED BIOL, V53, P5675, DOI 10.1088/0031-9155/53/20/007; Ghammraoui B, 2014, PHYS MED BIOL, V59, P3501, DOI 10.1088/0031-9155/59/13/3501; Harding G., 2006, P SOC PHOTO-OPT INS; King BW, 2011, PHYS MED BIOL, V56, P4377, DOI 10.1088/0031-9155/56/14/010; King BW, 2010, PHYS MED BIOL, V55, P855, DOI 10.1088/0031-9155/55/3/020; Liu J, 2016, SCI REPORTS; Marcus C, 2014, CLIN NUCL MED, V39, pE413, DOI 10.1097/RLU.0000000000000547; Oliveira OR, 2008, J RADIAT RES, V49, P527, DOI 10.1269/jrr.08027; Poletti ME, 2002, PHYS MED BIOL, V47, P47, DOI 10.1088/0031-9155/47/1/304; Salvat F, 2006, OECD NEA 2006; Schleeger M, 2013, POLYMER, V54, P2473, DOI 10.1016/j.polymer.2013.02.029; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Tartari A, 2002, PHYS MED BIOL, V47, P163, DOI 10.1088/0031-9155/47/1/312	20	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228720	10.1371/journal.pone.0228720	http://dx.doi.org/10.1371/journal.pone.0228720			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045461	Green Published, gold			2022-12-26	WOS:000534633200033
J	Liu, JX; Yeung, SLA; Kwok, MK; Leung, JYY; Hui, LL; Leung, GM; Schooling, CM				Liu, Junxi; Yeung, Shiu Lun Au; Kwok, Man Ki; Leung, June Yue Yan; Hui, Lai Ling; Leung, Gabriel Matthew; Schooling, C. Mary			The effect of liver enzymes on body composition: A Mendelian randomization study	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; CARDIOVASCULAR-DISEASE; SARCOPENIA; ADIPOSITY; ASSOCIATION; INSTRUMENTS; HORMONE; STATINS; EVENTS; HEART	Background Higher alanine transaminase (ALT), indicating poor liver function, is positively associated with diabetes but inversely associated with body mass index (BMI) in Mendelian randomization (MR) studies, suggesting liver function affects muscle mass. To clarify, we assessed the associations of liver enzymes with muscle and fat mass observationally with two-sample MR as a validation. Methods In the population-representative "Children of 1997" birth cohort (n = 3,455), we used multivariable linear regression to assess the adjusted associations of ALT and alkaline phosphatase (ALP) at similar to 17.5 years with muscle mass and body fat percentage observationally. Genetic variants predicting ALT, ALP and gamma glutamyltransferase (GGT) were applied to fat-free and fat mass in the UK Biobank (n = similar to 331,000) to obtain unconfounded MR estimates. Results Observationally, ALT was positively associated with muscle mass (0.11 kg per IU/L, 95% confidence interval (CI) 0.10 to 0.12) and fat percentage (0.15% per IU/L, 95% CI 0.13 to 0.17). ALP was inversely associated with muscle mass (-0.03 kg per IU/L, 95% CI-0.04 to -0.02) and fat percentage (-0.02% per IU/L, 95% CI -0.03 to-0.01). Using MR, ALT was inversely associated with fat-free mass (-0.41 kg per 100% in concentration, 95% CI-0.64 to-0.19) and fat mass (-0.58 kg per 100% in concentration, 95% CI-0.85 to-0.30). ALP and GGT were unclearly associated with fat-free mass or fat mass. Conclusion ALT reducing fat-free mass provides a possible pathway for the positive association of ALT with diabetes and suggests a potential target of intervention.	[Liu, Junxi; Yeung, Shiu Lun Au; Kwok, Man Ki; Leung, June Yue Yan; Hui, Lai Ling; Leung, Gabriel Matthew; Schooling, C. Mary] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Peoples R China; [Hui, Lai Ling] Chinese Univ Hong Kong, Fac Med, Dept Paediat, Hong Kong, Peoples R China; [Schooling, C. Mary] CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA	University of Hong Kong; Chinese University of Hong Kong; City University of New York (CUNY) System	Schooling, CM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Peoples R China.; Schooling, CM (corresponding author), CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA.	cms1@hku.hk	SL, Au Yeung/ABD-3938-2021	SL, Au Yeung/0000-0001-6136-1836; Schooling, Mary/0000-0001-9933-5887; Leung, June Yue Yan/0000-0001-8448-9584; HUI, Lai Ling/0000-0003-0688-3329; Leung, Gabriel/0000-0002-2503-6283	Health Care and Promotion Fund, Health and Welfare Bureau, Government of the Hong Kong SAR [HCPF] [216106]; Health and Health Services Research Fund, Government of the Hong Kong SAR [HHSRF] [03040771]; Research Fund for the Control of Infectious Diseases in Hong Kong, the Government of Hong Kong SAR [RFCID] [04050172]; WYNG Foundation; University Research Committee Strategic Research Theme (SRT) of Public Health, the University of Hong Kong; MRC [MC_PC_12028] Funding Source: UKRI	Health Care and Promotion Fund, Health and Welfare Bureau, Government of the Hong Kong SAR [HCPF]; Health and Health Services Research Fund, Government of the Hong Kong SAR [HHSRF]; Research Fund for the Control of Infectious Diseases in Hong Kong, the Government of Hong Kong SAR [RFCID]; WYNG Foundation; University Research Committee Strategic Research Theme (SRT) of Public Health, the University of Hong Kong(University of Hong Kong); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is a substudy of the "Children of 1997" birth cohort which was initially supported by the Health Care and Promotion Fund, Health and Welfare Bureau, Government of the Hong Kong SAR [HCPF grant 216106] and reestablished in 2005 with support from the Health and Health Services Research Fund, Government of the Hong Kong SAR, [HHSRF grant 03040771]; the Research Fund for the Control of Infectious Diseases in Hong Kong, the Government of Hong Kong SAR [RFCID grant 04050172]; the University Research Committee Strategic Research Theme (SRT) of Public Health, the University of Hong Kong. The Biobank Clinical follow-up was partly supported by the WYNG Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrist JD, 2010, J ECON PERSPECT, V24, P3, DOI 10.1257/jep.24.2.3; [Anonymous], STAT YOUTH HLTH RELA; Au WM, 2014, ALCOHOL ALCOHOLISM, V49, P668, DOI 10.1093/alcalc/agu063; Booth ML, 2008, J PAEDIATR CHILD H, V44, P686, DOI 10.1111/j.1440-1754.2008.01407.x; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bredella MA, 2017, ADV EXP MED BIOL, V1043, P9, DOI 10.1007/978-3-319-70178-3_2; Burgess S, 2016, EPIDEMIOLOGY; Burgess S, 2016, GENET EPIDEMIOL, V40, P597, DOI 10.1002/gepi.21998; Burgess S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7325; Cabrera D, 2016, DIGEST DIS SCI, V61, P3190, DOI 10.1007/s10620-016-4285-0; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Crandall JP, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2017-000438; Davies NM, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k601; De Silva NMG, 2019, DIABETES, V68, P1681, DOI 10.2337/db18-1048; Dehghan M, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-26; Elshorbagy AK, 2009, OBESITY, V17, P1435, DOI 10.1038/oby.2008.671; Fall T, 2015, DIABETES, V64, P1841, DOI 10.2337/db14-0988; Fan JG, 2017, J HEPATOL, V67, P862, DOI 10.1016/j.jhep.2017.06.003; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Fraser A, 2007, ARTERIOSCL THROM VAS, V27, P2729, DOI 10.1161/ATVBAHA.107.152298; Freeman G, 2013, INT J EPIDEMIOL, V42, P1157, DOI 10.1093/ije/dyt110; Ghouri N, 2010, HEPATOLOGY, V52, P1156, DOI 10.1002/hep.23789; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Guichelaar MMJ, 2014, HEPATOLOGY, V59, P1668, DOI 10.1002/hep.27058; Hazlehurst JM, 2016, METABOLISM, V65, P1096, DOI 10.1016/j.metabol.2016.01.001; Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408; HKSAR HKCaSDo, 2018, 64 HKSAR HKCASDO; Hong HC, 2014, HEPATOLOGY, V59, P1772, DOI 10.1002/hep.26716; Howrigan D, 2017, NEALE LAB; Jaruvongvanich Veeravich, 2017, Ann Hepatol, V16, P382, DOI 10.5604/16652681.1235481; Jose J, 2016, J PHARM BIOALLIED SC, V8, P23, DOI 10.4103/0975-7406.171699; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lear SA, 2009, J CLIN ENDOCR METAB, V94, P4696, DOI 10.1210/jc.2009-1030; Lee YH, 2016, HEPATOLOGY, V63, P776, DOI 10.1002/hep.28376; Liu JX, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52489-8; Liu JX, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222141; Liu JX, 2016, SCI REP-UK, V6, DOI 10.1038/srep38813; Liu Z, 2019, MENDELIAN RANDOMIZAT, DOI [10.1101/657734, DOI 10.1101/657734]; Lonardo A, 2019, HEPATOLOGY, V70, P1457, DOI 10.1002/hep.30626; Lopez PM, 2019, J CLIN EPIDEMIOL, V113, P123, DOI 10.1016/j.jclinepi.2019.05.005; Marchesini G, 2008, J CLIN ENDOCR METAB, V93, pS74, DOI 10.1210/jc.2008-1399; Meisinger C, 2006, ATHEROSCLEROSIS, V189, P297, DOI 10.1016/j.atherosclerosis.2006.01.010; Mu RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072916; Nevill AM, 2006, AM J PHYS ANTHROPOL, V129, P151, DOI 10.1002/ajpa.20262; Rees JMB, 2017, STAT MED, V36, P4705, DOI 10.1002/sim.7492; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Ruhl CE, 2010, GASTROENTEROLOGY, V138, P1346, DOI 10.1053/j.gastro.2009.12.053; Sandhu MS, 2005, ENDOCR DEV, V9, P44, DOI 10.1159/000085755; Schooling CM, 2014, EUR J CLIN INVEST, V44, P1135, DOI 10.1111/eci.12342; Schooling CM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-57; Schooling CM, 2012, INT J EPIDEMIOL, V41, P611, DOI 10.1093/ije/dyq243; Schooling CM, 2010, ARCH DIS CHILD, V95, P437, DOI 10.1136/adc.2009.168542; Sjogren K, 2001, DIABETES, V50, P1539, DOI 10.2337/diabetes.50.7.1539; Stranges S, 2004, HEPATOLOGY, V39, P754, DOI 10.1002/hep.20149; VanderWeele TJ, 2016, INT J EPIDEMIOL, V45, P1904, DOI 10.1093/ije/dyw277; Verbanck M, 2018, NAT GENET, V50, P693, DOI 10.1038/s41588-018-0099-7; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Yavorska OO, 2017, INT J EPIDEMIOL, V46, P1734, DOI 10.1093/ije/dyx034; Yeung CHC, 2019, DIABETOLOGIA, V62, P789, DOI 10.1007/s00125-019-4826-0	60	0	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228737	10.1371/journal.pone.0228737	http://dx.doi.org/10.1371/journal.pone.0228737			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045441	Green Submitted, gold, Green Published			2022-12-26	WOS:000534633200035
J	Badarudeen, B; Gupta, R; Nair, SV; Chandrasekharan, A; Manna, TK				Badarudeen, Binshad; Gupta, Ria; Nair, Sreeja, V; Chandrasekharan, Aneesh; Manna, Tapas K.			The ubiquitin ligase FBXW7 targets the centriolar assembly protein HsSAS-6 for degradation and thereby regulates centriole duplication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell division; centriole; centrosome; mitotic spindle; E3 ubiquitin ligase; centriole; centrosome; F-Box and WD repeat domain-containing 7 (FBXW7); human SAS-6 centriolar assembly protein (HsSAS6); ubiquitin; procentriole; ubiquitin; mitosis	CENTROSOME DUPLICATION; MEDIATED DEGRADATION; SINGLE PROCENTRIOLE; TUMOR SUPPRESSION; 9-FOLD SYMMETRY; C-ELEGANS; SAS-6; PLK4; ARCHITECTURE; CARTWHEEL	Formation of a single new centriole from a pre-existing centriole is strictly controlled to maintain correct centrosome number and spindle polarity in cells. However, the mechanisms that govern this process are incompletely understood. Here, using several human cell lines, immunofluorescence and structured illumination microscopy methods, and ubiquitination assays, we show that the E3 ubiquitin ligase F-box and WD repeat domain?containing 7 (FBXW7), a subunit of the SCF ubiquitin ligase, down-regulates spindle assembly 6 homolog (HsSAS-6), a key protein required for procentriole cartwheel assembly, and thereby regulates centriole duplication. We found that FBXW7 abrogation stabilizes HsSAS-6 and increases its recruitment to the mother centriole at multiple sites, leading to supernumerary centrioles. Ultrastructural analyses revealed that FBXW7 is broadly localized on the mother centriole and that its presence is reduced at the site where the HsSAS-6?containing procentriole is formed. This observation suggested that FBXW7 restricts procentriole assembly to a specific site to generate a single new centriole. In contrast, during HsSAS-6 overexpression, FBXW7 strongly associated with HsSAS-6 at the centriole. We also found that SCFFBXW7 interacts with HsSAS-6 and targets it for ubiquitin-mediated degradation. Further, we identified putative phosphodegron sites in HsSAS-6, whose substitutions rendered it insensitive to FBXW7-mediated degradation and control of centriole number. In summary, SCFFBXW7 targets HsSAS-6 for degradation and thereby controls centriole biogenesis by restraining HsSAS-6 recruitment to the mother centriole, a molecular mechanism that controls supernumerary centrioles/centrosomes and the maintenance of bipolar spindles.	[Badarudeen, Binshad; Gupta, Ria; Nair, Sreeja, V; Manna, Tapas K.] Indian Inst Sci Educ & Res, Sch Biol, Thiruvananthapuram 695551, Kerala, India; [Chandrasekharan, Aneesh] Rajiv Gandhi Ctr Biotechnol, Thiruvananthapuram 695014, Kerala, India	Indian Institute of Science Education & Research (IISER) - Thiruvananthapuram; Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Manna, TK (corresponding author), Indian Inst Sci Educ & Res, Sch Biol, Thiruvananthapuram 695551, Kerala, India.	tmanna@iisertvm.ac.in			DST-SERB, Government of India; INSPIRE fellowship from DST, Government of India	DST-SERB, Government of India; INSPIRE fellowship from DST, Government of India	This work was supported by DST-SERB, Government of India, and by an INSPIRE fellowship from DST, Government of India (to B. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Arquint C, 2014, CURR BIOL, V24, P351, DOI 10.1016/j.cub.2013.12.016; Avidor-Reiss T, 2013, CURR OPIN CELL BIOL, V25, P72, DOI 10.1016/j.ceb.2012.10.016; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Brito DA, 2012, CURR OPIN CELL BIOL, V24, P4, DOI 10.1016/j.ceb.2012.01.003; Cizmecioglu O, 2012, J CELL SCI, V125, P981, DOI 10.1242/jcs.095075; Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Davis RJ, 2014, CANCER CELL, V26, P455, DOI 10.1016/j.ccell.2014.09.013; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Firat-Karalar EN, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0460; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Gonczy P, 2012, NAT REV MOL CELL BIO, V13, P425, DOI 10.1038/nrm3373; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Guderian G, 2010, J CELL SCI, V123, P2163, DOI 10.1242/jcs.068502; Guichard P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14813; Guichard P, 2013, CURR BIOL, V23, P1620, DOI 10.1016/j.cub.2013.06.061; Gupta H, 2015, BIOCHEMISTRY-US, V54, P6413, DOI 10.1021/acs.biochem.5b00978; Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049; Hilbert M, 2016, NAT CELL BIOL, V18, P393, DOI 10.1038/ncb3329; Hilbert M, 2013, P NATL ACAD SCI USA, V110, P11373, DOI 10.1073/pnas.1302721110; Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Jana SC, 2014, CURR OPIN CELL BIOL, V26, P96, DOI 10.1016/j.ceb.2013.12.001; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Levine MS, 2017, DEV CELL, V40, P313, DOI 10.1016/j.devcel.2016.12.022; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Maskey D, 2015, EMBO J, V34, P2424, DOI 10.15252/embj.201490831; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Nigg EA, 2018, NAT REV MOL CELL BIO, V19, P297, DOI 10.1038/nrm.2017.127; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Ohta M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6267; Ohtake F, 2016, MOL CELL, V64, P251, DOI 10.1016/j.molcel.2016.09.014; Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036; Puklowski A, 2011, NAT CELL BIOL, V13, P1004, DOI 10.1038/ncb2282; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Sillibourne JE, 2010, MOL BIOL CELL, V21, P547, DOI 10.1091/mbc.E09-06-0505; Skaar JR, 2008, NAT CELL BIOL, V10, P755, DOI 10.1038/ncb0708-755; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Sonnen KF, 2012, BIOL OPEN, V1, P965, DOI 10.1242/bio.20122337; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; van Breugel M, 2014, ELIFE, V3, DOI 10.7554/eLife.01812; van Breugel M, 2011, SCIENCE, V331, P1196, DOI 10.1126/science.1199325; Zou CZ, 2005, J CELL BIOL, V171, P437, DOI 10.1083/jcb.200506185	50	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4428	4437		10.1074/jbc.AC119.012178	http://dx.doi.org/10.1074/jbc.AC119.012178			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32086376	hybrid, Green Published			2022-12-26	WOS:000524499700006
J	Cardoso, AV				Cardoso, Antonio Valadao			An experimental erythrocyte rigidity index (Ri) and its correlations with Transcranial Doppler velocities (TAMMV), Gosling Pulsatility Index PI, hematocrit, hemoglobin concentration and red cell distribution width (RDW)	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; AGGREGATE STRENGTH; DISEASE PATIENTS; DEFORMABILITY; HYDROXYUREA; VISCOSITY; HEMORHEOLOGY; MEMBRANE; RHEOLOGY; ANEMIA	Brain artery velocities (Time-Averaged Maximum Mean Velocity, TAMMV) by Transcranial Doppler (TCD), hematocrit, hemoglobin, Red blood cell (RBC) Distribution Width (RDW) and RBC rigidity index (Ri), when reported together with their correlations, provide a accurate and useful diagnostic picture than blood viscosity measurements alone. Additionally, our study included a sixth parameter provided by TCD, the Gosling Pulsatility Index PI, which is an indicator of CBF (Cerebral Blood Flow) resistance. All these parameters are routine in Hematology except for values of Ri. The rigidity (Ri) of the RBC is the main rheological characteristic of the blood of Sickle Cell Anemia (SCA) patients and several pathologies. However, its quantification depends on many commercial and experimental techniques, none disseminated and predominant around the World. The difference in absorbance values of the blood, during the process of sedimentation in a microwell of a Microplate Reader, is a straightforward way of semi-quantifying the RBC rigidity Ri, since the fraction of irreversibly sickled red blood cells does not form rouleaux. Erythrocyte Rigidity Index (Ri) was calculated using initial absorbance A(initial) (6 s) and final A(final) (540 s), Ri = 1 / (Ai-Af). The Ri of 119 patients (2-17 y / o, M & F) SCA, SCC (Sickle Cell/hemoglobin C), SCD (Sickle Cell/hemoglobin D), S beta 0thal (Sickle Cell/hemoglobin Beta Zero Thalassemia) and 71 blood donors (20-65 y / o, M & F) were measured in our laboratory while the five parameters (TAMMV and PI by TCD, Hct, Hb and RDW) were obtained from medical records. The in vitro addition of hydroxyurea (HU, 50mg /dl, n = 51 patients, and n = 8 healthy donors) in the samples decreased the rouleaux adhesion strength of both donor and patients' blood samples, leading to extraordinarily high Ri values. The correlation between the studied parameters was especially significant for the direct relationships between Ri, TAMMV, and PI.	[Cardoso, Antonio Valadao] Univ Estado Minas Gerais, Rheol Lab, Mat Engn Postgrad Program REDEMAT UEMG DESP ED, Belo Horizonte, MG, Brazil	Universidade do Estado de Minas Gerais; Universidade Federal de Minas Gerais	Cardoso, AV (corresponding author), Univ Estado Minas Gerais, Rheol Lab, Mat Engn Postgrad Program REDEMAT UEMG DESP ED, Belo Horizonte, MG, Brazil.	antonio.cardoso@uemg.br		Valadao Cardoso, Antonio/0000-0003-0225-5157	Cemig GT S/A (Centrais Eletricas de Minas Gerais)	Cemig GT S/A (Centrais Eletricas de Minas Gerais)	Sources of funding for this study: Cemig GT S/A (Centrais Eletricas de Minas Gerais). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our thanks go to the Patients, their Parents, and Donors for their kindness and to accept to participate in our research, to Hemominas staff especially Dr. Ce ' lia Maria Silva, MD, and Dr. Andre ' Belisa ' rio; to REDEMAT UFOP-UEMG for the institutional support and to Gabriel Leon de Queiroz Sousa on 1-collecting the samples and part of data at the medical archives at Hemominas Foundation and 2-painstakingly performing the experiments with the Microplate Reader; and to Prof. Maria Lu ' cia Malard for the help in reading and correcting the text.	AARTS PAMM, 1986, BLOOD, V67, P1474; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Adanho CS, CORRELATIONS TRANSCR; Ahmed F, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039897; Akcaboy M, 2018, J PEDIATR ENDOCR MET, V31, P275, DOI 10.1515/jpem-2017-0436; Allard C, 1978, RED CELL RHEOLOGY, P209; [Anonymous], 2010, CLIN HEMORHEOL MICRO, V44, P1, DOI 10.3233/CH-2010-1256A; Athanassiou G, 2006, CLIN HEMORHEOL MICRO, V35, P291; Baskurt O., 2011, RED BLOOD CELL AGGRE; Baskurt OK, 2009, BIORHEOLOGY, V46, P251, DOI 10.3233/BIR-2009-0536; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Basu H, 2011, BIOPHYS J, V101, P1604, DOI 10.1016/j.bpj.2011.08.043; BERTLES JF, 1969, BLOOD-J HEMATOL, V33, P884, DOI 10.1182/blood.V33.6.884.884; Bessis M., 1978, RED CELL RHEOLOGY; Boisseau MR, 2006, CLIN HEMORHEOL MICRO, V35, P11; Borzage MT, 2016, J APPL PHYSIOL, V120, P976, DOI 10.1152/japplphysiol.00994.2015; Bowers AS, 2016, CLIN HEMORHEOL MICRO, V64, P199, DOI 10.3233/CH-162063; Bowers AS, 2018, INT J ANGIOLOGY, V27; Bull B.S., 1986, CLIN HEMORHEOL, V6, P439; BULL BS, 1972, BLOOD-J HEMATOL, V40, P550, DOI 10.1182/blood.V40.4.550.550; Bush AM, 2016, AM J HEMATOL, V91, P912, DOI 10.1002/ajh.24441; Caimi G, 2004, ACTA DIABETOL, V41, P99, DOI 10.1007/s00592-004-0151-1; Cardoso A.V., 2002, Mat. Res., V5, P263, DOI 10.1590/S1516-14392002000300008; Cardoso Antonio Valadão, 2007, Mat. Res., V10, P31, DOI 10.1590/S1516-14392007000100008; Chachanidze R., 2018, THESIS; Chen YY, 2018, BIOMICROFLUIDICS, V12, DOI 10.1063/1.5024598; CHIEN S, 1970, J CLIN INVEST, V49, P623, DOI 10.1172/JCI106273; CLARK MR, 1980, J CLIN INVEST, V65, P189, DOI 10.1172/JCI109650; COKELET GR, 1968, SCIENCE, V162, P275, DOI 10.1126/science.162.3850.275; Connes P, 2018, CLIN HEMORHEOL MICRO, V68, P103, DOI 10.3233/CH-189001; Connes P, 2014, BRIT J HAEMATOL, V165, P564, DOI 10.1111/bjh.12786; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; Detterich J, 2013, TRANSFUSION, V53, P297, DOI 10.1111/j.1537-2995.2012.03822.x; DINTENFASS L, 1968, NATURE, V219, P956, DOI 10.1038/219956a0; DINTENFASS L, 1985, CLIN HEMORHEOL, V5, P241; Dobbe JGG, 2003, IEEE T BIO-MED ENG, V50, P97, DOI 10.1109/TBME.2002.807319; Duez J, 2018, NAT PROTOC, V13, P1362, DOI 10.1038/nprot.2018.035; Esin A, 2018, NAT ECOL EVOL, V2, P367, DOI 10.1038/s41559-017-0420-3; Fischer T., 1978, RED CELL RHEOLOGY, P347; FISHER M, 1991, STROKE, V22, P1164, DOI 10.1161/01.STR.22.9.1164; Fontes A, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2870108; Garcia-Seisdedos H, 2019, ANGEW CHEM INT EDIT, V58, P5514, DOI 10.1002/anie.201806092; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; GRONER W, 1980, CLIN CHEM, V26, P1435; Grosenbaugh D. A., 1997, Journal of Veterinary Emergency & Critical Care, V7, P36, DOI 10.1111/j.1476-4431.1997.tb00042.x; Guilliams KP, 2018, BLOOD, V131, P1012, DOI 10.1182/blood-2017-06-789842; Gutierrez M, 2018, LANGMUIR, V34, P2363, DOI 10.1021/acs.langmuir.7b03890; HORNE MK, 1981, AM J MED, V70, P288, DOI 10.1016/0002-9343(81)90764-6; Huang JM, 2006, FREE RADICAL BIO MED, V40, P1675, DOI 10.1016/j.freeradbiomed.2006.01.002; Huang Z, 2001, AM J HEMATOL, V67, P151, DOI 10.1002/ajh.1098; HUDAK ML, 1986, AM J PHYSIOL, V251, pH63, DOI 10.1152/ajpheart.1986.251.1.H63; Iragorri MAL, 2018, LAB CHIP, V18, P2975, DOI 10.1039/c8lc00637g; Iss C, 2019, SOFT MATTER, V15, P2971, DOI 10.1039/c8sm02571a; Karemore MN, 2018, PREGNANCY HYPERTENS, V13, P187, DOI 10.1016/j.preghy.2018.06.014; Kim BJ, 2019, ANALYST, V144, P3144, DOI 10.1039/c8an02135j; Kuong KJ, 2009, J MOL BIOL, V390, P845, DOI 10.1016/j.jmb.2009.05.038; Laureano A, 2015, J DERMATOL CASE REP, V9, P38, DOI 10.3315/jdcr.2015.1198; Lemonne N, 2015, CLIN HEMORHEOL MICRO, V61, P5, DOI [10.3324/haematol.2008.005371, DOI 10.3324/HAEMATOL.2008.005371]; Lim H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197619; Martins GS, 2007, REV MAT, V12, P206; Martins GS, 2007, REV MAT, V12, P193; Martins GS, 2007, THESIS; MOHANDAS N, 1983, SEMIN HEMATOL, V20, P225; Nakamura Filho A., 2010, THESIS; Nazaretyan SA, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00713-17; Parrow NL, 2018, JOVE-J VIS EXP, V12; Patavino Giuseppina M., 2006, Rev. Bras. Hematol. Hemoter., V28, P253, DOI 10.1590/S1516-84842006000400007; Pizarro VA, 2017, THESIS; QUEMADA D, 1980, J BIOMECH, V13, P811, DOI 10.1016/0021-9290(80)90318-8; Rabai M, 2014, BIORHEOLOGY, V51, P159, DOI 10.3233/BIR-140660; Renoux C, 2019, SCI REPORTS, P9, DOI [10.1038/s41598-018-36956-2, DOI 10.1038/S41598-018-36956-2]; Renoux C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158182; Renoux C, 2016, CLIN HEMORHEOL MICRO, V62, P173, DOI 10.3233/CH-151979; Roa D, 1997, J CLIN LAB ANAL, V11, P208, DOI 10.1002/(SICI)1098-2825(1997)11:4<208::AID-JCLA6>3.0.CO;2-4; Seed WA., 2012, MECH CIRCULATION; Sun WX, 2013, 2013 INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY AND APPLICATIONS (ITA), P30, DOI 10.1109/ITA.2013.13; Tazhbayev Y, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11080410; THOMAS DJ, 1982, STROKE, V13, P285, DOI 10.1161/01.STR.13.3.285; Tikhomirova IA, 2011, CLIN HEMORHEOL MICRO, V49, P295, DOI 10.3233/CH-2011-1480; Tomaiuolo G, 2016, MED ENG PHYS, V38, P11, DOI 10.1016/j.medengphy.2015.05.007; Tripette J, 2009, HAEMATOL-HEMATOL J, V94, P1060, DOI 10.3324/haematol.2008.005371; Uyuklu M, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3652712; Uyuklu M, 2009, CLIN HEMORHEOL MICRO, V41, P269, DOI 10.3233/CH-2009-1178; Vaclavu L, 2018, BRIT J HAEMATOL, V180, P432, DOI 10.1111/bjh.15043; Vaya A, 2015, CLIN HEMORHEOL MICRO, V61, P407, DOI 10.3233/CH-141859; Vent-Schmidt J, 2015, CLIN HEMORHEOL MICRO, V59, P115, DOI 10.3233/CH-131727; von Herbing IH, 2019, BIOL BULL-US, V236, P29, DOI 10.1086/700832; Waltz X, 2012, CLIN HEMORHEOL MICRO, V52, P15, DOI 10.3233/CH-2012-1540; WEBSTER P, 1986, ANN CLIN LAB SCI, V16, P274; Ziegler D, 2017, J NEUROTRAUM, V34, P121, DOI 10.1089/neu.2015.3967; Zijlstra W. G., 2000, VISIBLE NEAR INFRARE; ZIJLSTRA WG, 1991, CLIN CHEM, V37, P1633; ZINGG W, 1970, CAN J PHYSIOL PHARM, V48, P202, DOI 10.1139/y70-037	93	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229105	10.1371/journal.pone.0229105	http://dx.doi.org/10.1371/journal.pone.0229105			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084188	Green Published, gold			2022-12-26	WOS:000535227900053
J	Chang, TS; Tsai, YH; Lin, YH; Chen, CH; Lu, CK; Huang, WS; Yang, YH; Chen, WM; Hsieh, YY; Wu, YC; Tung, SY; Huang, YH				Chang, Te-Sheng; Tsai, Ying-Huang; Lin, Yi-Heng; Chen, Chun-Hsien; Lu, Chung-Kuang; Huang, Wen-Shih; Yang, Yao-Hsu; Chen, Wei-Ming; Hsieh, Yung-Yu; Wu, Yu-Chih; Tung, Shui-Yi; Huang, Yen-Hua			Limited effects of antibiotic prophylaxis in patients with Child-Pugh class A/B cirrhosis and upper gastrointestinal bleeding	PLOS ONE			English	Article							ACUTE VARICEAL HEMORRHAGE; BACTERIAL-INFECTIONS; PORTAL-HYPERTENSION; RISK; CARE; THERAPY; ASCITES	Current guidelines recommend antibiotic prophylaxis for all patients with various degrees of cirrhosis and upper gastrointestinal (UGI) bleeding. This study assessed the need for antibiotic prophylaxis in patients with low Child-Pugh scores. We retrospectively screened all patients with cirrhosis who underwent upper endoscopies for UGI bleeding in a referral hospital in Taiwan between 2003 and 2014, from which 913 patients were enrolled after excluding patients with active bacterial infections, recent antibiotic use, early death, and Child-Pugh class C cirrhosis. Among them, 73 (8%) received prophylactic antibiotics, and 45 (4.9%) exhibited 14-day bacterial infection. Neither Child-Pugh score nor model for end stage liver disease score were optimal for predicting bacterial infection because their areas under the curves were 0.610 (95% confidence interval [CI]: 0.529-0.691) and 0.666 (95% CI: 0.591-0.742), respectively. Antibiotic prophylaxis did not reduce the risks of 14-day bacterial infection (relative risk [RR]: 0.932, 95% CI: 0.300-2.891, P = 0.902), 14-day rebleeding (RR: 0.791, 95% CI: 0.287-2.181, P = 0.650), or 42-day mortality (RR: 2.710, 95% CI: 0.769-9.524, P = 0.121). The results remained similar after propensity score adjustment. On-demand antibiotic treatment might suffice for patients with Child-Pugh class A/B cirrhosis and UGI bleeding.	[Chang, Te-Sheng; Chen, Chun-Hsien; Lu, Chung-Kuang; Chen, Wei-Ming; Hsieh, Yung-Yu; Tung, Shui-Yi] Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Chiayi, Taiwan; [Chang, Te-Sheng; Tsai, Ying-Huang; Huang, Wen-Shih; Yang, Yao-Hsu; Chen, Wei-Ming; Hsieh, Yung-Yu; Tung, Shui-Yi] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chang, Te-Sheng; Lin, Yi-Heng; Huang, Yen-Hua] Taipei Med Univ, Coll Med, Dept Biochem & Mol Cell Biol, Taipei, Taiwan; [Tsai, Ying-Huang] Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Chiayi, Taiwan; [Lin, Yi-Heng; Wu, Yu-Chih; Huang, Yen-Hua] Taipei Med Univ, Res Ctr Cell Therapy & Regenerat Med, Taipei, Taiwan; [Huang, Wen-Shih] Chang Gung Mem Hosp, Dept Surg, Div Colon & Rectal Surg, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Hlth Informat & Epidemiol Lab, Chiayi, Taiwan; [Huang, Yen-Hua] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Huang, Yen-Hua] Taipei Med Univ Hosp, Ctr Reprod Med, Taipei, Taiwan; [Huang, Yen-Hua] Taipei Med Univ, Comprehens Canc Ctr, Taipei, Taiwan; [Huang, Yen-Hua] Taipei Med Univ, Coll Med, Int PhD Program Cell Therapy & Regenerat Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Taipei Medical University; Chang Gung Memorial Hospital; Taipei Medical University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University	Tung, SY (corresponding author), Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Chiayi, Taiwan.; Tung, SY (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Huang, YH (corresponding author), Taipei Med Univ, Coll Med, Dept Biochem & Mol Cell Biol, Taipei, Taiwan.; Huang, YH (corresponding author), Taipei Med Univ, Res Ctr Cell Therapy & Regenerat Med, Taipei, Taiwan.; Huang, YH (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.; Huang, YH (corresponding author), Taipei Med Univ Hosp, Ctr Reprod Med, Taipei, Taiwan.; Huang, YH (corresponding author), Taipei Med Univ, Comprehens Canc Ctr, Taipei, Taiwan.; Huang, YH (corresponding author), Taipei Med Univ, Coll Med, Int PhD Program Cell Therapy & Regenerat Med, Taipei, Taiwan.	ma1898@cgmh.org.tw; rita1204@tmu.edu.tw	; Yang, Yao-Hsu/A-3450-2019	Chen, Wei-Ming/0000-0002-4949-393X; Hsieh, Yung-Yu/0000-0001-8465-5204; Yang, Yao-Hsu/0000-0002-8080-0504	Chang Gung Memorial Hospital, Taiwan [CORPG6F0053]; Ministry of Science and Technology, Taiwan [MOST 1062314-B-182-065, MOST108-2314-B-038006, MOST108-2321-B-038-003]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by research grants from Chang Gung Memorial Hospital, Taiwan (CORPG6F0053) to TSC, and the Ministry of Science and Technology, Taiwan (MOST 1062314-B-182-065 to TSC; MOST108-2314-B-038006 and MOST108-2321-B-038-003 to YHH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Razik A, 2020, EUR J GASTROEN HEPAT, V32, P718, DOI 10.1097/MEG.0000000000001578; Bonnel AR, 2011, CLIN GASTROENTEROL H, V9, P727, DOI 10.1016/j.cgh.2011.02.031; Boursier J, 2009, J CLIN GASTROENTEROL, V43, P580, DOI 10.1097/MCG.0b013e3181889468; Centers for Disease Control, 2013, ANTIBIOTIC RESISTANC; Chavez-Tapia NC, 2011, ALIMENT PHARM THER, V34, P509, DOI 10.1111/j.1365-2036.2011.04746.x; Conejo I, 2016, LIVER INT, V36, P994, DOI 10.1111/liv.13038; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; Deschenes M, 1999, AM J GASTROENTEROL, V94, P2193, DOI 10.1016/S0002-9270(99)00349-4; GARCIATSAO G, 1985, HEPATOLOGY, V5, P419, DOI 10.1002/hep.1840050313; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hou MC, 2004, HEPATOLOGY, V39, P746, DOI 10.1002/hep.20126; Jalan R, 2014, J HEPATOL, V60, P1310, DOI 10.1016/j.jhep.2014.01.024; Kamath PS, 2015, J HEPATOL, V63, P543, DOI 10.1016/j.jhep.2015.07.001; Kanwal F, 2012, GASTROENTEROLOGY, V143, P70, DOI 10.1053/j.gastro.2012.03.038; Lin HC, 2016, E DA MED J, V3, P9; Moon AM, 2016, CLIN GASTROENTEROL H, V14, P1629, DOI 10.1016/j.cgh.2016.05.040; O'Leary JG, 2015, CLIN GASTROENTEROL H, V13, P753, DOI 10.1016/j.cgh.2014.07.060; Pauwels A, 1996, HEPATOLOGY, V24, P802; Runyon BA, 2009, HEPATOLOGY, V49, P2087, DOI 10.1002/hep.22853; Shehab N, 2008, CLIN INFECT DIS, V47, P735, DOI 10.1086/591126; Tandon P, 2015, CLIN GASTROENTEROL H, V13, P1189, DOI 10.1016/j.cgh.2014.11.019; Terg R, 2015, J HEPATOL, V62, P1056, DOI 10.1016/j.jhep.2014.11.036; Wu CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061666	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229101	10.1371/journal.pone.0229101	http://dx.doi.org/10.1371/journal.pone.0229101			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084186	Green Published, gold			2022-12-26	WOS:000535227900052
J	Schneider, J; Algharably, E; Budnick, A; Wenzel, A; Drager, D; Kreutz, R				Schneider, Juliana; Algharably, Engi; Budnick, Andrea; Wenzel, Arlett; Draeger, Dagmar; Kreutz, Reinhold			Deficits in pain medication in older adults with chronic pain receiving home care: A cross-sectional study in Germany	PLOS ONE			English	Article							MINI-MENTAL-STATE; PERSISTENT PAIN; MANAGEMENT; APPROPRIATENESS; CANNABINOIDS; PREVALENCE; UPDATE; EUROPE	Objective To analyze the pattern and appropriateness of pain medications in older adults receiving home care. Methods We performed a prospective cross-sectional study in patients >= 65 years old having chronic pain and receiving home care in Berlin, Germany. Data on prescribed pain medications were collected using self-reported information, nursing documents, and medication plans during interviews at home. Pain intensity was determined with the numeric rating scale (NRS) and the Pain Assessment In Advanced dementia (PAINAD) scale. The Pain Medication Appropriateness Scale score (S-PMAS) was applied to evaluate inappropriateness (i.e. a score <= 67) of pain medication. Results Overall 322 patients with a mean age of 82.1 +/- 7.4 years (71.4% females) were evaluated. The average pain intensity scores during the last 24 hours were 5.3 +/- 2.1 and 2.3 +/- 2.3 on NRS and PAINAD scale (range 0-10, respectively). Sixty (18.6%) patients did not receive any pain medication. Among the treated patients, dipyrone was the most frequently prescribed analgesic (71.4%), while 50.8% and 19.1% received systemic treatment with opioids and non-steroidal anti-inflammatory drugs, respectively. The observed median SPMAS was 47.6 (range 0-100) with 58 (18.0%) of patients achieving appropriate values. Half of the patients were treated with scheduled, while 29.9% were only treated with on-demand medications. Cognitive status had no effect on appropriateness of pain treatment. Conclusions We observed substantial deficits in dosing patterns and appropriateness of pain medication in older adults with pain receiving home care. This applied to both patients with and without severe cognitive impairment.	[Schneider, Juliana; Algharably, Engi; Kreutz, Reinhold] Charite Univ Med Berlin, Inst Clin Pharmacol & Toxicol, Berlin, Germany; [Schneider, Juliana; Algharably, Engi; Budnick, Andrea; Wenzel, Arlett; Draeger, Dagmar; Kreutz, Reinhold] Free Univ Berlin, Berlin, Germany; [Schneider, Juliana; Algharably, Engi; Budnick, Andrea; Wenzel, Arlett; Draeger, Dagmar; Kreutz, Reinhold] Humboldt Univ, Berlin, Germany; [Schneider, Juliana; Algharably, Engi; Budnick, Andrea; Wenzel, Arlett; Draeger, Dagmar; Kreutz, Reinhold] Berlin Inst Hlth, Berlin, Germany; [Budnick, Andrea; Wenzel, Arlett; Draeger, Dagmar] Charite Univ Med Berlin, Inst Med Sociol & Rehabil Sci, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kreutz, R (corresponding author), Charite Univ Med Berlin, Inst Clin Pharmacol & Toxicol, Berlin, Germany.; Kreutz, R (corresponding author), Free Univ Berlin, Berlin, Germany.; Kreutz, R (corresponding author), Humboldt Univ, Berlin, Germany.; Kreutz, R (corresponding author), Berlin Inst Hlth, Berlin, Germany.	reinhold.kreutz@charite.de	Kreutz, Reinhold/AEV-0507-2022	Budnick, Andrea/0000-0002-0036-4790; Schneider, Juliana/0000-0002-6015-8251; Wenzel, Arlett/0000-0002-0982-1839; Algharably, Engi/0000-0002-2402-0693	National Association of Statutory Health Insurance Funds of Germany [GKV-27.03.2017]	National Association of Statutory Health Insurance Funds of Germany	The study was financial supported by the National Association of Statutory Health Insurance Funds of Germany (GKV-27.03.2017). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla A, 2013, AGE AGEING, V42, pI1, DOI 10.1093/ageing/afs200; Abrams DI, 2018, EUR J INTERN MED, V49, P7, DOI 10.1016/j.ejim.2018.01.003; Basler HD, 2006, SCHMERZ, V20, P519, DOI 10.1007/s00482-006-0490-7; Blyth FM, 2001, PAIN, V89, P127, DOI 10.1016/S0304-3959(00)00355-9; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Demuth A, 2017, AVP, V44, P39; Deutsches Institut fur Medizinische Dokumentation und Information (DIMDI), 2019, ICD 10 GM VERS 2019; Dzau VJ, 2014, JAMA-J AM MED ASSOC, V312, P1507, DOI 10.1001/jama.2014.12986; Fayaz A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010364; Federal Statistical Office, 2018, PFLEG 2017 STAT AN N; Ferrell B, 2009, J AM GERIATR SOC, V57, P1331, DOI 10.1111/j.1532-5415.2009.02376.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FOMBONNE E, 1991, J CHILD PSYCHOL PSYC, V32, P677, DOI 10.1111/j.1469-7610.1991.tb00343.x; Galicia-Castillo M, 2016, CLEV CLIN J MED, V83, P443, DOI 10.3949/ccjm.83a.15023; Hadjistavropoulos T, 2014, LANCET NEUROL, V13, P1216, DOI 10.1016/S1474-4422(14)70103-6; Hamza SA, 2019, PHARMACOEPIDEM DR S, V28, P849, DOI 10.1002/pds.4775; Holt S, POTENTIALLY INAPPROP; Hutt E, 2006, J AM GERIATR SOC, V54, P231, DOI 10.1111/j.1532-5415.2005.00582.x; Kirchberger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030556; Kolzsch M, 2013, SCHMERZ, V27, P497, DOI 10.1007/s00482-013-1352-8; Kolzsch M, 2012, EUR J PAIN, V16, P439, DOI 10.1002/j.1532-2149.2011.00029.x; Konner F, 2015, EUR J PAIN, V19, P1331, DOI 10.1002/ejp.663; Konijnenbelt-Peters J, 2017, PAIN PRACT, V17, P402, DOI 10.1111/papr.12467; Leiske M, 2015, SCHMERZ, V29, P431, DOI 10.1007/s00482-015-0001-9; Lubke N, 2004, Z GERONTOL GERIATR, V37, P316, DOI 10.1007/s00391-004-0233-2; Lu┬ffle M., 2003, INFORM BIOMETRIE EPI, P601; MAHONEY F I, 1965, Md State Med J, V14, P61; Makris UE, 2014, JAMA-J AM MED ASSOC, V312, P825, DOI 10.1001/jama.2014.9405; Malec M, 2015, MED CLIN N AM, V99, P337, DOI 10.1016/j.mcna.2014.11.007; Marcum ZA, 2016, CLIN GERIATR MED, V32, P705, DOI 10.1016/j.cger.2016.06.007; Markotic F, 2013, PAIN MED, V14, P247, DOI 10.1111/pme.12035; Murray CJL, 2018, LANCET, V392, P1995, DOI [10.1016/S0140-6736(18)32278-5, 10.1016/s0140-6736(18)32278-5]; Nawai A, 2017, AGING CLIN EXP RES, V29, P1139, DOI 10.1007/s40520-016-0700-9; Nikolova I, 2012, BIOTECHNOL BIOTEC EQ, V26, P3329, DOI 10.5504/BBEQ.2012.0089; Oscanoa TJ, 2017, EUR J CLIN PHARMACOL, V73, P759, DOI 10.1007/s00228-017-2225-3; Parker SJ, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-43; Pazan F, 2019, DRUG AGING, V36, P481, DOI 10.1007/s40266-019-00669-6; PETERSON RA, 1994, J CONSUM RES, V21, P381, DOI 10.1086/209405; Rabenberg A, 2019, DRUG AGING, V36, P969, DOI 10.1007/s40266-019-00703-7; Radbruch L, 1999, J PAIN SYMPTOM MANAG, V18, P180, DOI 10.1016/S0885-3924(99)00064-0; Reid KJ, 2011, CURR MED RES OPIN, V27, P449, DOI 10.1185/03007995.2010.545813; ROY R, 1986, CAN FAM PHYSICIAN, V32, P513; Savvas S, 2015, AUST FAM PHYSICIAN, V44, P198; Schmidt M, 2016, EUR HEART J, V37, P1015, DOI 10.1093/eurheartj/ehv505; Shropshire M, 2018, NURS FORUM, V53, P538, DOI 10.1111/nuf.12284; Smith BH, 2019, PAIN, V160, P83, DOI 10.1097/j.pain.0000000000001360; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Tsai YF, 2010, J PAIN SYMPTOM MANAG, V40, P575, DOI 10.1016/j.jpainsymman.2010.02.013; Warden Victoria, 2003, J Am Med Dir Assoc, V4, P9, DOI 10.1097/00130535-200301000-00002; Wastesson JW, 2018, EXPERT OPIN DRUG SAF, V17, P1185, DOI 10.1080/14740338.2018.1546841; Whiting PF, 2015, JAMA-J AM MED ASSOC, V313, P2456, DOI 10.1001/jama.2015.6358; Zwakhalen SMG, 2012, J AM MED DIR ASSOC, V13, P384, DOI 10.1016/j.jamda.2011.04.002	52	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229229	10.1371/journal.pone.0229229	http://dx.doi.org/10.1371/journal.pone.0229229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8DJ	32084203	gold, Green Published			2022-12-26	WOS:000535227900073
J	Sugrue, A; Vaidya, VR; Livia, C; Padmanabhan, D; Abudan, A; Isath, A; Witt, T; DeSimone, CV; Stalboerger, P; Kapa, S; Asirvatham, SJ; McLeod, CJ				Sugrue, Alan; Vaidya, Vaibhav R.; Livia, Christopher; Padmanabhan, Deepak; Abudan, Anas; Isath, Ameesh; Witt, Tyra; DeSimone, Christopher, V; Stalboerger, Paul; Kapa, Suraj; Asirvatham, Samuel J.; McLeod, Christopher J.			Feasibility of selective cardiac ventricular electroporation	PLOS ONE			English	Article							IRREVERSIBLE ELECTROPORATION; ELECTRICAL BREAKDOWN; PURKINJE-CELLS; ABLATION; ELECTROCHEMOTHERAPY; SYSTEM; SAFETY	Introduction The application of brief high voltage electrical pulses to tissue can lead to an irreversible or reversible electroporation effect in a cell-specific manner. In the management of ventricular arrhythmias, the ability to target different tissue types, specifically cardiac conduction tissue (His-Purkinje System) vs. cardiac myocardium would be advantageous. We hypothesize that pulsed electric fields (PEFs) can be applied safely to the beating heart through a catheter-based approach, and we tested whether the superficial Purkinje cells can be targeted with PEFs without injury to underlying myocardial tissue. Methods In an acute (n = 5) and chronic canine model (n = 6), detailed electroanatomical mapping of the left ventricle identified electrical signals from myocardial and overlying Purkinje tissue. Electroporation was effected via percutaneous catheter-based Intracardiac bipolar current delivery in the anesthetized animal. Repeat Intracardiac electrical mapping of the heart was performed at acute and chronic time points; followed by histological analysis to assess effects. Results PEF demonstrated an acute dose-dependent functional effect on Purkinje, with titration of pulse duration and/or voltage associated with successful acute Purkinje damage. Electrical conduction in the insulated bundle of His (n = 2) and anterior fascicle bundle (n = 2), was not affected. At 30 days repeat cardiac mapping demonstrated resilient, normal electrical conduction throughout the targeted area with no significant change in myocardial amplitude (pre 5.9 +/- 1.8 mV, 30 days 5.4 +/- 1.2 mV, p = 0.92). Histopathological analysis confirmed acute Purkinje fiber targeting, with chronic studies showing normal Purkinje fibers, with minimal subendocardial myocardial fibrosis. Conclusion PEF provides a novel, safe method for non-thermal acute modulation of the Purkinje fibers without significant injury to the underlying myocardium. Future optimization of this energy delivery is required to optimize conditions so that selective electroporation can be utilized in humans the treatment of cardiac disease.	[Sugrue, Alan; Vaidya, Vaibhav R.; Padmanabhan, Deepak; Abudan, Anas; Isath, Ameesh; DeSimone, Christopher, V; Kapa, Suraj; Asirvatham, Samuel J.; McLeod, Christopher J.] Mayo Clin, Div Heart Rhythm Serv, Dept Cardiovasc Dis, Rochester, MN 55902 USA; [Livia, Christopher; Witt, Tyra; Stalboerger, Paul] Mayo Clin, Dept Cardiovasc Med, Ctr Regenerat Med, Rochester, MN USA; [Livia, Christopher; Witt, Tyra; Stalboerger, Paul] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Ctr Regenerat Med, Rochester, MN USA; [Asirvatham, Samuel J.] Mayo Clin, Div Pediat Cardiol, Dept Pediat & Adolescent Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	McLeod, CJ (corresponding author), Mayo Clin, Div Heart Rhythm Serv, Dept Cardiovasc Dis, Rochester, MN 55902 USA.	mcleod.christopher@mayo.edu	Isath, Ameesh/GPK-5434-2022; Isath, Ameesh/GSJ-0986-2022; Sugrue, Alan/AAN-8589-2021	Isath, Ameesh/0000-0002-7992-8113; Livia, Christopher/0000-0003-1772-450X				Agarwal A, 2007, ANAL CHEM, V79, P3589, DOI 10.1021/ac062049e; Ben Caref E, 2008, EUROPACE, V10, P1218, DOI 10.1093/europace/eun248; BENZ R, 1980, BIOCHIM BIOPHYS ACTA, V597, P637, DOI 10.1016/0005-2736(80)90236-9; Bertacchini C, 2007, TECHNOL CANCER RES T, V6, P313, DOI 10.1177/153303460700600408; Boyden PA, 2016, HEART RHYTHM, V13, P1172, DOI 10.1016/j.hrthm.2016.01.011; Cannon R, 2013, J SURG ONCOL, V107, P544, DOI 10.1002/jso.23280; CHANG DC, 1990, BIOPHYS J, V58, P1, DOI 10.1016/S0006-3495(90)82348-1; Charpentier KP, 2011, HPB, V13, P168, DOI 10.1111/j.1477-2574.2010.00261.x; Corovic S, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-16; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Dosdall DJ, 2008, AM J PHYSIOL-HEART C, V295, pH883, DOI 10.1152/ajpheart.00466.2008; Gianni C, 2018, J INTERVENTIONAL CAR; GLASER RW, 1988, BIOCHIM BIOPHYS ACTA, V940, P275, DOI 10.1016/0005-2736(88)90202-7; Golberg A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08485; Haissaguerre M, 2002, LANCET, V359, P677, DOI 10.1016/S0140-6736(02)07807-8; Han W, 2002, AM J PHYSIOL-HEART C, V283, pH2495, DOI 10.1152/ajpheart.00389.2002; Han W, 2001, CIRCULATION, V104, P2095, DOI 10.1161/hc4201.097134; Hong J, 2009, IEEE ENG MED BIO, P3381, DOI 10.1109/IEMBS.2009.5332816; Huang J, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000495; JAMES TN, 1971, CIRCULATION, V44, P9, DOI 10.1161/01.CIR.44.1.9; Kaminska I, 2012, GEN PHYSIOL BIOPHYS, V31, P19, DOI 10.4149/gpb_2012_003; Kos B, 2015, RADIOL ONCOL, V49, P234, DOI 10.1515/raon-2015-0031; Kranjc M, 2015, RADIOLOGY, V274, P115, DOI 10.1148/radiol.14140311; Lang D, 2015, CIRC-ARRHYTHMIA ELEC, V8, P409, DOI 10.1161/CIRCEP.114.002065; Li W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018831; Livia C, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009070; Lopera G, 2004, J CARDIOVASC ELECTR, V15, P52, DOI 10.1046/j.1540-8167.2004.03189.x; Mali B, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/1475-925X-14-S3-S5; Maor E, 2008, IEEE T BIO-MED ENG, V55, P2268, DOI 10.1109/TBME.2008.923909; Maor E, 2007, TECHNOL CANCER RES T, V6, P307, DOI 10.1177/153303460700600407; Maor E, 2010, J VASC INTERV RADIOL, V21, P1708, DOI 10.1016/j.jvir.2010.06.024; Maor E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004757; Marty M, 2006, EJC SUPPL, V4, P3, DOI 10.1016/j.ejcsup.2006.08.002; Miklavcic D, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-29; MIR LM, 1991, CR ACAD SCI III-VIE, V313, P613; NEUMANN E, 1992, BIOELECTROCH BIOENER, V28, P247, DOI 10.1016/0302-4598(92)80017-B; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Nogami A, 2005, HEART RHYTHM, V2, P646, DOI 10.1016/j.hrthm.2005.02.006; OKINO M, 1987, JPN J CANCER RES, V78, P1319; ORLOWSKI S, 1988, BIOCHEM PHARMACOL, V37, P4727, DOI 10.1016/0006-2952(88)90344-9; Reddy VY, 2019, J AM COLL CARDIOLOGY; Reddy VY, 2018, ULTRARAPID TISSUE SE; Rosazza C, 2016, CURR GENE THER, V16, P98, DOI 10.2174/1566523216666160331130040; Schoellnast H, 2011, RADIOLOGY, V260, P421, DOI 10.1148/radiol.11103505; SERSA G, 1995, CANCER RES, V55, P3450; Stewart MT, 2019, HEART RHYTHM, V16, P754, DOI 10.1016/j.hrthm.2018.10.030; Sugrue A, 2018, EXPERT REV CARDIOVAS; Sung Raphael K, 2017, JACC Clin Electrophysiol, V3, P1343, DOI 10.1016/j.jacep.2017.07.011; Thomson KR, 2011, J VASC INTERV RADIOL, V22, P611, DOI 10.1016/j.jvir.2010.12.014; van Driel VJ, 2014, CIRCULATION ARRHYTHM; Walton RD, 2014, CARDIOVASC RES, V103, P629, DOI 10.1093/cvr/cvu165; Witt CM, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009575; Wittkampf FH, 2018, ELECTROPORATION ITS; Wittkampf FH, 2012, CIRC-ARRHYTHMIA ELEC, DOI [10.1161/CIRCEP.112.975888, DOI 10.1161/CIRCEP.112.975888]; Wittkampf FH, 2011, J CARDIOVASC ELECTR, V22, P302, DOI 10.1111/j.1540-8167.2010.01863.x; Wojtaszczyk A, 2018, J CARDIOVASC ELECTR, V29, P643, DOI 10.1111/jce.13454	56	13	14	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229214	10.1371/journal.pone.0229214	http://dx.doi.org/10.1371/journal.pone.0229214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084220	Green Published, gold			2022-12-26	WOS:000535227900072
J	Criscuolo, NG; Angelini, C				Criscuolo, Nicola G.; Angelini, Claudia			StructuRly: A novel shiny app to produce comprehensive, detailed and interactive plots for population genetic analysis	PLOS ONE			English	Article							CLUSTERS; SOFTWARE	Population genetics focuses on the analysis of genetic differences within and between-group of individuals and the inference of the populations' structure. These analyses are usually carried out using Bayesian clustering or maximum likelihood estimation algorithms that assign individuals to a given population depending on specific genetic patterns. Although several tools were developed to perform population genetics analysis, their standard graphical outputs may not be sufficiently informative for users lacking interactivity and complete information. StructuRly aims to resolve this problem by offering a complete environment for population analysis. In particular, StructuRly combines the statistical power of the R language with the friendly interfaces implemented using the shiny libraries to provide a novel tool for performing population clustering, evaluating several genetic indexes, and comparing results. Moreover, graphical representations are interactive and can be easily personalized. StructuRly is available either as R package on GitHub, with detailed information for its installation and use and as shinyapps.io servers for those users who are not familiar with R and the RStudio IDE. The application has been tested on Linux, macOS and Windows operative systems and can be launched as a shiny app in every web browser.	[Criscuolo, Nicola G.] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland; [Angelini, Claudia] CNR, Ist Applicaz Calcolo M Picone, Naples, Italy	Swiss Federal Institutes of Technology Domain; ETH Zurich; Consiglio Nazionale delle Ricerche (CNR)	Angelini, C (corresponding author), CNR, Ist Applicaz Calcolo M Picone, Naples, Italy.	c.angelini@iac.cnr.it	Angelini, Claudia/AAL-2555-2020; Angelini, Claudia/J-4106-2012	Criscuolo, Nicola/0000-0002-0394-0888; Angelini, Claudia/0000-0001-8350-8464	MIUR Italian Flaghip Project EPIGEN; Regione Campania Project ADViSE	MIUR Italian Flaghip Project EPIGEN; Regione Campania Project ADViSE	The manuscript has been partially supported by the MIUR Italian Flaghip Project EPIGEN and the Regione Campania Project ADViSE assigned to Dr. Claudia Angelini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Behr AA, 2016, BIOINFORMATICS, V32, P2817, DOI 10.1093/bioinformatics/btw327; Chang W., Shiny: Web Application Framework for R2020 R Package Version 1.4.0.2 2021; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Cicatelli A, 2013, PLANT SCI, V210, P82, DOI 10.1016/j.plantsci.2013.05.011; Criscuolo N, PLANTS, P8; D'Agostino N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34207-y; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fengchao Zhang, 2015, 2015 IEEE 33rd VLSI Test Symposium (VTS). Proceedings, P1, DOI 10.1109/VTS.2015.7116294; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Hughes LD, 2017, EXPRESSIONDB OPEN SO, P1; Khomtchouk BB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176334; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kos MZ, 2006, HUM BIOL, DOI 10.1353/hub.2007.0007; McCandlish DM, 2014, Q REV BIOL, V89, P225, DOI 10.1086/677571; Odong TL, 2011, THEOR APPL GENET, V123, P195, DOI 10.1007/s00122-011-1576-x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Porras-Hurtado Liliana, 2013, Frontiers in Genetics, V4, P98, DOI 10.3389/fgene.2013.00098; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, R LANG ENV STAT COMP; Ramasamy RK, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-431; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Rotondi A, 2017, FOOD CHEM, V224, P78, DOI 10.1016/j.foodchem.2016.12.050; Rotondi A, 2011, FOOD CHEM, V129, P1825, DOI 10.1016/j.foodchem.2011.05.122; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sievert C., PLOTLY FOR R; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; STODDART JA, 1988, GENETICS, V118, P705; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yeung K, 2001, BIOINFORMATICS, P1, DOI [10.1186/1471-2105-2-1, DOI 10.1186/1471-2105-2-1]; Yuan A, 2003, MATH MED BIOL, V20, P327, DOI 10.1093/imammb20.4.327	32	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0229330	10.1371/journal.pone.0229330	http://dx.doi.org/10.1371/journal.pone.0229330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074134	Green Published, gold			2022-12-26	WOS:000535220600040
J	Herrmann, M; Babler, A; Moshkova, I; Gremse, F; Kiessling, F; Kusebauch, U; Nelea, V; Kramann, R; Moritz, RL; Mckee, MD; Jahnen-Dechent, W				Herrmann, Marietta; Babler, Anne; Moshkova, Irina; Gremse, Felix; Kiessling, Fabian; Kusebauch, Ulrike; Nelea, Valentin; Kramann, Rafael; Moritz, Robert L.; Mckee, Marc D.; Jahnen-Dechent, Willi			Lumenal calcification and microvasculopathy in fetuin-A-deficient mice lead to multiple organ morbidity	PLOS ONE			English	Article							CONTAINING CALCIPROTEIN PARTICLES; VASCULAR CALCIFICATION; AORTIC-VALVE; MINERAL DEPOSITION; STATISTICAL-MODEL; MATRIX VESICLES; SERUM; PROTEIN; OSTEOPONTIN; EXPRESSION	The plasma protein fetuin-A mediates the formation of protein-mineral colloids known as calciprotein particles (CPP)-rapid clearance of these CPP by the reticuloendothelial system prevents errant mineral precipitation and therefore pathological mineralization (calcification). The mutant mouse strain D2, Ahsg-/- combines fetuin-A deficiency with the calcification-prone DBA/2 genetic background, having a particularly severe compound phenotype of microvascular and soft tissue calcification. Here we studied mechanisms leading to soft tissue calcification, organ damage and death in these mice. We analyzed mice longitudinally by echocardiography, X-ray-computed tomography, analytical electron microscopy, histology, mass spectrometry proteomics, and genome-wide microarray-based expression analyses of D2 wildtype and Ahsg-/- mice. Fetuin-A-deficient mice had calcified lesions in myocardium, lung, brown adipose tissue, reproductive organs, spleen, pancreas, kidney and the skin, associated with reduced growth, cardiac output and premature death. Importantly, early-stage calcified lesions presented in the lumen of the microvasculature suggesting precipitation of mineral containing complexes from the fluid phase of blood. Genome-wide expression analysis of calcified lesions and surrounding (not calcified) tissue, together with morphological observations, indicated that the calcification was not associated with osteochondrogenic cell differentiation, but rather with thrombosis and fibrosis. Collectively, these results demonstrate that soft tissue calcification can start by intravascular mineral deposition causing microvasculopathy, which impacts on growth, organ function and survival. Our study underscores the importance of fetuin-A and related systemic regulators of calcified matrix metabolism to prevent cardiovascular disease, especially in dysregulated mineral homeostasis.	[Herrmann, Marietta; Babler, Anne; Moshkova, Irina; Jahnen-Dechent, Willi] RWTH Aachen Univ Hosp, Helmholtz Inst Biomed Engn, Biointerface Lab, Aachen, Germany; [Gremse, Felix; Kiessling, Fabian] RWTH Aachen Univ Hosp, Helmholtz Inst Biomed Engn, Expt Mol Imaging, Aachen, Germany; [Kusebauch, Ulrike; Moritz, Robert L.] Inst Syst Biol, Seattle, WA USA; [Nelea, Valentin; Mckee, Marc D.] McGill Univ, Dept Anat & Cell Biol, Fac Dent, Fac Med, Montreal, PQ, Canada; [Kramann, Rafael] RWTH Aachen Univ Hosp, Div Nephrol, Aachen, Germany	Helmholtz Association; RWTH Aachen University; RWTH Aachen University Hospital; Helmholtz Association; RWTH Aachen University; RWTH Aachen University Hospital; Institute for Systems Biology (ISB); McGill University; RWTH Aachen University; RWTH Aachen University Hospital	Jahnen-Dechent, W (corresponding author), RWTH Aachen Univ Hosp, Helmholtz Inst Biomed Engn, Biointerface Lab, Aachen, Germany.; Mckee, MD (corresponding author), McGill Univ, Dept Anat & Cell Biol, Fac Dent, Fac Med, Montreal, PQ, Canada.	marc.mckee@mcgill.ca; willi.jahnen@rwth-aachen.de	Babler, Anne/AAA-7250-2021; Herrmann, Marietta/AAS-6253-2020; Kiessling, Fabian/Y-2417-2019; Kramann, Rafael/K-7995-2013	Kiessling, Fabian/0000-0002-7341-0399; Herrmann, Marietta/0000-0002-2412-7474; Kramann, Rafael/0000-0003-4048-6351; Moritz, Robert/0000-0002-3216-9447; McKee, Marc/0000-0001-8349-965X	IZKF Aachen of the Medical Faculty of RWTH Aachen; German Research Foundation [DFG SFB/TRR219]; National Institutes of Health from the National Institute of General Medical Sciences (NIGMS) [R01GM087221, S10RR027584, 2P50GM076547]; National Science Foundation MRI [0923536]; Canadian Institutes of Health Research	IZKF Aachen of the Medical Faculty of RWTH Aachen; German Research Foundation(German Research Foundation (DFG)); National Institutes of Health from the National Institute of General Medical Sciences (NIGMS); National Science Foundation MRI(National Science Foundation (NSF)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants awarded to WJD by the IZKF Aachen of the Medical Faculty of RWTH Aachen and by the German Research Foundation (DFG SFB/TRR219-Project C-03). This work was also funded in part by National Institutes of Health from the National Institute of General Medical Sciences (NIGMS) grants R01GM087221, S10RR027584 and 2P50GM076547 to the Center for Systems Biology, the National Science Foundation MRI grant 0923536, and the Canadian Institutes of Health Research. We thank Sarah Li and Lydia Malynowsky for expert technical assistance. MDM is a member of the FRQS Network for Oral and Bone Health Research.	Akiva A, 2015, BONE, V75, P192, DOI 10.1016/j.bone.2015.02.020; Anger T, 2009, EXP MOL PATHOL, V86, P10, DOI 10.1016/j.yexmp.2008.11.001; Babler A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228938; BALL CR, 1965, ANAT RECORD, V152, P199, DOI 10.1002/ar.1091520211; Bertazzo S, 2013, NAT MATER, V12, P576, DOI [10.1038/NMAT3627, 10.1038/nmat3627]; Bilgir O, 2010, INTERNAL MED, V49, P1281, DOI 10.2169/internalmedicine.49.3223; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; BOSTROM K, 1995, AM J CARDIOL, V75, pB88, DOI 10.1016/0002-9149(95)80020-S; Brunnert SR, 1997, LAB ANIM SCI, V47, P11; Brylka LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187030; Carlson M, MOUSE4302 DB AFFYMET; De Heller-Milev M, 2000, BRIT J DERMATOL, V143, P733, DOI 10.1046/j.1365-2133.2000.03768.x; De Yoreo JJ, 2015, SCIENCE, V349, DOI 10.1126/science.aaa6760; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Deutsch EW, 2015, PROTEOM CLIN APPL, V9, P745, DOI 10.1002/prca.201400164; EATON GJ, 1978, AM J PATHOL, V90, P173; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Epaso LH, 2010, DIABETES CARE, V33, P408, DOI 10.2337/dc09-1541; Ferrer MD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07203-x; FITZPATRICK LA, 1994, J CLIN INVEST, V94, P1597, DOI 10.1172/JCI117501; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman R., GENEFILTER METHODS F; Gentleman R., ANNOTATE ANNOTATION; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gremse F, 2016, THERANOSTICS, V6, P328, DOI 10.7150/thno.13624; Hamano T, 2010, J AM SOC NEPHROL, V21, P1998, DOI 10.1681/ASN.2009090944; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Herrmann M, 2012, CIRC RES, V111, P575, DOI 10.1161/CIRCRESAHA.111.261479; Hortells L, 2017, KIDNEY INT, V92, P1384, DOI 10.1016/j.kint.2017.06.019; Hutcheson JD, 2016, NAT MATER, V15, P335, DOI 10.1038/nmat4519; Ix JH, 2007, CIRCULATION, V115, P2533, DOI 10.1161/CIRCULATIONAHA.106.682450; Jahnen-Dechent W, 2008, J MOL MED, V86, P379, DOI 10.1007/s00109-007-0294-y; JahnenDechent W, 1997, J BIOL CHEM, V272, P31496, DOI 10.1074/jbc.272.50.31496; Kaden JJ, 2004, J MOL CELL CARDIOL, V36, P57, DOI 10.1016/j.yjmcc.2003.09.015; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kerschnitzki M, 2016, BONE, V83, P65, DOI 10.1016/j.bone.2015.10.009; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; KIM KM, 1976, FED PROC, V35, P156; Kockx MM, 1996, AM J PATHOL, V148, P1771; Koos R, 2009, EUR HEART J, V30, P2054, DOI 10.1093/eurheartj/ehp158; Koppert S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01991; Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Lok ZSY, 2019, ARTERIOSCL THROM VAS, V39, P613, DOI 10.1161/ATVBAHA.118.311577; Loohuis KMO, 2010, KIDNEY INT, V77, P77, DOI 10.1038/ki.2009.407; Lorenz G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12859-6; Martens L, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.000133; Matsui I, 2009, KIDNEY INT, V75, P915, DOI 10.1038/ki.2008.700; McKee MD, 1996, ANAT RECORD, V245, P394, DOI 10.1002/(SICI)1097-0185(199606)245:2<394::AID-AR19>3.0.CO;2-K; Merx MW, 2005, J AM SOC NEPHROL, V16, P3357, DOI 10.1681/ASN.2005040365; Miura M, 2018, 2018 THIRTEENTH INTERNATIONAL CONFERENCE ON KNOWLEDGE, INFORMATION AND CREATIVITY SUPPORT SYSTEMS (KICSS), P1; Morgan M, GSEABASE GENE SET EN; Murshed M, 2010, CURR OPIN NEPHROL HY, V19, P359, DOI 10.1097/MNH.0b013e3283393a2b; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; O'Neill WC, 2017, KIDNEY INT, V92, P1316, DOI 10.1016/j.kint.2017.07.020; O'Neill WC, 2014, KIDNEY INT, V85, P668, DOI 10.1038/ki.2013.351; Pasch A, 2012, J AM SOC NEPHROL, V23, P1744, DOI 10.1681/ASN.2012030240; Pollard K, 2009, MULTTEST RESAMPLING; Pradervand S, 2004, EMBO J, V23, P4517, DOI 10.1038/sj.emboj.7600454; Price PA, 2003, J BIOL CHEM, V278, P22153, DOI 10.1074/jbc.M300739200; Price PA, 2009, J BIOL CHEM, V284, P17092, DOI 10.1074/jbc.M109.007013; Reynolds JL, 2005, J AM SOC NEPHROL, V16, P2920, DOI 10.1681/ASN.2004100895; Rubio-Aliaga I, 2000, BIOCHEM BIOPH RES CO, V276, P734, DOI 10.1006/bbrc.2000.3546; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; SHANAHAN CM, 1994, J CLIN INVEST, V93, P2393, DOI 10.1172/JCI117246; Shioi A, 2000, Z KARDIOL, V89, P75; Shook LL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aah4707; Shteynberg D, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007690; Smith C., 2008, ANNAFFY ANNOTATION T; Smith ER, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05474-y; Smith ER, 2014, J AM SOC NEPHROL, V25, P339, DOI 10.1681/ASN.2013060635; Smith ER, 2013, NEPHROLOGY, V18, P215, DOI 10.1111/nep.12021; Smith ER, 2012, NEPHROL DIAL TRANSPL, V27, P1957, DOI 10.1093/ndt/gfr609; Speer MY, 2002, J EXP MED, V196, P1047, DOI 10.1084/jem.20020911; Steitz SA, 2002, AM J PATHOL, V161, P2035, DOI 10.1016/S0002-9440(10)64482-3; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Stejskal D, 2008, BJU INT, V101, P1151, DOI 10.1111/j.1464-410X.2007.07432.x; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; TANIMURA A, 1986, Journal of Experimental Pathology (New York), V2, P261; Towler DA, 1998, J BIOL CHEM, V273, P30427, DOI 10.1074/jbc.273.46.30427; Tyson KL, 2003, ARTERIOSCL THROM VAS, V23, P489, DOI 10.1161/01.ATV.0000059406.92165.31; Villa-Bellosta R, 2011, AM J PHYSIOL-CELL PH, V300, pC210, DOI 10.1152/ajpcell.00229.2010; Wald J, 2011, SOFT MATTER, V7, P2869, DOI 10.1039/c0sm01191f; Westenfeld R, 2007, NEPHROL DIAL TRANSPL, V22, P1537, DOI 10.1093/ndt/gfm094; Wu CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008058; Young JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005421; Zheng L, 2009, AM J RESP CELL MOL, V41, P85, DOI 10.1165/rcmb.2007-0401OC; Zimmermann N, 2005, AM J RESP CELL MOL, V32, P428, DOI 10.1165/rcmb.2004-0269OC	91	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228503	10.1371/journal.pone.0228503	http://dx.doi.org/10.1371/journal.pone.0228503			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074120	gold, Green Published			2022-12-26	WOS:000535220600016
J	Gottfried, I; Gottfried, T; Lesinski, G; Hebda, G; Ignaczak, M; Wojtaszyn, G; Jurczyszyn, M; Fuszara, M; Fuszara, E; Grzywinski, W; Blachowski, G; Hejduk, J; Jaros, R; Kowalski, M				Gottfried, Iwona; Gottfried, Tomasz; Lesinski, Grzegorz; Hebda, Grzegorz; Ignaczak, Maurycy; Wojtaszyn, Grzegorz; Jurczyszyn, Miroslaw; Fuszara, Maciej; Fuszara, Elzbieta; Grzywinski, Witold; Blachowski, Grzegorz; Hejduk, Janusz; Jaros, Radoslaw; Kowalski, Marek			Long-term changes in winter abundance of the barbastelle Barbastella barbastellus in Poland and the climate change - Are current monitoring schemes still reliable for cryophilic bat species?	PLOS ONE			English	Article							PIPISTRELLUS-NATHUSII; TREND ANALYSIS; TEMPERATURE; CHIROPTERA; VESPERTILIONIDAE; HIBERNATION; SELECTION; IMPACTS; CAVE; CONSTRAINTS	Warmer winters may lead to changes in the hibernation behaviour of bats, such as the barbastelle Barbastella barbastellus, which prefers to hibernate at low temperatures. The species is also known for its large annual fluctuations in the number of wintering individuals, so inference about population trends should be based on long-term data. Prior to 2005, analyses indicated stable or even increasing barbastelle population in Poland. We analysed the results of 13 winter bat counts (2005-2017) of the species from 15 of the largest hibernacula, and additional site of 47 small bunkers, in Poland. The total number of wintering individuals remained stable during the study period, because the barbastelle is not a long-distance migrant, this likely reflects the national population trend. On the basis of mean winter air temperatures we divided the country into four thermal regions. Analyses of barbastelle abundance in hibernacula in the four regions revealed a 4.8% annual mean increase in numbers in the coldest region, where mean winter temperatures were below -2 degrees C, annual mean declines of 3.3% and 3.1% in two warmer regions of western Poland, but no trend in the region of intermediate mean winter temperatures of between -1 degrees C and -2 degrees C. Overall, there was a significant, but weak, negative correlation between the abundance of hibernating individuals and the mean winter temperature. On the other hand, the number of individuals hibernating in small bunkers increased, even though the site was located in one of the warm regions. The results indicate a warming climate will likely reduce the use of large, well-insulated winter roosts by species that prefer colder conditions-and that this is already happening. For forest-dwelling bats, such as the barbastelle, for which monitoring schemes are primarily based on winter surveys of large hibernacula, estimations of population trends may consequently become less reliable.	[Gottfried, Iwona] Univ Wroclaw, Dept Behav Ecol, Wroclaw, Poland; [Gottfried, Tomasz] Polish Soc Wildlife Friends Pro Nat, Wroclaw, Poland; [Lesinski, Grzegorz] Warsaw Univ Life Sci, Inst Anim Sci, Warsaw, Poland; [Hebda, Grzegorz] Univ Opole, Inst Biol, Opole, Poland; [Ignaczak, Maurycy; Blachowski, Grzegorz] Polish Soc Bat Protect, Poznan, Poland; [Wojtaszyn, Grzegorz; Jaros, Radoslaw] Polish Soc Nat Conservat SALAMANDRA, Poznan, Poland; [Jurczyszyn, Miroslaw] Adam Mickiewicz Univ, Dept Systemat Zool, Poznan, Poland; [Fuszara, Maciej] Cardinal Stefan Wyszynski Univ Warsaw, Fac Biol Sci, Warsaw, Poland; [Fuszara, Elzbieta] Univ Warsaw, Dept Anim Physiol, Warsaw, Poland; [Grzywinski, Witold] Poznan Univ Life Sci, Fac Forestry, Poznan, Poland; [Hejduk, Janusz] Univ Lodz, Dept Biodivers Studies Teacher Training & Bioeduc, Lodz, Poland; [Kowalski, Marek] Wildlife Soc STORK, Warsaw, Poland	University of Wroclaw; Warsaw University of Life Sciences; University of Opole; Adam Mickiewicz University; Cardinal Stefan Wyszynski University in Warsaw; University of Warsaw; Poznan University of Life Sciences; University of Lodz	Gottfried, I (corresponding author), Univ Wroclaw, Dept Behav Ecol, Wroclaw, Poland.	iwona.gottfried@uwr.edu.pl	Gottfried, Iwona IG/W-6226-2018; Grzywiński, Witold/AAQ-3465-2021; Fuszara, Maciej/GZL-2490-2022	Wojtaszyn, Grzegorz/0000-0003-3826-7707; Grzywinski, Witold/0000-0002-7501-0698; Hebda, Grzegorz/0000-0002-8668-1809; Gottfried, Iwona/0000-0001-8294-6614; Fuszara, Elzbieta/0000-0003-2707-984X; Fuszara, Maciej/0000-0003-0106-2177				Altermatt F, 2010, P ROY SOC B-BIOL SCI, V277, P1281, DOI 10.1098/rspb.2009.1910; Ancillotto L, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1334-7; Bashta Andriy-Taras, 2004, Vespertilio, V8, P3; Bashta Andriy-Taras, 2012, Vespertilio, V16, P55; Bayazit M, 2015, ENVIRON PROCESS, V2, P527, DOI 10.1007/s40710-015-0081-7; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Boyles JG, 2007, J EXP BIOL, V210, P4345, DOI 10.1242/jeb.007294; Chmielewski FM, 2004, AGR FOREST METEOROL, V121, P69, DOI 10.1016/S0168-1923(03)00161-8; Cichocki J, 2014, P 23 POL C 28 30 MAR, P9; Cichocki J, 2015, P 24 POL CHIR C, P36; Cook M., 2016, BARBASTELLE NOTTINGH; Cooper EJ, 2014, ANNU REV ECOL EVOL S, V45, P271, DOI 10.1146/annurev-ecolsys-120213-091620; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Fleming TH, 2003, BAT ECOLOGY, P156; Fuszara E., 2003, NYCTALUS, V8, P528; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Gottfried I., 2017, METHODOLOGY NATURE M, P1; Gottfried I, 2015, NORTH-WEST J ZOOL, V11, P194; Grzywinski Witold, 2012, Vespertilio, V16, P149; Hahn S, 2003, NYCTALUS, V8, P559; Hannah Lee, 2005, P3; Haysom K, 2013, 192013 EEA, P66; Hejduk J, 2003, NYCTALUS, V8, P581; Hillen J, 2009, BIOL CONSERV, V142, P817, DOI 10.1016/j.biocon.2008.12.017; HIRSCH RM, 1982, WATER RESOUR RES, V18, P107, DOI 10.1029/WR018i001p00107; Huang JP, 2016, NAT CLIM CHANGE, V6, P166, DOI [10.1038/nclimate2837, 10.1038/NCLIMATE2837]; Humphries MM, 2002, NATURE, V418, P313, DOI 10.1038/nature00828; Iwinska Karolina, 2017, Chronmy Przyrode Ojczysta, V73, P437; Jahelkova Helena, 2014, Vespertilio, V17, P95; Jonasson KA, 2012, J EXP BIOL, V215, P2141, DOI 10.1242/jeb.066514; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; Jurczyszyn M, 2003, NYCTALUS, V8, P610; Kendall M., 1975, MULTIVARIATE ANAL, P210, DOI DOI 10.1002/BIMJ.4710190413; Kocsis M, 2011, APPL ECOL ENV RES, V9, P43, DOI 10.15666/aeer/0901_043072; Kokurewicz T, 1996, GORZO PRIME WIELKOPO, P195; Kuzuchowski K, 2005, POL J ECOL, V53, P283; Lehotska B, 2003, NYCTALUS, V8, P603; Lesinski G, 2005, FOLIA ZOOL, V54, P351; LESINSKI G, 1986, ACTA THERIOL, V31, P507, DOI 10.4098/AT.arch.86-45; Lesinski G., 2006, WPLYW ANTROPOGENICZN, P212; Lesinski G, 2011, MAMMALIA, V75, P163, DOI 10.1515/MAMM.2011.003; Levinsky I, 2007, BIODIVERS CONSERV, V16, P3803, DOI 10.1007/s10531-007-9181-7; Limpens HJGA, 2003, NYCTALUS, V8, P608; Lundy M, 2010, J BIOGEOGR, V37, P2232, DOI 10.1111/j.1365-2699.2010.02384.x; Luo JH, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0961; Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877; Malkiewicz A., 2003, PRZEG ZOOL, VXLVII, P161; Marosz M, 2011, REZULTATY PROJEKTU K, V47, P51, DOI [10.1038/416389a, DOI 10.1038/416389A]; Masing Matti, 2007, Acta Zoologica Lituanica, V17, P47; Millard SP, 2013, ENVSTATS R PACKAGE E, DOI [10.1007/978-1-4614-8456-1, DOI 10.1007/978-1-4614-8456-1]; Pannekoek, 2005, TRIM 3 MANUAL TRENDS; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pauza DH, 2003, NYCTALUS, V8, P639; Perry RW, 2013, ENVIRON REV, V21, P28, DOI 10.1139/er-2012-0042; Podlutsky AJ, 2005, J GERONTOL A-BIOL, V60, P1366, DOI 10.1093/gerona/60.11.1366; R Core Team, 2013, R LANG ENV STAT COMP; Rachwald A, 2018, FOLIA ZOOL, V67, P231, DOI 10.25225/fozo.v67.i3-4.a12.2018; Rachwald Alek, 2017, Lesne Prace Badawcze, V78, P333, DOI 10.1515/frp-2017-0037; Rebelo H, 2010, GLOBAL CHANGE BIOL, V16, P561, DOI 10.1111/j.1365-2486.2009.02021.x; Rehak Z, 1999, ACTA CHIROPTEROL, V1, P113; RICHTER AR, 1993, CONSERV BIOL, V7, P407, DOI 10.1046/j.1523-1739.1993.07020407.x; Roue S, 2003, NYCTALUS, V8, P646; Russo D, 2004, BIOL CONSERV, V117, P73, DOI 10.1016/S0006-3207(03)00266-0; Rydell Jens, 1997, Mammalian Species, V557, P1; Sachanowicz K, 2002, MAMM BIOL, V67, P179, DOI 10.1078/1616-5047-00026; Sachanowicz K, 2005, NIETOPERZE POLSKI, P128; SMITHSON PA, 1991, THEOR APPL CLIMATOL, V44, P65, DOI 10.1007/BF00865553; Sparks TH, 2005, INT J CLIMATOL, V25, P271, DOI 10.1002/joc.1136; Stawski C, 2014, J ZOOL, V292, P86, DOI 10.1111/jzo.12105; Streda T, 2012, CONTRIB GEOPHYS GEOD, V42, P243, DOI 10.2478/v10126-012-0010-y; Tank AMGK, 2003, J CLIMATE, V16, P3665, DOI [10.1175/1520-0442(2003)016<3665:TIIODT>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;3665:TIIODT&gt;2.0.CO;2]; Trouwborst A, 2015, BIODIVERS CONSERV, V24, P1567, DOI 10.1007/s10531-015-0894-8; Tryjanowski P, 2002, IBIS, V144, P62, DOI 10.1046/j.0019-1019.2001.00022.x; Tryjanowski Piotr, 2008, Kosmos (Warsaw), V57, P261; Uhrin M, 2016, MAMMAL REV, V46, P1, DOI 10.1111/mam.12050; Vautard R, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034006; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WEIDNER H, 2000, NYCTALUS, V7, P423; Wesolowski T, 2009, CLIM RES, V38, P199, DOI 10.3354/cr00789; WuEjcik R., 2014, PRZEGLAD GEOGRAFICZN, V86, P339, DOI DOI 10.7163/PRZG.2014.3.3; Zawora T., 2005, ACTA AGROPHYSICA, V6, P281; Zeale MRK, 2012, J MAMMAL, V93, P1110, DOI 10.1644/11-MAMM-A-366.1	83	6	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0227912	10.1371/journal.pone.0227912	http://dx.doi.org/10.1371/journal.pone.0227912			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7XT	32069315	Green Published, gold			2022-12-26	WOS:000535212900008
J	Kalev-Altman, R; Hanael, E; Zelinger, E; Blum, M; Monsonego-Ornan, E; Sela-Donenfeld, D				Kalev-Altman, Rotem; Hanael, Erez; Zelinger, Einat; Blum, Martin; Monsonego-Ornan, Efrat; Sela-Donenfeld, Dalit			Conserved role of matrix metalloproteases 2 and 9 in promoting the migration of neural crest cells in avian and mammalian embryos	FASEB JOURNAL			English	Article						cell migration; chick embryo; EMT; gelatinases; MMP2; MMP9; mouse embryo	B-LIKE ENZYME; IV COLLAGENASE; CRANIOFACIAL DEVELOPMENT; MOLECULAR-CLONING; PROGENITOR CELLS; SKELETAL-MUSCLE; GROWTH-FACTOR; MOUSE EMBRYO; GELATINASE-B; EXPRESSION	Neural crest cells (NCCs) are a unique embryonic cell population that initially reside at the dorsal neural tube but later migrate in the embryo and differentiate into multiple types of derivatives. To acquire motility, NCCs undergo epithelial-to-mesenchymal transition and invade the surrounding extracellular matrix (ECM). Matrix metalloproteases (MMPs) are a large family of proteases which regulate migration of various embryonic and adult cells via ECM remodeling. The gelatinase's subgroup of MMPs is the most studied one due to its key role in metastasis. As it is composed of only two proteases, MMP2 and MMP9, it is important to understand whether each is indispensable or redundant in its biological function. Here we explored the role of the gelatinases in executing NCC migration, by determining whether MMP2 and/or MMP9 regulate migration across species in singular, combined, or redundant manners. Chick and mouse embryos were utilized to compare expression and activity of both MMPs using genetic and pharmacological approaches in multiple in vivo and ex vivo assays. Both MMPs were found to be expressed and active in mouse and chick NCCs. Inhibition of each MMP was sufficient to prevent NCC migration in both species. Yet, NCC migration was maintained in MMP2(-/-) or MMP9(-/-) mouse mutants due to compensation between the gelatinases, but reciprocal pharmacological inhibition in each mutant prevented NCC migration. This study reveals for the first time that both gelatinases are expressed in avian and mammalian NCCs, and demonstrates their fundamental and conserved role in promoting embryonic cell migration.	[Kalev-Altman, Rotem; Hanael, Erez; Sela-Donenfeld, Dalit] Hebrew Univ Jerusalem, Fac Agr Food & Environm Sci, Koret Sch Vet Med, Rehovot, Israel; [Kalev-Altman, Rotem; Monsonego-Ornan, Efrat] Hebrew Univ Jerusalem, Fac Agr Food & Environm Sci, Inst Biochem & Nutr, Rehovot, Israel; [Zelinger, Einat] Hebrew Univ Jerusalem, Fac Agr Food & Environm Sci, Core Facil Unit, Rehovot, Israel; [Blum, Martin] Univ Hohenheim, Inst Zool, Stuttgart, Germany	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University Hohenheim	Monsonego-Ornan, E (corresponding author), Hebrew Univ Jerusalem, Inst Biochem & Nutr, POB 12, IL-76100 Rehovot, Israel.; Sela-Donenfeld, D (corresponding author), Hebrew Univ Jerusalem, Koret Sch Vet Med, POB 12, IL-76100 Rehovot, Israel.	Efrat.mo@mail.huji.ac.il; dalit.seladon@mail.huji.ac.il		Sela-Donenfeld, Dalit/0000-0001-7498-061X	Ministry of Health, Chief Scientist Fund [3-0000-33793]; Israel Science Foundation [1252/19]; Einstein Kaye Foundation; University of Hohenheim; Hebrew University	Ministry of Health, Chief Scientist Fund; Israel Science Foundation(Israel Science Foundation); Einstein Kaye Foundation; University of Hohenheim; Hebrew University	Ministry of Health, Chief Scientist Fund, Grant/Award Number: 3-0000-33793; University of Hohenheim; Hebrew University; Israel Science Foundation, Grant/Award Number: 1252/19; Einstein Kaye Foundation	Adameyko I, 2012, DEVELOPMENT, V139, P397, DOI 10.1242/dev.065581; AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Alexander SM, 1997, DEV DYNAM, V209, P261, DOI 10.1002/(SICI)1097-0177(199707)209:3<261::AID-AJA2>3.0.CO;2-G; Alfandari D, 2018, GENESIS, V56, DOI 10.1002/dvg.23095; Andrieu C, 2018, BASOLATERAL LOCALIZA; Apte SS, 1997, J BIOL CHEM, V272, P25511, DOI 10.1074/jbc.272.41.25511; Bar A., 2014, ROLE PROTEASES CELLU, P103, DOI [10.1007/978-1-4614-9099-9, DOI 10.1007/978-1-4614-9099-9]; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Biga PR, 2013, J NUTR BIOCHEM, V24, P1462, DOI 10.1016/j.jnutbio.2012.12.005; BRONNERFRASER M, 1986, DEV BIOL, V115, P44, DOI 10.1016/0012-1606(86)90226-5; Burstyn-Cohen T, 2004, DEVELOPMENT, V131, P5327, DOI 10.1242/dev.01424; Burstyn-Cohen T, 2002, DEV CELL, V3, P383, DOI 10.1016/S1534-5807(02)00221-6; Cai DH, 2000, ANAT RECORD, V259, P168, DOI 10.1002/(SICI)1097-0185(20000601)259:2<168::AID-AR7>3.0.CO;2-U; Chen JW, 2017, ARCH ORAL BIOL, V76, P30, DOI 10.1016/j.archoralbio.2017.01.002; Chin JR, 1997, DEVELOPMENT, V124, P1519; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Crawford BD, 2005, DEV BIOL, V286, P405, DOI 10.1016/j.ydbio.2005.06.035; Dan H, 2009, J ANIM SCI, V87, P3544, DOI 10.2527/jas.2009-2068; Duong TD, 2004, DEV DYNAM, V229, P42, DOI 10.1002/dvdy.10465; Eguchi T, 2008, MOL CELL BIOL, V28, P2391, DOI 10.1128/MCB.01288-07; El-Brolosy MA, 2019, NATURE, V568, P193, DOI 10.1038/s41586-019-1064-z; El-Brolosy MA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006780; Esparza J, 2004, FASEB J, V18, P1682, DOI 10.1096/fj.04-2445com; Garmon T, 2018, DEV DYNAM, V247, P1083, DOI 10.1002/dvdy.24661; Gross JB, 2008, DEV BIOL, V317, P389, DOI 10.1016/j.ydbio.2008.02.046; Hahn-Dantona EA, 2000, J BIOL CHEM, V275, P40827, DOI 10.1074/jbc.M006234200; Hanael E, 2019, EPILEPSIA, V60, P1005, DOI 10.1111/epi.14739; Hotta R, 2016, NEUROGASTROENT MOTIL, V28, P498, DOI 10.1111/nmo.12744; Hutchins EJ, 2018, J CELL BIOL, V217, P3683, DOI 10.1083/jcb.201709149; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Kalcheim C, 2019, METHODS MOL BIOL, V1976, P1, DOI 10.1007/978-1-4939-9412-0_1; Kalev-Altman R, 2017, PROTEASES PHYSL PATH, P27; Kawaguchi J, 2010, DEVELOPMENT, V137, P693, DOI 10.1242/dev.046896; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; Keow JY, 2011, MATRIX BIOL, V30, P169, DOI 10.1016/j.matbio.2011.01.003; Kerosuo L, 2012, SEMIN CELL DEV BIOL, V23, P320, DOI 10.1016/j.semcdb.2012.03.010; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Kwan JA, 2004, FASEB J, V18, P690, DOI 10.1096/fj.02-1202fje; Le Douarin NM, 1999, NEURAL CREST, V2; Le Lievre C S, 1975, J Embryol Exp Morphol, V34, P125; Levin JI, 2001, BIOORG MED CHEM LETT, V11, P235, DOI 10.1016/S0960-894X(00)00642-9; Maeda Y, 2017, EUR J HISTOCHEM, V61, P20, DOI 10.4081/ejh.2017.2750; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Mannello F, 2012, PROG HISTOCHEM CYTO, V47, P27, DOI 10.1016/j.proghi.2011.12.002; Marchant DJ, 2014, NAT MED, V20, P497, DOI 10.1038/nm.3508; Martignetti JA, 2001, NAT GENET, V28, P261, DOI 10.1038/90100; McKeown SJ, 2013, DEV BIOL, V373, P244, DOI 10.1016/j.ydbio.2012.10.028; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Monsonego-Ornan E, 2012, DEV BIOL, V364, P162, DOI 10.1016/j.ydbio.2012.01.028; Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060; Mosig RA, 2013, DIS MODEL MECH, V6, P397, DOI 10.1242/dmm.007914; Mundell NA, 2011, DEVELOPMENT, V138, P641, DOI 10.1242/dev.054718; NICHOLS DH, 1981, J EMBRYOL EXP MORPH, V64, P105; Orgaz JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5255; Pirici D, 2012, NEUROPATHOLOGY, V32, P492, DOI 10.1111/j.1440-1789.2011.01279.x; Randall LE, 2002, CONNECT TISSUE RES, V43, P205, DOI 10.1080/03008200290000538; Reich A, 2010, J APPL PHYSIOL, V108, P172, DOI 10.1152/japplphysiol.00821.2009; REPONEN P, 1992, J BIOL CHEM, V267, P7856; REPONEN P, 1995, DEV DYNAM, V202, P388, DOI 10.1002/aja.1002020408; Robbins JR, 1999, DEV BIOL, V212, P255, DOI 10.1006/dbio.1999.9373; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Roth L, 2017, INT J DEV BIOL, V61, P245, DOI 10.1387/ijdb.160286ds; Rubino MT, 2011, CHEMMEDCHEM, V6, P1258, DOI 10.1002/cmdc.201000540; Schiffmacher AT, 2018, DEV BIOL, V444, pS237, DOI 10.1016/j.ydbio.2018.06.018; Schwarz Q, 2009, P NATL ACAD SCI USA, V106, P6164, DOI 10.1073/pnas.0811521106; Sela-Donenfeld D, 1999, DEVELOPMENT, V126, P4749; Shi J, 2008, DEV BIOL, V313, P196, DOI 10.1016/j.ydbio.2007.10.017; Shibata S, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-31; Shimo T, 2004, DEV DYNAM, V231, P136, DOI 10.1002/dvdy.20109; Simsa S, 2007, AM J PHYSIOL-REG I, V292, pR2216, DOI 10.1152/ajpregu.00864.2006; Sternlicht M, 2009, ANN REV CELL BIOL, V17, P463; Tamura Y, 1998, J MED CHEM, V41, P640, DOI 10.1021/jm9707582; Taneyhill LA, 2008, CELL ADHES MIGR, V2, P223, DOI 10.4161/cam.2.4.6835; TAUTZ D, 1992, BIOESSAYS, V14, P263, DOI 10.1002/bies.950140410; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tomlinson ML, 2009, CHEM BIOL, V16, P93, DOI 10.1016/j.chembiol.2008.12.005; Tong A, 2003, J BONE MINER RES, V18, P1443, DOI 10.1359/jbmr.2003.18.8.1443; Trainor PA, 2010, AM J MED GENET A, V152A, P2984, DOI 10.1002/ajmg.a.33454; Ulmer B, 2013, CELL REP, V3, P615, DOI 10.1016/j.celrep.2013.02.015; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang WJ, 2002, CIRCULATION, V106, P1543, DOI 10.1161/01.CIR.0000028818.33488.7B; Werb Z, 1998, ANN NY ACAD SCI, V857, P110, DOI 10.1111/j.1749-6632.1998.tb10111.x; Yeghiazaryan M, 2012, HISTOCHEM CELL BIOL, V138, P75, DOI 10.1007/s00418-012-0940-5; Zimowska M, 2013, BIOL CELL, V105, P334, DOI 10.1111/boc.201300020	87	7	7	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5240	5261		10.1096/fj.201901217RR	http://dx.doi.org/10.1096/fj.201901217RR		FEB 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32067275				2022-12-26	WOS:000515248200001
J	Liu, K; Wang, BJ; Han, WW; Chi, CH; Gu, C; Wang, Y; Fu, XH; Huang, W; Liu, ZG; Song, XL				Liu, Kai; Wang, Ben-Jun; Han, WeiWei; Chi, Chun-Hua; Gu, Chao; Wang, Yu; Fu, Xiaohai; Huang, Wei; Liu, Zhiguo; Song, Xilin			CFIm25-regulated lncRNA acv3UTR promotes gastric tumorigenesis via miR-590-5p/YAP1 axis	ONCOGENE			English	Article							COMPETING ENDOGENOUS RNA; MONOCYTE/MACROPHAGE DIFFERENTIATION; POSTTRANSCRIPTIONAL REGULATION; CANCER CELLS; CERNA; EXPRESSION; INVASION; ACTIVIN; PROLIFERATION; PHOSPHORYLATION	Accumulating evidences indicate that 3MODIFIER LETTER PRIMEUTR of the coding gene can act as crucial regulators in gastric cancer (GC). However, the detailed mechanisms and responsive targets are not well established. Here, we found that acvr1b gene 3MODIFIER LETTER PRIMEUTR (acv3UTR) was elevated in GC tissue, the expression of which was significantly correlated with advanced pTNM-stage and poor outcome in clinical patients. Forced expression of acv3UTR promoted GC cells growth in vitro and in vivo. Mechanistically, our results suggested that acv3UTR functioned as an oncogenic competing endogenous RNA via sponging miR-590-5p and enhancing YAP1 level. Tumor suppressor miR-590-5p was a molecular module in acv3UTR regulatory axis, the forced expression of which led to impairing of oncogenic potential of acv3UTR. The positive correlation of acv3UTR and YAP1 expression, and the negative correlation of acv3UTR and miR-590-5p expression, were verified in GC patients. Moreover, CFIm25 was identified as a key regulator contributing to acv3UTR aberrant expression in GC binding to UGUA-264 motif. Overall, our finding defines a mechanism for understanding the potential role of acv3UTR transcription in GC tumorigenesis, and indicates a correlation between 3MODIFIER LETTER PRIMEUTR trans-regulatory effect and GC development.	[Liu, Kai; Song, Xilin] Shandong Canc Hosp & Inst, Dept Gastrointestinal Surg, Jinan, Peoples R China; [Wang, Ben-Jun; Han, WeiWei; Chi, Chun-Hua; Gu, Chao] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Dept Anorectal Surg, Jinan 250014, Shandong, Peoples R China; [Wang, Yu] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Dept Radiol, Jinan 250014, Shandong, Peoples R China; [Fu, Xiaohai] Shouguang Peoples Hosp, Dept Intens Care Unit, Shouguang, Shandong, Peoples R China; [Huang, Wei] Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China; [Liu, Zhiguo] Shandong Canc Hosp & Inst, PET CT Ctr, Jinan, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences	Song, XL (corresponding author), Shandong Canc Hosp & Inst, Dept Gastrointestinal Surg, Jinan, Peoples R China.	xilin_song1980@163.com			National Natural Science Foundation of China [81773232, 81601554]; Natural Science Foundation of Shandong Province [ZR2013H1109, ZR2013HM43]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported by the National Natural Science Foundation of China (81773232 and 81601554) and Natural Science Foundation of Shandong Province (ZR2013H1109 and ZR2013HM43).	Abdelmohsen K, 2010, WIRES RNA, V1, P214, DOI 10.1002/wrna.4; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Arun Kanagaraj, 2018, Oncotarget, V9, P18386, DOI 10.18632/oncotarget.24841; Briata P, 2011, FRONT BIOSCI-LANDMRK, V16, P1787, DOI 10.2741/3821; Chen MT, 2015, MOL CELL BIOL, V35, P3212, DOI 10.1128/MCB.00429-15; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Ergun S, 2015, TUMOR BIOL, V36, P3129, DOI 10.1007/s13277-015-3346-x; Ferro A, 2014, EUR J CANCER, V50, P1330, DOI 10.1016/j.ejca.2014.01.029; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gao SM, 2016, J MOL HISTOL, V47, P135, DOI 10.1007/s10735-016-9659-2; Gratacos FM, 2010, WIRES RNA, V1, P457, DOI 10.1002/wrna.26; Hanninen UA, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007200; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harrison CA, 2003, J BIOL CHEM, V278, P21129, DOI 10.1074/jbc.M302015200; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hu-Lowe DD, 2011, CANCER RES, V71, P1362, DOI 10.1158/0008-5472.CAN-10-1451; Jiang XF, 2012, MOL CELLS, V33, P545, DOI 10.1007/s10059-012-2267-4; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kang W, 2011, CLIN CANCER RES, V17, P2130, DOI 10.1158/1078-0432.CCR-10-2467; Karimi P, 2014, CANCER EPIDEM BIOMAR, V23, P700, DOI 10.1158/1055-9965.EPI-13-1057; Karreth FA, 2015, CELL, V161, P319, DOI 10.1016/j.cell.2015.02.043; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Li FX, 2018, MED SCI MONITOR, V24, P37, DOI 10.12659/MSM.905410; Lin HS, 2014, J LEUKOCYTE BIOL, V96, P1023, DOI 10.1189/jlb.1A0514-240R; Liu X, 2013, ONCOGENE, V32, P1266, DOI 10.1038/onc.2012.147; Lu MH, 2016, ONCOGENE, V35, P3524, DOI 10.1038/onc.2015.413; Mahoney S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152010; Masamha CP, 2014, NATURE, V510, P412, DOI 10.1038/nature13261; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mercer TR, 2011, NUCLEIC ACIDS RES, V39, P2393, DOI 10.1093/nar/gkq1158; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Mizuno Y, 2009, FEBS LETT, V583, P2263, DOI 10.1016/j.febslet.2009.06.006; Morlando M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020570; Nomura M, 2013, BIOCHEM BIOPH RES CO, V430, P340, DOI 10.1016/j.bbrc.2012.11.011; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Ou CL, 2017, CANCER LETT, V399, P53, DOI 10.1016/j.canlet.2017.04.011; Peleteiro B, 2014, EUR J CANCER PREV, V23, P524, DOI 10.1097/CEJ.0b013e328364f2b6; Qiu WL, 2016, GASTROENTEROLOGY, V150, P218, DOI 10.1053/j.gastro.2015.09.013; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Song M, 2012, ANTICANCER RES, V32, P3827; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; TENDIJKE P, 1993, ONCOGENE, V8, P2879; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; Togashi Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-126; Vislovukh Andrii, 2014, World J Biol Chem, V5, P40, DOI 10.4331/wjbc.v5.i1.40; Wan XC, 2018, ONCOTARGET, V9, P4798, DOI 10.18632/oncotarget.23219; Xiao XC, 2012, ONCOL RES, V20, P537, DOI 10.3727/096504013X13775486749335; Xu J, 2015, NUCLEIC ACIDS RES, V43, P8169, DOI 10.1093/nar/gkv853; Xu Y, 2018, CELL PHYSIOL BIOCHEM, V46, P2445, DOI 10.1159/000489651; Yang Q, 2011, STRUCTURE, V19, P368, DOI 10.1016/j.str.2010.12.021; Zanconato F, 2019, NAT REV CANCER, V19, P454, DOI 10.1038/s41568-019-0168-y; Zhang G, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0829-6; Zhang JL, 2019, ONCOGENE, V38, P33, DOI 10.1038/s41388-018-0430-x; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhao J, 2015, CELL CYCLE, V14, P3112, DOI 10.1080/15384101.2015.1078034; Zheng LF, 2018, EUR J CELL BIOL, V97, P23, DOI 10.1016/j.ejcb.2017.11.002; Zhu Y, 2018, MOL CELL, V69, P62, DOI 10.1016/j.molcel.2017.11.031	60	6	6	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	15					3075	3088		10.1038/s41388-020-1213-8	http://dx.doi.org/10.1038/s41388-020-1213-8		FEB 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LB8NS	32066878	hybrid, Green Published			2022-12-26	WOS:000514052700001
J	Shi, XL; Zhu, KY; Ye, ZD; Yue, JB				Shi, Xianli; Zhu, Kaiyuan; Ye, Zuodong; Yue, Jianbo			VCP/p97 targets the nuclear export and degradation of p27(Kip1) during G1 to S phase transition	FASEB JOURNAL			English	Article						cell cycle; p21(Cip1); p27(Kip1); UFD1; VCP/p97	VALOSIN-CONTAINING PROTEIN; CELL-CYCLE; EXPRESSION LEVEL; AAA-ATPASE; ELEVATED EXPRESSION; POOR-PROGNOSIS; P97; PHOSPHORYLATION; INHIBITORS; BINDING	One of the critical regulatory mechanisms for cell cycle progression is the timely degradation of CDK inhibitors, including p21(Cip1) and p27(Kip1). VCP/p97, an AAA-ATPase, is reported to be overexpressed in many types of cancers. Here, we found that treatment of MCF-7 human breast cancer cells with DBeQ, a VCP inhibitor, or VCP knockdown in MCF-7 cells arrested cells at G1 phase, accompanied with the blockage of both p21 and p27 degradation. Whereas, double knockdown of p21 and p27 in MCF-7 cells rendered cells refractory to DBeQ-induced G1 arrest. Moreover, inhibition or knockdown of VCP or UFD1, one of VCP's co-factors, in MCF-7, NIH3T3, or HEK293T cells blocked the nuclear export of p27 during earlier G1 phase after mitogen stimulation. We also identified the nuclear localization sequence (NLS) of VCP, and found that adding back wild-type VCP, not the NLS-deleted VCP mutant, restored the nuclear export and degradation of p27 in VCP knockout MCF-7 cells. Importantly, we found that VCP inhibition sensitized breast cancer cells to the treatment of several anticancer therapeutics both in vitro and in vivo. Taken together, our study not only uncovers the mechanisms underlying VCP-mediated cell proliferation control but also provides potential therapeutic option for cancer treatment.	[Shi, Xianli; Zhu, Kaiyuan; Ye, Zuodong; Yue, Jianbo] City Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Shi, Xianli; Zhu, Kaiyuan; Ye, Zuodong; Yue, Jianbo] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Peoples R China	City University of Hong Kong; City University of Hong Kong	Yue, JB (corresponding author), City Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.	yue.jianbo@cityu.edu.hk	; Yue, Jianbo/K-8002-2015	ZHU, Kaiyuan/0000-0003-4579-0790; Yue, Jianbo/0000-0001-6384-5447	Hong Kong Research Grant Council (RGC) [11101717]; CAS-Croucher Funding Scheme for Joint Laboratories (CAS-Croucher Joint Lab Scheme) [2016A050503010]; Guangdong-Hong Kong joint innovation Research Scheme [2016A050503010]; Shenzhen government research grant [JCYJ20160229165235739, JCYJ20170413141331470]; NSFC \ International Cooperation and Exchange Programme [21778045]; Sichuan Science & Technology Research [2019YJ0633]	Hong Kong Research Grant Council (RGC)(Hong Kong Research Grants Council); CAS-Croucher Funding Scheme for Joint Laboratories (CAS-Croucher Joint Lab Scheme); Guangdong-Hong Kong joint innovation Research Scheme; Shenzhen government research grant; NSFC \ International Cooperation and Exchange Programme(National Natural Science Foundation of China (NSFC)); Sichuan Science & Technology Research	Hong Kong Research Grant Council (RGC), Grant/Award Number: 11101717; CAS-Croucher Funding Scheme for Joint Laboratories (CAS-Croucher Joint Lab Scheme), Grant/Award Number: 2016A050503010; Guangdong-Hong Kong joint innovation Research Scheme, Grant/Award Number: 2016A050503010; Shenzhen government research grant, Grant/Award Number: JCYJ20160229165235739 and JCYJ20170413141331470; NSFC | International Cooperation and Exchange Programme, Grant/Award Number: 21778045; Sichuan Science & Technology Research, Grant/Award Number: 2019YJ0633	Abbastabar M, 2018, DNA REPAIR, V69, P63, DOI 10.1016/j.dnarep.2018.07.008; Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; Bachs Oriol, 2018, Oncotarget, V9, P26259, DOI 10.18632/oncotarget.25447; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Buchberger A, 2015, FEBS LETT, V589, P2578, DOI 10.1016/j.febslet.2015.08.028; Caballero OL, 2002, ONCOGENE, V21, P3003, DOI 10.1038/sj.onc.1205390; Cayli S, 2009, J BIOL CHEM, V284, P34944, DOI 10.1074/jbc.M109.037952; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Cui Y, 2015, TUMOR BIOL, V36, P9919, DOI 10.1007/s13277-015-3748-9; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; HAYASHI M, 1992, BIOCHEM BIOPH RES CO, V182, P939, DOI 10.1016/0006-291X(92)91822-8; Heubes S, 2007, J CELL SCI, V120, P1325, DOI 10.1242/jcs.006924; Hnit SST, 2015, INT J BIOCHEM CELL B, V68, P9, DOI 10.1016/j.biocel.2015.08.005; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Ishida N, 2000, J BIOL CHEM, V275, P25146, DOI 10.1074/jbc.M001144200; Jang BC, 2003, J BIOL CHEM, V278, P2773, DOI 10.1074/jbc.C200620200; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Livingstone M, 2005, CANCER RES, V65, P7533, DOI 10.1158/0008-5472.CAN-04-3729; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Mann DJ, 1999, EMBO J, V18, P654, DOI 10.1093/emboj/18.3.654; Mayr PSM, 1999, EUR J CELL BIOL, V78, P224, DOI 10.1016/S0171-9335(99)80055-7; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Nakayama K, 1998, BIOESSAYS, V20, P1020, DOI 10.1002/(SICI)1521-1878(199812)20:12<1020::AID-BIES8>3.0.CO;2-D; Nowis D, 2006, EXP CELL RES, V312, P2921, DOI 10.1016/j.yexcr.2006.05.013; Parisi E, 2018, EMBO J, V37, DOI 10.15252/embj.201798724; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Sa G, 2005, CELL CYCLE, V4, P618; Sekimoto T, 2004, EMBO J, V23, P1934, DOI 10.1038/sj.emboj.7600198; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Shin I, 2005, J BIOL CHEM, V280, P6055, DOI 10.1074/jbc.M412367200; Skrott Z, 2017, NATURE, V552, P194, DOI 10.1038/nature25016; Stach L, 2017, BIOCHEM J, V474, P2953, DOI 10.1042/BCJ20160783; Tang DM, 2008, J BIOL CHEM, V283, P6085, DOI 10.1074/jbc.M707715200; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Totsukawa G, 2011, EMBO J, V30, P3581, DOI 10.1038/emboj.2011.260; Tsujimoto Y, 2004, CLIN CANCER RES, V10, P3007, DOI 10.1158/1078-0432.CCR-03-0191; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; van den Boom J, 2018, MOL CELL, V69, P182, DOI 10.1016/j.molcel.2017.10.028; van den Boom J, 2016, MOL CELL, V64, P189, DOI 10.1016/j.molcel.2016.08.037; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; Vekaria PH, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00181; Xia D, 2016, GENE, V583, P64, DOI 10.1016/j.gene.2016.02.042; Yamamoto S, 2005, ANN SURG ONCOL, V12, P925, DOI 10.1245/ASO.2005.07.002; Yamamoto S, 2004, CLIN CANCER RES, V10, P5558, DOI 10.1158/1078-0432.CCR-0723-03; Yamamoto S, 2004, ANN SURG ONCOL, V11, P697, DOI 10.1245/ASO.2004.10.018; Yamamoto S, 2004, ANN SURG ONCOL, V11, P165, DOI 10.1245/ASO.2004.05.012; Yamamoto S, 2003, J CLIN ONCOL, V21, P2537, DOI 10.1200/JCO.2003.12.102; Yamamoto S, 2003, J CLIN ONCOL, V21, P447, DOI 10.1200/JCO.2003.06.068; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Zhu WW, 2013, ASIAN PAC J CANCER P, V14, P6439, DOI 10.7314/APJCP.2013.14.11.6439	60	4	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5193	5207		10.1096/fj.201901506R	http://dx.doi.org/10.1096/fj.201901506R		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32067276				2022-12-26	WOS:000515246400001
J	Struve, N; Binder, ZA; Stead, LF; Brend, T; Bagley, SJ; Faulkner, C; Ott, L; Muller-Goebel, J; Weik, AS; Hoffer, K; Krug, L; Rieckmann, T; Bussmann, L; Henze, M; Morrissette, JJD; Kurian, KM; Schuller, U; Petersen, C; Rothkamm, K; O'Rourke, DM; Short, SC; Kriegs, M				Struve, Nina; Binder, Zev A.; Stead, Lucy F.; Brend, Tim; Bagley, Stephen J.; Faulkner, Claire; Ott, Leonie; Mueller-Goebel, Justus; Weik, Anna-Sophie; Hoffer, Konstantin; Krug, Leonie; Rieckmann, Thorsten; Bussmann, Lara; Henze, Marvin; Morrissette, Jennifer J. D.; Kurian, Kathreena M.; Schueller, Ulrich; Petersen, Cordula; Rothkamm, Kai; O'Rourke, Donald M.; Short, Susan C.; Kriegs, Malte			EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; VARIANT III EGFRVIII; PROGNOSTIC-SIGNIFICANCE; ADJUVANT TEMOZOLOMIDE; PAIRED PRIMARY; EXPRESSION; GENE; MUTATIONS; THERAPY; CELLS	The oncogene epidermal growth factor receptor variant III (EGFRvIII) is frequently expressed in glioblastomas (GBM) but its impact on therapy response is still under controversial debate. Here we wanted to test if EGFRvIII influences the sensitivity towards the alkylating agent temozolomide (TMZ). Therefore, we retrospectively analyzed the survival of 336 GBM patients, demonstrating that under standard treatment, which includes TMZ, EGFRvIII expression is associated with prolonged survival, but only in patients with O6-methylguanine-DNA methyltransferase (MGMT) promoter methylated tumors. Using isogenic GBM cell lines with endogenous EGFRvIII expression we could demonstrate that EGFRvIII increases TMZ sensitivity and results in enhanced numbers of DNA double-strand breaks and a pronounced S/G2-phase arrest after TMZ treatment. We observed a higher expression of DNA mismatch repair (MMR) proteins in EGFRvIII+ cells and patient tumor samples, which was most pronounced for MSH2 and MSH6. EGFRvIII-specific knockdown reduced MMR protein expression thereby increasing TMZ resistance. Subsequent functional kinome profiling revealed an increased activation of p38- and ERK1/2-dependent signaling in EGFRvIII expressing cells, which regulates MMR protein expression downstream of EGFRvIII. In summary, our results demonstrate that the oncoprotein EGFRvIII sensitizes a fraction of GBM to current standard of care treatment through the upregulation of DNA MMR.	[Struve, Nina; Ott, Leonie; Mueller-Goebel, Justus; Weik, Anna-Sophie; Hoffer, Konstantin; Krug, Leonie; Rieckmann, Thorsten; Bussmann, Lara; Henze, Marvin; Petersen, Cordula; Rothkamm, Kai; Kriegs, Malte] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Hubertus Wald Tumorzentrum, Lab Radiobiol & Expt Radiat Oncol, Hamburg, Germany; [Binder, Zev A.; O'Rourke, Donald M.] Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Stead, Lucy F.; Brend, Tim; Short, Susan C.] St James Univ Hosp, Leeds Inst Med Res St Jamess, Wellcome Trust Brenner Bldg, Leeds, W Yorkshire, England; [Bagley, Stephen J.] Univ Penn, Dept Med, Perelman Sch Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Faulkner, Claire] Southmead Hosp, Bristol Genet Lab, Bristol, Avon, England; [Krug, Leonie; Rieckmann, Thorsten; Bussmann, Lara] Univ Med Ctr Hamburg Eppendorf, Dept Otorhinolaryngol & Head & Neck Surg, Hamburg, Germany; [Henze, Marvin; Petersen, Cordula] Univ Med Ctr Hamburg Eppendorf, Dept Radiotherapy & Radiooncol, Hamburg, Germany; [Morrissette, Jennifer J. D.] Hosp Univ Penn, Dept Pathol & Lab Med, Div Precis & Computat Diagnost, 3400 Spruce St, Philadelphia, PA 19104 USA; [Kurian, Kathreena M.] Univ Bristol, Bristol Brain Tumour Res Ctr, Bristol, Avon, England; [Schueller, Ulrich] Childrens Canc Ctr Hamburg, Res Inst, Hamburg, Germany; [Schueller, Ulrich] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Schueller, Ulrich] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Pennsylvania; Pennsylvania Medicine; Saint James's University Hospital; University of Pennsylvania; Pennsylvania Medicine; Southmead Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Pennsylvania; Pennsylvania Medicine; University of Bristol; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Struve, N (corresponding author), Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Hubertus Wald Tumorzentrum, Lab Radiobiol & Expt Radiat Oncol, Hamburg, Germany.	ni.struve@uke.de	O'Rourke, Donald/AAC-3376-2021; Petersen, Cordula/AAW-9789-2020; Ott, Leonie/ABA-2973-2020; Rothkamm, Kai/A-2164-2014	Brend, Tim/0000-0001-9703-7042; Kurian, Kathreena/0000-0003-0303-3716; Bussmann, Lara/0000-0001-6302-0859; Stead, Lucy/0000-0002-9550-4150; Short, Susan/0000-0003-4423-7256; Rothkamm, Kai/0000-0001-7414-5729; Rieckmann, Thorsten/0000-0001-8426-107X	Brigitte and Dr. Konstanze Wegener-Stiftung; Wilhelm-Sander-Stiftung; Forschungsforderungsfonds des Fachbereichs Medizin des Universitatsklinikums Hamburg-Eppendorf; Federal Ministry of Education and Research (BMBF) [02NUK032]; Cancer Research UK [CRUK/21600]; Brain Tumour Charity [TBTC13/192]; Medical Research Council [MR/K015214/1]; University of Leeds Academic Fellowship; Templeton Family Research Fund; Maria and Gabriele Troiano Brain Cancer Immunotherapy Fund; National Institutes of Health [NIH 2R01-NS042645-11A1]; Fordergemeinschaft Kinderkrebs-Zentrum Hamburg; Projekt DEAL	Brigitte and Dr. Konstanze Wegener-Stiftung; Wilhelm-Sander-Stiftung; Forschungsforderungsfonds des Fachbereichs Medizin des Universitatsklinikums Hamburg-Eppendorf; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Cancer Research UK(Cancer Research UK); Brain Tumour Charity; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Leeds Academic Fellowship; Templeton Family Research Fund; Maria and Gabriele Troiano Brain Cancer Immunotherapy Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fordergemeinschaft Kinderkrebs-Zentrum Hamburg; Projekt DEAL	This work was supported by the Brigitte and Dr. Konstanze Wegener-Stiftung (MK), Wilhelm-Sander-Stiftung (MK), Forschungsforderungsfonds des Fachbereichs Medizin des Universitatsklinikums Hamburg-Eppendorf (NS) and the Federal Ministry of Education and Research (BMBF grant 02NUK032; MK, KR), Cancer Research UK (CRUK/21600; SCS, TB), The Brain Tumour Charity (TBTC13/192; SCS, TB), Medical Research Council (MR/K015214/1; SCS, TB), University of Leeds Academic Fellowship (LFS), The Templeton Family Research Fund (ZAB), The Maria and Gabriele Troiano Brain Cancer Immunotherapy Fund (ZAB, DOR) and the National Institutes of Health (NIH 2R01-NS042645-11A1; DOR). U.S. is supported by the Fordergemeinschaft Kinderkrebs-Zentrum Hamburg. Open access funding provided by Projekt DEAL.	Arni S, 2017, ONCOTARGET, V8, P68599, DOI 10.18632/oncotarget.19803; Bienkowski M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065444; Binder ZA, 2018, CANCER CELL, V34, P163, DOI 10.1016/j.ccell.2018.06.006; Boyd PS, 2016, NANOSCALE, V8, P20037, DOI 10.1039/c6nr05880a; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Brown PD, 2008, J CLIN ONCOL, V26, P5603, DOI 10.1200/JCO.2008.18.0612; Cominelli M, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv041; D'Atri S, 1998, MOL PHARMACOL, V54, P334, DOI 10.1124/mol.54.2.334; Dosch J, 1998, CARCINOGENESIS, V19, P567, DOI 10.1093/carcin/19.4.567; Dunn J, 2009, BRIT J CANCER, V101, P124, DOI 10.1038/sj.bjc.6605127; Fan QW, 2013, CANCER CELL, V24, P438, DOI 10.1016/j.ccr.2013.09.004; Faulkner C, 2015, BRIT J NEUROSURG, V29, P23, DOI 10.3109/02688697.2014.950631; Felsberg J, 2017, CLIN CANCER RES, V23, P6846, DOI 10.1158/1078-0432.CCR-17-0890; Felsberg J, 2011, INT J CANCER, V129, P659, DOI 10.1002/ijc.26083; Gan HK, 2009, J CLIN NEUROSCI, V16, P748, DOI 10.1016/j.jocn.2008.12.005; Gazzoli I, 2003, MOL CELL BIOL, V23, P7992, DOI 10.1128/MCB.23.22.7992-8007.2003; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Ito M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062351; Kaina B, 2002, INT J CLIN PHARM TH, V40, P354; Kaina B, 2001, PROG NUCLEIC ACID RE, V68, P41; Kriegs M, 2015, RADIOTHER ONCOL, V115, P120, DOI 10.1016/j.radonc.2015.02.018; Lei XF, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh098; Li G, 2012, J NEURO-ONCOL, V108, P395, DOI 10.1007/s11060-012-0842-3; Liu L, 2005, J MOL MED, V83, P917, DOI 10.1007/s00109-005-0700-2; McFaline-Figueroa JL, 2015, CANCER RES, V75, P3127, DOI 10.1158/0008-5472.CAN-14-3616; Mojas N, 2007, GENE DEV, V21, P3342, DOI 10.1101/gad.455407; Montano N, 2011, NEOPLASIA, V13, P1113, DOI 10.1593/neo.111338; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853; Nasrallah MP, 2019, ACAD PATHOL, V6, DOI 10.1177/2374289519848353; O'Rourke DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaa0984; Peereboom DM, 2010, J NEURO-ONCOL, V98, P93, DOI 10.1007/s11060-009-0067-2; Portnow J, 2009, CLIN CANCER RES, V15, P7092, DOI 10.1158/1078-0432.CCR-09-1349; Qi ST, 2011, ONCOL REP, V26, P1479, DOI 10.3892/or.2011.1428; Quiros S, 2010, CELL CYCLE, V9, P168, DOI 10.4161/cc.9.1.10363; Reardon DA, 2017, NEURO-ONCOLOGY, V19, P965, DOI 10.1093/neuonc/now257; Riedel M, 2016, ONCOTARGET, V7, P61988, DOI 10.18632/oncotarget.11328; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Scherer SJ, 2000, J BIOL CHEM, V275, P37469, DOI 10.1074/jbc.M006990200; Shinojima N, 2003, CANCER RES, V63, P6962; Smrdel U, 2016, RADIOL ONCOL, V50, P394, DOI 10.1515/raon-2015-0041; Struve N, 2015, ONCOTARGET, V6, P33867, DOI 10.18632/oncotarget.5293; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; van den Bent M, 2017, CANCER CHEMOTH PHARM, V80, P1209, DOI 10.1007/s00280-017-3451-1; van den Bent MJ, 2015, NEURO-ONCOLOGY, V17, P935, DOI 10.1093/neuonc/nov013; Wachsberger PR, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00013; Weller M, 2017, LANCET ONCOL, V18, P1373, DOI 10.1016/S1470-2045(17)30517-X; Weller M, 2014, INT J CANCER, V134, P2437, DOI 10.1002/ijc.28576; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; Yip S, 2009, CLIN CANCER RES, V15, P4622, DOI 10.1158/1078-0432.CCR-08-3012; Zheng QF, 2014, NEURO-ONCOLOGY, V16, P1229, DOI 10.1093/neuonc/nou046	53	27	27	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	15					3041	3055		10.1038/s41388-020-1208-5	http://dx.doi.org/10.1038/s41388-020-1208-5		FEB 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LB8NS	32066879	hybrid, Green Published			2022-12-26	WOS:000514052700003
J	Broughton-Neiswanger, LE; Rivera-Velez, SM; Suarez, MA; Slovak, JE; Pineyro, PE; Hwang, JK; Villarino, NF				Broughton-Neiswanger, Liam E.; Rivera-Velez, Sol M.; Suarez, Martin A.; Slovak, Jennifer E.; Pineyro, Pablo E.; Hwang, Julianne K.; Villarino, Nicolas F.			Urinary chemical fingerprint left behind by repeated NSAID administration: Discovery of putative biomarkers using artificial intelligence	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RENAL-DISEASE; METABOLOMICS; TAURINE; RISK; DYSFUNCTION; VALIDATION; CISPLATIN; GLUCOSE; INDEX	Prediction and early detection of kidney damage induced by nonsteroidal anti-inflammatories (NSAIDs) would provide the best chances of maximizing the anti-inflammatory effects while minimizing the risk of kidney damage. Unfortunately, biomarkers for detecting NSAID-induced kidney damage in cats remain to be discovered. To identify potential urinary biomarkers for monitoring NSAID-based treatments, we applied an untargeted metabolomics approach to urine collected from cats treated repeatedly with meloxicam or saline for up to 17 days. Applying multivariate analysis, this study identified a panel of seven metabolites that discriminate meloxicam treated from saline treated cats. Combining artificial intelligence machine learning algorithms and an independent testing urinary metabolome data set from cats with meloxicam-induced kidney damage, a panel of metabolites was identified and validated. The panel of metabolites including tryptophan, tyrosine, taurine, threonic acid, pseudouridine, xylitol and lyxitol, successfully distinguish meloxicam-treated and saline-treated cats with up to 75-100% sensitivity and specificity. This panel of urinary metabolites may prove a useful and non-invasive diagnostic tool for monitoring potential NSAID induced kidney injury in feline patients and may act as the framework for identifying urine biomarkers of NSAID induced injury in other species.	[Broughton-Neiswanger, Liam E.; Rivera-Velez, Sol M.; Hwang, Julianne K.; Villarino, Nicolas F.] Washington State Univ, Coll Vet Med, Program Individualized Med, Dept Vet Clin Sci, Pullman, WA 99164 USA; [Suarez, Martin A.] Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99164 USA; [Slovak, Jennifer E.] Anim Med Ctr, New York, NY USA; [Pineyro, Pablo E.] Iowa State Univ, Coll Vet Med, Vet Diagnost Lab, Ames, IA USA	Washington State University; Washington State University; Iowa State University	Villarino, NF (corresponding author), Washington State Univ, Coll Vet Med, Program Individualized Med, Dept Vet Clin Sci, Pullman, WA 99164 USA.	nicolas.villarino@wsu.edu	Slovak, Jennifer/AAC-1247-2022	Hwang, Julianne/0000-0002-9222-1729	Autzen Foundation; John and Ruth Ottmar Memorial Endowment intramural funds from the College of Veterinary Medicine at Washington State University, USA	Autzen Foundation; John and Ruth Ottmar Memorial Endowment intramural funds from the College of Veterinary Medicine at Washington State University, USA	N.F.V: The Autzen Foundation and the John and Ruth Ottmar Memorial Endowment intramural funds from the College of Veterinary Medicine at Washington State University, USA funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakwaa FM, 2018, J PROTEOME RES, V17, P337, DOI 10.1021/acs.jproteome.7b00595; Bargnoux AS, 2018, CLIN CHIM ACTA, V478, P111, DOI 10.1016/j.cca.2017.12.025; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Boudonck KJ, 2009, TOXICOL PATHOL, V37, P280, DOI 10.1177/0192623309332992; Campbell R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179508; Chan ECY, 2011, NAT PROTOC, V6, P1483, DOI 10.1038/nprot.2011.375; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Chen TL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/298183; Chesney RW, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S4; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Cuperlovic-Culf M, 2018, METABOLITES, V8, DOI 10.3390/metabo8010004; Das J, 2012, AMINO ACIDS, V43, P1509, DOI 10.1007/s00726-012-1225-y; Drucker E, 2013, EPMA J, V4, DOI 10.1186/1878-5085-4-7; Enot DP, 2008, NAT PROTOC, V3, P446, DOI 10.1038/nprot.2007.511; Erdem A, 2000, NEPHROL DIAL TRANSPL, V15, P1175, DOI 10.1093/ndt/15.8.1175; Fiehn Oliver, 2007, V358, P3, DOI 10.1007/978-1-59745-244-1_1; Fiehn Oliver, 2016, Curr Protoc Mol Biol, V114, DOI 10.1002/0471142727.mb3004s114; Ghiculescu Razvan A, 2006, Am J Kidney Dis, V48, pe89, DOI 10.1053/j.ajkd.2006.08.009; Giskeodegard GF, 2015, SCI REP-UK, V5, DOI 10.1038/srep14843; Gowda GAN, 2013, CURR METABOL, V1, P227, DOI 10.2174/2213235X113019990005; Hackstadt AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-11; Hagar HH, 2006, CLIN EXP PHARMACOL P, V33, P189, DOI 10.1111/j.1440-1681.2006.04345.x; Harirforoosh S, 2009, EXPERT OPIN DRUG SAF, V8, P669, DOI 10.1517/14740330903311023; Hocher B, 2017, NAT REV NEPHROL, V13, P269, DOI 10.1038/nrneph.2017.30; Horl WH, 2010, PHARMACEUTICALS, V3, P2291, DOI 10.3390/ph3072291; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Hu JM, 2009, ADV EXP MED BIOL, V643, P75, DOI 10.1007/978-0-387-75681-3_8; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; KAOJARERN S, 1983, AM J PHYSIOL, V244, pF134, DOI 10.1152/ajprenal.1983.244.2.F134; Khamdang S, 2002, J PHARMACOL EXP THER, V303, P534, DOI 10.1124/jpet.102.037580; KIM YK, 1995, TOXICOL APPL PHARM, V130, P19, DOI 10.1006/taap.1995.1003; Kim YS, 2017, ADV EXP MED BIOL, V975, P1191, DOI 10.1007/978-94-024-1079-2_95; Kohler M, 2015, ADV EXP MED BIOL, V845, P121, DOI 10.1007/978-94-017-9523-4_12; Kosmides Alyssa K., 2013, Critical Reviews in Biomedical Engineering, V41, P205; Krittanawong C, 2017, J AM COLL CARDIOL, V69, P2657, DOI 10.1016/j.jacc.2017.03.571; Laine L, 2001, GASTROENTEROLOGY, V120, P594, DOI 10.1053/gast.2001.21907; Liu ZS, 2005, J CHROMATOGR B, V819, P155, DOI 10.1016/j.jchromb.2005.02.005; MACPHERSON NA, 1991, CLIN INVEST MED, V14, P101; Marcobal A, 2013, ISME J, V7, P1933, DOI 10.1038/ismej.2013.89; Matsui H, 2011, J CLIN BIOCHEM NUTR, V48, P107, DOI 10.3164/jcbn.10-79; McLeland SM, 2015, VET PATHOL, V52, P524, DOI 10.1177/0300985814561095; Morita I, 2002, PROSTAG OTH LIPID M, V68-9, P165, DOI 10.1016/S0090-6980(02)00029-1; Niemann CU, 2007, EXPERT OPIN DRUG MET, V3, P527, DOI 10.1517/17425225.3.4.527; Niewczas MA, 2014, KIDNEY INT, V85, P1214, DOI 10.1038/ki.2013.497; Portilla D, 2006, KIDNEY INT, V69, P2194, DOI 10.1038/sj.ki.5000433; Racz Oliver, 2012, EJIFCC, V23, P33; Rivera-Velez SM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40686-4; Rivera-Velez SM, 2018, J FELINE MED SURG, V20, P155, DOI 10.1177/1098612X17701010; Ross L, 2011, VET CLIN N AM-SMALL, V41, P1, DOI 10.1016/j.cvsm.2010.09.003; Rysz J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081702; Sharma K, 2013, J AM SOC NEPHROL, V24, P1901, DOI 10.1681/ASN.2013020126; Silva RE, 2018, BIOCHIMIE, V152, P14, DOI 10.1016/j.biochi.2018.06.009; Soder J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180086; Sostres C, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4175; Srivastava S, 2018, ANN EPIDEMIOL, V28, P135, DOI 10.1016/j.annepidem.2017.10.013; Szymanska E, 2012, METABOLOMICS, V8, pS3, DOI 10.1007/s11306-011-0330-3; Taylor JMG, 2008, CLIN CANCER RES, V14, P5977, DOI 10.1158/1078-0432.CCR-07-4534; Thevenot EA, 2015, J PROTEOME RES, V14, P3322, DOI 10.1021/acs.jproteome.5b00354; van de Poll MCG, 2004, AM J CLIN NUTR, V79, P185; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Vernocchi P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01144; Verzola D, 2002, J INVEST MED, V50, P443, DOI 10.1136/jim-50-06-04; Wei QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106647; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9	65	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228989	10.1371/journal.pone.0228989	http://dx.doi.org/10.1371/journal.pone.0228989			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053695	Green Published, gold			2022-12-26	WOS:000535198700083
J	Murakami, I; Murakami, K; Hashimoto, M; Tanaka, M; Ito, H; Fujii, T; Torii, M; Ikeda, K; Kuwabara, A; Tanaka, K; Yoshida, A; Akizuki, S; Nakashima, R; Yoshifuji, H; Ohmura, K; Usui, T; Morita, S; Mimori, T				Murakami, Isao; Murakami, Kosaku; Hashimoto, Motomu; Tanaka, Masao; Ito, Hiromu; Fujii, Takao; Torii, Mie; Ikeda, Kaori; Kuwabara, Akiko; Tanaka, Kiyoshi; Yoshida, Akiko; Akizuki, Shuji; Nakashima, Ran; Yoshifuji, Hajime; Ohmura, Koichiro; Usui, Takashi; Morita, Satoshi; Mimori, Tsuneyo			Intake frequency of vegetables or seafoods negatively correlates with disease activity of rheumatoid arthritis	PLOS ONE			English	Article							MEDITERRANEAN DIET; FATTY-ACIDS; MANAGEMENT	Objective To clarify the relationship between dietary habit and disease activity of rheumatoid arthritis (RA). Methods This study enrolled RA patients who met the ACR/EULAR 2010 classification criteria from Kyoto University Rheumatoid Arthritis Management Alliance (KURAMA) cohort in 2015. 22-item food frequency questionnaire (FFQ) was taken for the measurement of dietary habit in a single-institution cohort of RA (Kyoto University Rheumatoid Arthritis Management Alliance: KURAMA) in 2015. The disease activities of RA using the Disease Activity Score calculated based on the erythrocyte sedimentation rate (DAS28-ESR), Simplified Disease Activity Index (SDAI), Health Assessment Questionnaire (HAQ), and serum matrix metallo-proteinase-3 (MMP-3) level, the use of disease-modifying anti-rheumatic drugs (DMARDs), disease duration, rheumatoid factor, anti-cyclic citrullinated antibody, and body mass index were also examined. All of them were combined and statistically analyzed. Results 441 RA patients (81% women; mean age 65 years; mean disease duration 15 years) were enrolled from the KURAMA cohort. Average Disease Activity Score-28 using the erythrocyte sedimentation rate (DAS28-ESR) was 2.7. Univariate analysis showed that intake frequency of vegetables had a statistically significant negative correlation with disease activity markers, such as DAS28-ESR (rho = -0.11, p<0.01), Simplified Disease Activity Index (SDAI) (rho = - 0.16, p<0.001), matrix metalloproteinase-3 (MMP-3) (rho = - 0.21, p<0.0001), and Health Assessment Questionnaire (HAQ) (rho = -0.13, p<0.01). Factor analysis with varimax rotation was done to simplify the relevance of disease activity to various food items. 22 foods were categorized into five dietary patterns: "seafoods", "vegetables/fruits", "meats/fried foods", "snacks", and "processed foods". The multivariate analysis adjusted for clinically significant confounders showed that "seafoods" had statistically significant negative correlations with DAS28-ESR (beta = - 0.15, p<0.01), SDAI (beta = - 0.18, p<0.001), MMP-3 (beta = -0.15, p<0.01), and HAQ (beta = -0.24, p<0.0001). "Vegetables/fruits" had statistically significant negative correlations with SDAI (beta = -0.11 p<0.05), MMP-3 (beta = -0.12, p<0.01), and HAQ (beta = - 0.11, p<0.05) Conclusions These results suggest that high intake frequency of vegetables/fruits and/or seafoods might correlate with low disease activity.	[Murakami, Isao; Murakami, Kosaku; Yoshida, Akiko; Akizuki, Shuji; Nakashima, Ran; Yoshifuji, Hajime; Ohmura, Koichiro; Usui, Takashi; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Hashimoto, Motomu; Tanaka, Masao] Kyoto Univ, Grad Sch Med, Dept Adv Med Rheumat Dis, Kyoto, Japan; [Ito, Hiromu] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan; [Fujii, Takao] Wakayama Med Univ, Dept Rheumatol & Clin Immunol, Wakayama, Japan; [Torii, Mie] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan; [Ikeda, Kaori] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto, Japan; [Kuwabara, Akiko] Osaka Prefecture Univ, Fac Comprehens Rehabil, Dept Clin Nutr, Osaka, Japan; [Tanaka, Kiyoshi] Kobe Gakuin Univ, Dept Fac Nutr, Kobe, Hyogo, Japan; [Morita, Satoshi] Kyoto Univ, Dept Biomed Stat & Bioinformat, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Wakayama Medical University; Kyoto University; Kyoto University; Osaka Metropolitan University; Kobe Gakuin University; Kyoto University	Murakami, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan.	kosaku@kuhp.kyoto-u.ac.jp	Akizuki, Shuji/ABE-7043-2020; Yoshifuji, Hajime/AAZ-1657-2020	Murakami, Kosaku/0000-0001-5981-4648	Nagahama City, Shiga, Japan; Mitsubishi Tanabe Pharma Co.; Chugai Pharmaceutical Co. Ltd; UCB Japan Co. Ltd; AYUMI Pharmaceutical Co.; Daiichi Sankyo Co. Ltd.;  [17K10000]	Nagahama City, Shiga, Japan; Mitsubishi Tanabe Pharma Co.; Chugai Pharmaceutical Co. Ltd; UCB Japan Co. Ltd(UCB Pharma SA); AYUMI Pharmaceutical Co.; Daiichi Sankyo Co. Ltd.(Daiichi Sankyo Company Limited); 	Source of funding in this study was obtained from Grants-in-Aid for Scientific Research (KAKENHI) Research (C), 2017-2019 (17K10000, Kosaku Murakami). The Department of Advanced Medicine for Rheumatic Diseases is supported by Nagahama City, Shiga, Japan and four pharmaceutical companies (Mitsubishi Tanabe Pharma Co., Chugai Pharmaceutical Co. Ltd, UCB Japan Co. Ltd, and AYUMI Pharmaceutical Co.). KURAMA cohort study is supported by grant from Daiichi Sankyo Co. Ltd. These companies had no role in the design of the study, the collection or analysis of the data, the writing of the manuscript or decision to submit the manuscript for the publication.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Cheng ZJ, 2017, BEST PRACT RES CL RH, V31, P19, DOI 10.1016/j.berh.2017.08.001; Deane KD, 2017, BEST PRACT RES CL RH, V31, P3, DOI 10.1016/j.berh.2017.08.003; Forsyth C, 2018, RHEUMATOL INT, V38, P737, DOI 10.1007/s00296-017-3912-1; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gheita T, 2012, CLIN RHEUMATOL, V31, P363, DOI 10.1007/s10067-011-1848-5; Gheita TA, 2012, PHYTOTHER RES, V26, P1246, DOI 10.1002/ptr.3679; Gioxari A, 2018, NUTRITION, V45, P114, DOI 10.1016/j.nut.2017.06.023; Hayashi H, 2012, NUTRITION, V28, P1109, DOI 10.1016/j.nut.2012.02.009; Ikeda K, 2018, DIABETES RES CLIN PR, V141, P26, DOI 10.1016/j.diabres.2018.04.006; Katz P, 2008, ARTHRIT RHEUM-ARTHR, V59, P1416, DOI 10.1002/art.24110; Matsuda Y, 2003, ARTHRIT RHEUM-ARTHR, V49, P784, DOI 10.1002/art.11465; Matsumoto Y, 2018, CLIN NUTR, V37, P675, DOI 10.1016/j.clnu.2017.02.011; Moran LJ, 2017, OBESITY, V25, P1022, DOI 10.1002/oby.21848; Nakagami Y, 2019, ARTHRIT CARE RES, V71, P1216, DOI 10.1002/acr.23779; Norling LV, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85922; Rodrigo CP, 2015, NUTR HOSP, V31, P49, DOI 10.3305/nh.2015.31.sup3.8751; Skoczynska Marta, 2018, Reumatologia (Warsaw), V56, P259, DOI 10.5114/reum.2018.77979; Smolen JS, 2016, LANCET, V388, P1984; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Suzuki N, 2018, J NUTR SCI VITAMINOL, V64, P129, DOI 10.3177/jnsv.64.129; Tedeschi SK, 2018, ARTHRIT CARE RES, V70, P327, DOI 10.1002/acr.23295; Terao C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085376; Thompson FE, 2015, J ACAD NUTR DIET, V115, P1986, DOI 10.1016/j.jand.2015.08.016; Tokudome Shinkan, 2004, Asian Pac J Cancer Prev, V5, P40; Torii M, 2019, MOD RHEUMATOL, V29, P589, DOI 10.1080/14397595.2018.1510565	26	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228852	10.1371/journal.pone.0228852	http://dx.doi.org/10.1371/journal.pone.0228852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053642	Green Published, gold, Green Submitted			2022-12-26	WOS:000535198700062
J	Yu, ZB; Feng, JB; Wang, W; Deng, ZY; Zhang, Y; Xiao, L; Wang, ZY; Liu, CH; Liu, Q; Chen, S; Wu, MH				Yu, Zhibin; Feng, Jianbo; Wang, Wei; Deng, Zhiyong; Zhang, Yan; Xiao, Lan; Wang, Zeyou; Liu, Changhong; Liu, Qing; Chen, Shuai; Wu, Minghua			The EGFR-ZNF263 signaling axis silences SIX3 in glioblastoma epigenetically	ONCOGENE			English	Article							INTEGRATED GENOMIC ANALYSIS; TUMOR-SUPPRESSOR; C-MYC; MUTATION; REPRESSION; EXPRESSION; FAMILY; EGFR; IDH1; METHYLATION	The homeotic protein SIX3 is a transcription factor vital for neurogenesis and has a bivalent promoter. We previously showed that SIX3 can be transcriptionally silenced by DNA hypermethylation, functions as a tumor suppressor gene, and inhibits human glioblastoma transcriptionally. Here, we show that the activation of epidermal growth factor (EGFR) induces DNA methylation of SIX3 promoter through the MAPK pathway. ERK, when activated, binds with ZNF263, consequently abrogating the ubiquitination of ZNF263 and leading to its stabilization. ZNF263 binds to the core promoter region of SIX3 and recruits the KAP1/HATS/DNMT corepressor complex to induce transcriptional silencing of SIX3 through H3K27me3 and methylation of SIX3 promoter. Activation of the EGFR-ZNF263 signaling axis in phenotypically normal astrocytes or glioblastoma cells triggers or enhances tumorigenic activities, while elevated expression of the EGFR-ZNF263 signaling components in glioblastoma tissues is associated with poor prognosis of the patients. Together, our findings demonstrate that epigenetic silencing of SIX3 is controlled by a sophisticated and highly ordered oncogenic signaling pathway and therefore provide new insights into initiation and progression of glioblastoma.	[Yu, Zhibin; Feng, Jianbo; Deng, Zhiyong; Zhang, Yan; Liu, Changhong; Chen, Shuai; Wu, Minghua] Cent South Univ, Xiangya Med Sch, Hunan Prov Tumor Hosp, Changsha 410013, Hunan, Peoples R China; [Yu, Zhibin; Feng, Jianbo; Deng, Zhiyong; Zhang, Yan; Liu, Changhong; Chen, Shuai; Wu, Minghua] Cent South Univ, Xiangya Med Sch, Affiliated Tumor Hosp, Changsha 410013, Hunan, Peoples R China; [Yu, Zhibin; Feng, Jianbo; Zhang, Yan; Xiao, Lan; Liu, Changhong; Wu, Minghua] Cent South Univ, Sch Basic Med Sci, Canc Res Inst,Minist Hlth, Key Lab Carcinogenesis & Canc Invas,Minist Educ,K, Changsha 410078, Hunan, Peoples R China; [Yu, Zhibin; Feng, Jianbo] Shanghai Jiao Tong Univ, Yale Inst Immune Metab, Sch Med, Shanghai 200025, Peoples R China; [Wang, Wei] Jining Med Univ, Dept Pathol, Affiliated Hosp, Jining 272000, Shandong, Peoples R China; [Wang, Zeyou] Cent South Univ, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China; [Liu, Qing] Cent South Univ, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China	Central South University; Central South University; Central South University; Shanghai Jiao Tong University; Jining Medical University; Central South University; Central South University	Chen, S; Wu, MH (corresponding author), Cent South Univ, Xiangya Med Sch, Hunan Prov Tumor Hosp, Changsha 410013, Hunan, Peoples R China.; Chen, S; Wu, MH (corresponding author), Cent South Univ, Xiangya Med Sch, Affiliated Tumor Hosp, Changsha 410013, Hunan, Peoples R China.; Wu, MH (corresponding author), Cent South Univ, Sch Basic Med Sci, Canc Res Inst,Minist Hlth, Key Lab Carcinogenesis & Canc Invas,Minist Educ,K, Changsha 410078, Hunan, Peoples R China.	chenshuai16@139.com; wuminghua554@aliyun.com			National Natural Science Foundation of China [81874850, 81502185]; Graduate Student Research Innovation Project in Hunan Province [2019zzts084]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Student Research Innovation Project in Hunan Province	This work was supported by the National Natural Science Foundation of China (Grant No. 81874850, 81502185) and Graduate Student Research Innovation Project in Hunan Province (2019zzts084).	Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Bierhoff H, 2014, MOL CELL, V54, P675, DOI 10.1016/j.molcel.2014.03.032; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Carl M, 2002, DEVELOPMENT, V129, P4057; Carlin D, 2012, DEVELOPMENT, V139, P2614, DOI 10.1242/dev.076018; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Dingar D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05660-0; Ecco G, 2017, DEVELOPMENT, V144, P2719, DOI 10.1242/dev.132605; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Forloni M, 2016, CELL REP, V16, P457, DOI 10.1016/j.celrep.2016.05.087; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Ge YZ, 2004, J BIOL CHEM, V279, P25447, DOI 10.1074/jbc.M312296200; Geng X, 2016, DEVELOPMENT, V143, P4462, DOI 10.1242/dev.132142; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Hernandez-Hernandez A, 2006, EMBO J, V25, P3264, DOI 10.1038/sj.emboj.7601228; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Koh KH, 2016, METHODS MOL BIOL, V1366, P41, DOI 10.1007/978-1-4939-3127-9_5; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Lengler J, 2001, BIOCHEM BIOPH RES CO, V287, P372, DOI 10.1006/bbrc.2001.5605; Li QJ, 2003, EMBO J, V22, P281, DOI 10.1093/emboj/cdg028; Lidke DS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.064972; Lupo A, 2013, CURR GENOMICS, V14, P268, DOI 10.2174/13892029113149990002; Lv DG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01731-w; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ozawa T, 2014, CANCER CELL, V26, P288, DOI 10.1016/j.ccr.2014.06.005; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pasquier L, 2000, EUR J HUM GENET, V8, P797, DOI 10.1038/sj.ejhg.5200540; Pasquier L, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023416; Persons DL, 2000, J BIOL CHEM, V275, P35778, DOI 10.1074/jbc.M004267200; Riso V, 2016, NUCLEIC ACIDS RES, V44, P8165, DOI 10.1093/nar/gkw505; Roy DM, 2014, PROTEIN CELL, V5, P265, DOI 10.1007/s13238-014-0031-6; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Serra RW, 2014, ELIFE, V3, DOI 10.7554/eLife.02313; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Stupp R, 2014, ANN ONCOL, V25, P93, DOI 10.1093/annonc/mdu050; Thillainadesan G, 2012, MOL CELL, V46, P636, DOI 10.1016/j.molcel.2012.03.027; Thoresen SB, 2014, NAT CELL BIOL, V16, P547, DOI 10.1038/ncb2959; Tsai WB, 2012, CANCER RES, V72, P2622, DOI 10.1158/0008-5472.CAN-11-3605; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wajapeyee N, 2013, GENE DEV, V27, P2221, DOI 10.1101/gad.227413.113; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Yu ZB, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0483-2; Zhu CQC, 2002, DEVELOPMENT, V129, P2835; Zhu H, 2009, P NATL ACAD SCI USA, V106, P2712, DOI 10.1073/pnas.0813314106	54	13	14	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	15					3163	3178		10.1038/s41388-020-1206-7	http://dx.doi.org/10.1038/s41388-020-1206-7		FEB 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LB8NS	32051553	Green Published, hybrid			2022-12-26	WOS:000513108700001
J	Zwingli, G; Yerly, J; Mivelaz, Y; Stoppa-Vaucher, S; Dwyer, AA; Pitteloud, N; Stuber, M; Hauschild, M				Zwingli, Gaetan; Yerly, Jerome; Mivelaz, Yvan; Stoppa-Vaucher, Sophie; Dwyer, Andrew A.; Pitteloud, Nelly; Stuber, Matthias; Hauschild, Michael			Non-invasive assessment of coronary endothelial function in children and adolescents with type 1 diabetes mellitus using isometric handgrip exercise-MRI: A feasibility study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; PULSE-WAVE VELOCITY; ARTERIAL STIFFNESS; DYSFUNCTION; DISEASE; ATHEROSCLEROSIS; DISTENSIBILITY; MORTALITY; STATEMENT; ONSET	Background Type 1 diabetes mellitus (T1DM) in children and adolescents is associated with significant cardiovascular morbidity and mortality. Early detection of vascular dysfunction is key to patient management yet current assessment techniques are invasive and not suitable for pediatric patient populations. A novel approach using isometric handgrip exercise during magnetic resonance imaging (IHE-MRI) has recently been developed to evaluate coronary endothelial function non-invasively in adults. This project aimed to assess endothelium-dependent coronary arterial response to IHE-MRI in children with T1DM and in age matched healthy controls. Materials and methods Healthy volunteers and children with T1DM (> 5 years) were recruited. IHE-MRI cross-sectional coronary artery area measurements were recorded at rest and under stress. Carotid intima media thickness (CIMT) and aortic pulse wave velocity (PWV) were assessed for comparison. Student's t-tests were used to compare results between groups. Results and discussion Seven children with T1DM (3 female, median 14.8 years, mean 14.8 +/- 1.9 years) and 16 healthy controls (7 female, median 14.8 years, mean 14.2 +/- 2.4 years) participated. A significant increase in stress-induced cross-sectional coronary area was measured in controls (5.4 mm(2) at rest to 6.39 mm(2) under stress, 18.8 +/- 10.7%, p = 0.0004). In contrast, mean area change in patients with T1DM was not significant (7.17 mm(2) at rest to 7.59 mm(2) under stress, 10.5% +/- 28.1%, p = n.s.). There was no significant difference in the results for neither PWV nor CIMT between patients and controls, (5.3 +/- 1.5 m/s vs.4.8 +/- 0.7 m/s and 0.4 +/- 0.03mm vs.0.46 mm +/- 0.03 respectively, both p = n.s.). Conclusions Our pilot study demonstrates the feasibility of using a totally non-invasive IHE-MRI technique in children and adolescents with and without T1DM. Preliminary results suggest a blunted endothelium-dependent coronary vasomotor function in children with T1DM (>5 years). Better knowledge and new methodologies may improve surveillance and care for T1DM patients to reduce cardiovascular morbidity and mortality.	[Zwingli, Gaetan] Lausanne Univ UNIL, Fac Biol & Med, Lausanne, Switzerland; [Yerly, Jerome; Stuber, Matthias] Lausanne Univ Hosp CHUV, Ctr Biomed Imaging, Dept Radiol, Lausanne, Switzerland; [Mivelaz, Yvan] Lausanne Univ Hosp CHUV, Serv Pediat, Pediat Cardiol Unit, Lausanne, Switzerland; [Stoppa-Vaucher, Sophie] Hop Neuchatelois, Dept Pediat, Neuchatel, Switzerland; [Stoppa-Vaucher, Sophie; Pitteloud, Nelly; Hauschild, Michael] Lausanne Univ Hosp CHUV, Serv Pediat, Pediat Endocrinol Diabetol & Obes Unit, Lausanne, Switzerland; [Dwyer, Andrew A.] Boston Coll, William F Connell Sch Nursing, Chestnut Hill, MA 02167 USA; [Pitteloud, Nelly] Lausanne Univ Hosp CHUV, Serv Endocrinol Diabetol & Metab, Lausanne, Switzerland	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Boston College; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Hauschild, M (corresponding author), Lausanne Univ Hosp CHUV, Serv Pediat, Pediat Endocrinol Diabetol & Obes Unit, Lausanne, Switzerland.	michael.hauschild@chuv.ch	Dwyer, Andrew A./D-8099-2012; Hauschild, Michael/AAZ-6990-2021	Dwyer, Andrew A./0000-0002-7023-6794; Hauschild, Michael/0000-0002-1940-8730; Yerly, Jerome/0000-0003-4347-8613	Swiss National Science Foundation [320030_143923, 326030_150828]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project has been supported in part by the Swiss National Science Foundation Grants 320030_143923 and 326030_150828. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aad G, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.261803; ANDERSON TJ, 1995, NEW ENGL J MED, V332, P488, DOI 10.1056/NEJM199502233320802; ARJUNAN K, 1986, J AM COLL CARDIOL, V8, P1119, DOI 10.1016/S0735-1097(86)80390-4; Armstrong AC, 2017, DIABETES CARE, V40, P405, DOI 10.2337/dc16-1889; BERENSON GS, 1992, AM J CARDIOL, V70, P851, DOI 10.1016/0002-9149(92)90726-F; Brandts A, 2012, INT J CARDIOVAS IMAG, V28, P543, DOI 10.1007/s10554-011-9841-2; Brunvand L, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0288-1; Dalla Pozza R, 2007, J CLIN ENDOCR METAB, V92, P2053, DOI 10.1210/jc.2006-2868; Deanfield J, 2005, J HYPERTENS, V23, P7, DOI 10.1097/00004872-200501000-00004; Gagnum V, 2015, DIABETOLOGIA, V58, P1779, DOI 10.1007/s00125-015-3623-7; Hambrecht R, 2000, NEW ENGL J MED, V342, P454, DOI 10.1056/NEJM200002173420702; Hays AG, 2015, AM J PHYSIOL-HEART C, V308, pH1343, DOI 10.1152/ajpheart.00023.2015; Hays AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058047; Hays AG, 2010, J AM COLL CARDIOL, V56, P1657, DOI 10.1016/j.jacc.2010.06.036; Higashi Y, 1999, CIRCULATION, V100, P1194, DOI 10.1161/01.CIR.100.11.1194; Iantorno M, 2017, AIDS, V31, P1281, DOI 10.1097/QAD.0000000000001469; Iantorno M, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.003954; Iantorno M, 2014, TRENDS CARDIOVAS MED, V24, P149, DOI 10.1016/j.tcm.2013.10.001; Keehn L, 2014, J HYPERTENS, V32, P1464, DOI 10.1097/HJH.0000000000000203; Kelle S, 2011, AM J CARDIOL, V108, P491, DOI 10.1016/j.amjcard.2011.03.078; Kim WY, 2007, CIRCULATION, V115, P228, DOI 10.1161/CIRCULATIONAHA.106.633339; Lind M, 2014, NEW ENGL J MED, V371, P1972, DOI 10.1056/NEJMoa1408214; Margeirsdottir HD, 2010, DIABETES CARE, V33, P2043, DOI 10.2337/dc10-0505; Mayer-Davis EJ, 2017, NEW ENGL J MED, V376, P1419, DOI 10.1056/NEJMoa1610187; McCulloch MA, 2015, PEDIATR DIABETES, V16, P90, DOI 10.1111/pedi.12241; Mivelaz Y, 2016, J HYPERTENS, V34, P2227, DOI 10.1097/HJH.0000000000001065; Mivelaz Y, 2016, AM J CARDIOL, V118, P597, DOI 10.1016/j.amjcard.2016.05.055; Nathan DM, 2003, NEW ENGL J MED, V348, P761; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nitenberg A, 2004, ATHEROSCLEROSIS, V173, P115, DOI 10.1016/j.atherosclerosis.2003.12.030; Reusz GS, 2010, HYPERTENSION, V56, P217, DOI 10.1161/HYPERTENSIONAHA.110.152686; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; Shi Y, 2017, J DIABETES, V9, P434, DOI 10.1111/1753-0407.12521; Terlemez S, 2016, J DIABETES COMPLICAT, V30, P864, DOI 10.1016/j.jdiacomp.2016.03.012; Townsend RR, 2015, HYPERTENSION, V66, P698, DOI 10.1161/HYP.0000000000000033; Urbina EM, 2009, HYPERTENSION, V54, P919, DOI 10.1161/HYPERTENSIONAHA.109.192639; van Elderen SGC, 2010, EUR RADIOL, V20, P1132, DOI 10.1007/s00330-009-1655-4; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; WEISS RG, 1990, NEW ENGL J MED, V323, P1593, DOI 10.1056/NEJM199012063232304; Yerly J, 2018, MAGN RESON MED, V79, P108, DOI 10.1002/mrm.26646; Yerly J, 2016, MAGN RESON MED, V76, P1443, DOI 10.1002/mrm.26050	41	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228569	10.1371/journal.pone.0228569	http://dx.doi.org/10.1371/journal.pone.0228569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053613	Green Published, gold			2022-12-26	WOS:000535198700033
J	Jalbert, I; Rahardjo, D; Yashadhana, A; Liew, G; Gopinath, B				Jalbert, Isabelle; Rahardjo, Dian; Yashadhana, Aryati; Liew, Gerald; Gopinath, Bamini			A qualitative exploration of Australian eyecare professional perspectives on Age-Related Macular Degeneration (AMD) care	PLOS ONE			English	Article							AFRICAN-AMERICANS; DIABETIC-RETINOPATHY; REFERRAL PATHWAYS; BARRIERS; OPTOMETRISTS; PREVALENCE; ATTITUDES; GLAUCOMA; DISEASE; SUPPLEMENTATION	Despite the existence of evidence-based recommendations to decrease risk and progression of Age-Related Macular Degeneration (AMD) for some time, self-reported practices suggest that eyecare professionals' advice and people with AMD's adherence to these recommendations can be very poor. This study uses qualitative methods to explore Australian eyecare professionals' perspective on barriers to effective AMD care. Seven focus groups involving 65 optometrists were conducted by an experienced facilitator. A nominal group technique was used to identify, prioritize and semi-quantify barriers and enablers to AMD care. Participants individually ranked their perceived top five barriers and enablers with the most important granted a score of 5 and the least important a score of 1. For each barrier or enabler, the number of votes it received and its total score were recorded. Barriers and enablers selected by at least one participant in their top 5 were then qualitatively analysed, grouped using thematic analysis and total score calculated for each consolidated barrier or enabler. In-depth individual interviews were conducted with 10 ophthalmologists and 2 optometrists. Contributions were audio-recorded, transcribed verbatim and analysed with NVivo software. One hundred and sixty-nine barriers and 51 enablers to AMD care were identified in the focus groups. Of these, 102 barriers and 42 enablers were selected as one of their top 5 by at least one participant and further consolidated into 16 barriers and 10 enablers after thematic analysis. Factors impacting AMD care identified through analysis of the transcripts were coded to three categories of influence: patient-centered, practition-ercentered, and structural factors. Eyecare professionals considered poor care pathways, people with AMD's poor disease understanding / denial, and cost of care / lack of funding, as the most significant barriers to AMD care; they considered shared care model, access, and communication as the most significant enablers to good AMD care. These findings suggest that Australian eyecare professionals perceive that there is a need for improved patient support systems and appropriately funded, clearer care pathway to benefit people with AMD.	[Jalbert, Isabelle; Rahardjo, Dian; Yashadhana, Aryati] UNSW Sydney, Sch Optometry & Vis Sci, Sydney, NSW, Australia; [Liew, Gerald; Gopinath, Bamini] Univ Sydney, Ctr Vis Res, Westmead Inst Med Res, Dept Ophthalmol, Sydney, NSW, Australia	University of New South Wales Sydney; University of Sydney; Westmead Institute for Medical Research	Jalbert, I (corresponding author), UNSW Sydney, Sch Optometry & Vis Sci, Sydney, NSW, Australia.	i.jalbert@unsw.edu.au	Yashadhana, Aryati/AAB-6194-2021; Liew, Gerald/AAB-6870-2022; Jalbert, Isabelle/T-5888-2017	Yashadhana, Aryati/0000-0003-2573-8637; Jalbert, Isabelle/0000-0002-1351-0072	Blackmores Macular Disease Foundation Australia [RG151916]	Blackmores Macular Disease Foundation Australia	IJ, GL, BG received the Blackmores Macular Disease Foundation Australia research grant RG151916 (www.mdfoundation.com.au).The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnahedh T, 2015, CLIN EXP OPTOM, V98, P263, DOI 10.1111/cxo.12238; American Academy of Ophthalmology Retina/Vitreous Panel, 2015, PREP PRACT PATT AG R; Barrett C, 2018, CLIN EXP OPTOM, V101, P90, DOI 10.1111/cxo.12573; Birken SA, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-016-0534-z; Boxell EM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012790; Caban-Martinez AJ, 2011, PREV CHRONIC DIS, V8; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Carlton Jill, 2019, Br Ir Orthopt J, V15, P133, DOI 10.22599/bioj.137; Chang CW, 2003, CAN J OPHTHALMOL, V38, P27, DOI 10.1016/S0008-4182(03)80005-4; Charkoudian LD, 2008, OPHTHALMOLOGY, V115, P1032, DOI 10.1016/j.ophtha.2007.08.003; Congdon N, 2011, OPHTHALMOLOGY, V118, P2343, DOI 10.1016/j.ophtha.2011.06.016; Dahlin-Ivanoff S, 1998, PATIENT EDUC COUNS, V34, P63, DOI 10.1016/S0738-3991(98)00041-X; Department of Health, 2015, RUR CLASS REF FREQ A; Downie LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124533; Dreer LE, 2013, OPTOMETRY VISION SCI, V90, P883, DOI 10.1097/OPX.0000000000000009; Evans JR, 2012, COCHRANE DATABASE SY; Gary TL, 2009, ARCH INTERN MED, V169, P1788, DOI 10.1001/archinternmed.2009.338; Glaser B.G., 1968, DISCOV GROUNDED THEO; GLASER BG, 1965, SOC PROBL, V12, P436, DOI 10.1525/sp.1965.12.4.03a00070; Gopinath B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122548; Gopinath B, 2014, BRIT J NUTR, V111, P1673, DOI 10.1017/S000711451300408X; Gopinath B, 2014, MATURITAS, V77, P263, DOI 10.1016/j.maturitas.2013.12.001; Gopinath B, 2013, AM J CLIN NUTR, V98, P129, DOI 10.3945/ajcn.112.057091; Jamous KF, 2014, CLIN EXP OPTOM, V97, P248, DOI 10.1111/cxo.12119; Jamous KF, 2014, CLIN EXP OPTOM, V97, P152, DOI 10.1111/cxo.12102; Jamous KF, 2014, CLIN EXP OPTOM, V97, P565, DOI 10.1111/cxo.12194; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Keel S, 2017, JAMA OPHTHALMOL, V135, P1242, DOI 10.1001/jamaophthalmol.2017.4182; Lawrenson JG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-564; Levesque JF, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-18; Loughman J, 2011, OPTOMETRY PRACTICE, V12, P135; Ly A, 2016, OPHTHAL PHYSL OPT, V36, P632, DOI 10.1111/opo.12322; Mitchell J, 2002, BRIT J OPHTHALMOL, V86, P777, DOI 10.1136/bjo.86.7.777; Mitchell P, 2011, EYES FUTURE CLEAR OU; Mitchell P, 2018, LANCET, V392, P1147, DOI 10.1016/S0140-6736(18)31550-2; Muen Wisam J, 2011, JRSM Short Rep, V2, P64, DOI 10.1258/shorts.2011.011042; National Insitute for Health and Care Excellent [NICE], 2018, NICE GUIDELINE 82; National Institute of Clinical Studies, 2006, IDENTIFYING BARRIERS; Neely DC, 2017, JAMA OPHTHALMOL, V135, P570, DOI 10.1001/jamaophthalmol.2017.0830; Ng WT, 2006, CLIN EXP OPHTHALMOL, V34, P9, DOI 10.1111/j.1442-9071.2006.01141.x; Nicklas TA, 2013, J ACAD NUTR DIET, V113, P1317, DOI 10.1016/j.jand.2013.05.004; O'Connor PM, 2012, MED J AUSTRALIA, V196, P646, DOI 10.5694/mja11.10856; Owsley C, 2006, INVEST OPHTH VIS SCI, V47, P2797, DOI 10.1167/iovs.06-0107; Parfitt A, 2019, BMJ OPEN OPHTHALMOL, V4, DOI 10.1136/bmjophth-2019-000276; Shah R, 2009, BRIT J OPHTHALMOL, V93, P492, DOI 10.1136/bjo.2008.145623; Sharma HE, 2014, BRIT J OPHTHALMOL, V98, P1625, DOI 10.1136/bjophthalmol-2014-304959; Shickle D, 2014, OPHTHAL PHYSL OPT, V34, P38, DOI 10.1111/opo.12100; Steele C., OPTOM TODAY; Stevens R, 2017, BRIT J VISUAL IMPA, V35, P185, DOI 10.1177/0264619616683989; Stevens R, 2014, BRIT J VISUAL IMPA, V32, P77, DOI 10.1177/0264619613519341; Strauss, 2015, BASICS QUALITATIVE R; Suttle CM, 2015, OPTOMETRY VISION SCI, V92, P514, DOI 10.1097/OPX.0000000000000550; Suttle CM, 2012, CLIN EXP OPTOM, V95, P28, DOI 10.1111/j.1444-0938.2011.00663.x; Taylor DJ, 2019, EYE LOND; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tong A, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1528-5; Townsend D, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007400; VANDEVEN AH, 1972, AM J PUBLIC HEALTH N, V62, P337, DOI 10.2105/AJPH.62.3.337; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yan XX, 2012, ARCH OPHTHALMOL-CHIC, V130, P761, DOI 10.1001/archophthalmol.2012.145	61	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228858	10.1371/journal.pone.0228858	http://dx.doi.org/10.1371/journal.pone.0228858			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9KA	32045445	gold, Green Published			2022-12-26	WOS:000534633200043
J	Stribny, J; Thines, L; Deschamps, A; Goffin, P; Morsomme, P				Stribny, Jiri; Thines, Louise; Deschamps, Antoine; Goffin, Philippe; Morsomme, Pierre			The human Golgi protein TMEM165 transports calcium and manganese in yeast and bacterial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; calcium transport; manganese; Golgi; glycosylation; yeast; CDG; TMEM165	LACTOCOCCUS-LACTIS; DEFICIENCY; TRANSFORMATION; GLYCOSYLATION; MUTATIONS; MEMBRANE; DISORDER	Cases of congenital disorders of glycosylation (CDG) have been associated with specific mutations within the gene encoding the human Golgi TMEM165 (transmembrane protein 165), belonging to UPF0016 (uncharacterized protein family 0016), a family of secondary ion transporters. To date, members of this family have been reported to be involved in calcium, manganese, and pH homeostases. Although it has been suggested that TMEM165 has cation transport activity, direct evidence for its Ca2+- and Mn2+-transporting activities is still lacking. Here, we functionally characterized human TMEM165 by heterologously expressing it in budding yeast (Saccharomyces cerevisiae) and in the bacterium Lactococcus lactis. Protein production in these two microbial hosts was enhanced by codon optimization and truncation of the putatively autoregulatory N terminus of TMEM165. We show that TMEM165 expression in a yeast strain devoid of Golgi Ca2+ and Mn2+ transporters abrogates Ca2+- and Mn2+-induced growth defects, excessive Mn2+ accumulation in the cell, and glycosylation defects. Using bacterial cells loaded with the fluorescent Fura-2 probe, we further obtained direct biochemical evidence that TMEM165 mediates Ca2+ and Mn2+ influxes. We also used the yeast and bacterial systems to evaluate the impact of four disease-causing missense mutations identified in individuals with TMEM165-associated CDG. We found that a mutation leading to a E108G substitution within the conserved UPF0016 family motif significantly reduces TMEM165 activity. These results indicate that TMEM165 can transport Ca2+ and Mn2+, which are both required for proper protein glycosylation in cells. Our work also provides tools to better understand the pathogenicity of CDG-associated TMEM165 mutations.	[Stribny, Jiri; Thines, Louise; Deschamps, Antoine; Morsomme, Pierre] Catholic Univ Louvain, Louvain Inst Biomol Sci & Technol, B-1348 Louvain La Neuve, Belgium; [Goffin, Philippe] Univ Libre Bruxelles, Cellular & Mol Microbiol Lab, B-6041 Gosselies, Belgium	Universite Catholique Louvain; Universite Libre de Bruxelles	Morsomme, P (corresponding author), Catholic Univ Louvain, Louvain Inst Biomol Sci & Technol, B-1348 Louvain La Neuve, Belgium.	pierre.morsomme@uclouvain.be		Stribny, Jiri/0000-0002-2449-3167; Morsomme, Pierre/0000-0001-7780-7230	Fonds National de la Recherche Scientifique [PDR-T.0206.16]	Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS)	The work was supported by Fonds National de la Recherche Scientifique Grant PDR-T.0206.16. The authors declare that they have no conflicts of interest with the contents of this article.	Althoff SS, 2016, JIMD REP, V26, P21, DOI 10.1007/8904_2015_455; Colinet AS, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12729; Colinet AS, 2016, SCI REP-UK, V6, DOI 10.1038/srep24282; Demaegd D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100851; Demaegd D, 2013, P NATL ACAD SCI USA, V110, P6859, DOI 10.1073/pnas.1219871110; Dulary E, 2018, BBA-GEN SUBJECTS, V1862, P394, DOI 10.1016/j.bbagen.2017.11.006; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Frank J, 2019, NEW PHYTOL, V221, P866, DOI 10.1111/nph.15407; Gentzsch M, 1997, GLYCOBIOLOGY, V7, P481, DOI 10.1093/glycob/7.4.481; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Kunji ERS, 2003, BBA-BIOMEMBRANES, V1610, P97, DOI 10.1016/S0005-2736(02)00712-5; Lebredonchel E, 2019, BIOCHIMIE, V165, P123, DOI 10.1016/j.biochi.2019.07.016; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; Potelle S, 2017, BIOCHEM J, V474, P1481, DOI 10.1042/BCJ20160910; Potelle S, 2016, HUM MOL GENET, V25, P1489, DOI 10.1093/hmg/ddw026; Rosnoblet C, 2013, HUM MOL GENET, V22, P2914, DOI 10.1093/hmg/ddt146; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; Schneider A, 2016, PLANT CELL, V28, P892, DOI 10.1105/tpc.15.00812; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Thines L, 2018, J BIOL CHEM, V293, P8048, DOI 10.1074/jbc.RA118.002324	22	17	17	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3865	3874		10.1074/jbc.RA119.012249	http://dx.doi.org/10.1074/jbc.RA119.012249			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32047108	Green Published, hybrid			2022-12-26	WOS:000527704400012
J	Wagner, MJ; Hsiung, MS; Gish, GD; Bagshaw, RD; Doodnauth, SA; Soliman, MA; Jorgensen, C; Tucholska, M; Rottapel, R				Wagner, Melany J.; Hsiung, Marilyn S.; Gish, Gerald D.; Bagshaw, Rick D.; Doodnauth, Sasha A.; Soliman, Mohamed A.; Jorgensen, Claus; Tucholska, Monika; Rottapel, Robert			The Shb scaffold binds the Nck adaptor protein, p120 RasGAP, and Chimaerins and thereby facilitates heterotypic cell segregation by the receptor EphB2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						receptor tyrosine kinase; signal transduction; phosphotyrosine signaling; Src homology 2 domain (SH2 domain); GTPase-activating protein (GAP); Chimaerin; EphB2; Eph receptor tyrosine kinase; Nck; p120 RasGAP; Shb	TYROSINE-KINASE; NEURONAL CIRCUITS; EPHA4; ACTIVATION; ADHESION; ALPHA-2-CHIMAERIN; MECHANISMS; EPHRIN-B3; MESODERM; REVEALS	Eph receptors are a family of receptor tyrosine kinases that control directional cell movement during various biological processes, including embryogenesis, neuronal pathfinding, and tumor formation. The biochemical pathways of Eph receptors are context-dependent in part because of the varied composition of a heterotypic, oligomeric, active Eph receptor complex. Downstream of the Eph receptors, little is known about the essential phosphorylation events that define the context and instruct cell movement. Here, we define a pathway that is required for Eph receptor B2 (EphB2)?mediated cell sorting and is conserved among multiple Eph receptors. Utilizing a HEK293 model of EphB2(+)/ephrinB1(+) cell segregation, we found that the scaffold adaptor protein SH2 domain?containing adaptor protein B (Shb) is essential for EphB2 functionality. Further characterization revealed that Shb interacts with known modulators of cytoskeletal rearrangement and cell mobility, including Nck adaptor protein (Nck), p120-Ras GTPase-activating protein (RasGAP), and the ?- and ?-Chimaerin Rac GAPs. We noted that phosphorylation of Tyr(297), Tyr(246), and Tyr(336) of Shb is required for EphB2?ephrinB1 boundary formation, as well as binding of Nck, RasGAP, and the chimaerins, respectively. Similar complexes were formed in the context of EphA4, EphA8, EphB2, and EphB4 receptor activation. These results indicate that phosphotyrosine-mediated signaling through Shb is essential in EphB2-mediated heterotypic cell segregation and suggest a conserved function for Shb downstream of multiple Eph receptors.	[Wagner, Melany J.; Doodnauth, Sasha A.; Rottapel, Robert] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5S 1A8, Canada; [Wagner, Melany J.; Hsiung, Marilyn S.; Gish, Gerald D.; Bagshaw, Rick D.; Soliman, Mohamed A.; Tucholska, Monika] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Jorgensen, Claus] Univ Manchester, Canc Res UK Manchester Inst, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England; [Rottapel, Robert] Univ Toronto, Dept Med, Toronto, ON M5S, Canada; [Rottapel, Robert] Univ Toronto, Dept Immunol, Toronto, ON M5S, Canada; [Rottapel, Robert] Univ Toronto, Dept Med Biophys, Toronto, ON M5S, Canada; [Rottapel, Robert] St Michaels Hosp, Div Rheumatol, 30 Bond St, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Cancer Research UK; University of Manchester; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Wagner, MJ; Rottapel, R (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5S 1A8, Canada.; Wagner, MJ (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.; Rottapel, R (corresponding author), Univ Toronto, PMCRT MaRS, 101 Coll St,Rm 12-704, Toronto, ON M5G 1L7, Canada.	mjdwagner@hotmail.com; rottapel@gmail.com		Bagshaw, Rick/0000-0001-5013-4291; Jorgensen, Claus/0000-0002-7841-943X	Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a foundation grant from the Canadian Institutes for Health Research (to R. R.).	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Batlle E, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008227; Becker E, 2000, MOL CELL BIOL, V20, P1537, DOI 10.1128/MCB.20.5.1537-1545.2000; Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036; Bisson N, 2011, NAT BIOTECHNOL, V29, P653, DOI 10.1038/nbt.1905; Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Cayuso J, 2015, DEV BIOL, V401, P122, DOI 10.1016/j.ydbio.2014.11.013; Chaki Sankar P, 2013, Bioarchitecture, V3, P57, DOI 10.4161/bioa.25744; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Fawcett JP, 2007, P NATL ACAD SCI USA, V104, P20973, DOI 10.1073/pnas.0710316105; Finger C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000547; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Holmqvist K, 2003, CELL SIGNAL, V15, P171, DOI 10.1016/S0898-6568(02)00076-1; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Janes PW, 2011, J CELL BIOL, V195, P1033, DOI 10.1083/jcb.201104037; Jorgensen C, 2009, SCIENCE, V326, P1502, DOI 10.1126/science.1176615; Kania A, 2016, NAT REV MOL CELL BIO, V17, P240, DOI 10.1038/nrm.2015.16; Kim I, 2002, FASEB J, V16, P1126, DOI 10.1096/fj.01-0805fje; Kriz V, 2006, J BIOL CHEM, V281, P34484, DOI 10.1074/jbc.M604084200; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Li W, 2001, ONCOGENE, V20, P6403, DOI 10.1038/sj.onc.1204782; Lindholm CK, 1999, J BIOL CHEM, V274, P28050, DOI 10.1074/jbc.274.39.28050; Lisabeth EM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009159; Liu GM, 2010, NAT BIOTECHNOL, V28, P1015, DOI 10.1038/nbt1010-1015; Matskova LV, 2007, ONCOGENE, V26, P4908, DOI 10.1038/sj.onc.1210298; Noren NK, 2009, BIOCHEM J, V422, P433, DOI 10.1042/BJ20090014; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Poliakov A, 2008, J CELL BIOL, V183, P933, DOI 10.1083/jcb.200807151; Shah K, 2002, CHEM BIOL, V9, P35, DOI 10.1016/S1074-5521(02)00086-8; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; Warner N, 2008, FEBS J, V275, P2561, DOI 10.1111/j.1742-4658.2008.06405.x; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Xiao Z, 2012, CANCER BIOL THER, V13, P630, DOI 10.4161/cbt.20080; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zisch AH, 1997, J NEUROSCI RES, V47, P655, DOI 10.1002/(SICI)1097-4547(19970315)47:6<655::AID-JNR12>3.0.CO;2-U	46	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3932	3944		10.1074/jbc.RA119.009276	http://dx.doi.org/10.1074/jbc.RA119.009276			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32060095	hybrid, Green Published			2022-12-26	WOS:000527704400018
J	Gu, WP; Wang, WG; Tong, PF; Liu, CX; Jia, J; Lu, CX; Han, YY; Sun, XM; Kuang, DX; Li, N; Dai, JJ				Gu, Wenpeng; Wang, Wenguang; Tong, Pinfen; Liu, Chenxiu; Jia, Jie; Lu, Caixia; Han, Yuanyuan; Sun, Xiaomei; Kuang, Dexuan; Li, Na; Dai, Jiejie			Comparative genomic analysis of Proteus spp. isolated from tree shrews indicated unexpectedly high genetic diversity	PLOS ONE			English	Article							ISLAND 1 VARIANT; ANIMAL-MODEL; MIRABILIS; CLASSIFICATION; EXPRESSION; SEQUENCE; IDENTIFICATION; PATHOGENS; FLAGELLIN; ALIGNMENT	Proteus spp. are commensal gastrointestinal bacteria in many hosts, but information regarding the mutual relationships between these bacteria and their hosts is limited. The tree shrew is an alternative laboratory animal widely used for human disease research. However, little is known about the relationship between Proteus spp. and tree shrews. In this study, the complete genome sequencing method was used to analyse the characteristics of Proteus spp. isolated from tree shrews, and comparative genomic analysis was performed to reveal their relationships. The results showed that 36 Proteus spp. bacteria were isolated, including 34 Proteus mirabilis strains and two Proteus vulgaris strains. The effective rate of sequencing was 93.53%+/- 2.73%, with an average GC content of 39.94%+/- 0.25%. Briefly, 3682.89 +/- 90.37, 2771.36 +/- 36.01 and 2832.06 +/- 42.49 genes were annotated in the NCBI non-redundant nucleotide database (NR), SwissProt database and KEGG database, respectively. The high proportions of macrolide-, vancomycin-, bacitracin-, and tetracycline-resistance profiles of the strains were annotated in the Antibiotic Resistance Genes Database (ARDB). Flagella, lipooligosaccharides, type 1 fimbriae and P fimbriae were the most abundantly annotated virulence factors in the Virulence Factor Database (VFDB). SNP variants indicated high proportions of base transitions (Ts), homozygous mutations (Hom) and non-synonymous mutations (Non-Syn) in Proteus spp. (P<0.05). Phylogenetic analysis of Proteus spp. and other references revealed high genetic diversity for strains isolated from tree shrews, and host specificity of Proteus spp. bacteria was not found. Overall, this study provided important information on characteristics of genome for Proteus spp. isolated from tree shrews.	[Gu, Wenpeng; Wang, Wenguang; Tong, Pinfen; Liu, Chenxiu; Jia, Jie; Lu, Caixia; Han, Yuanyuan; Sun, Xiaomei; Kuang, Dexuan; Li, Na; Dai, Jiejie] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Ctr Tree Shrew Germplasm Resources,Yunnan Innovat, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Yunnan, Peoples R China; [Gu, Wenpeng] Yunnan Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Kunming, Yunnan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases; Peking Union Medical College	Dai, JJ (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Ctr Tree Shrew Germplasm Resources,Yunnan Innovat, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Yunnan, Peoples R China.	djj@imbcams.com.cn	Wang, WenGuang/AAW-2800-2020		Yunnan Science and Technology Talent and Platform Program [2017HC019]; Yunnan Joint Support for National Program [2015GA009]; Yunnan Province Major Science and Technology Project [2017ZF007]; National Natural Science Foundation of China (NSFC) [U1702282]	Yunnan Science and Technology Talent and Platform Program; Yunnan Joint Support for National Program; Yunnan Province Major Science and Technology Project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by Yunnan Science and Technology Talent and Platform Program (2017HC019); Yunnan Joint Support for National Program (2015GA009); Yunnan Province Major Science and Technology Project (2017ZF007); and National Natural Science Foundation of China (NSFC) (U1702282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeolu M, 2016, INT J SYST EVOL MICR, V66, P5575, DOI 10.1099/ijsem.0.001485; Akhter S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks406; Akinbowale OL, 2007, J APPL MICROBIOL, V103, P2016, DOI 10.1111/j.1365-2672.2007.03445.x; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Bittar F, 2014, SCI REP-UK, V4, DOI 10.1038/srep07174; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Buhnik-Rosenblau K, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-149; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Doublet B, 2010, J ANTIMICROB CHEMOTH, V65, P2260, DOI 10.1093/jac/dkq283; Drzewiecka D, 2016, MICROB ECOL, V72, P741, DOI 10.1007/s00248-015-0720-6; Feng Y, 2017, J GEN VIROL, V98, P2069, DOI 10.1099/jgv.0.000869; Fuchs E, 2005, CNS SPECTRUMS, V10, P182, DOI 10.1017/S1092852900010038; Gaastra W, 1996, VET MICROBIOL, V48, P57, DOI 10.1016/0378-1135(95)00133-6; Gu WP, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1581-9; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamilton AL, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00085-17; Han YY, 2017, INT J MOL MED, V40, P1679, DOI 10.3892/ijmm.2017.3168; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Iredell J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6420; Knirel YA, 2011, INNATE IMMUN-LONDON, V17, P70, DOI 10.1177/1753425909360668; Kroemer S, 2014, COMP IMMUNOL MICROB, V37, P97, DOI 10.1016/j.cimid.2013.10.001; Kuan L, 2014, J MED MICROBIOL, V63, P911, DOI 10.1099/jmm.0.069971-0; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RF, 2018, J THORAC DIS, V10, pS2272, DOI 10.21037/jtd.2017.12.121; Liu M, 2019, NUCLEIC ACIDS RES, V47, pD660, DOI 10.1093/nar/gky1123; Lopez-Yglesias AH, 2014, J IMMUNOL, V192, P1587, DOI 10.4049/jimmunol.1301893; Lowe BA, 2011, VET MICROBIOL, V147, P346, DOI 10.1016/j.vetmic.2010.06.025; Lu CX, 2018, AGING-US, V10, P833, DOI 10.18632/aging.101437; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Ma Q, 2012, ISME J, V6, P1356, DOI 10.1038/ismej.2011.210; MASSAD G, 1994, INFECT IMMUN, V62, P1989, DOI 10.1128/IAI.62.5.1989-1994.1994; Meyer U, 2001, HIPPOCAMPUS, V11, P329, DOI 10.1002/hipo.1047; Morgenstein RM, 2010, FEMS MICROBIOL REV, V34, P753, DOI 10.1111/j.1574-6976.2010.00229.x; Narasimhan V, 2016, BIOINFORMATICS, V32, P1749, DOI 10.1093/bioinformatics/btw044; O'Hara CM, 2000, INT J SYST EVOL MICR, V50, P1869, DOI 10.1099/00207713-50-5-1869; O'Hara CM, 2000, CLIN MICROBIOL REV, V13, P534, DOI 10.1128/CMR.13.4.534-546.2000; Olaitan AO, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00643; Pearson MM, 2008, J BACTERIOL, V190, P4027, DOI 10.1128/JB.01981-07; Qin SS, 2015, ANTIMICROB AGENTS CH, V59, P6601, DOI 10.1128/AAC.00292-15; Rozalski A, 1997, MICROBIOL MOL BIOL R, V61, P65; Schaffer JN, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.UTI-0017-2013; Shen Pei-Qing, 2011, Zoological Research, V32, P109, DOI 10.3724/SP.J.1141.2011.01109; WINSOR DK, 1981, APPL ENVIRON MICROB, V42, P1123, DOI 10.1128/AEM.42.6.1123-1124.1981; Yang ZF, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-111; Yao YG, 2017, ZOOL RES, V38, P118, DOI 10.24272/j.issn.2095-8137.2017.032; Yong LH, 2008, TROP BIOMED, V25, P134; Zhu S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-382	51	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229125	10.1371/journal.pone.0229125	http://dx.doi.org/10.1371/journal.pone.0229125			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084183	gold, Green Published			2022-12-26	WOS:000535227900055
J	Hsieh, YC; Hsieh, WH; Li, CH; Liao, YC; Lin, JC; Weng, CJ; Lo, MT; Tuan, TC; Lin, SF; Yeh, HI; Huang, JL; Haugan, K; Larsen, BD; Lin, YJ; Lin, WW; Wu, TJ; Chen, SA				Hsieh, Yu-Cheng; Hsieh, Wan-Hsin; Li, Cheng-Hung; Liao, Ying-Chieh; Lin, Jiunn-Cherng; Weng, Chi-Jen; Lo, Men-Tzung; Tuan, Ta-Chuan; Lin, Shien-Fong; Yeh, Hung-, I; Huang, Jin-Long; Haugan, Ketil; Larsen, Bjarne D.; Lin, Yenn-Jiang; Lin, Wei-Wen; Wu, Tsu-Juey; Chen, Shih-Ann			Ventricular divergence correlates with epicardial wavebreaks and predicts ventricular arrhythmia in isolated rabbit hearts during therapeutic hypothermia	PLOS ONE			English	Article							T-WAVE ALTERNANS; INTRACELLULAR CALCIUM; DISCORDANT ALTERNANS; FIBRILLATION; INCREASES; TEMPERATURE; TACHYCARDIA; RESTITUTION; MECHANISM; ISCHEMIA	Introduction High beat-to-beat morphological variation (divergence) on the ventricular electrogram during programmed ventricular stimulation (PVS) is associated with increased risk of ventricular fibrillation (VF), with unclear mechanisms. We hypothesized that ventricular divergence is associated with epicardial wavebreaks during PVS, and that it predicts VF occurrence. Method and results Langendorff-perfused rabbit hearts (n = 10) underwent 30-min therapeutic hypothermia (TH, 30 degrees C), followed by a 20-min treatment with rotigaptide (300 nM), a gap junction modifier. VF inducibility was tested using burst ventricular pacing at the shortest pacing cycle length achieving 1:1 ventricular capture. Pseudo-ECG (p-ECG) and epicardial activation maps were simultaneously recorded for divergence and wavebreaks analysis, respectively. A total of 112 optical and p-ECG recordings (62 at TH, 50 at TH treated with rotigaptide) were analyzed. Adding rotigaptide reduced ventricular divergence, from 0.13 +/- 0.10 at TH to 0.09 +/- 0.07 (p = 0.018). Similarly, rotigaptide reduced the number of epicardial wavebreaks, from 0.59 +/- 0.73 at TH to 0.30 +/- 0.49 (p = 0.036). VF inducibility decreased, from 48 +/- 31% at TH to 22 +/- 32% after rotigaptide infusion (p = 0.032). Linear regression models showed that ventricular divergence correlated with epicardial wavebreaks during TH (p<0.001). Conclusion Ventricular divergence correlated with, and might be predictive of epicardial wavebreaks during PVS at TH. Rotigaptide decreased both the ventricular divergence and epicardial wavebreaks, and reduced the probability of pacing-induced VF during TH.	[Hsieh, Yu-Cheng; Li, Cheng-Hung; Liao, Ying-Chieh; Lin, Jiunn-Cherng; Weng, Chi-Jen; Huang, Jin-Long; Lin, Wei-Wen; Wu, Tsu-Juey] Taichung Vet Gen Hosp, Cardiovasc Ctr, Taichung, Taiwan; [Hsieh, Yu-Cheng; Li, Cheng-Hung; Liao, Ying-Chieh; Lin, Jiunn-Cherng; Weng, Chi-Jen; Huang, Jin-Long; Lin, Wei-Wen; Wu, Tsu-Juey] Chiayi Branch, Taichung, Taiwan; [Hsieh, Yu-Cheng; Li, Cheng-Hung; Liao, Ying-Chieh; Lin, Jiunn-Cherng; Weng, Chi-Jen; Huang, Jin-Long; Lin, Wei-Wen; Wu, Tsu-Juey] Taichung Vet Gen Hosp, Cardiovasc Ctr, Chiayi, Taiwan; [Hsieh, Yu-Cheng; Li, Cheng-Hung; Liao, Ying-Chieh; Lin, Jiunn-Cherng; Weng, Chi-Jen; Huang, Jin-Long; Lin, Wei-Wen; Wu, Tsu-Juey] Chiayi Branch, Chiayi, Taiwan; [Hsieh, Yu-Cheng; Li, Cheng-Hung; Liao, Ying-Chieh; Lin, Jiunn-Cherng; Weng, Chi-Jen; Tuan, Ta-Chuan; Huang, Jin-Long; Lin, Yenn-Jiang; Wu, Tsu-Juey; Chen, Shih-Ann] Natl Yang Ming Univ, Sch Med, Cardiovasc Res Ctr, Inst Clin Med,Fac Med,Dept Internal Med, Taipei, Taiwan; [Hsieh, Yu-Cheng; Li, Cheng-Hung; Liao, Ying-Chieh; Lin, Jiunn-Cherng; Weng, Chi-Jen] Providence Univ, Dept Data Sci & Big Data Analyt, Taichung, Taiwan; [Hsieh, Yu-Cheng; Li, Cheng-Hung; Liao, Ying-Chieh; Lin, Jiunn-Cherng; Weng, Chi-Jen] Providence Univ, Dept Financial Engn, Taichung, Taiwan; [Hsieh, Wan-Hsin] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu, Taiwan; [Lo, Men-Tzung] Natl Cent Univ, Res Ctr Adapt Data Anal, Jhongli, Taiwan; [Tuan, Ta-Chuan; Lin, Yenn-Jiang; Chen, Shih-Ann] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Lin, Shien-Fong] Indiana Univ Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; [Lin, Shien-Fong] Indiana Univ Sch Med, Div Cardiol, Dept Med, Indianapolis, IN 46202 USA; [Lin, Shien-Fong] Natl Chiao Tung Univ, Inst Biomed Engn, Hsinchu, Taiwan; [Yeh, Hung-, I] Mackay Mem Hosp, Mackay Med Coll, Dept Internal Med, New Taipei, Taiwan; [Yeh, Hung-, I] Mackay Mem Hosp, Mackay Med Coll, Dept Med Res, New Taipei, Taiwan; [Haugan, Ketil] Zealand Univ Hosp, Dept Cardiol, Roskilde, Denmark; [Larsen, Bjarne D.] Zealand Pharma AS, Glostrup, Denmark; [Lin, Wei-Wen] Tunghai Univ, Dept Life Sci, Taichung, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Providence University - Taiwan; Providence University - Taiwan; Industrial Technology Research Institute - Taiwan; National Central University; Taipei Veterans General Hospital; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; National Yang Ming Chiao Tung University; Mackay Medical College; Mackay Memorial Hospital; Mackay Medical College; Mackay Memorial Hospital; Zealand Pharma A/S; Tunghai University	Hsieh, YC (corresponding author), Taichung Vet Gen Hosp, Cardiovasc Ctr, Taichung, Taiwan.; Hsieh, YC (corresponding author), Chiayi Branch, Taichung, Taiwan.; Hsieh, YC (corresponding author), Taichung Vet Gen Hosp, Cardiovasc Ctr, Chiayi, Taiwan.; Hsieh, YC (corresponding author), Chiayi Branch, Chiayi, Taiwan.; Hsieh, YC (corresponding author), Natl Yang Ming Univ, Sch Med, Cardiovasc Res Ctr, Inst Clin Med,Fac Med,Dept Internal Med, Taipei, Taiwan.; Hsieh, YC (corresponding author), Providence Univ, Dept Data Sci & Big Data Analyt, Taichung, Taiwan.; Hsieh, YC (corresponding author), Providence Univ, Dept Financial Engn, Taichung, Taiwan.	ychsieh@vghtc.gov.tw		Lin, Shien-fong/0000-0003-1270-3961; Lin, Wei-Wen/0000-0002-9384-1970; Lin, Yenn-Jiang/0000-0001-8395-1052	National Science Council, Taipei, Taiwan [104-2314-B-367-001, 105-2314-B-075A-016 -MY3]; Taichung Veterans General Hospital, Taichung, Taiwan [TCVGH1033105C, TCVGH-1043109C, TCVGH-1053108C, VGHUST104-G5-2-2, VGHUST107-G5-1-3, TCVGH-VHCY1068606, TCVGH-VHCY1078603]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan); Taichung Veterans General Hospital, Taichung, Taiwan	This study was supported by grants from the National Science Council (104-2314-B-367-001 and 105-2314-B-075A-016 -MY3), Taipei, Taiwan; and Taichung Veterans General Hospital (TCVGH1033105C, TCVGH-1043109C, TCVGH-1053108C, VGHUST104-G5-2-2, VGHUST107-G5-1-3, TCVGH-VHCY1068606, and TCVGH-VHCY1078603), Taichung, Taiwan. Zealand Pharma A/S provided support in the form of salaries for author [BDL] and rotigaptide, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khatib Sana M, 2018, J Am Coll Cardiol, V72, pe91, DOI 10.1016/j.jacc.2017.10.054; Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Camm AJ, 1996, EUR HEART J, V17, P354; Cao JM, 1999, CIRC RES, V84, P1318, DOI 10.1161/01.RES.84.11.1318; Choi BR, 2007, HEART RHYTHM, V4, P1057, DOI 10.1016/j.hrthm.2007.03.037; Chorro FJ, 2002, AM J PHYSIOL-HEART C, V283, pH2331, DOI 10.1152/ajpheart.00207.2002; Chou CC, 2005, CIRCULATION, V111, P2889, DOI 10.1161/CIRCULATIONAHA.104.498758; Donnino MW, 2015, CIRCULATION, V132, P2448, DOI 10.1161/CIR.0000000000000313; Erkapic D, 2015, EUROPACE, V17, P591, DOI 10.1093/europace/euu282; Gold MR, 2000, J AM COLL CARDIOL, V36, P2247, DOI 10.1016/S0735-1097(00)01017-2; Harada M, 2008, AM J PHYSIOL-HEART C, V294, pH1896, DOI 10.1152/ajpheart.00986.2007; Hayashi H, 2007, HEART RHYTHM, V4, P927, DOI 10.1016/j.hrthm.2007.02.028; Hsieh YC, 2016, HEART RHYTHM, V13, P251, DOI 10.1016/j.hrthm.2015.07.023; Hsieh YC, 2013, CIRC-ARRHYTHMIA ELEC, V6, P410, DOI 10.1161/CIRCEP.111.000152; Hsieh YC, 2011, CIRC J, V75, P1706, DOI 10.1253/circj.CJ-10-1001; Hsieh YC, 2009, CIRC J, V73, P2214, DOI 10.1253/circj.CJ-09-0432; Hwang GS, 2006, CIRCULATION, V114, P2595, DOI 10.1161/CIRCULATIONAHA.106.630509; Kjolbye AL, 2008, AM J PHYSIOL-HEART C, V294, pH41, DOI 10.1152/ajpheart.01089.2006; Liu YB, 2003, J CARDIOVASC ELECTR, V14, P1103, DOI 10.1046/j.1540-8167.2003.03218.x; Myerburg RJ, 2012, CIRCULATION, V125, P1043, DOI 10.1161/CIRCULATIONAHA.111.023846; Nearing BD, 2002, CIRC RES, V91, P727, DOI 10.1161/01.RES.0000038887.17976.33; Pastore JM, 1999, CIRCULATION, V99, P1385, DOI 10.1161/01.CIR.99.10.1385; Raatikainen MJP, 2005, PACE, V28, pS193, DOI 10.1111/j.1540-8159.2005.00110.x; Shiroshita-Takeshita A, 2007, CIRCULATION, V115, P310, DOI 10.1161/CIRCULATIONAHA.106.665547; Shusterman V, 2006, CIRCULATION, V113, P2880, DOI 10.1161/CIRCULATIONAHA.105.607895; SMITH JM, 1988, CIRCULATION, V77, P110, DOI 10.1161/01.CIR.77.1.110; Swerdlow C, 2011, CIRCULATION, V123, P1052, DOI 10.1161/CIRCULATIONAHA.110.986364; Tachibana H, 1998, AM J PHYSIOL-HEART C, V275, pH116, DOI 10.1152/ajpheart.1998.275.1.H116; Tuan TC, 2014, J CARDIOVASC ELECTR, V25, P411, DOI 10.1111/jce.12340; Ullah A, 1996, J STAT PLAN INFER, V49, P137, DOI 10.1016/0378-3758(95)00034-8; Weiss JN, 2000, CIRC RES, V87, P1103, DOI 10.1161/01.RES.87.12.1103; Xing DZ, 2003, J CARDIOVASC ELECTR, V14, P510, DOI 10.1046/j.1540-8167.2003.02329.x; Zaitsev AV, 2003, CIRC RES, V92, P546, DOI 10.1161/01.RES.0000061917.23107.F7	33	1	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0228818	10.1371/journal.pone.0228818	http://dx.doi.org/10.1371/journal.pone.0228818			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084145	Green Published, gold			2022-12-26	WOS:000535227900030
J	Seo, JY; Lee, JE; Chung, GE; Shin, E; Kwak, MS; Yang, JI; Yim, JY				Seo, Ji Yeon; Lee, Jong-Eun; Chung, Goh Eun; Shin, Eunsoon; Kwak, Min-Sun; Yang, Jong In; Yim, Jeong Yoon			A genome-wide association study on liver enzymes in Korean population	PLOS ONE			English	Article							BILIRUBIN LEVELS; SERUM BILIRUBIN; ALKALINE-PHOSPHATASE; IDENTIFIES LOCI; ISCHEMIC-STROKE; HEART-DISEASE; VARIANTS; UGT1A1; ABO; UGT1A1-ASTERISK-28	Background Although genetic features vary across ethnicities, few genome-wide association studies (GWAS) have reported the genetic determinants of liver enzyme expression. This study was aimed to evaluate the associations of genome-wide single nuclear polymorphisms (SNPs) with the liver enzymes in a Korean population. Methods We performed a GWAS to identify genetic loci influencing liver function, as measured by concentrations of alkaline phosphatase (ALP), alanine transaminase (ALT), gamma-glutamyl transferase (GGT) and total bilirubin (BIL) in in Korean study participants. Results A total of 6,488 subjects (4,457 in the discovery and 2,031 in the validation set) were included. The mean subject age was 50.0 +/- 10.6 years (male, 53.7%). Among a total of 546,738 SNPs tested, rs651007 and rs579459 located in the ABO gene showed strong associations with ALP (P = 1.63x10(-8) and 5.61x10(-8), respectively [discovery set]; P = 4.08x10(-15) and 9.92x10(-16), respectively [validation set]). Additionally, rs5751901 and rs2006092, which are located in the GGT1 gene, showed strong associations with GGT (P = 6.44x10(-15) and 1.26x10(-15), respectively [discovery set]; P = 4.13x10(-10) and 5.15x10(-11), respectively [validation set]). Among the 13 SNPs that showed genome-wide significance with total bilirubin levels, rs10929302 and rs6742078 showed the most significant association (P = 3.08x10(-64) and 2.05x10(-62), respectively [discovery set]; P = 1.33x10(-116) and 2.24x10(-118), respectively [validation set]). No genome-wide significant associations was found for ALT. Conclusions We demonstrated that ABO, GGT1 and UGT1A family were associated with ALP, GGT and BIL, respectively in Korean population. These findings differ from reported results in GWAS in European populations in terms of associated genes and locations, suggesting different genetic mechanisms of liver enzyme regulation according to ethnicity.	[Seo, Ji Yeon; Chung, Goh Eun; Kwak, Min-Sun; Yang, Jong In; Yim, Jeong Yoon] Seoul Natl Univ Hosp, Gangnam Healthcare Ctr, Dept Internal Med, Seoul, South Korea; [Lee, Jong-Eun; Shin, Eunsoon] DNALink Inc, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital	Chung, GE (corresponding author), Seoul Natl Univ Hosp, Gangnam Healthcare Ctr, Dept Internal Med, Seoul, South Korea.	gohwom@snu.ac.kr		Chung, Goh Eun/0000-0001-8344-7737	DNA Link	DNA Link	Funding organization: DNA Link. Jong-Eun Lee declares to be CEO of a company of DNA link. Eunsoon Shin declare a paid employee of a company of DNA link.The funder provided support in the form of salaries for authors [J.E. Lee and E. Shin], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bathum L, 2001, CLIN CHEM, V47, P81; Bruzelius M, 2014, THROMB RES, V134, P426, DOI 10.1016/j.thromres.2014.03.054; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Chen GJ, 2012, EUR J HUM GENET, V20, P463, DOI 10.1038/ejhg.2011.206; Choe EK, 2018, EUR J CANCER PREV, V27, P453, DOI 10.1097/CEJ.0000000000000359; Chung GE, 2016, CLIN MOL HEPATOL, V22, P146, DOI 10.3350/cmh.2016.22.1.146; Coltell O, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010090; Jinno H, 2003, DRUG METAB DISPOS, V31, P108, DOI 10.1124/dmd.31.1.108; Johnson AD, 2009, HUM MOL GENET, V18, P2700, DOI 10.1093/hmg/ddp202; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kang TW, 2010, HUM MOL GENET, V19, P3672, DOI 10.1093/hmg/ddq281; KILLIP T, 1960, CIRCULATION, V21, P646, DOI 10.1161/01.CIR.21.5.646; Kim JS, 2013, YONSEI MED J, V54, P1149, DOI 10.3349/ymj.2013.54.5.1149; Kollerits B, 2010, J MED GENET, V47, P116, DOI 10.1136/jmg.2009.066597; Lazo M, 2008, ANN INTERN MED, V148, P348, DOI 10.7326/0003-4819-148-5-200803040-00005; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; Ling XM, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0671-7; Masuda Masatoshi, 2015, Hum Genome Var, V2, P15019, DOI 10.1038/hgv.2015.19; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Middelberg RP, 2012, HUM MOL GENET, V21, P446, DOI 10.1093/hmg/ddr478; Monami M, 2008, METABOLISM, V57, P387, DOI 10.1016/j.metabol.2007.10.015; Nakano T, 2006, BIOCHEM BIOPH RES CO, V341, P33, DOI 10.1016/j.bbrc.2005.12.145; Oussalah A, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000925; Park Tae-Joon, 2013, Genomics & Informatics, V11, P149, DOI 10.5808/GI.2013.11.3.149; Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707; Rahmioglu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004435; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Tang W, 2012, HUM MOL GENET, V21, P1918, DOI 10.1093/hmg/ddr619; Urawa N, 2006, ONCOL REP, V16, P801; van Beek JHDA, 2013, BEHAV GENET, V43, P329, DOI 10.1007/s10519-013-9593-y; WHITFIELD JB, 1983, AM J HUM GENET, V35, P978; Williams FMK, 2013, ANN NEUROL, V73, P16, DOI 10.1002/ana.23838; Young KA, 2019, OBESITY, V27, P1331, DOI 10.1002/oby.22527; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; Zhang HQ, 2005, METHOD ENZYMOL, V401, P468, DOI 10.1016/S0076-6879(05)01028-1	37	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229374	10.1371/journal.pone.0229374	http://dx.doi.org/10.1371/journal.pone.0229374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084209	Green Published, gold			2022-12-26	WOS:000535227900099
J	Gupta, A; Stocker, H				Gupta, Avantika; Stocker, Hugo			tpHusion: An efficient tool for clonal pH determination in Drosophila	PLOS ONE			English	Article							INTRACELLULAR PH; IMAGINAL DISC; GROWTH; DIFFERENTIATION; ACIDIFICATION; EXPRESSION; EXCHANGE; DESIGN; SIZE	Genetically encoded pH indicators (GEpHI) have emerged as important tools for investigating intracellular pH (pHi) dynamics in Drosophila. However, most of the indicators are based on the Gal4/UAS binary expression system. Here, we report the generation of a ubiquitously-expressed GEpHI. The fusion protein of super ecliptic pHluorin and FusionRed was cloned under the tubulin promoter (tpHusion) to drive it independently of the Gal4/UAS system. The function of tpHusion was validated in various tissues from different developmental stages of Drosophila. Differences in pHi were also indicated correctly in fixed tissues. Finally, we describe the use of tpHusion for comparative analysis of pHi in manipulated clones and the surrounding cells in epithelial tissues. Our findings establish tpHusion as a robust tool for studying pHi in Drosophila.	[Gupta, Avantika; Stocker, Hugo] Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland	ETH Zurich	Stocker, H (corresponding author), Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland.	stocker@imsb.biol.ethz.ch		Gupta, Avantika/0000-0002-8170-6720	Swiss National Science Foundation [SNF 31003A_166680]; Swiss Cancer League [KLS-3407-02-2014]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League	This work was supported by grants from the Swiss National Science Foundation (SNF 31003A_166680; http://www.snf.ch) and the Swiss Cancer League (KLS-3407-02-2014; https://www. krebsliga.ch) to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bencina M, 2013, SENSORS-BASEL, V13, P16736, DOI 10.3390/s131216736; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; de la Loza MCD, 2017, MECH DEVELOP, V144, P23, DOI 10.1016/j.mod.2016.10.003; Delloye-Bourgeois C, 2014, JOVE-J VIS EXP, DOI 10.3791/50883; Eichler K, 2017, NATURE, V548, P175, DOI 10.1038/nature23455; Flinck M, 2018, ACTA PHYSIOL, V223, DOI 10.1111/apha.13068; Freyberg Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10652; Gao W, 2014, CELL PHYSIOL BIOCHEM, V33, P185, DOI 10.1159/000356661; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Grillo-Hill BK, 2015, ELIFE, P4; Grillo-Hill BK, 2014, METHOD CELL BIOL, V123, P429, DOI 10.1016/B978-0-12-420138-5.00023-9; Halfar K, 2001, DEVELOPMENT, V128, P1687; Han JY, 2010, CHEM REV, V110, P2709, DOI 10.1021/cr900249z; Handke B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107333; Hariharan IK, 2017, CURR OPIN CELL BIOL, V48, P10, DOI 10.1016/j.ceb.2017.03.005; Hariharan IK, 2015, DEV CELL, V34, P255, DOI 10.1016/j.devcel.2015.07.012; HARRIS KP, 2016, ELIFE, P5; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Karim FD, 1998, DEVELOPMENT, V125, P1; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Kramer Jamie M, 2003, Genet Mol Res, V2, P43; Li XJ, 2009, AM J PHYSIOL-HEART C, V296, pH159, DOI 10.1152/ajpheart.00375.2008; Loiselle FB, 2010, METHODS MOL BIOL, V637, P311, DOI 10.1007/978-1-60761-700-6_17; Majdi A, 2016, J NEUROSCI RES, V94, P879, DOI 10.1002/jnr.23757; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mirzoyan Z, 2019, FRONT GENET, P10; Nowak K, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007347; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Peters NC, 2016, METHODS MOL BIOL, V1457, P35, DOI 10.1007/978-1-4939-3795-0_4; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Poskanzer KE, 2003, NATURE, V426, P559, DOI 10.1038/nature02184; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; Ramon-Canellas P, 2019, NEUROSCIENCE, V399, P39, DOI 10.1016/j.neuroscience.2018.12.014; Rossano AJ, 2017, J PHYSIOL-LONDON, V595, P805, DOI 10.1113/JP273105; Rossano AJ, 2013, J PHYSIOL-LONDON, V591, P1691, DOI 10.1113/jphysiol.2012.248377; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Scheffer LK, 2019, ANNU REV CELL DEV BI, V35, P637, DOI 10.1146/annurev-cellbio-100818-125444; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shemiakina II, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2208; Shih CT, 2015, CURR BIOL, V25, P1249, DOI 10.1016/j.cub.2015.03.021; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; Stawarski M, 2020, J NEUROSCI, V40, P1611, DOI 10.1523/JNEUROSCI.1774-19.2020; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Tanida I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110600; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Treisman JE, 2013, WIRES DEV BIOL, V2, P545, DOI 10.1002/wdev.100; Tsao CK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163744; Ulmschneider B, 2016, J CELL BIOL, V215, P345, DOI 10.1083/jcb.201606042; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; White KA, 2019, CANCER METAST REV, V38, P17, DOI 10.1007/s10555-019-09791-8; Yagi R, 2010, P NATL ACAD SCI USA, V107, P16166, DOI 10.1073/pnas.1005957107; Zartman J, 2013, DEVELOPMENT, V140, P667, DOI 10.1242/dev.088872; Zecca M, 2002, DEVELOPMENT, V129, P1357	55	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0228995	10.1371/journal.pone.0228995	http://dx.doi.org/10.1371/journal.pone.0228995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7VI	32059043	Green Published, gold			2022-12-26	WOS:000535206600025
J	Henderson, DM; Denkers, ND; Hoover, CE; McNulty, EE; Cooper, SK; Bracchi, LA; Mathiason, CK; Hoover, EA				Henderson, Davin M.; Denkers, Nathaniel D.; Hoover, Clare E.; McNulty, Erin E.; Cooper, Sarah K.; Bracchi, Lauren A.; Mathiason, Candace K.; Hoover, Edward A.			Progression of chronic wasting disease in white-tailed deer analyzed by serial biopsy RT-QuIC and immunohistochemistry	PLOS ONE			English	Article							QUAKING-INDUCED CONVERSION; CERVUS-ELAPHUS-NELSONI; PRION PROTEIN; ANTEMORTEM DETECTION; LYMPHOID-TISSUES; ELK; MANAGEMENT; POLYMORPHISMS; URINE; ASSAY	Chronic wasting disease (CWD) continues to spread or be recognized in the United States, Canada, and Europe. CWD is diagnosed by demonstration of the causative misfolded prion protein (PrPCWD) in either brain or lymphoid tissue using immunodetection methods, with immunohistochemistry (IHC) recognized as the gold standard. In recent years, in vitro amplification assays have been developed that can detect CWD prion seeding activity in tissues, excreta, and body fluids of affected cervids. These methods potentially offer earlier and more facile detection of CWD, both pre- and post-mortem. Here we provide a longitudinal profile of CWD infection progression, as assessed by both real-time quaking-induced conversion (RT-QuIC) and IHC on serial biopsies of mucosal lymphoid tissues of white-tailed deer orally exposed to low doses of CWD prions. We report that detection of CWD infection by RT-QuIC preceded that by IHC in both tonsil and recto-anal lymphoid tissue (RAMALT) in 14 of 19 deer (74%). Of the 322 biopsy samples collected in post-exposure longitudinal monitoring, positive RT-QuIC results were obtained for 146 samples, 91 of which (62%) were concurrently also IHC-positive. The lower frequency of IHC positivity was manifest most in the earlier post-exposure periods and in biopsies in which lymphoid follicles were not detected. For all deer in which RT-QuIC seeding activity was detected in a tonsil or RAMALT biopsy, PrPCWD was subsequently or concurrently detected by IHC. Overall, this study (a) provides a longitudinal profile of CWD infection in deer after low yet infectious oral prion exposure; (b) illustrates the value of RT-QuIC for sensitive detection of CWD; and (c) demonstrates an ultimate high degree of correlation between RT-QuIC and IHC positivity as CWD infection progresses.	[Henderson, Davin M.; Denkers, Nathaniel D.; Hoover, Clare E.; McNulty, Erin E.; Cooper, Sarah K.; Bracchi, Lauren A.; Mathiason, Candace K.; Hoover, Edward A.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Prion Res Ctr, Ft Collins, CO 80523 USA	Colorado State University	Hoover, EA (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Prion Res Ctr, Ft Collins, CO 80523 USA.	edward.hoover@colostate.edu		Cooper, Sarah/0000-0001-9656-2283; McNulty, Erin/0000-0003-1918-6207	National Institutes of Health [R01-AI112956, R01-NS061902, P01-AI-077774]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	EAH; R01-NS061902, P01-AI-077774. National Institutes of Health https://www.nih.gov/CKM; R01-AI112956. National Institutes of Health https://www.nih.gov/The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agriculture SBo, 2019, IMM SICKN; Atarashi R, 2011, PRION, V5, P150, DOI 10.4161/pri.5.3.16893; Benestad SL, 2016, VET RES, V47, DOI 10.1186/s13567-016-0375-4; Cheng YC, 2017, JOVE-J VIS EXP, DOI 10.3791/56373; Cheng YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166187; Conner MM, 2007, ECOL APPL, V17, P140, DOI 10.1890/1051-0761(2007)017[0140:AMAFEM]2.0.CO;2; Conner MM, 2008, ANN NY ACAD SCI, V1134, P146, DOI 10.1196/annals.1439.005; Davenport KA, 2018, J CLIN MICROBIOLOGY, V56; Davenport KA, 2018, J GEN VIROL, V99, P753, DOI 10.1099/jgv.0.001053; Davenport KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183927; Denkers ND, 2016, J GEN VIROL, V97, P2023, DOI 10.1099/jgv.0.000515; Denkers ND, 2013, J VIROL, V87, P1890, DOI 10.1128/JVI.02852-12; Elder AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080203; Haley NJ, 2018, PRION, V12, P93, DOI 10.1080/19336896.2018.1436925; Haley NJ, 2016, J CLIN MICROBIOL, V54, P1108, DOI 10.1128/JCM.02699-15; Haley NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081488; Henderson DM, 2015, J VIROL, V89, P9338, DOI 10.1128/JVI.01118-15; Henderson DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074377; Hoover CE, 2017, J VIROLOGY, V91; John TR, 2013, PRION, V7, P253, DOI 10.4161/pri.24430; Johnson C, 2006, J GEN VIROL, V87, P2109, DOI 10.1099/vir.0.81615-0; Johnson CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017450; Joly DO, 2006, J WILDLIFE DIS, V42, P578, DOI 10.7589/0090-3558-42.3.578; Keane DP, 2008, J VET DIAGN INVEST, V20, P58, DOI 10.1177/104063870802000110; Kelly AC, 2008, PRION, V2, P28, DOI 10.4161/pri.2.1.6321; Manne S, 2017, PRION, V11, P415, DOI 10.1080/19336896.2017.1368936; Nalls AV, 2017, J VIROL, V91, DOI 10.1128/JVI.00501-17; Orru CD, 2015, FLUID, V6, P1, DOI DOI 10.1128/MBI0.02451-14; Orru CD, 2014, NEW ENGL J MED, V371, P519, DOI 10.1056/NEJMoa1315200; Perucchini M, 2008, J GEN VIROL, V89, P1324, DOI 10.1099/vir.0.83424-0; Pirisinu L, 2018, EMERG INFECT DIS, V24, P2210, DOI 10.3201/eid2412.180702; Race B, 2011, J VIROL, V85, P9235, DOI 10.1128/JVI.00790-11; Robinson SJ, 2012, PRION, V6, P153, DOI 10.4161/pri.19640; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sohn HJ, 2002, J VET MED SCI, V64, P855, DOI 10.1292/jvms.64.855; Spraker TR, 2004, VET REC, V155, P295, DOI 10.1136/vr.155.10.295; Vikoren T, 2019, J WILDLIFE DIS, V55, P970, DOI 10.7589/2018-10-262; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Williams ES, 2002, REV SCI TECH OIE, V21, P305, DOI 10.20506/rst.21.2.1340	40	10	10	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0228327	10.1371/journal.pone.0228327	http://dx.doi.org/10.1371/journal.pone.0228327			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7VI	32059005	gold, Green Published, Green Submitted			2022-12-26	WOS:000535206600008
J	Pinto, CFD; Lehr, W; Pignone, VN; Chain, CP; Trevizan, L				Dourado Pinto, Caroline Fredrich; Lehr, Willian; Pignone, Viviam Nunes; Chain, Caio Peixoto; Trevizan, Luciano			Evaluation of teeth injuries in Beagle dogs caused by autoclaved beef bones used as a chewing item to remove dental calculus	PLOS ONE			English	Article							ESOPHAGEAL FOREIGN-BODIES; ORAL-HEALTH; PERIODONTAL-DISEASE; SODIUM HEXAMETAPHOSPHATE; BODY REMOVAL; DIET; ACCUMULATION; HYGIENE; PLAQUE; RAWHIDE	Dental calculus (DC) is the most widespread oral problem in domestic dogs. Chewing items are used to remove DC from the tooth surface; they also favor oral health and animal welfare. Raw beef bone mastication also shortly reduces DC in adult dogs. However, it can cause oral lesions and hence is not popular. This study evaluated the impact of bone mastication on the dental roots, enamel, and gingiva of dogs. Twelve adult Beagle dogs were randomly divided into 2 treatment groups in a completely randomized block design: cortical bone (CB) or spongy bone (SB). Intraoral radiographs were obtained on days 0 and 14, and calculus assessment was performed using images captured on days 0, 3, 6, 9, 12, and 14; an integration program was used to measure the proportion between the area covered by calculus and the total area of teeth. DC was completely removed from the first and second premolars and molars from both the arcades in less than 3 days of supplementation, indicating that these teeth were frequently used for chewing (P < 0.10). Bones were highly effective for DC removal and gingival inflammation reduction. Despite the hardness of bones, no lesions or teeth root and enamel fracture, or esophageal or intestinal obstructions-complications related to bone ingestion-were noted. However, SB showed some gingival lesions (n = 4) and bone remnants between teeth (n = 2). Gingival lesions were caused by the daily and continuous supply of new pieces of bone for 13 days. Specific pieces of bone should be used for oral home care programs because they shortly remove almost 90% of DC, allowing longer intervals between periodontal cleaning procedures. Long-term studies are required to evaluate the use of bones and evaluate their impact on teeth and periodontium after prolonged supplementation.	[Dourado Pinto, Caroline Fredrich; Lehr, Willian; Trevizan, Luciano] Univ Fed Rio Grande do Sul, Dept Anim Sci, Porto Alegre, RS, Brazil; [Pignone, Viviam Nunes] AllPet Odonto, Porto Alegre, RS, Brazil; [Chain, Caio Peixoto] Univ Fed Rural Rio de Janeiro, Dept Publ Adm, Seropedica, RJ, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal Rural do Rio de Janeiro (UFRRJ)	Trevizan, L (corresponding author), Univ Fed Rio Grande do Sul, Dept Anim Sci, Porto Alegre, RS, Brazil.	ltrevizan@ufrgs.br	Fredrich, Caroline/AAW-6686-2021; Trevizan, Luciano/AAH-3405-2020	Trevizan, Luciano/0000-0002-1819-0653; Fredrich Dourado Pinto, Caroline/0000-0002-3531-3985	Brazilian governmental research support institution Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES	Brazilian governmental research support institution Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES	This study was supported by the Brazilian governmental research support institution Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SL, 2009, PESQUISA VET BRASIL, V29, P666, DOI 10.1590/S0100-736X2009000800011; ANNEROTH G, 1975, ACTA ODONTOL SCAND, V33, P119, DOI 10.3109/00016357509026352; Buckley C, 2011, BRIT J NUTR, V106, pS124, DOI 10.1017/S0007114511000821; Carciofi A. C., 2007, Ars Veterinaria, V23, P47; Colyer F, 1990, COLYERS VARIATIONS D; Crossley D, 2002, VET DENT BASICS; DeBowes L J, 1996, J Vet Dent, V13, P57; Doring D, 2016, J VET BEHAV, V13, P39, DOI 10.1016/j.jveb.2016.03.010; Floyd M R, 1991, J Vet Dent, V8, P18; Fujita K, 2008, J ANIM CLIN MED, V17, P109; Gawor JP, 2006, J NUTR, V136, p2021S, DOI 10.1093/jn/136.7.2021S; Gianella P, 2009, J SMALL ANIM PRACT, V50, P649, DOI 10.1111/j.1748-5827.2009.00845.x; Gorrel C, 1998, J NUTR, V128, p2712S, DOI 10.1093/jn/128.12.2712S; Gracis M, 1998, J Vet Dent, V15, P65; Greggianin BF, 2013, J CLIN PERIODONTOL, V40, P319, DOI 10.1111/jcpe.12072; Harvey C, 2015, J VET DENT, V32, P16, DOI 10.1177/089875641503200102; Hennet P, 2006, J VET DENT, V23, P6, DOI 10.1177/089875640602300101; Juvet F, 2010, IRISH VET J, V63, P163, DOI 10.1186/2046-0481-63-3-163; Kapoor V, 2016, RES VET SCI, V107, P213, DOI 10.1016/j.rvsc.2016.06.009; Kortegaard HE, 2008, J SMALL ANIM PRACT, V49, P610, DOI 10.1111/j.1748-5827.2008.00609.x; Laflamme D, 1997, CANINE PRACT, V22, P10; LAGE A, 1990, J AM VET MED ASSOC, V197, P213; Leib MS, 2008, JAVMA-J AM VET MED A, V232, P1021, DOI 10.2460/javma.232.7.1021; Logan EI, 2002, J VET DENT, V19, P15, DOI 10.1177/089875640201900102; Lopes FM, 2005, J VET DENT, V22, P86, DOI 10.1177/089875640502200202; Marx FR, 2016, AUST VET J, V94, P18, DOI 10.1111/avj.12394; National Research Council, 2006, NUTR REQ DOGS CATS, V10th; Paiva AC, 2007, ARQ BRAS MED VET ZOO, V59, P1177, DOI 10.1590/S0102-09352007000500013; Pavlica Z, 2008, J VET DENT, V25, P97, DOI 10.1177/089875640802500210; Pinto ABF, 2008, ARQ BRAS MED VET ZOO, V60, P1426, DOI 10.1590/S0102-09352008000600018; Quest BW, 2013, J VET DENT, V30, P84, DOI 10.1177/089875641303000203; Rousseau A, 2007, J VET EMERG CRIT CAR, V17, P159, DOI 10.1111/j.1476-4431.2007.00227.x; Shelbourne T, 2010, WOLF PRINT, V39, P12; Stookey G. K., 1996, Journal of Veterinary Dentistry, V13, P27; Stookey GK, 2009, J VET DENT, V26, P82, DOI 10.1177/089875640902600202; STOOKEY GK, 1995, AM J VET RES, V56, P913; Thompson HC, 2012, J VET EMERG CRIT CAR, V22, P253, DOI 10.1111/j.1476-4431.2011.00700.x; Valkenburgh BV, 2019, ELIFE, V8, P1; VOSBURGH KM, 1982, J ZOO ANIM MED, V13, P104, DOI 10.2307/20094590; WATSON ADJ, 1994, AUST VET J, V71, P313, DOI 10.1111/j.1751-0813.1994.tb00905.x; Wiggs RB., 1997, VET DENT PRINCIPLES, P165; Zambori C., 2012, ANIM SCI BIOTECHNOL, V45, P208	42	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228146	10.1371/journal.pone.0228146	http://dx.doi.org/10.1371/journal.pone.0228146			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053619	Green Published, gold			2022-12-26	WOS:000535198700019
J	Kang, W; Tong, T; Park, T				Kang, Wesuk; Tong, Tao; Park, Taesun			Corticotropin releasing factor-overexpressing mouse is a model of chronic stress-induced muscle atrophy	PLOS ONE			English	Article							ALTERS SIGNALING PATHWAYS; SKELETAL-MUSCLE; GLUCOCORTICOID-RECEPTOR; PSYCHOLOGICAL STRESS; INSULIN-RESISTANCE; PROTEIN-SYNTHESIS; TRANSGENIC MICE; VISCERAL FAT; RESPONSES; TURNOVER	Chronic stress and continually high glucocorticoid levels can induce muscle atrophy. Unfortunately, there is a lack of appropriate animal models for stress-induced muscle atrophy research. Corticotropin releasing factor-overexpressing (CRF-OE) mice are a transgenic model of chronic stress that exhibit increased plasma corticosterone levels and Cushing's syndrome; however, the skeletal muscle pathology of the CRF-OE mouse has not been well studied. We observed that male, 19-week-old CRF-OE mice had significantly lower skeletal muscle mass, average cross-sectional myofiber area, and total muscle protein content than their wild type (WT) littermates. Muscle function determined by grip strength, wire-hang, and open field tests showed that 19-week-old male CRF-OE mice had impaired physical ability. Additionally, the skeletal muscles of CRF-mice exhibited decreased expression of factors involved in the IGF-1/AKT/mTOR protein synthesis pathway and increased ubiquitin proteasome pathway activity compared to the WT control mice. In conclusion, 19-week-old CRF-OE mice display numerous features of muscle atrophy and thus serve as a model for investigating stress-induced muscle atrophy and interventions to target the deleterious effects of stress on skeletal muscle.	[Kang, Wesuk; Tong, Tao; Park, Taesun] Yonsei Univ, Dept Food & Nutr, Brain Korea Plus Project 21, Seoul, South Korea	Yonsei University	Park, T (corresponding author), Yonsei Univ, Dept Food & Nutr, Brain Korea Plus Project 21, Seoul, South Korea.	tspark@yonsei.ac.kr	Kang, Wesuk/HGD-3210-2022; Tong, Tao/Q-8856-2016	Tong, Tao/0000-0002-9309-2893	National Research Foundation of Korea (NRF) - Korean government (MSIT) [2019R1A2C2003340]	National Research Foundation of Korea (NRF) - Korean government (MSIT)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2019R1A2C2003340).	Allen DL, 2010, AM J PHYSIOL-REG I, V299, pR889, DOI 10.1152/ajpregu.00296.2010; Amirouche A, 2009, ENDOCRINOLOGY, V150, P286, DOI 10.1210/en.2008-0959; Belizario JE, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2197-2; Borst SE, 2005, CYTOKINE, V32, P39, DOI 10.1016/j.cyto.2005.07.008; Branth S, 2007, NUTR METAB CARDIOVAS, V17, P427, DOI 10.1016/j.numecd.2006.03.001; DARDEVET D, 1995, J CLIN INVEST, V96, P2113, DOI 10.1172/JCI118264; DEBOER SF, 1988, PHYSIOL BEHAV, V44, P273, DOI 10.1016/0031-9384(88)90149-7; DEKHUIJZEN PNR, 1995, J APPL PHYSIOL, V78, P629, DOI 10.1152/jappl.1995.78.2.629; Depke M, 2008, ENDOCRINOLOGY, V149, P2714, DOI 10.1210/en.2008-0038; Domingues-Faria C, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-47; Durieux AC, 2007, ENDOCRINOLOGY, V148, P3140, DOI 10.1210/en.2006-1500; Engelbrecht AM, 2010, STRESS, V13, P132, DOI 10.3109/10253890903089834; Gilson H, 2007, ENDOCRINOLOGY, V148, P452, DOI 10.1210/en.2006-0539; Goebel M, 2010, NEUROSCI LETT, V473, P11, DOI 10.1016/j.neulet.2010.01.068; Goldberg AL, 1980, FEDERATION P; Grissom N, 2009, NEUROBIOL LEARN MEM, V92, P215, DOI 10.1016/j.nlm.2008.07.001; Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004; HALLER RG, 1984, MED CLIN N AM, V68, P91, DOI 10.1016/S0025-7125(16)31243-3; HAMMARQVIST F, 1994, METABOLISM, V43, P1158, DOI 10.1016/0026-0495(94)90060-4; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Johansen KL, 2003, KIDNEY INT, V63, P291, DOI 10.1046/j.1523-1755.2003.00704.x; Kaasik P, 2007, J STEROID BIOCHEM, V105, P85, DOI 10.1016/j.jsbmb.2006.11.024; KELLY FJ, 1986, MUSCLE NERVE, V9, P1, DOI 10.1002/mus.880090102; Kuo TY, 2012, P NATL ACAD SCI USA, V109, P11160, DOI 10.1073/pnas.1111334109; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lofberg E, 2002, EUR J CLIN INVEST, V32, P345, DOI 10.1046/j.1365-2362.2002.00993.x; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; Million M, 2007, AM J PHYSIOL-REG I, V292, pR1429, DOI 10.1152/ajpregu.00626.2006; Mizoguchi K, 2003, NEUROSCIENCE, V119, P887, DOI 10.1016/S0306-4522(03)00105-2; Moldin SO, 2001, MAMM GENOME, V12, P575, DOI 10.1007/s00335-001-4005-7; Paddon-Jones D, 2006, J CLIN ENDOCR METAB, V91, P4836, DOI 10.1210/jc.2006-0651; Pasini Evasio, 2003, Ital Heart J, V4, P232; Pellegrinelli V, 2015, DIABETES, V64, P3121, DOI 10.2337/db14-0796; Poornimn KN, 2014, J CLIN DIAGN RES, V8, P8, DOI [10.7860/JCDR/2014/7014.3966, 10.7860/JCDR/20147014.3966]; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Rom O, 2012, ANN NY ACAD SCI, V1259, P47, DOI 10.1111/j.1749-6632.2012.06532.x; Roubenoff R, 2004, OBES RES, V12, P887, DOI 10.1038/oby.2004.107; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Seene T, 2003, J STEROID BIOCHEM, V86, P201, DOI 10.1016/j.jsbmb.2003.08.002; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Shinahara M, 2009, ENDOCR J, V56, P879, DOI 10.1507/endocrj.K09E-038; Sishi B, 2011, EXP PHYSIOL, V96, P179, DOI 10.1113/expphysiol.2010.054189; STENZELPOORE MP, 1992, ENDOCRINOLOGY, V130, P3378, DOI 10.1210/en.130.6.3378; STENZELPOORE MP, 1994, J NEUROSCI, V14, P2579; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Surjo D, 2001, PHYSIOL BEHAV, V73, P691, DOI 10.1016/S0031-9384(01)00526-1; Tatem KS, 2014, JOVE-J VIS EXP, DOI 10.3791/51785; THIAGARAJAN AB, 1989, PSYCHOPHARMACOLOGY, V97, P548, DOI 10.1007/BF00439562; Traish AM, 2011, HORM MOL BIOL CLIN I, V8, P431, DOI 10.1515/HMBCI.2011.132; van Putten M., 2011, USE HANGING WIRE TES; Velloso CP, 2008, BRIT J PHARMACOL, V154, P557, DOI 10.1038/bjp.2008.153; Wallace K, 2010, AM J PATHOL, V177, P1225, DOI 10.2353/ajpath.2010.100107; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wang LX, 2017, BIOL SEX DIFFER, V8, DOI 10.1186/s13293-016-0122-6; Williams-Dautovich J, 2017, JBMR PLUS, V1, P46, DOI 10.1002/jbm4.10009; Zimmers T.A., 2016, SEMINARS CELL DEV BI	59	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0229048	10.1371/journal.pone.0229048	http://dx.doi.org/10.1371/journal.pone.0229048			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32049987	Green Published, gold			2022-12-26	WOS:000535192300045
J	Diaz-Coranguez, M; Lin, CM; Liebner, S; Antonetti, DA				Diaz-Coranguez, Monica; Lin, Cheng-Mao; Liebner, Stefan; Antonetti, David A.			Norrin restores blood-retinal barrier properties after vascular endothelial growth factor?induced permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vascular endothelial growth factor (VEGF); tight junction; permeability; retina; endothelium; cell signaling; tetraspanin; Wnt signaling; blood-retinal barrier; diabetic retinopathy; norrin; tetraspanin 12 (TSPAN12)	FAMILIAL EXUDATIVE VITREORETINOPATHY; TIGHT JUNCTION TRAFFICKING; PROTEIN-COUPLED RECEPTOR; BRAIN-BARRIER; WNT/BETA-CATENIN; BETA-CATENIN; CNS ANGIOGENESIS; MUTATION SPECTRUM; LRP5 MUTATIONS; DISEASE	Vascular endothelial growth factor (VEGF) contributes to blood-retinal barrier (BRB) dysfunction in several blinding eye diseases, including diabetic retinopathy. Signaling via the secreted protein norrin through the frizzled class receptor 4 (FZD4)/LDL receptor?related protein 5?6 (LRP5?6)/tetraspanin 12 (TSPAN12) receptor complex is required for developmental vascularization and BRB formation. Here, we tested the hypothesis that norrin restores BRB properties after VEGF-induced vascular permeability in diabetic rats or in animals intravitreally injected with cytokines. Intravitreal co-injection of norrin with VEGF completely ablated VEGF-induced BRB permeability to Evans Blue-albumin. Likewise, 5-month diabetic rats exhibited increased permeability of FITC-albumin, and a single norrin injection restored BRB properties. These results were corroborated in vitro, where co-stimulation of norrin with VEGF or stimulation of norrin after VEGF exposure restored barrier properties, indicated by electrical resistance or 70-kDa RITC-dextran permeability in primary endothelial cell culture. Interestingly, VEGF promoted norrin signaling by increasing the FZD4 co-receptor TSPAN12 at cell membranes in an MAPK/ERK kinase (MEK)/ERK-dependent manner. Norrin signaling through ?-catenin was required for BRB restoration, but glycogen synthase kinase 3 ?/? (GSK-3?/?) inhibition did not restore BRB properties. Moreover, levels of the tight junction protein claudin-5 were increased with norrin and VEGF or with VEGF alone, but both norrin and VEGF were required for enriched claudin-5 localization at the tight junction. These results suggest that VEGF simultaneously induces vascular permeability and promotes responsiveness to norrin. Norrin, in turn, restores tight junction complex organization and BRB properties in a ?-catenin?dependent manner.	[Diaz-Coranguez, Monica; Lin, Cheng-Mao; Antonetti, David A.] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, 1000 Wall St, Ann Arbor, MI 48105 USA; [Liebner, Stefan] Goethe Univ, Univ Hosp, Inst Neurol, Edinger Inst, D-60538 Frankfurt, Germany	University of Michigan System; University of Michigan; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Antonetti, DA (corresponding author), Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, 1000 Wall St, Ann Arbor, MI 48105 USA.	dantonet@med.umich.edu			National Institutes of Health [EY012021, P30EY007003, DK020572]; Jules Doris Stein Professorship from Research to Prevent Blindness; American Diabetes Association Minority Postdoctoral Fellowship Award [4-16PMF-003]; Deutsche Forschungsgemeinschaft (DFG) [FOR2325, LI 911/5-1]; Excellence Cluster Cardio-Pulmonary Institute (CPI); European Union HORIZON 2020 Grant [MSCA-ITN-2015 675619]; German Centre for Heart and Circulation Research (DZHK) [81X2800146]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jules Doris Stein Professorship from Research to Prevent Blindness; American Diabetes Association Minority Postdoctoral Fellowship Award; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Excellence Cluster Cardio-Pulmonary Institute (CPI); European Union HORIZON 2020 Grant; German Centre for Heart and Circulation Research (DZHK)	This work was supported by National Institutes of Health Grant EY012021 (to D. A. A.) and Core Grants P30EY007003 and DK020572, the Jules Doris Stein Professorship from Research to Prevent Blindness (to D. A.) American Diabetes Association Minority Postdoctoral Fellowship Award 4-16PMF-003 (to M. D.-C.) and the Deutsche Forschungsgemeinschaft (DFG) research group FOR2325, "The Neurovascular Interface Grant LI 911/5-1; the Excellence Cluster Cardio-Pulmonary Institute (CPI); the European Union HORIZON 2020 Grant MSCA-ITN-2015 675619 "BtRAIN"; and the German Centre for Heart and Circulation Research (DZHK) Grant 81X2800146 (to S. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antonetti David A, 2003, Methods Mol Med, V89, P365; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Bassett EA, 2016, ELIFE, V5, DOI 10.7554/eLife.16764; Beck SC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24476-y; Berger W, 1996, HUM MOL GENET, V5, P51, DOI 10.1093/hmg/5.1.51; BERGER W, 1992, HUM MOL GENET, V1, P461, DOI 10.1093/hmg/1.7.461; Braunger BM, 2013, NEUROBIOL DIS, V50, P1, DOI 10.1016/j.nbd.2012.09.008; Bucher F, 2017, CIRCULATION, V136, P180, DOI 10.1161/CIRCULATIONAHA.116.025604; Chang JL, 2017, NAT MED, V23, P450, DOI 10.1038/nm.4309; Chen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030203; Chen J, 2011, CIRCULATION, V124, P1871, DOI 10.1161/CIRCULATIONAHA.111.040337; Chen Q, 2017, VISION RES, V139, P47, DOI 10.1016/j.visres.2017.02.007; Chen Y, 2009, AM J PATHOL, V175, P2676, DOI 10.2353/ajpath.2009.080945; Chen YJ, 2015, STROKE, V46, P529, DOI 10.1161/STROKEAHA.114.007265; Cho C, 2017, NEURON, V95, P1056, DOI 10.1016/j.neuron.2017.07.031; Cullen M, 2011, P NATL ACAD SCI USA, V108, P5759, DOI 10.1073/pnas.1017192108; Dailey WA, 2017, EXP EYE RES, V164, P129, DOI 10.1016/j.exer.2017.08.012; Fei P, 2015, SCI REP-UK, V5, DOI 10.1038/srep16120; Fei P, 2014, MOL VIS, V20, P395; Frey T, 2011, ANTIOXID REDOX SIGN, V15, P1271, DOI 10.1089/ars.2011.3906; Gal M, 2014, AM J MED GENET A, V164, P2996, DOI 10.1002/ajmg.a.36739; Halfter W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189857; Harhaj NS, 2002, J CELL PHYSIOL, V193, P349, DOI 10.1002/jcp.10183; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Ke JY, 2013, GENE DEV, V27, P2305, DOI 10.1101/gad.228544.113; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Lai MB, 2017, CELL REP, V19, P2809, DOI 10.1016/j.celrep.2017.06.004; Lee H, 2013, ACTA HISTOCHEM, V115, P447, DOI 10.1016/j.acthis.2012.10.008; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lin CM, 2018, AM J PATHOL, V188, P2392, DOI 10.1016/j.ajpath.2018.06.020; Liu Yuqing, 2017, Yichuan, V39, P241, DOI 10.16288/j.yczz.16-339; Mazzoni J, 2017, NEURON, V96, P1055, DOI 10.1016/j.neuron.2017.10.025; MEINDL A, 1992, NAT GENET, V2, P139, DOI 10.1038/ng1092-139; MEITINGER T, 1993, NAT GENET, V5, P376, DOI 10.1038/ng1293-376; Murakami T, 2012, DIABETES, V61, P1573, DOI 10.2337/db11-1367; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Musada GR, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0236-y; Musada GR, 2016, MOL VIS, V22, P491; Muthusamy A, 2014, J CEREBR BLOOD F MET, V34, P522, DOI 10.1038/jcbfm.2013.230; Ngo MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158320; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Ohlmann A, 2005, J NEUROSCI, V25, P1701, DOI 10.1523/JNEUROSCI.4756-04.2005; Ohlmann A, 2010, J NEUROSCI, V30, P183, DOI 10.1523/JNEUROSCI.3210-09.2010; Paes KT, 2011, INVEST OPHTH VIS SCI, V52, P6452, DOI 10.1167/iovs.10-7146; Panagiotou ES, 2017, AM J HUM GENET, V100, P960, DOI 10.1016/j.ajhg.2017.05.001; Parzefall T, 2014, AUDIOL NEURO-OTOL, V19, P203, DOI 10.1159/000358866; Posokhova E, 2015, CELL REP, V10, P123, DOI 10.1016/j.celrep.2014.12.020; Rattner A, 2014, INVEST OPHTH VIS SCI, V55, P8614, DOI 10.1167/iovs.14-15693; Richter M, 1998, INVEST OPHTH VIS SCI, V39, P2450; Roux PP, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00070-18; Rubio RG, 2016, DEV OPHTHALMOL, V55, P28, DOI 10.1159/000431129; Schafer NF, 2009, INVEST OPHTH VIS SCI, V50, P906, DOI 10.1167/iovs.08-1731; Schatz P, 2017, ACTA OPHTHALMOL, V95, P705, DOI 10.1111/aos.13411; Seitz R, 2010, J NEUROSCI, V30, P5998, DOI 10.1523/JNEUROSCI.0730-10.2010; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Thibeault S, 2010, MOL CELL, V39, P468, DOI 10.1016/j.molcel.2010.07.013; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Ulrich F, 2016, DEVELOPMENT, V143, P147, DOI 10.1242/dev.123059; Vanhollebeke B, 2015, ELIFE, V4, DOI 10.7554/eLife.06489; Wang YS, 2018, P NATL ACAD SCI USA, V115, pE11827, DOI 10.1073/pnas.1813217115; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Wisniewska-Kruk J, 2016, AM J PATHOL, V186, P1044, DOI 10.1016/j.ajpath.2015.11.019; Wu JH, 2016, HUM MOL GENET, V25, P1637, DOI 10.1093/hmg/ddw041; Xia CH, 2008, HUM MOL GENET, V17, P1605, DOI 10.1093/hmg/ddn047; Xia CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075186; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Xu QW, 2001, INVEST OPHTH VIS SCI, V42, P789; Xu Y, 2014, MOL VIS, V20, P1296; Ye X, 2011, GENE EXPR PATTERNS, V11, P151, DOI 10.1016/j.gep.2010.10.007; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Zeilbeck LF, 2016, EXP EYE RES, V145, P317, DOI 10.1016/j.exer.2015.12.001; Zeilbeck LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095546; Zhang C, 2018, ARTERIOSCL THROM VAS, V38, P2691, DOI 10.1161/ATVBAHA.118.311689; Zhang L, 2016, GENET TEST MOL BIOMA, V20, P346, DOI 10.1089/gtmb.2015.0322; Zhou YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143650; Zhou YL, 2014, DEV CELL, V31, P248, DOI 10.1016/j.devcel.2014.08.018; Zhou YL, 2014, J CLIN INVEST, V124, P3825, DOI 10.1172/JCI76431; Zuercher J, 2012, HUM MOL GENET, V21, P2619, DOI 10.1093/hmg/dds087	80	16	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4647	4660		10.1074/jbc.RA119.011273	http://dx.doi.org/10.1074/jbc.RA119.011273			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32086377	hybrid, Green Published			2022-12-26	WOS:000524499700023
J	Wiechmann, S; Maisonneuve, P; Grebbin, BM; Hoffmeister, M; Kaulich, M; Clevers, H; Rajalingam, K; Kurinov, I; Farin, HF; Sicheri, F; Ernst, A				Wiechmann, Svenja; Maisonneuve, Pierre; Grebbin, Britta M.; Hoffmeister, Meike; Kaulich, Manuel; Clevers, Hans; Rajalingam, Krishnaraj; Kurinov, Igor; Farin, Henner F.; Sicheri, Frank; Ernst, Andreas			Conformation-specific inhibitors of activated Ras GTPases reveal limited Ras dependency of patient-derived cancer organoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein engineering; crystal structure; phage display; colorectal cancer; substrate specificity; GTPase; protein design; protein-protein interaction; cancer organoids; oncogenic Ras; CRAF RBD; Ras-binding domain; conformation-specific inhibitors; Ras signaling; MAPK pathway; organoids; cancer; cell signaling	MAP KINASE; MACROMOLECULAR STRUCTURES; RAS/EFFECTOR; MUTANTS; REFINEMENT; EXTRACTION; PROTEINS; DELIVERY; BINDING	The small GTPases H, K, and NRAS are molecular switches indispensable for proper regulation of cellular proliferation and growth. Several mutations in the genes encoding members of this protein family are associated with cancer and result in aberrant activation of signaling processes caused by a deregulated recruitment of downstream effector proteins. In this study, we engineered variants of the Ras-binding domain (RBD) of the C-Raf proto-oncogene, Ser/Thr kinase (CRAF). These variants bound with high affinity with the effector-binding site of Ras in an active conformation. Structural characterization disclosed how the newly identified RBD mutations cooperate and thereby enhance affinity with the effector-binding site in Ras compared with WT RBD. The engineered RBD variants closely mimicked the interaction mode of naturally occurring Ras effectors and acted as dominant-negative affinity reagents that block Ras signal transduction. Experiments with cancer cells showed that expression of these RBD variants inhibits Ras signaling, reducing cell growth and inducing apoptosis. Using these optimized RBD variants, we stratified patient-derived colorectal cancer organoids with known Ras mutational status according to their response to Ras inhibition. These results revealed that the presence of Ras mutations was insufficient to predict sensitivity to Ras inhibition, suggesting that not all of these tumors required Ras signaling for proliferation. In summary, by engineering the Ras/Raf interface of the CRAF-RBD, we identified potent and selective inhibitors of Ras in its active conformation that outcompete binding of Ras-signaling effectors.	[Wiechmann, Svenja; Hoffmeister, Meike; Kaulich, Manuel; Ernst, Andreas] Goethe Univ Frankfurt, Univ Hosp, Med Fac, Inst Biochem 2, D-60596 Frankfurt, Germany; [Wiechmann, Svenja; Ernst, Andreas] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Maisonneuve, Pierre; Sicheri, Frank] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON MSG 1X5, Canada; [Grebbin, Britta M.; Farin, Henner F.] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Grebbin, Britta M.; Farin, Henner F.] Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, D-60596 Frankfurt, Germany; [Grebbin, Britta M.; Farin, Henner F.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Hoffmeister, Meike] Brandenburg Med Sch MHB Theodor Fontane, Inst Biochem, D-14770 Brandenburg, Germany; [Kaulich, Manuel] Frankfurt Canc Inst, D-60596 Frankfurt, Germany; [Clevers, Hans] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CX Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CX Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, Canc Genom Netherlands, NL-3584 CX Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, Dept Genet, Ctr Mol Med, NL-3584 CX Utrecht, Netherlands; [Rajalingam, Krishnaraj] JGU Mainz, Cell Biol Unit, Univ Med Ctr Mainz, D-55131 Mainz, Germany; [Kurinov, Igor] Cornell Univ, Dept Chem & Chem Biol, NE CAT, Argonne, IL 60439 USA	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Fraunhofer Gesellschaft; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Helmholtz Association; German Cancer Research Center (DKFZ); Octapharma; Helmholtz Association; German Cancer Research Center (DKFZ); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Johannes Gutenberg University of Mainz; Cornell University	Ernst, A (corresponding author), Goethe Univ Frankfurt, Univ Hosp, Med Fac, Inst Biochem 2, D-60596 Frankfurt, Germany.	ernst2001@gmail.com	Farin, Henner/AAC-2574-2021; Kaulich, Manuel/U-4523-2017	Farin, Henner/0000-0003-1558-5366; Kaulich, Manuel/0000-0002-9528-8822; Maisonneuve, Pierre/0000-0001-8292-5741	NIGMS, National Institutes of Health (NIH) [P41 GM103403]; NIH-ORIP HEI Grant [S10 RR029205]	NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-ORIP HEI Grant	We thank Mani Ravichandran from the Structural and Genomic Consortium (SGC) of Toronto for providing X-ray crystallography screening kits. Diffraction work conducted at the Northeastern Collaborative Access Team beamlines was funded by NIGMS, National Institutes of Health (NIH), Grant P41 GM103403 and by NIH-ORIP HEI Grant S10 RR029205. We thank Nancy R. Gough (BioSerendipity, LLC) for constructive comments and editorial assistance. We thank Jason Moffat (University of Toronto) for donation of inducible lentiviral plasmids. We thank Georg Tascher for help in analyzing MS data, Mateusz Putyrski for cloning lentiviral gateway constructs, and Suchithra Guntur and Andrew Vorobyov for assistance during the revision.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Auger A, 2015, MOL PHARMACEUT, V12, P2962, DOI 10.1021/acs.molpharmaceut.5b00233; Burgess MR, 2017, CELL, V168, P817, DOI 10.1016/j.cell.2017.01.020; Campbell-Valois FX, 2005, P NATL ACAD SCI USA, V102, P14988, DOI 10.1073/pnas.0500465102; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erijman A, 2016, MINI-REV MED CHEM, V16, P370, DOI 10.2174/1389557515666151001141838; Ernst A, 2013, SCIENCE, V339, P590, DOI 10.1126/science.1230161; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fellouse FAS, 2007, MAKING USING ANTIBOD, P157; Fetics SK, 2015, STRUCTURE, V23, P505, DOI 10.1016/j.str.2014.12.017; Filchtinski D, 2010, J MOL BIOL, V399, P422, DOI 10.1016/j.jmb.2010.03.046; Fridman M, 2000, J BIOL CHEM, V275, P30363, DOI 10.1074/jbc.M003193200; Fu AL, 2014, BIOCONJUGATE CHEM, V25, P1602, DOI 10.1021/bc500320j; Guillard S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16111; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karimkhani C, 2014, AM J CLIN DERMATOL, V15, P323, DOI 10.1007/s40257-014-0083-7; Kauke MJ, 2018, MOL CANCER THER, V17, P1773, DOI 10.1158/1535-7163.MCT-17-0645; Kauke MJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05889-7; Khan I, 2019, ONCOGENE, V38, P2984, DOI 10.1038/s41388-018-0636-y; Kiel C, 2004, J MOL BIOL, V340, P1039, DOI 10.1016/j.jmb.2004.05.050; Kiel C, 2009, J BIOL CHEM, V284, P31893, DOI 10.1074/jbc.M109.031153; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Kovalevskiy O, 2016, ACTA CRYSTALLOGR D, V72, P1149, DOI 10.1107/S2059798316014534; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Manzano JL, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.06.07; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGee JH, 2018, J BIOL CHEM, V293, P3265, DOI 10.1074/jbc.M117.816348; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakhaeizadeh H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167145; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Roderer D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13253-8; Rudolph MG, 2001, J BIOL CHEM, V276, P23914, DOI 10.1074/jbc.M011600200; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shin SM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15090; Spencer-Smith R, 2017, NAT CHEM BIOL, V13, P62, DOI [10.1038/nchembio.2231, 10.1038/NCHEMBIO.2231]; Tanaka T, 2007, EMBO J, V26, P3250, DOI 10.1038/sj.emboj.7601744; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Trinh TB, 2016, ACS COMB SCI, V18, P75, DOI 10.1021/acscombsci.5b00164; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Weber CK, 2001, CANCER RES, V61, P3595; Wiechmann S, 2017, J BIOL CHEM, V292, P15340, DOI 10.1074/jbc.M117.794255; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Yuryev A, 2000, MOL CELL BIOL, V20, P4870, DOI 10.1128/MCB.20.13.4870-4878.2000	56	10	11	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4526	4540		10.1074/jbc.RA119.011025	http://dx.doi.org/10.1074/jbc.RA119.011025			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32086379	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000524499700014
J	Holleman, GA; Hessels, RS; Kemner, C; Hooge, ITC				Holleman, Gijs A.; Hessels, Roy S.; Kemner, Chantal; Hooge, Ignace T. C.			Implying social interaction and its influence on gaze behavior to the eyes	PLOS ONE			English	Article							DUAL FUNCTION; ATTENTION; FACE; MOVEMENTS; CONTACT	Researchers have increasingly focused on how the potential for social interaction modulates basic processes of visual attention and gaze behavior. In this study, we investigated why people may experience social interaction and what factors contributed to their subjective experience. We furthermore investigated whether implying social interaction modulated gaze behavior to people's faces, specifically the eyes. To imply the potential for interaction, participants received either one of two instructions: 1) they would be presented with a person via a 'live' video-feed, or 2) they would be presented with a pre-recorded video clip of a person. Prior to the presentation, a confederate walked into a separate room to suggest to participants that (s)he was being positioned behind a webcam. In fact, all participants were presented with a pre-recorded clip. During the presentation, we measured participants' gaze behavior with an eye tracker, and after the presentation, participants were asked whether they believed that the confederate was `live' or not, and, why they thought so. Participants varied greatly in their judgements about whether the confederate was `live' or not. Analyses of gaze behavior revealed that a large subset of participants who received the live-instruction gazed less at the eyes of confederates compared with participants who received the pre-recorded-instruction. However, for both the live-instruction group and the prerecorded instruction group, another subset of participants gazed predominantly at the eyes. The current findings may contribute to the development of experimental designs aimed to capture the interactive aspects of social cognition and visual attention.	[Holleman, Gijs A.; Hessels, Roy S.; Kemner, Chantal; Hooge, Ignace T. C.] Univ Utrecht, Helmholtz Inst, Expt Psychol, Utrecht, Netherlands; [Holleman, Gijs A.; Hessels, Roy S.; Kemner, Chantal] Univ Utrecht, Dev Psychol, Utrecht, Netherlands; [Kemner, Chantal] Univ Med Ctr Utrecht, Brain Ctr, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center	Holleman, GA (corresponding author), Univ Utrecht, Helmholtz Inst, Expt Psychol, Utrecht, Netherlands.; Holleman, GA (corresponding author), Univ Utrecht, Dev Psychol, Utrecht, Netherlands.	g.a.holleman@uu.nl		Holleman, Gijs/0000-0002-6443-6212	Consortium on Individual Development (CID); Gravitation program of the Dutch Ministry of Education, Culture, and Science; NWO [024.001.003]	Consortium on Individual Development (CID); Gravitation program of the Dutch Ministry of Education, Culture, and Science; NWO(Netherlands Organization for Scientific Research (NWO))	Authors RSH and GAH were supported by the Consortium on Individual Development (CID). CID is funded through the Gravitation program of the Dutch Ministry of Education, Culture, and Science and the NWO (Grant No. 024.001.003). https://www.nwo.nl/en/funding/ourfunding-instruments/nwo/gravitation/gravitation.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, JASP VERS 0 9 COMP S; Arizpe J, 2017, VISION RES, V141, P191, DOI 10.1016/j.visres.2016.10.013; Baltrusaitis T, 2016, IEEE WINT CONF APPL; Beaudry O, 2014, COGNITION EMOTION, V28, P416, DOI 10.1080/02699931.2013.833500; Bernstein I.S., 1970, Primate Behav, V1, P71; Birmingham E, 2009, VISION RES, V49, P2992, DOI 10.1016/j.visres.2009.09.014; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brandi ML, 2020, BEHAV RES METHODS, V52, P1044, DOI 10.3758/s13428-019-01299-x; Buchan JN, 2007, SOC NEUROSCI-UK, V2, P1, DOI 10.1080/17470910601043644; Buswell Guy Thomas, 1935, PEOPLE LOOK PICTURES; Canigueral R, 2019, ACTA PSYCHOL, V195, P50, DOI 10.1016/j.actpsy.2019.02.002; Caruana N, 2017, NEUROSCI BIOBEHAV R, V74, P115, DOI 10.1016/j.neubiorev.2016.12.022; CHANCE MRA, 1967, MAN, V2, P503, DOI 10.2307/2799336; De Jaegher H, 2010, TRENDS COGN SCI, V14, P441, DOI 10.1016/j.tics.2010.06.009; Dovidio J. F., 1985, POWER DOMINANCE NONV, P129, DOI DOI 10.1007/978-1-4612-5106-4_7; Duncan S, 2015, FACE FACE INTERACTIO; ELLSWORTH PC, 1972, J PERS SOC PSYCHOL, V21, P302, DOI 10.1037/h0032323; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Foulsham T, 2011, VISION RES, V51, P1920, DOI 10.1016/j.visres.2011.07.002; Franchak JM, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12626; Freeth M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053286; Gobel MS, 2015, COGNITION, V136, P359, DOI 10.1016/j.cognition.2014.11.040; Goffman E, 2008, BEHAV PUBLIC PLACES; Gredeback G, 2010, DEVELOPMENTAL SCI, V13, P839, DOI 10.1111/j.1467-7687.2009.00945.x; Gregory NJ, 2019, Q J EXP PSYCHOL, V72, P779, DOI 10.1177/1747021818772812; GUERIN B, 1986, J EXP SOC PSYCHOL, V22, P38, DOI 10.1016/0022-1031(86)90040-5; Hamilton AFD, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0080; Henderson JM, 2005, MEM COGNITION, V33, P98, DOI 10.3758/BF03195300; Hessels RS, 2019, COGNITION, V184, P28, DOI 10.1016/j.cognition.2018.12.005; Hessels RS, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180502; Hessels RS, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01367; Hessels RS, 2018, J EXP PSYCHOPATHOL, V9, DOI 10.5127/jep.062917; Hessels RS, 2017, CAN J EXP PSYCHOL, V71, P226, DOI 10.1037/cep0000113; Hessels RS, 2016, BEHAV RES METHODS, V48, P1694, DOI 10.3758/s13428-015-0676-y; Hessels RS, 2015, BEHAV RES METHODS, V47, P848, DOI 10.3758/s13428-014-0507-6; Ho S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136905; Holmqvist K., 2012, P S EYE TRACK RES AP, P4552; Holmqvist K., 2011, EYE TRACKING COMPREH; Hooge I.T., 2018, BEHAV RES METHODS, P1; Hooge Ignace, 2013, Front Psychol, V4, P996, DOI 10.3389/fpsyg.2013.00996; Itier RJ, 2007, NEUROPSYCHOLOGIA, V45, P1019, DOI 10.1016/j.neuropsychologia.2006.09.004; KENDON A, 1967, ACTA PSYCHOL, V26, P22, DOI 10.1016/0001-6918(67)90005-4; Kerby D.S., 2014, INNOVATIVE TEACHING, V3, DOI [10.2466/11.IT.3.1, DOI 10.2466/11.IT.3.1]; Kingstone A, 2009, CURR OPIN NEUROBIOL, V19, P52, DOI 10.1016/j.conb.2009.05.004; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Laidlaw KEW, 2011, P NATL ACAD SCI USA, V108, P5548, DOI 10.1073/pnas.1017022108; LATANE B, 1981, AM PSYCHOL, V36, P343, DOI 10.1037/0003-066X.36.4.343; Macdonald RG, 2018, Q J EXP PSYCHOL, V71, P2162, DOI 10.1177/1747021817739221; Mehoudar E, 2014, J VISION, V14, DOI 10.1167/14.7.6; Myllyneva A, 2015, BIOL PSYCHOL, V109, P151, DOI 10.1016/j.biopsycho.2015.05.005; Nasiopoulos E., 2015, MANY FACES SOCIAL AT, P129, DOI DOI 10.1007/978-3-319-21368-2; Nation K, 2008, DEV PSYCHOPATHOL, V20, P79, DOI 10.1017/S0954579408000047; Neath KN, 2014, COGNITION EMOTION, V28, P115, DOI 10.1080/02699931.2013.812557; Niehorster DC, 2018, BEHAV RES METHODS, V50, P213, DOI 10.3758/s13428-017-0863-0; Nystrom M, 2013, BEHAV RES METHODS, V45, P272, DOI 10.3758/s13428-012-0247-4; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Peterson MF, 2016, J VISION, V16, DOI 10.1167/16.7.12; Peterson MF, 2013, PSYCHOL SCI, V24, P1216, DOI 10.1177/0956797612471684; Pfeiffer UJ, 2013, NEUROSCI BIOBEHAV R, V37, P2516, DOI 10.1016/j.neubiorev.2013.07.017; Pfeiffer UJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027591; Risko EF, 2016, CURR DIR PSYCHOL SCI, V25, P70, DOI 10.1177/0963721415617806; Risko EF, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00143; Risko EF, 2011, ATTEN PERCEPT PSYCHO, V73, P291, DOI 10.3758/s13414-010-0042-1; Robinson Peter, 2013, P IEEE INT C COMP VI; Rousselet GA, 2017, EUR J NEUROSCI, V46, P1738, DOI 10.1111/ejn.13610; Schilbach L, 2015, CURR OPIN BEHAV SCI, V3, P130, DOI 10.1016/j.cobeha.2015.03.006; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; VALENTI S S, 1991, Ecological Psychology, V3, P77, DOI 10.1207/s15326969eco0302_2; VAN HOOF J. A. R. A. M., 1967, P7; Vo MLH, 2012, J VISION, V12, DOI 10.1167/12.13.3; WALKERSMITH GJ, 1977, PERCEPTION, V6, P313, DOI 10.1068/p060313; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; Yu C, 2016, CURR BIOL, V26, P1235, DOI 10.1016/j.cub.2016.03.026; ZAJONC RB, 1965, SCIENCE, V149, P269, DOI 10.1126/science.149.3681.269; ZUCKERMAN M, 1983, PERS SOC PSYCHOL B, V9, P578, DOI 10.1177/0146167283094007	76	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229203	10.1371/journal.pone.0229203	http://dx.doi.org/10.1371/journal.pone.0229203			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8DW	32092089	Green Published, gold			2022-12-26	WOS:000535229300031
J	Han, SJ; Lovaszi, M; Kim, M; D'Agati, V; Hasko, G; Lee, HT				Han, Sang Jun; Lovaszi, Marianna; Kim, Mihwa; D'Agati, Vivette; Hasko, Gyorgy; Lee, H. Thomas			P2X4 receptor exacerbates ischemic AKI and induces renal proximal tubular NLRP3 inflammasome signaling	FASEB JOURNAL			English	Article						apoptosis; inflammasome; inflammation; ischemia and reperfusion injury; necrosis; neutrophil	ACUTE KIDNEY INJURY; A2B ADENOSINE RECEPTOR; REPERFUSION INJURY; SPHINGOSINE KINASE; HEPATIC-INJURY; KNOCKOUT MICE; PROTECTS; HYPOXIA; ACTIVATION; METABOLISM	We tested the hypothesis that the P2X4 purinergic receptor (P2X4) exacerbates ischemic acute kidney injury (AKI) by promoting renal tubular inflammation after ischemia and reperfusion (IR). Supporting this, P2X4-deficient (KO) mice were protected against ischemic AKI with significantly attenuated renal tubular necrosis, inflammation, and apoptosis when compared to P2X4 wild-type (WT) mice subjected to renal IR. Furthermore, WT mice treated with P2X4 allosteric agonist ivermectin had exacerbated renal IR injury whereas P2X4 WT mice treated with a selective P2X4 antagonist (5-BDBD) were protected against ischemic AKI. Mechanistically, induction of kidney NLRP3 inflammasome signaling after renal IR was significantly attenuated in P2X4 KO mice. A P2 agonist ATP gamma S increased NLRP3 inflammasome signaling (NLRP3 and caspase 1 induction and IL-1 beta processing) in isolated renal proximal tubule cells from WT mice whereas these increases were absent in renal proximal tubules isolated from P2X4 KO mice. Moreover, 5-BDBD attenuated ATP gamma S induced NLRP3 inflammasome induction in renal proximal tubules from WT mice. Finally, P2X4 agonist ivermectin induced NLRP3 inflammasome and pro-inflammatory cytokines in cultured human proximal tubule cells. Taken together, our studies suggest that renal proximal tubular P2X4 activation exacerbates ischemic AKI and promotes NLRP3 inflammasome signaling.	[Han, Sang Jun; Lovaszi, Marianna; Kim, Mihwa; Hasko, Gyorgy; Lee, H. Thomas] Columbia Univ, Coll Phys & Surg, Dept Anesthesiol, New York, NY USA; [D'Agati, Vivette] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA	Columbia University; Columbia University	Lee, HT (corresponding author), Columbia Univ, Dept Anesthesiol, Anesthesiol Res Labs, P&S Box 46,PH-5,630 West 168th St, New York, NY 10032 USA.	tl128@columbia.edu			HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK-109544, DK-115694, DK-113790]; HHS | NIH | National Institute of General Medical Sciences (NIGMS) [GM-066189]	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK-109544, DK-115694 and DK-113790; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM-066189	Antonioli L, 2019, CURR OPIN PHARMACOL, V47, P65, DOI 10.1016/j.coph.2019.02.011; Bakker PJ, 2014, AM J PATHOL, V184, P2013, DOI 10.1016/j.ajpath.2014.04.005; Bauerle JD, 2011, J AM SOC NEPHROL, V22, P14, DOI 10.1681/ASN.2009121217; Burnstock G, 2016, PURINERG SIGNAL, V12, P59, DOI 10.1007/s11302-015-9493-0; Chan AH, 2019, J EXP MED; Chen KH, 2013, INT J BIOCHEM CELL B, V45, P932, DOI 10.1016/j.biocel.2013.02.009; Colgan SP, 2012, ANNU REV PHYSIOL, V74, P153, DOI 10.1146/annurev-physiol-020911-153230; Csoka B, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99431; Daemen MARC, 2002, TRANSPLANTATION, V73, P1693; de Caestecker M, 2015, J AM SOC NEPHROL, V26, P2905, DOI 10.1681/ASN.2015070832; Dunton CL, 2018, INT UROL NEPHROL, V50, P1607, DOI 10.1007/s11255-018-1948-0; Eckle T, 2014, J IMMUNOL, V192, P1249, DOI 10.4049/jimmunol.1100593; Ehrentraut H, 2013, FASEB J, V27, P2207, DOI 10.1096/fj.12-225201; Elapavaluru S, 2007, ACTA CLIN BELG, V62, P326, DOI 10.1179/acb.2007.074; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2006, METH MOL B, V341, P73; Eltzschig HK, 2013, TRENDS MOL MED, V19, P345, DOI 10.1016/j.molmed.2013.02.005; Frangogiannis NG, 2007, THROMB HAEMOSTASIS, V97, P738, DOI 10.1160/TH07-01-0022; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Gallos G, 2005, AM J PHYSIOL-RENAL, V289, pF369, DOI 10.1152/ajprenal.00470.2004; Guo C, 2007, MOL PHARMACOL, V72, P1447, DOI 10.1124/mol.107.035980; Han SJ, 2019, KIDNEY RES CLIN PRAC, V38, P427, DOI 10.23876/j.krcp.19.062; Hart ML, 2008, ARTERIOSCL THROM VAS, V28, P1477, DOI 10.1161/ATVBAHA.108.169219; Hart ML, 2009, J IMMUNOL, V182, P3965, DOI 10.4049/jimmunol.0802193; Hung SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070210; JABLONSKI P, 1983, TRANSPLANTATION, V35, P198, DOI 10.1097/00007890-198303000-00002; Jacobson KA, 2016, NEUROPHARMACOLOGY, V104, P31, DOI 10.1016/j.neuropharm.2015.12.001; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Joo JD, 2007, AM J PHYSIOL-RENAL, V293, pF1847, DOI 10.1152/ajprenal.00336.2007; Joo JD, 2006, J AM SOC NEPHROL, V17, P3115, DOI 10.1681/ASN.2006050424; Ju C, 2016, J MOL MED, V94, P613, DOI 10.1007/s00109-016-1408-1; Kim HJ, 2013, J PHARMACOL EXP THER, V346, P465, DOI 10.1124/jpet.113.205732; Kim M, 2010, AM J NEPHROL, V31, P353, DOI 10.1159/000298339; Kim MJ, 2014, NEPHROL DIAL TRANSPL, V29, P1350, DOI 10.1093/ndt/gfu019; Kim M, 2010, AM J PHYSIOL-RENAL, V299, pF347, DOI 10.1152/ajprenal.00194.2010; Koeppen M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03105-2; Koeppen M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006784; Lee HT, 2006, AM J PHYSIOL-REG I, V291, pR959, DOI 10.1152/ajpregu.00034.2006; Lee HT, 2013, J AM SOC NEPHROL, V24, P445, DOI 10.1681/ASN.2012090943; Lee HT, 2012, AM J PHYSIOL-RENAL, V303, pF1216, DOI 10.1152/ajprenal.00220.2012; Lee HT, 2004, J AM SOC NEPHROL, V15, P102, DOI 10.1097/01.ASN.0000102474.68613.AE; Lee JW, 2019, ANESTHESIOLOGY; Legrand M, 2008, MOL MED, V14, P502, DOI 10.2119/2008-00006.Legrand; Menzies RI, 2017, KIDNEY INT, V91, P315, DOI 10.1016/j.kint.2016.08.029; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Molitoris BA, 2014, J CLIN INVEST, V124, P2355, DOI 10.1172/JCI72269; Nazir S, 2017, BLOOD, V130, P2664, DOI 10.1182/blood-2017-05-782102; Okusa MD, 2000, AM J PHYSIOL-RENAL, V279, pF809, DOI 10.1152/ajprenal.2000.279.5.F809; Ozaki T, 2016, SCI REP-UK, V6, DOI 10.1038/srep25893; Park SW, 2012, AM J PHYSIOL-RENAL, V303, pF721, DOI 10.1152/ajprenal.00157.2012; Park SW, 2012, J AM SOC NEPHROL, V23, P266, DOI 10.1681/ASN.2011050503; Park SW, 2011, KIDNEY INT, V80, P1315, DOI 10.1038/ki.2011.281; Park SW, 2009, AM J PHYSIOL-RENAL, V297, pF885, DOI 10.1152/ajprenal.00317.2009; Pefanis A, 2019, KIDNEY INT, V96, P291, DOI 10.1016/j.kint.2019.02.009; Rabadi M, 2018, AM J PHYSIOL-RENAL, V314, pF293, DOI 10.1152/ajprenal.00364.2017; Ronco C, 2019, LANCET, V394, P1949, DOI 10.1016/S0140-6736(19)32563-2; Roy JP, 2020, INDIAN J PEDIATR, V87, P600, DOI 10.1007/s12098-019-03096-y; Shigeoka AA, 2010, J IMMUNOL, V185, P6277, DOI 10.4049/jimmunol.1002330; Sim JA, 2006, J NEUROSCI, V26, P9006, DOI 10.1523/JNEUROSCI.2370-06.2006; Solini A, 2015, J AM SOC NEPHROL, V26, P1007, DOI 10.1681/ASN.2014070721; Song JH, 2010, AM J PHYSIOL-RENAL, V298, pF1041, DOI 10.1152/ajprenal.00115.2009; Spinello A, 2019, J CHEM INF MODEL, V59, P351, DOI 10.1021/acs.jcim.8b00565; Tang TT, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0378-3; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Van Opdenbosch N, 2019, IMMUNITY, V50, P1352, DOI 10.1016/j.immuni.2019.05.020; Verma R, 2017, BRAIN BEHAV IMMUN, V66, P302, DOI 10.1016/j.bbi.2017.07.155; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; VINAY P, 1981, AM J PHYSIOL, V241, pF403, DOI 10.1152/ajprenal.1981.241.4.F403; Weinberg JM, 2000, P NATL ACAD SCI USA, V97, P2826, DOI 10.1073/pnas.97.6.2826; Xu J, 2016, J NEUROSCI, V36, P8902, DOI 10.1523/JNEUROSCI.1496-16.2016; Yan YL, 2015, AM J PHYSIOL-CELL PH, V308, pC463, DOI 10.1152/ajpcell.00245.2014; Yang RH, 2015, COMPUT STRUCT BIOTEC, V13, P1, DOI 10.1016/j.csbj.2014.11.002; Yang TH, 2014, CIRC-HEART FAIL, V7, P510, DOI 10.1161/CIRCHEARTFAILURE.113.001023; Yap SC, 2012, CURR OPIN NEPHROL HY, V21, P24, DOI 10.1097/MNH.0b013e32834d2ec9; Yuan XY, 2018, ANESTH ANALG, V126, P308, DOI 10.1213/ANE.0000000000002288	76	22	27	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5465	5482		10.1096/fj.201903287R	http://dx.doi.org/10.1096/fj.201903287R		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32086866	Green Accepted, Bronze			2022-12-26	WOS:000515260000001
J	Wietlisbach, M; Benden, C; Koutsokera, A; Jahn, K; Soccal, PM; Radtke, T				Wietlisbach, Martina; Benden, Christian; Koutsokera, Angela; Jahn, Kathleen; Soccal, Paola M.; Radtke, Thomas			Perceptions towards physical activity in adult lung transplant recipients with cystic fibrosis	PLOS ONE			English	Article							EXERCISE; FATIGUE; COPD	Background Barriers and motives towards physical activity (PA) in lung transplant (LTx) recipients with cystic fibrosis (CF) are largely unknown. We aimed to explore perceptions towards PA in LTx recipients with CF to better understand individuals' needs and preferences. Methods Participants completed an online survey at two Swiss LTx and one follow-up shared care centre between June and December 2018. Results One hundred and eleven individuals completed the survey (87.4% response rate). Overall, survey participants perceive PA as important for their daily life and health. Perceived motives of PA were improving muscle strength, endurance and quality of life (QoL), to feel better, fun, to achieve personal goals and having more energy for everyday life. Fatigue was the most common perceived barrier to PA and associated with poorer QoL (r = -0.43, p<0.001) and health status (r = -0.31, p = 0.001). Participants with lung allograft dysfunction (LAD, n = 20) reported lower habitual PA (p = 0.009) and health status (p = 0.011), and rated shortness of breath, bad weather and concerns regarding lung rejection higher than those without LAD (all p< 0.05). When we asked how an optimal training programme should look like, the majority would prefer individual, non-supervised (60%), outdoor (77%), endurance training (90%), once or twice a week (47%) for 40-60 minutes (48%). Only a minority of patients (14%) would be willing to use exercise applications for their home-based training. Conclusions LTx recipients with CF value PA as important for their health. People with CF should be encouraged individually by their multidisciplinary transplant team to implement PA in their daily life, potential barriers should be identified and addressed. Overall, knowledge on perceived barriers and motives for PA should be considered in the development of future patient-centred PA programmes.	[Wietlisbach, Martina] Zurich Univ Appl Sci, Sch Hlth Profess, Inst Physiotherapy, Winterthur, Switzerland; [Benden, Christian] Univ Hosp Zurich, Div Pulmonol, Zurich, Switzerland; [Koutsokera, Angela] CHU Vaudois, Div Pulmonol, Lausanne, Switzerland; [Jahn, Kathleen] Univ Hosp Basel, Clin Pulm Med & Pulm Cell Res, Basel, Switzerland; [Soccal, Paola M.] Geneva Univ Hosp, Div Pulm Dis, Geneva, Switzerland; [Radtke, Thomas] Univ Zurich, Epidemiol Biostat & Prevent Inst, Div Occupat & Environm Med, Zurich, Switzerland; [Radtke, Thomas] Univ Hosp Zurich, Zurich, Switzerland	Zurich University of Applied Sciences; University of Zurich; University Zurich Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel; University of Geneva; University of Zurich; University of Zurich; University Zurich Hospital	Radtke, T (corresponding author), Univ Zurich, Epidemiol Biostat & Prevent Inst, Div Occupat & Environm Med, Zurich, Switzerland.; Radtke, T (corresponding author), Univ Hosp Zurich, Zurich, Switzerland.	thomas.radtke@uzh.ch	Benden, Christian/E-9774-2012	Koutsokera, Angela/0000-0003-1227-1679; Radtke, Thomas/0000-0002-1723-1070				Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Eidt-Koch D, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-55; Epton T, 2017, J CONSULT CLIN PSYCH, V85, P1182, DOI 10.1037/ccp0000260; Goetzmann L, 2018, CLIN TRANSPLANT, V32, DOI 10.1111/ctr.13393; Gruet M, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01285; Gustaw T, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.12929; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hirche TO, 2014, PULM MED, V2014, DOI 10.1155/2014/621342; Keogh RH, 2018, J CYST FIBROS, V17, P218, DOI 10.1016/j.jcf.2017.11.019; Lands LC, 1999, J HEART LUNG TRANSPL, V18, P113, DOI 10.1016/S1053-2498(98)00027-8; Langer D, 2015, RESPIRATION, V89, P353, DOI 10.1159/000430451; Langer D, 2009, J HEART LUNG TRANSPL, V28, P572, DOI 10.1016/j.healun.2009.03.007; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Leiner D.J., 2018, SOSCI SURVEY THE PRO; MacKenzie T, 2014, ANN INTERN MED, V161, P233, DOI 10.7326/M13-0636; Martin C, 2016, J CYST FIBROS, V15, P204, DOI 10.1016/j.jcf.2015.09.002; Maury G, 2008, AM J TRANSPLANT, V8, P1275, DOI 10.1111/j.1600-6143.2008.02209.x; Myers LB, 2009, J CYST FIBROS, V8, P425, DOI 10.1016/j.jcf.2009.08.005; Reinsma GD, 2006, J HEART LUNG TRANSPL, V25, P1310, DOI 10.1016/j.healun.2006.08.008; Singer LG, 2015, AM J RESP CRIT CARE, V192, P965, DOI 10.1164/rccm.201501-0126OC; Spruit MA, 2017, LANCET RESP MED, V5, P542, DOI 10.1016/S2213-2600(17)30158-3; Street R, 2016, J HEALTH PSYCHOL, V21, P261, DOI 10.1177/1359105314527141; Stridsman C, 2015, COPD, V12, P199, DOI 10.3109/15412555.2014.922176; Teichman B J, 2000, Prog Transplant, V10, P113; Tse T, 2017, J HEART LUNG TRANSPL, V36, pS411; van Adrichem EJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162725; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wickerson L, 2010, J HEART LUNG TRANSPL, V29, P497, DOI 10.1016/j.healun.2009.12.008; Williams TJ, 2012, COMPR PHYSIOL, V2, P1937, DOI 10.1002/cphy.c110021	29	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229296	10.1371/journal.pone.0229296	http://dx.doi.org/10.1371/journal.pone.0229296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084221	Green Published, gold			2022-12-26	WOS:000535227900085
J	Hsu, WC; Li, WM; Lee, YC; Huang, AM; Chang, LL; Lin, HH; Wu, WJ; Li, CC; Liang, PI; Ke, HL				Hsu, Wei-Chi; Li, Wei-Ming; Lee, Yi-Chen; Huang, A-Mei; Chang, Lin-Li; Lin, Hui-Hui; Wu, Wen-Jeng; Li, Ching-Chia; Liang, Peir-In; Ke, Hung-Lung			MicroRNA-145 suppresses cell migration and invasion in upper tract urothelial carcinoma by targeting ARF6	FASEB JOURNAL			English	Article						ARF6; cell invasion; miR-145-5p; MMP7; upper tract urothelial carcinoma	POOR-PROGNOSIS; RADICAL NEPHROURETERECTOMY; PROSTATE-CANCER; METALLOPROTEINASE-7 MATRILYSIN; MATRIX METALLOPROTEINASE-7; MIR-145 EXPRESSION; TUMOR-SUPPRESSOR; OVER-EXPRESSION; DOWN-REGULATION; METASTASIS	ADP-ribosylation factor 6 (ARF6) is a well-studied protein that is involved in multiple biological functions including cell migration and invasion. The mechanism by which ARF6 regulates the migration and invasion of upper tract urothelial carcinoma (UTUC) is still unknown. MiR-145-5p is a tumor suppressor microRNA, which is downregulated in several cancer types. We aimed to elucidate the molecular mechanism underlying the regulation of ARF6 by miR-145-5p in UTUC. ARF6 expression was observed to be higher in UTUC tissues than paired adjacent normal tissues. A reverse correlation between ARF6 and miR-145-5p was found in UTUC tissues. MiR-145-5p inhibited ARF6 expression by directly targeting its 3 '-UTR. The functional studies indicated that ARF6 expression reversed the miR-145-5p-reduced tumor cell migration and invasion. Notably, miR-145-5p reduced MMP2, N-cadherin, FAK and MMP7, and elevated E-cadherin protein levels in vitro; however, the above effects were reversed by ARF6. Further, the expression of epithelial-to-mesenchymal transition (EMT) markers and cell invasion was suppressed by knocking down MMP7 in UTUC cells. These findings suggest that miR-145-5p may suppress UTUC cell motility and invasion by targeting ARF6/MMP7 through EMT.	[Hsu, Wei-Chi; Huang, A-Mei; Chang, Lin-Li; Lin, Hui-Hui; Wu, Wen-Jeng; Ke, Hung-Lung] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Li, Wei-Ming; Lin, Hui-Hui; Wu, Wen-Jeng; Li, Ching-Chia; Ke, Hung-Lung] Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Li, Wei-Ming; Wu, Wen-Jeng; Li, Ching-Chia; Ke, Hung-Lung] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Urol, 100 Shih Chuan 1st Rd, Kaohsiung 80708, Taiwan; [Li, Wei-Ming] Minist Hlth & Welf Pingtung Hosp, Dept Urol, Pingtung, Taiwan; [Lee, Yi-Chen] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Anat, Kaohsiung, Taiwan; [Huang, A-Mei] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Huang, A-Mei] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Biochem, Kaohsiung, Taiwan; [Huang, A-Mei] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Chang, Lin-Li] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Microbiol, Kaohsiung, Taiwan; [Liang, Peir-In] Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Ke, HL (corresponding author), Kaohsiung Med Univ, Coll Med, Sch Med, Dept Urol, 100 Shih Chuan 1st Rd, Kaohsiung 80708, Taiwan.	hunglungke@gmail.com	Ke, Hung-Lung/HCH-9079-2022	Lin, Hui-Hui/0000-0002-3514-0391; Ke, Hung-Lung/0000-0002-4208-3858; Hsu, Wei-Chi/0000-0001-8184-6945	Ministry of Science and Technology [MOST107-2314-B-037-011]; Kaohsiung Medical University Hospital [KMUH-104-4R43, KMUH-105-5R70, KMUH106-6R59]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Kaohsiung Medical University Hospital	Ministry of Science and Technology, Grant/Award Number: MOST107-2314-B-037-011; Kaohsiung Medical University Hospital, Grant/Award Number: KMUH-104-4R43, KMUH-105-5R70 and KMUH106-6R59	Avgeris M, 2013, BRIT J CANCER, V108, P2573, DOI 10.1038/bjc.2013.250; Bandyopadhyay S, 2009, BIOINFORMATICS, V25, P2625, DOI 10.1093/bioinformatics/btp503; Barille S, 1999, J IMMUNOL, V163, P5723; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bolenz C, 2018, BLADDER CANCER, V4, P67, DOI 10.3233/BLC-170124; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chang L, 2017, AM J CANCER RES, V7, P2305; Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067; Cui SY, 2014, J CELL MOL MED, V18, P1913, DOI 10.1111/jcmm.12358; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Duan XC, 2014, GENE, V541, P67, DOI 10.1016/j.gene.2014.03.018; Eades G, 2015, MOL CANCER RES, V13, P330, DOI 10.1158/1541-7786.MCR-14-0251; Favaretto RL, 2018, INT BRAZ J UROL, V44, P22, DOI [10.1590/s1677-5538.ibju.2017.0204, 10.1590/S1677-5538.IBJU.2017.0204]; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fernandez MI, 2009, UROLOGY, V73, P142, DOI 10.1016/j.urology.2008.07.042; Gotte M, 2010, ONCOGENE, V29, P6569, DOI 10.1038/onc.2010.386; Grada A, 2017, J INVEST DERMATOL, V137, pE11, DOI 10.1016/j.jid.2016.11.020; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Grindel BJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25435-3; Grollman AP, 2013, ENVIRON MOL MUTAGEN, V54, P1, DOI 10.1002/em.21756; Grossmann Allie H, 2019, Small GTPases, V10, P1, DOI 10.1080/21541248.2016.1259710; Grossmann AH, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003398; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Hashimoto A, 2016, J CELL BIOL, V213, P81, DOI 10.1083/jcb.201510002; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hashimoto S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10656; Health Promotion Administration Ministry of Health and Welfare T, 2018, CANC REG ANN REP TAI, V2016, P88; Hu ZZ, 2013, EXP CELL RES, V319, P1932, DOI 10.1016/j.yexcr.2013.05.028; Ii M, 2006, EXP BIOL MED, V231, P20; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Lee YC, 2017, CLIN GENITOURIN CANC, V15, pE653, DOI 10.1016/j.clgc.2017.01.002; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CC, 2008, EUR UROL, V54, P1127, DOI 10.1016/j.eururo.2008.01.054; Li R, 2017, LIFE SCI, V182, P80, DOI 10.1016/j.lfs.2017.06.008; Li WM, 2017, INT J MED SCI, V14, P1360, DOI 10.7150/ijms.17367; Liang C, 2017, CANCER LETT, V388, P303, DOI 10.1016/j.canlet.2016.12.014; Liu Q, 2019, J CELL BIOCHEM, V120, P8409, DOI 10.1002/jcb.28126; Marchesin V, 2015, J CELL BIOL, V211, P339, DOI 10.1083/jcb.201506002; Margulis V, 2009, CANCER-AM CANCER SOC, V115, P1224, DOI 10.1002/cncr.24135; Munoz JJ, 2000, J UROLOGY, V164, P1523, DOI 10.1016/S0022-5347(05)67019-X; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Noe V, 2001, J CELL SCI, V114, P111; Sachdeva M, 2010, AM J TRANSL RES, V2, P170; Shen H, 2015, BIOMED PHARMACOTHER, V69, P301, DOI 10.1016/j.biopha.2014.12.019; Shen SN, 2019, MOL ONCOL, V13, P2554, DOI 10.1002/1878-0261.12555; Shi L, 2019, J CELL BIOCHEM, V120, P8016, DOI 10.1002/jcb.28079; Shiomi T, 2003, CANCER METAST REV, V22, P145, DOI 10.1023/A:1023039230052; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soria F, 2017, WORLD J UROL, V35, P379, DOI 10.1007/s00345-016-1928-x; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Szarvas T, 2011, PATHOL ONCOL RES, V17, P325, DOI 10.1007/s12253-010-9320-4; Szarvas T, 2010, CANCER SCI, V101, P1300, DOI 10.1111/j.1349-7006.2010.01506.x; Tokar T, 2018, NUCLEIC ACIDS RES, V46, pD360, DOI 10.1093/nar/gkx1144; TSUCHIYA M, 1991, J BIOL CHEM, V266, P2772; Tzeng CC, 1996, ANTICANCER RES, V16, P1797; Wang FQ, 2006, CANCER LETT, V236, P292, DOI 10.1016/j.canlet.2005.05.042; Wang FQ, 2005, INT J CANCER, V114, P19, DOI 10.1002/ijc.20697; Wang M, 2016, INT J ONCOL, V48, P595, DOI 10.3892/ijo.2015.3270; Wang QY, 2015, TUMOR BIOL, V36, P3703, DOI 10.1007/s13277-014-3009-3; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Yamauchi Yohei, 2017, Advances in Biological Regulation, V63, P115, DOI 10.1016/j.jbior.2016.10.004; Yoo JH, 2016, CANCER CELL, V29, P889, DOI 10.1016/j.ccell.2016.04.015; Zeinali T, 2019, BIOMED PHARMACOTHER, V109, P195, DOI 10.1016/j.biopha.2018.10.037; Zhang QS, 2007, P NATL ACAD SCI USA, V104, P7444, DOI 10.1073/pnas.0702136104; Zhang X, 2015, PROSTATE INT, V3, P71, DOI 10.1016/j.prnil.2014.09.001; Zhang Y, 2016, EUR REV MED PHARMACO, V20, P3026	68	20	21	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5975	5992		10.1096/fj.201902555R	http://dx.doi.org/10.1096/fj.201902555R		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32077148	Bronze			2022-12-26	WOS:000515256100001
J	Gogoi, K; Kumar, U; Banerjee, K; Jhala, YV				Gogoi, Keshab; Kumar, Ujjwal; Banerjee, Kausik; Jhala, Yadvendradev V.			Spatially explicit density and its determinants for Asiatic lions in the Gir forests	PLOS ONE			English	Article							PANTHERA-LEO-PERSICA; HUMAN-DOMINATED LANDSCAPE; POPULATION-SIZE; GAME RESERVE; BLACK BEAR; ABUNDANCE; CONSERVATION; RESPONSES; GUJARAT; HABITAT	Asiatic lions (Panthera leo persica) are an icon of conservation success, yet their status is inferred from total counts that cannot account for detection bias and double counts. With an effort of 4,797 km in 725 km(2) of western Gir Protected Area, India, we used polygon search based spatially explicit capture recapture framework to estimate lion density. Using vibrissae patterns and permanent body marks we identified 67 lions from 368 lion sightings. We conducted distance sampling on 35 transects with an effort of 101.5 km to estimate spatial prey density using generalized additive modeling (GAM). Subsequently, we modeled lion spatial density with prey, habitat characteristics, anthropogenic factors and distance to baiting sites. Lion density (> 1-year-old lions) was estimated at 8.53 (SE 1.05)/100 km(2) with lionesses having smaller movement parameter (sigma = 2.55 km; SE 0.12) compared to males (sigma = 5.32 km; SE 0.33). Detection corrected sex ratio (female:male lions) was 1.14 (SE 0.02). Chital (Axis axis) was the most abundant ungulate with a density of 63.29 (SE 10.14) as determined by conventional distance sampling (CDS) and 58.17 (SE 22.17)/km(2) with density surface modeling (DSM), followed by sambar (Rusa unicolor) at 3.84 (SE 1.07) and 4.73 (SE 1.48)/km(2) estimated by CDS and DSM respectively. Spatial lion density was best explained by proximity to baiting sites and flat valley habitat but not as much by prey density. We demonstrate a scientifically robust approach to estimate lion abundance, that due to its spatial context, can be useful for management of habitat and human-lion interface. We recommend this method for lion population assessment across their range. High lion densities in western Gir were correlated with baiting. The management practice of attracting lions for tourism can perturb natural lion densities, disrupt behavior, lion social dynamics and have detrimental effects on local prey densities.	[Gogoi, Keshab; Kumar, Ujjwal; Banerjee, Kausik; Jhala, Yadvendradev V.] Wildlife Inst India, Dehra Dun, Uttarakhand, India	Wildlife Institute of India	Jhala, YV (corresponding author), Wildlife Inst India, Dehra Dun, Uttarakhand, India.	jhalay@wii.gov.in		KUMAR, UJJWAL/0000-0003-4215-8781; JHALA, YADVENDRADEV/0000-0003-3276-1384	Wildlife Institute of India, Dehradun, India; Department of Science and Technology, Government of India [SERB/F/0601/2013-2014]	Wildlife Institute of India, Dehradun, India; Department of Science and Technology, Government of India(Department of Science & Technology (India))	The study was funded by the Wildlife Institute of India, Dehradun, India and a small grant from the Department of Science and Technology, Government of India (Grant number: SERB/F/0601/2013-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alexander JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134815; Artelle KA, 2014, SCIENCE, V343, P1311, DOI 10.1126/science.343.6177.1311-a; Awasthi N, 2016, REG ENVIRON CHANGE, V16, P31, DOI 10.1007/s10113-016-0953-z; Banerjee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049457; Banerjee K, 2012, J MAMMAL, V93, P1420, DOI 10.1644/11-MAMM-A-231.1; Banerjee K, 2010, ORYX, V44, P248, DOI 10.1017/S0030605309990949; Bauer H, 2015, P NATL ACAD SCI USA, V112, P14894, DOI 10.1073/pnas.1500664112; Beckmann JP, 2003, J ZOOL, V261, P207, DOI 10.1017/S0952836903004126; Belant JL, 2016, SCI REP, V6, P1; Blake S, 2004, CONSERV BIOL, V18, P1191, DOI 10.1111/j.1523-1739.2004.01860.x; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Borchers D, 2012, J ORNITHOL, V152, pS435, DOI 10.1007/s10336-010-0583-z; Breitenmoser U., 2008, IUCN RED LIST THREAT, V3; Brink H, 2013, AFR J ECOL, V51, P366, DOI 10.1111/aje.12051; Buckland Anderson D, 2001, INTRO DISTANCE SAMPL; Cadell P., 1935, J BOMBAY NATURAL HIS; Chakrabarti S, 2017, BEHAV ECOL, V28, P1532, DOI 10.1093/beheco/arx118; Champion H., 1968, REVISED STUDY FOREST; Chapron G, 2014, SCIENCE, V343, P1199, DOI 10.1126/science.343.6176.1199-b; Conroy M.J., 2009, QUANTITATIVE CONSERV; Creel S, 2015, SCIENCE, V350, P1473, DOI 10.1126/science.aac4768; Dave C. V., 2008, THESIS; Dave C, 2011, J TROP ECOL, V27, P239, DOI 10.1017/S0266467410000738; Divyabhanusinh, 2005, STORY ASIAS LIONS; Dunkley L., 2003, COMPREHENSIVE REV EC, P21; Durant SM, 2011, J APPL ECOL, V48, P1490, DOI 10.1111/j.1365-2664.2011.02042.x; Efford M., 2014, SECRLINEAR SPATIALLY, P1; Efford M., 2018, POLYGON TRANSECT DET, P1; Efford MG, 2014, ECOLOGY, V95, P1341, DOI 10.1890/13-1497.1; Efford M. G., 2018, DENSITY SURFACES SEC; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; Efford MG, 2011, ECOLOGY, V92, P2202, DOI 10.1890/11-0332.1; Elliot NB, 2017, CONSERV BIOL, V31, P934, DOI 10.1111/cobi.12878; Feinleib M, 1999, BIOSTATISTICAL ANAL; Fox J., 2016, USING R COMMANDER PO; Fuller TK, 1989, WILDL MONOGR; Gandiwa E, 2014, AFR J ECOL, V52, P274, DOI 10.1111/aje.12114; GEC ENVIS, 2015, 14 LION POP EST REP; Gerber BD, 2012, POPUL ECOL, V54, P43, DOI 10.1007/s10144-011-0276-3; GITTLEMAN JL, 1996, CARNIVORE BEHAV ECOL, V2; Hanski I, 1999, OIKOS, V87, P209, DOI 10.2307/3546736; Harihar A, 2014, DIVERS DISTRIB, V20, P567, DOI 10.1111/ddi.12174; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Hayward MW, 2015, J APPL ECOL, V52, P286, DOI 10.1111/1365-2664.12408; Hedley SL, 2004, J AGR BIOL ENVIR ST, V9, P181, DOI 10.1198/1085711043578; Herrero S, 2011, J WILDLIFE MANAGE, V75, P596, DOI 10.1002/jwmg.72; Hone J, 2010, J APPL ECOL, V47, P507, DOI 10.1111/j.1365-2664.2010.01812.x; Howe EJ, 2017, METHODS ECOL EVOL, V8, P1558, DOI 10.1111/2041-210X.12790; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Jhala Y, 2005, LION SOFTWARE IDENTI; Jhala Y, 2011, J APPL ECOL, V48, P14, DOI 10.1111/j.1365-2664.2010.01901.x; Jhala Yadvendradev V., 1999, Journal of the Bombay Natural History Society, V96, P3; Jhala YV, 2009, BIODIVERS CONSERV, V18, P3383, DOI 10.1007/s10531-009-9648-9; Jhala YV, 2019, ASIATIC LION ECOLOGY, V7, P1, DOI [10.3389/fevo.2019.00312, DOI 10.3389/FEVO.2019.00312]; Jhala YV, 2014, TECHNICAL REPORT; JOHNSINGH A J T, 1983, Journal of the Bombay Natural History Society, V80, P1; Karanth KU, 2003, ANIM CONSERV, V6, P141, DOI 10.1017/S1367943003003184; Khan JA, 1996, J TROP ECOL, V12, P149, DOI 10.1017/S0266467400009366; Lampa S, 2013, J WILDLIFE MANAGE, V77, P1490, DOI 10.1002/jwmg.604; Loveridge AJ, 2016, BIOL CONSERV, V204, P247, DOI 10.1016/j.biocon.2016.10.024; Maheshwari A, 2006, THESIS; Masse S, 2014, J WILDLIFE MANAGE, V78, P1228, DOI 10.1002/jwmg.778; McCullagh P, 1989, GEN LINEAR MODELS; Meena R.L., 2012, MANAGEMENT PLAN GIR, V1; Meena V, 2011, J ZOOL, V284, P60, DOI 10.1111/j.1469-7998.2010.00780.x; Midlane N, 2015, BIODIVERS CONSERV; Miller DL, 2013, METHODS ECOL EVOL, V4, P1001, DOI 10.1111/2041-210X.12105; Mweetwa T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197030; O'Brien SJ., 2003, TEARS CHEETAH OTHER; Ogutu JO, 1998, J ECOL, DOI [10.1046/j.1365-2028.1998.113-89113.x, DOI 10.1046/J.1365-2028.1998.113-89113.X]; Ogutu JO, 2010, ECOL MONOGR, V80, P241, DOI 10.1890/09-0439.1; Otis DL, 1978, STAT INFERENCE CAPTU, V27, P938; Packer C, 2005, SCIENCE, V307, P390, DOI 10.1126/science.1105122; Panwar H., 1979, INDIAN FOR, P18; PENNYCUICK CJ, 1970, J ZOOL, V160, P497; POLLOCK KH, 1983, BIOMETRICS, V39, P1035, DOI 10.2307/2531337; Pollock KH, 1990, SOURCE WILDLIFE MONO; Qureshi Q, 2004, RR04002 WILDL I IND; Reddy PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046732; Rosenblatt E, 2014, BIOL CONSERV, V180, P176, DOI 10.1016/j.biocon.2014.10.006; Royle JA, 2009, J APPL ECOL, V46, P118, DOI 10.1111/j.1365-2664.2008.01578.x; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Russell RE, 2012, J WILDLIFE MANAGE, V76, P1551, DOI 10.1002/jwmg.412; Schaller G. B., 1972, SERENGETI LION STUDY; Singh A. P., 2018, Indian Forester, V144, P887; Singh HS, 2017, CURR SCI INDIA, V112, P933, DOI 10.18520/cs/v112/i05/933-940; Singh HS, 2011, BIOL CONSERV, V144, P1753, DOI 10.1016/j.biocon.2011.02.009; Skalski John R, 2005, WILDLIFE DEMOGRAPHY; Snyman A, 2018, AFR J WILDL RES, V48, DOI 10.3957/056.048.023001; Stapleton S, 2014, BIOL CONSERV, V170, P38, DOI 10.1016/j.biocon.2013.12.040; Stephens PA, 2015, J APPL ECOL, V52, P1, DOI 10.1111/1365-2664.12383; Tende T, 2010, AFR J ECOL, V48, P949, DOI 10.1111/j.1365-2028.2009.01196.x; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Thompson CM, 2012, J WILDLIFE MANAGE, V76, P863, DOI 10.1002/jwmg.317; Tilman, 1997, SPATIAL ECOLOGY ROLE; Tweedie M.C.K., 1984, STAT APPL NEW DIRECT, P579; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Williams R, 2011, CONSERV BIOL, V25, P526, DOI 10.1111/j.1523-1739.2011.01656.x; Woodroffe R., 2005, CONSERV BIOL	101	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228374	10.1371/journal.pone.0228374	http://dx.doi.org/10.1371/journal.pone.0228374			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074110	Green Published, gold			2022-12-26	WOS:000535220600013
J	Hernandez, V; Suzuki, T; Venture, G				Hernandez, Vincent; Suzuki, Tomoya; Venture, Gentiane			Convolutional and recurrent neural network for human activity recognition: Application on American sign language	PLOS ONE			English	Article							MOTION	Human activity recognition is an important and difficult topic to study because of the important variability between tasks repeated several times by a subject and between subjects. This work is motivated by providing time-series signal classification and a robust validation and test approaches. This study proposes to classify 60 signs from the American Sign Language based on data provided by the LeapMotion sensor by using different conventional machine learning and deep learning models including a model called DeepConvLSTM that integrates convolutional and recurrent layers with Long-Short Term Memory cells. A kinematic model of the right and left forearm/hand/fingers/thumb is proposed as well as the use of a simple data augmentation technique to improve the generalization of neural networks. DeepConvLSTM and convolutional neural network demonstrated the highest accuracy compared to other models with 91.1 (3.8) and 89.3 (4.0) % respectively compared to the recurrent neural network or multi-layer perceptron. Integrating convolutional layers in a deep learning model seems to be an appropriate solution for sign language recognition with depth sensors data.	[Hernandez, Vincent; Suzuki, Tomoya; Venture, Gentiane] Univ Agr & Technol Tokyo, GVLAB, Tokyo, Japan		Hernandez, V (corresponding author), Univ Agr & Technol Tokyo, GVLAB, Tokyo, Japan.	vincent.hernandez1985@gmail.com	Venture, Gentiane/E-7060-2013	Venture, Gentiane/0000-0001-7767-4765	Institute of Global Innovation Research, Tokyo University of Agriculture and Technology	Institute of Global Innovation Research, Tokyo University of Agriculture and Technology	This study was funded by the Institute of Global Innovation Research, Tokyo University of Agriculture and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M., 2016, TENSORFLOW LARGE SCA; ALTMAN NS, 1992, AM STAT, V46, P175, DOI 10.2307/2685209; [Anonymous], 2008, 2008 IEEE Hot Chips 20 Symposium (HCS), DOI 10.1109/HOTCHIPS.2008.7476516; Carpinella I, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-19; Chuan CH, 2014, 2014 13TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA), P541, DOI 10.1109/ICMLA.2014.110; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dong C, 2015, AM SIGN LANGUAGE ALP, P44; Fok KY, 2015, 2015 INTERNATIONAL CONFERENCE ON CYBER-ENABLED DISTRIBUTED COMPUTING AND KNOWLEDGE DISCOVERY, P411, DOI 10.1109/CyberC.2015.81; Gers FA, 2000, NEURAL COMPUT, V12, P2451, DOI 10.1162/089976600300015015; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Kingma DP., 2014, ADAM METHOD STOCHAST; Koller O, 2016, DEEP SIGN HYBRID CNN; Kumar P, 2017, PATTERN RECOGN LETT, V86, P1, DOI 10.1016/j.patrec.2016.12.004; Lee H., 2009, P 26 ANN INT C MACH, P609, DOI [DOI 10.1145/1553374.1553453, 10.1145/1553374.1553453]; Lipton Z.C., 2015, COMPUT SCI, DOI DOI 10.1093/eurheartj/ehw128; Marin G, 2014, IEEE IMAGE PROC, P1565, DOI 10.1109/ICIP.2014.7025313; Naidu C, 2016, INT J SCI RES RAIPUR, P2319; Ordonez FJ, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16010115; Ravi S, 2019, J COMPUT LANG, V52, P88, DOI 10.1016/j.cola.2019.04.002; Redmon J., 2016, PROC CVPR IEEE, DOI [10.1109/CVPR.2016.91, DOI 10.1109/CVPR.2016.91]; Sainath TN, 2015, INT CONF ACOUST SPEE, P4580, DOI 10.1109/ICASSP.2015.7178838; Sarawate N, 2015, TURKISH J ELECT ENG, V23, P2017; Savur C, 2016, IEEE SYS MAN CYBERN, P2872, DOI 10.1109/SMC.2016.7844675; Shin H, 2019, ICIGP 2019: PROCEEDINGS OF THE 2ND INTERNATIONAL CONFERENCE ON IMAGE AND GRAPHICS PROCESSING / 2019 5TH INTERNATIONAL CONFERENCE ON VIRTUAL REALITY, P52, DOI 10.1145/3313950.3313967; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; Um T.T., 2017, P 19 ACM INT C MULT, P216, DOI 10.1145/3136755.3136817; Weerasekera C, 2013, ROBUST ASL FINGERSPE, P1; Weichert F, 2013, SENSORS-BASEL, V13, P6380, DOI 10.3390/s130506380; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Yang S, 2017, CONTINUOUS CHINESE S, P7; Zafrulla Z., 2011, P 13 INT C MULT INT, P279, DOI DOI 10.1145/2070481.2070532; Zaremba Wojciech, 2014, ABS14092329 CORR; Zimmermann T, 2018, IMU TO SEGMENT ASSIG, V18	33	12	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228869	10.1371/journal.pone.0228869	http://dx.doi.org/10.1371/journal.pone.0228869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074124	Green Published, gold			2022-12-26	WOS:000535220600028
J	Chen, LS; Yao, XW; Yao, HB; Ji, Q; Ding, G; Liu, XF				Chen, Lisha; Yao, Xingwang; Yao, Hongbing; Ji, Qin; Ding, Guo; Liu, Xiangfeng			Exosomal miR-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells	FASEB JOURNAL			English	Article						exosome; hepatic fibrosis; hepatic stellate cell; macrophage; miRNA	GENE-EXPRESSION; LIVER FIBROSIS; INFLAMMATION; BIOGENESIS; MICRORNAS; MECHANISM; GAMMA	Hepatic fibrosis occurs during chronic hepatic injury and is involved in hepatic stellate cells (HSCs) activated by several types of immune cells. Among the immune cells, hepatic macrophages and their crosstalk with HSCs play a vital role in all stages of hepatic fibrosis. Exosomes, which are 30-150 nm lipid bilayer vehicles, can transfer specific lipid, nucleic acids, proteins, and other bioactive molecules. Exosomes can act as good communication between macrophages and HSCs. Herein, we investigated the role of exosomes between THP-1 macrophage and HSCs in the progression of liver fibrosis. Exosomes originating from lipopolysaccharide (LPS)-treated THP-1 macrophages promoted HSCs proliferation and induced the increased expression of fibrotic genes. LPS could alter the miRNA profile in exosomes secreted from THP-1 macrophages. The changed miR-103-3p in exosomes could promote HSCs proliferation and activation by targeting Kruppel-like factor 4 (KLF4) and it plays important roles in the crosstalk between THP-1 macrophages and HSCs during the progression of liver fibrosis. Moreover, miR-103-3p in serum exosomes from liver fibrosis patients could be a biomarker for liver fibrosis. Therefore, exosomes may have important roles in the crosstalk between macrophage and HSCs in the progression of chronic liver diseases.	[Chen, Lisha] Cent South Univ, Xiangya Hosp 2, Dept Neurosurg, Cent Lab, Changsha, Peoples R China; [Yao, Xingwang; Ji, Qin; Ding, Guo; Liu, Xiangfeng] Cent South Univ, Xiangya Hosp 2, Dept Hepatobiliary & Pancreat Surg, 139 Renmin Rd, Changsha 410011, Hunan, Peoples R China; [Yao, Hongbing] Guilin Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Guilin, Peoples R China	Central South University; Central South University; Guilin Medical University	Liu, XF (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Hepatobiliary & Pancreat Surg, 139 Renmin Rd, Changsha 410011, Hunan, Peoples R China.	Thomasxy93@csu.edu.cn	Chen, Lisha/HGC-6247-2022		Scientific Research Project of the Hunan Finance Department of China [2050205]	Scientific Research Project of the Hunan Finance Department of China	Scientific Research Project of the Hunan Finance Department of China, Grant/Award Number: 2050205	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Chen L, 2019, HEPATOL COMMUN, V3, P180, DOI 10.1002/hep4.1290; Chen L, 2017, METHODS MOL BIOL, V1489, P465, DOI 10.1007/978-1-4939-6430-7_38; Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002; Devhare PB, 2017, J VIROL, V91, DOI 10.1128/JVI.02225-16; Dill MT, 2014, J CLIN INVEST, V124, P1568, DOI 10.1172/JCI70408; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Ge SF, 2016, ANN HEPATOL, V15, P918, DOI 10.5604/16652681.1222111; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Lakner AM, 2012, HEPATOLOGY, V56, P300, DOI 10.1002/hep.25613; Lee YS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03389-2; Liao XD, 2010, J MOL CELL CARDIOL, V49, P334, DOI 10.1016/j.yjmcc.2010.04.008; Liu Y, 2003, J BIOL CHEM, V278, P48004, DOI 10.1074/jbc.M301902200; Men RT, 2017, SCI REP-UK, V7, DOI 10.1038/srep40468; Niu ZY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00523-6; Qu Y, 2017, J CELL MOL MED, V21, P2491, DOI 10.1111/jcmm.13170; Ramachandran P, 2012, J HEPATOL, V56, P1417, DOI 10.1016/j.jhep.2011.10.026; Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332; Seo W, 2016, HEPATOLOGY, V64, P616, DOI 10.1002/hep.28644; Shen JL, 2017, J CELL MOL MED, V21, P986, DOI 10.1111/jcmm.12950; Sun X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196541; Sun ZQ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0897-7; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Tao L, 2018, ARCH TOXICOL, V92, P2935, DOI 10.1007/s00204-018-2278-9; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Xiao XC, 2015, INT J MOL MED, V35, P1596, DOI 10.3892/ijmm.2015.2189; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Yu FJ, 2016, CELL PHYSIOL BIOCHEM, V40, P183, DOI 10.1159/000452536; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001	35	46	49	8	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5178	5192		10.1096/fj.201902307RRR	http://dx.doi.org/10.1096/fj.201902307RRR		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32061112	hybrid			2022-12-26	WOS:000517898100001
J	Das, J; Mapder, T; Chattopadhyay, S; Banik, SK				Das, Jagannath; Mapder, Tarunendu; Chattopadhyay, Sudip; Banik, Suman K.			Computational study of parameter sensitivity in DevR regulated gene expression	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SIGNAL-TRANSDUCTION; OPTIMIZATION; 2-COMPONENT; AMPLIFICATION; TRANSCRIPTION; PHOSPHORELAY; ADAPTATION; ACTIVATION; BINDING	The DevRS two-component system plays a pivotal role in signal transmission and downstream gene regulation in Mycobacterium tuberculosis. Under the hypoxic condition, phosphorylated DevR interacts with multiple binding sites at the promoter region of the target genes. In the present work, we carried out a detailed computational analysis to figure out the sensitivity of the kinetic parameters. The set of kinetic parameters takes care of the interaction among phosphorylated DevR and the binding sites, transcription and translation processes. We employ the method of stochastic optimization to quantitate the relevant kinetic parameter set necessary for DevR regulated gene expression. Measures of different correlation coefficients provide the relative ordering of kinetic parameters involved in gene regulation. Results obtained from correlation coefficients are further corroborated by sensitivity amplification.	[Das, Jagannath; Mapder, Tarunendu; Chattopadhyay, Sudip] Indian Inst Engn Sci & Technol, Dept Chem, Sibpur, Howrah, India; [Banik, Suman K.] Bose Inst, Dept Chem, Kolkata, India; [Mapder, Tarunendu] Queensland Univ Technol, ARC Ctr Excellence Math & Stat Frontiers, Sch Math Sci, Brisbane, Qld, Australia	Indian Institute of Engineering Science Technology Shibpur (IIEST); Department of Science & Technology (India); Bose Institute; Queensland University of Technology (QUT)	Chattopadhyay, S (corresponding author), Indian Inst Engn Sci & Technol, Dept Chem, Sibpur, Howrah, India.; Banik, SK (corresponding author), Bose Inst, Dept Chem, Kolkata, India.	sudip@chem.iiests.ac.in; skbanik@jcbose.ac.in	Mapder, Tarunendu/U-5406-2019	Mapder, Tarunendu/0000-0002-1630-0716	Indian Institute of Engineering Science and Technology, Shibpur, Howrah, India; Bose Institute, Kolkata, India	Indian Institute of Engineering Science and Technology, Shibpur, Howrah, India; Bose Institute, Kolkata, India(Department of Science & Technology (India))	Jagannath Das is thankful to Indian Institute of Engineering Science and Technology, Shibpur, Howrah, India, for a research fellowship. Suman K Banik acknowledges research support from Bose Institute, Kolkata, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby JL, 1996, CELL, V86, P845, DOI 10.1016/S0092-8674(00)80158-0; Bandyopadhyay Arnab, 2014, Syst Synth Biol, V8, P3, DOI 10.1007/s11693-014-9133-y; Bretl DJ, 2011, MICROBIOL MOL BIOL R, V75, P566, DOI 10.1128/MMBR.05004-11; Chauhan S, 2008, J BACTERIOL, V190, P5394, DOI 10.1128/JB.00488-08; Chauhan S, 2008, J BACTERIOL, V190, P4301, DOI 10.1128/JB.01308-07; Chauhan S, 2011, NUCLEIC ACIDS RES, V39, P7400, DOI 10.1093/nar/gkr375; Feng XJ, 2004, BIOPHYS J, V87, P2195, DOI 10.1529/biophysj.104.044131; GOLDBETER A, 1982, Q REV BIOPHYS, V15, P555, DOI 10.1017/S0033583500003449; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; KIRKPATRICK S, 1984, J STAT PHYS, V34, P975, DOI 10.1007/BF01009452; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kohar V, 2018, NPJ SYST BIOL APPL, V4, DOI 10.1038/s41540-018-0076-x; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Leon M, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0375-z; Mapder T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147281; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Meir E, 2002, CURR BIOL, V12, P778, DOI 10.1016/S0960-9822(02)00839-4; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Salteli A, 2004, SENSITIVITY ANAL PRA; Saltelli A, 2005, CHEM REV, V105, P2811, DOI 10.1021/cr040659d; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Talukder S, 2013, J CHEM SCI, V125, P1619, DOI 10.1007/s12039-013-0502-y; WHO, TUBERCULOSIS	26	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228967	10.1371/journal.pone.0228967	http://dx.doi.org/10.1371/journal.pone.0228967			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053690	Green Published, gold, Green Submitted			2022-12-26	WOS:000535198700079
J	Li, XQ; Zhang, YY; Pei, WY; Zhang, MY; Yang, H; Zhong, M; Kong, X; Xu, Y; Zhu, XL; Chen, TB; Ye, JJ; Lv, K				Li, Xueqin; Zhang, Yingying; Pei, Weiya; Zhang, Mengying; Yang, Hui; Zhong, Min; Kong, Xiang; Xu, Yang; Zhu, Xiaolong; Chen, Tianbing; Ye, Jingjing; Lv, Kun			LncRNA Dnmt3aos regulates Dnmt3a expression leading to aberrant DNA methylation in macrophage polarization	FASEB JOURNAL			English	Article						DNA methylation; Dnmt3a; LncRNA; macrophage polarization	LONG NONCODING RNA; GENE-EXPRESSION; DIFFERENTIATION; TRANSCRIPTION; MICROARRAY; INFLAMMATION; ACTIVATION; INTERACTS; PROFILES; PATTERNS	Long non-coding RNAs (lncRNAs) play key roles in various biological processes. However, the roles of lncRNAs in macrophage polarization remain largely unexplored. In this study, thousands of lncRNAs were identified that are differentially expressed in distinct polarized bone marrow-derived macrophages. Among them, Dnmt3aos (DNA methyltransferase 3A, opposite strand), as a known lncRNA, locates on the antisense strand of Dnmt3a. Functional experiments further confirmed that Dnmt3aos were highly expressed in M(IL-4) macrophages and participated in the regulation of Dnmt3a expression, and played a key role in macrophage polarization. The DNA methylation profiles between the Dnmt3aos knockdown group and the control group in M(IL-4) macrophages were determined by MeDIP-seq technique for the first time, and the Dnmt3aos-Dnmt3a axis-mediated DNA methylation modification-regulated macrophage polarization- related gene IFN-gamma was identified. Our study will help to enrich our knowledge of the mechanism of macrophage polarization.	[Li, Xueqin; Zhang, Yingying; Pei, Weiya; Zhang, Mengying; Yang, Hui; Zhong, Min; Kong, Xiang; Xu, Yang; Zhu, Xiaolong; Chen, Tianbing; Ye, Jingjing; Lv, Kun] Wannan Med Coll, Key Lab Noncoding RNA Transformat Res, Anhui Higher Educ Inst, Wuhu, Peoples R China; [Li, Xueqin; Pei, Weiya; Zhang, Mengying; Yang, Hui; Zhong, Min; Kong, Xiang; Xu, Yang; Zhu, Xiaolong; Chen, Tianbing; Ye, Jingjing; Lv, Kun] Wannan Med Coll, Cent Lab, Yijishan Hosp, 2 Western Zheshan Rd, Wuhu 241001, Peoples R China; [Zhang, Yingying] Wannan Med Coll, Yijishan Hosp, Lab Med, Wuhu, Peoples R China	Wannan Medical College; Wannan Medical College; Wannan Medical College	Lv, K (corresponding author), Wannan Med Coll, Cent Lab, Yijishan Hosp, 2 Western Zheshan Rd, Wuhu 241001, Peoples R China.	lvkun315@126.com	Yang, Xu/AGR-8189-2022	Yang, Xu/0000-0001-8778-3885; Chen, Tianbing/0000-0002-3487-6487; Yang, Hui/0000-0002-3938-9530	National Natural Science Foundation of China (NSFC) [81772180, 81701557, 81802503, 81870017, 81970699]; Key Projects of Natural Science Research of Universities in Anhui Province [KJ2019A0413, KJ2018A0265]; Funding of "Peak" Training Program for Scientific Research of Yijishan Hospital, Wannan Medical College [GF2019T01, GF2019G09]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Projects of Natural Science Research of Universities in Anhui Province; Funding of "Peak" Training Program for Scientific Research of Yijishan Hospital, Wannan Medical College	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81772180, 81701557, 81802503, 81870017 and 81970699; Key Projects of Natural Science Research of Universities in Anhui Province, Grant/Award Number: KJ2019A0413 and KJ2018A0265; Funding of "Peak" Training Program for Scientific Research of Yijishan Hospital, Wannan Medical College, Grant/Award Number: GF2019T01 and GF2019G09	Alderborn A, 2000, GENOME RES, V10, P1249, DOI 10.1101/gr.10.8.1249; Backdahl L, 2009, INT J BIOCHEM CELL B, V41, P176, DOI 10.1016/j.biocel.2008.08.023; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Buscher K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16041; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Chacon-Salinas R, 2005, CLIN EXP IMMUNOL, V140, P443, DOI 10.1111/j.1365-2249.2005.02797.x; Chan J, 2015, J IMMUNOL, V195, P1359, DOI 10.4049/jimmunol.1500264; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Chen MT, 2015, MOL CELL BIOL, V35, P3212, DOI 10.1128/MCB.00429-15; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Gong CG, 2015, DEV CELL, V34, P181, DOI 10.1016/j.devcel.2015.05.009; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haney SL, 2016, CELL REP, V15, P1190, DOI 10.1016/j.celrep.2016.04.004; Huang ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19705; Jiang L, 2017, MOL MED REP, V16, P7382, DOI 10.3892/mmr.2017.7511; Kang K, 2017, IMMUNITY, V47, P235, DOI 10.1016/j.immuni.2017.07.017; Labonte AC, 2014, MOL CELLS, V37, P275, DOI 10.14348/molcells.2014.2374; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Luczak MW, 2006, FOLIA HISTOCHEM CYTO, V44, P143; Mao AP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1270-5; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Maunakea AK, 2010, CIRC RES, V107, P327, DOI 10.1161/CIRCRESAHA.110.222463; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Qiao Y, 2016, CELL REP, V16, P3121, DOI 10.1016/j.celrep.2016.08.051; Qin WS, 2016, NUCLEIC ACIDS RES, V44, P6423, DOI 10.1093/nar/gkw341; Reddy MA, 2014, DIABETES, V63, P4249, DOI 10.2337/db14-0298; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Shikauchi Y, 2009, MOL CELL BIOL, V29, P1944, DOI 10.1128/MCB.00840-08; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takeuch O, 2011, EUR J IMMUNOL, V41, P2490, DOI 10.1002/eji.201141792; Tang RZ, 2019, J MOL CELL CARDIOL, V128, P11, DOI 10.1016/j.yjmcc.2019.01.009; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Wang LH, 2016, ELIFE, V5, DOI 10.7554/eLife.14620; Wang LJ, 2015, CELL RES, V25, P335, DOI 10.1038/cr.2015.21; Wang XF, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87748; Xu J, 2014, P NATL ACAD SCI USA, V111, P2620, DOI 10.1073/pnas.1400150111; Yang XS, 2014, MOL ENDOCRINOL, V28, P565, DOI 10.1210/me.2013-1293; Yu J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30053; Zhang GQ, 2015, NUCLEIC ACIDS RES, V43, P6112, DOI 10.1093/nar/gkv518; Zhang YY, 2017, INT J MOL MED, V39, P373, DOI 10.3892/ijmm.2017.2852; Zhang YY, 2013, INT J MOL MED, V31, P797, DOI 10.3892/ijmm.2013.1260; Zhang YT, 2016, P CHIN MARK INT CONF, P6; Zhao JL, 2016, CANCER RES, V76, P1403, DOI 10.1158/0008-5472.CAN-15-2019; Zhou YX, 2018, INT J BIOCHEM CELL B, V104, P25, DOI 10.1016/j.biocel.2018.08.017	54	16	18	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5077	5091		10.1096/fj.201902379R	http://dx.doi.org/10.1096/fj.201902379R		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32052888	Green Submitted, hybrid			2022-12-26	WOS:000513849600001
J	Miao, H; Liu, QN; Jiang, GL; Zhang, W; Liu, K; Gao, X; Huo, YJ; Chen, S; Kato, T; Sakamoto, N; Kuno, T; Fang, Y				Miao, Hao; Liu, Qiannan; Jiang, Guanglie; Zhang, Wen; Liu, Kun; Gao, Xiang; Huo, Yujie; Chen, Si; Kato, Toshiaki; Sakamoto, Norihiro; Kuno, Takayoshi; Fang, Yue			AMPK alpha Subunit Ssp2 and Glycogen Synthase Kinases Gsk3/Gsk31 are involved in regulation of sterol regulatory element-binding protein (SREBP) activity in fission yeast	PLOS ONE			English	Article							GOLGI; OXYGEN; CALCINEURIN; PATHWAY; SENSOR; CDC48; SCAP; IDENTIFICATION; CHOLESTEROL; HOMEOSTASIS	Sterol regulatory element-binding protein (SREBP), a highly conserved family of membrane-bound transcription factors, is an essential regulator for cellular cholesterol and lipid homeostasis in mammalian cells. Sre1, the homolog of SREBP in the fission yeast Schizosaccharomyces pombe (S. pombe), regulates genes involved in the transcriptional responses to low sterol as well as low oxygen. Previous study reported that casein kinase 1 family member Hhp2 phosphorylated the Sre1 N-terminal transcriptional factor domain (Sre1N) and accelerated Sre1N degradation, and other kinases might exist for regulating the Sre1 function. To gain insight into the mechanisms underlying the Sre1 activity and to identify additional kinases involved in regulation of Sre1 function, we developed a luciferase reporter system to monitor the Sre1 activity through its binding site called SRE2 in living yeast cells. Here we showed that both ergosterol biosynthesis inhibitors and hypoxia-mimic CoCl2 caused a dose-dependent increase in the Sre1 transcription activity, concurrently, these induced transcription activities were almost abolished in Delta sre1 cells. Surprisingly, either AMPK alpha Subunit Ssp2 deletion or Glycogen Synthase Kinases Gsk3/Gsk31 double deletion significantly suppressed ergosterol biosynthesis inhibitors- or CoCl2-induced Sre1 activity. Notably, the Delta ssp2 Delta gsk3 Delta gsk31 mutant showed further decreased Sre1 activity when compared with their single or double deletion. Consistently, the Delta ssp2 Delta gsk3 Delta gsk31 mutant showed more marked temperature sensitivity than any of their single or double deletion. Moreover, the fluorescence of GFP-Sre1N localized at the nucleus in wild-type cells, but significantly weaker nuclear fluorescence of GFP-Sre1N was observed in Delta ssp2, Delta gsk3 Delta gsk31, Delta ssp2 Delta gsk3, Delta ssp2 Delta gsk31 or Delta ssp2 Delta gsk3 Delta gsk31 cells. On the other hand, the immunoblot showed a dramatic decrease in GST-Sre1N levels in the Delta gsk3 Delta gsk31 or the Delta ssp2 Delta gsk3 Delta gsk31 cells but not in the Delta ssp2 cells. Altogether, our findings suggest that Gsk3/Gsk31 may regulate Sre1N degradation, while Ssp2 may regulate not only the degradation of Sre1N but also its translocation to the nucleus.	[Miao, Hao; Liu, Qiannan; Jiang, Guanglie; Zhang, Wen; Liu, Kun; Gao, Xiang; Huo, Yujie; Chen, Si; Kuno, Takayoshi; Fang, Yue] China Med Univ, Sch Pharm, Dept Microbial & Biochem Pharm, Shenyang, Liaoning, Peoples R China; [Kato, Toshiaki; Sakamoto, Norihiro; Kuno, Takayoshi] Kobe Univ, Grad Sch Med, Div Food & Drug Evaluat Sci, Kobe, Hyogo, Japan	China Medical University; Kobe University	Fang, Y (corresponding author), China Med Univ, Sch Pharm, Dept Microbial & Biochem Pharm, Shenyang, Liaoning, Peoples R China.	yfang@cmu.edu.cn		Miao, Hao/0000-0002-6393-0753	Natural Science Foundations of Liaoning Province of China [2019-MS-384]; Research Fund from PhD research startup foundation of Liaoning Province, China [2019-BS-284]	Natural Science Foundations of Liaoning Province of China; Research Fund from PhD research startup foundation of Liaoning Province, China	This work was supported by grants from the Natural Science Foundations of Liaoning Province of China (No. 2019-MS-384) to YF. This work was also supported by Research Fund from PhD research startup foundation of Liaoning Province, China (No. 2019-BS-284) to SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa H, 2018, METHODS MOL BIOL, V1721, P105, DOI 10.1007/978-1-4939-7546-4_10; Asakawa H, 2014, NUCLEUS-PHILA, V5, P149, DOI 10.4161/nucl.28487; Bien CM, 2010, EUKARYOT CELL, V9, P352, DOI 10.1128/EC.00358-09; Brookheart RT, 2014, J BIOL CHEM, V289, P2725, DOI 10.1074/jbc.M113.511899; Burr R, 2017, J BIOL CHEM, V292, P16333, DOI 10.1074/jbc.M117.802025; Clasen SJ, 2017, ELIFE, V6, DOI 10.7554/eLife.28563; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Garza RM, 2005, NATURE, V435, P37, DOI 10.1038/435037a; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hirayama S, 2003, J BIOL CHEM, V278, P18078, DOI 10.1074/jbc.M212900200; Hoffman CS, 2015, GENETICS, V201, P403, DOI 10.1534/genetics.115.181503; Hughes AL, 2007, J BIOL CHEM, V282, P24388, DOI 10.1074/jbc.M701326200; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83; Hwang J, 2016, EMBO J, V35, P2332, DOI 10.15252/embj.201693923; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Koike A, 2012, J BIOL CHEM, V287, P19294, DOI 10.1074/jbc.M111.310615; Lee CYS, 2011, MOL CELL, V44, P225, DOI 10.1016/j.molcel.2011.08.031; Lloyd SJA, 2013, J BIOL CHEM, V288, P21043, DOI 10.1074/jbc.M113.468215; Ma Y, 2007, CURR GENET, V52, P97, DOI 10.1007/s00294-007-0142-1; Maguire SL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004076; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; Ogiso Y, 2004, MOL CELL BIOL, V24, P2324, DOI 10.1128/MCB.24.6.2324-2331.2004; Qingyun, 2016, Kobe J Med Sci, V62, pE70; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Stewart EV, 2012, J BIOL CHEM, V287, P672, DOI 10.1074/jbc.M111.317370; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Toda T, 1996, MOL CELL BIOL, V16, P6752; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Zhou X, 2010, J BIOL CHEM, V285, P32818, DOI 10.1074/jbc.M110.135764	32	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228845	10.1371/journal.pone.0228845	http://dx.doi.org/10.1371/journal.pone.0228845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053662	Green Published, gold			2022-12-26	WOS:000535198700060
J	Murabayashi, M; Daimon, M; Murakami, H; Fujita, T; Sato, E; Tanabe, J; Matsuhashi, Y; Takayasu, S; Yanagimachi, M; Terui, K; Kageyama, K; Tokuda, I; Sawada, K; Ihara, K				Murabayashi, Masaya; Daimon, Makoto; Murakami, Hiroshi; Fujita, Tomoyuki; Sato, Eri; Tanabe, Jutaro; Matsuhashi, Yuki; Takayasu, Shinobu; Yanagimachi, Miyuki; Terui, Ken; Kageyama, Kazunori; Tokuda, Itoyo; Sawada, Kaori; Ihara, Kazushige			Association between higher urinary normetanephrine and insulin resistance in a Japanese population	PLOS ONE			English	Article							DIABETES-MELLITUS; PHEOCHROMOCYTOMA; SENSITIVITY; INHIBITION; SECRETION; SYSTEM; EPINEPHRINE	Since activation of the sympathetic nervous system is associated with both impaired insulin secretion and insulin resistance, or namely with diabetes, evaluation of such activation in ordinary clinical settings may be important. Therefore, we evaluated the relationships between urinary concentrations of the catecholamine metabolites, urinary normetanephrine (U-NM) and urinary metanephrine (U-M), and glucose metabolism in a general population. From 1,148 participants in the 2016 population-based Iwaki study of Japanese, enrolled were 733 individuals (gender (M/F): 320/413; age: 52.1 +/- 15.1), who were not on medication affecting serum catecholamines, not diabetic, and had complete data-set and blood glucose levels appropriate for the evaluation of insulin secretion and resistance, using homeostasis model assessment (HOMA-beta and HOMA-R, respectively). Univariate linear regression analyses revealed significant correlations between both U-NM and U-M, and HOMA-beta, but adjustment for multiple factors correlated with HOMA indices abolished these (beta = -0.031, p = 0.499, and beta = -0.055, p = 0.135, respectively). However, the correlation between U-NM and HOMA-R observed using univariate linear regression analysis (beta = 0.132, p<0.001) remained significant even after these adjustments (beta = 0.107, p = 0.007), whereas U-M did not correlate with HOMA-R. Furthermore, use of the optimal cut-off value of U-NM for the prediction of insulin resistance (HOMA-R > 1.6) determined by ROC analysis (0.2577 mg/gCr) showed that individuals at risk had an odds ratio of 2.65 (confidence interval: 1.42-4.97) after adjustment for the same factors used above. Higher U-NM concentrations within the physiologic range are a significant risk factor for increased insulin resistance in a general Japanese population.	[Murabayashi, Masaya; Daimon, Makoto; Murakami, Hiroshi; Fujita, Tomoyuki; Sato, Eri; Tanabe, Jutaro; Matsuhashi, Yuki; Takayasu, Shinobu; Yanagimachi, Miyuki; Terui, Ken; Kageyama, Kazunori] Hirosaki Univ, Dept Endocrinol & Metab, Grad Sch Med, Hirosaki, Aomori, Japan; [Tokuda, Itoyo; Sawada, Kaori; Ihara, Kazushige] Hirosaki Univ, Dept Social Med, Grad Sch Med, Hirosaki, Aomori, Japan	Hirosaki University; Hirosaki University	Daimon, M (corresponding author), Hirosaki Univ, Dept Endocrinol & Metab, Grad Sch Med, Hirosaki, Aomori, Japan.	mdaimon@hirosaki-u.ac.jp	Takayasu, Shinobu/ABH-9199-2020; Daimon, Makoto/AAY-1289-2020	Daimon, Makoto/0000-0002-3775-1719	Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	The Japan Science and Technology Agency.	Abe I, 2019, ENDOCR J, V66, P187, DOI 10.1507/endocrj.EJ18-0407; COLWELL JA, 1969, ANN INTERN MED, V71, P251, DOI 10.7326/0003-4819-71-2-251; Daimon M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175204; Daimon M, 2016, J CLIN ENDOCR METAB, V101, P889, DOI 10.1210/jc.2015-3568; Diamanti-Kandarakis Evanthia, 2003, Hormones (Athens), V2, P61; DIPAOLO S, 1989, DIABETES METAB, V15, P409; ESLER M, 1988, HYPERTENSION, V11, P3, DOI 10.1161/01.HYP.11.1.3; ESLER M, 1990, PHYSIOL REV, V70, P963, DOI 10.1152/physrev.1990.70.4.963; Gamboa A, 2014, HYPERTENSION, V64, P867, DOI 10.1161/HYPERTENSIONAHA.114.03738; Grassi G, 2015, CIRC RES, V116, P976, DOI 10.1161/CIRCRESAHA.116.303604; HAMAJI M, 1979, J CLIN ENDOCR METAB, V49, P322, DOI 10.1210/jcem-49-3-322; ISLES CG, 1983, CLIN ENDOCRINOL, V18, P37, DOI 10.1111/j.1365-2265.1983.tb03184.x; Komada H, 2017, J CLIN ENDOCR METAB, V102, P3400, DOI 10.1210/jc.2017-00357; La Batide-Alanore A, 2003, J HYPERTENS, V21, P1703, DOI 10.1097/00004872-200309000-00020; LEMBO G, 1992, J CLIN INVEST, V90, P24, DOI 10.1172/JCI115842; LERNER RL, 1971, J CLIN INVEST, V50, P2453, DOI 10.1172/JCI106744; Liggett SB, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000606; PORTE D, 1966, J CLIN INVEST, V45, P228, DOI 10.1172/JCI105335; Rosengren AH, 2010, SCIENCE, V327, P217, DOI 10.1126/science.1176827; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; STENSTROM G, 1984, ACTA ENDOCRINOL-COP, V106, P511, DOI 10.1530/acta.0.1060511; TURNBULL DM, 1980, J CLIN ENDOCR METAB, V51, P930, DOI 10.1210/jcem-51-4-930; VANCE JE, 1969, J CLIN ENDOCR METAB, V29, P911, DOI 10.1210/jcem-29-7-911; WERBEL SS, 1995, MED CLIN N AM, V79, P131, DOI 10.1016/S0025-7125(16)30088-8; Wiesner TD, 2003, J CLIN ENDOCR METAB, V88, P3632, DOI 10.1210/jc.2003-030000; WILBER JF, 1966, LANCET, V2, P733	26	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228787	10.1371/journal.pone.0228787	http://dx.doi.org/10.1371/journal.pone.0228787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053635	Green Published, gold			2022-12-26	WOS:000535198700054
J	Petzold, A; Hassanin, A				Petzold, Alice; Hassanin, Alexandre			A comparative approach for species delimitation based on multiple methods of multi-locus DNA sequence analysis: A case study of the genus Giraffa (Mammalia, Cetartiodactyla)	PLOS ONE			English	Article							POPULATION-STRUCTURE; COMPREHENSIVE ANALYSIS; PROGRAM; MITOCHONDRIAL; INFERENCE; TAXONOMY; RECOMMENDATIONS; CHIROPTERA; SPECIATION; PHYLOGENY	Molecular data are now commonly used in taxonomy for delimiting cryptic species. In the case of giraffes, which were treated as a single species (Giraffa camelopardalis) during half of a century, several molecular studies have suggested a splitting into four to seven species, but the criteria applied for taxonomic delimitation were not fully described. In this study, we have analysed all multi-locus DNA sequences available for giraffes using multispecies coalescent (MSC: *BEAST, BPP and STACEY), population genetic (STRUCTURE, allelic networks, haplotype network and bootstrapping, haplowebs and conspecificity matrix) and phylogenetic (MrBayes, PhyML, SuperTRI) methods to identify the number of species. Our results show that depending on the method chosen, different taxonomic hypotheses, recognizing from two to six species, can be considered for the genus Giraffa. Our results confirm that MSC methods can lead to taxonomic over-splitting, as they delimit geographic structure rather than species. The 3-species hypothesis, which recognizes G. camelopardalis sensu strico A, G. giraffa, and G. tippelskirchi, is highly supported by phylogenetic analyses and also corroborated by most population genetic and MSC analyses. The three species show high levels of nucleotide divergence in both nuclear (0.35-0.51%) and mitochondrial sequences (3-4%), and they are characterised by 7 to 12 exclusive synapomorphies (ES) detected in nine of the 21 nuclear introns analysed for this study. By contrast, other putative species, such as G. peralta, G. reticulata, G. thornicrofti or G. tippelskirchi sensu stricto, do not exhibit any ES in the nuclear genes. A robust mito-nuclear conflict was found for the position and monophyly of G. giraffa and G. tippelskirchi, which is interpreted as the result of a mitochondrial introgression from Masai to southeastern giraffe during the Pleistocene and nuclear gene flow mediated by male dispersal between southern populations (subspecies G. g. giraffa and G. g. angolensis).	[Petzold, Alice; Hassanin, Alexandre] Sorbonne Univ, Inst Systemat Evolut Biodiversite ISYEB, EPHE, CNRS,MNHN, Paris, France; [Petzold, Alice; Hassanin, Alexandre] Museum Natl Hist Nat, CP51, Paris, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Museum National d'Histoire Naturelle (MNHN)	Hassanin, A (corresponding author), Sorbonne Univ, Inst Systemat Evolut Biodiversite ISYEB, EPHE, CNRS,MNHN, Paris, France.; Hassanin, A (corresponding author), Museum Natl Hist Nat, CP51, Paris, France.	alexandre.hassanin@mnhn.fr	HASSANIN, Alexandre/AAO-3327-2021; Hassanin, Alexandre/AAP-8634-2020	Hassanin, Alexandre/0000-0002-4905-8540; Petzold, Alice/0000-0002-0743-2004	LabEx BCDiv; Agence Nationale de la Recherche [LabEx ANR-10-LABX-0003-BCDiv, ANR-11-IDEX-0004-02]	LabEx BCDiv; Agence Nationale de la Recherche(French National Research Agency (ANR))	The PhD thesis of AP was funded by LabEx BCDiv (https://labex-bcdiv.mnhn.fr) (project written by AH in 2015). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by a grant from Agence Nationale de la Recherche under the LabEx ANR-10-LABX-0003-BCDiv, in the program "Investissements d'avenir" n ANR-11-IDEX-0004-02.	Akaike H, 2017, IEEE T AUTOMATIC CON, V19, P716; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BAUM DA, 1995, MONOG SYST BOTAN, V53, P289; Bercovitch FB, 2006, HORM BEHAV, V50, P314, DOI 10.1016/j.yhbeh.2006.04.004; Bercovitch FB, 2017, CURR BIOL, V27, pR136, DOI 10.1016/j.cub.2016.12.039; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Brown DM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-57; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Carter KD, 2013, ANIM BEHAV, V85, P385, DOI 10.1016/j.anbehav.2012.11.011; Castaneda IS, 2016, EARTH PLANET SC LETT, V450, P306, DOI 10.1016/j.epsl.2016.06.049; Dagg A.I., 1976, GIRAFFE ITS BIOL BEH; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Deacon F, 2019, ORYX, V53, P45, DOI 10.1017/S0030605317001612; Debortoli N, 2016, CURR BIOL, V26, P723, DOI 10.1016/j.cub.2016.01.031; DONOGHUE MJ, 1985, BRYOLOGIST, V88, P172, DOI 10.2307/3243026; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Etoundi E, DISTINCT BIOGEOGRAPH; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fennessy J, 2016, CURR BIOL, V26, P2543, DOI 10.1016/j.cub.2016.07.036; Fischer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021605; Fiser C, 2018, MOL ECOL, V27, P613, DOI 10.1111/mec.14486; Flot JF, 2015, SYST BIOL, V64, P897, DOI 10.1093/sysbio/syv071; Flot JF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-171; Fujisawa T, 2016, SYST BIOL, V65, P759, DOI 10.1093/sysbio/syw028; Gilbert KJ, 2012, MOL ECOL, V21, P4925, DOI 10.1111/j.1365-294X.2012.05754.x; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Groves CP, 2017, CONSERV GENET, V18, P1247, DOI 10.1007/s10592-017-0976-0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hassanin A, 2007, P ROY SOC B-BIOL SCI, V274, P2849, DOI 10.1098/rspb.2007.0830; Hassanin A, 2018, MOL PHYLOGENET EVOL, V129, P96, DOI 10.1016/j.ympev.2018.08.006; Hassanin A, 2018, J ZOOL SYST EVOL RES, V56, P1, DOI 10.1111/jzs.12176; Hassanin A, 2015, CR BIOL, V338, P494, DOI 10.1016/j.crvi.2015.04.008; Hassanin A, 2015, CR BIOL, V338, P197, DOI 10.1016/j.crvi.2014.12.003; Hassanin A, 2013, MOL PHYLOGENET EVOL, V66, P766, DOI 10.1016/j.ympev.2012.11.003; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; Hassanin A, 2010, MITOCHONDR DNA, V21, P68, DOI 10.3109/19401736.2010.490583; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; IUCN, 2011, GUID US IUCN RED LIS; Jackson ND, 2017, SYST BIOL, V66, P799, DOI 10.1093/sysbio/syw117; Janes JK, 2017, MOL ECOL, V26, P3594, DOI 10.1111/mec.14187; Jones G, 2017, J MATH BIOL, V74, P447, DOI 10.1007/s00285-016-1034-0; Jones G, 2015, BIOINFORMATICS, V31, P991, DOI 10.1093/bioinformatics/btu770; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; KINGDON J, 2013, MAMMALS AFRICA; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Krumbiegel I., 1971, GIRAFFE GIRAFFA CAME; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lydekker R., 1914, CATALOGUE UNGULATE M, P234; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Mello B, 2018, BIOL CONSERV, V217, P397, DOI 10.1016/j.biocon.2017.11.017; Miller M, 2012, RITUAL FESTIV CELEBR, V2, P1; Mitchell G., 2003, Transactions of the Royal Society of South Africa, V58, P51; Olave M, 2014, SYST BIOL, V63, P263, DOI 10.1093/sysbio/syt106; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Porras-Hurtado Liliana, 2013, Frontiers in Genetics, V4, P98, DOI 10.3389/fgene.2013.00098; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK., 2010, DOCUMENTATION STRUCT; Rabosky DL, 2016, BIOL J LINN SOC, V118, P13, DOI 10.1111/bij.12703; Rambaut A., 2007, TREEANNOTATOR V1 4 8; RAMBAUT A, 2018, SYST BIOL, V67, P901, DOI [10.1093/sysbio/syy032, DOI 10.1093/SYSBIO/SYY032, DOI 10.1093/SYSBI0/SYY032]; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Ropiquet A, 2006, MOL PHYLOGENET EVOL, V41, P395, DOI 10.1016/j.ympev.2006.05.033; Ropiquet A, 2009, CR BIOL, V332, P832, DOI 10.1016/j.crvi.2009.05.001; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Saint-Hilaire G, 1827, ANN SCI NAT, P210; Stanton DWG, 2019, CONSERV GENET, V20, P101, DOI 10.1007/s10592-019-01149-5; STOTT KW, 1981, MAMMALIA, V45, P261; Sukumaran J, 2017, P NATL ACAD SCI USA, V114, P1607, DOI 10.1073/pnas.1607921114; Suraud JP, 2012, ORYX, V46, P577, DOI 10.1017/S0030605311000639; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Thomas O., 1901, J ZOOL, V71, P474; Wilson D.E., 2005, MAMMAL SPECIES WORLD; Winter S, 2018, ECOL EVOL, V8, P10156, DOI 10.1002/ece3.4490; Yang ZH, 2015, CURR ZOOL, V61, P854, DOI 10.1093/czoolo/61.5.854; Yang ZH, 2014, MOL BIOL EVOL, V31, P3125, DOI 10.1093/molbev/msu279	87	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0217956	10.1371/journal.pone.0217956	http://dx.doi.org/10.1371/journal.pone.0217956			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053589	gold, Green Published, Green Submitted			2022-12-26	WOS:000535198700003
J	Mambetsariev, I; Wang, YY; Chen, C; Nadaf, S; Pharaon, R; Fricke, J; Amanam, I; Amini, A; Bild, A; Chu, PG; Erhunmwunsee, L; Kim, J; Munu, J; Pillai, R; Raz, D; Sampath, S; Vora, L; Qiu, F; Smith, L; Batra, SK; Massarelli, E; Koczywas, M; Reckamp, K; Salgia, R				Mambetsariev, Ise; Wang, Yingyu; Chen, Chen; Nadaf, Sorena; Pharaon, Rebecca; Fricke, Jeremy; Amanam, Idoroenyi; Amini, Arya; Bild, Andrea; Chu, Peiguo; Erhunmwunsee, Loretta; Kim, Jae; Munu, Janet; Pillai, Raju; Raz, Dan; Sampath, Sagus; Vora, Lalit; Qiu, Fang; Smith, Lynette; Batra, Surinder K.; Massarelli, Erminia; Koczywas, Marianna; Reckamp, Karen; Salgia, Ravi			Precision medicine and actionable alterations in lung cancer: A single institution experience	PLOS ONE			English	Article							MOLECULAR TESTING GUIDELINE; OPEN-LABEL; TARGETED THERAPIES; COST-EFFECTIVENESS; CLINICAL ONCOLOGY; AMERICAN SOCIETY; POLICY STATEMENT; PHASE-III; RESISTANCE; ARID1A	Objectives Oncology has become more reliant on new testing methods and a greater use of electronic medical records, which provide a plethora of information available to physicians and researchers. However, to take advantage of vital clinical and research data for precision medicine, we must initially make an effort to create an infrastructure for the collection, storage, and utilization of this information with uniquely designed disease-specific registries that could support the collection of a large number of patients. Materials and methods In this study, we perform an in-depth analysis of a series of lung adenocarcinoma patients (n = 415) with genomic and clinical data in a recently created thoracic patient registry. Results Of the 415 patients with lung adenocarcinoma, 59% (n = 245) were female; the median age was 64 (range, 22-92) years with a median OS of 33.29 months (95% CI, 29.77-39.48). The most common actionable alterations were identified in EGFR (n = 177/415 [42.7%]), ALK (n = 28/377 [7.4%]), and BRAF V600E (n = 7/288 [2.4%]). There was also a discernible difference in survival for 222 patients, who had an actionable alteration, with a median OS of 39.8 months as compared to 193 wild-type patients with a median OS of 26.0 months (P< 0.001). We identified an unprecedented number of actionable alterations [53.5% (222/ 415)], including distinct individual alteration rates, as compared with 15.0% and 22.3% in TCGA and GENIE respectively. Conclusion The use of patient registries, focused genomic panels and the appropriate use of clinical guidelines in community and academic settings may influence cohort selection for clinical trials and improve survival outcomes.	[Mambetsariev, Ise; Pharaon, Rebecca; Fricke, Jeremy; Amanam, Idoroenyi; Bild, Andrea; Massarelli, Erminia; Koczywas, Marianna; Reckamp, Karen; Salgia, Ravi] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA; [Wang, Yingyu; Chen, Chen; Nadaf, Sorena; Munu, Janet] City Hope Natl Med Ctr, Ctr Informat, Duarte, CA USA; [Amini, Arya; Sampath, Sagus] City Hope Natl Med Ctr, Dept Radiat Oncol, Duarte, CA USA; [Chu, Peiguo; Pillai, Raju] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA USA; [Erhunmwunsee, Loretta; Kim, Jae; Raz, Dan] City Hope Natl Med Ctr, Dept Thorac Surg, Duarte, CA USA; [Vora, Lalit] City Hope Natl Med Ctr, Dept Diagnost Radiol, Duarte, CA USA; [Qiu, Fang; Smith, Lynette] Univ Nebraska Med Ctr, Dept Biostat, Omaha, NE USA; [Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA	City of Hope; City of Hope; City of Hope; City of Hope; City of Hope; City of Hope; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Salgia, R (corresponding author), City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA.	rsalgia@coh.org	Pillai, Raju/AAB-7230-2022	Pharaon, Rebecca/0000-0003-0618-590X; Pillai, Raju/0000-0001-8553-4252	National Cancer Institute of the National Institutes of Health [P30CA033572, R01CA218545, U54CA209978]; American Association for Cancer Research	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Association for Cancer Research	Research reported in this publication included work performed in the Core facilities, Biostatistics Core and Center for Informatics Core, supported by the National Cancer Institute of the National Institutes of Health under award number P30CA033572. Pilot Projects and Early Phase Clinical Research Support reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers R01CA218545 and U54CA209978. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The American Association for Cancer Research provided its financial and material support in the development of the AACR Project GENIE registry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2016, J THORAC ONCOL, V11, P1040, DOI 10.1016/j.jtho.2016.03.010; Agrawal N, 2012, CANCER DISCOV, V2, P899, DOI 10.1158/2159-8290.CD-12-0189; Aisner D, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.11510; Ali SM, 2016, ONCOLOGIST, V21, P762, DOI 10.1634/theoncologist.2015-0497; Andre F, 2017, CANCER DISCOV, V7, P818, DOI 10.1158/2159-8290.CD-17-0151; Andrews Audrey, 2015, Am Health Drug Benefits, V8, P37; Aso T, 2015, ANTICANCER RES, V35, P6819; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Carey LA, 2016, NEW ENGL J MED, V375, P83, DOI 10.1056/NEJMe1603691; Chuang JC, 2017, J THORAC ONCOL, V12, P833, DOI 10.1016/j.jtho.2017.01.023; Cornen S, 2012, ONCOGENE, V31, P4255, DOI 10.1038/onc.2011.598; Coyne GO, 2017, CURR PROB CANCER, V41, P182, DOI 10.1016/j.currproblcancer.2017.02.001; Daniel DC, 2002, MICROSC RES TECHNIQ, V59, P68, DOI 10.1002/jemt.10178; Drilon A.R., 2016, J CLIN ONCOL S, V34, DOI DOI 10.1200/JC0.2016.34.15_SUPPL.108; Drilon A, 2016, LANCET ONCOL, V17, P1653, DOI 10.1016/S1470-2045(16)30562-9; Jardim DLF, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv253; Gallego CJ, 2015, J CLIN ONCOL, V33, P2084, DOI 10.1200/JCO.2014.59.3665; Gerber DE, 2015, CLIN PHARMACOL THER, V97, P447, DOI 10.1002/cpt.91; Gong Jun, 2018, Oncotarget, V9, P15792, DOI 10.18632/oncotarget.24353; Gutierrez ME, 2017, CLIN LUNG CANCER, V18, P651, DOI 10.1016/j.cllc.2017.04.004; Haslem DS, 2017, J ONCOL PRACT, V13, pE108, DOI 10.1200/JOP.2016.011486; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Herbst RS, 2015, CLIN CANCER RES, V21, P1514, DOI 10.1158/1078-0432.CCR-13-3473; Hida T, 2017, LANCET, V390, P29, DOI 10.1016/S0140-6736(17)30565-2; Huang HT, 2015, ONCOL REP, V33, P283, DOI 10.3892/or.2014.3584; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Itchins M, 2017, ASIA-PAC J CLIN ONCO, V13, P3, DOI 10.1111/ajco.12754; Janku F, 2012, CLIN CANCER RES, V18, P6356, DOI 10.1158/1078-0432.CCR-12-0178; Joyner MJ, 2016, JAMA-J AM MED ASSOC, V316, P1355, DOI 10.1001/jama.2016.11076; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kim H, 2018, EUR RADIOL, V28, P861, DOI 10.1007/s00330-017-5006-6; Kirkwood MK, 2017, J ONCOL PRACT, V13, pE353, DOI 10.1200/JOP.2016.020743; Kirkwood MK, 2016, J ONCOL PRACT, V12, P339, DOI 10.1200/JOP.2015.010462; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Le Tourneau C, 2015, LANCET ONCOL, V16, P1324, DOI 10.1016/S1470-2045(15)00188-6; Li CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028204; Li SYD, 2017, GENOME MED, V9, DOI [10.1186/S13073-017-0478-1, 10.1186/s13073-017-0478-1]; Li YH, 2015, MOL DIAGN THER, V19, P169, DOI 10.1007/s40291-015-0140-9; Lim C, 2015, ANN ONCOL, V26, P1415, DOI 10.1093/annonc/mdv208; Lindeman NI, 2013, ARCH PATHOL LAB MED, V137, P828, DOI [10.5858/arpa.2012-0720-OA, 10.1097/JTO.0b013e318290868f]; Lindeman NI, 2018, J MOL DIAGN, V20, P129, DOI 10.1016/j.jmoldx.2017.11.004; Marignani P, 2018, J THORAC ONCOL, V13, pS989, DOI 10.1016/j.jtho.2018.08.1872; Mason C, J CLIN PATHWAYS, V4, P49; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Natarajan TG, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-13; National Comprehensive Cancer Network (NCCN), 2020, CLIN PRACT GUID ONC; Paik PK, 2015, CANCER DISCOV, V5, P842, DOI 10.1158/2159-8290.CD-14-1467; Planchard D, 2017, LANCET ONCOL, V18, P1307, DOI 10.1016/S1470-2045(17)30679-4; Prasad V, 2016, NATURE, V537, pS63, DOI 10.1038/537S63a; Presley CJ, 2018, JAMA-J AM MED ASSOC, V320, P469, DOI 10.1001/jama.2018.9824; Ramalingam SS, 2018, J CLIN ONCOL, V36, P841, DOI 10.1200/JCO.2017.74.7576; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sabari JK, 2017, CURR ONCOL REP, V19, DOI 10.1007/s11912-017-0587-4; Schwaederle M, 2016, JAMA ONCOL, V2, P1452, DOI 10.1001/jamaoncol.2016.2129; Schwaederle M, 2015, J CLIN ONCOL, V33, P3817, DOI 10.1200/JCO.2015.61.5997; Seibel NL, 2017, CURR PROB CANCER, V41, P194, DOI 10.1016/j.currproblcancer.2017.01.002; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Shaw AT, 2017, LANCET ONCOL, V18, P1590, DOI 10.1016/S1470-2045(17)30680-0; Siegel RL, 2018, CA-CANCER J CLIN, V68, P30; Soria JC, 2015, LANCET ONCOL, V16, P990, DOI 10.1016/S1470-2045(15)00121-7; Spicer J, 2015, ANN ONCOL         S1, V26, pi57, DOI [DOI 10.1093/ANNONC/MDV128.04, 10.1093/annonc/mdv128.04]; Streppel MM, 2014, ONCOGENE, V33, P347, DOI 10.1038/onc.2012.586; Takebe N, 2015, NAT REV CLIN ONCOL, V12, P132, DOI 10.1038/nrclinonc.2015.19; Tannock IF, 2016, NEW ENGL J MED, V375, P1289, DOI 10.1056/NEJMsb1607705; Wang Z, 2018, J THORAC ONCOL, V13, pS704, DOI 10.1016/j.jtho.2018.08.1157; Watanabe R, 2014, CANCER RES, V74, P2465, DOI 10.1158/0008-5472.CAN-13-3608; Yoshimoto T, 2015, PATHOL INT, V65, P595, DOI 10.1111/pin.12350; Yuan Y, 2017, ONCOTARGET, V8, P26414, DOI 10.18632/oncotarget.14476; Zhao HY, 2015, J THORAC ONCOL, V10, P655, DOI 10.1097/JTO.0000000000000445; Zon RT, 2016, J ONCOL PRACT, V12, P261, DOI 10.1200/JOP.2015.009134; Zon RT, 2009, J CLIN ONCOL, V27, P986, DOI 10.1200/JCO.2008.16.3691	71	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228188	10.1371/journal.pone.0228188	http://dx.doi.org/10.1371/journal.pone.0228188			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045431	gold, Green Published			2022-12-26	WOS:000534633200007
J	Walter, A; Unsleber, S; Rismondo, J; Jorge, AM; Peschel, A; Grundling, A; Mayer, C				Walter, Axel; Unsleber, Sandra; Rismondo, Jeanine; Jorge, Ana Maria; Peschel, Andreas; Gruendling, Angelika; Mayer, Christoph			Phosphoglycerol-type wall and lipoteichoic acids are enantiomeric polymers differentiated by the stereospecific glycerophosphodiesterase GlpQ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						teichoic acid; cell wall; glycobiology; microbiology; Bacillus; Gram-positive bacteria; glycerolphosphate; lipoteichoic acid (LTA); stereochemistry; teichoicase; wall teichoic acid (WTA)	GRAM-POSITIVE BACTERIA; TEICHOIC-ACID; CELL-WALL; BACILLUS-SUBTILIS; D-ALANINE; PHOSPHODIESTERASE GDPD; STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; IDENTIFICATION	The cell envelope of Gram-positive bacteria generally comprises two types of polyanionic polymers linked to either peptidoglycan (wall teichoic acids; WTA) or to membrane glycolipids (lipoteichoic acids; LTA). In some bacteria, including Bacillus subtilis strain 168, both WTA and LTA are glycerolphosphate polymers yet are synthesized through different pathways and have distinct but incompletely understood morphogenetic functions during cell elongation and division. We show here that the exolytic sn-glycerol-3-phosphodiesterase GlpQ can discriminate between B. subtilis WTA and LTA. GlpQ completely degraded unsubstituted WTA, which lacks substituents at the glycerol residues, by sequentially removing glycerolphosphates from the free end of the polymer up to the peptidoglycan linker. In contrast, GlpQ could not degrade unsubstituted LTA unless it was partially precleaved, allowing access of GlpQ to the other end of the polymer, which, in the intact molecule, is protected by a connection to the lipid anchor. Differences in stereochemistry between WTA and LTA have been suggested previously on the basis of differences in their biosynthetic precursors and chemical degradation products. The differential cleavage of WTA and LTA by GlpQ reported here represents the first direct evidence that they are enantiomeric polymers: WTA is made of sn-glycerol-3-phosphate, and LTA is made of sn-glycerol-1-phosphate. Their distinct stereochemistries reflect the dissimilar physiological and immunogenic properties of WTA and LTA. It also enables differential degradation of the two polymers within the same envelope compartment in vivo, particularly under phosphate-limiting conditions, when B. subtilis specifically degrades WTA and replaces it with phosphate-free teichuronic acids.	[Walter, Axel; Unsleber, Sandra; Mayer, Christoph] Univ Tubingen, Microbiol Glycobiol, Interfac Inst Microbiol & Infect Med Tubingen, Morgenstelle 28, D-72076 Tubingen, Germany; [Jorge, Ana Maria; Peschel, Andreas] Univ Tubingen, Infect Biol, Interfac Inst Microbiol & Infect Med Tubingen, D-72076 Tubingen, Germany; [Rismondo, Jeanine; Gruendling, Angelika] Imperial Coll London, Sect Mol Microbiol, London SW7 2AZ, England; [Rismondo, Jeanine; Gruendling, Angelika] Imperial Coll London, MRC, Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Rismondo, Jeanine] Georg August Univ Gottingen, Dept Gen Microbiol, GZMB, D-37077 Gottingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Imperial College London; Imperial College London; University of Gottingen	Mayer, C (corresponding author), Univ Tubingen, Microbiol Glycobiol, Interfac Inst Microbiol & Infect Med Tubingen, Morgenstelle 28, D-72076 Tubingen, Germany.	christoph.mayer@uni-tuebingen.de	Mayer, Christoph/S-8666-2017	Mayer, Christoph/0000-0003-4731-4851; Peschel, Andreas/0000-0002-3209-8626; Grundling, Angelika/0000-0002-6235-8687; Walter, Axel/0000-0001-9462-9712	Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy [EXC 2124]; MRC [MR/P011071/1, MR/P028225/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy (EXC 2124 Controlling Microbes to Fight Infections). The authors declare that they have no conflicts of interest with the contents of this article.	Allison SE, 2011, J BIOL CHEM, V286, P23708, DOI 10.1074/jbc.M111.241265; ARCHIBALD A, 1961, NATURE, V191, P570, DOI 10.1038/191570a0; ARMSTRONG JJ, 1959, NATURE, V184, P247, DOI 10.1038/184247a0; BADDILEY J, 1989, BIOESSAYS, V10, P207, DOI 10.1002/bies.950100607; Bhavsar AP, 2004, J BACTERIOL, V186, P7865, DOI 10.1128/JB.186.23.7865-7873.2004; Biswas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041415; Bontemps-Gallo Sebastien, 2017, EcoSal Plus, V7, DOI 10.1128/ecosalplus.ESP-0001-2017; Borisova M, 2016, MBIO, V7, DOI 10.1128/mBio.00923-16; BROOKS D, 1971, J BACTERIOL, V107, P223, DOI 10.1128/JB.107.1.223-229.1971; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; CHILDS WC, 1980, J BACTERIOL, V143, P293, DOI 10.1128/JB.143.1.293-301.1980; DEBOER WR, 1976, EUR J BIOCHEM, V62, P1; Ellwood D. C., 1972, ADV MICROBIAL PHYSL, P82; ELLWOOD DC, 1969, BIOCHEM J, V111, P1; Fischer W., 1990, HDB LIPID RES, P123; Formstone A, 2008, J BACTERIOL, V190, P1812, DOI 10.1128/JB.01394-07; Gerlach D, 2018, NATURE, V563, P705, DOI 10.1038/s41586-018-0730-x; Gisin J, 2013, NAT CHEM BIOL, V9, P491, DOI 10.1038/nchembio.1289; GRANT WD, 1979, J BACTERIOL, V137, P35, DOI 10.1128/JB.137.1.35-43.1979; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; HAYASHI K, 1975, ANAL BIOCHEM, V67, P503, DOI 10.1016/0003-2697(75)90324-3; HEPTINSTALL S, 1970, NATURE, V225, P519, DOI 10.1038/225519a0; Jorge AM, 2018, J BIOL CHEM, V293, P14916, DOI 10.1074/jbc.RA118.004584; Jorge AM, 2017, MOL MICROBIOL, V103, P229, DOI 10.1111/mmi.13552; Kho K, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00017-18; Kluj RM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02725; Kohler T, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P75; LARSON TJ, 1988, ARCH BIOCHEM BIOPHYS, V260, P577, DOI 10.1016/0003-9861(88)90484-5; LARSON TJ, 1983, J BIOL CHEM, V258, P5428; Ma D, 2018, NATURE, V562, P286, DOI 10.1038/s41586-018-0568-2; Matias VRF, 2008, J BACTERIOL, V190, P7414, DOI 10.1128/JB.00581-08; Mayer C, 2019, INT J MED MICROBIOL, V309, DOI 10.1016/j.ijmm.2019.06.006; Mootz HD, 2001, J BIOL CHEM, V276, P37289, DOI 10.1074/jbc.M103556200; Morath S, 2002, J EXP MED, V195, P1635, DOI 10.1084/jem.20020322; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Myers CL, 2016, J BIOL CHEM, V291, P26066, DOI 10.1074/jbc.M116.760447; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Percy MG, 2016, J BACTERIOL, V198, P2029, DOI 10.1128/JB.00116-16; Percy MG, 2014, ANNU REV MICROBIOL, V68, P81, DOI 10.1146/annurev-micro-091213-112949; PEREGO M, 1995, J BIOL CHEM, V270, P15598, DOI 10.1074/jbc.270.26.15598; Pooley HM, 2000, MICROBIOL-SGM, V146, P797, DOI 10.1099/00221287-146-4-797; Potekhina NV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P745, DOI 10.1134/S0006297911070042; Reichmann NT, 2013, MICROBIOL-SGM, V159, P1868, DOI 10.1099/mic.0.069898-0; Reichmann NT, 2011, FEMS MICROBIOL LETT, V319, P97, DOI 10.1111/j.1574-6968.2011.02260.x; Rismondo J., 2019, GTCA IS REQUIRED LTA, DOI [10.1101/2019.12.12.873851, DOI 10.1101/2019.12.12.873851]; Rismondo J, 2018, J BIOL CHEM, V293, P3293, DOI 10.1074/jbc.RA117.001614; Romaniuk JAH, 2018, BIOCHEMISTRY-US, V57, P3966, DOI 10.1021/acs.biochem.8b00495; Santelli E, 2004, PROTEINS, V56, P167, DOI 10.1002/prot.20120; Schaffer C, 2005, MICROBIOL-SGM, V151, P643, DOI 10.1099/mic.0.27749-0; Schirner K, 2009, EMBO J, V28, P830, DOI 10.1038/emboj.2009.25; Shi L, 2008, PROTEINS, V72, P280, DOI 10.1002/prot.21921; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; van Dalen R, 2019, MBIO, V10, DOI 10.1128/mBio.00330-19; van der Es D, 2017, CHEM SOC REV, V46, P1464, DOI 10.1039/c6cs00270f; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Wood BM, 2018, J BIOL CHEM, V293, P17985, DOI 10.1074/jbc.RA118.004561; Xia GQ, 2010, INT J MED MICROBIOL, V300, P148, DOI 10.1016/j.ijmm.2009.10.001	58	11	11	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					4024	4034		10.1074/jbc.RA120.012566	http://dx.doi.org/10.1074/jbc.RA120.012566			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32047114	hybrid, Green Published			2022-12-26	WOS:000527704400026
J	Harb, AK; Mohammed, H; Furegato, M; Wayal, S; Mercer, CH; Hughes, G				Harb, Ana K.; Mohammed, Hamish; Furegato, Martina; Wayal, Sonali; Mercer, Catherine H.; Hughes, Gwenda			The association between region of birth and sexually transmitted infections among people of black Caribbean ethnicity attending sexual health services in England, 2015	PLOS ONE			English	Article							RATES; GONORRHEA; BEHAVIOR; RISK	Background/Introduction In England, people of Black Caribbean (BC) ethnicity are disproportionately affected by sexually transmitted infections (STIs), but it is unclear whether this varies by their region of birth. Aim(s)/Objectives To examine differences in STI diagnoses among UK- and Caribbean-born BC people. Methods Data on STI diagnoses in BC people attending specialist sexual health services (SHSs) during 2015 and living in England were obtained from the GUMCAD STI surveillance system, the national surveillance system for STIs in England. Associations between being UK- or Caribbean-born and each of several STI diagnoses were examined, using univariate and multivariable generalised estimated equations logistic regression models adjusted for sexual orientation, place of residence (London vs. non-London), HIV status, area-level deprivation, and STI diagnosis in the last year. All analyses were stratified by age (< 25 vs. >= 25 years). Results In 2015, 63,568 BC people made 108,881 attendances at specialist SHSs; 81.9% of these attendances were made by UK-born BCs. The median age (years) was 26 for UK-born and 35 for Caribbean-born people (p <= 0.001). Chlamydia, gonorrhoea and non-specific genital infection (NSGI) were the most commonly diagnosed STIs among UK- (5.8%, 2.1% and 2.8%) and Caribbean-born people (4.5%, 1.7% and 3.5%) respectively. Among BCs aged under 25, no significant differences in STIs were found between UK- and Caribbean-born people. Among BCs aged >= 25, compared to Caribbean-born people, those who were UK-born were more likely to be diagnosed with chlamydia (AOR 1.15 [95%C.I. 1.04-1.27]); gonorrhoea (AOR 1.23 [95%C.I. 1.06-1.45]) and genital herpes (AOR 1.23 [95% C.I. 1.10-1.56]) and less likely to be diagnosed with NSGI (AOR 0.89 [95% C.I. 0.80-0.99]) and Trichomoniasis (AOR 0.84 [95% C.I. 0.71-0.99]). Discussion/Conclusion STI diagnoses in BC people aged >= 25 attending specialist SHSs vary by region of birth. Country of birth may have an influence on social and sexual networks and therefore transmission of STIs.	[Harb, Ana K.; Mohammed, Hamish; Furegato, Martina; Hughes, Gwenda] Publ Hlth England, Natl Infect Serv, London, England; [Mohammed, Hamish; Wayal, Sonali; Mercer, Catherine H.] UCL, Ctr Populat Res Sexual Hlth & HIV, London, England; [Furegato, Martina] St Georges Univ, Appl Diagnost Res & Evaluat Unit ADREU, London, England; [Wayal, Sonali; Mercer, Catherine H.; Hughes, Gwenda] UCL, Natl Inst Hlth Res, Hlth Protect Res Unit Blood Borne & Sexually Tran, London, England	Public Health England; University of London; University College London; St Georges University London; University of London; University College London	Harb, AK (corresponding author), Publ Hlth England, Natl Infect Serv, London, England.	ana.harb@phe.gov.uk		Mercer, Catherine/0000-0002-4220-5034; Hughes, Gwenda/0000-0003-2090-7702	National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Blood Borne and Sexually Transmitted Infections at UCL; Public Health England (PHE); London School of Hygiene and Tropical Medicine	National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Blood Borne and Sexually Transmitted Infections at UCL; Public Health England (PHE); London School of Hygiene and Tropical Medicine	The research and SW are funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Blood Borne and Sexually Transmitted Infections at UCL, http://bbsti.hpru.nihr.ac.uk/, in partnership with Public Health England (PHE), https://www.gov.uk/government/organisations/public-health-england, and in collaboration with the London School of Hygiene and Tropical Medicine. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health and Social Care, or PHE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora AA, 2005, J INFECT DIS, V191, pS115, DOI 10.1086/425280; Agyemang C, 2005, J EPIDEMIOL COMMUN H, V59, P1014, DOI 10.1136/jech.2005.035964; Aicken CRH, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4396-3; Aicken CRH, 2020, SEX TRANSM INFECT, V96, P283, DOI 10.1136/sextrans-2018-053739; [Anonymous], IMM PATT NONUK BORN; BASHH, 2019, STAND MAN SEX TRANSM; ECDC, 2013, MIGR HLTH SEX TRANSM; Fenton KA, 2005, LANCET, V365, P1246, DOI 10.1016/S0140-6736(05)74813-3; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Furegato M, 2016, EPIDEMIOL INFECT, V144, P3253, DOI 10.1017/S0950268816001679; Gerressu M, 2012, J PUBLIC HEALTH-UK, V34, P411, DOI 10.1093/pubmed/fds007; Goerg SJ, 2009, STATA J, V9, P454, DOI 10.1177/1536867X0900900307; Hughes G, 2015, FUTURE MICROBIOL, V10, P35, DOI 10.2217/fmb.14.110; Hughes G, 2013, SEX TRANSM INFECT, V89, P38, DOI 10.1136/sextrans-2012-050495; International Organization for Migration, 2007, JAM MAPP EX PDF; Low N, 2001, SEX TRANSM INFECT, V77, P15, DOI 10.1136/sti.77.1.15; Malek R, 2015, EURO SURVEILL, V20; Mohammed H, 2016, EMERG INFECT DIS, V22, P88, DOI 10.3201/eid2201.151331; Morse JQ, 2007, CAMBRIDGE HANDBOOK OF PSYCHOLOGY, HEALTH AND MEDICINE, 2ND EDITION, P383; ONS, 2015, ENGL IND DEPR; PHE, 2014, SEX TRANSM INF STIS; PHE, 2016, SPOTL SEX TRANSM INF; Prah P, 2015, EPIDEMIOL INFECT, V143, P1500, DOI 10.1017/S0950268814002155; Rendall MSJ, 2005, FOCUS PEOPLE MIGRATI; Sastre F, 2014, GLOB HEALTH PROMOT, V21, P19, DOI 10.1177/1757975914523455; Savage EJ, 2014, EUROSURVEILLANCE, V19, P23, DOI 10.2807/1560-7917.ES2014.19.48.20981; Wayal S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208315; Wayal S, 2018, JMIR PUBLIC HLTH SUR, V4, P263, DOI 10.2196/publichealth.9010; Wayal S, 2017, LANCET PUBLIC HEALTH, V2, pE458, DOI 10.1016/S2468-2667(17)30159-7; World Health Organization, REP GLOB SEX TRANSM	30	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0228654	10.1371/journal.pone.0228654	http://dx.doi.org/10.1371/journal.pone.0228654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084155	Green Accepted, Green Published, gold			2022-12-26	WOS:000535227900023
J	Jalal, N; Lee, SF				Jalal, Naif; Lee, Song F.			The MsrAB reducing pathway of Streptococcus gordonii is needed for oxidative stress tolerance, biofilm formation, and oral colonization in mice	PLOS ONE			English	Article							METHIONINE SULFOXIDE REDUCTASE; ESCHERICHIA-COLI; OXIDIZED PROTEINS; FUSION PROTEIN; EXPRESSION; GENE; THIOREDOXIN; IDENTIFICATION; MAINTENANCE; PNEUMONIAE	The ability of Streptococcus gordonii to cope with oxidative stress is important for survival and persistence in dental plaque. In this study, we used mutational, phenotypic, and biochemical approaches to characterize the role of a methionine sulfoxide reductase (MsrAB) and proteins encoded by genes in the msrAB operon and an adjacent operon in oxidative stress tolerance in S. gordonii. The results showed that MsrAB and four other proteins encoded in the operons are needed for protection from H2O2 and methionine sulfoxide. These five proteins formed a reducing pathway that was needed for oxidative stress tolerance, biofilm formation, and oral colonization in mice. In the pathway, MsrAB was the enzyme that repaired oxidatively damaged proteins, and the two thioredoxin-like lipoproteins (SdbB and Sgo_1177) and two CcdA proteins were proteins that maintained the catalytic cycle of MsrAB. Consistent with the role in oxidative stress tolerance, the production of MsrAB, SdbB, and Sgo_11777 was induced in aerobic growth and planktonic cells.	[Jalal, Naif; Lee, Song F.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Jalal, Naif; Lee, Song F.] Dalhousie Univ, Canadian Ctr Vaccinol, Izaak Walton Killam Hlth Ctr, Nova Scotia Hlth Author, Halifax, NS, Canada; [Lee, Song F.] Dalhousie Univ, Fac Dent, Dept Appl Oral Sci, Halifax, NS, Canada; [Jalal, Naif] Umm Al Qura Univ, Fac Med, Dept Med Microbiol, Mecca, Saudi Arabia	Dalhousie University; Dalhousie University; Dalhousie University; Umm Al Qura University	Lee, SF (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.; Lee, SF (corresponding author), Dalhousie Univ, Canadian Ctr Vaccinol, Izaak Walton Killam Hlth Ctr, Nova Scotia Hlth Author, Halifax, NS, Canada.; Lee, SF (corresponding author), Dalhousie Univ, Fac Dent, Dept Appl Oral Sci, Halifax, NS, Canada.	Song.Lee@Dal.Ca	Jalal, Naif A./AAC-9551-2022; Jalal, Naif A./GVS-0022-2022	Jalal, Naif A./0000-0002-3866-1010	Natural Sciences and Engineering Research Council of Canada (NSERC) [183712]; Saudi Cultural Bureau; Umm Al-Qura University	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Saudi Cultural Bureau; Umm Al-Qura University	Funding for this study was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) grant #183712 to SFL. NJ is a recipient of a postgraduate scholarship from the Saudi Cultural Bureau and Umm Al-Qura University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard JP, 1999, INFECT IMMUN, V67, P6558; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Blanchette-Cain K, 2013, MBIO, V4, DOI 10.1128/mBio.00745-13; BROT N, 1981, P NATL ACAD SCI-BIOL, V78, P2155, DOI 10.1073/pnas.78.4.2155; Burne RA, 1999, J BACTERIOL, V181, P2863, DOI 10.1128/JB.181.9.2863-2871.1999; CLAVERYS JP, 1995, GENE, V164, P123, DOI 10.1016/0378-1119(95)00485-O; Davey L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166656; DUNNY GM, 1991, APPL ENVIRON MICROB, V57, P1194, DOI 10.1128/AEM.57.4.1194-1201.1991; Etienne F, 2003, BIOCHEM BIOPH RES CO, V300, P378, DOI 10.1016/S0006-291X(02)02870-X; Ezraty B, 2005, BBA-PROTEINS PROTEOM, V1703, P221, DOI 10.1016/j.bbapap.2004.08.017; Ezraty B, 2005, J BACTERIOL, V187, P231, DOI 10.1128/JB.187.1.231-237.2005; Ezraty B, 2017, NAT REV MICROBIOL, V15, P385, DOI 10.1038/nrmicro.2017.26; Gennaris A, 2015, NATURE, V528, P409, DOI 10.1038/nature15764; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Haase EM, 2015, APPL ENVIRON MICROB, V81, P5363, DOI 10.1128/AEM.01221-15; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; Jakubovics NS, 2002, MICROBIOL-SGM, V148, P3255, DOI 10.1099/00221287-148-10-3255; Jalal NA, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00030-19; Kim YK, 2009, MOL MICROBIOL, V72, P699, DOI 10.1111/j.1365-2958.2009.06680.x; Knight JB, 2008, CLIN VACCINE IMMUNOL, V15, P925, DOI 10.1128/CVI.00500-07; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Lee SF, 2003, CURR OPIN INFECT DIS, V16, P231, DOI 10.1097/00001432-200306000-00008; Lei Y, 2011, MOL MICROBIOL, V80, P726, DOI 10.1111/j.1365-2958.2011.07603.x; Liu XH, 2011, P NATL ACAD SCI USA, V108, P2668, DOI 10.1073/pnas.1018391108; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Saleh M, 2013, EMBO MOL MED, V5, P1852, DOI 10.1002/emmm.201202435; Shi YN, 2018, PROTEIN EXPRES PURIF, V142, P37, DOI 10.1016/j.pep.2017.09.015; Si MR, 2015, APPL ENVIRON MICROB, V81, P2781, DOI 10.1128/AEM.04221-14; Vats N, 2001, MICROBIOL-UK, V147, P653, DOI 10.1099/00221287-147-3-653; Vriesema AJM, 2000, INFECT IMMUN, V68, P1061, DOI 10.1128/IAI.68.3.1061-1068.2000; Williamson JA, 2015, NAT STRUCT MOL BIOL, V22, P809, DOI 10.1038/nsmb.3099; Winther JR, 2014, BBA-GEN SUBJECTS, V1840, P838, DOI 10.1016/j.bbagen.2013.03.031; Zheng LY, 2011, APPL ENVIRON MICROB, V77, P4318, DOI 10.1128/AEM.00309-11; Zhu L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/717843	37	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229375	10.1371/journal.pone.0229375	http://dx.doi.org/10.1371/journal.pone.0229375			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084213	Green Published, gold, Green Submitted			2022-12-26	WOS:000535227900100
J	Yang, ZY; Hu, K; Hou, YJ; Wang, YL; Yao, Y; Lei, XQ; Yan, BH; Jiang, QL; Xiong, CX; Xu, LQ; Zeng, LG				Yang, Zongying; Hu, Kun; Hou, Yujie; Wang, Yulan; Yao, Yi; Lei, Xiaoqing; Yan, Baohua; Jiang, Qinglong; Xiong, Chunxian; Xu, Liangqing; Zeng, Liugen			Transcriptome analysis of hepatopancreas of Eriocheir sinensis with hepatopancreatic necrosis disease (HPND)	PLOS ONE			English	Article							CHINESE MITTEN CRAB; SPIROPLASMA-ERIOCHEIRIS; GENE DISCOVERY; IDENTIFICATION; DELTAMETHRIN; INFECTION; BINDING; STRESS; SHRIMP; TOPHAT	Hepatopancreatic necrosis disease (HPND) is a newly emerging disease in the Chinese mitten crab, Eriocheir sinensis, which has resulted in large economic losses. However, the underlying cause of this disease remains unclear. To better understand the pathogenesis and pathogenic mechanism of HPND, we compared the transcriptome differences of the hepatopancreas of E. sinensis with and without HPND. The analysis yielded > 30 million reads for each sample of three test (with HPND) and three control groups (without HPND). We observed 978 downregulated genes and 644 upregulated genes. Among the gene ontology categories "biological process," "cellular component," and "molecular function", the subcategories cellular process, single-organism process, biological regulation, metabolic process, cell part, organelle, organelle part, binding, and catalytic were enriched. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis showed that "metabolism of xenobiotics by cytochrome P450," "drug metabolism-cytochrome P450," "chemical carcinogenesis," and "material metabolism" were the "five" most significantly enriched pathways in the hepatopancreas of E. sinensis with HPND. The results revealed that material metabolic abnormalities and drug effects from the external environment might be associated with HPND in the Chinese mitten crab. Considering the wide use of pyrethroids for pond cleaning in Xinghua city, we speculated that pyrethroids might cause HPND in the Chinese mitten crab. Our study provided useful information about the cause and pathogenetic mechanisms of HPND and could help to prevent this disease in production practice.	[Yang, Zongying; Hou, Yujie; Wang, Yulan; Yao, Yi; Lei, Xiaoqing; Yan, Baohua; Jiang, Qinglong; Xiong, Chunxian; Xu, Liangqing; Zeng, Liugen] Nanchang Acad Agr Sci, Nanchang, Jiangxi, Peoples R China; [Hu, Kun] Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China	Shanghai Ocean University	Zeng, LG (corresponding author), Nanchang Acad Agr Sci, Nanchang, Jiangxi, Peoples R China.	bingjianla2008@163.com			Jiangxi Agriculture Research System [JXARS-10]	Jiangxi Agriculture Research System	LGZ received the Jiangxi Agriculture Research System (grant number JXARS-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Banka L, 1997, J ENVIRON SCI HEAL B, V32, P789, DOI 10.1080/03601239709373113; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Chavez-Mardones J, 2014, AQUACULTURE, V433, P421, DOI 10.1016/j.aquaculture.2014.06.017; Chen XW, 2017, FISH SHELLFISH IMMUN, V70, P302, DOI 10.1016/j.fsi.2017.08.031; Ding Z, 2016, J FISH DIS, V39, P1043, DOI 10.1111/jfd.12437; Ding ZF, 2018, FISH SHELLFISH IMMUN, V72, P443, DOI 10.1016/j.fsi.2017.11.028; Djami-Tchatchou AT, 2012, J PHYTOPATHOL, V160, P449, DOI 10.1111/j.1439-0434.2012.01925.x; Gao TH, 2018, AQUACULTURE, V491, P338, DOI 10.1016/j.aquaculture.2018.03.030; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gavery MR, 2012, COMP BIOCHEM PHYS D, V7, P94, DOI 10.1016/j.cbd.2011.12.003; Gross PS, 2001, DEV COMP IMMUNOL, V25, P565, DOI 10.1016/S0145-305X(01)00018-0; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053915; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Liu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028516; MACKETT DB, 1992, FISH PHYSIOL BIOCHEM, V10, P229, DOI 10.1007/BF00004517; Manunza B, 1997, CARBOHYD RES, V300, P89, DOI 10.1016/S0008-6215(97)00028-1; Meng QG, 2014, FISH SHELLFISH IMMUN, V40, P182, DOI 10.1016/j.fsi.2014.06.029; Olsvik PA, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-48; Ou JT, 2012, FISH SHELLFISH IMMUN, V32, P345, DOI 10.1016/j.fsi.2011.11.027; Pan ZH, 2017, FISHERIES AQUACULTUR, V8, P3; Pascual C, 2003, AQUACULTURE, V218, P637, DOI 10.1016/S0044-8486(02)00300-9; Racotta IS, 2000, COMP BIOCHEM PHYS A, V125, P437, DOI 10.1016/S1095-6433(00)00171-9; Ried C, 1996, J BIOL CHEM, V271, P28120, DOI 10.1074/jbc.271.45.28120; Roux MM, 2002, J VIROL, V76, P7140, DOI 10.1128/JVI.76.14.7140-7149.2002; Shen HS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00732; Song LS, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0112-y; Sui LY, 2011, AQUACULTURE, V315, P16, DOI 10.1016/j.aquaculture.2010.06.021; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Weerd JH, 1998, COMP BIOCHEM PHYS A, V120, P107, DOI 10.1016/S1095-6433(98)10017-X; Wang W, 2011, J INVERTEBR PATHOL, V106, P18, DOI 10.1016/j.jip.2010.09.018; Wang W, 2007, J INVERTEBR PATHOL, V94, P77, DOI 10.1016/j.jip.2006.09.008; [温小波 Wen Xiaobo], 2002, [华东师范大学学报. 自然科学版, Journal of East China Normal University], V0, P105; Wheelock CE, 2006, ENVIRON TOXICOL CHEM, V25, P973, DOI 10.1897/05-334R.1; Yang Zong-Ying, 2018, Acta Hydrobiologica Sinica, V42, P17, DOI 10.7541/2018.003; Yang ZY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184581	38	11	11	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0228623	10.1371/journal.pone.0228623	http://dx.doi.org/10.1371/journal.pone.0228623			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084152	Green Published, gold			2022-12-26	WOS:000535227900022
J	Hartanti, MD; Rosario, R; Hummitzsch, K; Bastian, NA; Hatzirodos, N; Bonner, WM; Bayne, RA; Irving-Rodgers, HF; Anderson, RA; Rodgers, RJ				Hartanti, Monica D.; Rosario, Roseanne; Hummitzsch, Katja; Bastian, Nicole A.; Hatzirodos, Nicholas; Bonner, Wendy M.; Bayne, Rosemary A.; Irving-Rodgers, Helen F.; Anderson, Richard A.; Rodgers, Raymond J.			Could perturbed fetal development of the ovary contribute to the development of polycystic ovary syndrome in later life?	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TGF-BETA; CELLS; HERITABILITY; PREVALENCE; PROGRESS; DENND1A; VARIANT; WEIGHT; WOMEN	Polycystic ovary syndrome (PCOS) affects around 10% of young women, with adverse consequences on fertility and cardiometabolic outcomes. PCOS appears to result from a genetic predisposition interacting with developmental events during fetal or perinatal life. We hypothesised that PCOS candidate genes might be expressed in the fetal ovary when the stroma develops; mechanistically linking the genetics, fetal origins and adult ovarian phenotype of PCOS. In bovine fetal ovaries (n = 37) of 18 PCOS candidate genes only SUMO1P1 was not expressed. Three patterns of expression were observed: early gestation (FBN3, GATA4, HMGA2, TOX3, DENND1A, LHCGR and FSHB), late gestation (INSR, FSHR, and LHCGR) and throughout gestation (THADA, ERBB4, RAD50, C8H9orf3, YAP1, RAB5B, SUOX and KRR1). A splice variant of FSHB exon 3 was also detected early in the bovine ovaries, but exon 2 was not detected. Three other genes, likely to be related to the PCOS aetiology (AMH, AR and TGFB1I1), were also expressed late in gestation. Significantly within each of the three gene groups, the mRNA levels of many genes were highly correlated with each other, despite, in some instances, being expressed in different cell types. TGF beta is a well-known stimulator of stromal cell replication and collagen synthesis and TGF beta treatment of cultured fetal ovarian stromal cells inhibited the expression of INSR, AR, C8H9orf3 and RAD50 and stimulated the expression of TGFB1I1. In human ovaries (n = 15, < 150 days gestation) many of the same genes as in bovine (FBN3, GATA4, HMGA2, FSHR, DENND1A and LHCGR but not TOX3 or FSHB) were expressed and correlated with each other. With so many relationships between PCOS candidate genes during development of the fetal ovary, including TGF beta and androgen signalling, we suggest that future studies should determine if perturbations of these genes in the fetal ovary can lead to PCOS in later life.	[Hartanti, Monica D.; Hummitzsch, Katja; Bastian, Nicole A.; Hatzirodos, Nicholas; Bonner, Wendy M.; Irving-Rodgers, Helen F.; Rodgers, Raymond J.] Univ Adelaide, Sch Med, Robinson Res Inst, Discipline Obstet & Gynaecol, Adelaide, SA, Australia; [Hartanti, Monica D.] Trisakti Univ, Fac Med, Jakarta, Indonesia; [Rosario, Roseanne; Bayne, Rosemary A.; Anderson, Richard A.] Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Irving-Rodgers, Helen F.] Griffith Univ, Sch Med Sci, Brisbane, Qld, Australia	Robinson Research Institute; University of Adelaide; Universitas Trisakti; University of Edinburgh; Griffith University	Rodgers, RJ (corresponding author), Univ Adelaide, Sch Med, Robinson Res Inst, Discipline Obstet & Gynaecol, Adelaide, SA, Australia.	ray.rodgers@adelaide.edu.au	Hummitzsch, Katja/K-6940-2013	Hummitzsch, Katja/0000-0001-5023-2668; Hartanti, Monica/0000-0001-7542-6434; Anderson, Richard/0000-0002-7495-518X; Rodgers, Raymond/0000-0002-2139-2969	Australian Government; University of Adelaide; National Health and Medical Research Council of Australia; NHMRC Centre for Research Excellence in the Evaluation, Management and Health Care Needs of Polycystic Ovary Syndrome; UK Medical Research Council [G1100357]; MRC [G1100357, MR/N022556/1] Funding Source: UKRI	Australian Government(Australian GovernmentCGIAR); University of Adelaide; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Centre for Research Excellence in the Evaluation, Management and Health Care Needs of Polycystic Ovary Syndrome(National Health and Medical Research Council (NHMRC) of Australia); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research activities conducted in Australia were funded by the Australia Awards Scholarship from the Australian Government, The University of Adelaide, the National Health and Medical Research Council of Australia, the NHMRC Centre for Research Excellence in the Evaluation, Management and Health Care Needs of Polycystic Ovary Syndrome. The research activities conducted in the UK were supported by the UK Medical Research Council (grant no G1100357).	Adams GP, 2008, THERIOGENOLOGY, V69, P72, DOI 10.1016/j.theriogenology.2007.09.026; Azziz R, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.57; Bastian NA, 2016, REPRODUCTION, V152, P127, DOI 10.1530/REP-16-0172; Ben-Hafaiedh C, 2017, RESEARCH HANDBOOK ON ENTREPRENEURIAL TEAMS: THEORY AND PRACTICE, P1; Bozdag G, 2016, HUM REPROD, V31, P2841, DOI 10.1093/humrep/dew218; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Coutts SM, 2008, DEV BIOL, V314, P189, DOI 10.1016/j.ydbio.2007.11.026; Coviello AD, 2009, J CLIN ENDOCR METAB, V94, P4361, DOI 10.1210/jc.2009-1333; Cummings M, 2011, ANAL BIOCHEM, V416, P123, DOI 10.1016/j.ab.2011.05.009; Davies MJ, 2012, HUM REPROD, V27, P1475, DOI 10.1093/humrep/des027; Day FR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9464; Diamanti-Kandarakis E, 2006, ENDOCRINE, V30, P19, DOI 10.1385/ENDO:30:1:19; Dumesic DA, 2007, REV ENDOCR METAB DIS, V8, P127, DOI 10.1007/s11154-007-9046-0; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Filippou P, 2017, HUM REPROD UPDATE, V23, P421, DOI 10.1093/humupd/dmx013; Goodarzi MO, 2015, J STEROID BIOCHEM, V145, P213, DOI 10.1016/j.jsbmb.2014.06.003; Hartanti MD, 2019, DRYAD DIGITAL REPOSI; Hartanti MD, 2018, REPROD FERTILITY DEV; Hatzirodos N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213575; Hatzirodos N, 2011, FASEB J, V25, P2256, DOI 10.1096/fj.11-181099; Hayes MG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8502; Heeren AM, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0054-0; Hughesdon P E, 1982, Obstet Gynecol Surv, V37, P59, DOI 10.1097/00006254-198202000-00001; Hummitzsch K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214130; Hummitzsch K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055578; Jimenez R, 2010, SEX DEV, V3, P291, DOI 10.1159/000280584; Jones MR, 2016, FERTIL STERIL, V106, P25, DOI 10.1016/j.fertnstert.2016.04.040; Juengel JL, 2002, MOL CELL ENDOCRINOL, V191, P1, DOI 10.1016/S0303-7207(02)00045-X; Kanamarlapudi V, 2016, REPROD BIOMED ONLINE, V32, P635, DOI 10.1016/j.rbmo.2016.03.003; KONISHI I, 1986, J ANAT, V148, P121; LeBlanc M, 2012, J PSYCHIATR RES, V46, P271, DOI 10.1016/j.jpsychires.2011.11.001; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Massam-Wu T, 2010, J CELL SCI, V123, P3006, DOI 10.1242/jcs.073437; Matti N, 2010, MOL CELL ENDOCRINOL, V321, P207, DOI 10.1016/j.mce.2010.02.019; McAllister JM, 2015, TRENDS ENDOCRIN MET, V26, P118, DOI 10.1016/j.tem.2014.12.004; McAllister JM, 2014, P NATL ACAD SCI USA, V111, pE1519, DOI 10.1073/pnas.1400574111; MHASKAR R, 1989, INT J GYNECOL OBSTET, V29, P35, DOI 10.1016/0020-7292(89)90126-4; Mutib MT, 2014, IRAN J REPROD MED, V12, P8; Ning Z, 2017, EUR REV MED PHARMACO, V21, P5, DOI [10.1007/s10815-013-0166-z, DOI 10.1007/S10815-013-0166-Z]; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Padmanabhan V, 2013, STEROIDS, V78, P734, DOI 10.1016/j.steroids.2013.05.004; Padmanabhan V, 2009, J CLIN ENDOCR METAB, V94, P1883, DOI 10.1210/jc.2009-0492; Raja-Khan N, 2014, REPROD SCI, V21, P20, DOI 10.1177/1933719113485294; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rodgers RJ, 2019, MED HYPOTHESES, V124, P31, DOI 10.1016/j.mehy.2019.01.019; Rodgers RJ, 2019, ENDOCR CONNECT, V8, pR71, DOI 10.1530/EC-18-0502; Rozen S, 2000, Methods Mol Biol, V132, P365; Russe I, 1983, Bibl Anat, V24, P77; Shi YY, 2012, NAT GENET, V44, P1020, DOI 10.1038/ng.2384; Stepto NK, 2019, J CLIN ENDOCR METAB, V2, P2019; Stewart AG, 2018, RESPIROLOGY, V23, P1096, DOI 10.1111/resp.13415; Tata B, 2018, NAT MED, V24, P834, DOI 10.1038/s41591-018-0035-5; Tee MK, 2016, MOL CELL ENDOCRINOL, V434, P25, DOI 10.1016/j.mce.2016.06.011; Teede H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-41; Teede HJ, 2011, MED J AUSTRALIA, V195, pS69, DOI 10.5694/mja11.10915; Urbanek M, 2007, J CLIN ENDOCR METAB, V92, P4191, DOI 10.1210/jc.2007-0761; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vink JM, 2006, J CLIN ENDOCR METAB, V91, P2100, DOI 10.1210/jc.2005-1494; Walters KA, 2018, BEST PRACT RES CL EN, V32, P271, DOI 10.1016/j.beem.2018.03.008; Walters KA, 2016, CURR OPIN ENDOCRINOL, V23, P257, DOI 10.1097/MED.0000000000000245; Wang TG, 2015, J CLIN ENDOCR METAB, V100, pE1560, DOI 10.1210/jc.2015-2664; Wu XQ, 2014, J ASSIST REPROD GEN, V31, P371, DOI 10.1007/s10815-013-0166-z	65	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0229351	10.1371/journal.pone.0229351	http://dx.doi.org/10.1371/journal.pone.0229351			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8CF	32078641	Green Published, gold, Green Submitted			2022-12-26	WOS:000535224600027
J	Shin, TE; Park, JW; Jeon, WY; Lee, EJ; Kwon, H; Jeon, B; Kang, HE; Kim, MJ; Kim, DK; Kim, HH; Ko, JJ; Lee, JH				Shin, Tai Eun; Park, Jin Woo; Jeon, Won-Yong; Lee, Eun Ji; Kwon, Hyojeong; Jeon, Boyoung; Kang, Hyo Eun; Kim, Myung Joo; Kim, Dae Keun; Kim, Hyug-Han; Ko, Jung Jae; Lee, Jae Ho			Motility enhancement of human spermatozoa using electrical stimulation in the nano-Ampere range with enzymatic biofuel cells	PLOS ONE			English	Article							HUMAN SPERM; ASTHENOZOOSPERMIA; PHOSPHORYLATION; MITOCHONDRIA	Sperm motility is a crucial factor for normal fertilisation that is partly supported by mitochondrial activity. Enzymatic biofuel cells (EBFCs) generate electric currents by an electron grade from anodic to cathodic electrodes in a culture media. We demonstrate that electrical stimulation by EBFC at the nano-Ampere range enhances sperm motility that can potentially allow the development of a new therapeutic tool for male infertility, including poor motility. EBFC was set up with three different electrical currents (112 nA/cm(2) and 250 nA/cm(2)) at two different times (1 h, 2 h). Each sample was evaluated for its motility by computer-assisted sperm analyses and sperm viability testing. In the expanded study, we used the optimal electrical current of the EBFC system to treat asthenozoospermia and sperm with 0% motility. Results showed that optimal electrical stimulation schemes with EBFCs enhanced sperm motility by 30-40% compared with controls. Activated spermatozoa led to tyrosine phosphorylation in the tail area of the sperm following the electrical stimulation in the nano-Ampere range. However, the electrically stimulated group did not exhibit increased acrosomal reaction rates compared with the control group. In cases related to asthenozoospermia, 40% of motility was recovered following the electrical stimulation at the nano-Ampere range. However, motility is not recovered in sperm with 0% motility. In conclusion, we found that sperm motility was enhanced by exposure to electrical currents in the nano-Ampere range induced by optimal EBFCs. Electrical stimulation enhanced the motility of the sperm though tyrosine phosphorylation in spermatozoa. Therefore, our results show that electrical currents in the nano-Ampere range can be potentially applied to male infertility therapy as enhancers of sperm motility in assisted reproductive technology.	[Shin, Tai Eun; Park, Jin Woo; Lee, Eun Ji; Kwon, Hyojeong; Jeon, Boyoung; Kang, Hyo Eun; Kim, Myung Joo; Lee, Jae Ho] CHA Fertil Ctr, Seoul Stn, Seoul, South Korea; [Jeon, Won-Yong; Kim, Hyug-Han] Dankook Univ, Coll Adv Sci, Dept Chem, Cheonan, South Korea; [Jeon, Won-Yong] Sungkyunkwan Univ, Sch Chem Engn, Suwon, South Korea; [Kim, Dae Keun] CHA Univ, CHA Fertil Ctr, Dept Urol, Seoul Stn, Seoul, South Korea; [Ko, Jung Jae; Lee, Jae Ho] CHA Univ, Coll Life Sci, Dept Biomed Sci, Pochen, Gyounggi Do, South Korea	Dankook University; Sungkyunkwan University (SKKU); Pochon Cha University; Pochon Cha University	Lee, JH (corresponding author), CHA Fertil Ctr, Seoul Stn, Seoul, South Korea.; Kim, HH (corresponding author), Dankook Univ, Coll Adv Sci, Dept Chem, Cheonan, South Korea.; Ko, JJ; Lee, JH (corresponding author), CHA Univ, Coll Life Sci, Dept Biomed Sci, Pochen, Gyounggi Do, South Korea.	hhkim@dankook.ac.kr; highko@cha.ac.kr; jaeho@cha.ac.kr		Kim, Dae Keun/0000-0003-3237-6304	basic science research program through the national research foundation of Korea [2018R1D1A1B07050138, 2018R1C1B5045516, 2018R1D1A1B07044016]	basic science research program through the national research foundation of Korea(National Research Foundation of Korea)	This project was supported by a basic science research program through the national research foundation of Korea [grant numbers 2018R1D1A1B07050138, 2018R1C1B5045516, and 2018R1D1A1B07044016].	Agarwal A, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0032-1; Ainsworth C, 2005, HUM REPROD, V20, P2261, DOI 10.1093/humrep/dei024; Amaral A, 2013, REPRODUCTION, V146, pR163, DOI 10.1530/REP-13-0178; Barratt CLR, 2017, HUM REPROD UPDATE, V23, P660, DOI 10.1093/humupd/dmx021; Barton SC, 2004, CHEM REV, V104, P4867, DOI 10.1021/cr020719k; Cao Xing-Wu, 2011, Zhonghua Nan Ke Xue, V17, P1059; Cosnier S, 2014, ELECTROCHEM COMMUN, V38, P19, DOI 10.1016/j.elecom.2013.09.021; Curi SM, 2003, ARCH ANDROLOGY, V49, P343, DOI 10.1080/01485010390219656; Kinutani Masayuki, 1999, Hiroshima Journal of Medical Sciences, V48, P117; Lee JH, 2015, BIOMATERIALS, V53, P358, DOI 10.1016/j.biomaterials.2015.02.062; Mendeluk GR, 2010, FERTIL STERIL, V94, pE28, DOI 10.1016/j.fertnstert.2010.03.001; Nassar A, 1999, FERTIL STERIL, V71, P919, DOI 10.1016/S0015-0282(99)00013-8; Ortega C, 2011, HUM REPROD UPDATE, V17, P684, DOI 10.1093/humupd/dmr018; Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003; Piomboni P, 2012, INT J ANDROL, V35, P109, DOI 10.1111/j.1365-2605.2011.01218.x; Practice Comm Amer Soc Reprod Med, 2015, FERTIL STERIL, V103, pE18, DOI 10.1016/j.fertnstert.2014.12.103; Ruiz-Pesini E, 2000, CLIN CHIM ACTA, V300, P97, DOI 10.1016/S0009-8981(00)00305-3; Ruiz-Pesini E, 1998, CLIN CHEM, V44, P1616; Sakkas D, 2003, BIOL REPROD, V68, P1463, DOI 10.1095/biolreprod.102.011023; Sangani AK, 2017, POULTRY SCI, V96, P211, DOI 10.3382/ps/pew273; SCOTT L, 1995, FERTIL STERIL, V63, P166, DOI 10.1016/S0015-0282(16)57313-0; TARLATZIS BC, 1995, ARCH ANDROLOGY, V34, P33, DOI 10.3109/01485019508987828; Tomes CN, 2004, DEV BIOL, V265, P399, DOI 10.1016/j.ydbio.2003.09.032; Turner RM, 2006, REPROD FERT DEVELOP, V18, P25, DOI 10.1071/RD05120; Urner F, 2003, REPRODUCTION, V125, P17, DOI 10.1530/rep.0.1250017	25	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0228097	10.1371/journal.pone.0228097	http://dx.doi.org/10.1371/journal.pone.0228097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8CF	32078626	gold, Green Published			2022-12-26	WOS:000535224600006
J	Ouyang, DJ; Lief, L; Russell, D; Xu, JH; Berlin, DA; Gentzler, E; Su, A; Cooper, ZR; Senglaub, SS; Maciejewski, PK; Prigerson, HG				Ouyang, Daniel J.; Lief, Lindsay; Russell, David; Xu, Jiehui; Berlin, David A.; Gentzler, Eliza; Su, Amanda; Cooper, Zara R.; Senglaub, Steven S.; Maciejewski, Paul K.; Prigerson, Holly G.			Timing is everything: Early do-not-resuscitate orders in the intensive care unit and patient outcomes	PLOS ONE			English	Article							QUALITY-OF-LIFE; PALLIATIVE CARE; ADVANCED CANCER; END; DEATH; DISCUSSIONS; PREDICTORS; HEALTH; COMMUNICATION; ASSOCIATIONS	Background The use of Do-Not-Resuscitate (DNR) orders has increased but many are placed late in the dying process. This study is to determine the association between the timing of DNR order placement in the intensive care unit (ICU) and nurses' perceptions of patients' distress and quality of death. Methods 200 ICU patients and the nurses (n = 83) who took care of them during their last week of life were enrolled from the medical ICU and cardiac care unit of New York Presbyterian Hospital/Weill Cornell Medicine in Manhattan and the surgical ICU at the Brigham and Women's Hospital in Boston. Nurses were interviewed about their perceptions of the patients' quality of death using validated measures. Patients were divided into 3 groups-no DNR, early DNR, late DNR placement during the patient's final ICU stay. Logistic regression analyses modeled perceived patient quality of life as a function of timing of DNR order placement. Patient's comorbidities, length of ICU stay, and procedures were also included in the model. Results 59 patients (29.5%) had a DNR placed within 48 hours of ICU admission (early DNR), 110 (55%) placed after 48 hours of ICU admission (late DNR), and 31 (15.5%) had no DNR order placed. Compared to patients without DNR orders, those with an early but not late DNR order placement had significantly fewer non-beneficial procedures and lower odds of being rated by nurses as not being at peace (Adjusted Odds Ratio namely AOR = 0.30; [CI = 0.09-0.94]), and experiencing worst possible death (AOR = 0.31; [CI = 0.1-0.94]) before controlling for procedures; and consistent significance in severe suffering (AOR = 0.34; [CI = 0.12-0.96]), and experiencing a severe loss of dignity (AOR = 0.33; [CI = 0.12-0.94]), controlling for non-beneficial procedures. Conclusions Placement of DNR orders within the first 48 hours of the terminal ICU admission was associated with fewer non-beneficial procedures and less perceived suffering and loss of dignity, lower odds of being not at peace and of having the worst possible death.	[Ouyang, Daniel J.; Lief, Lindsay; Russell, David; Xu, Jiehui; Berlin, David A.; Gentzler, Eliza; Su, Amanda; Maciejewski, Paul K.; Prigerson, Holly G.] Weill Cornell Med, Ctr Res End Life Care, New York, NY 10065 USA; [Lief, Lindsay; Berlin, David A.; Maciejewski, Paul K.; Prigerson, Holly G.] Weill Cornell Med, Dept Med, New York, NY 10065 USA; [Russell, David] Appalachian State Univ, Dept Sociol, Boone, NC 28608 USA; [Cooper, Zara R.; Senglaub, Steven S.] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Maciejewski, Paul K.] Weill Cornell Med, Dept Radiol, New York, NY USA	Cornell University; Cornell University; University of North Carolina; Appalachian State University; Harvard University; Brigham & Women's Hospital; Cornell University	Prigerson, HG (corresponding author), Weill Cornell Med, Ctr Res End Life Care, New York, NY 10065 USA.; Prigerson, HG (corresponding author), Weill Cornell Med, Dept Med, New York, NY 10065 USA.	hgp2001@med.cornell.edu	Russell, David/AAZ-6102-2020; Prigerson, Holly/GWV-3283-2022	Russell, David/0000-0001-8433-0821; Ouyang, Jie/0000-0001-5124-0504	NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The corresponding author Holly Prigerson, PhD receives an R35 fund from NIH. She is the PI for the clinical trial described in the manuscript.	Adelman RD, 2014, JAMA-J AM MED ASSOC, V311, P1052, DOI 10.1001/jama.2014.304; Alsirafy SA, 2015, AM J HOSP PALLIAT ME, V32, P544, DOI 10.1177/1049909114529014; Araw AC, 2014, PALLIAT SUPPORT CARE, V12, P101, DOI 10.1017/S1478951512001010; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Bishop JP, 2010, AM J BIOETHICS, V10, P61, DOI 10.1080/15265160903469328; Burden E, 2020, POSTGRAD MED J, V96, P186, DOI 10.1136/postgradmedj-2019-136565; Chang DW, 2014, J GEN INTERN MED, V29, P1256, DOI 10.1007/s11606-014-2906-x; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; Detsky ME, 2017, JAMA-J AM MED ASSOC, V317, P2187, DOI 10.1001/jama.2017.4078; Downey L, 2010, J PAIN SYMPTOM MANAG, V39, P9, DOI 10.1016/j.jpainsymman.2009.05.012; Faigle R, 2017, CRIT CARE MED, V45, P2046, DOI 10.1097/CCM.0000000000002762; Horton R, 2002, PALLIATIVE MED, V16, P488, DOI 10.1191/0269216302pm588oa; JAYES RL, 1993, JAMA-J AM MED ASSOC, V270, P2213, DOI 10.1001/jama.270.18.2213; JUDE JR, 1961, JAMA-J AM MED ASSOC, V178, P1063, DOI 10.1001/jama.1961.03040500005002; Krakauer EL, 2002, J AM GERIATR SOC, V50, P182, DOI 10.1046/j.1532-5415.2002.50027.x; Levin Tomer T, 2008, Palliat Support Care, V6, P341, DOI 10.1017/S1478951508000540; Loggers ET, 2013, J PALLIAT MED, V16, P1249, DOI 10.1089/jpm.2013.0164; Loggers ET, 2009, J CLIN ONCOL, V27, P5559, DOI 10.1200/JCO.2009.22.4733; Mack JW, 2008, CANCER-AM CANCER SOC, V112, P2509, DOI 10.1002/cncr.23476; Mack JW, 2010, J CLIN ONCOL, V28, P1203, DOI 10.1200/JCO.2009.25.4672; Maxfield M, 2007, PSYCHOL AGING, V22, P341, DOI 10.1037/0882-7974.22.2.341; Morrell ED, 2008, J MED ETHICS, V34, P642, DOI 10.1136/jme.2007.022517; Nekolaichuk CL, 1999, PALLIATIVE MED, V13, P311, DOI 10.1191/026921699675854885; Phillips RS, 2000, J AM GERIATR SOC, V48, pS1, DOI 10.1111/j.1532-5415.2000.tb03118.x; Prigerson HG, 2015, JAMA ONCOL, V1, P778, DOI 10.1001/jamaoncol.2015.2378; RABKIN MT, 1976, NEW ENGL J MED, V295, P364, DOI 10.1056/NEJM197608122950705; Richardson DK, 2013, RESUSCITATION, V84, P483, DOI 10.1016/j.resuscitation.2012.08.327; Scheunemann LP, 2011, CHEST, V139, P543, DOI 10.1378/chest.10-0595; Sharp T, 2013, BRIT J GEN PRACT, V63, pE657, DOI 10.3399/bjgp13X673667; Shepardson LB, 1999, J GEN INTERN MED, V14, P15, DOI 10.1046/j.1525-1497.1999.00275.x; Silvennoinen R, 2008, SPECULAR GLOSS, P53, DOI 10.1016/B978-008045314-9.50007-4; Sinuff T, 2004, CAN J ANAESTH, V51, P1034, DOI 10.1007/BF03018494; Sneeuw KCA, 2002, J CLIN EPIDEMIOL, V55, P1130, DOI 10.1016/S0895-4356(02)00479-1; Su A, 2018, J PAIN SYMPTOM MANAG, V55, P1591, DOI 10.1016/j.jpainsymman.2018.02.005; Sulmasy DP, 1998, ANN INTERN MED, V128, P621, DOI 10.7326/0003-4819-128-8-199804150-00002; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; TOMLINSON T, 1988, NEW ENGL J MED, V318, P43, DOI 10.1056/NEJM198801073180109; WENGER NS, 1995, ARCH INTERN MED, V155, P2056, DOI 10.1001/archinte.155.19.2056; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Wright AA, 2010, J CLIN ONCOL, V28, P4457, DOI 10.1200/JCO.2009.26.3863; Zhang BH, 2012, ARCH INTERN MED, V172, P1133, DOI 10.1001/archinternmed.2012.2364; Zingmond DS, 2005, ARCH INTERN MED, V165, P1705, DOI 10.1001/archinte.165.15.1705	42	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0227971	10.1371/journal.pone.0227971	http://dx.doi.org/10.1371/journal.pone.0227971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7XT	32069306	Green Published, gold			2022-12-26	WOS:000535212900037
J	Pitts, JB; Kramer, J; Reed, SK; Schiltz, P; Thombs, L; Keegan, KG				Pitts, Jael B.; Kramer, Joanne; Reed, Shannon K.; Schiltz, Paul; Thombs, Lori; Keegan, Kevin G.			Effect of induced hindlimb length difference on body-mounted inertial sensor measures used to evaluate hindlimb lameness in horses	PLOS ONE			English	Article							PELVIC MOVEMENT ASYMMETRY; SUBJECTIVE EVALUATION; LIMB LAMENESS; SYSTEM; REPEATABILITY; HEAD	This study has investigated the immediate effect of induced hindlimb length difference on hindlimb lameness measured as differences in minimum (Pmin) and maximum (Pmax) pelvic heights in 16 horses trotting in a straight line and lungeing on both hard and soft surfaces with body-mounted inertial sensors. Hindlimb length differences were induced by applying an Easyboot Glue-on shoe to one hindlimb. Changes in Pmin and Pmax with induced hindlimb length difference were assessed with a two-way repeated-measures ANOVA with trial (straight, lunge with inside limb elevation, lunge with outside limb elevation) and surface (hard, soft) as within-subject factors. Change in Pmin, indicating an impact-type lameness, in the hind limb with the elevation, was significant in both the straight line and while lunging on both hard and soft surfaces. Change in Pmax, indicating pushoff-type lameness, in the opposite, non-elevated hind limb, was significant when trotting in a straight line but not while lunging.	[Pitts, Jael B.; Kramer, Joanne; Reed, Shannon K.; Keegan, Kevin G.] Univ Missouri, Coll Vet Med, Vet Hlth Ctr, Dept Vet Med & Surg, Columbia, MO 65211 USA; [Schiltz, Paul] William Woods Univ, Equestrian Studies, Fulton, MO USA; [Thombs, Lori] Univ Missouri, Dept Stat, Social Sci Stat Ctr, Columbia, MO 65211 USA; [Pitts, Jael B.] Waller Equine Hosp, Waller, TX 77484 USA; [Reed, Shannon K.] Ohio State Univ, Coll Vet Med, Galbreath Equine Ctr, Dept Clin Sci, Columbus, OH 43210 USA	University of Missouri System; University of Missouri Columbia; William Woods University; University of Missouri System; University of Missouri Columbia; University System of Ohio; Ohio State University	Pitts, JB (corresponding author), Univ Missouri, Coll Vet Med, Vet Hlth Ctr, Dept Vet Med & Surg, Columbia, MO 65211 USA.; Pitts, JB (corresponding author), Waller Equine Hosp, Waller, TX 77484 USA.	jpitts@wallerequine.com		Pitts, Jael/0000-0001-8305-7712				Bell RP, 2016, AM J VET RES, V77, P337, DOI 10.2460/ajvr.77.4.337; Cully P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198545; DALIN G, 1985, EQUINE VET J, V17, P292, DOI 10.1111/j.2042-3306.1985.tb02501.x; Gurney B, 2002, GAIT POSTURE, V15, P195, DOI 10.1016/S0966-6362(01)00148-5; Keegan KG, 2010, EQUINE VET J, V42, P92, DOI 10.2746/042516409X479568; Keegan KG, 2013, AM J VET RES, V74, P17, DOI 10.2460/ajvr.74.1.17; Keegan KG, 2011, AM J VET RES, V72, P1156, DOI 10.2460/ajvr.72.9.1156; Keegan KG, 2004, AM J VET RES, V65, P665, DOI 10.2460/ajvr.2004.65.665; Keegan KG, 2002, BIOMED SCI INSTRUM, V38, P107; Perttunen JR, 2004, SCAND J MED SCI SPOR, V14, P49, DOI 10.1111/j.1600-0838.2003.00307.x; Pfau T, 2016, EQUINE VET J, V48, P83, DOI 10.1111/evj.12374; Rhodin M, 2016, EQUINE VET J, V48, P315, DOI 10.1111/evj.12446; Rhodin M, 2013, VET J, V198, pE39, DOI 10.1016/j.tvjl.2013.09.031; van Heel MCV, 2010, EQUINE VET J, V42, P444, DOI 10.1111/j.2042-3306.2010.00064.x; Vertz J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199447; White SC, 2004, CLIN ORTHOP RELAT R, P287, DOI 10.1097/01.blo.0000119460.33630.6d	16	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0228872	10.1371/journal.pone.0228872	http://dx.doi.org/10.1371/journal.pone.0228872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7XT	32069321	Green Published, gold			2022-12-26	WOS:000535212900017
J	Sun, LQ; Huang, SS; Sun, GL; Zhang, YJ; Hu, X; Nevo, E; Peng, JH; Sun, DF				Sun, Longqing; Huang, Sisi; Sun, Genlou; Zhang, Yujuan; Hu, Xin; Nevo, Eviatar; Peng, Junhua; Sun, Dongfa			SNP-based association study of kernel architecture in a worldwide collection of durum wheat germplasm	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; DOMESTICATION TRAITS; GRAIN WEIGHT; TRITICUM-DICOCCOIDES; GENETIC DISSECTION; WINTER-WHEAT; QTL ANALYSIS; LINKAGE MAP; YIELD; POPULATION	Durum wheat, genetic resource with favorable alleles is considered as natural gene pool for wheat breeding. Kernel size and weight are important factors affecting grain yield in crops. Here, association analysis was performed to dissect the genetic constitution of kernelrelated traits in 150 lines collected from 46 countries and regions using a set of EST-derived and genome-wide SNP markers with five consecutive years of data. Total 109 significant associations for eight kernel-related traits were detected under a mix linear model, generating 54 unique SNP markers distributed on 13 of 14 chromosomes. Of which, 19 marker-trait associations were identified in two or more environments, including one stable and pleiotropic SNP BE500291_5_A_37 on chromosome 5A correlated with six kernel traits. Although most of our SNP loci were overlapped with the previously known kernel weight QTLs, several novel loci for kernel traits in durum were reported. Correlation analysis implied that the moderate climatic variables during growth and development of durum are needed for the large grain size and high grain weight. Combined with our previous studies, we found that chromosome 5A might play an important role in durum growth and development.	[Sun, Longqing; Huang, Sisi; Zhang, Yujuan; Hu, Xin; Sun, Dongfa] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Sun, Genlou] St Marys Univ, Biol Dept, Halifax, NS, Canada; [Nevo, Eviatar] Univ Haifa, Inst Evolut, Haifa, Israel; [Peng, Junhua] Huazhi Biotech Inst, Germplasm Enhancement Dept, Changsha, Hunan, Peoples R China; [Sun, Dongfa] Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Hubei, Peoples R China	Huazhong Agricultural University; Saint Marys University - Canada; University of Haifa	Sun, DF (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China.; Sun, DF (corresponding author), Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Hubei, Peoples R China.	sundongfa1@mail.hzau.edu.cn	Peng, Junhua/HHZ-2344-2022	Peng, Junhua/0000-0002-8428-3137	China National Key Project Grant [2016YFD0100102]; National Natural Science Foundation of China [31601294]; China Postdoctoral Science Foundation [2015M582241]	China National Key Project Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by China National Key Project Grant (http://www.most.gov.cn/) (Grant No. 2016YFD0100102) and Dongfa Sun was the host of this project. This work was also supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (Grant No. 31601294) and Longqing Sun was the host of this project. This work was also supported by China Postdoctoral Science Foundation (http://www.chinapostdoctor.org.cn/) (Grant No. 2015M582241) and Longqing Sun was the host of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00886; Asseng S, 2011, GLOBAL CHANGE BIOL, V17, P997, DOI 10.1111/j.1365-2486.2010.02262.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blanco A, 2012, MOL BREEDING, V30, P79, DOI 10.1007/s11032-011-9600-z; Chen WG, 2019, EUPHYTICA, V215, DOI 10.1007/s10681-018-2333-x; Chenu K, 2017, TRENDS PLANT SCI, V22, P472, DOI 10.1016/j.tplants.2017.02.003; Cichon S, 2016, NEUROBIOLOGY OF SCHIZOPHRENIA, P39, DOI 10.1016/B978-0-12-801829-3.00011-2; Cui F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04028-6; Daba SD, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01045; Dekkers BJW, 2016, PLANT J, V85, P451, DOI 10.1111/tpj.13118; Elouafi I, 2004, THEOR APPL GENET, V108, P401, DOI 10.1007/s00122-003-1440-8; Faris JD, 2014, THEOR APPL GENET, V127, P2333, DOI 10.1007/s00122-014-2380-1; Fiedler JD, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2017.05.0038; Figueroa M, 2018, MOL PLANT PATHOL, V19, P1523, DOI 10.1111/mpp.12618; Giraldo P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166577; Golabadi M, 2011, EUPHYTICA, V177, P207, DOI 10.1007/s10681-010-0242-8; Graziani M, 2014, CROP PASTURE SCI, V65, P80, DOI 10.1071/CP13349; Hanif M, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-015-0425-z; Hong YT, 2014, FUNCT INTEGR GENOMIC, V14, P341, DOI 10.1007/s10142-014-0380-5; Hu MJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01902; Hu MJ, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0449-z; Hu X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130854; Huang SS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206226; Jiang QY, 2011, FUNCT INTEGR GENOMIC, V11, P49, DOI 10.1007/s10142-010-0188-x; Kidane YG, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01230; Klymiuk V., 2019, APPL GENETIC GENOMIC, P201, DOI [10.1016/B978-0-08-102163-7.00010-7, DOI 10.1016/B978-0-08-102163-7.00010-7]; Kumar V, 2018, THEOR APPL GENET, V131, P1627, DOI 10.1007/s00122-018-3103-9; Li FJ, 2018, THEOR APPL GENET, V131, P1903, DOI 10.1007/s00122-018-3122-6; Li KN, 2016, INT J BIOMETEOROL, V60, P21, DOI 10.1007/s00484-015-1002-1; Liu B, 2019, GLOBAL CHANGE BIOL, V25, P1428, DOI 10.1111/gcb.14542; Liu LC, 2015, P NATL ACAD SCI USA, V112, P11102, DOI 10.1073/pnas.1512748112; Lv LH, 2013, CHIL J AGR RES, V73, P233, DOI 10.4067/S0718-58392013000300005; Ma DY, 2012, MOL BREEDING, V29, P43, DOI 10.1007/s11032-010-9524-z; Ma L, 2016, PLANT BIOTECHNOL J, V14, P1269, DOI 10.1111/pbi.12492; Maccaferri M, 2016, J EXP BOT, V67, P1161, DOI 10.1093/jxb/erw039; Mangini G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190162; Mir RR, 2012, MOL BREEDING, V29, P963, DOI 10.1007/s11032-011-9693-4; Mohammadi M., 2012, African Journal of Biotechnology, V11, P2931; Norouzian F, 2016, EUROP RADAR CONF, P117; Patil RM, 2013, EUPHYTICA, V190, P117, DOI 10.1007/s10681-012-0785-y; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Peleg Z, 2011, J EXP BOT, V62, P5051, DOI 10.1093/jxb/err206; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Thanh PT, 2013, BIOTECHNOL BIOTEC EQ, V27, P3627, DOI 10.5504/BBEQ.2013.0008; Qin L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-107; Qiu X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138110; Rahim MS, 2018, ADV BIOCHEM ENG BIOT, V164, P83, DOI 10.1007/10_2017_50; Rasheed A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-128; Rellstab C, 2015, MOL ECOL, V24, P4348, DOI 10.1111/mec.13322; Ren J, 2013, INT J MOL SCI, V14, P7061, DOI 10.3390/ijms14047061; Reynolds M, 2012, PLANT CELL ENVIRON, V35, P1799, DOI 10.1111/j.1365-3040.2012.02588.x; Roncallo PF, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-2058-2; Russo MA, 2014, MOL BREEDING, V34, P1579, DOI 10.1007/s11032-014-0181-5; Sabiel SA, 2017, BREEDING SCI, P16074; Sajjad M, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1114-3; Simmons JG, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-115; Sinclair TR, 2006, FIELD CROP RES, V98, P60, DOI 10.1016/j.fcr.2005.12.006; Soriano JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178290; Su QN, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01484; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Tzarfati R, 2014, MOL BREEDING, V34, P1613, DOI 10.1007/s11032-014-0182-4; Wang SS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00783; Xiao YG, 2012, CROP SCI, V52, P44, DOI 10.2135/cropsci2011.05.0246; Xu LP, 2016, DNA RES, V23, P43, DOI 10.1093/dnares/dsv035; Yin CB, 2015, THEOR APPL GENET, V128, P1969, DOI 10.1007/s00122-015-2560-7; Zanke CD, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00644; Zhang JJ, 2015, NEW PHYTOL, V205, P293, DOI 10.1111/nph.13030; Zhang L, 2012, NEW PHYTOL, V195, P574, DOI 10.1111/j.1469-8137.2012.04194.x; Zhang Y, 2018, PLANT J, V94, P857, DOI 10.1111/tpj.13903; Zhang YJ, 2014, MOL BREEDING, V34, P1097, DOI 10.1007/s11032-014-0102-7; Zhang YM, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00100; Zhang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0056344, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0065268]	72	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0229159	10.1371/journal.pone.0229159	http://dx.doi.org/10.1371/journal.pone.0229159			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7VI	32059028	Green Published, gold			2022-12-26	WOS:000535206600033
J	Tuvdendorj, A; Feenstra, T; Tseveen, B; Buskens, E				Tuvdendorj, Ariuntuya; Feenstra, Talitha; Tseveen, Badamsuren; Buskens, Erik			Smoking-attributable burden of lung cancer in Mongolia a data synthesis study on differences between men and women	PLOS ONE			English	Article							AIR-POLLUTION; MORTALITY; RISKS; CHINA; PREVALENCE; TOBACCO	Background Smoking is widely recognized as one of the most prevalent and preventable causes of many cancer types. This study aimed to quantify the population attributable fraction (PAF) of the lung cancer burden for smoking in Mongolia. Methods Lung cancer incidence and lung cancer-related death data came from the population-based national registry covering the period 2007-2016. Smoking prevalence data came from the STEPwise approach (STEP) national survey. The lung cancer-related disease burden was calculated and expressed in Disability Adjusted Life Years (DALYs) lost by gender and by year. This was combined with current smoking and former smoking prevalence data, and relative risks (RR) of lung cancer-related deaths for current smokers and former smokers versus never smokers from region-specific cohort studies to estimate the PAF of lung cancer attributable to "ever-smoking" in Mongolia. Results Between 2007 and 2016, lung cancer accounted for the loss of over 63,000 DALYs in Mongolia. The PAF of lung cancer-related deaths attributable to current and former smoking combined was 58.1% (95% IR = 43.1%-72.2%) for men and 8.9% (95% IR = 4.1% -13.5%) for women. Smoking-attributable DALYs loss amounted to 2589 years (95% IR = 1907-3226) in 2016. Conclusions A considerable health loss may be prevented with an effective anti-smoking policy. In Mongolia, more than one third of lung cancer-related DALY loss is attributable to active smoking, and thus is potentially preventable. Furthermore, a gender-specific tobacco control policy may be worthwhile because of the large gender difference in smoking exposure in Mongolia. Next to this, age specific policy, including a smoke-free generation policy for adolescents, with targeted education, and mass media campaigns is needed.	[Tuvdendorj, Ariuntuya] Mongolian Natl Univ Med Sci, Sch Publ Hlth, Dept Hlth Policy, Ulaanbaatar, Mongolia; [Tuvdendorj, Ariuntuya; Feenstra, Talitha; Buskens, Erik] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Feenstra, Talitha] Natl Inst Publ Hlth & Environm RIVM, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands; [Tseveen, Badamsuren] Natl Canc Ctr, Res Training & Informat Dept, Ulaanbaatar, Mongolia	Mongolian National University of Medical Sciences; University of Groningen; Netherlands National Institute for Public Health & the Environment	Tuvdendorj, A (corresponding author), Mongolian Natl Univ Med Sci, Sch Publ Hlth, Dept Hlth Policy, Ulaanbaatar, Mongolia.; Tuvdendorj, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	t.ariunaa@gmail.com		Tuvdendorj, Ariuntuya/0000-0002-3847-6974; buskens, erik/0000-0002-6463-1106	Mongolian government; UMCG	Mongolian government; UMCG	This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. AT received an unconditional grant for her PhD research from the Mongolian government and from the UMCG.	Allen RW, 2013, AIR QUAL ATMOS HLTH, V6, P137, DOI 10.1007/s11869-011-0154-3; Ando M, 2003, INT J CANCER, V105, P249, DOI 10.1002/ijc.11043; [Anonymous], 2011, INT STAT CLASS DIS R; [Anonymous], 2012, WHO GLOBAL REPORT WH; [Anonymous], 2009, MONGOLIA AIR POLLUTI; Barendregt JJ., 2003, POPUL HEALTH METR, V1, P4, DOI [DOI 10.1186/1478-7954-1-4, 10.1186/1478-7954-1-4]; Chen XS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-84; Chen ZM, 2015, CANCER-AM CANCER SOC, V121, P3097, DOI 10.1002/cncr.29560; Chimed T, 2017, INT J CANCER, V140, P302, DOI 10.1002/ijc.30463; Chimeddamba O, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2040-7; Demaio AR, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-213; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Ezzati M, 2005, INT J CANCER, V116, P963, DOI 10.1002/ijc.21100; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Giovino G, 2012, TOBACCO USE IN 3 BIL; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; Hanley JA, 2001, HEURISTIC APPROACH F; International Agency for Research on Cancer (IARC), 2004, IARC MONOGRAPHS EVAL; Jee SH, 2004, CANCER CAUSE CONTROL, V15, P341, DOI 10.1023/B:CACO.0000027481.48153.97; Jung KJ, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016060; Lee PN, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-385; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Lim S, 2013, COMP RISK ASSESSMENT; Murray CJ, 1994, QUANTIFYING BURDEN D; National Health Statistics, 2017, HLTH IND 2017; Oza S, 2011, PREV MED, V52, P428, DOI 10.1016/j.ypmed.2011.04.007; Park S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-406; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Reinsch CH, 1967, SMOOTHING SPLINE FUN; Sandagdorj T, 2010, ASIAN PAC J CANCER P, V11, P1509; Takahashi I, 2008, P HLTH DIFFERENCES I; Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127; Wen CP, 2004, PREV MED, V39, P528, DOI 10.1016/j.ypmed.2004.02.010; WHO, 2017, MONG COMPR TOB CONTR; World Health Organization, 2008, WHO REP GLOB TOB EP; World Health Organization, 2018, WHO GLOB REP TRENDS, V2nd; Yang JJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.1474; Zhao Y, 2006, SCI TOTAL ENVIRON, V366, P500, DOI 10.1016/j.scitotenv.2005.10.010; Zheng W, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001631	41	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0229090	10.1371/journal.pone.0229090	http://dx.doi.org/10.1371/journal.pone.0229090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7VI	32059049	gold, Green Published			2022-12-26	WOS:000535206600030
J	Cohen, EP; Olson, JD; Tooze, JA; Bourland, JD; Dugan, GO; Cline, JM				Cohen, Eric P.; Olson, John D.; Tooze, Janet A.; Bourland, J. Daniel; Dugan, Greg O.; Cline, J. Mark			Detection and quantification of renal fibrosis by computerized tomography	PLOS ONE			English	Article							RADIATION	Objectives Reliable biomarkers for renal fibrosis are needed for clinical care and for research. Existing non-invasive biomarkers are imprecise, which has limited their utility. Methods We developed a method to quantify fibrosis by subject size-adjusted CT Hounsfield units. This was accomplished using CT measurements of renal cortex in previously irradiated non-human primates. Results Renal cortex mean CT Hounsfield units that were adjusted for body size had a very good direct correlation with renal parenchymal fibrosis, with an area under the curve of 0.93. Conclusions This metric is a promising and simple non-invasive biomarker for renal fibrosis.	[Cohen, Eric P.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Cohen, Eric P.] Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Olson, John D.; Tooze, Janet A.; Bourland, J. Daniel; Dugan, Greg O.; Cline, J. Mark] Wake Forest Univ, Dept Comparat Med, Wake Forest, NC USA	University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; Wake Forest University	Cohen, EP (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.; Cohen, EP (corresponding author), Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA.	ecohen@som.umaryland.edu		Cohen, Eric/0000-0003-4299-2290	United States Department of Veterans Affairs Office of Biomedical Laboratory Research and Development [BX002256-01A1]; National Institutes of Health [U19A167798]; National Cancer Institute [P30CA012197]	United States Department of Veterans Affairs Office of Biomedical Laboratory Research and Development(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	EPC. BX002256-01A1. United States Department of Veterans Affairs Office of Biomedical Laboratory Research and Development. https://www.research.va.gov/JMC.U19A167798.National Institutes of Health. https://www.niaid.nih.gov/JAT.P30CA012197.National Cancer Institute. https://www.cancer.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basile DP, 2016, J AM SOC NEPHROL, V27, P687, DOI 10.1681/ASN.2015030309; Boas EF, 2012, IMAGING MED, V4, P229, DOI DOI 10.2217/IIM.12.13; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Chaplais E, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-242; CHEUNG Y, 1992, RADIOGRAPHICS, V12, P429, DOI 10.1148/radiographics.12.3.1609136; COHEN EP, 1995, MED HYPOTHESES, V45, P459, DOI 10.1016/0306-9877(95)90221-X; Cohen EP, 2017, RADIAT RES, V188, P661, DOI 10.1667/RR24857.1; Farris AB, 2011, J AM SOC NEPHROL, V22, P176, DOI 10.1681/ASN.2009091005; Farris M, 2018, RADIAT RES, V190, P63, DOI 10.1667/RR15007.1; Fortman JD, 2002, LAB NONHUMAN PRIMATE; Hale LP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210663; Leung G, 2017, CLIN J AM SOC NEPHRO, V12, P1019, DOI 10.2215/CJN.07900716; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Mansour SG, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0490-0; McCollough C., 2008, REPORT AAPM TASK GRO; Moghazi S, 2005, KIDNEY INT, V67, P1515, DOI 10.1111/j.1523-1755.2005.00230.x; Prokop M., 2003, SPIRAL MULTISLICE CO; STEPHENS LC, 1995, INT J RADIAT ONCOL, V31, P865, DOI 10.1016/0360-3016(94)00437-4	18	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228626	10.1371/journal.pone.0228626	http://dx.doi.org/10.1371/journal.pone.0228626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053617	Green Published, gold			2022-12-26	WOS:000535198700037
J	Hiscock, R; Augustin, NH; Branston, JR; Gilmore, AB				Hiscock, Rosemary; Augustin, Nicole H.; Branston, J. Robert; Gilmore, Anna B.			Standardised packaging, minimum excise tax, and RYO focussed tax rise implications for UK tobacco pricing	PLOS ONE			English	Article							SMOKING PREVALENCE; REDUCING SMOKING; POLICY; INTERVENTIONS; CIGARETTES; INCREASE; IMPACT; SALES; ROLL	Background Standardised packaging for factory made (FM) and roll your own (RYO) tobacco was fully implemented in the UK in May 2017. Around the same time, several changes to the tax system were applied (a Minimum Excise Tax (MET) for FM products and tax increases weighted towards RYO products). The tobacco industry claims that standardised packaging will lower prices (a disincentive for quitting) by commoditising the product, yet had itself taken advantage of the previous tax regime to achieve large profits from premium brands while also keeping some products' prices relatively low. Here we evaluate the impact of standardised packaging, the MET and the RYO focussed tax changes on price and industry profitability. Methods and findings Nielsen electronic point of sale (EPOS) data (May 2015 to April 2018) were used to calculate real (inflation adjusted) monthly price per stick overall, by cigarette type (FM and RYO) and by seven market segments. Trend estimation, using additive mixed models, assessed weighted average price (weighted by volume of sales) and tobacco industry net revenue changes. The beginning and end of the data series were compared in terms of: (a) average monthly price growth, (b) average monthly net revenue growth, and (c) undershifting and overshifting patterns after tax changes. FM and RYO real prices changed little over the 3-year period-overall prices rose by about 1p per stick. There was no evidence of commoditisation with prices of all FM segments (but not RYO) rising faster after the implementation of standardised packaging than immediately beforehand. The prices of the cheapest FM brands rose with the implementation of the MET. RYO price increases did not close the gap to FM pricing levels despite RYO focussed tax increases. Tax changes following the implementation of standardised packaging and the MET were more widely and quickly passed on to smokers in the form of higher prices than the tax change pre-implementation. The main limitations are first that because we do not know the exact mechanism by which Nielsen scales up sample data to provide UK estimates, we could only use data for a set three year period during which the same adjustments are made. Second, the tax and standardised packaging events were sometimes too close in time to separate their consequences statistically. Third, tobacco prices may also be affected by external factors such as changes in smokers' disposable income or availability of electronic nicotine delivery systems. Conclusions There was no long-term lowering of tobacco prices after the implementation of standardised packaging as predicted by the industry. The introduction of the MET was successful in increasing the price of the cheapest FM cigarettes and narrowing the price gap between FM brands. The RYO tax increases were, however, insufficient to narrow the price gap between RYO and FM. Overall, undershifting became less extensive indicating that tobacco industry manipulation of the tax system which had previously kept cheap products available had declined. This suggests that standardised packaging and a MET will likely contribute to further declines in UK tobacco use.	[Hiscock, Rosemary; Gilmore, Anna B.] Univ Bath, Dept Hlth, Tobacco Control Res Grp, Bath, Avon, England; [Augustin, Nicole H.] Univ Bath, Dept Math Sci, Bath, Avon, England; [Branston, J. Robert] Univ Bath, Sch Management, Bath, Avon, England	University of Bath; University of Bath; University of Bath	Hiscock, R (corresponding author), Univ Bath, Dept Hlth, Tobacco Control Res Grp, Bath, Avon, England.	r.hiscock@bath.ac.uk		Gilmore, Anna/0000-0003-0281-1248; Augustin, Nicole/0000-0001-6644-3742; Branston, J Robert/0000-0002-2332-2403; Hiscock, Rosemary/0000-0001-9741-9083	Policy Research Centre Cancer Research UK; British Heart Foundation [A23168]	Policy Research Centre Cancer Research UK; British Heart Foundation(British Heart Foundation)	RH, NA, JRB and AG received joint funding from the Policy Research Centre Cancer Research UK and the British Heart Foundation, Award Number A23168 (see https://www.cancerresearchuk.org/and https://www.bhf.org.uk/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, P 2 INT S INF BN PET; Amato MS, 2015, AM J PUBLIC HEALTH, V105, pE5, DOI 10.2105/AJPH.2014.302438; [Anonymous], ALC DEPR HELP HAND L; [Anonymous], 2018, LANG ENV STAT COMP; ASH, 2011, KEY DAT HIST ANT CAM; Ash Scotland, TOB CONTR LEG SCOTL; Baayen RH, 2018, QUANT METH HUMAN SOC, P49, DOI 10.1007/978-3-319-69830-4_4; Bader P, 2011, INT J ENV RES PUB HE, V8, P4118, DOI 10.3390/ijerph8114118; BARB, 2015, REP REG VIEW BARB ST; Branston JR, 2018, DRUG ALCOHOL DEPEN, V193, P110, DOI 10.1016/j.drugalcdep.2018.07.047; Branston JR, 2014, TOB CONTROL, V23, P45, DOI 10.1136/tobaccocontrol-2011-050385; Breton MO, 2018, ADDICTION, V113, P1883, DOI 10.1111/add.14282; Breton MO, 2019, TOB CONTROL; Brown R., 2018, GROCERY DATA EXPLAIN; Brown T, 2014, EUR J PUBLIC HEALTH, V24, P551, DOI 10.1093/eurpub/cku065; CareerOneStop, 2011, CAR; Critchlow N, 2018, ADDICTION; Crosbie E, 2019, TOB CONTROL, V28, P195, DOI 10.1136/tobaccocontrol-2017-054227; Ekpu VU, 2015, TOB USE INSIGHTS, V8, P1, DOI 10.4137/TUI.S15628; Etter JF, 2015, DRUG ALCOHOL DEPEN, V147, P68, DOI 10.1016/j.drugalcdep.2014.12.007; Euromonitor Passport, 2018, CIG CIG UK DAT 2018; Euromonitor Passport, 2018, MARK SIZ VAP PROD; European Commision ECExcise duty tables, 2018, EXC DUT TABL 3; Evans-Reeves K, BMJ OPEN; ExpertChoice, 2009, EXPERTCHOICE; Farley SM, 2015, TOB CONTROL, V24, pE10, DOI 10.1136/tobaccocontrol-2013-051272; Fooks G, 2014, TOB CONTROL, V23, DOI 10.1136/tobaccocontrol-2012-050869; Forey B., 2016, INT SMOKING STAT; Gilmore AB, 2015, J PUBLIC HEALTH-UK, V37, P78, DOI 10.1093/pubmed/fdu048; Gilmore AB, 2013, ADDICTION, V108, P1317, DOI 10.1111/add.12159; GOV.UK, 2017, POL PAP AUT BUDG 201; GOV.UK, 2016, POL PAP BUDG 2016; Government Digital Service, VAT RAT; Hatchard JL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012634; Hatchard Jenny L., 2014, BRIT MED J, V4, P3757; Hill S, 2013, TOB CONTROL; Hiscock R, 2019, TOB CONTROL; Hiscock R, 2018, TOB CONTROL, V27, P488, DOI 10.1136/tobaccocontrol-2017-053891; Hiscock R, 2012, J PUBLIC HEALTH-UK, V34, P390, DOI 10.1093/pubmed/fds012; Hitchman SC, 2016, AIMS PUBLIC HEALTH, V3, P110, DOI 10.3934/publichealth.2016.1.110; HM Treasury, 2010, BUDGET 2010; HM Treasury, 2012, BUDG 2012; HM Treasury, 2013, BUDG 2013; HM Treasury, 2014, BUDG 2014; HM TREASURY, 2016, BUDG 2016; HM Treasury, 2017, SPRING BUDG 2017; HM Treasury, 2015, BUDG 2015; HMRC, 2016, HM REV CUST VAL ADD; HMRC, 2018, HM REV CUST TOB B; HMRC, 2017, MIN EXC TAX 2017; HMRC, 2016, HIM REV CUST TOB B; IBISWorld, 2018, TOB UK MARK RES REP; IGD, 2015, UK GROC RET 2015; International Agency for Research on Cancer World Health Organisation, 2011, OV TOB TAX; Joe CK, 2014, ELASTICITY TOBACCO D, V7; Joossens L, 2006, TOB CONTROL, V15, P247, DOI 10.1136/tc.2005.015347; Kids CfTF, 2017, UKR TOB TAX SUCC STO; Legislation UK, 2015, EXPL MEM SATND PACK; Levy DT, 2013, B WORLD HEALTH ORGAN, V91, P509, DOI 10.2471/BLT.12.113878; Levy DT, 2012, AM J PREV MED, V43, pS179, DOI 10.1016/j.amepre.2012.07.037; Lillard DR, 2013, J HEALTH ECON, V32, P114, DOI 10.1016/j.jhealeco.2012.08.006; Lin XH, 1999, J ROY STAT SOC B, V61, P381, DOI 10.1111/1467-9868.00183; Lopez-Nicolas A, 2013, NICOTINE TOB RES, V15, P1963, DOI 10.1093/ntr/ntt038; Lopez-Nicolas A, 2013, TOB CONTROL, V22, DOI 10.1136/tobaccocontrol-2011-050344; Lorenc T, 2013, J EPIDEMIOL COMMUN H, V67, P190, DOI 10.1136/jech-2012-201257; MacLean JC, 2015, HLTH EC; Mader EM, 2015, J PUBLIC HLTH MANAGE; Moodie C, 2018, TOB CONTROL; Nagelhout GE, 2012, ADDICTION, V107, P407, DOI 10.1111/j.1360-0443.2011.03642.x; National Cancer Institute World Health Organisation, 2017, TOB CONTR MON SER, V21; Nielsen, 2017, TOB SAMPL; Nielsen, 2017, RET MEAS SERV DES SU; Partos TR, 2017, NICOTINE TOB RES; Philip Morris Limited, 2011, SUBM  TOB PLAIN PACK; Reed H, 2013, EUR J PUBLIC HLTH S1, V23; Resolution Foundation, 2018, LIV STAND AUD 2018; Scollo M, 2015, TOB CONTROL, V24, pII82, DOI 10.1136/tobaccocontrol-2014-051950; Scollo Michelle, 2014, BMJ Open, V4, pe005873, DOI 10.1136/bmjopen-2014-005873; Shirane R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001248; Smith KE, 2013, TOB CONTROL, V22, P144, DOI 10.1136/tobaccocontrol-2011-050098; Tavakoly B, 2012, WORLD C TOB HLTH SIG; Treasury H, 2014, CLOS CONS MIN EXC TA; Ulucanlar S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002125; Ulucanlar S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001629; van Hasselt M, 2015, ADDICT BEHAV, V45, P104, DOI 10.1016/j.addbeh.2015.01.023; van Walbeek C., 2003, TOBACCO EXCISE TAXAT; Wagner, 2002, J CLIN PHARM THERAPE; West R, 2018, STS120720 LATEST TRE; Whitehead R, 2018, STRENGTHS LIMITATION; Wilson LM, 2012, J ENV PUBLIC HLTH, V2012; Wood S.N., 2017, GEN ADDITIVE MODELS	91	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228069	10.1371/journal.pone.0228069	http://dx.doi.org/10.1371/journal.pone.0228069			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7SH	32053603	Green Published, gold			2022-12-26	WOS:000535198700017
J	Orekhova, EV; Prokofyev, AO; Nikolaeva, AY; Schneiderman, JF; Stroganova, TA				Orekhova, Elena, V; Prokofyev, Andrey O.; Nikolaeva, Anastasia Yu; Schneiderman, Justin F.; Stroganova, Tatiana A.			Additive effect of contrast and velocity suggests the role of strong excitatory drive in suppression of visual gamma response	PLOS ONE			English	Article							EXCITATION/INHIBITION BALANCE; ORIENTATION DISCRIMINATION; SPATIOTEMPORAL FREQUENCY; OSCILLATION FREQUENCY; STIMULUS SELECTIVITY; BAND OSCILLATIONS; PEAK FREQUENCY; CORTEX; RHYTHMS; POWER	It is commonly acknowledged that gamma-band oscillations arise from interplay between neural excitation and inhibition; however, the neural mechanisms controlling the power of stimulus-induced gamma responses (GR) in the human brain remain poorly understood. A moderate increase in velocity of drifting gratings results in GR power enhancement, while increasing the velocity beyond some 'transition point' leads to GR power attenuation. We tested two alternative explanations for this nonlinear input-output dependency in the GR power. First, the GR power can be maximal at the preferable velocity/temporal frequency of motion-sensitive V1 neurons. This 'velocity tuning' hypothesis predicts that lowering contrast either will not affect the transition point or shift it to a lower velocity. Second, the GR power attenuation at high velocities of visual motion can be caused by changes in excitation/inhibition balance with increasing excitatory drive. Since contrast and velocity both add to excitatory drive, this 'excitatory drive' hypothesis predicts that the 'transition point' for low-contrast gratings would be reached at a higher velocity, as compared to high-contrast gratings. To test these alternatives, we recorded magnetoencephalography during presentation of low (50%) and high (100%) contrast gratings drifting at four velocities. We found that lowering contrast led to a highly reliable shift of the GR suppression transition point to higher velocities, thus supporting the excitatory drive hypothesis. No effects of contrast or velocity were found in the alpha-beta range. The results have implications for understanding the mechanisms of gamma oscillations and developing gamma-based biomarkers of disturbed excitation/inhibition balance in brain disorders.	[Orekhova, Elena, V; Prokofyev, Andrey O.; Nikolaeva, Anastasia Yu; Stroganova, Tatiana A.] Moscow State Univ Psychol & Educ, Ctr Neurocognit Res, MEG Ctr, Moscow, Russia; [Orekhova, Elena, V; Schneiderman, Justin F.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden; [Orekhova, Elena, V; Schneiderman, Justin F.] Sahlgrens Univ Hosp, MedTech West, Gothenburg, Sweden	Moscow State University of Psychology & Education; University of Gothenburg; Sahlgrenska University Hospital	Orekhova, EV (corresponding author), Moscow State Univ Psychol & Educ, Ctr Neurocognit Res, MEG Ctr, Moscow, Russia.; Orekhova, EV (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden.; Orekhova, EV (corresponding author), Sahlgrens Univ Hosp, MedTech West, Gothenburg, Sweden.	Orekhova.Elena.V@gmail.com	Orekhova, Elena V/S-9043-2018; Prokofyev, Andrey/ABG-9238-2020; Schneiderman, Justin F/D-4508-2013; Stroganova, Tatiana T.A./C-5773-2014	Orekhova, Elena V/0000-0003-0950-1613; Schneiderman, Justin F/0000-0002-4441-2360; 	Moscow State University of Psychology and Education; Charity Foundation "Way Out"; Swedish Childhood Cancer [MT2014-0007]; Knut and Alice Wallenberg Foundation [2014.0102]; Swedish Research Council [2017-0068]	Moscow State University of Psychology and Education; Charity Foundation "Way Out"; Swedish Childhood Cancer; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Moscow State University of Psychology and Education; the Charity Foundation "Way Out"; Swedish Childhood Cancer (MT2014-0007); Knut and Alice Wallenberg Foundation (2014.0102) and Swedish Research Council (2017-0068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2017, NEURON, V95, P1147, DOI 10.1016/j.neuron.2017.08.014; Alitto HJ, 2004, J NEUROPHYSIOL, V91, P2797, DOI 10.1152/jn.00943.2003; Angelucci A, 2017, ANNU REV NEUROSCI, V40, P425, DOI 10.1146/annurev-neuro-072116-031418; Anver H, 2011, NEUROPSYCHOPHARMACOL, V36, P519, DOI 10.1038/npp.2010.183; Borgers C, 2005, NEURAL COMPUT, V17, P557, DOI 10.1162/0899766053019908; Brealy JA, 2015, PSYCHOL MED, V45, P783, DOI 10.1017/S0033291714001846; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Cannon J, 2014, EUR J NEUROSCI, V39, P705, DOI 10.1111/ejn.12453; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chai YH, 2019, NEUROIMAGE, V197, P13, DOI 10.1016/j.neuroimage.2019.04.048; Cousijn H, 2014, P NATL ACAD SCI USA, V111, P9301, DOI 10.1073/pnas.1321072111; de Pesters A, 2016, NEUROIMAGE, V134, P122, DOI 10.1016/j.neuroimage.2016.03.074; Dickinson A, 2016, J ABNORM PSYCHOL, V125, P412, DOI 10.1037/abn0000148; Edden RAE, 2009, J NEUROSCI, V29, P15721, DOI 10.1523/JNEUROSCI.4426-09.2009; Fawcett IP, 2004, NEUROIMAGE, V21, P1542, DOI 10.1016/j.neuroimage.2003.10.045; Ferando I, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00144; FOSTER KH, 1985, J PHYSIOL-LONDON, V365, P331, DOI 10.1113/jphysiol.1985.sp015776; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109, DOI 10.1152/jn.1984.51.5.1109; Gaetz W, 2011, NEUROIMAGE, V55, P616, DOI 10.1016/j.neuroimage.2010.12.077; Gaetz W, 2012, HUM BRAIN MAPP, V33, P2035, DOI 10.1002/hbm.21339; Gao R, 2017, NEUROIMAGE, V158, P70, DOI 10.1016/j.neuroimage.2017.06.078; Gramfort A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00267; Grent-'t-Jong T, 2016, SCHIZOPHR RES, V176, P177, DOI 10.1016/j.schres.2016.06.003; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Hadjipapas A, 2015, NEUROIMAGE, V112, P327, DOI 10.1016/j.neuroimage.2015.02.062; Hall SD, 2005, NEUROIMAGE, V26, P13, DOI 10.1016/j.neuroimage.2005.01.009; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Jensen O, 2014, TRENDS NEUROSCI, V37, P357, DOI 10.1016/j.tins.2014.04.001; Jia XX, 2013, J NEUROSCI, V33, P17, DOI 10.1523/JNEUROSCI.1687-12.2013; Jia XX, 2011, J NEUROSCI, V31, P9390, DOI 10.1523/JNEUROSCI.0645-11.2011; King PD, 2013, J NEUROSCI, V33, P5475, DOI 10.1523/JNEUROSCI.4188-12.2013; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Koelewijn L, 2011, NEUROIMAGE, V54, P2983, DOI 10.1016/j.neuroimage.2010.11.045; Kopell N., 2010, SPRINGER SERIES COMP; Kujala J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16347; Levin AR, 2015, NEUROTHERAPEUTICS, V12, P546, DOI 10.1007/s13311-015-0350-1; Livingstone MS, 2007, J NEUROPHYSIOL, V97, P849, DOI 10.1152/jn.00762.2006; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lowet E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004072; Mann EO, 2010, NAT NEUROSCI, V13, P205, DOI 10.1038/nn.2464; Murty DVPS, 2018, J NEUROSCI, V38, P2730, DOI 10.1523/JNEUROSCI.2270-17.2017; Muthukumaraswamy SD, 2013, NEUROIMAGE, V69, P223, DOI 10.1016/j.neuroimage.2012.12.038; Muthukumaraswamy SD, 2018, NEUROIMAGE, V179, P582, DOI 10.1016/j.neuroimage.2018.06.068; Muthukumaraswamy SD, 2016, CORTEX, V81, P266, DOI 10.1016/j.cortex.2016.03.004; Muthukumaraswamy SD, 2010, NEUROIMAGE, V49, P3349, DOI 10.1016/j.neuroimage.2009.11.045; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Orekhova EV, 2019, HUM BRAIN MAPP, V40, P1583, DOI 10.1002/hbm.24469; Orekhova EV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26779-6; Orekhova EV, 2015, J NEUROPHYSIOL, V114, P244, DOI 10.1152/jn.00232.2015; Orekhova EV, 2019, SPATIAL SUPPRESSION, DOI [10.1101/861765, DOI 10.1101/861765]; Perry G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124798; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Priebe NJ, 2006, J NEUROSCI, V26, P2941, DOI 10.1523/JNEUROSCI.3936-05.2006; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; Roberts MJ, 2013, NEURON, V78, P523, DOI 10.1016/j.neuron.2013.03.003; Salelkar S, 2018, J NEUROPHYSIOL, V120, P681, DOI 10.1152/jn.00807.2017; SHAPLEY RM, 1981, J PHYSIOL-LONDON, V318, P161; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Shaw AD, 2020, SCHIZOPHRENIA BULL, V46, P345, DOI 10.1093/schbul/sbz066; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Singh KD, 2000, NEUROIMAGE, V12, P550, DOI 10.1006/nimg.2000.0642; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; SPEAR PD, 1994, J NEUROPHYSIOL, V72, P402, DOI 10.1152/jn.1994.72.1.402; Stormer VS, 2016, J COGNITIVE NEUROSCI, V28, P433, DOI 10.1162/jocn_a_00915; Swettenham JB, 2009, J NEUROPHYSIOL, V102, P1241, DOI 10.1152/jn.91044.2008; Takada N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6333; Taulu S, 2009, HUM BRAIN MAPP, V30, P1524, DOI 10.1002/hbm.20627; Towers SK, 2004, J PHYSIOL-LONDON, V559, P721, DOI 10.1113/jphysiol.2004.071191; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Hooser SD, 2013, J NEUROSCI, V33, P11494, DOI 10.1523/JNEUROSCI.1464-13.2013; van Pelt S, 2018, NEUROIMAGE, V178, P702, DOI 10.1016/j.neuroimage.2018.06.005; van Pelt S, 2012, J NEUROSCI, V32, P3388, DOI 10.1523/JNEUROSCI.5592-11.2012; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vinck M, 2013, PRINCIPLES OF NEURAL CODING, P449; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	82	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228937	10.1371/journal.pone.0228937	http://dx.doi.org/10.1371/journal.pone.0228937			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7SH	32053681	gold, Green Published, Green Submitted			2022-12-26	WOS:000535198700076
J	Mahumud, RA; Alam, K; Dunn, J; Gow, J				Mahumud, Rashidul Alam; Alam, Khorshed; Dunn, Jeff; Gow, Jeff			The burden of chronic diseases among Australian cancer patients: Evidence from a longitudinal exploration, 2007-2017	PLOS ONE			English	Article							QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; BREAST-CANCER; LUNG-CANCER; COLON-CANCER; RISK-FACTORS; ADJUVANT CHEMOTHERAPY; COMORBIDITY INDEXES; PROSTATE-CANCER; WORK DISABILITY	Introduction Cancer is a major public health concern in terms of morbidity and mortality worldwide. Several types of cancer patients suffer from chronic comorbid conditions that are a major clinical challenge for treatment and cancer management. The main objective of this study was to investigate the distribution of the burden of chronic comorbid conditions and associated predictors among cancer patients in Australia over the period of 2007-2017. Methods The study employed a prospective longitudinal design using data from the Household, Income and Labour Dynamics in Australia survey. The number of chronic comorbid conditions was measured for each respondent. The longitudinal effect was captured using a fixed-effect negative binomial regression model, which predicted the potential factors that played a significant role in the occurrence of chronic comorbid conditions. Results Sixty-one percent of cancer patients experienced at least one chronic disease over the period, and 21% of patients experienced three or more chronic diseases. Age (> 65 years old) (incidence rate ratio, IRR = 1.15; 95% confidence interval, CI: 1.05, 1.40), inadequate levels of physical activity (IRR = 1.25; 95% CI: 1.09, 1.59), patients who suffered from extreme health burden (IRR = 2.30; 95% CI: 1.73, 3.05) or moderate health burden (IRR = 1.90; 95% CI: 1.45, 2.48), and patients living in the poorest households (IRR = 1.21; 95% CI: 1.11, 1.29) were significant predictors associated with a higher risk of chronic comorbid conditions. Conclusions A large number of cancer patients experience an extreme burden of chronic comorbid conditions and the different dimensions of these in cancer survivors have the potential to affect the trajectory of their cancer burden. It is also significant for health care providers, including physical therapists and oncologists, who must manage the unique problems that challenge this population and who should advocate for prevention and evidence-based interventions.	[Mahumud, Rashidul Alam; Alam, Khorshed; Dunn, Jeff; Gow, Jeff] Univ Southern Queensland, Ctr Hlth Informat & Econ Res, Hlth Econ & Policy Res, Toowoomba, Qld, Australia; [Mahumud, Rashidul Alam; Alam, Khorshed; Gow, Jeff] Univ Southern Queensland, Sch Commerce, Toowoomba, Qld, Australia; [Mahumud, Rashidul Alam] Bangladesh Icddr B, Hlth Econ Res Hlth Syst & Populat Studies Div, Int Ctr Diarrhoea Dis Res, Dhaka, Bangladesh; [Mahumud, Rashidul Alam] Dept Stat, Hlth & Epidemiol Res, Rajshahi, Bangladesh; [Dunn, Jeff] Canc Council Queensland, Canc Res Ctr, Fortitude Valley, Qld, Australia; [Dunn, Jeff] Prostate Canc Fdn Australia, St Leonards, NSW, Australia; [Gow, Jeff] Univ KwaZulu Natal, Sch Accounting Econ & Finance, Durban, South Africa	University of Southern Queensland; University of Southern Queensland; International Centre for Diarrhoeal Disease Research (ICDDR); Cancer Council Queensland; University of Kwazulu Natal	Mahumud, RA (corresponding author), Univ Southern Queensland, Ctr Hlth Informat & Econ Res, Hlth Econ & Policy Res, Toowoomba, Qld, Australia.; Mahumud, RA (corresponding author), Univ Southern Queensland, Sch Commerce, Toowoomba, Qld, Australia.; Mahumud, RA (corresponding author), Bangladesh Icddr B, Hlth Econ Res Hlth Syst & Populat Studies Div, Int Ctr Diarrhoea Dis Res, Dhaka, Bangladesh.; Mahumud, RA (corresponding author), Dept Stat, Hlth & Epidemiol Res, Rajshahi, Bangladesh.	rashed.mahumud@usq.edu.au	Mahumud, Rashidul Alam/O-2477-2018; Gow, Jeff/L-9647-2017	Mahumud, Rashidul Alam/0000-0001-9788-1868; Gow, Jeff/0000-0002-5726-298X; Alam, Khorshed/0000-0003-2232-0745; Dunn, Jeff/0000-0002-1180-3381				Aarts MJ, 2010, EUR J CANCER, V46, P2681, DOI 10.1016/j.ejca.2010.04.026; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Australian Institute of Health and Welfare, 2016, AUSTR HLTH SER, V15; Australian Institute of Health and Welfare, 2018, AUSTR HLTH SER, V16; Australian Institute of Health and Welfare, 2019, CANC SER AIHW; Australian Institute of health and welfare, 2019, AUSTR BURD DIS STUD, V19; Australian Statistical Geography Standard (ASGS): Volume 5-Remoteness Structure, 2016, DAT CUB 2017 POSTC 2; Banham D, 2018, CANCER EPIDEMIOL, V52, P75, DOI 10.1016/j.canep.2017.12.005; Brunet J, 2011, J SPORT EXERCISE PSY, V33, P759, DOI 10.1123/jsep.33.6.759; Capuano G, 2010, SUPPORT CARE CANCER, V18, P433, DOI 10.1007/s00520-009-0681-8; Carrera PM, 2018, CA-CANCER J CLIN, V68, P153, DOI 10.3322/caac.21443; Carstensen J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000809; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chipperfield K, 2013, PSYCHO-ONCOLOGY, V22, P2478, DOI 10.1002/pon.3310; Chrischilles EA, 2019, BREAST CANCER RES TR, V175, P675, DOI 10.1007/s10549-019-05184-1; Cleveland Clinic, 2019, MAN CANC TREATM SID; Cuthbert CA, 2018, J CANCER SURVIV, V12, P733, DOI 10.1007/s11764-018-0710-z; Der-Martirosian C, 2013, QUAL LIFE RES, V22, P2749, DOI 10.1007/s11136-013-0424-7; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Dunford M., 2017, AUSTR BURDEN DIS STU, P1; Elliott BA, 2004, QUAL LIFE RES, V13, P457, DOI 10.1023/B:QURE.0000018476.11278.35; Endo M, 2016, J CANCER SURVIV, V10, P320, DOI 10.1007/s11764-015-0478-3; Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528; Fleming ST, 2003, J CLIN EPIDEMIOL, V56, P1064, DOI 10.1016/S0895-4356(03)00213-0; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Galanti G, 2013, INT J GEN MED, V6, P245, DOI 10.2147/IJGM.S42720; Garman KS, 2003, J GERONTOL A-BIOL, V58, P1119, DOI 10.1093/gerona/58.12.M1119; Grimmett C, 2009, EUR J CANCER, V45, P2180, DOI 10.1016/j.ejca.2009.02.024; Gross CP, 2007, CANCER-AM CANCER SOC, V109, P2410, DOI 10.1002/cncr.22726; Gross CP, 2006, J AM GERIATR SOC, V54, P1898, DOI 10.1111/j.1532-5415.2006.00973.x; Gurney J, 2015, BRIT J CANCER, V113, P1375, DOI 10.1038/bjc.2015.355; Hagedoorn P, 2018, INT J CANCER, V142, P23, DOI 10.1002/ijc.31031; Hoebel J, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00402; Jones JM, 2016, J CANCER SURVIV, V10, P51, DOI 10.1007/s11764-015-0450-2; Jorgensen TL, 2012, BRIT J CANCER, V106, P1353, DOI 10.1038/bjc.2012.46; Klabunde CN, 2007, ANN EPIDEMIOL, V17, P584, DOI 10.1016/j.annepidem.2007.03.011; Kuijpers W, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2281; Lazarus R.S., 1999, STRESS EMOTION NEW S; Lindhagen L, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0217-8; Lins L, 2016, SAGE OPEN MED, V4, DOI 10.1177/2050312116671725; Loprinzi PD, 2012, BREAST CANCER-TOKYO, V19, P4, DOI 10.1007/s12282-011-0292-3; Mandelblatt JS, 2001, HEALTH SERV RES, V36, P1085; McTiernan A, 2008, NAT REV CANCER, V8, P205, DOI 10.1038/nrc2325; Meyerkardt JA, 2003, J CLIN ONCOL, V21, P433, DOI 10.1200/JCO.2003.07.125; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548; Ng HS, 2018, CANCER EPIDEMIOL, V54, P56, DOI 10.1016/j.canep.2018.03.010; Ni J, 2018, INTEGR CANCER THER, V17, P1195, DOI 10.1177/1534735418807970; Niessen LW, 2018, LANCET, V391, P2036, DOI [10.1016/S0140-6736(18)30482-3, 10.1016/s0140-6736(18)30482-3]; Noncommunicable diseases, 2018, KEY FACTS; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Parent ME, 2011, CANCER EPIDEMIOL, V35, P151, DOI 10.1016/j.canep.2010.09.004; Pergolotti M, 2015, CONTEMP CLIN TRIALS, V44, P89, DOI 10.1016/j.cct.2015.07.021; Piccirillo JF, 2004, MED CARE, V42, P482, DOI 10.1097/01.mlr.0000124254.88292.al; Piccirillo JF, 2000, LARYNGOSCOPE, V110, P593, DOI 10.1097/00005537-200004000-00011; Pilleron S, 2019, INT J CANCER, V144, P49, DOI 10.1002/ijc.31664; Pule L, 2018, BMC HEALTH SERV RES, V18, P1; RAND Corporation, RAND HLTH CAR COMM; Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X; Robb C, 2007, CRIT REV ONCOL HEMAT, V62, P84, DOI 10.1016/j.critrevonc.2006.11.003; Rock CL, 2012, CA-CANCER J CLIN, V62, P243, DOI 10.3322/caac.21142; Sarfati D, 2016, CA-CANCER J CLIN, V66, P338, DOI 10.3322/caac.21342; Sarfati D, 2016, ASIA-PAC J CLIN ONCO, V12, pE47, DOI 10.1111/ajco.12130; Sarfati D, 2014, MED CARE, V52, P586, DOI 10.1097/MLR.0000000000000149; Sarfati D, 2014, J CLIN EPIDEMIOL, V67, P586, DOI 10.1016/j.jclinepi.2013.11.012; Sarfati D, 2012, J CLIN EPIDEMIOL, V65, P924, DOI 10.1016/j.jclinepi.2012.02.017; Sarfati D, 2011, NEW ZEAL MED J, V124, P76; Sarfati D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-116; SATARIANO WA, 1994, ANN INTERN MED, V120, P104, DOI 10.7326/0003-4819-120-2-199401150-00002; Schrijvers CTM, 1997, CANCER-AM CANCER SOC, V80, P1482; Shankaran V, 2012, J CLIN ONCOL, V30, P1608, DOI 10.1200/JCO.2011.37.9511; Sharpe KH, 2018, SOCIOECONOMIC INEQUA; Short PF, 2008, PSYCHO-ONCOLOGY, V17, P91, DOI 10.1002/pon.1194; Sigel K, 2017, ANN AM THORAC SOC, V14, P1512, DOI 10.1513/AnnalsATS.201706-442ED; Sogaard Mette, 2013, Clin Epidemiol, V5, P3, DOI 10.2147/CLEP.S47150; Speck RM, 2010, J CANCER SURVIV, V4, P87, DOI 10.1007/s11764-009-0110-5; Stairmand J, 2015, ANN ONCOL, V26, P1325, DOI 10.1093/annonc/mdv025; Summerfield M, 2018, HILDA USER MANUAL RE; Tammemagi CM, 2003, INT J CANCER, V103, P792, DOI 10.1002/ijc.10882; Teng AM, 2017, INT J CANCER, V140, P1306, DOI 10.1002/ijc.30555; THE UNIV. OF TEX. AT AUSTIN OFFICE OF ADMISSIONS, 2011, STRONG FUT NO TERR P, V1; Thome B, 2004, QUAL LIFE RES, V13, P1067, DOI 10.1023/B:QURE.0000031342.11869.2f; Van Hemelrijck M, 2016, BJU INT, V117, P507, DOI 10.1111/bju.13059; van Muijen P, 2014, BMC CANCER, V14, P1, DOI DOI 10.1186/1471-2407-14-1; van Muijen P, 2013, J CANCER SURVIV, V7, P582, DOI 10.1007/s11764-013-0297-3; Vardar-Yagli Naciye, 2015, Asian Pac J Cancer Prev, V16, P585; Vartanian JG, 2006, ARCH OTOLARYNGOL, V132, P32, DOI 10.1001/archotol.132.1.32; World Health Organization, 2018, CANC KEY FACTS; Yabroff KR, 2004, JNCI-J NATL CANCER I, V96, P1322, DOI 10.1093/jnci/djh255; Yancik R, 2001, JAMA-J AM MED ASSOC, V285, P885, DOI 10.1001/jama.285.7.885; Yarlas AS, 2011, QUAL LIFE RES, V20, P383, DOI 10.1007/s11136-010-9764-8; Yu XQ, 2017, CHINESE J CANCER RES, V29, P395, DOI 10.21147/j.issn.1000-9604.2017.05.03; Yun YH, 2007, J CLIN EPIDEMIOL, V60, P1164, DOI 10.1016/j.jclinepi.2006.12.014	93	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228744	10.1371/journal.pone.0228744	http://dx.doi.org/10.1371/journal.pone.0228744			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7PV	32049978	Green Published, Green Accepted, gold			2022-12-26	WOS:000535192300023
J	Mendiguchia, J; Conceicao, F; Edouard, P; Fonseca, M; Pereira, R; Lopes, H; Morin, JB; Jimenez-Reyes, P				Mendiguchia, Jurdan; Conceicao, Filipe; Edouard, Pascal; Fonseca, Marco; Pereira, Rogerio; Lopes, Hernani; Morin, Jean-Benoit; Jimenez-Reyes, Pedro			Sprint versus isolated eccentric training: Comparative effects on hamstring architecture and performance in soccer players	PLOS ONE			English	Article							FEMORIS LONG HEAD; MUSCLE ARCHITECTURE; INJURY RISK; STRENGTH; EXERCISE; SPEED; QUANTIFICATION; ADAPTATION; ULTRASOUND; PREVENTION	Aims The purpose of this study was to compare the effects of hamstring eccentric (NHE) strength training versus sprint training programmed as complements to regular soccer practice, on sprint performance and its mechanical underpinnings, as well as biceps femoris long head (BFlh) architecture. Methods In this prospective interventional control study, sprint performance, sprint mechanics and BFlh architecture variables were compared before versus after six weeks of training during the first six preseason weeks, and between three different random match-pair groups of soccer players: "Soccer group" (n = 10), "Nordic group" (n = 12) and "Sprint group" (n = 10). Results For sprint performance and mechanics, small to large pre-post improvements were reported in "Sprint group" (except maximal running velocity), whereas only trivial to small negative changes were reported in "Soccer group" and "Nordic group". For BFlh architecture variables, "Sprint" group showed moderate increase in fascicle length compared to smaller augment for the "Nordic" group with trivial changes for "Soccer group". Only "Nordic" group presented small increases at pennation angle. Conclusions The results suggest that sprint training was superior to NHE in order to increase BFlh fascicle length although only the sprint training was able to both provide a preventive stimulus (increase fascicle length) and at the same time improve both sprint performance and mechanics. Further studies with advanced imaging techniques are needed to confirm the validity of the findings.	[Mendiguchia, Jurdan] ZENTRUM Rehab & Performance Ctr, Dept Phys Therapy, Baranain, Spain; [Conceicao, Filipe; Fonseca, Marco] Univ Porto, Fac Sports, Ctr Res Educ Innovat & Intervent Sport, Porto, Portugal; [Conceicao, Filipe; Fonseca, Marco] Univ Porto, LABIOMEP Porto Biomech Lab, Porto, Portugal; [Edouard, Pascal] Univ Jean Monnet, Univ Lyon, Interuniv Lab Human Movement Biol LIBM EA 7424, St Etienne, France; [Edouard, Pascal] Univ Hosp St Etienne, Fac Med, Dept Clin & Exercise Physiol, Sports Med Unity, St Etienne, France; [Edouard, Pascal] French Athlet Federat FFA, Med Commiss, Paris, France; [Fonseca, Marco] Portuguese Football Federat, Hlth & Performance Unit, Lisbon, Portugal; [Pereira, Rogerio] Espregueira Mendes Sports Ctr, FIFA Med Ctr Excellence, Clin Dragao, Porto, Portugal; [Lopes, Hernani] Polytech Porto, Sch Engn, DEM ISEP, Porto, Portugal; [Morin, Jean-Benoit] Univ Cote dAzur, LAMHESS, Nice, France; [Jimenez-Reyes, Pedro] Rey Juan Carlos Univ, Ctr Sport Studies, Madrid, Spain	Universidade do Porto; Universidade do Porto; CHU de St Etienne; Polytechnic Institute of Porto; UDICE-French Research Universities; Universite Cote d'Azur; Universidad Rey Juan Carlos	Jimenez-Reyes, P (corresponding author), Rey Juan Carlos Univ, Ctr Sport Studies, Madrid, Spain.	peterjr49@hotmail.com	Conceição, Filipe/AAK-7440-2020; Lopes, Hernani/AAM-7965-2020; Jimenez Reyes, Pedro/P-1075-2016	Lopes, Hernani/0000-0002-9344-8503; Jimenez Reyes, Pedro/0000-0002-8156-243X; conceicao, filipe/0000-0002-1636-2685				Alonso-Fernandez D, 2018, SCAND J MED SCI SPOR, V28, P88, DOI 10.1111/sms.12877; Arnason A, 2008, SCAND J MED SCI SPOR, V18, P40, DOI 10.1111/j.1600-0838.2006.00634.x; Azizi E, 2014, J EXP BIOL, V217, P376, DOI 10.1242/jeb.094383; Bahr R, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094826; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Blazevich AJ, 2003, MED SCI SPORT EXER, V35, P2013, DOI 10.1249/01.MSS.0000099092.83611.20; Bolsterlee B, 2015, J BIOMECH, V48, P1133, DOI 10.1016/j.jbiomech.2015.01.012; Butterfield TA, 2005, J APPL PHYSIOL, V99, P593, DOI 10.1152/japplphysiol.01128.2004; Chumanov ES, 2012, BRIT J SPORT MED, V46, P90, DOI 10.1136/bjsports-2011-090176; Cohen J.E., 1988, STAT POWER ANAL BEHA; di Prampero PE, 2005, J EXP BIOL, V208, P2809, DOI 10.1242/jeb.01700; Dick TJM, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.172371; Dorn TW, 2012, J EXP BIOL, V215, P1944, DOI 10.1242/jeb.064527; Douglas J, 2017, SPORTS MED, V47, P663, DOI 10.1007/s40279-016-0624-8; Ekstrand J, 2016, BRIT J SPORT MED, V50, P731, DOI 10.1136/bjsports-2015-095359; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Fiorentino NM, 2014, MED SCI SPORT EXER, V46, P776, DOI 10.1249/MSS.0000000000000172; Franchi MV, 2014, ACTA PHYSIOL, V210, P642, DOI 10.1111/apha.12225; Franchi MV, 2020, MED SCI SPORT EXER, V52, P233, DOI 10.1249/MSS.0000000000002123; Franchi MV, 2018, ULTRASOUND MED BIOL, V44, P2492, DOI 10.1016/j.ultrasmedbio.2018.07.010; Freeman BW, 2019, J SPORT MED PHYS FIT, V59, P1119, DOI 10.23736/S0022-4707.18.08703-0; Freitas SR, 2018, J ULTRAS MED, V37, P977, DOI 10.1002/jum.14436; Haugen TA, 2018, KINESIOLOGY, V50, P102; Hegyi A, 2019, MED SCI SPORT EXER, V51, P2274, DOI 10.1249/MSS.0000000000002060; Hopkins WG, 2004, INTRO PLANT PHYSL, P1; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Ishoi L, 2018, J SPORT SCI, V36, P1663, DOI 10.1080/02640414.2017.1409609; Jeong TS, 2011, J SPORT SCI, V29, P1161, DOI 10.1080/02640414.2011.583671; Klimstra M, 2007, J ELECTROMYOGR KINES, V17, P504, DOI 10.1016/j.jelekin.2006.04.011; Krommes K, 2017, BMC Res Notes, V10, P669, DOI 10.1186/s13104-017-2986-x; Lacome M, 2020, INT J SPORT PHYSIOL, V15, P81, DOI 10.1123/ijspp.2018-0947; Los Arcos A, 2015, J SPORT SCI MED, V14, P394; Lovell R, 2018, SCAND J MED SCI SPOR, V28, P658, DOI 10.1111/sms.12925; Malone S, 2018, J SCI MED SPORT, V21, P257, DOI 10.1016/j.jsams.2017.05.016; Malone S, 2017, J SCI MED SPORT, V20, P250, DOI 10.1016/j.jsams.2016.08.005; Mendiguchia J, 2016, J SPORT SCI, V34, P535, DOI 10.1080/02640414.2015.1122207; Mendiguchia J, 2015, SCAND J MED SCI SPOR, V25, pE621, DOI 10.1111/sms.12388; Mendiguchia J., 2019, SPORT PERFORM SCI RE, V1, P1, DOI [10.1136/bjsports-2015-095359, DOI 10.1136/BJSPORTS-2015-095359]; Morin JB, 2006, INT J SPORTS MED, V27, P158, DOI 10.1055/s-2005-837569; Morin JB, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00404; Morin JB, 2017, INT J SPORT PHYSIOL, V12, P840, DOI 10.1123/ijspp.2016-0444; Orchard JW, 2012, BRIT J SPORT MED, V46, P88, DOI 10.1136/bjsports-2011-090127; Petersen J, 2011, AM J SPORT MED, V39, P2296, DOI 10.1177/0363546511419277; Pimenta R, 2018, MED SCI SPORT EXER, V50, P2584, DOI 10.1249/MSS.0000000000001731; Potier TG, 2009, EUR J APPL PHYSIOL, V105, P939, DOI 10.1007/s00421-008-0980-7; Proske U, 2001, J PHYSIOL-LONDON, V537, P333, DOI 10.1111/j.1469-7793.2001.00333.x; Romero-Franco N, 2017, EUR J SPORT SCI, V17, P386, DOI 10.1080/17461391.2016.1249031; Samozino P, 2016, SCAND J MED SCI SPOR, V26, P648, DOI 10.1111/sms.12490; Stares J, 2018, J SCI MED SPORT, V21, P1019, DOI 10.1016/j.jsams.2018.03.012; Timmins RG, 2016, BRIT J SPORT MED, V50, P1524, DOI 10.1136/bjsports-2015-095362; Timmins RG, 2016, MED SCI SPORT EXER, V48, P499, DOI 10.1249/MSS.0000000000000795; Timmins RG, 2015, MED SCI SPORT EXER, V47, P905, DOI 10.1249/MSS.0000000000000507; van den Tillaar R, 2017, INT J SPORTS PHYS TH, V12, P718, DOI 10.16603/ijspt20170718	53	40	40	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228283	10.1371/journal.pone.0228283	http://dx.doi.org/10.1371/journal.pone.0228283			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045411	Green Published, gold			2022-12-26	WOS:000534633200009
J	Zhang, XY; Huang, ZY; Su, XH; Siu, A; Song, YP; Zhang, DQ; Fang, Q				Zhang, Xiao-Yu; Huang, Ziyuan; Su, Xuehui; Siu, Andrew; Song, Yuepeng; Zhang, Deqiang; Fang, Qing			Machine learning models for net photosynthetic rate prediction using poplar leaf phenotype data	PLOS ONE			English	Article								Background As an essential component in reducing anthropogenic CO2 emissions to the atmosphere, tree planting is the key to keeping carbon dioxide emissions under control. In 1992, the United Nations agreed to take action at the Earth Summit to stabilize and reduce net zero global anthropogenic CO2 emissions. Tree planting was identified as an effective method to offset CO2 emissions. A high net photosynthetic rate (Pn) with fast-growing trees could efficiently fulfill the goal of CO2 emission reduction. Net photosynthetic rate model can provide refernece for plant's stability of photosynthesis productivity. Methods and results Using leaf phenotype data to predict the Pn can help effectively guide tree planting policies to offset CO2 release into the atmosphere. Tree planting has been proposed as one climate change solution. One of the most popular trees to plant are poplars. This study used a Populus simonii (P. simonii) dataset collected from 23 artificial forests in northern China. The samples represent almost the entire geographic distribution of P. simonii. The geographic locations of these P. simonii trees cover most of the major provinces of northern China. The northwestern point reaches (36 degrees 30'N, 98 degrees 09'E). The northeastern point reaches (40 degrees 91'N, 115 degrees 83'E). The southwestern point reaches (32 degrees 31'N, 108 degrees 90'E). The southeastern point reaches (34 degrees 39'N, 113 degrees 74'E). The collected data on leaf phenotypic traits are sparse, noisy, and highly correlated. The photosynthetic rate data are nonnormal and skewed. Many machine learning algorithms can produce reasonably accurate predictions despite these data issues. Influential outliers are removed to allow an accurate and precise prediction, and cluster analysis is implemented as part of a data exploratory analysis to investigate further details in the dataset. We select four regression methods, extreme gradient boosting (XGBoost), support vector machine (SVM), random forest (RF) and generalized additive model (GAM), which are suitable to use on the dataset given in this study. Cross-validation and regularization mechanisms are implemented in the XGBoost, SVM, RF, and GAM algorithms to ensure the validity of the outputs. Conclusions The best-performing approach is XGBoost, which generates a net photosynthetic rate prediction that has a 0.77 correlation with the actual rates. Moreover, the root mean square error (RMSE) is 2.57, which is approximately 35 percent smaller than the standard deviation of 3.97. The other metrics, i.e., the MAE, R-2, and the min-max accuracy are 1.12, 0.60, and 0.93, respectively. This study demonstrates the ability of machine learning models to use noisy leaf phenotype data to predict the net photosynthetic rate with significant accuracy. Most net photosynthetic rate prediction studies are conducted on herbaceous plants. The net photosynthetic rate prediction of P. simonii, a kind of woody plant, illustrates significant guidance for plant science or environmental science regarding the predictive relationship between leaf phenotypic characteristics and the Pn for woody plants in northern China.	[Zhang, Xiao-Yu] Beijing Forestry Univ, Coll Sci, Beijing, Peoples R China; [Huang, Ziyuan] Harrisburg Univ Sci & Technol, Data Sci, Harrisburg, PA USA; [Su, Xuehui] Jiaozuo Acad Agr & Forestry Sci, Jiaozuo, Henan, Peoples R China; [Siu, Andrew] Amgen Inc, Thousand Oaks, CA 91320 USA; [Song, Yuepeng; Zhang, Deqiang] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China; [Fang, Qing] Yamagata Univ, Fac Sci, Yamagata, Japan	Beijing Forestry University; Amgen; Beijing Forestry University; Yamagata University	Zhang, XY (corresponding author), Beijing Forestry Univ, Coll Sci, Beijing, Peoples R China.; Song, YP (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China.	xyzhang@bjfu.edu.cn; YuepengSong@bjfu.edu.cn	Zhang, xiaoyu/GXA-3206-2022	Xiaoyu, Zhang/0000-0002-2794-3848	Fundamental Research Funds for the Central Universities [2017ZY30, 2015ZCQ-LY-01]; National Natural Science Foundation of China [11501032]; Japan Society for the Promotion of Science [19K03613]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The work is supported by the Fundamental Research Funds for the Central Universities (No. 2017ZY30), the Fundamental Research Funds for the Central Universities (No. 2015ZCQ-LY-01) and the National Natural Science Foundation of China (Grant No. 11501032). The work is partially supported by Japan Society for the Promotion of Science (Grant No. 19K03613). Author Andrew Siu is employed by Amgen. The funder provided support in the form of a salary for Andrew Siu but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of Andrew Siu are articulated in the 'author contributions' section.	Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen T., 2016, KDD16 P 22 ACM, DOI DOI 10.1145/2939672.2939785; Ci D, 2016, J EXP BOT, V67, P723, DOI 10.1093/jxb/erv485; Drucker H, 1997, ADV NEUR IN, V9, P155; Glime JM, 2007, BRYOPHYTE ECOLOGY, V1; Hastie T.J., 2017, STAT MODELS S, P249, DOI DOI 10.1201/9780203738535; Kaufman L., 1990, FINDING GROUPS DATA, P68, DOI [10.1002/9780470316801.ch2, DOI 10.1002/9780470316801.CH2]; LONG SP, 1979, J APPL ECOL, V16, P879, DOI 10.2307/2402861; Lu Wei, 2017, Journal of Agricultural Resources and Environment, V34, P582; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; OGREN E, 1991, PLANTA, V184, P538, DOI 10.1007/BF00197904; Shipley B, 2005, FUNCT ECOL, V19, P602, DOI 10.1111/j.1365-2435.2005.01008.x; Tyrchniewicz A, 2002, OFFSETTING CO2 EMISS; Zhang XY, 2019, Patent No. [CN 108229065 B, 108229065]; Zhang Zhuo, 2019, Scientia Agricultura Sinica, V52, P616, DOI 10.3864/j.issn.0578-1752.2019.04.004	15	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228645	10.1371/journal.pone.0228645	http://dx.doi.org/10.1371/journal.pone.0228645			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045452	Green Published, gold			2022-12-26	WOS:000534633200027
J	Merkl, PE; Pilsl, M; Fremter, T; Schwank, K; Engel, C; Langst, G; Milkereit, P; Griesenbeck, J; Tschochner, H				Merkl, Philipp E.; Pilsl, Michael; Fremter, Tobias; Schwank, Katrin; Engel, Christoph; Laengst, Gernot; Milkereit, Philipp; Griesenbeck, Joachim; Tschochner, Herbert			RNA polymerase I (Pol I) passage through nucleosomes depends on Pol I subunits binding its lobe structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nucleolus; RNA polymerase II; RNA polymerase I; ribosomal ribonucleic acid (rRNA) (ribosomal RNA); transcription; transcription elongation factor; RNA polymerase III; nucleosome; ribosome; chromatin; Rpa34; 5; Rpa49	TRANSCRIPTION INITIATION; SACCHAROMYCES-CEREVISIAE; CHROMATIN TRANSCRIPTION; MOLECULAR-STRUCTURES; TOPOISOMERASE-I; ELONGATION RATE; CROSS-LINKING; PAF1 COMPLEX; ARCHITECTURE; TFIIF	RNA polymerase I (Pol I) is a highly efficient enzyme specialized in synthesizing most ribosomal RNAs. After nucleosome deposition at each round of rDNA replication, the Pol I transcription machinery has to deal with nucleosomal barriers. It has been suggested that Pol I?associated factors facilitate chromatin transcription, but it is unknown whether Pol I has an intrinsic capacity to transcribe through nucleosomes. Here, we used in vitro transcription assays to study purified WT and mutant Pol I variants from the yeast Saccharomyces cerevisiae and compare their abilities to pass a nucleosomal barrier with those of yeast Pol II and Pol III. Under identical conditions, purified Pol I and Pol III, but not Pol II, could transcribe nucleosomal templates. Pol I mutants lacking either the heterodimeric subunit Rpa34.5/Rpa49 or the C-terminal part of the specific subunit Rpa12.2 showed a lower processivity on naked DNA templates, which was even more reduced in the presence of a nucleosome. Our findings suggest that the lobe-binding subunits Rpa34.5/Rpa49 and Rpa12.2 facilitate passage through nucleosomes, suggesting possible cooperation among these subunits. We discuss the contribution of Pol I?specific subunit domains to efficient Pol I passage through nucleosomes in the context of transcription rate and processivity.	[Merkl, Philipp E.; Pilsl, Michael; Fremter, Tobias; Schwank, Katrin; Engel, Christoph; Laengst, Gernot; Milkereit, Philipp; Griesenbeck, Joachim; Tschochner, Herbert] Univ Regensburg, Lehrstuhl Biochem 3, RCB, D-93053 Regensburg, Germany; [Merkl, Philipp E.] Tech Univ Munich, Arcisstr 21, D-80333 Munich, Germany	University of Regensburg; Technical University of Munich	Milkereit, P; Griesenbeck, J; Tschochner, H (corresponding author), Univ Regensburg, Lehrstuhl Biochem 3, RCB, D-93053 Regensburg, Germany.	philipp.milkereit@ur.de; joachim.griesenbeck@ur.de; herbert.tschochner@ur.de		Engel, Christoph/0000-0001-8451-3599	Deutsche Forschungsgemeinschaft [SFB 960]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 960. The authors declare that they have no conflicts of interest with the contents of this article.	Albert B, 2011, J CELL BIOL, V192, P277, DOI 10.1083/jcb.201006040; Amon JD, 2016, ELIFE, V5, DOI 10.7554/eLife.20533; Beckouet F, 2008, MOL CELL BIOL, V28, P1596, DOI 10.1128/MCB.01464-07; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bintu L, 2011, NAT STRUCT MOL BIOL, V18, P1394, DOI 10.1038/nsmb.2164; Birch JL, 2009, EMBO J, V28, P854, DOI 10.1038/emboj.2009.33; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Burke D., 2000, METHODS YEAST GENETI; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; Crickard JB, 2017, NUCLEIC ACIDS RES, V45, P6362, DOI 10.1093/nar/gkx220; DAMMANN R, 1993, NUCLEIC ACIDS RES, V21, P2331, DOI 10.1093/nar/21.10.2331; Darriere T, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008157; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Engel C, 2018, ANNU REV BIOPHYS, V47, P425, DOI 10.1146/annurev-biophys-070317-033058; Engel C, 2017, CELL, V169, P120, DOI 10.1016/j.cell.2017.03.003; Engel C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12129; Engel C, 2013, NATURE, V502, P650, DOI 10.1038/nature12712; Fernandez-Tornero C, 2013, NATURE, V502, P644, DOI 10.1038/nature12636; Gadal O, 1997, MOL CELL BIOL, V17, P1787, DOI 10.1128/MCB.17.4.1787; Gaykalova DA, 2015, P NATL ACAD SCI USA, V112, pE5787, DOI 10.1073/pnas.1508371112; Geiger SR, 2010, MOL CELL, V39, P583, DOI 10.1016/j.molcel.2010.07.028; Gout JF, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701484; Han Y, 2017, ELIFE, V6, DOI 10.7554/eLife.27414; Hoffmann NA, 2015, NATURE, V528, P231, DOI 10.1038/nature16143; Hoffmeister H, 2017, NUCLEIC ACIDS RES, V45, P10534, DOI 10.1093/nar/gkx711; Hsieh FK, 2013, P NATL ACAD SCI USA, V110, P7654, DOI 10.1073/pnas.1222198110; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; Jennebach S, 2012, NUCLEIC ACIDS RES, V40, P5591, DOI 10.1093/nar/gks220; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Khatter H, 2017, CURR OPIN STRUC BIOL, V47, P88, DOI 10.1016/j.sbi.2017.05.008; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kostrewa D, 2015, ACTA CRYSTALLOGR D, V71, P1850, DOI 10.1107/S1399004715012651; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Kulaeva OI, 2013, BBA-GENE REGUL MECH, V1829, P76, DOI 10.1016/j.bbagrm.2012.08.015; LILJELUND P, 1992, P NATL ACAD SCI USA, V89, P9302, DOI 10.1073/pnas.89.19.9302; Lisica A, 2016, P NATL ACAD SCI USA, V113, P2946, DOI 10.1073/pnas.1517011113; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luse DS, 2011, RNA BIOL, V8, P581, DOI 10.4161/rna.8.4.15389; Luse DS, 2011, J BIOL CHEM, V286, P6040, DOI 10.1074/jbc.M110.174722; Merkl P, 2014, MOL CELL BIOL, V34, P3817, DOI 10.1128/MCB.00395-14; Merz K, 2008, GENE DEV, V22, P1190, DOI 10.1101/gad.466908; MILLER OL, 1969, SCIENCE, V164, P955, DOI 10.1126/science.164.3882.955; Neyer S, 2016, NATURE, V540, P607, DOI 10.1038/nature20561; NOGI Y, 1993, MOL CELL BIOL, V13, P114, DOI 10.1128/MCB.13.1.114; Okuda M, 2000, EMBO J, V19, P1346, DOI 10.1093/emboj/19.6.1346; Osheim Yvonne N., 2008, V464, P55; Peltonen K, 2014, CANCER CELL, V25, P77, DOI 10.1016/j.ccr.2013.12.009; Pilsl M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12126; Prescott EM, 2004, P NATL ACAD SCI USA, V101, P6068, DOI 10.1073/pnas.0401393101; Ruan WJ, 2011, J BIOL CHEM, V286, P18701, DOI 10.1074/jbc.M111.222273; Sadian Y, 2017, EMBO J, V36, P2698, DOI 10.15252/embj.201796958; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanz-Murillo M, 2018, P NATL ACAD SCI USA, V115, P8972, DOI 10.1073/pnas.1802626115; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schneider DA, 2006, P NATL ACAD SCI USA, V103, P12707, DOI 10.1073/pnas.0605686103; Schweikhard V, 2014, P NATL ACAD SCI USA, V111, P6642, DOI 10.1073/pnas.1405181111; Scull CE, 2019, BIOCHEMISTRY-US, V58, P2116, DOI 10.1021/acs.biochem.8b01256; Studitsky VM, 1997, SCIENCE, V278, P1960, DOI 10.1126/science.278.5345.1960; Tafur L, 2019, ELIFE, V8, DOI 10.7554/eLife.43204; Tafur L, 2016, MOL CELL, V64, P1135, DOI 10.1016/j.molcel.2016.11.013; Teves SS, 2014, TRENDS BIOCHEM SCI, V39, P577, DOI 10.1016/j.tibs.2014.10.004; Torreira E, 2017, ELIFE, V6, DOI [10.7554/eLife.20832.001, 10.7554/eLife.20832]; Tschochner H, 1996, P NATL ACAD SCI USA, V93, P12914, DOI 10.1073/pnas.93.23.12914; Van Mullem V, 2002, MOL MICROBIOL, V43, P1105; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Venkatesh S, 2015, NAT REV MOL CELL BIO, V16, P178, DOI 10.1038/nrm3941; Wittner M, 2011, CELL, V145, P543, DOI 10.1016/j.cell.2011.03.051; Zhang YF, 2010, J BIOL CHEM, V285, P14152, DOI 10.1074/jbc.M110.115220; Zhang YF, 2009, P NATL ACAD SCI USA, V106, P2153, DOI 10.1073/pnas.0812939106	73	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4782	4795		10.1074/jbc.RA119.011827	http://dx.doi.org/10.1074/jbc.RA119.011827			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32060094	hybrid, Green Published			2022-12-26	WOS:000526887000004
J	Horning, KJ; Joshi, P; Nitin, R; Balachandran, RC; Yanko, FM; Kim, K; Christov, P; Aschner, M; Sulikowski, GA; Weaver, CD; Bowman, AB				Horning, Kyle J.; Joshi, Piyush; Nitin, Rachana; Balachandran, Rekha C.; Yanko, Frank M.; Kim, Kwangho; Christov, Plamen; Aschner, Michael; Sulikowski, Gary A.; Weaver, C. David; Bowman, Aaron B.			Identification of a selective manganese ionophore that enables nonlethal quantification of cellular manganese	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						manganese; metal homeostasis; transport metal; neurobiology; neurodegenerative disease; calcium transport; calcimycin; ionomycin; ionophore; MESM	SLC39A8 DEFICIENCY; TRANSPORTER; HOMEOSTASIS; MUTATIONS; PARKINSONISM; DYSTONIA; SLC30A10; A23187; IRON; HYPERMANGANESEMIA	Available assays for measuring cellular manganese (Mn) levels require cell lysis, restricting longitudinal experiments and multiplexed outcome measures. Conducting a screen of small molecules known to alter cellular Mn levels, we report here that one of these chemicals induces rapid Mn efflux. We describe this activity and the development and implementation of an assay centered on this small molecule, named manganese-extracting small molecule (MESM). Using inductively-coupled plasma?MS, we validated that this assay, termed here ?manganese-extracting small molecule estimation route? (MESMER), can accurately assess Mn in mammalian cells. Furthermore, we found evidence that MESM acts as a Mn-selective ionophore, and we observed that it has increased rates of Mn membrane transport, reduced cytotoxicity, and increased selectivity for Mn over calcium compared with two established Mn ionophores, calcimycin (A23187) and ionomycin. Finally, we applied MESMER to test whether prior Mn exposures subsequently affect cellular Mn levels. We found that cells receiving continuous, elevated extracellular Mn accumulate less Mn than cells receiving equally-elevated Mn for the first time for 24 h, indicating a compensatory cellular homeostatic response. Use of the MESMER assay versus a comparable detergent lysis-based assay, cellular Fura-2 Mn extraction assay, reduced the number of cells and materials required for performing a similar but cell lethality-based experiment to 25% of the normally required sample size. We conclude that MESMER can accurately quantify cellular Mn levels in two independent cells lines through an ionophore-based mechanism, maintaining cell viability and enabling longitudinal assessment within the same cultures.	[Horning, Kyle J.; Joshi, Piyush; Nitin, Rachana; Bowman, Aaron B.] Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN 37232 USA; [Balachandran, Rekha C.; Yanko, Frank M.; Bowman, Aaron B.] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA; [Kim, Kwangho; Christov, Plamen; Sulikowski, Gary A.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Kim, Kwangho; Sulikowski, Gary A.; Weaver, C. David] Vanderbilt Univ, Dept Chem, Box 1583, Nashville, TN 37235 USA; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Sulikowski, Gary A.; Weaver, C. David] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37212 USA	Vanderbilt University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Vanderbilt University; Vanderbilt University; Yeshiva University; Albert Einstein College of Medicine; Vanderbilt University	Bowman, AB (corresponding author), Purdue Univ, 550 Stadium Mall Dr,HAMP 1173A, W Lafayette, IN 47907 USA.	bowma117@purdue.edu		aschner, michael/0000-0002-2619-1656; Nitin, Rachana/0000-0002-3331-1580	NIH [1S10OD025281-01]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Panoptic plate reader was purchased from funds obtain through NIH Grant 1S10OD025281-01. The Panoptic is housed and managed in the Vanderbilt Institute of Chemical Biology's High-throughput Screen Facility.	Aydemir TB, 2018, J NUTR, V148, P174, DOI 10.1093/jn/nxx041; Aydemir TB, 2017, J NEUROSCI, V37, P5996, DOI 10.1523/JNEUROSCI.0285-17.2017; Bakthavatsalam S, 2015, CHEM COMMUN, V51, P2605, DOI 10.1039/c4cc09542a; Banci L, 2013, METAL IONS LIFE SCI, V12, P1, DOI 10.1007/978-94-007-5561-1; Bichell TJV, 2017, BBA-MOL BASIS DIS, V1863, P1596, DOI 10.1016/j.bbadis.2017.02.013; Bowman AB, 2014, NEUROTOXICOLOGY, V41, P141, DOI 10.1016/j.neuro.2014.01.010; Bryan MR, 2018, NEUROTOXICOLOGY, V64, P185, DOI 10.1016/j.neuro.2017.07.026; Choi EK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21464-0; Das S, 2019, INORG CHEM, V58, P13724, DOI 10.1021/acs.inorgchem.9b01389; Delnooz CCS, 2013, MOVEMENT DISORD, V28, P685, DOI 10.1002/mds.25390; DENNY MF, 1993, TOXICOL APPL PHARM, V122, P222, DOI 10.1006/taap.1993.1191; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Freedman JC, 2012, CELL PHYSL SOURCE BO, P61, DOI DOI 10.1016/B978-0-12-387738-3.00004-4; GAVIN CE, 1990, BIOCHEM J, V266, P329, DOI 10.1042/bj2660329; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Haynes EN, 2015, ENVIRON HEALTH PERSP, V123, P1066, DOI 10.1289/ehp.1408993; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; Hernandez EH, 2006, NEUROTOXICOLOGY, V27, P333, DOI 10.1016/j.neuro.2005.09.003; Horning KJ, 2015, ANNU REV NUTR, V35, P71, DOI 10.1146/annurev-nutr-071714-034419; Jenkitkasemwong S, 2018, P NATL ACAD SCI USA, V115, pE1769, DOI 10.1073/pnas.1720739115; Jin L, 2019, METALLOMICS, V11, P959, DOI 10.1039/c8mt00370j; Joshi P, 2019, NEUROTOXICOLOGY, V75, P148, DOI 10.1016/j.neuro.2019.09.007; Kalia K, 2008, NEUROTOXICOLOGY, V29, P466, DOI 10.1016/j.neuro.2008.02.012; KAUFFMAN RF, 1980, J BIOL CHEM, V255, P2735; Koike A, 2017, LIFE SCI, V173, P80, DOI 10.1016/j.lfs.2016.12.006; Komagiri Y, 2011, CELL CALCIUM, V49, P35, DOI 10.1016/j.ceca.2010.11.006; Kumar KK, 2014, SCI REP-UK, V4, DOI 10.1038/srep06801; Kumar KK, 2013, J BIOCHEM MOL TOXIC, V27, P42, DOI 10.1002/jbt.21457; Kumar KK, 2012, NEUROTOXICOLOGY, V33, P518, DOI 10.1016/j.neuro.2012.02.005; Kwakye Gunnar F, 2011, Curr Protoc Toxicol, VChapter 12, DOI 10.1002/0471140856.tx1218s48; Lechpammer M, 2014, ANN NEUROL, V75, P608, DOI 10.1002/ana.24131; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Li XL, 2013, BIOMETALS, V26, P941, DOI 10.1007/s10534-013-9670-y; LICCIONE JJ, 1988, J PHARMACOL EXP THER, V247, P156; Lin W, 2017, J CLIN INVEST, V127, P2407, DOI 10.1172/JCI90896; LOCKWICH T, 1993, MOL CELL BIOCHEM, V126, P143, DOI 10.1007/BF00925692; LUKACS GL, 1987, BIOCHEM J, V248, P609, DOI 10.1042/bj2480609; Madejczyk MS, 2012, BBA-BIOMEMBRANES, V1818, P651, DOI 10.1016/j.bbamem.2011.12.002; Morello M, 2008, NEUROTOXICOLOGY, V29, P60, DOI 10.1016/j.neuro.2007.09.001; Moynier F, 2017, SCI REP-UK, V7, DOI 10.1038/srep44255; OAKES SG, 1988, ANAL BIOCHEM, V169, P159, DOI 10.1016/0003-2697(88)90267-9; Pan Z, 2018, METHODS MOL BIOL, V1843, P55, DOI 10.1007/978-1-4939-8704-7_4; Park JH, 2018, GENET MED, V20, P259, DOI 10.1038/gim.2017.106; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; PFEIFFER DR, 1974, BIOCHEMISTRY-US, V13, P4007, DOI 10.1021/bi00716a029; PFEIFFER DR, 1979, FEBS LETT, V105, P360, DOI 10.1016/0014-5793(79)80649-3; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; REED PW, 1972, J BIOL CHEM, V247, P6970; Skulan J, 1999, P NATL ACAD SCI USA, V96, P13709, DOI 10.1073/pnas.96.24.13709; Stillwell W, 2016, INTRODUCTION TO BIOLOGICAL MEMBRANES: COMPOSITION, STRUCTURE AND FUNCTION, 2ND EDITION, P3, DOI 10.1016/B978-0-444-63772-7.00001-4; Taylor CA, 2019, J BIOL CHEM, V294, P1860, DOI 10.1074/jbc.RA118.005628; Tidball AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150372; Tidball AM, 2015, HUM MOL GENET, V24, P1929, DOI 10.1093/hmg/ddu609; Torres-Agustin R, 2013, ENVIRON RES, V121, P39, DOI 10.1016/j.envres.2012.10.007; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Vollet Kaitlin, 2016, Curr Environ Health Rep, V3, P392, DOI 10.1007/s40572-016-0108-x; Williams BB, 2010, TOXICOL SCI, V117, P169, DOI 10.1093/toxsci/kfq174; Xin YJ, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.25; Yin ZB, 2010, J NEUROCHEM, V112, P1190, DOI 10.1111/j.1471-4159.2009.06534.x; Zhao NN, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121335; Zogzas CE, 2018, METALLOMICS, V10, DOI 10.1039/c8mt00115d; Zogzas Charles E, 2017, Adv Neurobiol, V18, P35, DOI 10.1007/978-3-319-60189-2_3	62	1	1	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3875	3890		10.1074/jbc.RA119.009781	http://dx.doi.org/10.1074/jbc.RA119.009781			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32047113	Green Published, hybrid			2022-12-26	WOS:000527704400013
J	Munoz-Escobar, A; Reyes-Lopez, SY				Munoz-Escobar, Antonio; Yobanny Reyes-Lopez, Simon			Antifungal susceptibility of Candida species to copper oxide nanoparticles on polycaprolactone fibers (PCL-CuONPs)	PLOS ONE			English	Article							SILVER NANOPARTICLES	The integration of metallic or ceramic nanoparticles in polymer matrices has improved the antimicrobial and antifungal behavior, resulting in the search for composites with increased bactericidal and antimycotic properties. A polycaprolactone fibers with copper oxide nanoparticles was prepared. Polycaprolactone-copper fibers (PCL- CuONPs) were prepared into two major steps in situ method: (a) Synthesis of CuO particles, then (b) incorporation of polycaprolactone to electrospun process. The first step is the reduction of Cu+2 ions by gallic acid in N,N-dimethylformamide and tetrahydrofuran solution with the simple addition of polycaprolactone in the solution for the second electrospun step. Raman spectra provide information about the nature of the copper oxide synthesized. There are three Raman peaks in the sample, at 294 and 581 cm(-1) and a very broad band from 400 to 600 cm(-1) which are characteristics bands for CuO. Scanning electron microscopy (TEM) revealed copper oxide nanoparticles with semispherical shapes with diameter 35 +/- 11 nm. Dynamic light scattering (DLS) analysis showed uniform CuONPs in a range of 88 +/- 11 nm. Scanning electron microscopy (SEM) of PCL-CuONps reveled fibers with diameters ranging from 925 to 1080 nm were successfully obtained by electrospinning technique. Orientation, morphology and diameter were influenced by the increment on CuONPs concentration, with the smaller diameter present in samples prepared from low concentrated solutions. The antimycotic applicability of the composite was evaluated to determine the antifungal activity in three species of the genus Candida (Candida albicans, Candida glabrata and Candida tropicalis). PCL-CuONPs exhibit a considerable antifungal effect on all species tested. The preparation of PCL-CuONPs was simple, fast and low-cost for practical application as an antifungal dressing.	[Munoz-Escobar, Antonio; Yobanny Reyes-Lopez, Simon] Univ Autonoma Ciudad Juarez, Inst Ciencias Biomed, Envolvente PRONAF & Estocolmo S-N, Ciudad Juarez, Chihuahua, Mexico	Universidad Autonoma de Ciudad Juarez	Reyes-Lopez, SY (corresponding author), Univ Autonoma Ciudad Juarez, Inst Ciencias Biomed, Envolvente PRONAF & Estocolmo S-N, Ciudad Juarez, Chihuahua, Mexico.	simon.reyes@uacj.mx	Reyes-López, Simón Yobanny/J-8565-2019	Reyes-López, Simón Yobanny/0000-0002-9017-3233	PRODEP, Universidad Autonoma de Ciudad Juarez; CONACYT	PRODEP, Universidad Autonoma de Ciudad Juarez; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Thanks to PRODEP, Universidad Autonoma de Ciudad Juarez and CONACYT for supporting this investigation.	Baranowska-Korczyc A, 2016, RSC ADV, V6, P19647, DOI 10.1039/c6ra02486f; Brunke S, 2013, CELL MICROBIOL, V15, P701, DOI 10.1111/cmi.12091; Chalandar H. E., 2017, Biosciences, Biotechnology Research Asia, V14, P279, DOI 10.13005/bbra/2445; GAIBIMEI P, 2018, BULL ENVIRON PHARMAC, V7, P13; Hu LJ, 2019, MICROB PATHOGENESIS, V134, DOI 10.1016/j.micpath.2019.103575; Khan Z, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216250; Kim KJ, 2008, J MICROBIOL BIOTECHN, V18, P1482; Lopez-Esparza J, 2016, IND ENG CHEM RES, V55, P12532, DOI 10.1021/acs.iecr.6b02300; Lozano-Chiu M, 1999, J CLIN MICROBIOL, V37, P1625, DOI 10.1128/JCM.37.5.1625-1627.1999; Ludwig DB, 2018, MYCOPATHOLOGIA, V183, P659, DOI 10.1007/s11046-018-0253-x; De Paula MMM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209386; Nausa JG, 2015, NOVA, V13, P9; Nordin MAF, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-342; Pastrana-Alta EC, 2017, SINTESIS CARACTERIZA; Pazos-Ortiz E, 2017, J NANOMATER, V2017, DOI 10.1155/2017/4752314; Radakovic D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185916; Rani R., 2014, INT J PHARM RES DEV, V6, P72, DOI DOI 10.1007/S40304-015-0072-Z; Rodrigues CF, 2014, EUR J CLIN MICROBIOL, V33, P673, DOI 10.1007/s10096-013-2009-3; Varughese G, 2014, ADV MATER SCI, V14, P49, DOI 10.2478/adms-2014-0021; Reyes-Lopez SY, 2013, MACROMOL SYMP, V325, P21, DOI 10.1002/masy.201200100	20	19	20	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0228864	10.1371/journal.pone.0228864	http://dx.doi.org/10.1371/journal.pone.0228864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092072	Green Published, gold			2022-12-26	WOS:000535229300016
J	Angeles-Shim, RB; Shim, J; Vinarao, RB; Lapis, RS; Singleton, JJ				Angeles-Shim, Rosalyn B.; Shim, Junghyun; Vinarao, Ricky B.; Lapis, Ruby S.; Singleton, Joshua J.			A novel locus from the wild allotetraploid rice species Oryza latifolia Desv. confers bacterial blight (Xanthomonas oryzae pv. oryzae) resistance in rice (O. sativa)	PLOS ONE			English	Article							MARKER-ASSISTED SELECTION; DISEASE RESISTANCE; GENE; INTROGRESSION; LINES; IDENTIFICATION; CULTIVAR; KINASE; REGION	Bacterial blight caused by Xanthomonas oryzae pv. oryzae (Xoo) is a major limiting factor to rice productivity worldwide. Genetic control through the identification of novel sources of bacterial blight resistance and their utilization in resistance breeding remains the most effective and economical strategy to manage the disease. Here we report the identification of a novel locus from the wild Oryza species, Oryza latifolia, conferring a race-specific resistance to Philippine Xoo race 9A (PXO339). The locus was identified from two introgression lines i.e. WH12-2252 and WH12-2256 that segregated from O. latifolia monosomic alien addition lines (MAALs). The discrete segregation ratio of susceptible and resistant phenotypes in the F-2 (chi(2)([3:1]) = 0.22 at p>0.05) and F-3 (chi(2)([3:1]) = 0.36 at p>0.05) populations indicates that PXO339 resistance in the MAAL-derived introgression lines (MDILs) is controlled by a single, recessive gene. Genotyping of a total of 216 F-2, 1130 F-3 and 288 F-4 plants derived from crossing either of the MDILs with the recurrent parent used to generate the MAALs narrowed the candidate region to a 1,817 kb locus that extends from 10,425 to 12,266 kb in chromosome 12. Putative candidate genes that were identified by data mining and comparative sequence analysis can provide targets for further studies on mapping and cloning of the causal gene for PXO339 resistance in the MDILs. To our knowledge, this is the first report of a genetic locus from the allotetraploid wild rice, O. latifolia conferring race-speyyy	[Angeles-Shim, Rosalyn B.; Shim, Junghyun; Vinarao, Ricky B.; Lapis, Ruby S.; Singleton, Joshua J.] Int Rice Res Inst, Plant Breeding Div, Manila, Philippines; [Angeles-Shim, Rosalyn B.; Shim, Junghyun; Singleton, Joshua J.] Texas Tech Univ, Coll Agr Sci & Nat Resources, Dept Plant & Soil Sci, Lubbock, TX 79409 USA	CGIAR; International Rice Research Institute (IRRI); Texas Tech University System; Texas Tech University	Angeles-Shim, RB (corresponding author), Int Rice Res Inst, Plant Breeding Div, Manila, Philippines.; Angeles-Shim, RB (corresponding author), Texas Tech Univ, Coll Agr Sci & Nat Resources, Dept Plant & Soil Sci, Lubbock, TX 79409 USA.	rosalyn.shim@ttu.edu		Singleton, Joshua/0000-0001-9456-6002; Vinarao, Ricky/0000-0002-2420-1611; Angeles-Shim, Rosalyn/0000-0003-0220-3488				Angeles-Shim RB, 2020, RICE SCI, V27, P113, DOI 10.1016/j.rsci.2020.01.002; Angeles-Shim RB, 2014, J HERED, V105, P676, DOI 10.1093/jhered/esu032; Balachiranjeevi CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201271; Bryan GT, 2000, PLANT CELL, V12, P2033, DOI 10.1105/tpc.12.11.2033; Chang SH, 2003, ACTA BOT SIN, V45, P1071; Cheema KK, 2008, GENET RES, V90, P397, DOI 10.1017/S0016672308009786; Chen HL, 2002, PHYTOPATHOLOGY, V92, P750, DOI 10.1094/PHYTO.2002.92.7.750; Cheng DW, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-135; Chezem WR, 2017, PLANT CELL, V29, P1907, DOI 10.1105/tpc.16.00954; Deng H, 2012, PLANT PHYSIOL, V158, P867; Dilla-Ermita CJ, 2017, RICE, V10, DOI 10.1186/s12284-017-0147-4; Dokku P, 2013, EUPHYTICA, V192, P87, DOI 10.1007/s10681-013-0878-2; Gnanamanickam SS, 1999, CURR SCI INDIA, V77, P1435; Gu K, 2004, THEOR APPL GENET, V108, P800, DOI 10.1007/s00122-003-1491-x; Gunupuru LR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204992; Guo SiBin, 2010, Scientia Agricultura Sinica, V43, P2611; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Huang N, 1997, THEOR APPL GENET, V95, P313, DOI 10.1007/s001220050565; Hutin M, 2015, PLANT J, V84, P694, DOI 10.1111/tpj.13042; Ji ZY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103008; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Khush G. S., 1989, BACTERIAL BLIGHT RIC, P207; Khush GS, 2017, NUCLEUS CALCUTTA, V60, P251, DOI 10.1007/s13237-017-0222-7; Kim SM, 2018, THEOR APPL GENET, V131, P2733, DOI 10.1007/s00122-018-3187-2; Kou YJ, 2012, J BIOTECHNOL, V159, P283, DOI 10.1016/j.jbiotec.2011.07.002; Kumar PN, 2012, PHYTOPATHOLOGY, V102, P222, DOI 10.1094/PHYTO-03-11-0075; Li YB, 2016, PLANT PHYSIOL, V170, P2392, DOI 10.1104/pp.15.01930; Liu QS, 2011, PLANT CELL ENVIRON, V34, P1958, DOI 10.1111/j.1365-3040.2011.02391.x; Marzin S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150485; Mata-Perez C, 2019, PLANT SCI, V279, P27, DOI 10.1016/j.plantsci.2018.05.001; McDowell JM, 2003, TRENDS BIOTECHNOL, V21, P178, DOI 10.1016/S0167-7799(03)00053-2; MEW TW, 1992, PLANT DIS, V76, P1029, DOI 10.1094/PD-76-1029; Multani DS, 2003, THEOR APPL GENET, V107, P395, DOI 10.1007/s00122-003-1214-3; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Natarajkumar P., 2010, RICE GENET NEWSL, V25, P54; Oliva R, 2019, NAT BIOTECHNOL, V37, P1344, DOI 10.1038/s41587-019-0267-z; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Ramos JM, 2016, EUPHYTICA, V210, P151, DOI 10.1007/s10681-016-1685-3; RONALD PC, 1992, MOL GEN GENET, V236, P113, DOI 10.1007/BF00279649; Sanchez P.L., 2013, GENETICS GENOMICS RI, P616, DOI DOI 10.1007/978-1-4614-7903-1_2; Shanti ML, 2010, J PLANT PATHOL, V92, P495; Shim J, 2015, BREEDING SCI, V65, P345, DOI 10.1270/jsbbs.65.345; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Singh S, 2001, THEOR APPL GENET, V102, P1011, DOI 10.1007/s001220000495; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Suh JP, 2013, RICE, V6, DOI 10.1186/1939-8433-6-5; Sun LQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6372; Sundaram RM, 2008, EUPHYTICA, V160, P411, DOI 10.1007/s10681-007-9564-6; Sundaresha S, 2018, FUNCT PLANT BIOL, V45, P1026, DOI 10.1071/FP17299; Takabatake R, 2006, PLANT J, V47, P249, DOI 10.1111/j.1365-313X.2006.02781.x; Tan Guang-Xuan, 2004, Acta Genetica Sinica, V31, P724; Ullah I, 2012, GENET MOL RES, V11, P1960, DOI 10.4238/2012.July.20.1; Verdier V, 2012, J BIOTECHNOL, V159, P320, DOI 10.1016/j.jbiotec.2011.09.020; Xia YJ, 2004, CELL MICROBIOL, V6, P905, DOI 10.1111/j.1462-5822.2004.00438.x; Xu ZY, 2019, MOL PLANT, V12, P1434, DOI 10.1016/j.molp.2019.08.006; Yan Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162253; Yasuda N, 2015, PLANT DIS, V99, P904, DOI 10.1094/PDIS-02-14-0214-RE; Yen SK, 2001, PLANT PHYSIOL, V127, P517, DOI 10.1104/pp.010205; Zhang Q, 1998, RICE GENETICS NEWSLE, V15, P138; Zhang ZC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122851; Zheng ChongKe, 2009, Acta Agronomica Sinica, V35, P1173, DOI 10.3724/SP.J.1006.2009.01173	61	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229155	10.1371/journal.pone.0229155	http://dx.doi.org/10.1371/journal.pone.0229155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084193	Green Published, gold			2022-12-26	WOS:000535227900065
J	Azevedo, E; Figueiredo, RG; Pinto, RV; Ramos, TDF; Sampaio, GP; Santos, RPB; Guerreiro, MLD; Biondi, I; Trindade, SC				Azevedo, Elen; Figueiredo, Ricardo Gassmann; Pinto, Roberto Vieira; Freitas Ramos, Tarsila de Carvalho; Sampaio, Geraldo Pedral; Bulhosa Santos, Rebeca Pereira; da Silva Guerreiro, Marcos Lazaro; Biondi, Ilka; Trindade, Soraya Castro			Evaluation of systemic inflammatory response and lung injury induced by Crotalus durissus cascavella venom	PLOS ONE			English	Article							TERRIFICUS SNAKE-VENOM; SCORPION ENVENOMATION; ADHESION MOLECULES; BOTHROPS-ASPER; TNF-ALPHA; CROTOXIN; CYTOKINE; INVOLVEMENT; MECHANICS; HISTOLOGY	This study investigated the systemic inflammatory response and mechanism of pulmonary lesions induced by Crotalus durissus cascavella venom in murine in the state of Bahia. In order to investigate T helper Th1, Th2 and Th17 lymphocyte profiles, we measured interleukin (IL) -2, IL-4, IL-6, IL-10, IL-17, tumor necrosis factor (TNF) and interferon gamma (IFN-gamma) levels in the peritoneal fluid and macerated lungs of mice and histopathological alterations at the specific time windows of 1h, 3h, 6h, 12h, 24h and 48h after inoculation with Crotalus durissus cascavella venom. The data demonstrated an increase of acute-phase cytokines (IL-6 and TNF) in the first hours after inoculation, with a subsequent increase in IL-10 and IL-4, suggesting immune response modulation for the Th2 profile. The histopathological analysis showed significant morphological alterations, compatible with acute pulmonary lesions, with polymorphonuclear leukocyte (PMN) infiltration, intra-alveolar edema, congestion, hemorrhage and atelectasis. These findings advance our understanding of the dynamics of envenomation and contribute to improve clinical management and antiophidic therapy for individuals exposed to venom.	[Azevedo, Elen; da Silva Guerreiro, Marcos Lazaro; Biondi, Ilka] State Univ Feira de Santana, Biol Dept, Lab Venomous Anim & Herpetol, Feira De Santana, BA, Brazil; [Azevedo, Elen; Trindade, Soraya Castro] State Univ Feira de Santana, Postgrad Program Biotechnol, Feira De Santana, BA, Brazil; [Figueiredo, Ricardo Gassmann] State Univ Feira d Santana UEFS, Dept Hlth, Pulmonol Div, Feira De Santana, BA, Brazil; [Pinto, Roberto Vieira] Cardiopulm Clin, Pathol Anat Lab LABSEAP, Novo Mundo, Brazil; [Freitas Ramos, Tarsila de Carvalho] State Univ Feira de Santana, Lab Oral Pathol, Feira De Santana, BA, Brazil; [Sampaio, Geraldo Pedral; Bulhosa Santos, Rebeca Pereira] Fed Univ Bahia UFBA, Postgrad Program Immunol, Salvador, BA, Brazil; [Trindade, Soraya Castro] Feira de Santana State Univ, Dept Hlth, Feira De Santana, BA, Brazil	Universidade Estadual de Feira de Santana; Universidade Estadual de Feira de Santana; Universidade Estadual de Feira de Santana; Universidade Federal da Bahia	Biondi, I (corresponding author), State Univ Feira de Santana, Biol Dept, Lab Venomous Anim & Herpetol, Feira De Santana, BA, Brazil.; Trindade, SC (corresponding author), State Univ Feira de Santana, Postgrad Program Biotechnol, Feira De Santana, BA, Brazil.; Trindade, SC (corresponding author), Feira de Santana State Univ, Dept Hlth, Feira De Santana, BA, Brazil.	ilkabiondi@gmail.com; soraya.castrotrindade@gmail.com	Ramos, Tarsila/AAM-8541-2021; Figueiredo, Ricardo G./AAV-1911-2020	Ramos, Tarsila/0000-0002-6767-4662; Figueiredo, Ricardo G./0000-0003-2128-2775; Azevedo Costa, Elen/0000-0003-2808-9433	Comissao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Comissao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The author(s) received financial support from Comissao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).	Abdel-Haleem AHA, 2006, TOXICON, V47, P437, DOI 10.1016/j.toxicon.2005.12.008; Almeida CD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121427; AMARAL CFS, 1988, REV INST MED TROP SP, V30, P288, DOI 10.1590/S0036-46651988000400007; AMARAL CFS, 1991, REV INST MED TROP SP, V33, P251, DOI 10.1590/S0036-46651991000400002; Barraviera B., 1995, Journal of Venomous Animals and Toxins, V1, P11; Barros SF, 1998, MEDIAT INFLAMM, V7, P339, DOI 10.1080/09629359890866; Bart G, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002798; Bastos Ribeiro C, 2014, ISRN INFLAMM, V2014, DOI [10.1155/2014/563628, DOI 10.1155/2014/563628]; Benvenuti LA, 2003, TOXICON, V42, P331, DOI 10.1016/S0041-0101(03)00167-3; Boldrini-Franca J, 2010, J PROTEOMICS, V73, P1758, DOI 10.1016/j.jprot.2010.06.001; Bucaretchi F, 2016, CLIN TOXICOL, V54, P222, DOI 10.3109/15563650.2015.1135337; Burin SM, 2018, INT J BIOL MACROMOL, V109, P664, DOI 10.1016/j.ijbiomac.2017.12.101; Cardoso DF, 1997, TOXICON, V35, P607, DOI 10.1016/S0041-0101(96)00134-1; Cardoso DF, 2001, MEDIAT INFLAMM, V10, P125, DOI 10.1080/09629350120072699; Carneiro AS, 2008, TOXICON, V52, P619, DOI 10.1016/j.toxicon.2008.07.012; Cruz AH, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/874962; Cupo Palmira, 2003, Medicina (Ribeirao Preto), V36, P490; D'Suze G, 2004, TOXICON, V44, P851, DOI 10.1016/j.toxicon.2004.08.021; D'Suze G, 1999, TOXICON, V37, P173, DOI 10.1016/S0041-0101(98)00180-9; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Favoretto BC, 2011, TOXICON, V57, P600, DOI 10.1016/j.toxicon.2010.12.023; Feili-Hariri M, 2005, J LEUKOCYTE BIOL, V78, P656, DOI 10.1189/jlb.1104631; Fialho EMS, 2011, TOXICON, V58, P480, DOI 10.1016/j.toxicon.2011.08.006; Fonseca FV, 2006, PROTEIN J, V25, P183, DOI 10.1007/s10930-006-9001-z; Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4; Fukuhara YDM, 2003, TOXICON, V41, P49, DOI 10.1016/S0041-0101(02)00208-8; Gnanathasan A, 2014, CHEST, V146, P1403, DOI 10.1378/chest.13-2674; Cruz AH, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/103193; JORGE MT, 1992, REV INST MED TROP SP, V34, P347, DOI 10.1590/S0036-46651992000400013; Lima C, 2003, TOXICON, V42, P499, DOI 10.1016/S0041-0101(03)00228-9; Lin E, 2000, SURGERY, V127, P117, DOI 10.1067/msy.2000.101584; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luna K. P., 2011, INT J INFERERON CYTO, V3, P9; MAGALHAES RA, 1986, REV I MED TROP, V28, P228, DOI 10.1590/S0036-46651986000400004; Manock SR, 2008, T ROY SOC TROP MED H, V102, P1127, DOI 10.1016/j.trstmh.2008.03.026; Markland FS, 2013, TOXICON, V62, P3, DOI 10.1016/j.toxicon.2012.09.004; Martins AMC, 2002, TOXICON, V40, P1165, DOI 10.1016/S0041-0101(02)00119-8; Menezes TN, 2012, TOXICON, V60, P4, DOI 10.1016/j.toxicon.2012.03.008; Ministerio da Saude, 2001, MAN DIAGN TRAT AC AN; Ministerio da Saude, 2019, DATASUS TECNOLOGIA I; MOSMANN TR, 1989, ADV IMMUNOL, V46, P111, DOI 10.1016/S0065-2776(08)60652-5; Neto JD, 2017, TOXICON, V137, P144, DOI 10.1016/j.toxicon.2017.07.023; Nonaka PN, 2008, TOXICON, V51, P1158, DOI 10.1016/j.toxicon.2008.02.006; Ogawa Y, 2007, IMMUNOL ALLERGY CLIN, V27, P249, DOI 10.1016/j.iac.2007.03.013; Peres ACP, 2009, TOXICON, V53, P779, DOI 10.1016/j.toxicon.2009.02.002; Paret G, 1997, HUM EXP TOXICOL, V16, P683, DOI 10.1177/096032719701601110; Pessini AC, 2003, INT IMMUNOPHARMACOL, V3, P765, DOI 10.1016/S1567-5769(03)00078-X; Petricevich Vera L., 2004, Current Drug Targets - Inflammation and Allergy, V3, P325, DOI 10.2174/1568010043343642; Petricevich VL, 2000, TOXICON, V38, P1253, DOI 10.1016/S0041-0101(99)00227-5; Pinho F M, 2001, Rev Assoc Med Bras (1992), V47, P24, DOI 10.1590/S0104-42302001000100026; Rangel-Santos A, 2004, TOXICON, V44, P609, DOI 10.1016/j.toxicon.2004.07.004; Saidi H, 2018, INFLAMMATION, V41, P773, DOI 10.1007/s10753-018-0731-9; Sampaio SC, 2003, TOXICON, V41, P899, DOI 10.1016/S0041-0101(03)00069-2; Silveira KSO, 2004, RESP PHYSIOL NEUROBI, V139, P167, DOI 10.1016/j.resp.2003.10.002; Todd NW, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-11; Tomy SC, 2001, COAGULOPATHY FOLLOWI, P551; Voronov E., 1999, J VENOM ANIM TOXINS, V5, P5, DOI [10.1590/S0104-79301999000100002, DOI 10.1590/S0104-79301999000100002]; Ward PA, 1998, AM J RESP CRIT CARE, V157, pS123, DOI 10.1164/ajrccm.157.4.nhlbi-10; World Health Organization, 2007, NEGLECTED PUBLIC HLT; Zambelli VO, 2008, TOXICON, V51, P1357, DOI 10.1016/j.toxicon.2008.03.004; Zamuner SR, 2005, TOXICON, V46, P806, DOI 10.1016/j.toxicon.2005.08.011; Zamuner SR, 2001, TOXICON, V39, P1505, DOI 10.1016/S0041-0101(01)00123-4	62	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0224584	10.1371/journal.pone.0224584	http://dx.doi.org/10.1371/journal.pone.0224584			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084665	Green Published, gold			2022-12-26	WOS:000535227900004
J	Gupta, DK; Walford, GA; Ma, Y; Jarolim, P; Wang, TJ				Gupta, Deepak K.; Walford, Geoffrey A.; Ma, Yong; Jarolim, Petr; Wang, Thomas J.		DPP Res Grp	Racial/ethnic differences in circulating natriuretic peptide levels: The Diabetes Prevention Program	PLOS ONE			English	Article							NEPRILYSIN INHIBITION; LIPID MOBILIZATION; GENE; COMMON; RISK; BNP; ASSOCIATION; DYSFUNCTION; POPULATION; NESIRITIDE	Natriuretic peptides are cardiac-derived hormones that enhance insulin sensitivity and reduce fat accumulation. Low natriuretic peptide levels are associated with increased risk of type 2 diabetes mellitus (DM2); a condition with variable prevalence across racial/ethnic groups. Few studies have examined whether circulating natriuretic peptide levels and their response to preventive interventions for DM2 differ by race/ethnicity. The Diabetes Prevention Program (DPP) is a clinical trial (July 31, 1996- July 31, 2001) that randomized participants to preventive interventions for DM2. Using stored serum samples, we examined N-terminus pro-B-type natriuretic peptide (NT-proBNP) levels in 3,220 individuals (56% white; 19% African-American; 15% Hispanic; 5% American-Indian; 5% Asian). The influence of race/ethnicity on NT-proBNP concentrations at baseline and after two years of treatment with placebo, lifestyle, or metformin was examined with multivariable-adjusted regression. At baseline, NT-proBNP differed significantly by race (P<.001), with the lowest values in African-American individuals. Hispanic individuals also had lower baseline NT-proBNP levels compared with whites (P<.001), while NT-proBNP levels were similar between white, American-Indian, and Asian individuals. At two years of follow-up, NT-proBNP levels decreased in African-Americans in each of the DPP study arms, whereas they were stable or increased in the other racial/ethnic groups. In the DPP, African-American individuals had lower circulating NT-proBNP levels compared with individuals in other racial/ethnic groups at baseline and after two years of preventive interventions. Further studies should examine the cardio-metabolic implications of lower natriuretic peptide levels in African-Americans.	[Gupta, Deepak K.; Wang, Thomas J.] Vanderbilt Univ, Sch Med, Vanderbilt Translat & Clin Cardiovasc Res Ctr, Nashville, TN 37212 USA; [Gupta, Deepak K.; Wang, Thomas J.] Vanderbilt Univ, Sch Med, Div Cardiovasc Med, Nashville, TN 37212 USA; [Walford, Geoffrey A.] Massachusetts Gen Hosp, Diabet Unit, Diabet Res Ctr, Boston, MA 02114 USA; [Walford, Geoffrey A.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Walford, Geoffrey A.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Ma, Yong] George Washington Univ, Biostat Ctr, Diabet Prevent Program Data Coordinating Ctr, Rockville, MD USA; [Jarolim, Petr] Brigham & Womens Hosp, Dept Pathol, TIMI Clin Trial Lab, Biomarker Res Lab, 75 Francis St, Boston, MA 02115 USA; [Jarolim, Petr] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Vanderbilt University; Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; George Washington University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Gupta, DK (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Translat & Clin Cardiovasc Res Ctr, Nashville, TN 37212 USA.; Gupta, DK (corresponding author), Vanderbilt Univ, Sch Med, Div Cardiovasc Med, Nashville, TN 37212 USA.	d.gupta@vumc.org		Jarolim, Petr/0000-0002-9612-8652	National Heart, Lung, and Blood Institute [K12 HL109019, 1K23HL12892801A1, R01-HL-086875]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000445, DK099249-01A1]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health [U01 DK048489]; NIDDK; Indian Health Service; National Institute of Child Health and Human Development; National Institute on Aging; National Eye Institute; National Heart Lung and Blood Institute; National Cancer Institute; Office of Research on Women's Health; National Institute on Minority Health and Health Disparities; Centers for Disease Control and Prevention; American Diabetes Association	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Indian Health Service(United States Department of Health & Human Services); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); American Diabetes Association(American Diabetes Association)	Research reported in this publication was supported by the National Heart, Lung, and Blood Institute grants K12 HL109019, 1K23HL12892801A1, and R01-HL-086875; the National Center for Advancing Translational Sciences of the National Institutes of Health award numbers UL1TR000445 (Vanderbilt University) and DK099249-01A1 to GAW. During the DPP and DPPOS, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health provided funding to the clinical centers and the Coordinating Center for the design and conduct of the study, and collection, management, analysis, and interpretation of the data (U01 DK048489). The Southwestern American Indian Centers were supported directly by the NIDDK, including its Intramural Research Program, and the Indian Health Service. The General Clinical Research Center Program, National Center for Research Resources, and the Department of Veterans Affairs supported data collection at many of the clinical centers. Funding was also provided by the National Institute of Child Health and Human Development, the National Institute on Aging, the National Eye Institute, the National Heart Lung and Blood Institute, the National Cancer Institute, the Office of Research on Women's Health, the National Institute on Minority Health and Health Disparities, the Centers for Disease Control and Prevention, and the American Diabetes Association. Merck KGaA provides medication for DPPOS. DPP/DPPOS have also received donated materials from Bristol-Myers Squibb, Parke-Davis, and LifeScan Inc. LifeScan Inc., Health O Meter, Hoechst Marion Roussel, Inc., Merck-Medco Managed Care, Inc., Merck and Co., Nike Sports Marketing, Slim Fast Foods Co., and Quaker Oats Co. donated materials, equipment, or medicines for concomitant conditions. McKesson BioServices Corp., Matthews Media Group, Inc., and the Henry M. Jackson Foundation provided support services under subcontract with the Coordinating Center.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], 2000, Diabetes Care, V23, P1619; Arora P, 2013, J CLIN INVEST, V123, P3378, DOI 10.1172/JCI67383; Birkenfeld AL, 2005, J CLIN ENDOCR METAB, V90, P3622, DOI 10.1210/jc.2004-1953; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bray GA, 1999, DIABETES CARE, V22, P623; Cannone V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189858; Cannone V, 2011, J AM COLL CARDIOL, V58, P629, DOI 10.1016/j.jacc.2011.05.011; Choi EY, 2012, CIRC-HEART FAIL, V5, P727, DOI 10.1161/CIRCHEARTFAILURE.112.968701; Choquet H, 2009, HUM MOL GENET, V18, P2495, DOI 10.1093/hmg/ddp169; Colucci WS, 2000, NEW ENGL J MED, V343, P246, DOI 10.1056/NEJM200007273430403; Daniels LB, 2012, EUR J HEART FAIL, V14, P22, DOI 10.1093/eurjhf/hfr157; de Lemos JA, 2009, AM HEART J, V157, P746, DOI 10.1016/j.ahj.2008.12.017; Diabetes Prevention Progam, 2005, DIABETES, V54, P1150; Dries DL, 2005, CIRCULATION, V112, P2403, DOI 10.1161/CIRCULATIONAHA.105.568881; Gupta DK, 2017, AM J CARDIOL, V120, P1008, DOI 10.1016/j.amjcard.2017.06.030; Gupta DK, 2015, JACC-HEART FAIL, V3, P513, DOI 10.1016/j.jchf.2015.02.008; Gupta DK, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001831; Heinisch BB, 2012, DIABETOLOGIA, V55, P1400, DOI 10.1007/s00125-011-2392-1; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Krauser DG, 2006, J CARD FAIL, V12, P452, DOI 10.1016/j.cardfail.2006.04.005; Lazo M, 2013, DIABETES, V62, P3189, DOI 10.2337/db13-0478; Magnusson M, 2012, J CLIN ENDOCR METAB, V97, P638, DOI 10.1210/jc.2011-2425; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Meirhaeghe A, 2007, HUM MOL GENET, V16, P1343, DOI 10.1093/hmg/ddm084; Miyashita K, 2009, DIABETES, V58, P2880, DOI 10.2337/db09-0393; Montagnana M, 2008, CLIN CHEM LAB MED, V46, P714, DOI 10.1515/CCLM.2008.130; Moro C, 2004, FASEB J, V18, P908, DOI 10.1096/fj.03-1086fje; Mueller T, 2004, CLIN CHEM LAB MED, V42, P942, DOI 10.1515/CCLM.2004.153; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; O'Connor CM, 2011, NEW ENGL J MED, V365, P32, DOI 10.1056/NEJMoa1100171; Packer M, 2015, CIRCULATION, V131, P54, DOI 10.1161/CIRCULATIONAHA.114.013748; Patel N, 2019, CIRC RES, V125, P957, DOI 10.1161/CIRCRESAHA.119.315026; Salomaa V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010100; Sanchez OA, 2015, DIABETES METAB, V41, P378, DOI 10.1016/j.diabet.2015.04.005; Volpe M, 2014, EUR HEART J, V35, P419, DOI 10.1093/eurheartj/eht466; Walford GA, 2014, DIABETOLOGIA, V57, P935, DOI 10.1007/s00125-014-3183-2; Wang TJ, 2012, NEW ENGL J MED, V367, P377, DOI 10.1056/NEJMcibr1204796; Wang TJ, 2003, CIRCULATION, V108, P13, DOI 10.1161/01.CIR.0000081657.83724.A7	40	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229280	10.1371/journal.pone.0229280	http://dx.doi.org/10.1371/journal.pone.0229280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084251	gold, Green Published, Green Submitted			2022-12-26	WOS:000535227900079
J	Olson, MW				Olson, Michael W.			Static loading of the knee joint results in modified single leg landing biomechanics	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; MEDIAL COLLATERAL LIGAMENT; GENDER-DIFFERENCES; INJURY RISK; FATIGUE; STIFFNESS; CREEP; ACL; EPIDEMIOLOGY; BASKETBALL	Background External loading of the ligamentous tissues induces mechanical creep, which modifies neuromuscular response to perturbations. It is not well understood how ligamentous creep affects athletic performance and contributes to modifications of knee biomechanics during functional tasks. Hypothesis/purpose The purpose of this study was to examine the mechanical and neuromuscular responses to single leg drop landing perturbations before and after passive loading of the knee joint. Methods Descriptive laboratory study. Male (n = 7) and female (n = 14) participants' (21.3 +/- 2.1 yrs., 1.69 +/- 0.09 m, 69.3 +/- 13.0 kg) right hip, knee, and ankle kinematics were assessed during drop landings performed from a 30 cm height onto a force platform before and after a 10 min creep protocol. Electromyography (EMG) signals were recorded from rectus femoris (RF), vastus lateralis (VL), vastus medialis (VM), semimembranosus (SM), and biceps femoris (BF) muscles. The creep protocol involved fixing the knee joint at 35 degrees during static loading with perpendicular loads of either 200 N (males) or 150 N (females). Maximum, minimum, range of motion (ROM), and angular velocities were assessed for the hip, knee, and ankle joints, while normalized EMG (NEMG), vertical ground reaction forces (VGRF), and rate of force development (RFD) were assessed at landing using ANOVAs. Alpha was set at 0.05. Results Maximum hip flexion velocity decreased (p < 0.01). Minimum knee flexion velocity increased (p < 0.02). Minimum knee ad/abduction velocity decreased (p < 0.001). Ankle ROM decreased (p < 0.001). aVGRF decreased (p < 0.02). RFD had a non-significant trend (p = 0.076). NAEMG was significant between muscle groups (p < 0.02). Conclusion Distinct changes in velocity parameters are attributed to the altered mechanical behavior of the knee joint tissues and may contribute to changes in the loading of the leg during landing.	[Olson, Michael W.] Southern Illinois Univ Carbondale, Dept Kinesiol, Carbondale, IL 62901 USA; [Olson, Michael W.] Midwestern State Univ, Dept Athlet Training & Exercise Physiol, Wichita Falls, TX 76308 USA	Southern Illinois University System; Southern Illinois University	Olson, MW (corresponding author), Southern Illinois Univ Carbondale, Dept Kinesiol, Carbondale, IL 62901 USA.; Olson, MW (corresponding author), Midwestern State Univ, Dept Athlet Training & Exercise Physiol, Wichita Falls, TX 76308 USA.	michael.olson@msutexas.edu						Bates NA, 2015, AM J SPORT MED, V43, P2259, DOI 10.1177/0363546515589165; Blackburn JT, 2013, J ATHL TRAINING, V48, P764, DOI 10.4085/1062-6050-48.4.01; Blackburn JT, 2011, CLIN BIOMECH, V26, P278, DOI 10.1016/j.clinbiomech.2010.10.002; Bollier M, 2014, J KNEE SURG, V27, P359, DOI 10.1055/s-0034-1381961; Brazen DM, 2010, CLIN J SPORT MED, V20, P286, DOI 10.1097/JSM.0b013e3181e8f7dc; Butler RJ, 2003, CLIN BIOMECH, V18, P511, DOI 10.1016/S0268-0033(03)00071-8; Chappell JD, 2008, AM J SPORT MED, V36, P1081, DOI 10.1177/0363546508314425; Cheng XR, 2014, J ELECTROMYOGR KINES, V24, P271, DOI 10.1016/j.jelekin.2014.01.005; Chu D, 2003, CLIN BIOMECH, V18, P222, DOI 10.1016/S0268-0033(03)00002-0; Elias ARC, 2015, J ORTHOP SPORT PHYS, V45, P273, DOI 10.2519/jospt.2015.5335; Fagenbaum R, 2003, AM J SPORT MED, V31, P233, DOI 10.1177/03635465030310021301; Fong CM, 2011, J ATHL TRAINING, V46, P5, DOI 10.4085/1062-6050-46.1.5; Fujii M, 2012, J SPORT SCI MED, V11, P255; Heebner NR, 2017, J ATHL TRAINING, V52, P1101, DOI 10.4085/1062-6050-52.11.25; Herrington L, 2011, J STRENGTH COND RES, V25, P262, DOI 10.1519/JSC.0b013e3181b62c77; Hewett TE, 2006, AM J SPORT MED, V34, P299, DOI 10.1177/0363546505284183; Ingram JG, 2008, AM J SPORT MED, V36, P1116, DOI 10.1177/0363546508314400; Jenkins WL, 2017, PHYS THER SPORT, V24, P1, DOI 10.1016/j.ptsp.2016.09.005; Kernozek TW, 2008, AM J SPORT MED, V36, P554, DOI 10.1177/0363546507308934; Kernozek TW, 2005, MED SCI SPORT EXER, V37, P1003, DOI 10.1249/01.mss.0000171616.14640.2b; Kraus T, 2012, ARCH ORTHOP TRAUM SU, V132, P773, DOI 10.1007/s00402-012-1480-0; Laughlin WA, 2011, J BIOMECH, V44, P1845, DOI 10.1016/j.jbiomech.2011.04.010; de Souza LML, 2018, HUM MOVEMENT SCI, V58, P307, DOI 10.1016/j.humov.2017.12.012; Leppanen M, 2017, AM J SPORT MED, V45, P386, DOI 10.1177/0363546516665810; LUDWIG J, 2017, SPORTS, P5, DOI DOI 10.3390/SPORTS5010014; Lyle MA, 2014, J BIOMECH, V47, P512, DOI 10.1016/j.jbiomech.2013.10.038; McLean SG, 2010, CLIN BIOMECH, V25, P781, DOI 10.1016/j.clinbiomech.2010.06.002; Nilstad A, 2015, J ORTHOP SPORT PHYS, V45, P998, DOI 10.2519/jospt.2015.5612; Norcross MF, 2013, J ATHL TRAINING, V48, P748, DOI 10.4085/1062-6050-48.4.09; Nuccio S, 2018, PHYS THER SPORT, V32, P187, DOI 10.1016/j.ptsp.2018.05.013; Ortiz A, 2010, J STRENGTH COND RES, V24, P1019, DOI 10.1519/JSC.0b013e3181c7c5d4; Palmieri-Smith RM, 2007, AM J SPORT MED, V35, P1269, DOI 10.1177/0363546506296417; Pollard CD, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117726267; Salem HS, 2018, ARTHROSCOPY, V34, P200, DOI 10.1016/j.arthro.2017.07.039; Sbriccoli P, 2005, AM J SPORT MED, V33, P543, DOI 10.1177/0363546504268408; Schmitz RJ, 2015, J ATHL TRAINING, V50, P23, DOI 10.4085/1062-6050-49.3.79; Solomonow M, 2006, J ELECTROMYOGR KINES, V16, P549, DOI 10.1016/j.jelekin.2006.08.004; Solomonow M, 2003, CLIN BIOMECH, V18, P890, DOI 10.1016/S0268-0033(03)00173-6; Swenson DM, 2013, MED SCI SPORT EXER, V45, P462, DOI 10.1249/MSS.0b013e318277acca; Thein R, 2017, J KNEE SURG, V30, P565, DOI 10.1055/s-0036-1593620; Thornton GM, 2007, ANN BIOMED ENG, V35, P1713, DOI 10.1007/s10439-007-9349-z; Thornton GM, 2001, J RHEOL, V45, P493, DOI 10.1122/1.1343877; Verniba D, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-016-0072-x; Yao J, 2006, J BIOMECH ENG-T ASME, V128, P135, DOI 10.1115/1.2132373; Zazulak BT, 2007, AM J SPORT MED, V35, P1123, DOI 10.1177/0363546507301585	45	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0219648	10.1371/journal.pone.0219648	http://dx.doi.org/10.1371/journal.pone.0219648			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084138	Green Published, gold, Green Submitted			2022-12-26	WOS:000535227900002
J	O'Rourke, A; Lee, MD; Nierman, WC; Everroad, RC; Dupont, CL				O'Rourke, Aubrie; Lee, Michael D.; Nierman, William C.; Everroad, R. Craig; Dupont, Chris L.			Genomic and phenotypic characterization of Burkholderia isolates from the potable water system of the International Space Station	PLOS ONE			English	Article							CEPACIA COMPLEX; ANNOTATION; INFECTION; BACTERIAL; CLUSTERS; TOXIN; GENES	The opportunistic pathogens Burkholderia cepacia and Burkholderia contaminans, both genomovars of the Burkholderia cepacia complex (BCC), are frequently cultured from the potable water dispenser (PWD) of the International Space Station (ISS). Here, we sequenced the genomes and conducted phenotypic assays to characterize these Burkholderia isolates. All recovered isolates of the two species fall within monophyletic clades based on phylogenomic trees of conserved single-copy core genes. Within species, the ISS-derived isolates all demonstrate greater than 99% average nucleotide identity (with 95-99% of genomes aligning) and share around 90% of the identified gene clusters from a pangenomic analysis-suggesting that the two groups are each composed of highly similar genomic lineages and their members may have all stemmed from the same two founding populations. The differences that can be observed between the recovered isolates at the pangenomic level are primarily located within putative plasmids. Phenotypically, macrophage intracellularization and lysis occurred at generally similar rates between all ISS-derived isolates, as well as with their respective type-terrestrial strain references. All ISS-derived isolates exhibited antibiotic sensitivity similar to that of the terrestrial reference strains, and minimal differences between isolates were observed. With a few exceptions, biofilm formation rates were generally consistent across each species. And lastly, though isolation date does not necessarily provide any insight into how long a given isolate had been aboard the ISS, none of the assayed physiology correlated with either date of isolation or distances based on nucleotide variation. Overall, we find that while the populations of Burkholderia present in the ISS PWS each maintain virulence, they are likely are not more virulent than those that might be encountered on planet and remain susceptible to clinically used antibiotics.	[O'Rourke, Aubrie; Nierman, William C.; Dupont, Chris L.] J Craig Venter Inst, San Diego, CA 92037 USA; [Lee, Michael D.; Everroad, R. Craig] NASA, Ames Res Ctr, Exobiol Branch, Mountain View, CA USA; [Lee, Michael D.] Blue Marble Space Inst Sci, Seattle, WA USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	O'Rourke, A (corresponding author), J Craig Venter Inst, San Diego, CA 92037 USA.	aorourke@jcvi.org		O'Rourke, Aubrie/0000-0002-2890-1682	NASA Space Biology [NNH16ZTT001N-MOBE]; NASA Astrobiology Institute Alternative Earths	NASA Space Biology; NASA Astrobiology Institute Alternative Earths	Aubrie O'Rourke was funded by NASA Space Biology under grant 80NSSC17K0035. Michael D. Lee was funded by NASA Space Biology under grant NNH16ZTT001N-MOBE. Chris L. Dupont was funded by the NASA Astrobiology Institute Alternative Earths. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M., 2016, INT J VACCINES VACCI, V3, P64, DOI [10.15406/ijvv.2016.03.00064, DOI 10.15406/IJVV.2016.03.00064]; Andrews S., 2015, FASTQC QUALITY CONTR; Antipov D, 2016, BIOINFORMATICS, DOI [10.1093/bioinformatics/btw493, DOI 10.1093/BIOINFORMATICS/BTW493]; Baldwin A, 2004, INFECT IMMUN, V72, P1537, DOI 10.1128/IAI.72.3.1537-1547.2004; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Casacuberta E, 2013, MOL ECOL, V22, P1503, DOI 10.1111/mec.12170; Cho J, 2017, MICROBIOL-SGM, V163, P308, DOI 10.1099/mic.0.000436; Eren AM, 2015, PEERJ, V3, DOI 10.7717/peerj.1319; Flieger A, 2001, J BACTERIOL, V183, P2121, DOI 10.1128/JB.183.6.2121-2124.2001; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; Ganesan S, 2012, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00025; Gronow S, 2003, J BIOL CHEM, V278, P1647, DOI 10.1074/jbc.M206942200; Gruzelle V., MANAGEMENT INITIAL C, P1, DOI [10.21203/rs.2.11997/v1, DOI 10.21203/RS.2.11997/V1]; Jain C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07641-9; Jenkins CH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47483-z; Juhas M, 2008, CELL MICROBIOL, V10, P2377, DOI 10.1111/j.1462-5822.2008.01187.x; Kukor JJ, 1996, APPL ENV MICROBIOL; Lee AHY, 2017, GENOME RES, V27, P650, DOI 10.1101/gr.213363.116; Lee MD, 2019, BIOINFORMATICS, V35, P4162, DOI 10.1093/bioinformatics/btz188; Maryatt, 2018, 48 INT C ENV SYSTEMS; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Miller SCM, 2002, APPL ENVIRON MICROB, V68, P3750, DOI 10.1128/AEM.68.8.3750-3758.2002; MIRAS I, 1995, RES MICROBIOL, V146, P17, DOI 10.1016/0923-2508(96)80267-1; Mudgett PD, 1999, SAE TECHNICAL PAPERS, DOI [10.4271/1999-01-2029, DOI 10.4271/1999-01-2029]; National Research Council, 2000, METHODS DEV SPACECRA, DOI [10.17226/9892, DOI 10.17226/9892]; Nunvar J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160975; PANLILIO AL, 1992, CLIN INFECT DIS, V14, P1078, DOI 10.1093/clinids/14.5.1078; Pompilio A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01349; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; Ryan MP, 2013, J MED MICROBIOL, V62, P1025, DOI 10.1099/jmm.0.054759-0; Shaw LA, 2010, INT SPACE STATION US; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Tancsics A, 2010, SYST APPL MICROBIOL, V33, P398, DOI 10.1016/j.syapm.2010.08.005; Tatusova T, 2016, NUCLEIC ACIDS RES, V44, P6614, DOI 10.1093/nar/gkw569; Tegos GP, 2012, VIRULENCE, V3, P234, DOI 10.4161/viru.19844; Thomson ELS, 2012, VIRULENCE, V3, P286, DOI 10.4161/viru.19355; Toon K, 2012, INT SPACE STATION US, DOI [10.2514/6.2010-6250, DOI 10.2514/6.2010-6250]; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Valvano MA, 2005, CURR OPIN MICROBIOL, V8, P99, DOI 10.1016/j.mib.2004.12.002; Valvano MA, 2015, CAN J MICROBIOL, V61, P607, DOI 10.1139/cjm-2015-0316; van Dongen S, 2012, METHODS MOL BIOL, V804, P281, DOI 10.1007/978-1-61779-361-5_15; Vanlaere E, 2009, INT J SYST EVOL MICR, V59, P102, DOI 10.1099/ijs.0.001123-0; Wikstrom P, 1996, J BIOTECHNOL, V52, P107, DOI 10.1016/S0168-1656(96)01635-5; Zurita J, 2014, INT J INFECT DIS, V29, P96, DOI 10.1016/j.ijid.2014.07.016	46	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0227152	10.1371/journal.pone.0227152	http://dx.doi.org/10.1371/journal.pone.0227152			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074104	Green Published, Green Submitted, gold			2022-12-26	WOS:000535220600004
J	Shida, A; Ikeda, T; Tani, N; Morioka, F; Aoki, Y; Ikeda, K; Watanabe, M; Ishikawa, T				Shida, Alissa; Ikeda, Tomoya; Tani, Naoto; Morioka, Fumiya; Aoki, Yayoi; Ikeda, Kei; Watanabe, Miho; Ishikawa, Takaki			Cortisol levels after cold exposure are independent of adrenocorticotropic hormone stimulation	PLOS ONE			English	Article							POSTMORTEM BIOCHEMISTRY; ENVIRONMENTAL-TEMPERATURE; ACCIDENTAL HYPOTHERMIA; CATECHOLAMINE LEVELS; FATAL HYPOTHERMIA; ADRENAL TUMORS; PITUITARY; DEATH; IMMUNOASSAY; DIAGNOSIS	We previously showed that postmortem serum levels of adrenocorticotropic hormone (ACTH) were significantly higher in cases of hypothermia (cold exposure) than other causes of death. This study examined how the human hypothalamic-pituitary-adrenal axis, and specifically cortisol, responds to hypothermia. Human samples: Autopsies on 205 subjects (147 men and 58 women; age 15-98 years, median 60 years) were performed within 3 days of death. Cause of death was classified as either hypothermia (cold exposure, n = 14) or non-cold exposure (controls; n = 191). Cortisol levels were determined in blood samples obtained from the left and right cardiac chambers and common iliac veins using a chemilu-minescent enzyme immunoassay. Adrenal gland tissues samples were stained for cortisol using a rabbit anti-human polyclonal antibody. Cell culture: AtT20, a mouse ACTH secretory cell line, and Y-1, a corticosterone secretory cell line derived from a mouse adrenal tumor, were analyzed in mono-and co-culture, and times courses of ACTH (in AtT20) and corticosterone (in Y-1) secretion were assessed after low temperature exposure mimicking hypothermia and compared with data for samples collected postmortem for other cases of death. However, no correlation between ACTH concentration and cortisol levels was observed in hypothermia cases. Immunohistologic analyses of samples from hypothermia cases showed that cortisol staining was localized primarily to the nucleus rather than the cytoplasm of cells in the zona fasciculata of the adrenal gland. During both mono-culture and co-culture, AtT20 cells secreted high levels of ACTH after 10-15 minutes of cold exposure, whereas corticosterone secretion by Y-1 cells increased slowly during the first 15-20 minutes of cold exposure. Similar to autopsy results, no correlation was detected between ACTH levels and corticosterone secretion, either in mono-culture or co-culture experiments. These results suggested that ACTH-independent cortisol secretion may function as a stress response during cold exposure.	[Shida, Alissa; Ikeda, Tomoya; Tani, Naoto; Morioka, Fumiya; Aoki, Yayoi; Ikeda, Kei; Watanabe, Miho; Ishikawa, Takaki] Osaka City Univ, Dept Legal Med, Med Sch, Osaka, Japan; [Ikeda, Tomoya; Tani, Naoto; Ishikawa, Takaki] Medicolegal Consultat & Postmortem Invest Support, Forens Autopsy Sect, Osaka, Japan; [Watanabe, Miho] Univ Tsukuba, Fac Med, Lab Clin Regenerat Med, Hlth & Med Sci Innovat Lab,Dept Neurosurg, Tsukuba, Ibaraki, Japan	Osaka Metropolitan University; University of Tsukuba	Shida, A (corresponding author), Osaka City Univ, Dept Legal Med, Med Sch, Osaka, Japan.	shida.alissa@med.osaka-cu.ac.jp	Tani, Naoto/AAX-1858-2021	Shida, Alissa/0000-0001-8736-8681; Tani, Naoto/0000-0002-4981-0456				Almamy A, 2017, J MOL NEUROSCI, V62, P163, DOI 10.1007/s12031-017-0920-2; AVRAMEAS S, 1992, J IMMUNOL METHODS, V150, P23, DOI 10.1016/0022-1759(92)90062-X; BAHN R, 1957, AM J PATHOL, V33, P1075; Banka K, 2013, FORENSIC SCI INT, V229, P60, DOI 10.1016/j.forsciint.2013.03.003; Bright FM, 2014, J FORENSIC SCI, V59, P983, DOI 10.1111/1556-4029.12451; Briot R, 2007, HYPOTHERMIES ACCIDEN; BUONASSISI V, 1962, P NATL ACAD SCI USA, V48, P1184, DOI 10.1073/pnas.48.7.1184; Byard RW, 2019, J FORENSIC SCI, V64, P443, DOI 10.1111/1556-4029.13885; Carroll JA, 2001, AM J VET RES, V62, P561, DOI 10.2460/ajvr.2001.62.561; Chen JH, 2012, INT J LEGAL MED, V126, P747, DOI 10.1007/s00414-012-0732-4; COHEN AI, 1957, AM J PATHOL, V33, P631; COHEN AI, 1957, P SOC EXP BIOL MED, V95, P304; Costa ET, 2004, ENDOCR RES, V30, P503, DOI 10.1081/ERC-200043600; DANZL DF, 1987, ANN EMERG MED, V16, P1042, DOI 10.1016/S0196-0644(87)80757-6; Dinner S, 2016, JOVE-J VIS EXP, DOI 10.3791/54061; Dirnhofer VR, 1978, BEITR GERICHTE MED, V37, P159; Fallo F, 2017, ENDOCRINE, V58, P503, DOI 10.1007/s12020-017-1295-4; FINLAYSON NB, 1965, J PEDIATR-US, V67, P248, DOI 10.1016/S0022-3476(65)80247-5; FURTH J, 1953, P SOC EXP BIOL MED, V84, P253; Gamby C, 1996, J BIOL CHEM, V271, P10023, DOI 10.1074/jbc.271.17.10023; Hache RJG, 1999, J BIOL CHEM, V274, P1432, DOI 10.1074/jbc.274.3.1432; Hauser S, 2018, INT J MED MICROBIOL, V308, P829, DOI 10.1016/j.ijmm.2018.07.004; Hervet T, 2016, FORENSIC SCI MED PAT, V12, P163, DOI 10.1007/s12024-016-9764-2; Higgs P, 2014, J SMALL ANIM PRACT, V55, P153, DOI 10.1111/jsap.12181; HIRVONEN J, 1976, Forensic Science, V8, P155, DOI 10.1016/0300-9432(76)90059-5; Inada M, 2008, INTERNAL MED, V47, P2157, DOI 10.2169/internalmedicine.47.1165; Irvine KL, 2016, VET CLIN PATH, V45, P154, DOI 10.1111/vcp.12326; Ishikawa T, 2004, Leg Med (Tokyo), V6, P157; Ishikawa T, 2008, FORENSIC SCI INT, V179, P147, DOI 10.1016/j.forsciint.2008.04.023; Ishikawa T, 2014, LEGAL MED-TOKYO, V16, P344, DOI 10.1016/j.legalmed.2014.07.006; Ishikawa T, 2013, FORENSIC SCI INT, V228, P52, DOI 10.1016/j.forsciint.2013.02.008; Ishikawa T, 2011, HUM CELL, V24, P74, DOI 10.1007/s13577-011-0012-5; Ishikawa Takaki, 2009, Leg Med (Tokyo), V11 Suppl 1, pS228, DOI 10.1016/j.legalmed.2009.02.049; ITO A, 1978, GANN, V69, P525; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; Kameda H, 2019, ENDOCRINOLOGY, V160, P276, DOI 10.1210/en.2018-00920; Kanto-Nishimaki Y, 2014, LEGAL MED-TOKYO, V16, P321, DOI 10.1016/j.legalmed.2014.06.010; Krjukoff A., 1914, VJSCHR GERICHTL MED, V47, P79; LEPPALUOTO J, 1988, ACTA PHYSIOL SCAND, V132, P543, DOI 10.1111/j.1748-1716.1988.tb08363.x; Lim C, 2008, PATHOLOGY, V40, P46, DOI 10.1080/00313020701716466; MAINS RE, 1976, J BIOL CHEM, V251, P4115; Mallet ML, 2002, QJM-INT J MED, V95, P775, DOI 10.1093/qjmed/95.12.775; MANT A K, 1964, Med Sci Law, V4, P44; Meiman J, 2015, MMWR-MORBID MORTAL W, V64, P141; Miller WL, 2018, HORM RES PAEDIAT, V89, P212, DOI 10.1159/000487755; Mizukami H, 1999, Leg Med (Tokyo), V1, P204, DOI 10.1016/S1344-6223(99)80039-X; MUROFUSHI H, 1987, J BIOCHEM-TOKYO, V102, P1101, DOI 10.1093/oxfordjournals.jbchem.a122148; NAKANE T, 1987, LIFE SCI, V40, P2161, DOI 10.1016/0024-3205(87)90006-3; Nakano S, 2007, AM J PHYSIOL-ENDOC M, V292, pE1213, DOI 10.1152/ajpendo.00340.2006; Nara A, 2016, INT J LEGAL MED, V130, P765, DOI 10.1007/s00414-015-1266-3; NICHOLSON ML, 1978, CANCER RES, V38, P3673; Nixdorf-Miller A, 2006, ARCH PATHOL LAB MED, V130, P1297; Ohkawara T, 2005, CLIN EXP IMMUNOL, V140, P241, DOI 10.1111/j.1365-2249.2005.02771.x; OKADA Y, 1970, J CLIN ENDOCR METAB, V30, P393, DOI 10.1210/jcem-30-3-393; Palmiere C, 2016, J FORENSIC LEG MED, V42, P51, DOI 10.1016/j.jflm.2016.04.013; Palmiere C, 2014, INT J LEGAL MED, V128, P607, DOI 10.1007/s00414-014-0977-1; Palmiere C, 2013, FORENSIC SCI INT, V226, P54, DOI 10.1016/j.forsciint.2012.12.007; Palmiere C, 2013, INT J LEGAL MED, V127, P267, DOI 10.1007/s00414-012-0738-y; Peek GJ, 2008, YB INTENSIVE CARE EM, P147; Peeters B, 2015, MOL CELL ENDOCRINOL, V408, P235, DOI 10.1016/j.mce.2014.11.012; PORSTMANN T, 1992, J IMMUNOL METHODS, V150, P5, DOI 10.1016/0022-1759(92)90061-W; Rege J, 2014, J CLIN ENDOCR METAB, V99, pE518, DOI 10.1210/jc.2013-3198; Rose R, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny274; Rousseau G, 2018, CLIN CHEM LAB MED, V56, P1819, DOI 10.1515/cclm-2018-0153; SAKLY M, 1982, MOL CELL ENDOCRINOL, V28, P27, DOI 10.1016/0303-7207(82)90038-7; Sato E, 2019, BIOCHEM J, V476, P827, DOI 10.1042/BCJ20180832; SCHNEIDER V, 1980, Z RECHTSMED, V86, P59; Schwerk C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030069; STONER HB, 1980, CLIN SCI, V59, P19, DOI 10.1042/cs0590019; Sugiyama F, 2006, J BONE MINER METAB, V24, P439, DOI 10.1007/s00774-006-0711-2; Tabernero C, 1997, J VIROL, V71, P95, DOI 10.1128/JVI.71.1.95-101.1997; Tani N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198673; Tani N, 2016, LEGAL MED-TOKYO, V22, P23, DOI 10.1016/j.legalmed.2016.07.006; THOMPSON EB, 1977, ENDOCRINOLOGY, V100, P406; Turk EE, 2010, FORENSIC SCI MED PAT, V6, P106, DOI 10.1007/s12024-010-9142-4; Vassal T, 2001, CHEST, V120, P1998, DOI 10.1378/chest.120.6.1998; Whyte DG, 2007, AM J PHYSIOL-REG I, V292, pR137, DOI 10.1152/ajpregu.00465.2006; WILKERSON JE, 1974, J APPL PHYSIOL, V36, P183, DOI 10.1152/jappl.1974.36.2.183; WITTERT GA, 1992, J CLIN ENDOCR METAB, V75, P750, DOI 10.1210/jc.75.3.750; WOOLF PD, 1972, J CLIN ENDOCR METAB, V34, P460, DOI 10.1210/jcem-34-3-460; Yajima D, 2015, LEGAL MED-TOKYO, V17, P451, DOI 10.1016/j.legalmed.2015.09.005; YANASE T, 1992, J STEROID BIOCHEM, V43, P973, DOI 10.1016/0960-0760(92)90325-D; YASUMURA Y, 1966, CANCER RES, V26, P529; Yoshida C, 2011, INT J LEGAL MED, V125, P11, DOI 10.1007/s00414-009-0374-3	84	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0218910	10.1371/journal.pone.0218910	http://dx.doi.org/10.1371/journal.pone.0218910			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7XT	32069307	Green Submitted, Green Published, gold			2022-12-26	WOS:000535212900002
J	Wang, M; Braasch, T; Dietrich, C				Wang, Magnus; Braasch, Thiemo; Dietrich, Christian			Reduction of variability for the assessment of side effects of toxicants on honeybees and understanding drivers for colony development	PLOS ONE			English	Article							WORKER SURVIVAL; BEE BROOD; METHOD IMPROVEMENTS; POPULATION-GROWTH; VARROA-JACOBSONI; HYMENOPTERA; SIZE; THRESHOLD; SEMIFIELD; BEHAVIOR	The statistical power of studies for the assessment of side effects of toxicants on honeybees conducted according to current guidelines is often limited. A new test design and modified field methods have therefore been developed to decrease uncertainty and variability and to be able to detect small effects. The new test design comprises a monitoring phase (before the tunnel phase) for the selection of honeybee colonies and modified methods, which include assessments of colony strength, an evaluation of the cell content of all cells of hives using photos and digital analysis, and the use of video recordings for the assessment of foraging activity and forager mortality. With the proposed new study design and the modified field methods variability between hives was considerably reduced, which resulted in a marked reduction of the minimum detectable difference (MDD). This makes it possible to address the Specific Protection Goals defined by the European Food Safety Authority and to gain unprecedented insight into the development of hives and driving factors.	[Wang, Magnus; Braasch, Thiemo; Dietrich, Christian] WSC Sci GmbH, Heidelberg, Germany		Wang, M (corresponding author), WSC Sci GmbH, Heidelberg, Germany.	magnus.wang@wsc-regexperts.com			commercial company WSC Scientific GmbH	commercial company WSC Scientific GmbH	This research was funded entirely by the commercial company WSC Scientific GmbH. The funder provided support in the form of salaries for authors [MW, TB, CD] and materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section	Aagaard A, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3290; [Anonymous], 2010, EPPO B, V40, P313, DOI DOI 10.1111/J.1365-2338.2010.02418.X; Becker R, 2018, JULIUS-KUHN-ARCH, V462, P95, DOI 10.5073/jka.2018.462.023; Becker R, 2015, JULIUS-KUHN-ARCH, V450, P83; Beekman M, 2004, FUNCT ECOL, V18, P829, DOI 10.1111/j.0269-8463.2004.00924.x; Berry JA, 2001, J APICULT RES, V40, P3, DOI 10.1080/00218839.2001.11101042; Berry JA, 2010, APIDOLOGIE, V41, P40, DOI 10.1051/apido/2009049; Boesten J, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2668; Brock TCM, 2015, ENVIRON SCI POLLUT R, V22, P1160, DOI 10.1007/s11356-014-3398-2; Candolfi M.P., 2018, J AGR SCI TECHNOLOGY, V8, P142; Colin T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205816; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Cutler GC, 2014, PEERJ, V2, DOI 10.7717/peerj.652; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; DELAPLANE KS, 1987, J APICULT RES, V26, P37, DOI 10.1080/00218839.1987.11100732; Delaplane KS, 1999, APIDOLOGIE, V30, P383, DOI 10.1051/apido:19990504; Delaplane KS, 1997, J APICULT RES, V36, P125, DOI 10.1080/00218839.1997.11100938; European Food Safety Authority, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4607; FREE JB, 1975, ANIM BEHAV, V23, P650, DOI 10.1016/0003-3472(75)90143-8; HARBO JR, 1986, J APICULT RES, V25, P22, DOI 10.1080/00218839.1986.11100687; HARBO JR, 1983, ENVIRON ENTOMOL, V12, P1559, DOI 10.1093/ee/12.5.1559; HARBO JR, 1993, J ECON ENTOMOL, V86, P1672, DOI 10.1093/jee/86.6.1672; HARBO JR, 1988, J ECON ENTOMOL, V81, P1606, DOI 10.1093/jee/81.6.1606; HELLMICH RL, 1986, APIDOLOGIE, V17, P13, DOI 10.1051/apido:19860102; Human H, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.10; IMDORF A, 1987, APIDOLOGIE, V18, P137, DOI 10.1051/apido:19870204; Jeker L, 2012, J APICULT RES, V51, P63, DOI 10.3896/IBRA.1.51.1.08; Knopp JA, 2006, BEE CULTURE      MAR, P19; Medrzycki P, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.14; Nansen C., 2002, Portugaliae Acta Biologica, V20, P249; OECD (Organization for Economic Cooperation and Development), 2007, 75 OECD, P3; Pistorius J, 2012, JULIUS-KUHN-ARCH, V437, P115, DOI 10.5073/jka.2012.437.033; R Core Team, 2013, R LANG ENV STAT COMP; Rolke D, 2016, ECOTOXICOLOGY, V25, P1648, DOI 10.1007/s10646-016-1725-8; Schmickl T, 2001, J COMP PHYSIOL A, V187, P541, DOI 10.1007/s003590100226; Strange JP, 2001, J ECON ENTOMOL, V94, P1324, DOI 10.1603/0022-0493-94.6.1324; Sun WF, 2013, SUPERLATTICE MICROST, V60, P29, DOI 10.1016/j.spmi.2013.04.021; Szczesniak B, 2018, JULIUS-KUHN-ARCH, V462, P111, DOI 10.5073/jka.2018.462.030; WADDINGTON KD, 1994, BEHAV ECOL SOCIOBIOL, V35, P423, DOI 10.1007/BF00165845; Wang M., 2015, SETAC EUR 23 ANN M B; Wang M, 2017, SETAC EUR 27 ANN M B; Winston M., 1987, The biology of the honey bee.; 2013, EFSA J, V11, DOI DOI 10.2903/J.EFSA.2013.3295	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0229295	10.1371/journal.pone.0229295	http://dx.doi.org/10.1371/journal.pone.0229295			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7VI	32059037	Green Published, Green Submitted, gold			2022-12-26	WOS:000535206600036
J	Mekonen, HH; Birhanu, MM; Mossie, TB; Gebreslassie, HT				Mekonen, Haftea Hagos; Birhanu, Mulugeta Molla; Mossie, Tilahun Belete; Gebreslassie, Hagos Tsegabrhan			Factors associated with stroke among adult patients with hypertension in Ayder Comprehensive Specialized Hospital, Tigray, Ethiopia, 2018: A case-control study	PLOS ONE			English	Article							RISK-FACTORS; MEDICATION ADHERENCE; BLOOD-PRESSURE; POPULATION; UPDATE	Background Globally, the burden of stroke is increasing at an alarming rate. Factors associated with stroke among hypertensive patients are not consistent across different studies and there are limited studies particularly to hypertensive stroke in the particular setting. This study aimed to assess factors associated with stroke among patients with hypertension in Ayder Comprehensive Specialized Hospital, Mekelle, Tigray, Ethiopia, in 2018. Methods Hospital-based case-control study was conducted from February to April 2018. Cases were adult hypertensive patients with stroke and controls were adult hypertensive patients without a stroke. Cases and controls were identified from the patient's card review. Using a systematic random sampling technique 89 cases and 356 controls were included in this study. Record review, physical measurement, and interview techniques were used to collect data. Data was entered and analyzed by using SPSS version 23. Variables with a p-value of less than 0.25 in the bivariate logistic regression were selected for multivariable logistic regression. The adjusted odds ratio and 95% confidence interval were used to determine the association. P-value < 0.05 was used to declare statistical significance. Results The mean age of cases and controls were 56.3 years (SD +/- 13.53) and 51.9 years (SD +/- 12.67) respectively. Lost to follow-up (AOR = 2.474, 95%CI: 1.368-4.929), alcohol drinking (AOR = 2.440, 95%CI: 1.291-4.613), use of excessive salt in diet (AOR = 3.249, 95%CI: (1.544-6.837), medication non-adherence (AOR = 3.967, 95%CI: 2.256-6.973), uncontrolled systolic blood pressure, (AOR = 3.196, 95%CI: 1.60-6.382), uncontrolled diastolic blood pressure (AOR = 2.204, 95%CI: 1.130-4.297) and high cholesterol level (AOR = 2.413, 95%CI: 1.319-4.414) were found to be significant factors. Conclusion Lost to follow-up, alcohol drinking, uses of excessive salt in diet, medication non-adherence, and uncontrolled systolic and diastolic blood pressure were associated with stroke. Health education on lifestyle practices and hypertension-related complications in each follow-up visit is very essential for improving the primary stroke prevention.	[Mekonen, Haftea Hagos] Adigrat Univ, Coll Med & Hlth Sci, Dept Nursing, Tigray, Ethiopia; [Birhanu, Mulugeta Molla] St Pauls Hosp, Dept Nursing, Millennium Med Coll, Addis Ababa, Ethiopia; [Mossie, Tilahun Belete] Bahirdar Univ, Coll Hlth Sci, Dept Nursing, Tigray, Ethiopia; [Gebreslassie, Hagos Tsegabrhan] Mekelle Univ, Coll Hlth Sci, Dept Nursing, Tigray, Ethiopia	Bahir Dar University; Mekelle University	Mekonen, HH (corresponding author), Adigrat Univ, Coll Med & Hlth Sci, Dept Nursing, Tigray, Ethiopia.	hafteahagos2@gmail.com	Mossie, Tilahun Belete/H-6775-2017	Mossie, Tilahun Belete/0000-0003-4013-7733; Hagos, Haftea/0000-0002-4947-2768; Birhanu, Mulugeta/0000-0003-0364-279X	Mekelle University (from internal organization)	Mekelle University (from internal organization)	The crossponding author gets fund from Mekelle University (from internal organization) but the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A.G, 2019, NEUROSCIENCE BIOBEHA; Aljeesh Y.I, 2003, STROKE NONCOMPLIANCE; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Brunner LS., 2010, HDB BRUNNER SUDDARTH, V1; Cummings DM, 2013, J AM SOC HYPERTENS, V7, P363, DOI 10.1016/j.jash.2013.05.002; Feigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P161, DOI 10.1159/000441085; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; FMHACA, 2014, STAND TREATM GUID GE; Gebremariam Sennay A, 2016, eNeurologicalSci, V3, P41, DOI 10.1016/j.ensci.2016.02.010; Gidey K., 2017, ETHIOPIAN MED J, V56; Health Fmo, 2015, HLTH SECT TRANSF PLA, P159; Ismail K.H, RISK FACTORS STROKE; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Klungel OH, 2000, STROKE, V31, P420, DOI 10.1161/01.STR.31.2.420; Li CR, 2005, STROKE, V36, P725, DOI 10.1161/01.STR.0000158925.12740.87; Li JW, 2019, J HYPERTENS, V37, P1991, DOI 10.1097/HJH.0000000000002116; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; O'Donnell MJ, 2016, LANCET, V388, P761, DOI 10.1016/S0140-6736(16)30506-2; Owolabi MO, 2013, J NEUROL SCI, V325, P51, DOI 10.1016/j.jns.2012.11.016; Siddiqui M.R, 2013, A KHAN MODERN MED CO, V4, P18; Silberberg D, 2015, NATURE, V527, pS151, DOI 10.1038/nature16028; Walker RW, 2013, LANCET GLOB HEALTH, V1, pE282, DOI 10.1016/S2214-109X(13)70068-8	22	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228650	10.1371/journal.pone.0228650	http://dx.doi.org/10.1371/journal.pone.0228650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053644	Green Published, gold			2022-12-26	WOS:000535198700041
J	Onoya, D; Nattey, C; Jinga, N; Mongwenyana, C; Sherman, G				Onoya, Dorina; Nattey, Cornelius; Jinga, Nelly; Mongwenyana, Constance; Sherman, Gayle			Time of HIV diagnosis, CD4 count and viral load at antenatal care start and delivery in South Africa	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; RISK; TRANSMISSION; PREGNANCY; WOMEN; RNA	Background Despite the success of prevention of mother to child transmission (PMTCT) program in South Africa, the 30% HIV prevalence among women of childbearing age requires the PMTCT program to be maximally efficient to sustain gains in the prevention of vertical HIV transmission. We aimed to determine the immunologic and virologic status at entry into antenatal care (ANC) and at childbirth among HIV positive women who conceived under the CD4<500 cells/mu l antiretroviral therapy (ART) eligibility threshold and universal test and treat (UTT) policies in the Gauteng province of South Africa. Method We conducted a retrospective cohort study of 692 HIV positive adult (>18 years) postpartum women who gave birth between September 2016 and December 2017. Demographic, viral load (VL) and CD4 data at ANC start (3-9 months before delivery) and delivery (3 months before/after) were obtained from medical records of consenting women. We compared CD4 >= 500 cell/mu l and viral load (VL) suppression (<400 copes/ml) rates at ANC start and delivery among women with a pre-pregnancy ART, women known HIV positive but with in-pregnancy ART and newly diagnosed women with in-pregnancy ART. Predictors of having a high CD4 and suppressed VL were assessed by log-binomial regression. Results Of the 692 participants, 394 (57.0%) had CD4 data and 326 (47.1%) had VL data. Overall women with a pre-pregnancy ART were more likely to start ANC with CD4 count >= 500 cell/mu l (46.3% vs 24.8%, adjusted risk ratio (aRR) = 1.9; 95% confidence interval (95% CI): 1.4-2.5), compared to newly diagnosed women. This difference was no longer apparent at the time of delivery (aRR 1.2 95% CI: 0.4-3.7). Similarly, viral suppression at delivery was higher among women with pre-pregnancy ART (87.2% vs 69.3%, aRR 1.3, 95% CI: 1.1-1.6) as compared to the newly diagnosed women. Viral suppression rate among newly diagnosed women increased substantially by the time of delivery from 43.5% to 69.3% (p = 0.001). Conclusion These results show that pre-pregnancy ART improves immunologic and virologic control during pregnancy and call for renewed efforts in HIV testing, linkage to ART and viral monitoring.	[Onoya, Dorina; Nattey, Cornelius; Jinga, Nelly; Mongwenyana, Constance] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa; [Sherman, Gayle] Univ Witwatersrand, Fac Hlth Sci, Dept Paediat & Child Hlth, Johannesburg, South Africa; [Sherman, Gayle] Natl Inst Communicable Dis, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; National Institute for Communicable Diseases (NICD)	Onoya, D (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa.	donoya@heroza.org	Onoya, Dorina/AAW-2839-2020	Onoya, Dorina/0000-0002-2664-7342; Nattey, Cornelius/0000-0002-8272-9529	President's Emergency Plan for AIDS Relief (PEPFAR) through United States Agency for International Development (USAID) [AID-674-A-12-00029, 72067419CA00004]; Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) [2016/353-ONO]; South African National Research Foundation (NRF) [TTK 150708124222]	President's Emergency Plan for AIDS Relief (PEPFAR) through United States Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Collaborative Initiative for Paediatric HIV Education and Research (CIPHER); South African National Research Foundation (NRF)(National Research Foundation - South Africa)	This study has been made possible by the generous support of the American People and the President's Emergency Plan for AIDS Relief (PEPFAR) through United States Agency for International Development (USAID) under the terms of Cooperative Agreements AID-674-A-12-00029 and 72067419CA00004 to the Health Economics and Epidemiology Research Office. Additional support for this study came from the Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) funding award 2016/353-ONO, and the South African National Research Foundation (NRF) funding award TTK 150708124222. The contents are the responsibility of the authors and do not necessarily reflect the views of PEPFAR, USAID, the United States, CIPHER or the NRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Coetzee LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187456; Dickover RE, 1996, JAMA-J AM MED ASSOC, V275, P599, DOI 10.1001/jama.275.8.599; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Haberer JE, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25232; Hackl KL, 1997, HEALTH SOC WORK, V22, P53, DOI 10.1093/hsw/22.1.53; Human Sciences Research Council (HSRC), 2018, 5 S AFR NAT HIV PREV; Igumbor J, 2013, SAHARA J-J SOC ASP H, V10, P25, DOI 10.1080/17290376.2013.807070; Iyun V, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019979; Katz IT, 2015, ANN INTERN MED, V162, P90, DOI 10.7326/M13-2005; Katz IT, 2010, JAIDS-J ACQ IMM DEF, V54, P27, DOI 10.1097/QAI.0b013e3181caea89; Merenstein D, 2009, AIDS PATIENT CARE ST, V23, P289, DOI 10.1089/apc.2008.0161; Mokhele I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214849; Momplaisir FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132262; Moyo F, 2018, SAMJ S AFR MED J, V108, P319, DOI [10.7196/SAMJ.2017.v108i4.12630, 10.7196/samj.2018.v108i4.12630, 10.7196/SAMJ.2018.v108i4.12630]; Nattey C, 2018, AIDS PATIENT CARE ST, V32, P251, DOI 10.1089/apc.2018.0023; NDOH, 2012, NAT ANT SENT HIV HER; NDoH, 2015, NAT CONS GUID PREV M; NDOH, 2012, DEP HLTH ANN REP 201; NDOH, 2018, RP2462016 NDOH; NDoH S, 2013, NAT ANT TREATM GUID; Omonaiye O, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5651-y; Onoya D, 2017, AIDS, V31, P1593, DOI 10.1097/QAD.0000000000001517; Pascoe S, 2018, 22 INT AIDS C JUL 23; Phillips TK, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25114; Rosen S, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002015, 10.1371/journal.pmed.1002106]; Rosenblum M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007196; Scott LE, 2011, J VIROL METHODS, V172, P78, DOI 10.1016/j.jviromet.2010.12.006; Solarin I, 2013, MATERN CHILD HLTH J, V17, P359, DOI 10.1007/s10995-012-1019-6; Townsend CL, 2008, AIDS, V22, P973, DOI 10.1097/QAD.0b013e3282f9b67a; Warszawski J, 2008, AIDS, V22, P289, DOI 10.1097/QAD.0b013e3282f3d63c; Westreich D, 2012, JAIDS-J ACQ IMM DEF, V60, P489, DOI 10.1097/QAI.0b013e318256b310; Woldesenbet S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132425; World Health Organization, 2016, CONS GUID US ANT DRU	34	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0229111	10.1371/journal.pone.0229111	http://dx.doi.org/10.1371/journal.pone.0229111			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KT6GX	32053679	Green Published, gold			2022-12-26	WOS:000519113500001
J	Sultana, S; Baumgartner, JB; Dominiak, BC; Royer, JE; Beaumont, LJ				Sultana, Sabira; Baumgartner, John B.; Dominiak, Bernard C.; Royer, Jane E.; Beaumont, Linda J.			Impacts of climate change on high priority fruit fly species in Australia	PLOS ONE			English	Article							DIPTERA TEPHRITIDAE DACINAE; BACTROCERA-TRYONI FROGGATT; CERATITIS-CAPITATA; DISTRIBUTION MODELS; ECOLOGICAL NICHE; DACUS-TRYONI; QUEENSLAND; RECORDS; ESTABLISHMENT; DISTRIBUTIONS	Tephritid fruit flies are among the most destructive horticultural pests posing risks to Australia's multi-billion-dollar horticulture industry. Currently, there are 11 pest fruit fly species of economic concern in Australia. Of these, nine are native to this continent (Bactrocera aquilonis, B. bryoniae, B. halfordiae, B. jarvisi, B. kraussi, B. musae, B. neohumeralis, B. tryoni and Zeugodacus cucumis), while B. frauenfeldi and Ceratitis capitata are introduced. To varying degrees these species are costly to Australia's horticulture through in-farm management, monitoring to demonstrate pest freedom, quarantine and trade restrictions, and crop losses. Here, we used a common species distribution model, Maxent, to assess climate suitability for these 11 species under baseline (1960-1990) and future climate scenarios for Australia. Projections indicate that the Wet Tropics is likely to be vulnerable to all 11 species until at least 2070, with the east coast of Australia also likely to remain vulnerable to multiple species. While the Cape York Peninsula and Northern Territory are projected to have suitable climate for numerous species, extrapolation to novel climates in these areas decreases confidence in model projections. The climate suitability of major horticulture areas currently in eastern Queensland, southern-central New South Wales and southern Victoria to these pests may increase as climate changes. By highlighting areas at risk of pest range expansion in the future our study may guide Australia's horticulture industry in developing effective monitoring and management strategies.	[Sultana, Sabira; Baumgartner, John B.; Beaumont, Linda J.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Sultana, Sabira] Jahangirnagar Univ, Dept Zool, Dhaka, Bangladesh; [Baumgartner, John B.] Univ Melbourne, Ctr Excellence Risk Anal CEBRA, Sch BioSci, Parkville, Vic, Australia; [Dominiak, Bernard C.] New South Wales Dept Primary Ind, Orange, NSW, Australia; [Royer, Jane E.] Queensland Dept Agr & Fisheries, Biosecur Queensland, Brisbane, Qld, Australia	Macquarie University; Jahangirnagar University; University of Melbourne; NSW Department of Primary Industries; Queensland Department of Agriculture & Fisheries	Sultana, S (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.; Sultana, S (corresponding author), Jahangirnagar Univ, Dept Zool, Dhaka, Bangladesh.	sabira.sultana@hdr.mq.edu.au	Sultana, Sabira/AAT-1431-2020	Beaumont, Linda/0000-0001-6307-1680	Hort Frontiers Fruit Fly Fund, part of the Hort Frontiers strategic partnership initiative [HG14033]; Australian Government	Hort Frontiers Fruit Fly Fund, part of the Hort Frontiers strategic partnership initiative; Australian Government(Australian GovernmentCGIAR)	Project Raising Q-fly Sterile Insect Technique to World Standard (HG14033) is funded by the Hort Frontiers Fruit Fly Fund, part of the Hort Frontiers strategic partnership initiative developed by Hort Innovation, with co-investment from Macquarie University and contributions from the Australian Government."	Abdalla A., 2012, BENEFIT COST ANAL NA; Aguilar G., 2015, UNITEC EPRESS PERSPE, V2, P1; ALLWOOD A J, 1979, Queensland Journal of Agricultural and Animal Sciences, V36, P105; [Anonymous], 2016, AUSTR HORT STAT HDN; [Anonymous], 2010, MAPPING SPECIES DIST; [Anonymous], 1963, QUEENSLAND J AGR SCI, V20, P1; Australian Pesticides and Veterinary Medicines Authority, 2012, FENTH RES DIET RISK; Australian Pesticides and Veterinary Medicines Authority, 2011, DIM RES DIET RISK AS; BATEMAN MA, 1972, ANNU REV ENTOMOL, V17, P493, DOI 10.1146/annurev.en.17.010172.002425; Beaumont LJ, 2016, ECOL MODEL, V342, P135, DOI 10.1016/j.ecolmodel.2016.10.004; Bush A, 2016, ECOL LETT, V19, P1468, DOI 10.1111/ele.12696; Cameron EC, 2006, THESIS; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Clarke AR, 2011, ANN APPL BIOL, V158, P26, DOI 10.1111/j.1744-7348.2010.00448.x; De Meyer M, 2008, J BIOGEOGR, V35, P270, DOI 10.1111/j.1365-2699.2007.01769.x; De Meyer M, 2010, B ENTOMOL RES, V100, P35, DOI 10.1017/S0007485309006713; De Meyer M., 2002, P 6 INT FRUIT FLY S; Dominiak BC, 2018, CROP PROT, V106, P79, DOI 10.1016/j.cropro.2017.11.015; Dominiak BC, 2017, J ECON ENTOMOL, V110, P2459, DOI 10.1093/jee/tox237; Dominiak Bernard C., 2017, General and Applied Entomology, V45, P1; Dominiak BC, 2013, CROP PROT, V51, P57, DOI 10.1016/j.cropro.2013.04.006; Dominiak BC, 2012, AUST J ENTOMOL, V51, P104, DOI 10.1111/j.1440-6055.2011.00842.x; Dominiak BC, 2011, CROP PROT, V30, P958, DOI 10.1016/j.cropro.2011.02.028; DREW R A I, 1989, Memoirs of the Queensland Museum, V26, P1; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2013, PREDICTING DISTRIBUT; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; FITT GP, 1980, J AUST ENTOMOL SOC, V19, P240; GIBBS G. W., 1967, AUST J ZOOL, V15, P1123, DOI 10.1071/ZO9671123; Gillespie P., 2003, General and Applied Entomology, V32, P41; Greenberg JA, 2015, GDALUTILS WRAPPERS G; Guillen D., 2007, P653, DOI 10.1007/978-1-4020-6059-5_60; Hancock D.L., 2000, DISTRIBUTION HOST PL; Hijmans R.J., 2013, DISMO SPECIES DISTRI, V0, P8; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill MP, 2016, BIOL INVASIONS, V18, P1105, DOI 10.1007/s10530-016-1078-5; Holz G., 2010, CLIMATE FUTURES TASM; Horticultural Policy Council, 1991, IMP FRUIT FIL AUSTR; Ihlow F, 2012, GLOBAL CHANGE BIOL, V18, P1520, DOI 10.1111/j.1365-2486.2011.02623.x; Jessup A. J., 1998, General and Applied Entomology, V28, P73; Kriticos DJ, 2007, RISKS ESTABLISHMENT; Kumar S, 2016, J ECON ENTOMOL, V109, P2043, DOI 10.1093/jee/tow166; Kumar S, 2015, J ECON ENTOMOL, V108, P1708, DOI 10.1093/jee/tov166; Kumar S, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00050.1; Kumar S, 2014, J ECON ENTOMOL, V107, P1032, DOI 10.1603/EC14052; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Moise A., 2015, CCIA 2015 CLIMATE CH; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Muthuthantri S, 2010, AUST J ENTOMOL, V49, P221, DOI 10.1111/j.1440-6055.2010.00759.x; Newbold T, 2010, OIKOS, V119, P1326, DOI 10.1111/j.1600-0706.2009.18295.x; OLOUGHLIN GT, 1984, AUST J ZOOL, V32, P353, DOI 10.1071/ZO9840353; Pebesma E.J., 2005, R NEWS, V5; Permkam Surakrai, 1994, Invertebrate Taxonomy, V8, P1325, DOI 10.1071/IT9941325; Peters GP, 2013, NAT CLIM CHANGE, V3, P4, DOI 10.1038/nclimate1783; PHA, 2009, EC ASS IMPL PROP N 1; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P272, DOI 10.1111/j.0906-7590.2008.5378.x; Plant Health Australia, 2008, DRAFT NAT FRUIT FLY, P2600; Plant Health Australia, 2018, AUSTR HDB ID FRUIT F; Plant Health Australia, 2016, PREV FRUIT FLY FRUIT; R Core Team, 2020, R LANG ENV STAT COMP; Royer JE, 2016, AUSTRAL ENTOMOL, V55, P100, DOI 10.1111/aen.12155; Royer JE, 2012, AUST J ENTOMOL, V51, P239, DOI 10.1111/j.1440-6055.2012.00864.x; Salamin N, 2010, TRENDS ECOL EVOL, V25, P692, DOI 10.1016/j.tree.2010.09.009; SMITH E S C, 1988, Queensland Journal of Agricultural and Animal Sciences, V45, P19; Stephens AEA, 2016, AUSTRAL ENTOMOL, V55, P177, DOI 10.1111/aen.12162; Sultana S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13307-1; Sutherst RW, 2000, AUST J AGR RES, V51, P467, DOI 10.1071/AR98203; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Szyniszewska AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111582; Team RC, 2014, R LANG ENV STAT COMP; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Vera MT, 2002, ENVIRON ENTOMOL, V31, P1009, DOI 10.1603/0046-225X-31.6.1009; Wang Y, 2003, B ENTOMOL RES, V93, P351, DOI 10.1079/BER2003249; White IM, 1992, FRUIT FLIES EC SIGNI, DOI DOI 10.1017/S0007485300041237; Wilson KA, 2005, BIOL CONSERV, V122, P99, DOI 10.1016/j.biocon.2004.07.004; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	81	15	17	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0213820	10.1371/journal.pone.0213820	http://dx.doi.org/10.1371/journal.pone.0213820			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053591	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000535198700002
J	Hannah, L; Roehrdanz, PR; Bahadur, KCK; Fraser, EDG; Donatti, CI; Saenz, L; Wright, TM; Hijmans, RJ; Mulligan, M; Berg, A; van Soesbergen, A				Hannah, Lee; Roehrdanz, Patrick R.; Bahadur, Krishna K. C.; Fraser, Evan D. G.; Donatti, Camila, I; Saenz, Leonardo; Wright, Timothy Max; Hijmans, Robert J.; Mulligan, Mark; Berg, Aaron; van Soesbergen, Arnout			The environmental consequences of climate-driven agricultural frontiers	PLOS ONE			English	Article							LAND-USE CHANGE; TEMPERATURE STRESS; SOIL-TEMPERATURE; CARBON-DIOXIDE; FOOD; GROWTH; IMPACTS; SENSITIVITY; EXPANSION; STOCKS	Growing conditions for crops such as coffee and wine grapes are shifting to track climate change. Research on these crop responses has focused principally on impacts to food production impacts, but evidence is emerging that they may have serious environmental consequences as well. Recent research has documented potential environmental impacts of shifting cropping patterns, including impacts on water, wildlife, pollinator interaction, carbon storage and nature conservation, on national to global scales. Multiple crops will be moving in response to shifting climatic suitability, and the cumulative environmental effects of these multi-crop shifts at global scales is not known. Here we model for the first time multiple major global commodity crop suitability changes due to climate change, to estimate the impacts of new crop suitability on water, biodiversity and carbon storage. Areas that become newly suitable for one or more crops are Climate-driven Agricultural Frontiers. These frontiers cover an area equivalent to over 30% of the current agricultural land on the planet and have major potential impacts on biodiversity in tropical mountains, on water resources downstream and on carbon storage in high latitude lands. Frontier soils contain up to 177 Gt of C, which might be subject to release, which is the equivalent of over a century of current United States CO2 emissions. Watersheds serving over 1.8 billion people would be impacted by the cultivation of the climate-driven frontiers. Frontiers intersect 19 global biodiversity hotspots and the habitat of 20% of all global restricted range birds. Sound planning and management of climate-driven agricultural frontiers can therefore help reduce globally significant impacts on people, ecosystems and the climate system.	[Hannah, Lee; Roehrdanz, Patrick R.; Donatti, Camila, I] Conservat Int, Betty & Gordon Moore Ctr Sci, Arlington, VA USA; [Bahadur, Krishna K. C.; Fraser, Evan D. G.; Berg, Aaron] Univ Guelph, Dept Geog Environm & Geomat, Guelph, ON, Canada; [Fraser, Evan D. G.] Univ Guelph, Arrell Food Inst, Guelph, ON, Canada; [Saenz, Leonardo; Wright, Timothy Max] Michigan Technol Univ, Houghton, MI 49931 USA; [Hijmans, Robert J.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Mulligan, Mark; van Soesbergen, Arnout] Kings Coll London, Dept Geog, London, England; [van Soesbergen, Arnout] UN Environm World Conservat Monitoring Ctr, Cambridge, England	Conservation International; University of Guelph; University of Guelph; Michigan Technological University; University of California System; University of California Davis; University of London; King's College London	Bahadur, KCK (corresponding author), Univ Guelph, Dept Geog Environm & Geomat, Guelph, ON, Canada.	krishnak@uoguelph.ca	Berg, Aaron/AAU-3547-2021	Berg, Aaron/0000-0001-8438-5662; KC, Krishna Bahadur/0000-0003-3966-2928; Fraser, Evan/0000-0001-5124-488X	Betty and Gordon Moore Center for Science at Conservation International; Canada First Research Excellence Fund	Betty and Gordon Moore Center for Science at Conservation International; Canada First Research Excellence Fund	The authors would like to thank the Betty and Gordon Moore Center for Science at Conservation International for supporting portions of the research. This paper is also a contribution by the Food from Thought research program of the University of Guelph supported by the Canada First Research Excellence Fund.	[Anonymous], 2015, BBC NEWS; [Anonymous], 2011, DEAC0500OR22725 DOE; [Anonymous], 2015, RUSSIA TODAY; [Anonymous], 2016, 21 CENT REAN VERS 2; [Anonymous], 2016, END BIRD SPEC DAT; Austin KG, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa6a88; Bahadur KCK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205683; Bakker M, 1999, SUGARCANE CULTIVATIO; Boden T.A., 2016, GLOBAL CO2 EMISSIONS; Channan S, 2014, GLOBAL MOSAICS STAND; Crowther TW, 2016, NATURE, V540, P104, DOI 10.1038/nature20150; Curtis PG, 2018, SCIENCE, V361, P1108, DOI 10.1126/science.aau3445; DAVIDSON EA, 1993, BIOGEOCHEMISTRY, V20, P161, DOI 10.1007/BF00000786; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; DUPUIS I, 1990, PLANT PHYSIOL, V94, P665, DOI 10.1104/pp.94.2.665; DWELLE RB, 1981, POTATO RES, V24, P49, DOI 10.1007/BF02362016; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Fraser E, 2016, TRENDS FOOD SCI TECH, V48, P78, DOI 10.1016/j.tifs.2015.11.006; Fraser EDG, 2013, GLOBAL ENVIRON CHANG, V23, P1662, DOI 10.1016/j.gloenvcha.2013.09.001; Friedl M. A., 2010, MODIS COLLECTION 5 G; Fritz S, 2015, GLOBAL CHANGE BIOL, V21, P1980, DOI 10.1111/gcb.12838; Gibbs HK, 2015, SCIENCE, V347, P377, DOI 10.1126/science.aaa0181; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Goldfarb L, 2016, J PEASANT STUD, V43, P562, DOI 10.1080/03066150.2015.1041107; Gourdji SM, 2011, ENVIRON RES LETT, V8, P24; Government of Northwest Territories, 2017, BUS FOOD FOOD PROD P; Griggs D, 2013, NATURE, V495, P305, DOI 10.1038/495305a; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Hannah L, 2013, P NATL ACAD SCI USA, V110, P6907, DOI 10.1073/pnas.1210127110; Hengl T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169748; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2001, PLANT GENETIC RESOUR, P15, DOI DOI 10.1007/s10344-011-0563-5; Hijmans RJ, 2005, DIVA GIS VERSION 5 2; Humpenoder F, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aa9e3b; Gasparri NI, 2016, CONSERV LETT, V9, P21, DOI 10.1111/conl.12173; IIASA and FAO, 2012, GLOB AGR ZON GAEZ V3, P196; IPCC, 2003, GOOD PRACTICE GUIDAN; IUCN, 2012, CONS STAND ID SIT CO; Kakani VG, 2005, ANN BOT-LONDON, V96, P59, DOI 10.1093/aob/mci149; KEATING BA, 1979, FIELD CROP RES, V2, P241, DOI 10.1016/0378-4290(79)90026-1; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Kriegler E, 2017, GLOBAL ENVIRON CHANG, V42, P297, DOI 10.1016/j.gloenvcha.2016.05.015; Langhammer P.F., 2007, IDENTIFICATION GAP A; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; Mittermeier Russell A., 2004, P1; Molotoks A, 2017, LAND-BASEL, V6, DOI 10.3390/land6040067; Muller M. D., 2009, Pesquisa Florestal Brasileira, P11; Mulligan M., 2009, GLOBAL DAMS DATABASE; Mulligan M, 2013, HYDROL RES, V44, P748, DOI 10.2166/nh.2012.217; Ong C. K., 1986, Agrometeorology of groundnut. Proceedings of an international symposium, ICRISAT Sahelian Center, 21-26 August 1985., P115; ONG CK, 1985, FIELD CROP RES, V11, P141, DOI 10.1016/0378-4290(85)90098-X; Pallas B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00437; Parry ML, 2004, GLOBAL ENVIRON CHANG, V14, P53, DOI 10.1016/j.gloenvcha.2003.10.008; Pearce Fred, 2007, RIVERS RUN DRY WATER; Phelps J, 2013, P NATL ACAD SCI USA, V110, P7601, DOI 10.1073/pnas.1220070110; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Popp A, 2017, GLOBAL ENVIRON CHANG, V42, P331, DOI 10.1016/j.gloenvcha.2016.10.002; Porter JR, 1999, EUR J AGRON, V10, P23, DOI 10.1016/S1161-0301(98)00047-1; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Prasad PVV, 2008, CROP SCI, V48, P1911, DOI 10.2135/cropsci2008.01.0036; Prasad PVV, 2000, PLANT SOIL, V222, P231, DOI 10.1023/A:1004793220787; Prasad PVV, 2000, J EXP BOT, V51, P777, DOI 10.1093/jexbot/51.345.777; Prestele R, 2016, GLOBAL CHANGE BIOL, V22, P3967, DOI 10.1111/gcb.13337; Ramankutty N, 2002, GLOBAL ECOL BIOGEOGR, V11, P377, DOI 10.1046/j.1466-822x.2002.00294.x; REDDY KR, 1995, AGRON J, V87, P820, DOI 10.2134/agronj1995.00021962008700050007x; REDDY KR, 1992, AGRON J, V84, P26, DOI 10.2134/agronj1992.00021962008400010006x; Reicosky DC, 1997, SOIL TILL RES, V41, P105, DOI 10.1016/S0167-1987(96)01080-X; Rogelj J, 2016, NATURE, V534, P631, DOI 10.1038/nature18307; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Sacks WJ, 2010, GLOBAL ECOL BIOGEOGR, V19, P607, DOI 10.1111/j.1466-8238.2010.00551.x; Scharlemann JPW, 2014, CARBON MANAG, V5, P81, DOI 10.4155/CMT.13.77; Schlesinger WH, 1999, SCIENCE, V284, P2095, DOI 10.1126/science.284.5423.2095; Semenov MA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00066; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Steffen W, 2018, P NATL ACAD SCI USA, V115, P8252, DOI 10.1073/pnas.1810141115; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Teixeira EI, 2013, AGR FOREST METEOROL, V170, P206, DOI 10.1016/j.agrformet.2011.09.002; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; Turner WR, 2010, CONSERV LETT, V3, P304, DOI 10.1111/j.1755-263X.2010.00128.x; United Nations Department of Economic and Social Affairs Population Divi- sion, 2017, STESASERA399 UN DEP; United Nations General Assembly, 2015, SUST DEV GOALS SDGS; Watson JEM, 2014, CONSERV LETT, V7, P1, DOI 10.1111/conl.12083; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Zabel F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107522	90	42	42	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228305	10.1371/journal.pone.0228305	http://dx.doi.org/10.1371/journal.pone.0228305			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7PV	32049959	gold, Green Published			2022-12-26	WOS:000535192300012
J	Khizar, M; Shi, J; Saleem, S; Liaquat, F; Ashraf, M; Latif, S; Haroon, U; Hassan, SW; Rehman, SU; Chaudhary, HJ; Quraishi, UM; Munis, MFH				Khizar, Maria; Shi, Jianxin; Saleem, Sadia; Liaquat, Fiza; Ashraf, Muhammad; Latif, Sadia; Haroon, Urooj; Hassan, Syed Waqas; Rehman, Shafiq ur; Chaudhary, Hassan Javed; Quraishi, Umar Masood; Munis, Muhammad Farooq Hussain			Resistance associated metabolite profiling of Aspergillus leaf spot in cotton through non-targeted metabolomics	PLOS ONE			English	Article							GOSSYPIUM-HIRSUTUM L.; PLANT-RESPONSE; ANTIOXIDANT; BIOSYNTHESIS; GLUTATHIONE; DERIVATIVES; MOLECULES; GROWTH; ACID	Aspergillus tubingensis is an important pathogen of economically important crops. Different biotic stresses strongly influence the balance of metabolites in plants. The aim of this study was to understand the function and response of resistance associated metabolites which, in turn are involved in many secondary metabolomics pathways to influence defense mechanism of cotton plant. Analysis of non-targeted metabolomics using ultra high performance liquid chromatography-mass spectrometry (UPLC-MS) revealed abundant accumulation of key metabolites including flavonoids, phenylpropanoids, terpenoids, fatty acids and carbohydrates, in response to leaf spot of cotton. The principal component analysis (PCA), orthogonal partial least squares discriminant analysis (OPLS-DA) and partial least squares discriminant analysis (PLS-DA) score plots illustrated the evidences of variation between two varieties of cotton under mock and pathogen inoculated treatments. Primary metabolism was affected by the up regulation of pyruvate and malate and by the accumulation of carbohydrates like cellobiose and inulobiose. Among 241 resistance related (RR) metabolites, 18 were identified as resistance related constitutive (RRC) and 223 as resistance related induced (RRI) metabolites. Several RRI metabolites, identified in the present study were the precursors for many secondary metabolic pathways. These included phenylpropanoids (stilbenes and furanocoumarin), flavonoids (phlorizin and kaempferol), alkaloids (indolizine and acetylcorynoline) and terpenoids (azelaic acid and oleanolic acid). Our results demonstrated that secondary metabolism, primary metabolism and energy metabolism were more active in resistant cultivar, as compared to sensitive cultivar. Differential protein and fatty acid metabolism was also depicted in both cultivars. Accumulation of these defense related metabolites in resistant cotton cultivar and their suppression in susceptible cotton cultivar revealed the reason of their respective tolerance and susceptibility against A. tubingensis.	[Khizar, Maria; Saleem, Sadia; Latif, Sadia; Haroon, Urooj; Chaudhary, Hassan Javed; Quraishi, Umar Masood; Munis, Muhammad Farooq Hussain] Quaid I Azam Univ, Fac Biol Sci, Dept Plant Sci, Islamabad, Pakistan; [Shi, Jianxin; Ashraf, Muhammad] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai, Peoples R China; [Liaquat, Fiza] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai, Peoples R China; [Hassan, Syed Waqas] Univ Wah, Dept Biosci, Quaid Ave, Wah Cantt, Pakistan; [Rehman, Shafiq ur] Univ Punjab, Coll Earth & Environm Sci, Lahore, Pakistan	Quaid I Azam University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Punjab	Munis, MFH (corresponding author), Quaid I Azam Univ, Fac Biol Sci, Dept Plant Sci, Islamabad, Pakistan.	munis@qau.edu.pk	Rather, R A/J-3509-2019; Ashraf, Muhammad/F-6294-2010	Hassan, Syed Waqas/0000-0003-1294-7173; Ashraf, Muhammad/0000-0002-8226-7758	Higher education commission, Pakistan [IRSIP-39-BMS-41]	Higher education commission, Pakistan(Higher Education Commission of Pakistan)	This work was supported by: Maria Khizar, IRSIP-39-BMS-41, Higher education commission, Pakistan, https://hec.gov.pk/english/scholarshipsgrants/IRSIP/Pages/default.aspx.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to Higher Education Commission (HEC), Pakistan for providing financial support under international research support initiative program (IRSIP-39-BMS-41). We are also grateful to Dr. Muhammad Ahmed for providing cotton seeds.	Abu-Nada Y., 2010, AM J PLANT SCI BIOTE, V4, P55; Ahmad N, 2011, NUCLEUS ISLAMABAD, V48, P249; Alcazar R, 2006, BIOTECHNOL LETT, V28, P1867, DOI 10.1007/s10529-006-9179-3; Asif MU, 2018, J INNOVATIVE SCI, V4, P83; Bach A, 2015, J BIOTECHNOLOGY COMP, V96, P39; Bollina V, 2010, MOL PLANT PATHOL, V11, P769, DOI 10.1111/j.1364-3703.2010.00643.x; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Boutigny AL, 2009, MYCOL RES, V113, P746, DOI 10.1016/j.mycres.2009.02.010; Canales J, 2011, FRONT PLANT SCI, V3, P15; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Cho K, 2012, J AGR FOOD CHEM, V60, P11015, DOI 10.1021/jf303702j; Desideri E, 2015, CANCER LETT, V356, P217, DOI 10.1016/j.canlet.2014.02.023; Dhokane D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155851; Ehetisham-ul-Haq M, 2018, INT J BIOSCIENCES; Fiehn O, 2003, EUR J BIOCHEM, V270, P579, DOI 10.1046/j.1432-1033.2003.03427.x; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Frendo P, 2013, FREE RADICAL BIO MED, V65, P724, DOI 10.1016/j.freeradbiomed.2013.07.035; FRYXELL PA, 1992, SYST BOT, V17, P91, DOI 10.2307/2419068; Gunnaiah R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040695; Guo JW, 2017, PLANT DIS, V101, P505, DOI 10.1094/PDIS-08-16-1183-PDN; HOLOWCZAK J, 1962, PHYTOPATHOLOGY, V52, P1019; Huma Ali, 2012, Asian Pacific Journal of Tropical Disease, pS396; Iqbal MJ, 2001, THEOR APPL GENET, V103, P547, DOI 10.1007/PL00002908; KRAMER RP, 1984, PHYTOCHEMISTRY, V23, P2203, DOI 10.1016/S0031-9422(00)80520-8; Kushagra Nagori, 2011, Journal of Pharmacy Research, V4, P2991; Kushalappa AC, 2013, TRENDS PLANT SCI, V18, P522, DOI 10.1016/j.tplants.2013.05.002; LAM KY, 2016, ADV PHARM SCI, V2016, P1; Lea PJ, 2007, ANN APPL BIOL, V150, P1, DOI 10.1111/j.1744-7348.2006.00104.x; Levi A, 2011, PHYSIOL PLANTARUM, V141, P265, DOI 10.1111/j.1399-3054.2010.01438.x; Liaquat F, 2019, PLANT DIS, V103, P766, DOI 10.1094/PDIS-07-18-1226-PDN; Lim TK, 2012, FRUITS, V4; Lim YS, 2019, PLANT DIS; Lutfunnessa Raozatul Jannat Ferdous, 2011, Dhaka University Journal of Biological Sciences, V20, P139; Ma WG, 1999, FITOTERAPIA, V70, P258, DOI 10.1016/S0367-326X(99)00045-3; MANSFIELD JW, 1980, PHYTOCHEMISTRY, V19, P1057, DOI 10.1016/0031-9422(80)83056-1; May O.L., 1999, COTTON ORIGIN HIST T, P65; Mazid M., 2011, Biology and Medicine, V3, P232; McCormick JP, 1982, ACS S SERIES AM CHEM; Mierziak J, 2014, MOLECULES, V19, P16240, DOI 10.3390/molecules191016240; Molina-Calle M, 2017, J FOOD COMPOS ANAL, V62, P155, DOI 10.1016/j.jfca.2017.05.004; Muhammad Tayyib, 2005, Pakistan Entomologist, V27, P63; Munafo JP, 2011, J AGR FOOD CHEM, V59, P995, DOI 10.1021/jf1036454; Nix A, 2017, PLANTS-BASEL, V6, DOI 10.3390/plants6040043; Ogawa K, 2005, ANTIOXID REDOX SIGN, V7, P973, DOI 10.1089/ars.2005.7.973; Okazaki Y, 2014, PLANT J, V79, P584, DOI 10.1111/tpj.12556; Olejnikova P, 2015, CHEM PAP, V69, P983, DOI 10.1515/chempap-2015-0093; Padmavati M, 1997, PHYTOCHEMISTRY, V46, P499, DOI 10.1016/S0031-9422(97)00325-7; Pedras MSC, 2003, CURR ORG CHEM, V7, P1635, DOI 10.2174/1385272033486242; Perrone G, 2006, APPL ENVIRON MICROB, V72, P680, DOI 10.1128/AEM.72.1.680-685.2006; Peshev D, 2013, J EXP BOT, V64, P1025, DOI 10.1093/jxb/ers377; Pollastri S, 2011, ANN BOT-LONDON, V108, P1225, DOI 10.1093/aob/mcr234; Rennenberg H, 2010, PLANT BIOLOGY, V12, P275, DOI 10.1111/j.1438-8677.2009.00309.x; Rojas CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00017; Rudrappa T, 2008, PLANT PHYSIOL, V148, P1547, DOI 10.1104/pp.108.127613; Sakihama Y, 2002, TOXICOLOGY, V177, P67, DOI 10.1016/S0300-483X(02)00196-8; Salunkhe VN, 2019, PLANT DIS; Samson RA, 2007, STUD MYCOL, P129, DOI 10.3114/sim.2007.59.13; Shirsath LP, 2018, PHYSIOL MOL BIOL PLA, V24, P711, DOI 10.1007/s12298-018-0557-9; Tovar-Mendez A, 2003, EUR J BIOCHEM, V270, P1043, DOI 10.1046/j.1432-1033.2003.03469.x; Walley JW, 2013, CURR OPIN PLANT BIOL, V16, P520, DOI 10.1016/j.pbi.2013.06.011; Zhu YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080218	62	10	10	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228675	10.1371/journal.pone.0228675	http://dx.doi.org/10.1371/journal.pone.0228675			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32049975	Green Published, gold			2022-12-26	WOS:000535192300020
J	Liu, FD; Mo, X; Zhang, S; Chen, FJ; Li, DS				Liu, Fude; Mo, Xue; Zhang, Sen; Chen, Feijie; Li, Desheng			Gas exchange characteristics and their influencing factors for halophytic plant communities on west coast of Bohai Sea	PLOS ONE			English	Article							LEAF TRAIT RELATIONSHIPS; NUTRIENT-USE EFFICIENCY; WATER-USE EFFICIENCY; PHOSPHORUS LIMITATION; SCALING RELATIONSHIPS; SOIL FERTILITY; CHANGING WORLD; CARBON GAIN; NITROGEN; PHOTOSYNTHESIS	Water-salt stress and nutrient limitation may affect leaf economic spectrum of halophytes and confuse our understanding on plant physiological principles in a changing world. In this study, three halophytic plant communities of Phragmites australis, Suaeda salsa, and Tamarix chinensis, were selected in two sites (sites 1 and 2) on the west coast of Bohai Sea. The net photosynthetic rate (P-n), transpiration rate (T-r), stomatal conductance (G(s)), leaf vapor pressure deficit (VPDleaf) and their influencing factors were studied to test the possible carbon assimilation strategies of the halophytes. P. australis had higher P-n, T-r, and G(s) than S. salsa and T. chinensis in both sites. Similar trends were found for leaf P and photosynthetic N and P efficiency (PNUE and PPUE, respectively) in one or both sites. By contrast, the leaf dry mass per area (LMA) increased in the order of P. australis < S. salsa < T. chinensis in both sites. For identical species in different sites, P-n, leaf P, and PNUE were lower but T-r, VPDleaf, leaf N, leaf N:P, and PPUE were higher in site 1 than in site 2 for one or more halophytes. Although soil physicochemical properties in different sites explained several variations among the halophytes, two-way ANOVA indicated that the species can explain most of the leaf traits compared with the site. LMA also had significant nonlinear relationships with P-n, T-r, G(s), and VPDleaf. PNUE and PPUE showed positive correlation with P-n in both sites, but they decreased in the power-law function with increasing LMA. Overall, the redundancy analysis showed that the gas exchange capacity of the halophytic plant communities was significantly affected by PPUE (60.0% of explanation), PNUE (57.1%), LMA (35.0%), leaf P (22.0%), and soil N (15.8%).	[Liu, Fude; Mo, Xue; Zhang, Sen; Chen, Feijie; Li, Desheng] Tianjin Univ Technol, Sch Environm Sci & Safety Engn, Tianjin, Peoples R China	Tianjin University of Technology	Liu, FD (corresponding author), Tianjin Univ Technol, Sch Environm Sci & Safety Engn, Tianjin, Peoples R China.	fudeliu2005@163.com			National Natural Science Foundation of China [41303057]; Tianjin Research Program of Application Foundation and Advanced Technology [14JCYBJC23000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of Application Foundation and Advanced Technology	This work is financially supported by National Natural Science Foundation of China (41303057), and Tianjin Research Program of Application Foundation and Advanced Technology (14JCYBJC23000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2003, OIKOS, V101, P489, DOI 10.1034/j.1600-0706.2003.12223.x; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Bahar NHA, 2018, FUNCT PLANT BIOL, V45, P813, DOI 10.1071/FP17134; Centritto M, 2005, AGR ECOSYST ENVIRON, V106, P115, DOI 10.1016/j.agee.2004.10.001; Cordell S, 2001, OECOLOGIA, V127, P198, DOI 10.1007/s004420000588; Crous KY, 2017, NEW PHYTOL, V215, P992, DOI 10.1111/nph.14591; DaMatta FM, 2002, J PLANT PHYSIOL, V159, P975, DOI 10.1078/0176-1617-00807; Dos Santos CM, 2017, AN ACAD BRAS CIENC, V89, P3015, DOI 10.1590/0001-3765201720160729; Egli P, 1999, ACTA OECOL, V20, P559, DOI 10.1016/S1146-609X(00)86623-0; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Evans J, 2015, PLANT J, V84, P800, DOI 10.1111/tpj.13041; Falster DS, SMATR STANDARDIZED M; Field C., 1986, EC PLANT FORM FUNCTI, pc1986; Fynn RWS, 2005, J ECOL, V93, P384, DOI 10.1111/j.0022-0477.2005.00993.x; Geng Y, 2017, ECOLOGY, V98, P1471, DOI 10.1002/ecy.1780; He JS, 2006, NEW PHYTOL, V170, P835, DOI 10.1111/j.1469-8137.2006.01704.x; Hikosaka K, 2009, J PLANT RES, V122, P245, DOI 10.1007/s10265-009-0222-z; KIKUZAWA K, 1995, CAN J BOT, V73, P158, DOI 10.1139/b95-019; KIRSCHBAUM MUF, 1990, AUST J PLANT PHYSIOL, V17, P527, DOI 10.1071/PP9900527; Leishman MR, 2007, NEW PHYTOL, V176, P635, DOI 10.1111/j.1469-8137.2007.02189.x; Li JY, 2016, ENVIRON EXP BOT, V130, P206, DOI 10.1016/j.envexpbot.2016.06.006; Liu FD, 2010, EUR J FOREST RES, V129, P1093, DOI 10.1007/s10342-010-0394-z; Liu FD, 2010, ACTA OECOL, V36, P149, DOI 10.1016/j.actao.2009.11.004; Mahowald N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2008GB003240; [牟晓杰 MOU Xiao-Jie], 2010, [湿地科学, Wetland Science], V8, P57; Niinemets U, 2003, ACTA OECOL, V24, P209, DOI 10.1016/S1146-609X(03)00094-8; Osnas JLD, 2018, P NATL ACAD SCI USA, V115, P5480, DOI 10.1073/pnas.1803989115; Penuelas J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3934; Penuelas J, 2012, GLOBAL CHANGE BIOL, V18, P3, DOI 10.1111/j.1365-2486.2011.02568.x; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; REICH PB, 1988, OECOLOGIA, V77, P25, DOI 10.1007/BF00380920; Romanello GA, 2008, AQUAT BOT, V89, P390, DOI 10.1016/j.aquabot.2008.04.007; Sardans J, 2012, PERSPECT PLANT ECOL, V14, P33, DOI 10.1016/j.ppees.2011.08.002; Shangguan ZP, 2000, ENVIRON EXP BOT, V44, P141, DOI 10.1016/S0098-8472(00)00064-2; Sheffield J, 2012, NATURE, V491, P435, DOI 10.1038/nature11575; Solomon S., 2007, ANTARCT RES SER, V9, P123; Tsuji Y, 2015, MAR BIOTECHNOL, V17, P428, DOI 10.1007/s10126-015-9632-1; Verhoeven JTA, 2014, J ENVIRON MANAGE, V139, P217, DOI 10.1016/j.jenvman.2014.02.035; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Voesenek LACJ, 2006, NEW PHYTOL, V170, P213, DOI 10.1111/j.1469-8137.2006.01692.x; Warton DI, 2002, BIOMETRICAL J, V44, P161, DOI 10.1002/1521-4036(200203)44:2<161::AID-BIMJ161>3.0.CO;2-N; Whitehead D, 2005, OECOLOGIA, V144, P233, DOI 10.1007/s00442-005-0068-6; Wright IJ, 2005, NEW PHYTOL, V166, P485, DOI 10.1111/j.1469-8137.2005.01349.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x; Xie ZL, 2012, OCEAN COAST MANAGE, V56, P56, DOI 10.1016/j.ocecoaman.2011.06.010; Xu ZZ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00701; Yu Q, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032162, 10.1371/journal.pone.0050902]; Yuan ZY, 2015, NAT CLIM CHANGE, V5, P465, DOI [10.1038/nclimate2549, 10.1038/NCLIMATE2549]; Zhong C, 2019, PLANT PHYSIOL BIOCH, V135, P41, DOI 10.1016/j.plaphy.2018.11.021	51	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0229047	10.1371/journal.pone.0229047	http://dx.doi.org/10.1371/journal.pone.0229047			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32049992	Green Published, gold			2022-12-26	WOS:000535192300044
J	Rahmel, T; Schmitz, S; Nowak, H; Schepanek, K; Bergmann, L; Halberstadt, P; Horter, S; Peters, J; Adamzik, M				Rahmel, Tim; Schmitz, Stefanie; Nowak, Hartmuth; Schepanek, Kaspar; Bergmann, Lars; Halberstadt, Peter; Hoerter, Stefan; Peters, Juergen; Adamzik, Michael			Long-term mortality and outcome in hospital survivors of septic shock, sepsis, and severe infections: The importance of aftercare	PLOS ONE			English	Article							UNITED-STATES; REHABILITATION; EPIDEMIOLOGY; PREDICTORS; TRENDS; COSTS; LIFE	Patients with severe infections and especially sepsis have a high in-hospital mortality, but even hospital survivors face long-term sequelae, decreased health-related quality of life, and high risk of death, suggesting a great need for specialized aftercare. However, data regarding a potential benefit of post-discharge rehabilitation in these patients are scarce. In this retrospective matched cohort study the claim data of a large German statutory health care insurer was analyzed. 83,974 hospital survivors having suffered from septic shock, sepsis, and severe infections within the years 2009-2016 were identified using an ICD abstraction strategy closely matched to the current Sepsis-3 definition. Cases were analyzed and compared with their matched pairs to determine their 5-year mortality and the impact of post-discharge rehabilitation. Five years after hospital discharge, mortality of initial hospital survivors were still increased after septic shock (HRadj 2.03, 95%-CI 1.87 to 2.19; P<0.001), sepsis (HRadj 1.73, 95%-CI 1.71 to 1.76; P<0.001), and also in survivors of severe infections without organ dysfunction (HRadj 1.70, 95%-CI 1.65 to 1.74; P<0.001) compared to matched controls without infectious diseases. Strikingly, patients treated in rehabilitation facilities showed a significantly improved 5-year survival after suffering from sepsis or septic shock (HRadj 0.81, 95%-CI 0.77 to 0.85; P<0.001) as well as severe infections without organ dysfunction (HRadj 0.81, 95%-CI 0.73 to 0.90; P<0.001) compared to matched patients discharged to home or self-care. Long-term mortality and morbidity of hospital survivors are markedly increased after septic shock, sepsis and severe infections without organ dysfunction, but best 5-year survival was recorded in patients discharged to a rehabilitation facility in all three groups. Thus, our data suggest that specialized aftercare programs may help to improve long-term outcome in these patients and warrants more vigilance in future investigations.	[Rahmel, Tim; Nowak, Hartmuth; Schepanek, Kaspar; Bergmann, Lars; Adamzik, Michael] Univ Klinikum Knappschaftskrankenhaus Bochum, Klin Anasthesiol Intens Med & Schmerztherapie, Bochum, Germany; [Schmitz, Stefanie; Halberstadt, Peter; Hoerter, Stefan] Knappschaft, Inst Versorgungsforsch Knappschaft, Bochum, Germany; [Peters, Juergen] Univ Duisburg Essen, Klin Anasthesiol & Intens Med, Essen, Germany; [Peters, Juergen] Univ Klinikum Essen, Essen, Germany	Ruhr University Bochum; Ruhr University Bochum; University of Duisburg Essen; University of Duisburg Essen	Rahmel, T (corresponding author), Univ Klinikum Knappschaftskrankenhaus Bochum, Klin Anasthesiol Intens Med & Schmerztherapie, Bochum, Germany.	Tim.Rahmel@ruhr-uni-bochum.de	Adamzik, Michael/HGE-9286-2022	Rahmel, Tim/0000-0002-7039-6288	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	We acknowledge support by the DFG Open Access Publication Funds of the Ruhr-Universitat Bochum, just for financial support for publication costs. This had no impact on our design or study, collection, analysis and interpretation of data.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Chao PW, 2014, AM J RESP CRIT CARE, V190, P1003, DOI 10.1164/rccm.201406-1170OC; CUTHBERTSON BH, 2009, BMJ-BRIT MED J, V339, DOI DOI 10.1136/BMJ.B3723; Delano MJ, 2016, IMMUNOL REV, V274, P330, DOI 10.1111/imr.12499; Denehy L, 2013, CRIT CARE, V17, DOI 10.1186/cc12835; Estenssoro E, 2018, CRIT CARE MED, V46, P1276, DOI 10.1097/CCM.0000000000003208; Fleischmann C, 2016, DTSCH ARZTEBL INT, V113, P159, DOI [10.3238/arztebl.2016.0159, 10.3238/arztebl.2016.0660b]; FLEISCHMANNSTRUZEK, 2018, PLOS ONE, V13, DOI DOI 10.1371/JOURNAL.PONE.0198847; Francisco J, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3054-4; Gadre SK, 2019, CHEST, V155, P483, DOI 10.1016/j.chest.2018.12.008; Henriksen Daniel P, 2017, Eur J Emerg Med, V24, P404, DOI 10.1097/MEJ.0000000000000379; Honselmann KC, 2015, J CRIT CARE, V30, P721, DOI 10.1016/j.jcrc.2015.03.009; Huang CY, 2018, INT J QUAL HLTH CARE; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Karlsson S, 2009, CRIT CARE MED, V37, P1268, DOI 10.1097/CCM.0b013e31819c13ac; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Kayambu G, 2013, CRIT CARE MED, V41, P1543, DOI 10.1097/CCM.0b013e31827ca637; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Prescott HC, 2018, JAMA-J AM MED ASSOC, V319, P62, DOI 10.1001/jama.2017.17687; Prescott HC, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2375; Prescott HC, 2014, AM J RESP CRIT CARE, V190, P62, DOI 10.1164/rccm.201403-0471OC; Remschmidt C, 2017, DTSCH ARZTEBL INT, V114, P858, DOI 10.3238/arztebl.2017.0858; Rhee C, 2017, JAMA-J AM MED ASSOC, V318, P1241, DOI 10.1001/jama.2017.13836; Schmidt K, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-283; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Szakmany A, 2019, CRIT CARE MED, V47, P15, DOI 10.1097/CCM.0000000000003424; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vincent JL, 2004, CRIT CARE MED, V32, P2029, DOI 10.1097/01.CCM.0000142574.00425.E9; Walsh TS, 2015, JAMA INTERN MED, V175, P901, DOI 10.1001/jamainternmed.2015.0822; Weycker D, 2003, CRIT CARE MED, V31, P2316, DOI 10.1097/01.CCM.0000085178.80226.0B; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d	33	22	25	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228952	10.1371/journal.pone.0228952	http://dx.doi.org/10.1371/journal.pone.0228952			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32050005	Green Published, gold, Green Submitted			2022-12-26	WOS:000535192300036
J	Wan, YM; Li, ZQ; Liu, C; He, YF; Wang, MJ; Wu, XN; Zhang, Y; Li, YH				Wan, Yue-Meng; Li, Zhi-qiang; Liu, Chang; He, Yue-Feng; Wang, Men-Jie; Wu, Xi-Nan; Zhang, Yuan; Li, Yu-Hua			Mesenchymal stem cells reduce alcoholic hepatitis in mice via suppression of hepatic neutrophil and macrophage infiltration, and of oxidative stress	PLOS ONE			English	Article							LIVER-INJURY; STROMAL CELLS; DISEASE; MECHANISMS; THERAPY	Mesenchymal stem cells (MSCs) are a population of pluripotent cells that have been tested for the treatment of many inflammatory diseases. It remains unclear whether MSCs were effective in treating mice with alcoholic hepatitis (AH) and its underlying mechanism. In the present study, MSCs were isolated from bone marrow of 4-6 week-old C57BL/6N male mice. AH was induced in female mice by chronic-binge ethanol feeding for 10 days. Intraperitoneal (i.p.) transplantation of MSCs or saline were performed in mice on day 10. Blood samples and hepatic tissues were harvested on day 11. Biochemical, liver histological and flow cytometric analyses were performed. Compared to the control mice, the AH mice had significantly increased liver/body weight ratio, serum alanine aminotransferase (ALT) and aspartate aminotransferases (AST), hepatic total cholesterol (TC), triglyceride (TG), malondialdehyde (MDA), hepatic neutrophil and macrophage infiltration (P<0.001), which were markedly reduced by i.p. transplantation of MSCs (P<0.01). Compared to the control mice, the hepatic glutathione (GSH) was prominently lower in the AH mice (P<0.001), which was markedly enhanced after i.p. injection of MSCs (P<0.001). MSCs were effective for the treatment of AH mice, which might be associated with their ability in inhibiting hepatic neutrophil and macrophage infiltration, and alleviating oxidative stress.	[Wan, Yue-Meng] Kunming Med Univ, Publ Hlth Inst, Kunming, Yunnan, Peoples R China; [Wan, Yue-Meng; Li, Zhi-qiang; Liu, Chang; He, Yue-Feng; Wang, Men-Jie; Wu, Xi-Nan; Li, Yu-Hua] Kunming Med Univ, Gastroenterol Dept, Affiliated Hosp 2, Kunming, Yunnan, Peoples R China; [Zhang, Yuan] Kunming Med Univ, Biomed Engn Res Ctr, Kunming, Yunnan, Peoples R China	Kunming Medical University; Kunming Medical University; Kunming Medical University	Wu, XN (corresponding author), Kunming Med Univ, Gastroenterol Dept, Affiliated Hosp 2, Kunming, Yunnan, Peoples R China.	wxnprof2011@163.com	Li, yu/HHZ-5236-2022		National Natural Science Foundation of China (NSFC) [81560525, 40115048]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	XNW received National Natural Science Foundation of China (NSFC) [Grant Number 81560525 and 40115048]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadbeigi N, 2013, STEM CELLS DEV, V22, P3052, DOI 10.1089/scd.2013.0005; Bertola A, 2013, HEPATOLOGY, V58, P1814, DOI 10.1002/hep.26419; Boetticher NC, 2008, GASTROENTEROLOGY, V135, P1953, DOI 10.1053/j.gastro.2008.08.057; Brown C, 2019, J TISSUE ENG REGEN M, V13, P1738, DOI 10.1002/term.2914; Domingues CC, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1393-8; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dubuquoy L, 2015, GUT, V64, P1949, DOI 10.1136/gutjnl-2014-308410; Fan JH, 2013, ASIAN PAC J CANCER P, V14, P7251, DOI 10.7314/APJCP.2013.14.12.7251; GALAMBOS JT, 1972, GASTROENTEROLOGY, V63, P1026; Ge XD, 2014, HEPATOLOGY, V59, P1600, DOI 10.1002/hep.26931; Huang A, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006163; Jaeschke H, 2002, ALCOHOL, V27, P23, DOI 10.1016/S0741-8329(02)00200-8; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; Kagia A, 2019, INFLAMMATION, V42, P1730, DOI 10.1007/s10753-019-01033-x; Ki SH, 2010, HEPATOLOGY, V52, P1291, DOI 10.1002/hep.23837; Kim H, 2014, CYTOTHERAPY, V16, P357, DOI 10.1016/j.jcyt.2013.10.011; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Leung TM, 2013, J HEPATOL, V58, P395, DOI 10.1016/j.jhep.2012.08.018; Li HH, 2014, ALCOHOL CLIN EXP RES, V38, P1520, DOI 10.1111/acer.12424; Liu ZC, 2014, CYTOTHERAPY, V16, P1207, DOI 10.1016/j.jcyt.2014.05.018; Louvet A, 2009, GASTROENTEROLOGY, V137, P541, DOI 10.1053/j.gastro.2009.04.062; Ma D, 2019, INT IMMUNOPHARMACOL, V74, DOI 10.1016/j.intimp.2019.105687; Mathurin P, 2007, ALIMENT PHARM THER, V25, P1047, DOI 10.1111/j.1365-2036.2007.03302.x; Nagy LE, 2016, GASTROENTEROLOGY, V150, P1756, DOI 10.1053/j.gastro.2016.02.035; Nagy LE, 2015, ALCOHOL RES-CURR REV, V37, P237; Nanji AA, 2001, AM J PHYSIOL-GASTR L, V281, pG1348, DOI 10.1152/ajpgi.2001.281.6.G1348; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Sala E, 2015, GASTROENTEROLOGY, V149, P163, DOI 10.1053/j.gastro.2015.03.013; Song WJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04766-7; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Wang WJ, 2019, WORLD J GASTROENTERO, V25, P1445, DOI 10.3748/wjg.v25.i12.1445; Wu XQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep18685	32	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228889	10.1371/journal.pone.0228889	http://dx.doi.org/10.1371/journal.pone.0228889			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045450	gold, Green Published			2022-12-26	WOS:000534633200045
J	Wang, BB; Li, Y; Sui, M; Qi, QQ; Wang, T; Liu, D; Zhou, ML; Zheng, YJ; Zhu, LQ; Zhang, B				Wang, Beibei; Li, Yang; Sui, Ming; Qi, Qinqin; Wang, Ting; Liu, Dan; Zhou, Meiling; Zheng, Yunjie; Zhu, Ling-Qiang; Zhang, Bin			Identification of the downstream molecules of agrin/Dok-7 signaling in muscle	FASEB JOURNAL			English	Article						Anxa3; CRISPR; Cas9; neuromuscular junction; phosphoproteomics	NEUROMUSCULAR-JUNCTION FORMATION; ACETYLCHOLINE-RECEPTOR; BETA-SUBUNIT; SYNAPSE FORMATION; GENE-EXPRESSION; NITRIC-OXIDE; ANNEXIN A3; AGRIN; PROTEIN; TARGET	The development of the neuromuscular junction depends on signaling processes that involve protein phosphorylation. Motor neuron releases agrin to activate muscle protein Dok-7, a key tyrosine kinase essential for the formation of a mature and functional neuromuscular junction. However, the signaling cascade downstream of Dok-7 remains poorly understood. In this study, we combined the clustered regularly interspaced short palindromic repeats/Cas9 technique and quantitative phosphoproteomics analysis to study the tyrosine phosphorylation events triggered by agrin/Dok-7. We found tyrosine phosphorylation level of 36 proteins increased specifically by agrin stimulation. In Dok-7 mutant myotubes, however, 13 of the 36 proteins failed to be enhanced by agrin stimulation, suggesting that these 13 proteins are Dok-7-dependent tyrosine-phosphorylated proteins, could work as downstream molecules of agrin/Dok-7 signaling. We validated one of the proteins, Anxa3, by in vitro and in vivo assays. Knocking down of Anxa3 in the cultured myotubes inhibited agrin-induced AChR clustering, whereas reduction of Anxa3 in mouse muscles induced abnormal postsynaptic development. Collectively, our phosphoproteomics analysis provides novel insights into the complicated signaling network downstream of agrin/Dok-7.	[Wang, Beibei; Li, Yang; Sui, Ming; Qi, Qinqin; Wang, Ting; Liu, Dan; Zhou, Meiling; Zheng, Yunjie; Zhang, Bin] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Physiol, Sch Basic Med, Wuhan 430030, Peoples R China; [Wang, Beibei; Li, Yang; Sui, Ming; Qi, Qinqin; Wang, Ting; Liu, Dan; Zhou, Meiling; Zhu, Ling-Qiang; Zhang, Bin] Huazhong Univ Sci & Technol, Collaborat Innovat Ctr Brain Sci, Inst Brain Res, Wuhan, Peoples R China; [Zhu, Ling-Qiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathophysiol, Sch Basic Med, Wuhan, Peoples R China; [Zhang, Bin] Huazhong Univ Sci & Technol, Hubei Key Lab Drug Target Res & Pharmacodynam Ev, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, B (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Physiol, Sch Basic Med, Wuhan 430030, Peoples R China.	binzhang@hust.edu.cn	Zhang, Bin/ABD-9523-2020	Zhang, Bin/0000-0003-1323-8678; Wang, Beibei/0000-0001-5887-4286	National Natural Science Foundation of China (NSFC) [81471283]; Fundamental Research Funds for the Central Universities [HUST: 2015QT007]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81471283; Fundamental Research Funds for the Central Universities, Grant/Award Number: HUST: 2015QT007	Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4; Bauche S, 2016, AM J HUM GENET, V99, P753, DOI 10.1016/j.ajhg.2016.06.033; Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837; BLOCH RJ, 1989, EXP CELL RES, V182, P583, DOI 10.1016/0014-4827(89)90261-9; Bloch RJ, 1997, SOC GEN PHY, V52, P177; Borges LS, 2008, J NEUROSCI, V28, P11468, DOI 10.1523/JNEUROSCI.2508-08.2008; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; BURDEN SJ, 1983, CELL, V35, P687, DOI 10.1016/0092-8674(83)90101-0; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; Cartaud A, 2011, BIOL CELL, V103, P287, DOI 10.1042/BC20110018; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dai ZS, 2000, J CELL BIOL, V150, P1321, DOI 10.1083/jcb.150.6.1321; Darabid H, 2014, NAT REV NEUROSCI, V15, P703, DOI 10.1038/nrn3821; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Defour A, 2017, HUM MOL GENET, V26, P1979, DOI 10.1093/hmg/ddx065; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dobbins GC, 2006, J MOL NEUROSCI, V30, P115, DOI 10.1385/JMN:30:1:115; Du RK, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0143-z; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Godfrey EW, 2007, DEV BIOL, V307, P195, DOI 10.1016/j.ydbio.2007.04.021; Godfrey EW, 2010, EXP CELL RES, V316, P1935, DOI 10.1016/j.yexcr.2010.03.016; Grewal T, 2016, BIOL CHEM, V397, P1031, DOI 10.1515/hsz-2016-0168; Hallock PT, 2010, GENE DEV, V24, P2451, DOI 10.1101/gad.1977710; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jones MA, 2004, MOL CELL NEUROSCI, V25, P195, DOI 10.1016/j.mcn.2003.10.013; Jones MA, 2000, MOL CELL NEUROSCI, V16, P649, DOI 10.1006/mcne.2000.0901; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kollerrmann J, 2008, EUR UROL, V54, P1314, DOI 10.1016/j.eururo.2008.01.001; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; LAROCHELLE WJ, 1986, J BIOL CHEM, V261, P5270; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Li L, 2018, ANNU REV PHYSIOL, V80, P159, DOI 10.1146/annurev-physiol-022516-034255; Lin H, 2008, J AM SOC NEPHROL, V19, P339, DOI 10.1681/ASN.2007050550; Lin S, 2008, P NATL ACAD SCI USA, V105, P11406, DOI 10.1073/pnas.0801683105; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Luo SW, 2008, NEURON, V60, P97, DOI 10.1016/j.neuron.2008.08.013; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; RODERICK TH, 1974, GENETICS, V76, P109; Rudell JB, 2013, DEV NEUROBIOL, V73, P399, DOI 10.1002/dneu.22070; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Schmidt N, 2012, J CELL BIOL, V198, P421, DOI 10.1083/jcb.201111130; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sun CJ, 2013, PROTEOMICS, V13, P3523, DOI 10.1002/pmic.201300286; Swaggart KA, 2014, P NATL ACAD SCI USA, V111, P6004, DOI 10.1073/pnas.1324242111; Tong M, 2015, STEM CELL REP, V5, P45, DOI 10.1016/j.stemcr.2015.05.013; van der Mijn JC, 2015, J PROTEOMICS, V127, P259, DOI 10.1016/j.jprot.2015.04.006; Vidaki M, 2017, NEURON, V95, P608, DOI 10.1016/j.neuron.2017.06.048; WALKER JH, 1984, EMBO J, V3, P2287, DOI 10.1002/j.1460-2075.1984.tb02127.x; Wang Q, 2006, J MOL NEUROSCI, V30, P223, DOI 10.1385/JMN:30:1:223; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Wiener MC, 2004, ANAL CHEM, V76, P6085, DOI 10.1021/ac0493875; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Wu N, 2013, CLIN TRANSL ONCOL, V15, P106, DOI 10.1007/s12094-012-0928-6; Xing GL, 2019, ELIFE, V8, DOI 10.7554/eLife.49180; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhang B, 2007, J NEUROSCI, V27, P3968, DOI 10.1523/JNEUROSCI.4691-06.2007; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37; Zhu D, 2008, J NEUROSCI, V28, P1688, DOI 10.1523/JNEUROSCI.4130-07.2008; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	75	1	1	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5144	5161		10.1096/fj.201901693RR	http://dx.doi.org/10.1096/fj.201901693RR		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32043676				2022-12-26	WOS:000512670500001
J	Endo, M; Druso, JE; Cerione, RA				Endo, Makoto; Druso, Joseph E.; Cerione, Richard A.			The two splice variant forms of Cdc42 exert distinct and essential functions in neurogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						small GTPase; CDC42; stem cells; mTOR complex (mTORC); differentiation; ACK; CDC42b; CDC42u; neurogenesis; splice variant	BINDING PROTEINS RHOA; MOLECULAR-CLONING; TYROSINE KINASE; HUMAN HOMOLOG; EXPRESSION; IDENTIFICATION; GTPASES; MTOR; GENE; LOCALIZATION	The small GTPase cell division cycle 42 (CDC42) plays essential roles in neurogenesis and brain development. Previously, using murine embryonic P19 cells as a model system, we showed that CDC42 stimulates mTOR complex 1 (mTORC1) activity and thereby up-regulates transcription factors required for the formation of neural progenitor cells. However, paradoxically, although endogenous CDC42 is required for both the initial transition of undifferentiated P19 cells to neural progenitors and their ultimate terminal differentiation into neurons, ectopic CDC42 overexpression promotes only the first stage of neurogenesis (i.e. the formation of neuroprogenitors) and not the second phase (differentiation into neurons). Here, using both P19 cells and mouse embryonic stem cells, we resolve this paradox, demonstrating that two splice variants of CDC42, differing only in nine amino acid residues in their very C-terminal regions, play distinct roles in neurogenesis. We found that a CDC42 splice variant that has a ubiquitous tissue distribution, termed here as CDC42u, specifically drives the formation of neuroprogenitor cells, whereas a brain-specific CDC42 variant, CDC42b, is essential for promoting the transition of neuroprogenitor cells to neurons. We further show that the specific roles of CDC42u and CDC42b in neurogenesis are due to their opposing effects on mTORC1 activity. Specifically, CDC42u stimulated mTORC1 activity and thereby induced neuroprogenitor formation, whereas CDC42b worked together with activated CDC42-associated kinase (ACK) in down-regulating mTOR expression and promoting neuronal differentiation. These findings highlight the remarkable functional specificities of two highly similar CDC42 splice variants in regulating distinct stages of neurogenesis.	[Endo, Makoto; Druso, Joseph E.; Cerione, Richard A.] Cornell Univ, Dept Mol Med, Coll Vet Med, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Baker Lab, Ithaca, NY 14853 USA; [Druso, Joseph E.] Univ Vermont, Robert Lamer Coll Med, Burlington, VT 05405 USA	Cornell University; Cornell University; University of Vermont	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Coll Vet Med, Ithaca, NY 14853 USA.	rac1@cornell.edu			NIGMS, National Institutes of Health [R35 GM122575]; NCI, National Institutes of Health [R01 CA201402]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIGMS, National Institutes of Health, Grant R35 GM122575 and NCI, National Institutes of Health, Grant R01 CA201402 (to R. A. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Chen F, 2000, CURR BIOL, V10, P758, DOI 10.1016/S0960-9822(00)00571-6; Chen L, 2006, P NATL ACAD SCI USA, V103, P16520, DOI 10.1073/pnas.0603533103; Dharmaiah S, 2016, P NATL ACAD SCI USA, V113, pE6766, DOI 10.1073/pnas.1615316113; Endo M, 2009, J BIOL CHEM, V284, P5107, DOI 10.1074/jbc.M807745200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; HART MJ, 1991, J BIOL CHEM, V266, P20840; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Lam B Daniel, 2013, Small GTPases, V4, P78, DOI 10.4161/sgtp.23310; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Maxwell KN, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00186-18; Melendez J, 2011, J BIOL CHEM, V286, P2375, DOI 10.1074/jbc.R110.200329; Michaelson D, 2005, MOL BIOL CELL, V16, P1606, DOI 10.1091/mbc.e04-11-0960; Moutin E, 2017, CEREB CORTEX, V27, P3618, DOI 10.1093/cercor/bhw183; MUNEMITSU S, 1990, MOL CELL BIOL, V10, P5977, DOI 10.1128/MCB.10.11.5977; Nishimura A, 2013, MOL CELL BIOL, V33, P1417, DOI 10.1128/MCB.01398-12; Olenik C, 1999, MOL BRAIN RES, V70, P9, DOI 10.1016/S0169-328X(99)00121-7; Olenik C, 1997, MOL BRAIN RES, V52, P263, DOI 10.1016/S0169-328X(97)00270-2; Peng X, 2013, PROTEIN CELL, V4, P231, DOI 10.1007/s13238-012-2098-2; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; SHINJO K, 1990, P NATL ACAD SCI USA, V87, P9853, DOI 10.1073/pnas.87.24.9853; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Urena JM, 2005, J COMP NEUROL, V490, P119, DOI 10.1002/cne.20656; van Hennik PB, 2003, J BIOL CHEM, V278, P39166, DOI 10.1074/jbc.M307001200; Wang C, 2015, DEV BIOL, V398, P11, DOI 10.1016/j.ydbio.2014.11.010; Wang JB, 2009, J CELL SCI, V122, P2024, DOI 10.1242/jcs.044644; Wirth A, 2013, BIOCHEM J, V456, P311, DOI 10.1042/BJ20130788; Yap K, 2016, CELL REP, V15, P1316, DOI 10.1016/j.celrep.2016.04.012; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	39	7	7	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4498	4512		10.1074/jbc.RA119.011837	http://dx.doi.org/10.1074/jbc.RA119.011837			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32071086	hybrid, Green Published			2022-12-26	WOS:000524499700012
J	Takahashi, S; Luo, YH; Ranjit, S; Xie, C; Libby, AE; Orlicky, DJ; Dvornikov, A; Wang, XXX; Myakala, K; Jones, BA; Bhasin, K; Wang, D; McManaman, JL; Krausz, KW; Gratton, E; Ir, D; Robertson, CE; Frank, DN; Gonzalez, FJ; Levi, M				Takahashi, Shogo; Luo, Yuhuan; Ranjit, Suman; Xie, Cen; Libby, Andrew E.; Orlicky, David J.; Dvornikov, Alexander; Wang, Xiaoxin X.; Myakala, Komuraiah; Jones, Bryce A.; Bhasin, Kanchan; Wang, Dong; McManaman, James L.; Krausz, Kristopher W.; Gratton, Enrico; Ir, Diana; Robertson, Charles E.; Frank, Daniel N.; Gonzalez, Frank J.; Levi, Moshe			Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic steatohepatitis in Western diet?fed mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						liver injury; liver metabolism; bile acid; metabolomics; lipid metabolism; bile acid sequestrants; microbiome; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis	GUT MICROBIOTA; CHOLESTEROL CRYSTALS; LIPID-ACCUMULATION; OBESITY; SEVELAMER; DYSBIOSIS; METABOLISM; DISEASE; BINDING; SENSITIVITY	Nonalcoholic fatty liver disease is a rapidly rising problem in the 21st century and is a leading cause of chronic liver disease that can lead to end-stage liver diseases, including cirrhosis and hepatocellular cancer. Despite this rising epidemic, no pharmacological treatment has yet been established to treat this disease. The rapidly increasing prevalence of nonalcoholic fatty liver disease and its aggressive form, nonalcoholic steatohepatitis (NASH), requires novel therapeutic approaches to prevent disease progression. Alterations in microbiome dynamics and dysbiosis play an important role in liver disease and may represent targetable pathways to treat liver disorders. Improving microbiome properties or restoring normal bile acid metabolism may prevent or slow the progression of liver diseases such as NASH. Importantly, aberrant systemic circulation of bile acids can greatly disrupt metabolic homeostasis. Bile acid sequestrants are orally administered polymers that bind bile acids in the intestine, forming nonabsorbable complexes. Bile acid sequestrants interrupt intestinal reabsorption of bile acids, decreasing their circulating levels. We determined that treatment with the bile acid sequestrant sevelamer reversed the liver injury and prevented the progression of NASH, including steatosis, inflammation, and fibrosis in a Western diet?induced NASH mouse model. Metabolomics and microbiome analysis revealed that this beneficial effect is associated with changes in the microbiota population and bile acid composition, including reversing microbiota complexity in cecum by increasing Lactobacillus and decreased Desulfovibrio. The net effect of these changes was improvement in liver function and markers of liver injury and the positive effects of reversal of insulin resistance.	[Takahashi, Shogo; Ranjit, Suman; Libby, Andrew E.; Wang, Xiaoxin X.; Myakala, Komuraiah; Jones, Bryce A.; Bhasin, Kanchan; Levi, Moshe] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA; [Jones, Bryce A.] Georgetown Univ, Dept Pharmacol & Physiol, Washington, DC 20057 USA; [Orlicky, David J.] Univ Colorado, Dept Pathol, Anschutz Med Campus, Aurora, CO 80045 USA; [Luo, Yuhuan; Ir, Diana; Robertson, Charles E.; Frank, Daniel N.] Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA; [McManaman, James L.] Univ Colorado, Div Reprod Sci, Anschutz Med Campus, Aurora, CO 80045 USA; [McManaman, James L.] Univ Colorado, Grad Program Integrated Physiol, Anschutz Med Campus, Aurora, CO 80045 USA; [Ranjit, Suman; Dvornikov, Alexander; Wang, Dong; Gratton, Enrico] Univ Calif Irvine, Dept Biomed Engn, Lab Fluorescence Dynam, Irvine, CA 92697 USA; [Takahashi, Shogo; Xie, Cen; Krausz, Kristopher W.; Gonzalez, Frank J.] NCI, NIH, Bethesda, MD 20892 USA	Georgetown University; Georgetown University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Levi, M (corresponding author), Georgetown Univ, Biochem & Mol & Cellular Biol, 3900 Reservoir Rd,Basic Sci 353, Washington, DC 20057 USA.	Moshe.Levi@georgetown.edu	Komuraiah, Myakala/AAQ-9961-2021; Takahashi, Shogo/GVS-9010-2022	Komuraiah, Myakala/0000-0003-3233-047X; Takahashi, Shogo/0000-0002-3831-5353; Libby, Andrew/0000-0003-3726-2170; Ranjit, Suman/0000-0003-3058-6332; Orlicky, David/0000-0002-0417-1400; Jones, Bryce/0000-0002-6950-8414; ROBERTSON, CHARLES/0000-0002-4136-4121	National Institute of Aging [AG049493]; National Institute of Diabetes and Digestive and Kidney Diseases [116567]; National Institutes of Health [2R01HD45965, R01-HD075285, P50GM076516, P41GM103540]; Colorado Clinical and Translational Sciences Institute/National Institutes of Health [TL1-TR001081]; Gastrointestinal and Liver Innate Immunity Program of the University of Colorado School of Medicine; American Heart Association Postdoctoral Fellowships [19POST34430001, 19POST34381041]	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Clinical and Translational Sciences Institute/National Institutes of Health; Gastrointestinal and Liver Innate Immunity Program of the University of Colorado School of Medicine; American Heart Association Postdoctoral Fellowships(American Heart Association)	This work was supported by National Institute of Aging Grant AG049493 (to M. L.), National Institute of Diabetes and Digestive and Kidney Diseases Grant 116567 (to M. L.), National Institutes of Health Grants 2R01HD45965 and R01-HD075285 (to J. L. M.), Colorado Clinical and Translational Sciences Institute/National Institutes of Health Grant TL1-TR001081 (to A. E. L.), and National Institutes of Health Grants P50GM076516 and P41GM103540 (to S. R., A. D., and E. G.). This work was also supported by funds from the Gastrointestinal and Liver Innate Immunity Program of the University of Colorado School of Medicine (to D. N. F., D. I., and C. E. R.) and American Heart Association Postdoctoral Fellowships 19POST34430001 (to A. E. L.) and 19POST34381041 (to K. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Arab JP, 2017, HEPATOLOGY, V65, P350, DOI 10.1002/hep.28709; Betrapally NS, 2016, GASTROENTEROLOGY, V150, P1745, DOI 10.1053/j.gastro.2016.02.073; Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356; Boyer JL, 2013, COMPR PHYSIOL, V3, P1035, DOI 10.1002/cphy.c120027; Braunlin W, 2002, KIDNEY INT, V62, P611, DOI 10.1046/j.1523-1755.2002.00459.x; Bronden A, 2015, DIABETES OBES METAB, V17, P116, DOI 10.1111/dom.12355; Caussy C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09455-9; Chiang John Y. L., 2018, Gene Expression, V18, P71, DOI 10.3727/105221618X15156018385515; Dawson PA, 2015, J LIPID RES, V56, P1085, DOI 10.1194/jlr.R054114; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ferslew BC, 2015, DIGEST DIS SCI, V60, P3318, DOI 10.1007/s10620-015-3776-8; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Friedman JE, 2018, HEPATOL COMMUN, V2, P313, DOI 10.1002/hep4.1139; Hendrikx T, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0652-0; Jiang CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10166; Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738; Jiang T, 2007, DIABETES, V56, P2485, DOI 10.2337/db06-1642; Jonscher KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152877; Kapil S, 2016, J GASTROEN HEPATOL, V31, P213, DOI 10.1111/jgh.13058; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kolodziejczyk AA, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809302; Kraus Daniel, 2015, Bio Protoc, V5; Lanaspa MA, 2018, J CLIN INVEST, V128, P2226, DOI 10.1172/JCI94427; Lanaspa MA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3434; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Leung C, 2016, NAT REV GASTRO HEPAT, V13, P412, DOI 10.1038/nrgastro.2016.85; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Libby AE, 2016, J BIOL CHEM, V291, P24231, DOI 10.1074/jbc.M116.759795; Lim RS, 2011, J LIPID RES, V52, P2177, DOI 10.1194/jlr.M018077; Lim RS, 2010, J LIPID RES, V51, P1729, DOI 10.1194/jlr.M003616; Liu RX, 2017, NAT MED, V23, P859, DOI 10.1038/nm.4358; Loomba R, 2017, CELL METAB, V25, P1054, DOI 10.1016/j.cmet.2017.04.001; McGettigan BM, 2016, J BIOL CHEM, V291, P23058, DOI 10.1074/jbc.M116.731042; Mehal WZ, 2013, NAT REV GASTRO HEPAT, V10, P637, DOI 10.1038/nrgastro.2013.146; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Molinaro A, 2018, TRENDS ENDOCRIN MET, V29, P31, DOI 10.1016/j.tem.2017.11.002; Nycz BT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191232; Orlicky DJ, 2019, J PHYSIOL-LONDON, V597, P1565, DOI 10.1113/JP277140; Pathak P, 2018, HEPATOLOGY, V68, P1574, DOI 10.1002/hep.29857; Ponziani FR, 2019, HEPATOLOGY, V69, P107, DOI 10.1002/hep.30036; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Ramakrishnan VR, 2015, J ALLERGY CLIN IMMUN, V136, P334, DOI 10.1016/j.jaci.2015.02.008; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Russell KN, 2007, JAVMA-J AM VET MED A, V230, P1329, DOI 10.2460/javma.230.9.1329; Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Shapiro H, 2018, J EXP MED, V215, P383, DOI 10.1084/jem.20171965; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Suhalim JL, 2012, BIOPHYS J, V102, P1988, DOI 10.1016/j.bpj.2012.03.016; Tilg H, 2016, GUT, V65, P2035, DOI 10.1136/gutjnl-2016-312729; Tripathi A, 2018, NAT REV GASTRO HEPAT, V15, P397, DOI 10.1038/s41575-018-0011-z; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ursell LK, 2012, J ALLERGY CLIN IMMUN, V129, P1204, DOI 10.1016/j.jaci.2012.03.010; Utzschneider KM, 2016, J CLIN ENDOCR METAB, V101, P2622, DOI 10.1210/jc.2015-4251; Vlassara H, 2012, CLIN J AM SOC NEPHRO, V7, P934, DOI 10.2215/CJN.12891211; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wang JJ, 2015, ISME J, V9, P1, DOI 10.1038/ismej.2014.99; Wang XXX, 2016, J AM SOC NEPHROL, V27, P1362, DOI 10.1681/ASN.2014121271; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wieland A, 2015, ALIMENT PHARM THER, V42, P1051, DOI 10.1111/apt.13376	69	23	24	5	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4733	4747		10.1074/jbc.RA119.011913	http://dx.doi.org/10.1074/jbc.RA119.011913			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32075905	hybrid, Green Published			2022-12-26	WOS:000524499700030
J	Anderson-Baron, M; Kunze, M; Mulet-Sierra, A; Adesida, AB				Anderson-Baron, Matthew; Kunze, Melanie; Mulet-Sierra, Aillette; Adesida, Adetola B.			Effect of cell seeding density on matrix-forming capacity of meniscus fibrochondrocytes and nasal chondrocytes in meniscus tissue engineering	FASEB JOURNAL			English	Article						meniscus; nasal cartilage; pellet model; tissue engineering	MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE; SAFRANIN-O; KNEE; OSTEOARTHRITIS; PHENOTYPE; COLLAGEN; TIME; DIFFERENTIATION; REGENERATION	The presence of intact menisci is imperative for the proper function of the knee joint. Meniscus injuries are often treated by the surgical removal of the damaged tissue, which increases the likelihood of post-traumatic osteoarthritis. Tissue engineering holds great promise in producing viable engineered meniscal tissue for implantation using the patient's own cells; however, the cell source for producing the engineered tissue is unclear. Nasal chondrocytes (NC) possess many attractive features for engineering meniscus. However, in order to validate the use of NC for engineering meniscus fibrocartilage, a thorough comparison of NC and meniscus fibrochondrocytes (MFC) must be considered. Our study presents an analysis of the relative features of NC and MFC and their respective chondrogenic potential in a pellet culture model. We showed considerable differences in the cartilage tissue formed by the two different cell types. Our data showed that NC were more proliferative in culture, deposited more extracellular matrix, and showed higher expression of chondrogenic genes than MFC. Overall, our data suggest that NC produce superior cartilage tissue to MFC in a pellet culture model. In addition, NCs produce higher quality cartilage tissue at higher cell seeding densities during cell expansion.	[Anderson-Baron, Matthew; Kunze, Melanie; Mulet-Sierra, Aillette; Adesida, Adetola B.] Univ Alberta, Fac Med & Dent, Dept Surg, Div Orthopaed Surg, Edmonton, AB T6G 2E1, Canada; [Anderson-Baron, Matthew; Kunze, Melanie; Mulet-Sierra, Aillette; Adesida, Adetola B.] Univ Alberta, Fac Med & Dent, Dept Surg, Div Surg Res, Edmonton, AB T6G 2E1, Canada; [Anderson-Baron, Matthew; Kunze, Melanie; Mulet-Sierra, Aillette; Adesida, Adetola B.] 3 021 Li Ka Shing Ctr Hlth Res Innovat, Lab Stem Cell Biol & Orthopaed Tissue Engn, Edmonton, AB, Canada	University of Alberta; University of Alberta	Adesida, AB (corresponding author), Univ Alberta, Fac Med & Dent, Dept Surg, Div Orthopaed Surg, Edmonton, AB T6G 2E1, Canada.; Adesida, AB (corresponding author), Univ Alberta, Fac Med & Dent, Dept Surg, Div Surg Res, Edmonton, AB T6G 2E1, Canada.	adesida@ualberta.ca	Adesida, Adetola B/H-3549-2011	Adesida, Adetola B/0000-0003-1798-6251	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR) [CIHR MOP 125921, CIHR PS 159661]; Alberta Cancer Foundation [ACFMIBRP 27128]; Canadian Foundation for Innovation [CFI 33786]; University Hospital Foundation [RES0028185]	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation; Canadian Foundation for Innovation(Canada Foundation for Innovation); University Hospital Foundation	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: CIHR MOP 125921 and CIHR PS 159661; Alberta Cancer Foundation, Grant/Award Number: ACFMIBRP 27128; Canadian Foundation for Innovation, Grant/Award Number: CFI 33786; University Hospital Foundation, Grant/Award Number: RES0028185	Adesida AB, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1929; Andrews SHJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06666-2; Andrews SHJ, 2017, CONNECT TISSUE RES, V58, P271, DOI 10.1080/03008207.2017.1303489; Baker BM, 2009, OSTEOARTHR CARTILAGE, V17, P336, DOI 10.1016/j.joca.2008.08.001; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123; Bornes TD, 2016, TISSUE ENG PART C-ME, V22, P208, DOI [10.1089/ten.tec.2015.0365, 10.1089/ten.TEC.2015.0365]; Buma P, 2004, BIOMATERIALS, V25, P1523, DOI 10.1016/S0142-9612(03)00499-X; CAMPLEJOHN KL, 1988, HISTOCHEMISTRY, V89, P185, DOI 10.1007/BF00489922; Candrian C, 2008, ARTHRITIS RHEUM-US, V58, P197, DOI 10.1002/art.23155; Chen S, 2017, CELL TISSUE RES, V370, P53, DOI 10.1007/s00441-017-2613-0; Cigan AD, 2016, J BIOMECH, V49, P1909, DOI 10.1016/j.jbiomech.2016.04.039; EVANS CH, 1983, MECH AGEING DEV, V22, P179, DOI 10.1016/0047-6374(83)90111-2; EYRE DR, 1983, FEBS LETT, V158, P265, DOI 10.1016/0014-5793(83)80592-4; FAIRBANK TJ, 1948, J BONE JOINT SURG BR, V30, P664, DOI 10.1302/0301-620X.30B4.664; Frohlich M, 2007, CELL BIOL INT, V31, P620, DOI 10.1016/j.cellbi.2006.12.003; Fulco I, 2014, LANCET, V384, P337, DOI 10.1016/S0140-6736(14)60544-4; Gunja NJ, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2293; Hatsushika D, 2014, OSTEOARTHR CARTILAGE, V22, P941, DOI 10.1016/j.joca.2014.04.028; Hatsushika D, 2013, J ORTHOP RES, V31, P1354, DOI 10.1002/jor.22370; HEINEGARD D, 1989, FASEB J, V3, P2042, DOI 10.1096/fasebj.3.9.2663581; HERWIG J, 1984, ANN RHEUM DIS, V43, P635, DOI 10.1136/ard.43.4.635; Karia M, 2019, EUR J ORTHOP SURG TR, V29, P509, DOI 10.1007/s00590-018-2317-5; Kiani C, 2002, CELL RES, V12, P19, DOI 10.1038/sj.cr.7290106; Kobayashi S, 2008, J ORTHOP RES, V26, P493, DOI 10.1002/jor.20507; Kon E, 2012, TISSUE ENG PT A, V18, P1573, DOI [10.1089/ten.TEA.2011.0572, 10.1089/ten.tea.2011.0572]; Liang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12096-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Marsano A, 2007, OSTEOARTHR CARTILAGE, V15, P48, DOI 10.1016/j.joca.2006.06.009; Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006; MCDEVITT CA, 1990, CLIN ORTHOP RELAT R, P8; Mine T, 2013, J ORTHOP SURG-HONG K, V21, P216, DOI 10.1177/230949901302100221; Mounts T, 2012, CARTILAGE, V3, P181, DOI 10.1177/1947603511420999; Mumme M, 2016, LANCET, V388, P1985, DOI 10.1016/S0140-6736(16)31658-0; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Nakata K, 2001, CLIN ORTHOP RELAT R, pS208; Papalia R, 2011, BRIT MED BULL, V99, P89, DOI 10.1093/bmb/ldq043; Pelttari K, 2017, CURR OPIN BIOTECH, V47, P1, DOI 10.1016/j.copbio.2017.05.007; Pelttari K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009688; RANGGER C, 1995, AM J SPORT MED, V23, P240, DOI 10.1177/036354659502300219; Roos H, 1995, OSTEOARTHR CARTILAGE, V3, P261, DOI 10.1016/S1063-4584(05)80017-2; ROSENBERG L, 1971, J BONE JOINT SURG AM, VA 53, P69, DOI 10.2106/00004623-197153010-00007; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scotti C, 2012, TISSUE ENG PT A, V18, P362, DOI [10.1089/ten.tea.2011.0234, 10.1089/ten.TEA.2011.0234]; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; STOKER MGP, 1967, NATURE, V215, P171, DOI 10.1038/215171a0; Tan GK, 2011, CELL ADHES MIGR, V5, P220, DOI 10.4161/cam.5.3.14463; Tay AG, 2004, TISSUE ENG, V10, P762, DOI 10.1089/1076327041348572; Verdonk PCM, 2005, OSTEOARTHR CARTILAGE, V13, P548, DOI 10.1016/j.joca.2005.01.010; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Wilson CG, 2009, TISSUE ENG PT A, V15, P1513, DOI 10.1089/ten.tea.2008.0106; Yang BW, 2019, CURR REV MUSCULOSKE, V12, P233, DOI 10.1007/s12178-019-09554-6; Yu HN, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0077-2	54	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5538	5551		10.1096/fj.201902559R	http://dx.doi.org/10.1096/fj.201902559R		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32090374	Bronze			2022-12-26	WOS:000515261300001
J	Pang, X; Fan, HY; Tang, YL; Wang, SS; Cao, MX; Wang, HF; Dai, LL; Wang, K; Yu, XH; Wu, JB; Tang, YJ; Liang, XH				Pang, Xin; Fan, Hua-yang; Tang, Ya-ling; Wang, Sha-sha; Cao, Ming-xin; Wang, Hao-fan; Dai, Lu-ling; Wang, Ke; Yu, Xiang-hua; Wu, Jing-biao; Tang, Ya-Jie; Liang, Xin-hua			Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma	PLOS ONE			English	Article							CLINICAL-RELEVANCE; T-CELLS; CANCER; PROLIFERATION; EPIDEMIOLOGY; ACCUMULATION; METASTASIS; ARGINASE; MURINE; GROWTH	Purpose The tumor-related myeloid derived suppressor cells (MDSCs), important immunosuppressive cells in tumor microenvironment, play an important role in the cancer progression. This study is aimed to investigate the crosstalk between MDSCs and oral squamous cell carcinoma (OSCC) cells and their role in the malignant progression of OSCC. Methods Immunochemistry (IHC) was used to investigate the expression of CD33 in 200 OSCC, 36 premalignant. CD33+ MDSCs were sorted and enriched via magnetic-activated cell sorting (MACS) from OSCC patients or health donor, and their phenotypes were identified by flow cytometry. With a co-culture system of MDSCs and OSCC, the effects of MDSCs on OSCC proliferation, apoptosis, migration invasion, epithelial-mesenchymal transition (EMT), and vasculogenic mimicry formation (VM) formation were assessed, respectively. Besides, peripheral blood mononuclear cells (PBMCs) from health donor were cultured with OSCC supernatant, the level of MDSCs and expressions of Arginase (Arg-1) and inducible nitric oxide synthase (iNOS) were measured. Results The number of MDSCs was increased in tumor tissues of OSCC patients, and was positively related to the T stage, pathological grade, lymph node metastasis and poor prognosis. Tumor-related MDSCs of the co-culture system promoted OSCC progression by contributing to cell proliferation, migration and invasion as well as inducing EMT and VM. In turn, OSCC cells had potential to induce MDSCs differentiation from PBMCs and increase the expression of Arg-1 and iNOS. Conclusion These indicated that the crosstalk between MDSCs and tumor cells facilitated the malignant progression of OSCC cells and the immune suppressive properties of MDSCs, which may provide new insights into tumor treatment on targeting tumor-associated immunosuppressive cells.	[Pang, Xin; Fan, Hua-yang; Tang, Ya-ling; Wang, Sha-sha; Cao, Ming-xin; Wang, Hao-fan; Dai, Lu-ling; Wang, Ke; Yu, Xiang-hua; Wu, Jing-biao; Liang, Xin-hua] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China; [Pang, Xin; Fan, Hua-yang; Tang, Ya-ling; Wang, Sha-sha; Cao, Ming-xin; Wang, Hao-fan; Dai, Lu-ling; Wang, Ke; Yu, Xiang-hua; Wu, Jing-biao; Liang, Xin-hua] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, Chengdu, Sichuan, Peoples R China; [Pang, Xin; Fan, Hua-yang; Tang, Ya-ling; Wang, Sha-sha; Cao, Ming-xin; Wang, Hao-fan; Dai, Lu-ling; Wang, Ke; Yu, Xiang-hua; Wu, Jing-biao; Liang, Xin-hua] Sichuan Univ, West China Hosp Stomatol, Dept Oral & Maxillofacial Surg, Chengdu, Sichuan, Peoples R China; [Tang, Ya-Jie] Shandong Univ, State Key Lab Microbial Technol, Qingdao, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Shandong University	Liang, XH (corresponding author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China.; Liang, XH (corresponding author), Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, Chengdu, Sichuan, Peoples R China.; Liang, XH (corresponding author), Sichuan Univ, West China Hosp Stomatol, Dept Oral & Maxillofacial Surg, Chengdu, Sichuan, Peoples R China.; Tang, YJ (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Qingdao, Peoples R China.	yajietang@qq.com; lxh88866@scu.edu.cn		Liang, Xinhua/0000-0003-0718-3658; , fan hua yang/0000-0003-2174-9208	National Natural Science Foundation of China [81972542, 81772891, 81672672, 81572650]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present study was supported by National Natural Science Foundation of China grants (grant nos. 81972542, 81772891, 81672672, and 81572650).	Alfaro C, 2016, CLIN CANCER RES, V22, P3924, DOI 10.1158/1078-0432.CCR-15-2463; Anani W, 2017, ADV EXP MED BIOL, V1036, P105, DOI 10.1007/978-3-319-67577-0_8; Bae WJ, 2016, ONCOL LETT, V12, P5315, DOI 10.3892/ol.2016.5336; Barrera L, 2018, CANCER IMMUNOL IMMUN, V67, P1393, DOI 10.1007/s00262-018-2196-y; Bray F, 2006, NAT REV CANCER, V6, P63, DOI 10.1038/nrc1781; Cao Y, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2376-0; Colditz GA, 2006, NAT REV CANCER, V6, P75, DOI 10.1038/nrc1784; Feng PH, 2012, AM J RESP CRIT CARE, V186, P1025, DOI 10.1164/rccm.201204-0636OC; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Fultang L, 2019, EBIOMEDICINE; Gielen PR, 2015, J NEUROPATH EXP NEUR, V74, P390, DOI 10.1097/NEN.0000000000000183; Horikawa N, 2017, CLIN CANCER RES, V23, P587, DOI 10.1158/1078-0432.CCR-16-0387; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Karakasheva TA, 2018, JCI INSIGHT, P3; Krstevska V, 2015, J BUON, V20, P943; Kubota K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01661-z; Lechner MG, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-90; Li Y, 2019, CANCER LETT, V459, P268, DOI 10.1016/j.canlet.2019.05.026; Malek E, 2016, BLOOD REV, V30, P341, DOI 10.1016/j.blre.2016.04.002; McMillin DW, 2012, BLOOD, V119, pE131, DOI 10.1182/blood-2011-04-348490; Meng J, 2019, ONCOGENE, V38, P228, DOI 10.1038/s41388-018-0428-4; Najjar YG, 2017, CLIN CANCER RES, V23, P2346, DOI 10.1158/1078-0432.CCR-15-1823; Namdar A, 2018, CANCER IMMUNOL IMMUN, V67, P367, DOI 10.1007/s00262-017-2088-6; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qu JX, 2019, INT J CANCER, V145, P2225, DOI 10.1002/ijc.32355; Raychaudhuri B, 2015, J NEURO-ONCOL, V122, P293, DOI 10.1007/s11060-015-1720-6; Rong XM, 2016, ONCOTARGET, V7, P83976, DOI 10.18632/oncotarget.6930; Sevmis M, 2017, IMMUNOL INVEST, V46, P663, DOI 10.1080/08820139.2017.1360339; Shou DW, 2016, ONCOTARGET, V7, P64505, DOI 10.18632/oncotarget.11352; Simpson KD, 2012, J IMMUNOL, V189, P5533, DOI 10.4049/jimmunol.1201161; Solito S, 2014, ANN NY ACAD SCI, V1319, P47, DOI 10.1111/nyas.12469; Srivastava MK, 2008, CANCER IMMUNOL IMMUN, V57, P1493, DOI 10.1007/s00262-008-0490-9; STROBER S, 1984, ANNU REV IMMUNOL, V2, P219, DOI 10.1146/annurev.iy.02.040184.001251; Taki M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03966-7; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Toh B, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001162; Trillo-Tinoco J, 2019, CANC RES; Wang HF, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12600; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Yafune A, 2013, TOXICOL LETT, V222, P295, DOI 10.1016/j.toxlet.2013.08.006; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505; Zhang H, 2015, CANCER IMMUNOL IMMUN, V64, P1587, DOI 10.1007/s00262-015-1765-6; Zhang L, 2017, ONCOTARGET, V8, P819, DOI 10.18632/oncotarget.13661; Zhang S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164514; Zhao T, 2015, ONCOGENE, V34, P1938, DOI 10.1038/onc.2014.143; Zhao T, 2016, ONCOTARGET, V7, P1529, DOI 10.18632/oncotarget.6414; Zhong LM, 2019, ORAL ONCOL, V95, P157, DOI 10.1016/j.oraloncology.2019.06.004; Zhu H, 2017, ONCOTARGET, V8, P114554, DOI 10.18632/oncotarget.23020	51	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229089	10.1371/journal.pone.0229089	http://dx.doi.org/10.1371/journal.pone.0229089			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092078	Green Published, gold			2022-12-26	WOS:000535229300021
J	Sanjenbam, P; Buddidathi, R; Venkatesan, R; Shivaprasad, PV; Agashe, D				Sanjenbam, Pratibha; Buddidathi, Radhika; Venkatesan, Radhika; Shivaprasad, P., V; Agashe, Deepa			Phenotypic diversity of Methylobacterium associated with rice landraces in North-East India	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; CONSUMPTION; ADAPTATION; METHANOL; GROWTH; TRADE	The ecology and distribution of many bacteria is strongly associated with specific eukaryotic hosts. However, the impact of such host association on bacterial ecology and evolution is not well understood. Bacteria from the genus Methylobacterium consume plant-derived methanol, and are some of the most abundant and widespread plant-associated bacteria. In addition, many of these species impact plant fitness. To determine the ecology and distribution of Methylobacterium in nature, we sampled bacteria from 36 distinct rice landraces, traditionally grown in geographically isolated locations in North-East (NE) India. These landraces have been selected for diverse phenotypic traits by local communities, and we expected that the divergent selection on hosts may have also generated divergence in associated Methylobacterium strains. We determined the ability of 91 distinct rice-associated Methylobacterium isolates to use a panel of carbon sources, finding substantial variability in carbon use profiles. Consistent with our expectation, across spatial scales this phenotypic variation was largely explained by host landrace identity rather than geographical factors or bacterial taxonomy. However, variation in carbon utilisation was not correlated with sugar exudates on leaf surfaces, suggesting that bacterial carbon use profiles do not directly determine bacterial colonization across landraces. Finally, experiments showed that at least some rice landraces gain an early growth advantage from their specific phyllosphere-colonizing Methylobacterium strains. Together, our results suggest that landrace-specific host-microbial relationships may contribute to spatial structure in rice-associated Methylobacterium in a natural ecosystem. In turn, association with specific bacteria may provide new ways to preserve and understand diversity in one of the most important food crops of the world.	[Sanjenbam, Pratibha; Buddidathi, Radhika; Venkatesan, Radhika; Shivaprasad, P., V; Agashe, Deepa] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Agashe, D (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	dagashe@ncbs.res.in		Shivaprasad, Padubidri/0000-0002-9296-4848; Agashe, Deepa/0000-0002-0374-8159	Department of Biotechnology, India [DBT-358 NER/AGRI/24/2013]; National Centre for Biological Sciences	Department of Biotechnology, India(Department of Biotechnology (DBT) India); National Centre for Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by: DA, Grant DBT-358 NER/AGRI/24/2013 from the Department of Biotechnology, India, and by the National Centre for Biological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank members of the Agashe lab for critical comments and discussion; Krushnamegh Kunte, Jharna Chakravorty, Kar Singh Megu, WIbobi Singh, Indrajit, S Chandrakanta Singh, S Akeshore Singh and local farmers for assistance with field work; Sagolsem Surmangal Singh (Krishi Vigyan Kendra Thoubal, Manipur) for providing rice samples; IBSD (Institute of Bioresources and Sustainable Development, Imphal) for access to laboratory facilities during fieldwork; Rittik Deb and Saurabh Mahajan for help with statistical analysis; Christopher Marx for kindly providing M. radiotolerans JCM strain; and the Korean Agriculture Culture Collection for providing reference strains KACC11585, KACC11761, KACC11437, KACC12263, KACC11431, KACC11543, and KACC11544. We also thank Mahesh Sankaran for access to a flatbed scanner, and the instrumentation and mechanical workshop teams at NCBS for making a portable enclosure for bacterial work. We acknowledge funding and support from the Department of Biotechnology (grant DBT-358 NER/AGRI/24/2013) and the National Centre for Biological Sciences.	Abanda-Nkpwatt D, 2006, J EXP BOT, V57, P4025, DOI 10.1093/jxb/erl173; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2014, J APPL ECOL, DOI [DOI 10.1111/1365-2664.12306, DOI 10.1016/S0167-8809(99)00024-9]; Bell T, 2010, ISME J, V4, P1357, DOI 10.1038/ismej.2010.77; Biswajit Das, 2013, International Journal of Integrative Biology, V14, P1; BOURQUE D, 1992, APPL MICROBIOL BIOT, V37, P7; Delaney NF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062957; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Dourado MN, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/909016; Ferenci T, 2016, TRENDS MICROBIOL, V24, P209, DOI 10.1016/j.tim.2015.11.009; Grange AL, 2009, J STAT SOFTW, P30; Guittar J., 2019, NAT COMMUN, V10, P1, DOI [10.1038/s41467-019-11974-4, DOI 10.1038/S41467-019-11974-4, 10.1038/s41467-019-08377-w, DOI 10.1038/S41467-019-08377-W]; HALL JL, 1978, PLANTA, V140, P59, DOI 10.1007/BF00389380; Hanamaratti N, 2017, CURR SCI, V25, P242; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Hijmans, 2017, GEOSPHERE SPHERICAL; Hore DK, 2005, GENET RESOUR CROP EV, V52, P1129, DOI 10.1007/s10722-004-6084-2; Ivanova EG, 2006, MICROBIOLOGY+, V75, P494, DOI 10.1134/S0026261706040217; Ivanova E. G., 2000, Mikrobiologiya, V69, P764; Jackson CR, 2011, MICROB ECOL, V61, P113, DOI 10.1007/s00248-010-9742-2; Kembel SW, 2014, P NATL ACAD SCI USA, V111, P13715, DOI 10.1073/pnas.1216057111; Knief C, 2012, ISME J, V6, P1378, DOI 10.1038/ismej.2011.192; Knief C, 2010, ISME J, V4, P719, DOI 10.1038/ismej.2010.9; Koskella B, 2015, ANNU REV ECOL EVOL S, V46, P503, DOI 10.1146/annurev-ecolsys-112414-054458; Kotake T, 2016, J PLANT RES, V129, P781, DOI 10.1007/s10265-016-0834-z; Kraemer SA, 2017, MOL ECOL, V26, P1860, DOI 10.1111/mec.13958; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kutschera U, 2007, PLANT SIGNAL BEHAV, V2, P74, DOI 10.4161/psb.2.2.4073; Lawas LMF, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz050; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Leveau JHJ, 2001, P NATL ACAD SCI USA, V98, P3446, DOI 10.1073/pnas.061629598; Levy A, 2018, NAT GENET, V50, P138, DOI 10.1038/s41588-017-0012-9; Lindow SE, 2006, CURR OPIN MICROBIOL, V13, P238; Ma L, 2017, PLANT CELL PHYSIOL, V58, P863, DOI 10.1093/pcp/pcx040; Madhaiyan M, 2007, INT J SYST EVOL MICR, V57, P326, DOI 10.1099/ijs.0.64603-0; Maignien L, 2014, MBIO, V5, DOI 10.1128/mBio.00682-13; Meena KK, 2012, ANTON LEEUW INT J G, V101, P777, DOI 10.1007/s10482-011-9692-9; Mercier J, 2000, APPL ENVIRON MICROB, V66, P369, DOI 10.1128/AEM.66.1.369-374.2000; Minami T, 2016, MICROBES ENVIRON, V31, P268, DOI 10.1264/jsme2.ME16035; Muthayya S, 2014, ANN NY ACAD SCI, V1324, P7, DOI 10.1111/nyas.12540; Norris JR, 1972, METHODS MICROBIOLOGY, V66A; Opulente DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054403; Pommerrenig B, 2007, PLANT PHYSIOL, V144, P1029, DOI 10.1104/pp.106.089151; Richardson MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00288; Roman-Reyna V, 2019, BIORXIV, DOI [10.1101/615278, DOI 10.1101/615278]; Roy S, 2015, PLOS ONE, V10, P1; Ryffel F, 2016, ISME J, V10, P632, DOI 10.1038/ismej.2015.141; Schlechter RO, 2019, J ADV RES, V19, P57, DOI 10.1016/j.jare.2019.03.003; Travis AJ, 2015, RICE, V8, DOI 10.1186/s12284-015-0068-z; Umakanth B, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01500; Varma V, 2013, BLACK SPOT LEAF AREA; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Warnes G, 2016, R PACKAGE VERSION 3; Wenner S, 2011, SYST APPL MICROBIOL, V34, P621, DOI 10.1016/j.syapm.2011.08.005; Yoshida Y, 2018, BIOSCI BIOTECH BIOCH, V83, P1, DOI [10.1080/s00248-010-9814-7, DOI 10.1080/S00248-010-9814-7]	55	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0228550	10.1371/journal.pone.0228550	http://dx.doi.org/10.1371/journal.pone.0228550			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092057	Green Submitted, Green Published, gold			2022-12-26	WOS:000535229300011
J	Gentili, V; Bortolotti, D; Benedusi, M; Alogna, A; Fantinati, A; Guiotto, A; Turrin, G; Cervellati, C; Trapella, C; Rizzo, R; Valacchi, G				Gentili, Valentina; Bortolotti, Daria; Benedusi, Mascia; Alogna, Andrea; Fantinati, Anna; Guiotto, Anna; Turrin, Giulia; Cervellati, Carlo; Trapella, Claudio; Rizzo, Roberta; Valacchi, Giuseppe			HelixComplex snail mucus as a potential technology against O-3 induced skin damage	PLOS ONE			English	Article							REDOX REGULATION; CIGARETTE-SMOKE; AMBIENT OZONE; MECHANISMS; POLLUTION; RESPONSES	Mucus form H. aspersa muller has been reported to have several therapeutic proprieties, such as antimicrobial activity, skin protection and wound repair. In this study, we have analyzed H. aspersa mucus (Helixcomplex) bio-adhesive efficacy and its defensive properties against the ozone (O-3) (0.5 ppm for 2 hours) exposure in human keratinocytes and reconstructed human epidermis models. Cytotoxicity, tissue morphology and cytokine levels were determined. We confirmed HelixComplex regenerative and bio-adhesive properties, the latter possibly via the characteristic mucopolysaccharide composition. In addition, HelixComplex was able to protect from O-3 exposure by preventing oxidative damage and the consequent pro-inflammatory response in both 2D and 3D models. Based on this study, it is possible to suggest HelixComplex as a potentially new protective technology against pollution induced skin damage.	[Gentili, Valentina; Bortolotti, Daria; Alogna, Andrea; Fantinati, Anna; Turrin, Giulia; Trapella, Claudio; Rizzo, Roberta] Univ Ferrara, Dept Chem & Pharmaceut Sci, Ferrara, Italy; [Benedusi, Mascia; Guiotto, Anna; Cervellati, Carlo; Valacchi, Giuseppe] Univ Ferrara, Dept Biomed & Specialist Surg Sci, Sect Med Biochem Mol Biol & Genet, Ferrara, Italy; [Valacchi, Giuseppe] Plants Human Hlth Inst, Dept Anim Sci, North Carolina Res Campus, Kannapolis, NC 28081 USA; [Valacchi, Giuseppe] Kyung Hee Univ, Dept Food & Nutr, Seoul, South Korea	University of Ferrara; University of Ferrara; Kyung Hee University	Rizzo, R (corresponding author), Univ Ferrara, Dept Chem & Pharmaceut Sci, Ferrara, Italy.; Valacchi, G (corresponding author), Univ Ferrara, Dept Biomed & Specialist Surg Sci, Sect Med Biochem Mol Biol & Genet, Ferrara, Italy.; Valacchi, G (corresponding author), Plants Human Hlth Inst, Dept Anim Sci, North Carolina Res Campus, Kannapolis, NC 28081 USA.; Valacchi, G (corresponding author), Kyung Hee Univ, Dept Food & Nutr, Seoul, South Korea.	rbr@unife.it; gvalacc@ncsu.edu	Cervellati, Carlo/K-6453-2015; Trapella, Claudio/I-2128-2012; Gentili, Valentina/AAC-1028-2022; Bortolotti, Daria/K-5125-2016; Rizzo, Roberta/K-4844-2016	Cervellati, Carlo/0000-0003-4777-6300; Trapella, Claudio/0000-0002-6666-143X; Gentili, Valentina/0000-0003-4572-5497; Bortolotti, Daria/0000-0003-4496-9561; Rizzo, Roberta/0000-0001-9507-9126; Fantinati, Anna/0000-0003-0437-5670	Italian Ministry of Education, University and Research (PNR 2015-2020 project) [ARS01_01163]; Camera di Commercio di Ferrara	Italian Ministry of Education, University and Research (PNR 2015-2020 project); Camera di Commercio di Ferrara	CT and RR are grateful to Italian Ministry of Education, University and Research (https://www.miur.gov.it/) (PNR 2015-2020 project no ARS01_01163 Green Chemistry) and to Camera di Commercio di Ferrara (http://www.fe.camcom.it/) (2018 Grant; Activae Project) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortolotti D, 2019, AM J REPROD IMMUNOL, V82, DOI 10.1111/aji.13174; Bortolotti D, 2016, BRIT J BIOMED SCI, V73, P49, DOI 10.1080/09674845.2016.1155377; Bromberg PA, 2016, BBA-GEN SUBJECTS, V1860, P2771, DOI 10.1016/j.bbagen.2016.07.015; Cervellati F, 2014, TOXICOL IN VITRO, V28, P999, DOI 10.1016/j.tiv.2014.04.012; Cross CE, 2002, AM J RESP CRIT CARE, V166, pS44, DOI 10.1164/rccm.2206015; Dellambra E, 2019, ALTEX-ALTERN ANIM EX, V36, P177, DOI 10.14573/altex.1808022; [EEA European environment agency], 2017, AIR QUAL EUR 2017 RE; Forman HJ, 2014, FREE RADICAL BIO MED, V66, P24, DOI 10.1016/j.freeradbiomed.2013.05.045; Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395; Kousha T, 2015, J TOXICOL ENV HEAL A, V78, P524, DOI 10.1080/15287394.2014.991053; Larrieu S, 2009, AM J EPIDEMIOL, V169, P1201, DOI 10.1093/aje/kwp032; Lei YL, 2015, MED RES REV, V35, P306, DOI 10.1002/med.21330; Lim Y, 2006, TOXICOL LETT, V160, P127, DOI 10.1016/j.toxlet.2005.06.013; Lisowska E, 1996, BIOMETHODS SERIES, V7, P115; Angulo DEL, 2016, INT J BIOL MACROMOL, V92, P645, DOI 10.1016/j.ijbiomac.2016.07.029; Magnani ND, 2016, TOXICOL SCI, V149, P227, DOI 10.1093/toxsci/kfv230; McDaniel D, 2018, J COSMET DERMATOL-US, V17, P124, DOI 10.1111/jocd.12518; Muresan XM, 2019, ARCH BIOCHEM BIOPHYS, V666, P1, DOI 10.1016/j.abb.2019.03.005; Newar J, 2015, LANGMUIR, V31, P12155, DOI 10.1021/acs.langmuir.5b03498; Pecorelli A, 2019, BIOFACTORS, V45, P536, DOI 10.1002/biof.1513; Pryor WA, MECH RADICAL FORMATI; Sticozzi C, 2018, FREE RADICAL BIO MED, V126, P287, DOI 10.1016/j.freeradbiomed.2018.07.007; Sticozzi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033592; Sticozzi C, 2010, INT J MOL SCI, V11, P3375, DOI 10.3390/ijms11093375; Trapella C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35816-3; Valacchi G, 2005, BRIT J DERMATOL, V153, P1096, DOI 10.1111/j.1365-2133.2005.06939.x; Valacchi G, 2002, TOXICOLOGY, V179, P163, DOI 10.1016/S0300-483X(02)00240-8; Valacchi G, 2000, FEBS LETT, V466, P165, DOI 10.1016/S0014-5793(99)01787-1; Valacchi G, 2017, J INVEST DERMATOL, V137, P1373, DOI 10.1016/j.jid.2017.01.034; Valacchi G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131097; Valacchi G, 2015, INT J OCCUP MED ENV, V28, P771, DOI 10.13075/ijomeh.1896.00267; Valacchi G, 2012, ANN NY ACAD SCI, V1271, P75, DOI 10.1111/j.1749-6632.2012.06724.x; Valacchi G, 2009, EXP DERMATOL, V18, P516, DOI 10.1111/j.1600-0625.2008.00816.x; Weber SU, 2001, CURR PROBL DERMATOL, V29, P52; Xu F, 2011, BRIT J DERMATOL, V165, P224, DOI 10.1111/j.1365-2133.2011.10349.x	35	14	14	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229613	10.1371/journal.pone.0229613	http://dx.doi.org/10.1371/journal.pone.0229613			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084249	Green Published, gold, Green Submitted			2022-12-26	WOS:000535227900116
J	Najjaa, H; Ben Arfa, A; Elfalleh, W; Zouari, N; Neffati, M				Najjaa, Hanen; Ben Arfa, Abdelkarim; Elfalleh, Walid; Zouari, Nacim; Neffati, Mohamed			Jujube (Zizyphus lotus L.): Benefits and its effects on functional and sensory properties of sponge cake	PLOS ONE			English	Article							DIETARY FIBER; ANTIOXIDANT ACTIVITY; ACIDS COMPOSITION; FRUITS; CONSTITUENTS; ANTHOCYANIN; FLAVONOIDS; PRODUCTS; EXTRACT; COOKIES	Jujube (Ziziphus lotus L.) fruit has multiple functional properties and represents an interesting source of bioactive compounds. The purpose of this study was to improve the functionality and the sensory properties of sponge cake enriched with Z. lotus fruit. The polyphenols and flavonoids levels in the sponge cake and its antioxidant potential increased with the addition of 0-10 g of jujube powder/100 g of wheat flour. The crumb color parameters, L* and b*, decreased with the addition of jujube powder, whereas the a* value increased. In the texture analysis, addition of jujube powder resulted in an increase of the hardness and chewiness, but the springiness was reduced. The sensory evaluation showed that supplementation of jujube powder did not manifest any undesirable organoleptic response and showed satisfactory consumer acceptability. Overall, the addition at 5% jujube powder showed the finest sensory properties of the sponge cake.	[Najjaa, Hanen; Ben Arfa, Abdelkarim; Neffati, Mohamed] Inst Arid Reg, Lab Pastoral Ecosyst & Valorizat Spontaneous Plan, Medenine, Tunisia; [Elfalleh, Walid] Univ Gabes, Lab Energie Eau Environm & Proc, LEEEP LR18ES35, Ecole Natl Ingenieurs Gabes, Gabes, Tunisia; [Zouari, Nacim] Univ Gabes, High Inst Appl Biol Medenine ISBAM, Medenine, Tunisia	Institut des Regions Arides; Universite de Gabes; Universite de Gabes	Najjaa, H (corresponding author), Inst Arid Reg, Lab Pastoral Ecosyst & Valorizat Spontaneous Plan, Medenine, Tunisia.; Elfalleh, W (corresponding author), Univ Gabes, Lab Energie Eau Environm & Proc, LEEEP LR18ES35, Ecole Natl Ingenieurs Gabes, Gabes, Tunisia.	hanen.najjaa@yahoo.fr; Walid.elfalleh@fst.rnu.tn	Elfalleh, Walid/K-2368-2012	Elfalleh, Walid/0000-0002-3493-6451				Abdoul-Azize S, 2016, J NUTR METAB, V2016, DOI 10.1155/2016/2867470; Ayadi MA, 2009, IND CROP PROD, V30, P40, DOI 10.1016/j.indcrop.2009.01.003; Ayranci E, 2013, MOLECULES, V18, P1798, DOI 10.3390/molecules18021798; Ben Yakoub AR, 2018, IND CROP PROD, V118, DOI [10.1155/2016/2867470, DOI 10.1155/2016/2867470]; Benammar C, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-54; Borgi W, 2008, S AFR J BOT, V74, P320, DOI 10.1016/j.sajb.2008.01.009; Boudraa S, 2010, FRUITS, V65, P75, DOI 10.1051/fruits/20010003; Boulanouar B, 2013, IND CROP PROD, V46, P85, DOI 10.1016/j.indcrop.2013.01.020; Brighente IMC, 2007, PHARM BIOL, V45, P156, DOI 10.1080/13880200601113131; Brunet J, 2016, FOOD CHEM, V207, P27, DOI [10.1016/j.foodchem.2016.03.082, DOI 10.1016/J.FOODCHEM.2016.03.082]; Chang SC, 2010, INT J BIOL MACROMOL, V47, P445, DOI 10.1016/j.ijbiomac.2010.06.010; Dhingra D, 2012, J FOOD SCI TECH MYS, V49, P255, DOI 10.1007/s13197-011-0365-5; Dias SA, 2009, PHARM BIOL, V47, P717, DOI 10.1080/13880200902933336; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Elfalleh W, 2017, J FOOD PROCESS PRES, V41, DOI 10.1111/jfpp.13302; Fakhfakh N, 2017, LWT-FOOD SCI TECHNOL, V75, P656, DOI 10.1016/j.lwt.2016.10.015; Galla NR, 2010, FOOD HYDROCOLLOID, V24, P479, DOI 10.1016/j.foodhyd.2009.12.003; Ghazghazi H, 2014, NAT PROD RES, V28, P1106, DOI 10.1080/14786419.2014.913244; Hammi KM, 2017, INT J FOOD ENG, V13, DOI 10.1515/ijfe-2017-0343; Hammi KM, 2015, FOOD CHEM, V184, P80, DOI 10.1016/j.foodchem.2015.03.047; HATANO T, 1988, CHEM PHARM BULL, V36, P2090; Hong J-S, 1993, APPL BIOL CHEM, V36, P73; Hossain MA, 2019, J KING SAUD UNIV SCI, V31, P1352, DOI 10.1016/j.jksus.2018.12.003; Hsu CP, 2012, J AGR FOOD CHEM, V60, P3686, DOI 10.1021/jf204619n; Kakkar Sahil, 2014, ISRN Pharmacol, V2014, P952943, DOI 10.1155/2014/952943; Kang K-C, 1990, KOREAN J FOOD SCI TE, V22, P19; Kaptso KG, 2015, J FOOD SCI TECH MYS, V52, P4915, DOI 10.1007/s13197-014-1580-7; Khanduja KL, 2003, INDIAN J BIOCHEM BIO, V40, P416; Kim K-H, 2009, J KOREAN SOC FOOD SC, DOI [10.3746/jkfn.2009.38.7.926, DOI 10.3746/JKFN.2009.38.7.926]; Kindl M, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/403950; KINSELLA J E, 1976, Critical Reviews in Food Science and Nutrition, V7, P219; Kwon Dong-Jin, 2007, 한국식품저장유통학회지, V14, P414; Mishra K, 2012, FOOD CHEM, V130, P1036, DOI 10.1016/j.foodchem.2011.07.127; Murray JM, 2001, FOOD RES INT, V34, P461, DOI 10.1016/S0963-9969(01)00070-9; Nasri N, 2011, NAT PROD RES, V25, P1733, DOI 10.1080/14786419.2010.523827; Noda Y, 2000, TOXICOLOGY, V148, P119, DOI 10.1016/S0300-483X(00)00202-X; Nyam KL, 2009, LWT-FOOD SCI TECHNOL, V42, P1396, DOI 10.1016/j.lwt.2009.03.006; Piazza L, 1997, CEREAL CHEM, V74, P135, DOI 10.1094/CCHEM.1997.74.2.135; PROSKY L, 1988, J ASSOC OFF ANA CHEM, V71, P1017; Purlis E, 2007, J FOOD ENG, V80, P1107, DOI 10.1016/j.jfoodeng.2006.09.007; Romo C, 2008, J AM DIET ASSOC, V108, P76, DOI DOI 10.1016/j.jada.2008.06.205; Safari A, 2018, GREEN ENERGY TECHNOL, P1, DOI 10.1007/978-981-10-8393-8_1; Singh DP., 2018, J PLANT BIOCH PHYSL, V6, P1, DOI [10.4172/2329-9029.1000219, DOI 10.4172/2329-9029.1000219]; Sudha ML, 2007, FOOD CHEM, V104, P686, DOI 10.1016/j.foodchem.2006.12.016; Tang D, 2008, J SEP SCI, V31, P3519, DOI 10.1002/jssc.200800173; Uthumporn U, 2015, CYTA-J FOOD, V13, P220, DOI 10.1080/19476337.2014.942700; VRATANINA DL, 1978, J FOOD SCI, V43, P1590, DOI 10.1111/j.1365-2621.1978.tb02550.x; Yokozawa T, 1998, BIOCHEM PHARMACOL, V56, P213, DOI 10.1016/S0006-2952(98)00128-2; Zhao YX, 2013, MOLECULES, V18, P951, DOI 10.3390/molecules18010951	49	12	12	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0227996	10.1371/journal.pone.0227996	http://dx.doi.org/10.1371/journal.pone.0227996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084133	Green Published, gold			2022-12-26	WOS:000535227900013
J	Sarli, M; Novoa, MB; Mazzucco, MN; Signorini, ML; Echaide, IE; de Echaide, ST; Primo, ME				Sarli, Macarena; Novoa, Maria B.; Mazzucco, Matilde N.; Signorini, Marcelo L.; Echaide, Ignacio E.; de Echaide, Susana T.; Primo, Maria E.			A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge	PLOS ONE			English	Article							MAJOR SURFACE PROTEIN-2; T-LYMPHOCYTE; IMMUNOGENICITY; INFECTION; IDENTIFICATION; EXPRESSION; PEPTIDES; ANTIGENS; COMPLEX; IMPACT	Anaplasma marginale is the most prevalent tick-borne livestock pathogen with worldwide distribution. Bovine anaplasmosis is a significant threat to cattle industry. Anaplasmosis outbreaks in endemic areas are prevented via vaccination with live A. centrale produced in splenectomized calves. Since A. centrale live vaccine can carry other pathogens and cause disease in adult cattle, research efforts are directed to develop safe recombinant subunit vaccines. Previous work found that the subdominant proteins of A. marginale type IV secretion system (T4SS) and the subdominant elongation factor-Tu (Ef-Tu) were involved in the protective immunity against the experimental challenge in cattle immunized with the A. marginale outer membrane (OM). This study evaluated the immunogenicity and protection conferred by recombinant VirB9.1, VirB9.2, VirB10, VirB11, and Ef-Tu proteins cloned and expressed in E. coli. Twenty steers were randomly clustered into four groups (G) of five animals each. Cattle from G1 and G2 were immunized with a mixture of 50 mu g of each recombinant protein with Quil A (R) or Montanide (TM) adjuvants, respectively. Cattle from G3 and G4 (controls) were immunized with Quil A and Montanide adjuvants, respectively. Cattle received four immunizations at three-week intervals and were challenged with 107 A. marginale-parasitized erythrocytes 42 days after the fourth immunization. After challenge, all cattle showed clinical signs, with a significant drop of packed cell volume and a significant increase of parasitized erythrocytes (p<0.05), requiring treatment with oxytetracycline to prevent death. The levels of IgG2 induced in the immunized groups did not correlate with the observed lack of protection. Additional strategies are required to evaluate the role of these proteins and their potential utility in the development of effective vaccines.	[Sarli, Macarena; Novoa, Maria B.; Mazzucco, Matilde N.; Signorini, Marcelo L.; Echaide, Ignacio E.; de Echaide, Susana T.; Primo, Maria E.] Inst Nacl Tecnol Agr, Estn Expt Agr Rafaela, Santa Fe, Argentina; [Sarli, Macarena; Novoa, Maria B.; Signorini, Marcelo L.; Primo, Maria E.] Consejo Nacl Invest Cient & Tecn CONICET, Santa Fe, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Sarli, M (corresponding author), Inst Nacl Tecnol Agr, Estn Expt Agr Rafaela, Santa Fe, Argentina.; Sarli, M (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Santa Fe, Argentina.	sarli.macarena@inta.gob.ar		Novoa, Maria Belen/0000-0001-6726-5239; Sarli, Macarena/0000-0001-8592-6635	ANPCyT [PICT 2013-0369]; TCP INTA EEA Rafaela [426100]	ANPCyT(ANPCyT); TCP INTA EEA Rafaela	This work was supported by ANPCyT (PICT 2013-0369) and TCP INTA EEA Rafaela. Asoc. Coop. 426100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JR, 2005, J IMMUNOL, V174, P6702, DOI 10.4049/jimmunol.174.11.6702; Abdala A A, 1990, Rev Elev Med Vet Pays Trop, V43, P155; Albarrak SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046372; Anziani O., 1979, MEM REUN ANU INF TEC, P63; Baravalle ME, 2012, VET PARASITOL, V190, P391, DOI 10.1016/j.vetpar.2012.06.037; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brown WC, 1998, INFECT IMMUN, V66, P5406, DOI 10.1128/IAI.66.11.5406-5413.1998; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Coetzee JF, 2006, VET THER, V7, P347; Crowther JR., 2000, METHODS MOL BIOL; de la Fuente J, 2007, VET MICROBIOL, V119, P375, DOI 10.1016/j.vetmic.2006.09.011; Deirdre R., 2015, PLOS ONE, V10, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Diaz AA, 2010, BIOTECHNOL BIOENG, V105, P374, DOI 10.1002/bit.22537; Dormitzer PR, 2008, TRENDS BIOTECHNOL, V26, P659, DOI 10.1016/j.tibtech.2008.08.002; ERIKS IS, 1993, J CLIN MICROBIOL, V31, P2091, DOI 10.1128/JCM.31.8.2091-2096.1993; Gallimore A, 1998, EUR J IMMUNOL, V28, P3301, DOI 10.1002/(SICI)1521-4141(199810)28:10<3301::AID-IMMU3301>3.0.CO;2-Q; Gasparini MR, 2013, REV BRAS PARASITOL V, V22, P253, DOI 10.1590/S1984-29612013000200044; Guglielmone A. A., 1999, Revista de Medicina Veterinaria (Buenos Aires), V80, P66; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Junior DSG, 2010, MEM I OSWALDO CRUZ, V105, P843, DOI 10.1590/S0074-02762010000700001; Kocan KM, 2003, CLIN MICROBIOL REV, V16, P698, DOI 10.1128/CMR.16.4.698-712.2003; Kong B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020307; Lopez JE, 2005, INFECT IMMUN, V73, P8109, DOI 10.1128/IAI.73.12.8109-8118.2005; Lopez JE, 2008, J IMMUNOL METHODS, V332, P129, DOI 10.1016/j.jim.2007.12.018; Lopez JE, 2007, INFECT IMMUN, V75, P2333, DOI 10.1128/IAI.00061-07; Molad T, 2006, VET MICROBIOL, V113, P55, DOI 10.1016/j.vetmic.2005.10.026; Moore DP, 2011, VET PARASITOL, V175, P245, DOI 10.1016/j.vetpar.2010.10.020; Morse K, 2012, IMMUNOGENETICS, V64, P507, DOI 10.1007/s00251-012-0606-4; Noh SM, 2008, INFECT IMMUN, V76, P2219, DOI 10.1128/IAI.00008-08; Noh SM, 2013, CLIN VACCINE IMMUNOL, V20, P651, DOI 10.1128/CVI.00600-12; Noh SM, 2010, VACCINE, V28, P3741, DOI 10.1016/j.vaccine.2010.02.067; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; Oukka M, 1996, J IMMUNOL, V157, P3039; Palmer GH, 1999, PARASITOL TODAY, V15, P281, DOI 10.1016/S0169-4758(99)01469-6; POTGIETER FT, 1983, ONDERSTEPOORT J VET, V50, P29; Primo ME, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211149; ROGERS RJ, 1988, AUST VET J, V65, P285, DOI 10.1111/j.1751-0813.1988.tb16144.x; Sarli M, 2020, J VET DIAGN INVEST, V32, P70, DOI 10.1177/1040638719892953; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shkap V, 2002, INFECT IMMUN, V70, P642, DOI 10.1128/IAI.70.2.642-648.2002; Sutten EL, 2010, INFECT IMMUN, V78, P1314, DOI 10.1128/IAI.01207-09; Tabachnick WJ, 2010, J EXP BIOL, V213, P946, DOI 10.1242/jeb.037564; TEBELE N, 1991, INFECT IMMUN, V59, P3199, DOI 10.1128/IAI.59.9.3199-3204.1991; Telford JL, 2008, CELL HOST MICROBE, V3, P408, DOI 10.1016/j.chom.2008.05.004; Willadsen P, 2008, TRENDS PARASITOL, V24, P164, DOI 10.1016/j.pt.2008.01.005; Yang Z, 2014, KOREAN J PARASITOL, V52, P367, DOI [10.3347/kjp.2014.52.4.367, 10.3347/kjp.2014.52.4.367.]; Zhao LH, 2016, DIAGN PATHOL, V11, DOI 10.1186/s13000-016-0464-8	47	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229301	10.1371/journal.pone.0229301	http://dx.doi.org/10.1371/journal.pone.0229301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084216	gold, Green Published, Green Submitted			2022-12-26	WOS:000535227900086
J	Xie, MX; Niu, XQ				Xie, Mingxia; Niu, Xinqiang			A 3D roaming and collision detection algorithm applicable for massive spatial data	PLOS ONE			English	Article								In this paper, a novel 3D roaming algorithm considering collision detection and interaction is proposed that adopts a triangle mesh to organize and manage massive spatial data and uses a customized bounding box intersector to rapidly obtain the potential collided triangles. The proposed algorithm can satisfy the requirements of timeliness and practicability during complicated large 3D scene collision detection. Moreover, we designed a method to calculate the collision point coordinates according to the spatial position relation and distance change between the virtual collision detection sphere and triangles, with the triangle edges and three vertices being considered. Compared to the methods that use the native intersector of OpenSceneGraph (OSG) to obtain the collision point coordinates, the calculation efficiency of the proposed method is greatly improved. Usually, when there is a big split/pit in the scene, the viewpoints will fly off the scene due to the fall of the collision detection sphere, or the region interior cannot be accessed when the entrance of some local region (e.g., internal grotto) of the scene is too small. These problems are solved in this paper through 3D scene-path training and by self-adaptively adjusting the radius of the virtual collision detection sphere. The proposed 3D roaming and collision detection method applicable for massive spatial data overcomes the limitation that the existing roaming and collision detection methods are only applicable to 3D scenes with a small amount of data and simple models. It provides technical supports for freewill browsing and roaming of indoor/outdoor and overground/underground of the 3D scene in cases of massive spatial data.	[Xie, Mingxia] Minist Land & Resources, Key Lab Urban Land Resources Monitoring & Simulat, Shenzhen, Peoples R China; [Xie, Mingxia; Niu, Xinqiang] Changjiang Inst Survey Planning Design & Res, Wuhan, Peoples R China	Ministry of Natural Resources of the People's Republic of China	Xie, MX (corresponding author), Minist Land & Resources, Key Lab Urban Land Resources Monitoring & Simulat, Shenzhen, Peoples R China.; Xie, MX (corresponding author), Changjiang Inst Survey Planning Design & Res, Wuhan, Peoples R China.	xmx0424@aliyun.com			Open Fund of Key Laboratory of Urban Land Resources Monitoring and Simulation, Ministry of Land and Resources [KF-2018-03-050]; China Postdoctoral Science Foundation [2018M642800]; National Key R&D Program of China [2017YFC1502600]	Open Fund of Key Laboratory of Urban Land Resources Monitoring and Simulation, Ministry of Land and Resources; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Key R&D Program of China	This work was supported by the Project Supported by the Open Fund of Key Laboratory of Urban Land Resources Monitoring and Simulation, Ministry of Land and Resources (KF-2018-03-050), and China Postdoctoral Science Foundation (2018M642800), National Key R&D Program of China(2017YFC1502600).	Chen YJ, 2017, COMPUTER SIMULATION, V34, P268; Fauerby K., 2003, IMPROVED COLLISION D, V1, P48; He B, 2010, IEEE INT C COMP AID; He XZ, 2018, RES DYNAMIC PATH PLA; Jiang G.Y, 2012, THESIS U ELECT SCI T; Klosowski J. T., 2002, IEEE T VISUALIZATION, V4, P21; Li JJ, 2014, INDOOR BUILDING 3D M; [林涛 Lin Tao], 2012, [计算机仿真, Computer Simulation], V29, P277; Liu J., 2018, RES COLLISION DETECT; Ma Deng-wu, 2006, Journal of System Simulation, V18, P1058; Moore M., 1988, Computer Graphics, V22, P289, DOI 10.1145/378456.378528; Steed, 2018, IEEE T VIS COMPUT GR, V99, P1; Wang C, 2018, J SYSTEM SIMULATION, V30, P213; Wang TT, 2018, COMPUT GRAPH-UK, V73, P70, DOI 10.1016/j.cag.2018.04.001; [王崴 Wang Wei], 2016, [计算机应用与软件, Computer Applications and Software], V33, P235; Wang X., 2013, COMPUTER TECHNOLOGY, V23, P241; Wu QX, 2017, DESIGN IMPLEMENTATIO; Xiao J. L., 2016, ELECT DESIGN ENG, V24, P54; Yang X, 2011, COMPUTER TECHNOLOGY, V21, P32; Yang Y., 2015, TARGET DECISION OPTI; Zhao QK, 2010, RES IMPLEMENTATION I; Zhu H.-J., 2012, COMPUTER SYSTEM APPL, V21, P36; Zhu XX, 2018, COMPUTER TECHNOLOGY, V28, P207	23	2	2	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229038	10.1371/journal.pone.0229038	http://dx.doi.org/10.1371/journal.pone.0229038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084165	Green Published, gold			2022-12-26	WOS:000535227900044
J	Mwaura, M; Kao, K; Wambugu, J; Trollip, A; Sikhondze, W; Omesa, E; Dlamini, S; Mzizi, N; Dlamini, M; Sibandze, B; Dlamini, B; Albert, H; Dondorp, W; Engel, N				Mwaura, Muthoni; Kao, Kekeletso; Wambugu, Jesse; Trollip, Andre; Sikhondze, Welile; Omesa, Eunice; Dlamini, Sindi; Mzizi, Nompumelelo; Dlamini, Muyalo; Sibandze, Busizwe; Dlamini, Brian; Albert, Heidi; Dondorp, Wybo; Engel, Nora			Situating trade-offs: Stakeholder perspectives on overtreatment versus missed diagnosis in transition to Xpert MTB/RIF Ultra in Kenya and Swaziland	PLOS ONE			English	Article							ROLL-OUT; TUBERCULOSIS; ENGAGEMENT	Implementing new diagnostics in public health programs can involve difficult trade-off decisions between individual patient benefits and public health considerations. Such decision-making processes are often not documented and may not include engagement of affected communities. This paper examines the perspectives of stakeholders on the trade-off between over-treatment and missed diagnosis captured during decision-making workshops on the transition from use of Xpert MTB/RIF to diagnose tuberculosis to Xpert MTB/RIF Ultra in Kenya and Swaziland. Xpert MTB/RIF Ultra has an overall increase in sensitivity but a decrease in specificity when compared to its predecessor. We conducted a qualitative study using four focus group discussions with a total of 47 participants and non-participant observation. The analysis reveals how participants deemed Xpert MTB/RIF Ultra's reduced specificity vis-a-vis its increased sensitivity to be an acceptable trade-off. The way participants assessed this trade-off was shaped by their experiences with the general uncertainty of all diagnostic tests, alternative testing options, historical evolution of diagnostic practices, epidemiological factors and resource constraints. In assessing the trade-off community and individual benefit and harm was frequently discussed together. Qualitative research on stakeholder engagement activities for diagnostic development and implementation can identify everyday experiences and situate assessments and perspectives of key stakeholders and as such aid in decision-making, improving implementation as well as patient outcomes. Further research is needed on the intended and unintended consequences of such engagement activities, how findings are being incorporated by decision-makers, and the impact on programmatic implementation.	[Mwaura, Muthoni; Dondorp, Wybo; Engel, Nora] Maastricht Univ, Dept Hlth Eth & Soc, Maastricht, Netherlands; [Mwaura, Muthoni; Dondorp, Wybo; Engel, Nora] Maastricht Univ, Care & Publ Hlth Res Inst CAPHRI, Maastricht, Netherlands; [Kao, Kekeletso; Wambugu, Jesse; Trollip, Andre; Albert, Heidi] Fdn Innovat New Diagnost FIIND, Geneva, Switzerland; [Sikhondze, Welile; Mzizi, Nompumelelo; Dlamini, Muyalo; Sibandze, Busizwe; Dlamini, Brian] Minist Hlth, Natl TB Control Program, Mbabane, Eswatini; [Omesa, Eunice] Minist Hlth, Natl TB Leprosy & Lung Dis Program, Nairobi, Kenya; [Dlamini, Sindi] Minist Hlth, Swaziland Hlth Lab Serv, Mbabane, Eswatini	Maastricht University; Maastricht University	Engel, N (corresponding author), Maastricht Univ, Dept Hlth Eth & Soc, Maastricht, Netherlands.; Engel, N (corresponding author), Maastricht Univ, Care & Publ Hlth Res Inst CAPHRI, Maastricht, Netherlands.	n.engel@maastrichtuniversity.nl		Omesa, Eunice/0000-0002-0087-3333; Engel, Nora/0000-0002-1823-3908	Department for International Development, UK government [DFICORE-03]; Foundation for Innovative New Diagnostics	Department for International Development, UK government; Foundation for Innovative New Diagnostics	This project is supported by the Department for International Development, UK government. The URL of the funder's website is www.gov.uk/government/organisations/department-for-international-development.Grant number is DFICORE-03, and the funding was received by the Foundation for Innovative New Diagnostics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert H, 2016, EUR RESPIR J, V48, P516, DOI 10.1183/13993003.00543-2016; Bahr NC, 2018, LANCET INFECT DIS, V18, P68, DOI [10.1016/S1473-3099(17)30474-7, 10.1016/s1473-3099(17)30474-7]; CHAKRAVORTY S, 2017, AM SOC MICROBIOL, V8, DOI DOI 10.1128/MBIO.00812-17; Dans LF, 2011, J CLIN EPIDEMIOL, V64, P231, DOI 10.1016/j.jclinepi.2010.09.009; Dorman SE, 2018, LANCET INFECT DIS, V18, P76, DOI [10.1016/S1473-3099(17)30691-6, 10.1016/s1473-3099(17)30691-6]; Engel N, 2013, J EPIDEMIOL GLOB HEA, V3, P119, DOI 10.1016/j.jegh.2013.04.002; FIND, 2017, MULT NON DIAGN ACC S; Global Laboratory Initiative STP, 2017, PLANN COUNTR TRANS X; Juth N, 2012, INT LIBR ETH LAW NEW, V51, P1, DOI 10.1007/978-94-007-2045-9; Kendall EA, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002472; Lawn SD, 2012, EXPERT REV ANTI-INFE, V10, P631, DOI [10.1586/ERI.12.43, 10.1586/eri.12.43]; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lemke AA, 2015, GENET MED, V17, P949, DOI 10.1038/gim.2015.8; Ooko S., 2018, BUSINESS DAILY AFRIC; Reynolds L, 2018, CRIT PUBLIC HEALTH, V28, P257, DOI 10.1080/09581596.2018.1449598; Sanchez-Padilla E, 2012, EMERG INFECT DIS, V18, P29, DOI 10.3201/eid1801.110850; Sikhondze W, 2015, PUBLIC HEALTH ACTION, V5, P140, DOI 10.5588/pha.15.0001; Ulin PR, 2005, QUALITATIVE METHODS; Wambugu J., 2016, NATL TUBERCULOSIS LE; WHO, 2017, GLOB TUB REP 2017; World Health Organization, 2017, WHO M REPORT TECHNIC; World Health Organization, 2017, NEXT GEN XPERT R MTB; World Health Organization, 2008, ENG STAK RET TB CONT; Zar HJ, 2013, LANCET GLOB HEALTH, V1, pE97, DOI 10.1016/S2214-109X(13)70036-6	24	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228669	10.1371/journal.pone.0228669	http://dx.doi.org/10.1371/journal.pone.0228669			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074142	Green Published, gold, Green Submitted			2022-12-26	WOS:000535220600024
J	Singh, JA; Cleveland, JD				Singh, Jasvinder A.; Cleveland, John D.			National US time-trends in opioid use disorder hospitalizations and associated healthcare utilization and mortality	PLOS ONE			English	Article							UNITED-STATES; OVERDOSE DEATHS; CDC GUIDELINE; INCREASES; DRUG; PAIN	Background The opioid epidemic is a major public health crisis in the U.S. Contemporary data on opioid use disorder (OUD) related hospitalizations are needed. Our objective was to assess whether OUD hospitalizations and associated mortality are increasing over time and examine the factors associated healthcare utilization and mortality. Methods and findings We examined the rates of OUD hospitalizations and associated mortality using the U.S. National Inpatient Sample (NIS) data from 1998-2016. Multivariable-adjusted logistic regression assessed the association of demographic, clinical and hospital characteristics with inpatient mortality and healthcare utilization (total hospital charges, discharge to a rehabilitation facility, length of hospital stay) during the index hospitalization for opioid use disorder. We calculated the odds ratio (OR) and 95% confidence intervals (CI). We estimated 781,767 OUD hospitalizations. The rate of OUD hospitalization and associated mortality (/100,000 overall NIS hospitalizations) increased from 59.8 and 1.2 in 1998-2000 to 190.7 and 5.9 in 2015-16, respectively. In the multivariable-adjusted analysis, the following factors were associated with worse outcomes; compared to age < 34 years, older age was associated with higher risk of hospital charges above the median and length of stay > 3 days, slightly higher risk of discharge to a rehabilitation facility. Higher Deyo-Charlson score was associated with higher hospital charges, length of hospital stay, and inpatient mortality. Women had lower odds of inpatient mortality than men and blacks had lower odds of mortality than whites. Conclusions Rising OUD hospitalizations from 1998 to 2016 and increasing associated inpatient mortality are concerning. Certain groups are at higher risk of poor utilization outcomes and inpatient mortality. Resources and healthcare policies need to focus on the high-risk group to reduce mortality and associated utilization.	[Singh, Jasvinder A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Singh, Jasvinder A.; Cleveland, John D.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Singh, Jasvinder A.] Birmingham VA Med Ctr, Med Serv, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Singh, JA (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.; Singh, JA (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA.; Singh, JA (corresponding author), Birmingham VA Med Ctr, Med Serv, Birmingham, AL 35233 USA.	Jasvinder.md@gmail.com	Singh, Jasvinder/R-6172-2019	Singh, Jasvinder/0000-0003-3485-0006				Calcaterra S, 2013, DRUG ALCOHOL DEPEN, V131, P263, DOI 10.1016/j.drugalcdep.2012.11.018; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dowell D, 2016, HEALTH AFFAIR, V35, P1876, DOI 10.1377/hlthaff.2016.0448; Dowell D, 2016, AM FAM PHYSICIAN, V93, P970; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr6501e1, 10.1001/jama.2016.1464, 10.15585/mmwr.rr7103a1]; Haight SC, 2018, MMWR-MORBID MORTAL W, V67, P845, DOI 10.15585/mmwr.mm6731a1; Hser YI, 2017, J ADDICT MED, V11, P315, DOI 10.1097/ADM.0000000000000312; Kattan JA, 2016, AM J PUBLIC HEALTH, V106, P1430, DOI 10.2105/AJPH.2016.303274; Larochelle MR, 2018, ANN INTERN MED, V169, P137, DOI 10.7326/M17-3107; MANCHIKANTI L, 2012, PAIN PHYS S, V15, pES; Menendez ME, 2015, CLIN ORTHOP RELAT R, V473, P2402, DOI 10.1007/s11999-015-4173-5; Murthy VH, 2016, NEW ENGL J MED, V375, P2413, DOI 10.1056/NEJMp1612578; Nelson LS, 2015, JAMA-J AM MED ASSOC, V314, P1453, DOI 10.1001/jama.2015.12397; Peterson C, 2018, J SUBST ABUSE TREAT, V92, P35, DOI 10.1016/j.jsat.2018.06.008; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Seth P, 2018, MMWR-MORBID MORTAL W, V67, P349, DOI 10.15585/mmwr.mm6712a1; Song ZR, 2017, HEALTH AFFAIR, V36, P2054, DOI 10.1377/hlthaff.2017.0689; Sordo L, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1550; Unick GJ, 2017, INT J DRUG POLICY, V46, P112, DOI 10.1016/j.drugpo.2017.06.003; Veldhuizen S, 2014, ANN EPIDEMIOL, V24, P620, DOI 10.1016/j.annepidem.2014.06.001; Weiner SG, 2019, JT COMM J QUAL PATIE, V45, P3, DOI 10.1016/j.jcjq.2018.07.003; Yang YT, 2018, MAYO CLIN PROC, V93, P1177, DOI 10.1016/j.mayocp.2018.07.001	23	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0229174	10.1371/journal.pone.0229174	http://dx.doi.org/10.1371/journal.pone.0229174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7XT	32069314	Green Published, gold			2022-12-26	WOS:000535212900026
J	Alfaro-Ramirez, FU; Ramirez-Albores, JE; Vargas-Hernandez, JJ; Franco-Maass, S; Perez-Suarez, M				Uriel Alfaro-Ramirez, Farid; Enrique Ramirez-Albores, Jorge; Jesus Vargas-Hernandez, J.; Franco-Maass, Sergio; Perez-Suarez, Marlin			Potential reduction of Hartweg's Pine (Pinus hartwegii Lindl.) geographic distribution	PLOS ONE			English	Article							CLIMATE-CHANGE; TREE; CONSERVATION; SENSITIVITY; RESPONSES; IMPACTS; FOREST; MEXICO	Geographical distribution of forest species is closely regulated by environmental conditions, particularly temperature and precipitation. Climate change predicted by general circulation models is expected to modify the distribution of many species' distribution, especially those adapted to extreme environmental conditions, leading to large-scale migrations or local extinctions. The aim of this research was to determine the potential impact of climatic change on Pinus hartwegii geographic distribution and the niche breadth of its populations. Ecological niche models were used by generated with four different algorithms based on 19 bioclimatic variables in addition to altitude. Climatic niche breadth was delimited by the dispersion of species occurrence records within the intervals of the bioclimatic variables. We modelled future distribution based on three general circulation models, MIROC-ESMCHEM, CCSM4 and HadGEM2-ES, using two representative concentration pathways (RCP) 2.6 and 8.5, for two-time horizons 2050 and 2070. Niche breadth analysis showed narrow ranges of suitability, indicating a strong relationship between the presence of P. hartwegii with the temperature of the warmest quarter and precipitation of the coldest quarter. In addition, the suitability area of P. hartwegii is predicted to be reduced up to 70% by 2070; the populations of the extreme northern and southern latitudes will be reduced in greater proportion than those of central Mexico. This suggest that environmental suitability area of P. hartwegii are reduced by the effect of the increase in environmental temperature. Therefore, it is necessary to monitor extreme populations of this species in the long term in order to establish efficient conservation strategies and well adaptive management facing climate change.	[Uriel Alfaro-Ramirez, Farid; Enrique Ramirez-Albores, Jorge; Franco-Maass, Sergio; Perez-Suarez, Marlin] Univ Autonoma Estado Mexico, Inst Ciencias Agr & Rurales ICAR, Toluca De Lerdo, Estado De Mexic, Mexico; [Enrique Ramirez-Albores, Jorge] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Biol Evolut, Museo Zool Alfonso L Herrera, Ciudad De Mexico, Mexico; [Jesus Vargas-Hernandez, J.] Colegio Postgrad, Campus Montecillo,Carretera Mexico Texcoco, Montecillo, Estado De Mexic, Mexico	Universidad Nacional Autonoma de Mexico; Colegio de Postgraduados - Mexico	Perez-Suarez, M (corresponding author), Univ Autonoma Estado Mexico, Inst Ciencias Agr & Rurales ICAR, Toluca De Lerdo, Estado De Mexic, Mexico.	mperezs@uaemex.mx	Vargas-Hernández, J. Jesús/AAJ-9301-2020; Pérez-Suárez, Marlín/A-9850-2016	Vargas-Hernández, J. Jesús/0000-0001-7422-4953; Pérez-Suárez, Marlín/0000-0001-9996-4771; Alfaro-Ramirez, Farid Uriel/0000-0002-2604-7267	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [219696, 543046, 292688]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was funded by the Consejo Nacional de Ciencia y Tecnologia (CONACYT), basic science project number 219696 (https://www.conacyt.gob.mx/) to MPS and the PhD scholarship number 543046/292688 received by FUAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Alfaro-Ramirez FU, 2017, REV CHAPINGO SER CIE, V23, P261, DOI 10.5154/r.rchscfa.2016.10.055; Arriaga L., 2004, CAMBIO CLIMATICO VIS, P255; Arzate-Fernandez AM, 2016, DIVERSIDAD GENETICA; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown JL, 2017, PEERJ, V5, DOI 10.7717/peerj.4095; CALDERON G, 2005, FLORA FANEROGAMICA V; Castellanos-Acuna D, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00375.1; Collins W.J., 2008, 74 HCTN MET OFF HADL, DOI DOI 10.1088/1748-9326/8/2/024024; de Marco P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202403; Edenhofer O., 2014, CONTRIBUTION WORKING; ESRI, 2013, ARCGIS ARCMAP DESKT; FernuYndez-Eguiarte A., 2015, ACTUALIZACION ESCENA; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Fritts HC, 2001, TREE RINGS CLIMATE, P584; Gomez-Mendoza L, 2007, CONSERV BIOL, V21, P1545, DOI 10.1111/j.1523-1739.2007.00814.x; Gray PA, 2005, FOREST CHRON, V81, P655, DOI 10.5558/tfc81655-5; Guiterrez E, 2014, REV MEX BIODIVERS, V85, P179, DOI 10.7550/rmb.37737; HIjMAns R.J., 2012, DIVA GIS VERSION 7 5; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Jackson MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142110; KORNER C, 1995, ECOL STUD-ANAL SYNTH, V113, P45; Kozlowski TT, 2002, BOT REV, V68, P270, DOI 10.1663/0006-8101(2002)068[0270:AAAROW]2.0.CO;2; Kramer PJ, 1960, PHYSL TREES; LAUER W, 1978, ARCTIC ALPINE RES, V10, P383, DOI 10.2307/1550769; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; LYNCH M, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P234; Maciel-Mata Carlos Alberto, 2015, Acta univ, V25, P03, DOI 10.15174/au.2015.690; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Martinez-Meyer E, 2006, ORYX, V40, P411, DOI 10.1017/S0030605306001360; Martinez-Meyer Enrique, 2013, Biol Lett, V9, P20120637, DOI 10.1098/rsbl.2012.0637; Mckenney DW, 2007, BIOSCIENCE, V57, P939, DOI 10.1641/B571106; Mendes P, 2018, ENVIRON CONSERV, V45, P67, DOI [10.1017/s0376892917000194, 10.1017/S0376892917000194]; Met Office, 2008, HADLEY CTR GLOBAL EN; MUELLER LD, 1985, ECOLOGY, V66, P1204, DOI 10.2307/1939173; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Osorio-Olvera L., 2016, NICHETOOLBOX R PACKA; Owens HL, 2013, ECOL MODEL, V263, P10, DOI 10.1016/j.ecolmodel.2013.04.011; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Perry J. L., 1991, Proceedings. Seventh IEEE Conference on Artificial Intelligence Applications (Cat. No.91CH2967-8), P231, DOI 10.1109/CAIA.1991.120874; PETERS RL, 1990, FOREST ECOL MANAG, V35, P13, DOI 10.1016/0378-1127(90)90229-5; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; PETERSON AT, 2005, CLIMATE CHANGE BIODI, P211; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pompa-Garcia M, 2016, ATMOSFERA, V29, P209, DOI 10.20937/ATM.2016.29.03.03; R-Studio, 2016, R STUD SOFTW VERS 1; Reed TE, 2011, CONSERV BIOL, V25, P56, DOI 10.1111/j.1523-1739.2010.01552.x; Ricker M, 2007, CAN J FOREST RES, V37, P977, DOI 10.1139/X06-304; Rzedowski J., 1978, VEGETACI N M XICO, P432; Saenz-Romero C, 2016, REV CHAPINGO SER CIE, V22, P303, DOI 10.5154/r.rchscfa.2014.10.052; Saenz-Romero C, 2006, FOREST ECOL MANAG, V229, P340, DOI 10.1016/j.foreco.2006.04.014; Soberon J., 2009, MISC MAT, V49, P83; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; TRANQUIL.W, 1964, ANN REV PLANT PHYSIO, V15, P345, DOI 10.1146/annurev.pp.15.060164.002021; Villanueva-Diaz J, 2007, CLIMATIC CHANGE, V83, P117, DOI 10.1007/s10584-006-9144-0; Villers L, 2000, MEXICO VISION HACIA, P57; Viveros-Viveros H, 2009, FOREST ECOL MANAG, V257, P836, DOI 10.1016/j.foreco.2008.10.021; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x	60	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0229178	10.1371/journal.pone.0229178	http://dx.doi.org/10.1371/journal.pone.0229178			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7XT	32069302	Green Submitted, gold, Green Published			2022-12-26	WOS:000535212900027
J	Andreev, PS; Zhao, WJ; Wang, NZ; Smith, MM; Li, Q; Cui, XD; Zhu, M; Sansom, IJ				Andreev, Plamen S.; Zhao, Wenjin; Wang, Nian-Zhong; Smith, Moya M.; Li, Qiang; Cui, Xindong; Zhu, Min; Sansom, Ivan J.			Early Silurian chondrichthyans from the Tarim Basin (Xinjiang, China)	PLOS ONE			English	Article							FISHES; ORDOVICIAN; PLACODERM; HISTOLOGY; EVOLUTION; SCALES; SHARK	The Sinacanthida ordo nov. and Mongolepidida are spine- and scale-based taxa whose remains encompass some of the earliest reported fossils of chondrichthyan fish. Investigation of fragmentary material from the Early Silurian Tataertag and Ymogantau Formations of the Tarim Basin (Xinjiang Uygur Autonomous Region, China) has revealed a diverse mongolepidid and sinacanthid fauna dominated by mongolepids and sinacanthids in association with abundant dermoskeletal elements of the endemic 'armoured' agnathans known as galeaspids. Micro-computed tomography, scanning electron microscopy and histological sections were used to identify seven mongolepid genera (including Tielikewatielepis sinensis gen. et sp. nov., Xiaohaizilepis liui gen. et sp. nov. and Taklamakanolepis asiaticus gen. et sp. nov.) together with a new chondrichthyan (Yuanolepis bachunensis gen. et sp. nov.) with scale crowns consisting of a mongolepid-type atubular dentine (lamellin). Unlike the more elaborate crown architecture of mongolepids, Yuanolepis gen. nov. exhibits a single row of crown elements consistent with the condition reported in stem chondrichthyans from the Lower Devonian (e.g. in Seretolepis, Parexus). The results corroborate previous work by recognising lamellin as the main component of sinacanthid spines and point to corresponding developmental patterns shared across the dermal skeleton of taxa with lamellin and more derived chondrichthyans (e.g. Doliodus, Kathemacanthus, Seretolepis and Parexus). The Tarim mongolepid fauna is inclusive of coeval taxa from the South China Block and accounts for over two-thirds of the species currently attributed to Mongolepidida. This demonstrates considerable overlap between the Tarim and South China components of the Lower Silurian Zhangjiajie Vertebrate Fauna.	[Andreev, Plamen S.; Li, Qiang] Qujing Normal Univ, Res Ctr Nat Hist & Culture, Qujing, Yunnan, Peoples R China; [Andreev, Plamen S.; Zhao, Wenjin; Wang, Nian-Zhong; Cui, Xindong; Zhu, Min] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key CAS Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Zhao, Wenjin; Cui, Xindong; Zhu, Min] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhao, Wenjin; Zhu, Min] CAS Ctr Excellence Life & Paleoenvironm, Beijing, Peoples R China; [Smith, Moya M.] Nat Hist Museum London, Dept Earth Sci, London, England; [Smith, Moya M.] KCL, Fac Dent Oral & Craniofacial Sci, London, England; [Sansom, Ivan J.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Natural History Museum London; University of London; King's College London; University of Birmingham	Andreev, PS (corresponding author), Qujing Normal Univ, Res Ctr Nat Hist & Culture, Qujing, Yunnan, Peoples R China.; Andreev, PS; Zhu, M (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key CAS Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China.; Zhu, M (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Zhu, M (corresponding author), CAS Ctr Excellence Life & Paleoenvironm, Beijing, Peoples R China.	andreev@ivpp.ac.cn; zhumin@ivpp.ac.cn		Zhao, Wenjin/0000-0002-9649-2171; Andreev, Plamen/0000-0002-3496-1139	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB26000000, XDA19050102]; National Natural Science Foundation of China [41530102]; Key Research Program of Frontier Sciences, CAS [QYZDJ-SSW-DQC002]; Open Project Grant of the Key CAS Laboratory of Vertebrate Evolution and Human Origins, IVPP, CAS [LVEHO19001]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of Frontier Sciences, CAS; Open Project Grant of the Key CAS Laboratory of Vertebrate Evolution and Human Origins, IVPP, CAS	This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB26000000 to WJZ, XDA19050102 to MZ); the National Natural Science Foundation of China (41530102) to MZ; the Key Research Program of Frontier Sciences, CAS (Grant No. QYZDJ-SSW-DQC002) to MZ and an Open Project Grant of the Key CAS Laboratory of Vertebrate Evolution and Human Origins, IVPP, CAS (LVEHO19001 Project title: 'Evolution and diversity of Silurian jawed fish') to PSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge RJ, 2002, SILURIAN LLANDOVERY, P83; Andreev P, 2016, PEERJ, V4, DOI 10.7717/peerj.1850; Andreev PS, 2017, J VERTEBR PALEONTOL, V37, DOI 10.1080/02724634.2017.1245664; Burrow CJ, 2017, CAN J EARTH SCI, V54, P1248, DOI 10.1139/cjes-2017-0059; Burrow CJ, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.913421; Burrow CJ, 2013, ALCHERINGA, V37, P392, DOI 10.1080/03115518.2013.765656; Coates MI, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2418; Dean MN, 2006, ZOOLOGY, V109, P164, DOI 10.1016/j.zool.2006.03.002; Gagnier PY, 1996, PALAEONTOLOGY, V39, P241; Giles S, 2015, NATURE, V520, P82, DOI 10.1038/nature14065; Hanke GF, 2006, J VERTEBR PALEONTOL, V26, P526, DOI 10.1671/0272-4634(2006)26[526:AOTEDA]2.0.CO;2; Hanke Gavin F., 2010, P159; Hou H.-F., 1988, STRATIGRAPHY CHINA 7; Huxley T. H., 1880, Proceedings of the Zoological Society, P649; Jiang ZX, 2009, J EARTH SCI, V20, P921, DOI 10.1007/s12583-009-0079-z; Karatajute-Talimaa V., 1973, Palaeontographica Abt A, V143, P35; Karatajute-Talimaa V, 1997, PALEONTOL ZH, V5, P96; Karatajute-Talimaa Valentina, 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P39; Karatajute-Talimaa Valentina, 1998, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V1, P21; Karatajute-Talimaa Valentina, 1997, Geologija (Vilnius), V22, P5; KARATAJUTETALIM.V, 1992, FOSSIL FISHES LIVING, P223; KARATAJUTETALIMAA V, 1992, PALEONTOL ZH, P36; KARATAYUTETALIMAA VN, 1990, PALEONTOL ZH, P76; Li J., 1997, ACTA PALAEONTOLOGICA, V36, P136; Liu Shifan, 1995, Vertebrata Palasiatica, V33, P85; Liu Y-h., 1979, Acta Palaeontologica Sinica, V18, P592; Long JA, 2015, NATURE, V517, P196, DOI 10.1038/nature13825; Lu J, 2016, CURR BIOL, V26, P1602, DOI 10.1016/j.cub.2016.04.045; Lu Liwu, 2007, Acta Geoscientia Sinica, V28, P143; Maisey John G., 2017, American Museum Novitates, V3875, P1; Min Z, 1998, J VERTEBR PALEONTOL, V18, P650, DOI 10.1080/02724634.1998.10011091; Min Z, 1998, PALAEONTOLOGY, V41, P157; Orvig T., 1951, Arkiv for Zoologi (2), V2, P321; Pradel A, 2014, NATURE, V509, P608, DOI 10.1038/nature13195; Pradel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024938; Qiao T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163157; Qu Qing-Ming, 2010, Palaeoworld, V19, P146, DOI 10.1016/j.palwor.2009.11.003; Rong JY, 2019, SCI CHINA EARTH SCI, V62, P89, DOI 10.1007/s11430-017-9258-0; Rong JY., 2003, SILURIAN LANDS SEAS, V493, P243; Sansom IJ, 1996, NATURE, V379, P628, DOI 10.1038/379628a0; Sansom IJ, 2000, T ROY SOC EDIN-EARTH, V90, P255; Sansom IJ, 2005, ZOOL J LINN SOC-LOND, V144, P379, DOI 10.1111/j.1096-3642.2005.00171.x; Sansom IJ, 2001, SYST ASSOC SPEC VOL, V61, P156; Sansom IJ, 2019, EVOLUTION DEV FISHES, P274; Sansom IJ, 2012, PALAEONTOLOGY, V55, P243, DOI 10.1111/j.1475-4983.2012.01127.x; SCHULTZE H.-P., 1979, HDB PALEOICHTHYOLOGY, V5; Sennikov NV, 2015, PALAEOWORLD, V24, P231, DOI 10.1016/j.palwor.2015.02.001; Smith M.M., 2000, P65, DOI 10.1017/CBO9780511542626.005; Wang J-Q, 1996, NEW ADV STUDY PETROL, P8; Wang Jun-Qing, 2002, Vertebrata Palasiatica, V40, P245; Wang N.Z., 1986, 13 14 ANN CONV PAL S, P49; Wang Nianzhong, 1998, Vertebrata Palasiatica, V36, P257; Wang NZ, 2005, J VERTEBR PALEONTOL, V25, P745, DOI 10.1671/0272-4634(2005)025[0745:HOTGDA]2.0.CO;2; Xia SF, 1991, STUDY OIL GAS GEOLOG; Zhang C., 2001, OIL GAS GEOL, V22, P314; Zhang Shibeng, 1995, Journal of Stratigraphy, V19, P133; Zhao JH, 2016, ARAB J GEOSCI, V9, DOI 10.1007/s12517-016-2557-9; Zhao Wen-jin, 2009, Journal of Stratigraphy, V33, P225; Zhao Wen-Jin, 2010, Palaeoworld, V19, P4, DOI 10.1016/j.palwor.2009.11.007; Zhao WJ, 2018, ACTA GEOL POL, V68, P475, DOI 10.1515/agp-2018-0006; Zhao Wenjin, 2014, Dixue Qianyuan, V21, P185; ZHOU Z., 1992, BIOSTRATIGRAPHY GEOL; Zhu M, 2016, SCIENCE, V354, P334, DOI 10.1126/science.aah3764; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; Zigaite Z, 2008, ACTA GEOL POL, V58, P127; Zigaite Z, 2011, J MICROPALAEONTOL, V30, P97, DOI 10.1144/0262-821X11-016	66	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228589	10.1371/journal.pone.0228589	http://dx.doi.org/10.1371/journal.pone.0228589			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053606	Green Published, gold			2022-12-26	WOS:000535198700036
J	Bennett, DE; Meyler, KL; Cafferkey, MT; Cunney, RJ				Bennett, Desiree E.; Meyler, Kenneth L.; Cafferkey, Mary T.; Cunney, Robert J.			Diversity of meningococci associated with invasive meningococcal disease in the Republic of Ireland over a 19 year period, 1996-2015	PLOS ONE			English	Article							MENINGITIDIS SEROGROUP Y; H-BINDING-PROTEIN; NEISSERIA-MENINGITIDIS; SEQUENCE TYPE; MULTICOMPONENT VACCINE; NATIONAL SURVEILLANCE; EPIDEMIOLOGY; ENGLAND; WALES; COVERAGE	This study examined the capsular phenotype and genotype of invasive meningococcal disease (IMD)-associated Neisseria meningitidis recovered in the Republic of Ireland (RoI) between 1996 and 2015. This time period encompasses both pre- (when IMD was hyperendemic in the RoI) and post- meningococcal serogroup C conjugate (MCC) vaccine introduction. In total, 1327 isolates representing over one-third of all laboratory-confirmed cases of IMD diagnosed each epidemiological year (EY), were characterised. Serogroups B (menB) and C (menC) predominated throughout, although their relative abundance changed; with an initial increase in the proportion of menC in the late 1990s followed by their dramatic reduction post-MCC vaccine implementation and a concomitant dominance of menB, despite an overall decline in IMD incidence. While the increase in menC was associated with expansion of specific clonal-complexes (cc), cc11 and cc8; the dominance of menB was not. There was considerable variation in menB-associated cc with declines in cc41/44 and cc32, and increases in cc269 and cc461, contributing to a significant increase in the clonal diversity of menB isolates over the study. This increase in diversity was also displayed among the serosubtyping data, with significant declines in proportions of menB isolates expressing p1.4 and p1.15 antigens. These data highlight the changing diversity of IMD-associated meningococci since 1996 in the RoI and emphasise the need for on-going surveillance particularly in view of the recent introduction of a menB vaccine.	[Bennett, Desiree E.; Meyler, Kenneth L.; Cafferkey, Mary T.; Cunney, Robert J.] Childrens Hlth Ireland, Irish Meningitis & Sepsis Reference Lab, Dublin, Ireland; [Cafferkey, Mary T.; Cunney, Robert J.] Royal Coll Surgeons Ireland, Dept Microbiol, Dublin, Ireland; [Cunney, Robert J.] Childrens Hlth Ireland, Dept Clin Microbiol, Dublin, Ireland	Royal College of Surgeons - Ireland	Bennett, DE (corresponding author), Childrens Hlth Ireland, Irish Meningitis & Sepsis Reference Lab, Dublin, Ireland.	desiree.bennett@cuh.ie			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abad R, 2016, J INFECTION, V73, P296, DOI 10.1016/j.jinf.2016.06.010; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Bambini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065043; Bennett D, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S0950268819000396, 10.1017/s0950268819000396]; Bennett DE, 2006, J CLIN MICROBIOL, V44, P1127, DOI 10.1128/JCM.44.3.1127-1131.2006; Bennett DE, 2003, J MED MICROBIOL, V52, P781, DOI 10.1099/jmm.0.05225-0; Bevivino A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-228; Bijlsma MW, 2014, LANCET INFECT DIS, V14, P805, DOI 10.1016/S1473-3099(14)70806-0; Borgo F, 2007, INT DAIRY J, V17, P336, DOI 10.1016/j.idairyj.2006.03.002; Brehony C, 2007, FEMS MICROBIOL REV, V31, P15, DOI 10.1111/j.1574-6976.2006.00056.x; Brehony C, 2016, VACCINE, V34, P4690, DOI 10.1016/j.vaccine.2016.08.015; Clark SA, 2016, J INFECTION, V73, P63, DOI 10.1016/j.jinf.2016.03.012; Diep BA, 2003, J CLIN MICROBIOL, V41, P4559, DOI 10.1128/JCM.41.10.4559-4564.2003; du Chatelet IP, 2017, J INFECTION, V74, P564, DOI 10.1016/j.jinf.2017.02.011; Dyet KH, 2006, EPIDEMIOL INFECT, V134, P377, DOI 10.1017/S0950268805004954; Dyet KH, 2004, J CLIN MICROBIOL, V42, P1742, DOI 10.1128/JCM.42.4.1742-1745.2004; ECDC, 2019, INV MEN DIS ANN EP R; Findlow H, 2019, EUROSURVEILLANCE, V24, P17, DOI 10.2807/1560-7917.ES.2019.24.1.1700818; Fogarty I, 1997, Commun Dis Rep CDR Rev, V7, pR9; Gilca R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050659; Gray SJ, 2006, J MED MICROBIOL, V55, P887, DOI 10.1099/jmm.0.46288-0; Grunwald NJ, 2003, PHYTOPATHOLOGY, V93, P738, DOI 10.1094/PHYTO.2003.93.6.738; Hahne SJM, 2002, LANCET, V359, P582, DOI 10.1016/S0140-6736(02)07716-4; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Health Cluster Iraq, 2018, IRAQ QUAL CAR 2018 A, P1; Hedberg ST, 2011, EUROSURVEILLANCE, V16, P8; Heinsbroek E, 2013, J INFECTION, V67, P385, DOI 10.1016/j.jinf.2013.06.007; Helgerson Amy F, 2006, J Clin Microbiol, V44, P3074, DOI 10.1128/JCM.00617-06; Hickey P, 2015, SMOKING IRELAND 2014; Hickey P, 2014, SMOKING IRELAND 2013; Hill DMC, 2015, LANCET INFECT DIS, V15, P1420, DOI 10.1016/S1473-3099(15)00267-4; Jamieson FB, 2013, J MED MICROBIOL, V62, P46, DOI 10.1099/jmm.0.050369-0; Jandova Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167762; Jolley KA, 2007, FEMS MICROBIOL REV, V31, P89, DOI 10.1111/j.1574-6976.2006.00057.x; Jolley Keith A, 2018, Wellcome Open Res, V3, P124, DOI 10.12688/wellcomeopenres.14826.1; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Keogan S, 2012, THESIS; Kinlin LM, 2009, AM J EPIDEMIOL, V169, P588, DOI 10.1093/aje/kwn383; Knol MJ, 2017, LANCET PUBLIC HEALTH, V2, pE473, DOI 10.1016/S2468-2667(17)30157-3; Kyaw MH, 2002, J CLIN MICROBIOL, V40, P1834, DOI 10.1128/JCM.40.5.1834-1837.2002; Ladhani SN, 2015, CLIN INFECT DIS, V60, P578, DOI 10.1093/cid/ciu881; Ladhani SN, 2012, EMERG INFECT DIS, V18, P63, DOI 10.3201/eid1801.110901; Lucidarme J, 2015, J INFECTION, V71, P544, DOI 10.1016/j.jinf.2015.07.007; Lucidarme J, 2010, CLIN VACCINE IMMUNOL, V17, P919, DOI 10.1128/CVI.00027-10; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mallik S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-158; Mattheus W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139615; Mulhall RM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216771; Mulhall RM, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00196-18; Murphy KM, 2003, BRIT J BIOMED SCI, V60, P204, DOI 10.1080/09674845.2003.11783700; Muscat M, 2009, J MED MICROBIOL, V58, P1492, DOI 10.1099/jmm.0.011312-0; Mustapha MM, 2016, VACCINE, V34, P1515, DOI 10.1016/j.vaccine.2016.02.014; Neri A, 2012, J PREV MED HYG, V53, P109; Norheim G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003312; O'Connor L, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.21.21139; O'Lorcain P, 2018, PUBLIC HEALTH, V156, P44, DOI 10.1016/j.puhe.2017.11.027; Parikh SR, 2017, LANCET INFECT DIS, V17, P754, DOI 10.1016/S1473-3099(17)30170-6; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; Rebolledo J, 2014, EPIDEMIOL INFECT, V142, P1826, DOI 10.1017/S0950268813002732; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Sorhouet-Pereira C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058065; Stefanelli P, 2016, J INFECTION, V73, P136, DOI 10.1016/j.jinf.2016.05.003; Toros B, 2015, J CLIN MICROBIOL, V53, P2154, DOI 10.1128/JCM.03524-14; Tsang RSW, 2015, CAN J INFECT DIS MED, V26, P299, DOI 10.1155/2015/393659; Tzanakaki G, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-111; Vega T, 2015, INFLUENZA OTHER RESP, V9, P234, DOI 10.1111/irv.12330; Vescio F, 2015, EPIDEMIOL INFECT, V143, P1742, DOI 10.1017/S0950268814002659; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; Wasko I, 2015, POL J MICROBIOL, V64, P313, DOI 10.5604/17331331.1185912; Watkins ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045349; WEDEGE E, 1990, J MED MICROBIOL, V31, P195, DOI 10.1099/00222615-31-3-195; Whittaker R, 2017, VACCINE, V35, P2034, DOI 10.1016/j.vaccine.2017.03.007; Zarantonelli ML, 2008, CLIN MICROBIOL INFEC, V14, P467, DOI 10.1111/j.1469-0691.2008.01955.x	74	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228629	10.1371/journal.pone.0228629	http://dx.doi.org/10.1371/journal.pone.0228629			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053601	Green Published, gold, Green Submitted			2022-12-26	WOS:000535198700038
J	Jorba, G; Aguirre-Plans, J; Junet, V; Segu-Verges, C; Ruiz, JL; Pujol, A; Fernandez-Fuentes, N; Mas, JM; Oliva, B				Jorba, Guillem; Aguirre-Plans, Joaquim; Junet, Valentin; Segu-Verges, Cristina; Luis Ruiz, Jose; Pujol, Albert; Fernandez-Fuentes, Narcis; Manuel Mas, Jose; Oliva, Baldo			In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; HEART-FAILURE; MACULAR DEGENERATION; MINERALOCORTICOID RECEPTOR; NEPRILYSIN INHIBITION; ADULT; DYSREGULATION; DYSFUNCTION; EXPRESSION; VARIANTS	Unveiling the mechanism of action of a drug is key to understand the benefits and adverse reactions of a medication in an organism. However, in complex diseases such as heart diseases there is not a unique mechanism of action but a wide range of different responses depending on the patient. Exploring this collection of mechanisms is one of the clues for a future personalized medicine. The Therapeutic Performance Mapping System (TPMS) is a Systems Biology approach that generates multiple models of the mechanism of action of a drug. Each molecular mechanism generated could be associated to particular individuals, here defined as prototype-patients, hence the generation of models using TPMS technology may be used for detecting adverse effects to specific patients. TPMS operates by (1) modelling the responses in humans with an accurate description of a protein network and (2) applying a Multilayer Perceptron-like and sampling strategy to find all plausible solutions. In the present study, TPMS is applied to explore the diversity of mechanisms of action of the drug combination sacubitril/valsartan. We use TPMS to generate a wide range of models explaining the relationship between sacubitril/valsartan and heart failure (the indication), as well as evaluating their association with macular degeneration (a potential adverse effect). Among the models generated, we identify a set of mechanisms of action associated to a better response in terms of heart failure treatment, which could also be associated to macular degeneration development. Finally, a set of 30 potential biomarkers are proposed to identify mechanisms (or prototype-patients) more prone of suffering macular degeneration when presenting good heart failure response. All prototype-patients models generated are completely theoretical and therefore they do not necessarily involve clinical effects in real patients. Data and accession to software are available at http://sbi.upf.edu/data/tpms/.	[Jorba, Guillem; Junet, Valentin; Segu-Verges, Cristina; Luis Ruiz, Jose; Pujol, Albert; Manuel Mas, Jose] Anax Biotech SL, Barcelona, Catalonia, Spain; [Jorba, Guillem; Aguirre-Plans, Joaquim; Oliva, Baldo] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Struct Bioinformat Grp, Res Programme Biomed Informat, Barcelona, Catalonia, Spain; [Junet, Valentin] Univ Autanoma Barcelona, Inst Biotechnol & Biomed, Cerdanyola Del Valles, Catalonia, Spain; [Fernandez-Fuentes, Narcis] Univ Cent Catalunya, Dept Biosci, Univ Vic, U Sci Tech, Viv, Catalonia, Spain	Pompeu Fabra University; Autonomous University of Barcelona; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC)	Mas, JM (corresponding author), Anax Biotech SL, Barcelona, Catalonia, Spain.; Oliva, B (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Struct Bioinformat Grp, Res Programme Biomed Informat, Barcelona, Catalonia, Spain.	xouse@anaxomics.com; baldo.oliva@upf.edu	Aguirre-Plans, Joaquim/K-4089-2017	Aguirre-Plans, Joaquim/0000-0002-1971-1350; Jorba, Guillem/0000-0001-5209-5353; Junet, Valentin/0000-0002-6138-0612; Fernandez-Fuentes, Narcis/0000-0002-6421-1080	Spanish Ministry of Economy (MINECO) [BIO2017-85329-R, RYC-2015-17519]; "Unidad de Excelencia Maria de Maeztu" - Spanish Ministry of Economy [MDM-2014-0370]; PE I+D+i 2013-2016 - ISCIII [PT13/0001/0023]; FEDER; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [765912, 765158]; Agencia de Gestio D'ajuts Universitaris i de Recerca Generalitat de Catalunya [2017SGR00519]	Spanish Ministry of Economy (MINECO); "Unidad de Excelencia Maria de Maeztu" - Spanish Ministry of Economy; PE I+D+i 2013-2016 - ISCIII; FEDER(European Commission); European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant; Agencia de Gestio D'ajuts Universitaris i de Recerca Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya)	Public funders provided support for authors salaries: JAP, NFF and BO received support from the Spanish Ministry of Economy (MINECO) [BIO2017-85329-R] [RYC-2015-17519]; "Unidad de Excelencia Maria de Maeztu", funded by the Spanish Ministry of Economy [ref: MDM-2014-0370]. The Research Programme on Biomedical Informatics (GRIB) is a member of the Spanish National Bioinformatics Institute (INB), PRB2-ISCIII and is supported by grant PT13/0001/0023, of the PE I+D+i 2013-2016, funded by ISCIII and FEDER. GJ has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 765912. VJ is part of a project (COSMIC; www.cosmic-h2020.eu) that has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 765158. Funding for publication is from Agencia de Gestio D'ajuts Universitaris i de Recerca Generalitat de Catalunya [2017SGR00519]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Plans J, 2019, J MOL BIOL, V431, P2477, DOI 10.1016/j.jmb.2019.02.027; Albert-Fort M, 2014, EXP EYE RES, V124, P1, DOI 10.1016/j.exer.2014.04.018; Anaxomics Biotech SL, 2018, BIOL EFF DAT; Aoyagi T, 2011, CURR PHARM DESIGN, V17, P1818, DOI 10.2174/138161211796390976; Banevicius M, 2018, MED SCI MONITOR, V24, P190, DOI 10.12659/MSM.905311; Baranello RJ, 2015, CURR ALZHEIMER RES, V12, P32, DOI 10.2174/1567205012666141218140953; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Bujak M, 2009, ARCH IMMUNOL THER EX, V57, P165, DOI 10.1007/s00005-009-0024-y; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Childers RC, 2019, AM J PHYSIOL-HEART C, V316, pH596, DOI 10.1152/ajpheart.00095.2018; Collet P, 2011, INTELL INF TECHNOL, P1121, DOI [10.4018/978-1-59904-941-0.ch064, DOI 10.4018/978-1-59904-941-0.CH064]; DUBUISSON MP, 1994, INT C PATT RECOG, P566, DOI 10.1109/ICPR.1994.576361; Ennis IL, 2013, CURR CARDIOL REV, V9, P230, DOI 10.2174/1573403X113099990034; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Feldman AM, 2016, JAMA-J AM MED ASSOC, V315, P25, DOI 10.1001/jama.2015.17632; Frank RN, 1997, OPHTHALMIC RES, V29, P341, DOI 10.1159/000268032; Galindo Cristi L, 2014, Curr Heart Fail Rep, V11, P40; Garbayo E, 2016, SCI REP-UK, V6, DOI 10.1038/srep25932; Glenn JV, 2009, BBA-GEN SUBJECTS, V1790, P1109, DOI 10.1016/j.bbagen.2009.04.016; Gomez-Florit M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22444; Grossniklaus HE, 2004, AM J OPHTHALMOL, V137, P496, DOI 10.1016/j.ajo.2003.09.042; Han H, 2018, NUCLEIC ACIDS RES, V46, pD380, DOI 10.1093/nar/gkx1013; Hecker N, 2012, NUCLEIC ACIDS RES, V40, pD1113, DOI 10.1093/nar/gkr912; Hegab Z, 2012, WORLD J CARDIOL, V4, P90, DOI 10.4330/wjc.v4.i4.90; Herrando-Grabulosa M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147626; Higgins P, 2015, J MOL GENET MED, V8, P101, DOI [10.4172/1747-0862.1000101, DOI 10.4172/1747-0862.1000101]; Iborra-Egea O, 2019, JACC-BASIC TRANSL SC, V4, P831, DOI 10.1016/j.jacbts.2019.07.010; Iborra-Egea O, 2017, NPJ SYST BIOL APPL, V3, DOI 10.1038/s41540-017-0013-4; Kaarniranta K, 2013, AUTOPHAGY, V9, P973, DOI 10.4161/auto.24546; Kaarniranta K, 2011, J ALZHEIMERS DIS, V24, P615, DOI 10.3233/JAD-2011-101908; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; KARSANOV NV, 1986, BASIC RES CARDIOL, V81, P199, DOI 10.1007/BF01907384; Kawano H, 2000, HYPERTENSION, V35, P273, DOI 10.1161/01.HYP.35.1.273; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Lako-Futo Z, 2003, CIRCULATION, V108, P2414, DOI 10.1161/01.CIR.0000093193.63314.D9; Lee AY, 2010, BRIT J OPHTHALMOL, V94, P915, DOI 10.1136/bjo.2009.172007; Liu YH, 1997, J CLIN INVEST, V99, P1926, DOI 10.1172/JCI119360; Liu YC, 2015, GENOMICS, V105, P83, DOI 10.1016/j.ygeno.2014.12.002; Loren V, 2019, J CROHNS COLITIS, V13, P351, DOI 10.1093/ecco-jcc/jjy171; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Messaoudi S, 2012, MOL CELL ENDOCRINOL, V350, P266, DOI 10.1016/j.mce.2011.06.038; Miyata M, 2012, CIRC J, V76, P843, DOI 10.1253/circj.CJ-12-0153; Nassar K, 2015, GRAEF ARCH CLIN EXP, V253, P699, DOI 10.1007/s00417-014-2738-8; Nowak JZ, 2014, ACTA POL PHARM, V71, P900; Ohno-Matsui K, 2011, PROG RETIN EYE RES, V30, P217, DOI 10.1016/j.preteyeres.2011.02.004; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Oubina MP, 2002, J HYPERTENS, V20, P303, DOI 10.1097/00004872-200202000-00021; Pappalardo F, 2019, BRIEF BIOINFORM, V20, P1699, DOI 10.1093/bib/bby043; Patel VB, 2013, CIRC RES, V112, P1542, DOI 10.1161/CIRCRESAHA.111.300299; Perera S., 2014, NUTRAfoods, V13, P61; Pickering RJ, 2019, J CLIN INVEST, V129, P406, DOI 10.1172/JCI99987; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Pujol A, 2010, TRENDS PHARMACOL SCI, V31, P115, DOI 10.1016/j.tips.2009.11.006; Riddell Elizabeth, 2017, Curr Heart Fail Rep, V14, P134, DOI 10.1007/s11897-017-0327-y; Romeo-Guitart D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19767-3; Schrier RW, 2000, KIDNEY INT, V57, P1418, DOI 10.1046/j.1523-1755.2000.00986.x; Singh JSS, 2017, HEART, V103, P1569, DOI 10.1136/heartjnl-2017-311295; Skeie JM, 2011, MOL VIS, V17, P576; Sohn YI, 2013, BIOCHEM BIOPH RES CO, V439, P464, DOI 10.1016/j.bbrc.2013.08.091; Solomon SD, 2017, JACC-HEART FAIL, V5, P471, DOI 10.1016/j.jchf.2017.04.013; Sullivan RKP, 2007, INVEST OPHTH VIS SCI, V48, P2782, DOI 10.1167/iovs.06-1283; Szklarczyk D, 2016, NUCLEIC ACIDS RES, V44, pD380, DOI 10.1093/nar/gkv1277; Turner NA, 2014, VASC PHARMACOL, V60, P1, DOI 10.1016/j.vph.2013.06.002; van Riet EES, 2016, EUR J HEART FAIL, V18, P242, DOI 10.1002/ejhf.483; Verweij N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03062-8; Viceconti M, 2016, INT J CLIN TRIALS, V3, P37, DOI [10.18203/2349-3259.ijct20161408, DOI 10.18203/2349-3259.IJCT20161408]; Viceconti M, 2006, I S BIOMED IMAGING, P812; Wang XL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10124-4; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037; Xu JQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31692; Yuan XL, 2010, MOL CELL PROTEOMICS, V9, P1031, DOI 10.1074/mcp.M900523-MCP200; Zaman AKMT, 2009, EXP BIOL MED, V234, P246, DOI 10.3181/0811-RM-321; Zhang RS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146808; Zhang YN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148073; Zhang ZL, 2018, J GERIATR CARDIOL, V15, P540, DOI 10.11909/j.issn.1671-5411.2018.08.008	77	17	17	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228926	10.1371/journal.pone.0228926	http://dx.doi.org/10.1371/journal.pone.0228926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053711	gold, Green Submitted, Green Published			2022-12-26	WOS:000535198700073
J	Seynnes, OR; Cronin, NJ				Seynnes, Olivier R.; Cronin, Neil J.			Simple Muscle Architecture Analysis (SMA): An ImageJ macro tool to automate measurements in B-mode ultrasound scans	PLOS ONE			English	Article							FASCICLE LENGTH; RELIABILITY; TRACKING	In vivo measurements of muscle architecture (i.e. the spatial arrangement of muscle fascicles) are routinely included in research and clinical settings to monitor muscle structure, function and plasticity. However, in most cases such measurements are performed manually, and more reliable and time-efficient automated methods are either lacking completely, or are inaccessible to those without expertise in image analysis. In this work, we propose an ImageJ script to automate the entire analysis process of muscle architecture in ultrasound images: Simple Muscle Architecture Analysis (SMA). Images are filtered in the spatial and frequency domains with built-in commands and external plugins to highlight aponeuroses and fascicles. Fascicle dominant orientation is then computed in regions of interest using the OrientationJ plugin. Bland-Altman plots of analyses performed manually or with SMA indicate that the automated analysis does not induce any systematic bias and that both methods agree equally through the range of measurements. Our test results illustrate the suitability of SMA to analyse images from superficial muscles acquired with a broad range of ultrasound settings.	[Seynnes, Olivier R.] Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway; [Cronin, Neil J.] Univ Jyvaskyla, Fac Sport & Hlth Sci, Neuromuscular Res Ctr, Jyvaskyla, Finland	Norwegian School of Sport Sciences; University of Jyvaskyla	Seynnes, OR (corresponding author), Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway.	olivier.seynnes@nih.no	Cronin, Neil/AAA-8815-2022; Cronin, Neil/B-3860-2011	Seynnes, Olivier/0000-0002-1289-246X; Cronin, Neil/0000-0002-5332-1188				Buades A, 2011, IMAGE PROCESS ON LIN, V1, P208, DOI 10.5201/ipol.2011.bcm_nlm; Caresio C, 2017, ULTRASOUND MED BIOL, V43, P195, DOI 10.1016/j.ultrasmedbio.2016.08.032; Connolly B, 2015, CRIT CARE MED, V43, P897, DOI 10.1097/CCM.0000000000000821; Cronin NJ, 2013, GAIT POSTURE, V37, P305, DOI 10.1016/j.gaitpost.2012.07.024; Cronin NJ, 2011, J APPL PHYSIOL, V111, P1491, DOI 10.1152/japplphysiol.00530.2011; Darbon J, 2008, I S BIOMED IMAGING, P1331, DOI 10.1109/ISBI.2008.4541250; Farris DJ, 2016, COMPUT METH PROG BIO, V128, P111, DOI 10.1016/j.cmpb.2016.02.016; Fonck E, 2009, STROKE, V40, P2552, DOI 10.1161/STROKEAHA.108.528091; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Gibara T, CANNY EDGE DETECTOR; Konig N, 2014, J ULTRAS MED, V33, P769, DOI 10.7863/ultra.33.5.769; Kwah LK, 2013, J APPL PHYSIOL, V114, P761, DOI 10.1152/japplphysiol.01430.2011; Longair M, IMAGEJ; Muramatsu T, 2002, J APPL PHYSIOL, V92, P129, DOI 10.1152/jappl.2002.92.1.129; Nikolaidou ME, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170185; Puspoki Z, 2016, ADV ANAT EMBRYOL CEL, V219, P69, DOI 10.1007/978-3-319-28549-8_3; Rana M, 2009, J BIOMECH, V42, P2068, DOI 10.1016/j.jbiomech.2009.06.003; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Saalfeld S, IMAGEJ; Schindelin J, FFMPEG PLUGINS; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seynnes OR, 2015, J APPL PHYSIOL, V118, P133, DOI 10.1152/japplphysiol.00849.2014; Timmins RG, 2016, BRIT J SPORT MED, V50, P1467, DOI 10.1136/bjsports-2015-094881; Zhou G-Q, 2014, ULTRASONICS, DOI [10.1098/rsos.170185, DOI 10.1098/RSOS.170185]	25	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0229034	10.1371/journal.pone.0229034	http://dx.doi.org/10.1371/journal.pone.0229034			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32049973	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000535192300043
J	d'Errico, G; Aloj, V; Ventorino, V; Bottiglieri, A; Comite, E; Ritieni, A; Marra, R; Censi, SB; Flematti, GR; Pepe, O; Vinale, F				d'Errico, Giada; Aloj, Veronica; Ventorino, Valeria; Bottiglieri, Assunta; Comite, Ernesto; Ritieni, Alberto; Marra, Roberta; Censi, Sergio Bolletti; Flematti, Gavin R.; Pepe, Olimpia; Vinale, Francesco			Methyl t-butyl ether-degrading bacteria for bioremediation and biocontrol purposes	PLOS ONE			English	Article							HOST-SPECIFIC PHYTOTOXIN; MELOIDOGYNE-INCOGNITA; BACILLUS-ARYABHATTAI; BIOLOGICAL-CONTROL; SPOTTED KNAPWEED; SOIL; BIODEGRADATION; GROWTH; STRAINS; MTBE	A total of fifteen potential methyl t-butyl ether (MtBE)-degrading bacterial strains were isolated from contaminated soil. They have been identified as belonging to the genera Bacillus, Pseudomonas, Kocuria, Janibacter, Starkeya, Bosea, Mycolicibacterium, and Rhodovarius. Bacillus aryabhattai R1B, S. novella R8b, and M. mucogenicum R8i were able to grow using MtBE as carbon source, exhibiting different growth behavior and contaminant degradation ability. Their biocontrol ability was tested against various fungal pathogens. Both S. novella R8b and B. aryabhattai were effective in reducing the development of necrotic areas on leaves within 48 hours from Botritys cinerea and Alternaria alternata inoculation. Whereas, M. mucogenicum effectively controlled B. cinerea after 72 hours. Similar results were achieved using Pythium ultimum, in which the application of isolated bacteria increased seed germination. Only M. mucogenicum elicited tomato plants resistance against B. cinerea. This is the first report describing the occurrence of bioremediation and biocontrol activities in M. mucogenicum, B. aryabhattai and S. novella species. The production of maculosin and its antibiotic activity against Rhizoctonia solani has been reported for first time from S. novella. Our results highlight the importance of multidisciplinary approaches to achieve a consistent selection of bacterial strains useful for plant protection and bioremediation purposes.	[d'Errico, Giada; Aloj, Veronica; Ventorino, Valeria; Bottiglieri, Assunta; Comite, Ernesto; Marra, Roberta; Pepe, Olimpia] Univ Naples Federico II, Dept Agr Sci, Portici, NA, Italy; [Ritieni, Alberto] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Censi, Sergio Bolletti] Cosvitec Scar, Naples, Italy; [Flematti, Gavin R.] Univ Western Australia, Sch Mol Sci, Crawley, WA, Australia; [Vinale, Francesco] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Australia; [Vinale, Francesco] CNR, Inst Sustainable Plant Protect, Portici, NA, Australia	University of Naples Federico II; University of Naples Federico II; University of Western Australia	Vinale, F (corresponding author), Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Australia.; Vinale, F (corresponding author), CNR, Inst Sustainable Plant Protect, Portici, NA, Australia.	frvinale@unina.it		d'Errico, Giada/0000-0002-1665-4805; Ritieni, Alberto/0000-0003-0314-8839; Comite, Ernesto/0000-0003-0177-131X; Flematti, Gavin/0000-0003-2545-6939; , Olimpia/0000-0003-1287-4760	MIURPON grant [Marea 03PE_00106, Linfa 03PE_00026_1]; POR FESR CAMPANIA 2014/2020-O.S. 1.1 grant [Bioagro 559]; MISE CRESO Protection [F/050421/01-03/X32]; PSR Veneto 16.1.1 Divine [3589659]; Cosvitec scarl	MIURPON grant; POR FESR CAMPANIA 2014/2020-O.S. 1.1 grant; MISE CRESO Protection; PSR Veneto 16.1.1 Divine; Cosvitec scarl	This research was supported by MIURPON grant Marea 03PE_00106, POR FESR CAMPANIA 2014/2020-O.S. 1.1 grant Bioagro 559, MISE CRESO Protection n. F/050421/01-03/X32, PSR Veneto 16.1.1 Divine n. 3589659, and MIURPON grant Linfa 03PE_00026_1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Cosvitec scarl provided support in the form of research materials and salary to SBC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Alfonso-Gordillo G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167494; Alfonzo A, 2012, ANN MICROBIOL, V62, P1593, DOI 10.1007/s13213-011-0415-2; ALMASSI F, 1991, J NAT PROD, V54, P396, DOI 10.1021/np50074a008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amore A, 2013, CHIM OGGI, V31, P49; Barkay T, 2005, ADV APPL MICROBIOL, V57, P1, DOI 10.1016/S0065-2164(05)57001-1; Bobylev MM, 1996, J AGR FOOD CHEM, V44, P3960, DOI 10.1021/jf960091c; Chen H, 2008, BIOTECHNOL LETT, V30, P919, DOI 10.1007/s10529-007-9626-9; Cheung PY, 2001, APPL ENVIRON MICROB, V67, P2222, DOI 10.1128/AEM.67.5.2222-2229.2001; d'Errico G, 2017, ANN APPL BIOL, V171, P506, DOI 10.1111/aab.12397; d'Errico G, 2019, CROP PROT, V122, P159, DOI 10.1016/j.cropro.2019.05.004; d'Errico G, 2017, REDIA, V100, P95, DOI 10.19263/REDIA-100.17.12; Deeb RA, 2000, BIODEGRADATION, V11, P171, DOI 10.1023/A:1011113320414; Domenech J, 2006, BIOCONTROL, V51, P245, DOI 10.1007/s10526-005-2940-z; Dudasova H, 2014, J BASIC MICROB, V54, P253, DOI 10.1002/jobm.201200369; Fiorentino N, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00743; Francois A, 2002, APPL ENVIRON MICROB, V68, P2754, DOI 10.1128/AEM.68.6.2754-2762.2002; Gadd GM, 2009, J CHEM TECHNOL BIOT, V84, P13, DOI 10.1002/jctb.1999; Gadd GM, 2004, GEODERMA, V122, P109, DOI 10.1016/j.geoderma.2004.01.002; Gadd GM, 2005, SOIL BIOL, V3, P325; Gadd GM, 2001, FUNGI BIOREMEDIATION, P359, DOI DOI 10.1017/CBO9780511541780; Ghazali FM, 2004, INT BIODETER BIODEGR, V54, P61, DOI 10.1016/j.ibiod.2004.02.002; Ghosh PK, 2018, CHEMOSPHERE, V211, P407, DOI 10.1016/j.chemosphere.2018.07.148; Giacometti R, 2010, NEMATROPICA, V40, P263; Guisado IM, 2015, INT BIODETER BIODEGR, V97, P67, DOI 10.1016/j.ibiod.2014.11.008; Gunasekaran V, 2014, PROCESS BIOCHEM, V49, P124, DOI 10.1016/j.procbio.2013.09.028; Hockin SL, 2007, SULPHATE-REDUCING BACTERIA: ENVIRONMENTAL AND ENGINEERED SYSTEMS, P405, DOI 10.1017/CBO9780511541490.015; Hruska K, 2012, VET MED-CZECH, V57, P623, DOI 10.17221/6558-VETMED; Killian M, 2000, FZB24 BACILLUS SUBTI, P73; Kim HJ, 2006, PHYTOCHEMISTRY, V67, P2277, DOI 10.1016/j.phytochem.2006.07.022; Lee WM, 2015, CHEMOSPHERE, V128, P191, DOI 10.1016/j.chemosphere.2015.01.023; Levchuk I, 2014, SCI TOTAL ENVIRON, V476, P415, DOI 10.1016/j.scitotenv.2014.01.037; Li SS, 2014, CURR MICROBIOL, V68, P317, DOI 10.1007/s00284-013-0480-9; Li SS, 2015, ENVIRON SCI POLLUT R, V22, P10196, DOI 10.1007/s11356-015-4211-6; Lloyd JR, 2005, CURR OPIN BIOTECH, V16, P254, DOI 10.1016/j.copbio.2005.04.012; Lloyd JR, 2001, CURR OPIN BIOTECH, V12, P248, DOI 10.1016/S0958-1669(00)00207-X; Lombardi N, 2018, MOL PLANT MICROBE IN, V31, P982, DOI [10.1094/MPMI-12-17-0310-R, 10.1094/mpmi-12-17-0310-r]; Marra R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198728; Pailan S, 2015, INT BIODETER BIODEGR, V103, P191, DOI 10.1016/j.ibiod.2015.05.006; Perkins SD, 2009, APPL ENVIRON MICROB, V75, P5363, DOI 10.1128/AEM.00658-09; Pumpel T, 2001, ADV APPL MICROBIOL, V48, P135, DOI 10.1016/S0065-2164(01)48002-6; Roslev P, 2015, CHEMOSPHERE, V120, P284, DOI 10.1016/j.chemosphere.2014.07.003; Seddigi ZS, 2014, J HAZARD MATER, V264, P71, DOI 10.1016/j.jhazmat.2013.10.070; Siddiqui MN, 2014, J ENVIRON SCI HEAL A, V49, P52, DOI 10.1080/10934529.2013.824298; Singh N, 2016, CHEMOSPHERE, V164, P524, DOI 10.1016/j.chemosphere.2016.08.119; Smith CA, 2003, APPL ENVIRON MICROB, V69, P796, DOI 10.1128/AEM.69.2.796-804.2003; Squillace P. J., 1995, OCCURRENCE GASOLINE, P4; STIERLE AC, 1988, P NATL ACAD SCI USA, V85, P8008, DOI 10.1073/pnas.85.21.8008; Stocking AJ, 2000, BIODEGRADATION, V11, P187, DOI 10.1023/A:1011126414642; Sun LN, 2016, ENVIRON SCI POLLUT R, V23, P3727, DOI 10.1007/s11356-015-5606-0; Valls M, 2002, FEMS MICROBIOL REV, V26, P327, DOI 10.1111/j.1574-6976.2002.tb00618.x; Ventorino V., 2013, AGR SOILS MULTIDISCI, P145; Ventorino V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32688-5; Ventorino V, 2017, BIOENERG RES, V10, P488, DOI 10.1007/s12155-017-9814-y; Ventorino V, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02061; Ventorino V, 2014, SCI WORLD J, DOI 10.1155/2014/931793; Vinale F, 2017, NAT PROD RES, V31, P1778, DOI 10.1080/14786419.2017.1290624; Viscardi S, 2016, J SOIL SCI PLANT NUT, V16, P848; Wahla AQ, 2019, J HAZARD MATER, V366, P1, DOI 10.1016/j.jhazmat.2018.11.054; Watanabe K, 2001, CURR OPIN BIOTECH, V12, P237, DOI 10.1016/S0958-1669(00)00205-6; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Whipps JM, 1997, ADV BOT RES, V26, P1, DOI 10.1016/S0065-2296(08)60119-6; WHIPPS JM, 1987, NEW PHYTOL, V107, P127, DOI 10.1111/j.1469-8137.1987.tb04887.x; Zhang H, 2008, FOOD RES INT, V41, P495, DOI 10.1016/j.foodres.2008.02.006	64	3	3	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0228936	10.1371/journal.pone.0228936	http://dx.doi.org/10.1371/journal.pone.0228936			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084150	gold, Green Published			2022-12-26	WOS:000535227900035
J	Morfin, N; Goodwin, PH; Guzman-Novoa, E				Morfin, Nuria; Goodwin, Paul H.; Guzman-Novoa, Ernesto			Interaction of field realistic doses of clothianidin and Varroa destructor parasitism on adult honey bee (Apis mellifera L.) health and neural gene expression, and antagonistic effects on differentially expressed genes	PLOS ONE			English	Article							DEFORMED WING VIRUS; NEONICOTINOIDS; HYMENOPTERA; IMMUNITY; INSECT; MITE; RNA; IMPACT; ACETYLCHOLINESTERASE; SURVIVORSHIP	While many studies have examined the effects of neonicotinoid insecticides and the parasitic mite Varroa destructor on honey bees (Apis mellifera), more information on the combined effects of such stressors on gene expression, including neural related genes, and their impact on biological pathways is needed. This study analyzed the effects of field realistic concentrations of the neonicotinoid clothianidin on adult bees infested and not infested with V. destructor over 21 consecutive days and then determined bee survivorship, weight, deformed wing virus (DWV) levels and gene expression. V. destructor parasitism with or without clothianidin exposure was significantly associated with decreased survivorship, weight loss and higher DWV levels, while clothianidin exposure was only associated with higher levels of DWV. Expression analysis of the neural genes AmNlg-1, BlCh and AmAChE-2 showed that V. destructor caused a significant down-regulation of all of them, whereas clothianidin caused a significant down-regulation of only AmNrx-1 and BlCh. An interaction was only detected for AmNrx-1 expression. RNAseq analysis showed that clothianidin exposure resulted in 6.5 times more up-regulated differentially expressed genes (DEGs) than V. destructor alone and 123 times more than clothianidin combined with V. destructor. Similar results were obtained with down-regulated DEGs, except for a higher number of DEGs shared between V. destructor and the combined stressors. KEGG (Kyoto Encyclopedia of Genes and Genomes) biological pathway analysis of the DEGs showed that the stressor linked to the highest number of KEGG pathways was clothianidin, followed by V. destructor, and then considerably fewer number of KEGG pathways with the combined stressors. The reduced numbers of DEGs and KEGG pathways associated with the DEGs for the combined stressors compared to the stressors alone indicates that the interaction of the stressors is not additive or synergistic, but antagonistic. The possible implications of the antagonistic effect on the number of DEGs are discussed.	[Morfin, Nuria; Goodwin, Paul H.; Guzman-Novoa, Ernesto] Univ Guelph, Sch Environm Sci, Guelph, ON, Canada	University of Guelph	Morfin, N (corresponding author), Univ Guelph, Sch Environm Sci, Guelph, ON, Canada.	nmorfinr@uoguelph.ca		Guzman-Novoa, Ernesto/0000-0001-5632-0642; Morfin, Nuria/0000-0002-1841-2084	Agricultural Research Institute of Ontario; Ontario Ministry of Agriculture, Food and Rural Affairs; Pinchin family	Agricultural Research Institute of Ontario; Ontario Ministry of Agriculture, Food and Rural Affairs; Pinchin family	The Project was funded in part by the Agricultural Research Institute of Ontario, the Ontario Ministry of Agriculture, Food and Rural Affairs, and by a grant from the Pinchin family to EG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbo PM, 2017, INSECT SCI, V24, P467, DOI 10.1111/1744-7917.12335; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Alburaki M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125790; Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anguiano-Baez R, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew029; Arechavaleta-Velasco ME, 2001, APIDOLOGIE, V32, P157, DOI 10.1051/apido:2001121; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Bebane PSA, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.0718; Biswas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009133; Blanken LJ, 2015, P BIOL SCI B, P282; Boily M, 2013, ENVIRON SCI POLLUT R, V20, P5603, DOI 10.1007/s11356-013-1568-2; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bortolotti Laura, 2003, Bulletin of Insectology, V56, P63; Brandt A, 2016, J INSECT PHYSIOL, V86, P40, DOI 10.1016/j.jinsphys.2016.01.001; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Chang KCN, 2010, J STEROID BIOCHEM, V118, P117, DOI 10.1016/j.jsbmb.2009.11.003; Chen GYJ, 2000, J PHYTOPATHOL, V148, P57, DOI 10.1111/j.1439-0434.2000.tb04625.x; Christen V, 2016, ENVIRON SCI TECHNOL, V50, P4071, DOI 10.1021/acs.est.6b00678; Colovic MB, 2013, CURR NEUROPHARMACOL, V11, P315, DOI 10.2174/1570159X11311030006; Conte J, 2018, BIOTECHNIQUES, V64, P177, DOI 10.2144/btn-2018-2000; Currie RW, 2010, J APICULT RES, V49, P104, DOI 10.3896/IBRA.1.49.1.18; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Cutler GC, 2014, PEERJ, V2, DOI 10.7717/peerj.652; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; DEJONG D, 1983, J ECON ENTOMOL, V76, P766, DOI 10.1093/jee/76.4.766; Di Prisco G, 2016, P NATL ACAD SCI USA, V113, P3203, DOI 10.1073/pnas.1523515113; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doublet V, 2015, ENVIRON MICROBIOL, V17, P969, DOI 10.1111/1462-2920.12426; Dysthe JC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206851; Finley KD, 2003, J NEUROSCI, V23, P1254, DOI 10.1523/JNEUROSCI.23-04-01254.2003; FREE JB, 1958, J EXP BIOL, V35, P930; Gauthier M, 2010, ADV EXP MED BIOL, V683, P97; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Gregorc A, 2012, J INSECT PHYSIOL, V58, P1042, DOI 10.1016/j.jinsphys.2012.03.015; Gregory PG, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.7; Guzman-Novoa E, 2016, ONE HLTH CASE STUDIE, P204; Hamiduzzaman MM, 2017, BEHAV GENET, V47, P335, DOI 10.1007/s10519-017-9834-6; Hamiduzzaman MM, 2012, J INVERTEBR PATHOL, V111, P237, DOI 10.1016/j.jip.2012.09.001; Hatjina F, 2013, APIDOLOGIE, V44, P467, DOI 10.1007/s13592-013-0199-4; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; IBM Corp. Released, 2017, IBM SPSS STAT WIND V; Iqbal J, 2007, P R SOC B, V274, P1517, DOI 10.1098/rspb.2007.0022; Klein AM, 2006, P R SOC BIOL, V274, P303; Klowden MJ, 2013, PHYSL SYSTEMS INSECT, DOI [10.3390/insects4040712, DOI 10.3390/INSECTS4040712]; Knight D, 2011, MOL NEUROBIOL, V44, P426, DOI 10.1007/s12035-011-8213-1; Koleoglu G, 2018, PARASITOL RES, V117, P1175, DOI 10.1007/s00436-018-5796-8; Koleoglu G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169669; Kralj J, 2007, J COMP PHYSIOL A, V193, P363, DOI 10.1007/s00359-006-0192-8; Kralj J, 2006, APIDOLOGIE, V37, P577, DOI 10.1051/apido:2006040; Krupke CH, 2017, J APPL ECOL, V54, P1449, DOI 10.1111/1365-2664.12924; Laurino D, 2013, B INSECTOL, V66, P119; Li HL, 2015, INT J BIOL MACROMOL, V81, P624, DOI 10.1016/j.ijbiomac.2015.08.055; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marzouk SGM, 2017, EGYPT ACAD J BIOL SC, V9, P61; Morfin N, 2019, APIDOLOGIE, V50, P595, DOI 10.1007/s13592-019-00672-1; Morfin N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41365-0; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nauen R, 2008, PEST MANAG SCI, V64, P1081, DOI 10.1002/ps.1659; Navajas M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-301; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Papach A, 2017, J APICULT RES, V56, P475, DOI 10.1080/00218839.2017.1332541; R Core Team, 2021, R LANGUAGE ENV STAT; Ramsey SD, 2019, P NATL ACAD SCI USA, V116, P1792, DOI 10.1073/pnas.1818371116; Reissner C, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-213; Reyes-Quintana M, 2019, J INVERTEBR PATHOL, V164, P43, DOI 10.1016/j.jip.2019.04.009; Richards EH, 2011, PARASITOLOGY, V138, P602, DOI 10.1017/S0031182011000072; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rossi CD, 2013, MICROSC RES TECHNIQ, V76, P552, DOI 10.1002/jemt.22199; Samson-Robert O, 2015, SCI REP-UK, V5, DOI 10.1038/srep12636; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Shi TF, 2017, J ECON ENTOMOL, V110, P2283, DOI 10.1093/jee/tox262; Strada L, 2019, SUBST ABUSE TREAT PR, V14, DOI 10.1186/s13011-018-0187-9; Tan J, 2007, NEUROTOXICOLOGY, V28, P829, DOI 10.1016/j.neuro.2007.04.002; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; USEPA, 2003, EFED RISK ASSESSMENT; USEPA, 2010, CLOTH REG PROSP T400; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; WEINBERG KP, 1985, APIDOLOGIE, V16, P421, DOI 10.1051/apido:19850407; Winston M.L., 1991, BIOL HONEY BEE; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Wu-Smart J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32108; Yang X, 2007, PARASITOLOGY, V134, P405, DOI 10.1017/S0031182006000710; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102	92	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0229030	10.1371/journal.pone.0229030	http://dx.doi.org/10.1371/journal.pone.0229030			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8CF	32078633	Green Published, gold, Green Submitted			2022-12-26	WOS:000535224600014
J	Taboga, P; Beck, ON; Grabowski, AM				Taboga, Paolo; Beck, Owen N.; Grabowski, Alena M.			Prosthetic shape, but not stiffness or height, affects the maximum speed of sprinters with bilateral transtibial amputations	PLOS ONE			English	Article							STRETCH-SHORTENING CYCLE; LEG STIFFNESS; MECHANICAL-PROPERTIES; RUNNING SPEEDS; MASS MODEL; BIOMECHANICS; TENDONS; FORCE; LIMBS	Running-specific prostheses (RSPs) have facilitated an athlete with bilateral transtibial amputations to compete in the Olympic Games. However, the performance effects of using RSPs compared to biological legs remains controversial. Further, the use of different prosthetic configurations such as shape, stiffness, and height likely influence performance. We determined the effects of using 15 different RSP configurations on the maximum speed of five male athletes with bilateral transtibial amputations. These athletes performed sets of running trials up to maximum speed using three different RSP models (Freedom Innovations Catapult FX6, Ossur Flex-Foot Cheetah Xtend and Ottobock 1E90 Sprinter) each with five combinations of stiffness category and height. We measured ground reaction forces during each maximum speed trial to determine the biomechanical parameters associated with different RSP configurations and maximum sprinting speeds. Use of the J-shaped Cheetah Xtend and 1E90 Sprinter RSPs resulted in 8.3% and 8.0% (p<0.001) faster maximum speeds compared to the use of the C-shaped Catapult FX6 RSPs, respectively. Neither RSP stiffness expressed as a category (p = 0.836) nor as kN.m(-1) (p = 0.916) affected maximum speed. Further, prosthetic height had no effect on maximum speed (p = 0.762). Faster maximum speeds were associated with reduced ground contact time, aerial time, and overall leg stiffness, as well as with greater stance-average vertical ground reaction force, contact length, and vertical stiffness (p = 0.015 for aerial time, p<0.001 for all other variables). RSP shape, but not stiffness or height, influences the maximum speed of athletes with bilateral transtibial amputations.	[Taboga, Paolo] Calif State Univ Sacramento, Dept Kinesiol, Sacramento, CA 95819 USA; [Beck, Owen N.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Beck, Owen N.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Grabowski, Alena M.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Grabowski, Alena M.] Eastern Colorado Healthcare Syst, Dept Vet Affairs, Aurora, CO USA	California State University System; California State University Sacramento; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University of Colorado System; University of Colorado Boulder	Taboga, P (corresponding author), Calif State Univ Sacramento, Dept Kinesiol, Sacramento, CA 95819 USA.	paolo.taboga@csus.edu		TABOGA, PAOLO/0000-0001-6529-8299	BADER Consortium, a Department of Defense Congressionally Directed Medical Research Programs cooperative agreement [W81XWH-11-2-0222]	BADER Consortium, a Department of Defense Congressionally Directed Medical Research Programs cooperative agreement(United States Department of Defense)	This project was supported by the BADER Consortium, a Department of Defense Congressionally Directed Medical Research Programs cooperative agreement (W81XWH-11-2-0222). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arampatzis A, 1999, J BIOMECH, V32, P1349, DOI 10.1016/S0021-9290(99)00133-5; Baum BS, 2013, ARCH PHYS MED REHAB, V94, P1776, DOI 10.1016/j.apmr.2013.03.010; Beck ON, 2018, J APPL PHYSIOL, V124, P641, DOI 10.1152/japplphysiol.00737.2017; Beck ON, 2017, J APPL PHYSIOL, V123, P38, DOI 10.1152/japplphysiol.00896.2016; Beck ON, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0230; Beck ON, 2017, J APPL PHYSIOL, V122, P976, DOI 10.1152/japplphysiol.00587.2016; Beck ON, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168298; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; Bruggemann Gert-Peter., 2008, SPORTS TECHNOLOGY, V1, P220, DOI [10.1002/jst.63, DOI 10.1002/JST.63, DOI 10.1080/19346182.2008.9648476]; CAVAGNA GA, 1975, J APPL PHYSIOL, V39, P174, DOI 10.1152/jappl.1975.39.1.174; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Farley CT, 1996, J BIOMECH, V29, P181, DOI 10.1016/0021-9290(95)00029-1; FARLEY CT, 1993, J EXP BIOL, V185, P71; Foure A, 2010, J APPL PHYSIOL, V109, P849, DOI 10.1152/japplphysiol.01150.2009; Grabowski AM, 2010, BIOL LETTERS, V6, P201, DOI 10.1098/rsbl.2009.0729; Hobara H, 2013, J BIOMECH, V46, P2483, DOI 10.1016/j.jbiomech.2013.07.009; Hunter JP, 2004, MED SCI SPORT EXER, V36, P261, DOI 10.1249/01.MSS.0000113664.15777.53; IAAF, 2018, IAAF COMP RUL 2018 2; IPC, CLASS RUL REG 2018; IPC, ATHL CLASS RUL REG 2; Kubo K, 2000, ACTA PHYSIOL SCAND, V170, P127, DOI 10.1046/j.1365-201x.2000.00768.x; McGowan CP, 2012, J R SOC INTERFACE, V9, P1975, DOI 10.1098/rsif.2011.0877; MCMAHON TA, 1990, J BIOMECH, V23, P65, DOI 10.1016/0021-9290(90)90042-2; MERO A, 1992, SPORTS MED, V13, P376, DOI 10.2165/00007256-199213060-00002; Morin JB, 2006, INT J SPORTS MED, V27, P158, DOI 10.1055/s-2005-837569; Morin JB, 2005, J APPL BIOMECH, V21, P167, DOI 10.1123/jab.21.2.167; Morin JB, 2012, EUR J APPL PHYSIOL, V112, P3921, DOI 10.1007/s00421-012-2379-8; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; POLLOCK M, 1994, AM J PHYSIOL, V266, pR1016, DOI 10.1152/ajpregu.1994.266.3.R1016; Rabita G, 2015, SCAND J MED SCI SPOR, V25, P583, DOI 10.1111/sms.12389; RIEMERSMA DJ, 1985, RES VET SCI, V39, P263, DOI 10.1016/S0034-5288(18)31711-9; Ropret R, 1998, EUR J APPL PHYSIOL, V77, P547, DOI 10.1007/s004210050374; Schenau GJV, 1997, J APPL BIOMECH, V13, P484, DOI 10.1123/jab.13.4.484; Taboga P, 2016, J EXP BIOL, V219, P851, DOI 10.1242/jeb.133488; Weyand PG, 2010, J APPL PHYSIOL, V108, P1011, DOI [10.1152/japplphysiol.01238.2009, 10.1152/japplphysiol.01238.2009a]; Weyand PG, 2009, J APPL PHYSIOL, V107, P903, DOI 10.1152/japplphysiol.00174.2009; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991, DOI 10.1152/jappl.2000.89.5.1991; Zhao H, 2009, J APPL PHYSIOL, V106, P843, DOI 10.1152/japplphysiol.91212.2008	38	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0229035	10.1371/journal.pone.0229035	http://dx.doi.org/10.1371/journal.pone.0229035			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8CF	32078639	gold, Green Published			2022-12-26	WOS:000535224600015
J	Tirou, L; Russo, M; Faure, H; Pellegrino, G; Sharif, A; Ruat, M				Tirou, Linda; Russo, Mariagiovanna; Faure, Helene; Pellegrino, Giuliana; Sharif, Ariane; Ruat, Martial			C9C5 positive mature oligodendrocytes are a source of Sonic Hedgehog in the mouse brain	PLOS ONE			English	Article							CELL MAINTENANCE; ADULT BRAIN; PROLIFERATION; ASTROCYTES; ACTIVATION; NEURONS; RNA	In the mature rodent brain, Sonic Hedgehog (Shh) signaling regulates stem and progenitor cell maintenance, neuronal and glial circuitry and brain repair. However, the sources and distribution of Shh mediating these effects are still poorly characterized. Here, we report in the adult mouse brain, a broad expression pattern of Shh recognized by the specific monoclonal C9C5 antibody in a subset (11-12%) of CC1(+) mature oligodendrocytes that do not express carbonic anhydrase II. These cells express also Olig2 and Sox10, two oligodendrocyte lineage-specific markers, but not PDGFR alpha, a marker of oligodendrocyte progenitors. In agreement with oligodendroglial cells being a source of Shh in the adult mouse brain, we identify Shh transcripts by single molecule fluorescent in situ hybridization in a subset of cells expressing Olig2 and Sox10 mRNAs. These findings also reveal that Shh expression is more extensive than originally reported. The Shh-C9C5-associated signal labels the oligodendroglial cell body and decorates by intense puncta the processes. C9C5(+) cells are distributed in a grid-like manner. They constitute small units that could deliver locally Shh to its receptor Patched expressed in GFAP(+) and S100 beta(+) astrocytes, and in HuC/D+ neurons as shown in Ptc(LacZ/+) reporter mice. Postnatally, C9C5 immunoreactivity overlaps the myelination peak that occurs between P10 and P20 and is down regulated during ageing. Thus, our data suggest that C9C5(+)CC1(+) oligodendroglial cells are a source of Shh in the mouse postnatal brain.	[Tirou, Linda; Russo, Mariagiovanna; Faure, Helene; Pellegrino, Giuliana; Ruat, Martial] Paris Saclay Univ, CNRS, Neurosci Paris Saclay Inst, UMR 9197, Gif Sur Yvette, France; [Sharif, Ariane] Lille Univ, UMR S Inserm 1172, Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Universite de Lille - ISITE; Universite de Lille	Ruat, M (corresponding author), Paris Saclay Univ, CNRS, Neurosci Paris Saclay Inst, UMR 9197, Gif Sur Yvette, France.	ruat@inaf.cnrs-gif.fr	Sharif, Ariane/AGW-8363-2022	FAURE, Helene/0000-0002-0005-9331; Sharif, Ariane/0000-0003-0810-400X	Ministere de la Recherche; Fondation pour l'Aide a la Recherche sur la Sclerose En Plaque (ARSEP); ARSEP; Association pour la Recherche contre le Cancer (ARC); CNRS	Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Fondation pour l'Aide a la Recherche sur la Sclerose En Plaque (ARSEP); ARSEP; Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	M. R. and L. T. are the recipient of a doctoral fellowship from the Ministere de la Recherche and L.T. from Fondation pour l'Aide a la Recherche sur la Sclerose En Plaque (ARSEP), respectively. This work was supported by grants from ARSEP, Association pour la Recherche contre le Cancer (ARC) and CNRS to M. R.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahyari RV, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37555-x; Andreu-Cervera A, 2019, J NEUROSCI, V39, P2398, DOI 10.1523/JNEUROSCI.2199-18.2019; Angot E, 2008, STEM CELLS, V26, P2311, DOI 10.1634/stemcells.2008-0297; Bezard E, 2003, FASEB J, V17, P2337, DOI 10.1096/fj.03-0291fje; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Charytoniuk D, 2002, J PHYSIOLOGY-PARIS, V96, P9, DOI 10.1016/S0928-4257(01)00075-4; Chen RC, 2017, CELL REP, V18, P3227, DOI 10.1016/j.celrep.2017.03.004; Daynac M, 2016, STEM CELL REP, V7, P735, DOI 10.1016/j.stemcr.2016.08.016; Eitan E, 2016, BIOL OPEN, V5, P1086, DOI 10.1242/bio.019422; Falcao AM, 2018, NAT MED, V24, P1837, DOI 10.1038/s41591-018-0236-y; Farmer WT, 2016, SCIENCE, V351, P849, DOI 10.1126/science.aab3103; Ferent J, 2014, STEM CELL REP, V3, P312, DOI 10.1016/j.stemcr.2014.05.016; Ferent J, 2013, J NEUROSCI, V33, P1759, DOI 10.1523/JNEUROSCI.3334-12.2013; Garcia ADR, 2018, J NEUROSCI, V38, P9338, DOI 10.1523/JNEUROSCI.1662-18.2018; Garcia ADR, 2010, J NEUROSCI, V30, P13597, DOI 10.1523/JNEUROSCI.0830-10.2010; Gonzalez-Reyes LE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53192-4; Hill S, 2019, ELIFE, V8, DOI 10.7554/eLife.51163; Ihrie RA, 2011, NEURON, V71, P250, DOI 10.1016/j.neuron.2011.05.018; Jakel S, 2019, NATURE, V566, P543, DOI 10.1038/s41586-019-0903-2; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Laouarem Y, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00305; Lu WJ, 2018, P NATL ACAD SCI USA, V115, pE200, DOI 10.1073/pnas.1719109115; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Marques S, 2016, SCIENCE, V352, P1326, DOI 10.1126/science.aaf6463; Matsusue Y, 2014, J HISTOCHEM CYTOCHEM, V62, P211, DOI 10.1369/0022155413517700; Niu JQ, 2019, NAT NEUROSCI, V22, P709, DOI 10.1038/s41593-019-0369-4; Pascual O, 2005, EUR J NEUROSCI, V22, P389, DOI 10.1111/j.1460-9568.2005.04223.x; Rivell A, 2019, BIOL OPEN, V8, DOI 10.1242/bio.040592; Ruat M, 2015, TOP MED CHEM SER, V16, P147, DOI 10.1007/7355_2014_83; Ruat M, 2014, TRENDS PHARMACOL SCI, V35, P237, DOI 10.1016/j.tips.2014.03.002; Sanchez MA, 2018, NEUROBIOL DIS, V115, P145, DOI 10.1016/j.nbd.2018.04.003; Tang MZ, 2010, J NEUROSCI, V30, P9280, DOI 10.1523/JNEUROSCI.0860-10.2010; Dang TC, 2019, CELL REP, V27, P1073, DOI 10.1016/j.celrep.2019.03.084; Traiffort E, 2001, EUR J NEUROSCI, V14, P839, DOI 10.1046/j.0953-816x.2001.01708.x; Traiffort E, 1998, J NEUROCHEM, V70, P1327; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X	36	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0229362	10.1371/journal.pone.0229362	http://dx.doi.org/10.1371/journal.pone.0229362			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8CF	32078657	Green Published, gold			2022-12-26	WOS:000535224600028
J	Babler, A; Schmitz, C; Buescher, A; Herrmann, M; Gremse, F; Gorgels, T; Floege, J; Jahnen-Dechent, W				Babler, Anne; Schmitz, Carlo; Buescher, Andrea; Herrmann, Marietta; Gremse, Felix; Gorgels, Theo; Floege, Juergen; Jahnen-Dechent, Willi			Microvasculopathy and soft tissue calcification in mice are governed by fetuin-A, magnesium and pyrophosphate	PLOS ONE			English	Article							DYSTROPHIC CARDIAC CALCINOSIS; VASCULAR CALCIFICATION; PSEUDOXANTHOMA ELASTICUM; ECTOPIC MINERALIZATION; GLYCOPROTEIN/FETUIN-A; AORTIC CALCIFICATION; MOUSE MODEL; PHOSPHATE; PREVENTS; ABCC6	Calcifications can disrupt organ function in the cardiovascular system and the kidney, and are particularly common in patients with chronic kidney disease (CKD). Fetuin-A deficient mice maintained against the genetic background DBA/2 exhibit particularly severe soft tissue calcifications, while fetuin-A deficient C57BL/6 mice remain healthy. We employed molecular genetic analysis to identify risk factors of calcification in fetuin-A deficient mice. We sought to identify pharmaceutical therapeutic targets that could be influenced by dietary of parenteral supplementation. We studied the progeny of an intercross of fetuin-A deficient DBA/2 and C57BL/6 mice to identify candidate risk genes involved in calcification. We determined that a hypomorphic mutation of the Abcc6 gene, a liver ATP transporter supplying systemic pyrophosphate, and failure to regulate the Trpm6 magnesium transporter in kidney were associated with severity of calcification. Calcification prone fetuin-A deficient mice were alternatively treated with parenteral administration of fetuin-A dietary magnesium supplementation, phosphate restriction, or by or parenteral pyrophosphate. All treatments markedly reduced soft tissue calcification, demonstrated by computed tomography, histology and tissue calcium measurement. We show that pathological ectopic calcification in fetuin-A deficient DBA/2 mice is caused by a compound deficiency of three major extracellular and systemic inhibitors of calcification, namely fetuin-A, magnesium, and pyrophosphate. All three of these are individually known to contribute to stabilize protein-mineral complexes and thus inhibit mineral precipitation from extracellular fluid. We show for the first time a compound triple deficiency that can be treated by simple dietary or parenteral supplementation. This is of special importance in patients with advanced CKD, who commonly exhibit reduced serum fetuin-A, magnesium and pyrophosphate levels.	[Babler, Anne; Schmitz, Carlo; Buescher, Andrea; Herrmann, Marietta; Jahnen-Dechent, Willi] RWTH Aachen Univ Hosp, Biointerface Lab, Helmholtz Inst Biomed Engn, Aachen, Germany; [Herrmann, Marietta] Univ Wurzburg, Orthoped Ctr Musculoskeletal Res, IZKF Res Grp Tissue Regenerat Musculoskeletal Reg, Wurzburg, Germany; [Gremse, Felix] RWTH Aachen Univ Hosp, Helmholtz Inst Biomed Engn, Expt Mol Imaging, Aachen, Germany; [Gorgels, Theo] Maastricht Univ, Med Ctr, Univ Eye Clin Maastricht, Maastricht, Netherlands; [Floege, Juergen] RWTH Aachen Univ Hosp, Div Nephrol & Clin Immunol, Aachen, Germany	Helmholtz Association; RWTH Aachen University; RWTH Aachen University Hospital; University of Wurzburg; Helmholtz Association; RWTH Aachen University; RWTH Aachen University Hospital; Maastricht University; Maastricht University Medical Centre (MUMC); RWTH Aachen University; RWTH Aachen University Hospital	Jahnen-Dechent, W (corresponding author), RWTH Aachen Univ Hosp, Biointerface Lab, Helmholtz Inst Biomed Engn, Aachen, Germany.	willi.jahnen@rwth-aachen.de	Herrmann, Marietta/AAS-6253-2020; Babler, Anne/AAA-7250-2021	Herrmann, Marietta/0000-0002-2412-7474	IZKF Aachen of the Medical Faculty of RWTH Aachen; German Research Foundation [DFG SFB/TRR219-Project C03]	IZKF Aachen of the Medical Faculty of RWTH Aachen; German Research Foundation(German Research Foundation (DFG))	This work was supported by grants awarded to WJD by the IZKF Aachen of the Medical Faculty of RWTH Aachen and by the German Research Foundation (DFG SFB/TRR219-Project C03).	Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; ANDRIS A, 2020, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0228503; Azpiazu D, 2018, NEFROLOGIA, V38, P250, DOI 10.1016/j.nefro.2017.07.005; Barros X, 2016, J NEPHROL, V29, P241, DOI 10.1007/s40620-015-0221-1; BONUCCI E, 1973, AM J PATHOL, V71, P167; BOSKEY AL, 1980, CALCIFIED TISSUE INT, V32, P139, DOI 10.1007/BF02408533; Brandenburg VM, 2011, J NEPHROL, V24, P142, DOI 10.5301/JN.2011.6366; Bressendorff I, 2018, CLIN J AM SOC NEPHRO, V13, P1373, DOI 10.2215/CJN.13921217; BRUNNERT SR, 1990, LAB ANIM SCI, V40, P616; Brylka LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187030; Chubanov V, 2016, ELIFE, V5, DOI 10.7554/eLife.20914; Cozzolino M, 2010, BLOOD PURIFICAT, V29, P347, DOI 10.1159/000302722; De Schutter T, 2012, NEPHROL DIAL TRANSPL, V27, P52; Dedinszki D, 2017, EMBO MOL MED, V9, P1463, DOI 10.15252/emmm.201707532; Diaz-Tocados JM, 2017, KIDNEY INT, V92, P1084, DOI 10.1016/j.kint.2017.04.011; EATON GJ, 1978, AM J PATHOL, V90, P173; Ellam TJ, 2012, ATHEROSCLEROSIS, V220, P310, DOI 10.1016/j.atherosclerosis.2011.09.002; Finch JL, 2013, KIDNEY INT, V84, P1145, DOI 10.1038/ki.2013.213; Fuery MA, 2018, BONE, V109, P28, DOI 10.1016/j.bone.2017.07.006; Gorgels TGMF, 2005, HUM MOL GENET, V14, P1763, DOI 10.1093/hmg/ddi183; Gourgas O, 2018, ARTERIOSCL THROM VAS, V38, P363, DOI 10.1161/ATVBAHA.117.309808; Gremse F, 2016, THERANOSTICS, V6, P328, DOI 10.7150/thno.13624; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Herrmann M, 2012, CIRC RES, V111, P575, DOI 10.1161/CIRCRESAHA.111.261479; Hortells L, 2017, KIDNEY INT, V92, P1384, DOI 10.1016/j.kint.2017.06.019; Ivandic BT, 2001, PHYSIOL GENOMICS, V6, P137, DOI 10.1152/physiolgenomics.2001.6.3.137; Ix JH, 2006, NEPHROL DIAL TRANSPL, V21, P2144, DOI 10.1093/ndt/gfl204; Jahnen-Dechent W, 2012, CLIN KIDNEY J, V5, P3, DOI 10.1093/ndtplus/sfr163; Janett S, 2016, J PEDIATR GASTR NUTR, V62, pE39, DOI 10.1097/MPG.0000000000001087; Jansen RS, 2014, ARTERIOSCL THROM VAS, V34, P1985, DOI 10.1161/ATVBAHA.114.304017; Jansen RS, 2013, P NATL ACAD SCI USA, V110, P20206, DOI 10.1073/pnas.1319582110; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Kieboom BCT, 2015, AM J KIDNEY DIS, V66, P775, DOI 10.1053/j.ajkd.2015.05.012; Knoers NVAM, 2009, PEDIATR NEPHROL, V24, P697, DOI 10.1007/s00467-008-0968-x; Kramann R, 2016, CELL STEM CELL, V19, P628, DOI 10.1016/j.stem.2016.08.001; Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111; LaRusso J, 2009, J INVEST DERMATOL, V129, P1388, DOI 10.1038/jid.2008.391; Le Saux Olivier, 2012, Frontiers in Genetics, V3, P289, DOI 10.3389/fgene.2012.00289; Li QL, 2017, J INVEST DERMATOL, V137, P1025, DOI 10.1016/j.jid.2016.11.042; Li QL, 2012, AM J PATHOL, V181, P1190, DOI 10.1016/j.ajpath.2012.06.014; Li QL, 2009, EXP DERMATOL, V18, P1, DOI 10.1111/j.1600-0625.2008.00795.x; Lomashvili KA, 2004, J AM SOC NEPHROL, V15, P1392, DOI 10.1097/01.ASN.0000128955.83129.9C; Lomashvili KA, 2005, J AM SOC NEPHROL, V16, P2495, DOI 10.1681/ASN.2004080694; LOPEZABADIA I, 1993, J FORENSIC SCI, V38, P1183; LUOMA H, 1976, CALC TISS RES, V20, P291, DOI 10.1007/BF02546416; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Matsui I, 2009, KIDNEY INT, V75, P915, DOI 10.1038/ki.2008.700; Matsuzaki H, 2016, MAGNESIUM RES, V29, P48, DOI 10.1684/mrh.2016.0401; Meng HJ, 2007, P NATL ACAD SCI USA, V104, P4530, DOI 10.1073/pnas.0607620104; Merdler-Rabinowicz R, 2019, PEDIATR RES, V86, P603, DOI 10.1038/s41390-019-0499-0; Merx MW, 2005, J AM SOC NEPHROL, V16, P3357, DOI 10.1681/ASN.2005040365; Metry G, 2008, EUR J CLIN INVEST, V38, P804, DOI 10.1111/j.1365-2362.2008.02032.x; Moe SM, 2005, KIDNEY INT, V67, P2295, DOI 10.1111/j.1523-1755.2005.00333.x; Naderi ASA, 2008, NAT CLIN PRACT NEPHR, V4, P80, DOI 10.1038/ncpneph0680; O'Neill WC, 2017, KIDNEY INT, V92, P1316, DOI 10.1016/j.kint.2017.07.020; Phan O, 2008, NEPHROL DIAL TRANSPL, V23, P82, DOI 10.1093/ndt/gfm699; Porazko T, 2009, NEPHRON CLIN PRACT, V113, pC81, DOI 10.1159/000228539; Sakaguchi Y, 2018, KIDNEY WEEK     1012, P1317; Sanchis P, 2019, KIDNEY INT, V95, P958, DOI 10.1016/j.kint.2018.12.014; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schlieper G, 2016, NEPHROL DIAL TRANSPL, V31, P31, DOI 10.1093/ndt/gfv111; Shroff R, 2013, J AM SOC NEPHROL, V24, P179, DOI 10.1681/ASN.2011121191; Van TV, 2012, J CLIN BIOCHEM NUTR, V51, P27, DOI 10.3164/jcbn.11-96; ter Braake AD, 2020, NEPHROL DIAL TRANSPL, V35, P765, DOI 10.1093/ndt/gfz190; Tonelli M, 2010, NEW ENGL J MED, V362, P1312, DOI 10.1056/NEJMra0912522; van den Broek DHN, 2018, J VET INTERN MED, V32, P1359, DOI 10.1111/jvim.15141; van den Broek FAR, 1998, LAB ANIM, V32, P483, DOI 10.1258/002367798780599758; van den Broek FAR, 1998, BIOCHEM BIOPH RES CO, V253, P204, DOI 10.1006/bbrc.1998.9776; Villa-Bellosta R, 2018, KIDNEY INT, V93, P1293, DOI 10.1016/j.kint.2017.11.035; Westenfeld R, 2007, NEPHROL DIAL TRANSPL, V22, P1537, DOI 10.1093/ndt/gfm094; Williams EG, 2018, MOL CELL PROTEOMICS, V17, P1766, DOI 10.1074/mcp.RA118.000554; Yamada S, 2017, BONE, V100, P87, DOI 10.1016/j.bone.2016.11.012; Zhao JY, 2017, J INVEST DERMATOL, V137, P2336, DOI 10.1016/j.jid.2017.06.006	73	16	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228938	10.1371/journal.pone.0228938	http://dx.doi.org/10.1371/journal.pone.0228938			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074140	gold, Green Published, Green Submitted			2022-12-26	WOS:000535220600030
J	Billings, PC; Bizzaro, C; Yang, E; Chung, J; Mundy, C; Pacifici, M				Billings, Paul C.; Bizzaro, Candice; Yang, Evan; Chung, Juliet; Mundy, Christina; Pacifici, Maurizio			Human and mouse activin genes: Divergent expression of activin A protein variants and identification of a novel heparan sulfatebinding domain in activin B	PLOS ONE			English	Article							MECHANISMS; INSIGHTS; CELL	Activins are members of the transforming growth factor-beta (TGF-beta) superfamily of signaling proteins and were originally identified as components of follicular fluid. The proteins are now known to play critical roles in numerous normal and pathological processes and conditions, but less is clear about the relationships between their gene organization and protein variant expression and structure. The four human and mouse activin (Act) genes, termed INH beta A, INH beta B, INH beta C and INH beta E, differ in exon numbers. Human INH beta A is the most complex with 7 exons and elicits production of three Act A variants (Act A X1, X2 and X3) differing in their pro-region, as we showed previously. Here we further analyzed the mouse INH beta A gene and found that its 4 exons encode for a single open reading frame (mouse Act A), corresponding to the shortest human Act A X3 variant. Activins are synthesized and secreted as large complexes made of a long pro-region and a short mature C-terminal ligand and are known to interact with the heparan sulfate (HS) chains of cell surface and matrix proteoglycans. Human Act A X1 and X2 variants do have a HS-binding domain (HBD) with Cardin/Wein-traub traits in their pro-region, while the X3 variant does not as shown previously. We found that the mouse Act A lacks a HBD as well. However, we identified a typical HBD in the pro-region of both mouse and human Act B, and synthetic peptides containing that domain interacted with immobilized HS and cell surface with nanomolar affinity. In sum, human and mouse Act A genes elicit expression of different variant sets, while there is concordance in Act B protein expression, reflecting possible evolutionary diversity in function of, and responses to, these signaling proteins in the two species.	[Billings, Paul C.; Bizzaro, Candice; Yang, Evan; Chung, Juliet; Mundy, Christina; Pacifici, Maurizio] Childrens Hosp Philadelphia, Div Orthopaed Surg, Translat Res Program Pediat Orthopaed, Philadelphia, PA 19104 USA; [Yang, Evan] Harvard Med Sch, Grad Program Biol & Biomed Sci BBS, Boston, MA 02115 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Harvard Medical School	Billings, PC (corresponding author), Childrens Hosp Philadelphia, Div Orthopaed Surg, Translat Res Program Pediat Orthopaed, Philadelphia, PA 19104 USA.	BillingsP@email.chop.edu			Institute of Arthritis, Musculoskeletal and Skin Disease (NIAMS) at the National Institutes of Health [RO1AR061758, RO1AR071946]	Institute of Arthritis, Musculoskeletal and Skin Disease (NIAMS) at the National Institutes of Health	This work was supported by grants RO1AR061758 and RO1AR071946 from the Institute of Arthritis, Musculoskeletal and Skin Disease (NIAMS) at the National Institutes of Health to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asperti M, 2019, VITAM HORM, V110, P157, DOI 10.1016/bs.vh.2019.01.008; Billings PC, 2018, J BIOL CHEM, V293, P14371, DOI 10.1074/jbc.RA118.003191; Billings PC, 2015, CONNECT TISSUE RES, V56, P272, DOI 10.3109/03008207.2015.1045066; Bloise E, 2019, PHYSIOL REV, V99, P739, DOI 10.1152/physrev.00002.2018; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chang SC, 2011, J BIOL CHEM, V286, P44391, DOI 10.1074/jbc.M111.285361; Farach-Carson MC, 2014, MATRIX BIOL, V34, P64, DOI 10.1016/j.matbio.2013.08.004; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Goebel EJ, 2019, P NATL ACAD SCI USA, V116, P15505, DOI 10.1073/pnas.1906253116; Hatsell SJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4358; Iyer S, 2011, FEBS J, V278, P4304, DOI 10.1111/j.1742-4658.2011.08350.x; Jensen MA, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011024, 10.1371/journal.pone.0012965]; Li SL, 2010, J BIOL CHEM, V285, P36645, DOI 10.1074/jbc.M110.177865; Lowery JW, 2018, PHYSIOL REV, V98, P2431, DOI 10.1152/physrev.00028.2017; Makanji Y, 2014, ENDOCR REV, V35, P747, DOI 10.1210/er.2014-1003; Namwanje M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021881; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; PACIFICI M, 2018, MATRIX BIOL J INT SO, P77, DOI DOI 10.3897/NATURECONSERVATION.25.22387; Rider CC, 2017, MOLECULES, V22, DOI 10.3390/molecules22050713; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Shore EM, 2010, NAT REV RHEUMATOL, V6, P518, DOI 10.1038/nrrheum.2010.122; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; Walton KL, 2012, MOL CELL ENDOCRINOL, V359, P2, DOI 10.1016/j.mce.2011.06.030; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Yang E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222784; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	30	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0229254	10.1371/journal.pone.0229254	http://dx.doi.org/10.1371/journal.pone.0229254			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074129	Green Published, gold			2022-12-26	WOS:000535220600036
J	Ji, XL; Liu, TJ; Zhao, SY; Li, JJ; Li, LY; Wang, EB				Ji, Xianglu; Liu, Tianjing; Zhao, Shuyi; Li, Jianjun; Li, Lianyong; Wang, Enbo			WISP-2, an upregulated gene in hip cartilage from the DDH model rats, induces chondrocyte apoptosis through PPAR gamma in vitro	FASEB JOURNAL			English	Article						acetabular cartilage complex; chondrocyte apoptosis; developmental dysplasia of the hip; hip development; microarray analysis; pathological mechanism	INFLUENCE DEVELOPMENTAL DYSPLASIA; GROWTH-FACTOR; EXPRESSION; COLLAGEN; OSTEOARTHRITIS; ACTIVATION; CELLS; TISSUE	Chondrocyte apoptosis plays an important role in the developmental dysplasia of the hip (DDH) development. It has been found that WNT1 inducible signaling pathway protein 2 (WISP-2) and peroxisome proliferator-activated receptor gamma (PPAR gamma) are involved in cell apoptosis. In this study, we performed the straight-leg swaddling DDH rat model and we found that cartilage degradation and chondrocyte apoptosis were remarkably increased in DDH rats in vivo. Moreover, we found that WISP-2 was upregulated in hip acetabular cartilage of DDH rats compared to control rats. Next, the effects of WISP-2 on chondrocyte apoptosis and its possible underlying mechanism were examined in vitro. The lentivirus-mediated gain- and loss-of-function experiments of WISP-2 and peroxisome proliferator-activated receptor gamma (PPAR gamma) for cell viability and apoptosis were performed in primary rat chondrocytes. The results showed that the overexpression of WISP-2 induced chondrocyte apoptosis, and knockdown of WISP-2 could suppress the chondrocyte apoptosis induced by advanced glycation end products (AGE). Additionally, WISP-2 could negatively regulate the expression of PPAR gamma in chondrocytes. Moreover, the knockdown of PPAR gamma promoted chondrocyte apoptosis and overexpression of PPAR gamma abated the increased apoptosis and decreased cell viability of chondrocytes induced by WISP-2. This study demonstrated that WISP-2 might contribute to chondrocyte apoptosis of hip acetabular cartilage through regulating PPAR gamma expression and activation, which may play an important role in the development of DDH.	[Ji, Xianglu] China Med Univ, Shengjing Hosp, Dept Hand & Foot Surg, Shenyang, Peoples R China; [Liu, Tianjing; Zhao, Shuyi; Li, Lianyong; Wang, Enbo] China Med Univ, Shengjing Hosp, Dept Pediat Orthoped, 36 Sanhao St, Shenyang 110004, Peoples R China; [Li, Jianjun] China Med Univ, Shengjing Hosp, Dept Traumat Orthped, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Wang, EB (corresponding author), China Med Univ, Shengjing Hosp, Dept Pediat Orthoped, 36 Sanhao St, Shenyang 110004, Peoples R China.	wangenbodor@126.com	Wang, Enbo/AAQ-6993-2020		National Natural Science Foundation of China [30700877, 81171675]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (No. 30700877 and 81171675).	Ashraf A, 2014, CLIN ORTHOP RELAT R, V472, P2237, DOI 10.1007/s11999-014-3587-9; Bo N, 2012, CONNECT TISSUE RES, V53, P513, DOI 10.3109/03008207.2012.700346; Chen LQ, 2017, J CELL MOL MED, V21, P3347, DOI 10.1111/jcmm.13237; Chen XY, 2012, RHEUMATOL INT, V32, P3359, DOI 10.1007/s00296-011-2178-2; Chen YJ, 2015, J ORTHOP RES, V33, P373, DOI 10.1002/jor.22770; Chen YF, 2019, INT J ENDOCRINOL, V2019, DOI 10.1155/2019/7691531; Chowdhury S, 2014, ENDOCRINOLOGY, V155, P1629, DOI 10.1210/en.2013-1735; Das A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00916-z; Grunberg JR, 2014, J BIOL CHEM, V289, P6899, DOI 10.1074/jbc.M113.511964; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hammarstedt A, 2013, P NATL ACAD SCI USA, V110, P2563, DOI 10.1073/pnas.1211255110; Hwang HS, 2015, INT J MOL SCI, V16, P26035, DOI 10.3390/ijms161125943; Jansen IDC, 2010, J MOL HISTOL, V41, P9, DOI 10.1007/s10735-010-9257-7; Ji JF, 2014, ONCOL REP, V31, P533, DOI 10.3892/or.2013.2909; Ker DFE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139054; Knudson W, 1996, EXP CELL RES, V228, P216, DOI 10.1006/excr.1996.0320; Ko J, 2016, TOXICOL LETT, V260, P8, DOI 10.1016/j.toxlet.2016.08.016; Kocabayoglu P, 2017, ANN TRANSPL, V22, P446, DOI 10.12659/AOT.903497; Komatsu M, 2015, J ORTHOP SCI, V20, P708, DOI 10.1007/s00776-015-0727-3; KUTLU A, 1992, J PEDIATR ORTHOPED, V12, P598; Lee MC, 2006, ORTHOP CLIN N AM, V37, P119, DOI 10.1016/j.ocl.2005.12.001; Li CW, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.534; Li H, 2011, OSTEOARTHR CARTILAGE, V19, P1246, DOI 10.1016/j.joca.2011.07.011; Li LY, 2013, INT J CLIN EXP PATHO, V6, P212; Li P, 2015, J TOXICOL SCI, V40, P615, DOI 10.2131/jts.40.615; Liu XY, 2014, CELL SIGNAL, V26, P2276, DOI 10.1016/j.cellsig.2014.05.018; Mahan ST, 2008, PEDIATRICS, V121, P177, DOI 10.1542/peds.2007-1618; Mellor L, 2013, J BIOL CHEM, V288, P25838, DOI 10.1074/jbc.M113.494872; Nie HB, 2015, CELL PHYSIOL BIOCHEM, V35, P1201, DOI 10.1159/000373944; Oseni AO, 2013, J SURG RES, V181, P41, DOI 10.1016/j.jss.2012.05.087; Roposch A, 2013, CLIN ORTHOP RELAT R, V471, P2318, DOI 10.1007/s11999-013-2804-2; Russo JW, 2010, J CELL COMMUN SIGNAL, V4, P119, DOI 10.1007/s12079-010-0098-7; Sauer S, 2015, TRENDS PHARMACOL SCI, V36, P688, DOI 10.1016/j.tips.2015.06.010; Schwend RM, 2014, PEDIATR CLIN N AM, V61, P1095, DOI 10.1016/j.pcl.2014.08.008; van Sleuwen BE, 2007, PEDIATRICS, V120, pe1097, DOI 10.1542/peds.2006-2083; Vasheghani F, 2013, AM J PATHOL, V182, P1099, DOI 10.1016/j.ajpath.2012.12.012; Wang EB, 2012, J BONE JOINT SURG AM, V94A, P1071, DOI 10.2106/JBJS.K.00720; Wei YS, 2016, BALK MED J, V33, P639, DOI 10.5152/balkanmedj.2016.150557; Yamabe S, 2013, FEBS J, V280, P1617, DOI 10.1111/febs.12170; Zhang HB, 2016, APOPTOSIS, V21, P1082, DOI 10.1007/s10495-016-1280-z	41	4	4	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4904	4917		10.1096/fj.201901915R	http://dx.doi.org/10.1096/fj.201901915R		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32058630	Bronze			2022-12-26	WOS:000515245300001
J	Nathan, AM; Teh, CSJ; Jabar, KA; Teoh, BT; Tangaperumal, A; Westerhout, C; Zaki, R; Eg, KP; Thavagnanam, S; de Bruyne, JA				Nathan, Anna Marie; Teh, Cindy Shuan Ju; Jabar, Kartini Abdul; Teoh, Boon Teong; Tangaperumal, Anithaa; Westerhout, Caroline; Zaki, Rafdzah; Eg, Kah Peng; Thavagnanam, Surendran; de Bruyne, Jessie Anne			Bacterial pneumonia and its associated factors in children from a developing country: A prospective cohort study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; NONTYPABLE HAEMOPHILUS-INFLUENZAE; PNEUMOCOCCAL CONJUGATE VACCINE; RESPIRATORY-TRACT; STREPTOCOCCUS-PNEUMONIAE; HOSPITALIZED CHILDREN; STAPHYLOCOCCUS-AUREUS; CHILDHOOD PNEUMONIA; INDUCED SPUTUM; MULTIPLEX PCR	Introduction Pneumonia in children is a common disease yet determining its aetiology remains elusive. Objectives To determine the a) aetiology, b) factors associated with bacterial pneumonia and c) association between co-infections (bacteria + virus) and severity of disease, in children admitted with severe pneumonia. Methods A prospective cohort study involving children aged 1-month to 5-years admitted with very severe pneumonia, as per the WHO definition, over 2 years. Induced sputum and blood obtained within 24 hrs of admission were examined via PCR, immunofluorescence and culture to detect 17 bacteria/viruses. A designated radiologist read the chest radiographs. Results Three hundred patients with a mean (SD) age of 14 (+/- 15) months old were recruited. Significant pathogens were detected in 62% of patients (n = 186). Viruses alone were detected in 23.7% (n = 71) with rhinovirus (31%), human metapneumovirus (HMP) [22.5%] and respiratory syncytial virus (RSV) [16.9%] being the commonest. Bacteria alone was detected in 25% (n = 75) with Haemophilus influenzae (29.3%), Staphylococcus aureus (24%) and Streptococcus pneumoniae (22.7%) being the commonest. Co-infections were seen in 13.3% (n = 40) of patients. Male gender (AdjOR 1.84 [95% CI 1.10, 3.05]) and presence of crepitations (AdjOR 2.27 [95% CI 1.12, 4.60]) were associated with bacterial infection. C-reactive protein (CRP) [p = 0.007]) was significantly higher in patients with co-infections but duration of hospitalization (p = 0.77) and requirement for supplemental respiratory support (p = 0.26) were not associated with co-infection. Conclusions Bacteria remain an important cause of very severe pneumonia in developing countries with one in four children admitted isolating bacteria alone. Male gender and presence of crepitations were significantly associated with bacterial aetiology. Co-infection was associated with a higher CRP but no other parameters of severe clinical illness.	[Nathan, Anna Marie; Eg, Kah Peng; Thavagnanam, Surendran; de Bruyne, Jessie Anne] Univ Malaya Paediat, Dept Paediat, Kuala Lumpur, Malaysia; [Nathan, Anna Marie; Eg, Kah Peng; Thavagnanam, Surendran; de Bruyne, Jessie Anne] Univ Malaya, Child Hlth Res Grp, Kuala Lumpur, Malaysia; [Teh, Cindy Shuan Ju; Jabar, Kartini Abdul] Univ Malaya, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Teoh, Boon Teong] Univ Malaya, Dept Trop Infect Dis Res, Kuala Lumpur, Malaysia; [Teoh, Boon Teong] Univ Malaya, Educ Ctr TIDREC, Kuala Lumpur, Malaysia; [Tangaperumal, Anithaa; Westerhout, Caroline] Univ Malaya, Dept Biomed Imaging, Med Ctr, Kuala Lumpur, Malaysia; [Zaki, Rafdzah] Ctr Epidemiol & Evidence Based Practice, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Nathan, AM (corresponding author), Univ Malaya Paediat, Dept Paediat, Kuala Lumpur, Malaysia.; Nathan, AM (corresponding author), Univ Malaya, Child Hlth Res Grp, Kuala Lumpur, Malaysia.	psr9900@hotmail.com	Nathan, Anna/ABH-2362-2021; ABDUL JABAR, KARTINI/B-8752-2010; ZAKI, RAFDZAH AHMAD/B-9520-2010; Nathan, Anna M/G-4148-2015; Jabar, Kartini Abdul/AAG-8158-2021; Teoh, Boon-Teong/ABH-2475-2021; Tangaperumal, Anithaa/GOJ-8206-2022; eg, kah peng/W-8347-2018; Teh, Cindy/D-7161-2019	Nathan, Anna/0000-0003-3618-5820; ABDUL JABAR, KARTINI/0000-0002-8716-4416; ZAKI, RAFDZAH AHMAD/0000-0003-2884-5198; Jabar, Kartini Abdul/0000-0002-8716-4416; Teoh, Boon-Teong/0000-0001-6786-5023; Tangaperumal, Anithaa/0000-0002-3508-5900; eg, kah peng/0000-0002-6814-7418; Teh, Cindy/0000-0002-9062-3839; thavagnanam, surendran/0000-0002-4414-7915	Universiti Malaya [RP026-14HTM]	Universiti Malaya(Universiti Malaya)	This work was supported by Universiti Malaya, grant RP026-14HTM to AMN, JdB, CSJT, EKP, CW,ST, KAJ, RZ. The funder did not have any role in the study design, data collection, analysis, and decision to publish, or in the preparation of the manuscript.	Angoulvant F, 2014, CLIN INFECT DIS, V58, P918, DOI 10.1093/cid/ciu006; [Anonymous], 2014, INTEGRATED MANAGEMEN; Aydemir Y, 2017, PAEDIATR INT CHILD H, V37, P29, DOI 10.1080/20469047.2015.1106080; Baggett HC, 2017, CLIN INFECT DIS, V64, pS317, DOI 10.1093/cid/cix100; Caracciolo S, 2008, PEDIATR INFECT DIS J, V27, P406, DOI 10.1097/INF.0b013e318162a164; Chang AB, 2011, PAEDIATR RESPIR REV, V12, P97, DOI 10.1016/j.prrv.2010.10.008; Chang AB, 2013, FRONT PEDIATR, V1, DOI 10.3389/fped.2013.00029; Chochua S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167725; Clarke TB, 2011, CELL HOST MICROBE, V9, P404, DOI 10.1016/j.chom.2011.04.012; De Schutter I, 2011, CLIN INFECT DIS, V52, P1437, DOI 10.1093/cid/cir235; Dowell SF, 2001, CLIN INFECT DIS, V32, P824, DOI 10.1086/319205; El Kholy AA, 2016, EUR J CLIN MICROBIOL, V35, P1607, DOI 10.1007/s10096-016-2698-5; Elemraid MA, 2013, EUR RESPIR J, V42, P1595, DOI 10.1183/09031936.00199112; Enarson PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102955; Gothankar J, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5996-2; Grant LR, 2012, CLIN INFECT DIS, V54, pS140, DOI [10.1093/cid/cir1069, 10.1093/cid/cir1073]; Hamer DH, 2002, CLIN INFECT DIS, V34, P1025, DOI 10.1086/339446; Hammitt LL, 2012, CLIN INFECT DIS, V54, pS190, DOI 10.1093/cid/cir1071; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Isenberg HD, 2004, CLIN MICROBIOLOGY PR; Jourdain S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-100; Kumar A, 2015, INDIAN PEDIATR, V52, P35, DOI 10.1007/s13312-015-0563-8; Lahti E, 2009, THORAX, V64, P252, DOI 10.1136/thx.2008.099051; Lam WY, 2007, J CLIN MICROBIOL, V45, P3631, DOI 10.1128/JCM.00280-07; le Roux DM, 2017, PEDIATR RADIOL, V47, P1392, DOI 10.1007/s00247-017-3827-8; Lim FJ, 2016, RESPIROLOGY, V21, P648, DOI 10.1111/resp.12741; Lu GL, 2013, J MED VIROL, V85, P138, DOI 10.1002/jmv.23438; Mathew JL, 2015, J GLOB HEALTH, V5, P223, DOI 10.7189/jogh.05.020418; Mermond S, 2012, CLIN INFECT DIS, V54, pS180, DOI 10.1093/cid/cir1070; Moreno L, 2006, PEDIATR PULM, V41, P331, DOI 10.1002/ppul.20364; Murdoch DR, 2004, APMIS, V112, P713, DOI 10.1111/j.1600-0463.2004.apm11211-1202.x; Nelson Christopher T, 2002, Semin Respir Infect, V17, P10, DOI 10.1053/srin.2002.31687; Ngeow YF, 2005, INT J INFECT DIS, V9, P144, DOI 10.1016/j.ijid.2004.06.006; Panda S, 2014, INT J INFECT DIS, V25, P45, DOI 10.1016/j.ijid.2014.03.1394; Park DE, 2017, CLIN INFECT DIS, V64, pS328, DOI 10.1093/cid/cix104; PIIRILA P, 1992, CHEST, V102, P176, DOI 10.1378/chest.102.1.176; Rodrigues CMC, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01318-17; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Self WH, 2016, J INFECT DIS, V213, P584, DOI 10.1093/infdis/jiv323; SHANN F, 1986, PEDIATR INFECT DIS J, V5, P247, DOI 10.1097/00006454-198603000-00017; Shi T, 2015, J GLOB HEALTH, V5, P122, DOI 10.7189/jogh.05.010408; Simonsen L, 2014, LANCET RESP MED, V2, P387, DOI 10.1016/S2213-2600(14)70032-3; Slack MPE, 2017, PNEUMONIA, V9, DOI 10.1186/s41479-017-0033-2; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P172, DOI 10.1093/ije/dyq033; Turner P, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-434; Van Eldere J, 2014, LANCET INFECT DIS, V14, P1281, DOI 10.1016/S1473-3099(14)70734-0; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Walker CM, 2014, AM J ROENTGENOL, V202, P479, DOI 10.2214/AJR.13.11463; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Zaghloul MZ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-239; Zar HJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j2739; Zar HJ, 2016, LANCET RESP MED, V4, P463, DOI 10.1016/S2213-2600(16)00096-5	52	11	12	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0228056	10.1371/journal.pone.0228056	http://dx.doi.org/10.1371/journal.pone.0228056			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7VI	32059033	gold, Green Published, Green Submitted			2022-12-26	WOS:000535206600006
J	Wallace, JM; Milne, JS; Aitken, BW; Aitken, RP; Adam, CL				Wallace, Jacqueline M.; Milne, John S.; Aitken, Beth W.; Aitken, Raymond P.; Adam, Clare L.			Ovine prenatal growth-restriction and sex influence fetal adipose tissue phenotype and impact postnatal lipid metabolism and adiposity in vivo from birth until adulthood	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; GENE-EXPRESSION; INSULIN-RESISTANCE; MATERNAL NUTRITION; PLASMA LEPTIN; SUBJECTS BORN; FATTY-ACID; BODY-FAT; SHEEP; WEIGHT	Adipose tissue development begins in utero and is a key target of developmental programming. Here the influence of nutritionally-mediated prenatal growth-restriction on perirenal adipose tissue (PAT) gene expression and adipocyte phenotype in late fetal life was investigated in both sexes in an ovine model. Likewise circulating leptin concentrations and non-esterified fatty acid (NEFA) and glycerol responses to glucose challenge were determined in relation to offspring adiposity at key stages from birth to mid-adult life. In both studies' singleton-bearing adolescent sheep were fed control or high nutrient intakes to induce normal or growth-restricted pregnancies, respectively. Fetal growth-restriction at day 130 of gestation (32% lighter) was characterised by greater body-weight-specific PAT mass and higher PAT expression of peroxisome proliferator-activated receptor gamma (PPAR.), glycerol-3-phosphate dehydrogenase, hormone sensitive lipase (HSL), insulin-like growth factor 1 receptor, and uncoupling protein 1. Independent of prenatal growth, females had a greater body-weight-specific PAT mass, more multilocular adipocytes, higher leptin and lower insulin-like growth factor 1 mRNA than males. Growth-restricted offspring of both sexes (42% lighter at birth) were characterised by higher plasma NEFA concentrations across the life-course (post-fasting and after glucose challenge at 7, 32, 60, 85 and 106 weeks of age) consistent with reduced adipose tissue insulin sensitivity. Circulating plasma leptin correlated with body fat percentage (females> males) and restricted compared with normal females had more body fat and increased abundance of PPAR.;, HSL, leptin and adiponectin mRNA in PAT at necropsy (109 weeks). Therefore, prenatal nutrient supply and sex both influence adipose tissue development with consequences for lipid metabolism and body composition persisting throughout the life-course.	[Wallace, Jacqueline M.; Milne, John S.; Aitken, Beth W.; Aitken, Raymond P.; Adam, Clare L.] Univ Aberdeen, Rowett Inst, Aberdeen, Scotland	University of Aberdeen	Wallace, JM (corresponding author), Univ Aberdeen, Rowett Inst, Aberdeen, Scotland.	Jacqueline.Wallace@abdn.ac.uk		Wallace, Jacqueline/0000-0003-3099-5902	Scottish Government's Rural and Environmental Science and Analytical Services Division (RESAS); Strategic Partnership for Animal Science	Scottish Government's Rural and Environmental Science and Analytical Services Division (RESAS); Strategic Partnership for Animal Science	This work was funded by the Scottish Government's Rural and Environmental Science and Analytical Services Division (RESAS) including the Strategic Partnership for Animal Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam CL, 2013, INT J DEV NEUROSCI, V31, P608, DOI 10.1016/j.ijdevneu.2013.07.005; AFRC Energy and Protein Requirements of Ruminants, 1983, ADV MAN PREP AFRC TE; Barbour LA, 2018, CLIN THER, V40, P1638, DOI 10.1016/j.clinthera.2018.08.007; Beltrand J, 2008, BEST PRACT RES CL EN, V22, P503, DOI 10.1016/j.beem.2008.01.015; Bispham J, 2003, ENDOCRINOLOGY, V144, P3575, DOI 10.1210/en.2003-0320; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; BRUCE LA, 1991, J ENDOCRINOL, V128, pR1, DOI 10.1677/joe.0.128R001; Budge H, 2004, BIOL REPROD, V71, P359, DOI 10.1095/biolreprod.103.018986; Cagnacci A, 2006, EUR J OBSTET GYN R B, V124, P53, DOI 10.1016/j.ejogrb.2005.05.009; Crane JD, 2016, SCI REP-UK, V6, DOI 10.1038/srep31560; Delhaes F, 2018, PLACENTA, V69, P118, DOI 10.1016/j.placenta.2018.05.011; Dervishi E, 2012, J ANIM SCI, V90, P54, DOI 10.2527/jas.2011-4057; Du M, 2015, MEAT SCI, V109, P40, DOI 10.1016/j.meatsci.2015.04.010; Dunn L, 2015, EUR J OBSTET GYN R B, V185, P19, DOI 10.1016/j.ejogrb.2014.11.035; Edwards LJ, 2005, AM J PHYSIOL-REG I, V288, pR39, DOI 10.1152/ajpregu.00127.2004; Fensterseifer SR, 2018, ANIM REPROD SCI, V197, P231, DOI 10.1016/j.anireprosci.2018.08.033; Fruhbeck G, 2018, ADIPOCYTE, V7, P57, DOI 10.1080/21623945.2017.1402151; GEMMELL RT, 1978, AUST J BIOL SCI, V31, P505, DOI 10.1071/BI9780505; Grapov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048852; Hawkes CP, 2011, PEDIATRICS, V128, pE645, DOI 10.1542/peds.2010-3856; Heerwagen MJR, 2018, PLACENTA, V64, P53, DOI 10.1016/j.placenta.2018.03.001; Horvath TL, 2006, NAT MED, V12, P52, DOI 10.1038/nm0106-52; Ito M, 2017, PEDIATR INT, V59, P898, DOI 10.1111/ped.13320; Jaquet D, 2005, DIABETOLOGIA, V48, P849, DOI 10.1007/s00125-005-1724-4; Jaquet D, 2000, J CLIN ENDOCR METAB, V85, P1401, DOI 10.1210/jc.85.4.1401; Kajantie E, 2015, J CLIN ENDOCR METAB, V100, P244, DOI 10.1210/jc.2014-3184; Kayemba-Kays S, 2008, EUR J ENDOCRINOL, V159, P217, DOI 10.1530/EJE-08-0171; Knop MR, 2018, J AM HEART ASSOC, V7, DOI [10.1161/JAHA.118.008870, 10.1161/jaha.118.008870]; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Lie S, 2013, AM J PHYSIOL-ENDOC M, V305, pE931, DOI 10.1152/ajpendo.00180.2013; Liu YJ, 2017, J MATERN-FETAL NEO M, V30, P858, DOI 10.1080/14767058.2016.1189527; Long NM, 2012, J ANIM SCI, V90, P2201, DOI 10.2527/jas.2011-4343; Louveau I, 2016, ANIMAL, V10, P1839, DOI 10.1017/S1751731116000872; Luther J, 2007, BIOL REPROD, V77, P343, DOI 10.1095/biolreprod.107.061440; Marie M, 2001, J ENDOCRINOL, V170, P277, DOI 10.1677/joe.0.1700277; Matsuzaki M, 2006, REPROD FERT DEVELOP, V18, P357, DOI 10.1071/RD05067; MCKELVEY WAC, 1985, THERIOGENOLOGY, V24, P519, DOI 10.1016/0093-691X(85)90059-7; Meas T, 2010, DIABETES METAB, V36, P11, DOI 10.1016/j.diabet.2009.09.001; MELLOR DJ, 1977, J COMP PATHOL, V87, P629, DOI 10.1016/0021-9975(77)90070-6; Mericq V, 2005, DIABETOLOGIA, V48, P2609, DOI 10.1007/s00125-005-0036-z; MORAGAS A, 1983, BIOL NEONATE, V43, P80, DOI 10.1159/000241641; Muhlhausler BS, 2007, ENDOCRINOLOGY, V148, P6157, DOI 10.1210/en.2007-0770; Muhlhausler BS, 2007, ENDOCRINOLOGY, V148, P878, DOI 10.1210/en.2006-1115; Muhlhausler BS, 2009, ENDOCRINOLOGY, V150, P4287, DOI 10.1210/en.2009-0462; Muhlhausler BS, 2002, BIOL REPROD, V67, P493, DOI 10.1095/biolreprod67.2.493; Ong KK, 2006, HORM RES, V65, P65, DOI 10.1159/000091508; Poore KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090994; Poore KR, 2007, AM J PHYSIOL-ENDOC M, V292, P32; Pope M, 2014, ACTA PHYSIOL, V210, P20, DOI 10.1111/apha.12053; Pu Y, 2017, ENDOCRINOLOGY, V158, P3844, DOI 10.1210/en.2017-00615; Puttabyatappa M, 2018, REPROD SCI, V25, P1010, DOI 10.1177/1933719117746767; Quirke LD, 2001, BIOL REPROD, V65, P216, DOI 10.1095/biolreprod65.1.216; Rattanatray L, 2010, ENDOCRINOLOGY, V151, P5195, DOI 10.1210/en.2010-0501; Redmer DA, 2009, REPRODUCTION, V137, P749, DOI 10.1530/REP-08-0516; Reynolds CM, 2019, J ENDOCRINOL, V242, pT81, DOI 10.1530/JOE-18-0686; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; Schildberger B, 2016, GEBURTSH FRAUENHEILK, V76, P255, DOI 10.1055/s-0041-109198; Symonds ME, 2016, THERIOGENOLOGY, V86, P120, DOI 10.1016/j.theriogenology.2016.04.023; Symonds ME, 1998, J NEUROENDOCRINOL, V10, P885; Symonds ME, 2015, ANNU REV NUTR, V35, P295, DOI 10.1146/annurev-nutr-071813-105330; Symonds ME, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/305763; Szabo AJ, 2019, MED HYPOTHESES, V122, P82, DOI 10.1016/j.mehy.2018.10.022; Veiga-Lopez A, 2011, BIOL REPROD, V84, P87, DOI 10.1095/biolreprod.110.086686; Velickovic K, 2014, J CLIN ENDOCR METAB, V99, P151, DOI 10.1210/jc.2013-2017; Vickers MH, 2001, J ENDOCRINOL, V170, P323, DOI 10.1677/joe.0.1700323; Wallace J, 2016, PHYSIOL HEALTH DIS, P57, DOI 10.1007/978-1-4939-6386-7_4; Wallace JM, 2006, BRIT J NUTR, V96, P1060, DOI 10.1017/BJN20061979; Wallace JM, 2018, REPRODUCTION, V156, P103, DOI [10.1530/REP-18-0048, 10.1530/rep-18-0048]; Wallace JM, 2015, J MOL ENDOCRINOL, V54, P263, DOI 10.1530/JME-15-0048; Wallace JM, 2014, J MOL ENDOCRINOL, V53, P131, DOI 10.1530/JME-14-0123; Wallace JM, 2014, REPROD FERT DEVELOP, V26, P665, DOI 10.1071/RD13090; Wallace JM, 2012, BRIT J NUTR, V107, P510, DOI 10.1017/S0007114511003175; Wallace JM, 2011, REPROD FERT DEVELOP, V23, P275, DOI 10.1071/RD10103; Wallace JM, 2010, BIOL REPROD, V82, P320, DOI 10.1095/biolreprod.109.080069; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Wiebel ER, 1979, STEREOLOGICAL METHOD, V1; Winter J S, 1977, Birth Defects Orig Artic Ser, V13, P41; Yajnik CS, 2004, P NUTR SOC, V63, P387, DOI 10.1079/PNS2004365; Yuen BSJ, 2003, FASEB J, V17, P1102, DOI 10.1096/fj.02-0756fje	79	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0228732	10.1371/journal.pone.0228732	http://dx.doi.org/10.1371/journal.pone.0228732			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7VI	32059008	Green Published, gold			2022-12-26	WOS:000535206600014
J	Baqui, AH; McCollum, ED; Mahmud, A; Roy, A; Chowdhury, NH; Rafiqullah, I; Rizvi, SJR; Begum, N; Mitra, DK; Khanam, R; Harrison, M; Ahmed, S; Hasanuzzaman, M; Rahman, H; Islam, M; Ahmed, ZB; Quaiyum, MA; Koffi, A; Simmons, N; Checkley, W; Moulton, LH; Santosham, M; Saha, SK				Baqui, Abdullah H.; McCollum, Eric D.; Mahmud, Arif; Roy, Arunangshu; Chowdhury, Nabidul H.; Rafiqullah, Iftekhar; Rizvi, Syed Jafar Raza; Begum, Nazma; Mitra, Dipak K.; Khanam, Rasheda; Harrison, Meagan; Ahmed, Salahuddin; Hasanuzzaman, Md; Rahman, Hafizur; Islam, Maksuda; Ahmed, Zabed B.; Quaiyum, Md Abdul; Koffi, Alain; Simmons, Nicole; Checkley, William; Moulton, Lawrence H.; Santosham, Mathuram; Saha, Samir K.		Projahnmo Study Grp Bangladesh	Population-based incidence and serotype distribution of invasive pneumococcal disease prior to introduction of conjugate pneumococcal vaccine in Bangladesh	PLOS ONE			English	Article							CHILDREN; EPIDEMIOLOGY; PNEUMONIA; MORTALITY; IMPACT	Background Bangladesh introduced the 10-valent pneumococcal conjugate vaccine (PCV-10) in 2015. We measured population-based incidence of invasive pneumococcal disease (IPD) prior to introduction of PCV-10 to provide a benchmark against which the impact of PCV-10 can be assessed. Methods We conducted population, facility and laboratory-based surveillance in children 0-59 months of age in three rural sub-districts of Sylhet district of Bangladesh from January 2014 to June 2015. All children received two-monthly home visits with one week recall for morbidity and care seeking. Children attending the three Upazilla Health Complexes (UHC, subdistrict hospitals) in the surveillance area were screened for suspected IPD. Blood samples were collected from suspected IPD cases for culture and additionally, cerebrospinal fluid (CSF) was collected from suspected meningitis cases for culture and molecular testing. Pneumococcal isolates were serotyped by Quellung. Serotyping of cases detected by molecular testing was done by sequential multiplex polymerase chain reaction. Results Children under surveillance contributed to 126,657 child years of observations. Sixty-three thousand three hundred eighty-four illness episodes were assessed in the UHCs. Blood specimens were collected from 8,668 suspected IPD cases and CSF from 177 suspected meningitis cases. Streptococcus pneumoniae was isolated from 46 cases; 32 (70%) were vaccine serotype. The population-based incidence of IPD was 36.3/100,000 child years of observations. About 80% of the cases occurred in children below two years of age. Discussion IPD was common in rural Bangladesh suggesting the potential benefit of an effective vaccine. Measurement of the burden of IPD requires multiple surveillance modalities.	[Baqui, Abdullah H.; McCollum, Eric D.; Khanam, Rasheda; Harrison, Meagan; Koffi, Alain; Simmons, Nicole; Checkley, William; Moulton, Lawrence H.; Santosham, Mathuram] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA; [McCollum, Eric D.] Johns Hopkins Univ, Sch Med, Dept Pediat, Eudowood Div Pediat Resp Sci, Baltimore, MD 21205 USA; [Mahmud, Arif; Roy, Arunangshu; Chowdhury, Nabidul H.; Rizvi, Syed Jafar Raza; Begum, Nazma; Ahmed, Salahuddin] Projahnmo Res Fdn, Dhaka, Bangladesh; [Rafiqullah, Iftekhar; Mitra, Dipak K.] North South Univ, Dhaka, Bangladesh; [Hasanuzzaman, Md; Rahman, Hafizur; Islam, Maksuda; Ahmed, Zabed B.; Saha, Samir K.] Child Hlth Res Fdn, Dhaka, Bangladesh; [Quaiyum, Md Abdul] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Checkley, William] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; North South University (NSU); International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University	Baqui, AH (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA.	abaqui@jhu.edu	Rafiqullah, Iftekhar/P-2723-2016; Ahmed, Salahuddin/AAH-7005-2020; Ahmed, Salahuddin/ABC-3497-2021; Mitra, Dipak/W-9569-2018	Rafiqullah, Iftekhar/0000-0002-6974-525X; Ahmed, Salahuddin/0000-0001-6771-0638; Checkley, William/0000-0003-1106-8812; Mitra, Dipak/0000-0001-8680-4146; Hasanuzzaman, Md/0000-0002-6632-4521; CHOWDHURY, MD NABIDUL HAQUE/0000-0002-6149-1152; Baqui, Abdullah/0000-0001-8350-1983	Bill and Melinda Gates Foundation [OPP1117483]; GlaxoSmithKline	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); GlaxoSmithKline(GlaxoSmithKline)	Support for this study was provided by the Bill and Melinda Gates Foundation (grant number OPP1117483) AHB and and GlaxoSmithKline (https://www.gatesfoundation.org).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade AL, 2016, HUM VACC IMMUNOTHER, V12, P285, DOI 10.1080/21645515.2015.1117713; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Ansaldi F, 2011, HUM VACCINES, V7, P211, DOI 10.4161/hv.7.0.14602; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Arifeen SE, 2009, CLIN INFECT DIS, V48, pS103, DOI 10.1086/596543; Balsells E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177113; Baqui Abdullah H, 2018, Gates Open Res, V2, P21, DOI 10.12688/gatesopenres.12805.1; Bonner K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135270; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Campbell JD, 2004, PEDIATR INFECT DIS J, V23, P642, DOI 10.1097/01.inf.0000130951.85974.79; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Flasche S, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0882-9; Izurieta P, 2018, EXPERT REV VACCINES, V17, P479, DOI 10.1080/14760584.2018.1413354; Jaiswal N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096282; Katoh S, 2017, JPN J INFECT DIS, V70, P495, DOI 10.7883/yoken.JJID.2016.311; Lagos R, 2002, PEDIATR INFECT DIS J, V21, P1115, DOI 10.1097/00006454-200212000-00006; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Rurangwa J, 2016, AM J TROP MED HYG, V95, P680, DOI 10.4269/ajtmh.15-0923; Saha S, 2011, J TROP PEDIATRICS, V57, P192, DOI 10.1093/tropej/fmq070; Saha SK, 2016, PEDIATR INFECT DIS J, V35, P655, DOI 10.1097/INF.0000000000001037; Saha SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032134; Sigauque B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190687; Tricarico S, 2017, PNEUMONIA, V9, DOI 10.1186/s41479-017-0030-5; Usen S, 1998, PEDIATR INFECT DIS J, V17, P23, DOI 10.1097/00006454-199801000-00006; von Gottberg A, 2013, VACCINE, V31, P4200, DOI 10.1016/j.vaccine.2013.04.077; Warren JL, 2017, CLIN INFECT DIS, V65, P1813, DOI 10.1093/cid/cix638	26	3	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228799	10.1371/journal.pone.0228799	http://dx.doi.org/10.1371/journal.pone.0228799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053640	gold, Green Published			2022-12-26	WOS:000535198700056
J	Endres, L; Rose, RE; Doyle, F; Rahn, T; Lee, B; Seaman, J; McIntyre, WD; Fabris, D				Endres, Lauren; Rose, Rebecca E.; Doyle, Frank; Rahn, Taylor; Lee, Bethany; Seaman, Jessica; McIntyre, William D.; Fabris, Daniele			2 '-O-ribose methylation of transfer RNA promotes recovery from oxidative stress in Saccharomyces cerevisiae	PLOS ONE			English	Article							YEAST TRANSFER-RNA; CODON-BIASED TRANSLATION; POSTTRANSCRIPTIONAL MODIFICATIONS; IN-VITRO; GENOME; BASE; IDENTIFICATION; STABILIZATION; COMPILATION; SEQUENCES	Chemical modifications that regulate protein expression at the translational level are emerging as vital components of the cellular stress response. Transfer RNAs (tRNAs) are significant targets for methyl-based modifications, which are catalyzed by tRNA methyl-transferases (Trms). Here, Saccharomyces cerevisiae served as a model eukaryote system to investigate the role of 2'-O-ribose tRNA methylation in the cell's response to oxidative stress. Using 2'-O-ribose deletion mutants for trms 3, 7, 13, and 44, in acute and chronic exposure settings, we demonstrate a broad cell sensitivity to oxidative stress-inducing toxicants (i.e., hydrogen peroxide, rotenone, and acetic acid). A global analysis of hydrogen peroxide-induced tRNA modifications shows a complex profile of decreased, or undetectable, 2'-O-ribose modification events in 2'-O-ribose trm mutant strains, providing a critical link between this type of modification event and Trm status post-exposure. Based on the pronounced oxidative stress sensitivity observed for trm7 mutants, we used a bioinformatic tool to identify transcripts as candidates for regulation by Trm7-catalyzed modifications (i.e., enriched in UUC codons decoded by tRNA(PheGmAA)). This screen identified transcripts linked to diverse biological processes that promote cellular recovery after oxidative stress exposure, including DNA repair, chromatin remodeling, and nutrient acquisition (i.e., CRT10, HIR3, HXT2, and GNP1); moreover, these mutants were also oxidative stress-sensitive. Together, these results solidify a role for TRM3, 7, 13, and 44, in the cellular response to oxidative stress, and implicate 2'-O-ribose tRNA modification as an epitranscriptomic strategy for oxidative stress recovery.	[Endres, Lauren; Rahn, Taylor; Lee, Bethany; Seaman, Jessica] SUNY Polytech Inst, Coll Arts & Sci, Utica, NY 13502 USA; [Rose, Rebecca E.] New York Univ Langone Heath, Metabol Core Resource Lab, New York, NY USA; [Doyle, Frank] SUNY Polytech Inst, Coll Nanoscale Sci & Engn, Albany, NY USA; [McIntyre, William D.; Fabris, Daniele] Univ Connecticut, Dept Chem, U-60, Storrs, CT USA	SUNY Polytechnic Institute; SUNY Polytechnic Institute; University of Connecticut	Endres, L (corresponding author), SUNY Polytech Inst, Coll Arts & Sci, Utica, NY 13502 USA.	endresl@sunypoly.edu		Rahn, Taylor/0000-0002-5031-6914; Jones, Rebecca/0000-0002-5056-9292	SUNY Polytechnic Institute Seed Grant	SUNY Polytechnic Institute Seed Grant	This research was completed with support from a SUNY Polytechnic Institute Seed Grant (LE, https://sunypoly.edu/sponsoredresearch.html) and an award from the Dr. Nuala McGann Drescher Diversity and Inclusion Leave Program (LE, https://goer.ny.gov).	Agris PF, 2008, EMBO REP, V9, P629, DOI 10.1038/embor.2008.104; Agris Paul F, 2017, Enzymes, V41, P1, DOI 10.1016/bs.enz.2017.03.005; AGRIS PF, 1973, ARCH BIOCHEM BIOPHYS, V154, P277, DOI 10.1016/0003-9861(73)90058-1; Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molcel.2005.10.036; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Berg MD, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120612; Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030; CAPRA JD, 1968, J MOL BIOL, V33, P591, DOI 10.1016/0022-2836(68)90308-2; Chan C, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1611-1; Chan CTY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1938; Chan CTY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001247; Chan PP, 2016, NUCLEIC ACIDS RES, V44, pD184, DOI 10.1093/nar/gkv1309; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Davis DR., 1998, MODIFICATION EDITING, P85; Doyle F, 2016, METHODS, V107, P98, DOI 10.1016/j.ymeth.2016.05.010; EDMONDS CG, 1991, J BACTERIOL, V173, P3138, DOI 10.1128/JB.173.10.3138-3148.1991; Endres L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131335; Endres L, 2015, RNA BIOL, V12, P603, DOI 10.1080/15476286.2015.1031947; Feinberg JS, 2001, P NATL ACAD SCI USA, V98, P11120, DOI 10.1073/pnas.211184098; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; GEFTER ML, 1969, J MOL BIOL, V39, P145, DOI 10.1016/0022-2836(69)90339-8; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Giege R, 2014, TRANSFER RNA RECOGNI, P1; Grosjean H., 2009, DNA RNA MODIFICATION, P1; Grosjean Henri, 2008, P171; Gu C, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aas9184; Guy MP, 2015, RNA, V21, P61, DOI 10.1261/rna.047639.114; Guy MP, 2012, RNA, V18, P1921, DOI 10.1261/rna.035287.112; Han L, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007288; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Karlsborn T, 2014, RNA BIOL, V11, P1519, DOI 10.4161/15476286.2014.992276; KAWAI G, 1992, BIOCHEMISTRY-US, V31, P1040, DOI 10.1021/bi00119a012; Kotelawala L, 2008, RNA, V14, P158, DOI 10.1261/rna.811008; KOWALAK JA, 1994, BIOCHEMISTRY-US, V33, P7869, DOI 10.1021/bi00191a014; LADNER JE, 1975, P NATL ACAD SCI USA, V72, P4414, DOI 10.1073/pnas.72.11.4414; Machnicka MA, 2014, RNA BIOL, V11, P1619, DOI 10.4161/15476286.2014.992273; MCCLAIN WH, 1988, SCIENCE, V240, P793, DOI 10.1126/science.2452483; McIntyre W, 2018, NUCLEIC ACIDS RES, V46, P5776, DOI 10.1093/nar/gky029; Motorin Y, 2010, BIOCHEMISTRY-US, V49, P4934, DOI 10.1021/bi100408z; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; OLSON MV, 1981, NATURE, V291, P464, DOI 10.1038/291464a0; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Pintard L, 2002, EMBO J, V21, P1811, DOI 10.1093/emboj/21.7.1811; Rose RE, 2016, MOL CELL PROTEOMICS, V15, P932, DOI 10.1074/mcp.M115.054718; Rose RE, 2015, RNA, V21, P1361, DOI 10.1261/rna.049429.114; SCOTT JH, 1980, J BACTERIOL, V142, P414, DOI 10.1128/JB.142.2.414-423.1980; Shigi N, 2008, EMBO J, V27, P3267, DOI 10.1038/emboj.2008.246; SHUGART L, 1968, BIOCHEM BIOPH RES CO, V31, P404, DOI 10.1016/0006-291X(68)90490-7; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; Su D, 2014, NAT PROTOC, V9, P828, DOI 10.1038/nprot.2014.047; SVENSSON I, 1968, BIOCHEM BIOPH RES CO, V31, P216, DOI 10.1016/0006-291X(68)90733-X; Towns WL, 2012, DNA CELL BIOL, V31, P434, DOI 10.1089/dna.2011.1437; Tripp JD, 2013, YEAST, V30, P191, DOI 10.1002/yea.2951; Wakeman Catherine A., 2009, V540, P173, DOI 10.1007/978-1-59745-558-9_13; Wilkinson ML, 2007, RNA, V13, P404, DOI 10.1261/rna.399607; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yokoyama S, 1987, Adv Biophys, V23, P115, DOI 10.1016/0065-227X(87)90006-2; ZACHAU HG, 1966, H-S Z PHYSIOL CHEM, V347, P212, DOI 10.1515/bchm2.1966.347.1.212	60	7	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0229103	10.1371/journal.pone.0229103	http://dx.doi.org/10.1371/journal.pone.0229103			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053677	gold, Green Published			2022-12-26	WOS:000535198700099
J	Gravningen, K; Field, N; Blix, HS; Asfeldt, AM; Smabrekke, L				Gravningen, Kirsten; Field, Nigel; Blix, Hege Salvesen; Asfeldt, Anne Mette; Smabrekke, Lars			Non-prescription purchase of antibiotics during travel abroad among a general adult population in Norway: Findings from the seventh Tromso Study	PLOS ONE			English	Article							SELF-MEDICATION; SOCIAL INEQUALITIES; COMMUNITY; RESISTANCE; EUROPE; CARE; PRESCRIPTION; CONSUMPTION; COUNTRIES; HEALTH	Background Non-prescription purchase of antibiotics is undesirable and has not recently been investigated in a representative population in a high-income low-use country during travel abroad. This study examined self-reported prevalence of antibiotic purchase abroad with and without prescription among participants reporting international travel in a general adult population in Norway, and the associations with socio-demographic, lifestyle and health factors. Methods We analysed questionnaire-data from 19995 participants (10470 women) >= 40 years in the population-based Tromso Study 7, 2015-2016. Data from the Norwegian Prescription Database were used to examine antibiotic use in Norway. We calculated adjusted odds ratios (AOR) for "travel abroad", "any antibiotic purchase abroad", and "antibiotic purchase abroad with" and "without prescription" using multivariable logistic regression. Results Over half (55.0%, 95%CI 54.3-55.7%) participants reported travel abroad of > 1 week duration in the past year. Travelers were more likely than non-travelers to be women (AOR = 2.02, 95%CI 1.42-2.88%) and report high education/income, childhood mostly lived abroad, healthy lifestyle, and good/excellent self-rated health. In total, 17904 travel episodes to 148 countries were reported. Altogether, 3.7% (95% CI 3.4%-4.1%) of travelers had purchased antibiotic abroad in the past year. Non-prescription purchase (1.5%, 95% CI 1.3-1.7) was associated with younger age, being female (AOR 1.41, 1.0-1.97), number of travels (reference: one episode, two: AOR = 1.82, 1.25-2.67, three: 2.60, 1.58-4.28, four: 3.10, 1.40-6.36 and >= five: 4.70, 2.30-9.62), occurrences of diarrhoea (one: 2.42, 1.50-3.93 and >= two: 3.08, 1.29-7.35), and antibiotic use in Norway in the past year (1.84, 1.29-2.62), whereas purchase with prescription (2.4%, 2.1-2.7) was associated with low income, growing-up abroad, recent hospital admission, additionally including number of travels/diarrhoea, and antibiotic use in Norway. Thailand (10.7%, 95% CI 7.8-14.3), Turkey (5.5%, 3.8-7.8) and Spain (3.6%, 3.0-4.3) were the countries most commonly associated with any antibiotic purchase. About two in five travelers who bought antibiotics in Thailand had done so without prescription, three in five in Turkey, and less than one in three in Spain. Conclusion Overall, a small proportion of travelers had bought antibiotics abroad in the past year. Low prevalence of non-prescription purchase may be explained by awareness of the risks associated with self-medication, cultural views, unawareness of the non-prescription availability, and/or few infections. Divergent predictors for purchase abroad with versus without prescription may suggest different reasons for these practices.	[Gravningen, Kirsten; Asfeldt, Anne Mette] Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway; [Field, Nigel] UCL, Ctr Mol Epidemiol & Translat Res, Inst Global Hlth, London, England; [Blix, Hege Salvesen] Norwegian Inst Publ Hlth, Dept Drug Stat, Oslo, Norway; [Blix, Hege Salvesen] Univ Oslo, Dept Pharm, Oslo, Norway; [Asfeldt, Anne Mette] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway; [Smabrekke, Lars] UiT Arctic Univ Norway, Dept Pharm, Tromso, Norway; [Gravningen, Kirsten] Norwegian Inst Publ Hlth, Dept Antibiot Resistance & Infect Prevent, Oslo, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; University of London; University College London; Norwegian Institute of Public Health (NIPH); University of Oslo; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; Norwegian Institute of Public Health (NIPH)	Gravningen, K (corresponding author), Norwegian Inst Publ Hlth, Dept Antibiot Resistance & Infect Prevent, Oslo, Norway.	kirsten.gravningen@unn.no	Field, Nigel/ABG-3948-2020	Gravningen, Kirsten/0000-0002-8194-3208; Field, Nigel/0000-0002-2825-6652				Allen L, 2017, LANCET GLOB HEALTH, V5, pE277, DOI 10.1016/s2214-109x(17)30058-x; [Anonymous], 2015, NORW GUID ANT US HOS; [Anonymous], 2012, NAT GUID ANT PRIM CA; Antibiotic Centre for Primary Care-University of Oslo, 2016, ENORM ED INT NORW MU; Aubry C, 2012, TRAVEL MED INFECT DI, V10, P247, DOI 10.1016/j.tmaid.2012.09.004; Auta A, 2019, J INFECTION, V78, P8, DOI 10.1016/j.jinf.2018.07.001; Awad A, 2005, J PHARM PHARM SCI, V8, P326; Belderok SM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-295; Bloomfield K, 2006, ALCOHOL ALCOHOLISM, V41, pI26, DOI 10.1093/alcalc/agl073; Borg MA, 2012, J ANTIMICROB CHEMOTH, V67, P763, DOI 10.1093/jac/dkr541; Cars O., 2005, International Journal of Risk & Safety in Medicine, V17, P103; Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; European Centre for Disease Prevention and Control (ECDC), 2018, ANT EP REP 2017; European Commission, 2016, SPEC EUR 445 APR 201; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Grigoryan L, 2008, J ANTIMICROB CHEMOTH, V61, P1172, DOI 10.1093/jac/dkn054; Guinovart MC, 2018, ENFERM INFEC MICR CL, V36, P290, DOI 10.1016/j.eimc.2016.10.006; Hadi MA, 2016, INT J INFECT DIS, V47, P95, DOI 10.1016/j.ijid.2016.06.003; Institute of Transport Economics & Norwegian Centre for Transport Research, 2014, 13832014 TOI I TRANS; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Jha P, 2006, LANCET, V368, P367, DOI 10.1016/S0140-6736(06)68975-7; Ministry of Health and Care Services, 2016, NAT ACT PLAN PREV AN; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Muscat M, 2006, SCAND J INFECT DIS, V38, P597, DOI 10.1080/00365540600606507; NIVEL and University of Antwerp (NL) for the European Commission, 2017, ANT RES CAUS NONPR U; NORM/NORM-VET, 2018, US ANT AG OCC ANT NO; Norwegian Intitute of Public Health (NIPH), 2015, REP INT SURV ANT RES; Ocan M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2109-3; OKUYAN B, 2017, ACTA PHARM SCI, V55, P7, DOI DOI 10.23893/1307-2080.APS.0558; Plachouras D, 2010, EURO SURVEILL, V15; Saengcharoen Woranuch, 2010, Int J Pharm Pract, V18, P323, DOI 10.1111/j.2042-7174.2010.00066.x; Sommanustweechai A, 2018, B WORLD HEALTH ORGAN, V96, P101, DOI 10.2471/BLT.17.199679; [Statistics Norway (SSB) https://www.ssb.no/reise], 2017, TRAV SURV 4 QUART 20; UNWTO, 2018, UNWTO TOUR HIGHL 201, DOI 10.18111/9789284419876; Vaandnen MH, 2006, HEALTH POLICY, V77, P166, DOI 10.1016/j.healthpol.2005.07.001; WHO Collaborating Centre for Drug Statistics Methodology, INT LANG DRUG UT RES; World Atlas RTI, WORLD FACTS COUNTR	38	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228792	10.1371/journal.pone.0228792	http://dx.doi.org/10.1371/journal.pone.0228792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053671	Green Published, gold			2022-12-26	WOS:000535198700055
J	Laksono, AD; Rukmini, R; Wulandari, RD				Laksono, Agung Dwi; Rukmini, Rukmini; Wulandari, Ratna Dwi			Regional disparities in antenatal care utilization in Indonesia	PLOS ONE			English	Article							MATERNAL HEALTH-CARE; SERVICES; DETERMINANTS; PAKISTAN	Introduction The main strategy for decreasing maternal morbidity and mortality has been antenatal care (ANC). ANC aims to monitor and maintain the health and safety of the mother and the fetus, detect all complications of pregnancy and take the necessary actions, respond to complaints, prepare for birth, and promote a healthy lifestyle. This study aims to analyze interregional disparities in >= 4 ANC visits during pregnancy in Indonesia. Methods Data was acquired from the 2017 Indonesian Demographic and Health Survey (IDHS). The unit of analysis was women aged 15-49 years old, and a sample of 15,351 women was obtained. In addition to ANC as the dependent variable, the other variables analyzed in this study were a place of residence, age, husband/partner, education, parity, wealth status, and health insurance. For the final analysis, binary logistic regression was used to determine disparity. Results With the Papua region as a reference, all regions showed a gap except for the Maluku region, which was not significantly different in the use of ANC compared to the Papua region. Women in the Nusa Tenggara have 4.365 times the chance of making >= 4 ANC visits compared to those in the Papua region (95% CI 3.229-5.899). Women in Java-Bali have 3.607 times the chance of making >= 4 ANC visits compared to women in the Papua region (95% CI 2.741-4.746). Women in Sumatra have 1.370 times the chance of making >= 4 ANC visits compared to women in the Papua region (95% CI 1.066-1.761). Women in Kalimantan have 2.232 times the chance of making >= 4 ANC visits compared to women in the Papua region (1.664-2.994). Women in Sulawesi have 1.980 times more chance of making >= 4 ANC visits compared to women in the Papua region (1.523-2.574). In addition to the region category, other variables that contributed to the predictor were age, husband/partner, education, parity, wealth and insurance. Conclusion There were disparities in ANC utilization between the various regions of Indonesia. The structured policy is needed to reach regions that have low coverage of >= 4 ANC. Policymakers need to use the results of this study to take the necessary policies. Policies that focus on service equality to reduce disparities.	[Laksono, Agung Dwi; Rukmini, Rukmini] Minist Hlth, Natl Inst Hlth Res & Dev, Jakarta, Indonesia; [Wulandari, Ratna Dwi] Univ Airlangga, Fac Publ Hlth, Surabaya, Indonesia	Ministry of Health - Indonesia; National Institute of Health Research & Development - Indonesia; Airlangga University	Wulandari, RD (corresponding author), Univ Airlangga, Fac Publ Hlth, Surabaya, Indonesia.	ratna-d-w@fkm.unair.ac.id	Laksono, Agung Dwi/N-5161-2018; Wulandari, Ratna/AAN-9410-2020	Laksono, Agung Dwi/0000-0002-9056-0399; Wulandari, Ratna/0000-0003-4365-5747				Achadi EL, 2019, MATERNAL NEONATAL DE; Adewuyi EO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197324; Agustina R, 2019, LANCET, V393, P75, DOI 10.1016/S0140-6736(18)31647-7; Ahmed S, 2019, EUR J HUM GENET, V27, P848, DOI 10.1038/s41431-019-0353-1; Ba DM, 2019, SEX REPROD HEALTHC, V21, P26, DOI 10.1016/j.srhc.2019.06.002; Baraki Z, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2338-z; Blanchard AK, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0554-8; Bobo FT, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0602-2; Caselli G., 2019, DENMARK US GENUS, V75, P11, DOI [DOI 10.1186/S41118-019-0055-0, 10.1186/s41118-019-0055-0]; Chi PC, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0449-8; Chiang CL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010802; Data and Information Center Ministry of Health, 2014, MOTH DAY MAT HLTH SI; Dey A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204810; Directorate General of Health Services, 2019, 2018 DIR GEN HLTH SE; El-Sayed AM, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.020402; Hattar-Pollara M, 2019, J NURS SCHOLARSHIP, V51, P241, DOI 10.1111/jnu.12480; Hijazi HH, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0542-3; Jafaralilou H, 2019, J EGYPT PUBLIC HEAL, V94, DOI 10.1186/s42506-018-0001-6; Johar M, 2018, SOC SCI MED, V213, P134, DOI 10.1016/j.socscimed.2018.07.044; Jungari S, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2214-x; Laksono, 2019, HLTH SCI J INDONES, V10, P58, DOI [DOI 10.22435/HSJI.V10I1.1044, 10.22435/hsji.v10i1.1044]; Laksono A. D., 2019, MALAYSIAN J PUBLIC H, V19; Laksono AD., 2016, J REPROD HEAL, V07, P145, DOI [10.22435/kespro.v7i3.4349.145-155, DOI 10.22435/KESPRO.V7I3.4349.145-155]; Laksono AD, 2015, BUL PENELIT SIST KES, V18, P347; Luginaah IN, 2016, SOC SCI MED, V160, P75, DOI 10.1016/j.socscimed.2016.05.019; Megatsari H, 2018, BUL PENELIT SIST KES, V21, P247, DOI 10.22435/hsr.v2Ii4.231; Mekonnen T, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16050748; Ministry of National Development Planning / National Development Planning Agency, 2014, COLL SECT STUD EV SU; Miraldo M, 2018, SOC SCI MED, V217, P135, DOI 10.1016/j.socscimed.2018.09.028; Mubasyiroh R., 2016, ACCESSIBILITY HLTH S, P21; Mullerschon J, 2019, BMC INT HEALTH HUM R, V19, DOI 10.1186/s12914-019-0189-3; Mumtaz S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217827; National Institute of Health Research and Development of The Indonesia Ministry of Health, 2019, 2018 IND BAS HLTH SU; National Population and Family Planning Board Statistics Indonesia Ministry of Health The DHS Program, 2018, DHS PROGR; Nurrizka RH, 2018, INDONESIAN J PUB HLT, V14, P119; Olaitan T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176195; Olugbade Olukemi Titilope, 2019, Pan Afr Med J, V32, P13, DOI 10.11604/pamj.supp.2019.32.1.13345; Pafs J, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1051-4; Paul P, 2019, MIDWIFERY, V75, P66, DOI 10.1016/j.midw.2019.04.007; Pulok MH, 2018, HEALTH PLACE, V52, P205, DOI 10.1016/j.healthplace.2018.06.004; Sahito A, 2018, INT J HEALTH POLICY, V7, P699, DOI 10.15171/ijhpm.2017.148; Sakuma S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215635; Soewondo P., 2019, J ADM KESEHAT INDONE, V7, P89, DOI [10.20473/jaki.v7i1.2019.89-7, DOI 10.20473/JAKI.V7I1.2019.89-7, 10.20473/jaki.v7i1.2019.89-98, DOI 10.20473/JAKI.V7I1.2019.89-98]; Suharmiati, 2013, BUL PENELIT SIST KES, V16, P109; Sully EA, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001695; Sumankuuro J, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2414-4; Teye-Kwadjo E, 2019, INT J HEALTH PROMOT, V57, P256, DOI 10.1080/14635240.2019.1613163; Tikmani SS, 2019, SEMIN PERINATOL, V43, P297, DOI 10.1053/j.semperi.2019.03.020; Tirgil A, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.020412; United Nations Group of Experts on Geographical Names, 2017, UN C STAND GEOGR NAM; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; Wilson M, 2019, MIDWIFERY, V78, P16, DOI 10.1016/j.midw.2019.07.005; Yesuf EA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-131; You H, 2019, INQUIRY-J HEALTH CAR, V56, DOI 10.1177/0046958019865435; Zakar R, 2017, J OBSTET GYNAECOL, V37, P330, DOI 10.1080/01443615.2016.1250728	55	31	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0224006	10.1371/journal.pone.0224006	http://dx.doi.org/10.1371/journal.pone.0224006			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7SH	32053621	Green Published, gold, Green Submitted			2022-12-26	WOS:000535198700007
J	Scholnick, DA; Winslow, AE				Scholnick, David A.; Winslow, Alexandra E.			The role of fasting on spine regeneration and bacteremia in the purple sea urchin Strongylocentrotus purpuratus	PLOS ONE			English	Article							RESOURCE-ALLOCATION; NUTRITION; STIMPSON	Fasting has been shown to increase longevity and alter immune function in a variety of animals, but little is understood about how reduced caloric intake may impact regeneration and infections in animals that must regularly repair and regenerate tissue in marine environments that contain high levels of bacteria. We examined the possibility that fasting could enhance spine regeneration and reduce bacteremia in the purple sea urchin Strongylocentrotus purpuratus. A small number of spines were removed from urchins and rates of spine regrowth and levels of culturable bacteria from the coelomic fluid were measured for 21 days in fed and fasted urchins. Fasted urchins had higher rates of spine regrowth and lower levels of colony-forming units (CFU) per milliliter of coeolomic fluid. The predominant bacteria in the coelomic fluid was isolated and identified by DNA sequence-based methods as Vibrio cyclitrophicus. After 21 days, fasted and fed urchins were injected with V. cyclitrophicus. Two hours after injection, fed urchins had about 25% more culturable bacteria remaining in their coelomic fluid compared to fasted urchins. We found no evidence that fasting altered coelomic fluid cell number or righting response, indicators of physiologic and behavioral stress in urchins. Our results demonstrate that V. cyclitrophicus is present in purple urchin coelomic fluid, that fasting can increase spine regeneration and that fasted urchins have much lower levels of culturable bacteria in their coelomic fluid than fed urchins. Overall, our data suggests that fasting may ultimately reduce bacteremia and infection in injured or damaged urchins.	[Scholnick, David A.; Winslow, Alexandra E.] Pacific Univ, Dept Biol, Forest Grove, OR 97116 USA		Scholnick, DA (corresponding author), Pacific Univ, Dept Biol, Forest Grove, OR 97116 USA.	david.scholnick@pacificu.edu						Adamo SA, 2016, J EXP BIOL, V219, P706, DOI 10.1242/jeb.132936; Boudouresque CF, 1996, AQUAT BOT, V53, P245, DOI 10.1016/0304-3770(96)01021-2; Carnevali MDC, 2006, ISJ-INVERT SURVIV J, V3, P64; Challener RC, 2014, MAR FRESHW BEHAV PHY, V47, P41, DOI 10.1080/10236244.2013.875273; Chiaramonte M, 2015, ITAL J ZOOL, V82, P300, DOI 10.1080/11250003.2015.1061615; Chou HY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196890; Courtney Smith L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00070; DAVIES TT, 1972, J PALEONTOL, V46, P874; Deng H, 2009, AQUACULTURE, V287, P18, DOI 10.1016/j.aquaculture.2008.10.015; Emerson CE, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170140; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Guillou M, 2000, J EXP MAR BIOL ECOL, V245, P183, DOI 10.1016/S0022-0981(99)00162-8; Haag N, 2016, J EXP MAR BIOL ECOL, V482, P106, DOI 10.1016/j.jembe.2016.05.005; HARROLD C, 1985, ECOLOGY, V66, P1160, DOI 10.2307/1939168; HEATFIELD BM, 1971, J EXP ZOOL, V178, P233, DOI 10.1002/jez.1401780208; Hidalgo RB, 2008, SYST APPL MICROBIOL, V31, P215, DOI 10.1016/j.syapm.2008.04.001; James P, 2012, AQUACULTURE, V364, P173, DOI 10.1016/j.aquaculture.2012.08.022; Kawakami T, 1998, J EXP MAR BIOL ECOL, V226, P165, DOI 10.1016/S0022-0981(97)00236-0; Levantan DR, 1991, MAR BIOL, V11, P431; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Lyn JC, 2011, AGE, V33, P509, DOI 10.1007/s11357-010-9195-z; Matranga V., 1996, Progress in Molecular and Subcellular Biology, V15, P235; Matranga V, 2000, CELL STRESS CHAPERON, V5, P113, DOI 10.1379/1466-1268(2000)005<0113:CABRTE>2.0.CO;2; McMillan LE, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.173336; Pae M, 2012, AGING DIS, V3, P91; Reed MJ, 1996, MECH AGEING DEV, V89, P21, DOI 10.1016/0047-6374(96)01737-X; Reinardy HC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133860; Schram JB, 2011, J EXP MAR BIOL ECOL, V407, P266, DOI 10.1016/j.jembe.2011.06.024; Sellyei B, 2017, MAGY ALLATORVOSOK, V139, P421; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Sullivan K, 2016, BEHAV PROCESS, V128, P134, DOI 10.1016/j.beproc.2016.05.004; YUI MA, 1983, BIOL BULL-US, V165, P473, DOI 10.2307/1541213	32	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228711	10.1371/journal.pone.0228711	http://dx.doi.org/10.1371/journal.pone.0228711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053660	Green Published, gold			2022-12-26	WOS:000535198700048
J	Salas, MB; Alaminos, D; Fernandez, MA; Lopez-Valverde, F				Belen Salas, M.; Alaminos, David; Angel Fernandez, Manuel; Lopez-Valverde, Francisco			A global prediction model for sudden stops of capital flows using decision trees	PLOS ONE			English	Article							COUNTRIES; OPENNESS; OUTPUT; FLIGHT	Capital flows is an important aspect of the international monetary system because they provide great direct and indirect benefits, and at the same time, they carry risks of vulnerability for countries with an open economy. Numerous works have studied the behavior of these flows and have developed models to predict sudden stop events. However, the existing models have limitations and the literature demands more research on the subject given that the accuracy of the models is still poor, and they have only been developed for emerging countries. This paper presents a new prediction model of sudden stop events of capital flows for both emerging countries and developed countries with the ability to estimate accurately future sudden stop scenarios globally. A sample of 103 countries was used, including 73 emerging countries and 30 developed countries, which has allowed the use of sample combinations that consider the regional heterogeneity of the warning indicators. To the sample under study, a method of decision trees has been applied, which has provided excellent prediction results given its ability to learn characteristics and create long-term dependencies from sequential data and time series. Our model has a great potential impact on the adequacy of macroeconomic policy against the risks derived from sudden stops of capital flows, providing tools that help to achieve financial stability at the global level.	[Belen Salas, M.] Univ Malaga, PhD Program Econ & Business, Malaga, Spain; [Belen Salas, M.; Angel Fernandez, Manuel] Univ Malaga, Dept Finance & Accounting, Malaga, Spain; [Alaminos, David] Univ Malaga, PhD Program Mech Engn & Energy Efficiency, Malaga, Spain; [Lopez-Valverde, Francisco] Univ Malaga, Dept Languages & Comp Sci, Malaga, Spain	Universidad de Malaga; Universidad de Malaga; Universidad de Malaga; Universidad de Malaga	Salas, MB (corresponding author), Univ Malaga, PhD Program Econ & Business, Malaga, Spain.; Salas, MB (corresponding author), Univ Malaga, Dept Finance & Accounting, Malaga, Spain.	belensalas@uma.es			Universidad de Malaga	Universidad de Malaga	This research was funded by Universidad de Malaga to MBS.	Agosin MR, 2019, J INT MONEY FINANC, V96, P28, DOI 10.1016/j.jimonfin.2019.04.010; Agosin MR, 2012, J INT MONEY FINANC, V31, P1140, DOI 10.1016/j.jimonfin.2011.12.015; Akkermans DHM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179244; Alaminos D, 2018, LECT NOTES ARTIF INT, V10933, P296, DOI 10.1007/978-3-319-95786-9_23; Alzate JO, DOCUMENTOS CTR ESTUD; Bordo MD, 2010, J DEV ECON, V91, P227, DOI 10.1016/j.jdeveco.2009.09.005; Broner F, 2006, 8 ANN C CENTR BANK C; Calvo G. A., 1998, J APPL EC, V1, P35; Calvo GA, 2014, SCAND J ECON, V116, P5, DOI 10.1111/sjoe.12041; Catao LAV, 2014, J INT ECON, V94, P18, DOI 10.1016/j.jinteco.2014.05.003; Cavallo E, 2015, J INT MONEY FINANC, V51, P47, DOI 10.1016/j.jimonfin.2014.10.001; Cavallo EA, 2008, J INT MONEY FINANC, V27, P1430, DOI 10.1016/j.jimonfin.2007.10.004; Delen D, 2013, EXPERT SYST APPL, V40, P3970, DOI 10.1016/j.eswa.2013.01.012; Edwards S, 2004, AM ECON REV, V94, P59, DOI 10.1257/0002828041302217; Edwards S, 2007, J INT MONEY FINANC, V26, P814, DOI 10.1016/j.jimonfin.2007.04.010; Elaidi H, 2018, LOPAL 18 P INT C LEA, DOI [10.1145/3230905.3230916, DOI 10.1145/3230905.3230916]; European Commission, 2018, DRAFT ETH GUID TRUST; Forbes KJ, 2012, J INT ECON, V88, P235, DOI 10.1016/j.jinteco.2012.03.006; Guidotti P., 2004, ECONOMIA, V4, P1; Hutchison MM, 2006, J DEV ECON, V79, P225, DOI 10.1016/j.jdeveco.2004.12.002; Janus T, 2013, J POLICY MODEL, V35, P16, DOI 10.1016/j.jpolmod.2012.09.003; Koprinska I, 2019, LECT NOTES COMPUT SC, V11730, P436, DOI 10.1007/978-3-030-30490-4_35; Naseer T, 2017, ARTIF INTELL, DOI [10.4018/978-1-5225-1759-7.ch025, DOI 10.4018/978-1-5225-1759-7.CH025]; Osler J, 2013, 010547 CEDE; Pandya R., 2015, INT J COMP APP, V117; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Reinhart C, 2000, 6982 NBER U MAR MUCH; Rothenberg AD, 2011, REV INT ECON, V19, P509, DOI 10.1111/j.1467-9396.2011.00962.x; Saltelli A, 2002, COMPUT PHYS COMMUN, V145, P280, DOI 10.1016/S0010-4655(02)00280-1; Suh S, 2017, INT REV ECON FINANC, V48, P289, DOI 10.1016/j.iref.2016.12.013; Sula O, 2010, OPEN ECON REV, V21, P589, DOI 10.1007/s11079-008-9103-7; Zhang GP, 2005, EUR J OPER RES, V160, P501, DOI 10.1016/j.ejor.2003.08.037	33	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228387	10.1371/journal.pone.0228387	http://dx.doi.org/10.1371/journal.pone.0228387			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7PV	32049989	gold, Green Published			2022-12-26	WOS:000535192300014
J	Mettananda, S; Peiris, R; Pathiraja, H; Chandradasa, M; Bandara, D; de Silva, U; Mettananda, C; Premawardhena, A				Mettananda, Sachith; Peiris, Ravindu; Pathiraja, Hashan; Chandradasa, Miyuru; Bandara, Dayananda; de Silva, Udaya; Mettananda, Chamila; Premawardhena, Anuja			Psychological morbidity among children with transfusion dependent beta-thalassaemia and their parents in Sri Lanka	PLOS ONE			English	Article							BEHAVIORAL-PROBLEMS; ALPHA-GLOBIN; DEPRESSION; VERSION	Background Background Thalassaemia is a chronic disease which requires lifelong treatment in a majority. Despite recent advances in the medical care, minimal attempts are made to improve psychological health in these patients. In this study, we aim to describe the psychological morbidity in patients with transfusion dependent beta-thalassaemia and their mothers in Sri Lanka. Methods This case control study was conducted in the three largest thalassaemia centres of Sri Lanka. All patients with transfusion dependent beta-thalassaemia aged 4-18 years were recruited as cases whilst a randomly selected group of children without chronic diseases were recruited as controls. Psychological morbidity of children was assessed using the Strengths and Difficulties Questionnaire and depressive symptoms of mothers was assessed by the Centre for Epidemiological Studies Depression Scale. Results 288 transfusion dependent beta-thalassaemia patients and equal number of controls were recruited. Abnormal emotional, conduct, hyperactivity and peer relationship symptom scores were reported by 18%, 17%, 9% and 14% of patients with thalassaemia respectively. Prevalences of abnormal psychological symptom scores in all domains were significantly higher among patients compared to controls. Abnormal conduct symptoms were significantly more prevalent among patients with HbE beta-thalassaemia and those with suboptimal pretransfusion haemoglobin levels, lower transfusion volumes, hypothyroidism and undernutrition. Short stature was associated with abnormal emotional and hyperactivity scores. Depressive symptoms were significantly higher among mothers of patients with thalassaemia. Higher depressive symptom scores in mothers were significantly associated with abnormal emotional, conduct and peer relationship symptom scores in children. Conclusions A higher proportion of patients with transfusion dependent beta-thalassaemia had abnormal psychological symptom scores. Abnormal conduct symptoms were more prevalent among patients with HbE beta-thalassaemia, those who were inadequately transfused and having hypothyroidism and undernutrition. Mothers of the children with transfusion dependent beta-thalassaemia had significantly higher depressive symptoms which were significantly associated with psychological symptoms among children.	[Mettananda, Sachith; Peiris, Ravindu; Pathiraja, Hashan; Chandradasa, Miyuru] Univ Kelaniya, Fac Med, Dept Paediat, Ragama, Sri Lanka; [Mettananda, Sachith; Chandradasa, Miyuru; Premawardhena, Anuja] Colombo North Teaching Hosp, Ragama, Sri Lanka; [Bandara, Dayananda] Kurunegala Teaching Hosp, Kurunegala, Sri Lanka; [de Silva, Udaya] Anuradhapura Teaching Hosp, Anuradhapura, Sri Lanka; [Mettananda, Chamila] Univ Kelaniya, Fac Med, Dept Pharmacol, Kelaniya, Sri Lanka; [Premawardhena, Anuja] Univ Kelaniya, Fac Med, Dept Med, Kelaniya, Sri Lanka	University Kelaniya; University of Colombo; Colombo North Teaching Hospital; University Kelaniya; University Kelaniya	Mettananda, S (corresponding author), Univ Kelaniya, Fac Med, Dept Paediat, Ragama, Sri Lanka.; Mettananda, S (corresponding author), Colombo North Teaching Hosp, Ragama, Sri Lanka.	sachith.mettananda@kln.ac.lk	Premawardhena, Anuja/GLN-5388-2022; Mettananda, Sachith/H-4640-2019; Chandradasa, Miyuru/R-2045-2016	Premawardhena, Anuja/0000-0003-0605-9081; Mettananda, Sachith/0000-0002-0760-0418; Chandradasa, Miyuru/0000-0002-1873-8228				Behdani F, 2015, IRAN J PEDIATR, V25, DOI 10.5812/ijp.25(3)2015.322; Chandradasa M, 2019, ACAD PSYCHIATR, V43, P135, DOI 10.1007/s40596-018-0920-8; Chandradasa Miyuru, 2017, BJPsych Int, V14, P36; de Silva VA, 2014, CEYLON MED J, V59, P8, DOI 10.4038/cmj.v59i1.6732; Elzaree Fatma A, 2018, Open Access Maced J Med Sci, V6, P2337, DOI 10.3889/oamjms.2018.367; Higgs DR, 2012, LANCET, V379, P373, DOI 10.1016/S0140-6736(11)60283-3; Menegassi M, 2010, REV BRAS PSIQUIATR, V32, P132, DOI 10.1590/S1516-44462009005000008; Mettananda S, 2017, CEYLON MED J, V62, P73, DOI 10.4038/cmj.v62i2.8469; Mettananda S, 2017, SRI LANKA J CHILD HL, V46, P203, DOI DOI 10.4038/sljch.v46i3.8318; Mettananda S, 2018, SRI LANKA J CHILD HL, V47, P159, DOI [10.4038/sljch.v47i2.8484, DOI 10.4038/SLJCH.V47I2.8484]; Mettananda S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48204-2; Mettananda S, 2019, HEALTH QUAL LIFE OUT, V17, DOI 10.1186/s12955-019-1207-9; Mettananda S, 2019, PEDIATR BLOOD CANCER, V66, DOI 10.1002/pbc.27643; Mettananda S, 2018, HEMATOL ONCOL CLIN N, V32, P177, DOI 10.1016/j.hoc.2017.11.003; Mettananda S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00479-7; Mettananda S, 2017, HAEMATOLOGICA, V102, pE80, DOI 10.3324/haematol.2016.155655; Mettananda S, 2015, BLOOD, V125, P3694, DOI 10.1182/blood-2015-03-633594; Nadeem S, 2018, ASIAN J PSYCHIATR, V37, P85, DOI 10.1016/j.ajp.2018.08.018; Perera H, 2009, SRI LANKA J CHILD HE, V33, P78, DOI DOI 10.4038/SLJCH.V33I3.642; Perera S, 2013, CEYLON MED J, V58, P66, DOI 10.4038/cmj.v58i2.5682; Premawardhana AP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220852; Prior M, 2005, SOC PSYCH PSYCH EPID, V40, P654, DOI 10.1007/s00127-005-0942-x; Rohanachandra YM, 2018, ASIAN J PSYCHIATR, V33, P74, DOI 10.1016/j.ajp.2018.03.014; Shaligram D, 2007, INDIAN J PEDIATR, V74, P727, DOI 10.1007/s12098-007-0127-6; Suriapperuma Tharindi, 2018, BMC Res Notes, V11, P547, DOI 10.1186/s13104-018-3634-9; Taher AT, 2018, LANCET, V391, P155, DOI 10.1016/S0140-6736(17)31822-6; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348	27	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228733	10.1371/journal.pone.0228733	http://dx.doi.org/10.1371/journal.pone.0228733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9KA	32045443	Green Published, gold			2022-12-26	WOS:000534633200034
J	Balagopalan, L; Malik, H; McIntire, KM; Garvey, JA; Nguyen, T; Rodriguez-Pena, AB; Samelson, LE				Balagopalan, Lakshmi; Malik, Hiba; McIntire, Katherine M.; Garvey, Joseph A.; Nguyen, Tiffany; Rodriguez-Pena, Ana B.; Samelson, Lawrence E.			Bypassing ubiquitination enables LAT recycling to the cell surface and enhanced signaling in T cells	PLOS ONE			English	Article							ACTIVATION; LINKER; RESISTANT; PHOSPHORYLATION; RECRUITMENT; COMPLEXES	LAT molecules defective in ubiquitination have an increased half-life and induce enhanced signaling when expressed in T cells. In this study, we have examined the role of ubiquitination in regulating LAT endocytosis, recycling, and degradation in resting and stimulated T cells. By tracking and comparing plasma membrane-labeled wild type and ubiquitination-resistant 2KR LAT, we find that ubiquitination promotes the degradation of surface LAT in T cells. Activation of T cells increases LAT ubiquitination and promotes trafficking of internalized LAT to lysosomes for degradation. Ubiquitination of LAT does not change internalization rates from the cell surface, but prevents efficient recycling of LAT to the surface of T cells. Our study demonstrates that surface LAT levels are tightly controlled by ubiquitination. LAT in unstimulated cells lacks ubiquitin allowing for increased LAT stability and efficient T cell activation upon TCR triggering; ubiquitination leads to efficient removal of LAT after activation.	[Balagopalan, Lakshmi; Malik, Hiba; McIntire, Katherine M.; Garvey, Joseph A.; Nguyen, Tiffany; Rodriguez-Pena, Ana B.; Samelson, Lawrence E.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Balagopalan, L (corresponding author), NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	balagopl@mail.nih.gov; samelsonl@helix.nih.gov	Nguyen, Tiffany/HGD-2431-2022	Garvey, Joseph/0000-0003-3431-8773; Nguyen, Tiffany/0000-0002-5792-7208	Intramural Research Program of the NIH, NCI, CCR	Intramural Research Program of the NIH, NCI, CCR	This research was supported by the Intramural Research Program of the NIH, NCI, CCR.	Balagopalan L, 2007, MOL CELL BIOL, V27, P8622, DOI 10.1128/MCB.00467-07; Balagopalan L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04419-x; Balagopalan L, 2015, J BIOL CHEM, V290, P26422, DOI 10.1074/jbc.R115.665869; Balagopalan L, 2013, J IMMUNOL, V190, P3849, DOI 10.4049/jimmunol.1202760; Balagopalan L, 2011, P NATL ACAD SCI USA, V108, P2885, DOI 10.1073/pnas.1007098108; Barr VA, 2006, TRAFFIC, V7, P1143, DOI 10.1111/j.1600-0854.2006.00464.x; Bonello G, 2004, J CELL SCI, V117, P1009, DOI 10.1242/jcs.00968; Brignatz C, 2005, BBA-MOL CELL RES, V1746, P108, DOI 10.1016/j.bbamcr.2005.08.009; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Carpier JM, 2018, J EXP MED, V215, P1245, DOI 10.1084/jem.20162042; Courtney AH, 2018, TRENDS BIOCHEM SCI, V43, P108, DOI 10.1016/j.tibs.2017.11.008; Foot N, 2017, PHYSIOL REV, V97, P253, DOI 10.1152/physrev.00012.2016; Hyer ML, 2018, NAT MED, V24, P186, DOI 10.1038/nm.4474; Kunii N, 2013, HUM GENE THER, V24, P27, DOI 10.1089/hum.2012.130; Larghi P, 2013, NAT IMMUNOL, V14, P723, DOI 10.1038/ni.2609; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lin J, 1999, J BIOL CHEM, V274, P28861, DOI 10.1074/jbc.274.41.28861; Purbhoo MA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000645; Rodriguez-Pena AB, 2015, GENE THER, V22, P781, DOI 10.1038/gt.2015.48; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Soares H, 2013, J EXP MED, V210, P2415, DOI 10.1084/jem.20130150; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Xie JJ, 2013, J IMMUNOL, V190, P4027, DOI 10.4049/jimmunol.1202742; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	24	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229036	10.1371/journal.pone.0229036	http://dx.doi.org/10.1371/journal.pone.0229036			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084172	Green Published, gold, Green Submitted			2022-12-26	WOS:000535227900043
J	Kirchhoff, L; Arweiler-Harbeck, D; Arnolds, J; Hussain, T; Hansen, S; Bertram, R; Buer, J; Lang, S; Steinmann, J; Hoing, B				Kirchhoff, Lisa; Arweiler-Harbeck, Diana; Arnolds, Judith; Hussain, Timon; Hansen, Stefan; Bertram, Ralph; Buer, Jan; Lang, Stephan; Steinmann, Joerg; Hoeing, Benedikt			Imaging studies of bacterial biofilms on cochlear implants-Bioactive glass (BAG) inhibits mature biofilm	PLOS ONE			English	Article							NANOPARTICLES	The capability of Pseudomonas aeruginosa and Staphylococcus aureus to form biofilm on varying CI component materials differs in the presence and absence of bioactive glass (BAG). The application of BAG induces significant changes in biofilm morphology which can be visualized via scanning electron microscopy (SEM). Bacterial biofilm formation on medical devices, such as cochlear implants (CI), can lead to chronic infections. Interestingly, BAG of type S53P4 seems to be a promising tool for use in the reduction of biofilm development. Primarily, four bacterial species known to cause implant-related infections, P.aeruginosa (ATCC9027), S. aureus (ATCC6538), Staphylococcus epidermidis (ATCC12228) and Streptococcus pyogenes (ATCC19615) were analyzed regarding their capacity to form biofilm on CI components manufactured from three kinds of material: silicone, platinum and titanium. Subsequently, P. aeruginosa and S. aureus biofilms were visualized using scanning electron microscopy, comparing BAG-treated biofilm with non-treated biofilm. The four bacterial species presented biofilm-forming capabilities in a species and surface dependent manner. Metal CI components allowed for the greatest proliferation of biofilm. S. aureus and P. aeruginosa showed the highest rate of biofilm formation on polystyrene surfaces. For both species, SEM revealed altered biofilm morphology after treatment of S53P4 BAG. This study indicates that bacterial biofilm formation and structure on CI components is dependent on the surface composition, altering between metal and silicone surfaces. After application of BAG, changes in biofilm morphology on CI components were observed. These data highlight the impact of BAG on bacterial biofilm morphology.	[Kirchhoff, Lisa; Buer, Jan; Steinmann, Joerg] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany; [Arweiler-Harbeck, Diana; Arnolds, Judith; Hussain, Timon; Hansen, Stefan; Lang, Stephan; Hoeing, Benedikt] Univ Duisburg Essen, Univ Hosp Essen, Dept Otorhinolaryngol Head & Neck Surg, Essen, Germany; [Bertram, Ralph; Steinmann, Joerg] Paracelsus Med Univ, Inst Clin Hyg Med Microbiol & Clin Infectiol, Klinikum Nuernberg, Nurnberg, Germany	University of Duisburg Essen; University of Duisburg Essen; Klinikum Nurnberg Nord	Kirchhoff, L (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany.; Hoing, B (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Otorhinolaryngol Head & Neck Surg, Essen, Germany.	lisa.kirchhoff@uk-essen.de; Benedikt.Hoeng@uk-essen.de	Kirchhoff, Lisa/AAI-2124-2020	Buer, Jan/0000-0002-7602-1698; Kirchhoff, Lisa/0000-0003-2015-275X	Open Access Publication Fund of the University of Duisburg-Essen	Open Access Publication Fund of the University of Duisburg-Essen	The authors received no specific funding for this work other than support by the Open Access Publication Fund of the University of Duisburg-Essen.	ANDERSSON OH, 1991, J BIOMED MATER RES, V25, P1019, DOI 10.1002/jbm.820250808; Antonelli PJ, 2013, OTOL NEUROTOL, V34, pE65, DOI 10.1097/MAO.0b013e3182941101; Auregan JC, 2015, INJURY, V46, pS3, DOI 10.1016/S0020-1383(15)30048-6; Beales N, 2004, COMPR REV FOOD SCI F, V3, P1, DOI 10.1111/j.1541-4337.2004.tb00057.x; Carlson ML, 2012, OTOLARYNG CLIN N AM, V45, P221, DOI 10.1016/j.otc.2011.09.002; Cerca N, 2005, APPL ENVIRON MICROB, V71, P8677, DOI 10.1128/AEM.71.12.8677-8682.2005; Cunha MT, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3069-x; Cunningham CD, 2004, OTOLARYNG HEAD NECK, V131, P109, DOI 10.1016/j.otohns.2004.02.011; Drago L, 2018, MATERIALS, V11, DOI 10.3390/ma11020326; Drago L, 2015, FUTURE MICROBIOL, V10, P1293, DOI 10.2217/FMB.15.57; Drago L, 2014, FUTURE MICROBIOL, V9, P593, DOI 10.2217/fmb.14.20; Flemming HC, 2016, NAT REV MICROBIOL, V14, P563, DOI 10.1038/nrmicro.2016.94; Hoing B, 2018, OTOL NEUROTOL, V39, pE985, DOI 10.1097/MAO.0000000000002021; Im GJ, 2015, J AUDIOL OTOL, V19, P172, DOI 10.7874/jao.2015.19.3.172; Kahl BC, 2016, CLIN MICROBIOL REV, V29, P401, DOI 10.1128/CMR.00069-15; Kalejaiye A, 2017, LARYNGOSCOPE, V127, P720, DOI 10.1002/lary.26135; Lepparanta O, 2008, J MATER SCI-MATER M, V19, P547, DOI 10.1007/s10856-007-3018-5; Lindfors NC, 2010, BONE, V47, P212, DOI 10.1016/j.bone.2010.05.030; McAndrew J, 2013, IRISH J MED SCI, V182, P509, DOI 10.1007/s11845-012-0895-5; Munukka E, 2008, J MATER SCI-MATER M, V19, P27, DOI 10.1007/s10856-007-3143-1; Onyango LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077614; Perez-Tanoira R, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5569-1; Ruellan K, 2010, OTOL NEUROTOL, V31, P1320, DOI 10.1097/MAO.0b013e3181e3d36b; Stoor P, 1998, ACTA ODONTOL SCAND, V56, P161, DOI 10.1080/000163598422901; Tamura M, 2018, CELL STRESS CHAPERON, V23, P1337, DOI 10.1007/s12192-018-0922-1; Tran N, 2010, INT J NANOMED, V5, P277; Veerachamy S, 2014, P I MECH ENG H, V228, P1083, DOI 10.1177/0954411914556137	28	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229198	10.1371/journal.pone.0229198	http://dx.doi.org/10.1371/journal.pone.0229198			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084198	gold, Green Published			2022-12-26	WOS:000535227900069
J	Nonterah, EA; Agorinya, IA; Kanmiki, EW; Kagura, J; Tamimu, M; Ayamba, EY; Nonterah, EW; Kaburise, MB; Al-Hassan, M; Ofosu, W; Oduro, AR; Awonoor-Williams, JK				Nonterah, Engelbert A.; Agorinya, Isaiah A.; Kanmiki, Edmund W.; Kagura, Juliana; Tamimu, Mariatu; Ayamba, Emmanuel Y.; Nonterah, Esmond W.; Kaburise, Michael B.; Al-Hassan, Majeedallahi; Ofosu, Winfred; Oduro, Abraham R.; Awonoor-Williams, John K.			Trends and risk factors associated with stillbirths: A case study of the Navrongo War Memorial Hospital in Northern Ghana	PLOS ONE			English	Article							NEONATAL-MORTALITY; PREDICTORS	Background Maternal and Child health remains at the core of global health priorities transcending the Millennium Development Goals into the current era of Sustainable Development Goals. Most low and middle-income countries including Ghana are yet to achieve the required levels of reduction in child and maternal mortality. This paper analysed the trends and the associated risk factors of stillbirths in a district hospital located in an impoverished and remote region of Ghana. Methods Retrospective hospital maternal records on all deliveries conducted in the Navrongo War Memorial hospital from 2003-2013 were retrieved and analysed. Descriptive and inferential statistics were used to summarise trends in stillbirths while the generalized linear estimation logistic regression is used to determine socio-demographic, maternal and neonatal factors associated with stillbirths. Results A total of 16,670 deliveries were analysed over the study period. Stillbirth rate was 3.4% of all births. There was an overall decline in stillbirth rate over the study period as stillbirths declined from 4.2% in 2003 to 2.1% in 2013. Female neonates were less likely to be stillborn (Adjusted Odds ratio = 0.62 and 95%CI [0.46, 0.84]; p = 0.002) compared to male neonates; neonates with low birth weight (4.02 [2.92, 5.53]) and extreme low birth weight (18.9 [10.9, 32.4]) were at a higher risk of still birth (p < 0.001). Mothers who had undergone Female Genital Mutilation had 47% (1.47 [1.04, 2.09]) increase odds of having a stillbirth compared to non FGM mothers (p = 0.031). Mothers giving birth for the first time also had a 40% increase odds of having a stillbirth compared to those who had more than one previous births (p = 0.037). Conclusion Despite the modest reduction in stillbirth rates over the study period, it is evident from the results that stillbirth rate is still relatively high. Primiparous women and preterm deliveries leading to low birth weight are identified factors that result in increased stillbirths. Efforts aimed at impacting on stillbirths should include the elimination of outmoded cultural practices such as FGM.	[Nonterah, Engelbert A.; Agorinya, Isaiah A.; Ayamba, Emmanuel Y.; Nonterah, Esmond W.; Kaburise, Michael B.; Oduro, Abraham R.] Ghana Hlth Serv, Navrongo Hlth Res Ctr, Navrongo, Ghana; [Nonterah, Engelbert A.; Kaburise, Michael B.; Al-Hassan, Majeedallahi] Ghana Hlth Serv, Navrongo War Mem Hosp, Navrongo, Ghana; [Nonterah, Engelbert A.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands; [Agorinya, Isaiah A.] Swiss Trop & Publ Hlth Inst, Socinstr, Basel, Switzerland; [Agorinya, Isaiah A.] Univ Basel, Peterpl, Basel, Switzerland; [Kanmiki, Edmund W.] Univ Ghana, Reg Inst Populat Studies RIPS, Legon, Accra, Ghana; [Kagura, Juliana] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Johannesburg, South Africa; [Tamimu, Mariatu] Univ Nairobi, Obstet & Gynaecol Dept, Nairobi, Kenya; [Ofosu, Winfred] Ghana Hlth Serv, Upper East Reg Hlth Directorate, Bolgatanga, Ghana; [Awonoor-Williams, John K.] Ghana Hlth Serv, Planning Monitoring Div, Policy, Legon, Accra, Ghana	Ghana Health Service; Navrongo Health Research Center; Ghana Health Service; Utrecht University; Utrecht University Medical Center; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Ghana; University of Witwatersrand; University of Nairobi; Ghana Health Service; Ghana Health Service	Nonterah, EA (corresponding author), Ghana Hlth Serv, Navrongo Hlth Res Ctr, Navrongo, Ghana.; Nonterah, EA (corresponding author), Ghana Hlth Serv, Navrongo War Mem Hosp, Navrongo, Ghana.; Nonterah, EA (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands.	drenanonterah@gmail.com		Kanmiki, Edmund Wedam/0000-0001-7175-5222; Nonterah, Engelbert/0000-0001-8491-6478; Al-hassan, Majeedallahi/0000-0003-0869-4433; Agorinya, Isaiah/0000-0002-6194-2021; ODURO, ABRAHAM/0000-0002-4191-7419; Nonterah, Esmond/0000-0002-9469-3084				Adongo P., 1998, AFR J REPROD HEALTH, V2, P25; Aminu M, 2017, ACTA OBSTET GYN SCAN, V96, P519, DOI 10.1111/aogs.13126; Awoonor-Williams JK, 2015, GLOB PUBLIC HEALTH, V10, P1118, DOI 10.1080/17441692.2015.1027247; Ballinger GA, 2004, ORGAN RES METHODS, V7, P127, DOI 10.1177/1094428104263672; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Boileau A, 2019, ADV OPT MATER, V7, DOI 10.1002/adom.201801516; Chalumeau M, 2002, INT J EPIDEMIOL, V31, P661, DOI 10.1093/ije/31.3.661; Chi BH, 2007, OBSTET GYNECOL, V110, P989, DOI 10.1097/01.AOG.0000281667.35113.a5; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Cowgill KD, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0592-2; Diallo AH, 2011, J PERINATOL, V31, P656, DOI 10.1038/jp.2011.6; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P430, DOI 10.1111/j.1365-3016.2008.00961.x; Engmann C, 2012, J PERINATOL, V32, P585, DOI 10.1038/jp.2011.154; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-58; Ghana Statistical Service(GSS); Ghana Health Service (GHS); ICF International, 2015, ICF INT GHAN DEM HLT; Ghana Statistical Services, 2018, GHAN LIV STAND SURV; Ghana Survey Department, 1996, COUNTR SHAP DAT; GOURBIN C, 1995, B WORLD HEALTH ORGAN, V73, P449; Hardin J. W., 2002, GEN ESTIMATING EQUAT, DOI [10.1201/9781420035285, DOI 10.1201/9781420035285]; Jammeh A, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/186867; Kanmiki EW, 2019, PLOS ONE, V14, P1; Kramer MS, 2002, AM J EPIDEMIOL, V156, P493, DOI 10.1093/aje/kwf077; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; McClure EM, 2006, INT J GYNECOL OBSTET, V94, P82, DOI 10.1016/j.ijgo.2006.03.023; Mehtsun WT, 2012, ARCH SURG-CHICAGO, V147, P542, DOI 10.1001/archsurg.2012.449; Nonterah EA, 2019, AFR J PRIM HEALTH CA, V11, DOI 10.4102/phcfm.v11i1.1892; Oduro A, 2006, GHANA MED J, P40, DOI [10.4314/gmj.v40i3.55258, DOI 10.4314/GMJ.V40I3.55258]; Reinebrant HE, 2018, BJOG-INT J OBSTET GY, V125, P212, DOI 10.1111/1471-0528.14971; Saleem S, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0526-3; Say Lale, 2006, Reprod Health, V3, P1, DOI 10.1186/1742-4755-3-1; Strand R T, 2009, Afr J Reprod Health, V13, P75; Upadhyay RP, 2012, INDIAN PEDIATR, V49, P291, DOI 10.1007/s13312-012-0044-2; W. H. Organization, 2019, INT CLASS DIS 11 REV; Walsh CA, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.018; Weiner L, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2122-7; WHO, 2010, INT STAT CLASS DIS R; World Health Organization (WHO), 2007, NEON PER MORT COUNTR	39	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229013	10.1371/journal.pone.0229013	http://dx.doi.org/10.1371/journal.pone.0229013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084170	Green Accepted, Green Published, gold			2022-12-26	WOS:000535227900041
J	Boet, O; Arnan, X; Retana, J				Boet, Olga; Arnan, Xavier; Retana, Javier			The role of environmental vs. biotic filtering in the structure of European ant communities: A matter of trait type and spatial scale	PLOS ONE			English	Article							PLANT FUNCTIONAL TRAITS; HYMENOPTERA-FORMICIDAE; COMPETITIVE-EXCLUSION; LATITUDINAL GRADIENT; SPECIES RICHNESS; DIVERSITY; ECOLOGY; ASSEMBLAGES; DOMINANT; FOREST	Functional trait-based approaches are increasingly used for studying the processes underlying community assembly. The relative influence of different assembly rules might depend on the spatial scale of analysis, the environmental context and the type of functional traits considered. By using a functional trait-based approach, we aim to disentangle the relative role of environmental filtering and interspecific competition on the structure of European ant communities according to the spatial scale and the type of trait considered. We used a large database on ant species composition that encompasses 361 ant communities distributed across the five biogeographic regions of Europe; these communities were composed of 155 ant species, which were characterized by 6 functional traits. We then analysed the relationship between functional divergence and co-occurrence between species pairs across different spatial scales (European, biogeographic region and local) and considering different types of traits (ecological tolerance and niche traits). Three different patterns emerged: negative, positive and non-significant regression coefficients suggest that environmental filtering, competition and neutrality are at work, respectively. We found that environmental filtering is important for structuring European ant communities at large spatial scales, particularly at the scale of Europe and most biogeographic regions. Competition could play a certain role at intermediate spatial scales where temperatures are more favourable for ant productivity (i.e. the Mediterranean region), while neutrality might be especially relevant in spatially discontinuous regions (i.e. the Alpine region). We found that no ecological mechanism (environmental filtering or competition) prevails at the local scale. The type of trait is especially important when looking for different assembly rules, and multi-trait grouping works well for traits associated with environmental responses (tolerance traits), but not for traits related to resource exploitation (niche traits). The spatial scale of analysis, the environmental context and the chosen traits merit special attention in trait-based analyses of community assembly mechanisms.	[Boet, Olga; Arnan, Xavier; Retana, Javier] CREAF, Bellaterra, Catalonia, Spain; [Retana, Javier] Univ Autonoma Barcelona, Cerdanyola Del Valles, Catalonia, Spain	Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Autonomous University of Barcelona	Boet, O (corresponding author), CREAF, Bellaterra, Catalonia, Spain.	o.boet@creaf.uab.cat	Arnan, Xavier/N-7829-2013	Arnan, Xavier/0000-0002-9904-274X; Boet, Olga/0000-0002-7260-0959	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana [RYC-201518448]	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana	This study was supported by the Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (RYC-201518448). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinvi O, 2008, INSECT SOC, V55, P1, DOI 10.1007/s00040-007-0964-3; Andersen AN, 2008, AUSTRAL ECOL, V33, P211, DOI 10.1111/j.1442-9993.2007.01810.x; ANDERSEN AN, 1995, J BIOGEOGR, V22, P15, DOI 10.2307/2846070; ANDERSEN AN, 1992, AM NAT, V140, P401, DOI 10.1086/285419; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2014, J APPL ECOL, DOI [DOI 10.1111/1365-2664.12306, DOI 10.1016/S0167-8809(99)00024-9]; Arnan X, 2015, FRONT ECOL EVOL, V3, P1; Arnan X, 2018, GLOBAL CHANGE BIOL, V24, P4614, DOI 10.1111/gcb.14331; Arnan X, 2017, ECOGRAPHY, V40, P448, DOI 10.1111/ecog.01938; Arnan X, 2015, GLOBAL ECOL BIOGEOGR, V24, P1454, DOI 10.1111/geb.12363; Arnan X, 2014, J ANIM ECOL, V83, P1398, DOI 10.1111/1365-2656.12227; Arnan X, 2013, ECOGRAPHY, V36, P1182, DOI 10.1111/j.1600-0587.2013.00155.x; Arnan X, 2012, OECOLOGIA, V170, P489, DOI 10.1007/s00442-012-2315-y; Asefa M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00166-z; Bhaskar R, 2014, FUNCT ECOL, V28, P1256, DOI 10.1111/1365-2435.12257; Cadotte MW, 2017, TRENDS ECOL EVOL, V32, P429, DOI 10.1016/j.tree.2017.03.004; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Cerda X, 2013, MYRMECOL NEWS, V18, P131; Cornell HV, 2014, ANNU REV ECOL EVOL S, V45, P45, DOI 10.1146/annurev-ecolsys-120213-091759; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Czechowski W, 2005, POL J ECOL, V53, P467; Diamond SE, 2008, ECOLOGY, V89; Diaz S, 1999, J VEG SCI, V10, P651, DOI 10.2307/3237080; Economo EP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04218-4; Gibb H, 2010, OECOLOGIA, V164, P1061, DOI 10.1007/s00442-010-1703-4; Gibb H., 2015, P ROY SOC LOND B BIO, V282, P1808; GOWER JC, 1986, J CLASSIF, V3, P5, DOI 10.1007/BF01896809; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Helms JA, 2018, MYRMECOL NEWS, V26, P19; Holldobler B., 1990, pi; Jetschke G., 2001, ECOLOGY, V83; Kaspari M, 2000, AM NAT, V155, P280, DOI 10.1086/303313; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kraft NJB, 2015, P NATL ACAD SCI USA, V112, P797, DOI 10.1073/pnas.1413650112; Kunstler G, 2016, NATURE, V529, P204, DOI 10.1038/nature16476; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Levine JM, 2016, NATURE, V529, P163, DOI 10.1038/nature16862; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Maechler, 2016, CLUSTER ANAL BASICS; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mouchet MA, 2013, OIKOS, V122, P247, DOI 10.1111/j.1600-0706.2012.20411.x; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Parr CL, 2017, INSECT CONSERV DIVER, V10, P5, DOI 10.1111/icad.12211; Pottier J, 2013, GLOBAL ECOL BIOGEOGR, V22, P52, DOI 10.1111/j.1466-8238.2012.00790.x; Real R, 1996, SYST BIOL, V45, P380, DOI 10.2307/2413572; Rees M, 2013, ECOL LETT, V16, P291, DOI 10.1111/ele.12037; Retana J, 2000, OECOLOGIA, V123, P436, DOI 10.1007/s004420051031; Retana J, 2015, ECOLOGY, V96, P2781, DOI 10.1890/14-2326.1.sm; SAVOLAINEN R, 1989, OECOLOGIA, V81, P481, DOI 10.1007/BF00378955; SAVOLAINEN R, 1989, OIKOS, V56, P3, DOI 10.2307/3566082; Silvertown J, 2006, P ROY SOC B-BIOL SCI, V273, P39, DOI 10.1098/rspb.2005.3288; Slingsby JA, 2006, AM NAT, V168, P14, DOI 10.1086/505158; Spasojevic MJ, 2012, J ECOL, V100, P652, DOI 10.1111/j.1365-2745.2011.01945.x; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stuble KL, 2017, MYRMECOL NEWS, V24, P71; Stuble KL, 2013, ECOL EVOL, V3, P482, DOI 10.1002/ece3.473; Vasconcelos HL, 2018, J BIOGEOGR, V45, P248, DOI 10.1111/jbi.13113; Xu JS, 2017, ECOL EVOL, V7, P5056, DOI 10.1002/ece3.3068; Zobel M, 1997, TRENDS ECOL EVOL, V12, P266, DOI 10.1016/S0169-5347(97)01096-3	62	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228625	10.1371/journal.pone.0228625	http://dx.doi.org/10.1371/journal.pone.0228625			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074138	Green Published, Green Submitted, gold			2022-12-26	WOS:000535220600022
J	Zhang, Y; Vakhtin, AA; Jennings, JS; Massaband, P; Wintermark, M; Craig, PL; Ashford, JW; Clark, JD; Furst, AJ				Zhang, Yu; Vakhtin, Andrei A.; Jennings, Jennifer S.; Massaband, Payam; Wintermark, Max; Craig, Patricia L.; Ashford, J. Wesson; Clark, J. David; Furst, Ansgar J.			Diffusion tensor tractography of brainstem fibers and its application in pain	PLOS ONE			English	Article							CEREBRAL WHITE-MATTER; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE; SPATIAL STATISTICS; MRI TRACTOGRAPHY; BASAL GANGLIA; ATLAS; STIMULATION; SYSTEM	Evaluation of brainstem pathways with diffusion tensor imaging (DTI) and tractography may provide insights into pathophysiologies associated with dysfunction of key brainstem circuits. However, identification of these tracts has been elusive, with relatively few in vivo human studies to date. In this paper we proposed an automated approach for reconstructing nine brainstem fiber trajectories of pathways that might be involved in pain modulation. We first performed native-space manual tractography of these fiber tracts in a small normative cohort of participants and confirmed the anatomical precision of the results using existing anatomical literature. Second, region-of-interest pairs were manually defined at each extracted fiber's termini and nonlinearly warped to a standard anatomical brain template to create an atlas of the region-of-interest pairs. The resulting atlas was then transformed nonlinearly into the native space of 17 veteran patients' brains for automated brainstem tractography. Lastly, we assessed the relationships between the integrity levels of the obtained fiber bundles and pain severity levels. Fractional anisotropy (FA) measures derived using automated tractography reflected the respective tracts' FA levels obtained via manual tractography. A significant inverse relationship between FA and pain levels was detected within the automatically derived dorsal and medial longitudinal fasciculi of the brainstem. This study demonstrates the feasibility of DTI in exploring brainstem circuitries involved in pain processing. In this context, the described automated approach is a viable alternative to the time-consuming manual tractography. The physiological and functional relevance of the measures derived from automated tractography is evidenced by their relationships with individual pain severities.	[Zhang, Yu; Vakhtin, Andrei A.; Jennings, Jennifer S.; Ashford, J. Wesson; Furst, Ansgar J.] VA Palo Alto Hlth Care Syst, War Related Illness & Injury Study Ctr WRIISC, Palo Alto, CA 94304 USA; [Vakhtin, Andrei A.; Wintermark, Max; Ashford, J. Wesson; Furst, Ansgar J.] Stanford Univ, Psychiat & Behav Sci, Stanford, CA 94305 USA; [Massaband, Payam; Craig, Patricia L.] VA Palo Alto Hlth Care Syst, Radiol, Palo Alto, CA USA; [Wintermark, Max] Stanford Univ, Neuroradiol, Stanford, CA 94305 USA; [Clark, J. David] VA Palo Alto Hlth Care Syst, Pain Clin, Palo Alto, CA USA; [Clark, J. David] Stanford Univ, Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA; [Furst, Ansgar J.] Stanford Univ, Neurol & Neurol Sci, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Zhang, Y (corresponding author), VA Palo Alto Hlth Care Syst, War Related Illness & Injury Study Ctr WRIISC, Palo Alto, CA 94304 USA.	yuzhangucsfedu@gmail.com	Ashford, J. Wesson/D-3929-2009	Zhang, Yu/0000-0001-8066-7275	Department of Veterans Affairs, Office of Academic Affiliations, California War Related Illness and Injury Study Center (WRIISC-CA) fellowship program	Department of Veterans Affairs, Office of Academic Affiliations, California War Related Illness and Injury Study Center (WRIISC-CA) fellowship program	This research is supported by the Department of Veterans Affairs, Office of Academic Affiliations, California War Related Illness and Injury Study Center (WRIISC-CA) fellowship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2004, NMR BIOMED, V17, P411, DOI 10.1002/nbm.907; Aganj I, 2011, MED IMAGE ANAL, V15, P414, DOI 10.1016/j.media.2011.01.003; AMATRUDA TT, 1975, BRAIN RES, V98, P501, DOI 10.1016/0006-8993(75)90369-8; ANDERSSON G, 1988, EXP BRAIN RES, V72, P450; Andica C, 2018, PARKINSONISM RELAT D, V51, P55, DOI 10.1016/j.parkreldis.2018.02.046; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; Baliki MN, 2006, J NEUROSCI, V26, P12165, DOI 10.1523/JNEUROSCI.3576-06.2006; BASBAUM AI, 1978, ANN NEUROL, V4, P451, DOI 10.1002/ana.410040511; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Benarroch EE, 2012, NEUROLOGY, V78, P210, DOI 10.1212/WNL.0b013e31823fcdee; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bianciardi M, 2015, BRAIN CONNECT, V5, P597, DOI 10.1089/brain.2015.0347; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Castellano A, 2012, NEURO-ONCOLOGY, V14, P192, DOI 10.1093/neuonc/nor188; Cleeland CS, 1989, ADV PAIN RES THER, P391, DOI DOI 10.1093/BRAIN/113.5.1589; Coenen VA, 2015, ACTA NEUROCHIR, V157, P739, DOI 10.1007/s00701-015-2356-1; Coenen VA, 2012, INT REV NEUROBIOL, V107, P207, DOI 10.1016/B978-0-12-404706-8.00011-5; COOTE JH, 1990, J CARDIOVASC PHARM, V15, pS35, DOI 10.1097/00005344-199001001-00005; Davis KD, 2017, NAT REV NEUROL, V13, P624, DOI 10.1038/nrneurol.2017.122; De Benedictis A, 2014, J ANAT, V225, P132, DOI 10.1111/joa.12204; Di Matteo V, 2008, PROG BRAIN RES, V172, P423, DOI 10.1016/S0079-6123(08)00921-7; Dum RP, 2009, J NEUROSCI, V29, P14223, DOI 10.1523/JNEUROSCI.3398-09.2009; Elliott R, 2011, NEUROPSYCHOPHARMACOL, V36, P153, DOI 10.1038/npp.2010.77; Engelhardt E, 2013, J HIST NEUROSCI, V22, P353, DOI 10.1080/0964704X.2012.761076; Engelhardt Eliasz, 2010, Dement. neuropsychol., V4, P293, DOI 10.1590/S1980-57642010DN40400007; Fernandez-Miranda JC, 2008, NEUROSURGERY, V62, P989, DOI [10.1227/01.NEU.0000297076.98175.67, 10.1227/01.neu.0000333767.05328.49]; Fields HL, 2014, SCIENCE, V345, P513, DOI 10.1126/science.1258477; Fischer FU, 2012, J MAGN RESON IMAGING, V36, P84, DOI 10.1002/jmri.23621; Foley KM, 1999, ARCH NEUROL-CHICAGO, V56, P413, DOI 10.1001/archneur.56.4.413; FREDETTE BJ, 1991, ANAT EMBRYOL, V184, P225, DOI 10.1007/BF01673258; Galvez JF, 2015, PROG NEURO-PSYCHOPH, V58, P59, DOI 10.1016/j.pnpbp.2014.12.003; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hadjipavlou G, 2006, PAIN, V123, P169, DOI 10.1016/j.pain.2006.02.027; Hale MW, 2011, PSYCHOPHARMACOLOGY, V213, P243, DOI 10.1007/s00213-010-2089-z; HODGE CJ, 1990, CRIT REV NEUROBIOL, V5, P363; Irfanoglu MO, 2012, NEUROIMAGE, V61, P275, DOI 10.1016/j.neuroimage.2012.02.054; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Karachi C, 2010, J CLIN INVEST, V120, P2745, DOI 10.1172/JCI42642; Keay KA, 2001, NEUROSCI BIOBEHAV R, V25, P669, DOI 10.1016/S0149-7634(01)00049-5; Keltner JR, 2006, J NEUROSCI, V26, P4437, DOI 10.1523/JNEUROSCI.4463-05.2006; Kluger BM, 2016, MOVEMENT DISORD, V31, P625, DOI 10.1002/mds.26511; Kroeger D, 2017, J NEUROSCI, V37, P1352, DOI 10.1523/JNEUROSCI.1405-16.2016; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Malone DA, 2009, BIOL PSYCHIAT, V65, P267, DOI 10.1016/j.biopsych.2008.08.029; Martucci KT, 2014, FUTUR NEUROL, V9, P616, DOI 10.2217/FNL.14.57; Meola A, 2016, NEUROSURGERY, V79, P437, DOI 10.1227/NEU.0000000000001224; Mesaros S, 2012, NEUROLOGY, V78, P969, DOI 10.1212/WNL.0b013e31824d5859; MEYERS R, 1951, NEUROLOGY, V1, P341, DOI 10.1212/WNL.1.9-10.341; Moayedi M, 2012, PAIN, V153, P1467, DOI 10.1016/j.pain.2012.04.003; Monti JM, 2010, SLEEP MED REV, V14, P307, DOI 10.1016/j.smrv.2009.11.004; Nagae-Poetscher LM, 2004, AM J NEURORADIOL, V25, P1325; Nir TM, 2017, MAGN RESON MED, V78, P2322, DOI 10.1002/mrm.26623; O'Donnell LJ, 2011, NEUROSURG CLIN N AM, V22, P185, DOI 10.1016/j.nec.2010.12.004; Oishi K, 2012, J NEUROIMAGING, V22, P365, DOI 10.1111/j.1552-6569.2011.00633.x; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Panksepp J, 2005, CONSCIOUS COGN, V14, P30, DOI 10.1016/j.concog.2004.10.004; Paterson DS, 2009, AUTON NEUROSCI-BASIC, V147, P48, DOI 10.1016/j.autneu.2009.01.004; Pavese N, 2010, BRAIN, V133, P3434, DOI 10.1093/brain/awq268; Rosnow RL, 2000, PSYCHOL SCI, V11, P446, DOI 10.1111/1467-9280.00287; Schlaepfer TE, 2005, LANCET, V366, P1420, DOI 10.1016/S0140-6736(05)67582-4; Senjem ML, 2005, NEUROIMAGE, V26, P600, DOI 10.1016/j.neuroimage.2005.02.005; Shapey J, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00023; Shirayama Y, 2006, CURR NEUROPHARMACOL, V4, P277, DOI 10.2174/157015906778520773; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stein N, 2012, PAIN, V153, P2210, DOI 10.1016/j.pain.2012.07.010; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Tan WQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17283; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Van Riper SM, 2017, PAIN, V158, P2364, DOI 10.1097/j.pain.0000000000001038; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Welniarz Q, 2017, DEV NEUROBIOL, V77, P810, DOI 10.1002/dneu.22455; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; Zhang YJ, 2010, NEUROIMAGE, V52, P1289, DOI 10.1016/j.neuroimage.2010.05.049; Zhang Y, 2015, MOVEMENT DISORD, V30, P1229, DOI 10.1002/mds.26251; Zrinzo L, 2008, BRAIN, V131, P1588, DOI 10.1093/brain/awn075	85	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0213952	10.1371/journal.pone.0213952	http://dx.doi.org/10.1371/journal.pone.0213952			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7XT	32069284	Green Submitted, Green Published, gold			2022-12-26	WOS:000535212900001
J	Borrell, LN; Rodriguez-Alvarez, E; Dallo, FJ				Borrell, Luisa N.; Rodriguez-Alvarez, Elena; Dallo, Florence J.			Racial/ethnic inequities in the associations of allostatic load with all-cause and cardiovascular-specific mortality risk in US adults	PLOS ONE			English	Article							CUMULATIVE BIOLOGICAL RISK; SOCIOECONOMIC POSITION; OLDER-ADULTS; STRESS; MACARTHUR; HEALTH; DISPARITIES	Non-Hispanic blacks have higher mortality rates than non-Hispanic whites whereas Hispanics have similar or lower mortality rates than non-Hispanic blacks and whites despite Hispanics' lower education and access to health insurance coverage. This study examines whether allostatic load, a proxy for cumulative biological risk, is associated with all-cause and cardiovascular (CVD)-specific mortality risks in US adults; and whether these associations vary with race/ethnicity and further with age, sex and education across racial/ethnic groups. Data from the third National Health and Nutritional Examination Survey (NHANES III, 1988-1994) and the 2015 Linked Mortality File were used for adults 25 years or older (n = 13,673 with 6,026 deaths). Cox proportional hazards regression was used to estimate the associations of allostatic load scores (2 and >= 3 relative to <= 1) with a) all-cause and b) CVD-specific mortality risk among NHANES III participants before and after controlling for selected characteristics. Allostatic load scores are associated with higher all-cause and CVD-specific mortality rates among U.S. adults aged 25 years or older, with stronger rates observed for CVD-specific mortality. All-cause mortality rates for each racial/ethnic group differed with age and education whereas for CVD-specific mortality rates, this difference was observed for sex. Our findings of high allostatic load scores associated with all-cause and CVD-specific mortality among US adults call attention to monitor conditions associated with the allostatic load's biomarkers to identify high-risk groups to help monitor social inequities in mortality risk, especially premature mortality.	[Borrell, Luisa N.] CUNY, Dept Epidemiol & Biostat, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA; [Borrell, Luisa N.; Rodriguez-Alvarez, Elena] Univ Basque Country UPV EHU, OPIK Res Grp Social Determinants Hlth & Demog Cha, Bizkaia, Spain; [Borrell, Luisa N.] Univ Alcala, Dept Surg Med & Social Sci, Madrid, Spain; [Rodriguez-Alvarez, Elena] Univ Basque Country UPV EHU, Fac Med & Nursing, Dept Nursing 1, Bizkaia, Spain; [Dallo, Florence J.] Oakland Univ, Dept Publ & Environm Wellness, Sch Hlth Sci, Rochester, MI 48063 USA	City University of New York (CUNY) System; University of Basque Country; Universidad de Alcala; University of Basque Country; Oakland University	Borrell, LN (corresponding author), CUNY, Dept Epidemiol & Biostat, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA.; Borrell, LN (corresponding author), Univ Basque Country UPV EHU, OPIK Res Grp Social Determinants Hlth & Demog Cha, Bizkaia, Spain.; Borrell, LN (corresponding author), Univ Alcala, Dept Surg Med & Social Sci, Madrid, Spain.	Luisa.Borrell@sph.cuny.edu	Borrell, Luisa N./G-8753-2018	Borrell, Luisa N./0000-0002-0560-4853				Acevedo-Garcia D, 2005, PEDIATRICS, V115, pE20, DOI 10.1542/peds.2004-1306; Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; [Anonymous], 2018, HLTH INSURANCE COVER; [Anonymous], VITAL HLTH STAT; Solis CB, 2016, SOC SCI MED, V165, P19, DOI 10.1016/j.socscimed.2016.07.031; Borrell LN, 2010, PUBLIC HEALTH REP, V125, P810, DOI 10.1177/003335491012500608; Castagne R, 2018, EUR J EPIDEMIOL, V33, P441, DOI 10.1007/s10654-018-0364-1; Centers for Disease Control and Prevention, 2019, 2015 PUBL US LINK MO; Curtin Sally C, 2019, NCHS Data Brief, P1; Data Linkage Team, 2010, COMP AN NHANES 3 PUB; Duru OK, 2012, J NATL MED ASSOC, V104, P89, DOI 10.1016/S0027-9684(15)30120-6; Finch Brian Karl, 2003, J Immigr Health, V5, P109, DOI 10.1023/A:1023987717921; Fox M, 2015, AM J PUBLIC HEALTH, V105, pS409, DOI 10.2105/AJPH.2015.302571; Geronimus Arline T., 1992, Ethnicity and Disease, V2, P207; Geronimus AT, 2006, AM J PUBLIC HEALTH, V96, P826, DOI 10.2105/AJPH.2004.060749; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grundy E, 2001, J EPIDEMIOL COMMUN H, V55, P895, DOI 10.1136/jech.55.12.895; Heron Melonie, 2019, Natl Vital Stat Rep, V68, P1; Howard JT, 2016, POPUL RES POLICY REV, V35, P421, DOI 10.1007/s11113-016-9382-4; Hummer Robert A, 2013, Popul Bull, V68, P1; Hwang AC, 2014, J AM MED DIR ASSOC, V15, P490, DOI 10.1016/j.jamda.2014.02.001; Karlamangla AS, 2006, PSYCHOSOM MED, V68, P500, DOI 10.1097/01.psy.0000221270.93985.82; Karlamangla AS, 2002, J CLIN EPIDEMIOL, V55, P696, DOI 10.1016/S0895-4356(02)00399-2; Kochanek Kenneth D, 2019, Natl Vital Stat Rep, V68, P1; Krueger PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131809; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; MARKIDES KS, 1986, PUBLIC HEALTH REP, V101, P253; McEwen BS, 1999, ANN NY ACAD SCI, V896, P30, DOI 10.1111/j.1749-6632.1999.tb08103.x; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Murphy Sherry L, 2018, NCHS Data Brief, P1; National Center for Health Statistics, 2015, PUBL US LINK MORT FI; Robertson T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183297; Robertson T, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2796-4; Robertson T, 2015, BRAIN BEHAV IMMUN, V45, P41, DOI 10.1016/j.bbi.2014.10.005; Ryan C.L., 2016, ED ATTAINMENT US 201; Seeman TE, 2004, SOC SCI MED, V58, P1985, DOI 10.1016/S0277-9536(03)00402-7; Seeman T, 2008, SOC SCI MED, V66, P72, DOI 10.1016/j.socscimed.2007.08.027; Steptoe A, 2011, BRAIN BEHAV IMMUN, V25, P1292, DOI 10.1016/j.bbi.2011.04.010	40	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228336	10.1371/journal.pone.0228336	http://dx.doi.org/10.1371/journal.pone.0228336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7SH	32053626	gold, Green Published			2022-12-26	WOS:000535198700025
J	Mashela, PW; Shokoohi, E; Pofu, KM				Mashela, Phatu W.; Shokoohi, Ebrahim; Pofu, Kgabo M.			Shelf-life in cucurbitacin-containing phytonematicides: Non-conformity to Arrhenius model	PLOS ONE			English	Article							WILD CUCUMBER; BIOSYNTHESIS	Shelf-life information provides end-users with the assurance that the product is still in compliance with label claims. Behavioral reaction orders of the Arrhenius model had been consistently used under fixed conditions to provide shelf-life in food products. Due to nonconformity of the cucurbitacin-containing phytonematicides to the Arrhenius behavioral reaction orders, an alternative quadratic model consistent with the behavioral reaction orders of cucurbitacins was developed under chilled (5 degrees C at 95-98% RH) and fixed tropical (38 degrees C at 90% RH) conditions, while room temperature constituted unfixed conditions. Sampling for cucurbitacins was done at time-frames compliant with geometric series, with cucurbitacin analysis regularly performed using high-performance liquid chromatography techniques. Under chilled conditions, neither the Arrhenius nor the quadratic model could predict the shelf-life for Nemarioc-AL phytonematicide, whereas Nemafric-BL phytonematicide had shelf-life of 35 weeks. In contrast, under tropical conditions, the positive quadratic models showed that Nemarioc-AL and Nemafric-BL phytonematicides had shelf-life of 35 and 825 weeks, respectively. In conclusion, the two phytonematicides could be stored under fixed tropical conditions to enhance the shelf-life of their active ingredients.	[Mashela, Phatu W.; Shokoohi, Ebrahim; Pofu, Kgabo M.] Univ Limpopo, Green Biotechnol Res Ctr Excellence, Sovenga, South Africa; [Pofu, Kgabo M.] Agr Res Council VOP, Pretoria, South Africa	University of Limpopo	Mashela, PW (corresponding author), Univ Limpopo, Green Biotechnol Res Ctr Excellence, Sovenga, South Africa.	phatu.mashela@ul.ac.za	Pofu, Kgabo/AAT-7433-2021		Flemish Interuniversity Council; Agricultural Research Council (ARC) through the ARC-Universities Collaboration Centers; National Research Foundation of South Africa through the Smallholder Development grant from the Department of Agriculture, Forestry and Fisheries	Flemish Interuniversity Council; Agricultural Research Council (ARC) through the ARC-Universities Collaboration Centers; National Research Foundation of South Africa through the Smallholder Development grant from the Department of Agriculture, Forestry and Fisheries	This work was supported by the Flemish Interuniversity Council, the Agricultural Research Council (ARC) through the ARC-Universities Collaboration Centers, the National Research Foundation of South Africa through the Smallholder Development grant from the Department of Agriculture, Forestry and Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borijindakul L., 2013, FOOD APP BIOSCI J, V1, P69; Brand M, 2009, EUR J PLANT PATHOL, V124, P309, DOI 10.1007/s10658-008-9421-z; Causton DR, 1977, CONT BIOL BIOL MATH; Chen CH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-578; Chen JC, 2005, NAT PROD REP, V22, P386, DOI 10.1039/b418841c; Corradini MG, 2006, TRENDS FOOD SCI TECH, V18, P37, DOI 10.1016/j.tifs.2006.07.011; Higa T., 1994, BENEFICIAL EFFECTIVE; Kaushik Ujjwal, 2015, Pharmacogn Rev, V9, P12, DOI 10.4103/0973-7847.156314; Kilscast D, 2000, STABILITY SHELF LIFE; LABUZA TP, 1982, FOOD TECHNOL-CHICAGO, V36, P66; MAATOOQ G, 1995, J NAT PRODUCTS, V58, P165, DOI 10.1021/np50116a001; Mashela P. W., 2011, Scientific Research and Essays, V6, P6762; Mashela P.W., 2017, NEMATOLOGY S AFRICA, P151, DOI DOI 10.1007/978-3-319-44210-5_7; Mashela PW, 2002, NEMATROPICA, V32, P13; MILLER JD, 1986, CAN J BOT, V64, P1, DOI 10.1139/b86-001; Mphahlele R. R., 2012, African Journal of Agricultural Research, V7, P3786; Muller J, 2006, J SCI FOOD AGR, V86, P2543; Nzanza B., 2012, African Journal of Biotechnology, V11, P16077; Phan K.K.T., 2017, INT J ADV SCI ENG IN, V7, P263, DOI [10.18517/ijaseit.7.1.1620, DOI 10.18517/IJASEIT.7.1.1620]; Phimolsiripol Y, 2016, TECHNIQUES SHELF LIF, DOI [10.1016/B978-0-08-100596-5.03293-5, DOI 10.1016/B978-0-08-100596-5.03293-5]; Shadung K., 2015, Journal of Agricultural Science (Toronto), V7, P181; Shadung KG, 2016, ACTA AGR SCAND B-S P, V66, P381, DOI 10.1080/09064710.2015.1122829; Shadung KG, 2016, HORTTECHNOLOGY, V26, P816, DOI 10.21273/HORTTECH03400-16; Shadung KG, 2016, THESIS; Shaik RS, 2017, CROP PROT, V92, P29, DOI 10.1016/j.cropro.2016.10.005; Steele R., 2004, UNDERSTANDING MEASUR; Subbiah V, 1999, United States Patent, Patent No. [5:925:356, 5925356]; Van den Heuvel M., 2014, ENCY MATH ED; Wanke M, 2001, ACTA BIOCHIM POL, V48, P663	29	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0227959	10.1371/journal.pone.0227959	http://dx.doi.org/10.1371/journal.pone.0227959			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32049984	Green Published, gold			2022-12-26	WOS:000535192300006
J	Ticho, AL; Malhotra, P; Manzella, C; Dudeja, PK; Saksena, S; Gill, RK; Alrefai, WA				Ticho, Alexander L.; Malhotra, Pooja; Manzella, Christopher; Dudeja, Pradeep K.; Saksena, Seema; Gill, Ravinder K.; Alrefai, Waddah A.			S-acylation modulates the function of the apical sodium-dependent bile acid transporter in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bile acid; membrane transport; intestinal epithelium; protein acylation; intestine; apical sodium-dependent bile acid transporter (ASBT); bile acid transport; intestinal epithelial cells; posttranslational modification (PTM); S-acylation; ileum; lipid modification	PROTEIN PALMITOYLATION; ZDHHC FAMILY; FATTY-ACIDS; CSS-PALM; ASBT; NA+; LOCALIZATION; DEGRADATION; SELECTIVITY; SUBUNIT	The ileal apical sodium-dependent bile acid transporter (ASBT) is crucial for the enterohepatic circulation of bile acids. ASBT function is rapidly regulated by several posttranslational modifications. One reversible posttranslational modification is S-acylation, involving the covalent attachment of fatty acids to cysteine residues in proteins. However, whether S-acylation affects ASBT function and membrane expression has not been determined. Using the acyl resin-assisted capture method, we found that the majority of ASBT (?80%) was S-acylated in ileal brush border membrane vesicles from human organ donors, as well as in HEK293 cells stably transfected with ASBT (2BT cells). Metabolic labeling with alkyne?palmitic acid (100 ?m for 15 h) also showed that ASBT is S-acylated in 2BT cells. Incubation with the acyltransferase inhibitor 2-bromopalmitate (25 ?m for 15 h) significantly reduced ASBT S-acylation, function, and levels on the plasma membrane. Treatment of 2BT cells with saturated palmitic acid (100 ?m for 15 h) increased ASBT function, whereas treatment with unsaturated oleic acid significantly reduced ASBT function. Metabolic labeling with alkyne?oleic acid (100 ?m for 15 h) revealed that oleic acid attaches to ASBT, suggesting that unsaturated fatty acids may decrease ASBT's function via a direct covalent interaction with ASBT. We also identified Cys-314 as a potential S-acylation site. In conclusion, these results provide evidence that S-acylation is involved in the modulation of ASBT function. These findings underscore the potential for unsaturated fatty acids to reduce ASBT function, which may be useful in disorders in which bile acid toxicity is implicated.	[Malhotra, Pooja; Dudeja, Pradeep K.; Saksena, Seema; Gill, Ravinder K.; Alrefai, Waddah A.] Univ Illinois, Coll Med, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60612 USA; [Ticho, Alexander L.; Manzella, Christopher] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Dudeja, Pradeep K.; Saksena, Seema; Alrefai, Waddah A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Alrefai, WA (corresponding author), Univ Illinois, Coll Med, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60612 USA.; Alrefai, WA (corresponding author), Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA.	walrefai@uic.edu		Gill, Ravinder/0000-0002-5337-2567; Ticho, Alexander/0000-0002-2115-010X	Veterans Affairs [BX000152]; NIDDK, National Institutes of Health [DK109709, F30 DK113703, F30 DK117535, DK054016, DK98170]; Veterans Affairs Merit Award [BX002867]; Veteran Affairs Merit Award [BX002011]; Veterans Affairs Senior Research Career Scientist Award	Veterans Affairs(US Department of Veterans Affairs); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs Merit Award(US Department of Veterans Affairs); Veteran Affairs Merit Award; Veterans Affairs Senior Research Career Scientist Award	This work was supported by the Veterans Affairs Research Career Scientist Award and Merit Award BX000152 (to W. A. A.). This work was also supported by NIDDK, National Institutes of Health, Grants DK109709 (to W. A. A.), F30 DK113703 (to C. R. M.), F30 DK117535 (to A. L. T.), DK054016 (to P. K. D.), DK98170 (to R. K. G.); by Veterans Affairs Merit Award BX002867 (to S. S.) and Veteran Affairs Merit Award BX002011 (to P. K. D.); and by a Veterans Affairs Senior Research Career Scientist Award (to P. K. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or reflect the position or policy of the Department of Veterans Affairs or the United States government.	Annaba F, 2008, AM J PHYSIOL-GASTR L, V294, pG489, DOI 10.1152/ajpgi.00237.2007; Annaba F, 2012, AM J PHYSIOL-GASTR L, V302, pG1216, DOI 10.1152/ajpgi.00017.2012; Annaba F, 2010, AM J PHYSIOL-GASTR L, V299, pG898, DOI 10.1152/ajpgi.00139.2010; Banerjee A, 2005, BIOCHEMISTRY-US, V44, P8908, DOI 10.1021/bi050553s; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASEY WM, 1994, J BIOL CHEM, V269, P2082; Chamberlain LH, 2015, PHYSIOL REV, V95, P341, DOI 10.1152/physrev.00032.2014; Chavda B, 2014, EXPERT OPIN DRUG DIS, V9, P1005, DOI 10.1517/17460441.2014.933802; Chen LH, 2012, AM J PHYSIOL-ENDOC M, V302, pE68, DOI 10.1152/ajpendo.00323.2011; Chothe PP, 2018, BBA-BIOMEMBRANES, V1860, P645, DOI 10.1016/j.bbamem.2017.11.016; Dawson PA, 2003, J BIOL CHEM, V278, P33920, DOI 10.1074/jbc.M306370200; DUDEJA PK, 1994, BBA-BIOMEMBRANES, V1193, P67, DOI 10.1016/0005-2736(94)90334-4; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Foster JD, 2011, J BIOL CHEM, V286, P5175, DOI 10.1074/jbc.M110.187872; Fritz KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075868; Gaebler A, 2013, J LIPID RES, V54, P2282, DOI 10.1194/jlr.D038653; Gill RK, 2005, AM J PHYSIOL-CELL PH, V289, pC846, DOI 10.1152/ajpcell.00112.2005; Greaves J, 2017, P NATL ACAD SCI USA, V114, pE1365, DOI 10.1073/pnas.1612254114; HARIG JM, 1990, BIOCHEM BIOPH RES CO, V167, P438, DOI 10.1016/0006-291X(90)92042-X; Hong V, 2010, BIOCONJUGATE CHEM, V21, P1912, DOI 10.1021/bc100272z; Hu LL, 2011, BIOCHIMIE, V93, P489, DOI 10.1016/j.biochi.2010.10.022; Hussainzada N, 2006, MOL PHARMACOL, V70, P1565, DOI 10.1124/mol.106.028647; Jang D, 2015, J CELL SCI, V128, P2179, DOI 10.1242/jcs.169409; Jiang H, 2018, CHEM REV, V118, P43, DOI 10.1021/acs.chemrev.6b00750; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Korycka J, 2012, EUR J CELL BIOL, V91, P107, DOI 10.1016/j.ejcb.2011.09.013; Lemonidis K, 2017, BIOCHEM SOC T, V45, P751, DOI 10.1042/BST20160309; Liang XQ, 2001, J BIOL CHEM, V276, P30987, DOI 10.1074/jbc.M104018200; McClure M, 2012, PROTEIN ENG DES SEL, V25, P7, DOI 10.1093/protein/gzr054; McClure ML, 2014, BIOCHEM J, V459, P417, DOI 10.1042/BJ20131037; Miyata M, 2013, EUR J PHARMACOL, V714, P507, DOI 10.1016/j.ejphar.2013.06.036; Moore RH, 2013, BIOCHEMISTRY-US, V52, P5117, DOI 10.1021/bi400028q; Moritz AE, 2015, J BIOL CHEM, V290, P29095, DOI 10.1074/jbc.M115.667055; Mueller GM, 2010, J BIOL CHEM, V285, P30453, DOI 10.1074/jbc.M110.151845; Mukherjee A, 2014, J BIOL CHEM, V289, P14351, DOI 10.1074/jbc.M113.526020; Muszbek L, 1999, LIPIDS, V34, pS331, DOI 10.1007/BF02562334; Muthusamy S, 2015, AM J PHYSIOL-CELL PH, V308, pC964, DOI 10.1152/ajpcell.00023.2015; Oelkers P, 1997, J CLIN INVEST, V99, P1880, DOI 10.1172/JCI119355; Rao A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf4823; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Ren WY, 2013, ADIPOCYTE, V2, P17, DOI 10.4161/adip.22117; Sanders SS, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004405; Sarwar Z, 2009, AM J PHYSIOL-GASTR L, V297, pG532, DOI 10.1152/ajpgi.00052.2009; Shipston MJ, 2014, J GEN PHYSIOL, V143, P659, DOI 10.1085/jgp.201411176; Spinelli M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123820; Spinelli M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02221-9; Sun AQ, 2003, J BIOL CHEM, V278, P4000, DOI 10.1074/jbc.M207163200; Tabaczar S, 2017, EXP BIOL MED, V242, P1150, DOI 10.1177/1535370217707732; Thorne RF, 2010, BBA-MOL CELL RES, V1803, P1298, DOI 10.1016/j.bbamcr.2010.07.002; Ticho AL, 2018, AM J PHYSIOL-GASTR L, V315, pG529, DOI 10.1152/ajpgi.00133.2018; Tiessen RG, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-017-0736-0; Werno MW, 2015, SCI REP-UK, V5, DOI 10.1038/srep12413; Wu YL, 2013, J MED CHEM, V56, P5094, DOI 10.1021/jm400459m; Xia XF, 2004, J BIOL CHEM, V279, P44931, DOI 10.1074/jbc.M400969200; Xie YB, 2016, SCI REP-UK, V6, DOI 10.1038/srep28249; Xu ZY, 2015, BIOCHEM BIOPH RES CO, V460, P949, DOI 10.1016/j.bbrc.2015.03.132; Yap MC, 2010, J LIPID RES, V51, P1566, DOI 10.1194/jlr.D002790; Zhao L, 2018, J HEPATOL, V69, P705, DOI 10.1016/j.jhep.2018.04.006; Zhou Bo, 2014, J Proteomics Bioinform, V7, P256; Zhou FF, 2006, BIOINFORMATICS, V22, P894, DOI 10.1093/bioinformatics/btl013	60	7	7	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4488	4497		10.1074/jbc.RA119.011032	http://dx.doi.org/10.1074/jbc.RA119.011032			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32071081	hybrid, Green Published			2022-12-26	WOS:000524499700011
J	Min, KB; Yoon, SS				Min, Kyung Bae; Yoon, Sang Sun			Transcriptome analysis reveals that the RNA polymerase?binding protein DksA1 has pleiotropic functions in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Pseudomonas aeruginosa; quorum sensing; virulence factor; stress response; transcription regulation; DksA1; transcription factor; stringent response; gene regulation; polyamine metabolism; anaerobic respiration	GENE-EXPRESSION; LIFE-STYLE; PPGPP; VIRULENCE; BIOSYNTHESIS; INFECTIONS; INITIATION; REGULATOR; HIERARCHY; SIGNAL	The stringent response (SR) is a highly conserved stress response in bacteria. It is composed of two factors, (i) a nucleotide alarmone, guanosine tetra- and pentaphosphate ((p)ppGpp), and (ii) an RNA polymerase-binding protein, DksA, that regulates various phenotypes, including bacterial virulence. The clinically significant opportunistic bacterial pathogen Pseudomonas aeruginosa possesses two genes, dksA1 and dksA2, that encode DksA proteins. It remains elusive, however, which of these two genes plays a more important role in SR regulation. In this work, we compared genome-wide, RNA-Seq?based transcriptome profiles of ?dksA1, ?dksA2, and ?dksA1?dksA2 mutants to globally assess the effects of these gene deletions on transcript levels coupled with phenotypic analyses. The ?dksA1 mutant exhibited substantial defects in a wide range of phenotypes, including quorum sensing (QS), anaerobiosis, and motility, whereas the ?dksA2 mutant exhibited no significant phenotypic changes, suggesting that the dksA2 gene may not have an essential function in P. aeruginosa under the conditions used here. Of note, the ?dksA1 mutants displayed substantially increased transcription of genes involved in polyamine biosynthesis, and we also detected increased polyamine levels in these mutants. Because SAM is a shared precursor for the production of both QS autoinducers and polyamines, these findings suggest that DksA1 deficiency skews the flow of SAM toward polyamine production rather than to QS signaling. Together, our results indicate that DksA1, but not DksA2, controls many important phenotypes in P. aeruginosa. We conclude that DksA1 may represent a potential target whose inhibition may help manage recalcitrant P. aeruginosa infections.	[Min, Kyung Bae; Yoon, Sang Sun] Yonsei Univ, Coll Med, Dept Microbiol & Immunol, 50-1 Yonsei Ro, Seoul 03722, South Korea; [Min, Kyung Bae; Yoon, Sang Sun] Yonsei Univ, Coll Med, Brain Korea 21 PLUS Project Med Sci, Seoul 03722, South Korea; [Yoon, Sang Sun] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul 03722, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yoon, SS (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol & Immunol, 50-1 Yonsei Ro, Seoul 03722, South Korea.	sangsun_yoon@yuhs.ac		Yoon, Sang Sun/0000-0003-2979-365X	National Research Foundation (NRF) of Korea [2017M3A9F3041233, 2019R1A6A1A03032869]; Korean Government	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Korean Government(Korean Government)	This work was supported by National Research Foundation (NRF) of Korea Grants 2017M3A9F3041233 and 2019R1A6A1A03032869, funded by the Korean Government. The authors declare that they have no conflicts of interest with the contents of this article.	Aberg A, 2009, J BACTERIOL, V191, P3226, DOI 10.1128/JB.01410-08; Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; Azriel S, 2016, INFECT IMMUN, V84, P375, DOI 10.1128/IAI.01135-15; Basu P, 2019, MICROBIOL-SGM, V165, P102, DOI 10.1099/mic.0.000743; Blaby-Haas CE, 2011, MOL MICROBIOL, V79, P700, DOI 10.1111/j.1365-2958.2010.07475.x; Boes N, 2008, J BACTERIOL, V190, P7189, DOI 10.1128/JB.00600-08; Boutte CC, 2013, TRENDS MICROBIOL, V21, P174, DOI 10.1016/j.tim.2013.01.002; Branny P, 2001, J BACTERIOL, V183, P1531, DOI 10.1128/JB.183.5.1531-1539.2001; Chernish RN, 2003, CURR OPIN PULM MED, V9, P509, DOI 10.1097/00063198-200311000-00011; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Chou HT, 2008, J BACTERIOL, V190, P1966, DOI 10.1128/JB.01804-07; Coggan KA, 2012, CURR ISSUES MOL BIOL, V14, P47; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Davenport PW, 2015, J BACTERIOL, V197, P2072, DOI 10.1128/JB.02557-14; Furman R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120746; Galan-Vasquez Edgardo, 2011, Microb Inform Exp, V1, P3, DOI 10.1186/2042-5783-1-3; Gourse RL, 2018, ANNU REV MICROBIOL, V72, P163, DOI 10.1146/annurev-micro-090817-062444; Gray MJ, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00664-18; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Hammond JH, 2015, J BACTERIOL, V197, P2810, DOI 10.1128/JB.00182-15; HARSHEY RM, 1994, MOL MICROBIOL, V13, P389, DOI 10.1111/j.1365-2958.1994.tb00433.x; Henard CA, 2014, MOL MICROBIOL, V91, P790, DOI 10.1111/mmi.12498; HENRICHSEN J, 1972, BACTERIOL REV, V36, P478, DOI 10.1128/MMBR.36.4.478-503.1972; Hwang S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26223; Hwang W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37422-9; Jude F, 2003, J BACTERIOL, V185, P3558, DOI 10.1128/JB.185.12.3558-3566.2003; KANG PJ, 1990, J BACTERIOL, V172, P2055, DOI 10.1128/jb.172.4.2055-2064.1990; Khakimova M, 2013, J BACTERIOL, V195, P2011, DOI 10.1128/JB.02061-12; Kim HY, 2018, J BIOL CHEM, V293, P5679, DOI [10.1074/jbc.RA117.000383, 10.1074/jbc.ra117.000383]; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Lee J, 2015, PROTEIN CELL, V6, P26, DOI 10.1007/s13238-014-0100-x; Lee KM, 2011, INFECT IMMUN, V79, P2792, DOI 10.1128/IAI.01361-10; Lee K, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01182-17; Lee K, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw104; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Montravers P, 2016, ADV THER, V33, P151, DOI 10.1007/s12325-016-0293-x; Oh YT, 2015, J BIOL CHEM, V290, P13178, DOI 10.1074/jbc.M115.640466; Pal RR, 2012, J BACTERIOL, V194, P5638, DOI 10.1128/JB.00518-12; Parshin A, 2015, P NATL ACAD SCI USA, V112, pE6862, DOI 10.1073/pnas.1521365112; Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Perron K, 2005, MOL MICROBIOL, V56, P1087, DOI 10.1111/j.1365-2958.2005.04597.x; Pletzer D, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01867; Potrykus K, 2006, J BIOL CHEM, V281, P15238, DOI 10.1074/jbc.M601531200; Pruitt BA, 1998, WORLD J SURG, V22, P135; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Ross W, 2016, MOL CELL, V62, P811, DOI 10.1016/j.molcel.2016.04.029; Ruparell A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33101; Rutherford ST, 2007, J MOL BIOL, V366, P1243, DOI 10.1016/j.jmb.2006.12.013; Schafhauser J, 2014, J BACTERIOL, V196, P1641, DOI 10.1128/JB.01086-13; Sharma AK, 2006, MOL MICROBIOL, V62, P469, DOI 10.1111/j.1365-2958.2006.05376.x; Smale Stephen T, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5423; Steindler L, 2007, FEMS MICROBIOL LETT, V266, P1, DOI 10.1111/j.1574-6968.2006.00501.x; Toyofuku M, 2018, ADV MICROB PHYSIOL, V72, P117, DOI 10.1016/bs.ampbs.2018.01.005; Toyofuku M, 2008, J BACTERIOL, V190, P7947, DOI 10.1128/JB.00968-08; Van Delden C, 2001, J BACTERIOL, V183, P5376, DOI 10.1128/JB.183.18.5376-5384.2001; Vrentas CE, 2005, GENE DEV, V19, P2378, DOI 10.1101/gad.344505; Webb C, 1999, MOL MICROBIOL, V34, P112, DOI 10.1046/j.1365-2958.1999.01581.x; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Wu J, 2009, J CELL PHYSIOL, V220, P297, DOI 10.1002/jcp.21797; Xu XH, 2016, MICROBIOL RES, V192, P84, DOI 10.1016/j.micres.2016.06.005; Yoon MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016105; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2	63	11	12	2	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3851	3864		10.1074/jbc.RA119.011692	http://dx.doi.org/10.1074/jbc.RA119.011692			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32047111	hybrid, Green Published			2022-12-26	WOS:000527704400011
J	Sayadi, V; Karimzadeh, G; Monfared, SR; Naghavi, MR				Sayadi, Vahid; Karimzadeh, Ghasem; Monfared, Sajad Rashidi; Naghavi, Mohammad Reza			Identification and expression analysis of S-alk (en)yl-L-cysteine sulfoxide lyase isoform genes and determination of allicin contents in Allium species	PLOS ONE			English	Article							BIOCHEMICAL-CHARACTERIZATION; FLAVOR COMPONENTS; SATIVUM L.; ALLIINASE; ONION; DIVERSITY; LOCALIZATION; PHYLOGENY; FRAGMENT; COMPLEX	Alliinase is the key enzyme in allicin biosynthesis pathway. In the current study, the identification and sequencing of alliinase genes along with determination of allicin contents were reported for Allium species with a novel report for Iranian endemic species. The presence of different isoforms in the Allium being discovered for the first time. In bulbs tissue, the highest allicin concentration was in Allium sativum, A. umbilicatum, and A. fistolosum (1.185%, 0.367%, and 0.34%, respectively), followed by A. spititatum (0.072%), A. lenkoranicum (0.055%), A. atroviolaseum (0.36%), A. rubellum (0.041%), and A. stamineum (0.007%). The highest allicin content in the leaves and roots were in A. sativum (0.13%), and A. stamineum (0.195%), respectively. The ORFs length ranged from 1416 in A. sativum (iso-alliinase2; ISA2) to 1523 bp in A. sativum (alliinase); the identity with A. sativum (alliinase) varies from 95% to 68% for A. ampeloprasum, and A. sativum (iso-alliinase1, ISA1) respectively. These data suggested that both ISA1 and ISA2 had a high expression in the roots and bulbs compared to A. sativum as the control in all species. Note that ISA1 and ISA2 were not expressed in the leaves. The results showed that isoforms expression patterns among different tissues in Allium species were variable. The presence of various isoforms is a possible explanation for the difference between the species in terms of obtained results, especially the amount of allicin.	[Sayadi, Vahid; Karimzadeh, Ghasem] Tarbiat Modares Univ, Fac Agr, Dept Plant Genet & Breeding, Tehran, Iran; [Monfared, Sajad Rashidi] Tarbiat Modares Univ, Fac Agr, Dept Agr Biotechnol, Tehran, Iran; [Naghavi, Mohammad Reza] Univ Tehran, Agr Coll, Agron & Plant Breeding Dept, Karaj, Iran	Tarbiat Modares University; Tarbiat Modares University; University of Tehran	Karimzadeh, G (corresponding author), Tarbiat Modares Univ, Fac Agr, Dept Plant Genet & Breeding, Tehran, Iran.	karimzadeh_g@modares.ac.ir	Naghavi, Mohammad Reza/L-8722-2017; sayadi, vahid/AAU-3380-2021; , Rashidims/AAU-3949-2021	Naghavi, Mohammad Reza/0000-0002-2427-3332; sayadi, vahid/0000-0002-8741-5369; 	Tarbiat Modares University, Tehran, Iran	Tarbiat Modares University, Tehran, Iran	Authors gratefully acknowledge the support provided for this survey by the Tarbiat Modares University, Tehran, Iran.	Abedini D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23351-0; Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arzanlou M, 2010, FOOD CHEM, V120, P179, DOI 10.1016/j.foodchem.2009.10.004; Baghalian K, 2005, SCI HORTIC-AMSTERDAM, V103, P155, DOI 10.1016/j.scienta.2004.07.001; Benkeblia N., 2007, FOOD, V1, P193, DOI DOI 10.1021/JF60174A007; BLOCK E, 1992, J AGR FOOD CHEM, V40, P2418, DOI 10.1021/jf00024a017; Borlinghaus J, 2014, MOLECULES, V19, P12591, DOI 10.3390/molecules190812591; BRODNITZ MH, 1971, J AGR FOOD CHEM, V19, P273, DOI 10.1021/jf60174a007; Burland T G, 2000, Methods Mol Biol, V132, P71; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Clark SA, 1998, J FOOD BIOCHEM, V22, P91, DOI 10.1111/j.1745-4514.1998.tb00233.x; Cortijo S, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20188591; DAVIS C G, 1990, New Biologist, V2, P410; Druga B, 2011, NOT BOT HORTI AGROBO, V39, P293; Edris AE, 2002, EUR FOOD RES TECHNOL, V214, P105, DOI 10.1007/s00217-001-0429-2; ELLMORE GS, 1994, AM J BOT, V81, P89, DOI 10.2307/2445567; Etoh T., 2002, P101, DOI 10.1079/9780851995106.0101; FREEMAN GG, 1975, J SCI FOOD AGR, V26, P471, DOI 10.1002/jsfa.2740260413; Friesen Nikolai, 2006, Aliso, V22, P372; Fritsch R. M., 2002, P5, DOI 10.1079/9780851995106.0005; Fritsch R. M., 2001, HERBERTIA, V56, P19; Garlic Schulz V., 1998, RATIONAL PHYTOTHERAP, P107; Hamidi F, 2018, TURK J BIOL, V42, P322, DOI 10.3906/biy-1802-86; Herden T, 2016, MOL PHYLOGENET EVOL, V95, P79, DOI 10.1016/j.ympev.2015.11.004; IBERL B, 1990, PLANTA MED, V56, P320, DOI 10.1055/s-2006-961198; Isaacsohn JL, 1998, ARCH INTERN MED, V158, P1189, DOI 10.1001/archinte.158.11.1189; Jabbes N., 2011, Journal of Agricultural Science (Toronto), V3, P77, DOI 10.5539/jas.v3n4p77; Kakeshpour T, 2017, GENE EXPR PATTERNS, V25-26, P76, DOI 10.1016/j.gep.2017.06.005; Keller ERJ, 2001, ACTA HORTIC, P189, DOI 10.17660/ActaHortic.2001.555.28; Kim MY, 1997, KOREAN J POSTHARVEST, V4, P61; Kuettner EB, 2002, J BIOL CHEM, V277, P46402, DOI 10.1074/jbc.M208669200; Kusterer J, 2011, J AGR FOOD CHEM, V59, P8289, DOI 10.1021/jf201052u; Lampasona SG, 2003, EUPHYTICA, V132, P115, DOI 10.1023/A:1024606004596; LANCASTER JE, 1981, PLANT SCI LETT, V22, P169, DOI 10.1016/0304-4211(81)90139-5; Lancaster JE, 2000, PLANT PHYSIOL, V122, P1269, DOI 10.1104/pp.122.4.1269; LAWSON LD, 1992, PLANTA MED, V58, P345, DOI 10.1055/s-2006-961482; 김창현, 2012, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V41, P1645; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louie GV, 1997, MOL CELL, V1, P67, DOI 10.1016/S1097-2765(00)80008-8; Manabe T, 1998, EUR J BIOCHEM, V257, P21, DOI 10.1046/j.1432-1327.1998.2570021.x; Mansor N., 2016, J MED BIOENG, V5, P24, DOI [DOI 10.12720/JOMB.5.1.24-27, 10.12720/jomb.5.1.24-27]; Mastakani FD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199673; Nasim SA, 2009, FOOD CHEM TOXICOL, V47, P888, DOI 10.1016/j.fct.2009.01.024; NOCK LP, 1987, PLANT PHYSIOL, V85, P1079, DOI 10.1104/pp.85.4.1079; Nwachukwu ID, 2012, NAT PROD COMMUN, V7, P395; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pharmacopoeia B., 2007, BRIT PHARMACOPOEIA A, V4; Prati P, 2014, FOOD SCI TECH-BRAZIL, V34, P623, DOI [10.1590/1678-457x.6397, 10.1590/1678-457X.6397]; RABINKOV A, 1994, APPL BIOCHEM BIOTECH, V48, P149, DOI 10.1007/BF02788739; Rabinowitch H. D., 1984, 3rd Eucarpia Alliumsymposium, Wageningen, 4-6 September 1984., P27; Ramirez EC, 1998, J FOOD BIOCHEM, V22, P427, DOI 10.1111/j.1745-4514.1998.tb00254.x; Rasouli O, 2018, SCI HORTIC-AMSTERDAM, V231, P144, DOI 10.1016/j.scienta.2017.12.010; Rechinger KH, 1971, FLORA IRANICA 76 GRA; Salehi M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31079-0; Salehi M, 2018, IND CROP PROD, V112, P130, DOI 10.1016/j.indcrop.2017.11.002; SCHWIMMER S, 1969, ARCH BIOCHEM BIOPHYS, V130, P312, DOI 10.1016/0003-9861(69)90038-1; Sehringer B, 2005, ANAL BIOANAL CHEM, V383, P768, DOI 10.1007/s00216-005-0067-9; Shimon LJW, 2007, J MOL BIOL, V366, P611, DOI 10.1016/j.jmb.2006.11.041; Smeets K, 1997, GLYCOCONJUGATE J, V14, P331, DOI 10.1023/A:1018570628180; STOLL A, 1947, EXPERIENTIA, V3, P114; Su CC, 2006, IN VIVO, V20, P85; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang HP, 2014, EUPHYTICA, V198, P243, DOI 10.1007/s10681-014-1097-1; Wang J, 2011, ULTRASON SONOCHEM, V18, P534, DOI 10.1016/j.ultsonch.2010.09.008; Weiner L, 2009, PROTEIN SCI, V18, P196, DOI 10.1002/pro.10; Zeidabadi DD, 2018, 3 BIOTECH, V8, DOI 10.1007/s13205-018-1404-y	67	4	4	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0228747	10.1371/journal.pone.0228747	http://dx.doi.org/10.1371/journal.pone.0228747			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092058	Green Published, gold			2022-12-26	WOS:000535229300012
J	Drake, S; Fournier, A				Drake, Sienna; Fournier, Alyson			Nogo BACE jumps on the exosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								The protein Nogo-A has been widely studied for its role in inhibiting axonal regeneration following injury to the central nervous system, but the mechanism by which the membrane-bound Nogo-A is presented intercellularly is not fully understood. New research suggests that a highly inhibitory fragment of Nogo-A is generated by the amyloid precursor protein protease BACE1 and presented on the membranes of exosomes following spinal cord injury. This finding represents a new mode through which Nogo-A may exert its effects in the central nervous system.	[Drake, Sienna; Fournier, Alyson] Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University	Fournier, A (corresponding author), Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada.	alyson.fournier@mcgill.ca		Fournier, Alyson/0000-0002-1859-7015				Akbik F, 2012, EXP NEUROL, V235, P43, DOI 10.1016/j.expneurol.2011.06.006; Lopez-Verrilli MA, 2013, GLIA, V61, P1795, DOI 10.1002/glia.22558; Frohlich D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0510; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Hessvik NP, 2018, CELL MOL LIFE SCI, V75, P193, DOI 10.1007/s00018-017-2595-9; Korkut C, 2013, NEURON, V77, P1039, DOI 10.1016/j.neuron.2013.01.013; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Sekine Y, 2020, J BIOL CHEM, V295, P2175, DOI 10.1074/jbc.RA119.009896; Vassar R, 2014, J NEUROCHEM, V130, P4, DOI 10.1111/jnc.12715; Zagrebelsky M, 2010, J NEUROSCI, V30, P13220, DOI 10.1523/JNEUROSCI.1044-10.2010	10	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2184	2185		10.1074/jbc.H120.012745	http://dx.doi.org/10.1074/jbc.H120.012745			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	32086246	Green Published, hybrid			2022-12-26	WOS:000517330200003
J	Lee, W; Lee, S; Chong, S; Lee, K; Lee, J; Choi, JC; Lim, C				Lee, Wonje; Lee, Seungho; Chong, Semin; Lee, Kyungmin; Lee, Jongha; Choi, Jae Chol; Lim, Changwon			Radiation dose reduction and improvement of image quality in digital chest radiography by new spatial noise reduction algorithm	PLOS ONE			English	Article								Purpose To evaluate the image quality of low-dose chest digital radiographic images obtained with a new spatial noise reduction algorithm, compared to a conventional de-noising technique. Materials and methods In 69 patients, the dose reduction protocol was divided into A, B, and C test groups-60% (n = 22), 50% (n = 23), and 40% (n = 24) of the baseline dose. In each patient, baseline dose radiographs were obtained with conventional image processing while low-dose images were acquired with new image processing. A set of baseline and low-dose radiographic images per patient was evaluated and scored on a 5-point scale over seven anatomical landmarks (radiolucency of unobscured lung, pulmonary vascularity, trachea, edge of rib, heart border, intervertebral disc space, and pulmonary vessels in the retrocardiac area) and three representative abnormal findings (nodule, consolidation, and interstitial marking) by two thoracic radiologists. A comparison of paired baseline and low-dose images was statistically analyzed using a non-inferiority test based on the paired t-test or the Wilcoxon signedrank test. Results In A, B, and C test groups, the mean dose reduction rate of the baseline radiation dose was 63.4%, 53.9%, and 47.8%, respectively. In all test groups, the upper limit of the 95% confidence interval was less than the non-inferiority margin of 0.5 every seven anatomical landmarks and three representative abnormal findings, which suggested that the image quality of the low-dose image was not inferior to that of the baseline dose image even if the maximum average dose reduction rate was reduced to 47.8% of the baseline dose. Conclusion In our study, an image processing technique integrating a new noise reduction algorithm achieved dose reductions of approximately half without compromising image quality for abnormal lung findings and anatomical landmarks seen on chest radiographs. This feature-preserving, noise reduction algorithm adopted in the proposed engine enables a lower radiation dose boundary for the sake of patient's and radiography technologist's radiation safety in routine clinical practice, in compliance with regulatory guidelines.	[Lee, Wonje] Samsung Elect, Hlth & Med Equipment Business, Clin Res Grp, Suwon, South Korea; [Lee, Seungho] Chung Ang Univ Hosp, Dept Radiol, Seoul, South Korea; [Chong, Semin; Lee, Kyungmin] Sungkyunkwan Univ, Samsung Med Ctr, Dept Radiol, Sch Med, Seoul, South Korea; [Lee, Jongha] Samsung Elect, Hlth & Med Equipment Business, Med Imaging R&D Grp, Suwon, South Korea; [Choi, Jae Chol] Chung Ang Univ, Coll Med, Dept Internal Med, Div Pulm Med, Seoul, South Korea; [Lim, Changwon] Chung Ang Univ, Dept Appl Stat, Seoul, South Korea	Samsung; Samsung Electronics; Chung Ang University; Chung Ang University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Samsung Electronics; Chung Ang University; Chung Ang University Hospital; Chung Ang University	Chong, S (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Radiol, Sch Med, Seoul, South Korea.	smchong337@gmail.com	Lee, Wonje/AAE-6069-2022	Lee, Wonje/0000-0003-4362-561X; Chong, Semin/0000-0002-7429-2566	Samsung Electronics	Samsung Electronics(Samsung)	This work was supported by a research grant from the Samsung Electronics. The funder provided support in the form of research allowances for S.L., S.C., J.C.C. and C.L. but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. S.C. was solely responsible for the decision to publish and preparation of the manuscript. W.L. and J.L. are employees and researchers of the clinical research group and R&D group of the funder, respectively. W.L. and J.L., as scientists for convergence research of Engineering and Medicine, provided technical concepts for research, advised on technical data acquisition and interpretation, and participated in manuscript review and editing.	Brosi P, 2011, RADIOL PHYS TECHNOL, V4, P148, DOI 10.1007/s12194-011-0115-4; Buades A., 2005, P 2005 IEEE COMP VIS, VVolume 2, P60, DOI DOI 10.1109/CVPR.2005.38; Directorate-General XII: Science RaD, 1996, EUR GUID QUAL CRIT D; Grewal RK, 2012, AUSTRALAS PHYS ENG S, V35, P71, DOI 10.1007/s13246-012-0125-5; Hoeppner S, 2002, EQUALIZED CONTRAST D; Kroft LJM, 2007, BRIT J RADIOL, V80, P984, DOI 10.1259/bjr/80232832; Kroft LJM, 2006, RADIOLOGY, V241, P392, DOI 10.1148/radiol.2412051326; LINDENBAUM M, 1994, PATTERN RECOGN, V27, P1, DOI 10.1016/0031-3203(94)90013-2; Liu YL, 2008, J COMPUT SCI TECH-CH, V23, P270, DOI 10.1007/s11390-008-9129-8; Schaefer-Prokop C, 2008, EUR RADIOL, V18, P1818, DOI 10.1007/s00330-008-0948-3; Stahl M, 2000, MED PHYS, V27, P56, DOI 10.1118/1.598857; Sun ZH, 2012, CLIN IMAG, V36, P279, DOI 10.1016/j.clinimag.2011.09.006; Tomasi C., 1998, 6 INT C COMP VIS BOM; Veldkamp WJH, 2009, EUR J RADIOL, V72, P209, DOI 10.1016/j.ejrad.2009.05.039; Vuylsteke P, 1994, MULTISCALE IMAGE CON; Yin L, 1996, IEEE T CIRCUITS-II, V43, P157, DOI 10.1109/82.486465; Yu Lifeng, 2009, Imaging Med, V1, P65, DOI 10.2217/iim.09.5	17	6	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0228609	10.1371/journal.pone.0228609	http://dx.doi.org/10.1371/journal.pone.0228609			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084154	Green Published, gold			2022-12-26	WOS:000535227900021
J	Schneider, J; Han, WH; Matthew, R; Sauve, Y; Lemieux, H				Schneider, Jillian; Han, Woo Hyun; Matthew, Rebecca; Sauve, Yves; Lemieux, Helene			Age and sex as confounding factors in the relationship between cardiac mitochondrial function and type 2 diabetes in the Nile Grass rat	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; FATTY-ACID OXIDATION; SKELETAL-MUSCLE; ENERGY-METABOLISM; GLUCOSE-HOMEOSTASIS; LYSINE ACETYLATION; OLDER-ADULTS; HEART; SIRT1; DIET	Our study revisits the role of cardiac mitochondrial adjustments during the progression of type 2 diabetes mellitus (T2DM), while considering age and sex as potential confounding factors. We used the Nile Grass rats (NRs) as the animal model. After weaning, animals were fed either a Standard Rodent Chow Diet (SRCD group) or a Mazuri Chinchilla Diet (MCD group) consisting of high-fiber and low-fat content. Both males and females in the SRCD group, exhibited increased body mass, body mass index, and plasma insulin compared to the MCD group animals. However, the females were able to preserve their fasting blood glucose throughout the age range on both diets, while the males showed significant hyperglycemia starting at 6 months in the SRCD group. In the males, a higher citrate synthase activity-a marker of mitochondrial content-was measured at 2 months in the SRCD compared to the MCD group, and this was followed by a decline with age in the SRCD group only. In contrast, females preserved their mitochondrial content throughout the age range. In the males exclusively, the complex IV capacity expressed independently of mitochondrial content varied with age in a diet-specific pattern; the capacity was elevated at 2 months in the SRCD group, and at 6 months in the MCD group. In addition, females, but not males, were able to adjust their capacity to oxidize long-chain fatty acid in accordance with the fat content of the diet. Our results show clear sexual dimorphism in the variation of mitochondrial content and oxidative phosphorylation capacity with diet and age. The SRCD not only leads to T2DM but also exacerbates age-related cardiac mitochondrial defects. These observations, specific to male NRs, might reflect deleterious dietary-induced changes on their metabolism making them more prone to the cardiovascular consequences of aging and T2DM.	[Schneider, Jillian; Han, Woo Hyun; Matthew, Rebecca; Lemieux, Helene] Univ Alberta, Fac St Jean, Edmonton, AB, Canada; [Schneider, Jillian; Sauve, Yves] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Han, Woo Hyun; Sauve, Yves] Univ Alberta, Dept Ophthalmol & Visual Sci, Edmonton, AB, Canada; [Lemieux, Helene] Univ Alberta, Women & Childrens Hlth Res Inst, Dept Med, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Lemieux, H (corresponding author), Univ Alberta, Fac St Jean, Edmonton, AB, Canada.; Lemieux, H (corresponding author), Univ Alberta, Women & Childrens Hlth Res Inst, Dept Med, Edmonton, AB, Canada.	helene.lemieux@ualberta.ca			NSERC [RGPIN 402636]; Canadian Foundation for Innovation equipment grant [12979]; Faculty Saint-Jean grant; Canadian Institutes of Health (CIHR) [MOP 125873]; Frederick Banting and Charles Best Canada Graduate Scholarship; Queen Elizabeth II Graduate Scholarship; University of Alberta Faculty of Medicine and Dentistry 75th anniversary scholarship; Alberta Heritage Foundation for Medical Research Senior Scholarship [200800242]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation equipment grant; Faculty Saint-Jean grant; Canadian Institutes of Health (CIHR)(Canadian Institutes of Health Research (CIHR)); Frederick Banting and Charles Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Queen Elizabeth II Graduate Scholarship; University of Alberta Faculty of Medicine and Dentistry 75th anniversary scholarship; Alberta Heritage Foundation for Medical Research Senior Scholarship(Alberta Heritage Foundation for Medical Research)	Funding provided by NSERC discovery grant (RGPIN 402636), Canadian Foundation for Innovation equipment grant (12979) and Faculty Saint-Jean grant to HL, and from Canadian Institutes of Health (CIHR; MOP 125873) to YS. JS received a Frederick Banting and Charles Best Canada Graduate Scholarship and a Queen Elizabeth II Graduate Scholarship; WHH received a University of Alberta Faculty of Medicine and Dentistry 75th anniversary scholarship; YS received an Alberta Heritage Foundation for Medical Research Senior Scholarship (200800242).	Aguer C, 2015, FASEB J, V29, P336, DOI 10.1096/fj.14-255901; Alrob OA, 2014, CARDIOVASC RES, V103, P485, DOI 10.1093/cvr/cvu156; Anderson EJ, 2009, J AM COLL CARDIOL, V54, P1891, DOI 10.1016/j.jacc.2009.07.031; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Baekkerud FH, 2019, CARDIOVASCULAR TOXIC; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Battiprolu Pavan K, 2010, Drug Discov Today Dis Mech, V7, pe135; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Benton CR, 2010, DIABETOLOGIA, V53, P2008, DOI 10.1007/s00125-010-1773-1; Bonen A, 2015, DIABETOLOGIA, V58, P2381, DOI 10.1007/s00125-015-3691-8; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Chaabo F, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-29; Crewe C, 2017, J BIOL CHEM, V292, P305, DOI 10.1074/jbc.M116.754127; Crewe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077280; Croston TL, 2014, AM J PHYSIOL-HEART C, V307, pH54, DOI 10.1152/ajpheart.00845.2013; Deepa SS, 2018, AGING CELL, V17, DOI 10.1111/acel.12769; Deepa SS, 2013, FASEB J, V27, P1371, DOI 10.1096/fj.12-221879; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Duncan JG, 2007, CIRCULATION, V115, P909, DOI 10.1161/CIRCULATIONAHA.106.662296; Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Fu H, 2014, J DIABETES COMPLICAT, V28, P477, DOI 10.1016/j.jdiacomp.2014.02.009; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Gnaiger E, 2000, LIFE IN THE COLD, P431; Gnaiger E., 2014, MITOCHONDR PHYSL NET; Gomez-Perez Y, 2008, CELL PHYSIOL BIOCHEM, V22, P539, DOI 10.1159/000185538; Halter JB, 2014, DIABETES, V63, P2578, DOI 10.2337/db14-0020; Han WH, 2017, INVEST OPHTH VIS SCI, V58, P3826, DOI 10.1167/iovs.17-21929; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Hill S, 2017, MOL CELL ENDOCRINOL, V455, P103, DOI 10.1016/j.mce.2017.03.019; Hoppel CL, 2017, ADV EXP MED BIOL, V982, P451, DOI 10.1007/978-3-319-55330-6_24; Hubbard BP, 2014, TRENDS PHARMACOL SCI, V35, P146, DOI 10.1016/j.tips.2013.12.004; Jain SS, 2014, DIABETES, V63, P1907, DOI 10.2337/db13-0816; John C, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00732; Kerr M, 2017, CLIN SCI, V131, P2079, DOI [10.1042/cs20160671, 10.1042/CS20160671]; KUO TH, 1985, BIOCHIM BIOPHYS ACTA, V806, P9, DOI 10.1016/0005-2728(85)90076-3; Kuznetsov AV, 2000, TRANSPLANT P, V32, P45, DOI 10.1016/S0041-1345(99)00869-6; Labbadia John, 2014, F1000Prime Rep, V6, P7, DOI 10.12703/P6-7; Labbadia J, 2017, CELL REP, V21, P1481, DOI 10.1016/j.celrep.2017.10.038; Lanza IR, 2010, PFLUG ARCH EUR J PHY, V459, P277, DOI 10.1007/s00424-009-0724-5; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lashin OM, 2006, FREE RADICAL BIO MED, V40, P886, DOI 10.1016/j.freeradbiomed.2005.10.040; Le Couteur DG, 2018, J GERONTOL A-BIOL, V73, P139, DOI 10.1093/gerona/glx221; Lemieux H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02789-8; Lemieux H, 2011, INT J BIOCHEM CELL B, V43, P1729, DOI 10.1016/j.biocel.2011.08.008; Lemieux H, 2011, MITOCHONDRION, V11, P97, DOI 10.1016/j.mito.2010.07.014; Lemieux H, 2010, J GERONTOL A-BIOL, V65, P1157, DOI 10.1093/gerona/glq141; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Li X, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040203; Liepinsh E, 2017, BIOFACTORS, V43, P718, DOI 10.1002/biof.1378; Liepinsh E, 2016, BIOCHEM J, V473, P1191, DOI 10.1042/BCJ20160164; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lou PH, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13388; Makrecka M, 2014, MOL CELL BIOCHEM, V395, P1, DOI 10.1007/s11010-014-2106-3; Makrecka-Kuka M, 2020, ACTA PHYSIOL, V228, DOI 10.1111/apha.13430; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Montaigne D, 2014, CIRCULATION, V130, P554, DOI 10.1161/CIRCULATIONAHA.113.008476; Monteiro JP, 2013, PROG LIPID RES, V52, P513, DOI 10.1016/j.plipres.2013.06.002; Montgomery MK, 2013, J LIPID RES, V54, P3322, DOI 10.1194/jlr.M040451; Mozet C, 2009, AGING CLIN EXP RES, V21, P14; Neves FA, 2014, J NUTR BIOCHEM, V25, P50, DOI 10.1016/j.jnutbio.2013.08.014; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Noda K, 2010, FASEB J, V24, P2443, DOI 10.1096/fj.09-152678; Paglialunga S, 2012, DIABETOLOGIA, V55, P2759, DOI 10.1007/s00125-012-2626-x; Park SJ, 2017, EBIOMEDICINE, V18, P128, DOI 10.1016/j.ebiom.2017.03.019; Pellizzon MA, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0243-5; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Popkov VA, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1560, DOI 10.1134/S0006297915120032; Pulliam DA, 2014, BIOCHEM J, V462, P359, DOI 10.1042/BJ20140291; Qian MX, 2018, ADV EXP MED BIOL, V1086, P235, DOI 10.1007/978-981-13-1117-8_15; Rabiu S, 1997, ACTA THERIOL, V42, P55, DOI 10.4098/AT.arch.97-7; Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498; Regitz-Zagrosek V, 2017, PHYSIOL REV, V97, P1, DOI 10.1152/physrev.00021.2015; Rosca MG, 2009, ADV DRUG DELIVER REV, V61, P1332, DOI 10.1016/j.addr.2009.06.009; Ruetenik A, 2015, BBA-BIOENERGETICS, V1847, P1434, DOI 10.1016/j.bbabio.2015.05.005; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; SCHMUCKER DL, 1985, MECH AGEING DEV, V31, P89, DOI 10.1016/0047-6374(85)90028-4; Schneider J, 2018, PLOS ONE, V13, P1; Sergi D, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00532; Serrano Jose C E, 2016, Diseases, V4, DOI 10.3390/diseases4010014; Smith JJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-31; Subramaniam A, 2019, NUTRIENTS, P11; Subramaniam A, 2018, NUTRIENTS, P10; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Tocchetti CG, 2012, DIABETES, V61, P3094, DOI 10.2337/db12-0072; Tominaga H, 2008, AM J PHYSIOL-HEART C, V295, pH105, DOI 10.1152/ajpheart.01307.2007; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Vazquez EJ, 2015, CARDIOVASC RES, V107, P453, DOI 10.1093/cvr/cvv183; Vinciguerra M, 2010, DIS MODEL MECH, V3, P298, DOI 10.1242/dmm.004655; Wang XZ, 2015, J PROTEOME RES, V14, P2849, DOI 10.1021/acs.jproteome.5b00128; WHO, 2016, GLOB REP PSOR; Wright JJ, 2009, CARDIOVASC RES, V82, P351, DOI 10.1093/cvr/cvp017; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197; Yang H, 2010, HUM MOL GENET, V19, P170, DOI 10.1093/hmg/ddp477; Yang KY, 2016, J ENDOCRINOL, V229, P343, DOI 10.1530/JOE-15-0517; Zamora M, 2015, BIOCHEM PHARMACOL, V98, P16, DOI 10.1016/j.bcp.2015.06.032; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151	102	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0228710	10.1371/journal.pone.0228710	http://dx.doi.org/10.1371/journal.pone.0228710			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084168	Green Published, gold			2022-12-26	WOS:000535227900024
J	Sok, P; Lupo, PJ; Richard, MA; Rabin, KR; Ehli, EA; Kallsen, NA; Davies, GE; Scheurer, ME; Brown, AL				Sok, Pagna; Lupo, Philip J.; Richard, Melissa A.; Rabin, Karen R.; Ehli, Erik A.; Kallsen, Noah A.; Davies, Gareth E.; Scheurer, Michael E.; Brown, Austin L.			Utilization of archived neonatal dried blood spots for genome-wide genotyping	PLOS ONE			English	Article							VITAMIN-D; DNA; STORAGE; PHENYLKETONURIA; HISTORY; RISK	Introduction Heel pricks are performed on newborns for diagnostic screenings of various pre-symptomatic metabolic and genetic diseases. Excess blood is spotted on Guthrie cards and archived by many states in biobanks for follow-up diagnoses and public health research. However, storage environment may vary across biobanks and across time within biobanks. With increased applications of DNA extracted from spots for genetic studies, identifying factors associated with genotyping success is critical to maximize DNA quality for future studies. Method We evaluated 399 blood spots, which were part of a genome-wide association study of childhood leukemia risk in children with Down syndrome, archived at the Michigan Neonatal Biobank between 1992 and 2008. High quality DNA was defined as having post-quality control call rate >= 99.0% based on the Illumina GenomeStudio 2.0 GenCall algorithm after processing the samples on the Illumina Infinium Global Screening Array. Bivariate analyses and multivariable logistic regression models were applied to evaluate effects of storage environment and storage duration on DNA genotyping quality. Results Both storage environment and duration were associated with sample genotyping call rates (p-values < 0.001). Sample call rates were associated with storage duration independent of storage environment (p-trend = 0.006 for DBS archived in an uncontrolled environment and p-trend = 0.002 in a controlled environment). However, 95% of the total sample had high genotyping quality with a call rate >= 95.0%, a standard threshold for acceptable sample quality in many genetic studies. Conclusion Blood spot DNA quality was lower in samples archived in uncontrolled storage environments and for samples archived for longer durations. Still, regardless of storage environment or duration, neonatal biobanks including the Michigan Neonatal Biobanks can provide access to large collections of spots with DNA quality acceptable for most genotyping studies.	[Sok, Pagna; Lupo, Philip J.; Richard, Melissa A.; Rabin, Karen R.; Scheurer, Michael E.; Brown, Austin L.] Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA; [Ehli, Erik A.; Kallsen, Noah A.; Davies, Gareth E.] Avera Inst Human Genet, Sioux Falls, SD USA	Baylor College of Medicine	Brown, AL (corresponding author), Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA.	Austin.Brown@bcm.edu		Ehli, Erik/0000-0002-7865-3015; Sok, Pagna/0000-0001-8210-4580; Lupo, Philip/0000-0003-0978-5863; Scheurer, Michael/0000-0002-8379-6088	Cancer Prevention and Research Institute of Texas [RP170074]; National Cancer Institute [K07 CA218362]	Cancer Prevention and Research Institute of Texas; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by funding from the Cancer Prevention and Research Institute of Texas (RP170074, MPI: Rabin/Lupo) and the National Cancer Institute (K07 CA218362, PI: Brown). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almannai M, 2016, CURR OPIN PEDIATR, V28, P694, DOI 10.1097/MOP.0000000000000414; [Anonymous], 2014, GUID AN INF GEN DAT; Beger RD, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1094-6; Bhatti P, 2015, INT J CANCER, V136, P2481, DOI 10.1002/ijc.29291; Brown AL, 2019, BLOOD, V134, P1227, DOI 10.1182/blood.2018890764; Castellani C, 2016, LANCET RESP MED, V4, P653, DOI 10.1016/S2213-2600(16)00053-9; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chaturvedi S, 2016, AM J HEMATOL, V91, P5, DOI 10.1002/ajh.24235; Choi Eun-Hye, 2014, Osong Public Health Res Perspect, V5, P351, DOI 10.1016/j.phrp.2014.09.005; El-Hattab AW, 2018, PEDIATR CLIN N AM, V65, P389, DOI 10.1016/j.pcl.2017.11.013; GUTHRIE R, 1963, PEDIATRICS, V32, P338; Hannelius U, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032987; Hollegaard MV, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-58; Hollegaard MV, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-297; Hollegaard MV, 2009, GENET TEST MOL BIOMA, V13, P173, DOI 10.1089/gtmb.2008.0073; Hollegaard MV, 2009, ELECTROPHORESIS, V30, P2532, DOI 10.1002/elps.200800655; Horsdal HT, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.14401; Koulman A, 2014, METABOLOMICS, V10, P1018, DOI 10.1007/s11306-014-0628-z; Kyvsgaard JN, 2017, PEDIATR DIABETES, V18, P637, DOI 10.1111/pedi.12476; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lewis MH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004474; Mei JV, 2011, CLIN CHIM ACTA, V412, P455, DOI 10.1016/j.cca.2010.11.028; MILLINGTON DS, 1990, J INHERIT METAB DIS, V13, P321, DOI 10.1007/BF01799385; Mitchell C, 2008, J CLIN MICROBIOL, V46, P2945, DOI 10.1128/JCM.00359-08; Nielsen NM, 2017, NEUROLOGY, V88, P44, DOI 10.1212/WNL.0000000000003454; Olney RS, 2006, J PEDIATR-US, V148, P618, DOI 10.1016/j.jpeds.2005.12.053; Pedersen CB, 2018, MOL PSYCHIATR, V23, P6, DOI 10.1038/mp.2017.196; Pena LDM, 2016, MOL GENET METAB, V118, P272, DOI 10.1016/j.ymgme.2016.05.007; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schwartz A, 2015, AM J TROP MED HYG, V92, P922, DOI 10.4269/ajtmh.14-0602; Staunstrup NH, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0242-1; Turner S, 2011, CURR PROTOC HUM GENE; Wiemels JL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02596-9; Wong NC, 2008, BIOTECHNIQUES, V45, P423, DOI 10.2144/000112945	34	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229352	10.1371/journal.pone.0229352	http://dx.doi.org/10.1371/journal.pone.0229352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084225	gold, Green Published			2022-12-26	WOS:000535227900097
J	Takematsu, E; Spencer, A; Auster, J; Chen, PC; Graham, A; Martin, P; Baker, AB				Takematsu, Eri; Spencer, Adrianne; Auster, Jeff; Chen, Po-Chih; Graham, Annette; Martin, Patricia; Baker, Aaron B.			Genome wide analysis of gene expression changes in skin from patients with type 2 diabetes	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; MITOCHONDRIAL CITRATE CARRIER; RECEPTOR-RELATED PROTEIN-1; LONG NONCODING RNAS; SUPEROXIDE-DISMUTASE; PROTEOMIC ANALYSIS; CANDIDATE GENES; ARTERY-DISEASE; INFLAMMATION; DYSFUNCTION	Non-healing chronic ulcers are a serious complication of diabetes and are a major healthcare problem. While a host of treatments have been explored to heal or prevent these ulcers from forming, these treatments have not been found to be consistently effective in clinical trials. An understanding of the changes in gene expression in the skin of diabetic patients may provide insight into the processes and mechanisms that precede the formation of non-healing ulcers. In this study, we investigated genome wide changes in gene expression in skin between patients with type 2 diabetes and non-diabetic patients using next generation sequencing. We compared the gene expression in skin samples taken from 27 patients (13 with type 2 diabetes and 14 non-diabetic). This information may be useful in identifying the causal factors and potential therapeutic targets for the prevention and treatment of diabetic related diseases.	[Takematsu, Eri; Spencer, Adrianne; Auster, Jeff; Chen, Po-Chih; Baker, Aaron B.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Graham, Annette; Martin, Patricia] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Dept Biol & Biomed Sci, Glasgow, Lanark, Scotland; [Baker, Aaron B.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Baker, Aaron B.] Univ Texas Austin, Inst Computat Engn & Sci, Austin, TX 78712 USA; [Baker, Aaron B.] Univ Texas Austin, Inst Biomat Drug Delivery & Regenerat Med, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Glasgow Caledonian University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Baker, AB (corresponding author), Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.; Baker, AB (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.; Baker, AB (corresponding author), Univ Texas Austin, Inst Computat Engn & Sci, Austin, TX 78712 USA.; Baker, AB (corresponding author), Univ Texas Austin, Inst Biomat Drug Delivery & Regenerat Med, Austin, TX 78712 USA.	abbaker1@gmail.com	Baker, Aaron/AAT-4635-2020		American Heart Association [17IRG33410888]; DOD CDMRP [W81XWH16-1-0580, W81XWH-16-1-0582]; National Institutes of Health [1R21EB023551-01, 1R21EB024147-01A1, 1R01HL141761-01]; Animal Free Research; NIH; DOD CDMRP; AHA	American Heart Association(American Heart Association); DOD CDMRP(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Animal Free Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD CDMRP(United States Department of Defense); AHA(American Heart Association)	The authors gratefully acknowledge funding through the American Heart Association (17IRG33410888), the DOD CDMRP (W81XWH16-1-0580; W81XWH-16-1-0582) and the National Institutes of Health (1R21EB023551-01; 1R21EB024147-01A1; 1R01HL141761-01) to ABB. We thank Sebastian Greenhough for collection and processing of tissue via the GCU Skin Tissue bank, supported by a grant from Animal Free Research (AG) and who did not participate in any experiments involving animals or animal tissue. The URLs for the funders are follows: NIH (https://www.nih.gov/), DOD CDMRP (https://cdmrp.army.mil/), AHA (https://www.heart.org/), and Animal Free Research (https://www.animalfreeresearchuk.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen H, 2005, DIABETIC MED, V22, P1401, DOI 10.1111/j.1464-5491.2005.01649.x; Anderson Abraham A, 2009, Pathogenetics, V2, P1, DOI 10.1186/1755-8417-2-1; [Anonymous], 2017, NAT DIAB STAT REP; Ansseau E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146893; Avogaro A, 2011, DIABETES CARE, V34, pS285, DOI 10.2337/dc11-s239; Baldari S, 2017, ONCOTARGET, V8, P1190, DOI 10.18632/oncotarget.13595; Barrientos S, 2014, WOUND REPAIR REGEN, V22, P569, DOI 10.1111/wrr.12205; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bellot GL, 2019, REDOX BIOL, V20, P307, DOI 10.1016/j.redox.2018.10.014; Berchtold LA, 2011, P NATL ACAD SCI USA, V108, pE681, DOI 10.1073/pnas.1104384108; Berry GJ, 2015, GENOM DATA, V5, P184, DOI 10.1016/j.gdata.2015.05.041; Bettahi I, 2014, DIABETES, V63, P715, DOI 10.2337/db13-1260; Blackburn K, 2017, J PROTEOME RES, V16, P1579, DOI 10.1021/acs.jproteome.6b00972; Bosnakovski D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35150-8; Bosnakovski D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007003; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Cai Y, 2018, J AM COLL CARDIOL, V72, pC74, DOI 10.1016/j.jacc.2018.08.419; Carrier Y, 2011, J INVEST DERMATOL, V131, P2428, DOI 10.1038/jid.2011.234; Chakroun I, 2015, FASEB J, V29, P4738, DOI 10.1096/fj.15-277053; Chen YT, 2016, ONCOTARGET, V7, P39162, DOI 10.18632/oncotarget.10043; Chen YY, 2016, ADIPOCYTE, V5, P326, DOI 10.1080/21623945.2016.1148835; Coon EA, 2016, JAMA NEUROL, V73, P236, DOI 10.1001/jamaneurol.2015.2976; Corton JC, 2000, ANNU REV PHARMACOL, V40, P491, DOI 10.1146/annurev.pharmtox.40.1.491; D'Souza DM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00379; Das S, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00082; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Frankel DS, 2008, CIRCULATION, V118, P2533, DOI 10.1161/CIRCULATIONAHA.108.792986; Fujiwara T, 2016, EXP DERMATOL, V25, P206, DOI 10.1111/exd.12909; Gaultier A, 2010, MATRIX BIOL, V29, P22, DOI 10.1016/j.matbio.2009.08.003; GEO, HARM; Gnoni GV, 2010, ENDOCRINOLOGY, V151, P1551, DOI 10.1210/en.2009-1352; Gottfried I, 2010, BIOCHEM SOC T, V38, P187, DOI 10.1042/BST0380187; Gragnano F, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/5620314; Gu Y, 2018, BIOMED REP, V9, P291, DOI 10.3892/br.2018.1135; Guan FL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29586; Gupta M, 2016, MOL PSYCHIATR, V21, P1717, DOI 10.1038/mp.2016.6; Hansen JS, 2015, DIABETOLOGIA, V58, P1845, DOI 10.1007/s00125-015-3584-x; Hebbar P, 2017, SCI REP-UK, V7, DOI 10.1038/srep40988; Hsieh YY, 2010, J CLIN LAB ANAL, V24, P262, DOI 10.1002/jcla.20409; Iacobazzi V, 2009, BIOCHEM BIOPH RES CO, V386, P186, DOI 10.1016/j.bbrc.2009.06.003; Jiang ZW, 2017, J INVEST DERMATOL, V137, P2620, DOI 10.1016/j.jid.2017.07.820; KAPLAN RS, 1990, ARCH BIOCHEM BIOPHYS, V280, P181, DOI 10.1016/0003-9861(90)90534-6; Karthik D, 2012, APPL BIOCHEM BIOTECH, V166, P1507, DOI 10.1007/s12010-012-9544-8; Khalfaoui T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074337; Kiss RS, 2006, J BIOL CHEM, V281, P12081, DOI 10.1074/jbc.M600621200; Konishi Y, 2006, BRAIN RES, V1116, P93, DOI 10.1016/j.brainres.2006.07.103; Kulkarni SS, 2016, DIABETES, V65, P3552, DOI 10.2337/db15-1725; Lambert S, 2017, J INVEST DERMATOL, V137, P1501, DOI 10.1016/j.jid.2016.12.032; Lawi Z., 2018, J GLOB PHARMA TECHNO, V10, P70; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Le Guelte A, 2015, EMBO J, V34, P1147, DOI 10.15252/embj.201591448; Ling C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006558; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035145; Longmate WM, 2017, J CELL BIOL, V216, P1473, DOI 10.1083/jcb.201510042; Longmate WM, 2014, ADV WOUND CARE, V3, P229, DOI 10.1089/wound.2013.0516; Magli A, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000153; Malt EA, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00059; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mannucci PM, 1998, ARTERIOSCL THROM VAS, V18, P1359, DOI 10.1161/01.ATV.18.9.1359; Margadant C, 2009, J CELL SCI, V122, P278, DOI 10.1242/jcs.029108; Meng WH, 2015, EBIOMEDICINE, V2, P1386, DOI 10.1016/j.ebiom.2015.08.001; Meng ZX, 2014, DIABETES, V63, P1533, DOI 10.2337/db13-1061; Miragliotta V, 2009, VET DERMATOL, V20, P27, DOI 10.1111/j.1365-3164.2008.00718.x; Monk DH, 2001, RES EDUC PRODUCT, V1, P1; Monteforte AJ, 2016, BIOMATERIALS, V94, P45, DOI 10.1016/j.biomaterials.2016.03.048; Montgomery MK, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0092; Nasarre L, 2014, ACTA DIABETOL, V51, P23, DOI 10.1007/s00592-012-0436-8; Nilsson E, 2014, DIABETES, V63, P2962, DOI 10.2337/db13-1459; Nogusa Y, 2006, INT J MOL MED, V17, P491; Ozbayer C, 2017, BIOTECHNOL BIOTEC EQ, V31, P563, DOI 10.1080/13102818.2017.1294034; Park SY, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.52; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Popov KM, 2010, REGULATION ENERGY ME; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Ramirez HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137133; Reynolds LE, 2008, J CLIN INVEST, V118, P965, DOI 10.1172/JCI33538; Rice JB, 2014, DIABETES CARE, V37, P651, DOI 10.2337/dc13-2176; Rodriguez-Fraticelli AE, 2015, NAT CELL BIOL, V17, P241, DOI 10.1038/ncb3106; Rovira-Llopis S, 2017, REDOX BIOL, V11, P637, DOI 10.1016/j.redox.2017.01.013; Roy S, 2009, PHYSIOL GENOMICS, V37, P211, DOI 10.1152/physiolgenomics.90362.2008; Said G, 2007, NAT CLIN PRACT NEURO, V3, P331, DOI 10.1038/ncpneuro0504; Schonrock N, 2012, CIRC RES, V111, P1349, DOI 10.1161/CIRCRESAHA.112.268953; Seligman BGS, 2000, DIABETES CARE, V23, P1395, DOI 10.2337/diacare.23.9.1395; Sethumadhavan S, 2012, J BIOL CHEM, V287, P22174, DOI 10.1074/jbc.M111.327866; Shi C, 2018, MED SCI MONITOR, V24, P8831, DOI 10.12659/MSM.910932; Shi XH, 2018, CANCER LETT, V433, P76, DOI 10.1016/j.canlet.2018.06.015; Shu B, 2016, J STEM CELL RES THER, V6, P348, DOI [10.4172/2157-7633.1000348, DOI 10.4172/2157-7633.1000348]; Sinyov VV, 2016, RUSS J GENET+, V52, P847, DOI 10.1134/S1022795416080123; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Small EM, 2000, MECH DEVELOP, V96, P259, DOI 10.1016/S0925-4773(00)00400-7; Suryavanshi SV, 2018, J CARDIOVASC DEV DIS, V5, DOI 10.3390/jcdd5010007; Tajhya RB, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.324; Takagi N, 2017, EXP DERMATOL, V26, P137, DOI 10.1111/exd.13115; Tan L, 2013, MOL NEUROBIOL, V47, P382, DOI 10.1007/s12035-012-8359-5; Tanner MR, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-018-1783-9; Tanner MR, 2017, FASEB J, V31, P3309, DOI 10.1096/fj.201601097R; Thangarajah H, 2010, CELL CYCLE, V9, P75, DOI 10.4161/cc.9.1.10371; Theocharidis G, 2018, DIABETES, V67, DOI 10.2337/db18-647-P; Thimmarayappa J, 2006, MOL ENDOCRINOL, V20, P2747, DOI 10.1210/me.2006-0128; Thiruvoipati T, 2015, WORLD J DIABETES, V6, P961, DOI 10.4239/wjd.v6.i7.961; Tian C, 2011, DIABETOLOGIA, V54, P803, DOI 10.1007/s00125-010-2004-5; Hien TT, 2016, J BIOL CHEM, V291, P3552, DOI 10.1074/jbc.M115.654384; Ung C, 2017, VISION RES, V139, P168, DOI 10.1016/j.visres.2017.03.007; Van Vranken JG, 2014, CELL METAB, V20, P241, DOI 10.1016/j.cmet.2014.05.012; Vanderplanck C, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-017-0148-4; Wang T, 2008, PROG BIOPHYS MOL BIO, V96, P499, DOI 10.1016/j.pbiomolbio.2007.07.006; Wang XJ, 2014, KIDNEY INT, V86, P712, DOI 10.1038/ki.2014.111; Wang Y, 2018, J CELL BIOL, V217, P1915, DOI 10.1083/jcb.201708007; Weijers RNM, 2012, CURR DIABETES REV, V8, P390, DOI 10.2174/157339912802083531; Weis S., 2011, COLD SPRING HARB PER, V1, P6478, DOI DOI 10.1101/CSHPERSPECT.A006478; Wight M, 2013, ESSAYS BIOCHEM, V54, P91, DOI [10.1042/BSE0540091, 10.1042/bse0540091]; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Wu C, 2017, ONCOTARGET, V8, P34601, DOI 10.18632/oncotarget.16118; Xie XT, 2016, OBESITY, V24, P1506, DOI 10.1002/oby.21528; Xu J, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180017; Yan JL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02425-z; Yuan XL, 2016, MED SCI MONITOR, V22, P3910, DOI 10.12659/MSM.896297; Zhao X, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0191-4	118	14	14	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0225267	10.1371/journal.pone.0225267	http://dx.doi.org/10.1371/journal.pone.0225267			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084158	Green Published, gold			2022-12-26	WOS:000535227900006
J	Arya, S; Wilton, P; Page, D; Boma-Fischer, L; Floros, G; Dainty, KN; Winikoff, R; Sholzberg, M				Arya, Sumedha; Wilton, Pamela; Page, David; Boma-Fischer, Laurence; Floros, Georgina; Dainty, Katie N.; Winikoff, Rochelle; Sholzberg, Michelle			Healthcare provider perspectives on inequities in access to care for patients with inherited bleeding disorders	PLOS ONE			English	Article							SOCIAL DETERMINANTS; UNITED-STATES; DISPARITIES; DIAGNOSIS; CANADA; HEMOPHILIA; MORTALITY; BARRIERS; OUTCOMES; DISEASE	Introduction The ways in which social determinants of health affect patients with inherited bleeding disorders remains unclear. The objective of this study was to understand healthcare provider perspectives regarding access to care and diagnostic delay amongst this patient population. Methods A healthcare provider survey comprising 24 questions was developed, tested, and subsequently disseminated online with recruitment to all members of The Association of Hemophilia Clinic Directors of Canada (N = 73), members of the Canadian Association of Nurses in Hemophilia Care (N = 40) and members of the Canadian Physiotherapists in Hemophilia Care (N = 44). Results There were 70 respondents in total, for a total response rate of 45%. HCPs felt that there were diagnostic delays for patients with mild symptomatology (71%, N = 50), women presenting with abnormal uterine bleeding as their only or primary symptom (59%, N = 41), and patients living in rural Canada (50%, N = 35). Fewer respondents felt that factors such as socioeconomic status (46%, N = 32) or race (21%, N = 15) influenced access to care, particularly as compared to the influence of rural location (77%, N = 54). Discussion We found that healthcare providers identified patients with mild symptomatology, isolated abnormal uterine bleeding, and residence in rural locations as populations at risk for inequitable access to care. These factors warrant further study, and will be investigated further by our group using our nation-wide patient survey and ongoing in-depth qualitative patient interviews.	[Arya, Sumedha] Univ Toronto, Dept Med, Toronto, ON, Canada; [Wilton, Pamela; Page, David] Canadian Hemophilia Soc, Montreal, PQ, Canada; [Boma-Fischer, Laurence] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada; [Boma-Fischer, Laurence; Floros, Georgina] St Michaels Hosp, Dept Hematol, Toronto, ON, Canada; [Floros, Georgina] St Michaels Hosp, Dept Nursing, Toronto, ON, Canada; [Dainty, Katie N.] North York Gen Hosp, Toronto, ON, Canada; [Dainty, Katie N.] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Winikoff, Rochelle] CHU Ste Justine, Div Hematol Oncol, Montreal, PQ, Canada; [Sholzberg, Michelle] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Sholzberg, Michelle] St Michaels Hosp, Dept Med & Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Toronto; Universite de Montreal; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Sholzberg, M (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.; Sholzberg, M (corresponding author), St Michaels Hosp, Dept Med & Lab Med & Pathobiol, Toronto, ON, Canada.	SholzbergM@smh.ca			American Society of Hematology (ASH) HONORS award; University of Toronto Postgraduate Medical Education (PGME) research award	American Society of Hematology (ASH) HONORS award; University of Toronto Postgraduate Medical Education (PGME) research award	SA received support for this research through the American Society of Hematology (ASH) HONORS award and the University of Toronto Postgraduate Medical Education (PGME) research award.	Aldridge RW, 2018, LANCET, V391, P241, DOI 10.1016/S0140-6736(17)31869-X; Amjad S, 2019, PAEDIATR PERINAT EP, V33, P88, DOI 10.1111/ppe.12529; BRECHNER RJ, 1993, JAMA-J AM MED ASSOC, V270, P1714, DOI 10.1001/jama.270.14.1714; BROOK RH, 1990, MED CARE, V28, P392, DOI 10.1097/00005650-199005000-00002; Donkin A, 2018, BMJ GLOB HEALTH, P3; Forsyth AL, 2015, PATIENT PREFER ADHER, V9, P1549, DOI 10.2147/PPA.S87659; Hahn R A, 1998, J Am Med Womens Assoc (1972), V53, P96; Heckman TG, 1998, AIDS CARE, V10, P365, DOI 10.1080/713612410; James AH, 2009, THROMB RES, V124, pS7, DOI 10.1016/S0049-3848(09)70151-3; KAHN KL, 1994, JAMA-J AM MED ASSOC, V271, P1169, DOI 10.1001/jama.271.15.1169; Kulkarni R, 2015, EUR J HAEMATOL, V95, P2, DOI 10.1111/ejh.12580; Lasser KE, 2006, AM J PUBLIC HEALTH, V96, P1300, DOI 10.2105/AJPH.2004.059402; Lund C, 2018, LANCET PSYCHIAT, V5, P357, DOI 10.1016/S2215-0366(18)30060-9; Marmot M, 2014, AM J PUBLIC HLTH, V104; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; MCDONALD TP, 1988, SOC SCI MED, V27, P167, DOI 10.1016/0277-9536(88)90325-5; McGrail KM, 2009, AM J PUBLIC HEALTH, V99, P1856, DOI 10.2105/AJPH.2007.129361; MOORE RD, 1994, NEW ENGL J MED, V330, P763, DOI 10.1056/NEJM199403173301107; NAVARRO V, 1990, LANCET, V336, P1238, DOI 10.1016/0140-6736(90)92846-A; Penman-Aguilar A, 2016, J PUBLIC HEALTH MAN, V22, pS33, DOI 10.1097/PHH.0000000000000373; Peyvandi F, 2013, SEMIN THROMB HEMOST, V39, P579, DOI 10.1055/s-0033-1349221; Peyvandi F, 2009, SEMIN THROMB HEMOST, V35, P349, DOI 10.1055/s-0029-1225757; Potosky AL, 1998, MED CARE, V36, P257, DOI 10.1097/00005650-199803000-00004; Reding MT, 2012, J MULTIDISCIP HEALTH, V5, P277, DOI 10.2147/JMDH.S35272; Renault NK, 2011, HAEMOPHILIA, V17, P237, DOI 10.1111/j.1365-2516.2010.02424.x; VanderMeulen H, 2018, ASS HEM CLIN DIR CAN; Willson AE, 2009, INT SOCIOL, V24, P93, DOI 10.1177/0268580908099155; Witkop M, 2015, AM J HEMATOL, V90, pS3, DOI 10.1002/ajh.24220	28	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0229099	10.1371/journal.pone.0229099	http://dx.doi.org/10.1371/journal.pone.0229099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8CF	32078655	Green Published, gold			2022-12-26	WOS:000535224600018
J	Lisboa, M; Fronteira, I; Mason, PH; Martins, MDO				Lisboa, Miguelhete; Fronteira, Ines; Mason, Paul H.; Martins, Maria do Rosario O.			National TB program shortages as potential factor for poor-quality TB care cascade: Healthcare workers' perspective from Beira, Mozambique	PLOS ONE			English	Article							TUBERCULOSIS; IMPLEMENTATION; INITIATION	Background Mozambique is one of the countries with the deadly implementation gaps in the tuberculosis (TB) care and services delivery. In-hospital delays in TB diagnosis and treatment, transmission and mortality still persist, in part, due to poor-quality of TB care cascade. Objective We aimed to assess, from the healthcare workers' (HCW) perspective, factors associated with poor-quality TB care cascade and explore local sustainable suggestions to improve in-hospital TB management. Methods In-depth interviews and focus group discussions were conducted with different categories of HCW. Audio-recording and written notes were taken, and content analysis was performed through atlas.ti7. Results Bottlenecks within hospital TB care cascade, lack of TB staff and task shifting, centralized and limited time of TB laboratory services, and fear of healthcare workers getting infected by TB were mentioned to be the main factors associated with implementation gaps. Interviewees believe that task shifting from nurses to hospital auxiliary workers, and from higher and well-trained to lower HCW are accepted and feasible. The expansion and use of molecular TB diagnostic tools are seen by the interviewees as a proper way to fight effectively against both sensitive and MDR TB. Ensuring provision of N95 respiratory masks is believed to be an essential requirement for effective engagement of the HCW on high-quality in-hospital TB care. For monitoring and evaluation, TB quality improvement teams in each health facility are considered to be an added value. Conclusion Shortage of resources within the national TB control programme is one of the potential factors for poor-quality of the TB care cascade. Task shifting of TB care and services delivery, decentralization of the molecular TB diagnostic tools, and regular provision of N95 respiratory masks should contribute not just to reduce the impact of resource scarceness, but also to ensure proper TB diagnosis and treatment to both sensitive and MDR TB.	[Lisboa, Miguelhete] INS, CIOB, Beira, Mozambique; [Lisboa, Miguelhete; Fronteira, Ines; Martins, Maria do Rosario O.] Univ Nova Lisboa, Global Hlth & Trop Med, IHMT, Lisbon, Portugal; [Mason, Paul H.] Monash Univ, Sch Social Sci, Clayton, Vic, Australia	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Monash University	Lisboa, M (corresponding author), INS, CIOB, Beira, Mozambique.; Lisboa, M (corresponding author), Univ Nova Lisboa, Global Hlth & Trop Med, IHMT, Lisbon, Portugal.	miguelhetelisboa@gmail.com	Fronteira, Inês/I-2380-2012; Lisboa, Miguelhete/Q-9088-2019	Fronteira, Inês/0000-0003-1406-4585; Lisboa, Miguelhete/0000-0002-3759-7715; Oliveira Martins, Maria do Rosario/0000-0002-7941-0285	Fundacao Calouste Gulbenkian (FCG) [P-135647/SBG/2014]; World Health Organization, The Special Programme for Research and Training in Tropical Diseases (WHO/TDR); United Nations Children's Fund; United Nations Development Programme; World Bank; WHO [B40151/2014]	Fundacao Calouste Gulbenkian (FCG); World Health Organization, The Special Programme for Research and Training in Tropical Diseases (WHO/TDR); United Nations Children's Fund; United Nations Development Programme; World Bank(The World Bank India); WHO(World Health Organization)	This study was elaborated based on the work of first Miguelhete Lisboa's doctoral program, a Fundacao Calouste Gulbenkian (FCG) scholarship holder (ID: P-135647/SBG/2014) and, used grants obtained from World Health Organization, The Special Programme for Research and Training in Tropical Diseases (WHO/TDR) and co-sponsored by the United Nations Children's Fund, United Nations Development Programme, World Bank and WHO -award ID number: B40151/2014. The FCG and WHO/TDR were neither involved in the design of the study and collection, analysis, interpretation of data, nor in the writing of manuscript or decision to publish. Therefore, the authors are responsible for all information.	Barrera E, 2015, INT J TUBERC LUNG D, V19, P381, DOI 10.5588/ijtld.14.0680; Brouwer M, 2015, INT J TUBERC LUNG D, V19, P44, DOI 10.5588/ijtld.14.0337; Brouwer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114364; DireccAo Provincial de Saude de Sofala, 2016, SOF PROV AN TUB REP; Engelbrecht M. C., 2013, Southern African Journal of Epidemiology & Infection, V28, P221; Garcia-Basteiro AL, 2018, PULMONOLOGY, V24, P73, DOI 10.1016/j.rppnen.2017.12.002; INE| Instituto Nacional de Estatistica, 2017, AN EST STAT YB 2016; Jacobson KR, 2013, CLIN INFECT DIS, V56, P503, DOI 10.1093/cid/cis920; Lisboa M, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-018-3656-x; Ministerio da Saude, 2010, MOZ POL PLAN TB INF; Orlando S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200523; Rustagi AS, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0009-3; Saifodine A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-559; Shete PB, 2017, INT J TUBERC LUNG D, V21, P746, DOI 10.5588/ijtld.16.0699; Sohn H, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1384-8; Sullivan BJ, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1290317; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2007, TASK SHIFT TACKL HLT; Yin R.K., 2015, QUALITATIVE RES STAR	19	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0228927	10.1371/journal.pone.0228927	http://dx.doi.org/10.1371/journal.pone.0228927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KT6GL	32059032	Green Published, gold			2022-12-26	WOS:000519112200001
J	Bandak, G; Sakhuja, AK; Andrijasevic, NM; Gunderson, TM; Gajic, O; Kashani, K				Bandak, Ghassan; Sakhuja, An Kit; Andrijasevic, Nicole M.; Gunderson, Tina M.; Gajic, Ognjen; Kashani, Kianoush			Use of diuretics in shock: Temporal trends and clinical impacts in a propensity-matched cohort study	PLOS ONE			English	Article							GOAL-DIRECTED THERAPY; VOLUME OVERLOAD; SEVERE SEPSIS; SEPTIC SHOCK; MORTALITY; FAILURE	Objective Fluid overload is common among critically ill patients and is associated with worse outcomes. We aimed to assess the effect of diuretics on urine output, vasopressor dose, acute kidney injury (AKI) incidence, and need for renal replacement therapies (RRT) among patients who receive vasopressors. Patients and methods This is a single-center retrospective study of all adult patients admitted to the intensive care unit between January 2006 and December 2016 and received >6 hours of vasopressor therapy and at least one concomitant dose of diuretic. We excluded patients from cardiac care units. Hourly urine output and vasopressor dose for 6 hours before and after the first dose of diuretic therapy was compared. Rates of AKI development and RRT initiation were assessed with a propensity-matched cohort of patients who received vasopressors but did not receive diuretics. Results There was an increasing trend of prescribing diuretics in patients receiving vasopressors over the course of the study. We included 939 patients with median (IQR) age of 68(57, 78) years old and 400 (43%) female. The average hourly urine output during the first six hours following time zero in comparison with average hourly urine output during the six hours prior to time zero was significantly higher in diuretic group in comparison with patients who did not receive diuretics [81 (95% CI 73-89) ml/h vs. 42 (95% CI 39-45) ml/h, respectively; p<0.001]. After propensity matching, the rate of AKI within 7 days of exposure and the need for RRT were similar between the study and matched control patients (66 (15.6%) vs. 83 (19.6%), p = 0.11, and 34 (8.0%) vs. 37 (8.7%), p = 0.69, respectively). Mortality, however, was higher in the group that received diuretics. Ninety-day mortality was 191 (45.2%) in the exposed group VS 156 (36.9%) p = .009. Conclusions While the use of diuretic therapy in critically ill patients receiving vasopressor infusions augmented urine output, it was not associated with higher vasopressor requirements, AKI incidence, and need for renal replacement therapy.	[Bandak, Ghassan] Marshall Hlth, Div Pulm & Crit Care Med, Huntington, WV USA; [Sakhuja, An Kit] Univ West Virginia, Div Pulm & Crit Care Med, Morgantown, WV USA; [Andrijasevic, Nicole M.] Mayo Clin, Dept Anesthesiol & Perioperat Med, Rochester, MN USA; [Gunderson, Tina M.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Gajic, Ognjen; Kashani, Kianoush] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN 55902 USA; [Kashani, Kianoush] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55902 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Kashani, K (corresponding author), Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN 55902 USA.; Kashani, K (corresponding author), Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55902 USA.	kashani.kianoush@mayo.edu		Kashani, Kianoush/0000-0003-2184-3683	Critical Care research committee at Mayo Clinic	Critical Care research committee at Mayo Clinic	This work was supported by a small Grant for statistical support from Critical Care research committee at Mayo Clinic. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheampong A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0970-1; Bagshaw SM, 2008, CRIT CARE MED, V36, pS172, DOI 10.1097/CCM.0b013e318168c92f; Besen Bruno Adler Maccagnan Pinheiro, 2015, World J Crit Care Med, V4, P116, DOI 10.5492/wjccm.v4.i2.116; CANTAROVICH F, 1973, BMJ-BRIT MED J, V4, P449, DOI 10.1136/bmj.4.5890.449; de Louw EJ, 2015, J CRIT CARE, V30, P619, DOI 10.1016/j.jcrc.2015.01.023; Dhondup T, 2020, J CRIT CARE, V55, P16, DOI 10.1016/j.jcrc.2019.09.025; Felker GM, 2012, J AM COLL CARDIOL, V59, P2145, DOI 10.1016/j.jacc.2011.10.910; Grams ME, 2011, CLIN J AM SOC NEPHRO, V6, P966, DOI 10.2215/CJN.08781010; He X, 2009, TRANSPLANTATION, V87, P384, DOI 10.1097/TP.0b013e31819004a1; Herasevich V, 2010, MAYO CLIN PROC, V85, P247, DOI 10.4065/mcp.2009.0479; Hoste EA, 2014, BRIT J ANAESTH, V113, P740, DOI 10.1093/bja/aeu300; Kelm DJ, 2015, SHOCK, V43, P68, DOI 10.1097/SHK.0000000000000268; Khanna A, 2017, NEW ENGL J MED, V377, P419, DOI 10.1056/NEJMoa1704154; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; McCoy IE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217911; Mehta RL, 2002, JAMA-J AM MED ASSOC, V288, P2547, DOI 10.1001/jama.288.20.2547; Miller WL, 2014, JACC-HEART FAIL, V2, P298, DOI 10.1016/j.jchf.2014.02.007; Mitchell KH, 2015, ANN AM THORAC SOC, V12, P1837, DOI 10.1513/AnnalsATS.201504-187OC; Ostermann M, 2019, CHEST, V156, P594, DOI 10.1016/j.chest.2019.04.004; Paren P, 2019, EUR J CLIN PHARMACOL, V75, P247, DOI 10.1007/s00228-018-2574-6; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sakhuja A, 2019, MAYO CLIN PROC, V94, P1509, DOI 10.1016/j.mayocp.2019.01.040; Shen YF, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2309-9; Sirvent JM, 2015, AM J EMERG MED, V33, P186, DOI 10.1016/j.ajem.2014.11.016; St Sauver JL, 2012, MAYO CLIN PROC, V87, P151, DOI 10.1016/j.mayocp.2011.11.009; Teixeira C, 2013, CRIT CARE, V17, DOI 10.1186/cc12484; Thongprayoon C, 2016, J NEPHROL, V29, P221, DOI 10.1007/s40620-015-0211-3; Uchino S, 2004, CRIT CARE MED, V32, P1669, DOI 10.1097/01.CCM.0000132892.51063.2F; Vincent JL, 2013, NEW ENGL J MED, V369, P1726, DOI 10.1056/NEJMra1208943; Wang N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1085-4; Yeh Daniel Dante, 2014, J Emerg Trauma Shock, V7, P83, DOI 10.4103/0974-2700.130876	32	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228274	10.1371/journal.pone.0228274	http://dx.doi.org/10.1371/journal.pone.0228274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053637	Green Published, gold			2022-12-26	WOS:000535198700023
J	Batiha, GE; Beshbishy, AM; Adeyemi, OS; Nadwa, E; Rashwan, E; Yokoyama, N; Igarashi, I				Batiha, Gaber El-Saber; Beshbishy, Amany Magdy; Adeyemi, Oluyomi Stephen; Nadwa, Eman; Rashwan, Eman; Yokoyama, Naoaki; Igarashi, Ikuo			Safety and efficacy of hydroxyurea and eflornithine against most blood parasites Babesia and Theileria	PLOS ONE			English	Article							TRYPANOSOMA-BRUCEI; IN-VITRO; COMBINATION; GROWTH; DRUG; MULTIPLICATION; MULTICENTER; BIGEMINA; THERAPY; MICROTI	Background The plenteous resistance to and undesirable consequences of the existing antipiroplasmic therapies have emphasized the urgent need for new chemotherapeutics and drug targets for both prophylaxis and chemotherapy. Hydroxyurea (HYD) is an antineoplastic agent with antitrypanosomal activity. Eflornithine (alpha-difluoro-methyl ornithine, DFMO) is the best choice therapy for the treatment of late-stage Gambian human African trypanosomiasis. Methods In this study, the inhibitory and combination efficacy of HYD and DFMO with existing babesicidal drugs (diminazene aceturate (DA), atovaquone (ATV), and clofazimine (CLF)) deoxyribonucleotide in vitro against the multiplication of Babesia and Theileria. As well as, their chemotherapeutic effects were assessed on B. microti strain that infects rodents. The Cell Counting Kits-8 (CCK-8) test was used to examine their cytotoxicity on human foreskin fibroblast (HFF), mouse embryonic fibroblast (NIH/3T3), and Madin-Darby bovine kidney (MDBK) cells. Findings HYD and DFMO suppressed the multiplication of all tested species (B. bigemina, B. bovis, B. caballi, B. divergens, and T. equi) in a dose-related manner. HFF, NIH/3T3, or MDBK cell viability was not influenced by DFMO at 1000 mu M, while HYD affected the MDBK cell viability at EC50 value of 887.5 +/- 14.4 mu M. The in vitro combination treatments of DFMO and HYD with CLF, DA, and ATV exhibited synergistic and additive efficacy toward all tested species. The in vivo experiment revealed that HYD and DFMO oral administration at 100 and 50 mg/kg inhibited B. microti multiplication in mice by 60.1% and 78.2%, respectively. HYD-DA and DFMO-DA combined treatments showed higher chemotherapeutic efficacy than their monotherapies. Conclusion These results indicate the prospects of HYD and DFMO as drug candidates for piroplasmosis treatment, when combined mainly with DA, ATV, and CLF. Therefore, further studies are needed to combine HYD or DFMO with either ATV or CLF and examine their impact on B. microti infection in mice.	[Batiha, Gaber El-Saber; Beshbishy, Amany Magdy; Yokoyama, Naoaki; Igarashi, Ikuo] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido, Japan; [Batiha, Gaber El-Saber] Damanhour Univ, Fac Vet Med, Dept Pharmacol & Therapeut, Damanhour, Al Beheira, Egypt; [Adeyemi, Oluyomi Stephen] Landmark Univ, Dept Biochem, Med Biochem Nanomed & Toxicol Lab, Omu Aran, Kwara State, Nigeria; [Nadwa, Eman] Jouf Univ, Coll Med, Dept Pharmacol & Therapeut, Jouf, Egypt; [Nadwa, Eman] Cairo Univ, Fac Med, Dept Med Pharmacol, Cairo, Egypt; [Rashwan, Eman] Al Azhar Univ, Coll Med, Dept Physiol, Assiut, Egypt; [Rashwan, Eman] Jouf Univ, Coll Med, Dept Physiol, Sakaka, Saudi Arabia	Obihiro University of Agriculture & Veterinary Medicine; Egyptian Knowledge Bank (EKB); Damanhour University; Landmark University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Al Azhar University; Al Jouf University	Igarashi, I (corresponding author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido, Japan.	igarcpmi@obihiro.ac.jp	Adeyemi, Oluyomi/AAV-2988-2021; Nadwa, Eman/AAJ-8435-2020; Adeyemi, Oluyomi Stephen/E-1680-2012	Adeyemi, Oluyomi/0000-0001-9342-8505; Nadwa, Eman/0000-0002-8963-790X; Adeyemi, Oluyomi Stephen/0000-0001-9342-8505; Rashwan, Eman K./0000-0002-4100-8995	Ministry of Higher Education Egypt; Japanese Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan (JSPS) (KAKEN) [18H02337]	Ministry of Higher Education Egypt(Ministry of Higher Education & Scientific Research (MHESR)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan (JSPS) (KAKEN)	This study was supported by the Ministry of Higher Education Egypt, the Japanese Society for the Promotion of Science, and the Ministry of Education, Culture, Sports, Science and Technology, Japan (JSPS) (KAKEN Grant Number: 18H02337). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldissera MD, 2016, EXP PARASITOL, V166, P144, DOI 10.1016/j.exppara.2016.04.015; Barry DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017510; Batiha GE, 2019, TROP MED HEALTH, V47, DOI 10.1186/s41182-019-0171-8; Batiha GE, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007030; Beshbishy AM, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3520-x; Beshbishy AM, 2019, ASIAN PAC J TROP MED, V12, P425, DOI 10.4103/1995-7645.267586; Bork S, 2003, PARASITOLOGY, V127, P311, DOI 10.1017/S0031182003003895; Butterworth RF, 2019, DRUGS, V79, P31, DOI 10.1007/s40265-018-1024-1; Chappuis F, 2005, CLIN INFECT DIS, V41, P748, DOI 10.1086/432576; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Chowdhury AR, 2008, EUKARYOT CELL, V7, P425, DOI 10.1128/EC.00369-07; Cokic VP, 2008, BLOOD, V111, P1117, DOI 10.1182/blood-2007-05-088732; COSGROVE WB, 1979, J PROTOZOOL, V26, P643, DOI 10.1111/j.1550-7408.1979.tb04212.x; Oliveira GLD, 2015, PHARMACOL RES, V102, P138, DOI 10.1016/j.phrs.2015.10.005; Davis PK, 2001, BIOTECHNIQUES, V30, P1322, DOI 10.2144/01306rv01; Batiha GE, 2019, TICKS TICK-BORNE DIS, V10, P949, DOI 10.1016/j.ttbdis.2019.04.016; El-Sayed SA, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3296-z; Goo YK, 2010, PARASITOL INT, V59, P481, DOI 10.1016/j.parint.2010.06.004; Guswanto A, 2018, INT J PARASITOL-DRUG, V8, P104, DOI 10.1016/j.ijpddr.2018.02.005; Hardbower DM, 2017, P NATL ACAD SCI USA, V114, pE751, DOI 10.1073/pnas.1614958114; Igarashi I, 1998, EXP PARASITOL, V90, P290, DOI 10.1006/expr.1998.4331; Keithly J.S., 1987, LEISHMANIASIS CURREN, V163, P749; Khalid A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38823-0; Kumar A, 2016, DRUG DELIV, V23, P1495, DOI 10.3109/10717544.2014.951746; Lawres LA, 2016, J EXP MED, V213, P1307, DOI 10.1084/jem.20151519; Majumdar R, 2015, AMINO ACIDS IN HIGHER PLANTS, P156, DOI 10.1079/9781780642635.0156; Martinez-Rojano H, 2008, ANTIMICROB AGENTS CH, V52, P3642, DOI 10.1128/AAC.00124-08; McGann PT, 2015, EXPERT OPIN DRUG SAF, V14, P1749, DOI 10.1517/14740338.2015.1088827; Melo EJT, 2003, BRAZ J MED BIOL RES, V36, P65, DOI 10.1590/S0100-879X2003000100009; MILORD F, 1992, LANCET, V340, P652, DOI 10.1016/0140-6736(92)92180-N; Lopez JM, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00026; Pepin J, 2000, B WORLD HEALTH ORGAN, V78, P1284; Priotto G, 2008, BMJ-BRIT MED J, V336, P705, DOI 10.1136/bmj.39485.592674.BE; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Rizk MA, 2018, INFECT DRUG RESIST, V11, P1605, DOI 10.2147/IDR.S159519; Rizk MA, 2017, EXP PARASITOL, V179, P43, DOI 10.1016/j.exppara.2017.06.003; Salama AA, 2014, PARASITOL RES, V113, P275, DOI 10.1007/s00436-013-3654-2; Salama AA, 2013, VET PARASITOL, V191, P1, DOI 10.1016/j.vetpar.2012.08.022; Sclafani Serena, 2016, Hematol Rep, V8, P6678, DOI 10.4081/hr.2016.6678; Singh A, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00734-17, 10.1128/aac.00734-17]; Tayebwa DS, 2018, TICKS TICK-BORNE DIS, V9, P1192, DOI 10.1016/j.ttbdis.2018.04.019; VANNIEUWENHOVE S, 1985, T ROY SOC TROP MED H, V79, P692, DOI 10.1016/0035-9203(85)90195-6; Vial HJ, 2006, VET PARASITOL, V138, P147, DOI 10.1016/j.vetpar.2006.01.048	43	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228996	10.1371/journal.pone.0228996	http://dx.doi.org/10.1371/journal.pone.0228996			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053698	Green Published, gold			2022-12-26	WOS:000535198700086
J	Carvalho, B; Bastias, CC; Escudero, A; Valladares, F; Benavides, R				Carvalho, Barbara; Bastias, Cristina C.; Escudero, Adrian; Valladares, Fernando; Benavides, Raquel			Intraspecific perspective of phenotypic coordination of functional traits in Scots pine	PLOS ONE			English	Article							PLANT ECONOMICS SPECTRUM; LEAF LIFE-SPAN; ENVIRONMENTAL GRADIENTS; HYDRAULIC ARCHITECTURE; NOTHOFAGUS-PUMILIO; WOOD DENSITY; TREE SIZE; FOREST; ECOLOGY; STEM	Functional traits have emerged as a key to understand species responses to environmental conditions. The concerted expression of multiple traits gives rise to the phenotype of each individual, which is the one interacting with the environment and evolving. However, patterns of trait covariation and how they vary in response to environmental conditions remain poorly understood, particularly at the intraspecific scale. Here, we have measured traits at different scales and in different organs, and analysed their covariation in a large number of conspecifics distributed in two contrasting environments. We expected significant correlations among traits, not only within clusters of traits as found in global, multispecies studies, but also among clusters, with more relationships within clusters, due to genetic constraints, and among clusters due to more coordinated phenotypes than community level, multispecies studies. We surveyed 100 Pinus sylvestris trees in a Mediterranean mountainous area distributed in two contrasting elevations. We measured 13 functional traits, in three clusters (leaf, stem and whole-plant traits), and analysed their variation and coordination. We found significant coordination among traits belonging to different clusters that reveals coordinated phenotypes. However, we found fewer correlations within trait clusters than initially expected. Trait correlation structures (number, intensity and type of correlations among traits) differed among individuals at different elevations. We observed more correlations within trait clusters at low elevation compared to those at high elevation. Moreover, the higher number of correlations among different trait clusters and the lower trait variation at the higher elevation suggests that variability decreases under more stressful conditions. Altogether, our results reveal that traits at intraspecific scale are coordinated in a broad network and not only within clusters of traits but also that this trait covariation is significantly affected by environmental conditions.	[Carvalho, Barbara; Bastias, Cristina C.; Valladares, Fernando; Benavides, Raquel] Museo Nacl Ciencias Nat, MNCN CSIC, Dept Biogeog & Cambio Global, LINCGlobal, Madrid, Spain; [Carvalho, Barbara; Escudero, Adrian; Valladares, Fernando] Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Universidad Rey Juan Carlos	Carvalho, B (corresponding author), Museo Nacl Ciencias Nat, MNCN CSIC, Dept Biogeog & Cambio Global, LINCGlobal, Madrid, Spain.; Carvalho, B (corresponding author), Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Madrid, Spain.	babic.barbosa@gmail.com	Carvalho, Bárbara/Y-2725-2019; Bastias, Cristina C./C-3657-2017; Benavides, Raquel/AAQ-5427-2020; Escudero, Adrian/H-5046-2015; Valladares, Fernando/K-9406-2014	Carvalho, Bárbara/0000-0002-4129-2746; Bastias, Cristina C./0000-0002-2479-2001; Benavides, Raquel/0000-0003-2328-5371; Escudero, Adrian/0000-0002-1427-5465; Valladares, Fernando/0000-0002-5374-4682	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -CAPES [DOC-PLENO - Programa de Doutorado Pleno no Exterior] [99999.001266/2015-02]; European Union Horizon 2020 Research and Innovation Programme Project GenTree [676876]; REMEDINAL TC-CM [Autonomous Community of Madrid] project [S2018/EMT-4338]; COMEDIAS FEDER [Spanish Ministry of Science, Innovation and Universities] project [CGL2017-83170-R]; LINCGlobal project [4540-143AP]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -CAPES [DOC-PLENO - Programa de Doutorado Pleno no Exterior]; European Union Horizon 2020 Research and Innovation Programme Project GenTree; REMEDINAL TC-CM [Autonomous Community of Madrid] project; COMEDIAS FEDER [Spanish Ministry of Science, Innovation and Universities] project; LINCGlobal project	BC thanks for a research scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -CAPES [DOC-PLENO - Programa de Doutorado Pleno no Exterior. Grant Agreement No 99999.001266/2015-02]. All authors acknowledge support from the European Union Horizon 2020 Research and Innovation Programme Project GenTree [Grant Agreement No. 676876]; REMEDINAL TC-CM [Autonomous Community of Madrid, S2018/EMT-4338]; COMEDIAS FEDER [CGL2017-83170-R, Spanish Ministry of Science, Innovation and Universities] and LINCGlobal [4540-143AP] projects.	Molina JGA, 2016, DENDROCHRONOLOGIA, V37, P116, DOI 10.1016/j.dendro.2016.01.003; Armbruster WS, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0245; Auger S, 2013, J VEG SCI, V24, P419, DOI 10.1111/j.1654-1103.2012.01473.x; Baraloto C, 2010, ECOL LETT, V13, P1338, DOI 10.1111/j.1461-0248.2010.01517.x; Bastias CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172495; Bennett AC, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.139, 10.1038/nplants.2015.139]; BERG RL, 1960, EVOLUTION, V14, P171, DOI 10.2307/2405824; Birmann K, 2009, PLANT ECOL DIVERS, V2, P233, DOI 10.1080/17550870903473894; Blonder B, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv049; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Brando PM, 2012, GLOBAL CHANGE BIOL, V18, P630, DOI 10.1111/j.1365-2486.2011.02533.x; Bucci SJ, 2004, TREE PHYSIOL, V24, P891, DOI 10.1093/treephys/24.8.891; CHAPIN FS, 1993, AM NAT, V142, pS78, DOI 10.1086/285524; Chauvin KM, 2018, OECOLOGIA, V186, P765, DOI 10.1007/s00442-017-4043-9; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; CHEVERUD JM, 1984, J THEOR BIOL, V110, P155, DOI 10.1016/S0022-5193(84)80050-8; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; de Bello F, 2011, METHODS ECOL EVOL, V2, P163, DOI 10.1111/j.2041-210X.2010.00071.x; de la Riva EG, 2016, J VEG SCI, V27, P187, DOI 10.1111/jvs.12341; Diaz S, 2016, NATURE, V529, P167, DOI 10.1038/nature16489; Edwards EJ, 2014, J ECOL, V102, P328, DOI 10.1111/1365-2745.12209; Escudero A, 2016, OECOLOGIA, V180, P919, DOI 10.1007/s00442-016-3578-5; Evans RD, 2001, TRENDS PLANT SCI, V6, P121, DOI 10.1016/S1360-1385(01)01889-1; Fajardo A, 2019, TRENDS ECOL EVOL, V34, P193, DOI 10.1016/j.tree.2018.10.011; Fajardo A, 2018, ECOLOGY, V99, P1024, DOI 10.1002/ecy.2194; Fajardo A, 2012, J ECOL, V100, P782, DOI 10.1111/j.1365-2745.2012.01955.x; Fajardo A, 2011, NEW PHYTOL, V189, P259, DOI 10.1111/j.1469-8137.2010.03468.x; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Fortunel C, 2012, FUNCT ECOL, V26, P1153, DOI 10.1111/j.1365-2435.2012.02020.x; Freschet GT, 2010, J ECOL, V98, P362, DOI 10.1111/j.1365-2745.2009.01615.x; GAUCH HG, 1982, ECOLOGY, V63, P1643, DOI 10.2307/1940105; Gianoli E, 2009, OIKOS, V118, P1924, DOI 10.1111/j.1600-0706.2009.17884.x; Greenwood S, 2017, ECOL LETT, V20, P539, DOI 10.1111/ele.12748; HILL MO, 1980, VEGETATIO, V42, P47, DOI 10.1007/BF00048870; Hultine KR, 2000, OECOLOGIA, V123, P32, DOI 10.1007/s004420050986; Ishida A, 2008, OECOLOGIA, V156, P193, DOI 10.1007/s00442-008-0965-6; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lei TT, 1996, PHYSIOL PLANTARUM, V96, P411, DOI 10.1111/j.1399-3054.1996.tb00452.x; Lusk CH, 2003, NEW PHYTOL, V160, P329, DOI 10.1046/j.1469-8137.2003.00879.x; Martin AR, 2017, FUNCT ECOL, V31, P604, DOI 10.1111/1365-2435.12790; Martinez-Vilalta J, 2009, NEW PHYTOL, V184, P353, DOI 10.1111/j.1469-8137.2009.02954.x; Mason CM, 2016, ECOL LETT, V19, P54, DOI 10.1111/ele.12542; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Messier J, 2017, J ECOL, V105, P1775, DOI 10.1111/1365-2745.12755; Messier J, 2017, ECOGRAPHY, V40, P685, DOI 10.1111/ecog.02006; Messier J, 2010, ECOL LETT, V13, P838, DOI 10.1111/j.1461-0248.2010.01476.x; Mugica FF, 1998, HOLOCENE, V8, P69, DOI 10.1191/095968398675691171; Murren CJ, 2012, INTEGR COMP BIOL, V52, P64, DOI 10.1093/icb/ics043; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nicotra AB, 1997, AM J BOT, V84, P1542, DOI 10.2307/2446616; NIINEMETS U, 1995, TREE PHYSIOL, V15, P307, DOI 10.1093/treephys/15.5.307; Niinemets U, 2007, ANN BOT-LONDON, V100, P283, DOI 10.1093/aob/mcm107; Niinemets U, 2015, NEW PHYTOL, V205, P79, DOI 10.1111/nph.13001; Niklas KJ, 1999, AM J BOT, V86, P465, DOI 10.2307/2656806; Okland RH, 1999, J VEG SCI, V10, P131, DOI 10.2307/3237168; Oksanen J., 2019, R PACKAGE VERSION; Olson ME, 2018, P NATL ACAD SCI USA, V115, P7551, DOI 10.1073/pnas.1721728115; Onoda Y, 2017, NEW PHYTOL, V214, P1447, DOI 10.1111/nph.14496; Paine CET, 2010, FUNCT ECOL, V24, P1202, DOI 10.1111/j.1365-2435.2010.01736.x; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pigliucci M, 2003, ECOL LETT, V6, P265, DOI 10.1046/j.1461-0248.2003.00428.x; Premoli AC, 2003, J HERED, V94, P218, DOI 10.1093/jhered/esg052; Premoli AC, 2007, AUST J BOT, V55, P585, DOI 10.1071/BT06026; Qiang WY, 2003, TREES-STRUCT FUNCT, V17, P258, DOI 10.1007/s00468-002-0235-x; R Core Team, 2018, R LANG ENV STAT COMP; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Revelle W., 2018, USE PSYCH PACKAGE FA; Salgado-Negret B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00511; Santiago LS, 2004, OECOLOGIA, V140, P543, DOI 10.1007/s00442-004-1624-1; Sides CB, 2014, AM J BOT, V101, P56, DOI 10.3732/ajb.1300284; Sperry JS, 2008, PLANT CELL ENVIRON, V31, P632, DOI 10.1111/j.1365-3040.2007.01765.x; Toivonen JM, 2014, FUNCT PLANT BIOL, V41, P301, DOI 10.1071/FP13210; Umana MN, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2745; Valladares F, 2014, ECOL LETT, V17, P1351, DOI 10.1111/ele.12348; Vasseur F, 2012, ECOL LETT, V15, P1149, DOI 10.1111/j.1461-0248.2012.01839.x; Verhoeven A, 2014, NEW PHYTOL, V201, P57, DOI 10.1111/nph.12466; VINES RG, 1968, AUST J BOT, V16, P499, DOI 10.1071/BT9680499; Violle C, 2012, TRENDS ECOL EVOL, V27, P244, DOI 10.1016/j.tree.2011.11.014; Violle C, 2009, J PLANT ECOL-UK, V2, P87, DOI 10.1093/jpe/rtp007; Walsh B, 2009, ANNU REV ECOL EVOL S, V40, P41, DOI 10.1146/annurev.ecolsys.110308.120232; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x; Wright IJ, 2007, ANN BOT-LONDON, V99, P1003, DOI 10.1093/aob/mcl066; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zarter CR, 2006, NEW PHYTOL, V172, P283, DOI 10.1111/j.1469-8137.2006.01816.x	91	10	10	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228539	10.1371/journal.pone.0228539	http://dx.doi.org/10.1371/journal.pone.0228539			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053614	Green Published, gold			2022-12-26	WOS:000535198700031
J	Rossler, B; Goschin, J; Maleczek, M; Piringer, F; Thell, R; Mittlbock, M; Schebesta, K				Roessler, Bernhard; Goschin, Julius; Maleczek, Mathias; Piringer, Felix; Thell, Rainer; Mittlboeck, Martina; Schebesta, Karl			Providing the best chest compression quality: Standard CPR versus chest compressions only in a bystander resuscitation model	PLOS ONE			English	Article							HOSPITAL CARDIAC-ARREST; BASIC LIFE-SUPPORT; EARLY DEFIBRILLATION; GUIDELINES; DEPTH	Aim of the study Bystander-initiated basic life support (BLS) for the treatment of prehospital cardiac arrest increases survival but is frequently not performed due to fear and a lack of knowledge. A simple flowchart can improve motivation and the quality of performance. Furthermore, guidelines do recommend a chest compression (CC)-only algorithm for dispatcher-assisted bystander resuscitation, which may lead to increased fatigue and a loss of compression depth. Consequently, we wanted to test the hypothesis that CCs are more correctly delivered in a flowchart-assisted standard resuscitation algorithm than in a CC-only algorithm. Methods With the use of a manikin model, 84 laypersons were randomized to perform either flowchart-assisted standard resuscitation or CC-only resuscitation for 5min. The primary outcome was the total number of CCs. Results The total number of correct CCs did not significantly differ between the CC-only group and the standard group (63 [+/- 81] vs. 79 [+/- 86]; p = 0.394; 95% CI of difference: 21-53). The total hand-off time was significantly lower in the CC-only group than in the standard BLS group. The relative number of correct CCs (the fraction of the total number of CCs achieving 5-6cm) and the level of exhaustion after BLS did not significantly differ between the groups. Conclusion Standard BLS did not lead to an increase in correctly delivered CCs compared to CC-only resuscitation and exhibited significantly more hand-off time. The low rate of CCs in both groups indicates the need for an increased focus on performance during BLS training.	[Roessler, Bernhard; Goschin, Julius; Maleczek, Mathias; Schebesta, Karl] Med Univ Vienna, Univ Dept Anaesthesia Intens Care Med & Pain Med, Med Simulat & Emergency Management Res Grp, Vienna, Austria; [Roessler, Bernhard; Schebesta, Karl] Med Univ Vienna, Acad Simulat Ctr Vienna, Vienna, Austria; [Roessler, Bernhard; Schebesta, Karl] Vienna Hosp Assoc, Vienna, Austria; [Maleczek, Mathias; Piringer, Felix; Thell, Rainer] St John Ambulance, Vienna, Austria; [Mittlboeck, Martina] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Schebesta, K (corresponding author), Med Univ Vienna, Univ Dept Anaesthesia Intens Care Med & Pain Med, Med Simulat & Emergency Management Res Grp, Vienna, Austria.; Schebesta, K (corresponding author), Med Univ Vienna, Acad Simulat Ctr Vienna, Vienna, Austria.; Schebesta, K (corresponding author), Vienna Hosp Assoc, Vienna, Austria.	karl.schebesta@meduniwien.ac.at	Schebesta, Karl/V-4626-2019	Mittlboeck, Martina/0000-0003-1097-4047; Maleczek, Mathias/0000-0002-1431-0742				Carifio J, 2008, MED EDUC, V42, P1150, DOI 10.1111/j.1365-2923.2008.03172.x; Hasselqvist-Ax I, 2015, N ENGL J MED; Heidenreich JW, 2006, ACAD EMERG MED; Heidenreich JW, 2012, J EMERG MED; Hellevuo H, 2013, RESUSCITATION; Hunziker S, 2011, INTENS CARE MED, V37, P1473, DOI 10.1007/s00134-011-2277-2; Hupfl M, 2010, LANCET; Iwami T, 2015, CIRCULATION; Kleinman ME, 2015, CIRCULATION, V132, pS414, DOI 10.1161/CIR.0000000000000259; Koster RW, 2010, RESUSCITATION, V81, P1277, DOI 10.1016/j.resuscitation.2010.08.009; Larsen MP, 1993, ANN EMERG MED; McDonald CH, 2013, EMERG MED J; Min MK, 2013, RESUSCITATION; Muller D, 2006, CIRCULATION; Nolan JR, 2017, SEMIN NEUROL, V37, P5, DOI 10.1055/s-0036-1597832; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; Perkins GD, 2015, RESUSCITATION; Rossler B, 2013, RESUSCITATION, V84, P982, DOI 10.1016/j.resuscitation.2013.01.001; Saner H, 2013, RESUSCITATION, V84, P1197, DOI 10.1016/j.resuscitation.2013.02.023; Sans S, 1997, EUR HEART J, V18, P1231; Savastano S, 2011, RESUSCITATION, V82, P568, DOI 10.1016/j.resuscitation.2010.12.010; Song Y, 2016, RESUSCITATION, V103, P20, DOI 10.1016/j.resuscitation.2016.03.014; Stiell IG, 2014, CIRCULATION, V130, P1962, DOI 10.1161/CIRCULATIONAHA.114.008671; Stiell IG, 2012, CRIT CARE MED, V40, P1192, DOI 10.1097/CCM.0b013e31823bc8bb; Swor R, 2006, ACAD EMERG MED, V13, P596, DOI 10.1197/j.aem.2005.12.021; van Alem AP, 2003, BMJ-BRIT MED J, V327, P1312, DOI 10.1136/bmj.327.7427.1312; Yamanaka S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189412; Zijlstra JA, 2014, RESUSCITATION, V85, P1444, DOI 10.1016/j.resuscitation.2014.07.020	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228702	10.1371/journal.pone.0228702	http://dx.doi.org/10.1371/journal.pone.0228702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053634	Green Published, gold			2022-12-26	WOS:000535198700047
J	Letinic, BD; Dahan-Moss, Y; Koekemoer, LL				Letinic, Blazenka D.; Dahan-Moss, Yael; Koekemoer, Lizette L.			Characterising the effect of Akirin knockdown on Anopheles arabiensis (Diptera: Culicidae) reproduction and survival, using RNA-mediated interference	PLOS ONE			English	Article							AFRICAN MALARIA VECTOR; PYRETHROID RESISTANCE; MAMFENE; SUBOLESIN/AKIRIN; INFESTATIONS; EXPRESSION; DROSOPHILA; PROTEINS; MOSQUITO; ANTIGEN	Anopheles arabiensis is an opportunistic malaria vector that rests and feeds outdoors, circumventing current vector control methods. Furthermore, this vector will readily feed on animal as well as human hosts. Targeting the vector, while feeding on animals, can provide an additional intervention for the current vector control activities. Agricultural animals are regularly vaccinated with recombinant proteins for the control of multiple endo- and ecto-parasitic infestations. The use of a Subolesin-vaccine showed a mark reduction in tick reproductive fitness. The orthologous gene of Subolesin, called Akirin in insects, might provide a valuable species-specific intervention against outdoor biting An. arabiensis. However, the biological function of this nuclear protein has not yet been investigated in this mosquito. The effects on An. arabiensis lifetable parameters were evaluated after Akirin was knocked down using commercial small-interfering RNA (siRNA) and in vitro transcribed double-stranded RNA (dsRNA). The siRNA mediated interference of Akirin significantly reduced fecundity by 17%, fertility by 23% and longevity by 32% when compared to the controls in the female mosquitoes tested. Similarly, dsRNA treatment had a 25% decrease in fecundity, 29% decrease in fertility, and 48% decrease in longevity, when compared to the control treatments. Mosquitoes treated with Akirin dsRNA had a mean survival time of 15-days post-inoculation, which would impact on their ability to transmit malaria parasites. These results strongly suggest that Akirin has a pleiotropic function in An. arabiensis longevity and reproductive fitness.	[Letinic, Blazenka D.; Dahan-Moss, Yael; Koekemoer, Lizette L.] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Wits Res Inst Malaria, Johannesburg, South Africa; [Letinic, Blazenka D.; Dahan-Moss, Yael; Koekemoer, Lizette L.] Natl Inst Communicable Dis Natl Hlth Lab Serv, Ctr Emerging Zoonot & Parasit Dis, Johannesburg, South Africa	University of Witwatersrand	Koekemoer, LL (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Wits Res Inst Malaria, Johannesburg, South Africa.; Koekemoer, LL (corresponding author), Natl Inst Communicable Dis Natl Hlth Lab Serv, Ctr Emerging Zoonot & Parasit Dis, Johannesburg, South Africa.	lizette.koekemoer@wits.ac.za		Koekemoer, Lizette/0000-0003-4236-6345; Letinic, Blazenka Danica/0000-0002-2659-4324	National Research Foundation (NRF) Competitive Programme for Rated Researchers (CPRR), Incentive Funding [85538]; DST/NRF Research Chair Initiative grant; Medical Faculty Research Endowment Fund; South African Medical Research Council -Self-Initiated Research Grant	National Research Foundation (NRF) Competitive Programme for Rated Researchers (CPRR), Incentive Funding; DST/NRF Research Chair Initiative grant; Medical Faculty Research Endowment Fund; South African Medical Research Council -Self-Initiated Research Grant	This project was supported by funding from the National Research Foundation (NRF) Competitive Programme for Rated Researchers (CPRR), Incentive Funding ((UID) 85538), and the DST/NRF Research Chair Initiative grant awarded to L.L.K., as well as the Medical Faculty Research Endowment Fund awarded to B.D.L, and funding Y. D.M. from the South African Medical Research Council -Self-Initiated Research Grant. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almazan C, 2005, VACCINE, V23, P4403, DOI 10.1016/j.vaccine.2005.04.012; Almazan C, 2003, VACCINE, V21, P1492, DOI 10.1016/S0264-410X(02)00683-7; [Anonymous], 1987, JPSAIM; Bonnay F, 2014, EMBO J, V33, P2349, DOI 10.15252/embj.201488456; BRAY RS, 1982, BRIT MED BULL, V38, P117, DOI 10.1093/oxfordjournals.bmb.a071746; Brooke BD, 2015, S AFR J SCI, V111, P190; Canales M, 2009, PARASITOL RES, V105, P97, DOI 10.1007/s00436-009-1368-2; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; da Costa M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-470; Dandalo LC, 2017, J MED ENTOMOL, V54, P1758, DOI 10.1093/jme/tjx169; de la Fuente J, 2013, TRANSBOUND EMERG DIS, V60, P172, DOI 10.1111/tbed.12146; de la Fuente J, 2006, VACCINE, V24, P4082, DOI 10.1016/j.vaccine.2006.02.046; de la Fuente J, 2011, VET PARASITOL, V181, P17, DOI 10.1016/j.vetpar.2011.04.018; Debalke S, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3414-y; Galindo RC, 2009, DEV COMP IMMUNOL, V33, P612, DOI 10.1016/j.dci.2008.11.002; Goto A, 2008, NAT IMMUNOL, V9, P97, DOI 10.1038/ni1543; Hargreaves K, 2003, MED VET ENTOMOL, V17, P417, DOI 10.1111/j.1365-2915.2003.00460.x; Hummon AB, 2007, BIOTECHNIQUES, V42, P467, DOI 10.2144/000112401; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Letinic BD, 2018, AFR ENTOMOL, V26, P422, DOI 10.4001/003.026.0422; Macqueen DJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-34; Moreno-Cid JA, 2010, VACCINE, V29, P77, DOI 10.1016/j.vaccine.2010.10.011; Mouatcho JC, 2009, S AFR J SCI, V105, P127; Munhenga G, 2011, AFR J BIOTECHNOL, V10, DOI 10.5897/AJB11.363; Nowak Scott J, 2012, Bioarchitecture, V2, P209, DOI 10.4161/bioa.22907; Rich JT, 2010, OTOLARYNG HEAD NECK, V143, P331, DOI 10.1016/j.otohns.2010.05.007; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-117; Sutterwala FS, 2008, NATURE, V451, P254, DOI 10.1038/451254a; Wang JD, 2013, PEST MANAG SCI, V69, P781, DOI 10.1002/ps.3432; WHO, 2017, VECT BORN DIS FACT S; World Malaria Report WHO, WORLD MAL REP; Zamore PD, 2001, NAT STRUCT BIOL, V8, P746, DOI 10.1038/nsb0901-746	34	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228576	10.1371/journal.pone.0228576	http://dx.doi.org/10.1371/journal.pone.0228576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32049962	gold, Green Published			2022-12-26	WOS:000535192300018
J	Jeannin, AC; Salem, JE; Massy, Z; Aubert, CE; Vemeer, C; Amouyal, C; Phan, F; Halbron, M; Funck-Brentano, C; Hartemann, A; Bourron, O				Jeannin, Anne-Caroline; Salem, Joe-Elie; Massy, Ziad; Aubert, Carole Elodie; Vemeer, Cees; Amouyal, Chloe; Phan, Franck; Halbron, Marine; Funck-Brentano, Christian; Hartemann, Agnes; Bourron, Olivier			Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; RISK-FACTORS; CARDIOVASCULAR RISK; NERVE-CONDUCTION; INHIBITION; CRITERIA; RECEPTOR; PREVALENCE; DIAGNOSIS; ALPHA	Aims/Hypothesis Diabetic peripheral neuropathy is a frequent and severe complication of diabetes. As Matrixgla-protein (MGP) is expressed in several components of the nervous system and is involved in some neurological disease, MGP could play a role in peripheral nervous system homeostasis. The aim of this study was to evaluate factors associated with sensitive diabetic neuropathy in Type 2 Diabetes, and, in particular, dephospho-uncarboxylated MGP (dp-ucMGP), the inactive form of MGP. Methods 198 patients with Type 2 Diabetes were included. Presence of sensitive diabetic neuropathy was defined by a neuropathy disability score (NDS) >= 6. Plasma levels of dp-ucMGP were measured by ELISA. Results In this cohort, the mean age was 64+/-8.4 years old, and 80% of patients were men. Peripheral neuropathy was present in 15.7% of the patients and was significantly associated (r = 0.51, p<0.0001) with dp-ucMGP levels (beta = -0.26, p = 0.045) after integrating effects of height (beta = -0.38, p = 0.01), insulin treatment (beta = 0.42, p = 0.002), retinopathy treated by laser (beta = 0.26, p = 0.02), and total cholesterol levels (beta = 0.3, p = 0.03) by multivariable analysis. Conclusions The association between diabetic neuropathy and the inactive form of MGP suggests the existence of new pathophysiological pathways to explore. Further studies are needed to determine if dp-ucMGP may be used as a biomarker of sensitive neuropathy. Since dp-ucMGP is a marker of poor vitamin K status, clinical studies are warranted to explore the potential protective effect of high vitamin K intake on diabetic peripheral neuropathy.	[Jeannin, Anne-Caroline; Salem, Joe-Elie; Amouyal, Chloe; Phan, Franck; Halbron, Marine; Funck-Brentano, Christian; Hartemann, Agnes; Bourron, Olivier] Sorbonne Univ, Paris, France; [Jeannin, Anne-Caroline; Amouyal, Chloe; Phan, Franck; Halbron, Marine; Hartemann, Agnes; Bourron, Olivier] Hop La Pitie Salpetriere, AP HP, Diabetol Dept, Paris, France; [Salem, Joe-Elie; Funck-Brentano, Christian] Hop La Pitie Salpetriere, AP HP, Dept Pharmacol, Paris, France; [Salem, Joe-Elie; Funck-Brentano, Christian] Hop La Pitie Salpetriere, AP HP, CIC 1421, Paris, France; [Salem, Joe-Elie; Funck-Brentano, Christian] INSERM, CIC 1421, Paris, France; [Salem, Joe-Elie; Amouyal, Chloe; Phan, Franck; Halbron, Marine; Funck-Brentano, Christian; Hartemann, Agnes; Bourron, Olivier] Inst Cardiometab & Nutr ICAN, Paris, France; [Massy, Ziad] Univ Paris Saclay, Pitie Salpetrie Re Hosp, Ambroise Pare Hosp, AP HP,Div Nephrol, Paris, France; [Aubert, Carole Elodie] Univ Bern, Bern Univ Hosp, Dept Gen Internal Med, Inselspital, Bern, Switzerland; [Aubert, Carole Elodie] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland; [Vemeer, Cees] Maastricht Univ, Cardiovasc Res Inst Car, Maastricht, Netherlands; [Phan, Franck; Hartemann, Agnes; Bourron, Olivier] INSERM, Ctr Rech Cordeliers, UMR S 1138, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; University of Bern; University Hospital of Bern; University of Bern; Maastricht University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Bourron, O (corresponding author), Sorbonne Univ, Paris, France.; Bourron, O (corresponding author), Hop La Pitie Salpetriere, AP HP, Diabetol Dept, Paris, France.; Bourron, O (corresponding author), Inst Cardiometab & Nutr ICAN, Paris, France.; Bourron, O (corresponding author), INSERM, Ctr Rech Cordeliers, UMR S 1138, Paris, France.	olivier.bourron@aphp.fr		Salem, Joe-Elie/0000-0002-0331-3307; Aubert, Carole Elodie/0000-0001-8325-8784	Lilly Company; University of Lausanne; Ministere francais des Affaires Sociales et de la Sante	Lilly Company; University of Lausanne; Ministere francais des Affaires Sociales et de la Sante	This work was supported by a fund from the Lilly Company. The research activities of C.E.A. were supported by a doctoral research scholarship from the University of Lausanne. A.C.J received a grant from Ministere francais des Affaires Sociales et de la Sante (Bourse annee recherche 2017/2018) The company was involved neither in the design of the study nor in data collection.	Abbott CA, 2002, DIABETIC MED, V19, P377, DOI 10.1046/j.1464-5491.2002.00698.x; Alleman CJM, 2015, DIABETES RES CLIN PR, V109, P215, DOI 10.1016/j.diabres.2015.04.031; Andreassen CS, 2006, DIABETES, V55, P806, DOI 10.2337/diabetes.55.03.06.db05-1237; Aubert CE, 2014, DIABETES-METAB RES, V30, P679, DOI 10.1002/dmrr.2529; Bourron O, 2014, J CLIN ENDOCR METAB, V99, P4250, DOI 10.1210/jc.2014-1047; Cefalu WT, 2019, DIABETES CARE, V42, pS124, DOI 10.2337/dc19-S011; Chalk C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004572.pub2; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Cranenburg ECM, 2011, J THROMB HAEMOST, V9, P1225, DOI 10.1111/j.1538-7836.2011.04263.x; Cranenburg ECM, 2010, THROMB HAEMOSTASIS, V104, P811, DOI 10.1160/TH09-11-0786; Dalmeijer GW, 2013, DIABETES CARE, V36, P3766, DOI 10.2337/dc13-0065; Dore JJ, 2005, DEV NEUROSCI-BASEL, V27, P37, DOI 10.1159/000084531; Druet C, 2013, PRESSE MED, V42, P830, DOI 10.1016/j.lpm.2013.02.312; DYCK PJ, 1992, NEUROLOGY, V42, P1164, DOI 10.1212/WNL.42.6.1164; DYCK PJ, 1991, NEUROLOGY, V41, P799, DOI 10.1212/WNL.41.6.799; DYCK PJ, 1980, ANN NEUROL, V8, P590, DOI 10.1002/ana.410080608; DYCK PJ, 1987, DIABETES CARE, V10, P432, DOI 10.2337/diacare.10.4.432; DYCK PJ, 1993, NEUROLOGY, V43, P817, DOI 10.1212/WNL.43.4.817; DYCK PJ, 1988, MUSCLE NERVE, V11, P21, DOI 10.1002/mus.880110106; DYCK PJ, 1985, BRAIN, V108, P861, DOI 10.1093/brain/108.4.861; ENGELKE JA, 1991, BIOCHIM BIOPHYS ACTA, V1078, P31, DOI 10.1016/0167-4838(91)90088-H; Feki I, 2001, MUSCLE NERVE, V24, P555, DOI 10.1002/mus.1040; Feldman EL, 2017, NEURON, V93, P1296, DOI 10.1016/j.neuron.2017.02.005; Forsblom CM, 1998, DIABETOLOGIA, V41, P1253, DOI 10.1007/s001250051062; GADIA MT, 1987, DIABETES CARE, V10, P613, DOI 10.2337/diacare.10.5.613; Gonzalez-Perez F, 2013, INT REV NEUROBIOL, V108, P257, DOI 10.1016/B978-0-12-410499-0.00010-1; Goritz C, 2007, GLIA, V55, P1108, DOI 10.1002/glia.20531; Grote CW, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00581; HALL JG, 1980, AM J MED, V68, P122, DOI 10.1016/0002-9343(80)90181-3; Hur DJ, 2005, AM J MED GENET A, V135A, P36, DOI 10.1002/ajmg.a.30680; Inoue T, 2009, J BONE MINER METAB, V27, P66, DOI 10.1007/s00774-008-0008-8; Kurnatowska I, 2016, KIDNEY BLOOD PRESS R, V41, P231, DOI 10.1159/000443426; Li JB, 2013, DIABETES CARE, V36, P3405, DOI 10.2337/dc13-0590; Majdazari A, 2013, J NEUROSCI, V33, P15132, DOI 10.1523/JNEUROSCI.4748-12.2013; Mertsch S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-302; Moon JI, 2008, DEV BIOL, V315, P404, DOI 10.1016/j.ydbio.2007.12.041; NAKAJIMA M, 1993, DEV BRAIN RES, V73, P17, DOI 10.1016/0165-3806(93)90041-8; Nishimoto Satoru Ken, 2014, Int J Cell Biol, V2014, P807013, DOI 10.1155/2014/807013; Nishimoto SK, 2005, MATRIX BIOL, V24, P353, DOI 10.1016/j.matbio.2005.05.004; Papanas Nikolaos, 2015, Rev Diabet Stud, V12, P48, DOI 10.1900/RDS.2015.12.48; Papanas N, 2014, EXPERT OPIN PHARMACO, V15, P2721, DOI 10.1517/14656566.2014.972935; PECORARO RE, 1990, DIABETES CARE, V13, P513, DOI 10.2337/diacare.13.5.513; Popescu DC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203057; PRICE PA, 1994, PROTEIN SCI, V3, P822; PRICE PA, 1983, BIOCHEM BIOPH RES CO, V117, P765, DOI 10.1016/0006-291X(83)91663-7; Puzantian H, 2018, AM J HYPERTENS, V31, P988, DOI 10.1093/ajh/hpy079; Roumeliotis S., 2019, INT J MOL SCI, V20; Roustit M, 2016, J CLIN ENDOCR METAB, V101, P3401, DOI 10.1210/jc.2016-2030; Santa-Maria I, 2010, NEUROSCI LETT, V468, P225, DOI 10.1016/j.neulet.2009.11.002; Schurgers LJ, 2007, J THROMB HAEMOST, V5, P2503, DOI 10.1111/j.1538-7836.2007.02758.x; Thornalley PJ, 2003, ARCH BIOCHEM BIOPHYS, V419, P31, DOI 10.1016/j.abb.2003.08.013; Vinik AI, 2005, CLIN THER, V27, P1164, DOI 10.1016/j.clinthera.2005.08.001; Vissers LET, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000455; Wang YL, 2007, BRIT J ORAL MAX SURG, V45, P197, DOI 10.1016/j.bjoms.2006.06.003; Wei FF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33257-6; Weintrob N, 2007, J DIABETES COMPLICAT, V21, P13, DOI 10.1016/j.jdiacomp.2005.11.002; YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200; Zhu T, 2015, NEUROSCI LETT, V585, P28, DOI 10.1016/j.neulet.2014.11.020	59	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229145	10.1371/journal.pone.0229145	http://dx.doi.org/10.1371/journal.pone.0229145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092076	Green Published, gold			2022-12-26	WOS:000535229300026
J	Yu, SY; Li, BC; Zhang, M; Gong, TW; Li, XM; Li, ZJ; Gao, XF; Zhang, SD; Jiang, T; Chen, CS				Yu, Shuyuan; Li, Baichen; Zhang, Meng; Gong, Tianwei; Li, Xiaomei; Li, Zhaojun; Gao, Xuefei; Zhang, Shudong; Jiang, Ting; Chen, Chuansheng			Automaticity in processing spatial-numerical associations: Evidence from a perceptual orientation judgment task of Arabic digits in frames	PLOS ONE			English	Article							VERBAL NUMBERS; SPACE; SNARC; REPRESENTATION; ACCOUNT; SIZE	Human adults are faster to respond to small/large numerals with their left/right hand when they judge the parity of numerals, which is known as the SNARC (spatial-numerical association of response codes) effect. It has been proposed that the size of the SNARC effect depends on response latencies. The current study introduced a perceptual orientation task, where participants were asked to judge the orientation of a digit or a frame surrounding the digit. The present study first confirmed the SNARC effect with native Chinese speakers (Experiment 1) using a parity task, and then examined whether the emergence and size of the SNARC effect depended on the response latencies (Experiments 2, 3, and 4) using a perceptual orientation judgment task. Our results suggested that (a) the automatic processing of response-related numerical-spatial information occurred with Chinese-speaking participants in the parity task; (b) the SNARC effect was also found when the task did not require semantic access; and (c) the size of the effect depended on the processing speed of the task-relevant dimension. Finally, we proposed an underlying mechanism to explain the SNARC effect in the perceptual orientation judgment task.	[Yu, Shuyuan; Li, Zhaojun] Ohio State Univ, Dept Psychol, Columbus, OH USA; [Li, Baichen] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; [Zhang, Meng; Gong, Tianwei; Jiang, Ting] Beijing Normal Univ, Fac Psychol, Beijing, Peoples R China; [Li, Xiaomei] Univ Illinois, Dept Human Dev & Family Studies, Champaign, IL USA; [Gao, Xuefei] Queensland Univ Technol, Sch Psychol & Counselling5, Brisbane, Qld, Australia; [Zhang, Shudong] Beijing Normal Univ, Fac Educ, Beijing, Peoples R China; [Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA 92697 USA	University System of Ohio; Ohio State University; Maastricht University; Beijing Normal University; University of Illinois System; University of Illinois Urbana-Champaign; Queensland University of Technology (QUT); Beijing Normal University; University of California System; University of California Irvine	Jiang, T (corresponding author), Beijing Normal Univ, Fac Psychol, Beijing, Peoples R China.; Zhang, SD (corresponding author), Beijing Normal Univ, Fac Educ, Beijing, Peoples R China.	zsd@bnu.edu.cn; psytingjiang@gmail.com	Gong, Tianwei/GSN-8040-2022	Li, Xiaomei/0000-0003-2457-7704; Chen, Chuansheng/0000-0002-8224-1005; Li, Baichen/0000-0003-0314-2381	2020 Comprehensive Discipline Construction Fund of Faculty of Education, Beijing Normal University	2020 Comprehensive Discipline Construction Fund of Faculty of Education, Beijing Normal University	2020 Comprehensive Discipline Construction Fund of Faculty of Education, Beijing Normal University The sponsor play the role in the data collection and analysis.	Antoine S, 2016, PSYCHON B REV, V23, P148, DOI 10.3758/s13423-015-0856-x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Butterworth B., 1999, MATH BRAIN; Campbell J. I. D., 2005, HDB MATH COGNITION; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; Cleland AA, 2019, Q J EXP PSYCHOL, V47; Cleland AA, 2019, J EXP PSYCHOL LEARN, V45, P333, DOI 10.1037/xlm0000590; Dehaene S, 2003, TRENDS COGN SCI, V7, P145, DOI 10.1016/S1364-6613(03)00055-X; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DEHAENE S, 1990, J EXP PSYCHOL HUMAN, V16, P626, DOI 10.1037/0096-1523.16.3.626; Dehaene S., 2011, NUMBER SENSE MIND CR, P29; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Fias W, 2001, COGNITIVE BRAIN RES, V12, P415, DOI 10.1016/S0926-6410(01)00078-7; Fias W, 2001, PSYCHOL RES-PSYCH FO, V65, P250, DOI 10.1007/s004260100065; Fias W., 1996, MATH COGNITION, V2, P95, DOI [DOI 10.1080/135467996387552, 10.1080/135467996387552]; Fias W, 2016, CAN J EXP PSYCHOL, V70, P33, DOI 10.1037/cep0000071; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; Fischer MH, 2003, PSYCHOL SCI, V14, P278, DOI 10.1111/1467-9280.03435; GALLISTEL CR, 1992, COGNITION, V44, P43, DOI 10.1016/0010-0277(92)90050-R; Gevers W, 2006, J EXP PSYCHOL HUMAN, V32, P32, DOI 10.1037/0096-1523.32.1.32; Gevers W, 2005, EUR J COGN PSYCHOL, V17, P659, DOI 10.1080/09541440540000112; HENIK A, 1982, MEM COGNITION, V10, P389, DOI 10.3758/BF03202431; Hoffmann D, 2014, COGN PROCESS, V15, P329, DOI 10.1007/s10339-014-0601-9; Hoffmann D, 2013, J EXP CHILD PSYCHOL, V116, P775, DOI 10.1016/j.jecp.2013.07.013; Hung YH, 2008, COGNITION, V106, P1441, DOI 10.1016/j.cognition.2007.04.017; Kadosh RC, 2008, J EXP PSYCHOL LEARN, V34, P1377, DOI 10.1037/a0013413; Kleiner M, 2007, PERCEPTION, V36, P14; Kopiske KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163897; Lammertyn J, 2002, CORTEX J DEVOTED STU; LORCH RF, 1990, J EXP PSYCHOL LEARN, V16, P149, DOI 10.1037/0278-7393.16.1.149; Mitchell T, 2012, Q J EXP PSYCHOL, V65, P1945, DOI 10.1080/17470218.2012.673631; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Nuerk H-C., 2005, PSYCHOL SCI, V47, P34; Nuerk HC, 2005, EXP PSYCHOL, V52, P187, DOI 10.1027/1618-3169.52.3.187; Nuerk HC, 2004, Q J EXP PSYCHOL-A, V57, P835, DOI 10.1080/02724980343000512; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pesenti M, 2000, J COGNITIVE NEUROSCI, V12, P461, DOI 10.1162/089892900562273; Pinhas M, 2012, BEHAV RES METHODS, V44, P788, DOI 10.3758/s13428-011-0172-y; Schwarz W, 2003, J EXP PSYCHOL HUMAN, V29, P507, DOI 10.1037/0096-1523.29.3.507; Siegler RS, 2003, PSYCHOL SCI, V14, P237, DOI 10.1111/1467-9280.02438; Spss II, 2011, IBM SPSS STAT WIND V, P440; Tzelgov J, 1996, J EXP PSYCHOL LEARN, V22, P336; Tzelgov J, 2005, HDB MATH COGNITION, P55; Tzelgov J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00302; van Dijck JP, 2011, COGNITION, V119, P114, DOI 10.1016/j.cognition.2010.12.013; Wood G., 2008, PSYCHOL SCI	46	3	3	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229130	10.1371/journal.pone.0229130	http://dx.doi.org/10.1371/journal.pone.0229130			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8DW	32092079	gold, Green Published			2022-12-26	WOS:000535229300024
J	Majewski, M; Lis, B; Olas, B; Ognik, K; Juskiewici, J				Majewski, Michal; Lis, Bernadette; Olas, Beata; Ognik, Katarzyna; Juskiewici, Jerzy			Dietary supplementation with copper nanoparticles influences the markers of oxidative stress and modulates vasodilation of thoracic arteries in young Wistar rats	PLOS ONE			English	Article							KYNURENINE PATHWAY; PLATELET MEMBRANES; DISULFIDE GROUPS; NITRIC-OXIDE; II SALT; MECHANISMS; SULFHYDRYL; TOXICITY; CYCLASE; ACID	We aimed to study the physiological effects of diet supplemented with copper (Cu) nanoparticles (NPs). During the eight weeks of the experiment, young Wistar rats (at seven weeks of age, n = 9) were supplemented with 6.5 mg of Cu either as NPs or carbonate salt (Cu-6.5). A diet that was not supplemented with Cu served as a negative control (Cu-0). The impact of nano Cu supplementation on lipid (reflected as thiobarbituric acid reactive substances-TBARS) and protein peroxidation (thiol and carbonyl groups) in blood plasma as well as the influence on the vasodilatory mechanism(s) of isolated rat thoracic arteries were studied. Supplementation with Cu enhanced lipid peroxidation (TBARS) in NP6.5 (x2.4) and in Cu-6.5 (x1.9) compared to the negative control. Significant increase in TBARS was also observed in NP6.5 (x1.3) compared to the Cu-6.5 group. The level of thiol groups increased in NP6.5 (x1.6) compared to Cu-6.5. Meanwhile, significant (x0.6) decrease was observed in the Cu-6.5 group compared to the negative control. Another marker of protein oxidation, carbonyl groups increased in NP6.5 (x1.4) and Cu-6.5 (x2.3) compared to the negative control. However significant difference (x0.6) was observed between NP6.5 and Cu-6.5. Arteries from Cu supplemented rats exhibited an enhanced vasodilation to gasotransmitters: nitric oxide (NO) and carbon monoxide (CO). An enhanced vasodilation to NO was reflected in the increased response to acetylcholine (ACh) and calcium ionophore A23187. The observed responses to ACh and CO releasing molecule (CORM-2) were more pronounced in NP6.5. The activator of cGMP-dependent protein kinases (8-bromo-cGMP) induced similar vasodilation of thoracic arteries in NP6.5 and Cu-0 groups, while an increased response was observed in the Cu-6.5 group. Preincubation with the inducible nitric oxide (iNOS) synthase inhibitor- 1400W, decreased the ACh-induced vasodilation in NP6.5, exclusively. Meanwhile the eicosanoid metabolite of arachidonic acid (20-HETE) synthesis inhibitor-HET0016, enhanced vasodilation of arteries from Cu-0 group. In conclusion, this study demonstrates that supplementation with nano Cu influences oxidative stress, which further has modified the vascular response.	[Majewski, Michal] Univ Warmia & Mazury, Fac Med, Dept Pharmacol & Toxicol, Olsztyn, Poland; [Lis, Bernadette; Olas, Beata] Univ Lodz, Fac Biol & Environm Protect, Dept Gen Biochem, Lodz, Poland; [Ognik, Katarzyna] Univ Life Sci, Fac Biol Anim Sci & Bioecon, Dept Biochem & Toxicol, Lublin, Poland; [Juskiewici, Jerzy] Polish Acad Sci, Div Food Sci, Inst Anim Reprod & Food Res, Olsztyn, Poland	University of Warmia & Mazury; University of Lodz; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences	Majewski, M (corresponding author), Univ Warmia & Mazury, Fac Med, Dept Pharmacol & Toxicol, Olsztyn, Poland.	michal.majewski@uwm.edu.pl	Majewski, Michal/J-4858-2015; Ognik, Katarzyna/T-9316-2018; Lis, Bernadetta/I-4301-2017; JUSKIEWICZ, Jerzy/H-7193-2017	Majewski, Michal/0000-0001-6304-0673; Ognik, Katarzyna/0000-0003-4393-4092; Lis, Bernadetta/0000-0002-6589-3001; Olas, Beata/0000-0002-7048-2952; JUSKIEWICZ, Jerzy/0000-0003-0068-5970	Medical University of Olsztyn, Poland	Medical University of Olsztyn, Poland	The work was supported in part by the Medical University of Olsztyn, Poland, Statutory funding, grant No.61.610.001-110 (MM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adach W, 2019, FUTURE MED CHEM, V11, P60, DOI 10.4155/fmc-2018-0215; ANDO Y, 1973, BIOCHIM BIOPHYS ACTA, V311, P26, DOI 10.1016/0005-2736(73)90251-4; ANDO Y, 1973, BIOCHIM BIOPHYS ACTA, V311, P38, DOI 10.1016/0005-2736(73)90252-6; Bartosz B., 2008, WARSZAWA1, V7, P99; Blanco-Rivero J, 2007, CARDIOVASC RES, V75, P398, DOI 10.1016/j.cardiores.2007.03.006; Browner NC, 2004, AM J PHYSIOL-CELL PH, V287, pC88, DOI 10.1152/ajpcell.00039.2004; Cao Y, 2018, ADV EXP MED BIOL, V1048, P59, DOI 10.1007/978-3-319-72041-8_4; Cholewinska E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197083; Decaluwe K, 2012, EUR J PHARMACOL, V674, P370, DOI 10.1016/j.ejphar.2011.11.004; ESCALANTE B, 1989, J PHARMACOL EXP THER, V248, P229; Grosicka-Maciag E, 2011, POSTEP HIG MED DOSW, V65, P357, DOI 10.5604/17322693.948816; Ho E, 2013, REDOX BIOL, V1, P483, DOI 10.1016/j.redox.2013.07.006; Karolkiewicz J., 2011, GERONTOL POL, V19, P59; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Majewski M, 2016, J PHYSIOL PHARMACOL, V67, P3; Majewski M, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103595; Majewski M, 2019, PHARMACOL REP, V71, P862, DOI 10.1016/j.pharep.2019.03.011; Majewski M, 2019, J ELEMENTOL, V24, P911, DOI 10.5601/jelem.2019.24.1.1813; Majewski M, 2019, PHARMACOL REP, V71, P509, DOI 10.1016/j.pharep.2019.02.007; Majewski M, 2018, TOXICOL APPL PHARM, V359, P62, DOI 10.1016/j.taap.2018.09.016; Majewski M, 2018, TOXICOL APPL PHARM, V341, P16, DOI 10.1016/j.taap.2018.01.004; Majewski M, 2017, PHARMACOL REP, V69, P1282, DOI 10.1016/j.pharep.2017.06.001; Neumaier F, 2018, J NEUROCHEM, V147, P310, DOI 10.1111/jnc.14546; Nowak Pawel, 2010, Postepy Biochem, V56, P239; Ognik K, 2019, J ANIM PHYSIOL AN N, V103, P675, DOI 10.1111/jpn.13025; Oliveira APS, 2009, VASC PHARMACOL, V50, P153, DOI 10.1016/j.vph.2008.11.010; Sagredo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073474; Shah MR, 2013, INT J MOL SCI, V14, P4334, DOI 10.3390/ijms14024334; Sharma AK, 2018, PHARMACOL REP, V70, P789, DOI 10.1016/j.pharep.2018.02.023; Sharma AK, 2018, MICROVASC RES, V120, P59, DOI 10.1016/j.mvr.2018.06.003; Sharma AK, 2016, RSC ADV, V6, P36870, DOI 10.1039/c6ra03890e; Shi Y, 2007, BRIT J PHARMACOL, V152, P1033, DOI 10.1038/sj.bjp.0707439; Shimokawa H, 2010, PFLUG ARCH EUR J PHY, V459, P915, DOI 10.1007/s00424-010-0790-8; Tang HQ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072140; Tomaszewska E, 2017, J TRACE ELEM MED BIO, V42, P103, DOI 10.1016/j.jtemb.2017.05.002; Toth P, 2013, BRIT J PHARMACOL, V168, P1878, DOI 10.1111/bph.12079; WACHOWICZ B, 1984, CELL BIOCHEM FUNCT, V2, P167, DOI 10.1002/cbf.290020310; WANG T, 1992, J LIPID RES, V33, P525	39	9	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229282	10.1371/journal.pone.0229282	http://dx.doi.org/10.1371/journal.pone.0229282			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084205	Green Published, gold			2022-12-26	WOS:000535227900080
J	Chen, YX; Yu, HP; Zhu, DY; Liu, P; Yin, JH; Liu, DL; Zheng, MH; Gao, JJ; Zhang, CQ; Gao, YS				Chen, Yixuan; Yu, Hongping; Zhu, Daoyu; Liu, Pei; Yin, Junhui; Liu, Delin; Zheng, Minghao; Gao, Junjie; Zhang, Changqing; Gao, Youshui			miR-136-3p targets PTEN to regulate vascularization and bone formation and ameliorates alcohol-induced osteopenia	FASEB JOURNAL			English	Article						microRNA-136-3p; phosphatase and tensin homolog deleted on chromosome ten; type-H vessel	MESENCHYMAL STEM-CELLS; ENDOTHELIAL-CELLS; VESSEL FORMATION; CORTICAL BONE; ETHANOL; REGENERATION; ANGIOGENESIS; OSTEOGENESIS; ASSOCIATION; CONSUMPTION	Alcohol consumption is regarded as one of the leading risk factors for secondary osteopenia. Coupled angiogenesis and osteogenesis via distinct type-H vessels orchestrates subtle biological processes of bone homeostasis. The dysfunction of angiogenesis and osteogenesis contributes to decreased bone mass during the development of osteopenia. Herein, we identified microRNA-136-3p was remarkedly downregulated in the mouse model of alcohol-induced osteopenia. Following the alcohol administration, downregulated microRNA-136-3p significantly suppressed vascularization and osteogenic differentiation in human umbilical vein endothelial cells (HUVECs) and bone mesenchymal stem cells (BMSCs), respectively. Furthermore, microRNA-136-3p could target phosphatase and tensin homolog deleted on chromosome ten (PTEN) in both HUVECs and BMSCs, thus substantially modulating the capacity of vessel formation and osteogenic differentiation. In the mouse model, microRNA-136-3p Agomir ameliorated alcohol-induced osteopenia, with the concomitant restoration of bone mass and type-H vessel formation. For the first time, this study demonstrated the pivotal role of microRNA-136-3p/PTEN axis in regulations of vascularization and bone formation, which might become the potential therapeutic target of alcohol-induced bone loss.	[Chen, Yixuan; Yu, Hongping; Zhu, Daoyu; Liu, Pei; Yin, Junhui; Gao, Junjie; Zhang, Changqing; Gao, Youshui] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Orthoped Surg, 600 Yishan Rd, Shanghai 200233, Peoples R China; [Yin, Junhui; Zhang, Changqing] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Inst Microsurg Extrem, Shanghai, Peoples R China; [Liu, Delin; Zheng, Minghao; Gao, Junjie; Gao, Youshui] Univ Western Australia, Ctr Orthopaed Translat Res, Med Sch, Nedlands, WA, Australia; [Zheng, Minghao; Gao, Junjie; Gao, Youshui] Perron Inst Neurol & Translat Sci, Nedlands, WA, Australia	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Western Australia	Gao, JJ; Zhang, CQ; Gao, YS (corresponding author), Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Orthoped Surg, 600 Yishan Rd, Shanghai 200233, Peoples R China.	colingjj@163.com; zhangcq@sjtu.edu.cn; gaoyoushui@sjtu.edu.cn	GAO, YOUSHUI/U-8349-2019	zhang, changqing/0000-0002-7408-4126; Zheng, Minghao/0000-0003-1185-4768	National Natural Science Foundation of China [81672143, 81702137, 81802247, 81902237]; Shanghai Jiao Tong University, School of Medicine [DLY201616]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiao Tong University, School of Medicine	National Natural Science Foundation of China, Grant/Award Number: 81672143, 81702137, 81802247 and 81902237; Shanghai Jiao Tong University, School of Medicine, Grant/Award Number: DLY201616	Bae WJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061742; Balansky R, 2016, TOXICOLOGY, V373, P54, DOI 10.1016/j.tox.2016.11.008; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Beermann J, 2016, PHYSIOL REV, V96, P1297, DOI 10.1152/physrev.00041.2015; Berg KM, 2008, AM J MED, V121, P406, DOI 10.1016/j.amjmed.2007.12.012; Bratton A, 2018, J ORTHOP TRAUMA, V32, P288, DOI 10.1097/BOT.0000000000001160; Cancedda Ranieri, 2003, Novartis Found Symp, V249, P133; Capulli M, 2018, J BONE MINER RES, V33, P1141, DOI 10.1002/jbmr.3406; Chakkalakal DA, 2005, ALCOHOL CLIN EXP RES, V29, P2077, DOI 10.1097/01.alc.0000192039.21305.55; Chamorro-Jorganes A, 2016, CIRC RES, V118, P38, DOI 10.1161/CIRCRESAHA.115.307408; Chen JR, 2006, J PHARMACOL EXP THER, V319, P1182, DOI 10.1124/jpet.106.109454; Chen PJ, 2018, ONCOL LETT, V15, P5995, DOI 10.3892/ol.2018.8081; Chen YX, 2019, FEBS J, V286, P1101, DOI 10.1111/febs.14754; Chen YX, 2017, NANOSCALE, V9, P6765, DOI 10.1039/c7nr00601b; Chen YX, 2017, ONCOTARGET, V8, P31065, DOI 10.18632/oncotarget.16075; Chen YX, 2018, CHEM ENG J, V341, P112, DOI 10.1016/j.cej.2018.02.010; Choi JY, 2018, J BONE MINER RES, V33, P2059, DOI 10.1002/jbmr.3549; Cui Z, 2016, ANN RHEUM DIS, V75, P1714, DOI 10.1136/annrheumdis-2015-207923; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Di Rocco G, 2019, CELL MOL LIFE SCI, V76, P231, DOI 10.1007/s00018-018-2931-8; Elmadhun NY, 2015, J SURG RES, V193, P536, DOI 10.1016/j.jss.2014.05.048; Gaddini GW, 2016, ALCOHOL CLIN EXP RES, V40, P657, DOI 10.1111/acer.13000; Girault V, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.29; Greenhill Claire, 2014, Nat Rev Endocrinol, V10, P250, DOI 10.1038/nrendo.2014.28; Grol MW, 2018, CURR OPIN PHARMACOL, V40, P59, DOI 10.1016/j.coph.2018.03.005; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; He L, 2006, J BIOL CHEM, V281, P11126, DOI 10.1074/jbc.M510724200; Hopkins BD, 2014, TRENDS BIOCHEM SCI, V39, P183, DOI 10.1016/j.tibs.2014.02.006; Huang B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13885; Huang J, 2018, THERANOSTICS, V8, P2435, DOI 10.7150/thno.22144; Jiang Z, 2014, J CELL PHYSIOL, V229, P384, DOI 10.1002/jcp.24460; Johnson TL, 2014, ALCOHOL CLIN EXP RES, V38, P1365, DOI 10.1111/acer.12366; Kahler-Quesada AM, 2019, ALCOHOL CLIN EXP RES, V43, P2494, DOI 10.1111/acer.14202; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Krzeszinski JY, 2014, NATURE, V512, P431, DOI 10.1038/nature13375; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Langen UH, 2017, NAT CELL BIOL, V19, P189, DOI 10.1038/ncb3476; le Noble F, 2014, NATURE, V507, P313, DOI 10.1038/nature13210; Li CJ, 2015, J CLIN INVEST, V125, P1509, DOI 10.1172/JCI77716; Li Y, 2015, MOL THER, V23, P1349, DOI 10.1038/mt.2015.101; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Liao L, 2016, STEM CELLS, V34, P1054, DOI 10.1002/stem.2274; Liu Y, 2016, STEM CELLS, V34, P2157, DOI 10.1002/stem.2392; Maeda Y, 2017, J BONE MINER RES, V32, P461, DOI 10.1002/jbmr.3005; Maurel DB, 2012, JOINT BONE SPINE, V79, P492, DOI 10.1016/j.jbspin.2011.10.004; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Mikosch P, 2014, WIEN MED WOCHENSCHR, V164, P15, DOI 10.1007/s10354-013-0258-5; Nucera S, 2016, CANCER CELL, V29, P905, DOI 10.1016/j.ccell.2016.05.007; Qiu N, 2012, J CELL SCI, V125, P1945, DOI 10.1242/jcs.095893; Radek KA, 2008, AM J PHYSIOL-HEART C, V295, pH174, DOI 10.1152/ajpheart.00699.2007; Ramasamy SK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13601; Ramasamy SK, 2016, ANNU REV CELL DEV BI, V32, P649, DOI 10.1146/annurev-cellbio-111315-124936; Santori C, 2008, J ENDOCRINOL INVEST, V31, P321, DOI 10.1007/BF03346365; Serra H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8935; Shimizu Y, 2011, BONE, V48, P1075, DOI 10.1016/j.bone.2011.01.008; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stegen S, 2018, BONE, V115, P50, DOI 10.1016/j.bone.2017.08.022; Sun L, 2016, P NATL ACAD SCI USA, V113, P164, DOI 10.1073/pnas.1523762113; Wahl E. C., 2012, British Journal of Medicine and Medical Research, V2, P510; Wan L, 2018, EXP THER MED, V16, P3419, DOI 10.3892/etm.2018.6625; Wang G, 2018, J AGR FOOD CHEM, V66, P9522, DOI [10.1021/acs.jafc.8b02949, 10.1021/acs.jafc.8b05116]; Wang G, 2016, J APPL TOXICOL, V36, P692, DOI 10.1002/jat.3201; Wang L, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.36; Yang M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16003; Yu KK, 2014, ALCOHOL CLIN EXP RES, V38, P2597, DOI 10.1111/acer.12512; Zhang L, 2017, J BONE MINER RES, V32, P2466, DOI 10.1002/jbmr.3230; Zhang XJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10376; Zhang YY, 2016, ALCOHOL, V54, P27, DOI 10.1016/j.alcohol.2016.05.003	69	16	18	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5348	5362		10.1096/fj.201902463RR	http://dx.doi.org/10.1096/fj.201902463RR		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32072664				2022-12-26	WOS:000515254800001
J	Inguglia, L; Chiaramonte, M; Arizza, V; Turiak, L; Vekey, K; Drahos, L; Pitonzo, R; Avellone, G; Di Stefano, V				Inguglia, Luigi; Chiaramonte, Marco; Arizza, Vincenzo; Turiak, Lilla; Vekey, Karoly; Drahos, Laszlo; Pitonzo, Rosa; Avellone, Giuseppe; Di Stefano, Vita			Changes in the proteome of sea urchin Paracentrotus lividus coelomocytes in response to LPS injection into the body cavity	PLOS ONE			English	Article							IMMUNE-SYSTEM; N-WASP; CYTOTOXIC ACTIVITY; PROTEINS; IDENTIFICATION; GTPASES; FAMILY; GENES; KEGG; CYTOSKELETON	Background The immune system of echinoderm sea urchins is characterised by a high degree of complexity that is not completely understood. The Mediterranean sea urchin Paracentrotus lividus coelomocytes mediate immune responses through phagocytosis, encapsulation of non-self particles, and production of diffusible factors including antimicrobial molecules. Details of these processes, and molecular pathways driving these mechanisms, are still to be fully elucidated. Principal findings In the present study we treated the sea urchin P. lividus with the bacterial lipopolysaccharide (LPS) and collected coelomocytes at different time-points (1, 3, 6 and 24 hours). We have shown, using label-free quantitative mass spectrometry, how LPS is able to modulate the coelomocyte proteome and to effect cellular pathways, such as endocytosis and phagocytosis, as soon as the immunomodulating agent is injected. The present study has also shown that treatment can modulate various cellular processes such as cytoskeleton reorganisation, and stress and energetic homeostasis. Conclusions Our data demonstrates, through mass spectrometry and the following functional annotation bioinformatics analysis, how the bacterial wall constituent is sufficient to set off an immune response inducing cytoskeleton reorganisation, the appearance of clusters of heat shock proteins (Hsp) and histone proteins and the activation of the endocytic and phagocytic pathways. Data are available via ProteomeXchange with identifier PXD008439.	[Inguglia, Luigi; Chiaramonte, Marco; Arizza, Vincenzo; Pitonzo, Rosa; Avellone, Giuseppe; Di Stefano, Vita] Univ Study Palermo, Dept STEBICEF, Palermo, Italy; [Turiak, Lilla; Vekey, Karoly; Drahos, Laszlo] Hungarian Acad Sci, Res Ctr Nat Sci, MS Prote Res Grp, Budapest, Hungary	University of Palermo; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Chiaramonte, M (corresponding author), Univ Study Palermo, Dept STEBICEF, Palermo, Italy.	marco.chiaramonte01@unipa.it	, Di Stefano Vita/AFQ-1480-2022; Avellone, Giuseppe/Q-2826-2016; Drahos, László/ADF-1942-2022; Chiaramonte, Marco/AAB-4840-2019; Arizza, Vincenzo/I-3477-2012; Inguglia, Luigi/F-9653-2016	, Di Stefano Vita/0000-0002-4483-2058; Avellone, Giuseppe/0000-0002-4539-6059; Chiaramonte, Marco/0000-0002-4437-5256; Arizza, Vincenzo/0000-0002-8772-7143; Inguglia, Luigi/0000-0001-6853-0874	National Research Development and Innovation Office [OTKA PD 121187]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences	National Research Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the National Research Development and Innovation Office (OTKA PD 121187) and the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ambade A, 2012, HEPATOLOGY, V55, P1585, DOI 10.1002/hep.24802; Arizza V, 2007, COMP BIOCHEM PHYS A, V147, P389, DOI 10.1016/j.cbpa.2007.01.022; Arizza V, 2013, COMP BIOCHEM PHYS A, V164, P447, DOI 10.1016/j.cbpa.2012.11.021; Bayram HL, 2016, J PROTEOMICS, V135, P38, DOI 10.1016/j.jprot.2015.12.027; Beauchamp S, 1950, J IMMUNOLOGY; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Buckley KM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00136; Chiaramonte M, 2015, ITAL J ZOOL, V82, P300, DOI 10.1080/11250003.2015.1061615; Chiaramonte M, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2019.118558; Chiaramonte M, 2019, FISH SHELLFISH IMMUN, V92, P384, DOI 10.1016/j.fsi.2019.06.017; Chiaramonte M, 2019, INT J IMMUNOGENET, V46, P192, DOI 10.1111/iji.12424; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Coyne VE, 2011, ISJ-INVERT SURVIV J, V8, P48; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Dheilly NM, 2013, DEV COMP IMMUNOL, V40, P35, DOI 10.1016/j.dci.2013.01.007; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Ghosh J, 2010, DEV COMP IMMUNOL, V34, P235, DOI 10.1016/j.dci.2009.10.008; Hatanaka R, 2009, ISJ-INVERT SURVIV J, V6, P32; Hirano M, 2016, IMMUNOL CELL BIOL, V94, P809, DOI 10.1038/icb.2016.67; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Ho HYH, 2001, P NATL ACAD SCI USA, V98, P11306, DOI 10.1073/pnas.211420498; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Kakiuchi S., 1985, CALCIUM CELL PHYSL, P227, DOI 10.1007/978-3-642-70070-5_11; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Liska AJ, 2003, PROTEOMICS, V3, P19, DOI 10.1002/pmic.200390004; Martinez-Quiles N, 2001, NAT CELL BIOL, V3, P484, DOI 10.1038/35074551; Mathesius U, 2002, PROTEOMICS, V2, P1288, DOI 10.1002/1615-9861(200209)2:9<1288::AID-PROT1288>3.0.CO;2-H; Matranga V, 2005, PROG MOLEC, V39, P85; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Mostowy S, 2015, NAT REV IMMUNOL, V15, P559, DOI 10.1038/nri3877; Mun H, 2012, MOL CELLS, V34, P71, DOI 10.1007/s10059-012-0097-z; Nikapitiya C, 2013, ISJ-INVERT SURVIV J, V10, P94; Pinsino A, 2015, DEV COMP IMMUNOL, V49, P198, DOI 10.1016/j.dci.2014.11.013; Romero A, 2016, DEV COMP IMMUNOL, V62, P29, DOI 10.1016/j.dci.2016.04.018; Russo R, 2015, DEV COMP IMMUNOL, V51, P271, DOI 10.1016/j.dci.2015.04.007; Satake H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00034; Schillaci D, 2010, J APPL MICROBIOL, V108, P17, DOI 10.1111/j.1365-2672.2009.04394.x; Schillaci D, 2012, ANN NY ACAD SCI, V1270, P79, DOI 10.1111/j.1749-6632.2012.06652.x; Smith LC, 2006, ISJ-INVERT SURVIV J, V3, P25; Smith LC, 2010, ADV EXP MED BIOL, V708, P260; Smith LC, 1996, J IMMUNOL, V156, P593; Spinello A, 2018, MAR DRUGS, V16, DOI 10.3390/md16100366; Stabili L, 2015, CHEMOSPHERE, V134, P60, DOI 10.1016/j.chemosphere.2015.04.006; Swovick K, 2018, MOL CELL PROTEOMICS, V17, P580, DOI 10.1074/mcp.RA117.000574; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Terwilliger DP, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-16; Triantafilou M, 2004, BIOCHEM SOC T, V32, P636, DOI 10.1042/BST0320636; Vazzana M, 2020, COMP BIOCHEM PHYS A, V242, DOI 10.1016/j.cbpa.2020.110650; Vazzana M, 2018, FISH SHELLFISH IMMUN, V72, P334, DOI 10.1016/j.fsi.2017.11.021; Vazzana M, 2015, FISH SHELLFISH IMMUN, V42, P306, DOI 10.1016/j.fsi.2014.11.010; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Vo TV, 2016, CELL, V164, P310, DOI 10.1016/j.cell.2015.11.037; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wada J, 2017, DIABETOL INT, V8, P244, DOI 10.1007/s13340-017-0321-3; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wang XX, 2017, SCI REP-UK, V7, DOI 10.1038/srep43020; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Wright JC, 2010, METHODS MOL BIOL, V604, P123, DOI 10.1007/978-1-60761-444-9_9; Zhen Y, 2015, J CELL SCI, V128, P3171, DOI 10.1242/jcs.166074	66	4	5	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228893	10.1371/journal.pone.0228893	http://dx.doi.org/10.1371/journal.pone.0228893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074628	Green Published, Green Accepted, gold			2022-12-26	WOS:000535220600029
J	Arnold, EA; Fuller, SM; Martinez, O; Lechuga, J; Steward, WT				Arnold, Emily A.; Fuller, Shannon M.; Martinez, Omar; Lechuga, Julia; Steward, Wayne T.			Documenting best practices for maintaining access to HIV prevention, care and treatment in an era of shifting immigration policy and discourse	PLOS ONE			English	Article							UNDOCUMENTED IMMIGRANTS; PATIENT-CARE	Changes in the United States federal-level political landscape have been felt within immigrant communities, and the public health clinics that serve them. We sought to document how HIV prevention and care clinics are reaching and retaining their immigrant community patients during a period of retrenchment of accessible public resources and immigrant rights. From May 2018 through January 2019, we conducted 20 in-depth interviews with clinicians, case workers, advocates, legal experts, and peer navigators in Northern and Central California. Interviews were recorded and transcribed. Several themes emerged which can be grouped into three primary areas: changes post-election, challenges meeting the needs of patients, and best practices for maintaining access to prevention and care services. Post-election, providers reported some of their patients skipping clinic appointments due to fear of Immigration and Customs Enforcement (ICE) raids and deportation while other patients had moved to locations that they felt were less policed. Challenges emerged around linguistic competency, meeting basic needs such as housing stability and employment, and treating mental health sequelae resulting from trauma experienced in home countries or during migration itself. Best practices included hiring bi-lingual and bi-cultural staff, linking to legal services to assist with immigration status, holding trainings around immigrant rights and responses to ICE raids, and building trust with immigrant patients by assuring them that their status would not be collected or reported. In light of adverse policy changes affecting immigrants, agencies have begun to institute best practices to mitigate the negative impact of those policies on their clients and patients.	[Arnold, Emily A.; Fuller, Shannon M.; Steward, Wayne T.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Martinez, Omar] Temple Univ, Dept Social Work, Philadelphia, PA 19122 USA; [Lechuga, Julia] Univ Texas El Paso, Dept Publ Hlth Sci, El Paso, TX 79968 USA	University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Texas System; University of Texas El Paso	Arnold, EA (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	Emily.Arnold@ucsf.edu			California HIV/AIDS Research Program, Office of the President, University of California [RP15-SF-096]; National Institute of Drug Use [R25 DA028567]	California HIV/AIDS Research Program, Office of the President, University of California; National Institute of Drug Use	This research was supported by a grant from the California HIV/AIDS Research Program (http://www.californiaaidsresearch.org), Office of the President, University of California, Grant Number RP15-SF-096 (WS, EA, SF), and by a training grant from the National Institute of Drug Use (http://www.drugabuse.gov) R25 DA028567 (OM, JL, EA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Civil Liberty Union, FAM SEP NUMB; Artiga S, 2018, FAMILY CONSEQUENCES; Artiga S., 2017, LIVING IMMIGRANT FAM; Bovell-Ammon A, 2018, AM PUBL HLTH ASS ANN; California Department of Health State Office of AIDS, 2019, HIV CAR CONT 2017; Castaneda H, 2015, ANNU REV PUBL HEALTH, V36, P375, DOI 10.1146/annurev-publhealth-032013-182419; Centers for Disease Control and Prevention, 2017, HIV SURVEILLANCE REP; Dang BN, 2016, AIDS BEHAV, V20, P2477, DOI 10.1007/s10461-016-1340-y; Department of Homeland Security. Office of the Inspector General, 2019, MAN AL DHS NEED ADDR; Eskenazi B, 2019, JAMA PEDIATR, V173, P744, DOI 10.1001/jamapediatrics.2019.1475; Fauci AS, 2019, JAMA-J AM MED ASSOC, V321, P844, DOI 10.1001/jama.2019.1343; Fuller SM, 2020, J IMMIGR MINOR HEALT, V22, P212, DOI 10.1007/s10903-019-00919-0; Galletly CL, 2019, J RACIAL ETHN HEALTH, V6, P668, DOI 10.1007/s40615-019-00565-0; Graff CCS, 2017, INT J QUAL STUD EDUC, V30, P999, DOI 10.1080/09518398.2017.1312592; Guest G, 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Hatzenbuehler ML, 2016, AM PSYCHOL, V71, P742, DOI 10.1037/amp0000068; Johnson H., 2018, JUST FACTS IMMIGRANT; La C, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101824; Levison JH, 2017, AIDS PATIENT CARE ST, V31, P394, DOI 10.1089/apc.2017.0084; Martinez O, 2017, J LAW MED ETHICS, V45, P260, DOI 10.1177/1073110517720654; Martinez O, 2015, J IMMIGR MINOR HEALT, V17, P947, DOI 10.1007/s10903-013-9968-4; Mathema VB, 2019, EVOL BIOINFORM, V15, DOI 10.1177/1176934319843130; Munoz SusanaM., 2018, ASS MEXICAN AM EDUCA, V12, P33, DOI [10.24974/amae.12.3.405, DOI 10.24974/AMAE.12.3.405, DOI 10.24974/AMAE.12.3.406]; Office of Refugee Resettlement, UN AL CHILDR; Pappas G, 2014, AM J PUBLIC HEALTH, V104, pE49, DOI 10.2105/AJPH.2014.302022; Passel J.S., 2014, UNAUTHORIZED IMMIGRA; Perreira KM, 2018, NEW ENGL J MED, V379, P901, DOI 10.1056/NEJMp1808020; Philbin MM, 2018, SOC SCI MED, V199, P29, DOI 10.1016/j.socscimed.2017.04.007; Ross J, 2017, AIDS CARE, V29, P1491, DOI 10.1080/09540121.2017.1307921; Steward WT, 2015, 2015 NAT HIV PREV C	30	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0229291	10.1371/journal.pone.0229291	http://dx.doi.org/10.1371/journal.pone.0229291			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7XT	32069309	Green Published, gold			2022-12-26	WOS:000535212900030
J	Lee, W; Lee, JG; Yoon, JH; Lee, JH				Lee, Wanhyung; Lee, Jae-Gwang; Yoon, Jin-Ha; Lee, June-Hee			Relationship between occupational dust exposure levels and mental health symptoms among Korean workers	PLOS ONE			English	Article							PULMONARY INFLAMMATION; AIRWAY INFLAMMATION; ROAD DUST; PATHOPHYSIOLOGY; MECHANISMS; METALS; FUMES; GAS	Dust and fumes are complex mixtures of airborne gases and fine particles present in all environments inhabited by people. This study investigated the relationship between occupational dust exposure levels and mental health problems such as depression or anxiety, fatigue, and insomnia or sleep disturbance. We analyzed data from the third and fourth Korean Working Conditions Survey (KWCS) conducted by the Korea Occupational Safety and Health Agency in 2011 and 2014. We performed chi-square tests to compare the different baseline and occupational characteristics and mental health status according to occupational dust exposure levels. The odds ratio (OR) and 95% confidence intervals (95% CIs) for mental health symptoms (fatigue, depression or anxiety, and insomnia or sleep disturbance) were calculated using adjusted multiple logistic regression models. A total of 78,512 participants (43,979 in men, 34,533 in women) were included in this study. Among them, 6,013 (7.7%) and 2,625 (3.3%) reported "moderate" and "severe" dust exposure, respectively. Among those who answered "yes" to depression or anxiety, fatigue, insomnia or sleep disturbance, 50 (4.6%), 961 (4.8%), and 123 (5.9%), respectively, demonstrated "severe" occupational dust exposure. Compared to "low" levels of dust exposure, "moderate" and "severe" exposure increased the risk of depression and anxiety (OR = 1.09, 95%CI: 0.88-1.36; OR = 1.16, 95%CI: 0.87-1.58, per exposure respectively); however, this was not statistically significant. For fatigue, significance was observed for "moderate" 1.54 (1.46-1.64) and "severe" 1.65 (1.52-1.80) exposure levels. "Severe" levels increased the risk of insomnia or sleep disturbance (OR = 1.52, 95%CI: 1.25-1.85). These results suggest that the "dust annoyance" concept of mental health, which may be explained by a neurocognitive mechanism, is plausible. Occupational "dust annoyance" has been linked to workers' mental health status, particularly in terms of fatigue and sleep disturbance; a dose-response relationship has been observed. Workers should be protected against dust to support their health and productivity.	[Lee, Wanhyung] Gachon Univ, Gil Med Ctr, Dept Occupat & Environm Med, Coll Med, Incheon, South Korea; [Lee, Jae-Gwang; Lee, June-Hee] Soonchunhyang Univ Hosp, Dept Occupat & Environm Med, Seoul, South Korea; [Yoon, Jin-Ha] Yonsei Univ, Dept Prevent Med, Coll Med, Seoul, South Korea	Gachon University; Soonchunhyang University; Soonchunhyang University Hospital; Yonsei University; Yonsei University Health System	Lee, JH (corresponding author), Soonchunhyang Univ Hosp, Dept Occupat & Environm Med, Seoul, South Korea.	junelee@schmc.ac.kr		Yoon, Jin-Ha/0000-0003-4198-2955	Soonchunhyang University Research Fund	Soonchunhyang University Research Fund	This work was supported by the Soonchunhyang University Research Fund.(JHL) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2016, J ALLERGY CLIN IMMUN, V138, P16, DOI 10.1016/j.jaci.2016.05.011; Berk M, 2011, NEUROSCI BIOBEHAV R, V35, P804, DOI 10.1016/j.neubiorev.2010.10.001; Costello S, 2018, AM J EPIDEMIOLOGY; Danese A, 2008, ARCH GEN PSYCHIAT, V65, P409, DOI 10.1001/archpsyc.65.4.409; Derbyshire E, 2007, AMBIO, V36, P73, DOI 10.1579/0044-7447(2007)36[73:NMDAHH]2.0.CO;2; Duong TTT, 2011, J ENVIRON MANAGE, V92, P554, DOI 10.1016/j.jenvman.2010.09.010; Fedak KM, 2015, EMERG THEMES EPIDEMI, V12, DOI 10.1186/s12982-015-0037-4; Guha N, 2017, LANCET ONCOL, V18, P581, DOI 10.1016/S1470-2045(17)30255-3; Hill AB, 1965, ENV DIS ASS CAUSATIO; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kang D, 2019, KOREAN J OPT PHOTONI, V30, P48, DOI 10.3807/KJOP.2019.30.2.048; Kuempel ED, 2003, J BIOSCIENCES, V28, P61, DOI 10.1007/BF02970133; Lee S, 2017, J OCCUP ENVIRON MED, V59, P191, DOI 10.1097/JOM.0000000000000935; Lee W, 2016, OCCUP ENVIRON MED, V73, P794, DOI 10.1136/oemed-2016-103552; Lin Q-H, 2014, J OCCUP HEALTH; Louati K, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0784-1; Maatta J, 2006, TOXICOL SCI, V93, P96, DOI 10.1093/toxsci/kfl026; MALMBERG P, 1990, AM J IND MED, V17, P7, DOI 10.1002/ajim.4700170104; Manno E, 2006, ATMOS ENVIRON, V40, P5929, DOI 10.1016/j.atmosenv.2006.05.020; Mehta AJ, 2012, AM J RESP CRIT CARE, V185, P1292, DOI 10.1164/rccm.201110-1917OC; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Mojtabai R, 2013, AM J PUBLIC HEALTH, V103, P1656, DOI 10.2105/AJPH.2012.300911; Motivala SJ, 2005, PSYCHOSOM MED, V67, P187, DOI 10.1097/01.psy.0000149259.72488.09; Mu L., 2012, EFFECT PARTICULATE M; Oberdorster G, 2001, INT ARCH OCC ENV HEA, V74, P1; Pace TWW, 2007, BRAIN BEHAV IMMUN, V21, P9, DOI 10.1016/j.bbi.2006.08.009; Park S, 2019, SAFETY HLTH WORK; Peters M, 2006, THORAX, V61, P134, DOI 10.1136/thx.2005.049403; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Salim S, 2012, ADV PROTEIN CHEM STR, V88, P1, DOI 10.1016/B978-0-12-398314-5.00001-5; Schyllert C, 2016, OCCUP ENVIRON MED, V73, P663, DOI 10.1136/oemed-2016-103595; Sjogren B, 1997, OCCUP ENVIRON MED, V54, P466, DOI 10.1136/oem.54.7.466; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Straif K, 2009, LANCET ONCOL, V10, P453, DOI 10.1016/S1470-2045(09)70134-2; Ulvestad B, 2001, EUR RESPIR J, V17, P416, DOI 10.1183/09031936.01.17304160; Wu WD, 2018, J ALLERGY CLIN IMMUN, V141, P833, DOI 10.1016/j.jaci.2017.12.981; Yaghmaie P, 2013, J ALLERGY CLIN IMMUN, V131, P428, DOI 10.1016/j.jaci.2012.10.041; Yoon JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105321	38	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0228853	10.1371/journal.pone.0228853	http://dx.doi.org/10.1371/journal.pone.0228853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7VI	32059015	Green Published, gold			2022-12-26	WOS:000535206600016
J	Luiken, S; Fraas, A; Bieg, M; Sugiyanto, R; Goeppert, B; Singer, S; Ploeger, C; Warsow, G; Marquardt, JU; Sticht, C; De La Torre, C; Pusch, S; Mehrabi, A; Gretz, N; Schlesner, M; Eils, R; Schirmacher, P; Longerich, T; Roessler, S				Luiken, Sarah; Fraas, Angelika; Bieg, Matthias; Sugiyanto, Raisatun; Goeppert, Benjamin; Singer, Stephan; Ploeger, Carolin; Warsow, Gregor; Marquardt, Jens U.; Sticht, Carsten; De La Torre, Carolina; Pusch, Stefan; Mehrabi, Arianeb; Gretz, Norbert; Schlesner, Matthias; Eils, Roland; Schirmacher, Peter; Longerich, Thomas; Roessler, Stephanie			NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesis	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; ORNITHINE-DECARBOXYLASE; MYC; SURVEILLANCE; HEPATOCYTES; MUTATIONS; PATHWAY; ROLES; FATE; SOX2	NOTCH receptor signaling plays a pivotal role in liver homeostasis and hepatocarcinogenesis. However, the role of NOTCH pathway mutations and the NOTCH target gene HES5 in liver tumorigenesis are poorly understood. Here we performed whole-exome sequencing of 54 human HCC specimens and compared the prevalence of NOTCH pathway component mutations with the TCGA-LIHC cohort (N = 364). In addition, we functionally characterized the NOTCH target HES5 and the patient-derived HES5-R31G mutation in vitro and in an orthotopic mouse model applying different oncogenic backgrounds, to dissect the role of HES5 in different tumor subgroups in vivo. We identified nonsynonymous mutations in 14 immediate NOTCH pathway genes affecting 24.1% and 16.8% of HCC patients in the two independent cohorts, respectively. Among these, the HES5-R31G mutation was predicted in silico to have high biological relevance. Functional analyses in cell culture showed that HES5 reduced cell migration and clonogenicity. Further analyses revealed that the patient-derived HES5-R31G mutant protein was non-functional due to loss of DNA binding and greatly reduced nuclear localization. Furthermore, HES5 exhibited a negative feedback loop by directly inhibiting the NOTCH target HES1 and downregulated the pro-proliferative MYC targets ODC1 and LDHA. Interestingly, HES5 inhibited MYC-dependent hepatocarcinogenesis, whereas it promoted AKT-dependent liver tumor formation and stem cell features in a murine model. Thus, NOTCH pathway component mutations are commonly observed in HCC. Furthermore, the NOTCH target gene HES5 has both pro- and anti-tumorigenic functions in liver cancer proposing a driver gene dependency and it promotes tumorigenesis with its interaction partner AKT.	[Luiken, Sarah; Fraas, Angelika; Sugiyanto, Raisatun; Goeppert, Benjamin; Singer, Stephan; Ploeger, Carolin; Schirmacher, Peter; Longerich, Thomas; Roessler, Stephanie] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany; [Bieg, Matthias; Eils, Roland] Berlin Inst Hlth, Ctr Digital Hlth, Berlin, Germany; [Bieg, Matthias; Eils, Roland] Charite Univ Med Berlin, Berlin, Germany; [Bieg, Matthias; Eils, Roland] Heidelberg Ctr Personalized Oncol DKFZ HIPO, Heidelberg, Germany; [Warsow, Gregor; Schlesner, Matthias] German Canc Res Ctr, Bioinformat & Omics Data Analyt, Heidelberg, Germany; [Marquardt, Jens U.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 1, Mainz, Germany; [Sticht, Carsten; De La Torre, Carolina; Gretz, Norbert] Heidelberg Univ, Med Res Ctr, Mannheim, Germany; [Pusch, Stefan] Univ Hosp Heidelberg, Dept Neuropathol, Heidelberg, Germany; [Pusch, Stefan] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, Heidelberg, Germany; [Mehrabi, Arianeb] Univ Hosp Heidelberg, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany; [Eils, Roland] Univ Hosp Heidelberg, Hlth Data Sci Unit, Heidelberg, Germany; [Eils, Roland] Heidelberg Univ, German Ctr Lung Res DZL, Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); Johannes Gutenberg University of Mainz; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Roessler, S (corresponding author), Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany.	Stephanie.Roessler@med.uni-heidelberg.de	Goeppert, Benjamin/AAC-2303-2022; Eils, Roland/B-6121-2009; Roessler, Stephanie/J-8432-2019	Eils, Roland/0000-0002-0034-4036; Roessler, Stephanie/0000-0002-5333-5942; Fritzsche, Sarah/0000-0003-4621-1391	German Research Foundation (DFG) CRC SFB/TR 209 Liver Cancer; European Union [667273]; HIPO project [H014]; Projekt DEAL	German Research Foundation (DFG) CRC SFB/TR 209 Liver Cancer(German Research Foundation (DFG)); European Union(European Commission); HIPO project; Projekt DEAL	We thank Darjus F. Tschaharganeh (University Hospital Heidelberg) for providing vectors used for hydrodynamic tail vein injection. Tissue samples were provided by the tissue bank of the National Center for Tumor Diseases (NCT; Heidelberg, Germany) in accordance with the regulations of the tissue bank and the approval of the Ethics Committee of Heidelberg University. We thank Veronika Geissler (NCT tissue bank, Heidelberg), the Center for Model System and Comparative Pathology (CMCP) of the Institute of Pathology Heidelberg and Leon Schwab for technical assistance. We thank the Nikon Imaging Center Heidelberg for help with image acquisition and Dr Carlo Beretta from MATH-Clinic (University Heidelberg) for help with Fiji Macro. This work was supported by German Research Foundation (DFG) CRC SFB/TR 209 Liver Cancer (B01 to SR, B04 to SS, B08 to TL and Z01 to PS) and the European Union's Horizon 2020 research and innovation program under grant agreement number 667273 (HEP-CAR) to PS and SR. We thank the Genomics and Proteomics Core Facility (GPCF) of DKFZ for Whole Genome Sequencing and the DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO) for technical support and funding through HIPO project H014. Open access funding provided by Projekt DEAL.	Abitbol S, 2018, J HEPATOL, V68, P1203, DOI 10.1016/j.jhep.2017.12.018; Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Aster JC, 2017, ANNU REV PATHOL-MECH, V12, P245, DOI 10.1146/annurev-pathol-052016-100127; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Braccioli L, 2018, STEM CELL RES, V33, P110, DOI 10.1016/j.scr.2018.10.005; Bray SJ, 2016, NAT REV MOL CELL BIO, V17, P722, DOI 10.1038/nrm.2016.94; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Chen X, 2014, AM J PATHOL, V184, P912, DOI 10.1016/j.ajpath.2013.12.002; Chen ZZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12598; Dill MT, 2013, HEPATOLOGY, V57, P1607, DOI 10.1002/hep.26165; Ding L, 2018, CELL, V173, P305, DOI 10.1016/j.cell.2018.03.033; Dugger SA, 2018, NAT REV DRUG DISCOV, V17, P183, DOI 10.1038/nrd.2017.226; Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003; Evert M, 2013, HEPATOLOGY, V58, P1857, DOI 10.1002/hep.26411; Fan B, 2012, J CLIN INVEST, V122, P2911, DOI 10.1172/JCI63212; Fu WY, 2019, CLIN CANCER RES, V25, P2835, DOI 10.1158/1078-0432.CCR-18-2732; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Geisler F, 2015, HEPATOLOGY, V61, P382, DOI 10.1002/hep.27268; Giachino C, 2015, CANCER CELL, V28, P730, DOI 10.1016/j.ccell.2015.10.008; Gramantieri L, 2007, LIVER INT, V27, P997, DOI 10.1111/j.1478-3231.2007.01544.x; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hoare M, 2016, NAT CELL BIOL, V18, P979, DOI 10.1038/ncb3397; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Imayoshi I, 2013, SCIENCE, V342, P1203, DOI 10.1126/science.1242366; Jiang WD, 2010, INT J CANCER, V127, P1011, DOI 10.1002/ijc.25118; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Kuang SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061807; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lachenmayer A, 2012, CLIN CANCER RES, V18, P4997, DOI 10.1158/1078-0432.CCR-11-2322; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Liu HY, 2015, NAT CELL BIOL, V17, P1036, DOI 10.1038/ncb3210; Liu LM, 2016, HEPATOLOGY, V64, P814, DOI 10.1002/hep.28690; Llovet JM, 2015, NAT REV CLIN ONCOL, V12, P408, DOI [10.1038/nrclinonc.2015.103, 10.1038/nrclinonc.2015.121]; Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29; Morell CM, 2014, J HEPATOL, V60, P885, DOI 10.1016/j.jhep.2013.11.028; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Ploeger C, 2016, HEPATOLOGY, V64, P828, DOI 10.1002/hep.28684; Roessler S, 2012, GASTROENTEROLOGY, V142, P957, DOI 10.1053/j.gastro.2011.12.039; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Sun LC, 2015, ANTI-CANCER AGENT ME, V15, P809, DOI 10.2174/1871520615666150202102809; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Tschaharganeh DF, 2014, CELL, V158, P579, DOI 10.1016/j.cell.2014.05.051; Tschaharganeh DF, 2013, GASTROENTEROLOGY, V144, P1530, DOI 10.1053/j.gastro.2013.02.009; Viatour P, 2011, J EXP MED, V208, P1963, DOI 10.1084/jem.20110198; Villanueva A, 2012, GASTROENTEROLOGY, V143, P1660, DOI 10.1053/j.gastro.2012.09.002; Zender S, 2013, CANCER CELL, V23, P784, DOI 10.1016/j.ccr.2013.04.019; Zhou L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057382, 10.1371/journal.pone.0073724]	52	15	15	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	15					3128	3144		10.1038/s41388-020-1198-3	http://dx.doi.org/10.1038/s41388-020-1198-3		FEB 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LB8NS	32055024	hybrid, Green Published			2022-12-26	WOS:000513314100002
J	Gu, LH; Wang, F; Lin, ZM; Xu, TS; Lin, DJ; Xing, MP; Yang, SX; Chao, Z; Ye, BG; Lin, P; Hui, CH; Lu, LZ; Hou, SS				Gu, Lihong; Wang, Feng; Lin, Zhemin; Xu, Tieshan; Lin, Dajie; Xing, Manping; Yang, Shaoxiong; Chao, Zhe; Ye, Baoguo; Lin, Peng; Hui, Chunhui; Lu, Lizhi; Hou, Shuisheng			Genetic characteristics of Jiaji Duck by whole genome re-sequencing	PLOS ONE			English	Article							SELECTION; REVEALS; ADAPTATION; SIGNATURES	Jiaji Duck (JJ) is a Muscovy duck species that possesses many superior characteristics, and it has become an important genetic resource in China. However, to date, its genetic characteristics and genetic relationship with other duck breeds have not been explored yet, which greatly limits the utilization of JJ. In the present study, we investigated the genome sequences of 15 individual ducks representing five different duck populations, including JJ, French Muscovy duck (FF), mallard (YD), hong duck (HD) and Beijing duck (BD). Moreover, we investigated the characteristics of JJ-specific single nucleotide polymorphisms (SNPs) and compared the genome sequences of JJ vs. YD and JJ vs. BD using integrated strategies, including mutation detection, selective screening, and Gene Ontology (GO) analysis. More than 40 Gb of clean data were obtained for each population (mean coverage of 13.46 Gb per individual). A total number of 22,481,367 SNPs and 4,156,829 small insertion-deletions (Indels) were identified for the five duck populations, which could be used as molecular markers in breeding and utilization of JJ. Moreover, we identified 1,447,932 JJ-specific SNPs, and found that genes covering at least one JJ-specific SNP mainly involved in protein phosphorylation and dephosphorylation, as well as DNA modification. Phylogenetic tree and principal components analysis (PCA) revealed that the genetic relationship of JJ was closest to FF, while it was farthest to BD. A total of 120 and 111 genes were identified as positive selection genes for JJ vs. BD and JJ vs. YD, respectively. GO and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses showed that the positive selection genes for JJ vs. BD ducks mainly involved in pigmentation, muscle contraction and stretch, gland secretion, and immunology, while the positive selection genes obtained from JJ vs. YD ducks mainly involved in embryo development, muscle contraction and stretch, and gland secretion. Taken together, our findings enabled us to better understand the characteristics of JJ and provided a molecular basis for the breeding and hybrid utilization of JJ in the future.	[Gu, Lihong; Wang, Feng; Lin, Zhemin; Lin, Dajie; Xing, Manping; Yang, Shaoxiong; Chao, Zhe; Ye, Baoguo; Hui, Chunhui] Hainan Acad Agr Sci, Inst Anim Sci & Vet, Haikou, Hainan, Peoples R China; [Xu, Tieshan] Chinese Acad Trop Agr Sci, Trop Crops Genet Resources Inst, Haikou, Hainan, Peoples R China; [Lin, Peng] Hainan Chuanwei Muscovy Duck Breeding Co Ltd, Wenchang, Peoples R China; [Lu, Lizhi] Zhejiang Acad Agr Sci, Inst Anim Sci & Vet, Hangzhou, Peoples R China; [Hou, Shuisheng] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Zhejiang Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Xu, TS (corresponding author), Chinese Acad Trop Agr Sci, Trop Crops Genet Resources Inst, Haikou, Hainan, Peoples R China.	xutieshan760412@163.com						Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Barik A, 2014, DEV NEUROBIOL, V74, P828, DOI 10.1002/dneu.22190; Cardet JC, 2013, CURR ALLERGY ASTHM R, V13, P10, DOI 10.1007/s11882-012-0326-8; Carneiro M, 2014, SCIENCE, V345, P1074, DOI 10.1126/science.1253714; Chen K.W., 2010, ANIMAL GENETIC RESOU; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; De Summa S, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1537-8; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Hunger S, 2003, GENOME, V46, P70, DOI 10.1139/G02-106; Junier T, 2010, BIOINFORMATICS, V26, P1669, DOI 10.1093/bioinformatics/btq243; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080813; Komi DEA, 2018, CLIN REV ALLERG IMMU, V54, P432, DOI 10.1007/s12016-017-8646-z; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li HF, 2010, MOL PHYLOGENET EVOL, V57, P634, DOI 10.1016/j.ympev.2010.07.011; Loehr J, 2007, J EVOLUTION BIOL, V20, P818, DOI 10.1111/j.1420-9101.2006.01272.x; Meyer RS, 2016, NAT GENET, V48, P1083, DOI 10.1038/ng.3633; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qiu Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10283; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Schiavo G, 2016, ANIM GENET, V47, P181, DOI 10.1111/age.12392; Schneider K, 2001, MOL BREEDING, V8, P63, DOI 10.1023/A:1011902916194; Tsivitse S, 2010, INT J BIOL SCI, V6, P268; Van der Auwera GA, 2013, CURR PROTOC BIOINFOR, V43, P111; Xu TS, 2015, GENET MOL RES, V14, P4448, DOI 10.4238/2015.May.4.2; Xu TS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211908; Zhang Z, 2018, ANIM GENET, V49, P132, DOI 10.1111/age.12639; Zhou ZK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04868-4	34	5	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228964	10.1371/journal.pone.0228964	http://dx.doi.org/10.1371/journal.pone.0228964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32049997	Green Published, gold			2022-12-26	WOS:000535192300037
J	Jodeleit, H; Milchram, L; Soldo, R; Beikircher, G; Schonthaler, S; Al-amodi, O; Wolf, E; Beigel, F; Weinhausel, A; Siebeck, M; Gropp, R				Jodeleit, Henrika; Milchram, Lisa; Soldo, Regina; Beikircher, Gabriel; Schoenthaler, Silvia; Al-amodi, Omar; Wolf, Eckhard; Beigel, Florian; Weinhaeusel, Andreas; Siebeck, Matthias; Gropp, Roswitha			Autoantibodies as diagnostic markers and potential drivers of inflammation in ulcerative colitis	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; BETA-CELL FUNCTION; MONONUCLEAR-CELLS; DENDRITIC CELLS; IMMUNOMODULATION; DIFFERENTIATION; SUSCEPTIBILITY; MONOCYTES; DIAPEP277; MULTIPLE	To date, no comprehensive analysis of autoantibodies in sera of patients with ulcerative colitis has been conducted. To analyze the spectrum of autoantibodies and to elucidate their role serum-IgG from UC patients (n = 49) and non-UC donors (n = 23) were screened by using a human protein microarray. Screening yielded a remarkable number of 697 differentially-reactive at the nominal 0.01 significance level (FDR<0.1) of the univariate test between the UC and the non-UC group. CD99 emerged as a biomarker to discriminate between both groups (p = 1e-04, AUC = 0.8). In addition, cytokines, chemokines and growth factors were analyzed by Olink's Proseek (R) Multiplex Inflammation-I 96x96 immuno-qPCR assay and 31 genes were significant at the nominal 0.05 level of the univariate test to discriminate between UC and non-UC donors. MCP-3, HGF and CXCL-9 were identified as the most significant markers to discriminate between UC patients with clinically active and inactive disease. Levels of CXCL10 (cor = 0.3; p = 0.02), CCL25 (cor = 0.25; p = 0.04) and CCL28 (cor = 0.3; p = 0.02) correlated positively with levels of anti CD99. To assess whether autoantibodies are detectable prior to diagnosis with UC, sera from nine donors at two different time points (T-early, median 21 months and T-late, median 6 months) were analyzed. 1201 features were identified with higher reactivity in samples at time points closer to clinical UC presentation. In vitro, additional challenge of peripheral mononuclear cells with CD99 did not activate CD4+ T cells but induced the secretion of IL-10 (-CD99: 20.21 +/- 20.25; +CD99: 130.20 +/- 89.55; mean +/- sd; p = 0.015). To examine the effect of CD99 in vivo, inflammation and autoantibody levels were examined in NOD/ScidIL2R gamma(null) mice reconstituted with PBMC from UC donors (NSG-UC). Additional challenge with CD99 aggravated disease symptoms and pathological phenotype as indicated by the elevated clinical score (-CD99: 1.85 +/- 1.94; +CD99: 4.25 +/- 1.48) and histological score (-CD99: 2.16 +/- 0.83; +CD99: 3.15 +/- 1.16, p = 0.01). Furthermore, levels of anti-CD99 antibodies increased (Control: 398 +/- 323; mean MFI +/- sd; Ethanol + PBS: 358 +/- 316; Ethanol + CD99: 1363 +/- 1336; Control versus	[Jodeleit, Henrika; Al-amodi, Omar; Siebeck, Matthias; Gropp, Roswitha] Hosp Ludwig Maximilian Univ Munich, Dept Gen Visceral & Transplantat Surg, Munich, Germany; [Milchram, Lisa; Soldo, Regina; Beikircher, Gabriel; Schoenthaler, Silvia; Weinhaeusel, Andreas] Austrian Inst Technol GmbH AIT, Giefinggasse, Vienna, Austria; [Wolf, Eckhard] Ludwig Maximilians Univ Munchen, Gene Ctr, Inst Mol Anim Breeding & Biotechnol, Lab Funct Genome Anal LAFUGA, Munich, Germany; [Beigel, Florian] Hosp Ludwig Maximilian Univ Munich, Dept Med 2, Munich, Germany	University of Munich; Austrian Institute of Technology (AIT); University of Munich; University of Munich	Gropp, R (corresponding author), Hosp Ludwig Maximilian Univ Munich, Dept Gen Visceral & Transplantat Surg, Munich, Germany.	roswitha.gropp@med.uni-muenchen.de	Wolf, Eckhard/AAT-7500-2021; Weinhaeusel, Andreas/A-7644-2018	Wolf, Eckhard/0000-0002-0430-9510; Gropp, Roswitha/0000-0003-4756-261X	Bundesministerium fur Bildung und Forschung [03V0556, 03V0558]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was funded by the Bundesministerium fur Bildung und Forschung [grant numbers 03V0556 to EW and 03V0558 to MS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Austrian Institute of Technology (AIT) provided support in the form of salaries for authors [L.M., R.S., G.B., A.W.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Berger S, 1996, EUR J IMMUNOL, V26, P1297, DOI 10.1002/eji.1830260618; Brezina Stefanie, 2015, Microarrays (Basel), V4, P162, DOI 10.3390/microarrays4020162; de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2016.186, 10.1038/nrgastro.2015.186]; Doecke JD, 2013, INFLAMM BOWEL DIS, V19, P240, DOI 10.1097/MIB.0b013e3182810041; Dong ZG, 2013, INT J MOL MED, V31, P989, DOI 10.3892/ijmm.2013.1287; Fischer B, 2010, EXPERT OPIN BIOL TH, V10, P265, DOI 10.1517/14712590903555176; Fohlinger M, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1048-9; Francis OL, 2016, HAEMATOLOGICA, V101, P417, DOI 10.3324/haematol.2015.125336; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Han HW, 2013, J IMMUNOL, V190, P904, DOI 10.4049/jimmunol.1201808; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jodeleit H, 2019, INFLAMM BOWEL DIS; Jodeleit H, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.036210; Jodeleit H, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1368-4; Jovanovic K, 2014, CLIN EXP IMMUNOL, V178, P201, DOI 10.1111/cei.12409; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kovacs M, 2014, WORLD J GASTROENTERO, V20, P4873, DOI 10.3748/wjg.v20.i17.4873; Kovacs M, 2012, J PEDIATR GASTR NUTR, V55, P429, DOI 10.1097/MPG.0b013e318256b516; Leidinger P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128235; Luna-Coronell JA, 2016, PROTEOMICS, V16, P1204, DOI 10.1002/pmic.201500378; Mahler M, 2013, CLIN CHIM ACTA, V424, P267, DOI 10.1016/j.cca.2013.06.005; MARSH CB, 1995, J IMMUNOL, V155, P3161; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Moran CJ, 2013, INFLAMM BOWEL DIS, V19, P115, DOI 10.1002/ibd.22974; Nagata Y, 2007, INT ARCH ALLERGY IMM, V144, P305, DOI 10.1159/000106319; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Oh MH, 2011, J IMMUNOL, V186, P7232, DOI 10.4049/jimmunol.1100504; Omar Alamodi HJ, 2017, INFLAMM BOWEL DIS; Onuma EK, 2000, CLIN EXP IMMUNOL, V121, P466, DOI 10.1046/j.1365-2249.2000.01330.x; Palamides P, 2016, DIS MODEL MECH, V9, P985, DOI 10.1242/dmm.025452; Pfeifle R, 2017, NAT IMMUNOL, V18, P104, DOI 10.1038/ni.3579; Holgado MP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02814; Prideaux L, 2012, INFLAMM BOWEL DIS, V18, P1340, DOI 10.1002/ibd.21903; Raz I, 2001, LANCET, V358, P1749, DOI 10.1016/S0140-6736(01)06801-5; Rosskopf S, 2015, J IMMUNOL METHODS, V418, P39, DOI 10.1016/j.jim.2015.01.009; Tanaka M, 2009, J IMMUNOL, V183, P2349, DOI 10.4049/jimmunol.0801683; van Herwijnen MJC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128373; Walmsley RS, 1998, GUT, V43, P29, DOI 10.1136/gut.43.1.29; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Zaunders JJ, 2009, J IMMUNOL, V183, P2827, DOI 10.4049/jimmunol.0803548	40	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228615	10.1371/journal.pone.0228615	http://dx.doi.org/10.1371/journal.pone.0228615			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32050001	gold, Green Published			2022-12-26	WOS:000535192300019
J	Han, JJ; Wang, XF; Tang, SS; Lu, CY; Wan, HT; Zhou, J; Li, Y; Ming, TH; Wang, ZJ; Su, XR				Han, Jiaojiao; Wang, Xiaofeng; Tang, Shasha; Lu, Chenyang; Wan, Haitao; Zhou, Jun; Li, Ye; Ming, Tinghong; Wang, Zaijie Jim; Su, Xiurong			Protective effects of tuna meat oligopeptides (TMOP) supplementation on hyperuricemia and associated renal inflammation mediated by gut microbiota	FASEB JOURNAL			English	Article						fecal microbiota transplantation; gut microbiota; hyperuricemia; renal inflammation; signaling pathways; Tuna meat oligopeptides	CHAIN FATTY-ACIDS; IDENTIFICATION; ALLOPURINOL; MODULATION; EXPRESSION; GOUT	Recently, interest in using whole food-derived mixtures to alleviate chronic metabolic syndrome through potential synergistic interactions among different components is increasing. In this study, the effects and mechanisms of tuna meat oligopeptides (TMOP) on hyperuricemia and associated renal inflammation were investigated in mice. Dietary administration of TMOP alleviated hyperuricemia and renal inflammation phenotypes, reprogramed uric acid metabolism pathways, inhibited the activation of NLRP3 inflammasome and TLR4/MyD88/NF-kappa B signaling pathways, and suppressed the phosphorylation of p65-NF-kappa B. In addition, TMOP treatments repaired the intestinal epithelial barrier, reversed the gut microbiota dysbiosis and increased the production of short-chain fatty acids. Moreover, the antihyperuricemia effects of TMOP were transmissible by transplanting the fecal microbiota from TMOP-treated mice, indicating that the protective effects were at least partially mediated by the gut microbiota. Thus, for the first time, we clarify the potential effects of TMOP as a whole food derived ingredient on alleviating hyperuricemia and renal inflammation in mice, and additional efforts are needed to confirm the beneficial effects of TMOP on humans.	[Han, Jiaojiao; Wang, Xiaofeng; Tang, Shasha; Lu, Chenyang; Wan, Haitao; Zhou, Jun; Li, Ye; Ming, Tinghong; Su, Xiurong] Ningbo Univ, State Key Lab Managing Biot & Chem Threats Qual, 169 Qixing South Rd, Ningbo, Peoples R China; [Han, Jiaojiao; Wang, Xiaofeng; Tang, Shasha; Lu, Chenyang; Wan, Haitao; Zhou, Jun; Li, Ye; Ming, Tinghong; Su, Xiurong] Ningbo Univ, Sch Marine Sci, Ningbo, Peoples R China; [Wang, Zaijie Jim] Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL USA	Ningbo University; Ningbo University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Su, XR (corresponding author), Ningbo Univ, State Key Lab Managing Biot & Chem Threats Qual, 169 Qixing South Rd, Ningbo, Peoples R China.	suxiurong_public@163.com			Natural Science Foundation of Zhejiang Province [LY19C010003, LY18C010001]; National Key R&D Program of China [2018YFD0901102]; Open Fund of State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products; Public Welfare Project of Ningbo city [2019C10064]; Ningbo University	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Key R&D Program of China; Open Fund of State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products; Public Welfare Project of Ningbo city; Ningbo University	Natural Science Foundation of Zhejiang Province, Grant/Award Number: LY19C010003 and LY18C010001; National Key R&D Program of China, Grant/Award Number: 2018YFD0901102; Open Fund of State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products; Public Welfare Project of Ningbo city, Grant/Award Number: 2019C10064; Ningbo University	Ansari-Ramandi MM, 2017, J CARDIOVASC THORAC, V9, P102, DOI 10.15171/jcvtr.2017.17; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Chen LY, 2013, FOOD CHEM TOXICOL, V52, P28, DOI 10.1016/j.fct.2012.10.037; Dong LS, 2018, J AGR FOOD CHEM, V66, P154, DOI 10.1021/acs.jafc.7b04743; Duan YH, 2019, FASEB J, V33, P10019, DOI 10.1096/fj.201900665RR; Dubchak N, 2010, INT J NEPHROL RENOV, V3, P145, DOI 10.2147/IJNRD.S6048; Guo Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep20602; Han JJ, 2018, RSC ADV, V8, P14109, DOI 10.1039/c8ra00889b; Han X, 2018, J CHROMATOGR B, V1099, P73, DOI 10.1016/j.jchromb.2018.09.013; He WW, 2019, FOOD CHEM, V272, P453, DOI 10.1016/j.foodchem.2018.08.057; Hou CL, 2019, FREE RADICAL BIO MED, V136, P135, DOI 10.1016/j.freeradbiomed.2019.04.007; Hu QH, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801265; Huang FJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12896-x; Jhang JJ, 2018, J AGR FOOD CHEM, V66, P765, DOI 10.1021/acs.jafc.7b05113; Ji JJ, 2019, FASEB J, V33, P9308, DOI 10.1096/fj.201802659RR; Kim SC, 2018, J AM COLL CARDIOL, V71, P994, DOI 10.1016/j.jacc.2017.12.052; Koguchi T, 2019, INT J VITAM NUTR RES, V89, P89, DOI 10.1024/0300-9831/a000548; Li LZ, 2017, DRUG DES DEV THER, V11, P3531, DOI 10.2147/DDDT.S150825; Li QY, 2018, FOOD FUNCT, V9, P107, DOI 10.1039/c7fo01174a; Li YJ, 2018, PEPTIDES, V107, P45, DOI 10.1016/j.peptides.2018.08.001; Liu N, 2018, J AGR FOOD CHEM, V67, P220; Liu Y, 2019, INT J FOOD SCI TECH, V54, P263, DOI 10.1111/ijfs.13970; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00905; Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082; Murota I, 2014, J AGR FOOD CHEM, V62, P2392, DOI 10.1021/jf405504u; Nakagawa T, 2005, NAT CLIN PRACT NEPHR, V1, P80, DOI 10.1038/ncpneph0019; Nieuwdorp M, 2014, GASTROENTEROLOGY, V146, P1525, DOI 10.1053/j.gastro.2014.02.008; Peng YJ, 2019, FREE RADICAL BIO MED, V136, P96, DOI 10.1016/j.freeradbiomed.2019.04.005; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Shao TJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00268; Song PG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22570-9; Su GW, 2018, FOOD RES INT, V105, P556, DOI 10.1016/j.foodres.2017.11.037; Tan JY, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801402; Vieira AT, 2015, ARTHRITIS RHEUMATOL, V67, P1646, DOI 10.1002/art.39107; Wang HN, 2019, NUTRITION, V62, P63, DOI 10.1016/j.nut.2018.11.018; Wang MX, 2015, EUR J PHARMACOL, V747, P59, DOI 10.1016/j.ejphar.2014.11.035; Xu J, 2015, ISME J, V9, P552, DOI 10.1038/ismej.2014.177; Yoshihara E, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00514; Yu YR, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02233; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774	41	29	31	17	88	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5061	5076		10.1096/fj.201902597RR	http://dx.doi.org/10.1096/fj.201902597RR		FEB 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32043638				2022-12-26	WOS:000512670000001
J	Samano, R; Martinez-Rojano, H; Chico-Barba, G; Hernandez-Trejo, M; Guzman, R; Arteaga-Troncoso, G; Figueroa-Perez, MA; Morales, RM; Martinez, G				Samano, Reyna; Martinez-Rojano, Hugo; Chico-Barba, Gabriela; Hernandez-Trejo, Maria; Guzman, Raymundo; Arteaga-Troncoso, Gabriel; Alejandra Figueroa-Perez, Mariana; Maria Morales, Rosa; Martinez, Gabriela			Associations between prenatal serum levels of leptin, IGF-I, and estradiol and adolescent mothers' height gain during and after pregnancy	PLOS ONE			English	Article							GROWTH-FACTOR-I; BODY-MASS INDEX; MATERNAL GROWTH; BIRTH-WEIGHT; NUTRITIONAL-STATUS; INFANTS BORN; CHILDREN; HORMONE; PHYSIOLOGY; PUBERTY	Mexico is within the top three Latin American countries with the highest proportion of adolescent pregnancies while being in the lowest ten Latin American countries in terms of height. It is still unclear how much growth in adolescence is affected by pregnancy; therefore, this study was designed to study the association between prenatal serum concentrations of leptin, IGF-I, and estradiol and the increase in the height of a group of pregnant adolescents between the 28th week of gestation to one year postpartum. We conducted a cohort study from 2009 to 2017 in pregnant adolescents in their third trimester of pregnancy receiving prenatal care at Mexico's National Institute of Perinatology. Data on hormones, other covariates, and confounding variables were analyzed through bivariate analysis and then a linear univariate analysis. Our patients were an average of 15.5 +/- 1 years and gained an average of 9.5 mm during the study period. A Pearson's correlation showed a positive and significant height increase between height and leptin and IGF-I, and negative between height and estradiol. The general linear model (adjusted by age, bone age, gynecological age, parent's stature, breastfeeding, body fat, energy intake, and BMI) found that leptin and estradiol serum concentrations explained 39.6% of height increase; IGF-I did not have any predictive effect. Leptin and estradiol concentrations in the third trimester of pregnancy are associated with increased height in our group of teenage mothers. No effect association was observed between height and IGF-I concentrations.	[Samano, Reyna; Chico-Barba, Gabriela; Maria Morales, Rosa] Inst Nacl Perinatol, Dept Nutr & Bioprogramac, Mexico City, DF, Mexico; [Martinez-Rojano, Hugo] Inst Politecn Nacl, Escuela Super Med, Secc Posgrad & Invest, Mexico City, DF, Mexico; [Chico-Barba, Gabriela] Univ Panamer, Fac Ciencias Salud, Escuela Enfermeria, Mexico City, DF, Mexico; [Hernandez-Trejo, Maria] Inst Nacl Perinatol, Neurobiol Desarrollo, Mexico City, DF, Mexico; [Guzman, Raymundo] Inst Nacl Perinatol, Dept Diagnost Imagen, Mexico City, DF, Mexico; [Arteaga-Troncoso, Gabriel] Inst Nacl Perinatol, Dept Fisiol & Desarrollo Celular, Mexico City, DF, Mexico; [Alejandra Figueroa-Perez, Mariana] Univ Iberoamer, Mexico City, DF, Mexico; [Martinez, Gabriela] Univ Valle Mexico Chapultepec, Coordinac Nutr, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico; Universidad Panamericana - Ciudad de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Iberoamericana Ciudad de Mexico	Martinez-Rojano, H (corresponding author), Inst Politecn Nacl, Escuela Super Med, Secc Posgrad & Invest, Mexico City, DF, Mexico.	hmartinez_59@yahoo.com.mx	Sámano, Reyna/AAU-7514-2020; Arteaga-Troncoso, Gabriel/AAS-3220-2021; Martínez, Gabriela/GWR-1584-2022	Sámano, Reyna/0000-0001-5490-1363; Chico-Barba, Gabriela/0000-0002-5741-0241	Instituto Nacional de Perinatologia [212250-49451]	Instituto Nacional de Perinatologia	The Instituto Nacional de Perinatologia (No. 212250-49451) funded thestudy.	Almeida M, 2017, PHYSIOL REV, V97, P135, DOI 10.1152/physrev.00033.2015; [Anonymous], 2013, NORMA OFICIAL MEXICA; Bentham J, 2016, ELIFE, V5, DOI 10.7554/eLife.13410.001; Booz C, 2019, J COMPUT ASSIST TOMO, V43, P39, DOI 10.1097/RCT.0000000000000786; Casanueva E, 2006, J NUTR, V136, P2498, DOI 10.1093/jn/136.10.2498; Chen XX, 2015, J BONE MINER METAB, V33, P474, DOI 10.1007/s00774-014-0569-7; Christian P, 2018, ANN NUTR METAB, V72, P316, DOI 10.1159/000488865; Cortes-Blanco A, 1999, PEDIATRICIAN ESP, V51, P167; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Elchert J, 2015, J PEDIATR-US, V167, P579, DOI 10.1016/j.jpeds.2015.05.043; Ergen EB, 2017, GINEKOL POL, V88, P674, DOI 10.5603/GP.a2017.0120; Fernandez-Ortega JA, 2012, REV U SALUD, V15, P21; Frisancho AR, 1997, ANN NY ACAD SCI, V817, P272, DOI 10.1111/j.1749-6632.1997.tb48213.x; FRISANCHO AR, 1984, AM J CLIN NUTR, V40, P801, DOI 10.1093/ajcn/40.4.801; FRISANCHO AR, 1983, AM J CLIN NUTR, V38, P739, DOI 10.1093/ajcn/38.5.739; Gigante DP, 2005, J NUTR, V135, P74, DOI 10.1093/jn/135.1.74; Greulich W., 1959, RADIOGRAPHIC ATLAS S; IndiceI de Nivel Socioeconomico de la Asociacion Mexicana de Agencias de Investigacion de Mercados y Opinion Publica (AMAI), 2014, REGL AMAI NSE 8X7; Institute of Medicine of the National Academies, 2005, DIET REF INT EN CARB; Instituto Nacional de Salud Publica, 1996, MEX SNUT 21 SIST CAL; Isojima T, 2012, ENDOCR J, V59, P771, DOI 10.1507/endocrj.EJ12-0110; Jones RL, 2010, BJOG-INT J OBSTET GY, V117, P200, DOI 10.1111/j.1471-0528.2009.02371.x; JUUL A, 1994, J CLIN ENDOCR METAB, V78, P744, DOI 10.1210/jc.78.3.744; KEENAN BS, 1993, J CLIN ENDOCR METAB, V76, P996, DOI 10.1210/jc.76.4.996; Kristrom B, 1997, J CLIN ENDOCR METAB, V82, P2889, DOI 10.1210/jc.82.9.2889; Lausten-Thomsen U, 2016, SCAND J CLIN LAB INV, V76, P561, DOI 10.1080/00365513.2016.1210226; Lee WL, 2016, J CHIN MED ASSOC, V79, P301, DOI 10.1016/j.jcma.2016.02.002; Lira Plascencia Josefina, 2006, Ginecol Obstet Mex, V74, P241; Lohman T, 1988, HUMAN KINETICS; LUNA AM, 1983, J CLIN ENDOCR METAB, V57, P268, DOI 10.1210/jcem-57-2-268; Marvin-Dowle K, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1059-9; Ott SM, 2008, J CLIN ENDOCR METAB, V93, P1175, DOI 10.1210/jc.2008-0379; Pauli JM, 2013, ARCH GYNECOL OBSTET, V288, P679, DOI 10.1007/s00404-013-2781-4; Rah JH, 2008, J NUTR, V138, P1505, DOI 10.1093/jn/138.8.1505; Sagawa N, 2002, PLACENTA, V23, pS80, DOI 10.1053/plac.2002.0814; Samano R, 2011, SALUD PUBLICA MEXICO, V53, P2, DOI 10.1590/S0036-36342011000100002; Scholl TO, 2000, AM J CLIN NUTR, V72, P1542; SCHOLL TO, 1994, AM J CLIN NUTR, V60, P183, DOI 10.1093/ajcn/60.2.183; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; STEVENSSIMON C, 1993, J ADOLESCENT HEALTH, V14, P428, DOI 10.1016/1054-139X(93)90112-3; United Nations Population Division, FERT6 UN POP DIV; Wallace J, 2001, REPRODUCTION, V122, P347, DOI 10.1530/rep.0.1220347; Wallace JM, 2019, J ENDOCRINOL, V242, pT1, DOI 10.1530/JOE-18-0670; Wallace JM, 2004, BIOL REPROD, V70, P1277, DOI 10.1095/biolreprod.103.023853; Wang Tiankui, 2004, Environ Health Prev Med, V9, P41, DOI 10.1007/BF02897930; Weise M, 2001, P NATL ACAD SCI USA, V98, P6871, DOI 10.1073/pnas.121180498; WHO, 2009, INF YOUNG CHILD FEED; World Health Organization, GROWTH REF DAT 5 19; World Health Organization, 2006, WHO CHILD GROWTH STA; World Health Organization,, 2011, MAT NEWB CHILD AD HL; Zhu HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185561; Zong XN, 2017, ANN HUM BIOL, V44, P214, DOI 10.1080/03014460.2016.1232750	52	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228706	10.1371/journal.pone.0228706	http://dx.doi.org/10.1371/journal.pone.0228706			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045435	Green Published, gold			2022-12-26	WOS:000534633200031
J	Zhao, YH; Zhao, YD; Guo, YS; Su, K; Shi, XC; Liu, D; Zhang, JJ				Zhao, Yuhui; Zhao, Yidi; Guo, Yinshan; Su, Kai; Shi, Xiaochang; Liu, Di; Zhang, Jijun			High-density genetic linkage-map construction of hawthorn and QTL mapping for important fruit traits	PLOS ONE			English	Article							VITIS-VINIFERA L.; DISEASE RESISTANCE; PHENOLIC-COMPOUNDS; CHINESE HAWTHORN; CRATAEGUS SPP.; SNP; GENOME; GRAPE; SSR; DNA	Few reports exist on QTL mapping of the important economic traits of hawthorn. We hybridized the cultivars 'Shandongdamianqiu' (female parent) and 'Xinbinruanzi' (male parent), and 130 F1 individuals and the two parents were used for RAD-seq, SNP development, and high-density linkage map construction. Three genetic maps were obtained, one for each of the parents and an integrated one. In these three maps, 17 linkage groups were constructed. The female and male parent maps contained 2657 and 4088 SNP markers, respectively, and had genetic distances of 2689.65 and 2558.41 cM, respectively, whereas the integrated map was 2470.02 cM, and contained 6,384 SNP markers. QTL mapping based on six agronomic traits, namely fruit transverse diameter, vertical diameter, single fruit weight, pericarp brittleness, pericarp puncture hardness, and average sarcocarp firmness were conducted, and 25 QTLs were detected in seven linkage groups. Explained phenotypic variation rate ranged from 17.7% to 35%. This genetic map contains the largest number of molecular markers ever obtained from hawthorn and will provide an important future reference for fine QTL mapping of economic traits and molecular assisted selection of hawthorn.	[Zhao, Yuhui; Zhao, Yidi; Guo, Yinshan; Su, Kai; Shi, Xiaochang; Liu, Di] Shenyang Agr Univ, Coll Hort, Shenyang, Peoples R China; [Guo, Yinshan] Natl & Local Joint Engn Res Ctr Northern Hort Fac, Shenyang, Peoples R China; [Zhang, Jijun] Hebei Normal Univ Sci & Technol, Coll Hort Sci & Technol, Qinhuangdao, Peoples R China	Shenyang Agricultural University; Hebei Normal University of Science & Technology	Guo, YS (corresponding author), Shenyang Agr Univ, Coll Hort, Shenyang, Peoples R China.; Guo, YS (corresponding author), Natl & Local Joint Engn Res Ctr Northern Hort Fac, Shenyang, Peoples R China.; Zhang, JJ (corresponding author), Hebei Normal Univ Sci & Technol, Coll Hort Sci & Technol, Qinhuangdao, Peoples R China.	guoyinshan77@syau.edu.cn; zjjqhd@163.com			National Natural Science Funds of China [31101515]; Natural Science Founds of Liaoning Province of China [20170540804]; Shenyang Science and Technology Development Funds [18-013-0-38]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Natural Science Founds of Liaoning Province of China; Shenyang Science and Technology Development Funds	This research was supported by the National Natural Science Funds of China (grant #31101515), the Natural Science Founds of Liaoning Province of China (grant #20170540804) and the Shenyang Science and Technology Development Funds (grant No. 18-013-0-38) to Yuhui Zhao.	Adam-Blondon AF, 2004, THEOR APPL GENET, V109, P1017, DOI 10.1007/s00122-004-1704-y; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Chai WM, 2014, J AGR FOOD CHEM, V62, P123, DOI 10.1021/jf405385j; Chen J, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0428-2; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Cheng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep39000; Dalbo MA, 2000, GENOME, V43, P333, DOI 10.1139/gen-43-2-333; Divne AM, 2005, FORENSIC SCI INT, V154, P111, DOI 10.1016/j.forsciint.2004.09.134; Doligez A, 2002, THEOR APPL GENET, V105, P780, DOI 10.1007/s00122-002-0951-z; Doucleff M, 2004, THEOR APPL GENET, V109, P1178, DOI 10.1007/s00122-004-1728-3; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Fischer BM, 2004, THEOR APPL GENET, V108, P501, DOI 10.1007/s00122-003-1445-3; Fujii H, 2013, TREE GENET GENOMES, V9, P145, DOI 10.1007/s11295-012-0542-3; Gao G. Y., 1995, Yaoxue Xuebao, V30, P138; Grando MS, 2003, THEOR APPL GENET, V106, P1213, DOI 10.1007/s00122-002-1170-3; Hanania U, 2004, PLANT MOL BIOL REP, V22, P173, DOI 10.1007/BF02772724; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Houston RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-244; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Iwanami H, 2008, HORTSCIENCE, V43, P1377, DOI 10.21273/HORTSCI.43.5.1377; Johnston JW, 2002, NEW ZEAL J CROP HORT, V30, P145, DOI 10.1080/01140671.2002.9514210; Kakioka R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-32; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li T, 2015, PLANT CELL PHYSIOL, V56, P1909, DOI 10.1093/pcp/pcv111; Lin H, 2009, PLANT CELL, V21, P1512, DOI 10.1105/tpc.109.065987; Lin H, 2019, SCI HORTIC-AMSTERDAM, V244, P200, DOI 10.1016/j.scienta.2018.09.045; Liu DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098855; Liu PZ, 2011, FOOD CHEM, V127, P1370, DOI 10.1016/j.foodchem.2011.01.103; Liu PZ, 2010, FOOD CHEM, V121, P1188, DOI 10.1016/j.foodchem.2010.02.002; Liu XW, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-018-0036-z; Lowe KM, 2006, THEOR APPL GENET, V112, P1582, DOI 10.1007/s00122-006-0264-8; Machemer K, 2011, PLANT J, V68, P337, DOI 10.1111/j.1365-313X.2011.04690.x; Marguerit E, 2009, THEOR APPL GENET, V118, P1261, DOI 10.1007/s00122-009-0979-4; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moyano E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196953; Murray KD, 2018, BIOINFORMATICS, V34, P3924, DOI 10.1093/bioinformatics/bty432; Ozcan M, 2005, J FOOD ENG, V69, P409, DOI 10.1016/j.jfoodeng.2004.08.032; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Riaz S, 2006, THEOR APPL GENET, V113, P1317, DOI 10.1007/s00122-006-0385-0; Riaz S, 2004, THEOR APPL GENET, V108, P864, DOI 10.1007/s00122-003-1488-5; Salmaso M, 2008, THEOR APPL GENET, V116, P1129, DOI 10.1007/s00122-008-0741-3; Sapkota S, 2019, THEOR APPL GENET, V132, P137, DOI 10.1007/s00122-018-3203-6; Shao CW, 2015, DNA RES, V22, P161, DOI 10.1093/dnares/dsv001; Sibout R, 2008, CURR BIOL, V18, P458, DOI 10.1016/j.cub.2008.02.070; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Sun R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1946-x; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Tanksley SD, 1998, EUPHYTICA, V99, P77, DOI 10.1023/A:1018320232663; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Van Ooijen JW, 2006, SOFTWARE CALCULATION; Verma S.K., 2007, J HERB MED TOXICOL, V1, P65, DOI DOI 10.1155/2013/149363; Vezzulli S, 2008, THEOR APPL GENET, V117, P499, DOI 10.1007/s00122-008-0794-3; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Wang G., 2015, BIOTECHNOLOGY BIOTEC, V29, P1, DOI DOI 10.1080/13102818; Wang LH, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2316-4; Wang YK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124781; Wu JQ, 2014, MOLECULES, V19, P1685, DOI 10.3390/molecules19021685; Wu J, 2014, J EXP BOT, V65, P5771, DOI 10.1093/jxb/eru311; Wu Yonghui, 2008, Comput Syst Bioinformatics Conf, V7, P285, DOI 10.1142/9781848162648_0025; Yang BR, 2012, J SCI FOOD AGR, V92, P1578, DOI 10.1002/jsfa.5671; Yang H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151424; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zhang JK, 2009, THEOR APPL GENET, V119, P1039, DOI 10.1007/s00122-009-1107-1; Zhao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109850; Zhao YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05756-5; Zhu JC, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1575-z	70	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0229020	10.1371/journal.pone.0229020	http://dx.doi.org/10.1371/journal.pone.0229020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045463	Green Published, gold, Green Submitted			2022-12-26	WOS:000534633200052
J	Kader, T; Porteous, CM; Jones, GT; Dickerhof, N; Narayana, VK; Tull, D; Taraknath, S; McCormick, SPA				Kader, Tanjina; Porteous, Carolyn M.; Jones, Gregory T.; Dickerhof, Nina; Narayana, Vinod K.; Tull, Dedreia; Taraknath, Sreya; McCormick, Sally P. A.			Ribose-cysteine protects against the development of atherosclerosis in apoE-deficient mice	PLOS ONE			English	Article							APOLIPOPROTEIN-E; CARDIOVASCULAR-DISEASE; OXIDIZED PHOSPHOLIPIDS; OXIDATIVE STRESS; GLUTATHIONE; CHOLESTEROL; PLASMA; RISK; HEPATOTOXICITY; PROGRESSION	Ribose-cysteine is a synthetic compound designed to increase glutathione (GSH) synthesis. Low levels of GSH and the GSH-dependent enzyme, glutathione peroxidase (GPx), is associated with cardiovascular disease (CVD) in both mice and humans. Here we investigate the effect of ribose-cysteine on GSH, GPx, oxidised lipids and atherosclerosis development in apolipoprotein E-deficient (apoE-/-) mice. Female 12-week old apoE-/- mice (n = 15) were treated with 4-5 mg/day ribose-cysteine in drinking water for 8 weeks or left untreated. Blood and livers were assessed for GSH, GPx activity and 8-isoprostanes. Plasma alanine transferase (ALT) and lipid levels were measured. Aortae were quantified for atherosclerotic lesion area in the aortic sinus and brachiocephalic arch and 8-isoprostanes measured. Ribose-cysteine treatment significantly reduced ALT levels (p<0.0005) in the apoE-/- mice. Treatment promoted a significant increase in GSH concentrations in the liver (p<0.05) and significantly increased GPx activity in the liver and erythrocytes of apoE-/-mice (p<0.005). The level of 8-isoprostanes were significantly reduced in the livers and arteries of apoE-/- mice (p<0.05 and p<0.0005, respectively). Ribose-cysteine treatment showed a significant decrease in total and low density lipoprotein (LDL) cholesterol (p< 0.05) with no effect on other plasma lipids with the LDL reduction likely through upregulation of scavenger receptor-B1 (SR-B1). Ribose-cysteine treatment significantly reduced atherosclerotic lesion area by > 50% in both the aortic sinus and brachiocephalic branch (p< 0.05). Ribose-cysteine promotes a significant GSH-based antioxidant effect in multiple tissues as well as an LDL-lowering response. These effects are accompanied by a marked reduction in atherosclerosis suggesting that ribose-cysteine might increase protection against CVD.	[Kader, Tanjina; Porteous, Carolyn M.; Taraknath, Sreya; McCormick, Sally P. A.] Univ Otago, Sch Biomed Sci, Dept Biochem, Dunedin, New Zealand; [Jones, Gregory T.] Univ Otago, Dunedin Sch Med, Dept Surg Sci, Dunedin, New Zealand; [Dickerhof, Nina] Univ Otago Christchurch, Ctr Free Rad Res, Dept Pathol & Biomed Sci, Christchurch, New Zealand; [Narayana, Vinod K.; Tull, Dedreia] Univ Melbourne, Bio21 Inst Mol Sci & Biotechnol, Metabol Australia, Melbourne, Vic, Australia; [Kader, Tanjina] Sir Peter MacCallum Canc Ctr, Canc Genom Program, Melbourne, Vic, Australia	University of Otago; University of Otago; University of Otago; University of Melbourne; Peter Maccallum Cancer Center	McCormick, SPA (corresponding author), Univ Otago, Sch Biomed Sci, Dept Biochem, Dunedin, New Zealand.	sally.mccormick@otago.ac.nz	Kader, Tanjina/AAU-4912-2021; Narayana, Vinod/AAQ-1659-2020	Kader, Tanjina/0000-0002-1463-7593; McCormick, Sally/0000-0001-9857-0703; Narayana, Vinod/0000-0003-3980-7496; Dickerhof, Nina/0000-0003-2269-4595	Max International, LLC, Salt Lake City, UT, USA; Otago School of Medical Sciences Bequest Fund; Otago Postgraduate Research Scholarship	Max International, LLC, Salt Lake City, UT, USA; Otago School of Medical Sciences Bequest Fund; Otago Postgraduate Research Scholarship	This study was supported by funding from Max International, LLC, Salt Lake City, UT, USA who provided the ribose-cysteine and by an Otago School of Medical Sciences Bequest Fund. ST was supported by an Otago Postgraduate Research Scholarship.	Biswas SK, 2005, BIOCHEM BIOPH RES CO, V338, P1368, DOI 10.1016/j.bbrc.2005.10.098; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Bonomini F, 2010, EXP GERONTOL, V45, P149, DOI 10.1016/j.exger.2009.11.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASTELLI WP, 1986, AM J MED, V80, P23, DOI 10.1016/0002-9343(86)90157-9; Cheng F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072063; Cheng ML, 2009, AM J CARDIOL, V103, P471, DOI 10.1016/j.amjcard.2008.09.104; Cui YQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16339; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Espinola-Klein C, 2007, AM J CARDIOL, V99, P808, DOI 10.1016/j.amjcard.2006.10.041; Ferre N, 2009, AM J PHYSIOL-GASTR L, V296, pG553, DOI 10.1152/ajpgi.00547.2007; Forgione MA, 2002, CIRCULATION, V106, P1154, DOI 10.1161/01.CIR.0000026820.87824.6A; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Harwood DT, 2009, J CHROMATOGR B, V877, P3393, DOI 10.1016/j.jchromb.2009.04.018; Hortle E, 2016, BLOOD, V128, P1290, DOI 10.1182/blood-2015-09-666834; Jones GT, 2005, J VASC RES, V42, P237, DOI 10.1159/000085553; Kader T, 2014, ATHEROSCLEROSIS, V237, P725, DOI 10.1016/j.atherosclerosis.2014.10.101; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Lu YG, 2011, J ATHEROSCLER THROMB, V18, P998; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; Lucas AM, 2000, TOXICOL PATHOL, V28, P697, DOI 10.1177/019262330002800510; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mayr M, 2005, ARTERIOSCL THROM VAS, V25, P2135, DOI 10.1161/01.ATV.0000183928.25844.f6; Millea PJ, 2009, AM FAM PHYSICIAN, V80, P265; Nordestgaard BG, 2016, CIRC RES, V118, P547, DOI 10.1161/CIRCRESAHA.115.306249; Pastori D, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003682; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Pratico D, 1998, NAT MED, V4, P1189, DOI 10.1038/2685; PURCELLHUYNH DA, 1995, J CLIN INVEST, V95, P2246, DOI 10.1172/JCI117915; ROBERTS JC, 1987, J MED CHEM, V30, P1891, DOI 10.1021/jm00393a034; ROBERTS JC, 1992, PHARMACOL TOXICOL, V70, P281, DOI 10.1111/j.1600-0773.1992.tb00472.x; ROBERTS JC, 1991, TOXICOL LETT, V59, P245, DOI 10.1016/0378-4274(91)90078-K; Sharma A, 2016, VASC PHARMACOL, V79, P32, DOI 10.1016/j.vph.2015.11.001; Shimada K, 2009, CIRC J, V73, P1337, DOI 10.1253/circj.CJ-08-1148; Shimizu H, 2004, STROKE, V35, P2072, DOI 10.1161/01.STR.0000138022.86509.2d; Slitt AML, 2005, BASIC CLIN PHARMACOL, V96, P487, DOI 10.1111/j.1742-7843.2005.pto_13.x; Torzewski M, 2007, ARTERIOSCL THROM VAS, V27, P850, DOI 10.1161/01.ATV.0000258809.47285.07; Treweeke AT, 2012, DIABETOLOGIA, V55, P2920, DOI 10.1007/s00125-012-2685-z; Tsimikas S, 2006, J AM COLL CARDIOL, V47, P2219, DOI 10.1016/j.jacc.2006.03.001; Tsimikas S, 2009, CIRCULATION, V119, P1711, DOI 10.1161/CIRCULATIONAHA.108.836940; Ueda Y, 1999, J BIOL CHEM, V274, P7165, DOI 10.1074/jbc.274.11.7165; VALE JA, 1995, LANCET, V346, P547, DOI 10.1016/S0140-6736(95)91385-8; Zhang JX, 2014, J GERIATR CARDIOL, V11, P141, DOI 10.3969/j.issn.1671-5411.2014.02.003	43	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0228415	10.1371/journal.pone.0228415	http://dx.doi.org/10.1371/journal.pone.0228415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084149	Green Published, gold			2022-12-26	WOS:000535227900018
J	Xu, L; Yang, M; Fu, HT; Sun, SM; Qiao, H; Zhang, WY; Gong, YS; Jiang, SF; Xiong, YW; Jin, SB; Wu, Y				Xu, Lei; Yang, Ming; Fu, Hongtuo; Sun, Shengming; Qiao, Hui; Zhang, Wenyi; Gong, Yongsheng; Jiang, Sufei; Xiong, Yiwei; Jin, Shubo; Wu, Yan			Molecular cloning, expression, and in situ hybridization analysis of MnGPx-3 and MnGPx-4 from oriental river prawn, Macrobrachium nipponense, in response to hypoxia and reoxygenation	PLOS ONE			English	Article							GLUTATHIONE-PEROXIDASE; OXIDATIVE STRESS; LITOPENAEUS-VANNAMEI; ANTIOXIDANT ENZYME; SEQUENCE-ANALYSIS; GILL MORPHOLOGY; MESSENGER-RNA; WHITE SHRIMP; LIVER; MECHANISMS	Glutathione peroxidase (GPx) has been the focus of increased research because of its important role as an antioxidant and in reactive oxygen species (ROS) induced damage repair. Studies on GPxs have relevance with Macrobrachium nipponense because it has poor tolerance to hypoxia in Macrobrachium nipponense. The two subunits named as MnGPx-3 and MnGPx-4 according to the glutathione peroxidase nomenclature system. Both full-length cDNAs were cloned from the hepatopancreas. In this study, we analyzed the expression of two GPxs in Macrobrachium nipponense in response to changes in environmental oxygen. Expression levels of MnGPx-3 and MnGPx-4 indicated that both have strong responses to hypoxia. In situ hybridization showed that MnGPx-3 and MnGPx-4 were located in secretory and storage cells in hepatopancreas. These results suggest that GPx gene is expressed and released by secretory cells and released response to hypoxia. In the gill tissue, however, GPxs are located in blood cells, suggesting that they perform different functions in different tissues or organs. The results of in situ hybridization were consistent with those of quantitative Real-time PCR. This study provides a basis for understanding the oxidative stress response in M. nipponense under hypoxia.	[Xu, Lei; Yang, Ming; Fu, Hongtuo] Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Jiangsu, Peoples R China; [Fu, Hongtuo; Sun, Shengming; Qiao, Hui; Zhang, Wenyi; Gong, Yongsheng; Jiang, Sufei; Xiong, Yiwei; Jin, Shubo; Wu, Yan] Chinese Acad Fishery Sci, Key Lab Freshwater Fisheries & Germplasm Resource, Minist Agr, Freshwater Fisheries Res Ctr, Wuxi, Jiangsu, Peoples R China	Nanjing Agricultural University; Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Ministry of Agriculture & Rural Affairs	Fu, HT (corresponding author), Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Jiangsu, Peoples R China.; Fu, HT (corresponding author), Chinese Acad Fishery Sci, Key Lab Freshwater Fisheries & Germplasm Resource, Minist Agr, Freshwater Fisheries Res Ctr, Wuxi, Jiangsu, Peoples R China.	fuht@ffrc.cn		Xu, Lei/0000-0003-0306-0933; Jin, Shubo/0000-0002-6550-9268	Jiangsu Agricultural Industry Technology System [JF RS02]; National Key R&D Progrom of China [2018YFD0901303]; National Natural Science F oundation of China [31572617, CARS48]; New cultiv ar breeding Major Project of Jiangsu province [PZCZ201745]; Six talent peaks project in Jiangsu Province [NY-112]	Jiangsu Agricultural Industry Technology System; National Key R&D Progrom of China; National Natural Science F oundation of China(National Natural Science Foundation of China (NSFC)); New cultiv ar breeding Major Project of Jiangsu province; Six talent peaks project in Jiangsu Province	This research was supported by grants from Jiangsu Agricultural Industry Technology System JF RS02; the National Key R&D Progrom of China (2018YFD0901303); the National Natural Science F oundation of China (31572617); the China Agriculture Research System48 (CARS48); the New cultiv ar breeding Major Project of Jiangsu province (PZCZ201745); Six talent peaks project in Jiangsu Province (NY-112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastos VLFC, 2007, BIOCHIMIE, V89, P1332, DOI 10.1016/j.biochi.2007.04.003; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Choi CY, 2007, COMP BIOCHEM PHYS C, V145, P595, DOI 10.1016/j.cbpc.2007.02.007; Dias FA, 2016, INSECT BIOCHEM MOLEC, V69, P105, DOI 10.1016/j.ibmb.2015.08.007; Duan YF, 2015, FISH SHELLFISH IMMUN, V46, P354, DOI 10.1016/j.fsi.2015.06.032; EPP O, 1983, EUR J BIOCHEM, V133, P51, DOI 10.1111/j.1432-1033.1983.tb07429.x; GUAN Y-q, 2010, J HEBEI U NATURAL SC, V3; Halliwell B., 1985, FREE RADICALS BIOL M, DOI 10.1016/0748-5514(85)90140-0; Han Xiao-lin, 2014, Yuye Kexue Jinzhan, V35, P104; Hong MeiLing, 2007, Journal of Fishery Sciences of China, V14, P412; Hu YN, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082258; Kanninen K., 2011, INT J ALZHEIMERS DIS, V2011; KRAMER JH, 1994, ANN NY ACAD SCI, V723, P180, DOI 10.1111/j.1749-6632.1994.tb36725.x; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Li F, 2018, COMP BIOCHEM PHYS B, V218, P1, DOI 10.1016/j.cbpb.2017.12.016; Li FX, 2017, FISH SHELLFISH IMMUN, V71, P380, DOI 10.1016/j.fsi.2017.10.018; Liu CH, 2007, FISH SHELLFISH IMMUN, V23, P34, DOI 10.1016/j.fsi.2006.09.002; Liu GD, 2016, GENE, V578, P210, DOI 10.1016/j.gene.2015.12.034; Liu Na, 2007, Chinese Journal of Zoology, V42, P15; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lushchak VI, 2001, AM J PHYSIOL-REG I, V280, pR100, DOI 10.1152/ajpregu.2001.280.1.R100; Ma KY, 2011, GENE, V487, P160, DOI 10.1016/j.gene.2011.07.017; Matey V, 2008, J EXP BIOL, V211, P1063, DOI 10.1242/jeb.010181; Matey V, 2011, CAN J ZOOL, V89, P307, DOI [10.1139/z11-002, 10.1139/Z11-002]; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Mork H, 1998, EXPRESSION PATTERN G, DOI [10.1080/01635589809514720, DOI 10.1080/01635589809514720]; Parrilla-Taylor DP, 2011, AQUACULTURE, V318, P379, DOI 10.1016/j.aquaculture.2011.05.015; Pi JB, 2010, TOXICOL APPL PHARM, V244, P77, DOI 10.1016/j.taap.2009.05.025; Qiao H, 2015, COMP BIOCHEM PHYS A, V185, P1, DOI [10.1016/j.cbpa.2015.03.005, 10.1016/j.hemonc.2014.09.004]; Qu Z.X., 1990, FRESHW FISH, V01, P3; [任海 Ren Hai], 2014, [农业环境科学学报, Journal of Agro-Environment Science], V33, P647; Shan DY, 2018, J WORLD AQUACULT SOC, V49, P356, DOI 10.1111/jwas.12502; Singh AK, 1998, J BIOL CHEM, V273, P26171, DOI 10.1074/jbc.273.40.26171; Storey KB, 1996, BRAZ J MED BIOL RES, V29, P1715; Sun SM, 2016, FISH SHELLFISH IMMUN, V54, P68, DOI 10.1016/j.fsi.2016.03.167; Takebe G, 2002, J BIOL CHEM, V277, P41254, DOI 10.1074/jbc.M202773200; [陶易凡 Tao Yifan], 2016, [中国水产科学, Journal of Fishery Sciences of China], V23, P1279; Thompson JL, 2010, COMP BIOCHEM PHYS B, V156, P287, DOI 10.1016/j.cbpb.2010.04.007; Toppo S, 2009, BBA-GEN SUBJECTS, V1790, P1486, DOI 10.1016/j.bbagen.2009.04.007; Tosatto SCE, 2008, ANTIOXID REDOX SIGN, V10, P1515, DOI 10.1089/ars.2008.2055; TRAYSTMAN RJ, 1991, J APPL PHYSIOL, V71, P1185, DOI 10.1152/jappl.1991.71.4.1185; Marinho JFU, 2014, ECOTOX ENVIRON SAFE, V110, P239, DOI 10.1016/j.ecoenv.2014.09.010; Wang PH, 1998, P NATL ACAD SCI USA, V95, P4556, DOI 10.1073/pnas.95.8.4556; Wang YL, 2018, AQUACULTURE, V495, P940, DOI 10.1016/j.aquaculture.2018.06.065; Wu LT, 2010, COMP BIOCHEM PHYS B, V155, P26, DOI 10.1016/j.cbpb.2009.09.005; Xu L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103102; Yang Fu-Yi, 2005, Chinese Journal of Zoology, V40, P74; Yeh SP, 2009, FISH SHELLFISH IMMUN, V27, P181, DOI 10.1016/j.fsi.2009.03.022; Zhang J, 2013, DEV COMP IMMUNOL, V40, P195, DOI 10.1016/j.dci.2013.01.011	49	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229171	10.1371/journal.pone.0229171	http://dx.doi.org/10.1371/journal.pone.0229171			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084182	gold, Green Published			2022-12-26	WOS:000535227900066
J	Singh, H; Ramamohan, V				Singh, Himanshu; Ramamohan, Varun			A model-based investigation into urban-rural disparities in tuberculosis treatment outcomes under the Revised National Tuberculosis Control Programme in India	PLOS ONE			English	Article							COST-EFFECTIVENESS; IMPACT	In this study, we investigate differences in tuberculosis (TB) treatment outcomes between urban and rural India and estimate their impact on epidemiological outcomes such as TB incidence, prevalence and mortality using a mathematical model of TB transmission dynamics. Publicly available district-level treatment outcomes data for new and previously treated TB cases was analyzed in conjunction with census data providing the proportion of urban population in each district to determine the effect of urbanity/rurality on treatment outcomes. Districts were grouped in clusters based on the proportion of urban population in each district, wherein the clusters were identified by applying machine learning methods. Regression analyses revealed that average treatment success rates among both new and previously treated cases decline with increase in the proportion of urban population in a district cluster, with substantially sharper declines in treatment success rates with degree of urbanity observed for previously treated cases. The impact of differences in treatment outcomes on epidemiological outcomes was estimated using a dynamic transmission model developed for this purpose. For example, the cluster with highest treatment success rates is projected to have an average of 3.2% fewer deaths per 100,000 population in comparison with the national average across 2019-24, and the cluster with the lowest treatment success rates has an average of 4.5% more deaths per 100,000 in comparison with the national average. We anticipate that these disparities in TB treatment outcomes and epidemiology between urban and rural India may motivate investigations into the associated causes and their redressal.	[Singh, Himanshu; Ramamohan, Varun] Indian Inst Technol Delhi, Dept Mech Engn, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Ramamohan, V (corresponding author), Indian Inst Technol Delhi, Dept Mech Engn, New Delhi, India.	varunr@mech.iitd.ac.in		Ramamohan, Varun/0000-0001-6517-9142				Abubakar I, 2008, EPIDEMIOL INFECT, V136, P122, DOI 10.1017/S0950268807008333; Anand S, 2016, HLTH WORKFORCE INDIA; [Anonymous], 2016, EC TIMES; Briggs AH, 2012, VALUE HEALTH, V15, P835, DOI 10.1016/j.jval.2012.04.014; Central TB Division, 2014, REV NAT TUB CONTR PR; Central TB Division, 2018, REV NAT TUB CONTR PR; Central TB Division. Revised National Tuberculosis Control Programme, 2017, ANN STAT REP 2017; Dangisso MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114225; Goyal V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4779-5; Itogo N, 2014, PUBLIC HEALTH ACTION, V4, pS25, DOI 10.5588/pha.13.0078; Mandal S, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0809-5; Mukhopadhyay Sujishnu, 2011, Indian J Community Med, V36, P146, DOI 10.4103/0970-0218.84136; Muniyandi M, 2015, INDIAN J MED RES, V141, P624; Murray CJL, 1998, P NATL ACAD SCI USA, V95, P13881, DOI 10.1073/pnas.95.23.13881; Pandey S, 2017, INT J TUBERC LUNG D, V21, P366, DOI 10.5588/ijtld.16.0182; Rajeswari R, 1999, INT J TUBERC LUNG D, V3, P869; Resch SC, 2006, PLOS MED, V3, P1048, DOI 10.1371/journal.pmed.0030241; Sharma A, 2017, LANCET INFECT DIS, V3099, P1; Suen SC, 2015, INT J TUBERC LUNG D, V19, P1115, DOI 10.5588/ijtld.15.0158; Suen SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089822; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2010, BRIEF HIST TUB CONTR	22	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0228712	10.1371/journal.pone.0228712	http://dx.doi.org/10.1371/journal.pone.0228712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7VI	32059003	Green Published, gold			2022-12-26	WOS:000535206600013
J	Zhou, JM; Sun, XW; Yang, L; Wang, LQ; Ran, G; Wang, JH; Cao, Q; Wu, LZ; Bryant, A; Ling, C; Pi, LY				Zhou, Junmei; Sun, Xiaowei; Yang, Lu; Wang, Liqun; Ran, Gai; Wang, Jinhui; Cao, Qi; Wu, Lizi; Bryant, Andrew; Ling, Chen; Pi, Liya			Hepatocyte nuclear factor 4 alpha negatively regulates connective tissue growth factor during liver regeneration	FASEB JOURNAL			English	Article						connective tissue growth factor (Ctgf); hepatocyte nuclear factor 4 alpha (Hnf4 alpha); liver injury; liver regeneration	GENE-EXPRESSION; FACTOR CTGF; FIBROSIS; IDENTIFICATION; TRANSCRIPTION; DOMAIN; PHASE; CCN2; FATE; RATS	Liver regeneration after injury requires fine-tune regulation of connective tissue growth factor (Ctgf). It also involves dynamic expression of hepatocyte nuclear factor (Hnf)4 alpha, Yes-associated protein (Yap), and transforming growth factor (Tgf)-beta. The upstream inducers of Ctgf, such as Yap, etc, are well-known. However, the negative regulator of Ctgf remains unclear. Here, we investigated the Hnf4 alpha regulation of Ctgf post-various types of liver injury. Both wild-type animals and animals contained siRNA-mediated Hnf4 alpha knockdown and Cre-mediated Ctgf conditional deletion were used. We observed that Ctgf induction was associated with Hnf4 alpha decline, nuclear Yap accumulation, and Tgf-beta upregulation during early stage of liver regeneration. The Ctgf promoter contained an Hnf4 alpha binding sequence that overlapped with the cis-regulatory element for Yap and Tgf-beta. Ctgf loss attenuated inflammation, hepatocyte proliferation, and collagen synthesis, whereas Hnf4 alpha knockdown enhanced Ctgf induction and liver fibrogenesis. These findings provided a new mechanism about fine-tuned regulation of Ctgf through Hnf4 alpha antagonism of Yap and Tgf-beta activities to balance regenerative and fibrotic signals.	[Zhou, Junmei; Sun, Xiaowei; Ran, Gai; Ling, Chen; Pi, Liya] Univ Florida, Dept Pediat, Gainesville, FL USA; [Zhou, Junmei] Univ South China, Inst Cardiovasc Dis, Key Lab Arteriosclerol Hunan Prov, Hengyang, Peoples R China; [Sun, Xiaowei] Lanzhou Univ, Inst Pathol, Sch Basic Med Sci, Lanzhou, Peoples R China; [Yang, Lu; Wang, Jinhui] City Hope Natl Med Ctr, Integrat Genom Core, Beckman Res Inst, Duarte, CA USA; [Wang, Liqun; Bryant, Andrew] Univ Florida, Dept Med, Gainesville, FL USA; [Ran, Gai; Ling, Chen] Fudan Univ, Zhongshan Hosp, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200438, Peoples R China; [Cao, Qi] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD USA; [Wu, Lizi] Univ Florida, Coll Med, Dept Microbiol & Mol Genet, Gainesville, FL USA	State University System of Florida; University of Florida; University of South China; Lanzhou University; City of Hope; Beckman Research Institute of City of Hope; State University System of Florida; University of Florida; Fudan University; University System of Maryland; University of Maryland Baltimore; State University System of Florida; University of Florida	Ling, C (corresponding author), Fudan Univ, Zhongshan Hosp, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200438, Peoples R China.; Pi, LY (corresponding author), Univ Florida, Coll Med, Dept Pediat, 1200 S Newell Dr, Gainesville, FL 32610 USA.	lingchenchina@fudan.edu.cn; lingchenchina@fudan.edu.cn	Wang, Jin/GYA-2019-2022		HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA) [KO1AA024174, R01AA028035]; Children Miracle Network Foundation; National Key Research and Development Program of China [2018YFA0109400]; Shanghai Sailing Program [17YF1401300]; Shanghai Eastern Scholarship [TP2016004]	HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA); Children Miracle Network Foundation; National Key Research and Development Program of China; Shanghai Sailing Program; Shanghai Eastern Scholarship	HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA), Grant/Award Number: KO1AA024174 and R01AA028035; Children Miracle Network Foundation; National Key Research and Development Program of China, Grant/Award Number: 2018YFA0109400; Shanghai Sailing Program, Grant/Award Number: 17YF1401300; Shanghai Eastern Scholarship, Grant/Award Number: TP2016004	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Cai WY, 2017, HEPATOLOGY, V65, P1206, DOI 10.1002/hep.28911; Deshpande KT, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010005; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fausto N, 2012, J HEPATOL, V57, P692, DOI 10.1016/j.jhep.2012.04.016; Fujii M, 2012, J EXP MED, V209, P479, DOI 10.1084/jem.20111653; Geier A, 2008, AM J PHYSIOL-GASTR L, V295, pG226, DOI 10.1152/ajpgi.00012.2008; Gressner OA, 2008, LIVER INT, V28, P1065, DOI 10.1111/j.1478-3231.2008.01826.x; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huck I, 2019, HEPATOLOGY, V70, P666, DOI 10.1002/hep.30405; Jiao H, 2015, CELL PHYSIOL BIOCHEM, V36, P2317, DOI 10.1159/000430195; Klaas M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27398; Kuttippurathu L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2492-x; Leask A, 2001, J CLIN PATHOL-MOL PA, V54, P180, DOI 10.1136/mp.54.3.180; Lin SB, 2018, MOL CELL, V71, P244, DOI 10.1016/j.molcel.2018.06.001; Ling CQ, 2018, J INTEGR MED-JIM, V16, P236, DOI 10.1016/j.joim.2018.05.002; Liu LP, 2012, HEPATOLOGY, V55, P1529, DOI 10.1002/hep.24815; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Lu H, 2010, TOXICOL SCI, V118, P380, DOI 10.1093/toxsci/kfq280; Mitra RN, 2018, BIOMATERIALS, V157, P26, DOI 10.1016/j.biomaterials.2017.12.004; Nishiyama K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136774; Nwidu LL, 2019, J INTEGR MED-JIM, V17, P46, DOI 10.1016/j.joim.2018.11.008; Nwidu LL, 2018, J INTEGR MED-JIM, V16, P263, DOI 10.1016/j.joim.2018.05.001; Oh SH, 2018, J HEPATOL, V69, P359, DOI 10.1016/j.jhep.2018.05.008; Patel SH, 2017, GASTROENTEROLOGY, V152, P533, DOI 10.1053/j.gastro.2016.10.047; Pi LY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00138; Pi LY, 2015, HEPATOLOGY, V61, P678, DOI 10.1002/hep.27425; Pi LY, 2012, FASEB J, V26, P3365, DOI 10.1096/fj.11-200154; Pi LY, 2005, GASTROENTEROLOGY, V128, P2077, DOI 10.1053/j.gastro.2005.03.081; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roychowdhury S, 2012, ALCOHOL CLIN EXP RES, V36, P1139, DOI 10.1111/j.1530-0277.2011.01720.x; Sato A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092515; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Stroup D, 2000, J LIPID RES, V41, P1; Su AI, 2002, P NATL ACAD SCI USA, V99, P11181, DOI 10.1073/pnas.122359899; Sun K, 2007, MOL ENDOCRINOL, V21, P1297, DOI 10.1210/me.2006-0300; Tong ZY, 2009, HEPATOLOGY, V50, P939, DOI 10.1002/hep.23102; Urtasun R, 2011, HEPATOLOGY, V54, P2149, DOI 10.1002/hep.24587; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Wu YS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06898-4; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zheng M, 2016, FASEB J, V30, P1076, DOI 10.1096/fj.15-280511	45	5	5	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4970	4983		10.1096/fj.201902382R	http://dx.doi.org/10.1096/fj.201902382R		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32057145	Green Published, hybrid			2022-12-26	WOS:000515244600001
J	Amin, MEK; Abdelmageed, A				Amin, Mohamed Ezzat Khamis; Abdelmageed, Ahmed			RAMCOM: A qualitative study of clinicians' viewpoints on a tool for communication with Muslim patients considering fasting during Ramadan	PLOS ONE			English	Article							PERSPECTIVES	Objectives Fasting during the month of Ramadan is a basic pillar of Islam. While patients may be religiously exempted from fasting, literature indicates that the majority decide to fast. Caring for millions of Muslim patients who decide to fast during Ramadan can be challenging for clinicians around the globe. This study proposes a communication tool, RAMCOM, which aims to assist clinicians in communicating with Muslim patients considering fasting during Ramadan. It addresses the following questions: What are the clinicians' preferences for the tool in terms of Content, Format, Style, Length and language? How do clinicians perceive factors that would impact their intentions to sue the tool? What would facilitate the implementation and dissemination of the proposed tool? Methods Semi-structured interviews were conducted with a purposeful sample of clinicians in Egypt (11) and the US (10). Clinicians were purposefully sampled to assure variance in age, gender, time in practice, specialty, and religious background. Directed content analysis was conducted and emerging data were mapped to constructs within the theory of planned behavior. Iterative sampling and analysis continued until saturation was reached. Results In total, 21 clinicians were interviewed. The tool was iteratively revised according to clinicians' comments on format, content, language and usability. Factors contributing to using RAMCOM included perception of tool (need for use, perceived burden of use), perceived norm (perceived patient expectations), and ability to use tool (time, frequency of seeing patients, knowledge of Ramadan and Islam). Practice environment factors that impact the use of RAMCOM include education, early reminders, colored laminated copies, communication training, involvement of support staff, and patient education. Conclusion Clinicians provided valuable perceptions on the implementability and use of RAMCOM, a new communication tool designed to assist in caring for Muslim patients during Ramadan. These perceptions should be considered by different stakeholders to facilitate goal-concordant care for Muslim patients considering fasting.	[Amin, Mohamed Ezzat Khamis] Beirut Arab Univ, Dept Pharm Practice, Fac Pharm, Beirut, Lebanon; [Abdelmageed, Ahmed] Univ Manchester, Coll Pharm, Dept Pharm Practice, Ft Wayne, IN USA	Beirut Arab University	Amin, MEK (corresponding author), Beirut Arab Univ, Dept Pharm Practice, Fac Pharm, Beirut, Lebanon.	m.amin@bau.edu.lb	Abdel-Megied, Ahmed Mohamed/AAJ-3700-2021; Amin, Mohamed Ezzat Khamis/K-7976-2013	Amin, Mohamed Ezzat Khamis/0000-0003-0404-2040				Ahmedani MY, 2020, J DIABETES METAB DIS, V19, P29, DOI 10.1007/s40200-019-00471-6; Ajzen I., 2012, HDB THEORIES SOCIAL, VVolume 1, P438, DOI DOI 10.4135/9781446249215.N22; Al Jaziri A al-R, 2009, ISLAMIC JURISPRUDENC, P1; Al-Hilali M, 2005, KING FAHD COMPLEX PR; Ali R, 2007, JCPSP-J COLL PHYSICI, V17, P112; Alomi Y, 2018, UPDATE 2018 DRUG THE; Amin MEK, 2016, INT J PHARM PRACT, V24, P419, DOI 10.1111/ijpp.12282; Amin MEK, 2021, J RELIG HEALTH, V60, P922, DOI 10.1007/s10943-019-00910-x; Amin MEK, 2020, J RELIG HEALTH, V59, P1370, DOI 10.1007/s10943-019-00820-y; [Anonymous], 1985, NATURALIST INQUIRY; Brunett PH, 2001, ACAD MED, V76, P390, DOI 10.1097/00001888-200104000-00021; Chewning B, 2012, PATIENT EDUC COUNS, V86, P9, DOI 10.1016/j.pec.2011.02.004; Cook, 2010, HCAHPS HDB HARDWIRE; Dar-alifta.org, ET JUR DIFF; Dar-alifta.org, FAT MANN MAK MISS FA; Dar-alifta.org, FAT THINGS WHICH VIT; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Ilkilic I, 2017, MED HEALTH CARE PHIL, V20, P561, DOI 10.1007/s11019-017-9777-y; Islamic Organization for Medical Science, 1997, 9 FIQH MED SEM ISL V; Islamqa.info, PREGN WOM BREASTF MO; Jabbar A, 2019, DIABETES RES CLIN PR, V151, P285, DOI 10.1016/j.diabres.2019.02.021; Kastner M, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-19; Kristiansen M, 2019, HDB HEALTHCARE ARAB, P1, DOI [10.1007/978-3-319-74365-3_53-1, DOI 10.1007/978-3-319-74365-3_53-1]; Kumar N, 2009, BRIT J OPHTHALMOL, V93, P551, DOI 10.1136/bjo.2008.151001; Lorie A, 2017, PATIENT EDUC COUNS, V100, P411, DOI 10.1016/j.pec.2016.09.018; Miller W L, 1994, Fam Pract Res J, V14, P289; Mir G, 2010, ETHNIC HEALTH, V15, P327, DOI 10.1080/13557851003624273; Myers PR, 2019, DIABETES RES CLIN PR, V150, P282, DOI 10.1016/j.diabres.2018.12.011; Mygind A, 2013, INT J CLIN PHARM-NET, V35, P281, DOI 10.1007/s11096-012-9716-1; Nikoo MK, 2014, INT J DIABETES DEV C, V34, P180, DOI 10.1007/s13410-013-0184-5; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Patel NR, 2015, HEALTH EXPECT, V18, P1698, DOI 10.1111/hex.12163; Pathy R, 2011, ETHNIC HEALTH, V16, P43, DOI 10.1080/13557858.2010.523780; Peeters B, 2012, PRIM CARE DIABETES, V6, P293, DOI 10.1016/j.pcd.2012.02.003; Pinelli Nicole R, 2011, J Pharm Pract, V24, P211, DOI 10.1177/0897190010367432; Register SJ, 2020, CLIN SIMUL NURS, V38, P14, DOI 10.1016/j.ecns.2019.09.005; Robinson T, 2005, ETHNIC DIS, V15, P1; Salti I, 2004, DIABETES CARE, V27, P2306, DOI 10.2337/diacare.27.10.2306; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Savas E, 2014, J RELIG HEALTH, V53, P135, DOI 10.1007/s10943-012-9605-x; Sistani.org, FAST LAWS THINGS INV; Skaggs MKD, 2018, J EMERG NURS, V44, P37, DOI 10.1016/j.jen.2017.10.011; Willems S, 2005, PATIENT EDUC COUNS, V56, P139, DOI 10.1016/j.pec.2004.02.011; Zeeneldin AA, 2012, J EGYPT NATL CANCER, V24, P133, DOI 10.1016/j.jnci.2012.06.003	45	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228888	10.1371/journal.pone.0228888	http://dx.doi.org/10.1371/journal.pone.0228888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KQ8VX	32053645	gold, Green Published			2022-12-26	WOS:000517200700001
J	Kang, MK; Kim, TJ; Kim, Y; Nam, KW; Jeong, HY; Kim, SK; Lee, JS; Ko, SB; Yoon, BW				Kang, Min Kyoung; Kim, Tae Jung; Kim, Yerim; Nam, Ki-Woong; Jeong, Han-Yeong; Kim, Sung Kyung; Lee, Ji Sung; Ko, Sang-Bae; Yoon, Byung-Woo			Geriatric nutritional risk index predicts poor outcomes in patients with acute ischemic stroke - Automated undernutrition screen tool	PLOS ONE			English	Article							SERUM-ALBUMIN; MALNUTRITION; PREVALENCE; IMPACT	Background Premorbid undernutrition has been proven to have an adverse effect on the prognosis of stroke patients. The evaluation of nutritional status is important, but there is no universally accepted screen methodology. Purpose We aimed to use the geriatric nutritional risk index (GNRI) for evaluating the effect of premorbid undernutrition on short-term outcomes in patients with acute ischemic stroke. Methods A total of 1,906 patients were included for analysis. Baseline characteristics were collected. We evaluated the nutritional status of the patients using the GNRI and body mass index (BMI). The GNRI was calculated as {1.519xserum albumin(g/dL) + 41.7xpresent weight (kg)/ideal body weight (kg)}. All patients were categorized into four groups on the basis of the GNRI score. Results Among the included patients, 546 patients had an unfavorable outcomes. The proportion of patients with moderate and severe risk, assessed in GNRI, was significantly higher in the unfavorable outcome group compared to the favorable outcome group (33.3% vs 15.0%). The increased risk of premorbid undernutrition was associated with an increased risk of unfavorable outcome in a dose-response manner after adjusting for covariates. Conclusions This study demonstrated that GNRI was associated with poor prognosis in patients with acute ischemic stroke. GNRI may be used to screen patients at high risk for unfavorable outcome.	[Kang, Min Kyoung; Kim, Tae Jung; Nam, Ki-Woong; Jeong, Han-Yeong; Ko, Sang-Bae; Yoon, Byung-Woo] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Kang, Min Kyoung; Kim, Tae Jung; Ko, Sang-Bae; Yoon, Byung-Woo] Seoul Natl Univ, Dept Neurol, Coll Med, Seoul, South Korea; [Kim, Yerim] Hallym Univ, Kangdong Sacred Heart Hosp, Dept Neurol, Med Ctr, Seoul, South Korea; [Kim, Sung Kyung] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul, South Korea; [Lee, Ji Sung] Asan Med Ctr, Clin Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Hallym University; Seoul National University (SNU); Seoul National University Hospital; Samsung; University of Ulsan; Asan Medical Center	Yoon, BW (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea.; Yoon, BW (corresponding author), Seoul Natl Univ, Dept Neurol, Coll Med, Seoul, South Korea.	bwyoon@snu.ac.kr	Kim, Soo Young/GLR-4223-2022	Ko, Sang-Bae/0000-0002-9429-9597; MinKyoung, Kang/0000-0002-3598-8165	Ministry of Health and Welfare [HI 16C1078]	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Ministry of Health and Welfare (HI 16C1078), Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Aquilani R, 2011, NUTR CLIN PRACT, V26, P339, DOI 10.1177/0884533611405793; Aziz EF, 2011, HEART INT, V6, P3, DOI 10.4081/hi.2011.e2; Ballmer PE, 2001, CLIN NUTR, V20, P271, DOI 10.1054/clnu.2001.0439; Bharadwaj S, 2016, GASTROENTEROL REP, V4, P272, DOI 10.1093/gastro/gow013; Bo YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155903; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777, DOI 10.1093/ajcn/82.4.777; Cano N, 2000, ANN MED INTERNE, V151, P563; Cereda E, 2006, NUTRITION, V22, P680, DOI 10.1016/j.nut.2006.02.003; Chai J, 2008, SINGAP MED J, V49, P290; Davis JP, 2004, STROKE, V35, P1930, DOI 10.1161/01.STR.0000135227.10451.c9; Dennis M, 2003, STROKE, V34, P1450, DOI 10.1161/01.STR.0000074037.49197.8C; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; DOWEIKO JP, 1991, JPEN-PARENTER ENTER, V15, P476, DOI 10.1177/0148607191015004476; Ezzell L, 2000, AM J CLIN NUTR, V72, P1415; Finestone HM, 1996, ARCH PHYS MED REHAB, V77, P340, DOI 10.1016/S0003-9993(96)90081-7; Foley NC, 2009, STROKE, V40, pE66, DOI 10.1161/STROKEAHA.108.518910; Guigoz Y, 1996, NUTR REV, V54, pS59; Gyan E, 2017, JPEN J PARENTER ENTE; Jones CH, 1998, NEPHROL DIAL TRANSPL, V13, P393, DOI 10.1093/oxfordjournals.ndt.a027836; Kastin DA, 2002, CURR OPIN CLIN NUTR, V5, P699, DOI 10.1097/00075197-200211000-00014; Keusch GT, 2003, J NUTR, V133, p336S, DOI 10.1093/jn/133.1.336S; Kim S, 2014, NUTR NEUROSCI, V17, P138, DOI 10.1179/1476830513Y.0000000078; Kim Y, 2015, INT J STROKE, V10, P62, DOI 10.1111/ijs.12554; Kunimura A, 2017, J CARDIOL, V69, P383, DOI 10.1016/j.jjcc.2016.09.004; Kushiyama S, 2018, IN VIVO, V32, P1667, DOI 10.21873/invivo.11430; Lawson JA, 2001, J RENAL NUTR, V11, P16, DOI 10.1016/S1051-2276(01)85914-8; Le Bouc R, 2018, STROKE, V49, P1686, DOI 10.1161/STROKEAHA.117.020511; Lee JH, 2011, J CRIT CARE, V26, P287, DOI 10.1016/j.jcrc.2010.10.007; Prasad N, 2016, Indian J Nephrol, V26, P27, DOI 10.4103/0971-4065.158449; Rabadi MH, 2008, NEUROLOGY, V71, P1856, DOI 10.1212/01.wnl.0000327092.39422.3c; Sorensen RT, 2013, J NEUROSCI NURS, V45, P139, DOI 10.1097/JNN.0b013e31828a412c; Spatola L, 2019, J RENAL NUTR, V29, P438, DOI 10.1053/j.jrn.2019.01.012	33	22	22	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228738	10.1371/journal.pone.0228738	http://dx.doi.org/10.1371/journal.pone.0228738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053672	Green Published, gold			2022-12-26	WOS:000535198700052
J	Largent, EA; Harkins, K; van Dyck, CH; Hachey, S; Sankar, P; Karlawish, J				Largent, Emily A.; Harkins, Kristin; van Dyck, Christopher H.; Hachey, Sara; Sankar, Pamela; Karlawish, Jason			Cognitively unimpaired adults' reactions to disclosure of amyloid PET scan results	PLOS ONE			English	Article							APPROPRIATE USE CRITERIA; ALZHEIMERS-DISEASE; DEMENTIA; RISK; CARE; INSURANCE; BEHAVIOR; STIGMA; SAFETY	Importance Clinical guidelines currently recommend against amyloid imaging for cognitively unimpaired persons. The goal of Alzheimer's disease (AD) prevention, together with advances in understanding the pathophysiology of AD, however, has led to trials testing drugs in cognitively unimpaired persons who show evidence of AD biomarkers. Assuming the eventual success of such trials, millions of patients will be affected. There is a need to understand the effects of biomarker disclosure on those individuals. Design The Study of Knowledge and Reactions to Amyloid Testing (SOKRATES) involved 2 semi-structured telephone interviews with individuals who received amyloid PET scan results as part of screening for research participation. Post-disclosure interviews were conducted at 4 to 12 weeks and again 1 year later. Data were collected from November 5, 2014 to November 30, 2016. Interviews were transcribed and coded in NVivo 12.0. Participants 80 adults aged 65 and older: 50 who received "elevated" and 30 who received "not-elevated" amyloid PET scan results. Main outcomes Interviews examined four domains: (1) comprehension of the amyloid PET scan result; (2) implications of the result for sense of self, memory, and future; (3) sharing of results with others; and (4) AD risk-reduction behaviors. Results Participants who received an elevated amyloid PET scan result viewed the result as more serious and sensitive than other medical test results given its unique implications for identity, self-determination, and stigma. In contrast, participants who received a not-elevated amyloid PET scan result described feeling relief and reinterpreted perceived memory impairments as normal aging. Participants with elevated amyloid reported contemplating and making more changes to health behaviors and future plans than their peers with not-elevated amyloid. Conclusions Clinical practice in the diagnosis and treatment of persons with preclinical AD, a stage of the disease defined by the presence of biomarkers in the absence of cognitive impairment, will need to address matters of identity, stigma, and life-planning.	[Largent, Emily A.; Sankar, Pamela; Karlawish, Jason] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Harkins, Kristin; Karlawish, Jason] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [van Dyck, Christopher H.] Yale Univ, Sch Med, New Haven, CT USA; [Hachey, Sara] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Karlawish, Jason] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Pennsylvania Medicine	Largent, EA (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA.	elargent@pennmedicine.upenn.edu		Harkins, Kristin/0000-0001-5360-1043; Largent, Emily/0000-0002-7536-5077	Investigator-Initiated Research Grant "Study of Knowledge and Reactions to Amyloid Testing" from the Alzheimer's Association; National Institute on Aging [P30AG010124]; NIA [K01-AG064123]	Investigator-Initiated Research Grant "Study of Knowledge and Reactions to Amyloid Testing" from the Alzheimer's Association; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Investigator-Initiated Research Grant "Study of Knowledge and Reactions to Amyloid Testing" from the Alzheimer's Association awarded to Dr. Karlawish and by grant P30AG010124 from the National Institute on Aging (Dr. Karlawish, co-investigator). Dr. Largent is supported by NIA K01-AG064123. The funders had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; preparation or approval of the manuscript; and decision to submit the manuscript for publication.	[Anonymous], 2017, ADHD ATTENTION DE S1, V9, pS1, DOI 10.1007/s12402-017-0224-y; Arias JJ, 2018, J LAW MED ETHICS, V46, P485, DOI 10.1177/1073110518782955; Bemelmans SASA, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0212-z; Benbow SM, 2000, HOSP MED, V61, P174, DOI 10.12968/hosp.2000.61.3.1295; Brookmeyer R, 2018, ALZHEIMERS DEMENT, V14, P981, DOI 10.1016/j.jalz.2018.03.005; Burns JM, 2017, ALZHEIMERS DEMENT, V13, P1024, DOI 10.1016/j.jalz.2017.01.022; Caselli RJ, 2014, MAYO CLIN PROC, V89, P1389, DOI 10.1016/j.mayocp.2014.05.016; Chao S, 2008, ALZ DIS ASSOC DIS, V22, P94, DOI 10.1097/WAD.0b013e31815a9dcc; Chetelat G, 2013, NEUROIMAGE-CLIN, V2, P356, DOI 10.1016/j.nicl.2013.02.006; de Wilde A, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0398-3; Gaugler J, 2019, ALZHEIMERS DEMENT, V15, P321, DOI 10.1016/j.jalz.2019.01.010; Green RC, 2009, NEW ENGL J MED, V361, P245, DOI 10.1056/NEJMoa0809578; Grill JD, SHORT TERM PSYCHOL I; Grill JD, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0452-1; Grill JD, 2013, NEURODEGENER DIS MAN, V3, P43, DOI 10.2217/NMT.12.75; Harkins K, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0112-7; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Jack CR, 2016, NEUROLOGY, V87, P539, DOI 10.1212/WNL.0000000000002923; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Johnson KA, 2013, ALZHEIMERS DEMENT, V9, pE1, DOI [10.1016/j.jalz.2013.01.002, 10.1016/j.jalz.2012.10.007, 10.1016/j.jalz.2013.06.001]; Johnson KA, 2013, J NUCL MED, V54, P1011, DOI 10.2967/jnumed.113.127068; Kim H, 2019, PROG MOL BIOL TRANSL, V165, P401, DOI 10.1016/bs.pmbts.2019.05.002; Largent EA, 2019, JAMA NEUROL, V76, P631, DOI 10.1001/jamaneurol.2019.0165; Lim YY, 2016, ALZHEIMERS DEMENT, V12, P454, DOI 10.1016/j.jalz.2015.09.005; Lingler JH, 2013, ALZHEIMERS DEMENT, V9, P741, DOI 10.1016/j.jalz.2012.09.014; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mozersky J, 2018, JAMA NEUROL, V75, P44, DOI 10.1001/jamaneurol.2017.2954; Roberts JS, 2013, NEURODEGENER DIS MAN, V3, P219, DOI 10.2217/NMT.13.25; Shulman MB, 2013, NEUROLOGY, V81, P1114, DOI 10.1212/WNL.0b013e3182a55f4a; Sperling RA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007941; Stites SD, 2018, ALZHEIMERS DEMENT, V14, P925, DOI 10.1016/j.jalz.2018.01.006; Taswell C, 2018, MENT HLTH FAM MED, V14, P748; Volvo Group Magazine, 2016, VOLVO GROUP MAGAZINE, V2, P23; Wake T, 2018, INT PSYCHOGERIATR, V30, P635, DOI 10.1017/S1041610217002204; Zick CD, 2005, HEALTH AFFAIR, V24, P483, DOI 10.1377/hlthaff.24.2.483	35	38	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0229137	10.1371/journal.pone.0229137	http://dx.doi.org/10.1371/journal.pone.0229137			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KQ8WD	32053667	Green Published, gold			2022-12-26	WOS:000517201300001
J	Negre, CFA; Ushijima-Mwesigwa, H; Mniszewski, SM				Negre, Christian F. A.; Ushijima-Mwesigwa, Hayato; Mniszewski, Susan M.			Detecting multiple communities using quantum annealing on the D-Wave system	PLOS ONE			English	Article							OPTIMIZATION	A very important problem in combinatorial optimization is the partitioning of a network into communities of densely connected nodes; where the connectivity between nodes inside a particular community is large compared to the connectivity between nodes belonging to different ones. This problem is known as community detection, and has become very important in various fields of science including chemistry, biology and social sciences. The problem of community detection is a twofold problem that consists of determining the number of communities and, at the same time, finding those communities. This drastically increases the solution space for heuristics to work on, compared to traditional graph partitioning problems. In many of the scientific domains in which graphs are used, there is the need to have the ability to partition a graph into communities with the "highest quality" possible since the presence of even small isolated communities can become crucial to explain a particular phenomenon. We have explored community detection using the power of quantum annealers, and in particular the D-Wave 2X and 2000Q machines. It turns out that the problem of detecting at most two communities naturally fits into the architecture of a quantum annealer with almost no need of reformulation. This paper addresses a systematic study of detecting two or more communities in a network using a quantum annealer.	[Negre, Christian F. A.] Los Alamos Natl Lab, Theoret Div, Los Alamos, NM USA; [Ushijima-Mwesigwa, Hayato; Mniszewski, Susan M.] Los Alamos Natl Lab, Comp Computat & Stat Sci Div, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Mniszewski, SM (corresponding author), Los Alamos Natl Lab, Comp Computat & Stat Sci Div, Los Alamos, NM 87545 USA.	smm@lanl.gov	Mniszewski, Susan/AAX-2025-2020	Ushijima-Mwesigwa, Hayato/0000-0002-1442-3077	U.S. Department of Energy (DOE) National Nuclear Security Administration (NNSA) Advanced Simulation and Computing (ASC) program at Los Alamos National Laboratory (LANL); LANL Information Science and Technology Institute (ISTI), Laboratory Directed Research and Development (LDRD), and ASC program; U.S. Department of Energy [89233218NCA000001]	U.S. Department of Energy (DOE) National Nuclear Security Administration (NNSA) Advanced Simulation and Computing (ASC) program at Los Alamos National Laboratory (LANL); LANL Information Science and Technology Institute (ISTI), Laboratory Directed Research and Development (LDRD), and ASC program; U.S. Department of Energy(United States Department of Energy (DOE))	This research was supported by the U.S. Department of Energy (DOE) National Nuclear Security Administration (NNSA) Advanced Simulation and Computing (ASC) program at Los Alamos National Laboratory (LANL). This research has been funded by the LANL Information Science and Technology Institute (ISTI), Laboratory Directed Research and Development (LDRD), and ASC program. Assigned: Los Alamos Unclassified Report LA-UR-18-30760. LANL is operated by Triad National Security, LLC, for the National Nuclear Security Administration of U.S. Department of Energy (Contract No. 89233218NCA000001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albash T, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.031016; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Berend D, 2010, PROBAB MATH STAT-POL, V30, P185; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boettcher S, 2001, PHYS REV LETT, V86, P5211, DOI 10.1103/PhysRevLett.86.5211; Booth M, 2017, D WAVE TECH REP SER; Cafieri S, 2014, DISCRETE APPL MATH, V163, P65, DOI 10.1016/j.dam.2012.03.030; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Ding CHQ, 2001, 2001 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P107, DOI 10.1109/ICDM.2001.989507; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2016, PHYS REP, V659, P1, DOI 10.1016/j.physrep.2016.09.002; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Geron A, 2017, HANDS ON MACHINE LEA; Ghale P, 2017, SIAM J SCI COMPUT, V39, pC466, DOI 10.1137/16M109404X; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goldberg DE, 1989, GENETIC ALGORITHMS S, DOI DOI 10.1111/J.1365-2486.2009.02080.X; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kaur S, 2016, NEURAL NETW WORLD, V26, P625, DOI 10.14311/NNW.2016.26.036; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Knuth DE., 1993, STANFORD GRAPH BASE; Lanting T, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021041; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Negre CFA, 2018, P NATL ACAD SCI USA, V115, pE12201, DOI 10.1073/pnas.1810452115; Neukart F, 2018, FRONT PHYS-LAUSANNE, V6, DOI 10.3389/fphy.2018.00055; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Niklasson AMN, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4952650; Rivalta I, 2012, P NATL ACAD SCI USA, V109, pE1428, DOI 10.1073/pnas.1120536109; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Ugander J., 2011, ARXIV11114503; Ushijima-Mwesigwa H, 2017, PROCEEDINGS OF 2ND INTERNATIONAL WORKSHOP ON POST MOORE'S ERA SUPERCOMPUTING (PMES 2017), P22, DOI 10.1145/3149526.3149531; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wei H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1388; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	41	12	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0227538	10.1371/journal.pone.0227538	http://dx.doi.org/10.1371/journal.pone.0227538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053622	Green Submitted, gold, Green Published			2022-12-26	WOS:000535198700013
J	Lively, A; Minard, LV; Scott, S; Deal, H; Lambourne, T; Giffin, J				Lively, Allison; Minard, Laura, V; Scott, Samantha; Deal, Heidi; Lambourne, Tessa; Giffin, Jenn			Exploring the perspectives of healthcare professionals in delivering optimal oncology medication education	PLOS ONE			English	Article							RELATING INFORMATION-NEEDS; QUALITY-OF-LIFE; BREAST-CANCER; PATIENT; SATISFACTION; CHEMOTHERAPY; PHARMACISTS; EXPERIENCE	Background To optimize patient education, it is important to understand what healthcare professionals perceive to be ideal oncology medication education for patients to receive, and what they feel is their role and the role of others in its delivery. Education provided to patients is an important component of chemotherapy as it has been shown to benefit and positively impact patients who receive it. Educational interventions are often provided by multidisciplinary teams with the goal of improving patient care. However, few studies have explored the roles of healthcare professionals in delivering oncology medication education. Objective To explore the perspectives of healthcare professionals working in medical, gynaecological or hematological oncology to identify what they perceive to be optimal oncology medication education for patients. Methods Healthcare professionals (physicians, nurses and pharmacists) working in medical, gynaecological or hematological oncology at the Nova Scotia Health Authority, Central Zone were invited to participate in one-on-one, semi-structured interviews which were audio-recorded, transcribed and analyzed using thematic analysis. Findings Fifteen interviews, including five physicians, four nurses and six pharmacists were conducted from February to April 2018. Four major themes were identified: Delivery of oncology medication education, Facilitating the patient learning process, Multidisciplinary Approach and Understanding barriers to the healthcare professional in providing education. Conclusion The identified themes uncovered novel ideas about how healthcare professionals felt oncology medication education could ideally be delivered to patients, and supported findings in the literature. Although participants discussed barriers to their ability to deliver optimal education, they also identified ways in which they can facilitate patient learning, for example, through the reinforcement of education. Participants recognized the importance of increasing collaboration and communication with the multidisciplinary team. This research will inform the design of any new models for oncology medication education at the Nova Scotia Health Authority, Central Zone and potentially other sites.	[Lively, Allison; Minard, Laura, V; Scott, Samantha] QEII Hlth Sci Ctr, Dept Pharm, Nova Scotia Hlth Author Cent Zone, Halifax, NS, Canada; [Deal, Heidi] Dalhousie Univ, Coll Pharm, Halifax, NS, Canada; [Lambourne, Tessa] Aberdeen Reg Hosp, Dept Pharm, Nova Scotia Hlth Author Northern Zone, New Glasgow, NS, Canada; [Giffin, Jenn] QEII Hlth Sci Ctr, Nova Scotia Hlth Author Cent Zone, Halifax, NS, Canada	Queen Elizabeth II Health Sciences Centre; Dalhousie University; Queen Elizabeth II Health Sciences Centre	Lively, A (corresponding author), QEII Hlth Sci Ctr, Dept Pharm, Nova Scotia Hlth Author Cent Zone, Halifax, NS, Canada.	Allisona.lively@nshealth.ca						Ahmadidarrehsima Sudabeh, 2016, Asian Pac J Cancer Prev, V17, P4555; [Anonymous], 2017, CHEM WORKS; [Anonymous], 2009, STAND PRACT ONC PHAR; Arber A, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12413; Barbour SY, 2008, AM J HEALTH-SYST PH, V65, pS16, DOI 10.2146/ajhp080090; Basch E, 2016, J CLIN ONCOL, V34, P557, DOI 10.1200/JCO.2015.63.0830; Capirci C, 2005, PATIENT EDUC COUNS, V56, P174, DOI 10.1016/j.pec.2004.02.006; Chung C, 2011, AM J HEALTH-SYST PH, V68, P1740, DOI 10.2146/ajhp100626; Cohen MR, 1996, AM J HEALTH-SYST PH, V53, P737, DOI 10.1093/ajhp/53.7.737; DiCicco-Bloom B, 2006, MED EDUC, V40, P314, DOI 10.1111/j.1365-2929.2006.02418.x; Divakaruni A, 2018, J ONCOL PHARM PRACT, V24, P337, DOI 10.1177/1078155217703790; Dohler N, 2011, PATIENT EDUC COUNS, V83, P367, DOI 10.1016/j.pec.2011.03.002; Donald G, 2017, J ONCOL PHARM PRACT; Esper P, 2015, J AM ASSOC NURSE PRA, V27, P308, DOI 10.1002/2327-6924.12169; FREDETTE SL, 1990, CANCER NURS, V13, P207, DOI 10.1097/00002820-199008000-00001; Gourdji I, 2003, J NURS CARE QUAL, V18, P43, DOI 10.1097/00001786-200301000-00007; Harris KA, 1998, CANCER PRACT, V6, P39, DOI 10.1046/j.1523-5394.1998.1998006039.x; Heisig SR, 2015, PSYCHO-ONCOLOGY, V24, P130, DOI 10.1002/pon.3611; Holloway S, 2012, CL LYMPH MYELOM LEUK, V12, P88, DOI 10.1016/j.clml.2011.10.004; Husson O, 2011, ANN ONCOL, V22, P761, DOI 10.1093/annonc/mdq413; Husson O, 2013, PSYCHO-ONCOLOGY, V22, P490, DOI 10.1002/pon.3042; Arraras JI, 2010, EUR J CANCER, V46, P2726, DOI 10.1016/j.ejca.2010.06.118; Iskandarsyah A, 2013, SUPPORT CARE CANCER, V21, P2999, DOI 10.1007/s00520-013-1877-5; Kaupp K, 2019, J ONCOL PHARM PRACT; Lambourne T, 2018, J CANC ED; Liekweg A, 2005, PHARM WORLD SCI, V27, P96, DOI 10.1007/s11096-004-5337-7; Morse J. M., 1995, QUALITATIVE RES METH; Ortlipp M, 2008, QUAL REP, V13, P695; Piredda M, 2008, EUR J ONCOL NURS, V12, P120, DOI 10.1016/j.ejon.2007.10.004; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Schrag D, 2007, J CLIN ONCOL, V25, P233, DOI 10.1200/JCO.2006.09.2437; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Thoma J, 2016, INT J CLIN PHARM-NET, V38, P855, DOI 10.1007/s11096-016-0297-2; Timmers L, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3110-2; Van der Molen B, 2000, EUR J CANCER CARE, V9, P41; Van der Molen B, 2000, EUR J CANCER CARE, V9, P48; Viele CS, 2007, AM J HEALTH-SYST PH, V64, pS25, DOI 10.2146/ajhp070037; Willis J.W., 2007, FDN QUALITATIVE RES; Yildirim S, 2018, J CANC ED	39	4	6	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228571	10.1371/journal.pone.0228571	http://dx.doi.org/10.1371/journal.pone.0228571			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7PV	32049970	Green Published, gold			2022-12-26	WOS:000535192300016
J	Dufresne, S; Gueritat, J; Chiavassa, S; Noblet, C; Assi, M; Rioux-Leclercq, N; Rannou-Bekono, F; Lefeuvre-Orfila, L; Paris, F; Rebillard, A				Dufresne, Suzanne; Gueritat, Jordan; Chiavassa, Sophie; Noblet, Caroline; Assi, Mohamad; Rioux-Leclercq, Nathalie; Rannou-Bekono, Francoise; Lefeuvre-Orfila, Luz; Paris, Francois; Rebillard, Amelie			Exercise training improves radiotherapy efficiency in a murine model of prostate cancer	FASEB JOURNAL			English	Article						oncology; physical activity; radiation therapy; treatment	RUNNING WHEEL EXERCISE; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; AEROBIC EXERCISE; MAMMARY CARCINOGENESIS; CONTROLLED-TRIAL; NK CELLS; PROGRESSION; TUMORS; MECHANISMS	Engaging in exercise while undergoing radiotherapy (RT) has been reported to be safe and achievable. The impact of exercise training (ET) on RT efficiency is however largely unknown. Our study aims to investigate the interactions between ET and RT on prostate cancer growth. Athymic mice received a subcutaneous injection of PPC-1 cells and were randomly assigned to either cancer control, cancer ET, cancer RT, or cancer RT combined with ET (CaRT-ET). Mice were sacrificed 24 days post-injection. All three intervention groups had reduced tumor size, the most important decrease being observed in CaRT-ET mice. Apoptotic marker cleaved caspase-3 was not modified by ET, but enhanced with RT. Importantly, this increase was the highest when the two strategies were combined. Furthermore, NK1.1 staining and gene expression of natural killer (NK) cell receptors Klrk1 and Il2r beta were not affected by ET alone but were increased with RT, this effect being potentiated when combined with ET. Overall, our study shows that (a) ET enhances RT efficiency by potentiating NK cell infiltration, and (b) while ET alone and ET combined with RT both reduce tumor growth, the mechanisms mediating these effects are different.	[Dufresne, Suzanne; Gueritat, Jordan; Assi, Mohamad; Rannou-Bekono, Francoise; Lefeuvre-Orfila, Luz; Rebillard, Amelie] Univ Rennes 2, ENS Rennes, EA 1274, Movement Sport & Hlth Sci Lab, Bruz, France; [Chiavassa, Sophie; Noblet, Caroline; Paris, Francois] Univ Nantes, Univ Angers, INSERM, CRCINA, Nantes, France; [Chiavassa, Sophie; Noblet, Caroline; Paris, Francois] Ouest Ctr Rene Gauducheau, Inst Cancerol, St Herblain, France; [Rioux-Leclercq, Nathalie] Univ Rennes 1, Dept Pathol Anat & Cytol, Rennes, France	Ecole Normale Superieure de Rennes (ENS Rennes); Universite Rennes 2; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Universite d'Angers; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Universite de Rennes	Dufresne, S; Rebillard, A (corresponding author), Sport & Hlth Sci Lab, EA 1274, Campus Ker Lann,Ave Robert Schuman, F-35170 Bruz, France.	suzanne.dufresne@ens-rennes.fr; amelie.rebillard@univ-rennes2.fr	Paris, francois E/L-4915-2015	Paris, francois E/0000-0002-0176-7348	Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche (MENESR)	Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche (MENESR)	Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche (MENESR)	Acosta AM, 2018, HUM PATHOL, V75, P1, DOI 10.1016/j.humpath.2017.11.015; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aoi W, 2013, GUT, V62, P882, DOI 10.1136/gutjnl-2011-300776; Ashcraft KA, 2019, SEMIN RADIAT ONCOL, V29, P16, DOI 10.1016/j.semradonc.2018.10.001; Ashcraft KA, 2016, CANCER RES, V76, P4032, DOI 10.1158/0008-5472.CAN-16-0887; Baumfalk DR, 2019, J APPL PHYSIOL, V126, P668, DOI 10.1152/japplphysiol.00829.2018; Betof AS, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv040; Bonn SE, 2015, CANCER EPIDEM BIOMAR, V24, P57, DOI 10.1158/1055-9965.EPI-14-0707; Bray F, 2018, CA CANC J CLIN; Cantoni C, 2016, J IMMUNOL RES, V2016, P1; Chamie K, 2015, JAMA ONCOL, V1, P60, DOI 10.1001/jamaoncol.2014.192; Cooperberg MR, 2010, J CLIN ONCOL, V28, P1117, DOI 10.1200/JCO.2009.26.0133; DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1; Dayanc BE, 2008, INT J HYPERTHER, V24, P41, DOI 10.1080/02656730701858297; Domanska-Senderowska D, 2019, INT J SPORTS MED, V40, P227, DOI 10.1055/a-0824-4813; Dufresne S, 2018, CANCER EPIDEM BIOMAR, V27, P11, DOI 10.1158/1055-9965.EPI-16-0969; Eisemann N, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0025-6; Esser KA, 2009, PROSTATE, V69, P1372, DOI 10.1002/pros.20987; Feng X, 2015, ONCOTARGET, V6, P32353, DOI 10.18632/oncotarget.5898; Finne E, 2018, CANCER MANAG RES, V10, P5125, DOI 10.2147/CMAR.S170064; Meneses-Echavez JF, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2733-z; Galvao DA, 2018, MED SCI SPORT EXER, V50, P393, DOI 10.1249/MSS.0000000000001454; Gannon NP, 2015, INT J CANCER, V136, pE197, DOI 10.1002/ijc.29142; Garcia E, 2016, J APPL PHYSIOL, V121, P15, DOI 10.1152/japplphysiol.00266.2016; Gueritat J, 2014, FREE RADICAL BIO MED, V77, P95, DOI 10.1016/j.freeradbiomed.2014.09.009; Guo NN, 2018, ONCOL LETT, V16, P6045, DOI 10.3892/ol.2018.9399; Heywood R, 2017, SUPPORT CARE CANCER, V25, P3031, DOI 10.1007/s00520-017-3827-0; Hojman P, 2011, AM J PHYSIOL-ENDOC M, V301, pE504, DOI 10.1152/ajpendo.00520.2010; Idorn M, 2016, TRENDS MOL MED, V22, P565, DOI 10.1016/j.molmed.2016.05.007; IJsbrandy C, 2018, CRIT REV ONCOL HEMAT, V122, P157, DOI 10.1016/j.critrevonc.2017.09.005; Isanejad A, 2016, LIFE SCI, V151, P30, DOI 10.1016/j.lfs.2016.02.090; Jones LW, 2012, J APPL PHYSIOL, V113, P263, DOI 10.1152/japplphysiol.01575.2011; Jones LW, 2005, CLIN CANCER RES, V11, P6695, DOI 10.1158/1078-0432.CCR-05-0844; Karamanolis G, 2013, Mediators Inflamm, V2013, P515048, DOI 10.1155/2013/515048; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kaur P, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00191; Kenfield SA, 2011, J CLIN ONCOL, V29, P726, DOI 10.1200/JCO.2010.31.5226; Knols R, 2005, J CLIN ONCOL, V23, P3830, DOI 10.1200/JCO.2005.02.148; Koukourakis MI, 2001, ANTICANCER RES, V21, P4285; Larsen Stine K., 2014, Critical Reviews in Oncogenesis, V19, P91; Lin SC, 2012, J CLIN ENDOCR METAB, V97, pE1515, DOI 10.1210/jc.2012-1450; Liu FF, 2018, ACTA PHARM SIN B, V8, P552, DOI 10.1016/j.apsb.2018.01.008; Mah AY, 2016, CRIT REV IMMUNOL, V36, P131, DOI 10.1615/CritRevImmunol.2016017387; McCullough DJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju036; McCullough DJ, 2013, J APPL PHYSIOL, V115, P1846, DOI 10.1152/japplphysiol.00949.2013; Mina DS, 2013, CUAJ-CAN UROL ASSOC, V7, pE692, DOI 10.5489/cuaj.235; Monga U, 2007, ARCH PHYS MED REHAB, V88, P1416, DOI 10.1016/j.apmr.2007.08.110; Park B, 2014, INT J MOL SCI, V15, P927, DOI 10.3390/ijms15010927; Pedersen L, 2016, CELL METAB, V23, P554, DOI 10.1016/j.cmet.2016.01.011; Pedersen L, 2015, CANCER J, V21, P111, DOI 10.1097/PPO.0000000000000096; Peeken JC, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00132; Phillips SM, 2015, J CANCER SURVIV, V9, P500, DOI 10.1007/s11764-015-0426-2; Quarmby S, 1999, ARTERIOSCL THROM VAS, V19, P588, DOI 10.1161/01.ATV.19.3.588; Reefman E, 2010, J IMMUNOL, V184, P4852, DOI 10.4049/jimmunol.0803954; Richman EL, 2011, CANCER RES, V71, P3889, DOI 10.1158/0008-5472.CAN-10-3932; Roth AJ, 2008, FUTURE ONCOL, V4, P561, DOI 10.2217/14796694.4.4.561; Sak K, 2018, ANTICANCER RES, V38, P6209, DOI 10.21873/anticanres.12975; Schadler KL, 2016, ONCOTARGET, V7, P65429, DOI 10.18632/oncotarget.11748; Schmitz KH, 2010, MED SCI SPORT EXER, V42, P1409, DOI 10.1249/MSS.0b013e3181e0c112; Segal RJ, 2009, J CLIN ONCOL, V27, P344, DOI 10.1200/JCO.2007.15.4963; SHEPHARD RJ, 1994, BRIT J SPORT MED, V28, P247, DOI 10.1136/bjsm.28.4.247; Shephard RJ, 2010, EXERC IMMUNOL REV, V16, P194; Smith DP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4817; Smyth MJ, 2005, MOL IMMUNOL, V42, P501, DOI 10.1016/j.molimm.2004.07.034; Sturgeon K, 2014, AM J PHYSIOL-REG I, V307, pR685, DOI 10.1152/ajpregu.00082.2014; Truong PT, 2011, AM J CLIN ONCOL-CANC, V34, P350, DOI 10.1097/COC.0b013e3181e841ec; UHLENBRUCK G, 1991, INT J SPORTS MED, V12, pS63, DOI 10.1055/s-2007-1024753; Urgard E, 2017, NUCLEIC ACID THER, V27, P295, DOI 10.1089/nat.2017.0670; Vandersluis AD, 2013, PROSTATE, V73, P1223, DOI 10.1002/pros.22673; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P64; Windsor PM, 2004, CANCER, V101, P550, DOI 10.1002/cncr.20378; Zhang Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0131-3; Zheng X, 2008, ONCOL REP, V19, P1583; Zheng X, 2012, NUTR CANCER, V64, P1029, DOI 10.1080/01635581.2012.716899; Zheng X, 2011, EXP THER MED, V2, P221, DOI 10.3892/etm.2011.203; Zhu ZJ, 2008, CANCER EPIDEM BIOMAR, V17, P1920, DOI 10.1158/1055-9965.EPI-08-0175; Zhu ZJ, 2012, CANCER PREV RES, V5, P414, DOI 10.1158/1940-6207.CAPR-11-0454	77	11	11	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4984	4996		10.1096/fj.201901728R	http://dx.doi.org/10.1096/fj.201901728R		FEB 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32043634				2022-12-26	WOS:000512671900001
J	French, AD; Shaw, K; Barnes, M; Canas-Carrell, JE; Conway, WC; Klein, DM				French, Amanda D.; Shaw, Katherine; Barnes, Melanie; Canas-Carrell, Jaclyn E.; Conway, Warren C.; Klein, David M.			Bioaccessibility of antimony and other trace elements from lead shot pellets in a simulated avian gizzard environment	PLOS ONE			English	Article							WOODCOCK SCOLOPAX-MINOR; UPLAND GAME BIRDS; AMERICAN WOODCOCK; RISK-ASSESSMENT; GRIT-USE; WINTERING WATERFOWL; ISOTOPE RATIOS; INGESTION; BIOAVAILABILITY; TOXICITY	Many studies have used grit (in the form of lead (Pb) pellets) presence in avian gizzards as an indicator of Pb shot exposure. However, due to nearly complete pellet absorption in gizzards or rapid passage of pellets, the absence of Pb shot presence in a gizzard does not confirm lack of Pb shot exposure. This study provides the basis for an additional technique to identify if elevated tissue Pb concentration is due to Pb shot exposure. Bioaccessibility of Pb and trace elements (Sb, As, and Sn) present in Pb shot were quantified to determine if any of these elements would be useful as a secondary marker of Pb shot exposure. An avian physiologically based extraction test (PBET) was used to determine pellet dissolution rate and bioaccessible concentrations of Pb, Sb, As, and Sn in a simulated gizzard environment. Of the three trace elements, only Sb concentrations (44-302 mu g/mL) extracted into the gizzard solution were greater than environmental background levels (US soil average 0.48 mu g/g); thus, no natural source likely provides this amount of Sb. Therefore, there is evidence that Sb can be extracted from Pb shot in bird gizzards at detectable concentrations (above natural background). While further studies are needed to delineate the mechanisms of absorption and distribution, this study lends credence to the hypothesis that Sb may be a useful marker of Pb shot exposure in biological tissues, particularly when Pb pellets are not present nor observed in avian tissues.	[French, Amanda D.; Shaw, Katherine; Canas-Carrell, Jaclyn E.; Klein, David M.] Texas Tech Univ, Inst Environm & Human Hlth, Dept Environm Toxicol, Lubbock, TX 79409 USA; [Barnes, Melanie] Texas Tech Univ, Dept Geosci, Lubbock, TX 79409 USA; [Conway, Warren C.] Texas Tech Univ, Dept Nat Resources Management, Lubbock, TX 79409 USA; [French, Amanda D.] Univ Waikato, Sch Sci, Hamilton, New Zealand	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; University of Waikato	French, AD (corresponding author), Texas Tech Univ, Inst Environm & Human Hlth, Dept Environm Toxicol, Lubbock, TX 79409 USA.; French, AD (corresponding author), Univ Waikato, Sch Sci, Hamilton, New Zealand.	amanda.french@waikato.ac.nz		French, Amanda D/0000-0002-8417-6091; Canas-Carrell, Jaclyn/0000-0002-0740-3182; Shaw, Katherine/0000-0002-7918-5890	Graduate School at Texas Tech University; Department of Environmental Toxicology; Rumsey Research and Development Fund; Bricker Endowment for Wildlife Management	Graduate School at Texas Tech University; Department of Environmental Toxicology; Rumsey Research and Development Fund; Bricker Endowment for Wildlife Management	Funding for this research was provided in part through the Graduate School at Texas Tech University and the Department of Environmental Toxicology, the Rumsey Research and Development Fund, and the Bricker Endowment for Wildlife Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadin H, 1998, TOXIC SUBST DIS REGI, P582, DOI DOI 10.1201/9781420061888_CH106; Adan EG, 2013, ARCH ENVIRON CON TOX, V65, P588, DOI 10.1007/s00244-013-9921-5; Amereih S, 2005, J ENVIRON MONITOR, V7, P1200, DOI 10.1039/b510321e; Anawar HM, 2011, ENVIRON GEOCHEM HLTH, V33, P353, DOI 10.1007/s10653-011-9378-2; Ansara-Ross TM, 2013, ECOTOXICOLOGY, V22, P1072, DOI 10.1007/s10646-013-1095-4; Bannon DI, 2009, ENVIRON SCI TECHNOL, V43, P9071, DOI 10.1021/es901834h; Baxter CE, 2015, ENVIRON TOXICOL CHEM, V34, P1505, DOI 10.1002/etc.2917; Bellrose F. C., 1959, B ILLINOIS NAT HIST, V27, P236; Berny P, 2015, ECOTOX ENVIRON SAFE, V118, P71, DOI 10.1016/j.ecoenv.2015.04.003; BEST LB, 1991, WILSON BULL, V103, P68; BEST TL, 1992, SOUTHWEST NAT, V37, P287, DOI 10.2307/3671871; Binkowski LJ, 2015, CHEMOSPHERE, V127, P101, DOI 10.1016/j.chemosphere.2015.01.003; BUERGER TT, 1986, J WILDLIFE MANAGE, V50, P1, DOI 10.2307/3801479; Buser M, 2017, TOXICOLOGICAL PROFIL; Chou S., 2007, TOXICOLOGICAL PROFIL; Church ME, 2006, ENVIRON SCI TECHNOL, V40, P6143, DOI 10.1021/es060765s; DAMRON BL, 1975, B ENVIRON CONTAM TOX, V14, P489, DOI 10.1007/BF01705517; De Francisco N, 2003, AVIAN PATHOL, V32, P3, DOI 10.1080/0307945021000070660; Denbow D. Michael, 2000, P299, DOI 10.1016/B978-012747605-6/50013-4; ECHA-European Chemicals Agency, 2021, ANN 15 RESTR REP LEA; Environmental Protection Agency, 1993, US WILDL EXP FACT HD, VI; Finkelstein ME, 2010, ENVIRON SCI TECHNOL, V44, P2639, DOI 10.1021/es903176w; Finkelstein ME, 2014, ENVIRON RES, V134, P270, DOI 10.1016/j.envres.2014.07.022; Finkelstein ME, 2012, P NATL ACAD SCI USA, V109, P11449, DOI 10.1073/pnas.1203141109; Fisher IJ, 2006, BIOL CONSERV, V131, P421, DOI 10.1016/j.biocon.2006.02.018; Flynn HC, 2003, ENVIRON POLLUT, V124, P93, DOI 10.1016/S0269-7491(02)00411-6; French AD, 2017, THESIS; French AD, 2017, B ENVIRON CONTAM TOX, V99, P287, DOI 10.1007/s00128-017-2137-z; Friend M., 1999, LEAD FIELD MANUAL WI; Frost GE, 1990, B AMMUNITION MAKING, P34; Furman O, 2006, J ENVIRON QUAL, V35, P450, DOI 10.2134/jeq2005.0316; Gerstenberger S, 2006, NEVADA J PUBLIC HLTH, V3; Gil-Jimenez E, 2017, SCI TOTAL ENVIRON, V583, P440, DOI 10.1016/j.scitotenv.2017.01.098; GIONFRIDDO JP, 1995, CONDOR, V97, P57, DOI 10.2307/1368983; Gionfriddo JP, 1996, WILSON BULL, V108, P685; Haig SM, 2014, CONDOR, V116, P408, DOI 10.1650/CONDOR-14-36.1; Harper C., 2005, TOXICOLOGICAL PROFIL; He MC, 2012, SCI TOTAL ENVIRON, V421, P41, DOI 10.1016/j.scitotenv.2011.06.009; Isomursu M, 2018, AMBIO, V47, P858, DOI 10.1007/s13280-018-1052-9; Ito S, 2006, SCI TOTAL ENVIRON, V368, P397, DOI 10.1016/j.scitotenv.2005.09.044; Jin ZF, 2015, CHEMOSPHERE, V119, P1247, DOI 10.1016/j.chemosphere.2014.09.100; JORGENSEN SS, 1987, AMBIO, V16, P11; Kendall RJ, 1996, ENVIRON TOXICOL CHEM, V15, P4, DOI 10.1002/etc.5620150103; Kerr R, 2010, ENVIRON TOXICOL CHEM, V29, P2869, DOI 10.1002/etc.355; KIMBALL WH, 1971, J WILDLIFE MANAGE, V35, P360, DOI 10.2307/3799614; Komarek M, 2008, ENVIRON INT, V34, P562, DOI 10.1016/j.envint.2007.10.005; Kreager N, 2008, ARCH ENVIRON CON TOX, V54, P331, DOI 10.1007/s00244-007-9020-6; Krone O., 2018, BIRDS PREY BIOL CONS, P251, DOI 10.1007/978-3-319-73745-4_; Krone O, 2019, AMBIO, V48, P1065, DOI 10.1007/s13280-019-01183-0; Larsen RT, 2007, WEST N AM NATURALIST, V67, P152, DOI 10.3398/1527-0904(2007)67[152:GSPACO]2.0.CO;2; Levengood JM, 2001, ECOTOXICOLOGY, V10, P299, DOI 10.1023/A:1016763418647; Lewis LA, 2001, ARCH ENVIRON CON TOX, V41, P208; Li JN, 2014, ECOTOX ENVIRON SAFE, V110, P308, DOI 10.1016/j.ecoenv.2014.09.009; Mann MJ, 1994, ASS FIREARM TOOLMARK, V26, P223; Martinez-Haro M, 2009, ENVIRON SCI TECHNOL, V43, P9480, DOI 10.1021/es901960e; Mateo R, 1998, ARCH ENVIRON CON TOX, V35, P342, DOI 10.1007/s002449900385; Mateo Rafael, 2009, P71; Mateo-Tomas P, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0662; Pain D.J., 1992, IWRB Special Publication, P7; Pain D. J., 2015, P OXF LEAD S LEAD AM, P58; Pain DJ, 2019, AMBIO, V48, P935, DOI 10.1007/s13280-019-01159-0; Pain Deborah J., 2009, P99, DOI 10.4080/ilsa.2009.0108; Patnaik P, 2003, HDB INORGANIC CHEM, P1; Pattee OH, 2007, HDB ECOTOXICOLOGY, P373; Qi CC, 2008, SCI TOTAL ENVIRON, V389, P225, DOI 10.1016/j.scitotenv.2007.09.007; Rooney CP, 2007, ENVIRON POLLUT, V149, P149, DOI 10.1016/j.envpol.2007.01.009; RUBY MV, 1992, ENVIRON SCI TECHNOL, V26, P1242, DOI 10.1021/es50002a614; Ruby MV, 1996, ENVIRON SCI TECHNOL, V30, P422, DOI 10.1021/es950057z; Sangster D. F., 2000, Environmental Reviews, V8, P115, DOI 10.1139/a00-008; Scheuhammer AM, 2003, ENVIRON TOXICOL CHEM, V22, P2585, DOI 10.1897/02-361; Scheuhammer AM, 1998, ECOTOXICOLOGY, V7, P37, DOI 10.1023/A:1008855617453; Schulz JH, 2012, 2011 MOURNING DOVE H; Stevenson AL, 2005, ARCH ENVIRON CON TOX, V48, P405, DOI 10.1007/s00244-004-0044-x; Storgaard S, 1987, AMBIO, V16, P11; Strom Sean M., 2009, P194; Strom SM, 2005, ARCH ENVIRON CON TOX, V49, P396, DOI 10.1007/s00244-005-7063-0; Sutherland RA, 2000, ENVIRON POLLUT, V110, P483, DOI 10.1016/S0269-7491(99)00311-5; Svanberg F, 2006, SCI TOTAL ENVIRON, V370, P416, DOI 10.1016/j.scitotenv.2006.07.006; Telford K, 2008, J ENVIRON MONITOR, V10, P136, DOI [10.1039/b715465h, 10.1039/B715465H]; Tranel Molly A., 2009, P318, DOI 10.4080/ilsa.2009.0307; TROST RE, 1981, J WILDLIFE MANAGE, V45, P64, DOI 10.2307/3807874; Vermillion B, 2005, J PALEOLIMNOL, V33, P189, DOI 10.1007/s10933-004-4078-x; Vest JL, 2009, ARCH ENVIRON CON TOX, V56, P302, DOI 10.1007/s00244-008-9184-8; von Uexkull O, 2005, J CLEAN PROD, V13, P19, DOI 10.1016/j.jclepro.2003.10.008; Vyas NB, 2001, ENVIRON POLLUT, V111, P135, DOI 10.1016/S0269-7491(99)00333-4; Vyas NB, 2000, ENVIRON POLLUT, V107, P159, DOI 10.1016/S0269-7491(99)00112-8; Walraven N, 2015, SCI TOTAL ENVIRON, V506, P149, DOI 10.1016/j.scitotenv.2014.10.118	87	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0229037	10.1371/journal.pone.0229037	http://dx.doi.org/10.1371/journal.pone.0229037			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045468	Green Published, gold			2022-12-26	WOS:000534633200053
J	Long, JC; Dalton, S; Arnolda, G; Ting, HP; Molloy, CJ; Hibbert, PD; Wiles, LK; Craig, S; Warwick, M; Churruca, K; Ellis, LA; Braithwaite, J				Long, Janet C.; Dalton, Sarah; Arnolda, Gaston; Ting, Hsuen P.; Molloy, Charlotte J.; Hibbert, Peter D.; Wiles, Louise K.; Craig, Simon; Warwick, Meagan; Churruca, Kate; Ellis, Louise A.; Braithwaite, Jeffrey		CareTrack Kids Investigative Team	Guideline adherence in the management of head injury in Australian children: A population-based sample survey	PLOS ONE			English	Article							HEALTH-CARE; VICTORIA; QUALITY; TRAUMA	Background Head injuries in children are a common and potentially devastating presentation. The Care-Track Kids (CTK) study assessed care of Australian children aged 0-15 years, in 2012 and 2013, to evaluate the proportion in line with guideline-based indicators for 17 common conditions. Overall adherence to guideline-based recommended practice occurred 59.8% of care encounters (95% CI: 57.5-62.0), and 78.3% (95% CI: 75.1-81.2) for head injury. This paper presents results for head injury, at indicator level. Methods A modified version of the RAND-UCLA method of indicator development was used. Indicators, measurable components of a standard or guideline, were developed from international and national guidelines relating to head injury in children and were ratified by clinical experts using a Delphi process. Paediatric nurses extracted data from medical records from general practitioners (GPs), emergency departments (EDs) and inpatient wards in Queensland, New South Wales and South Australia, for children under 15 years receiving care in 2012-13. Our purpose was to estimate the percentage adherent for each indicator. Results The medical records of 629 children with head injury were examined. Fifty-one percent of children were under 5 years old, with more males (61%) than females. Thirty-eight indicators were assessed. Avoidance of nasotracheal airways (100%; 95% CI: 99.4-100) or nasogastric tubes (99.7%; 95% CI: 98.5-100) for children with a head injury had the highest adherence. Indicators relating to primary and secondary assessment of head injuries were mostly adhered to. However, adherence to other indicators was poor (e.g., documentation of the past history of children (e.g., presence or absence of seizures) before the injury; 29.9% (95% CI: 24.5-35.7)), and for others was difficult to estimate with confidence due to small sample sizes (e.g., Children with a head injury who were intubated had PaO2 above 80mm Hg; 56.0% (95% CI: 28.6-80.9)). Indicators guiding clinical decision making regarding the need for CT scan had insufficient data to justify reporting. Conclusion This study highlights that management of head injury in children mostly follows guidelines, but also flags some specific areas of inconsistency. Individual sites are encouraged to use these results to guide investigation of local practices and inform quality improvement endeavours.	[Long, Janet C.; Arnolda, Gaston; Ting, Hsuen P.; Molloy, Charlotte J.; Hibbert, Peter D.; Wiles, Louise K.; Warwick, Meagan; Churruca, Kate; Ellis, Louise A.; Braithwaite, Jeffrey] Macquarie Univ, Australian Inst Hlth Innovat, Sydney, NSW, Australia; [Dalton, Sarah] Childrens Hosp Westmead, Emergency Dept, Sydney, NSW, Australia; [Dalton, Sarah] Agcy Clin Innovat, Sydney, NSW, Australia; [Molloy, Charlotte J.; Hibbert, Peter D.; Wiles, Louise K.] Univ South Australia, Canc Res Inst, Australian Ctr Precis Hlth, Adelaide, SA, Australia; [Hibbert, Peter D.; Wiles, Louise K.] South Australian Hlth & Med Res Inst SAHMRI, Adelaide, SA, Australia; [Craig, Simon] Monash Univ, Sch Clin Sci, Dept Paediat, Monash Hlth, Melbourne, Vic, Australia	Macquarie University; University of Sydney; University of South Australia; South Australian Health & Medical Research Institute (SAHMRI); Monash University	Braithwaite, J (corresponding author), Macquarie Univ, Australian Inst Hlth Innovat, Sydney, NSW, Australia.	jeffrey.braithwaite@mq.edu.au	Churruca, Kate/H-8623-2019; Arnolda, Gaston R/D-8528-2017; Craig, Simon/H-9410-2019; Braithwaite, Jeffrey/AAN-1467-2020; Wiles, Louise/I-3014-2015	Churruca, Kate/0000-0002-9923-3116; Arnolda, Gaston R/0000-0003-4948-7633; Braithwaite, Jeffrey/0000-0003-0296-4957; Warwick, Meagan/0000-0001-8337-2181; Molloy, Charlotte/0000-0001-7451-9751; Long, Janet/0000-0002-0553-682X; Craig, Simon/0000-0003-2594-1643; Wiles, Louise/0000-0002-6557-6196; Hibbert, Peter/0000-0001-7865-343X	Australian National Health and Medical Research partnership grant [APP1065898]; National Health and Medical Research Council; Bupa Health Foundation; Sydney Children's Hospital Network; New South Wales Kids and Families; Children's Health Queensland; South Australian Department of Health (SA Health)	Australian National Health and Medical Research partnership grant; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Bupa Health Foundation; Sydney Children's Hospital Network; New South Wales Kids and Families; Children's Health Queensland; South Australian Department of Health (SA Health)	The research was funded as an Australian National Health and Medical Research partnership grant (APP1065898) (JB), with contributions by the National Health and Medical Research Council, Bupa Health Foundation, Sydney Children's Hospital Network, New South Wales Kids and Families, Children's Health Queensland, and the South Australian Department of Health (SA Health). No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have declared that no competing interests exist.	Access Economics Pty Ltd, 2009, REP VICT NEUR IN; American College of Emergency Physicians, 2013, 10 THINGS PHYS PAT S; [Anonymous], 2008, NEUR DIS PUBL HLTH C, V65, P154, DOI 10.1001/archneurol.2007.19; Avidan A, 2012, INT J MED INFORM, V81, P173, DOI 10.1016/j.ijmedinf.2011.12.009; Braithwaite J, 2018, JAMA-J AM MED ASSOC, V319, P1113, DOI 10.1001/jama.2018.0162; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Coulter IC, 2011, SURG-J R COLL SURG E, V9, P83, DOI 10.1016/j.surge.2010.08.001; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Danisman B, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0010-0; Davies J, 2016, CLIN RADIOL, V71, P844, DOI 10.1016/j.crad.2016.04.024; DIETRICH AM, 1994, J PEDIATR SURG, V29, P28, DOI 10.1016/0022-3468(94)90517-7; Dresselhaus TR, 2002, J MED ETHICS, V28, P293, DOI 10.1136/jme.28.5.291; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Fitch K., 2001, RAND UCLA APPROPRIAT; Hooper TD, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007749; Huda W, 2007, AM J ROENTGENOL, V188, P540, DOI 10.2214/AJR.06.0101; Korn E, 1998, SURV METHODOL, V24, P193; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marlow Troy J., 1997, Journal of Emergency Medicine, V15, P187, DOI 10.1016/S0736-4679(96)00356-3; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; National Institute for Health and Clinical Excellence, 2014, HEAD INJ ASS EARL MA; Paul M, 2003, BRIT J ANAESTH, V91, P601, DOI 10.1093/bja/aeg203; Wiles LK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209637; Wiles LK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007748; Yiengprugsawan V, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-28	26	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228715	10.1371/journal.pone.0228715	http://dx.doi.org/10.1371/journal.pone.0228715			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045446	Green Accepted, Green Published, gold			2022-12-26	WOS:000534633200032
J	Wu, WC; Wang, SS; Liu, Q; Shan, TZ; Wang, XX; Feng, J; Wang, YZ				Wu, Weiche; Wang, Sisi; Liu, Qing; Shan, Tizhong; Wang, Xinxia; Feng, Jie; Wang, Yizhen			AMPK facilitates intestinal long-chain fatty acid uptake by manipulating CD36 expression and translocation	FASEB JOURNAL			English	Article						AMPK; CD36; fatty acid uptake; intestinal epithelial cell; m(6)A	LIPID-ACCUMULATION; PROTEIN; RNA; INSULIN; METABOLISM; M(6)A; N6-METHYLADENOSINE; TRANSLATION; ACTIVATION; INSIGHTS	Cellular long-chain fatty acids' (LCFAs) uptake is a crucial physiological process that regulates cellular energy homeostasis. AMPK has been shown to modulate LCFAs uptake in several kinds of cells, but whether it exerts an impact on intestinal LCFAs uptake is not quite clear. In the current study, we found that AMPK reinforced LCFAs uptake in intestinal epithelial cells (IECs). Moreover, intestinal epithelium-specific AMPK deletion impaired intestinal LCFAs absorption and protected mice from high-fat diet-induced obesity. Mechanistically, we discovered that AMPK deletion reduced the CD36 protein level by upregulating Parkin-mediated polyubiquitination of CD36 in IECs. Furthermore, our results revealed that AMPK affected PARK2 (gene name of Parkin) mRNA stability in a YTHDF2-dependent manner through FTO-dependent demethylation of N-6-methyladenosine (m(6)A). Besides, AMPK promoted the translocation of CD36 to the plasma membrane in IECs, but the inhibition of AKT signaling suppressed this effect, which also halted the accelerated fatty acid uptake induced by AMPK. These results suggest that AMPK facilitates the intestinal LCFAs uptake by upregulating CD36 protein abundance and promoting its membrane translocation simultaneously. Such findings shed light on the role of AMPK in the regulation of intestinal LCFAs uptake.	[Wu, Weiche; Wang, Sisi; Liu, Qing; Shan, Tizhong; Wang, Xinxia; Feng, Jie; Wang, Yizhen] Zhejiang Univ, Coll Anim Sci, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Wu, Weiche; Wang, Sisi; Liu, Qing; Shan, Tizhong; Wang, Xinxia; Feng, Jie; Wang, Yizhen] Zhejiang Univ, Key Lab Anim Nutr & Feed Sci, Minist Agr, Hangzhou, Peoples R China; [Wu, Weiche; Wang, Sisi; Liu, Qing; Shan, Tizhong; Wang, Xinxia; Feng, Jie; Wang, Yizhen] Zhejiang Univ, Zhejiang Prov Lab Feed & Anim Nutr, Hangzhou, Peoples R China	Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University; Zhejiang University	Feng, J; Wang, YZ (corresponding author), Zhejiang Univ, Coll Anim Sci, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	fengj@zju.edu.cn; yzwang321@zju.edu.cn		wang, yizhen/0000-0002-3908-7102	National Natural Science Foundation of China (NSFC) [3163000269]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 3163000269	Abumrad NA, 2011, J CLIN INVEST, V121, P3389, DOI 10.1172/JCI59219; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bujak AL, 2015, CELL METAB, V21, P883, DOI 10.1016/j.cmet.2015.05.016; Calder PC, 2012, P NUTR SOC, V71, P284, DOI 10.1017/S0029665112000067; Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005; Choi YJ, 2017, TOXICOL APPL PHARM, V316, P74, DOI 10.1016/j.taap.2016.12.019; D'Aquila T, 2016, BBA-MOL CELL BIOL L, V1861, P730, DOI 10.1016/j.bbalip.2016.04.012; Fentz J, 2015, FASEB J, V29, P1725, DOI 10.1096/fj.14-266650; Galli C, 1997, NUTRITION, V13, P978, DOI 10.1016/S0899-9007(97)00341-9; Gao ZJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01919-0; Goldberg IJ, 2009, J LIPID RES, V50, pS86, DOI 10.1194/jlr.R800085-JLR200; Habets DDJ, 2007, BIOCHEM BIOPH RES CO, V355, P204, DOI 10.1016/j.bbrc.2007.01.141; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hsieh FL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12837; Hsu PJ, 2017, CELL RES, V27, P1115, DOI 10.1038/cr.2017.99; Jang C, 2016, NAT MED, V22, P421, DOI 10.1038/nm.4057; Jeppesen J, 2011, J LIPID RES, V52, P699, DOI 10.1194/jlr.M007138; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jorgensen SB, 2006, J PHYSIOL-LONDON, V574, P17, DOI 10.1113/jphysiol.2006.109942; Khalifeh-Soltani A, 2014, NAT MED, V20, P175, DOI 10.1038/nm.3450; Kim KY, 2011, J CLIN INVEST, V121, P3701, DOI 10.1172/JCI44736; Li D, 2010, J BIOL CHEM, V285, P33499, DOI 10.1074/jbc.M110.159772; Li MM, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1436-y; Luiken JJFP, 2003, DIABETES, V52, P1627, DOI 10.2337/diabetes.52.7.1627; Luiken JJFP, 2016, BBA-MOL BASIS DIS, V1862, P2253, DOI 10.1016/j.bbadis.2016.09.004; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Patil DP, 2018, TRENDS CELL BIOL, V28, P113, DOI 10.1016/j.tcb.2017.10.001; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Ruxton CHS, 2005, NUTR RES REV, V18, P113, DOI 10.1079/NRR200497; Samovski D, 2012, J LIPID RES, V53, P709, DOI 10.1194/jlr.M023424; Schwenk RW, 2010, DIABETOLOGIA, V53, P2209, DOI 10.1007/s00125-010-1832-7; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Smith J, 2008, J BIOL CHEM, V283, P13578, DOI 10.1074/jbc.M800008200; Su R, 2018, CELL, V172, P90, DOI 10.1016/j.cell.2017.11.031; Sun XF, 2017, CELL DEATH DIFFER, V24, P819, DOI 10.1038/cdd.2017.14; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Toedebusch RG, 2016, PHYSIOL GENOMICS, V48, P101, DOI 10.1152/physiolgenomics.00078.2015; Wang B, 2016, CELL METAB, V23, P492, DOI 10.1016/j.cmet.2016.01.001; Wang TY, 2013, EUR J CLIN INVEST, V43, P1203, DOI 10.1111/eci.12161; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wu WC, 2018, MOL PHARMACEUT, V15, P3272, DOI 10.1021/acs.molpharmaceut.8b00332; Wu WC, 2018, J PHYSIOL BIOCHEM, V74, P195, DOI 10.1007/s13105-017-0604-y; Wu WT, 2017, PROC INT CONF DATA, P7, DOI 10.1109/ICDE.2017.10; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Yang XC, 2017, NAT REV NEPHROL, V13, P769, DOI 10.1038/nrneph.2017.126; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zhou XH, 2015, J NUTR BIOCHEM, V26, P1678, DOI 10.1016/j.jnutbio.2015.08.014	54	14	15	10	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4852	4869		10.1096/fj.201901994R	http://dx.doi.org/10.1096/fj.201901994R		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32048347				2022-12-26	WOS:000512896000001
J	Kuriya, B; Vigod, S; Luo, J; Widdifield, J; Haroon, N				Kuriya, Bindee; Vigod, Simone; Luo, Jin; Widdifield, Jessica; Haroon, Nigil			The risk of deliberate self-harm following a diagnosis of rheumatoid arthritis or ankylosing spondylitis: A population-based cohort study	PLOS ONE			English	Article							CHARLSON COMORBIDITY INDEX; ADMINISTRATIVE DATA; IDENTIFYING PATIENTS; SUICIDE ATTEMPTS; INFLAMMATION; PREVALENCE; VALIDATION; DEPRESSION; ONTARIO; MORTALITY	Objective Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are associated with mental illness. The risk of serious mental illness, including deliberate self-harm (DSH), in these conditions is not well known. We aimed to determine if RA or AS independently increases the risk for DSH. Methods We conducted retrospective, population-based cohort studies using administrative health data for the province of Ontario, Canada between April 1, 2002 and March 31, 2014. Individuals with incident RA (N = 53,240) or AS (N = 13,964) were separately matched 1:4 by age, sex, and year with comparators without RA or AS. The outcome was a first DSH attempt identified using emergency department data. We estimated hazard ratios (HR) and 95% confidence intervals (95% CI) for risk of DSH in RA and AS versus comparators, adjusting for demographic, clinical and health service utilization variables. Results Subjects with AS were significantly more likely to self-harm (crude incidence rate [IR] of 0.68/1,000 person years [PY] versus 0.32/1,000 PY in comparators), with an adjusted HR of 1.59 (95% CI 1.15 to 2.21). DSH was increased for RA subjects (IR 0.35/1,000 PY) versus comparators (IR 0.24/1,000 PY) only before (HR 1.43, 95% CI 1.16 to 1.74), but not after covariate adjustment (HR 1.07, 95% CI 0.86 to 1.33). Conclusions AS carries an increased risk for DSH but no such risk was observed in RA. Further evaluation of at-risk AS subjects is needed, including the longitudinal effects of disease and arthritis therapies on self-harm behaviour. This will inform whether specific risk-reduction strategies for DSH in inflammatory arthritis are needed.	[Kuriya, Bindee] Univ Toronto, Sinai Hlth Syst, Toronto, ON, Canada; [Vigod, Simone] Univ Toronto, Womens Coll Hosp, Toronto, ON, Canada; [Vigod, Simone; Luo, Jin; Widdifield, Jessica] ICES, Toronto, ON, Canada; [Widdifield, Jessica] Sunnybrook Res Inst, Holland Musculoskeletal Res Program, Toronto, ON, Canada; [Widdifield, Jessica] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Haroon, Nigil] Univ Toronto, Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Kuriya, B (corresponding author), Univ Toronto, Sinai Hlth Syst, Toronto, ON, Canada.	bindee.kuriya@sinaihealthsystem.ca			Canadian Rheumatology Association/The Arthritis Society Clinician Investigator Award [CCT-015-18]; Division of Rheumatology Pfizer Research Chair, University of Toronto; Sinai Health System Department of Medicine Clinical Research Support Program; ICES - Ontario Ministry of Health and Long-Term Care (MOHLTC)	Canadian Rheumatology Association/The Arthritis Society Clinician Investigator Award; Division of Rheumatology Pfizer Research Chair, University of Toronto; Sinai Health System Department of Medicine Clinical Research Support Program; ICES - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This work was supported by The Canadian Rheumatology Association/The Arthritis Society Clinician Investigator Award (CCT-015-18 for author BK) and study funding was also provided by the Division of Rheumatology Pfizer Research Chair, University of Toronto and the Sinai Health System Department of Medicine Clinical Research Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.	Benchimol EI, 2014, J CLIN EPIDEMIOL, V67, P887, DOI 10.1016/j.jclinepi.2014.02.019; Bethell J, 2013, CAN J PUBLIC HEALTH, V104, pE124, DOI 10.1007/BF03405675; Bethell Jennifer, 2009, Health Rep, V20, P35; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; DHoore W, 1996, J CLIN EPIDEMIOL, V49, P1429, DOI 10.1016/S0895-4356(96)00271-5; Dougados M, 2014, ANN RHEUM DIS, V73, P62, DOI 10.1136/annrheumdis-2013-204223; Egeberg A, 2016, BRIT J DERMATOL, V175, P493, DOI 10.1111/bjd.14633; Fleet JL, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-81; Fuller-Thomson E, 2016, RHEUMATOL INT, V36, P1237, DOI 10.1007/s00296-016-3498-z; Gananca L, 2016, PSYCHONEUROENDOCRINO, V63, P296, DOI 10.1016/j.psyneuen.2015.10.008; Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098; Haroon NN, 2015, ANN INTERN MED, V163, P409, DOI 10.7326/M14-2470; Hawton K, 2016, LANCET PSYCHIAT, V3, P740, DOI 10.1016/S2215-0366(16)30070-0; Hunter J, 2018, PSYCHIAT RES, V259, P333, DOI 10.1016/j.psychres.2017.09.029; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Koo J, 2017, J EUR ACAD DERMATOL, V31, P1999, DOI 10.1111/jdv.14460; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Matcham F, 2016, RHEUMATOLOGY, V55, P268, DOI 10.1093/rheumatology/kev306; Matcham F, 2013, RHEUMATOLOGY, V52, P2136, DOI 10.1093/rheumatology/ket169; Olfson M, 2017, AM J PSYCHIAT, V174, P765, DOI 10.1176/appi.ajp.2017.16111288; Owens D, 2002, BRIT J PSYCHIAT, V181, P193, DOI 10.1192/bjp.181.3.193; Ramjeet J, 2005, RHEUMATOLOGY, V44, P1166, DOI 10.1093/rheumatology/keh699; Rathbun AM, 2015, CLIN RHEUMATOL, V34, P653, DOI 10.1007/s10067-014-2759-z; Redeker I, 2018, ANN RHEUM DIS; Rosenblat JD, 2014, PROG NEURO-PSYCHOPH, V53, P23, DOI 10.1016/j.pnpbp.2014.01.013; Shah BR, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-42; Shen CC, 2016, J RHEUMATOL, V43, P625, DOI 10.3899/jrheum.150388; Singhal A, 2014, J ROY SOC MED, V107, P194, DOI 10.1177/0141076814522033; Slavich GM, 2014, PSYCHOL BULL, V140, P774, DOI 10.1037/a0035302; Smolen JS, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.1; Steele LS, 2004, MED CARE, V42, P960, DOI 10.1097/00005650-200410000-00004; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Timonen M, 2003, RHEUMATOLOGY, V42, P287, DOI 10.1093/rheumatology/keg082; Tu K, 2010, CHRONIC DIS CAN, V30, P141; Tu K, 2013, CAN J CARDIOL, V29, P1388, DOI 10.1016/j.cjca.2013.07.676; Tu Karen, 2007, Open Med, V1, pe18; Wang B, 2017, EUR J ENDOCRINOL, V177, pR169, DOI 10.1530/EJE-16-0952; Wang SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107791; Widdifield J, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-216; Widdifield J, 2013, ARTHRIT CARE RES, V65, P1582, DOI 10.1002/acr.22031; Wu JJ, 2017, J EUR ACAD DERMATOL, V31, P1168, DOI 10.1111/jdv.14175; Zochling J, 2008, CLIN EXP RHEUMATOL, V26, pS80	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229273	10.1371/journal.pone.0229273	http://dx.doi.org/10.1371/journal.pone.0229273			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8DJ	32084192	gold, Green Submitted, Green Published			2022-12-26	WOS:000535227900078
J	Moe, KK; Polat, M; Borjigin, L; Matsuura, R; Hein, ST; Moe, HH; Aida, Y				Moe, Kyaw Kyaw; Polat, Meripet; Borjigin, Liushiqi; Matsuura, Ryosuke; Hein, Si Thu; Moe, Hla Hla; Aida, Yoko			New evidence of bovine leukemia virus circulating in Myanmar cattle through epidemiological and molecular characterization	PLOS ONE			English	Article							ENV GENE; BLV INFECTION; IDENTIFICATION; GENOTYPES; PROVIRUS; SEQUENCE; SAMPLES; MILK; DNA	Bovine leukemia virus (BLV) is the etiological agent of enzootic bovine leukosis, which is the most common neoplastic disease of cattle. BLV infects cattle worldwide and causes serious problems for the cattle industry. In this study, we examined the prevalence of BLV infection and the distribution of BLV genotypes in cattle in the northern, central, and southern parts of Myanmar. The prevalence of BLV infection among Myanmar cattle (37.04%) in this study was markedly higher than the prevalence (9.1%) observed in our earlier study in which BLV was detected from the limited number of cattle only from a small area of Myanmar. Phylogenetic analysis of partial env-gp51 sequence of the isolated BLV strains revealed that there are at least three BLV genotypes (genotype-1, genotype-6, and genotype-10) in Myanmar, which have also been detected in the neighboring countries. We performed this study to estimate the BLV proviral load, which is a major diagnosis index for determining the virus transmission risk. The cattle of the three test regions with warm, wet, and humid climatic conditions (upper Sagaing, Yangon, and Kayin) exhibited a high mean proviral load, while cattle of three other regions with low annual rainfall and very high temperature (Mandalay, Magway, and upper Bago) exhibited a low mean proviral load. Further, the level of proviral load and the prevalence of BLV infection in Myanmar native cattle (N = 235) were lower than that in the hybrid cattle (Holstein Friesian x Myanmar native) (N = 62). We also observed that the cattle with high risk for BLV transmission, which have high proviral load, may enhance the BLV infection rate. Hence, to control BLV transmission, it is necessary to eliminate these cattle with high-risk for BLV transmission and to diagnose BLV provirus in cattle in the remaining regions/states of Myanmar sharing a boundary with neighboring countries.	[Moe, Kyaw Kyaw; Polat, Meripet; Borjigin, Liushiqi; Aida, Yoko] RIKEN Cluster Sci Technol & Innovat Hub, Baton Zone Program, Nakamura Lab, Wako, Saitama, Japan; [Moe, Kyaw Kyaw] Univ Vet Sci, Dept Pathol & Microbiol, Yezin, Nay Pyi Taw, Myanmar; [Matsuura, Ryosuke; Aida, Yoko] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Lab Viral Infect Dis, Wako, Saitama, Japan; [Hein, Si Thu] Univ Vet Sci, Dept Anat, Yezin, Nay Pyi Taw, Myanmar; [Moe, Hla Hla] Univ Vet Sci, Dept Genet & Anim Breeding, Yezin, Nay Pyi Taw, Myanmar	RIKEN; University of Tokyo	Aida, Y (corresponding author), RIKEN Cluster Sci Technol & Innovat Hub, Baton Zone Program, Nakamura Lab, Wako, Saitama, Japan.; Aida, Y (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Lab Viral Infect Dis, Wako, Saitama, Japan.	aida@riken.jp	Yamanaka, Meripet Polat/GQP-3765-2022	Moe, KyawKyaw/0000-0002-0123-7769	Japan Society for the Promotion of Science (JSPS) [16H02590]; Project of the NARO Biooriented Technology Research Advancement Institution [Special Scheme Project on Regional Developing Strategy] [16817983]; Special Scheme Project on Vitalizing Management Entities of Agriculture, Forestry and Fisheries [16930548]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Project of the NARO Biooriented Technology Research Advancement Institution [Special Scheme Project on Regional Developing Strategy]; Special Scheme Project on Vitalizing Management Entities of Agriculture, Forestry and Fisheries	The study was supported by the Grants-in-Aid for Scientific Research (A) from the Japan Society for the Promotion of Science (JSPS) (Grant No. 16H02590). This research was also supported by grants from the Project of the NARO Biooriented Technology Research Advancement Institution [the Special Scheme Project on Regional Developing Strategy (Grant No. 16817983) and the Special Scheme Project on Vitalizing Management Entities of Agriculture, Forestry and Fisheries (Grant No. 16930548)]. Kyaw Kyaw Moe is a JSPS International Research Fellow [FY2018 Invitational Fellowship for Research in Japan (Long-term)].; We thank LBVD staff, UVS staff, local veterinarians and farm owners for their kind assistance in blood sampling at the cattle farms in Myanmar, and the Support Unit at the Biomaterial Analysis, RIKEN BSI Research Resource Center for help with the sequence analysis. We also thank all members of the Viral Infectious Diseases Field, RIKEN, for technical assistance, help, and suggestions.	Aida Y, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00328; Asfaw Y, 2005, ARCH VIROL, V150, P493, DOI 10.1007/s00705-004-0433-5; Bai LL, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0233-x; Balic D, 2012, ARCH VIROL, V157, P1281, DOI 10.1007/s00705-012-1300-4; Bartlett PC, 2013, J DAIRY SCI, V96, P1591, DOI 10.3168/jds.2012-5930; Beier D, 2001, BERL MUNCH TIERARZTL, V114, P252; Buehring GC, 2014, EMERG INFECT DIS, V20, P772, DOI 10.3201/eid2005.131298; CALLEBAUT I, 1993, J VIROL, V67, P5321, DOI 10.1128/JVI.67.9.5321-5327.1993; Camargos MF, 2007, VIRUS GENES, V34, P343, DOI 10.1007/s11262-006-0011-x; Camargos MF, 2002, J VET MED B, V49, P325, DOI 10.1046/j.1439-0450.2002.00582.x; COULSTON J, 1990, J GEN VIROL, V71, P1737, DOI 10.1099/0022-1317-71-8-1737; DA Y, 1993, P NATL ACAD SCI USA, V90, P6538, DOI 10.1073/pnas.90.14.6538; Felmer R, 2005, VET MICROBIOL, V108, P39, DOI 10.1016/j.vetmic.2005.04.005; Gauttier S, 2019, TECHNOL SOC, V56, P93, DOI 10.1016/j.techsoc.2018.09.008; Gillet N, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-18; Jimba M, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-167; Jimba M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-91; Johnston ER, 2000, J VIROL, V74, P2930, DOI 10.1128/JVI.74.6.2930-2935.2000; Kobayashi S, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-1; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee E, 2016, INFECT GENET EVOL, V41, P245, DOI 10.1016/j.meegid.2016.04.010; Lee E, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0286-4; MAMOUN RZ, 1983, J GEN VIROL, V64, P1895, DOI 10.1099/0022-1317-64-9-1895; MAMOUN RZ, 1990, J VIROL, V64, P4180, DOI 10.1128/JVI.64.9.4180-4188.1990; Matsumura K, 2011, VIRUS RES, V155, P343, DOI 10.1016/j.virusres.2010.11.005; Monti G, 2005, ARCH VIROL, V150, P443, DOI 10.1007/s00705-004-0437-1; Moratorio G, 2010, ARCH VIROL, V155, P481, DOI 10.1007/s00705-010-0606-3; Mousavi Shalaleh, 2014, Vet Res Forum, V5, P135; National Consultative Committee Myanmar, 2013, NAT REP AN GEN RES; Norby B, 2016, J DAIRY SCI, V99, P2043, DOI 10.3168/jds.2015-10089; Ochirkhuu N, 2016, ARCH VIROL, V161, P985, DOI 10.1007/s00705-015-2676-8; Ohno A, 2015, VIRUS RES, V210, P283, DOI 10.1016/j.virusres.2015.08.020; Ooshiro M, 2013, VET REC, V173, P527, DOI 10.1136/vr.101833; Pandey GS, 2017, ARCH VIROL, V162, P1051, DOI 10.1007/s00705-016-3205-0; Panei CJ, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-95; Pluta A, 2017, ARCH VIROL, V162, P1563, DOI 10.1007/s00705-017-3241-4; Polat M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0876-4; Polat M, 2017, ARCH VIROL, V162, P425, DOI 10.1007/s00705-016-3118-y; Polat M, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0239-z; Polat M, 2015, ARCH VIROL, V160, P285, DOI 10.1007/s00705-014-2280-3; Rodriguez SM, 2009, J GEN VIROL, V90, P2788, DOI 10.1099/vir.0.011791-0; Rola-Luszczak M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058705; SAGATA N, 1985, P NATL ACAD SCI USA, V82, P677, DOI 10.1073/pnas.82.3.677; Sandev Nikolay, 2004, Veterinarski Arhiv, V74, P411; Sato H, 2018, ARCH VIROL, V163, P1519, DOI 10.1007/s00705-018-3744-7; Scherf BD, 2015, 2 REPORT STATE WORLD; Takeshima S, 2015, ARCH VIROL, V160, P1325, DOI 10.1007/s00705-015-2377-3; Wang M, 2018, ARCH VIROL, V163, P659, DOI 10.1007/s00705-017-3658-9; World Organisation for Animal Health (OIE), 2018, MANUAL DIAGNOSTIC TE; Yang Y, 2019, J DAIRY SCI, V102, P3469, DOI 10.3168/jds.2018-15481; Yuan Y, 2015, VIRUS RES, V210, P248, DOI 10.1016/j.virusres.2015.08.013; Zarkik S, 1997, FEBS LETT, V406, P205, DOI 10.1016/S0014-5793(97)00275-5; Zhao XR, 2007, VIROLOGY, V366, P150, DOI 10.1016/j.virol.2007.03.058	53	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229126	10.1371/journal.pone.0229126	http://dx.doi.org/10.1371/journal.pone.0229126			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084185	Green Published, gold			2022-12-26	WOS:000535227900056
J	Namakula, R; de Bree, LCJ; Tvedt, THA; Netea, MG; Cose, S; Hanevik, K				Namakula, Rhoda; de Bree, L. Charlotte J.; Tvedt, Tor Henrik A.; Netea, Mihai G.; Cose, Stephen; Hanevik, Kurt			Monocytes from neonates and adults have a similar capacity to adapt their cytokine production after previous exposure to BCG and beta-glucan	PLOS ONE			English	Article							VACCINE STRAIN; PROTECTION; TUBERCULOSIS; REINFECTION; IMMUNITY; INFANTS; BIRTH	The Bacillus Calmette-Guerin (BCG) vaccine is administered at birth in tuberculosis (TB) endemic countries. BCG vaccination is also associated with protective non-specific effects against non-tuberculous infections. This seems at least in part mediated through induction of innate immune memory in myeloid cells, a process termed trained immunity. beta-glucan, a component of the fungal cell wall from Candida albicans, induces a trained immunity phenotype in human monocytes with hyper-responsiveness against unrelated pathogens. We aimed to study the capacity of BCG and beta-glucan to induce a similar phenotype by examining cytokine production in cord blood monocytes following re-stimulation. We used a well-known model of in vitro induction of trained immunity. Adherent mononuclear cells from neonates and adults, which consist mainly of monocytes, were stimulated in vitro with BCG or beta-glucan for one day, after which the stimulus was washed away. Cells were rested for 5 days, then restimulated with LPS. Cytokine levels were measured using ELISA. Neonate and adult monocytes responded similarly in terms of cytokine production. BCG significantly increased IL-6 responses to LPS in both neonate and adult monocytes, while beta-glucan induced increases of IL-6, IL-10 and TNF production capacity. The BCG and beta-glucan induced increase in cytokine production, reminiscent of trained immunity, showed similar levelsin neonatal and adult monocytes. BCG mediated changes in cytokine production shows the feasibility of this in vitro assay for further studies regarding non-specific effects of vaccines.	[Namakula, Rhoda] Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth, Ctr Int Hlth, Bergen, Norway; [de Bree, L. Charlotte J.; Netea, Mihai G.] Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, Nijmegen, Netherlands; [de Bree, L. Charlotte J.; Netea, Mihai G.] Radboud Univ Nijmegen, Radboud Ctr Infect Dis, Med Ctr, Nijmegen, Netherlands; [Tvedt, Tor Henrik A.] Haukeland Hosp, Dept Med, Sect Hematol, Bergen, Norway; [Cose, Stephen] London Sch Hyg & Trop Med, Dept Clin Res, London, England; [Cose, Stephen] MRC UVRI & LSHTM Uganda Res Unit, Entebbe, Uganda; [Hanevik, Kurt] Univ Bergen, Fac Med, Dept Clin Sci, Bergen, Norway; [Hanevik, Kurt] Haukeland Hosp, Dept Med, Norwegian Natl Advisory Unit Trop Infect Dis, Bergen, Norway	University of Bergen; Radboud University Nijmegen; Radboud University Nijmegen; University of Bergen; Haukeland University Hospital; University of London; London School of Hygiene & Tropical Medicine; University of Bergen; University of Bergen; Haukeland University Hospital	Hanevik, K (corresponding author), Univ Bergen, Fac Med, Dept Clin Sci, Bergen, Norway.; Hanevik, K (corresponding author), Haukeland Hosp, Dept Med, Norwegian Natl Advisory Unit Trop Infect Dis, Bergen, Norway.	kurt.hanevik@med.uib.no	Hanevik, Kurt/I-1159-2012	Hanevik, Kurt/0000-0002-1466-2326	University of Bergen [3593288]; Haukeland University Hospital; Spinoza Grant of the Netherlands Organization for Scientific Research; ERC [833247]	University of Bergen; Haukeland University Hospital; Spinoza Grant of the Netherlands Organization for Scientific Research; ERC(European Research Council (ERC)European Commission)	This work was supported by research group funds from the University of Bergen, 3593288 (Mrs Rhoda Namakula) and Haukeland University Hospital. M.G.N was supported by a Spinoza Grant of the Netherlands Organization for Scientific Research and an ERC Advanced grant (#833247).	Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; Anderson EJ, 2012, VACCINE, V30, P2083, DOI 10.1016/j.vaccine.2012.01.053; Arts RJW, 2016, CELL REP, V17, P2562, DOI 10.1016/j.celrep.2016.11.011; Bekkering S, 2016, CLIN VACCINE IMMUNOL, V23, P926, DOI 10.1128/CVI.00349-16; Hamada A, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03225; Higgins JPT, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5170; Jensen KJ, 2015, J INFECT DIS, V211, P956, DOI 10.1093/infdis/jiu508; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Levy O, 2014, NEONATOLOGY, V105, P136, DOI 10.1159/000356035; Mangtani P, 2014, CLIN INFECT DIS, V58, P470, DOI 10.1093/cid/cit790; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Normann E, 2010, AM J REPROD IMMUNOL, V63, P66, DOI 10.1111/j.1600-0897.2009.00767.x; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Ritz N, 2012, AM J RESP CRIT CARE, V185, P213, DOI 10.1164/rccm.201104-0714OC; Sadia Saeed JQ, 2014, SCIENCE, V345; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Sigifredo Pedraza-Sanchez AGH, 2013, CLIN VACCINE IMMUNOL, V20; Smith SG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00644	19	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229287	10.1371/journal.pone.0229287	http://dx.doi.org/10.1371/journal.pone.0229287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084227	Green Published, gold			2022-12-26	WOS:000535227900082
J	Cheng, HG; Gonzalez-Reymundez, A; Li, I; Pathak, A; Pathak, DR; de los Campos, G; Vazquez, AI				Cheng, Hui G.; Gonzalez-Reymundez, Agustin; Li, Irene; Pathak, Ania; Pathak, Dorothy R.; de los Campos, Gustavo; Vazquez, Ana Ines			Breast cancer survival and the expression of genes related to alcohol drinking	PLOS ONE			English	Article							CONSUMPTION; RISK	Breast cancer is the leading cause of cancer-related disease in women. Cumulative evidence supports a causal role of alcohol intake and breast cancer incidence. In this study, we explore the change on expression of genes involved in the biological pathways through which alcohol has been hypothesized to impact breast cancer risk, to shed new insights on possible mechanisms affecting the survival of breast cancer patients. Here, we performed differential expression analysis at individual genes and gene set levels, respectively, across survival and breast cancer subtype data. Information about postdiagnosis breast cancer survival was obtained from 1977 Caucasian female participants in the Molecular Taxonomy of Breast Cancer International Consortium. Expression of 16 genes that have been linked in the literature to the hypothesized alcohol-breast cancer pathways, were examined. We found that the expression of 9 out of 16 genes under study were associated with cancer survival within the first 4 years of diagnosis. Results from gene set analysis confirmed a significant differential expression of these genes as a whole too. Although alcohol consumption is not analyzed, nor available for this dataset, we believe that further study on these genes could provide important information for clinical recommendations about potential impact of alcohol drinking on breast cancer survival.	[Cheng, Hui G.; Gonzalez-Reymundez, Agustin; Li, Irene; Pathak, Ania; Pathak, Dorothy R.; de los Campos, Gustavo; Vazquez, Ana Ines] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Gonzalez-Reymundez, Agustin; de los Campos, Gustavo; Vazquez, Ana Ines] Michigan State Univ, Inst Quantitat Hlth Sci & Engn, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Vazquez, AI (corresponding author), Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA.; Vazquez, AI (corresponding author), Michigan State Univ, Inst Quantitat Hlth Sci & Engn, E Lansing, MI 48824 USA.	avazquez@epi.msu.edu	Gonzalez-Reymundez, Agustin/AAK-2074-2020	Li, Irene/0000-0003-1942-9010; Cheng, Hui/0000-0001-7252-5090	National Institute on Drug Abuse [T32DA021129]; Michigan State University	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Michigan State University	The study is supported by funds from the National Institute on Drug Abuse grant T32DA021129 (to HGC), as well as Michigan State University. The opinions expressed in this paper are solely those of the authors and do not reflect those of the sponsoring agencies, which included the National Institute of Drug Abuse, the National Institutes of Health, and Michigan State University.; The authors would like to thank the support from the National Institute on Drug Abuse grant T32DA021129 (to HGC), as well as Michigan State University. The opinions expressed in this paper are solely those of the authors and do not reflect those of the sponsoring agencies, which included the National Institute of Drug Abuse, the National Institutes of Health, and Michigan State University.	Ali AMG, 2014, CANCER EPIDEM BIOMAR, V23, P934, DOI 10.1158/1055-9965.EPI-13-0901; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boffetta P, 2006, LANCET ONCOL, V7, P149, DOI 10.1016/S1470-2045(06)70577-0; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Gonzalez-Reymundez A, 2017, EUR J HUM GENET, V25, P538, DOI 10.1038/ejhg.2017.12; Lin J, 2010, CANCER RES, V70, P2397, DOI 10.1158/0008-5472.CAN-09-3648; Lowe R, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005457; Margolin AA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006112; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Mudry J, 2010, FOOD CULT SOC, V13, P91, DOI 10.2752/175174410X12549021368144; Park SY, 2014, INT J CANCER, V134, P1504, DOI 10.1002/ijc.28476; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roberts MR, 2011, CARCINOGENESIS, V32, P1223, DOI 10.1093/carcin/bgr096; Scoccianti C, 2014, AM J PREV MED, V46, pS16, DOI 10.1016/j.amepre.2013.10.031; Sen S, 2015, FREE RADICAL BIO MED, V86, P228, DOI 10.1016/j.freeradbiomed.2015.05.024; Shield KD, 2016, ALCOHOL CLIN EXP RES, V40, P1166, DOI 10.1111/acer.13071; Trafalis DT, 2010, EXPERT OPIN DRUG MET, V6, P307, DOI 10.1517/17425250903540238; Wang J, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0901-y; Wang YC, 2017, PHARMACOL RES, V115, P299, DOI 10.1016/j.phrs.2016.12.005; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Zheng WQ, 2016, ONCOTARGETS THER, V9, DOI 10.2147/OTT.S91796; Zhu H, 2018, CYSTATHIONINE BIOMED, V2018, DOI [10.1155/2018/3205125, DOI 10.1155/2018/3205125]	24	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0228957	10.1371/journal.pone.0228957	http://dx.doi.org/10.1371/journal.pone.0228957			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8CF	32078659	Green Published, gold			2022-12-26	WOS:000535224600010
J	Hollander, M; de Miranda, E; Smit, AM; de Graaf, I; Vandenbussche, F; van Dillen, J; Holten, L				Hollander, Martine; de Miranda, Esteriek; Smit, Anne-Marike; de Graaf, Irene; Vandenbussche, Frank; van Dillen, Jeroen; Holten, Lianne			'She convinced me'- partner involvement in choosing a high risk birth setting against medical advice in the Netherlands: A qualitative analysis	PLOS ONE			English	Article							HOME BIRTH; FATHERS EXPERIENCES; AUSTRALIAN FATHERS; EXPECTANT FATHERS; ANTENATAL CARE; PREGNANCY; CHILDBIRTH; WOMEN; METASYNTHESIS; CHOICE	Home births in high risk pregnancies and unassisted childbirth seem to be increasing in the Netherlands. There is a lack of qualitative data on women's partners' involvement in these choices in the Dutch maternity care system, where integrated midwifery care and home birth are regular options in low risk pregnancies. The majority of available literature focuses on the women's motivations, while the partner's influence on these decisions is much less well understood. We aimed to examine partners' involvement in the decision to birth outside the system, in order to provide medical professionals with insight and recommendations regarding their interactions with these partners in the outpatient clinic. An exploratory qualitative research design with a constructivist approach and a grounded theory method were used. In-depth interviews were performed with twenty-one partners on their involvement in the decision to go against medical advice in choosing a high risk childbirth setting. Open, axial and selective coding of the interview data was done in order to generate themes. Four main themes were found: 1) Talking it through, 2) A shared vision, 3) Defending our views, and 4) Doing it together. One overarching theme emerged that covered all other themes: `She convinced me'. These data show that the idea to choose a high risk birth setting almost invariably originated with the women, who did most of the research online, filtered the information and convinced the partners of the merit of their plans. Once the partners were convinced, they took a very active and supportive role in defending the plan to the outside world, as well as in preparing for the birth. Maternity care providers can use these findings in cases where there is a discrepancy between the wishes of the woman and the advice of the professional, so they can attempt to involve partners actively during consultations in pregnancy. That will ensure that partners also receive information on all options, risks and benefits of possible birth choices, and that they are truly in support of a final plan.	[Hollander, Martine; Vandenbussche, Frank; van Dillen, Jeroen] Radboud Univ Nijmegen, Amalie Childrens Hosp, Dept Obstet, Med Ctr, Nijmegen, Netherlands; [de Miranda, Esteriek; de Graaf, Irene] Amsterdam UMC, Dept Obstet, Acad Med Ctr, Amsterdam, Netherlands; [Smit, Anne-Marike; Holten, Lianne] VU EMGO Res Inst, AVAG Sch Midwifery & Amsterdam UMC, Amsterdam, Netherlands	Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam	Hollander, M (corresponding author), Radboud Univ Nijmegen, Amalie Childrens Hosp, Dept Obstet, Med Ctr, Nijmegen, Netherlands.	martine.hollander@radboudumc.nl						AMC, WHY WOM WANT OTH NO; [Anonymous], 2016, PERINATAL CARE NETHE; Atkin K, 2015, SOC SCI MED, V128, P212, DOI 10.1016/j.socscimed.2015.01.039; Bedwell C, 2011, SEX REPROD HEALTHC, V2, P71, DOI 10.1016/j.srhc.2010.12.001; Boucher D, 2009, J MIDWIFERY WOM HEAL, V54, P119, DOI 10.1016/j.jmwh.2008.09.006; Charmaz K., 2007, CONSTRUCTING GROUNDE; Chervenak FA, 2013, AM J OBSTET GYNECOL, V208, P31, DOI 10.1016/j.ajog.2012.10.002; Cheyney MJ, 2008, QUAL HEALTH RES, V18, P254, DOI 10.1177/1049732307312393; Cramer EM, 2018, AM J MENS HEALTH, V12, P313, DOI 10.1177/1557988316637576; Dejoy S., 2011, THESIS; Dheens S, 2013, INT J NURS STUD, V50, P121, DOI 10.1016/j.ijnurstu.2012.05.004; Draper H, 2013, MIDWIFERY, V29, P723, DOI 10.1016/j.midw.2013.02.007; Ehrlinger, 2016, ENCY MENTAL HLTH E; Fenwick J, 2012, SEX REPROD HEALTHC, V3, P3, DOI 10.1016/j.srhc.2011.11.001; Hendrix M, 2010, J PSYCHOSOM OBST GYN, V31, P243, DOI 10.3109/0167482X.2010.527400; Hildingsson I, 2011, WOMEN BIRTH, V24, P129, DOI 10.1016/j.wombi.2010.12.003; Hollander M, 2017, BMC PREGNANCY CHILDB, V16, P17; Holten L, 2018, QUAL HLTH RES; Jeffery T, 2015, J PERINAT EDUC, V24, P181, DOI 10.1891/1058-1243.24.3.181; Johansson M, 2015, MIDWIFERY, V31, P9, DOI 10.1016/j.midw.2014.05.005; Jouhki MR, 2015, AM J MENS HEALTH, V9, P421, DOI 10.1177/1557988314549413; Lindberg I, 2013, SEX REPROD HEALTHC, V4, P147, DOI 10.1016/j.srhc.2013.10.002; Lindgren H, 2006, MIDWIFERY, V22, P15, DOI 10.1016/j.midw.2005.04.002; Lindgren H, 2011, SEX REPROD HEALTHC, V2, P65, DOI 10.1016/j.srhc.2010.12.002; Locock L, 2006, SOC SCI MED, V62, P1349, DOI 10.1016/j.socscimed.2005.08.011; Longworth HL, 2011, MIDWIFERY, V27, P588, DOI 10.1016/j.midw.2010.06.013; Martínez-Mollá Teresa, 2015, Invest. educ. enferm, V33, P573, DOI 10.17533/udea.iee.v33n3a22; Miller AC, 2009, SOCIOL INQ, V79, P51, DOI 10.1111/j.1475-682X.2008.00272.x; Murray-Davis B, 2012, MIDWIFERY, V28, P576, DOI 10.1016/j.midw.2012.01.013; Osamor PE, 2018, BMC MED ETHICS, V19, DOI 10.1186/s12910-017-0241-6; Ryding EL, 2018, BIRTH-ISS PERINAT C, V45, P88, DOI 10.1111/birt.12309; Singh D, 2000, BECOMING FATHER MENS; Steen M, 2012, MIDWIFERY, V28, P422, DOI 10.1016/j.midw.2011.06.009; Sweeney S, 2015, WOMEN BIRTH, V28, P148, DOI 10.1016/j.wombi.2014.12.001; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Viisainen K, 2001, SOC SCI MED, V52, P1109, DOI 10.1016/S0277-9536(00)00206-9; Widarsson M, 2015, J CLIN NURS, V24, P1059, DOI 10.1111/jocn.12784; Williams RA, 2011, MIDWIFERY, V27, P861, DOI 10.1016/j.midw.2010.09.004; Xue WL, 2018, MIDWIFERY, V62, P20, DOI 10.1016/j.midw.2018.03.002	39	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0229069	10.1371/journal.pone.0229069	http://dx.doi.org/10.1371/journal.pone.0229069			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8CF	32078646	Green Published, gold			2022-12-26	WOS:000535224600016
J	Figueroa-Vega, N; Marin-Aragon, CI; Lopez-Aguilar, I; Ibarra-Reynoso, L; Perez-Luque, E; Malacara, JM				Figueroa-Vega, Nicte; Marin-Aragon, Carolina I.; Lopez-Aguilar, Itzel; Ibarra-Reynoso, Lorena; Perez-Luque, Elva; Manuel Malacara, Juan			Analysis of the percentages of monocyte subsets and ILC2s, their relationships with metabolic variables and response to hypocaloric restriction in obesity	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; BLOOD MONONUCLEAR-CELLS; IMMUNE-SYSTEM; PERIPHERAL-BLOOD; WEIGHT-LOSS; EXPRESSION; ATHEROSCLEROSIS; INFLAMMATION; REGULATORS; RECEPTORS	Purpose Obesity results from excess energy intake over expenditure and is characterized by chronic low-grade inflammation involving circulating monocytes (Mo) and group 2 innate lymphoid cells (ILC2s) imbalance. We analyzed circulating Mo subsets and ILC2s percentages and beta 2-adrenergic receptor (beta 2AR) expression in lean and obese subjects, and the possible effect of hypocaloric restriction on these innate immune cells. Methods In 139 individuals aged 45 to 57 years, classified in 74 lean individuals (>18.9kg/m(2) BMI <24.9kg/m(2)) and 65 with obesity (n = 65), we collected fasting blood samples to detect Mo subsets, ILC2s number, and beta 2AR expression by flow cytometry. Lipids, insulin, leptin, and acylated-ghrelin concentrations were quantified. Resting energy expenditure (REE) was estimated by indirect calorimetry. These measurements were repeated in obese subjects after 7-weeks of hypocaloric restriction. Results Non-classical monocytes (NCM) and beta 2AR expression on intermediate Mo (IM) were increased in obese individuals (p<0.001, in both cases), whereas the percent of ILC2s was decreased (p<0.0001). Stepwise regression analysis showed significantly negative associations of ILC2s with caloric intake, beta 2AR expression on IM with REE, but a positive relationship between NCM and HOMA-IR. Caloric restriction allowed a significant diminution of NCM and the beta 2AR expression on IM, as well as, an increase in the percent of classical Mo (CM), and ILC2s. Delta REE was related to Delta CD16(+)/CD16(-) ratio. Conclusions These findings show that in obesity occur changes in NCM, ILC2s and beta 2AR expression, which contribute to the low-grade inflammation linked to obesity and might revert with caloric restriction.	[Figueroa-Vega, Nicte; Marin-Aragon, Carolina I.; Lopez-Aguilar, Itzel; Ibarra-Reynoso, Lorena; Perez-Luque, Elva; Manuel Malacara, Juan] Univ Guanajuato, Dept Med Sci, Leon Campus, Leon, Gto, Mexico	Universidad de Guanajuato	Figueroa-Vega, N; Malacara, JM (corresponding author), Univ Guanajuato, Dept Med Sci, Leon Campus, Leon, Gto, Mexico.	ng.figueroa@ugto.mx; jmmalacara@hotmail.com	del Rocio Ibarra-Reynoso, Lorena/AAR-9678-2021		Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico) [CB2014-242065M]	Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the grant CB2014-242065M from Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico, to Juan M. Malacara). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles D, 2012, CYTOM PART A, V81A, P823, DOI 10.1002/cyto.a.22104; Aguilar-Ruiz SR, 2011, J LEUKOCYTE BIOL, V90, P1119, DOI 10.1189/jlb.0111022; Bartemes KR, 2014, J ALLERGY CLIN IMMUN, V134, P671, DOI 10.1016/j.jaci.2014.06.024; Berg KE, 2012, CIRC-CARDIOVASC GENE, V5, P122, DOI 10.1161/CIRCGENETICS.111.960385; Bolus WR, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13919; Bordon Y, 2012, NAT REV IMMUNOL, V12, P679, DOI 10.1038/nri3303; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Brodde O E, 1984, J Hypertens Suppl, V2, pS111; Canpolat U, 2016, CLIN APPL THROMB-HEM, V22, P476, DOI 10.1177/1076029615594002; Carneiro IP, 2016, ADV NUTR, V7, P476, DOI 10.3945/an.115.008755; Chalubinski M, 2016, IMMUNOL LETT, V179, P43, DOI 10.1016/j.imlet.2016.09.007; Pereira JAD, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/4527980; de Matos MA, 2016, CELL BIOCHEM FUNCT, V34, P209, DOI 10.1002/cbf.3178; De Rosa V, 2015, SEMIN IMMUNOL, V27, P300, DOI 10.1016/j.smim.2015.10.001; Devevre EF, 2015, J IMMUNOL, V194, P3917, DOI 10.4049/jimmunol.1402655; DiSpirito JR, 2015, SEMIN IMMUNOL, V27, P315, DOI 10.1016/j.smim.2015.10.005; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Fernandez-Riejos P, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568343; Flach M, 2015, CELL METAB, V21, P152, DOI 10.1016/j.cmet.2015.01.015; Galvez I, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112630; Garcia T, 2017, CYTOKINE GROWTH F R, V16, pS1359; Halim TYF, 2016, INT IMMUNOL, V28, P13, DOI 10.1093/intimm/dxv050; Hong S, 2008, BRAIN BEHAV IMMUN, V22, P590, DOI 10.1016/j.bbi.2007.12.003; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Idzkowska E, 2015, SCAND J IMMUNOL, V82, P163, DOI 10.1111/sji.12314; Jin CC, 2013, CELL METAB, V17, P873, DOI 10.1016/j.cmet.2013.05.011; Kenney MJ, 2014, COMPR PHYSIOL, V4, P1177, DOI 10.1002/cphy.c130051; Kim JE, 2017, NUTR RES, V40, P75, DOI 10.1016/j.nutres.2017.02.007; Krinninger P, 2014, J CLIN ENDOCR METAB, V99, P2500, DOI 10.1210/jc.2013-2611; Krychtiuk KA, 2015, J CLIN LIPIDOL, V9, P533, DOI 10.1016/j.jacl.2015.04.005; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Leite F, 2017, INT J MED SCI, V14, P853, DOI 10.7150/ijms.19638; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Manco M, 2007, J CLIN ENDOCR METAB, V92, P483, DOI 10.1210/jc.2006-0960; Martin SS, 2013, JAMA-J AM MED ASSOC, V310, P2061, DOI 10.1001/jama.2013.280532; Milling S, 2019, IMMUNOLOGY, V158, P1, DOI 10.1111/imm.13104; Mjosberg J, 2017, IMMUNITY, V46, P344, DOI 10.1016/j.immuni.2017.03.002; Monteiro L, 2019, J LEUKOCYTE BIOL, V106, P703, DOI 10.1002/JLB.MR1218-478R; Moriyama S, 2018, SCIENCE, V359, P1056, DOI 10.1126/science.aan4829; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nieman DC, 1996, INT J OBESITY, V20, P353; Odegaard JI, 2013, IMMUNITY, V38, P644, DOI 10.1016/j.immuni.2013.04.001; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Pecht T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159350; Pivovarova O, 2015, PEPTIDES, V65, P12, DOI 10.1016/j.peptides.2014.11.009; Poitou C, 2011, ARTERIOSCL THROM VAS, V31, P2322, DOI 10.1161/ATVBAHA.111.230979; Saetang J, 2018, MOL MED REP, V17, P1403, DOI 10.3892/mmr.2017.8038; Sanchez-Margalet V, 2003, CLIN EXP IMMUNOL, V133, P11, DOI 10.1046/j.1365-2249.2003.02190.x; Scanzano A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00171; Shimobayashi M, 2018, J CLIN INVEST, V128, P1538, DOI 10.1172/JCI96139; Takatsu K, 2008, CURR OPIN IMMUNOL, V20, P288, DOI 10.1016/j.coi.2008.04.001; van der Laan AM, 2012, AM HEART J, V163, P57, DOI 10.1016/j.ahj.2011.09.002; Villanova F, 2014, J INVEST DERMATOL, V134, P984, DOI 10.1038/jid.2013.477; Wang H, 2015, REV ENDOCR METAB DIS, V16, P47, DOI 10.1007/s11154-014-9306-8; Yona S, 2010, CURR OPIN HEMATOL, V17, P53, DOI 10.1097/MOH.0b013e3283324f80; Zawada AM, 2012, IMMUNOBIOLOGY, V217, P1273, DOI 10.1016/j.imbio.2012.07.001	56	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228637	10.1371/journal.pone.0228637	http://dx.doi.org/10.1371/journal.pone.0228637			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074122	Green Published, gold			2022-12-26	WOS:000535220600023
J	Che, H; Wang, YQ; Li, H; Li, Y; Sahil, A; Lv, J; Liu, YN; Yang, ZY; Dong, RX; Xue, HR; Wang, LH				Che, Hui; Wang, Yueqiu; Li, Hui; Li, Yang; Sahil, Abbas; Lv, Jie; Liu, Yining; Yang, Zhenyu; Dong, Ruixue; Xue, Hongru; Wang, Lihong			Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1/miR-141-mediated NLRP3 inflammasome and TGF-beta 1/Smads signaling in diabetic cardiomyopathy	FASEB JOURNAL			English	Article						diabetic cardiomyopathy; lncRNA MALAT1; melatonin; microRNA-141; NLRP3 inflammasome; TGF-beta 1; Smads	NONCODING RNA MALAT1; NEUROPEPTIDE-Y; RAT-HEART; PATHOGENESIS; ACTIVATION; EXPRESSION; PROTECTS; PATHWAY; INJURY	Melatonin is a hormone produced by the pineal gland, and it has extensive beneficial effects on various tissue and organs; however, whether melatonin has any effect on cardiac fibrosis in the pathogenesis of diabetic cardiomyopathy (DCM) is still unknown. Herein, we found that melatonin administration significantly ameliorated cardiac dysfunction and reduced collagen production by inhibiting TGF-beta 1/Smads signaling and NLRP3 inflammasome activation, as manifested by downregulating the expression of TGF-beta 1, p-Smad2, p-Smad3, NLRP3, ASC, cleaved caspase-1, mature IL-1 beta, and IL-18 in the heart of melatonin-treated mice with diabetes mellitus (DM). Similar beneficial effects of melatonin were consistently observed in high glucose (HG)-treated cardiac fibroblasts (CFs). Moreover, we also found that lncRNA MALAT1 (lncR-MALAT1) was increased along with concomitant decrease in microRNA-141 (miR-141) in DM mice and HG-treated CFs. Furthermore, we established NLRP3 and TGF-beta 1 as target genes of miR-141 and lncR-MALAT1 as an endogenous sponge or ceRNA to limit the functional availability of miR-141. Finally, we observed that knockdown of miR-141 abrogated anti-fibrosis action of melatonin in HG-treated CFs. Our findings indicate that melatonin produces an antifibrotic effect via inhibiting lncR-MALAT1/miR-141-mediated NLRP3 inflammasome activation and TGF-beta 1/Smads signaling, and it might be considered a potential agent for the treatment of DCM.	[Che, Hui; Wang, Yueqiu; Li, Hui; Li, Yang; Sahil, Abbas; Lv, Jie; Wang, Lihong] Harbin Med Univ, Affiliated Hosp 2, Dept Endocrinol, Harbin 150001, Heilongjiang, Peoples R China; [Liu, Yining; Yang, Zhenyu; Dong, Ruixue; Xue, Hongru] Harbin Med Univ, State Prov Key Labs Biomed Pharmaceut China, Key Lab Cardiovasc Res, Dept Pharmacol,Minist Educ,Coll Pharm, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Che, H; Wang, LH (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Endocrinol, Harbin 150001, Heilongjiang, Peoples R China.	chehui1203@163.com; nd6688@163.com			National Natural Science Foundation of China (NSFC) [81770809, 81600935]; China Postdoctoral Science Foundation [2017M621308]; Natural Science Foundation of Heilongjiang Province [QC2017108]; Graduate research and practice innovation project of Harbin medical university [YJSKYCX2018-52HYD]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Graduate research and practice innovation project of Harbin medical university	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81770809 and 81600935; China Postdoctoral Science Foundation, Grant/Award Number: 2017M621308; Natural Science Foundation of Heilongjiang Province, Grant/Award Number: QC2017108; Graduate research and practice innovation project of Harbin medical university, Grant/Award Number: YJSKYCX2018-52HYD	Abdulle LE, 2019, INT J MED SCI, V16, P548, DOI 10.7150/ijms.30097; Alonso N, 2018, ADV EXP MED BIOL, V1067, P197, DOI 10.1007/5584_2017_105; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Amin AH, 2015, EUR J PHARMACOL, V747, P166, DOI 10.1016/j.ejphar.2014.12.002; Artlett Carol M, 2012, Open Rheumatol J, V6, P80, DOI 10.2174/1874312901206010080; Artlett CM, 2011, ARTHRITIS RHEUM-US, V63, P3563, DOI 10.1002/art.30568; Aydin M, 2008, REGUL PEPTIDES, V146, P197, DOI 10.1016/j.regpep.2007.09.009; Bujak M, 2007, CIRCULATION, V116, P2127, DOI 10.1161/CIRCULATIONAHA.107.704197; Chaudhuri V, 2007, J CUTAN PATHOL, V34, P146, DOI 10.1111/j.1600-0560.2006.00584.x; Chen JQ, 2018, NATURE, V564, P71, DOI 10.1038/s41586-018-0761-3; Chen XY, 2015, INT J BIOCHEM CELL B, V69, P52, DOI 10.1016/j.biocel.2015.10.012; Ding MG, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12491; Dong PH, 2018, PHARMACOLOGY, V102, P272, DOI 10.1159/000492576; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dvorakova MC, 2008, NEUROSCIENCE, V151, P1016, DOI 10.1016/j.neuroscience.2007.07.069; Esmaiel EM, 2019, PAK J PHARM SCI, V32, P1453; Fowlkes V, 2013, LIFE SCI, V92, P669, DOI 10.1016/j.lfs.2013.01.003; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Goldsmith EC, 2014, J MOL CELL CARDIOL, V70, P92, DOI 10.1016/j.yjmcc.2014.01.008; He B, 2016, J PINEAL RES, V60, P313, DOI 10.1111/jpi.12312; Hu W, 2016, J PINEAL RES, V60, P121, DOI 10.1111/jpi.12302; Huang YH, 2015, INT J MOL MED, V35, P311, DOI 10.3892/ijmm.2014.2008; Hutchinson KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072080; Prado NJ, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0842-6; Kandemir YB, 2019, ADV CLIN EXP MED, V28, P1171, DOI 10.17219/acem/103799; Kandemir YB, 2018, CELL MOL BIOL, V64, P47, DOI 10.14715/cmb/2018.64.14.8; Khorsand M, 2019, J DIABETES METAB DIS, V18, P543, DOI 10.1007/s40200-019-00445-8; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Kuwar R, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1471-y; Laflamme AK, 1998, AM J HYPERTENS, V11, P219, DOI 10.1016/S0895-7061(97)00401-9; Li X, 2017, EXP CELL RES, V350, P327, DOI 10.1016/j.yexcr.2016.12.006; Li XL, 2019, BIOCHEM BIOPH RES CO, V514, P1, DOI 10.1016/j.bbrc.2019.04.110; Luo BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104771; Luo BB, 2014, CARDIOVASC DRUG THER, V28, P33, DOI 10.1007/s10557-013-6498-1; Luo DD, 2009, NEPHROL DIAL TRANSPL, V24, P2655, DOI 10.1093/ndt/gfp208; Nishiyama K, 2001, Am Heart J, V141, pE9, DOI 10.1067/mhj.2001.114368; Pan XC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020360; Pechanova O, 2014, INT J MOL SCI, V15, P17920, DOI 10.3390/ijms151017920; Russo I, 2016, J MOL CELL CARDIOL, V90, P84, DOI 10.1016/j.yjmcc.2015.12.011; Sedgwick B, 2014, CARDIOVASC PATHOL, V23, P204, DOI 10.1016/j.carpath.2014.03.004; Shi Y, 2018, J ALZHEIMERS DIS, V63, P911, DOI 10.3233/JAD-171178; Shieh JM, 2009, J PINEAL RES, V47, P339, DOI 10.1111/j.1600-079X.2009.00720.x; Simko F, 2016, J PINEAL RES, V61, P127, DOI 10.1111/jpi.12348; Stehle JH, 2011, J PINEAL RES, V51, P17, DOI 10.1111/j.1600-079X.2011.00856.x; Suetomi T, 2018, CIRCULATION, V138, P2530, DOI 10.1161/CIRCULATIONAHA.118.034621; SUNDKVIST G, 1992, DIABETES RES CLIN PR, V15, P219, DOI 10.1016/0168-8227(92)90028-P; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; Wang SJ, 2018, J CELL MOL MED, V22, P5132, DOI 10.1111/jcmm.13802; Wang ZV, 2015, CIRCULATION, V131, P771, DOI 10.1161/CIRCULATIONAHA.115.015357; Xiong FY, 2018, MOL MED REP, V17, P374, DOI 10.3892/mmr.2017.7841; Yu LM, 2018, BBA-MOL BASIS DIS, V1864, P563, DOI 10.1016/j.bbadis.2017.11.023; Zhang MY, 2016, INT J CARDIOL, V203, P214, DOI 10.1016/j.ijcard.2015.10.136; Zhang MY, 2016, INT J CARDIOL, V202, P753, DOI 10.1016/j.ijcard.2015.10.019; Zhang MM, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12418; Zhang PF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09482-6; Zhang Y, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12449; Zhao G, 2016, FEBS LETT, V590, P2884, DOI 10.1002/1873-3468.12315; Zhou H, 2018, CELL SIGNAL, V47, P88, DOI 10.1016/j.cellsig.2018.03.012; Zhou WY, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/5702103; Zuo GF, 2019, J CELL PHYSIOL, V234, P1925, DOI 10.1002/jcp.27070	60	60	65	1	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5282	5298		10.1096/fj.201902692R	http://dx.doi.org/10.1096/fj.201902692R		FEB 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32067273				2022-12-26	WOS:000515247200001
J	Gose, T; Shafi, T; Fukuda, Y; Das, S; Wang, Y; Allcock, A; McHarg, AG; Lynch, J; Chen, TS; Tamai, I; Shelat, A; Ford, RC; Schuetz, JD				Gose, Tomoka; Shafi, Talha; Fukuda, Yu; Das, Sourav; Wang, Yao; Allcock, Alice; Gavan McHarg, Ailsa; Lynch, John; Chen, Taosheng; Tamai, Ikumi; Shelat, Anang; Ford, Robert C.; Schuetz, John D.			ABCG2 requires a single aromatic amino acid to "clamp" substrates and inhibitors into the binding pocket	FASEB JOURNAL			English	Article						BCRP; cancer; CETSA; drug; thermal shift assay; kinase inhibitor; transporter	DRUG TARGET ENGAGEMENT; THERMAL SHIFT ASSAY; STEM-CELLS; IN-VITRO; EXPRESSION; TRANSPORTERS; ANALOG	ATP-binding cassette sub-family G member 2 (ABCG2) is a homodimeric ATP-binding cassette (ABC) transporter that not only has a key role in helping cancer cells to evade the cytotoxic effects of chemotherapy, but also in protecting organisms from multiple xeno- and endobiotics. Structural studies indicate that substrate and inhibitor (ligands) binding to ABCG2 can be differentiated quantitatively by the number of amino acid contacts, with inhibitors displaying more contacts. Although binding is the obligate initial step in the transport cycle, there is no empirical evidence for one amino acid being primarily responsible for ligand binding. By mutagenesis and biochemical studies, we demonstrated that the phylogenetically conserved amino acid residue, F439, was critical for both transport and the binding of multiple substrates and inhibitors. Structural modeling implied that the pi-pi interactions from each F439 monomer mediated the binding of a surprisingly diverse array of structurally unrelated substrates and inhibitors and that this symmetrical pi-pi interaction "clamps" the ligand into the binding pocket. Key molecular features of diverse ABCG2 ligands using the pi-pi clamp along with structural studies created a pharmacophore model. These novel findings have important therapeutic implications because key properties of ligands interacting with ABCG2 have been disovered. Furthermore, mechanistic insights have been revealed by demonstrating that for ABCG2 a single amino acid is essential for engaging and initiating transport of multiple drugs and xenobiotics.	[Gose, Tomoka; Fukuda, Yu; Wang, Yao; Allcock, Alice; Gavan McHarg, Ailsa; Lynch, John; Schuetz, John D.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Shafi, Talha; Ford, Robert C.] Univ Manchester, Sch Biol Sci, Manchester, Lancs, England; [Das, Sourav; Chen, Taosheng; Shelat, Anang] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA; [Tamai, Ikumi] Kanazawa Univ, Dept Pharmaceut Sci, Kanazawa, Ishikawa, Japan	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Manchester; St Jude Children's Research Hospital; Kanazawa University	Schuetz, JD (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	john.schuetz@stjude.org	Gose, Tomoka/AGX-9986-2022; Chen, Taosheng/I-6351-2013; Fukuda, Yu/GLT-1434-2022; Shelat, Anang/J-4995-2013	Gose, Tomoka/0000-0003-2388-8885; Chen, Taosheng/0000-0001-6420-3809; Das, Sourav/0000-0003-1759-0345; Shelat, Anang/0000-0002-6266-2910; Allcock, Alice/0000-0002-2574-5880	NIH, ALSAC [R01CA194057, R35-GM118041, P30CA21745, CA21865, CA96832]	NIH, ALSAC	NIH, ALSAC, Grant/Award Number: R01CA194057, R35-GM118041, P30CA21745, CA21865, CA96832	Allen JD, 2002, MOL CANCER THER, V1, P417; Ashok Y, 2015, PROTEIN ENG DES SEL, V28, P539, DOI 10.1093/protein/gzv049; Clark R, 2006, BRIT J PHARMACOL, V149, P506, DOI 10.1038/sj.bjp.0706904; Cox MH, 2018, BIOCHEM J, V105, P877; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Elkins CA, 2007, ANTIMICROB AGENTS CH, V51, P923, DOI 10.1128/AAC.01048-06; Enokizono J, 2008, DRUG METAB DISPOS, V36, P995, DOI 10.1124/dmd.107.019257; Ferreira RJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15452-z; Fukuda Y, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92409; Fukuda Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12353; Fukuda Y, 2012, BIOCHEM PHARMACOL, V83, P1073, DOI 10.1016/j.bcp.2011.12.042; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Haider AJ, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150150; Hosomi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030456; Hussaarts KGAM, 2019, THER ADV MED ONCOL, V11, DOI 10.1177/1758835918818347; Ichida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1756; Jackson SM, 2018, NAT STRUCT MOL BIOL, V25, P333, DOI 10.1038/s41594-018-0049-1; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Khunweeraphong N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11794-w; Lee JY, 2016, NATURE, V533, P561, DOI 10.1038/nature17666; Manolaridis I, 2018, NATURE, V563, P426, DOI 10.1038/s41586-018-0680-3; Matsuo H, 2009, SCI TRANSL MED, V120, P1791; Molina DM, 2016, ANNU REV PHARMACOL, V56, P141, DOI 10.1146/annurev-pharmtox-010715-103715; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Morfouace M, 2015, CANCER RES, V75, P3879, DOI 10.1158/0008-5472.CAN-15-0030; Nagai S, 2011, CANCER RES, V71, P1781, DOI 10.1158/0008-5472.CAN-10-1919; Pal A, 2007, J PHARMACOL EXP THER, V321, P1085, DOI 10.1124/jpet.106.119289; Reinhard FBM, 2015, NAT METHODS, V12, P1129, DOI 10.1038/nmeth.3652; Robey RW, 2018, NAT REV CANCER, V18, P452, DOI 10.1038/s41568-018-0005-8; Robey RW, 2004, CANCER RES, V64, P1242, DOI 10.1158/0008-5472.CAN-03-3298; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shukla S, 2014, MOL PHARMACEUT, V11, P2313, DOI 10.1021/mp400762h; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Takenaka K, 2007, CANCER RES, V67, P6965, DOI 10.1158/0008-5472.CAN-06-4720; Taylor NMI, 2017, NATURE, V546, P504, DOI 10.1038/nature22345; Vaidehi N, 2016, TRENDS PHARMACOL SCI, V37, P37, DOI 10.1016/j.tips.2015.09.005; Wang Z, 2017, ELIFE, V6, DOI 10.7554/eLife.24905; Wijaya J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122544; Yasuda K, 2018, DRUG METAB DISPOS, V46, P1725, DOI 10.1124/dmd.118.083584; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/pnas.192276999; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	41	20	19	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4890	4903		10.1096/fj.201902338RR	http://dx.doi.org/10.1096/fj.201902338RR		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32067270	Green Accepted			2022-12-26	WOS:000515246800001
J	Wu, H; Wei, SS; Huang, YL; Chen, LT; Wang, YR; Wu, XL; Zhang, ZD; Pei, YC; Wang, DY				Wu, Hao; Wei, Shuangshuang; Huang, Yonglin; Chen, Lintao; Wang, Yuerong; Wu, Xinli; Zhang, Zhuandan; Pei, Yechun; Wang, Dayong			A beta monomer induces phosphorylation of Tau at Ser-214 through beta 2AR-PKA-JNK signaling pathway	FASEB JOURNAL			English	Article						Alzheimer's disease; amyloid beta peptide; JNK; monomer; Tau	AMYLOID PRECURSOR PROTEIN; MILD COGNITIVE IMPAIRMENT; N-TERMINAL KINASE; ALZHEIMERS-DISEASE; MITOCHONDRIAL DYSFUNCTION; ADRENERGIC-RECEPTOR; INSULIN-RESISTANCE; PATHOGENESIS; EXPRESSION; ETIOLOGY	Alzheimer's disease (AD) is a progressive neurodegenerative disorder associated with synaptic dysfunction, pathological accumulation of beta-amyloid peptide 1-42 (A beta(1-42)), and neuronal loss. The self-association of A beta(1-42) monomers (A beta-M) into soluble oligomers seems to be crucial for the development of neurotoxicity. Previous publications have shown that A beta oligomers and dimers might play key roles in inducing AD. The role of A beta-M was rarely investigated and still unclear in AD. To understand the effects of A beta-M on neurons and other cell types in the brain could be the key to understand its function. In our study, we found that A beta-M expression slowly induced cell apoptosis within 48 hours after transfection, beta 2 adrenergic receptor (beta 2AR) interacted with A beta-M in the pull-down and the yeast two-hybrid assays, and A beta-M played a major role in inducing phosphorylation of Tau at Ser-214, c-Jun N-terminal kinase (JNK) at Thr-183/Tyr-185, p70 ribosomal protein S6 kinase (p70S6K) at Thr-389. We also discovered that beta 2AR, G protein-coupled receptor kinase 2 (GRK2), and protein kinase A (PKA) mediated the phosphorylation of Tau and JNK. A beta-M induced phosphorylation of Tau at Ser-214 through both beta 2AR-cAMP/PKA-JNK and beta 2AR-GRK signaling pathways. Mitogen-activated protein kinase kinase (MEK) mediated the phosphorylation of p70S6K induced by A beta-M.	[Wu, Hao; Wei, Shuangshuang; Huang, Yonglin; Chen, Lintao; Wang, Yuerong; Wu, Xinli; Zhang, Zhuandan; Wang, Dayong] Hainan Univ, Hainan Prov Key Lab Sustainable Utilizat Trop Bio, Haikou, Hainan, Peoples R China; [Wu, Hao; Wei, Shuangshuang; Huang, Yonglin; Chen, Lintao; Wang, Yuerong; Wu, Xinli; Zhang, Zhuandan; Wang, Dayong] Hainan Univ, Sch Life & Pharmaceut Sci, Lab Biotechnol & Mol Pharmacol, Haikou, Hainan, Peoples R China; [Pei, Yechun] Hainan Univ, Dept Vet Sci, Coll Anim Sci, Haikou, Hainan, Peoples R China	Hainan University; Hainan University; Hainan University	Wang, DY (corresponding author), Hainan Univ, Dept Biosci, 58 Peoples Rd, Haikou 570228, Hainan, Peoples R China.; Pei, YC (corresponding author), Hainan Univ, Dept Vet Sci, 58 Peoples Rd, Haikou 570228, Hainan, Peoples R China.	ycpei@hainanu.edu.cn; wangdy@hainanu.edu.cn			National Natural Science Foundation of China [31460226, 31760246]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 31460226 and 31760246	Ahmed S, 2015, NEUROL SCI, V36, P1; Alzheimer A, 1995, Clin Anat, V8, P429; Beyreuther K, 1991, BRAIN PATHOL, V1, P241, DOI 10.1111/j.1750-3639.1991.tb00667.x; Chami B, 2016, METAB BRAIN DIS, V31, P497, DOI 10.1007/s11011-016-9806-1; Claxton A, 2015, J ALZHEIMERS DIS, V44, P897, DOI 10.3233/JAD-141791; Combs CK, 2001, J NEUROSCI, V21, P1179; de la Monte SM, 2014, EUR NEUROPSYCHOPHARM, V24, P1954, DOI 10.1016/j.euroneuro.2014.06.008; Diniz BSO, 2008, WORLD J BIOL PSYCHIA, V9, P172, DOI 10.1080/15622970701535502; Freude S, 2009, CURR ALZHEIMER RES, V6, P213, DOI 10.2174/156720509788486527; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDGABER D, 1987, J NEURAL TRANSM, P23; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hashimoto Y, 2003, J NEUROCHEM, V84, P864, DOI 10.1046/j.1471-4159.2003.01585.x; Igbavboa U, 2006, NEUROSCIENCE, V142, P655, DOI 10.1016/j.neuroscience.2006.06.056; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kar S, 2004, J PSYCHIATR NEUROSCI, V29, P427; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Luchsinger JA, 2001, AM J EPIDEMIOL, V154, P635, DOI 10.1093/aje/154.7.635; Manassero G, 2016, AGING CELL, V15, P914, DOI 10.1111/acel.12500; Manczak M, 2012, HUM MOL GENET, V21, P5131, DOI 10.1093/hmg/dds360; Mitsuyama F, 2009, ALZHEIMERS DEMENTI S, V5, P109; Mitsuyama F, 2012, INT J ALZHEIMERS DIS, V2012; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Pei JJ, 2006, FEBS LETT, V580, P107, DOI 10.1016/j.febslet.2005.11.059; Rad SK, 2018, DRUG DES DEV THER, V12, P3999, DOI 10.2147/DDDT.S173970; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tamagno E, 2018, J ALZHEIMERS DIS, V62, P1241, DOI 10.3233/JAD-170581; van der Kant R, 2015, DEV CELL, V32, P502, DOI 10.1016/j.devcel.2015.01.022; Wang D., 2015, J IND MICROBIOL BIOT, V42, P1; Wang DY, 2013, J BIOL CHEM, V288, P10298, DOI 10.1074/jbc.M112.415141; Wang DY, 2010, FASEB J, V24, P3511, DOI 10.1096/fj.10-156661; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zhou XW, 2008, FEBS LETT, V582, P159, DOI 10.1016/j.febslet.2007.11.078; Zimbone S, 2018, AGING CELL, V17, DOI 10.1111/acel.12684	40	9	9	4	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5092	5105		10.1096/fj.201902230RR	http://dx.doi.org/10.1096/fj.201902230RR		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32067279				2022-12-26	WOS:000515247700001
J	Andrioli, DC; Busato, MA; Lutinski, JA				Andrioli, Denise Catarina; Busato, Maria Assunta; Lutinski, Junir Antonio			Spatial and temporal distribution of dengue in Brazil, 1990-2017	PLOS ONE			English	Article							CLIMATE; BURDEN; EPIDEMIOLOGY; MORTALITY; HEALTH; FEVER	Dengue is a viral disease caused by an arbovirus of the genus Flavivirus transmitted in Brazil by the mosquito Aedes aegypti (Linnaeus, 1762). Simultaneous circulation of the four viral serotypes (DENV1, 2, 3 and 4) has been occurring since 2010 and determines a scenario of hyperendemicity of the disease in the country. This study aimed to describe the epidemiological situation of dengue in Brazil in the last three decades. This is a descriptive, observational study that used data of dengue notifications of the National Surveillance System from 1990 to 2017, available in the Epidemiological Bulletins and publications of the Ministry of Health. Dengue incidence increased in all Brazilian regions and the interepidemic periods are distinct in the different regions. The greatest epidemics was recorded in 2015 (1,688,688 cases), with an incidence of 826.0 cases per 100,000 inhabitants, which illustrates the occurrence of dengue in the last decade with increasingly higher epidemic peaks and shortening of the interepidemic periods. The incidence and mortality indices point to the need to improve the organization of response to dengue epidemics. This study provides information on the epidemiology of dengue in the country and can be used in the formulation of public health policies to reduce the impacts of viral transmission.	[Andrioli, Denise Catarina; Busato, Maria Assunta; Lutinski, Junir Antonio] Community Univ Reg Chapeco Unochapeco, Postgrad Program Hlth Sci, Chapeco, SC, Brazil; [Andrioli, Denise Catarina] Community Univ Reg Chapeco, Chapeco, SC, Brazil	Universidade Comunitaria Regional de Chapeco; Universidade Comunitaria Regional de Chapeco	Busato, MA (corresponding author), Community Univ Reg Chapeco Unochapeco, Postgrad Program Hlth Sci, Chapeco, SC, Brazil.	assunta@unochapeco.edu.br	Lutinski, Junir Antônio/J-9861-2019	Lutinski, Junir Antônio/0000-0003-0149-5415				Achee NL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006822; Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI DOI 10.1371/JOURNAL.PNTD.0003655; Antonio FJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180715; Araujo Valdelaine Etelvina Miranda de, 2017, Rev Bras Epidemiol, V20Suppl 01, P205, DOI 10.1590/1980-5497201700050017; Bangert M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006796; Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Brazilian Ministry of Health, 2018, DENGUE; Brazilian Ministry of Health, 2016, DENG DIAGN MAN CLIN; Brazilian Ministry of Health, 2017, GUIA VIG SAUD; Brazilian Ministry of Health, 2017, SAUD BRAS 2015 2016; Brazilian Ministry of Health, 2002, PROGR NAC CONTR DENG; Clarke K., 2005, PRIMER GETTING START; Deininger Layza de Souza Chaves, 2014, Saúde debate, V38, P50, DOI 10.5935/0103-104.20140013; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Dias JP, 2006, THESIS; Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865; Instituto Brasileiro de Geografia e Estatistica, EST POP; Instituto Brasileiro de Geografia e Estatistica, MAP IBGE; Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382; Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783; Lopes N., 2014, REV PAN-AMAZ SAUDE, V5, P55, DOI [DOI 10.5123/S2176-62232014000300007, 10.5123/S2176-62232014000300007]; Lowe R, 2017, LANCET PLANET HEALTH, V1, pE142, DOI 10.1016/S2542-5196(17)30064-5; MacCormack-Gelles B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006990; Martins-Melo FR, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006559; Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430; Moraes GH, 2013, AM J TROP MED HYG, V88, P670, DOI 10.4269/ajtmh.11-0774; Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769; Paixao ES, 2015, REV SOC BRAS MED TRO, V48, P399, DOI 10.1590/0037-8682-0145-2015; Roiz D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006845; Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8; Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091; Siqueira Junior JB, 2011, SAUDE BRASIL 2010 AN, P157; Stevens GA, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002116, 10.1371/journal.pmed.1002056]; Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520; Teixeira MG, 2012, REV INST MED TROP SP, V54, pS1, DOI 10.1590/S0036-46652012000700002; WHO, 2018, DENG SEV DENG; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002; World Health Organization, 2017, GLOB VECT CONTR RESP; World Health Organization, 2012, GLOB STRAT DENG PREV; World Health Organization, 2018, DENG CONTR; World Health Organization (WHO), 2018, TOOLK NAT DENG BURD; Zubieta-Zavala A, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006938	47	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228346	10.1371/journal.pone.0228346	http://dx.doi.org/10.1371/journal.pone.0228346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053623	gold, Green Published			2022-12-26	WOS:000535198700026
J	Aungsumart, S; Apiwattanakul, M				Aungsumart, Saharat; Apiwattanakul, Metha			Cost effectiveness of rituximab and mycophenolate mofetil for neuromyelitis optica spectrum disorder in Thailand: Economic evaluation and budget impact analysis	PLOS ONE			English	Article							PLASMA-EXCHANGE; EFFICACY; AZATHIOPRINE; THERAPY; TOLERABILITY; OUTCOMES; RELAPSE	Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory condition of the central nervous system. The extent of disability depends on the severity of the disease and the number of relapses. Although azathioprine is currently the main treatment for patients with NMOSD in Thailand, patients often relapse during its use. Hence, it is argued that there are other drugs that would be more effective. The purpose of this study is to evaluate, from a societal perspective and from the economic impact on Thailand's healthcare system, the cost utility of treatment with mycophenolate mofetil (MMF) and rituximab in patients resistant to azathioprine. The Markov model with a one-year cycle length was applied to predict the health and cost outcomes in patients with NMOSD over a lifetime. The results showed that rituximab exhibited the highest quality-adjusted life year (QALY) gains among all the options. Among the rituximab-based treatments, the administration of a rituximab biosimilar with CD27(+) memory B cell monitoring proved to be the most cost-effective option. At the willingness-to-pay threshold of 160,000 Thai baht (THB), or 5,289 US dollar (USD), per QALY gained, the treatment exhibited the highest probability of being cost effective (48%). A sensitivity analysis based on the adjusted price of a generic MMF determined that the treatment was cost effective, exhibiting an incremental cost-effectiveness ratio of -164,653 THB (-5,443 USD) and a 32% probability of being cost effective. The calculated budget impact of treating patients resistant to conventional therapy was 1-6 million THB (33,000-198,000 USD) for the first three years, while after the third year, the budget impact stabilized at 3-4 million THB (99,000-132,000 USD). These data indicate that, in Thailand, treatment of drug resistant NMOSD with a rituximab biosimilar with CD27(+) memory B cell monitoring or treatment with a generic MMF would be cost effective and would result in a low budget impact. Therefore, the inclusion of both the rituximab biosimilar and a generic MMF in the National Drug List of Essential Medicine for the treatment of NMOSD may be appropriate.	[Aungsumart, Saharat; Apiwattanakul, Metha] Prasat Neurol Inst, Dept Neurol, Neuroimmunol Unit, Bangkok, Thailand		Aungsumart, S (corresponding author), Prasat Neurol Inst, Dept Neurol, Neuroimmunol Unit, Bangkok, Thailand.	Saharatau@hotmail.com			Prasat Neurological Institute, Department of Medical Services, Ministry of Public Health Thailand	Prasat Neurological Institute, Department of Medical Services, Ministry of Public Health Thailand	This project received financial support from the Prasat Neurological Institute, Department of Medical Services, Ministry of Public Health Thailand. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud H, 2016, MULT SCLER J, V22, P185, DOI 10.1177/1352458515581438; Akaishi T, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000640; [Anonymous], 2018, TRATMENT OUTCO UNPUB; Apiwattanakul M, 2016, COST EFFECTIVENESS P; Apiwattanakul M, 2012, J NEUROL SCI, V320, P118, DOI 10.1016/j.jns.2012.07.014; Aungsumart S, 2017, MULT SCLER RELAT DIS, V13, P93, DOI 10.1016/j.msard.2017.02.015; Biswas A, 2015, ANN INDIAN ACAD NEUR, V18, pS16, DOI 10.4103/0972-2327.164818; Bonnan M, 2018, J NEUROL NEUROSUR PS, V89, P346, DOI 10.1136/jnnp-2017-316286; Chanatittarat C, 2018, INT J TECHNOL ASSESS, V34, P584, DOI 10.1017/S0266462318003604; Chen H, 2017, EUR J NEUROL, V24, P219, DOI 10.1111/ene.13186; Collongues N, 2016, MULT SCLER J, V22, P955, DOI 10.1177/1352458515602337; Damato V, 2016, JAMA NEUROL, V73, P1342, DOI 10.1001/jamaneurol.2016.1637; Drug and Medical Supply Information Center, 2014, REF DRUG PRIC MIN PU; Fuller GW, 2016, NEUROEPIDEMIOLOGY, V47, P1, DOI 10.1159/000445997; Jeong IH, 2016, MULT SCLER J, V22, P329, DOI 10.1177/1352458515587752; Kim SH, 2011, ARCH NEUROL-CHICAGO, V68, P1412, DOI 10.1001/archneurol.2011.154; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Mealy MA, 2014, JAMA NEUROL, V71, P324, DOI 10.1001/jamaneurol.2013.5699; Nikoo Z, 2017, J NEUROL, V264, P2003, DOI 10.1007/s00415-017-8590-0; Prayoonwiwat N, 2013, PREVALENCE IDIOPATHI; Rotstein DL, 2019, MULT SCLER J, V25, P1218, DOI 10.1177/1352458519832249; Shosha E, 2019, MULT SCLER J, V25, P1217, DOI 10.1177/1352458519829694; Siritho S, 2018, MULT SCLER RELAT DIS, V24, P151, DOI 10.1016/j.msard.2018.07.004; Stellmann JP, 2017, J NEUROL NEUROSUR PS, V88, P639, DOI 10.1136/jnnp-2017-315603; Suksuchano K, 2017, J NEUROL SCI, V381, P1063, DOI 10.1016/j.jns.2017.08.3005; Torres J, 2015, J NEUROL SCI, V351, P31, DOI 10.1016/j.jns.2015.02.012; Vacharin P, 2013, GUIDELINES HLTH TECH; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Yang Y, 2018, J NEUROL SCI, V385, P192, DOI 10.1016/j.jns.2017.12.034; Zephir H, 2015, J NEUROL, V262, P2329, DOI 10.1007/s00415-015-7852-y	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0229028	10.1371/journal.pone.0229028	http://dx.doi.org/10.1371/journal.pone.0229028			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32050011	Green Published, gold			2022-12-26	WOS:000535192300042
J	Tseng, CC; Jia, BL; Barndt, RB; Dai, YH; Chen, YH; Du, PWA; Wang, JK; Tang, HJ; Lin, CY; Johnson, MD				Tseng, Chun-Che; Jia, Bailing; Barndt, Robert B.; Dai, Yang-Hong; Chen, Yu Hsin; Du, Po-Wen A.; Wang, Jehng-Kang; Tang, Hung-Jen; Lin, Chen-Yong; Johnson, Michael D.			The intracellular seven amino acid motif EEGEVFL is required for matriptase vesicle sorting and translocation to the basolateral plasma membrane	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; MATRIX-DEGRADING PROTEASE; SERINE-PROTEASE; ACTIVATION; IDENTIFICATION; INHIBITOR; COMPLEX; CANCER; CELLS; LOCALIZATION	Matriptase plays important roles in epithelial integrity and function, which depend on its sorting to the basolateral surface of cells, where matriptase zymogen is converted to an active enzyme in order to act on its substrates. After activation, matriptase undergoes HAI-1-mediated inhibition, internalization, transcytosis, and secretion from the apical surface into the lumen. Matriptase is a mosaic protein with several distinct protein domains and motifs, which are a reflection of matriptase's complex cellular itinerary, life cycle, and the tight control of its enzymatic activity. While the molecular determinants for various matriptase regulatory events have been identified, the motif(s) required for translocation of human matriptase to the basolateral plasma membrane is unknown. The motif previously identified in rat matriptase is not conserved between the rodent and the primate. We, here, revisit the question for human matriptase through the use of a fusion protein containing a green fluorescent protein linked to the matriptase N-terminal fragment ending at Gly-149. A conserved seven amino acid motif EEGEVFL, which is similar to the monoleucine C-terminal to an acidic cluster motif involved in the basolateral targeting for some growth factors, has been shown to be required for matriptase translocation to the basolateral plasma membrane of polarized MDCK cells. Furthermore, time-lapse video microscopy showed that the motif appears to be required for entry into the correct transport vesicles, by which matriptase can undergo rapid trafficking and translocate to the plasma membrane. Our study reveals that the EEGEVFL motif is necessary, but may not be sufficient, for matriptase basolateral membrane targeting and serves as the basis for further research on its pathophysiological roles.	[Tseng, Chun-Che; Jia, Bailing; Barndt, Robert B.; Du, Po-Wen A.; Lin, Chen-Yong; Johnson, Michael D.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Jia, Bailing] Zhengzhou Univ, Henan Prov Peoples Hosp, Dept Gastroenterol & Hepatol, Peoples Hosp, Zhengzhou, Peoples R China; [Dai, Yang-Hong] Triserv Gen Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Chen, Yu Hsin] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Du, Po-Wen A.; Wang, Jehng-Kang] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan; [Tang, Hung-Jen] Chi Mei Med Ctr, Sect Infect Dis, Tainan, Taiwan	Georgetown University; Zhengzhou University; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Chi Mei Hospital	Lin, CY; Johnson, MD (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA.; Tang, HJ (corresponding author), Chi Mei Med Ctr, Sect Infect Dis, Tainan, Taiwan.	8409d1@gmail.com; lincy@georgetown.edu; johnsom@georgetown.edu	Lin, Chen/GRR-2799-2022	Tseng, Chun-che/0000-0001-9637-4127; Dai, Yang-Hong/0000-0001-8054-0944; Lin, Chen-Yong/0000-0002-6391-2571; johnson, Michael/0000-0001-6260-7586	National Cancer Institute (NCI) [RO1 CA 123223]; Ministry of National Defense Medical Affairs Bureau, Taiwan [MAB-108-079]; Chi-Mei Medical Center, Tainan, Taiwan [CMNDMC10705, CMNDMC10813]; Lombardi Comprehensive Cancer Center support grant (NIH/NCI) [P30-CA051008]	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ministry of National Defense Medical Affairs Bureau, Taiwan; Chi-Mei Medical Center, Tainan, Taiwan; Lombardi Comprehensive Cancer Center support grant (NIH/NCI)	This study was supported by National Cancer Institute (NCI) Grant RO1 CA 123223 (to MDJ and CYL), and Grant (MAB-108-079) from the Ministry of National Defense Medical Affairs Bureau, Taiwan and Grants (CMNDMC10705; CMNDMC10813) from Chi-Mei Medical Center, Tainan, Taiwan (to J.-K. Wang). We also acknowledge the assistance provided by the Microscopy and Imaging Shared Resource and the Tissue Culture Shared Resource, which are supported in part by the Lombardi Comprehensive Cancer Center support grant (NIH/NCI grant P30-CA051008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Cho EG, 2001, J BIOL CHEM, V276, P44581, DOI 10.1074/jbc.M107059200; Chu LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092244; Friis S, 2011, J BIOL CHEM, V286, P5793, DOI 10.1074/jbc.M110.186874; Gephart JD, 2011, TRAFFIC, V12, P1793, DOI 10.1111/j.1600-0854.2011.01282.x; Godiksen S, 2008, BIOCHEM J, V413, P251, DOI 10.1042/BJ20071496; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673, DOI 10.1177/002215549904700509; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; Lin CY, 1997, J BIOL CHEM, V272, P9147; Murai N, 2009, CYTOTECHNOLOGY, V59, P169, DOI 10.1007/s10616-009-9205-0; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Satomi S, 2001, BIOCHEM BIOPH RES CO, V287, P995, DOI 10.1006/bbrc.2001.5686; SHI YE, 1993, CANCER RES, V53, P1409; Singh B, 2015, J CELL SCI, V128, P3444, DOI 10.1242/jcs.170852; Singh B, 2014, ANNU REV PHYSIOL, V76, P275, DOI 10.1146/annurev-physiol-021113-170406; Stoops EH, 2014, J AM SOC NEPHROL, V25, P1375, DOI 10.1681/ASN.2013080883; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Tseng CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183507; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009	25	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228874	10.1371/journal.pone.0228874	http://dx.doi.org/10.1371/journal.pone.0228874			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32049977	Green Published, gold			2022-12-26	WOS:000535192300031
J	Carvalho-Gomes, A; Cubells, A; Pallares, C; Hontangas, V; Conde, I; Di Maira, T; Peiro, S; Sanfelix-Gimeno, G; Lopez-Labrador, FX; Berenguer, M				Carvalho-Gomes, Angela; Cubells, Almudena; Pallares, Carmina; Hontangas, Vanessa; Conde, Isabel; Di Maira, Tomasso; Peiro, Salvador; Sanfelix-Gimeno, Gabriel; Xavier Lopez-Labrador, F.; Berenguer, Marina			A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area	PLOS ONE			English	Article							COHORT BABY BOOMERS; VIRUS-INFECTION; GENOTYPE DISTRIBUTION; GLOBAL EPIDEMIOLOGY; SURVEILLANCE; PERFORMANCE; COMMUNITY; ASSAYS	Background Data on the true prevalence of hepatitis C virus (HCV) infection in the general population is essential. We evaluated a program implementing free universal HCV screening using a non-invasive point-of-care test (POCT) (OraQuick-HCV rapid test) in oral fluid in an urban area in Valencia, South-Eastern Spain. Methods A cross-sectional study was performed during 2015-2017. Free HCV screening was offered by regular mail to 11,500 individuals aged 18 and over, randomly selected from all census residents in the Health Department. All responding participants filled in a questionnaire about HCV infection risk factors and were tested in their tertiary Hospital. In those with a positive POCT, results were confirmed by enzyme-immunoassay and HCV-RNA. Results 1,206 persons agreed to participate (response rate: 11.16%). HCV antibodies were detected in 19 (1.60%) cases (age-sex standardized rate: 1.31%; 95%CI: 0.82-2.07), but only 8 showed positive HCV-RNA (age-sex standardized rate: 0.56%; 95%CI: 0.28-1.14). The majority (89%) of the cases were born before 1965 and 74% had at least one known risk factor for HCV infection. All anti-HCV positive individuals were already aware of their infection, and no undiagnosed cases were detected. The performance of the POCT was excellent for detecting active infection. Conclusions These preliminary data suggest that HCV population screening with a POCT is feasible but, in our setting, mailing recruiting is not effective (11% response rate). The low prevalence of HCV antibodies and active infection in the participant population (with no new diagnoses made) suggests that, in our setting, underdiagnosis may be uncommon.	[Carvalho-Gomes, Angela; Cubells, Almudena; Pallares, Carmina; Hontangas, Vanessa; Di Maira, Tomasso; Berenguer, Marina] Inst Invest Sanitaria La Fe, Liver Transplantat & Hepatol Lab, Valencia, Spain; [Carvalho-Gomes, Angela; Pallares, Carmina; Berenguer, Marina] Inst Salud Carlos III, CIBERehd, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Conde, Isabel; Berenguer, Marina] Hosp Univ & Politecn La Fe, Liver Transplantat & Hepatol Unit, Valencia, Spain; [Peiro, Salvador; Sanfelix-Gimeno, Gabriel] Fdn Fomento Invest Sanitaria & Biomed Comunidad V, Hlth Serv Res Area, Valencia, Spain; [Xavier Lopez-Labrador, F.] Univ Valencia, Joint Units Genom & Hlth & Infect & Hlth Fdn Fome, Virol Lab, Valencia, Spain; [Xavier Lopez-Labrador, F.] Inst Salud Carlos III, Ctr Invest Biomed Red Epidemiol & Salud Publ, CIBEResp, Madrid, Spain; [Berenguer, Marina] Univ Valencia, Dept Med, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Hospital Universitari i Politecnic La Fe; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; University of Valencia	Lopez-Labrador, FX (corresponding author), Univ Valencia, Joint Units Genom & Hlth & Infect & Hlth Fdn Fome, Virol Lab, Valencia, Spain.; Lopez-Labrador, FX (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Epidemiol & Salud Publ, CIBEResp, Madrid, Spain.	F.Xavier.Lopez@uv.es	Berenguer, Marina/ABG-8602-2020; Sanfélix-Gimeno, Gabriel/E-9140-2012; Carvalho-Gomes, Angela/ABG-5267-2020; Peiro, Salvador/H-5778-2017; Di Maira, Tommaso/E-1594-2018	Berenguer, Marina/0000-0001-9246-4264; Sanfélix-Gimeno, Gabriel/0000-0001-7098-4576; Carvalho-Gomes, Angela/0000-0001-5424-3479; Peiro, Salvador/0000-0002-3902-569X; Di Maira, Tommaso/0000-0003-1903-2136; Lopez-Labrador, F. Xavier/0000-0002-9403-8258	Instituto de Salud Carlos III [PI15/02010, CM15/00133]; European Regional Development Fund; Gilead/Instituto de Salud Carlos III Fellowship Program [GLD1400269]; Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd) - Instituto de Salud Carlos III; Centro de Investigacion Biomedica en Red de Epidemiologia y Salud Publica (CIBEResp) - Instituto de Salud Carlos III; European Social Fund; Bankia	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund(European Commission); Gilead/Instituto de Salud Carlos III Fellowship Program; Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd) - Instituto de Salud Carlos III(Instituto de Salud Carlos III); Centro de Investigacion Biomedica en Red de Epidemiologia y Salud Publica (CIBEResp) - Instituto de Salud Carlos III; European Social Fund(European Social Fund (ESF)); Bankia	This study was supported by two competitive grants from the Instituto de Salud Carlos III (www.isciii.es) (PI15/02010, co-financed by the European Regional Development Fund), and the Gilead/Instituto de Salud Carlos III Fellowship Program (GLD1400269) (http://www.fellowshipgilead.es/).MB was also supported by the Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd) (https://www.ciberehd.org/) and FXLL by the Centro de Investigacion Biomedica en Red de Epidemiologia y Salud Publica (CIBEResp) (https://www.ciberesp.es), both funded by the Instituto de Salud Carlos III (co-financed by the European Regional Development Fund). TDM received a Rio Hortega Fellowship from the Instituto de Salud Carlos III (CM15/00133; co-financed by the European Social Fund), and AC received a FP Fellowship from Bankia (https://www.bankia.es/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaga A, 2018, ENFERM INFEC MICR CL, V36, P325, DOI 10.1016/j.eimc.2016.12.008; Allison WE, 2016, J EMERG MED, V50, P825, DOI 10.1016/j.jemermed.2016.02.001; Allison WE, 2016, AM J EMERG MED, V34, P697, DOI 10.1016/j.ajem.2015.12.072; Averhoff FM, 2012, CLIN INFECT DIS, V55, pS10, DOI 10.1093/cid/cis361; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Caballeria L, 2014, REV CLIN ESP, V214, P242, DOI 10.1016/j.rce.2014.01.024; Campbell JI, 2015, OFID S1, V2, P1, DOI DOI 10.1093/0FID/0FV010; Carvalhana SC, 2016, EUR J GASTROEN HEPAT, V28, P640, DOI 10.1097/MEG.0000000000000608; Cha YJ, 2013, ANN LAB MED, V33, P184, DOI 10.3343/alm.2013.33.3.184; Chak E, 2011, LIVER INT, V31, P1090, DOI 10.1111/j.1478-3231.2011.02494.x; Cuadrado A, 2018, GASTROENTEROL HEPA S, V41, P4; Departamento de Sanidad y Consumo, 2011, ENC SER COM AUT PAIS; Drobnik A, 2011, AM J PUBLIC HEALTH, V101, P2151, DOI 10.2105/AJPH.2011.300251; Duffell EF, 2015, J VIRAL HEPATITIS, V22, P590, DOI 10.1111/jvh.12367; Faustini A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-97; Comas LG, 2015, J MED VIROL, V87, P1697, DOI 10.1002/jmv.24219; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hayes B, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-645; Ibrahim S, 2015, CLIN ORAL INVEST, V19, P475, DOI 10.1007/s00784-014-1261-y; Garcia-Alonso FJ, 2016, DIGEST LIVER DIS, V48, P1237, DOI 10.1016/j.dld.2016.06.034; Jewett A, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/528904; Judd A, 2003, J MED VIROL, V71, P49, DOI 10.1002/jmv.10463; Kosack CS, 2016, TROP MED INT HEALTH, V21, P603, DOI 10.1111/tmi.12688; Lee SR, 2010, J CLIN VIROL, V48, P15, DOI 10.1016/j.jcv.2010.02.018; Lee SR, 2011, J VIROL METHODS, V172, P27, DOI 10.1016/j.jviromet.2010.12.009; Ministerio de Sanidad SS e Igualdad Sanidad DE Sociales S Igualdad E, PLAN ESTR AB HEP C S; Myers RP, 2014, CAN J GASTROENTEROL, V28, P243, DOI 10.1155/2014/317623; Pallares C, 2018, J CLIN VIROL, V102, P77, DOI 10.1016/j.jcv.2018.02.016; Parda N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013359; Parisi MR, 2017, NEW MICROBIOL, V40, P242; Shah HA, 2013, CAN MED ASSOC J, V185, P1325, DOI 10.1503/cmaj.121872; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Smith BD, 2011, CLIN INFECT DIS, V53, P780, DOI 10.1093/cid/cir499; Vuppalanchi R, 2013, GASTROENTEROLOGY, V144, pS951, DOI 10.1053/j.gastro.2012.12.013; WHO, 2017, WHO PUBLISHES LIST B; Zuure FR, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-66	37	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228351	10.1371/journal.pone.0228351	http://dx.doi.org/10.1371/journal.pone.0228351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045417	Green Published, gold			2022-12-26	WOS:000534633200011
J	Cattaneo, G; Bartres-Faz, D; Morris, TP; Sanchez, JS; Macia, D; Tormos, JM; Pascual-Leone, A				Cattaneo, Gabriele; Bartres-Faz, David; Morris, Timothy P.; Solana Sanchez, Javier; Macia, Didac; Tormos, Josep M.; Pascual-Leone, Alvaro			The Barcelona Brain Health Initiative: Cohort description and first follow-up	PLOS ONE			English	Article							MILD-COGNITIVE-IMPAIRMENT; LIFE-STYLE; PARKINSONS-DISEASE; ALZHEIMER-DISEASE; COHERENCE; QUESTIONNAIRE; DEMENTIA; PURPOSE; SCALE; SENSE	The Barcelona Brain Health Initiative is a longitudinal cohort study that began in 2017 and aims to understand and characterize the determinants of brain health maintenance in middle aged adults. A cohort of 4686 individuals between the ages of 40 and 65 years free from any neurological or psychiatric diseases was established, and we collected extensive demographic, socio-economic information along with measures of self-perceived health and lifestyles (general health, physical activity, cognitive activity, socialization, sleep, nutrition and vital plan). Here we report on the baseline characteristics of the participants, and the results of the one-year follow-up evaluation. Participants were mainly women, highly educated, and with better lifestyles compared with the general population. After one year 60% of participants completed the one-year follow-up, and these were older, with higher educational level and with better lifestyles in some domains. In the absence of any specific interventions to-date, these participants showed small improvements in physical activity and sleep, but decreased adherence to a Mediterranean diet. These changes were negatively associated with baseline scores, and poorer habits at baseline were predictive of an improvement in lifestyle domains. Of the 2353 participants who completed the one-year follow-up, 73 had been diagnosed with new neurological and neuropsychiatric diseases. Changes in vital plan at follow-up, as well as gender, sleep quality and sense of coherence at baseline were shown to be significant risk factors for the onset of these diagnoses. Notably, gender risk factor decreased in importance as we adjusted by sleep habits, suggesting its potential mediator effects. These findings stress the importance of healthy lifestyles in sustaining brain health, and illustrate the individual benefit that can be derived from participation in longitudinal observational studies. Modifiable lifestyles, specifically quality of sleep, may partially mediate the effect of other risk factors in the development of some neuropsychiatric conditions.	[Cattaneo, Gabriele; Bartres-Faz, David; Morris, Timothy P.; Solana Sanchez, Javier; Macia, Didac; Tormos, Josep M.; Pascual-Leone, Alvaro] UAB, Inst Guttmann, Inst Univ Neu Rorehabil, Barcelona, Spain; [Cattaneo, Gabriele; Solana Sanchez, Javier; Tormos, Josep M.] Univ Autonoma Barcelona, Barcelona, Spain; [Bartres-Faz, David; Macia, Didac] Univ Barcelona, Fac Med & Ciencies Salut, Dept Med, Barcelona, Spain; [Morris, Timothy P.] Harvard Med Sch, Berenson Allen Ctr Noninvas Brain Stimulat, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Pascual-Leone, Alvaro] Harvard Med Sch, Hinda & Arthur Marcus Inst Aging Res, Hebrew SeniorLife, Boston, MA 02115 USA	Autonomous University of Barcelona; Autonomous University of Barcelona; University of Barcelona; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Hebrew SeniorLife	Cattaneo, G (corresponding author), UAB, Inst Guttmann, Inst Univ Neu Rorehabil, Barcelona, Spain.; Cattaneo, G (corresponding author), Univ Autonoma Barcelona, Barcelona, Spain.	gcattaneo@guttmann.com	Macia, Didac/AAB-5182-2021; Bartres-Faz, David/C-8997-2011	Macia, Didac/0000-0003-3315-7293; Bartres-Faz, David/0000-0001-6020-4118; Tormos Munoz, Jose Maria/0000-0002-8764-2289	"la Caixa" Foundation [LCF/PR/PR16/11110004]; Institut Guttmann; Fundacio Abertis; Spanish Ministry of Economy and Competitiveness (MINECO) [PSI2015-64227-R]; Spanish Ministry of Science, Innovation and Universities [RTI2018-095181-B-C21]; INNOBRAIN [COMRDI15-1-0017]; Ad-Salutem Institute; Sodexo S.A.; I.C.A Informatica y Comunicaciones Avanzadas; Neuroelectrics; Corporacio Catalana de Mitjans Audiovisuals; Club Metropolitan; Casa Ametller; Agencia de Qualitat i Avaluacio Sanitaries de Catalunya-AQuAS	"la Caixa" Foundation(La Caixa Foundation); Institut Guttmann; Fundacio Abertis; Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Spanish Ministry of Science, Innovation and Universities(Spanish Government); INNOBRAIN; Ad-Salutem Institute; Sodexo S.A.; I.C.A Informatica y Comunicaciones Avanzadas; Neuroelectrics; Corporacio Catalana de Mitjans Audiovisuals; Club Metropolitan; Casa Ametller; Agencia de Qualitat i Avaluacio Sanitaries de Catalunya-AQuAS	The research leading to these results has received funding from "la Caixa" Foundation (grant agreement no LCF/PR/PR16/11110004), and also from Institut Guttmann and Fundacio Abertis. David Bartres-Faz was funded by the Spanish Ministry of Economy and Competitiveness (MINECO; PSI2015-64227-R) and the Spanish Ministry of Science, Innovation and Universities (RTI2018-095181-B-C21) research grants. Josep M. Tormos was partly supported by INNOBRAIN (COMRDI15-1-0017). Ad-Salutem Institute, Sodexo S.A., I.C.A Informatica y Comunicaciones Avanzadas, Neuroelectrics, Corporacio Catalana de Mitjans Audiovisuals, Club Metropolitan, Casa Ametller, and Agencia de Qualitat i Avaluacio Sanitaries de Catalunya-AQuAS are commercial companies supporting the Barcelona Brain Health Initiative and this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader DN, 2007, MED CARE, V45, pS1, DOI 10.1097/01.mlr.0000260537.45076.74; Rico-Uribe LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145264; Alimujiang A, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.4270; Alvaro PK, 2013, SLEEP, V36, P1059, DOI 10.5665/sleep.2810; ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z; Antonovsky A, 1996, HEALTH PROMOT INT, V11, P11, DOI 10.1093/heapro/11.1.11; ANTONOVSKY A, 1990, STRESS MEDICINE, V6, P71, DOI 10.1002/smi.2460060203; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; BARTRESFAZ D, 2018, ALZHEIMERS RES THER, V10, DOI DOI 10.1186/S13195-017-0329-8; Bermejo-Pareja F, 2008, J NEUROL SCI, V264, P63, DOI 10.1016/j.jns.2007.07.021; Boeckxstaens P, 2016, ANN FAM MED, V14, P337, DOI 10.1370/afm.1950; Booker CL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-249; Boyle PA, 2012, ARCH GEN PSYCHIAT, V69, P499, DOI 10.1001/archgenpsychiatry.2011.1487; Boyle PA, 2010, ARCH GEN PSYCHIAT, V67, P304, DOI 10.1001/archgenpsychiatry.2009.208; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Buysse D J, 1989, Psychiatry Res, V28, P193; Cartens J. A., 1997, PSYCHOL REP, V80, P1211; Cattaneo G, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00321; Cattaneo G, 2015, NEUROPSYCHOLOGIA, V66, P99, DOI 10.1016/j.neuropsychologia.2014.11.006; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Chiolero Arnaud, 2013, Front Public Health, V1, P29, DOI 10.3389/fpubh.2013.00029; Chung F, 2016, CHEST, V149, P631, DOI 10.1378/chest.15-0903; Cohen R, 2016, PSYCHOSOM MED, V78, P122, DOI 10.1097/PSY.0000000000000274; CONIGRAVE KM, 1995, ADDICTION, V90, P1479, DOI 10.1111/j.1360-0443.1995.tb02810.x; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Di Marco LY, 2014, J ALZHEIMERS DIS, V42, P119, DOI 10.3233/JAD-132225; Duzel S, 2016, GERONTOLOGY, V62, P345, DOI 10.1159/000441493; Eriksson M, 2006, J EPIDEMIOL COMMUN H, V60, P376, DOI 10.1136/jech.2005.041616; Caballero FF, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-177; Ferguson B., 2014, J CANADIAN CHIROPRAC, V58, P328; Ferrari AJ, 2013, PSYCHOL MED, V43, P471, DOI 10.1017/S0033291712001511; Fichter MM, 2009, SOC PSYCH PSYCH EPID, V44, P792, DOI 10.1007/s00127-009-0501-y; Fitzgerald D, 2019, J MED INTERNET RES, V21, DOI 10.2196/10672; Frankish H, 2017, LANCET, V390, P2614, DOI 10.1016/S0140-6736(17)31756-7; Freeman D, 2017, LANCET PSYCHIAT, V4, P749, DOI 10.1016/S2215-0366(17)30328-0; Garre-Olmo J, 2010, NEUROLOGY, V75, P1249, DOI 10.1212/WNL.0b013e3181f5d4c4; Generalitat de Catalunya Departament de Salut, 2015, INF 2013 LENQ SAL CA; Godin G., 1997, MED SCI SPORTS EXERC, V26, P14; Gomes-Osman J, 2018, NEUROL-CLIN PRACT, V8, P257, DOI 10.1212/CPJ.0000000000000460; Gustavson K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-918; Haukkala A, 2013, PSYCHOSOM MED, V75, P429, DOI 10.1097/PSY.0b013e31828c3fa4; Hayes, 2012, CISC VIS NETW IND GL; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hiskey S., 2009, SOCIAL SCI COMPUTER, V20, P250; Jansson-Frojmark M., 2008, ARTICLE J PSYCHOSOMA; JENKINS CD, 1988, J CLIN EPIDEMIOL, V41, P313, DOI 10.1016/0895-4356(88)90138-2; Kaneita Y, 2009, SLEEP MED, V10, P780, DOI 10.1016/j.sleep.2008.06.014; Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3; KESSLER RC, 1984, AM SOCIOL REV, V49, P620, DOI 10.2307/2095420; Kirkbride J. B., 2011, SYSTEMATIC REV INCID; Koelen M., 2016, HDB SALUTOGENESIS, P137, DOI DOI 10.1007/978-3-319-04600-6_15; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; LENO C, 1993, STROKE, V24, P792, DOI 10.1161/01.STR.24.6.792; Livingston G, 2017, LANCET, V6736; Lubben JE, 1988, FAM COMMUNITY HEALTH, V11, P42, DOI [10.1097/00003727-198811000-00008, DOI 10.1097/00003727-198811000-00008]; Lundman B, 2010, ARCH GERONTOL GERIAT, V51, P329, DOI 10.1016/j.archger.2010.01.013; MALLAMPALLI MP, 2002, J WOMENS HEALTH, V2014, P23, DOI DOI 10.1089/JWH.2014.4816; Martela F, 2016, J POSIT PSYCHOL, V11, P531, DOI 10.1080/17439760.2015.1137623; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005; Olazaran J., 2015, FRONT AGING NEUROSCI, V7, P1; Oldfield R. C., 1971, ASSESSMENT ANAL HAND; OLDHAM PD, 1962, J CHRON DIS, V15, P969, DOI 10.1016/0021-9681(62)90116-9; Panza F, 2005, AM J GERIAT PSYCHIAT, V13, P633, DOI 10.1176/appi.ajgp.13.8.633; Petersen RC, 2014, J INTERN MED, V275, P214, DOI 10.1111/joim.12190; Postuma Ronald B, 2012, Mov Disord, V27, P913, DOI 10.1002/mds.25037; Pradas J, 2013, AMYOTROPH LAT SCL FR, V14, P278, DOI 10.3109/21678421.2012.749915; Rami L, 2011, REV NEUROLOGIA, V52, P195, DOI 10.33588/rn.5204.2010478; Ryff Carol D, 2016, Curr Behav Neurosci Rep, V3, P318, DOI 10.1007/s40473-016-0096-z; Ryff CD, 2014, PSYCHOTHER PSYCHOSOM, V83, P10, DOI 10.1159/000353263; RYFF CD, 1995, CURR DIR PSYCHOL SCI, V4, P99, DOI 10.1111/1467-8721.ep10772395; RYFF CD, 1989, INT J BEHAV DEV, V12, P35, DOI 10.1177/016502548901200102; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; Solomon A, 2018, JAMA NEUROL, V75, P462, DOI 10.1001/jamaneurol.2017.4365; Steger MF, 2006, J COUNS PSYCHOL, V53, P80, DOI 10.1037/0022-0167.53.1.80; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Tambs K, 2009, TWIN RES HUM GENET, V12, P158, DOI 10.1375/twin.12.2.158; Teague S, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0586-7; Torvik FA, 2012, SOC PSYCH PSYCH EPID, V47, P805, DOI 10.1007/s00127-011-0387-3; Trompetter HR, 2013, PSYCHOL ASSESSMENT, V25, P1235, DOI 10.1037/a0033813; Vila-Corcoles A, 2014, REV NEUROLOGIA, V59, P490, DOI 10.33588/rn.5911.2014264; von Campenhausen S, 2005, EUR NEUROPSYCHOPHARM, V15, P473, DOI 10.1016/j.euroneuro.2005.04.007; Yu E, 2016, AM J PUBLIC HEALTH, V106, P1616, DOI 10.2105/AJPH.2016.303316; Yu L, 2015, STROKE, V347, P882	85	7	7	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228754	10.1371/journal.pone.0228754	http://dx.doi.org/10.1371/journal.pone.0228754			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9KA	32045448	Green Published, gold			2022-12-26	WOS:000534633200037
J	Ashok, Y; Maksimainen, MM; Kallio, T; Kilpelainen, P; Lehtio, L				Ashok, Yashwanth; Maksimainen, Mirko M.; Kallio, Tuija; Kilpelainen, Pekka; Lehtio, Lari			FMN-dependent oligomerization of putative lactate oxidase from Pediococcus acidilactici	PLOS ONE			English	Article							MECHANISM; SHOW	Lactate oxidases belong to a group of FMN-dependent enzymes and they catalyze a conversion of lactate to pyruvate with a release of hydrogen peroxide. Hydrogen peroxide is also utilized as a read out in biosensors to quantitate lactate levels in biological samples. Aerococcus viridans lactate oxidase is the best characterized lactate oxidase and our knowledge of lactate oxidases relies largely to studies conducted with that particular enzyme. Pediococcus acidilactici lactate oxidase is also commercially available for e.g. lactate measurements, but this enzyme has not been characterized in detail before. Here we report structural characterization of the recombinant enzyme and its co-factor dependent oligomerization. The crystal structures revealed two distinct conformations in the loop closing the active site, consistent with previous biochemical studies implicating the role of loop in catalysis. Despite the structural conservation of active site residues, we were not able to detect either oxidase or monooxygenase activity when L-lactate was used as a substrate. Pediococcus acidilactici lactate oxidase is therefore an example of a misannotation of an FMN-dependent enzyme, which catalyzes likely a so far unknown oxidation reaction.	[Ashok, Yashwanth; Maksimainen, Mirko M.; Lehtio, Lari] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Kallio, Tuija; Kilpelainen, Pekka] Univ Oulu, Kajaani Univ Consortium, Unit Measurement Technol, Kajaani, Finland	University of Oulu; University of Oulu	Lehtio, L (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland.	lari.lehtio@oulu.fi		Ashok, Yashwanth/0000-0002-5693-6372; Maksimainen, Mirko/0000-0001-8586-9538	Academy of Finland [287063, 294085]; European Regional Development Fund	Academy of Finland(Academy of Finland); European Regional Development Fund(European Commission)	LL; grants 287063 and 294085; Academy of Finland; www.aka.fi PK and TK; grant LIIKUTPA; European Regional Development Fund; www.rakennerahastot.fi The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; CHUNG ST, 1971, BIOCHEMISTRY-US, V10, P1205; Currano LJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33565-x; Dellero Y, 2015, J BIOL CHEM, V290, P1689, DOI 10.1074/jbc.M114.618629; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fitzpatrick PF, 2004, BIOORG CHEM, V32, P125, DOI 10.1016/j.bioorg.2003.02.001; Furuichi M, 2008, J MOL BIOL, V378, P436, DOI 10.1016/j.jmb.2008.02.062; Hamill MJ, 2011, BIOCHEMISTRY-US, V50, P10159, DOI 10.1021/bi201340t; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kean KM, 2019, PROTEIN SCI, V28, P135, DOI 10.1002/pro.3506; Leiros I, 2006, ACTA CRYSTALLOGR F, V62, P1185, DOI 10.1107/S1744309106044678; Li SJ, 2007, BIOCHEM BIOPH RES CO, V358, P1002, DOI 10.1016/j.bbrc.2007.05.021; LOCKRIDGE O, 1972, J BIOL CHEM, V247, P8097; MAEDAYORITA K, 1995, BIOCHIMIE, V77, P631, DOI 10.1016/0300-9084(96)88178-8; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Piiadov V, 2019, PROTEIN SCI, V28, P454, DOI 10.1002/pro.3528; Rassaei L, 2014, ANAL BIOANAL CHEM, V406, P123, DOI 10.1007/s00216-013-7307-1; Rathee Kavita, 2016, Biochem Biophys Rep, V5, P35, DOI 10.1016/j.bbrep.2015.11.010; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Sobrado P, 2003, BIOCHEMISTRY-US, V42, P15208, DOI 10.1021/bi035546n; Stoisser T, 2016, SCI REP-UK, V6, DOI 10.1038/srep27892; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tahallah N, 2002, J BIOL CHEM, V277, P36425, DOI 10.1074/jbc.M205841200; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Yorita K, 1996, J BIOL CHEM, V271, P28300, DOI 10.1074/jbc.271.45.28300; Zabaleta N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07827-1	29	5	5	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0223870	10.1371/journal.pone.0223870	http://dx.doi.org/10.1371/journal.pone.0223870			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092083	gold, Green Published, Green Submitted			2022-12-26	WOS:000535229300006
J	Orozco, P; Montoya, Y; Bustamante, J				Orozco, Paola; Montoya, Yuliet; Bustamante, John			Development of endomyocardial fibrosis model using a cell patterning technique: In vitro interaction of cell coculture of 3T3 fibroblasts and RL-14 cardiomyocytes	PLOS ONE			English	Article							CARDIAC FIBROSIS; VENTRICULAR CARDIOMYOCYTE; MYOCARDIAL FIBROSIS; ATRIAL-FIBRILLATION; HEART-DISEASE; STEM-CELLS; EXPRESSION; DIFFERENTIATION; MECHANISMS; FOCUS	Cardiac functions can be altered by changes in the microstructure of the heart, i.e., remodeling of the cardiac tissue, which may activate pathologies such as hypertrophy, dilation, or cardiac fibrosis. Cardiac fibrosis can develop due to an excessive deposition of extracellular matrix proteins, which are products of the activation of fibroblasts. In this context, the anatomical-histological change may interfere with the functioning of the cardiac tissue, which requires specialized cells for its operation. The purpose of the present study was to determine the cellular interactions and morphological changes in cocultures of 3T3 fibroblasts and RL-14 cardiomyocytes via the generation of a platform an in vitro model. For this purpose, a platform emulating the biological characteristics of endomyocardial fibrosis was generated using a cell patterning technique to study morphological cellular changes in compact and irregular patterns of fibrosis. It was found that cellular patterns emulating the geometrical distributions of endomyocardial fibrosis generated morphological changes after interaction of the RL-14 cardiomyocytes with the 3T3 fibroblasts. Through this study, it was possible to evaluate biological characteristics such as cell proliferation, adhesion, and spatial distribution, which are directly related to the type of emulated endomyocardial fibrosis. This research concluded that fibroblasts inhibited the proliferation of cardiomyocytes via their interaction with specific microarchitectures. This behavior is consistent with the histopathological distribution of cardiac fibrosis; therefore, the platform developed in this research could be useful for the in vitro assessment of cellular microdomains. This would allow for the experimental determination of interactions with drugs, substrates, or biomaterials within the engineering of cardiac tissues.	[Orozco, Paola; Montoya, Yuliet; Bustamante, John] Univ Pontificia Bolivariana, Ctr Bioingn, Grp Dinam Cardiovasc, Medellin, Colombia; [Montoya, Yuliet; Bustamante, John] Soc Colombiana Cardiol & Cirugia Cardiovasc, Com Trabajo Bioingn Cardiovasc, Bogota, Colombia	Universidad Pontificia Bolivariana	Montoya, Y (corresponding author), Univ Pontificia Bolivariana, Ctr Bioingn, Grp Dinam Cardiovasc, Medellin, Colombia.; Montoya, Y (corresponding author), Soc Colombiana Cardiol & Cirugia Cardiovasc, Com Trabajo Bioingn Cardiovasc, Bogota, Colombia.	yuliet.montoya@upb.edu.co	Bustamante, John/D-1372-2012	Bustamante, John/0000-0002-4855-9896; Orozco Valencia, Paola/0000-0001-6616-6749	Department of Science, Technology and Innovation-COLCIENCIAS, Colombia [121074455524]; International Center for Genetic Engineering and Biotechnology-ICGEB, Italy [CRP/COL17-03]	Department of Science, Technology and Innovation-COLCIENCIAS, Colombia; International Center for Genetic Engineering and Biotechnology-ICGEB, Italy	This research was supported by the Department of Science, Technology and Innovation-COLCIENCIAS, Colombia (project No. 121074455524) and the International Center for Genetic Engineering and Biotechnology-ICGEB, Italy (project No. CRP/COL17-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst Rosemary J., 2014, NAT REV DRUG DISCOV, V11, P1, DOI [10.1038/nrd3810.Targeting, DOI 10.1038/NRD3810.TARGETING]; ANDERSON KR, 1979, J PATHOL, V128, P79, DOI 10.1002/path.1711280205; Ankam S, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00069; Antzelevitch Charles, 2011, Card Electrophysiol Clin, V3, P23, DOI 10.1016/j.ccep.2010.10.012; Beaton Andrea M D, 2014, Glob Cardiol Sci Pract, V2014, P473, DOI 10.5339/gcsp.2014.60; Biernacka A, 2011, AGING DIS, V2, P158; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Camelliti P, 2004, CARDIOVASC RES, V62, P415, DOI 10.1016/j.cardiores.2004.01.027; Chen CZC, 2009, FIBROGENESIS TISSUE, V2, DOI 10.1186/1755-1536-2-7; Corradi D, 2014, CARDIOVASC PATHOL, V23, P71, DOI 10.1016/j.carpath.2013.12.001; D'Arcangelo E, 2015, BIOTECHNIQUES, V58, P13, DOI 10.2144/000114245; de Jong S, 2011, J CARDIOVASC PHARM, V57, P522, DOI 10.1097/FJC.0b013e31821823d9; de Jong S, 2011, J CARDIOVASC PHARM, V57, P630, DOI 10.1097/FJC.0b013e318207a35f; Disertori M, 2017, TRENDS CARDIOVAS MED, V27, P363, DOI 10.1016/j.tcm.2017.01.011; Duarte S., 2018, BIORXIV, DOI [10.1101/356642, DOI 10.1101/356642]; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Frangogiannis NG, 2019, MOL ASPECTS MED, V65, P70, DOI 10.1016/j.mam.2018.07.001; Heijman J, 2014, CIRC RES, V114, P1483, DOI 10.1161/CIRCRESAHA.114.302226; Hussain A, 2013, BIOTECHNOL BIOENG, V110, P637, DOI 10.1002/bit.24727; Javaherian S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020909; Jeremias A, 2005, J AM COLL CARDIOL, V45, P1908, DOI 10.1016/j.jacc.2005.03.007; Jessen BA, 2002, GENE, V299, P95, DOI 10.1016/S0378-1119(02)01017-X; Kobashigawa LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104888; Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322; LaFramboise WA, 2007, AM J PHYSIOL-CELL PH, V292, pC1799, DOI 10.1152/ajpcell.00166.2006; Li L, 2018, MATRIX BIOL, V68-69, P490, DOI 10.1016/j.matbio.2018.01.013; Maayah ZH, 2015, CELL BIOL TOXICOL, V31, P241, DOI 10.1007/s10565-015-9308-7; Maayah ZH, 2015, J PHARMACOL TOX MET, V71, P33, DOI 10.1016/j.vascn.2014.11.005; Mahrouf-Yorgov M, 2017, CELL DEATH DIFFER, V24, P1224, DOI 10.1038/cdd.2017.51; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Massare J., 2013, J CARDIOVASCULAR ELE, V21, P1031, DOI DOI 10.1111/J.1540-8167.2010.01736.X.DIMINISHED; McDowell KS, 2013, BIOPHYS J, V104, P2764, DOI 10.1016/j.bpj.2013.05.025; Moreno Pedro R., 2017, Rev. Colomb. Cardiol., V24, P34, DOI 10.1016/j.rccar.2016.02.005; Mosadegh B, 2014, ADV HEALTHC MATER, V31, P477, DOI [10.1016/j.immuni.2010.12.017.Two-stage, DOI 10.1016/J.IMMUNI.2010.12.017.TWO-STAGE]; Nayak AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072950; Negmadjanov U, 2016, J PATIENT CENT RES R, V3, P187, DOI DOI 10.17294/2330-0698.1407; Nguyen TP, 2014, J MOL CELL CARDIOL, V70, P83, DOI 10.1016/j.yjmcc.2013.10.018; Paz A C., 2012, J EPITHELIAL BIOL PH, V5, P77, DOI 10.2174/1875044301205010077; Paz AC, 2011, LAB CHIP, V11, P3440, DOI 10.1039/c1lc20506d; Pellman J, 2016, J MOL CELL CARDIOL, V94, P22, DOI 10.1016/j.yjmcc.2016.03.005; Raczkowska J, 2017, EUR POLYM J, V93, P726, DOI 10.1016/j.eurpolymj.2017.01.006; Rodríguez-González María Juliana, 2017, Rev. Colomb. Cardiol., V24, P407, DOI 10.1016/j.rccar.2016.07.006; Rother J, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150038; Sadeghi AH, 2017, ENG 3 DIMENSIONAL CA, V20, P48, DOI [10.1007/s10995-015-1800-4.Alcohol, DOI 10.1007/S10995-015-1800-4.ALCOHOL]; Schochlin Manuel, 2014, J Pathol Inform, V5, P40, DOI 10.4103/2153-3539.143335; Schuetze KB, 2014, J MOL CELL CARDIOL, V70, P100, DOI 10.1016/j.yjmcc.2014.02.015; Shivashankar GV, 2011, ANNU REV BIOPHYS, V40, P361, DOI 10.1146/annurev-biophys-042910-155319; Silva-falcon DMM, 2013, AV CARDIOL, V33, P45; Surolia R, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123253; Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z; Tian J, 2017, EXP THER MED, V13, P1660, DOI 10.3892/etm.2017.4224; van Spreeuwel ACC, 2017, J CARDIOVASC TRANSL, V10, P116, DOI 10.1007/s12265-017-9737-1; Villamil-Munevar A, 2017, FIBROSIS ENDOMIOCARD, V24, P1; Weber KT, 2004, J HYPERTENS, V22, P47, DOI 10.1097/00004872-200401000-00011; Xu QH, 2007, AM J PHYSIOL-RENAL, V293, pF631, DOI 10.1152/ajprenal.00379.2006	56	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229158	10.1371/journal.pone.0229158	http://dx.doi.org/10.1371/journal.pone.0229158			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092082	gold, Green Published			2022-12-26	WOS:000535229300028
J	Andersen, BR; Rasmussen, MB; Christensen, KB; Engel, KG; Ringsted, C; Lokkegaard, E; Tolsgaard, MG				Andersen, Betina Ristorp; Rasmussen, Maria Birkvad; Christensen, Karl Bang; Engel, Kirsten G.; Ringsted, Charlotte; Lokkegaard, Ellen; Tolsgaard, Martin G.			Making the best of the worst: Care quality during emergency cesarean sections	PLOS ONE			English	Article							SALMONS ITEM LIST; PATIENT SATISFACTION; BIRTH EXPERIENCE; WOMENS SATISFACTION; CHILDBIRTH; PERCEPTIONS; DELIVERY; LABOR	Objective This study aimed to identify factors influencing mothers' and their partners' perceptions of care quality, and to identify associated clinical factors. Methods Questionnaires were developed based on eight interviews with couples after emergency Cesarean Sections (ECS). The internal structure of the questionnaires was examined using Rasch analysis. Cronbach's alpha was calculated to evaluate internal consistency of questionnaire items. Finally, associations between questionnaire scores and ECS characteristics were determined. Results Thematic analysis of interview data demonstrated that team-dynamics, professionalism, information, safety, leadership and mother-child continuity of care are important to patient-perceived quality of care. Questionnaire responses from 119 women and 95 partners were included in the validation and demonstrated satisfying fit to the Rasch model. The questionnaires had acceptable internal consistency with Cronbach's alpha 0.8 and 0.7 for mothers and partners, respectively. Perceived quality of care was negatively associated with increasing urgency of the CS. Spearman rank correlation coefficients were -0.34 (p<0.001) and -0.32 (p = 0.004) for mothers and partners, respectively. Perceived quality of care differed significantly across CS indications for both mothers (p = 0.0006) and their partners (p<0.0001). Conclusion Team-dynamics, professionalism, information, safety, leadership and mother-child-continuity affect patients' perceptions of care. Perceptions of care were highly influenced by CS indications and urgency.	[Andersen, Betina Ristorp; Lokkegaard, Ellen] Univ Copenhagen, Hillerod Hosp, Northzealand Hosp, Dept Gynaecol & Obstet, Hillerod, Denmark; [Andersen, Betina Ristorp; Engel, Kirsten G.; Tolsgaard, Martin G.] Rigshosp, Copenhagen Acad Med Educ & Simulat, Copenhagen, Capital Region, Denmark; [Rasmussen, Maria Birkvad] Zealand Univ Hosp, Dept Gynaecol & Obstet, Roskilde, Denmark; [Christensen, Karl Bang] Univ Copenhagen, Dept Hlth, Sect Biostat, Copenhagen, Denmark; [Ringsted, Charlotte] Aarhus Univ, Fac Hlth, Ctr Hlth Sci Educ, Aarhus, Denmark; [Tolsgaard, Martin G.] Univ Copenhagen, Rigshosp, Dept Obstet, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Aarhus University; Rigshospitalet; University of Copenhagen	Andersen, BR (corresponding author), Univ Copenhagen, Hillerod Hosp, Northzealand Hosp, Dept Gynaecol & Obstet, Hillerod, Denmark.; Andersen, BR (corresponding author), Rigshosp, Copenhagen Acad Med Educ & Simulat, Copenhagen, Capital Region, Denmark.	betina.ristorp.andersen@regionh.dk	tolsgaard, Martin/AES-2153-2022	tolsgaard, Martin/0000-0001-9197-5564; Andersen, Betina/0000-0003-3096-4145; Christensen, Karl Bang/0000-0003-4518-5187	Danish foundation TrygFonden	Danish foundation TrygFonden	The study was funded with 500.000DKr. from the Danish foundation TrygFonden under Grant 75.000 USD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acikel A, 2017, TURK J ANAESTHESIOL, V45, P41, DOI 10.5152/TJAR.2017.38159; ANDERSEN EB, 1973, PSYCHOMETRIKA, V38, P123, DOI 10.1007/BF02291180; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bleich SN, 2009, B WORLD HEALTH ORGAN, V87, P271, DOI 10.2471/BLT.07.050401; Blomquist JL, 2011, AM J PERINAT, V28, P383, DOI 10.1055/s-0031-1274508; Bossano CM, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.04.027; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Carlos A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191248; Carquillat P, 2016, MIDWIFERY, V43, P21, DOI 10.1016/j.midw.2016.10.002; Christensen KB, 2017, APPL PSYCH MEAS, V41, P178, DOI 10.1177/0146621616677520; Christensen KB, 2013, RASCH MODELS HLTH; Cleland J., 2015, RES MED ED; Committee on Quality of Health Care in America I of M, 2001, CROSSING QUALITY CHA, DOI 10.17226/10027; Donate-Manzanares M, 2019, J CLIN MED, V8, DOI 10.3390/jcm8040434; Escuriet, 2015, BMC HLTH SERV RES, V15; Fisher C, 2006, SOC SCI MED, V63, P64, DOI 10.1016/j.socscimed.2005.11.065; Gawlik S, 2015, MIDWIFERY, V31, P221, DOI 10.1016/j.midw.2014.08.013; Gehlbach Hunter, 2010, Acad Med, V85, P925, DOI 10.1097/ACM.0b013e3181dd3e88; Handelzalts JE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169132; Hanefeld J, 2017, B WORLD HEALTH ORGAN, V95, P368, DOI [10.2471/BLT.16.179309, 10.2471/blt.16.179309]; Hodnett ED, 2002, AM J OBSTET GYNECOL, V186, pS160, DOI 10.1067/mob.2002.121141; Holland PW., 1993, DIFFERENTIAL ITEM FU, DOI DOI 10.4324/9780203357811; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hulton L, 2000, FRAMEWORK EVALUATION; KELDERMAN H, 1984, PSYCHOMETRIKA, V49, P223, DOI 10.1007/BF02294174; Kolen MJ, 2014, TEST EQUATING SCALIN; Kreiner S, 2011, APPL PSYCH MEAS, V35, P557, DOI 10.1177/0146621611410227; Lucas Angela, 2004, RCM Midwives, V7, P472; Lundsgaard KS, 2019, ACAD MED, V94, P838, DOI 10.1097/ACM.0000000000002642; Malterud K, 2012, SCAND J PUBLIC HEALT, V40, P795, DOI 10.1177/1403494812465030; National Perinatal epidemiology unit, NAT SURV WOM VIEWS M; Nielsen MB., 2019, PLOS ONE, V14, P1; O'Cathain A, 2011, BMJ QUAL SAF, V20, P134, DOI 10.1136/bmjqs.2009.036574; RCOG, 2010, CLASS URG CAES SECT, P11; Robinson PN, 1998, INT J OBSTET ANESTH, V7, P32, DOI 10.1016/S0959-289X(98)80026-5; Rosich-Medina A., 2007, BR J MIDWIFERY, V15, P66, DOI [10.12968/bjom.2007.15.2.22783, DOI 10.12968/BJOM.2007.15.2.22783]; SALMON P, 1992, J PSYCHOSOM RES, V36, P317, DOI 10.1016/0022-3999(92)90068-D; SALMON P, 1990, BRIT J MED PSYCHOL, V63, P255, DOI 10.1111/j.2044-8341.1990.tb01617.x; Smarandache A, 2017, J WOMENS HEALTH, V26, pA50; Soriano-Vidal FJ, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1100-z; Spaich S, 2013, EUR J OBSTET GYN R B, V170, P401, DOI 10.1016/j.ejogrb.2013.07.040; Stadlmayr W, 2004, EUR J OBSTET GYN R B, V115, P43, DOI 10.1016/j.ejogrb.2003.12.015; Stal KB, 2015, TROP MED INT HEALTH, V20, P934, DOI 10.1111/tmi.12496; Triolo PK, 2002, J NURS ADMIN, V32, P448, DOI 10.1097/00005110-200209000-00006; Tsai TC, 2015, ANN SURG, V261, P2, DOI 10.1097/SLA.0000000000000765; van der Linden W, 1997, HDB MODERN ITEM RESP; Waldenstrom U, 1999, J PSYCHOSOM RES, V47, P471, DOI 10.1016/S0022-3999(99)00043-4; Wiggins MN, 2009, MED EDUC, V43, P28, DOI 10.1111/j.1365-2923.2008.03176.x	48	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0227988	10.1371/journal.pone.0227988	http://dx.doi.org/10.1371/journal.pone.0227988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8DJ	32084173	gold, Green Published			2022-12-26	WOS:000535227900012
J	Aranguiz-Acuna, A; Luque, JA; Pizarro, H; Cerda, M; Heine-Fuster, I; Valdes, J; Fernandez-Galego, E; Wennrich, V				Aranguiz-Acuna, Adriana; Luque, Jose A.; Pizarro, Hector; Cerda, Mauricio; Heine-Fuster, Inger; Valdes, Jorge; Fernandez-Galego, Emma; Wennrich, Volker			Aquatic community structure as sentinel of recent environmental changes unraveled from lake sedimentary records from the Atacama Desert, Chile	PLOS ONE			English	Article							ECOLOGICAL CHANGES; NORTHERN CHILE; CLIMATE-CHANGE; RESPONSES; MACROINVERTEBRATES; PRECIPITATION; VARIABILITY; ENRICHMENT; SPECIATION; SELECTION	The Atacama Desert (21-26 degrees S) is currently one of the driest places on Earth and metal(loid) s are of special concern for this region, which hosts the largest-known porphyry copper deposits produced in Chile. Evidence of past environmental conditions is commonly preserved in natural archives, such as lacustrine sediments. Sediment records obtained from Inca Coya Lake (22 degrees 20'S-68 degrees 35'W, 2534 m.a.s.l.), a small lake located in the Atacama Desert, reflected the evolution of regional mining activity during the 20th century and sedimentation associated with decadal climate variability. We studied the aquatic community structure changes recorded in sediment records from Inca Coya Lake. By analysis of magnetic properties (susceptibility, hysteresis curves and Curie temperatures), grain size and geochemical composition of the sediments, we identified environmental periods and changes in the community of benthic and planktonic organisms (diatoms and diapausing egg bank). We identified three detrital episodes that we interpret as dry/wet phases during the last 90 years associated with the increase of flash flood events promoting hypoxia oscillations; anthropogenic (mining activity) signals were also identified. Invertebrate community structure (primary consumers) reflected the metal exposure, measured as changes in assemblage composition through species turnover. Diatom community composition was best associated with variables related to wetter/drier alternation and consequent changes in oxygen availability. Bioindicators analyzed (diatoms, diapausing egg bank and invertebrate community) demonstrated to be excellent indicators of the bioavailability of compounds in the aquatic ecosystem of Inca Coya Lake, allowing the environmental impact assessment of the water resources due to flash floods and mining activity in the driest desert of the world.	[Aranguiz-Acuna, Adriana; Heine-Fuster, Inger] Univ Catolica Norte, Ctr Invest Tecnol Agua Desierto CEITSAZA, Antofagasta, Chile; [Luque, Jose A.; Pizarro, Hector] Univ Catolica Norte, Dept Ciencias Geol, Antofagasta, Chile; [Cerda, Mauricio] UFF, PPBMAC, Lab Biogeoquim Ambientes Aquat, Rio De Janeiro, Brazil; [Cerda, Mauricio] UST, CiiCC, Santiago, Chile; [Valdes, Jorge] Univ Antofagasta, Inst Alexander von Humboldt, Antofagasta, Chile; [Fernandez-Galego, Emma; Wennrich, Volker] Univ Cologne, Inst Geol & Mineral, Cologne, Germany	Universidad Catolica del Norte; Universidad Catolica del Norte; Universidade Federal Fluminense; Universidad de Antofagasta; University of Cologne	Aranguiz-Acuna, A (corresponding author), Univ Catolica Norte, Ctr Invest Tecnol Agua Desierto CEITSAZA, Antofagasta, Chile.	aranguiz@ucn.cl	LEMA, MAURICIO LORENZO CERDA/ABK-0756-2022; Wennrich, Volker/I-3435-2012	Wennrich, Volker/0000-0003-3617-1963; Pizarro, Hector/0000-0002-0023-6027; Cerda, Mauricio/0000-0001-5770-0663; Aranguiz-Acuna, Adriana/0000-0002-9409-1147	Fondo Nacional de Desarrollo Cienti PRIME [11130653]	Fondo Nacional de Desarrollo Cienti PRIME	This work was supported by: A.A-A. Grant No 11130653 Fondo Nacional de Desarrollo Cienti ' fico y Tecnologica (Chile), https://www.conicyt.cl/fondecyt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott MB, 2003, PALAEOGEOGR PALAEOCL, V194, P123, DOI 10.1016/S0031-0182(03)00274-8; Adrian R, 2009, LIMNOL OCEANOGR, V54, P2283, DOI 10.4319/lo.2009.54.6_part_2.2283; ANTONOVICS J., 1971, Advances in Ecological Research, V7, P1, DOI 10.1016/S0065-2504(08)60202-0; Aranguiz-Acuna A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29487-3; Aranguiz-Acuna A, 2017, ECOTOXICOLOGY, V26, P329, DOI 10.1007/s10646-017-1766-7; Ariani AP, 2001, CRUSTACEANA, V74, P1241, DOI 10.1163/15685400152885219; Bellinger E. G., 2010, FRESHWATER ALGAE IDE; Bennett KD, 1996, NEW PHYTOL, V132, P155, DOI 10.1111/j.1469-8137.1996.tb04521.x; Betancourt JL, 2000, SCIENCE, V289, P1542, DOI 10.1126/science.289.5484.1542; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Bobst AL, 2001, PALAEOGEOGR PALAEOCL, V173, P21, DOI 10.1016/S0031-0182(01)00308-X; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Cantonati M, 2014, SCI TOTAL ENVIRON, V475, P201, DOI 10.1016/j.scitotenv.2013.10.018; Cerda M, 2019, J S AM EARTH SCI, V95, DOI 10.1016/j.jsames.2019.102302; Cerveny RS, 1998, CLIMATES SO CONTINEN, P107; COCHILCO, 2018, 152018 COCHILCO DEPP; Correa-Metrio A, 2012, QUATERNARY SCI REV, V38, P63, DOI 10.1016/j.quascirev.2012.01.025; Diaz FP, 2012, J BIOGEOGR, V39, P510, DOI 10.1111/j.1365-2699.2011.02617.x; Diederich JL, 2020, GLOBAL PLANET CHANGE, V184, DOI 10.1016/j.gloplacha.2019.103054; Dittmar T, 2004, SCI TOTAL ENVIRON, V325, P193, DOI 10.1016/j.scitotenv.2003.11.005; Evans M., 2003, ENV MAGNETISM PRINCI, V86; Gayo EM, 2012, EARTH-SCI REV, V113, P120, DOI 10.1016/j.earscirev.2012.04.003; Goldstein P, HAZARD RISK AGRARIAN; Gomez A, 2000, MOL ECOL, V9, P203, DOI 10.1046/j.1365-294x.2000.00849.x; Grosjean M, 2017, QUATERNARY RES, V48, P239; Guilizzoni Piero, 2001, Journal of Limnology, V60, P249; Hamilton PB, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0042; Hering D, 2006, FRESHWATER BIOL, V51, P1757, DOI 10.1111/j.1365-2427.2006.01610.x; Herkovits J, 2001, ENVIRON TOXICOL CHEM, V20, P1623, DOI 10.1002/etc.5620200801; HILL MO, 1980, VEGETATIO, V42, P47, DOI 10.1007/BF00048870; Hirst H, 2002, FRESHWATER BIOL, V47, P1752, DOI 10.1046/j.1365-2427.2002.00904.x; Houston J, 2006, INT J CLIMATOL, V26, P2181, DOI 10.1002/joc.1359; Jordan TE, 2019, ANDEAN GEOL, V46, P1, DOI [10.5027/andgeoV46n1-3087, 10.5027/andgeov46n1-3087]; Jordan TE, 2014, GEOL SOC AM BULL, V126, P1016, DOI 10.1130/B30978.1; Kasprzak P, 2008, LIMNOLOGICA, V38, P327, DOI 10.1016/j.limno.2008.07.002; KELLER W, 1992, CAN J FISH AQUAT SCI, V49, P25, DOI 10.1139/f92-297; Korosi JB, 2017, ENVIRON SCI TECHNOL, V51, P9446, DOI 10.1021/acs.est.7b02375; Krammer K., 1986, SUSSWASSERFLORA MITT, V2/1, P1; Krammer K., 1991, SUSSWASSERFLORA MITT, P1; Lamy F, 2000, TERRA NOVA, V12, P8; Lamy F, 1998, PALAEOGEOGR PALAEOCL, V141, P233, DOI 10.1016/S0031-0182(98)90052-9; Legendre P, 2011, METHODS ECOL EVOL, V2, P269, DOI 10.1111/j.2041-210X.2010.00078.x; LIU Y, 2019, WATER-SUI, V11, DOI DOI 10.3390/W11040655; Lopez-Sandoval O, 2016, REV MEX BIODIVERS, V87, P1, DOI 10.1016/j.rmb.2016.01.004; Maldonado A, 2005, J QUATERNARY SCI, V20, P493, DOI 10.1002/jqs.936; Marcial HS, 2005, HYDROBIOLOGIA, V546, P569, DOI 10.1007/s10750-005-4302-3; Ministerio del Medio Ambiente, 2004, DIAGN LAS CURS CUERP; Naranjo JA, 1981, REV GEOL CHILE, V13-14, P81; Neher D.A., 2005, ENCY SOILS ENV, DOI DOI 10.1016/B0-12-348530-4/00212-5; OECD, 1982, EUTR WAT MON ASS CON, DOI DOI 10.1002/IROH.19840690206; Oldfield, 1978, CATENA, V5, P1, DOI DOI 10.1016/S0341-8162(78)80002-2; Orsini L, 2016, MOL ECOL, V25, P6024, DOI 10.1111/mec.13907; Ortega C, 2019, GLOBAL PLANET CHANGE, V175, P226, DOI 10.1016/j.gloplacha.2019.02.011; Pell A, 2013, CHEMOSPHERE, V90, P556, DOI 10.1016/j.chemosphere.2012.08.028; PETTERSON G, 1993, J PALEOLIMNOL, V9, P195, DOI DOI 10.1007/BF00677213; Pigati JS, 2011, GEOL SOC AM BULL, V123, P2224, DOI 10.1130/B30357.1; Pizarro H, 2019, PALAEOGEOGR PALAEOCL, V516, P322, DOI 10.1016/j.palaeo.2018.12.009; Pizarro I, 2016, SCI TOTAL ENVIRON, V565, P557, DOI 10.1016/j.scitotenv.2016.04.199; Pollard HG, 2003, AMBIO, V32, P214, DOI 10.1639/0044-7447(2003)032[0214:ROCDCI]2.0.CO;2; Poulickova A, 2007, DIATOM RES, V22, P135; Quade J, 2008, QUATERNARY RES, V69, P343, DOI 10.1016/j.yqres.2008.01.003; Ramirez M, 2005, MAR POLLUT BULL, V50, P62, DOI 10.1016/j.marpolbul.2004.08.010; Rico-Martinez R., 2016, ROTIFERS MODELS TOXI, P58, DOI [10.5772/61771, DOI 10.5772/61771]; Ritter B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41743-8; Roberts AP, 1996, GEOPHYS RES LETT, V23, P2859, DOI 10.1029/96GL02831; Rogalski MA, 2015, ECOLOGY, V96, P1166, DOI 10.1890/14-1663.1; Rogalski MA, 2017, AM NAT, V189, P443, DOI 10.1086/691077; Rojas M, 2009, CLIM DYNAM, V32, P525, DOI 10.1007/s00382-008-0421-7; Romero L, 2003, APPL GEOCHEM, V18, P1399, DOI 10.1016/S0883-2927(03)00059-3; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Saez A, 2012, EARTH PLANET SC LETT, V355, P32, DOI 10.1016/j.epsl.2012.08.029; Salas I, 2016, SCI TOTAL ENVIRON, V571, P178, DOI 10.1016/j.scitotenv.2016.07.132; Salminen S, 2019, QUATERNARY, V2, DOI 10.3390/quat2020020; Salvarredy-Aranguren MM, 2008, APPL GEOCHEM, V23, P1299, DOI 10.1016/j.apgeochem.2007.11.019; Shaked Y, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00123; Sillitoe RH, 2010, ECON GEOL, V105, P3, DOI 10.2113/gsecongeo.105.1.3; Smilauer P., 2014, MULTIVARIATE ANAL EC, V5; Smith K. A., 2000, SOIL ENV ANAL; Stuut JBW, 2004, QUATERNARY RES, V62, P301, DOI 10.1016/j.yqres.2004.08.001; Tao Y, 2011, ECOTOX ENVIRON SAFE, V81, P55; Tapia J, 2019, SCI TOTAL ENVIRON, V678, P309, DOI 10.1016/j.scitotenv.2019.04.084; Tauxe L., 2005, ESSENTIALS PALEOMAGN; Tauxe L., 1998, MODERN APPROACHES GE; Tolotti R, 2019, J ENVIRON SCI, V75, P233, DOI 10.1016/j.jes.2018.03.034; Turko P, 2016, EVOLUTION, V70, P398, DOI 10.1111/evo.12859; Urrego DH, 2009, DEV PALEOENVIRON RES, V14, P283, DOI 10.1007/978-90-481-2672-9_12; Vargas G, 2000, REV GEOL CHILE, V27, P157; Ziervogel K, 2003, GEO-MAR LETT, V23, P43, DOI 10.1007/s00367-003-0123-4; Zolitschka B, 2015, QUATERNARY SCI REV, V117, P1, DOI 10.1016/j.quascirev.2015.03.019	89	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229453	10.1371/journal.pone.0229453	http://dx.doi.org/10.1371/journal.pone.0229453			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LD6YU	32084252	Green Submitted, Green Published, gold			2022-12-26	WOS:000526177800001
J	Machado, E; Pintro, PTM; Itavo, LCV; Agustinho, BC; Daniel, JLP; Santos, NW; Bragatto, JM; Ribeiro, MG; Zeoula, LM				Machado, Erica; Matumoto Pintro, Paula Toshimi; Vinhas Itavo, Luis Carlos; Agustinho, Bruna Calvo; Pratti Daniel, Joao Luiz; Santos, Nadine Woruby; Bragatto, Janaina Macieiro; Ribeiro, Matheus Goncalves; Zeoula, Lucia Maria			Reduction in lignin content and increase in the antioxidant capacity of corn and sugarcane silages treated with an enzymatic complex produced by white rot fungus	PLOS ONE			English	Article							PHANEROCHAETE-CHRYSOSPORIUM; FIBROLYTIC ENZYMES; DETERGENT FIBER; FED DIETS; DIGESTION; OXIDATION; KINETICS; MILK	The objective was to evaluate the effect of the addition of 0, 10, 20, and 30 mg.kg(-1) of natural matter of a lignocellulosic enzymatic complex produced by the white rot fungus on the chemical composition, cumulative gas production in vitro, and antioxidant compounds of corn and sugarcane silages. After being chopped and treated with the enzymatic complex, the plants were packed in vacuum-sealed bags. After 60 days, the mini silos were opened and the samples were dried in a forced ventilation oven at 55 degrees C for analysis of the proposed parameters. The experiment was conducted in a completely randomized design with four replicates per treatment. In the corn silage, there was a linear reduction in the lignin concentration. In the sugarcane silage showed a reduction of 12% in the lignin concentration, a linear reduction in the hemicellulose content, and a decrease of 8% in the cellulose concentration compared to the control treatment. The lignin monomers had linear increases in the syringyl:guaiacil ratio. This reflected on significant increases in the concentration of the non-fibrous carbohydrates and the A + B1 fraction of the carbohydrates, and a reduction in the C fraction. The in vitro gas production increased, the time of colonization and initiation of in vitro fermentation linearly decreased in both silages. The phenolic compounds and the antioxidant capacity increased linearly with the addition of the enzymes in both silages. The addition of the lignocellulolytic enzymes to the silages caused changes in the cell wall, resulting in improvements in the in vitro fermentative parameters, besides the additional effect on the antioxidant capacity. There was an effect of the addition of the enzymes on the evaluated fodder, and the best concentration was, on average, 20 mg kg(-1) MN for corn silage and 10 mg kg(-1) NM for sugarcane silage.	[Machado, Erica; Matumoto Pintro, Paula Toshimi; Agustinho, Bruna Calvo; Pratti Daniel, Joao Luiz; Santos, Nadine Woruby; Bragatto, Janaina Macieiro; Ribeiro, Matheus Goncalves; Zeoula, Lucia Maria] Univ Estadual Maringa, Dept Anim Sci, Maringa, Parana, Brazil; [Vinhas Itavo, Luis Carlos] Univ Fed Mato Grosso do Sul, Fac Vet Med & Anim Sci, Campo Grande, MS, Brazil	Universidade Estadual de Maringa; Universidade Federal de Mato Grosso do Sul	Machado, E (corresponding author), Univ Estadual Maringa, Dept Anim Sci, Maringa, Parana, Brazil.	ericamachado27@gmail.com	Ítavo, Luís Carlos Vinhas/AEY-8425-2022; Matumoto-Pintro, Paula/E-4971-2013	Ítavo, Luís Carlos Vinhas/0000-0001-6895-8483; Goncalves Ribeiro, Matheus/0000-0002-9292-554X; Calvo Agustinho, Bruna/0000-0001-5917-234X; Matumoto-Pintro, Paula/0000-0002-9182-5758; Machado, Erica/0000-0003-3276-8420	National Council for Scientific and Technological Development (CNPq); Higher Education Personnel Improvement Coordination (CAPES)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Higher Education Personnel Improvement Coordination (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The research was sponsored by the National Council for Scientific and Technological Development (CNPq). The authors EM, BCA, NWS, JMB and MGR received financial grant support from the Higher Education Personnel Improvement Coordination (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acero AP, 2008, ARCH ZOOTEC, V57, P25; Adesogan AT, 2014, J ANIM SCI, V92, P1317, DOI 10.2527/jas.2013-7273; Alves A. R., 2016, PUBVET, V10, P568; [Anonymous], 2010, J API PRODUCT API ME, DOI DOI 10.3896/IBRA.4.02.2.02; AOAC, 2007, OFFICIAL METHODS ANA, V18th; Arif M, 2019, LIVEST SCI, V219, P29, DOI 10.1016/j.livsci.2018.11.007; Badhan A, 2018, BIORESOURCE TECHNOL, V260, P76, DOI 10.1016/j.biortech.2018.03.086; Boudet AM, 2007, PHYTOCHEMISTRY, V68, P2722, DOI 10.1016/j.phytochem.2007.06.012; Bubna GA, 2011, J PLANT PHYSIOL, V168, P1627, DOI 10.1016/j.jplph.2011.03.005; Damiano VB, 2003, WORLD J MICROB BIOT, V19, P139, DOI 10.1023/A:1023244911314; de Medeiros PN, 2014, FLORESTA AMBIENTE, V21, P484, DOI 10.1590/2179-8087.051313; dos Santos Settimi Cysneiros Cristine, 2006, Ciencia Animal Brasileira, V7, P339; Fukushima RS, 2011, J AGR FOOD CHEM, V59, P3505, DOI 10.1021/jf104826n; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Hatfield RD, 1993, FORAGE CELL WALL STR, P315; Huntington GB, 1997, J ANIM SCI, V75, P852; Jalilvand G., 2008, Archivos de Zootecnia, V57, P155; Jobim Clóves Cabreira, 2007, R. Bras. Zootec., V36, P101; JUNG HG, 1989, AGRON J, V81, P33, DOI 10.2134/agronj1989.00021962008100010006x; Li KC, 1999, APPL ENVIRON MICROB, V65, P2654; MCDOUGALL EI, 1948, BIOCHEM J, V43, P99, DOI 10.1042/bj0430099; Mertens DR, 2002, J AOAC INT, V85, P1217; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Pouteau EB, 2003, EUR J NUTR, V42, P154, DOI 10.1007/s00394-003-0406-6; RATTO M, 1988, BIOTECHNOL LETT, V10, P661, DOI 10.1007/BF01024721; Rufino MSM, 2007, COMUNICADO TECNICO, V128; Santos NW, 2014, LIVEST SCI, V159, P37, DOI 10.1016/j.livsci.2013.11.015; SCHOFIELD P, 1994, J ANIM SCI, V72, P2980, DOI 10.2527/1994.72112980x; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; SNIFFEN CJ, 1992, J ANIM SCI, V70, P3562, DOI 10.2527/1992.70113562x; TIEN M, 1984, P NATL ACAD SCI-BIOL, V81, P2280, DOI 10.1073/pnas.81.8.2280; Valadares-Filho SC, 2009, NUTR RUMINANTES, P161; VANSOEST PJ, 1968, J ASSOC OFF ANA CHEM, V51, P780; WARIISHI H, 1992, J BIOL CHEM, V267, P23688; Woisky RG, 1998, J APICULT RES, V37, P99, DOI 10.1080/00218839.1998.11100961; Zhu QY, 2002, J AGR FOOD CHEM, V50, P6929, DOI 10.1021/jf0206163; Zopollatto M, 2009, REV BRAS ZOOTECN, V38, P170, DOI 10.1590/S1516-35982009001300018	37	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229141	10.1371/journal.pone.0229141	http://dx.doi.org/10.1371/journal.pone.0229141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084175	gold, Green Published			2022-12-26	WOS:000535227900060
J	Wang, GQ; Kennedy, RE; Goldberg, TE; Fowler, ME; Cutter, GR; Schneider, LS				Wang, Guoqiao; Kennedy, Richard E.; Goldberg, Terry E.; Fowler, Mackenzie E.; Cutter, Gary R.; Schneider, Lon S.			Using practice effects for targeted trials or sub-group analysis in Alzheimer's disease: How practice effects predict change over time	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; CLINICAL-TRIALS; ASSESSMENT SCALE; GALANTAMINE; PERFORMANCE; SOLANEZUMAB; DEMENTIA	Objective To describe the presence of practice effects in persons with Alzheimer disease (AD) or mild cognitive impairment (MCI) and to evaluate how practice effects affect cognitive progression and the outcome of clinical trials. Methods Using data from a meta-database consisting of 18 studies including participants from the Alzheimer disease Cooperative Study (ADCS) and the Alzheimer Disease Neuroimaging Initiative (ADNI) with ADAS-Cog(11) as the primary outcome, we defined practice effects based on the improvement in the first two ADAS-Cog(11) scores and then estimated the presence of practice effects and compared the cognitive progression between participants with and without practice effects. The robustness of practice effects was investigated using CDR SB, an outcome independent the definition itself. Furthermore, we evaluated how practice effects can affect sample size estimation. Results The overall percent of practice effects for AD participants was 39.0% and 53.3% for MCI participants. For AD studies, the mean change from baseline to 2 years was 12.8 points for the non-practice effects group vs 7.4 for the practice effects group; whereas for MCI studies, it was 4.1 for non-practice effects group vs 0.2 for the practice effects group. AD participants without practice effects progressed 0.9 points faster than those with practice effects over a period of 2 years in CDR-SB; whereas for MCI participants, the difference is 0.7 points. The sample sizes can be different by over 35% when estimated based on participants with/without practice effects. Conclusion Practice effects were prevalent and robust in persons with AD or MCI and affected the cognitive progression and sample size estimation. Planning of future AD or MCI clinical trials should account for practice effects to avoid underpower or considers target trials or stratification analysis based on practice effects.	[Wang, Guoqiao] Washington Univ, Div Biostat, St Louis, MO 63110 USA; [Kennedy, Richard E.] Univ Alabama Birmingham, Comprehens Ctr Aging Hlth, Birmingham, AL USA; [Goldberg, Terry E.] Columbia Univ, Dept Psychiat, New York, NY USA; [Fowler, Mackenzie E.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Cutter, Gary R.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Schneider, Lon S.] Univ Southern Calif, Keck Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90007 USA	Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham; Columbia University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Southern California	Schneider, LS (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90007 USA.	lschneid@usc.edu	Kennedy, Richard/K-1525-2018; Cutter, Gary/AAY-5392-2021	Kennedy, Richard/0000-0003-4638-126X; Cutter, Gary/0000-0002-8455-980X; , Guoqiao/0000-0002-6808-8737; Fowler, Mackenzie/0000-0003-2952-3705				Birks J., 2006, CHOLINESTERASE INHIB; Boada M, 2019, ALZH DEMENT-TRCI, V5, P61, DOI 10.1016/j.trci.2019.01.001; Calamia M, 2012, CLIN NEUROPSYCHOL, V26, P543, DOI 10.1080/13854046.2012.680913; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Cummings JL, 2011, CURR PSYCHIAT REP, V13, P437, DOI 10.1007/s11920-011-0234-y; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Doraiswamy PM, 1997, NEUROLOGY, V48, P1511, DOI 10.1212/WNL.48.6.1511; Duff K, 2017, J CLIN EXP NEUROPSYC, V39, P396, DOI 10.1080/13803395.2016.1230596; Duff K, 2015, ARCH CLIN NEUROPSYCH, V30, P264, DOI 10.1093/arclin/acv018; Duff K, 2014, ALZ DIS ASSOC DIS, V28, P247, DOI 10.1097/WAD.0000000000000021; Duff K, 2012, DEMENT GERIATR COGN, V33, P245, DOI 10.1159/000339268; Duff K, 2011, AM J GERIAT PSYCHIAT, V19, P932, DOI 10.1097/JGP.0b013e318209dd3a; Duff K, 2010, AM J GERIAT PSYCHIAT, V18, P91, DOI 10.1097/JGP.0b013e3181b7ef58; Egan MF, 2018, NEW ENGL J MED, V378, P1691, DOI 10.1056/NEJMoa1706441; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Goldberg TE, 2007, ARCH GEN PSYCHIAT, V64, P1115, DOI 10.1001/archpsyc.64.10.1115; Goldberg Terry E, 2015, Alzheimers Dement (Amst), V1, P103, DOI 10.1016/j.dadm.2014.11.003; Hassenstab J, 2015, ABSENCE PRACTICE EFF; Honig LS, 2018, NEW ENGL J MED, V378, P321, DOI 10.1056/NEJMoa1705971; Ito K, 2011, ALZHEIMERS DEMENT, V7, P151, DOI 10.1016/j.jalz.2010.03.018; Kennedy RE, ALZHEIMERS DEMENTIA; Kennedy RE, 2014, ALZHEIMERS DEMENT, V10, P349, DOI 10.1016/j.jalz.2013.03.003; Mohs RC, 1997, ALZ DIS ASSOC DIS, V11, pS13; Morris JC, 1993, NEUROLOGY; NESSELROADE JR, 1980, PSYCHOL BULL, V88, P622, DOI 10.1037/0033-2909.88.3.622; Rockwood K, 2010, INT J GERIATR PSYCH, V25, P191, DOI 10.1002/gps.2319; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Schneider LS, 2014, J INTERN MED, V275, P251, DOI 10.1111/joim.12191; Schneider LS, 2010, ALZHEIMERS DEMENT, V6, P367, DOI 10.1016/j.jalz.2010.07.004; Schott J, 2012, J NEUROL NEUROSUR PS, V83, DOI 10.1136/jnnp-2011-301993.66; Sperling RA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007941; Takeda A, 2006, INT J GERIATR PSYCH, V21, P17, DOI 10.1002/gps.1402; Vellas B, 2011, LANCET NEUROL, V10, P297, DOI 10.1016/S1474-4422(08)70087-5; Vellas B, 2013, ALZHEIMERS DEMENT, V9, P438, DOI 10.1016/j.jalz.2013.03.007	34	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0228064	10.1371/journal.pone.0228064	http://dx.doi.org/10.1371/journal.pone.0228064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8DJ	32084191	Green Published, gold			2022-12-26	WOS:000535227900014
J	Liu, BLD; Lee, G; Wu, JJ; Deming, J; Kuei, C; Harrington, A; Wang, L; Towne, J; Lovenberg, T; Liu, CL; Sun, SQ				Liu, Belinda; Lee, Grace; Wu, Jiejun; Deming, Janise; Kuei, Chester; Harrington, Anthony; Wang, Lien; Towne, Jennifer; Lovenberg, Timothy; Liu, Changlu; Sun, Siquan			The PAR2 signal peptide prevents premature receptor cleavage and activation	PLOS ONE			English	Article							CELL-CYCLE; PROTEIN COMPARTMENTALIZATION; FUNCTIONAL-SIGNIFICANCE; ENDOPLASMIC-RETICULUM; EXPRESSION; MEMBRANE; TRANSLOCON; PROTEASES; PROTEOLYSIS; MECHANISM	Unlike closely related GPCRs, protease-activated receptors (PAR1, PAR2, PAR3, and PAR4) have a predicted signal peptide at their N-terminus, which is encoded by a separate exon, suggesting that the signal peptides of PARs may serve an important and unique function, specific for PARs. In this report, we show that the PAR2 signal peptide, when fused to the N-terminus of IgG-Fc, effectively induced IgG-Fc secretion into culture medium, thus behaving like a classical signal peptide. The presence of PAR2 signal peptide has a strong effect on PAR2 cell surface expression, as deletion of the signal peptide (PAR2 Delta SP) led to dramatic reduction of the cell surface expression and decreased responses to trypsin or the synthetic peptide ligand (SLIGKV). However, further deletion of the tethered ligand region (SLIGKV) at the N-terminus rescued the cell surface receptor expression and the response to the synthetic peptide ligand, suggesting that the signal peptide of PAR2 may be involved in preventing PAR2 from intracellular protease activation before reaching the cell surface. Supporting this hypothesis, an Arg36Ala mutation on PAR2SP, which disabled the trypsin activation site, increased the receptor cell surface expression and the response to ligand stimulation. Similar effects were observed when PAR2 Delta SP expressing cells were treated with protease inhibitors. Our findings indicated that there is a role of the PAR2 signal peptide in preventing the premature activation of PAR2 from intracellular protease cleavage before reaching the cells surface. The same mechanism may also apply to PAR1, PAR3, and PAR4.	[Liu, Belinda; Lee, Grace; Wu, Jiejun; Deming, Janise; Kuei, Chester; Harrington, Anthony; Wang, Lien; Towne, Jennifer; Lovenberg, Timothy; Liu, Changlu; Sun, Siquan] Janssen Res & Dev LLC, San Diego, CA 92121 USA; [Liu, Belinda] Univ Calif San Diego, Revelle Coll, San Diego, CA 92103 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; University of California System; University of California San Diego	Liu, CL; Sun, SQ (corresponding author), Janssen Res & Dev LLC, San Diego, CA 92121 USA.	Cliu9@its.jnj.com; Ssun1@its.jnj.com			Janssen Research & Development, LLC	Janssen Research & Development, LLC	Janssen Research & Development, LLC provided support in the form of salaries for authors [BL, GL, JW, JD, CK, AH, LW, JT, TL, CL, SS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi KY, 2011, P NATL ACAD SCI USA, V108, P15219, DOI 10.1073/pnas.1107304108; Di Bacco A, 2006, CELL CYCLE, V5, P2310, DOI 10.4161/cc.5.20.3367; Goulet B, 2004, CELL CYCLE, V3, P986; Huang Y, 2010, BRIT J PHARMACOL, V159, P237, DOI 10.1111/j.1476-5381.2009.00517.x; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Kelly AJ, 1998, GENE DEV, V12, P880, DOI 10.1101/gad.12.6.880; Levine CG, 2005, MOL BIOL CELL, V16, P279, DOI 10.1091/mbc.E04-06-0508; Liebscher I, 2014, CELL REP, V9, P2018, DOI 10.1016/j.celrep.2014.11.036; Liu CL, 2015, MOL PHARMACOL, V88, P911, DOI 10.1124/mol.115.100412; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Loo TW, 1998, J BIOL CHEM, V273, P32373, DOI 10.1074/jbc.273.49.32373; Lu H, 2018, P NATL ACAD SCI USA, V115, P9557, DOI 10.1073/pnas.1806034115; Ly T, 2014, ELIFE, V3, DOI 10.7554/eLife.01630; MACEWAN DJ, 1995, MOL PHARMACOL, V48, P316; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Maher MP, 2016, J PHARMACOL EXP THER, V357, P394, DOI 10.1124/jpet.115.231712; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; McGrath PT, 2006, CELL, V124, P535, DOI 10.1016/j.cell.2005.12.033; Miller GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087675; Moller I, 1998, P NATL ACAD SCI USA, V95, P13425, DOI 10.1073/pnas.95.23.13425; Nikonov AV, 2003, BIOCHEM SOC T, V31, P1253; Okada T, 2003, J BIOL CHEM, V278, P31024, DOI 10.1074/jbc.M300923200; OTSU M, 1995, J BIOL CHEM, V270, P14958, DOI 10.1074/jbc.270.25.14958; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Rutz C, 2015, PROG MOL BIOL TRANSL, V132, P267, DOI 10.1016/bs.pmbts.2015.03.003; SCHEELE G, 1980, J CELL BIOL, V87, P611, DOI 10.1083/jcb.87.3.611; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Schulein R, 2017, CURR MOL PHARMACOL, V10, P311, DOI 10.2174/1874467210666170224094915; Schulein R, 2012, EUR J CELL BIOL, V91, P294, DOI 10.1016/j.ejcb.2011.02.006; Shaffer KL, 2005, DEV CELL, V9, P545, DOI 10.1016/j.devcel.2005.09.001; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Tam JKV, 2014, J MOL ENDOCRINOL, V52, pT1, DOI 10.1530/JME-13-0259; Taylor DL, 2002, J CELL SCI, V115, P1113; Teichmann A, 2012, J BIOL CHEM, V287, P27265, DOI 10.1074/jbc.M112.360594; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; WISE RJ, 1990, P NATL ACAD SCI USA, V87, P9378, DOI 10.1073/pnas.87.23.9378; Yamanaka A, 2000, MOL BIOL CELL, V11, P2821, DOI 10.1091/mbc.11.8.2821; Zhang HN, 2017, NATURE, V546, P259, DOI 10.1038/nature22363	38	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0222685	10.1371/journal.pone.0222685	http://dx.doi.org/10.1371/journal.pone.0222685			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8CF	32078628	Green Submitted, Green Published, gold			2022-12-26	WOS:000535224600001
J	Kouhi, F; Sorkheh, K; Ercisli, S				Kouhi, Farshid; Sorkheh, Karim; Ercisli, Sezai			MicroRNA expression patterns unveil differential expression of conserved miRNAs and target genes against abiotic stress in safflower	PLOS ONE			English	Article							CADMIUM-RESPONSIVE MICRORNAS; GENOME-WIDE IDENTIFICATION; MICROARRAY-BASED ANALYSIS; REGULATED MICRORNAS; HEAT-STRESS; SMALL RNAS; ARABIDOPSIS; DROUGHT; BIOGENESIS; TOLERANCE	Environmental stresses influence the growth and development of plants by influencing patterns of gene expression. Different regulators control gene expression, including transcription factors (TFs) and microRNAs. MicroRNAs (miRNAs: similar to 21 nucleotides long) are encoded by miRNA genes transcribed by RNA polymerase II (RNP-II) and play key roles in plant development and physiology. There is little knowledge currently available on miRNAs and their function in response to environmental stresses in safflower. To obtain more information on safflower miRNAs, we initially used a comparative genomics approach and succeeded in identifying 126 miRNAs belonging to 29 conserved families, along with their target genes. In this study, we investigated the expression profiles of seven conserved miRNAs related to drought, salinity, heat, and Cd stress in the leaf and root organs using qRT-PCR, for the first time. Gene Ontology (GO) analysis found that target genes of miRNAs are often TFs such as AP2/ERF and HD-ZIP as well as NAC domain-containing proteins. Expression analyses confirmed that miRNAs can play a vital role in keeping safflower stress-tolerant. Differential expression of miR156, miR162, miR164, miR166, miR172, miR398, and miR408 regulate the expression of their respective target genes. These genes activate several pathways leading to physiological and biochemical responses to abiotic stresses. Some conserved miRNAs were regulated by abiotic stresses. Our finding provides valuable information to understand miRNAs in relation to different abiotic stresses in safflower.	[Kouhi, Farshid; Sorkheh, Karim] Shahid Chamran Univ Ahvaz, Fac Agr, Dept Agron & Plant Breeding, Ahvaz, Iran; [Ercisli, Sezai] Ataturk Univ, Agr Fac, Dept Hort, Erzurum, Turkey	Shahid Chamran University of Ahvaz; Ataturk University	Sorkheh, K (corresponding author), Shahid Chamran Univ Ahvaz, Fac Agr, Dept Agron & Plant Breeding, Ahvaz, Iran.; Ercisli, S (corresponding author), Ataturk Univ, Agr Fac, Dept Hort, Erzurum, Turkey.	karimsorkheh@gmail.com; sercisli@gmail.com	Sorkheh, Karim/AAD-1040-2022	Sorkheh, Karim/0000-0002-8428-5175	Shahid Chamran University of Ahvaz, Iran [SHCH_AGF_Grant 1396]; Ataturk University, Erzurum, Turkey	Shahid Chamran University of Ahvaz, Iran; Ataturk University, Erzurum, Turkey(Ataturk University)	This research was funded via project No. SHCH_AGF_Grant 1396 Shahid Chamran University of Ahvaz, Iran, and Ataturk University, Erzurum, Turkey.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Arshad M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00356; Arslan Y, 2018, TURK J AGRIC FOR, V42, P45, DOI 10.3906/tar-1708-68; Ayadi R, 2018, TURK J AGRIC FOR, V42, P322, DOI 10.3906/tar-1801-16; Barrera-Figueroa BE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-127; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bazzini AA, 2007, P NATL ACAD SCI USA, V104, P12157, DOI 10.1073/pnas.0705114104; Cao SJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00489; Catsky J., 1960, BIOL PLANTARUM, V2, P76, DOI DOI 10.1007/BF02920701; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen L, 2012, PLANTA, V235, P375, DOI 10.1007/s00425-011-1514-9; Covarrubias AA, 2010, PLANT CELL ENVIRON, V33, P481, DOI 10.1111/j.1365-3040.2009.02048.x; Cui LG, 2014, PLANT J, V80, P1108, DOI 10.1111/tpj.12712; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Ding YF, 2011, J EXP BOT, V62, P3563, DOI 10.1093/jxb/err046; Dong CJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-47; Du JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017458; Eldem V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050298; Elhiti M, 2009, PLANT SIGNAL BEHAV, V4, P86, DOI 10.4161/psb.4.2.7692; Fadda A, 2018, TURK J AGRIC FOR, V42, P372, DOI 10.3906/tar-1711-27; Fang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081471; Fang YJ, 2014, J EXP BOT, V65, P2119, DOI 10.1093/jxb/eru072; Feng KW, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060156; Frazier TP, 2011, MOL BIOTECHNOL, V49, P159, DOI 10.1007/s12033-011-9387-5; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Guan QM, 2013, PLANT J, V74, P840, DOI 10.1111/tpj.12169; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Harvey JJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014639; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jovanovic Z, 2014, PLANT PHYSIOL BIOCH, V83, P26, DOI 10.1016/j.plaphy.2014.07.008; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Khaksefidi RE, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00741; Khraiwesh Basel, 2012, Biochim Biophys Acta, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Koch KA, 1997, CHEM BIOL, V4, P549, DOI 10.1016/S1074-5521(97)90241-6; Kohli Deshika, 2014, PLoS One, V9, pe108851, DOI 10.1371/journal.pone.0108851; Kouhi F, 2018, MODERN GENET, V13, P363; Kruszka K, 2014, J EXP BOT, V65, P6123, DOI 10.1093/jxb/eru353; Lee YS, 2014, RICE, V7, DOI 10.1186/s12284-014-0031-4; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li HY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-170; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Ma C, 2015, PLANT J, V84, P169, DOI 10.1111/tpj.12999; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Pennisi E, 2008, SCIENCE, V320, P171, DOI 10.1126/science.320.5873.171; Ramachandran P, 2017, J EXP BOT, V68, P55, DOI 10.1093/jxb/erw370; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Sayyad G, 2010, GEODERMA, V154, P311, DOI 10.1016/j.geoderma.2009.10.019; Sun XC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1416-5; Suneha Goswami, 2014, Australian Journal of Crop Science, V8, P697; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Tang ZH, 2012, PLANT PHYSIOL, V159, P721, DOI 10.1104/pp.112.196048; Thornton B, 2011, BIOCHEM MOL BIOL EDU, V39, P145, DOI 10.1002/bmb.20461; Tiwari B, 2018, TURK J AGRIC FOR, V42, P176, DOI 10.3906/tar-1709-1; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang L, 2007, FEBS LETT, V581, P3848, DOI 10.1016/j.febslet.2007.07.010; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wang Y, 2015, MOL GENET GENOMICS, V290, P471, DOI 10.1007/s00438-014-0931-4; Weiss E.A., 2000, SESAME OILSEED CROPS; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Xu L, 2013, J EXP BOT, V64, P4271, DOI 10.1093/jxb/ert240; Xue GP, 2011, MOL PLANT, V4, P697, DOI 10.1093/mp/ssr013; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072840; YERMANOS D. M., 1964, AGRON J, V56, P35; Yu N, 2010, PLANT CELL, V22, P2322, DOI 10.1105/tpc.109.072579; Yu X, 2012, J EXP BOT, V63, P1025, DOI 10.1093/jxb/err337; Zhang FT, 2016, BIOTECHNOL LETT, V38, P711, DOI 10.1007/s10529-015-2012-0; Zhao M, 2011, NEW PHYTOL, V190, P906, DOI 10.1111/j.1469-8137.2011.03647.x; Zhou Y, 2012, PLANT CELL, V24, P1034, DOI 10.1105/tpc.111.094383; Zhou ZS, 2012, J EXP BOT, V63, P4597, DOI 10.1093/jxb/ers136	85	18	19	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0228850	10.1371/journal.pone.0228850	http://dx.doi.org/10.1371/journal.pone.0228850			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7XT	32069300	Green Published, gold			2022-12-26	WOS:000535212900015
J	Liu, CF; Tseng, CH; Huang, CY; Sun, CC; Yang, ML; Chen, WY; Yeung, L				Liu, Chun-Fu; Tseng, Chung-Hsin; Huang, Chung-Ying; Sun, Chi-Chin; Yang, Meng-Ling; Chen, Wei-Yi; Yeung, Ling			Correlation between higher-order aberrations and visual acuity recovery (CoHORT) after spectacles treatment for pediatric refractive amblyopia: A pilot study using iDesign measurement	PLOS ONE			English	Article							LASIK; MANAGEMENT; CHILDREN; QUALITY; VISION; PLATFORMS; OUTCOMES	Purpose To determine the correlation between higher-order aberrations (HOAs) and best-corrected visual acuity (BCVA) recovery speed after spectacles treatment using iDesign measurements in refractive amblyopic children. Methods This is a prospective case series. Children aged from 3 to 7 years with refractive amblyopia (Landolt C equivalent < 0.8) were recruited. All participants were followed for at least 6 months after full correction of the refraction error by spectacles. The HOAs were measured using iDesign before and after cycloplegia at first visit and at 3-month intervals. Then correlation between BCVA recovery after treatment for 6 months and HOAs was determined. Results We analyzed 24 eyes of 12 children (mean age, 4.5 years). Baseline mean BCVA was logarithm of minimal angle of resolution (logMAR) 0.335 (Landolt C equivalent 0.46), which improved to logMAR 0.193 (Landolt C equivalent 0.64) after treatment with full-correction spectacles for 6 months. The amblyopic eye BCVA recovery was negatively correlated with tetrafoil with/without cycloplegia (P = 0.006 and 0.022, respectively) and trefoil with cycloplegia (P = 0.049). Conclusions trefoil and tetrafoil measured with iDesign negatively correlates with the BCVA recovery speed of refractive amblyopic eyes after spectacles treatment in this pilot study. The current study results may aid in further investigation for diagnosis and treatment of refractory refractive and idiopathic amblyopia.	[Liu, Chun-Fu; Chen, Wei-Yi] Natl Yang Ming Univ, Program Mol Med, Taipei, Taiwan; [Liu, Chun-Fu; Tseng, Chung-Hsin; Sun, Chi-Chin; Yeung, Ling] Chang Gung Mem Hosp, Dept Ophthalmol, Keelung, Taiwan; [Liu, Chun-Fu; Huang, Chung-Ying; Sun, Chi-Chin; Yang, Meng-Ling; Yeung, Ling] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Huang, Chung-Ying; Yang, Meng-Ling] Chang Gung Mem Hosp, Dept Ophthalmol, Linckou, Taiwan; [Chen, Wei-Yi] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei, Taiwan	National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; National Yang Ming Chiao Tung University	Chen, WY (corresponding author), Natl Yang Ming Univ, Program Mol Med, Taipei, Taiwan.; Yeung, L (corresponding author), Chang Gung Mem Hosp, Dept Ophthalmol, Keelung, Taiwan.; Yeung, L (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Chen, WY (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei, Taiwan.	chenwy@ym.edu.tw; lingyeung@gmail.com	Chen, Wei-Yi/CAG-0355-2022	Chen, Wei-Yi/0000-0002-0661-6899	Chang Gung Memorial Hospital, Keelung, Taiwan [CMRPG 2E0201-2E0202]	Chang Gung Memorial Hospital, Keelung, Taiwan(Chang Gung Memorial Hospital)	Publication of this article is supported by the research grant CMRPG 2E0201-2E0202 from Chang Gung Memorial Hospital, Keelung, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldebasi HI, 2013, SAUDI J OPHTHALMOL, V27, P253, DOI 10.1016/j.sjopt.2013.07.007; Asper L, 2018, CLIN EXP OPTOM, V101, P431, DOI 10.1111/cxo.12657; Attebo K, 1998, OPHTHALMOLOGY, V105, P154, DOI 10.1016/S0161-6420(98)91862-0; Cade F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054990; Chen LY, 2016, CURR OPIN OPHTHALMOL, V27, P316, DOI 10.1097/ICU.0000000000000268; Elflein HM, 2016, OPHTHALMOLOGE, V113, P283, DOI 10.1007/s00347-016-0247-3; FRIENDLY DS, 1987, PEDIATR CLIN N AM, V34, P1389; Gifford KL, 2019, INVEST OPHTH VIS SCI, V60, pM184, DOI 10.1167/iovs.18-25977; Hiraoka T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08177-6; Kirwan C, 2006, AM J OPHTHALMOL, V141, P67, DOI 10.1016/j.ajo.2005.08.031; Kirwan C, 2008, J PEDIAT OPHTH STRAB, V45, P92, DOI 10.3928/01913913-20080301-14; Kung JS, 2016, J REFRACT SURG, V32, P230, DOI 10.3928/1081597X-20151230-01; Lau JK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24906-x; Liao M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35702; Lin PW, 2016, CLIN EXP OPTOM, V99, P550, DOI 10.1111/cxo.12412; Manche E, 2018, CURR OPIN OPHTHALMOL, V29, P287, DOI 10.1097/ICU.000000000000488; Moseley MJ, 2009, OPTOMETRY VISION SCI, V86, P629, DOI 10.1097/OPX.0b013e3181a7b3e5; Moshirfar M, 2017, CLIN OPHTHALMOL, V11, P135, DOI 10.2147/OPTH.S115270; Moussa S, 2016, CLIN OPHTHALMOL, V10, P2489, DOI 10.2147/OPTH.S108002; Moussa S, 2016, EUR J OPHTHALMOL, V26, P529, DOI 10.5301/ejo.5000882; Philip K, 2014, VISION RES, V105, P233, DOI 10.1016/j.visres.2014.10.003; Prakash G, 2007, J CATARACT REFR SURG, V33, P901, DOI 10.1016/j.jcrs.2006.12.029; Prakash G, 2011, ACTA OPHTHALMOL, V89, pe257, DOI 10.1111/j.1755-3768.2009.01804.x; Simons K, 1996, SURV OPHTHALMOL, V41, P3, DOI 10.1016/S0039-6257(97)81990-X; Tailor V, 2016, BRIT MED BULL, V119, P75, DOI 10.1093/bmb/ldw030; Taylor K, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005137.pub3; Vincent SJ, 2012, VISION RES, V66, P39, DOI 10.1016/j.visres.2012.06.016; Webber Ann L, 2005, Clin Exp Optom, V88, P365; Yu CQ, 2016, J REFRACT SURG, V32, P224, DOI 10.3928/1081597X-20151222-03; Zhang N, 2013, INT J OPHTHALMOL-CHI, V6, P295, DOI 10.3980/j.issn.2222-3959.2013.03.07; Zhao PF, 2010, CHINESE MED J-PEKING, V123, P1431, DOI 10.3760/cma.j.issn.0366-6999.2010.11.015	31	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0228922	10.1371/journal.pone.0228922	http://dx.doi.org/10.1371/journal.pone.0228922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7VI	32059018	Green Published, gold			2022-12-26	WOS:000535206600019
J	Seung, BJ; Cho, SH; Kim, SH; Lim, HY; Sur, JH				Seung, Byung-Joon; Cho, Seung-Hee; Kim, Soo-Hyeon; Lim, Ha-Young; Sur, Jung-Hyang			Quantitative analysis of HER2 mRNA expression by RNA in situ hybridization in canine mammary gland tumors: Comparison with immunohistochemistry analysis	PLOS ONE			English	Article							HUMAN-BREAST-CANCER; ADJUVANT CHEMOTHERAPY; ANIMAL-MODEL; AMPLIFICATION; TRASTUZUMAB; CARCINOMAS; PLATFORM; RECEPTOR; IDENTIFICATION; PREDICTOR	Spontaneously occurring canine mammary gland tumors share many features with human breast cancer, including biological behavior and histologic features. Compared to transgenic murine model, canine models have advantages including naturally occurring models of human diseases and cancer. In humans, breast cancer is divided into molecular subtypes based on ER, PR, and HER2 expression. In contrast with humans, few studies have evaluated these subtypes in canine mammary gland tumors, including expression of HER2. HER2 expression in canine mammary tissues has been further complicated by controversy regarding the antibody's specificity. This study aimed to investigate c-erbB2 mRNA expression in retrospective formalin-fixed paraffin embedded samples, using RNA in situ hybridization with a novel quantitative assay and to compare this method with immunohistochemistry. Using 48 canine mammary tumor samples and 14 non-neoplastic canine mammary tissues, RNA in situ hybridization was performed with RNAscope (R) using a canine-specific target gene probe (ERBB2), and quantitative measurement was performed using the housekeeping gene (POLR2A) to calculate the target gene/housekeeping gene ratio. The ratio of ERBB2/POLR2A was quantified using open-source image analysis programs and compared with the immunohistochemistry results. A significant correlation was observed between the HER2 immunohistochemistry score and ERBB2/POLR2A RNA in situ hybridization (P < 0.001). When the HER2 immunohistochemistry score was 3+, significantly higher expression of HER2 mRNA was observed by RNA in situ hybridization. Interestingly, HER2 mRNA was also observed in non-neoplastic mammary tissues by RNA in situ hybridization. This assay potentially facilitates the reliable quantification of mRNA expression levels in retrospective formalin-fixed paraffin-embedded samples. Further studies are required to elucidate the role of HER2 in canine mammary gland tumors and to implement clinical trials in dogs.	[Seung, Byung-Joon; Cho, Seung-Hee; Kim, Soo-Hyeon; Lim, Ha-Young; Sur, Jung-Hyang] Konkuk Univ, Coll Vet Med, Small Anim Tumor Diagnost Ctr, Dept Vet Pathol, Seoul, South Korea	Konkuk University	Sur, JH (corresponding author), Konkuk Univ, Coll Vet Med, Small Anim Tumor Diagnost Ctr, Dept Vet Pathol, Seoul, South Korea.	jsur@konkuk.ac.kr	Seung, Byung-Joon/AFS-1857-2022	Seung, Byung-Joon/0000-0001-9611-2426; Kim, Soo-Hyeon/0000-0002-1662-2651; Sur, Jung-Hyang/0000-0003-4496-7582	Bio & Medical Technology Development Program of the NRF - Korean government, MSIT [2016M3A9B6903437]; Konkuk University Researcher Fund in 2019	Bio & Medical Technology Development Program of the NRF - Korean government, MSIT; Konkuk University Researcher Fund in 2019	This research was supported by the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIT (2016M3A9B6903437) (JHS). And this paper was supported by Konkuk University Researcher Fund in 2019 (BJS, SHC, SHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern TE, 1996, AM J VET RES, V57, P693; Buckley NE, 2016, SCI REP-UK, V6, DOI 10.1038/srep23383; Burrai GP, 2015, TUMOR BIOL, V36, P9083, DOI 10.1007/s13277-015-3661-2; Damasceno KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160419; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Gama A, 2008, VIRCHOWS ARCH, V453, P123, DOI 10.1007/s00428-008-0644-3; Goldschmidt M. H., 2017, Tumors in domestic animals, P723; Hsu WL, 2009, VET J, V180, P116, DOI 10.1016/j.tvjl.2007.10.013; Kim JH, 2011, VET J, V189, P318, DOI 10.1016/j.tvjl.2010.08.012; Kim KK, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0149-8; Kim NH, 2013, J COMP PATHOL, V148, P298, DOI 10.1016/j.jcpa.2012.08.009; Lana S.E, 2007, SMALL ANIMAL CLIN ON, P619; Lipscomb, 1999, INT HISTOLOGICAL CLA, V7, P11; Llombart-Cussac A, 2017, LANCET ONCOL, V18, P545, DOI 10.1016/S1470-2045(17)30021-9; Mason NJ, 2016, CLIN CANCER RES, V22, P4380, DOI 10.1158/1078-0432.CCR-16-0088; Muller BM, 2011, DIAGN MOL PATHOL, V20, P1, DOI 10.1097/PDM.0b013e3181e3630c; Novosad CA, 2003, CLIN TECH SMALL AN P, V18, P107, DOI 10.1053/svms.2003.36625; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pena L, 2014, VET PATHOL, V51, P127, DOI 10.1177/0300985813509388; Pena L, 2013, VET PATHOL, V50, P94, DOI 10.1177/0300985812447830; Perez EA, 2014, CANCER TREAT REV, V40, P276, DOI 10.1016/j.ctrv.2013.09.001; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Pinho SS, 2012, TRANSL RES, V159, P165, DOI 10.1016/j.trsl.2011.11.005; Press MF, 1997, J CLIN ONCOL, V15, P2894, DOI 10.1200/JCO.1997.15.8.2894; Queiroga FL, 2011, IN VIVO, V25, P455; Ressel L, 2013, RES VET SCI, V94, P299, DOI 10.1016/j.rvsc.2012.09.016; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Sakai K, 2020, VET PATHOL, V57, P56, DOI 10.1177/0300985819879445; Sakai K, 2018, VET COMP ONCOL, V16, P642, DOI 10.1111/vco.12434; Sassi F, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-5; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SESHADRI R, 1993, J CLIN ONCOL, V11, P1936, DOI 10.1200/JCO.1993.11.10.1936; Seung BJ, 2018, VET PATHOL, V55, P417, DOI 10.1177/0300985817750457; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sorenmo K, 2003, VET CLIN N AM-SMALL, V33, P573, DOI 10.1016/S0195-5616(03)00020-2; Starkey Mike P., 2005, Briefings in Functional Genomics & Proteomics, V4, P112; Tsuboi M, 2019, VET PATHOL, V56, P369, DOI 10.1177/0300985818817024; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang Z, 2013, J MOL DIAGN, V15, P210, DOI 10.1016/j.jmoldx.2012.10.003; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA	44	9	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0229031	10.1371/journal.pone.0229031	http://dx.doi.org/10.1371/journal.pone.0229031			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7VI	32059046	gold, Green Published			2022-12-26	WOS:000535206600029
J	Sorrentino, R; Belcastro, MG; Figus, C; Stephens, NB; Turley, K; Harcourt-Smith, W; Ryan, TM; Benazzi, S				Sorrentino, Rita; Belcastro, Maria Giovanna; Figus, Carla; Stephens, Nicholas B.; Turley, Kevin; Harcourt-Smith, William; Ryan, Timothy M.; Benazzi, Stefano			Exploring sexual dimorphism of the modern human talus through geometric morphometric methods	PLOS ONE			English	Article							FORENSIC ANTHROPOLOGY; GENDER-DIFFERENCES; SKELETAL REMAINS; SUBSTRATE USE; SHAPE; JOINT; BONE; AGE; RECOMMENDATIONS; RECONSTRUCTION	Sex determination is a pivotal step in forensic and bioarchaeological fields. Generally, scholars focus on metric or qualitative morphological features, but in the last few years several contributions have applied geometric-morphometric (GM) techniques to overcome limitations of traditional approaches. In this study, we explore sexual dimorphism in modern human tali from three early 20th century populations (Sassari and Bologna, Italy; New York, USA) at intra- and interspecific population levels using geometric morphometric (GM) methods. Statistical analyses were performed using shape, form, and size variables. Our results do not show significant differences in shape between males and females, either considering the pooled sample or the individual populations. Differences in talar morphology due to sexual dimorphism are mainly related to allometry, i.e. size-related changes of morphological traits. Discriminant function analysis using form space Principal Components and centroid size correctly classify between 87.7% and 97.2% of the individuals. The result is similar using the pooled sample or the individual population, except for a diminished outcome for the New York group (from 73.9% to 78.2%). Finally, a talus from the Bologna sample (not included in the previous analysis) with known sex was selected to run a virtual resection, followed by two digital reconstructions based on the mean shape of both the pooled sample and the Bologna sample, respectively. The reconstructed talus was correctly classified with a Ppost between 99.9% and 100%, demonstrating that GM is a valuable tool to cope with fragmentary tali, which is a common occurrence in forensic and bioarchaeological contexts.	[Sorrentino, Rita; Belcastro, Maria Giovanna] Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy; [Sorrentino, Rita; Figus, Carla; Benazzi, Stefano] Univ Bologna, Dept Cultural Heritage, Ravenna, Italy; [Belcastro, Maria Giovanna] Aix Marseille Univ, EFS, ADES, UMR 7268,CNRS, Marseille, France; [Stephens, Nicholas B.; Ryan, Timothy M.] Penn State Univ, Dept Anthropol, State Coll, PA USA; [Turley, Kevin] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Harcourt-Smith, William] CUNY, Grad Ctr, New York, NY USA; [Harcourt-Smith, William] New York Consortium Evolutionary Primatol, New York, NY USA; [Harcourt-Smith, William] Lehman Coll, Dept Anthropol, New York, NY USA; [Harcourt-Smith, William] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Benazzi, Stefano] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany	University of Bologna; University of Bologna; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Bordeaux-Montaigne; UDICE-French Research Universities; Aix-Marseille Universite; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Oregon; City University of New York (CUNY) System; City University of New York (CUNY) System; Lehman College (CUNY); American Museum of Natural History (AMNH); Max Planck Society	Benazzi, S (corresponding author), Univ Bologna, Dept Cultural Heritage, Ravenna, Italy.; Benazzi, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.	stefano_benazzi@eva.mpg.de	Sorrentino, Rita/C-9436-2018; Stephens, Nicholas/J-5162-2017	Sorrentino, Rita/0000-0002-6529-7250; Benazzi, Stefano/0000-0003-4305-6920; Stephens, Nicholas/0000-0002-2838-5606; BELCASTRO, MARIA GIOVANNA/0000-0002-8932-8509	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [724046 - SUCCESS]; Max-Planck society	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); Max-Planck society(Max Planck SocietyFoundation CELLEX)	This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No 724046 - SUCCESS) to SB; http://www.erc-success.eu/. In addition, the Max-Planck society supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsadi G., 1970, HIST HUMAN LIFE SPAN; Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Albanese J, 2003, J FORENSIC SCI, V48, P263; Ambers A, 2018, INT J LEGAL MED, V132, P1545, DOI 10.1007/s00414-018-1794-8; Arbour JH, 2014, METHODS ECOL EVOL, V5, P16, DOI 10.1111/2041-210X.12128; Asala SA, 2004, FORENSIC SCI INT, V145, P25, DOI 10.1016/j.forsciint.2004.03.010; Bailey SE, 2014, AM J PHYS ANTHROPOL, V154, P104, DOI 10.1002/ajpa.22477; Belcastro MG, 2017, INT J OSTEOARCHAEOL, V27, P912, DOI 10.1002/oa.2605; Benazzi S, 2008, FORENSIC SCI INT, V180, P7, DOI [10.1016/j.forsciint.2008.06, DOI 10.1016/J.FORSCIINT.2008.06]; Benazzi S, 2011, J HUM EVOL, V61, P75, DOI 10.1016/j.jhevol.2011.02.005; Benazzi S, 2009, J FORENSIC SCI, V54, P249, DOI 10.1111/j.1556-4029.2008.00947.x; Betti L, 2013, GLOBAL GEOMETRIC MOR, P8, DOI [10.1371/journal.pone.0055909, DOI 10.1371/JOURNAL.PONE.0055909]; Bidmos MA, 2004, J FORENSIC SCI, V49, P1165; Bidmos MA, 2003, AM J FOREN MED PATH, V24, P322, DOI 10.1097/01.paf.0000098507.78553.4a; Bidmos Mubarak, 2006, J Clin Forensic Med, V13, P247, DOI 10.1016/j.jcfm.2005.11.010; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bruzek J, 2002, AM J PHYS ANTHROPOL, V117, P157, DOI 10.1002/ajpa.10012; Brzobohata H, 2015, J FORENSIC SCI, V60, P29, DOI 10.1111/1556-4029.12641; Brzobohata H, 2012, COLLEGIUM ANTROPOL, V36, P801; Carlson KJ, 2007, AM J PHYS ANTHROPOL, V134, P9, DOI 10.1002/ajpa.20617; Cattaneo C, 2007, FORENSIC SCI INT, V165, P185, DOI 10.1016/j.forsciint.2006.05.018; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; Davies C M, 2014, Foot (Edinb), V24, P31, DOI 10.1016/j.foot.2013.12.001; Ellingham STD, 2017, FORENSIC SCI INT, V279, P229, DOI 10.1016/j.forsciint.2017.07.039; Figus C, 2017, J ARCHAEOL SCI-REP, V14, P382, DOI 10.1016/j.jasrep.2017.06.023; FRAYER DW, 1985, ANNU REV ANTHROPOL, V14, P429, DOI 10.1146/annurev.an.14.100185.002241; Varas CG, 2012, FORENSIC SCI INT, V219, pE19, DOI 10.1016/j.forsciint.2011.11.035; Gonzalez PN, 2007, J ARCHAEOL SCI, V34, P1720, DOI 10.1016/j.jas.2006.12.013; Graci V, 2012, GAIT POSTURE, V36, P461, DOI 10.1016/j.gaitpost.2012.04.006; Gualdi-Russo E, 2007, FORENSIC SCI INT, V171, P151, DOI 10.1016/j.forsciint.2006.10.014; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; Hackman L, 2013, J FORENSIC SCI, V58, pS146, DOI 10.1111/1556-4029.12004; Harcourt-Smith W., 2002, THESIS; Harris SM, 2012, J FORENSIC SCI, V57, P295, DOI 10.1111/j.1556-4029.2011.02004.x; Hens SM, 2008, J FORENSIC SCI, V53, P1040, DOI 10.1111/j.1556-4029.2008.00818.x; HOLLAND MM, 1993, J FORENSIC SCI, V38, P542; HOLLAND TD, 1995, AM J PHYS ANTHROPOL, V96, P315, DOI 10.1002/ajpa.1330960308; Iscan MY, 2005, FORENSIC SCI INT, V147, P107, DOI 10.1016/j.forsciint.2004.09.069; Islam K, 2014, BONE JOINT RES, V3, P139, DOI 10.1302/2046-3758.35.2000264; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kemkes-Grottenthaler A, 2001, FORENSIC SCI INT, V117, P65, DOI 10.1016/S0379-0738(00)00450-3; Kidd RS, 2002, PATTERNS MORPHOLOGIC, V181, P169, DOI [10.1002/ajpa.10021, DOI 10.1002/AJPA.10021]; Kimmerle EH, 2008, J FORENSIC SCI, V53, P558, DOI 10.1111/j.1556-4029.2008.00711.x; Kimmerle EH, 2008, J FORENSIC SCI, V53, P54, DOI 10.1111/j.1556-4029.2007.00627.x; Kivell TL, 2013, ANAT REC, V296, P19, DOI 10.1002/ar.22609; Klingenberg CP, 2016, DEV GENES EVOL, V226, P113, DOI 10.1007/s00427-016-0539-2; Kranioti EF, 2009, FORENSIC SCI INT, V189, P111, DOI 10.1016/j.forsciint.2009.04.013; Krishan K, 2016, FORENSIC SCI INT, V261, DOI 10.1016/j.forsciint.2016.02.007; Krogman WM., 1986, HUMAN SKELETON FOREN; Lee UY, 2015, FORENSIC SCI INT, V253, DOI 10.1016/j.forsciint.2015.05.017; Lee UY, 2012, J FORENSIC SCI, V57, P166, DOI 10.1111/j.1556-4029.2011.01914.x; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Mundorff AZ, 2012, FORENSIC SCI MED PAT, V8, P131, DOI 10.1007/s12024-011-9275-0; Mundorff AZ, 2009, J FORENSIC SCI, V54, P739, DOI 10.1111/j.1556-4029.2009.01045.x; MURAIL P, 2005, B MEM SOC ANTHRO PAR, V17, P167, DOI DOI 10.4000/BMSAP.1157; Nathena D, 2017, FORENSIC SCI INT, V277, DOI 10.1016/j.forsciint.2017.04.005; Nayak VC, 2010, FORENSIC SCI INT, V202, P112, DOI 10.1016/j.forsciint.2010.04.027; O'Higgins P, 2000, J ANAT, V197, P103, DOI 10.1046/j.1469-7580.2000.19710103.x; OBERG T, 1994, J REHABIL RES DEV, V31, P199; Osterholtz A.J., 2014, COMMINGLED DISARTICU, DOI 10.1007/978-1-4614-7560-6; Parr WCH, 2011, J THEOR BIOL, V272, P64, DOI 10.1016/j.jtbi.2010.11.030; Pretorius E, 2006, AM J PHYS ANTHROPOL, V129, P64, DOI 10.1002/ajpa.20251; Reichs K., 1998, FORENSIC OSTEOLOGY A; Riepert T, 1996, FORENSIC SCI INT, V77, P133, DOI 10.1016/0379-0738(95)01832-8; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Mediavilla ER, 2012, INT J LEGAL MED, V126, P623, DOI 10.1007/s00414-012-0715-5; Schlager S, 2017, ANAT REC, V300, P226, DOI 10.1002/ar.23450; Senck S, 2013, ANAT REC, V296, P745, DOI 10.1002/ar.22693; Slice DE, 2005, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/0-387-27614-9; Slizewski A., 2010, QUARTAR, V57, P179; Smith LK, 2002, J WOMEN HEALTH GEN-B, V11, P453, DOI 10.1089/15246090260137626; Sorrentino R, 2020, AM J PHYS ANTHROPOL, V171, DOI 10.1002/ajpa.23976; STEELE DG, 1976, AM J PHYS ANTHROPOL, V45, P581, DOI 10.1002/ajpa.1330450323; Suhani M, 2017, CLANDESTINE MULTIPLE, V278, P1, DOI [10.1016/j.forsciint.2017.05.014, DOI 10.1016/J.FORSCIINT.2017.05.014]; Turley K., 2015, Human Evolution, V30, P49; Turley K, 2014, ANAT REC, V297, P618, DOI 10.1002/ar.22879; Turley K, 2013, ANAT REC, V296, P877, DOI 10.1002/ar.22696; Ubelaker DH, 2018, NEW PERSPECTIVES IN FORENSIC HUMAN SKELETAL IDENTIFICATION, P295, DOI 10.1016/B978-0-12-805429-1.00025-9; Ubelaker DH, 2009, FORENSIC SCI INT, V183, P1, DOI 10.1016/j.forsciint.2008.09.019; Whitaker JM, 2002, AM J PHYS ANTHROPOL, V118, P385, DOI 10.1002/ajpa.10109; White T. D., 2005, HUMAN BONE MANUAL, DOI [10.1016/B978-0-12-088467-4.50022-3, DOI 10.1016/B978-0-12-088467-4.50022-3]	83	17	17	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0229255	10.1371/journal.pone.0229255	http://dx.doi.org/10.1371/journal.pone.0229255			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7VI	32059040	Green Published, gold			2022-12-26	WOS:000535206600034
J	Wang, T; Jing, B; Xu, DL; Liao, YL; Song, HY; Sun, BB; Guo, WZ; Xu, JH; Li, KM; Hu, M; Liu, SL; Ling, J; Kuang, YB; Zhang, T; Zhang, SW; Yao, F; Zhou, BHP; Deng, J				Wang, Tong; Jing, Bo; Xu, Dongliang; Liao, Yueling; Song, Hongyong; Sun, Beibei; Guo, Wenzheng; Xu, Jianhua; Li, Kaimi; Hu, Min; Liu, Shuli; Ling, Jing; Kuang, Yanbin; Zhang, Tuo; Zhang, Siwei; Yao, Feng; Zhou, Binhua P.; Deng, Jiong			PTGES/PGE(2) signaling links immunosuppression and lung metastasis in Gprc5a-knockout mouse model	ONCOGENE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; CANCER METASTASIS; SUPPRESSOR-CELLS; INDUCED EMT; GM-CSF; GPRC5A; IMMUNOTHERAPY; SYNTHASE-1; EXPRESSION; EPITHELIUM	Chronic inflammation has been linked to promotion of tumorigenesis and metastasis in lung. However, due to lack of a relevant animal model for characterization, the underlying mechanism remains elusive. Lung tumor suppressor gene Gprc5a-knockout (ko) mice are susceptible to lung inflammation, tumorigenesis and metastasis, which resembles the pathological features in human patients. Here, we showed that PTGES/PGE(2) signaling was highly associated with lung tumorigenesis and metastasis in Gprc5a-ko mice. Interestingly, Ptges-knockout in mouse lung tumor cells, although reduced their stemness and EMT-like features, still formed tumors and lung metastasis in immune-deficient nude mice, but not in immune-competent mice. This suggests that the major role of PTGES/PGE(2) signaling in tumorigenicity and lung metastasis is through immunosuppression. Mechanistically, PTGES/PGE(2) signaling intrinsically endows tumor cells resistant to T-cell cytotoxicity, and induces cytokines extrinsically for MDSC recruitment, which is crucial for suppression of T-cell immunity. Importantly, targeting PGE(2) signaling in Gprc5a-ko mice by PTGES inhibitor suppressed MDSC recruitment, restored T cells, and significantly repressed lung metastasis. Thus, PTGES/PGE(2) signaling links immunosuppression and metastasis in an inflammatory lung microenvironment of Gprc5a-ko mouse model.	[Wang, Tong; Jing, Bo; Xu, Dongliang; Liao, Yueling; Song, Hongyong; Guo, Wenzheng; Li, Kaimi; Hu, Min; Zhang, Siwei; Deng, Jiong] Shanghai Jiao Tong Univ, Key Lab Cell Differentiat & Apoptosis, Chinese Minister Educ, Sch Med, Shanghai, Peoples R China; [Wang, Tong; Jing, Bo; Xu, Dongliang; Liao, Yueling; Song, Hongyong; Li, Kaimi; Hu, Min; Zhang, Siwei; Deng, Jiong] Shanghai Jiao Tong Univ, Shanghai Key Lab Tumor Microenvironm & Inflammat, Sch Med, Shanghai, Peoples R China; [Sun, Beibei; Deng, Jiong] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Translat Med Res Ctr, Shanghai, Peoples R China; [Xu, Jianhua] Kunming Med Univ, Dept Pathol, Kunming, Yunnan, Peoples R China; [Liu, Shuli] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Oral & Maxillofacial Head & Neck Oncol, Coll Stomatol,Sch Med, Shanghai, Peoples R China; [Ling, Jing] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R China; [Kuang, Yanbin] Dalian Med Univ, Affiliated Hosp 2, Dept Resp Med, Dalian, Peoples R China; [Zhang, Tuo; Yao, Feng] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Thorac Surg, Shanghai, Peoples R China; [Zhou, Binhua P.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Markey Canc Ctr, Lexington, KY 40506 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Kunming Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Dalian Medical University; Shanghai Jiao Tong University; University of Kentucky	Deng, J (corresponding author), Shanghai Jiao Tong Univ, Key Lab Cell Differentiat & Apoptosis, Chinese Minister Educ, Sch Med, Shanghai, Peoples R China.; Deng, J (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Tumor Microenvironm & Inflammat, Sch Med, Shanghai, Peoples R China.; Deng, J (corresponding author), Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Translat Med Res Ctr, Shanghai, Peoples R China.; Yao, F (corresponding author), Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Thorac Surg, Shanghai, Peoples R China.; Zhou, BHP (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Markey Canc Ctr, Lexington, KY 40506 USA.	yaofeng6796678@126.com; peter.zhou@uky.edu; jiongdeng@shsmu.edu.cn		Yao, Feng/0000-0002-9635-9581; Shuli, Liu/0000-0002-8988-8899; Kuang, Yanbin/0000-0003-3041-7854	National Natural Science Foundation of China [81620108022, 91129303, 91729302, 81572759, 81572693]; Shenzhen Municipal Government of China [KQTD20170810160226082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government of China	This study was supported by grants from National Natural Science Foundation of China (81620108022, 91129303, 91729302 and 81572759 to JD, 81572693 to FY) and Shenzhen Municipal Government of China (KQTD20170810160226082).	Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Cheng YJ, 1998, J BIOL CHEM, V273, P35008, DOI 10.1074/jbc.273.52.35008; Cortes M, 2017, EMBO J, V36, P3336, DOI 10.15252/embj.201797345; Coulombe F, 2014, IMMUNITY, V40, P554, DOI 10.1016/j.immuni.2014.02.013; Coward JIG, 2012, LUNG CANCER, V75, P133, DOI 10.1016/j.lungcan.2011.11.001; Daley-Bauer LP, 2012, IMMUNITY, V37, P122, DOI 10.1016/j.immuni.2012.04.014; Deng JO, 2010, CANCER PREV RES, V3, P424, DOI 10.1158/1940-6207.CAPR-10-0032; Guo WZ, 2019, BIOMED PHARMACOTHER, V114, DOI 10.1016/j.biopha.2019.108791; Herbst RS, 2018, NATURE, V553, P446, DOI 10.1038/nature25183; Hu M, 2019, AM J CANCER RES, V9, P134; Hutchison S, 2019, VET IMMUNOL IMMUNOP, V216, DOI 10.1016/j.vetimm.2019.109912; Isono M, 2011, LIFE SCI, V88, P693, DOI 10.1016/j.lfs.2011.02.008; Katoh H, 2013, CANCER CELL, V24, P631, DOI 10.1016/j.ccr.2013.10.009; Kawahara K, 2015, BBA-MOL CELL BIOL L, V1851, P414, DOI 10.1016/j.bbalip.2014.07.008; Ke YB, 2017, AM J PHYSIOL-LUNG C, V313, pL710, DOI 10.1152/ajplung.00519.2016; Kim SH, 2016, PIGM CELL MELANOMA R, V29, P297, DOI 10.1111/pcmr.12455; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Kurtova AV, 2015, NATURE, V517, P209, DOI 10.1038/nature14034; Li KM, 2019, NEOPLASIA, V21, P602, DOI 10.1016/j.neo.2019.03.008; Li W, 2018, CELL METAB, V28, P87, DOI 10.1016/j.cmet.2018.04.022; Liao YL, 2015, CELL CYCLE, V14, P1403, DOI 10.1080/15384101.2015.1006006; Lin Y, 2017, ONCOGENE, V36, P3599, DOI 10.1038/onc.2016.516; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Liu SL, 2015, ONCOTARGET, V6, P6887, DOI 10.18632/oncotarget.3159; Majumder M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041019; Mak MP, 2016, CLIN CANCER RES, V22, P609, DOI 10.1158/1078-0432.CCR-15-0876; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Mondanelli G, 2017, IMMUNITY, V46, P233, DOI 10.1016/j.immuni.2017.01.005; Nandi P, 2017, BMC CANCER, V17, DOI 10.1186/s12885-016-3018-2; Ong HS, 2017, HEAD NECK-J SCI SPEC, V39, P2450, DOI 10.1002/hed.24914; Paff M, 2014, HUM VACC IMMUNOTHER, V10, P3322, DOI 10.4161/21645515.2014.983002; Palizgir MT, 2018, IMMUNOPHARM IMMUNOT, V40, P297, DOI 10.1080/08923973.2018.1474921; Prima V, 2017, P NATL ACAD SCI USA, V114, P1117, DOI 10.1073/pnas.1612920114; Quail DF, 2017, NAT CELL BIOL, V19, P974, DOI 10.1038/ncb3578; Roussel M, 2017, J LEUKOCYTE BIOL, V102, P437, DOI 10.1189/jlb.5MA1116-457R; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Schumacher Y, 2016, ONCOGENE, V35, P2602, DOI 10.1038/onc.2015.283; Song HY, 2019, INT J CANCER, V144, P777, DOI 10.1002/ijc.31726; Steele CW, 2016, CANCER CELL, V29, P832, DOI 10.1016/j.ccell.2016.04.014; Tao QG, 2007, JNCI-J NATL CANCER I, V99, P1668, DOI 10.1093/jnci/djm208; Tian XY, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4564-6; Tong DL, 2017, CANCER LETT, V389, P23, DOI 10.1016/j.canlet.2016.12.031; Waghray M, 2016, CANCER DISCOV, V6, P886, DOI 10.1158/2159-8290.CD-15-0947; Wang T, 2019, AM J CANCER RES, V9, P1145; Wang T, 2019, BIOCHEM BIOPH RES CO, V513, P319, DOI [10.1016/j.bbrc.2019.03.198, 10.1016/ibbrc.2019.03.198]; Wu AA, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1016700; Xu JS, 2005, AM J RESP CELL MOL, V32, P381, DOI 10.1165/rcmb.2004-0343OC; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhong SS, 2015, CANCER RES, V75, P1801, DOI 10.1158/0008-5472.CAN-14-2005	49	19	20	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	15					3179	3194		10.1038/s41388-020-1207-6	http://dx.doi.org/10.1038/s41388-020-1207-6		FEB 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LB8NS	32060421	hybrid, Green Published			2022-12-26	WOS:000513384600001
J	Kotarska, A; Fernandes, L; Kleene, R; Schachner, ML				Kotarska, Agnieszka; Fernandes, Luciana; Kleene, Ralf; Schachner, Melitta			Cell adhesion molecule close homolog of L1 binds to the dopamine receptor D2 and inhibits the internalization of its short isoform	FASEB JOURNAL			English	Article						monoaminergic receptors; neurotransmission; postsynaptic compartment; presynaptic compartment; striatum	INVERSE AGONIST ACTION; LOW-AFFINITY STATES; MICE DEFICIENT; CALL GENE; IMMUNOGLOBULIN SUPERFAMILY; DISPLAY ALTERATIONS; IN-VIVO; CHL1; LONG; RELEASE	Cell adhesion molecule close homolog of L1 (CHL1) and the dopamine receptor D2 (DRD2) are associated with psychiatric and mental disorders. We here show that DRD2 interacts with CHL1 in mouse brain, as evidenced by co-immunostaining, proximity ligation assay, co-immunoprecipitation, and pull-down assay with recombinant extracellular CHL1 domain fused to Fc (CHL1-Fc). Direct binding of CHL1-Fc to the first extracellular loop of DRD2 was shown by ELISA. Using HEK cells transfected to co-express CHL1 and the short (DRD2-S) or long (DRD2-L) DRD2 isoforms, co-localization of CHL1 and both isoforms was observed by immunostaining and proximity ligation assay. Moreover, CHL1 inhibited agonist-triggered internalization of DRD2-S. Proximity ligation assay showed close interaction between CHL1 and DRD2 in neurons expressing dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP32) or tyrosine hydroxylase (TH) in tissue sections of adult mouse striatum. In cultures of striatum or ventral midbrain, CHL1 was also closely associated with DRD2 in DARPP32- or TH-immunopositive cells, respectively. In the dorsal striatum of CHL1-deficient mice, lower levels of DRD2 and phosphorylated TH were observed, when compared to wild-type littermates. In the ventral striatum of CHL1-deficient mice, levels of phosphorylated DARPP32 were reduced. We propose that CHL1 regulates DRD2-dependent presynaptic and postsynaptic functions.	[Kotarska, Agnieszka; Fernandes, Luciana; Kleene, Ralf] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Hamburg, Germany; [Schachner, Melitta] Shantou Univ, Ctr Neurosci, Coll Med, 22 Xin Ling Rd, Shantou 515041, Guangdong, Peoples R China; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Shantou University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Schachner, ML (corresponding author), Shantou Univ, Ctr Neurosci, Coll Med, 22 Xin Ling Rd, Shantou 515041, Guangdong, Peoples R China.	schachner@stu.edu.cn			Li-Kashing Foundation	Li-Kashing Foundation	Li-Kashing Foundation	Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; Alsanie WF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09599-y; Andreyeva A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012018; Angeloni D, 1999, AM J MED GENET, V86, P482, DOI 10.1002/(SICI)1096-8628(19991029)86:5<482::AID-AJMG15>3.0.CO;2-L; Angeloni D, 1999, PSYCHIATR GENET, V9, P165, DOI 10.1097/00041444-199909000-00011; Anzalone A, 2012, J NEUROSCI, V32, P9023, DOI 10.1523/JNEUROSCI.0918-12.2012; Arias-Carrion O, 2007, ACTA NEUROBIOL EXP, V67, P481; Arreola R, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/3160486; Bartlett SE, 2005, P NATL ACAD SCI USA, V102, P11521, DOI 10.1073/pnas.0502418102; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Belujon P, 2017, INT J NEUROPSYCHOPH, V20, P1036, DOI 10.1093/ijnp/pyx056; Benoit-Marand M, 2001, J NEUROSCI, V21, P9134, DOI 10.1523/JNEUROSCI.21-23-09134.2001; Bullock CM, 2001, PROG NEURO-PSYCHOPH, V25, P1387, DOI 10.1016/S0278-5846(01)00198-1; Bye CR, 2015, P NATL ACAD SCI USA, V112, pE1946, DOI 10.1073/pnas.1501989112; CASTRO SW, 1993, J NEUROCHEM, V60, P372, DOI 10.1111/j.1471-4159.1993.tb05863.x; Centonze D, 2002, NEUROPSYCHOPHARMACOL, V27, P723, DOI 10.1016/S0893-133X(02)00367-6; Chen QY, 2005, SCHIZOPHR RES, V73, P269, DOI 10.1016/j.schres.2004.06.001; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; Choi Won-Seok, 2013, Methods Mol Biol, V1018, P61, DOI 10.1007/978-1-62703-444-9_6; Chong TTJ, 2016, PROG BRAIN RES, V229, P389, DOI 10.1016/bs.pbr.2016.05.007; Chu TT, 2010, J HUM GENET, V55, P285, DOI 10.1038/jhg.2010.24; Cuoco C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-12; DALTOSO R, 1989, EMBO J, V8, P4025, DOI 10.1002/j.1460-2075.1989.tb08585.x; DAVID C, 1991, BIOCHEM BIOPH RES CO, V179, P824, DOI 10.1016/0006-291X(91)91891-F; De Mei C, 2009, CURR OPIN PHARMACOL, V9, P53, DOI 10.1016/j.coph.2008.12.002; FISHBURN CS, 1995, J BIOL CHEM, V270, P29819; Frints SGM, 2003, HUM MOL GENET, V12, P1463, DOI 10.1093/hmg/ddg165; Gomes Ivone, 2016, Curr Protoc Pharmacol, V75, DOI 10.1002/cpph.15; Goto Y, 2007, INT REV NEUROBIOL, V78, P41, DOI 10.1016/S0074-7742(06)78002-3; Guo NN, 2010, NEUROPSYCHOPHARMACOL, V35, P806, DOI 10.1038/npp.2009.189; Hall DA, 1997, BRIT J PHARMACOL, V121, P731, DOI 10.1038/sj.bjp.0701196; Holm J, 1996, EUR J NEUROSCI, V8, P1613, DOI 10.1111/j.1460-9568.1996.tb01306.x; Irintchev A, 2004, BRAIN RES, V1029, P131, DOI 10.1016/j.brainres.2004.09.042; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Jomphe C, 2006, NEUROPHARMACOLOGY, V50, P595, DOI 10.1016/j.neuropharm.2005.11.010; Joseph JD, 2002, NEUROSCIENCE, V112, P39, DOI 10.1016/S0306-4522(02)00067-2; Kessler RM, 2009, BIOL PSYCHIAT, V65, P1024, DOI 10.1016/j.biopsych.2008.12.029; Khan ZU, 1998, P NATL ACAD SCI USA, V95, P7731, DOI 10.1073/pnas.95.13.7731; Kleene R, 2015, J CELL SCI, V128, P4642, DOI 10.1242/jcs.176941; Klein MO, 2019, CELL MOL NEUROBIOL, V39, P31, DOI 10.1007/s10571-018-0632-3; Ko F, 2002, NEUROREPORT, V13, P1017, DOI 10.1097/00001756-200206120-00007; Kobayashi M, 2004, P NATL ACAD SCI USA, V101, P11465, DOI 10.1073/pnas.0402028101; Kozell LB, 1997, MOL PHARMACOL, V52, P1137, DOI 10.1124/mol.52.6.1137; L'hirondel M, 1998, BRAIN RES, V792, P253, DOI 10.1016/S0006-8993(98)00146-2; Leshchyns'ka I, 2006, NEURON, V52, P1011, DOI 10.1016/j.neuron.2006.10.020; LEYSEN JE, 1993, PSYCHOPHARMACOLOGY, V110, P27, DOI 10.1007/BF02246947; Lindgren N, 2003, P NATL ACAD SCI USA, V100, P4305, DOI 10.1073/pnas.0730708100; Mailman Richard B, 2007, Handb Clin Neurol, V83, P77, DOI 10.1016/S0072-9752(07)83004-1; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Mercuri NB, 1997, NEUROSCIENCE, V79, P323; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Montag-Sallaz M, 2003, J NEUROBIOL, V57, P67, DOI 10.1002/neu.10254; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Morellini F, 2010, CEREB CORTEX, V20, P2712, DOI 10.1093/cercor/bhq017; Morellini F, 2007, MOL CELL NEUROSCI, V34, P121, DOI 10.1016/j.mcn.2006.10.006; Neve KA, 2013, NEUROSCIENCE, V248, P479, DOI 10.1016/j.neuroscience.2013.06.035; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Nikonenko AG, 2006, EUR J NEUROSCI, V23, P1839, DOI 10.1111/j.1460-9568.2006.04710.x; Pratte M, 2003, BEHAV BRAIN RES, V147, P31, DOI 10.1016/S0166-4328(03)00114-1; Pratte M, 2009, PHYSIOL BEHAV, V97, P394, DOI 10.1016/j.physbeh.2009.03.009; Roberts DJ, 2005, BRIT J PHARMACOL, V145, P34, DOI 10.1038/sj.bjp.0706073; Roberts DJ, 2004, MOL PHARMACOL, V66, P1573, DOI 10.1124/mol.104.004077; Roberts DJ, 2004, BIOCHEM PHARMACOL, V67, P1657, DOI 10.1016/j.bcp.2003.12.030; Robinson BG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04728-z; Rolf B, 2003, J NEUROSCI RES, V71, P835, DOI 10.1002/jnr.10533; Rouge-Pont F, 2002, J NEUROSCI, V22, P3293, DOI 10.1523/JNEUROSCI.22-08-03293.2002; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; Salamone JD, 2016, CURR TOP BEHAV NEURO, V27, P231, DOI 10.1007/7854_2015_383; Salyakina D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026049; Sander CY, 2016, NEUROPSYCHOPHARMACOL, V41, P1427, DOI 10.1038/npp.2015.296; Sarkar C, 2010, BRAIN BEHAV IMMUN, V24, P525, DOI 10.1016/j.bbi.2009.10.015; Schock SC, 2010, HISTOCHEM CELL BIOL, V134, P1, DOI 10.1007/s00418-010-0707-9; SEEMAN P, 1994, TRENDS PHARMACOL SCI, V15, P264, DOI 10.1016/0165-6147(94)90323-9; Seeman P, 2006, EXPERT OPIN THER TAR, V10, P515, DOI 10.1517/14728222.10.4.515; Senogles SE, 2004, J BIOL CHEM, V279, P1601, DOI 10.1074/jbc.M309792200; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; Shi L, 2001, BIOCHEMISTRY-US, V40, P12339, DOI 10.1021/bi011204a; Shoukier M, 2013, NEUROPEDIATRICS, V44, P268, DOI 10.1055/s-0033-1333874; SIBLEY DR, 1982, J BIOL CHEM, V257, P6351; Sierra M, 2015, J PARKINSON DIS, V5, P625, DOI 10.3233/JPD-150535; Skinbjerg M, 2012, BIOCHEM PHARMACOL, V83, P193, DOI 10.1016/j.bcp.2011.09.008; Strange PE, 1999, CLIN EXP PHARMACOL P, V26, pS3; Sytnyk V, 2017, TRENDS NEUROSCI, V40, P295, DOI 10.1016/j.tins.2017.03.003; Tam GWC, 2010, BIOCHEM SOC T, V38, P445, DOI 10.1042/BST0380445; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Wang S, 2018, NATURE, V555, P269, DOI 10.1038/nature25758; Wang YY, 2000, J NEUROSCI, V20, P8305, DOI 10.1523/JNEUROSCI.20-22-08305.2000; Weinstein JJ, 2018, MOL PSYCHIATR, V23, P1506, DOI 10.1038/mp.2017.107; WONG DF, 1986, SCIENCE, V234, P1558, DOI 10.1126/science.2878495; WREGGETT KA, 1984, MOL PHARMACOL, V25, P10; Xiao MF, 2009, J NEUROSCI, V29, P14752, DOI 10.1523/JNEUROSCI.4860-09.2009; Zhang Boyang, 2014, Adv Pharmacol, V70, P175, DOI 10.1016/B978-0-12-417197-8.00007-9; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	93	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4832	4851		10.1096/fj.201900577RRRR	http://dx.doi.org/10.1096/fj.201900577RRRR		FEB 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32052901				2022-12-26	WOS:000513849400001
J	Mazzola, V; Arciero, G; Fazio, L; Lanciano, T; Gelao, B; Bertolino, A; Bondolfi, G				Mazzola, Viridiana; Arciero, Giampiero; Fazio, Leonardo; Lanciano, Tiziana; Gelao, Barbara; Bertolino, Alessandro; Bondolfi, Guido			Emotion-body connection dispositions modify the insulae-midcingulate effective connectivity during anger processing	PLOS ONE			English	Article							THREATENING STIMULI; CORTEX; BRAIN; MODULATION; CINGULATE; RISK	The link between anger and bodily states is readily apparent based on the autonomic and behavioral responses elicited. In everyday life angry people react in different ways, from being agitated with an increased heart rate to remaining silent or detached. Neuroimaging evidence supports the role of mid-posterior insula and midcingulate cortex/MCC as key nodes of a sensorimotor network that predominantly responds to salient stimuli, integration of interoceptive and autonomic information, as well as to awareness of bodily movements for coordinated motion. However, there is still a lack of clarity concerning how interindividual variability in bodily states reactions drives the connectivity within these key nodes in the sensorimotor network during anger processing. Therefore, we investigated whether individual differences in body-centered emotional experience, that is an active (inward prone) or inactive (outward prone) emotion-body connection disposition, would differently affect the information flow within these brain regions. Two groups of participants underwent fMRI scanning session watching video clips of actors performing simple actions with angry and joyful facial expressions. The whole-brain group-by-session interaction analysis showed that the bilateral insula and the right MCC were selectively activated by inward group during the angry session, whereas the outward group activated more the precuneus during the joyful session. Accordingly, dynamic causal modeling analyses (DCM) revealed an excitatory modulatory effect exerted by anger all over the insulae-MCC connectivity in the inward group, whereas in the outward group the modulatory effect exerted was inhibitory. Modeling the variability related to individual differences in body-centered emotional experience allowed to better explain to what extent subjective dispositions contributed to the insular activity and its connectivity. In addition, from the perspective of a hierarchical model of neurovisceral integration, these findings add knowledge to the multiple ways which the insula and MCC dynamically integrate affective and bodily aspects of the human experience.	[Mazzola, Viridiana; Bondolfi, Guido] Univ Hosp Geneva, Dept Psychiat, Liaison Psychiat, Geneva, Switzerland; [Mazzola, Viridiana; Bondolfi, Guido] Univ Geneva, Fac Med, Dept Psychiat, Geneva, Switzerland; [Arciero, Giampiero] Univ Hosp Geneva, Dept Psychiat, Geneva, Switzerland; [Arciero, Giampiero] Inst Postrationalist Psychol IPRA, Rome, Italy; [Fazio, Leonardo; Gelao, Barbara; Bertolino, Alessandro] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Lanciano, Tiziana] Univ Bari, Dept Educ, Commun, Bari, Italy	University of Geneva; University of Geneva; University of Geneva; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Mazzola, V (corresponding author), Univ Hosp Geneva, Dept Psychiat, Liaison Psychiat, Geneva, Switzerland.; Mazzola, V (corresponding author), Univ Geneva, Fac Med, Dept Psychiat, Geneva, Switzerland.	Viridiana.Mazzola@hcuge.ch		Fazio, Leonardo/0000-0003-4000-974X; Mazzola, Viridiana/0000-0001-7151-3450				Acs F, 2008, NEUROIMAGE, V41, P380, DOI 10.1016/j.neuroimage.2008.02.007; Arciero G, 1989, EVOLUTIONARY EPISTEM; Arciero G., 2018, FDN PHENOMENOLOGICAL, DOI [10.1007/978-3-319-78087-0, DOI 10.1007/978-3-319-78087-0]; Arciero G., 2009, SELFHOOD IDENTITY PE; Baier B, 2008, STROKE, V39, P486, DOI 10.1161/STROKEAHA.107.495606; Barrett LF, 2015, NAT REV NEUROSCI, V16, P419, DOI 10.1038/nrn3950; Beissner F, 2013, J NEUROSCI, V33, P10503, DOI 10.1523/JNEUROSCI.1103-13.2013; Bertolino A, 2005, BIOL PSYCHIAT, V57, P1517, DOI 10.1016/j.biopsych.2005.02.031; Buckley T, 2015, EUR HEART J-ACUTE CA, V4, P493, DOI 10.1177/2048872615568969; Cauda F, 2012, NEUROIMAGE, V62, P343, DOI 10.1016/j.neuroimage.2012.04.012; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Christopher L, 2014, BRAIN, V137, P2143, DOI 10.1093/brain/awu084; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2005, TRENDS COGN SCI, V9, P566, DOI 10.1016/j.tics.2005.10.005; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Deen B, 2011, CEREB CORTEX, V21, P1498, DOI 10.1093/cercor/bhq186; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Edmondson D, 2013, EUR HEART J, V34, P300, DOI 10.1093/eurheartj/ehs398; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; Fernandez E, 2016, CLIN PSYCHOL REV, V46, P124, DOI 10.1016/j.cpr.2016.04.012; Franciotti R, 2009, NEUROIMAGE, V46, P1082, DOI 10.1016/j.neuroimage.2009.03.034; FRIJDA NH, 1989, J PERS SOC PSYCHOL, V57, P212, DOI 10.1037/0022-3514.57.2.212; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Garfinkel SN, 2016, SOC COGN AFFECT NEUR, V11, P150, DOI 10.1093/scan/nsv099; Garrido MI, 2007, NEUROIMAGE, V36, P571, DOI 10.1016/j.neuroimage.2007.03.014; Karnath HO, 2010, BRAIN STRUCT FUNCT, V214, P411, DOI 10.1007/s00429-010-0250-4; Kuppens P, 2010, PSYCHOL SCI, V21, P984, DOI 10.1177/0956797610372634; Kurth F, 2010, BRAIN STRUCTURE FUNC, P1; Lampert R, 2002, CIRCULATION, V106, P1800, DOI 10.1161/01.CIR.0000031733.51374.C1; Lampert R, 2016, TRENDS CARDIOVAS MED, V26, P68, DOI 10.1016/j.tcm.2015.04.008; Malinen S, 2010, P NATL ACAD SCI USA, V107, P6493, DOI 10.1073/pnas.1001504107; Mazzola V, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00109; Mazzola V, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01005; Mazzola V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075912; Mazzola V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015268; Mostofsky E, 2014, EUR HEART J, V35, P1404, DOI 10.1093/eurheartj/ehu033; Neumann J, 2003, NEUROIMAGE, V20, P1346, DOI 10.1016/S1053-8119(03)00443-9; Oppenheimer S, 2006, CLIN AUTON RES, V16, P6, DOI 10.1007/s10286-006-0276-0; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Oppenheimer S, 2016, COMPR PHYSIOL, V6, P1081, DOI 10.1002/cphy.c140076; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Penny WD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000709; Razi A, 2015, NEUROIMAGE, V106, P1, DOI 10.1016/j.neuroimage.2014.11.027; Rubino V, 2007, BRAIN RES BULL, V74, P250, DOI 10.1016/j.brainresbull.2007.06.019; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sethi AK, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00395; Smith R, 2017, NEUROSCI BIOBEHAV R, V75, P274, DOI 10.1016/j.neubiorev.2017.02.003; Spielberger C., 1988, MANUAL STATE TRAIT A; Spielberger C. D., 1999, MEASURING ANXIETY AN; Stemmler G, 2010, BIOL PSYCHOL, V84, P541, DOI 10.1016/j.biopsycho.2009.09.012; Steptoe A, 2012, NAT REV CARDIOL, V9, P360, DOI 10.1038/nrcardio.2012.45; Suls J, 2005, PSYCHOL BULL, V131, P260, DOI 10.1037/0033-2909.131.2.260; Suls J, 2013, PROG CARDIOVASC DIS, V55, P538, DOI 10.1016/j.pcad.2013.03.002; Taggart P, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00067; Tan LL, 2017, NAT NEUROSCI, V20, P1591, DOI 10.1038/nn.4645; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Vargas ER, 2016, ANN NEUROL, V79, P709, DOI 10.1002/ana.24642; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; Vogt BA, 2016, J CHEM NEUROANAT, V74, P28, DOI 10.1016/j.jchemneu.2016.01.010	62	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228404	10.1371/journal.pone.0228404	http://dx.doi.org/10.1371/journal.pone.0228404			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7SH	32053605	gold, Green Published			2022-12-26	WOS:000535198700027
J	Pinceloup, N; Poulin, M; Brice, MH; Pellerin, S				Pinceloup, Nicolas; Poulin, Monique; Brice, Marie-Helene; Pellerin, Stephanie			Vegetation changes in temperate ombrotrophic peatlands over a 35 year period	PLOS ONE			English	Article							BIOTIC HOMOGENIZATION; PLANT-COMMUNITIES; SOUTHERN QUEBEC; CLIMATE-CHANGE; SCALE CHANGES; DYNAMICS; DIVERSITY; GROWTH; TESTS; BOGS	Global changes in climate and land use are occurring at an unprecedented rate, often triggering drastic shifts in plant communities. This study aims to reconstruct the changes that occurred over 35 years in the plant communities of temperate bogs subjected to indirect human-induced disturbances. In 2015-17, we resurveyed the vascular flora of 76 plots located in 16 bogs of southern Quebec (Canada) first sampled in 1982. We evaluated changes in species richness, frequency of occurrence and abundance, while considering species shade-tolerance and preferential habitat. We calculated beta diversity as between-site similarities in composition, and evaluated differences between the two surveys using tests for homogeneity in multivariate dispersion. We found a significant increase in species richness and beta diversity over the last 35 years associated with major species turnovers, indicating a biotic differentiation of the Sphagnum-bog plant communities. These changes were mostly associated with an increase in the abundance and frequency of shade-tolerant and facultative species, suggesting a global phenomenon of woody encroachment. Because the observed changes occurred in a few decades on sites free of in situ human disturbances, we suggest that they were likely induced by the synergic effect of the agricultural drainage occurring in the surrounding mineral soils, climate warming, and nitrogen atmospheric depositions. We also believe that further changes are to be expected, as the triggering factors persist. Finally, our results highlight the need for increased bog conservation or restauration efforts. Indeed, a rise in beta diversity due to the introduction of nearby terrestrial species could induce biotic homogenization of the bog flora with that of surrounding habitats and ultimately impoverish the regional species pool.	[Pinceloup, Nicolas; Brice, Marie-Helene; Pellerin, Stephanie] Univ Montreal, Inst Rech Biol Vegetale, Montreal, PQ, Canada; [Pinceloup, Nicolas; Brice, Marie-Helene; Pellerin, Stephanie] Jardin Bot Montreal, Montreal, PQ, Canada; [Pinceloup, Nicolas; Poulin, Monique; Brice, Marie-Helene; Pellerin, Stephanie] McGill Univ, Quebec Ctr Biodivers Sci, Montreal, PQ, Canada; [Poulin, Monique] Univ Laval, Dept Phytol, Quebec City, PQ, Canada	Universite de Montreal; McGill University; Laval University	Pellerin, S (corresponding author), Jardin Bot Montreal, Montreal, PQ, Canada.; Pellerin, S (corresponding author), McGill Univ, Quebec Ctr Biodivers Sci, Montreal, PQ, Canada.	stephanie.pellerin.1@umontreal.ca		Pellerin, Stephanie/0000-0002-5148-1065; Brice, Marie-Helene/0000-0001-9505-1860	Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-05367, RGPIN-2014-05663]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research received financial support from the Natural Sciences and Engineering Research Council of Canada (Discovery grants to Ste ' phanie Pellerin Pellerin: RGPIN-2014-05367 and Monuique Poulin RGPIN-2014-05663). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Aronson MFJ, 2015, URBAN ECOSYST, V18, P31, DOI 10.1007/s11252-014-0382-z; BARRETT SCH, 1993, AQUAT BOT, V44, P105, DOI 10.1016/0304-3770(93)90068-8; Beauregard P, 2020, WETLANDS, V40, P351, DOI 10.1007/s13157-019-01186-3; Berendse F, 2001, GLOBAL CHANGE BIOL, V7, P591, DOI 10.1046/j.1365-2486.2001.00433.x; Brice MH, 2017, DIVERS DISTRIB, V23, P828, DOI 10.1111/ddi.12565; Broman KW, 2017, BROMAN K BROMANS R C; Brouillet L, 2017, DATABASE VASCULAR PL; Buteau P, 1989, ATLAS TOURBIERES QUE; CAMILLI G, 1978, PSYCHOL BULL, V85, P163, DOI 10.1037/0033-2909.85.1.163; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Colmer TD, 2009, FUNCT PLANT BIOL, V36, P665, DOI 10.1071/FP09144; Dyer EE, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000942; Environment Canada, 2011, CAN CLIM NORM 1981 2; Eppinga MB, 2009, PLANT ECOL, V200, P53, DOI 10.1007/s11258-007-9309-6; Favreau M, 2019, WETLANDS, V39, P841, DOI 10.1007/s13157-018-1122-6; Frelechoux F, 2000, CAN J FOREST RES, V30, P1114, DOI 10.1139/cjfr-30-7-1114; Galka M, 2019, ECOL INDIC, V97, P183, DOI 10.1016/j.ecolind.2018.10.015; Gong CF, 2013, LANDSCAPE URBAN PLAN, V120, P158, DOI 10.1016/j.landurbplan.2013.08.006; Gunnarsson U, 2002, ECOGRAPHY, V25, P685, DOI 10.1034/j.1600-0587.2002.250605.x; Hajkova P, 2011, J VEG SCI, V22, P891, DOI 10.1111/j.1654-1103.2011.01297.x; Heijmans MMPD, 2008, J VEG SCI, V19, P307, DOI 10.3170/2008-8-18368; Helm A, 2006, ECOL LETT, V9, P72, DOI 10.1111/j.1461-0248.2005.00841.x; Humbert L, 2007, ECOL INDIC, V7, P195, DOI 10.1016/j.ecolind.2005.12.002; Ireland AW, 2012, J ECOL, V100, P586, DOI 10.1111/j.1365-2745.2012.01961.x; Kapfer J, 2011, J ECOL, V99, P1179, DOI 10.1111/j.1365-2745.2011.01847.x; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; KOBE RK, 1995, ECOL APPL, V5, P517, DOI 10.2307/1942040; Kopecky M, 2015, DIVERS DISTRIB, V21, P322, DOI 10.1111/ddi.12299; Lachance D, 2005, ECOSCIENCE, V12, P161, DOI 10.2980/i1195-6860-12-2-161.1; Laine Jukka, 1995, Environmental Reviews, V3, P286, DOI 10.1139/a95-015; Lapointe M, 2014, PLANTES MILIEUX HUMI; Lavoie C, 2005, WETLANDS, V25, P64, DOI 10.1672/0277-5212(2005)025[0064:TDOACE]2.0.CO;2; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lichvar R.W., 2014, PHYTONEURON, V2014-41, P1; Linderholm HW, 2004, WETLANDS, V24, P357, DOI 10.1672/0277-5212(2004)024[0357:AAOTCT]2.0.CO;2; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Loisel J, 2013, GEOPHYS RES LETT, V40, P5508, DOI 10.1002/grl.50744; Lougheed VL, 2008, FRESHWATER BIOL, V53, P2402, DOI 10.1111/j.1365-2427.2008.02064.x; Magura T, 2010, GLOBAL ECOL BIOGEOGR, V19, P16, DOI 10.1111/j.1466-8238.2009.00499.x; McCune JL, 2013, J ECOL, V101, P1542, DOI 10.1111/1365-2745.12156; McGill BJ, 2015, TRENDS ECOL EVOL, V30, P104, DOI 10.1016/j.tree.2014.11.006; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI 10.1111/j.1466-822x.2006.00214.x; Olden JD, 2004, ECOLOGY, V85, P1867, DOI 10.1890/03-3131; Olden JD, 2003, AM NAT, V162, P442, DOI 10.1086/378212; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pasquet S, 2015, APPL VEG SCI, V18, P220, DOI 10.1111/avsc.12142; PAYETTE S, 1988, ECOLOGY, V69, P516, DOI 10.2307/1940450; Pellerin S, 2003, J ECOL, V91, P1008, DOI 10.1046/j.1365-2745.2003.00834.x; Pellerin S, 2009, APPL VEG SCI, V12, P107, DOI 10.1111/j.1654-109X.2009.01008.x; Pellerin S, 2016, WETLANDS, V36, P159, DOI 10.1007/s13157-015-0726-3; Petsch DK, 2016, INT REV HYDROBIOL, V101, P113, DOI 10.1002/iroh.201601850; Poulin M, 2016, WETL ECOL MANAG, V24, P651, DOI 10.1007/s11273-016-9494-y; Price EPF, 2018, J ECOL, V106, P1180, DOI 10.1111/1365-2745.12883; Qian H, 2008, BASIC APPL ECOL, V9, P617, DOI 10.1016/j.baae.2007.11.004; Qian H, 2010, DIVERS DISTRIB, V16, P119, DOI 10.1111/j.1472-4642.2009.00627.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reed PB, 1988, 8824 US DEP INT FISH; Santamaria L, 2002, ACTA OECOL, V23, P137, DOI 10.1016/S1146-609X(02)01146-3; Sax DF, 2008, P NATL ACAD SCI USA, V105, P11490, DOI 10.1073/pnas.0802290105; Smart SM, 2005, BIOL CONSERV, V124, P355, DOI 10.1016/j.biocon.2004.12.013; Song XP, 2018, NATURE, V560, P639, DOI 10.1038/s41586-018-0411-9; Swinehart AL, 2000, AM MIDL NAT, V143, P267, DOI 10.1674/0003-0031(2000)143[0267:PADOPI]2.0.CO;2; Talbot J, 2014, BOTANY, V92, P713, DOI 10.1139/cjb-2013-0319; Turunen J, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002154; USDA, 2015, PLANTS DAT; VITT DH, 1995, BRYOLOGIST, V98, P218, DOI 10.2307/3243306; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Warner BG, 2006, AQUAT SCI, V68, P240, DOI 10.1007/s00027-006-0853-2; Warren RJ, 2004, WETLANDS, V24, P364, DOI 10.1672/0277-5212(2004)024[0364:CAEORM]2.0.CO;2; WEIN RW, 1973, J ECOL, V61, P601, DOI 10.2307/2259047; Yagouti A, 2008, ATMOS OCEAN, V46, P243, DOI 10.3137/ao.460204; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; Zeeman BJ, 2017, J VEG SCI, V28, P550, DOI 10.1111/jvs.12507; Zhang M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00387	81	13	12	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0229146	10.1371/journal.pone.0229146	http://dx.doi.org/10.1371/journal.pone.0229146			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053706	Green Published, gold			2022-12-26	WOS:000535198700100
J	Sittner, A; Ben-Shmuel, A; Glinert, I; Bar-David, E; Schlomovitz, J; Kobiler, D; Weiss, S; Levy, H				Sittner, Assa; Ben-Shmuel, Amir; Glinert, Itai; Bar-David, Elad; Schlomovitz, Josef; Kobiler, David; Weiss, Shay; Levy, Haim			Using old antibiotics to treat ancient bacterium-beta-lactams for Bacillus anthracis meningitis	PLOS ONE			English	Article							INHALATIONAL ANTHRAX; PHARMACOKINETICS; PATHOLOGY	As Bacillus anthracis spores pose a proven bio-terror risk, the treatment focus has shifted from exposed populations to anthrax patients and the need for effective antibiotic treatment protocols increases. The CDC recommends carbapenems and Linezolid (oxazolidinone), for the treatment of anthrax, particularly for the late, meningeal stages of the disease. Previously we demonstrated that treatment with Meropenem or Linezolid, either as a single treatment or in combination with Ciprofloxacin, fails to protect rabbits from anthrax-meningitis. In addition, we showed that the failure of Meropenem was due to slow BBB penetration rather than low antibacterial activity. Herein, we tested the effect of increasing the dose of the antibiotic on treatment efficacy. We found that for full protection (88% cure rate) the dose should be increased four-fold from 40 mg/kg to 150 mg/kg. In addition, B. anthracis is a genetically stable bacterium and naturally occurring multidrug resistant B. anthracis strains have not been reported. In this manuscript, we report the efficacy of classical beta-lactams as a single treatment or in combination with beta-lactamase inhibitors in treating anthrax meningitis. We demonstrate that Ampicillin based treatment of anthrax meningitis is largely efficient (66%). The high efficacy (88-100%) of Augmentin (Amoxicillin and Clavulonic acid) and Unasyn (Ampicillin and Sulbactam) makes them a favorable choice due to reports of beta-lactam resistant B. anthracis strains. Tazocin (Piperacillin and Tazobactam) proved inefficient compared to the highly efficient Augmentin and Unasyn.	[Sittner, Assa; Ben-Shmuel, Amir; Glinert, Itai; Bar-David, Elad; Schlomovitz, Josef; Kobiler, David; Weiss, Shay; Levy, Haim] Israel Inst Biol Res, Dept Infect Dis, Ness Ziona, Israel		Levy, H (corresponding author), Israel Inst Biol Res, Dept Infect Dis, Ness Ziona, Israel.	haiml@iibr.gov.il		Sittner, Assa/0000-0002-1633-8191				ABRAMOVA FA, 1993, P NATL ACAD SCI USA, V90, P2291, DOI 10.1073/pnas.90.6.2291; Ben-Shmuel A, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00298-18; Bower WA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr6404a1; Brachman P S, 1980, Ann N Y Acad Sci, V353, P83, DOI 10.1111/j.1749-6632.1980.tb18910.x; Bresnitz EA, 2005, PHARMACOEPIDEM DR S, V14, P389, DOI 10.1002/pds.1086; BROGDEN RN, 1981, DRUGS, V22, P337, DOI 10.2165/00003495-198122050-00001; Cavallo JD, 2002, ANTIMICROB AGENTS CH, V46, P2307, DOI 10.1128/AAC.46.7.2307-2309.2002; Chai QQ, 2014, J VIROL, V88, P4698, DOI 10.1128/JVI.03149-13; Chen YH, 2003, J BACTERIOL, V185, P823, DOI 10.1128/JB.185.3.823-830.2003; Cohen-Wolkowiez M, 2014, ANTIMICROB AGENTS CH, V58, P2856, DOI 10.1128/AAC.02139-13; Coleman ME, 2008, BIOSECUR BIOTERROR, V6, P147, DOI 10.1089/bsp.2007.0066; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Doganay Mehmet, 2010, J Infect Public Health, V3, P98, DOI 10.1016/j.jiph.2010.07.004; Fellows PF, 2001, VACCINE, V19, P3241, DOI 10.1016/S0264-410X(01)00021-4; Glinert I, 2018, TOXINS, V10, DOI 10.3390/toxins10120506; GOLD H, 1951, NEW ENGL J MED, V244, P391, DOI 10.1056/NEJM195103152441102; Grinberg LM, 2001, MODERN PATHOL, V14, P482, DOI 10.1038/modpathol.3880337; Hanna P, 1998, CURR TOP MICROBIOL, V225, P13; Hendricks Katherine A, 2014, Emerg Infect Dis, V20, DOI 10.3201/eid2002.130687; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Keim P, 2009, MOL ASPECTS MED, V30, P397, DOI 10.1016/j.mam.2009.08.005; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; LABOCCETTA AC, 1948, AM J MED SCI, V216, P407, DOI 10.1097/00000441-194810000-00006; Levy H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112319; Levy H, 2012, INFECT IMMUN, V80, P2623, DOI 10.1128/IAI.00244-12; Riedel Stefan, 2005, Proc (Bayl Univ Med Cent), V18, P234; Roger C, 2018, CLIN PHARMACOKINET, V57, P559, DOI 10.1007/s40262-017-0601-x; Sambrook J, 1989, MOL CLOINING LAB MAN; Sirisanthana T, 2002, EMERG INFECT DIS, V8, P649, DOI 10.3201/eid0807.020062; Sittner A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186613; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892; Turnbull PCB, 2004, J CLIN MICROBIOL, V42, P3626, DOI 10.1128/jcm.42.8.3626-3634.2004; Twenhafel NA, 2010, VET PATHOL, V47, P819, DOI 10.1177/0300985810378112; WHO, 2008, ANTHRAX HUMANS ANIMA, VFourth edition	34	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228917	10.1371/journal.pone.0228917	http://dx.doi.org/10.1371/journal.pone.0228917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053632	Green Published, gold			2022-12-26	WOS:000535198700069
J	Yamaji, T; Iwasaki, M; Sawada, N; Shimazu, T; Inoue, M; Tsugane, S				Yamaji, Taiki; Iwasaki, Motoki; Sawada, Norie; Shimazu, Taichi; Inoue, Manami; Tsugane, Shoichiro			Fat mass and obesity-associated gene polymorphisms, pre-diagnostic plasma adipokine levels and the risk of colorectal cancer: The Japan Public Health Center-based Prospective Study	PLOS ONE			English	Article							SUSCEPTIBILITY VARIANTS; FTO GENE; HYPOMORPHISM; CHILDHOOD; RPGRIP1L; LEPTIN; INDEX	Although their functional outcomes remain largely unknown, single nucleotide polymorphisms (SNPs) in the fat mass and obesity-associated gene (FTO) may interact with adipokines, especially leptin and adiponectin, to modify the risk of colorectal cancer. We conducted a prospective study of 375 colorectal cancer cases and 750 matched controls to examine the effects of SNPs in the FTO, either alone or in interaction with pre-diagnostic plasma adipokine levels. Using a conditional logistic regression model, we obtained odds ratios (ORs) and their 95% confidence intervals (CIs) of colorectal cancer. Seven SNPs in strong linkage disequilibrium demonstrated a similarly positive association with colorectal cancer, and most evidently for rs1558902, rs8050136, rs3751812, and rs9939609 (P-trend = 0.02). Of interest, we observed a statistically significant interaction of rs8050136 with plasma total adiponectin levels (P-interaction = 0.03). Compared to non-carriers in the lowest quintile of plasma total adiponectin, A allele carriers in the same quintile showed a considerably elevated risk of colorectal cancer, with a body mass index-adjusted OR of 2.54 (95% CI, 1.36-4.75). This investigation of the interaction between SNPs in the FTO and pre-diagnostic plasma adipokine levels has revealed the importance of both genetic and hormonal factors associated with adiposity in colorectal carcinogenesis.	[Yamaji, Taiki; Iwasaki, Motoki; Sawada, Norie; Shimazu, Taichi; Inoue, Manami] Natl Canc Ctr, Epidemiol & Prevent Grp, Tokyo, Japan; [Tsugane, Shoichiro] Natl Canc Ctr, Ctr Publ Hlth Sci, Tokyo, Japan	National Cancer Center - Japan; National Cancer Center - Japan	Yamaji, T (corresponding author), Natl Canc Ctr, Epidemiol & Prevent Grp, Tokyo, Japan.	tyamaji@ncc.go.jp	Shimazu, Taichi/A-4470-2015	Shimazu, Taichi/0000-0001-6000-9830; Inoue, Manami/0000-0003-1276-2398	National Cancer Center Research and Development Fund from the Ministry of Health, Labour and Welfare of Japan [23-A-31[toku], 26-A-2, 29-A-4, 25-A-14]; Ministry of Health, Labour and Welfare of Japan; Japan Science and Technology Agency [37201101-01]; Japan Society for the Promotion of Science [15K08722]	National Cancer Center Research and Development Fund from the Ministry of Health, Labour and Welfare of Japan; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a National Cancer Center Research and Development Fund from the Ministry of Health, Labour and Welfare of Japan to S.T. (23-A-31[toku], 26-A-2 and 29-A-4 since 2011) and to M.I (25-A-14 from 2013 to 20 15), a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan to S.T. (from 1989 to 2010), Funds for integrated promotion of social system reform and research and development from the Japan Science and Technology Agency to S.T. (37201101-01 from 2011 to 2013), and a Grant-in-Aid for Scientific Research C from the Japan Society for the Promotion of Science to T.Y. (15K08722 since 2015 to 2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, J CLIN PATHOL; Delahanty RJ, 2011, AM J EPIDEMIOL, V174, P1115, DOI 10.1093/aje/kwr233; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Hernandez-Caballero ME, 2015, MOL BIOL REP, V42, P699, DOI 10.1007/s11033-014-3817-y; Fenton JI, 2008, INT J CANCER, V122, P2437, DOI 10.1002/ijc.23436; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fritz A, 2000, INT CLASSIFICATION D; Gaudet MM, 2010, CANCER EPIDEM BIOMAR, V19, P2106, DOI 10.1158/1055-9965.EPI-10-0515; Hills, 1993, STAT MODELS EPIDEMIO; Housa D, 2006, PHYSIOL RES, V55, P233, DOI 10.33549/physiolres.930848; Huang XF, 2009, OBES REV, V10, P610, DOI 10.1111/j.1467-789X.2009.00607.x; Huang XY, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12464; Iles MM, 2013, NAT GENET, V45, P428, DOI 10.1038/ng.2571; Iwasaki M, 2006, EUR J EPIDEMIOL, V21, P253, DOI 10.1007/s10654-006-0004-z; Joshi RK, 2014, ASIAN PAC J CANCER P, V15, P397, DOI 10.7314/APJCP.2014.15.1.397; Kaklamani V, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-52; Kang Y, 2017, ONCOTARGET, V8, P50987, DOI 10.18632/oncotarget.16446; Kitahara CM, 2012, CANCER EPIDEM BIOMAR, V21, P2268, DOI 10.1158/1055-9965.EPI-12-0790; Lim U, 2012, INT J CANCER, V131, pE1038, DOI 10.1002/ijc.27592; Lin YS, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-337; Long JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058350; Lurie G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016756; Meyer TE, 2010, CANCER EPIDEM BIOMAR, V19, P558, DOI 10.1158/1055-9965.EPI-09-0902; Parkin A, 2002, SIGHTS OF CONTESTATION: LOCALISM, GLOBALISM AND CULTURAL PRODUCTION IN ASIA AND THE PACIFIC, P155; Pierce BL, 2011, CANCER CAUSE CONTROL, V22, P877, DOI 10.1007/s10552-011-9760-5; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Stattin P, 2003, ONCOL REP, V10, P2015; Stratigopoulos G, 2016, J CLIN INVEST, V126, P1897, DOI 10.1172/JCI85526; Stratigopoulos G, 2014, CELL METAB, V19, P767, DOI 10.1016/j.cmet.2014.04.009; Stratigopoulos G, 2011, J BIOL CHEM, V286, P2155, DOI 10.1074/jbc.M110.188482; Tang HW, 2011, CANCER EPIDEM BIOMAR, V20, P779, DOI 10.1158/1055-9965.EPI-10-0845; Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Zhao J, 2016, FAM CANCER, V15, P145, DOI 10.1007/s10689-015-9843-7	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0229005	10.1371/journal.pone.0229005	http://dx.doi.org/10.1371/journal.pone.0229005			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053666	Green Published, gold			2022-12-26	WOS:000535198700087
J	Chiu, YM; Vanasse, A; Courteau, J; Chouinard, MC; Dubois, MF; Dubuc, N; Elazhary, N; Dufour, I; Hudon, C				Chiu, Yohann Moanahere; Vanasse, Alain; Courteau, Josiane; Chouinard, Maud-Christine; Dubois, Marie-France; Dubuc, Nicole; Elazhary, Nicolas; Dufour, Isabelle; Hudon, Catherine			Persistent frequent emergency department users with chronic conditions: A population-based cohort study	PLOS ONE			English	Article							HEALTH-CARE USE; PALLIATIVE CARE; CASE-MANAGEMENT; VISITS; STRATEGIES; ADMISSION; ADULTS; URBAN	Background Frequent emergency department users are patients cumulating at least four visits per year. Few studies have focused on persistent frequent users, who maintain their frequent user status for multiple consecutive years. This study targets an adult population with chronic conditions, and its aims are: 1) to estimate the prevalence of persistent frequent ED use; 2) to identify factors associated with persistent frequent ED use (frequent use for three consecutive years) and compare their importance with those associated with occasional frequent ED use (frequent use during the year following the index date); and 3) to compare characteristics of "persistent frequent users" to "occasional frequent users" and to "users other than persistent frequent users". Methods This is a retrospective cohort study using Quebec administrative databases. All adult patients who visited the emergency department in 2012, diagnosed with chronic conditions, and living in non-remote areas were included. Patients who died in the three years following their index date were excluded. The main outcome was persistent frequent use (>= 4 visits per year during three consecutive years). Potential predictors included sociodemographic characteristics, physical and mental comorbidities, and prior healthcare utilization. Odds ratios were computed using multivariable logistic regression. Results Out of 297,182 patients who visited ED at least once in 2012, 3,357 (1.10%) were persistent frequent users. Their main characteristics included poor socioeconomic status, mental and physical comorbidity, and substance abuse. Those characteristics were also present for occasional frequent users, although with higher percentages for the persistent user group. The number of previous visits to the emergency department was the most important factor in the regression model. The occasional frequent users' attrition rate was higher between the first and second year of follow-up than between the second and third year. Conclusions Persistent frequent users are a subpopulation of frequent users with whom they share characteristics, such as physical and mental comorbidities, though the former are poorer and younger. More research is needed in order to better understand what factors can contribute to persistent frequent use.	[Chiu, Yohann Moanahere; Vanasse, Alain; Courteau, Josiane; Elazhary, Nicolas; Dufour, Isabelle; Hudon, Catherine] Univ Sherbrooke, Fac Med & Sci Sante, Dept Med Famille & Med Durgence, Sherbrooke, PQ, Canada; [Chiu, Yohann Moanahere; Vanasse, Alain; Hudon, Catherine] Univ Sherbrooke, CHU Sherbrooke, Fac Med & Sci Sante, Ctr Rech, Sherbrooke, PQ, Canada; [Chouinard, Maud-Christine] Univ Quebec Chicoutimi, Dept Sci Sante, Chicoutimi, PQ, Canada; [Dubois, Marie-France] Univ Sherbrooke, Fac Med & Sci Sante, Dept Sci Sante Communautaire, Sherbrooke, PQ, Canada; [Dubuc, Nicole; Dufour, Isabelle] Univ Sherbrooke, Ecole Sci Infirmieres, Sherbrooke, PQ, Canada	University of Sherbrooke; University of Sherbrooke; University of Quebec; University of Quebec Chicoutimi; University of Sherbrooke; University of Sherbrooke	Chiu, YM (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Med Famille & Med Durgence, Sherbrooke, PQ, Canada.; Chiu, YM (corresponding author), Univ Sherbrooke, CHU Sherbrooke, Fac Med & Sci Sante, Ctr Rech, Sherbrooke, PQ, Canada.	yohann.chiu@usherbrooke.ca		Chiu, Yohann/0000-0001-7872-9457; Dubois, Marie-France/0000-0001-6553-7827	Fonds de recherche du Quebec-Sante; Quebec SPOR SUPPORT Unit; Centre de recherche du Centre hospitalier de l'universite de Sherbrooke	Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Quebec SPOR SUPPORT Unit; Centre de recherche du Centre hospitalier de l'universite de Sherbrooke	This study was supported by the Fonds de recherche du Quebec-Sante, the Quebec SPOR SUPPORT Unit, and the Centre de recherche du Centre hospitalier de l'universite de Sherbrooke.	ANDREN KG, 1987, SOC SCI MED, V25, P825, DOI 10.1016/0277-9536(87)90040-2; Barbera L, 2010, CAN MED ASSOC J, V182, P563, DOI 10.1503/cmaj.091187; Bieler G, 2012, ACAD EMERG MED, V19, P63, DOI 10.1111/j.1553-2712.2011.01246.x; Billings J, 2013, HEALTH AFFAIR, V32, P2099, DOI 10.1377/hlthaff.2012.1276; Blyth FM, 2004, PAIN, V111, P51, DOI 10.1016/j.pain.2004.05.020; Brown I, 2012, EXPERT SYST APPL, V39, P3446, DOI 10.1016/j.eswa.2011.09.033; Byrne M, 2003, ANN EMERG MED, V41, P309, DOI 10.1067/mem.2003.68; Canadian Institute for Health Information, AMB CAR SENS COND; Centers for Medicare & Medicaid Services, EL; Cheng TH, 2009, IEEE T SYST MAN CY A, V39, P1339, DOI 10.1109/TSMCA.2009.2025510; Chukmaitov AS, 2012, J AMBUL CARE MANAG, V35, P149, DOI 10.1097/JAC.0b013e318244d222; Colligan EM, 2016, ANN EMERG MED, V67, P721, DOI 10.1016/j.annemergmed.2016.01.033; Colligan EM, 2017, MED CARE RES REV, V74, P311, DOI 10.1177/1077558716641826; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Das LT, 2017, PEDIATR PULM, V52, P880, DOI 10.1002/ppul.23735; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Grinspan ZM, 2015, NEUROLOGY, V85, P1031, DOI 10.1212/WNL.0000000000001944; Griswold SK, 2005, CHEST, V127, P1579, DOI 10.1378/chest.127.5.1579; Gruneir A, 2011, MED CARE RES REV, V68, P131, DOI 10.1177/1077558710379422; Guo HX, 2017, EXPERT SYST APPL, V73, P220, DOI 10.1016/j.eswa.2016.12.035; Haggerty Jeannie L, 2007, Healthc Policy, V3, P72; Harrell FE, 2015, SPRINGER SER STAT, P1, DOI 10.1007/978-3-319-19425-7_1; Hudon C, RISK FREQUENT UNPUB; Hudon C, MED CARE; Hudon C, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2453-3; Hunt KA, 2006, ANN EMERG MED, V48, P1, DOI 10.1016/j.annemergmed.2005.12.030; Kanzaria HK, 2017, HEALTH AFFAIR, V36, P1720, DOI 10.1377/hlthaff.2017.0658; Kirby SE, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-216; Krieg C, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1852-1; Kumar GS, 2013, J EMERG MED, V44, P717, DOI 10.1016/j.jemermed.2012.08.035; Lee J, 2018, ARTHRITIS CARE RES H; Levesque LE, 2010, BMJ, V340, pb5087, DOI DOI 10.1136/BMJ.B5087; Mandelberg JH, 2000, ACAD EMERG MED, V7, P637, DOI 10.1111/j.1553-2712.2000.tb02037.x; McNamara BA, 2013, J PALLIAT MED, V16, P774, DOI 10.1089/jpm.2012.0403; Moe J, 2016, EMERG MED J, V33, P230, DOI 10.1136/emermed-2014-204496; Okuyemi K S, 2001, J Assoc Acad Minor Phys, V12, P119; Pampalon R., 2011, QUEBEC INDEX MAT SOC, DOI [10.1007/BF03403824, DOI 10.1007/BF03403824]; Peltz A, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0962; Rask KJ, 1998, J GEN INTERN MED, V13, P614, DOI 10.1046/j.1525-1497.1998.00184.x; Rechel B, 2016, HEALTH POLICY, V120, P758, DOI 10.1016/j.healthpol.2016.05.011; Richardson AM, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-206; Rosenwax LK, 2011, MED J AUSTRALIA, V194, P570, DOI 10.5694/j.1326-5377.2011.tb03106.x; Shumway M, 2008, AM J EMERG MED, V26, P155, DOI 10.1016/j.ajem.2007.04.021; Simard M, 2018, MED CARE, V56, P441, DOI 10.1097/MLR.0000000000000905; Spilsbury K, 2017, ANN EMERG MED, V69, P416, DOI 10.1016/j.annemergmed.2016.11.036	45	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0229022	10.1371/journal.pone.0229022	http://dx.doi.org/10.1371/journal.pone.0229022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7PV	32050010	Green Published, gold			2022-12-26	WOS:000535192300041
J	Chi, YL; Youn, DY; Xiaoli, AM; Liu, L; Pessin, JB; Yang, FJ; Pessin, JE				Chi, Yuling; Youn, Dou Yeon; Xiaoli, Alus M.; Liu, Li; Pessin, Jacob B.; Yang, Fajun; Pessin, Jeffrey E.			Regulation of gene expression during the fasting-feeding cycle of the liver displays mouse strain specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						liver; gene regulation; lipid metabolism; transcriptomics; nutrition; BALB; cJ; C57BL; 6J; mRNA-Seq; nutrient signaling; transcriptome	HIGH-FAT DIET; HOMEOSTASIS; RESPONSES; OBESITY; MICE	The liver maintains metabolic homeostasis by integrating the regulation of nutrient status with both hormonal and neural signals. Many studies on hepatic signaling in response to nutrients have been conducted in mice. However, no in-depth study is currently available that has investigated genome-wide changes in gene expression during the normal physiological fasting-feeding cycle in nutrient-sensitive and -insensitive mice. Using two strains of mice, C57BL/6J and BALB/cJ, and deploying deep RNA-Seq complemented with quantitative RT-PCR, we found that feeding causes substantial and transient changes in gene expression in the livers of both mouse strains. The majority of significantly changed transcripts fell within the areas of biological regulation and cellular and metabolic processes. Among the metabolisms of three major types of macronutrients (i.e. carbohydrates, proteins, and lipids), feeding affected lipid metabolism the most. We also noted that the C57BL/6J and BALB/cJ mice significantly differed in gene expression and in changes in gene expression in response to feeding. In both fasted and fed states, both mouse strains shared common expression patterns for about 10,200 genes, and an additional 400?600 genes were differentially regulated in one strain but not the other. Among the shared genes, more lipogenic genes were induced upon feeding in BABL/cJ than in C57BL/6J mice. In contrast, in the population of differentially enriched genes, C57BL/6J mice expressed more genes involved in lipid metabolism than BALB/cJ mice. In summary, these results reveal that the two mouse strains used here exhibit several differences in feeding-induced hepatic responses in gene expression, especially in lipogenic genes.	[Chi, Yuling; Youn, Dou Yeon; Xiaoli, Alus M.; Liu, Li; Pessin, Jacob B.; Yang, Fajun; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med, 1301 Morris Pk Ave, Bronx, NY 10461 USA; [Chi, Yuling; Youn, Dou Yeon; Xiaoli, Alus M.; Liu, Li; Pessin, Jacob B.; Yang, Fajun; Pessin, Jeffrey E.] Albert Einstein Coll Med, Fleischer Inst Diabet & Metab, Bronx, NY 10461 USA; [Xiaoli, Alus M.; Yang, Fajun] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Chi, YL; Pessin, JE (corresponding author), Albert Einstein Coll Med, Dept Med, 1301 Morris Pk Ave, Bronx, NY 10461 USA.	yuling.chi@einsteinmed.org; Jeffrey.Pessin@einsteinmed.org			NIDDK, National Institutes of Health [DK110063, DK020541, DK076169]	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by NIDDK, National Institutes of Health, Grants DK110063, DK020541, and DK076169 (to F. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Chan MY, 2008, OBESITY, V16, P972, DOI 10.1038/oby.2008.32; Cheng AA, 2018, PHYSIOL GENOMICS, V50, P1059, DOI 10.1152/physiolgenomics.00052.2018; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Flower DR, 1996, BIOCHEM J, V318, P1; Gazzana G, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-35; Geisler CE, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0122-x; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107; Kim EJ, 2010, J MED FOOD, V13, P743, DOI 10.1089/jmf.2009.1350; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Swindell WR, 2018, AGING-US, V10, P701, DOI 10.18632/aging.101424; Waller-Evans H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082825; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	18	7	7	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4809	4821		10.1074/jbc.RA119.012349	http://dx.doi.org/10.1074/jbc.RA119.012349			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32075912	Green Published, hybrid			2022-12-26	WOS:000526887000006
J	Kuan, YC; Takahashi, Y; Maruyama, T; Shimizu, M; Yamauchi, Y; Sato, R				Kuan Yen-Chou; Takahashi, Yu; Maruyama, Takashi; Shimizu, Makoto; Yamauchi, Yoshio; Sato, Ryuichiro			Ring finger protein 5 activates sterol regulatory element?binding protein 2 (SREBP2) to promote cholesterol biosynthesis via inducing polyubiquitination of SREBP chaperone SCAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; E3 ubiquitin ligase; endoplasmic reticulum (ER); lipid metabolism; polyubiquitin chain; post-translational modification (PTM); ring finger protein 5 (RNF5); SREBP chaperone (SCAP); sterol regulatory element-binding protein (SREBP)	HAMSTER OVARY CELLS; LIPID-METABOLISM; BINDING PROTEIN; UBIQUITIN LIGASE; DEGRADATION; INSIG-1; HOMEOSTASIS; STABILITY; KINASE; RNF5	Sterol regulatory element?binding protein 2 (SREBP2) is the master transcription factor that regulates cholesterol metabolism. SREBP2 activation is regulated by SREBP chaperone SCAP. Here we show that ring finger protein 5 (RNF5), an endoplasmic reticulum-anchored E3 ubiquitin ligase, mediates the Lys-29?linked polyubiquitination of SCAP and thereby activates SREBP2. RNF5 knockdown inhibited SREBP2 activation and reduced cholesterol biosynthesis in human hepatoma cells, and RNF5 overexpression activated SREBP2. Mechanistic studies revealed that RNF5 binds to the transmembrane domain of SCAP and ubiquitinates the Lys-305 located in cytosolic loop 2 of SCAP. Moreover, the RNF5-mediated ubiquitination enhanced an interaction between SCAP luminal loop 1 and loop 7, a crucial event for SREBP2 activation. Notably, an overexpressed K305R SCAP variant failed to restore the SREBP2 pathway in SCAP-deficient cell lines. These findings define a new mechanism by which an ubiquitination-induced SCAP conformational change regulates cholesterol biosynthesis.	[Kuan Yen-Chou; Takahashi, Yu; Maruyama, Takashi; Yamauchi, Yoshio; Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Food Biochem Lab, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Shimizu, Makoto; Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Nutri Life Sci Lab, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Sato, Ryuichiro] Japan Agcy Med Res & Dev, AMED CREST, Chiyoda Ku, Tokyo 1000004, Japan; [Kuan Yen-Chou] Natl Taiwan Univ, Dept Hort & Landscape Architecture, Coll Bioresources & Agr, 1,Sect 4,Roosevelt Rd, Taipei 10617, Taiwan	University of Tokyo; University of Tokyo; National Taiwan University	Sato, R (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	aroysato@mail.ecc.u-tokyo.ac.jp	Yamauchi, Yoshio/I-7539-2014	Yamauchi, Yoshio/0000-0001-5559-4596; Kuan, Yen-Chou/0000-0001-6870-0685	JSPS KAKENHI [15H05781, 17F17100]; Japanese Agency for Medical Research and Development [16gm0910008h0001]; Cross-ministerial Strategic Innovation Promotion Program [14533567]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Agency for Medical Research and Development; Cross-ministerial Strategic Innovation Promotion Program	This work was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (S) 15H05781, Cross-ministerial Strategic Innovation Promotion Program Grant 14533567, Japanese Agency for Medical Research and Development Grant 16gm0910008h0001 (to R. S.), and a JSPS KAKENHI Grant-in-Aid for JSPS Fellows 17F17100 (to Y.-C. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Asano L, 2017, CELL CHEM BIOL, V24, P207, DOI 10.1016/j.chembiol.2016.12.017; Brown MS, 2018, ANNU REV BIOCHEM, V87, P783, DOI 10.1146/annurev-biochem-062917-011852; Cheng CM, 2015, CANCER CELL, V28, P569, DOI 10.1016/j.ccell.2015.09.021; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Fei C, 2013, MOL CELL BIOL, V33, P4095, DOI 10.1128/MCB.00418-13; Feng X, 2019, AUTOPHAGY, V15, P1130, DOI 10.1080/15548627.2019.1570063; Fujita Y, 2018, CELL REP, V24, P3296, DOI 10.1016/j.celrep.2018.08.057; Jeon YJ, 2015, CANCER CELL, V27, P354, DOI 10.1016/j.ccell.2015.02.006; Jiang LY, 2018, J BIOL CHEM, V293, P4047, DOI 10.1074/jbc.RA117.001260; Jo Y, 2011, J BIOL CHEM, V286, P15022, DOI 10.1074/jbc.M110.211326; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Kim JY, 2018, CELL, V175, P133, DOI 10.1016/j.cell.2018.08.020; Kristariyanto YA, 2015, MOL CELL, V58, P83, DOI 10.1016/j.molcel.2015.01.041; Kuan YC, 2017, J BIOL CHEM, V292, P3016, DOI 10.1074/jbc.M116.767277; Kuang ES, 2013, TRENDS BIOCHEM SCI, V38, P453, DOI 10.1016/j.tibs.2013.06.008; Lee JH, 2014, HEPATOLOGY, V60, P844, DOI 10.1002/hep.27011; Lee JH, 2018, P NATL ACAD SCI USA, V115, pE12228, DOI 10.1073/pnas.1813458115; Lee PCW, 2005, J BIOL CHEM, V280, P25242, DOI 10.1074/jbc.M502989200; Li Y, 2019, NAT COMMUN, V10, DOI [10.1038/s41467-019-09525-y, 10.1038/s41467-019-12385-1]; Menzies SA, 2018, ELIFE, V7, DOI [10.7554/eLife.40009.001, 10.7554/eLife.40009]; Michel MA, 2015, MOL CELL, V58, P95, DOI 10.1016/j.molcel.2015.01.042; Miyata S, 2015, J BIOL CHEM, V290, P20565, DOI 10.1074/jbc.M115.656975; Nucifora FC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11792; Oishi Y, 2017, CELL METAB, V25, P412, DOI 10.1016/j.cmet.2016.11.009; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Sato R, 1999, J BIOL CHEM, V274, P24714, DOI 10.1074/jbc.274.35.24714; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Shao W, 2016, J LIPID RES, V57, P1564, DOI 10.1194/jlr.M069583; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Singh R, 2018, J CLIN INVEST, V128, P3129, DOI 10.1172/JCI96060; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Yu DH, 2018, J LIPID RES, V59, P1745, DOI 10.1194/jlr.P084269; Zhang L, 2017, ELIFE, V6, DOI 10.7554/eLife.28766.001; Zhang YX, 2016, J BIOL CHEM, V291, P12888, DOI 10.1074/jbc.M116.729798; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	43	14	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3918	3928		10.1074/jbc.RA119.011849	http://dx.doi.org/10.1074/jbc.RA119.011849			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32054686	Green Published, hybrid			2022-12-26	WOS:000527704400016
J	He, YF; Mi, JQ; Olson, A; Aldahl, J; Hooker, E; Yu, EJ; Le, V; Lee, DH; Kim, WK; Robins, DM; Geradts, J; Sun, ZJ				He, Yongfeng; Mi, Jiaqi; Olson, Adam; Aldahl, Joseph; Hooker, Erika; Yu, Eun-Jeong; Le, Vien; Lee, Dong-Hoon; Kim, Won Kyung; Robins, Diane M.; Geradts, Joseph; Sun, Zijie			Androgen receptor with short polyglutamine tract preferably enhances Wnt/beta-catenin-mediated prostatic tumorigenesis	ONCOGENE			English	Article							BETA-CATENIN; CANCER; GENE; CAG; ACTIVATION; EXPRESSION; TRANSCRIPTION; PROGRESSION; POLYPOSIS; REPEATS	Polyglutamine (polyQ) tract polymorphism within the human androgen receptor (AR) shows population heterogeneity. African American men possess short polyQ tracts significantly more frequently than Caucasian American men. The length of polyQ tracts is inversely correlated with the risk of prostate cancer, age of onset, and aggressiveness at diagnosis. Aberrant activation of Wnt signaling also reveals frequently in advanced prostate cancer, and an enrichment of androgen and Wnt signaling activation has been observed in African American patients. Here, we assessed aberrant expression of AR bearing different polyQ tracts and stabilized beta-catenin in prostate tumorigenesis using newly generated mouse models. We observed an early onset oncogenic transformation, accelerated tumor cell growth, and aggressive tumor phenotypes in the compound mice bearing short polyQ tract AR and stabilized beta-catenin. RNA sequencing analysis showed a robust enrichment of Myc-regulated downstream genes in tumor samples bearing short polyQ AR versus those with longer polyQ tract AR. Upstream regulator analysis further identified Myc as the top candidate of transcriptional regulators in tumor cells from the above mouse samples with short polyQ tract AR and beta-catenin. Chromatin immunoprecipitation analyses revealed increased recruitment of beta-catenin and AR on the c-Myc gene regulatory locus in the tumor tissues expressing stabilized beta-catenin and shorter polyQ tract AR. These data demonstrate a promotional role of aberrant activation of Wnt/beta-catenin in combination with short polyQ AR expression in prostate tumorigenesis and suggest a potential mechanism underlying aggressive prostatic tumor development, which has been frequently observed in African American patients.	[He, Yongfeng; Mi, Jiaqi; Olson, Adam; Aldahl, Joseph; Hooker, Erika; Yu, Eun-Jeong; Le, Vien; Lee, Dong-Hoon; Kim, Won Kyung; Sun, Zijie] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Robins, Diane M.] Univ Michigan, Dept Human Genet, Sch Med, Ann Arbor, MI 48109 USA; [Geradts, Joseph] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA; [Geradts, Joseph] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	City of Hope; Beckman Research Institute of City of Hope; University of Michigan System; University of Michigan; City of Hope; Beckman Research Institute of City of Hope; Duke University	Sun, ZJ (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA.	zjsun@coh.org	Mi, Jiaqi/GVU-4732-2022; le, vien/GWV-7308-2022; He, Yongfeng/AAR-8257-2020	Mi, Jiaqi/0000-0002-6537-7795; Hooker, Erika/0000-0002-4515-4041; Robins, Diane M./0000-0001-6727-6309; Olson, Adam W./0000-0003-3118-0393	Public Health Service [R01CA070297, R01CA166894, R21CA190021, R01DK104941]	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by Public Health Service grants R01CA070297, R01CA166894, R21CA190021, and R01DK104941.	Albertelli MA, 2006, MOL ENDOCRINOL, V20, P1248, DOI 10.1210/me.2006-0021; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett CL, 2002, J CLIN ONCOL, V20, P3599, DOI 10.1200/JCO.2002.11.085; Bierie B, 2003, ONCOGENE, V22, P3875, DOI 10.1038/sj.onc.1206426; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; Choong CS, 1998, J MOL ENDOCRINOL, V21, P235, DOI 10.1677/jme.0.0210235; Clark Peter E, 2003, Methods Mol Med, V81, P255; Culig Z, 2003, UROLOGY, V62, P21, DOI 10.1016/S0090-4295(03)00698-8; DeSantis CE, 2019, CA-CANCER J CLIN, V69, P211, DOI 10.3322/caac.21555; Dess RT, 2019, JAMA ONCOL, V5, P975, DOI 10.1001/jamaoncol.2019.0826; Drost J, 2016, NAT PROTOC, V11, P347, DOI 10.1038/nprot.2016.006; FLEMING WH, 1986, CANCER RES, V46, P1535; Gann PH, 1996, J NATL CANCER I, V88, P1118, DOI 10.1093/jnci/88.16.1118; Gounari F, 2002, ONCOGENE, V21, P4099, DOI 10.1038/sj.onc.1205562; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; IRVINE RA, 1995, CANCER RES, V55, P1937; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; Jenster G, 1999, SEMIN ONCOL, V26, P407; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koh Cheryl M, 2010, Genes Cancer, V1, P617, DOI 10.1177/1947601910379132; Kumar R, 2019, CANCER RES, V79, P1353, DOI 10.1158/0008-5472.CAN-18-2383; KYPRIANOU N, 1988, ENDOCRINOLOGY, V122, P552, DOI 10.1210/endo-122-2-552; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee J, 2007, NUCLEIC ACIDS RES, V35, P4523, DOI 10.1093/nar/gkm476; Lee SH, 2016, ONCOGENE, V35, P702, DOI 10.1038/onc.2015.117; Mahmoudi T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000539; McNamara MA, 2019, PROSTATE, V79, P1106, DOI 10.1002/pros.23822; MHATRE AN, 1993, NAT GENET, V5, P184, DOI 10.1038/ng1093-184; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mulholland DJ, 2002, J BIOL CHEM, V277, P17933, DOI 10.1074/jbc.M200135200; Pan HF, 2018, WORLD J SURG ONCOL, V16, DOI 10.1186/s12957-018-1352-3; Rennoll Sherri, 2015, World J Biol Chem, V6, P290, DOI 10.4331/wjbc.v6.i4.290; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Sartor O, 1999, UROLOGY, V53, P378, DOI 10.1016/S0090-4295(98)00481-6; Shukla S, 2013, PROSTATE, V73, P1507, DOI 10.1002/pros.22698; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Spratt DE, 2016, EUR UROL FOCUS, V2, P532, DOI 10.1016/j.euf.2016.03.010; Stanford JL, 1997, CANCER RES, V57, P1194; SUGIMURA Y, 1986, BIOL REPROD, V34, P973, DOI 10.1095/biolreprod34.5.973; Truica CI, 2000, CANCER RES, V60, P4709; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Wang BD, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/763569; Wang J, 2010, CANCER RES, V70, P10182, DOI 10.1158/0008-5472.CAN-10-2414; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Yu ZG, 2006, AM J PATHOL, V168, P195, DOI 10.2353/ajpath.2006.050619; Zhang L, 2012, TRANSGENIC RES, V21, P1117, DOI 10.1007/s11248-012-9598-y; Zheng CG, 2009, CANCER RES, V69, P2324, DOI 10.1158/0008-5472.CAN-08-4113; ZHOU ZX, 1994, RECENT PROG HORM RES, V49, P249; Zhu CF, 2011, J BIOL CHEM, V286, P33478, DOI 10.1074/jbc.M111.269894	54	7	7	1	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2020	39	16					3276	3291		10.1038/s41388-020-1214-7	http://dx.doi.org/10.1038/s41388-020-1214-7		FEB 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QF9OJ	32089544	Green Accepted			2022-12-26	WOS:000515215100001
J	Brand, C; Greve, B; Bolling, T; Eich, HT; Willich, N; Harrach, S; Hintelmann, H; Lenz, G; Mesters, RM; Kessler, T; Schliemann, C; Berdel, WE; Schwoppe, C				Brand, Caroline; Greve, Burkhard; Boelling, Tobias; Eich, Hans T.; Willich, Normann; Harrach, Saliha; Hintelmann, Heike; Lenz, Georg; Mesters, Rolf M.; Kessler, Torsten; Schliemann, Christoph; Berdel, Wolfgang E.; Schwoeppe, Christian			Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcoma	PLOS ONE			English	Article							TUMOR-VESSEL INFARCTION; AMINOPEPTIDASE-N; CLINICAL-SIGNIFICANCE; ENDOTHELIAL-CELLS; EXPRESSION; CANCER; ANGIOGENESIS; CHEMOTHERAPY; ANTIBODY; BINDING	Background Truncated tissue factor (tTF) retargeted by NGR-peptides to aminopeptidase N (CD13) in tumor vasculature is effective in experimental tumor therapy. tTF-NGR induces tumor growth inhibition in a variety of human tumor xenografts of different histology. To improve on the therapeutic efficacy we have combined tTF-NGR with radiotherapy. Methods Serum-stimulated human umbilical vein endothelial cells (HUVEC) and human HT1080 sarcoma cells were irradiated in vitro, and upregulated early-apoptotic phosphatidylserine (PS) on the cell surface was measured by standard flow cytometry. Increase of cellular procoagulant function in relation to irradiation and PS cell surface concentration was measured in a tTF-NGR-dependent Factor X activation assay. In vivo experiments with CD-1 athymic mice bearing human HT1080 sarcoma xenotransplants were performed to test the systemic therapeutic effects of tTF-NGR on tumor growth alone or in combination with regional tumor ionizing radiotherapy. Results As shown by flow cytometry with HUVEC and HT1080 sarcoma cells in vitro, irradiation with 4 and 6 Gy in the process of apoptosis induced upregulation of PS presence on the outer surface of both cell types. Proapoptotic HUVEC and HT1080 cells both showed significantly higher procoagulant efficacy on the basis of equimolar concentrations of tTF-NGR as measured by FX activation. This effect can be reverted by masking of PS with Annexin V. HT1080 human sarcoma xenografted tumors showed shrinkage induced by combined regional radiotherapy and systemic tTF-NGR as compared to growth inhibition achieved by either of the treatment modalities alone. Conclusions Irradiation renders tumor and tumor vascular cells procoagulant by PS upregulation on their outer surface and radiotherapy can significantly improve the therapeutic antitumor efficacy of tTF-NGR in the xenograft model used. This synergistic effect will influence design of future clinical combination studies.	[Brand, Caroline; Harrach, Saliha; Hintelmann, Heike; Lenz, Georg; Mesters, Rolf M.; Kessler, Torsten; Schliemann, Christoph; Berdel, Wolfgang E.; Schwoeppe, Christian] Univ Hosp Muenster, Dept Med Hematol Oncol A, Munster, Germany; [Greve, Burkhard; Boelling, Tobias; Eich, Hans T.; Willich, Normann] Univ Hosp Muenster, Dept Radiat Therapy & Radiat Oncol, Munster, Germany	University of Munster; University of Munster	Berdel, WE; Schwoppe, C (corresponding author), Univ Hosp Muenster, Dept Med Hematol Oncol A, Munster, Germany.	berdel@uni-muenster.de; christian.schwoeppe@uni-muenster.de	Kessler, Torsten/S-3319-2016	Kessler, Torsten/0000-0001-7679-5362	Deutsche Krebshilfe e. V. [110886]; Else Kroner-Fresenius-Stiftung [2013_A284]; Deutsche Forschungsgemeinschaft (DFG) [EXC 1003]	Deutsche Krebshilfe e. V.(Deutsche Krebshilfe); Else Kroner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was funded by Deutsche Krebshilfe e. V. (110886) to MD Wolfgang E. Berdel, Else Kroner-Fresenius-Stiftung (2013_A284) to PhD Christian Schwoppe and MD Wolfgang E. Berdel, and Deutsche Forschungsgemeinschaft (DFG) (EXC 1003) to MD Wolfgang E. Berdel and MD Georg Lenz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACH R, 1986, BIOCHEMISTRY-US, V25, P4007, DOI 10.1021/bi00362a005; Bauvois B, 2006, MED RES REV, V26, P88, DOI 10.1002/med.20044; BERDEL WE, 1983, RADIAT RES, V94, P166, DOI 10.2307/3575872; Bhagwat SV, 2001, BLOOD, V97, P652, DOI 10.1182/blood.V97.3.652; Bieker R, 2009, BLOOD, V113, P5019, DOI 10.1182/blood-2008-04-150318; Blankenberg FG, 1998, P NATL ACAD SCI USA, V95, P6349, DOI 10.1073/pnas.95.11.6349; Bombeli T, 1997, BLOOD, V89, P2429, DOI 10.1182/blood.V89.7.2429; Brand C, 2015, J ULTRAS MED, V34, P1227, DOI 10.7863/ultra.34.7.1227; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Corti A, 2013, BIODRUGS, V27, P591, DOI 10.1007/s40259-013-0048-z; Curnis F, 2002, CANCER RES, V62, P867; DacharyPrigent J, 1996, SEMIN THROMB HEMOST, V22, P157, DOI 10.1055/s-2007-999004; DENEKAMP J, 1982, BRIT J CANCER, V45, P136, DOI 10.1038/bjc.1982.16; Faintuch BL, 2014, APPL RADIAT ISOTOPES, V86, P41, DOI 10.1016/j.apradiso.2013.12.035; Ferreri AJM, 2019, BLOOD, V134, P252, DOI 10.1182/blood.2019000633; Gregorc V, 2010, J CLIN ONCOL, V28, P2604, DOI 10.1200/JCO.2009.27.3649; Guzman-Rojas L, 2012, P NATL ACAD SCI USA, V109, P1637, DOI 10.1073/pnas.1120790109; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hashida H, 2002, GASTROENTEROLOGY, V122, P376, DOI 10.1053/gast.2002.31095; He J, 2007, CLIN CANCER RES, V13, P5211, DOI 10.1158/1078-0432.CCR-07-0793; Hu S, 2012, MOL IMAGING BIOL, V14, P762, DOI 10.1007/s11307-012-0551-5; Huang XM, 1997, SCIENCE, V275, P547, DOI 10.1126/science.275.5299.547; Ichinose Y, 2003, JNCI-J NATL CANCER I, V95, P605, DOI 10.1093/jnci/95.8.605; Ikeda N, 2003, CLIN CANCER RES, V9, P1503; Kessler Torsten, 2008, Curr Drug Discov Technol, V5, P1; Lysov Z, 2015, BLOOD COAGUL FIBRIN, V26, P36, DOI 10.1097/MBC.0000000000000145; Mate G, 2015, EUR J PHARM SCI, V69, P61, DOI 10.1016/j.ejps.2015.01.002; Ostendorp M, 2008, CANCER RES, V68, P7676, DOI 10.1158/0008-5472.CAN-08-0689; Pasqualini R, 2000, CANCER RES, V60, P722; Persigehl T, 2014, ANGIOGENESIS, V17, P235, DOI 10.1007/s10456-013-9391-4; RUF W, 1991, J BIOL CHEM, V266, P2158; Schmidt LH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177146; Schwoppe C, 2013, J MED CHEM, V56, P2337, DOI 10.1021/jm301669z; Schwoppe C, 2010, THROMB RES, V125, pS143, DOI 10.1016/S0049-3848(10)70033-5; Stucke-Ring J, 2016, ONCOTARGET, V7, P82458, DOI 10.18632/oncotarget.12559; Surowiak P, 2006, INT J GYNECOL CANCER, V16, P1783, DOI 10.1111/j.1525-1438.2006.00657.x; Swystun LL, 2009, J THROMB HAEMOST, V7, P619, DOI 10.1111/j.1538-7836.2009.03300.x; Tokuhara T, 2006, CLIN CANCER RES, V12, P3971, DOI 10.1158/1078-0432.CCR-06-0338; Wickstrom M, 2011, CANCER SCI, V102, P501, DOI 10.1111/j.1349-7006.2010.01826.x	39	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229271	10.1371/journal.pone.0229271	http://dx.doi.org/10.1371/journal.pone.0229271			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084238	gold, Green Published			2022-12-26	WOS:000535227900077
J	Cassini, CS; Taucce, PPG; de Carvalho, TR; Fouquet, A; Sole, M; Haddad, CFB; Garcia, PCA				Cassini, Carla S.; Taucce, Pedro P. G.; de Carvalho, Thiago R.; Fouquet, Antoine; Sole, Mirco; Haddad, Celio F. B.; Garcia, Paulo C. A.			One step beyond a broad molecular phylogenetic analysis: Species delimitation of Adenomera marmorata Steindachner, 1867 (Anura: Leptodactylidae)	PLOS ONE			English	Article							GENUS ADENOMERA; ATLANTIC FOREST; EVOLUTION; AMPHIBIA; FROGS; DIVERSITY; PATTERNS; STATE; TOOL; DIVERSIFICATION	Taxonomists always have had intense discussions about how species should be delimited and recently many studies have used integrative approaches by combining molecular, morphological, and bioacoustic data. Although these studies are paramount for understanding species diversity, few of them actually formalize species delimitations to the final step of nomenclatural acts. Historically, the Neotropical frog genus Adenomera has been considered as a difficult taxonomic group because it comprises many morphologically similar species exhibiting high levels of intraspecific polymorphism. A recent work using molecular data shed light on the phylogenetic relationships within the genus and identified several lineages that may correspond to undescribed species but did not delimit species boundaries. In the Atlantic Forest, a clade formed by A. marmorata and two putative species (Adenomera sp. J and Adenomera sp. K) were identified. In this paper, we combine morphological, acoustic, and molecular data in order to evaluate species limits within this Atlantic Forest Adenomera clade. We provide a redescription of A. marmorata and restrict its type locality to the Tijuca Massif, in the Municipality of Rio de Janeiro, Brazil. Our results do not support A. marmorata and the two candidate species as diagnosable distinct species. Therefore A. marmorata corresponds to a species with pronounced morphological and acoustic variation in the genus and a complex phylogeographic structure.	[Cassini, Carla S.; Sole, Mirco] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil; [Taucce, Pedro P. G.; de Carvalho, Thiago R.; Haddad, Celio F. B.] Univ Estadual Paulista, Ctr Aquicultura CAUNESP, Inst Biociencias, Dept Biodiversidade, Rio Claro, SP, Brazil; [Fouquet, Antoine] CNRS UPS IRD, UMR5174, Lab Evolut & Diversite Biol, Batiment, France; [Garcia, Paulo C. A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Zool, Belo Horizonte, MG, Brazil	Universidade Estadual de Santa Cruz; Universidade Estadual Paulista; Institut de Recherche pour le Developpement (IRD); Universidade Federal de Minas Gerais	Cassini, CS (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil.	carlacassini@gmail.com	Carvalho, Thiago Ribeiro/GPG-1405-2022; Garcia, Paulo/A-9983-2010; Solé, Mirco/A-9722-2008; Goulart Taucce, Pedro Paulo/A-8515-2018; Haddad, Célio F. B./C-4267-2012	Garcia, Paulo/0000-0002-4789-7033; Solé, Mirco/0000-0001-7881-6227; Goulart Taucce, Pedro Paulo/0000-0002-3088-4543; Haddad, Célio F. B./0000-0002-7044-5764	FAPESP [2013/50741-7, 2010/51606-8, 2019/04076-8, 2012/15763-7, 2015/13404-8, 2017/08489-0]; CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Sao Paulo Research Foundation (FAPESP); Programa de Pos-Graduacao em Zoologia da UFMG; "Investissement d'Avenir" grant by Agence Nationale de la Recherche (CEBA) [ANR-10-LABX-25-01]; Fapemig	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Programa de Pos-Graduacao em Zoologia da UFMG; "Investissement d'Avenir" grant by Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR)); Fapemig(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was part of C. S. C.'s PhD degree and postdoctoral research and P. P. G. T.'s Master's degree. C. S. C. thanks FAPESP (grant #2010/51606-8) for doctorate scholarship and CNPq for current postdoctoral research funding. P. P. G. T. thanks for Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for MSc fellowship and FAPESP (grant #2019/04076-8) for current funding. Sao Paulo Research Foundation (FAPESP) and Programa de Pos-Graduacao em Zoologia da UFMG gave field financing. T. R. C. has received scholarship from FAPESP (#2012/15763-7, #2015/13404-8, and #2017/08489-0). This work has benefited from an "Investissement d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-25-01). C. F. B. H. thanks FAPESP (grant #2013/50741-7) and CNPq for financial support. P. C. A. G. thanks Fapemig and CNPq for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ADP, 2006, ZOOTAXA, P1; Angulo A, 2003, HERPETOLOGICA, V59, P490, DOI 10.1655/20-104; Angulo A, 2008, ZOOL J LINN SOC-LOND, V152, P59, DOI 10.1111/j.1096-3642.2007.00338.x; Angulo A, 2010, SYST BIODIVERS, V8, P357, DOI 10.1080/14772000.2010.507264; [Anonymous], 2019, R LANG ENV STAT COMP; Audacity team, 2017, FREE AUD ED REC VERS; Berneck BVM, 2008, ZOOTAXA, P46; Blotto BL, 2013, CLADISTICS, V29, P113, DOI 10.1111/j.1096-0031.2012.00417.x; Boistel Renaud, 2006, Acta Herpetologica, V1, P1; Bokermann W. C. A., 1956, Neotropica, V2, P37; Bokermann W. C. A., 1966, LISTA ANOTADA LOCALI; Boulenger GA, 1884, P ZOOL SOC LOND, V1883, P635, DOI [DOI 10.1111/J.1469-7998.1883.TB06669.X, 10.1111/j.1469-7998.1883.tb06669.x]; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Cassini CS, 2013, ZOOTAXA, V3616, P73, DOI 10.11646/zootaxa.3616.1.6; Clement M., 2002, P 16 INT PARALLEL DI, P7; Cochran D. M., 1955, Bulletin United States National Museum, VNo. 206, P1; Campos JR, 2009, HEREDITAS, V146, P104, DOI 10.1111/j.1601-5223.2009.02100.x; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; de Carvalho TR, 2019, HERPETOLOGICA, V75, P233, DOI 10.1655/D-18-00049; de Carvalho TR, 2019, J HERPETOL, V53, P131, DOI 10.1670/18-172; De Carvalho TR, 2013, ZOOTAXA, V3731, P533, DOI 10.11646/zootaxa.3731.4.6; De Carvalii TR, 2019, AM MUS NOVIT, P1; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Duellman W.E., 1970, Monograph Mus nat Hist Univ Kans, V1, P1; Flot JF, 2010, MOL ECOL RESOUR, V10, P162, DOI 10.1111/j.1755-0998.2009.02732.x; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fouquet A, 2014, J BIOGEOGR, V41, P855, DOI 10.1111/jbi.12250; Fouquet A, 2012, MOL PHYLOGENET EVOL, V65, P547, DOI 10.1016/j.ympev.2012.07.012; Gans C., 1955, Annals of the Carnegie Museum, V33, P275; Gehara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103958; Gridi-Papp M., 2007, SOUNDRULER ACOUSTIC; HEYER W R, 1973, Contributions in Science (Los Angeles), P1; Heyer WR, 1990, ARQ ZOOL, V31, P235; Hoegg S, 2004, MOL BIOL EVOL, V21, P1188, DOI 10.1093/molbev/msh081; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jansen M, 2007, J HERPETOL, V41, P724, DOI 10.1670/06-289.1; Johann L, 2013, ZOOTAXA, V3701, P238, DOI 10.11646/zootaxa.3701.2.6; Kaefer IL, 2012, ACTA ETHOL, V15, P187, DOI 10.1007/s10211-012-0126-0; Kassambara A, 2017, R PACKAGE VERSION, V1, P2016; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kok Philippe J. R., 2007, Phyllomedusa, V6, P45; Kwet Axel, 2007, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Zoologische Reihe, V83, P56, DOI 10.1002/mmnz.200600027; Kwet Axel, 2002, Alytes (Paris), V20, P28; Kwet A, 2009, STUD NEOTROP FAUNA E, V44, P93, DOI 10.1080/01650520902901659; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Langone JA, 2016, MOL PHYLOGENET EVOL, V95, P137, DOI 10.1016/j.ympev.2015.11.012; Ligges U, TUNER ANAL MUSIC; Lomolino MV, 2012, J BIOGEOGR, V39, P842, DOI 10.1111/j.1365-2699.2011.02656.x; LUTZ ADOLPHO, 1926, MEM INST OSWALDO CRUZ, V19, P139; LUTZ B, 1947, COPEIA, P242; Lyra ML, 2017, MOL ECOL RESOUR, V17, P966, DOI 10.1111/1755-0998.12648; MARQUEZ R, 1995, J ZOOL, V237, P313, DOI 10.1111/j.1469-7998.1995.tb02765.x; MATLAB, 2004, MATLAB LANGUAGE TECH; Meiri S, 2006, J BIOGEOGR, V33, P1571, DOI 10.1111/j.1365-2699.2006.01523.x; Menin M, 2009, J NAT HIST, V43, P2257, DOI 10.1080/00222930903097707; Meyer CP, 2003, BIOL J LINN SOC, V79, P401, DOI 10.1046/j.1095-8312.2003.00197.x; Montesinos R, 2012, BIOTROPICA, V44, P506, DOI 10.1111/j.1744-7429.2011.00835.x; MORITZ C, 1992, SYST BIOL, V41, P273, DOI 10.2307/2992567; Muller L., 1922, STUTTGART, V33, P167; Nabil A, 2010, ANN ZOOL, V60, P159, DOI 10.3161/000345410X499632; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Padial JM, 2009, ZOOL SCR, V38, P431, DOI 10.1111/j.1463-6409.2008.00381.x; Palumbi S. R., 1991, GENETIC ECOLOGY WHAL, P203; Pante E, 2015, SYST BIOL, V64, P152, DOI 10.1093/sysbio/syu083; Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633; Reboucas R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190153; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Scherzer K., 1861, NARRATIVE CIRCUMNAVI; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Schneider JG, 1799, CONTINENS RANAS CALA; SCHOENER TW, 1970, AM NAT, V104, P155, DOI 10.1086/282647; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steindachner F., 1867, ZOLOGISCHER 1; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Vu V. Q., 2011, GGBIPLOT GGPLOT2 BAS; Wiens JJ, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234625; Wilkinson JA, 1996, J HERPETOL, V30, P418, DOI 10.2307/1565184; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Zhang YH, 2014, MITOCHONDR DNA, V1736, P1	83	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229324	10.1371/journal.pone.0229324	http://dx.doi.org/10.1371/journal.pone.0229324			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084229	gold, Green Published			2022-12-26	WOS:000535227900091
J	Coulton, A; Przewieslik-Allen, AM; Burridge, AJ; Shaw, DS; Edwards, KJ; Barker, GLA				Coulton, Alexander; Przewieslik-Allen, Alexandra M.; Burridge, Amanda J.; Shaw, Daniel S.; Edwards, Keith J.; Barker, Gary L. A.			Segregation distortion: Utilizing simulated genotyping data to evaluate statistical methods	PLOS ONE			English	Article							WILD EMMER WHEAT; GENETIC-MARKERS; ANTHER-CULTURE; LINES; MAP; INHERITANCE; STERILITY	Segregation distortion is the phenomenon in which genotypes deviate from expected Mendelian ratios in the progeny of a cross between two varieties or species. There is not currently a widely used consensus for the appropriate statistical test, or more specifically the multiple testing correction procedure, used to detect segregation distortion for high-density single-nucleotide polymorphism (SNP) data. Here we examine the efficacy of various multiple testing procedures, including chi-square test with no correction for multiple testing, false-discovery rate correction and Bonferroni correction using an in-silico simulation of a biparental mapping population. We find that the false discovery rate correction best approximates the traditional p-value threshold of 0.05 for high-density marker data. We also utilize this simulation to test the effect of segregation distortion on the genetic mapping process, specifically on the formation of linkage groups during marker clustering. Only extreme segregation distortion was found to effect genetic mapping. In addition, we utilize replicate empirical mapping populations of wheat varieties Avalon and Cadenza to assess how often segregation distortion conforms to the same pattern between closely related wheat varieties.	[Coulton, Alexander; Przewieslik-Allen, Alexandra M.; Burridge, Amanda J.; Shaw, Daniel S.; Edwards, Keith J.; Barker, Gary L. A.] Univ Bristol, Sch Biol Sci, Life Sci Bldg, Bristol, Avon, England	University of Bristol	Coulton, A (corresponding author), Univ Bristol, Sch Biol Sci, Life Sci Bldg, Bristol, Avon, England.	acoulton.re@gmail.com		Shaw, Daniel/0000-0001-8183-2228; Burridge, Amanda/0000-0002-0140-5523; Coulton, Alexander/0000-0002-0826-5009; Barker, Gary/0000-0002-9018-9526	BBSRC [BB/M009122/1]; Biotechnology and Biological Sciences Research Council, UK [BBS/E/C/000I0280]; BBSRC [BB/S020519/1, BB/I01750X/1, BBS/E/C/000I0280, BB/L014106/1, BB/N021061/1, BB/N013360/1, BB/R000298/1, BB/L020718/1, BB/T018364/1, BBS/E/J/000PR9781, 1933018, BBS/E/J/000PR9782, BB/S019219/1, BB/N002628/1, BB/N020421/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AC is supported by the BBSRC funded South West Biosciences Doctoral Training Partnership (BB/M009122/1). We are grateful to the Biotechnology and Biological Sciences Research Council - https://bbsrc.ukri.org/BBSRC), UK, for funding this work under the Designing Future Wheat program (BBS/E/C/000I0280). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski T, 2014, ELECTRON J BIOTECHN, V17, P6, DOI 10.1016/j.ejbt.2013.12.002; Allen AM, 2017, PLANT BIOTECHNOL J, V15, P390, DOI 10.1111/pbi.12635; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Avni R, 2014, MOL BREEDING, V34, P1549, DOI 10.1007/s11032-014-0176-2; Castro P, 2011, EUPHYTICA, V179, P515, DOI 10.1007/s10681-011-0356-7; Coulton A., 2019, PEDIGREEWRAPPER; Dai BS, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02037; Gardner KA, 2016, PLANT BIOTECHNOL J, V14, P1406, DOI 10.1111/pbi.12504; Hackett CA, 2003, HEREDITY, V90, P33, DOI 10.1038/sj.hdy.6800173; Li CL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/830618; Li HB, 2010, MOL GENET GENOMICS, V284, P319, DOI 10.1007/s00438-010-0570-3; Liu Guo, 2010, PROGR SEGREGATION DI; Liu M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36398; LOEGERING WQ, 1963, CAN J GENET CYTOL, V5, P65, DOI 10.1139/g63-010; LORIEUX M, 1995, THEOR APPL GENET, V90, P81, DOI 10.1007/BF00220999; Lu H, 2002, THEOR APPL GENET, V105, P622, DOI 10.1007/s00122-002-0970-9; LYTTLE TW, 1993, TRENDS GENET, V9, P205, DOI 10.1016/0168-9525(93)90120-7; Manninen OM, 2000, THEOR APPL GENET, V100, P57, DOI 10.1007/s001220050008; Manrique-Carpintero NC, 2016, G3-GENES GENOM GENET, V6, P2617, DOI 10.1534/g3.116.030031; Pallotta M.A., 2003, P 10 INT WHEAT GEN S, P789; Peng J, 2000, GENOME RES, V10, P1509, DOI 10.1101/gr.150300; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Roorkiwal M, 2018, PLANT BIOTECHNOL J, V16, P890, DOI 10.1111/pbi.12836; Sayed H, 2002, EUPHYTICA, V125, P265, DOI 10.1023/A:1015861610226; Seymour DK, 2017, BIORXIV, DOI [10.1101/158527, DOI 10.1101/158527]; SILVER LM, 1993, TRENDS GENET, V9, P250, DOI 10.1016/0168-9525(93)90090-5; Singh K, 2007, THEOR APPL GENET, V115, P301, DOI 10.1007/s00122-007-0543-z; Takumi S, 2013, GENETICA, V141, P463, DOI 10.1007/s10709-013-9745-2; THOMPSON DM, 1991, THEOR APPL GENET, V81, P487, DOI 10.1007/BF00219438; Voorrips RE, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-248; Wang G, 2012, GENET MOL RES, V11, P693, DOI 10.4238/2012.March.19.3; Wasserstein RL, 2019, AM STAT, V73, P1, DOI 10.1080/00031305.2019.1583913; Wilkinson PA, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1139-x; Wingen LU, 2017, GENETICS, V205, P1657, DOI 10.1534/genetics.116.194688; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Yang JY, 2012, SCIENCE, V337, P1336, DOI 10.1126/science.1223702	36	7	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228951	10.1371/journal.pone.0228951	http://dx.doi.org/10.1371/journal.pone.0228951			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074141	gold, Green Published, Green Submitted			2022-12-26	WOS:000535220600031
J	Pan, YC; Li, L; Xiao, SJ; Chen, ZJ; Sarsaiya, S; Zhang, SB; Yanni, SG; Liu, HB; Xu, DL				Pan, Yinchi; Li, Lin; Xiao, Shiji; Chen, Zhongjie; Sarsaiya, Surendra; Zhang, Shebo; Yanni ShangGuan; Liu, Houbo; Xu, Delin			Callus growth kinetics and accumulation of secondary metabolites of Bletilla striata Rchb. f. using a callus suspension culture	PLOS ONE			English	Article								Bletilla striata is an endangered traditional Chinese medicinal plant with multiple uses and a slow regeneration rate of its germplasm resources. To evaluate the callus growth kinetics and accumulation of secondary metabolites (SMs), a callus suspension culture was proven to be a valuable approach for acquiring high yields of medicinal compounds. An effective callus suspension culture for obtaining B. striata callus growth and its SMs was achieved with the in vitro induction of calluses from B. striata seeds. The callus growth kinetics and accumulation of SMs were analyzed using a mathematical model. The resulting callus growth kinetic model revealed that the growth curves of B. striata suspension-cultured calluses were sigmoidal, indicating changes in the growth of the suspension-cultured calluses. Improved Murashige and Skoog callus growth medium was the most favorable medium for B. striata callus formation, with the highest callus growth occurring during the stationary phase of the cultivation period. Callus growth acceleration started after 7 days and thereafter gradually decreased until day 24 of the cultivation period and reached its highest at day 36 period in both the dry weight and fresh weight analyses. The coelonin concentration peaked during the exponential growth stage and decreased afterward during the stationary stage of the callus suspension culture. The maximum content of coelonin (approximately 0.3323 mg/g callus dry weight) was observed on the 18th day of the cultivation cycle, while dactylorhin A and militarine reached the highest concentrations at day 24, and p-hydroxybenzyl alcohol at day 39. This investigation also laid a foundation for a multimathematical model to better describe the accumulation variation of SMs. The production of SMs showed great specificity during callus growth and development. This research provided a well-organized way to increase the accumulation and production of SMs during the scaled-up biosynthesis of calluses in B. striata callus suspension cultures.	[Pan, Yinchi; Li, Lin; Chen, Zhongjie; Zhang, Shebo; Yanni ShangGuan; Liu, Houbo; Xu, Delin] Zunyi Med Univ, Dept Cell Biol, Zunyi, Guizhou, Peoples R China; [Pan, Yinchi] Zhejiang Putuo Hosp, Dept Sci & Educ, Zhoushan, Zhejiang, Peoples R China; [Xiao, Shiji] Zunyi Med Univ, Dept Pharm, Zunyi, Guizhou, Peoples R China; [Sarsaiya, Surendra] Zunyi Med Univ, Sch Pharm Chem, Zunyi, Guizhou, Peoples R China	Zunyi Medical University; Zunyi Medical University; Zunyi Medical University	Xu, DL (corresponding author), Zunyi Med Univ, Dept Cell Biol, Zunyi, Guizhou, Peoples R China.	xudelin2000@163.com	Li, Lin/GQI-2563-2022; Sarsaiya, Surendra/K-6970-2019	Sarsaiya, Surendra/0000-0002-0850-8592; Xu, Delin/0000-0003-3695-2997; lin, li/0000-0003-2916-9224	National Natural Science Foundation of China [31560079, 31560102]; Scientific Project of Guizhou Province [QKH-ZY[2013]3002, QKH-LH [2014]7549, [2017]5733-001]; Talents Promotion Project of Zunyi Medical University [JC2018-2-5 (1)]; PhD Science Foundation of Zunyi Medical University [F-809]; Talent Growth Project of Guizhou Education Department [KY[2017]194]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Project of Guizhou Province; Talents Promotion Project of Zunyi Medical University; PhD Science Foundation of Zunyi Medical University; Talent Growth Project of Guizhou Education Department	This research was financially supported by the National Natural Science Foundation of China (31560079, 31560102), the Scientific Project of Guizhou Province (QKH-ZY[2013]3002, QKH-LH [2014]7549, [2017]5733-001), Talents Promotion Project of Zunyi Medical University(JC2018-2-5 (1)), the PhD Science Foundation of Zunyi Medical University (F-809), and the Talent Growth Project of Guizhou Education Department (KY[2017]194). The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Costa JD, 2015, APPL BIOCHEM BIOTECH, V176, P892, DOI 10.1007/s12010-015-1618-y; Dong YS, 2015, PROCESS BIOCHEM, V50, P651, DOI 10.1016/j.procbio.2015.01.018; Glicklis R, 1998, BIOTECHNOL BIOENG, V57, P732, DOI 10.1002/(SICI)1097-0290(19980320)57:6&lt;732::AID-BIT10&gt;3.0.CO;2-9; He XR, 2017, J ETHNOPHARMACOL, V195, P20, DOI 10.1016/j.jep.2016.11.026; Hussein S., 2016, J MICROBIOL BIOTECHN, V4, P20; Murthy HN, 2016, METHODS MOL BIOL, V1391, P125, DOI 10.1007/978-1-4939-3332-7_9; Pan YC, 2018, CHIN TRADIT PAT MED, V40, P1142, DOI [10.3969/j.issn.1001-1528.2018.05.029, DOI 10.3969/J.ISSN.1001-1528.2018.05.029]; Shi Y, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1780-6; Wilson SA, 2012, PLANT BIOTECHNOL J, V10, P249, DOI 10.1111/j.1467-7652.2011.00664.x; Xiao S, 2017, J ASIAN NAT PROD RES, V19, P140, DOI 10.1080/10286020.2016.1184254; Xiao SJ, 2016, CHINESE J ORG CHEM, V36, P638, DOI 10.6023/cjoc201509023; Xu DL, 2016, N HORTIC, V2016, P157, DOI [10.11937/bfyy.201612039, DOI 10.11937/BFYY.201612039]; Yang L, 2018, MOLECULES, V23, DOI 10.3390/molecules23040762; Yu SJ, 2005, BIOL PHARM BULL, V28, P1016, DOI 10.1248/bpb.28.1016; Zhang D, 2006, BASIC CLIN PHARMACOL, V98, P55, DOI 10.1111/j.1742-7843.2006.pto_218.x; Zhang XJ, 2015, WIND STRUCT, V21, P407	16	8	8	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0220084	10.1371/journal.pone.0220084	http://dx.doi.org/10.1371/journal.pone.0220084			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074105	gold, Green Published			2022-12-26	WOS:000535220600002
J	Carmona, R; Barrena, S; Gambero, AJL; Rojas, A; Munoz-Chapuli, R				Carmona, Rita; Barrena, Silvia; Lopez Gambero, Antonio Jesus; Rojas, Anabel; Munoz-Chapuli, Ramon			Epicardial cell lineages and the origin of the coronary endothelium	FASEB JOURNAL			English	Article						cardiac development; cell tracing; coronary endothelium; epicardium; Wilms' tumor suppressor gene	LYMPHATIC VASCULATURE; LATERAL MESODERM; PROGENITOR CELLS; WT1 EXPRESSION; SINUS VENOSUS; CONTRIBUTE; ARTERIES; ADULT; FORM; ANGIOGENESIS	The embryonic epicardium generates a population of epicardial-derived mesenchymal cells (EPDC) whose contribution to the coronary endothelium is minor or, according to some reports, negligible. We have compared four murine cell-tracing models related to the EPDC in order to elucidate this contribution. Cre recombinase was expressed under control of the promoters of the Wilms' tumor suppressor (Wt1), the cardiac troponin (cTnT), and the GATA5 genes, activating expression of the R26R(EYFP) reporter. We have also used the G2 enhancer of the GATA4 gene as a driver due to its activation in the proepicardium. Recombination was found in most of the epicardium/EPDC in all cases. The contribution of these lineages to the cardiac endothelium was analyzed using confocal microscopy and flow cytometry. G2-GATA4 lineage cells are the most frequent in the endothelium, probably due to the recruitment of circulating endothelial progenitors. The contribution of the WT1 cell lineage increases along gestation due to further endothelial expression of WT1. GATA5 and cTnT lineages represent 4% of the cardiac endothelial cells throughout the gestation, probably standing for the actual EPDC contribution to the coronary endothelium. These results suggest caution when using a sole cell-tracing model to study the fate of the EPDC.	[Carmona, Rita; Barrena, Silvia; Lopez Gambero, Antonio Jesus; Munoz-Chapuli, Ramon] Univ Malaga, Fac Sci, Dept Anim Biol, E-29071 Malaga, Spain; [Carmona, Rita; Barrena, Silvia; Lopez Gambero, Antonio Jesus; Munoz-Chapuli, Ramon] Andalusian Ctr Nanomed & Biotechnol BIONAND, Malaga, Spain; [Carmona, Rita; Barrena, Silvia; Lopez Gambero, Antonio Jesus; Munoz-Chapuli, Ramon] Inst Biomed Res Malaga IBIMA, Malaga, Spain; [Rojas, Anabel] Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Seville, Spain; [Rojas, Anabel] Ctr Biomed Res Diabet & Associated Metab Disorder, Seville, Spain; [Lopez Gambero, Antonio Jesus] Reg Hosp Malaga, Inst Biomed Res Malaga IBIMA, Malaga, Spain	Universidad de Malaga; Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Universidad de Malaga	Munoz-Chapuli, R (corresponding author), Univ Malaga, Fac Sci, Dept Anim Biol, E-29071 Malaga, Spain.	chapuli@uma.es		Lopez Gambero, Antonio Jesus/0000-0001-7716-9056; Barrena Garcia, Silvia/0000-0002-0859-3969	Spanish Ministry of Science, Innovation and Universities [BFU201783907-P, BFU2017-82497-P]; Instituto de Salud Carlos III-TERCEL network [RD16/0011/0034, RD16/0011/0030]; Consejeria de Salud, Junta de Andalucia [PC00662017]; Instituto de Salud Carlos III [IFI18/00042]	Spanish Ministry of Science, Innovation and Universities; Instituto de Salud Carlos III-TERCEL network; Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by the Spanish Ministry of Science, Innovation and Universities under grants BFU201783907-P and BFU2017-82497-P; Instituto de Salud Carlos III-TERCEL network under grant RD16/0011/0034 and RD16/0011/0030; and Consejeria de Salud, Junta de Andalucia under grant PC00662017. AJLG is the recipient of a i-PFIS contract from Instituto de Salud Carlos III (IFI18/00042)	Bani D, 2010, J CELL MOL MED, V14, P2531, DOI 10.1111/j.1582-4934.2010.01119.x; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Canete A, 2017, HAEMATOLOGICA, V102, P647, DOI 10.3324/haematol.2016.155812; Cano E, 2016, P NATL ACAD SCI USA, V113, P656, DOI 10.1073/pnas.1509834113; Cano E, 2013, AM J PHYSIOL-LUNG C, V305, pL322, DOI 10.1152/ajplung.00424.2012; Casanova JC, 2013, GENESIS, V51, P32, DOI 10.1002/dvg.22353; Chen HI, 2014, DEVELOPMENT, V141, P4500, DOI 10.1242/dev.113639; Cossette S, 2011, DEV DYNAM, V240, P2344, DOI 10.1002/dvdy.22724; del Monte G, 2011, CIRC RES, V108, P824, DOI 10.1161/CIRCRESAHA.110.229062; Delgado I, 2014, HEPATOLOGY, V59, P2358, DOI 10.1002/hep.27005; Duim SN, 2015, J MOL CELL CARDIOL, V81, P127, DOI 10.1016/j.yjmcc.2015.02.007; Eley L, 2018, ELIFE, V7, DOI 10.7554/eLife.34110; Gordon EJ, 2008, DEV DYNAM, V237, P1901, DOI 10.1002/dvdy.21605; Gothert JR, 2005, BLOOD, V105, P2724, DOI 10.1182/blood-2004-08-3037; Grieskamp T, 2011, CIRC RES, V108, P813, DOI 10.1161/CIRCRESAHA.110.228809; Hosen N, 2007, LEUKEMIA, V21, P1783, DOI 10.1038/sj.leu.2404752; Ikeda N, 2017, BIOMED RES-TOKYO, V38, P228; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Kamimura T, 2018, DEV GROWTH DIFFER, V60, P97, DOI 10.1111/dgd.12422; Katz TC, 2012, DEV CELL, V22, P639, DOI 10.1016/j.devcel.2012.01.012; Klotz L, 2015, NATURE, V522, P62, DOI 10.1038/nature14483; Lee WS, 1998, CIRC RES, V82, P845; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Mifflin JJ, 2018, DEV DYNAM, V247, P1005, DOI [10.1002/DVDY.24641, 10.1002/dvdy.24641]; Norman S, 2016, CLIN ANAT, V29, P305, DOI 10.1002/ca.22638; Palmquist-Gomes P, 2018, DEV DYNAM, V247, P686, DOI 10.1002/dvdy.24610; Peeters MPFMV, 1999, ANAT EMBRYOL, V199, P367, DOI 10.1007/s004290050235; Plein A, 2018, NATURE, V562, P223, DOI 10.1038/s41586-018-0552-x; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Rojas A, 2005, DEVELOPMENT, V132, P3405, DOI 10.1242/dev.01913; Sharma B, 2017, ANNU REV PHYSIOL, V79, P1, DOI 10.1146/annurev-physiol-022516-033953; Tian XY, 2013, CELL RES, V23, P1075, DOI 10.1038/cr.2013.83; Wessels A, 2012, DEV BIOL, V366, P111, DOI 10.1016/j.ydbio.2012.04.020; Wood HB, 1997, BLOOD, V90, P2300; Wu BR, 2012, CELL, V151, P1083, DOI 10.1016/j.cell.2012.10.023; Yin YJ, 2004, ARTERIOSCL THROM VAS, V24, P691, DOI 10.1161/01.ATV.0000120375.51196.73; Zhang H, 2016, CIRC RES, V118, P1880, DOI 10.1161/CIRCRESAHA.116.308749; Zhao WN, 2016, METABOLISM, V65, P1755, DOI 10.1016/j.metabol.2016.09.007	39	10	10	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5223	5239		10.1096/fj.201902249RR	http://dx.doi.org/10.1096/fj.201902249RR		FEB 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32068311				2022-12-26	WOS:000515253600001
J	Gupta, G; Gliga, A; Hedberg, J; Serra, A; Greco, D; Wallinder, IO; Fadeel, B				Gupta, Govind; Gliga, Anda; Hedberg, Jonas; Serra, Angela; Greco, Dario; Odnevall Wallinder, Inger; Fadeel, Bengt			Cobalt nanoparticles trigger ferroptosis-like cell death (oxytosis) in neuronal cells: Potential implications for neurodegenerative disease	FASEB JOURNAL			English	Article						cobalt; ferroptosis; hard metal; nanoparticles; neurodegeneration; oxytosis	OXIDATIVE STRESS; INDUCED CYTOTOXICITY; TOXICITY; GLUTATHIONE; MECHANISM; HEALTH; METAL; PARTICLES; BIOLOGY; FORM	The neurotoxicity of hard metal-based nanoparticles (NPs) remains poorly understood. Here, we deployed the human neuroblastoma cell line SH-SY5Y differentiated or not into dopaminergic- and cholinergic-like neurons to study the impact of tungsten carbide (WC) NPs, WC NPs sintered with cobalt (Co), or Co NPs versus soluble CoCl2. Co NPs and Co salt triggered a dose-dependent cytotoxicity with an increase in cytosolic calcium, lipid peroxidation, and depletion of glutathione (GSH). Co NPs and Co salt also suppressed glutathione peroxidase 4 (GPX4) mRNA and protein expression. Co-exposed cells were rescued by N-acetylcysteine (NAC), a precursor of GSH, and partially by liproxstatin-1, an inhibitor of lipid peroxidation. Furthermore, in silico analyses predicted a significant correlation, based on similarities in gene expression profiles, between Co-containing NPs and Parkinson's disease, and changes in the expression of selected genes were validated by RT-PCR. Finally, experiments using primary human dopaminergic neurons demonstrated cytotoxicity and GSH depletion in response to Co NPs and CoCl2 with loss of axonal integrity. Overall, these data point to a marked neurotoxic potential of Co-based but not WC NPs and show that neuronal cell death may occur through a ferroptosis-like mechanism.	[Gupta, Govind; Fadeel, Bengt] Karolinska Inst, Inst Environm Med, Unit Mol Toxicol, Nobels Vag 13, S-17177 Stockholm, Sweden; [Gliga, Anda] Karolinska Inst, Inst Environm Med, Unit Met & Hlth, Stockholm, Sweden; [Hedberg, Jonas; Odnevall Wallinder, Inger] Royal Inst Technol, Div Surface & Corros Sci, Dept Chem, Stockholm, Sweden; [Serra, Angela; Greco, Dario] Univ Tampere, Inst Biosci & Med Technol, Tampere, Finland; [Serra, Angela; Greco, Dario] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	Karolinska Institutet; Karolinska Institutet; Royal Institute of Technology; Tampere University; University of Helsinki	Fadeel, B (corresponding author), Karolinska Inst, Inst Environm Med, Unit Mol Toxicol, Nobels Vag 13, S-17177 Stockholm, Sweden.	bengt.fadeel@ki.se	Gupta, Govind/AAU-5965-2020; Wallinder, Inger Odnevall/Q-6875-2017	Greco, Dario/0000-0001-9195-9003; Odnevall, Inger/0000-0003-2206-0082; Gupta, Govind/0000-0003-4703-418X	Swedish Foundation for Strategic Environmental Research	Swedish Foundation for Strategic Environmental Research(Swedish Foundation for Strategic Research)	Swedish Foundation for Strategic Environmental Research	Abdalkader M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00466; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Bastian S, 2009, ENVIRON HEALTH PERSP, V117, P530, DOI 10.1289/ehp.0800121; Bhattacharya K, 2017, NANOTOXICOLOGY, V11, P809, DOI 10.1080/17435390.2017.1363309; Cao JY, 2019, CELL REP, V26, P1544, DOI 10.1016/j.celrep.2019.01.043; Catalani S, 2012, HUM EXP TOXICOL, V31, P421, DOI 10.1177/0960327111414280; DAVIS JB, 1994, BRAIN RES, V652, P169, DOI 10.1016/0006-8993(94)90334-4; Di Bucchianico S, 2018, PART FIBRE TOXICOL, V15, DOI 10.1186/s12989-018-0268-y; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Estey MMP, 2013, CLIN CHEM, V59, P880, DOI 10.1373/clinchem.2012.193037; Fenoglio I, 2008, FREE RADICAL RES, V42, P737, DOI 10.1080/10715760802350904; Furberg A, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081774; Gallud A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40579-6; Hambright WS, 2017, REDOX BIOL, V12, P8, DOI 10.1016/j.redox.2017.01.021; Hedberg YS, 2017, ENVIRON POLLUT, V224, P275, DOI 10.1016/j.envpol.2017.02.006; Keegan GM, 2008, CRIT REV TOXICOL, V38, P645, DOI [10.1080/10408440701845534, 10.1080/10408440701845534 ]; Kloditz K, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0146-x; Kong LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068414; Korecka JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063862; Lewerenz J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00214; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Leyssens L, 2017, TOXICOLOGY, V387, P43, DOI 10.1016/j.tox.2017.05.015; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; LISON D, 1992, TOXICOL LETT, V60, P203, DOI 10.1016/0378-4274(92)90275-O; LISON D, 1995, CHEM RES TOXICOL, V8, P600, DOI 10.1021/tx00046a015; Lison D, 1996, CRIT REV TOXICOL, V26, P585, DOI 10.3109/10408449609037478; LISON D, 1990, ENVIRON RES, V52, P187, DOI 10.1016/S0013-9351(05)80253-1; LISON D, 1994, ARCH TOXICOL, V68, P528, DOI 10.1007/s002040050108; Lison D, 2015, HANDBOOK ON THE TOXICOLOGY OF METALS, VOL I & II, 4TH EDITION, P743, DOI 10.1016/B978-0-444-59453-2.00034-2; LLOBET JM, 1986, ARCH TOXICOL, V58, P278, DOI 10.1007/BF00297121; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Neitemeier S, 2017, REDOX BIOL, V12, P558, DOI 10.1016/j.redox.2017.03.007; Nyga A, 2015, NANOTOXICOLOGY, V9, P905, DOI 10.3109/17435390.2014.991430; Onate M, 2020, CELL DEATH DIFFER, V27, P1169, DOI 10.1038/s41418-019-0408-4; Paustenbach DJ, 2013, CRIT REV TOXICOL, V43, P316, DOI 10.3109/10408444.2013.779633; Rizzetti MC, 2009, LANCET, V373, P1052, DOI 10.1016/S0140-6736(09)60490-6; ROY S, 1969, J PATHOL, V99, P39, DOI 10.1002/path.1710990106; Scharf B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05729; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Serra A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37411-y; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741; Tan SL, 1998, J NEUROCHEM, V71, P95; Tan SL, 1998, J CELL BIOL, V141, P1423, DOI 10.1083/jcb.141.6.1423; Woelber Erik, 2016, JBJS Case Connect, V6, pe45, DOI 10.2106/JBJS.CC.15.00063; Zhao F, 2009, FREE RADICAL BIO MED, V47, P867, DOI 10.1016/j.freeradbiomed.2009.06.029; Zheng FL, 2019, TOXICOL APPL PHARM, V369, P90, DOI 10.1016/j.taap.2019.03.003; Zilka O, 2017, ACS CENTRAL SCI, V3, P232, DOI 10.1021/acscentsci.7b00028	50	26	26	7	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5262	5281		10.1096/fj.201902191RR	http://dx.doi.org/10.1096/fj.201902191RR		FEB 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32060981	Green Published			2022-12-26	WOS:000515245900001
J	de Rycke, Y; Tubach, F; Lafourcade, A; Guillo, S; Dalichampt, M; Dahlab, A; Bresse, X; Uhart, M; Bergeron, C; Borne, H; Cancalon, C; Lajoinie, A; Benard, S				de Rycke, Yann; Tubach, Florence; Lafourcade, Alexandre; Guillo, Sylvie; Dalichampt, Marie; Dahlab, Andre; Bresse, Xavier; Uhart, Mathieu; Bergeron, Christine; Borne, Helene; Cancalon, Charlotte; Lajoinie, Audrey; Benard, Steve			Cervical cancer screening coverage, management of squamous intraepithelial lesions and related costs in France	PLOS ONE			English	Article							DATABASES	Until 2018, cervical cancer screening in France was an unorganized individual screening, with the exception of some pilot programs in some territories. We aimed to assess, before the implementation of organized cervical cancer screening and human papillomavirus (HPV) nonavalent vaccine introduction in the vaccination schedule in 2018, (i) the individual cervical cancer screening coverage, (ii) the management of squamous intraepithelial lesions (SIL) and (iii) the related costs. We used the Systeme National des Donnees de Sante (SNDS) (Echantillon Generaliste de Bene ficiaires [EGB] and Programme de Medicalisation des systemes d'information [PMSI]) to assess the cervical screening coverage rate in France between January 1st, 2012 and December 31st, 2014, and to describe diagnostic investigations and therapeutic management of SIL in 2013. After extrapolation to the general population, a total of 10,847,814 women underwent at least one smear test over the 3-year study period, corresponding to a coverage rate of 52.4% of the women aged 25 to 64 included. In 2013, 126,095 women underwent HPV test, 327,444 women underwent colposcopy, and 9,653 underwent endocervical curettage; 31,863 had conization and 12,162 had laser ablation. Besides, 34,067 women experienced hospital stays related to management of SIL; 25,368 (74.5%) had high-grade lesions (HSIL) and 7,388 (21.7%) low-grade lesions (LSIL). Conization was the most frequent in-hospital therapeutic procedure: 89.5% (22,704) of women with an in-hospital procedure for HSIL and 64.7% (4,781) for LSIL. Mean cost of smear test, colposcopy and HPV tests were around 50(sic). Total cost for hospital stays in 2013 was estimated at M41(sic), or a mean cost of 1,211(sic) per woman; 76% were due to stays with HSIL. This study highlights the low coverage rate of individual cervical cancer screening and a high burden related to SIL management.	[de Rycke, Yann; Tubach, Florence; Lafourcade, Alexandre; Guillo, Sylvie] Sorbonne Univ, Unite Rech Clin PSL CFX, Hop Pitie Salpetriere,Dept Sante Publ,Ctr Pharmac, AP HP,INSERM,Inst Pierre Louis Epidemiol & Sante, Paris, France; [Dahlab, Andre; Uhart, Mathieu] Sanofi Pasteur MSD, Lyon, France; [Bresse, Xavier] MSD Vaccins, Lyon, France; [Bergeron, Christine] Lab Cerba, Cergy Pontoise, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Sanofi-Aventis; Sanofi France		sbenard@steve-consultants.com			SPMSD/MSD Vaccins	SPMSD/MSD Vaccins	The study was supported by SPMSD/MSD Vaccins. Andre Dahlab, Xavier Bresse and Mathieu Uhart are former employees of SPMSD. MSD Vaccins. Xavier Bresse is an employee of MSD vaccins. SPMSD/MSD Vaccins were involved in the study design, data analysis, decision to publish, and preparation of the manuscript. Charlotte Cancalon, Audrey Lajoinie and Steve Benard are employees of steve consultants. steve consultants did not fund the study but was in charge of designing and performing the study. Yann de Rycke, Florence Tubach, Alexandre Lafourcade, Sylvie Guillo and Marie Dalichampt received no specific funding for this work. Christine Bergeron and Helene Borne have been rewarded by SPMSD/MSD Vaccins as members of the study Independent Scientific Committee.	Abramowitz L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202564; ANAES, 2002, COND TEN DEV PAT AV; [Anonymous], EV RECH PAP HUM HPV; Baldauf JJ, 2013, J GYNECOL OBST BIO R, V42, P534, DOI 10.1016/j.jgyn.2013.05.004; Baldur-Felskov B, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt460; Beltzer N., 2017, Bulletin Epidemiologique Hebdomadaire, P26; Bergeron C, 2005, B EPIDEMIOL HEBD PA, V2, P5; Bergeron C, 2007, B EPIDEMIOL HEBD, V1, P4; Bezin J, 2017, PHARMACOEPIDEM DR S, V26, P954, DOI 10.1002/pds.4233; Boubli L, 2007, STERILITE COMPLICATI; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bruni L, 2016, LANCET GLOB HEALTH, V4, pE453, DOI 10.1016/S2214-109X(16)30099-7; Centers for Medicare and Medicaid Services (CMS) National Center for Health Statistics (NCHS), 2017, ICD 10 CM OFF GUID C; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; College National des Gynecologues et Obstetriciens Francais, REC PRAT CLIN PREV C; Conchez V, 2012, DEPISTAGE CANC COL U, P11; de Martel C, 2017, INT J CANCER, V141, P664, DOI 10.1002/ijc.30716; de Sante Haute Autorite, 2016, MAN PAT ABN CERV SME; Duport N., 2009, MISES J GYNECOLOGIE, P455; Hamers FF., 2019, B EPID MIOL HEBD, V2019, P417; Hariri S, 2015, VACCINE, V33, P1608, DOI 10.1016/j.vaccine.2015.01.084; Hartwig S, 2015, PAPILLOMAVIRUS RES, V1, P90, DOI 10.1016/j.pvr.2015.06.003; INCa, 2016, COND TEN DEV FEMM AY; INCA, 2017, PROJ INC MORT CANC F; Institut National du Cancer, PROGR DEP ORG CANC C; KCE, 2006, DEP CANC COL UT RECH; Kyrgiou M, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012847; Kyrgiou M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6192; Mathevet P, TECHNIQUES CHIRURGIC, P10; Maura G, 2017, EUR J CANCER PREV, DOI [10.1097/Cal0000000000000360, DOI 10.1097/CAL0000000000000360]; Mignot S, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5477-8; Moulis G, 2015, REV MED INTERNE, V36, P411, DOI 10.1016/j.revmed.2014.11.009; Pretet JL, 2008, INT J CANCER, V122, P428, DOI 10.1002/ijc.23092; Remy V, 2009, EUR J OBSTET GYN R B, V147, P210, DOI 10.1016/j.ejogrb.2009.08.011; Sante publique France, 2014, AN TUB NEUR; Tuppin P, 2010, REV EPIDEMIOL SANTE, V58, P286, DOI 10.1016/j.respe.2010.04.005; World Health Organization, 2019, HUM PAP HPV CERV CAN; World Health Organization (WHO), ICD 10 VERS 2016; Zhai LK, 2016, ANTIVIR RES, V130, P101, DOI 10.1016/j.antiviral.2016.03.016	39	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228660	10.1371/journal.pone.0228660	http://dx.doi.org/10.1371/journal.pone.0228660			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053648	gold, Green Published			2022-12-26	WOS:000535198700043
J	Hidber, T; Pauli, U; Steiner, A; Kuhnert, P				Hidber, Tobias; Pauli, Urs; Steiner, Adrian; Kuhnert, Peter			In vitro and ex vivo testing of alternative disinfectants to currently used more harmful substances in footbaths against Dichelobacter nodosus	PLOS ONE			English	Article							FOOT-ROT; GLUTARALDEHYDE; SHEEP; VIRULENT; STRAINS; FLOCKS	A footbath-based control program for ovine footrot, a contagious disease caused by Dichelobacter nodosus, will be implemented in Switzerland. The currently used footbath disinfectants formaldehyde, zinc sulfate and copper sulfate are carcinogenic or environmental pollutants. Hence, the aim of this study was to identify alternative disinfectants, which are highly effective, non-carcinogenic, environmentally acceptable, inexpensive, available as concentrate and suitable for licensing. The antimicrobial effect of a series of potential chemicals such as lactic acid, propionic acid, hydrogen peroxide, sodium hypochlorite, octenidine dihydrochloride, chlorocresol, Ampholyt 20 and the registered biocide DESINTEC (R) Hoof Care Special D (Desintec) were investigated by culture based in vitro testing. The microcidal effect of various Desintec concentrations were then compared against routinely used 4% formaldehyde and 10% zinc sulfate in ex vivo assays on sheep feet from slaughter. For this purpose a newly established PMA (propidium monoazid) real-time PCR using the improved dye PMAxx (TM) was applied that allows discrimination of viable and dead D. nodosus. In the ex vivo experiments, 4% formaldehyde was significantly more effective than 10% zinc sulfate and was chosen as positive control for assessing the new disinfectant. The disinfectant effect of Desintec in a minimal concentration of 6% was equally effective as 4% formaldehyde, meaning that it offers a comparable antimicrobial effect against virulent D. nodosus. In conclusion, Desintec is a promising disinfectant for replacing formaldehyde, copper sulfate and zinc sulfate in footbaths against footrot.	[Hidber, Tobias; Kuhnert, Peter] Univ Bern, Vetsuisse Fac, Inst Vet Bacteriol, Bern, Switzerland; [Hidber, Tobias; Steiner, Adrian] Univ Bern, Vetsuisse Fac, Clin Ruminants, Bern, Switzerland; [Pauli, Urs] Inst Virol & Immunol, Mittelhausern, Koniz, Switzerland	University of Bern; University of Bern	Kuhnert, P (corresponding author), Univ Bern, Vetsuisse Fac, Inst Vet Bacteriol, Bern, Switzerland.	peter.kuhnert@vetsuisse.unibe.ch	Steiner, Adrian/AAD-6814-2022; Kuhnert, Peter/O-1651-2014	Steiner, Adrian/0000-0003-2415-3768; Kuhnert, Peter/0000-0002-1575-5225	Swiss Federal Food Safety and Veterinary Office [1.18.02]; Office for Agriculture and Geoinformation, canton of Grisons, Switzerland	Swiss Federal Food Safety and Veterinary Office; Office for Agriculture and Geoinformation, canton of Grisons, Switzerland	The study was supported by funds of the Swiss Federal Food Safety and Veterinary Office (project number 1.18.02) and the Office for Agriculture and Geoinformation, canton of Grisons, Switzerland.	Agbaje M, 2018, PEERJ, V6, DOI 10.7717/peerj.5097; Amrutha B, 2017, MICROB PATHOGENESIS, V111, P156, DOI 10.1016/j.micpath.2017.08.042; [Anonymous], 2010, 1656 SN EN; [Anonymous], 2015, REQUIREMENTS METHODS; Arduser F, 2020, PREV VET MED, V178, DOI 10.1016/j.prevetmed.2019.05.001; ATSDR, 2017, TOX PROF GLUT; Beveridge W.I.B., 1941, BULLETIN, V140; Boillot C, 2008, ECOTOX ENVIRON SAFE, V71, P252, DOI 10.1016/j.ecoenv.2007.08.010; Fittipaldi M, 2012, J MICROBIOL METH, V91, P276, DOI 10.1016/j.mimet.2012.08.007; Fraise AP, 2012, PRINCIPLES PRACTICE; Godden SM, 2016, J DAIRY SCI, V99, P3675, DOI 10.3168/jds.2015-10379; GORMAN SP, 1980, J APPL BACTERIOL, V48, P161, DOI 10.1111/j.1365-2672.1980.tb01217.x; Greber D, 2016, VET J, V216, P25, DOI 10.1016/j.tvjl.2016.06.015; Hardi-Landerer MC, 2019, SCHWEIZ ARCH TIERH, V161, P377, DOI 10.17236/sat00210; Hardi-Landerer MC, 2017, SCHWEIZ ARCH TIERH, V159, P293, DOI 10.17236/sat00116; Hirshfield Irvin N., 2003, Science Progress, V86, P245, DOI 10.3184/003685003783238626; Johnston MD, 2000, J APPL MICROBIOL, V88, P237, DOI 10.1046/j.1365-2672.2000.00951.x; Keasler V, 2017, WOODHEAD PUBL SER EN, P539, DOI 10.1016/B978-0-08-101105-8.00023-1; Kennan RM, 2014, MBIO, V5, DOI 10.1128/mBio.01821-14; Kennan RM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001210; Kuhnert P, 2019, SCHWEIZ ARCH TIERH, V161, P465, DOI 10.17236/sat00215; Leung HW, 2001, ECOTOX ENVIRON SAFE, V49, P26, DOI 10.1006/eesa.2000.2031; LITTLEJOHN AI, 1972, VET REC, V90, P693, DOI 10.1136/vr.90.25.693; Loomis D, 2018, OCCUP ENVIRON MED, V75, P593, DOI 10.1136/oemed-2017-104944; MALECKI JC, 1982, RES VET SCI, V33, P192, DOI 10.1016/S0034-5288(18)32334-8; Meena RAA, 2018, ENVIRON SCI POLLUT R, V25, P4134, DOI 10.1007/s11356-017-0966-2; Nogva HK, 2003, BIOTECHNIQUES, V34, P804, DOI 10.2144/03344rr02; Ryssel H, 2009, BURNS, V35, P695, DOI 10.1016/j.burns.2008.11.009; Sharad J, 2013, CLIN COSMET INV DERM, V6, P281, DOI 10.2147/CCID.S34029; Stauble A, 2014, J CLIN MICROBIOL, V52, P1228, DOI 10.1128/JCM.03485-13; STEWART DJ, 1984, AUST VET J, V61, P348, DOI 10.1111/j.1751-0813.1984.tb07153.x; Takigawa T, 2006, J OCCUP HEALTH, V48, P75, DOI 10.1539/joh.48.75; Witcomb LA, 2015, VET MICROBIOL, V176, P321, DOI 10.1016/j.vetmic.2015.01.022; Zingg D, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00070	34	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0229066	10.1371/journal.pone.0229066	http://dx.doi.org/10.1371/journal.pone.0229066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053674	gold, Green Published			2022-12-26	WOS:000535198700095
J	Kushwaha, VS; Acar, S; Miedema, DM; Denisov, DV; Schall, P; Peterman, EJG				Kushwaha, Vandana S.; Acar, Seyda; Miedema, Daniel M.; Denisov, Dmitry, V; Schall, Peter; Peterman, Erwin J. G.			The crowding dynamics of the motor protein kinesin-II	PLOS ONE			English	Article							TORQUE GENERATION; IFT PARTICLES; TRANSPORT; PROCESSIVITY; DETERMINES; OBSTACLES; TRACKING	Intraflagellar transport (IFT) in C. elegans chemosensory cilia is an example of functional coordination and cooperation of two motor proteins with distinct motility properties operating together in large groups to transport cargoes: a fast and processive homodimeric kinesin-2, OSM-3, and a slow and less processive heterotrimeric kinesin-2, kinesin-II. To study the mechanism of the collective dynamics of kinesin-II of C. elegans cilia in an in vitro system, we used Total Internal Reflection Fluorescence microscopy to image the motility of truncated, heterodimeric kinesin-II constructs at high motor densities. Using an analysis technique based on correlation of the fluorescence intensities, we extracted quantitative motor parameters, such as motor density, velocity and average run length, from the image. Our experiments and analyses show that kinesin-II motility parameters are far less affected by (self) crowding than OSM-3. Our observations are supported by numerical calculations based on the TASEP-LK model (Totally Asymmetric Simple Exclusion Process-Langmuir Kinetics). From a comparison of data and modelling of OSM-3 and kinesin-II, a general picture emerges of the collective dynamics of the kinesin motors driving IFT in C. elegans chemosensory cilia and the way the motors deal with crowding.	[Kushwaha, Vandana S.; Acar, Seyda; Peterman, Erwin J. G.] Vrije Univ, Dept Phys & Astron & LaserLaB, Amsterdam, Netherlands; [Miedema, Daniel M.; Denisov, Dmitry, V; Schall, Peter] Univ Amsterdam, Inst Phys, Amsterdam, Netherlands; [Miedema, Daniel M.] Acad Med Ctr, Ctr Expt Mol Med CEMM, Lab Expt Oncol & Radiobiol LEXOR, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Peterman, EJG (corresponding author), Vrije Univ, Dept Phys & Astron & LaserLaB, Amsterdam, Netherlands.	e.j.g.peterman@vu.nl	Schall, Peter/ABA-9265-2021; Peterman, Erwin/G-5529-2010	Peterman, Erwin/0000-0003-1058-249X	Complexity Initiative of the Netherlands Organization for Scientific Research (NWO); NWO VICI [645.000.014, 680-47-615]; Foundation for Fundamental Research on Matter (FOM) [680-47-606];  [137 11BIB01]	Complexity Initiative of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO VICI(Netherlands Organization for Scientific Research (NWO)); Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); 	A grant from the Complexity Initiative of the Netherlands Organization for Scientific Research (NWO). Recipient PS, Project number 645.000.014. www.nwo.nl.NWO VICI grant. Recipient PS. Number 680-47-615 www.nwo.nl NWO VICI grant. Recipient EJGP Number: 680-47-606 www.nwo.nl "Barriers in the Brain" from the Foundation for Fundamental Research on Matter (FOM). Recipient EJGP. Number: Program nr. 137 11BIB01 Website: www.nwo.nl.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson JOL, 2015, CURR BIOL, V25, P1166, DOI 10.1016/j.cub.2015.03.013; Bieling P, 2008, EMBO REP, V9, P1121, DOI 10.1038/embor.2008.169; Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Brunnbauer M, 2012, MOL CELL, V46, P147, DOI 10.1016/j.molcel.2012.04.005; Brunnbauer M, 2010, P NATL ACAD SCI USA, V107, P10460, DOI 10.1073/pnas.1005177107; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chen GY, 2015, J BIOL CHEM, V290, P10274, DOI 10.1074/jbc.M114.628032; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; Conway L, 2012, P NATL ACAD SCI USA, V109, P20814, DOI 10.1073/pnas.1209304109; Feng QZ, 2018, BIOPHYS J, V114, P400, DOI 10.1016/j.bpj.2017.11.016; Hoeprich GJ, 2014, BIOPHYS J, V106, P1691, DOI 10.1016/j.bpj.2014.02.034; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Korten T, 2011, METHODS MOL BIOL, V783, P121, DOI 10.1007/978-1-61779-282-3_7; Leduc C, 2012, P NATL ACAD SCI USA, V109, P6100, DOI 10.1073/pnas.1107281109; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mangeol P, 2016, MOL BIOL CELL, V27, P1948, DOI 10.1091/mbc.E15-06-0404; Miedema DM, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.041037; Milic B, 2017, P NATL ACAD SCI USA, V114, pE6830, DOI 10.1073/pnas.1708157114; Muthukrishnan G, 2009, CURR BIOL, V19, P442, DOI 10.1016/j.cub.2009.01.058; Oswald F, 2016, BIOPHYS J, V110, P1139, DOI 10.1016/j.bpj.2016.01.010; Pan XY, 2006, J CELL BIOL, V174, P1035, DOI 10.1083/jcb.200606003; Pan XY, 2010, BIOCHEM BIOPH RES CO, V401, P53, DOI 10.1016/j.bbrc.2010.09.007; Prevo B, 2015, NAT CELL BIOL, V17, P1536, DOI 10.1038/ncb3263; Schroeder HW, 2012, BIOPHYS J, V103, P48, DOI 10.1016/j.bpj.2012.05.037; Seitz A, 2006, EMBO J, V25, P267, DOI 10.1038/sj.emboj.7600937; Shastry S, 2011, P NATL ACAD SCI USA, V108, P16253, DOI 10.1073/pnas.1102628108; Shastry S, 2010, CURR BIOL, V20, P939, DOI 10.1016/j.cub.2010.03.065; Stepp WL, 2017, EMBO REP, V18, P1947, DOI 10.15252/embr.201744097; Telley IA, 2009, BIOPHYS J, V96, P3341, DOI 10.1016/j.bpj.2009.01.015; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Wedaman KP, 1996, J CELL BIOL, V132, P371, DOI 10.1083/jcb.132.3.371; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228930	10.1371/journal.pone.0228930	http://dx.doi.org/10.1371/journal.pone.0228930			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053680	Green Published, gold			2022-12-26	WOS:000535198700074
J	Rinastiti, P; Ikeda, K; Rahardini, EP; Miyagawa, K; Tamada, N; Kuribayashi, Y; Hirata, K; Emoto, N				Rinastiti, Pranindya; Ikeda, Koji; Rahardini, Elda Putri; Miyagawa, Kazuya; Tamada, Naoki; Kuribayashi, Yuko; Hirata, Ken-ichi; Emoto, Noriaki			Loss of family with sequence similarity 13, member A exacerbates pulmonary hypertension through accelerating endothelial-to-mesenchymal transition	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BETA-CATENIN; FAM13A; DISEASE; LOCI; GENE	Pulmonary hypertension is a progressive lung disease with poor prognosis due to the consequent right heart ventricular failure. Pulmonary artery remodeling and dysfunction are culprits for pathologically increased pulmonary arterial pressure, but their underlying molecular mechanisms remain to be elucidated. Previous genome-wide association studies revealed a significant correlation between the genetic locus of family with sequence similarity 13, member A (FAM13A) and various lung diseases such as chronic obstructive pulmonary disease and pulmonary fibrosis; however whether FAM13A is also involved in the pathogenesis of pulmonary hypertension remained unknown. Here, we identified a significant role of FAM13A in the development of pulmonary hypertension. FAM13A expression was reduced in the lungs of mice with hypoxia-induced pulmonary hypertension. We identified that FAM13A was expressed in lung vasculatures, especially in endothelial cells. Genetic loss of FAM13A exacerbated pulmonary hypertension in mice exposed to chronic hypoxia in association with deteriorated pulmonary artery remodeling. Mechanistically, FAM13A decelerated endothelial-to-mesenchymal transition potentially by inhibiting beta-catenin signaling in pulmonary artery endothelial cells. Our data revealed a protective role of FAM13A in the development of pulmonary hypertension, and therefore increasing and/or preserving FAM13A expression in pulmonary artery endothelial cells is an attractive therapeutic strategy for the treatment of pulmonary hypertension.	[Rinastiti, Pranindya; Ikeda, Koji; Rahardini, Elda Putri; Miyagawa, Kazuya; Tamada, Naoki; Kuribayashi, Yuko; Emoto, Noriaki] Kobe Pharmaceut Univ, Lab Clin Pharmaceut Sci, Kobe, Hyogo, Japan; [Rinastiti, Pranindya; Rahardini, Elda Putri; Miyagawa, Kazuya; Tamada, Naoki; Hirata, Ken-ichi; Emoto, Noriaki] Kobe Univ, Dept Internal Med, Div Cardiovasc Med, Grad Sch Med, Kobe, Hyogo, Japan	Kobe Pharmaceutical University; Kobe University	Ikeda, K (corresponding author), Kobe Pharmaceut Univ, Lab Clin Pharmaceut Sci, Kobe, Hyogo, Japan.	ikedak-circ@umin.ac.jp		ikeda, Koji/0000-0002-9972-7255; Emoto, Noriaki/0000-0001-6673-2616				Bai Y, 2018, J NEUROSCI, V38, P32, DOI 10.1523/JNEUROSCI.1348-17.2017; Cho MH, 2014, LANCET RESP MED, V2, P214, DOI 10.1016/S2213-2600(14)70002-5; Choi SH, 2015, CLIN CANCER RES, V21, P3716, DOI 10.1158/1078-0432.CCR-14-3193; Corvol H, 2018, J CYST FIBROS, V17, P190, DOI 10.1016/j.jcf.2017.11.003; Eisenhut F, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1256526; Evrard SM, 2016, ATHEROSCLEROTIC LESI; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Good RB, 2015, AM J PATHOL, V185, P1850, DOI 10.1016/j.ajpath.2015.03.019; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hirano C, 2017, RESP MED, V123, P105, DOI 10.1016/j.rmed.2016.12.007; Hopper RK, 2016, CIRCULATION, V133, P1783, DOI 10.1161/CIRCULATIONAHA.115.020617; Hu W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44048-y; Jiang ZQ, 2016, AM J RESP CRIT CARE, V194, P185, DOI 10.1164/rccm.201505-0999OC; Jin ZG, 2015, MOL BIOL CELL, V26, P1160, DOI 10.1091/mbc.E14-08-1276; Li XN, 2011, J ALLERGY CLIN IMMUN, V127, P1457, DOI 10.1016/j.jaci.2011.01.056; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; Mahmood MQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11375-x; Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049; Rabinovitch M, 2008, SCI MED MOL PATHOGEN, V118; Ranchoux B, 2015, CIRCULATION, V131, P1006, DOI 10.1161/CIRCULATIONAHA.114.008750; Simonneau G, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01913-2018; Thompson AAR, 2017, TRENDS MOL MED, V23, P31, DOI 10.1016/j.molmed.2016.11.005; Troletti CD, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1294-2; Wardhana DA, 2018, P NATL ACAD SCI USA, V115, P1529, DOI 10.1073/pnas.1720475115; Widyantoro B, 2010, CIRCULATION, V121, P2407, DOI 10.1161/CIRCULATIONAHA.110.938217; Zaidi SHE, 2002, OVEREXPRESSION SERIN, P516; Zhong A, 2018, CARDIOVASC ENG TECHN, V9, P158, DOI 10.1007/s13239-018-0363-0	27	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0226049	10.1371/journal.pone.0226049	http://dx.doi.org/10.1371/journal.pone.0226049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053709	Green Submitted, Green Published, gold			2022-12-26	WOS:000535198700010
J	Lv, YX; Duanmu, JZ; Fu, XR; Li, TY; Jiang, QG				Lv, Yunxia; Duanmu, Jinzhong; Fu, Xiaorui; Li, Taiyuan; Jiang, Qunguang			Identifying a new microRNA signature as a prognostic biomarker in colon cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; EXPRESSION; SURVIVAL; MIGRATION; INVASION; RECEPTOR; MIR-101; TARGET; RISK	Background The aim was to identify a novel prognostic miRNA signature for colon cancer (CC) in silico. Methods Data on the expression of miRNAs and relevant clinical information for 407 patients were obtained from The Cancer Genome Atlas (TCGA), and the samples were randomly split into a validation set (n = 203) and training set (n = 204). The differential expression of miRNAs between normal tissues and patients with CC was analyzed. We detected a miRNA expression signature in the training dataset by using a Cox proportional hazard regression model. Then, we verified the signature in the validation set. Association of the miRNA signature with overall survival was assessed in the validation cohort and combined cohort by log-rank test and based on Kaplan-Meier curves. The receiver operating characteristic and disease-free survival analyses were performed to evaluate the miRNA signature of CC in the combined cohort. Multivariate and univariate Cox analyses related to survival for the miRNA signature were performed, and a nomogram was built as a prognostic model for CC. To explore the function of target genes of the miRNA signature, Gene Ontology analysis and Kyoto Encyclopedia of Genes and Genomes pathway analysis were used. Results Between the matched normal tissues and colon cancer tissues, 267 differentially expressed miRNAs were detected, and a single-factor CoxPH model showed that 13 miRNAs were related to overall survival in the training cohort. Then, a five-miRNA signature was identified using a CoxPH regression model with multiple factors. The five-miRNA signature had significant prognostic value in the training cohort and was validated in the validation cohort and combined cohort. A total of 193 target genes of the miRNA signature were identified. According to the results of functional analysis of the target genes, the signaling pathways MAPK, AMPK and PI3K-Akt, focal adhesion, and microRNAs in cancer were remarkably enriched. Conclusion A five-miRNA signature had increased prognostic value for CC, which may provide important biological insights for the discovery and development of molecular predictors to improve the prognosis of patients with CC.	[Lv, Yunxia] Nanchang Univ, Dept Thyroid Surg, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China; [Duanmu, Jinzhong; Li, Taiyuan; Jiang, Qunguang] Nanchang Univ, Dept Gastrointestinal Surg, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Fu, Xiaorui] Nanchang Univ, Queen Mary Sch, Med Dept, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Nanchang University	Jiang, QG (corresponding author), Nanchang Univ, Dept Gastrointestinal Surg, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China.	fbron.student@sina.com			National Nature Science Foundation of China [81560397]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Nature Science Foundation of China (No.81560397). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mandujano-Tinoco EA, 2017, BBA-MOL CELL RES, V1864, P1642, DOI 10.1016/j.bbamcr.2017.05.023; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chandramouli A, 2012, CANCER BIOL THER, V13, P175, DOI 10.4161/cbt.13.3.18874; Chao A, 2012, ONCOGENE, V31, P764, DOI 10.1038/onc.2011.269; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Feng B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043452; Gao W, 2015, ONCOGENE, V34, P1629, DOI 10.1038/onc.2014.101; Hasegawa T, 2018, MOL CANCER RES, V16, P669, DOI 10.1158/1541-7786.MCR-17-0321; Hwang WL, 2014, NAT CELL BIOL, V16, P268, DOI 10.1038/ncb2910; Jacob H, 2017, ONCOTARGET, V8, P87837, DOI 10.18632/oncotarget.21237; Li TT, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0287-1; Narayanankutty A, 2019, CURR DRUG TARGETS, V20, P1217, DOI 10.2174/1389450120666190618123846; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Nishida N, 2012, ANN SURG ONCOL, V19, P3065, DOI 10.1245/s10434-012-2246-1; Nosho K, 2014, CARCINOGENESIS, V35, P776, DOI 10.1093/carcin/bgt374; Okugawa Y, 2015, GASTROENTEROLOGY, V149, P1204, DOI 10.1053/j.gastro.2015.07.011; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Sohn W, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.68; Song Li-Jie, 2015, Asian Pac J Cancer Prev, V16, P3667; Valladares-Ayerbes M, 2011, INT J ONCOL, V39, P1253, DOI 10.3892/ijo.2011.1112; Wang CZ, 2018, AM J TRANSL RES, V10, P3310; Wang S, 2014, INT J CLIN EXP PATHO, V7, P3498; Wang ZS, 2016, ONCOTARGET, V7, P44266, DOI 10.18632/oncotarget.10023; Weissmann-Brenner A, 2012, INT J ONCOL, V40, P2097, DOI 10.3892/ijo.2012.1403; Xiao GF, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/364549; Xu M, 2017, NEOPLASMA, V64, P56, DOI 10.4149/neo_2017_107; Yu YJ, 2012, CARCINOGENESIS, V33, P68, DOI 10.1093/carcin/bgr246; Zhang FF, 2016, CANCER LETT, V373, P203, DOI 10.1016/j.canlet.2016.01.037; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128628; Zhang WJ, 2018, EUR J PHARMACOL, V825, P75, DOI 10.1016/j.ejphar.2018.02.019; Zhang WP, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0113-6	34	18	18	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228575	10.1371/journal.pone.0228575	http://dx.doi.org/10.1371/journal.pone.0228575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32049961	Green Published, gold			2022-12-26	WOS:000535192300017
J	Amaricai, E; Onofrei, RR; Suciu, O; Marcauteanu, C; Stoica, ET; Negrutiu, ML; David, VL; Sinescu, C				Amaricai, Elena; Onofrei, Roxana Ramona; Suciu, Oana; Marcauteanu, Corina; Stoica, Eniko Tunde; Negrutiu, Meda Lavinia; David, Vlad Laurentiu; Sinescu, Cosmin			Do different dental conditions influence the static plantar pressure and stabilometry in young adults?	PLOS ONE			English	Article							BODY POSTURE; TEMPOROMANDIBULAR DISORDERS; OCCLUSION; BALANCE; STABILITY	Background Posture is influenced by many factors and dental occlusion seems to have its role on postural stabilization. Our rationale to perform the study was to find out if there are differences of static plantar pressure and stabilometric parameters depending on different dental conditions. Methods The observational study consisted in plantar pressure assessment and stabilometric analysis of 95 right-handed healthy volunteer subjects (mean age 22.94 +/- 2.52 years) by using the PoData system. Each subject followed four measurements with open eyes: mandibular postural position, maximum intercuspation, biting on cotton rolls and maximum mouth opening. Plantar pressure was recorded on 1st and 5th metatarsal heads and heel, and was expressed as percentage of weight distribution on each foot. The recorded centre of pressure (CoP) parameters were: CoP path length, 90%confidence ellipse area and maximum CoP speed. Statistical analysis used repeated-measures ANOVA with Bonferroni posthoc analysis and Friedman test. Results Loading on the left 5th metatarsal head was significantly higher in maximum mouth opening condition when compared to maximum intercuspation and to biting on cotton rolls. The left heel loading was significantly lower in the maximum mouth opening in comparison to maximum intercuspation. The CoP path length and maximum CoP speed were significantly higher in maximum mouth opening compared to the other three conditions. Confidence ellipse area had significantly lower values in maximum intercuspation and in the biting on cotton rolls conditions compared to the mandibular postural position, and in maximum intercuspation compared to maximum mouth opening. Conclusion In young adults with an optimum functional occlusion the static plantar pressure is influenced by the maximum mouth opening. An improved postural stability was recorded in maximum intercuspation (a condition used during swallowing) in comparison to mandibular postural position (a condition that allows relaxation of the masticatory muscles after functional moments).	[Amaricai, Elena; Onofrei, Roxana Ramona; Suciu, Oana] Victor Babes Univ Med & Pharm, Dept Rehabil Phys Med & Rheumatol, Timisoara, Romania; [Marcauteanu, Corina; Stoica, Eniko Tunde] Victor Babes Univ Med & Pharm, Dept Occlusiol, Fac Dent, Timisoara, Romania; [Negrutiu, Meda Lavinia; Sinescu, Cosmin] Victor Babes Univ Med & Pharm, Dent Mat & Dent Prosthesis Dept, Fac Dent, Timisoara, Romania; [David, Vlad Laurentiu] Victor Babes Univ Med & Pharm, Dept Pediat Surg & Orthoped, Timisoara, Romania	Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara	Onofrei, RR (corresponding author), Victor Babes Univ Med & Pharm, Dept Rehabil Phys Med & Rheumatol, Timisoara, Romania.	onofrei.roxana@umft.ro	Suciu, Oana/AAS-8332-2020; NEGRUTIU, MEDA-LAVINIA/B-6974-2008; Elena, Amaricai/AAP-4152-2020; David, Vlad/AAE-1837-2020; Onofrei, Roxana-Ramona/J-7206-2019	NEGRUTIU, MEDA-LAVINIA/0000-0002-1126-3944; David, Vlad/0000-0003-4295-7487; Onofrei, Roxana-Ramona/0000-0003-2896-7523; Suciu, Oana/0000-0002-6378-4418	"Victor Babes" University of Medicine and Pharmacy Timisoara, Romania	"Victor Babes" University of Medicine and Pharmacy Timisoara, Romania	The publishing fee has been funded by the "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania.	[Anonymous], 2017, J Prosthet Dent, V117, pe1, DOI 10.1016/j.prosdent.2016.12.001; Asseman F, 2004, NEUROSCI LETT, V358, P83, DOI 10.1016/j.neulet.2003.12.102; Baldini A, 2013, J ELECTROMYOGR KINES, V23, P1474, DOI 10.1016/j.jelekin.2013.08.003; Baldini A, 2013, AVIAT SPACE ENVIR MD, V84, P823, DOI 10.3357/ASEM.3541.2013; Baldini A, 2013, CLINICS, V68, P45, DOI 10.6061/clinics/2013(01)OA07; Bracco P, 2004, NEUROSCI LETT, V356, P228, DOI 10.1016/j.neulet.2003.11.055; Cuccia A, 2009, CLINICS, V64, P61, DOI 10.1590/S1807-59322009000100011; Degani AM, 2017, J BIOMECH, V64, P8, DOI 10.1016/j.jbiomech.2017.08.029; Donath L, 2012, GAIT POSTURE, V36, P439, DOI 10.1016/j.gaitpost.2012.04.001; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Fasul F, POWER VERSION 3 1 7; Gangloff P, 2000, NEUROSCI LETT, V293, P203, DOI 10.1016/S0304-3940(00)01528-7; Global Postural System, 2014, MAN GPS 5 VERS 1042; Gobbi G., 2013, SPORT SCI HLTH, V9, P13, DOI [10.1007/s11332-013-0139-8, DOI 10.1007/S11332-013-0139-8]; Jbabdi Myriam, 2008, BMC Geriatr, V8, P8, DOI 10.1186/1471-2318-8-8; Julia-Sanchez S, 2019, J ORAL REHABIL, V46, P388, DOI 10.1111/joor.12767; Julia-Sanchez S, 2016, NEUROSCI LETT, V617, P116, DOI 10.1016/j.neulet.2016.02.003; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; Manfredini D, 2012, J ORAL REHABIL, V39, P463, DOI 10.1111/j.1365-2842.2012.02291.x; Michelotti Ambra, 2011, Prog Orthod, V12, P53, DOI 10.1016/j.pio.2010.09.010; Moon HJ, 2011, J ALTERN COMPLEM MED, V17, P995, DOI 10.1089/acm.2010.0739; Nagymate Gergely, 2016, 12th IASTED International Conference on Biomedical Engineering (BioMed 2016). Proceedings, P140, DOI 10.2316/P.2016.832-022; Nota A, 2017, J ELECTROMYOGR KINES, V37, P21, DOI 10.1016/j.jelekin.2017.08.006; Oie E, 2010, ANGLE ORTHOD, V80, P540, DOI 10.2319/032309-173.1; Okeson JP, 2019, MANAGEMENT TEMPOROMA, P74; Paillard T, 2006, SCAND J MED SCI SPOR, V16, P345, DOI 10.1111/j.1600-0838.2005.00502.x; Perinetti G, 2006, GAIT POSTURE, V24, P165, DOI 10.1016/j.gaitpost.2005.07.012; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Scharnweber B, 2017, CRANIO, V35, P358, DOI 10.1080/08869634.2016.1244971; Scoppa F, 2017, ACTA MEDICA MEDITERR, V33, P707, DOI 10.19193/0393-6384_2017_4_105	31	8	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228816	10.1371/journal.pone.0228816	http://dx.doi.org/10.1371/journal.pone.0228816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KW5RG	32045439	Green Published, gold			2022-12-26	WOS:000521221800001
J	Valladales-Restrepo, LF; Duran-Lengua, M; Castro-Osorio, EE; Machado-Alba, JE				Fernando Valladales-Restrepo, Luis; Duran-Lengua, Marlene; Eduardo Castro-Osorio, Edgar; Enrique Machado-Alba, Jorge			Consistency between anticholinergic burden scales in the elderly with fractures	PLOS ONE			English	Article							POTENTIALLY INAPPROPRIATE MEDICATIONS; RISK SCALES; POLYPHARMACY; OUTCOMES; POPULATION; EXPOSURE	Objective Falls and bone fractures are important causes of morbidity and mortality in the elderly. The objective of this study was to identify the degree of consistency between the anticholinergic scales used for patients diagnosed with fractures. Methods This was an analytical agreement study conducted in patients diagnosed with vertebral and nonvertebral fractures in Colombia. The quadratic-weighted kappa coefficient was used to identify the consistency between the Anticholinergic Drug Scale-ADS, Anticholinergic Cognitive Burden Scale-ACB and Anticholinergic Risk Scale-ARS in assessing the prescriptions of fracture patients during the month prior to the fracture, during their stay as an inpatient and at discharge, according to Landis criteria. Results 220 patients with fractures were included, with a mean age of 75.3 +/- 10.3 years, and 68.2% were women. The ACB scale identified the highest anticholinergic burden (26.8%) in prescriptions made the month before the fracture, and the highest agreement was between ACB and ADS (0.717); during hospitalization and at discharge, the cholinergic antagonists were best identified with ADS (77.7% and 72.1%, respectively), with the best agreement between ACB and ARS (0.613 and 0.568, respectively). The prescription of tramadol was found in 64.1% of hospitalized patients and in 61.4% of patients at the time of discharge. Conclusions The scales evaluated show marked discrepancies between them, with highly variable frequencies of anticholinergic drugs identified at the different prescription times, and with low agreement among them, which is why the scales are not interchangeable in patients with bone fractures.	[Fernando Valladales-Restrepo, Luis; Enrique Machado-Alba, Jorge] Univ Tecnol Pereira Audifarma SA, Grp Invest Farmacoepidemiol & Farmacovigilancia, Pereira, Risaralda, Colombia; [Fernando Valladales-Restrepo, Luis] Fdn Univ Autonoma Amer, Grp Biomed, Pereira, Risaralda, Colombia; [Duran-Lengua, Marlene] Univ Cartagena, Cartagena, Bolivar, Colombia; [Eduardo Castro-Osorio, Edgar] Hosp Univ Caldas, Grp Invest Farmacoepidemiol & Farmacovigilancia, Geriatr, Internal Med, Manizales, Colombia	Universidad Tecnologica de Pereira; Universidad de Cartagena	Machado-Alba, JE (corresponding author), Univ Tecnol Pereira Audifarma SA, Grp Invest Farmacoepidemiol & Farmacovigilancia, Pereira, Risaralda, Colombia.	machado@utp.edu.co		Valladales Restrepo, Luis Fernando/0000-0002-4245-0101; Machado-Alba, Jorge Enrique/0000-0002-8455-0936				Alpert Patricia T, 2015, Home Healthc Now, V33, P524, DOI 10.1097/NHH.0000000000000299; Beuscart JB, 2014, ARCH GERONTOL GERIAT, V59, P630, DOI 10.1016/j.archger.2014.08.006; Boustani M., 2008, AGING HLTH, V4, P311, DOI [10.2217/1745509x.4.3.311, DOI 10.2217/1745509X.4.3.311, 10.2217/1745509XA3.311, 10.2217/1745509X.4.3.311]; Carnahan RM, 2006, J CLIN PHARMACOL, V46, P1481, DOI 10.1177/0091270006292126; Collamati A, 2016, AGING CLIN EXP RES, V28, P25, DOI 10.1007/s40520-015-0359-7; Court-Brown CM, 2014, BONE JOINT J, V96B, P366, DOI 10.1302/0301-620X.96B3.33316; Court-Brown CM, 2016, J BONE JOINT SURG AM, V98, DOI 10.2106/JBJS.15.00793; Duran CE, 2013, EUR J CLIN PHARMACOL, V69, P1485, DOI 10.1007/s00228-013-1499-3; Machado-Alba JE, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2015.12.003; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Hammond T, 2013, NURS MIDWIFERY STUD, V2, P171; Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), CONS REG SAN; Kim J, 2017, NURS CLIN N AM, V52, P457, DOI 10.1016/j.cnur.2017.04.007; Lertxundi U, 2013, PSYCHOGERIATRICS, V13, P17, DOI 10.1111/j.1479-8301.2012.00418.x; Lu WH, 2015, CAN MED ASSOC J, V187, pE130, DOI 10.1503/cmaj.141219; Machado-Duque ME, 2018, INT PSYCHOGERIATR, V30, P941, DOI 10.1017/S1041610217002745; Machado-Duque ME, 2018, J GERIATR PSYCH NEUR, V31, P63, DOI 10.1177/0891988718757370; Naples JG, 2015, J AM GERIATR SOC, V63, P2120, DOI 10.1111/jgs.13647; Nishtala PS, 2016, EXPERT OPIN DRUG SAF, V15, P753, DOI 10.1517/14740338.2016.1165664; Pergolizzi Joseph, 2008, Pain Pract, V8, P287, DOI 10.1111/j.1533-2500.2008.00204.x; Pont LG, 2015, BRIT J CLIN PHARMACO, V80, P1169, DOI 10.1111/bcp.12670; Rudolph JL, 2008, ARCH INTERN MED, V168, P508, DOI 10.1001/archinternmed.2007.106; Salahudeen MS, 2016, DRUG AGING, V33, P305, DOI 10.1007/s40266-016-0362-5; Salahudeen MS, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0029-9; Turro-Garriga O, 2018, INT J GERIATR PSYCH, V33, P710, DOI 10.1002/gps.4844	25	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0228532	10.1371/journal.pone.0228532	http://dx.doi.org/10.1371/journal.pone.0228532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8DW	32092055	Green Published, gold			2022-12-26	WOS:000535229300010
J	Mohammed, OY; Tesfahun, E; Ahmed, AM; Bayleyegn, AD				Mohammed, Osman Yimer; Tesfahun, Esubalew; Ahmed, Abdurahman Mohammed; Bayleyegn, Alebachew Demelash			Self-reported physical activity status among adolescents in Debre Birhan town, Ethiopia: Cross-sectional study	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; UNIVERSITY-STUDENTS; INACTIVITY	Background Regular physical activity reduces the risk of ischaemic heart disease, stroke, diabetes, and breast and colon cancer. But, adolescents are insufficiently physically active. Therefore, this study was aimed to assess self-reported physical activity status and associated factors among adolescents in Debre Birhan town, Ethiopia. Methods School based cross-sectional study was conducted from April 20 to May 10/2019 in Debre Berhan town Secondary schools. Multi-stage sampling technique was used to select 580 study participants from three secondary schools. Physical activity was assessed using questions adopted from recreation, sport, and leisure-time physical activity assessment section of international physical activity questionnaire (IPAQ). Adolescents who have done moderate to vigorous exercise for 60 minutes per day for at least three days in the last seven days were categorized as physically active. Descriptive statistics, bivariable and multivariable logistic regression analysis was done. Probability value less than 0.05 was used as a cut of point to determined statistically significant association. Result A total of 580 students participated in this study. Less than 1 in 5 (17.2%, 95% confidence interval (CI) = 14.13%-20.27%) students were physically active. Male student (Adjusted odds ratio (AOR): 2.63, 95%CI = 1.5-4.59), age less than or equal to 16 (AOR: 2.04, 95% CI = 1.12-3.71) and access to sports center (gymnasium) (AOR: 2.09, 95% CI = 1.12-3.89 were positively associated with physical activity. Conclusion Physical activity status was very low. Therefore, the local, regional and national administrators in collaboration with sport and health offices administrators should make facilities accessible.	[Mohammed, Osman Yimer] Debre Birhan Univ, Coll Hlth Sci, Dept Midwifery, Debre Birhan, Amhara Regional, Ethiopia; [Tesfahun, Esubalew; Ahmed, Abdurahman Mohammed] Debre Birhan Univ, Dept Publ Hlth, Coll Hlth Sci, Debre Birhan, Amhara Regional, Ethiopia; [Bayleyegn, Alebachew Demelash] Debre Birhan Univ, Dept Nursing, Coll Hlth Sci, Debre Birhan, Amhara Regional, Ethiopia		Mohammed, OY (corresponding author), Debre Birhan Univ, Coll Hlth Sci, Dept Midwifery, Debre Birhan, Amhara Regional, Ethiopia.	oyimer86@gmail.com		Mohammed, Osman Yimer/0000-0002-7551-4503				Abdelghaffar E, 2019, ENVIRON HEALTH PREV, V24, DOI 10.1186/s12199-019-0775-y; Asare M, 2015, CHILD ADOL PSYCH MEN, V9, DOI 10.1186/s13034-015-0043-x; Ashton LM, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0257-6; Belanger M, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-117; Chen Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-744; Deliens T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1553-4; Payan DD, 2019, J NUTR EDUC BEHAV, V51, P478, DOI 10.1016/j.jneb.2018.10.001; Dwyer GM, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-66; EDHS, 2016, ETH DEM HLTH SURV 20, P14; Fondation BH, 2017, NEW REP ASS IMP PHYS; Foundation VHP, 2016, VICHEALTH; Gorely T, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-33; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Micklesfield LK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-40; Mielke GI, 2018, PREV MED, V107, P29, DOI 10.1016/j.ypmed.2017.12.008; Miles L., 2007, PHYS ACTIVITY HLTH, P314; Dias PJP, 2014, REV SAUDE PUBL, V48, P266, DOI 10.1590/S0034-8910.2014048004635; Pengpid S, 2015, INT J PUBLIC HEALTH, V60, P539, DOI 10.1007/s00038-015-0680-0; Poobalan AS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-640; Sigmundova D, 2014, EUR J PUBLIC HEALTH, V24, P210, DOI 10.1093/eurpub/ckt085; U. S. Department of Health and Human Services, 2014, HLTH CONSMOK 50 YE; Wasilewska M, 2018, ROCZNIKI PANSTWOWEGO, V69; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2015, PHYS IN DIAB; World Health Organization Regional Office for Africa, 2013, WHO COUNTR COOP STRA	26	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229522	10.1371/journal.pone.0229522	http://dx.doi.org/10.1371/journal.pone.0229522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084239	Green Published, gold			2022-12-26	WOS:000535227900111
J	Vieira, PCG; Espinoza-Culupu, AO; Nepomuceno, R; Alves, MR; Lebrun, I; Elias, WP; Ruiz, RC				Vieira, Paulo C. G.; Espinoza-Culupu, Abraham O.; Nepomuceno, Roberto; Alves, Marina R.; Lebrun, Ivo; Elias, Waldir P.; Ruiz, Rita C.			Secreted autotransporter toxin (Sat) induces cell damage during enteroaggregative Escherichia coli infection	PLOS ONE			English	Article							SERINE-PROTEASE AUTOTRANSPORTERS; EPITHELIAL-CELLS; SHIGELLA-FLEXNERI; VIRULENCE MARKERS; HIGH PREVALENCE; STRAINS; PET; ENTEROBACTERIACEAE; CHILDREN; IDENTIFICATION	Secreted autotransporter toxin (Sat) is a 107-kDa serine protease autotransporter of Enterobacteriaceae (SPATE) presenting cytotoxic activity in renal and bladder cells. Further studies have detected the Sat-encoding gene (sat) in enteroaggregative Escherichia coli (EAEC) and in E. coli strains isolated from neonatal septicemia and meningitis. Here, we investigated the role of Sat as a cytotoxin of EAEC. Sat was purified from a strain of E. coli harboring sat (DEC/Sat(+), O126:H2) and used to raise antibodies in rabbit. The presence of Sat was detected by ELISA in the supernatant of 93.7% of EAEC strains harboring sat and in none lacking the gene. The effect of Sat during infection was investigated in polarized Caco-2 cells infected with Sat-producing EAEC (CV323/77, O125ab:H21). This strain induced intense cell detachment, which was inhibited by PMSF or Sat antiserum. Also, sat transcription and Sat production were detected during infection. Here we demonstrate that Sat is internalized in polarized cells leading to F-actin disruption which preceded cell detachment. A comparative study of the toxin action in cell lines corresponding to the infection sites in which bacteria carrying the sat gene have been isolated was performed. Cells originating from the gastrointestinal tract (Caco-2), urinary (LLC-PK1) and endothelium (HUVEC) were incubated with purified Sat. The time required for observation of cell damage differed according to the cell line. HUVEC cells were more sensitive to Sat than cells derived from urinary and intestinal tracts. The intense activity of Sat on the endothelial cells suggests that Sat could also be a virulence factor for the bacteria in the bloodstream. In addition, this is the first work demonstrating that Sat induces cytotoxic effect during EAEC infection in vitro. The cell damage observed during infection indicates that Sat may be another toxin with cytotoxic role in the EAEC pathogenesis.	[Vieira, Paulo C. G.; Espinoza-Culupu, Abraham O.; Nepomuceno, Roberto; Alves, Marina R.; Elias, Waldir P.; Ruiz, Rita C.] Inst Butantan, Lab Bacteriol, Sao Paulo, SP, Brazil; [Lebrun, Ivo] Inst Butantan, Lab Bioquim & Biofis, Sao Paulo, SP, Brazil	Instituto Butantan; Instituto Butantan	Ruiz, RC (corresponding author), Inst Butantan, Lab Bacteriol, Sao Paulo, SP, Brazil.	rita.ruiz@butantan.gov.br	Espinoza-Culupú, Abraham Omar/G-2120-2019; Elias, Waldir P/B-9890-2013; Ruiz, Rita de Cassia/D-3492-2014	Espinoza-Culupú, Abraham Omar/0000-0002-5553-6385; Ruiz, Rita de Cassia/0000-0001-7361-1150; Alves, Marina/0000-0002-6343-2463; Elias, Waldir/0000-0003-3470-5706	FAPESP [2013/11212-9]; National Institute of Science and Technology on Complex Fluids (INCTFCx); Sao Paulo Research Foundation (FAPESP)	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institute of Science and Technology on Complex Fluids (INCTFCx); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by: RCR, FAPESP Grant 2013/11212-9 National Institute of Science and Technology on Complex Fluids (INCTFCx), Sao Paulo Research Foundation (FAPESP).	Abreu AG, 2013, APPL ENVIRON MICROB, V79, P411, DOI 10.1128/AEM.02635-12; Ali A, 2018, INT J BIOL MACROMOL, DOI [10.1016/j.ijbiomac.2018.02, DOI 10.1016/J.IJBIOMAC.2018.02]; Andrade FB, 2017, INFECT GENET EVOL, V50, P83, DOI 10.1016/j.meegid.2017.02.018; Andrade FB, 2014, J MICROBIOL METH, V106, P16, DOI 10.1016/j.mimet.2014.07.030; BAKER RD, 1995, DIGEST DIS SCI, V40, P510, DOI 10.1007/BF02064358; Boisen N, 2012, J INFECT DIS, V205, P431, DOI 10.1093/infdis/jir757; Boisen N, 2009, AM J TROP MED HYG, V80, P294, DOI 10.4269/ajtmh.2009.80.294; Campos LC, 2004, MEM I OSWALDO CRUZ, V99, P545, DOI 10.1590/S0074-02762004000600001; Clermont O, 2017, EPIDEMIOL INFECT, V145, P872, DOI 10.1017/S0950268816003010; CRAVIOTO A, 1979, CURR MICROBIOL, V3, P95, DOI 10.1007/BF02602439; Czeczulin JR, 1999, INFECT IMMUN, V67, P2692, DOI 10.1128/IAI.67.6.2692-2699.1999; Dautin N, 2010, TOXINS, V2, P1179, DOI 10.3390/toxins2061179; doValle GRF, 1997, FEMS MICROBIOL LETT, V152, P95; Dutta PR, 2002, INFECT IMMUN, V70, P7105, DOI 10.1128/IAI.70.12.7105-7113.2002; EASTON DM, 2011, FRONT MICROBIOL, V2, DOI DOI 10.3389/FMICB.2011.00002; Elias WP, 2002, EPIDEMIOL INFECT, V129, P49, DOI 10.1017/S0950268802007136; Eslava C, 1998, INFECT IMMUN, V66, P3155, DOI 10.1128/IAI.66.7.3155-3163.1998; FRAGA S, 1982, CAN J CHEM, V60, P2606, DOI 10.1139/v82-374; Frees Dorte, 2013, Subcell Biochem, V66, P161, DOI 10.1007/978-94-007-5940-4_7; Grijpstra J, 2013, RES MICROBIOL, V164, P562, DOI 10.1016/j.resmic.2013.03.010; Guignot J, 2007, CELL MICROBIOL, V9, P204, DOI 10.1111/j.1462-5822.2006.00782.x; Guyer DM, 2000, MOL MICROBIOL, V38, P53, DOI 10.1046/j.1365-2958.2000.02110.x; Guyer DM, 2002, INFECT IMMUN, V70, P4539, DOI 10.1128/IAI.70.8.4539-4546.2002; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Henderson IR, 1999, INFECT IMMUN, V67, P5587, DOI 10.1128/IAI.67.11.5587-5596.1999; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Iqbal J, 2016, INFECT DIS-NOR, V48, P461, DOI 10.3109/23744235.2016.1144142; KLAUSER T, 1993, BIOESSAYS, V15, P799, DOI 10.1002/bies.950151205; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lievin-Le Moal V, 2011, CELL MICROBIOL, V13, P992, DOI 10.1111/j.1462-5822.2011.01595.x; Mahjoub-Messai F, 2011, J INFECT DIS, V203, P1844, DOI 10.1093/infdis/jir189; Maroncle NM, 2006, INFECT IMMUN, V74, P6124, DOI 10.1128/IAI.01086-06; Merino I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188838; Miajlovic H, 2015, J MED MICROBIOL, P71, DOI [10.1099/jmm.0.00020, DOI 10.1099/JMM.0.00020]; Nataro JP, 1998, EMERG INFECT DIS, V4, P251, DOI 10.3201/eid0402.980212; Nava-Acosta R, 2013, MBIO, V4, DOI 10.1128/mBio.00838-13; Navarro-Garcia F, 1999, INFECT IMMUN, V67, P2184; Navarro-Garcia F, 2007, INFECT IMMUN, V75, P2101, DOI 10.1128/IAI.01515-06; Navarro-Garcia F, 2011, GUT MICROBES, V2, P13, DOI 10.4161/gmic.2.1.14933; Navarro-Garcia F, 2010, FUTURE MICROBIOL, V5, P1005, DOI [10.2217/fmb.10.69, 10.2217/FMB.10.69]; Nicolas V, 2015, INFECT IMMUN, V83, P907, DOI 10.1128/IAI.02759-14; Niyogi SK, 2004, CLIN MICROBIOL INFEC, V10, P574, DOI 10.1111/j.1469-0691.2004.00897.x; Nojoomi F., 2019, New Microbes and New Infections, V29, P100517, DOI 10.1016/j.nmni.2019.100517; Oh KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096896; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Piva IC, 2003, J CLIN MICROBIOL, V41, P1827, DOI 10.1128/JCM.41.5.1827-1832.2003; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Ruiz-Perez F, 2014, CELL MOL LIFE SCI, V71, P745, DOI 10.1007/s00018-013-1355-8; Saidi RF, 1996, INFECT IMMUN, V64, P5029, DOI 10.1128/IAI.64.12.5029-5034.1996; Sambrook J., 1989, SOCIETY, V68, P1232, DOI [10.1128/AEM.68.3.1232, DOI 10.1128/AEM.68.3.1232]; Schmidt H, 2001, INFECT IMMUN, V69, P6863, DOI 10.1128/IAI.69.11.6863-6873.2001; Souza Marina B, 2002, J PEDIAT RIO J, V78, P34, DOI [10.1590/S0021-75572002000100008, DOI 10.1590/S0021-75572002000100008]; Taddei CR, 2005, FEMS MICROBIOL LETT, V250, P263, DOI 10.1016/j.femsle.2005.07.013; Taddei CR, 2003, FEMS MICROBIOL LETT, V227, P249, DOI 10.1016/S0378-1097(03)00688-8; Tapader R, 2014, EUR J CLIN MICROBIOL, V33, P2015, DOI 10.1007/s10096-014-2161-4; Toloza L, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0591-5; Torres AG, 2002, MOL MICROBIOL, V45, P951, DOI 10.1046/j.1365-2958.2002.03094.x; Villaseca JM, 2000, INFECT IMMUN, V68, P5920, DOI 10.1128/IAI.68.10.5920-5927.2000; Welch RA, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0011-2012; Wells TJ, 2008, ENVIRON MICROBIOL, V10, P589, DOI 10.1111/j.1462-2920.2007.01479.x	60	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0228959	10.1371/journal.pone.0228959	http://dx.doi.org/10.1371/journal.pone.0228959			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084148	Green Published, gold			2022-12-26	WOS:000535227900036
J	Nakamoto, C; Kawamura, M; Nakatsukasa, E; Natsume, R; Takao, K; Watanabe, M; Abe, M; Takeuchi, T; Sakimura, K				Nakamoto, Chihiro; Kawamura, Meiko; Nakatsukasa, Ena; Natsume, Rie; Takao, Keizo; Watanabe, Masahiko; Abe, Manabu; Takeuchi, Tomonori; Sakimura, Kenji			GluD1 knockout mice with a pure C57BL/6N background show impaired fear memory, social interaction, and enhanced depressive-like behavior	PLOS ONE			English	Article							INBRED MOUSE STRAINS; LONG-TERM DEPRESSION; CHRONIC MILD STRESS; INHIBITORY PRESYNAPTIC DIFFERENTIATION; DELTA-2 GLUTAMATE-RECEPTOR; SYNAPSE FORMATION; ANIMAL-MODEL; MUTANT MICE; LATERAL HABENULA; CANDIDATE GENES	The GluD1 gene is associated with susceptibility for schizophrenia, autism, depression, and bipolar disorder. However, the function of GluD1 and how it is involved in these conditions remain elusive. In this study, we generated a Grid1 gene-knockout (GluD1-KO) mouse line with a pure C57BL/6N genetic background and performed several behavioral analyses. Compared to a control group, GluD1-KO mice showed no significant anxiety-related behavioral differences, evaluated using behavior in an open field, elevated plus maze, a light-dark transition test, the resident-intruder test of aggression and sensorimotor gating evaluated by the prepulse inhibition test. However, GluD1-KO mice showed (1) higher locomotor activity in the open field, (2) decreased sociability and social novelty preference in the three-chambered social interaction test, (3) impaired memory in contextual, but not cued fear conditioning tests, and (4) enhanced depressive-like behavior in a forced swim test. Pharmacological studies revealed that enhanced depressive-like behavior in GluD1-KO mice was restored by the serotonin reuptake inhibitors imipramine and fluoxetine, but not the norepinephrine transporter inhibitor desipramine. In addition, biochemical analysis revealed no significant difference in protein expression levels, such as other glutamate receptors in the synaptosome and postsynaptic densities prepared from the frontal cortex and the hippocampus. These results suggest that GluD1 plays critical roles in fear memory, sociability, and depressive-like behavior.	[Nakamoto, Chihiro; Kawamura, Meiko; Nakatsukasa, Ena; Natsume, Rie; Abe, Manabu; Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Anim Model Dev, Niigata, Japan; [Nakamoto, Chihiro; Takeuchi, Tomonori] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Nakamoto, Chihiro; Takeuchi, Tomonori] Aarhus Univ, Danish Res Inst Translat Neurosci DANDRITE, Nordic EMBL Partnership Mol Med, Aarhus, Denmark; [Takao, Keizo] Univ Toyama, Grad Sch Innovat Life Sci, Toyama, Japan; [Takao, Keizo] Univ Toyama, Life Sci Res Ctr, Toyama, Japan; [Watanabe, Masahiko] Hokkaido Univ, Fac Med, Dept Anat, Sapporo, Hokkaido, Japan	Niigata University; Aarhus University; Aarhus University; University of Toyama; University of Toyama; Hokkaido University	Abe, M (corresponding author), Niigata Univ, Brain Res Inst, Dept Anim Model Dev, Niigata, Japan.; Takeuchi, T (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.; Takeuchi, T (corresponding author), Aarhus Univ, Danish Res Inst Translat Neurosci DANDRITE, Nordic EMBL Partnership Mol Med, Aarhus, Denmark.	manabu@bri.niigata-u.ac.jp; tomonori.takeuchi@biomed.au.dk	Abe, Manabu/A-9221-2008; Takeuchi, Tomonori/P-5988-2016; Watanabe, Masahiko/S-3614-2019	Takeuchi, Tomonori/0000-0002-9981-4260; Watanabe, Masahiko/0000-0001-5037-7138; Sakimura, Kenji/0000-0002-8091-8879; Nakamoto, Chihiro/0000-0002-5685-8773	Novo Nordisk Foundation Young Investigator Award 2017 [NNF17OC0026774]; Aarhus Institute of Advanced Studies (AIAS)-EU FP7 Cofund programme [75451]; Lundbeckfonden [DANDRITE-R248-2016-2518]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [16H04650, 16H06276]	Novo Nordisk Foundation Young Investigator Award 2017; Aarhus Institute of Advanced Studies (AIAS)-EU FP7 Cofund programme; Lundbeckfonden(Lundbeckfonden); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funded by (TT) 1) NNF17OC0026774; Novo Nordisk Foundation Young Investigator Award 2017; https://novonordiskfonden.dk/en/.2) 75451; Aarhus Institute of Advanced Studies (AIAS)-EU FP7 Cofund programme; http://aias.au.dk/. 3) DANDRITE-R248-2016-2518; Lundbeckfonden; https://www.lundbeckfonden.com/en/.(KS) 1) 16H04650; the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); http://www.mext.go.jp/en/.2) 16H06276; the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); http://www.mext.go.jp/en/.	Adams DJ, 2005, NAT GENET, V37, P532, DOI 10.1038/ng1551; Ady V, 2014, EMBO REP, V15, P103, DOI 10.1002/embr.201337371; Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; ARAKI K, 1993, BIOCHEM BIOPH RES CO, V197, P1267, DOI 10.1006/bbrc.1993.2614; Balogh SA, 2003, BEHAV BRAIN RES, V140, P97, DOI 10.1016/S0166-4328(02)00279-6; Benamer N, 2018, MOL PSYCHIATR, V23, P691, DOI 10.1038/mp.2017.137; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; BRAFF D, 1978, PSYCHOPHYSIOLOGY, V15, P339, DOI 10.1111/j.1469-8986.1978.tb01390.x; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Bymaster FP, 2002, NEUROPSYCHOPHARMACOL, V27, P699, DOI 10.1016/S0893-133X(02)00346-9; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chaignat E, 2011, GENOME RES, V21, P106, DOI 10.1101/gr.112748.110; Chen FH, 2005, J NEUROCHEM, V92, P21, DOI 10.1111/j.1471-4159.2004.02835.x; Chen X, 2011, MOL PSYCHIATR, V16, P1117, DOI 10.1038/mp.2010.96; Clapcote SJ, 2006, GENETICS, V173, P2407, DOI 10.1534/genetics.106.060749; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Crawley JN, 1996, TRENDS NEUROSCI, V19, P181, DOI 10.1016/S0166-2236(96)20021-9; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Crusio WE, 2004, BIOL PSYCHIAT, V56, P381, DOI 10.1016/j.biopsych.2003.12.026; Dadak S, 2017, NEUROPHARMACOLOGY, V115, P92, DOI 10.1016/j.neuropharm.2016.06.001; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; Edwards AC, 2012, PSYCHIAT GENET, V22, P31, DOI 10.1097/YPG.0b013e32834acd07; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; Fossati M, 2019, NEURON, V104, P1081, DOI 10.1016/j.neuron.2019.09.027; Fukaya M, 2000, J COMP NEUROL, V426, P572; Gao JG, 2007, MOL CELL BIOL, V27, P4500, DOI 10.1128/MCB.02051-06; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; GRIEBEL G, 1993, BEHAV PROCESS, V29, P37, DOI 10.1016/0376-6357(93)90026-N; GRILLON C, 1992, BIOL PSYCHIAT, V32, P939, DOI 10.1016/0006-3223(92)90183-Z; Griswold AJ, 2012, HUM MOL GENET, V21, P3513, DOI 10.1093/hmg/dds164; Guo SZ, 2007, SCHIZOPHR RES, V93, P385, DOI 10.1016/j.schres.2007.03.007; Gupta SC, 2015, NEUROPHARMACOLOGY, V93, P274, DOI 10.1016/j.neuropharm.2015.02.013; Harkin AJ, 1999, EUR J PHARMACOL, V372, P207, DOI 10.1016/S0014-2999(99)00191-0; Hepp R, 2015, BRAIN STRUCT FUNCT, V220, P2797, DOI 10.1007/s00429-014-0827-4; Hirai H, 2005, EMBO REP, V6, P90, DOI 10.1038/sj.embor.7400312; HIRANO T, 1994, NEUROSCI LETT, V182, P172, DOI 10.1016/0304-3940(94)90790-0; Holmes A, 2003, GENES BRAIN BEHAV, V2, P365, DOI 10.1046/j.1601-1848.2003.00050.x; Holmes A, 2002, NEUROPSYCHOPHARMACOL, V27, P914, DOI 10.1016/S0893-133X(02)00374-3; Holmes A, 2001, NEUROSCI BIOBEHAV R, V25, P261, DOI 10.1016/S0149-7634(01)00012-4; Kakegawa W, 2008, J NEUROSCI, V28, P1460, DOI 10.1523/JNEUROSCI.2553-07.2008; Kakegawa W, 2007, J PHYSIOL-LONDON, V584, P89, DOI 10.1113/jphysiol.2007.141291; Kakegawa W, 2007, J PHYSIOL-LONDON, V579, P729, DOI 10.1113/jphysiol.2006.127100; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Katano T, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0407-2; Kato T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014185; Katoh A, 2005, EUR J NEUROSCI, V21, P1315, DOI 10.1111/j.1460-9568.2005.03946.x; KESSLER S, 1977, BEHAV GENET, V7, P313, DOI 10.1007/BF01066801; Kilpinen H, 2008, MOL PSYCHIATR, V13, P187, DOI 10.1038/sj.mp.4002031; Kishimoto Y, 2001, EUR J NEUROSCI, V13, P1249, DOI 10.1046/j.0953-816x.2001.01488.x; Kohda K, 2013, P NATL ACAD SCI USA, V110, pE948, DOI 10.1073/pnas.1218380110; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Konno K, 2014, J NEUROSCI, V34, P7412, DOI 10.1523/JNEUROSCI.0628-14.2014; Krishnan V, 2017, NATURE, V543, P507, DOI 10.1038/nature21678; Kuroda K, 2011, HUM MOL GENET, V20, P4666, DOI 10.1093/hmg/ddr400; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Li K, 2013, SCIENCE, V341, P1016, DOI 10.1126/science.1240729; Li W, 2007, P NATL ACAD SCI USA, V104, P18280, DOI 10.1073/pnas.0706900104; Liu XQ, 2001, BIOL PSYCHIAT, V49, P575, DOI 10.1016/S0006-3223(00)01028-3; Livide G, 2015, EUR J HUM GENET, V23, P195, DOI 10.1038/ejhg.2014.81; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; Lucki I, 2001, PSYCHOPHARMACOLOGY, V155, P315, DOI 10.1007/s002130100694; Matsuda K, 2010, SCIENCE, V328, P363, DOI 10.1126/science.1185152; Mineur YS, 2006, BEHAV BRAIN RES, V175, P43, DOI 10.1016/j.bbr.2006.07.029; Mineur YS, 2003, BEHAV GENET, V33, P513, DOI 10.1023/A:1025770616068; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Muglia P, 2010, MOL PSYCHIATR, V15, P589, DOI 10.1038/mp.2008.131; Nakamoto C, 2020, J COMP NEUROL, V528, P1003, DOI 10.1002/cne.24792; Nakamura K, 2001, EUR J NEUROSCI, V13, P179, DOI 10.1046/j.0953-816X.2000.01366.x; Nord AS, 2011, EUR J HUM GENET, V19, P727, DOI 10.1038/ejhg.2011.24; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Orsetti M, 2008, EUR J NEUROSCI, V27, P2156, DOI 10.1111/j.1460-9568.2008.06155.x; Orsetti M, 2009, PHARMACOGENET GENOM, V19, P600, DOI 10.1097/FPC.0b013e32832ee573; Otsuka S, 2016, J NEUROSCI, V36, P11801, DOI 10.1523/JNEUROSCI.0322-16.2016; Owen EH, 1997, NEUROSCIENCE, V80, P1087, DOI 10.1016/S0306-4522(97)00165-6; Owens MJ, 1997, J PHARMACOL EXP THER, V283, P1305; Paylor R, 1997, PSYCHOPHARMACOLOGY, V132, P169, DOI 10.1007/s002130050333; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; Phillips TJ, 1999, PSYCHOPHARMACOLOGY, V147, P5, DOI 10.1007/s002130051128; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Razafsha M, 2013, NEUROSCIENCE, V240, P204, DOI 10.1016/j.neuroscience.2013.02.045; Redrobe JP, 1996, EUR J PHARMACOL, V318, P213, DOI 10.1016/S0014-2999(96)00772-8; Reneric JP, 1998, PSYCHOPHARMACOLOGY, V136, P190, DOI 10.1007/s002130050555; Ryu K, 2012, BIOCHEM BIOPH RES CO, V417, P157, DOI 10.1016/j.bbrc.2011.11.075; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Seigneur E, 2018, J NEUROSCI, V38, P4774, DOI 10.1523/JNEUROSCI.0360-18.2018; Smith M, 2009, ANN NY ACAD SCI, V1151, P102, DOI 10.1111/j.1749-6632.2008.03571.x; Suryavanshi PS, 2016, MOL PHARMACOL, V90, P96, DOI 10.1124/mol.116.104786; SWERDLOW NR, 1994, ARCH GEN PSYCHIAT, V51, P139; TAKAYAMA C, 1995, NEUROSCI LETT, V188, P89, DOI 10.1016/0304-3940(95)11403-J; Takeuchi T, 2005, J NEUROSCI, V25, P2146, DOI 10.1523/JNEUROSCI.4740-04.2005; Takeuchi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002297; Tao WC, 2018, P NATL ACAD SCI USA, V115, pE5373, DOI 10.1073/pnas.1802737115; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; Treutlein J, 2009, SCHIZOPHR RES, V111, P123, DOI 10.1016/j.schres.2009.03.011; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; VALLE FP, 1970, AM J PSYCHOL, V83, P103, DOI 10.2307/1420860; Vaugeois JM, 1997, PSYCHOPHARMACOLOGY, V134, P387, DOI 10.1007/s002130050475; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Watanabe-Iida I, 2016, J NEUROCHEM, V136, P295, DOI 10.1111/jnc.13384; Wei J, 2014, BIOL PSYCHIAT, V75, P414, DOI 10.1016/j.biopsych.2013.06.009; Wolfer DP, 1997, BRAIN RES, V771, P1, DOI 10.1016/S0006-8993(97)00673-2; Wong EHF, 2000, BIOL PSYCHIAT, V47, P818, DOI 10.1016/S0006-3223(99)00291-7; Yadav R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060785; Yadav R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032969; YAMAZAKI M, 1992, BIOCHEM BIOPH RES CO, V183, P886, DOI 10.1016/0006-291X(92)90566-4; Yamazaki M, 2010, EUR J NEUROSCI, V31, P2204, DOI 10.1111/j.1460-9568.2010.07254.x; Yang Y, 2018, NATURE, V554, P317, DOI 10.1038/nature25509; Yasumura M, 2012, J NEUROCHEM, V121, P705, DOI 10.1111/j.1471-4159.2011.07631.x; Zhang HL, 2016, PHARMACOL BIOCHEM BE, V140, P17, DOI 10.1016/j.pbb.2015.10.018; Zhu YL, 2009, SCHIZOPHR RES, V109, P86, DOI 10.1016/j.schres.2009.01.022	119	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0229288	10.1371/journal.pone.0229288	http://dx.doi.org/10.1371/journal.pone.0229288			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8CF	32078638	Green Published, gold, Green Submitted			2022-12-26	WOS:000535224600024
J	Doroudi, R; Sequeira, P; Marsella, S; Ergun, O; Azghandi, R; Kaeli, D; Sun, YF; Griffin, J				Doroudi, Rozhin; Sequeira, Pedro; Marsella, Stacy; Ergun, Ozlem; Azghandi, Rana; Kaeli, David; Sun, Yifan; Griffin, Jacqueline			Effects of trust-based decision making in disrupted supply chains	PLOS ONE			English	Article							ORDER ALLOCATION; MANAGEMENT; SYSTEMS; AGENTS	The United States has experienced prolonged severe shortages of vital medications over the past two decades. The causes underlying the severity and prolongation of these shortages are complex, in part due to the complexity of the underlying supply chain networks, which involve supplier-buyer interactions across multiple entities with competitive and cooperative goals. This leads to interesting challenges in maintaining consistent interactions and trust among the entities. Furthermore, disruptions in supply chains influence trust by inducing over-reactive behaviors across the network, thereby impacting the ability to consistently meet the resulting fluctuating demand. To explore these issues, we model a pharmaceutical supply chain with boundedly rational artificial decision makers capable of reasoning about the motivations and behaviors of others. We use multiagent simulations where each agent represents a key decision maker in a pharmaceutical supply chain. The agents possess a Theory-of-Mind capability to reason about the beliefs, and past and future behaviors of other agents, which allows them to assess other agents' trustworthiness. Further, each agent has beliefs about others' perceptions of its own trustworthiness that, in turn, impact its behavior. Our experiments reveal several counter-intuitive results showing how small, local disruptions can have cascading global consequences that persist over time. For example, a buyer, to protect itself from disruptions, may dynamically shift to ordering from suppliers with a higher perceived trustworthiness, while the supplier may prefer buyers with more stable ordering behavior. This asymmetry can put the trust-sensitive buyer at a disadvantage during shortages. Further, we demonstrate how the timing and scale of disruptions interact with a buyer's sensitivity to trustworthiness. This interaction can engender different behaviors and impact the overall supply chain performance, either prolonging and exacerbating even small local disruptions, or mitigating a disruption's effects. Additionally, we discuss the implications of these results for supply chain operations.	[Doroudi, Rozhin; Ergun, Ozlem; Azghandi, Rana; Griffin, Jacqueline] Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA; [Sequeira, Pedro] SRI Int, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA; [Sequeira, Pedro; Marsella, Stacy] Northeastern Univ, Khoury Coll Comp Sci, Boston, MA 02115 USA; [Marsella, Stacy] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Kaeli, David; Sun, Yifan] Northeastern Univ, Dept Elect & Comp Engn, Boston, MA 02115 USA	Northeastern University; SRI International; Northeastern University; University of Glasgow; Northeastern University	Doroudi, R (corresponding author), Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA.	doroudi.r@northeastern.edu	Doroudi, Rozhin/GPC-4555-2022	Doroudi, Rozhin/0000-0002-3152-2712; Kaeli, David/0000-0002-5692-0151; Sun, Yifan/0000-0003-3532-6521	National Science Foundation [CMMI 1638302]; SRI International	National Science Foundation(National Science Foundation (NSF)); SRI International	This work is supported by the National Science Foundation under grant CMMI 1638302 to JG. (https://www.nsf.gov/awardsearch/showAward?AWD_ID= 1638302&HistoricalAwards=false). SRI International provided support in the form of salaries for author P. Sequeira but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	[Anonymous], 2017, EXPL REL US MARK FOR; [Anonymous], 2019, THE ECONOMIST; Arbaeen AFS., 2019, PLATINUM ANTICANCER; Cachon GP, 1999, MANAGE SCI, V45, P1091, DOI 10.1287/mnsc.45.8.1091; Chen CM, 2018, PROD OPER MANAG, V27, P553, DOI 10.1111/poms.12814; Doroudi R, 2018, WINT SIMUL C PROC, P88, DOI 10.1109/WSC.2018.8632387; Drug Shortages, 2011, DRUG SHORT CLOS LOOK; Durango-Cohen EJ, 2017, INT J PROD ECON, V184, P256, DOI 10.1016/j.ijpe.2016.10.013; Emery-Montemerlo R., 2004, PROC 3 INT JOINT C A, P136; Fu JX, 2015, ENG APPL ARTIF INTEL, V44, P91, DOI 10.1016/j.engappai.2015.05.002; Ghadimi P, 2018, EUR J OPER RES, V269, P286, DOI 10.1016/j.ejor.2017.07.014; Giannakis M, 2011, J PURCH SUPPLY MANAG, V17, P23, DOI 10.1016/j.pursup.2010.05.001; Gomez J., 1991, NATURAL THEORIES MIN, P195; Hantel A, 2019, JAMA INTERN MED, V179, P710, DOI 10.1001/jamainternmed.2018.8251; Hawley KL, 2016, ACAD EMERG MED, V23, P63, DOI 10.1111/acem.12838; Jalbut A, 2018, INT WORKSH MULT AG S, P45; Kawtummachai R, 2005, INT J PROD ECON, V93-4, P231, DOI 10.1016/j.ijpe.2004.06.022; Kim WS, 2009, JASSS-J ARTIF SOC S, V12; Kimbrough SO, 2002, DECIS SUPPORT SYST, V33, P323, DOI 10.1016/S0167-9236(02)00019-2; Lee JH, 2008, INT J PROD RES, V46, P233, DOI 10.1080/00207540701441921; Moyaux T., 2006, MULTIAGENT BASED SUP, P1; National Academies of Sciences, MED PROD SHROT DIS O; Pauwels K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119322; Pynadath DV, 2005, 19TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-05), P1181; Rong Y, 2008, FLEX SERV MANUF J, V20, P95, DOI 10.1007/s10696-009-9054-3; SARGENT RG, 1991, 1991 WINTER SIMULATION CONFERENCE PROCEEDINGS, P37, DOI 10.1109/WSC.1991.185589; Sarkar S, 2015, INT J PROD ECON, V169, P169, DOI 10.1016/j.ijpe.2015.07.032; Sen S, 2015, PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON AUTONOMOUS AGENTS & MULTIAGENT SYSTEMS (AAMAS'15), P137; Shaban Hanan, 2018, Fed Pract, V35, P24; Sheridan Kate, 2017, NEWSWEEK; Simchi-Levi D., 2008, DESIGNING MANAGING S; Snyder LV, 2016, IIE TRANS, V48, P89, DOI 10.1080/0740817X.2015.1067735; Swaminathan JM, 1998, DECISION SCI, V29, P607, DOI 10.1111/j.1540-5915.1998.tb01356.x; Thomas Katie, 2017, NY TIMES; WOOLDRIDGE M, 1995, KNOWL ENG REV, V10, P115, DOI 10.1017/S0269888900008122	35	5	5	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0224761	10.1371/journal.pone.0224761	http://dx.doi.org/10.1371/journal.pone.0224761			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7XT	32069295	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000535212900003
J	Lim, JH; Choi, JY; Im, Y; Yoo, H; Jhun, BW; Jeong, BH; Park, HY; Lee, K; Kim, H; Kwon, OJ; Han, J; Ahn, MJ; Kim, J; Um, SW				Lim, Jun Hyeok; Choi, Joon Young; Im, Yunjoo; Yoo, Hongseok; Jhun, Byung Woo; Jeong, Byeong-Ho; Park, Hye Yun; Lee, Kyungjong; Kim, Hojoong; Kwon, O. Jung; Han, Joungho; Ahn, Myung-Ju; Kim, Jhingook; Um, Sang-Won			Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in patients with malignant pleural mesothelioma	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; EXTRAPLEURAL PNEUMONECTOMY; SURVIVAL; CISPLATIN; CANCER	Introduction The maximum standardized uptake value (SUVmax) in F-18-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) may be of prognostic significance for patients with malignant pleural mesothelioma (MPM). This retrospective study aimed to investigate the prognostic value of the SUVmax in patients with MPM. Materials and methods Medical records were retrospectively reviewed for the patients who were diagnosed with histopathologically proven MPM between 2009 and 2018 at Samsung Medical Center. For each patient, SUVmax was calculated for the primary lesion on PET/CT. To determine optimal cutoff values for predicting mortality, receiver operating characteristic curves were used. Results Among the 54 study patients, 34 (63.0%) had epithelioid subtype, 13 (24.1%) had sarcomatoid or biphasic subtype, and 7 (13.0%) had mesothelioma, not otherwise specified (NOS). The median overall survival (OS) was 8.7 months, and the median SUVmax was 9.9. The median values of SUVmax were 5.5 in patients with epithelioid subtype, 11.7 in those with sarcomatoid/biphasic subtype, and 13.3 in those with NOS subtype (P = 0.003). The optimal cutoff values of SUVmax to predict mortality were 10.1 in all patients, and 8.5 in patients with epithelioid subtype. In multivariate analysis, SUVmax was significantly associated with overall survival in all patients (P = 0.003) and in patients with epithelioid subtype (P = 0.012), but not in those with non-epithelioid subtype. Conclusions SUVmax in PET/CT is an independent prognostic factor in patients with MPM, especially those with epithelioid subtype. The histologic subtype of MPM should be considered when evaluating the prognostic significance of SUVmax.	[Lim, Jun Hyeok; Im, Yunjoo; Yoo, Hongseok; Jhun, Byung Woo; Jeong, Byeong-Ho; Park, Hye Yun; Lee, Kyungjong; Kim, Hojoong; Kwon, O. Jung; Um, Sang-Won] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Pulm & Crit Care Med,Sch Med, Seoul, South Korea; [Lim, Jun Hyeok] Inha Univ, Inha Univ Hosp, Dept Internal Med, Div Pulmonol,Sch Med, Incheon, South Korea; [Choi, Joon Young] Sungkyunkwan Univ, Samsung Med Ctr, Dept Nucl Med, Sch Med, Seoul, South Korea; [Han, Joungho] Sungkyunkwan Univ, Samsung Med Ctr, Dept Pathol, Sch Med, Seoul, South Korea; [Ahn, Myung-Ju] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Hematol Oncol,Sch Med, Seoul, South Korea; [Kim, Jhingook] Sungkyunkwan Univ, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Inha University; Inha University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Um, SW (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Pulm & Crit Care Med,Sch Med, Seoul, South Korea.	sangwonum@skku.edu	Yoo, Hongseok/AAZ-8139-2020; Lim, Jun Hyeok/ABA-5277-2021	Im, Yunjoo/0000-0002-0892-334X; Jeong, Byeong-Ho/0000-0002-3124-1718	Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare, Korea [HI14C3418]	Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare, Korea	S-W.U. was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Korea (HI14C3418). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley EW, 2017, LANCET ONCOL, V18, P623, DOI 10.1016/S1470-2045(17)30169-9; Bille A, 2016, J THORAC ONCOL, V11, P249, DOI 10.1016/j.jtho.2015.10.003; Ceresoli GL, 2014, BRIT J CANCER, V111, P220, DOI 10.1038/bjc.2014.312; Ceresoli GL, 2006, J CLIN ONCOL, V24, P4587, DOI 10.1200/JCO.2006.06.8999; Curran D, 1998, J CLIN ONCOL, V16, P145, DOI 10.1200/JCO.1998.16.1.145; Disselhorst MJ, 2019, LANCET RESP MED, V7, P260, DOI 10.1016/S2213-2600(18)30420-X; Flores RM, 2007, J THORAC ONCOL, V2, P957, DOI 10.1097/JTO.0b013e31815608d9; Flores RM, 2006, J THORAC CARDIOV SUR, V132, P763, DOI 10.1016/j.jtcvs.2006.03.068; Herndon JE, 1998, CHEST, V113, P723, DOI 10.1378/chest.113.3.723; Kadota K, 2012, J THORAC ONCOL, V7, P1192, DOI 10.1097/JTO.0b013e3182519d96; Kaira K, 2012, EUR J CANCER, V48, P1244, DOI 10.1016/j.ejca.2012.01.016; Kao SC, 2013, CLIN LUNG CANCER, V14, P70, DOI 10.1016/j.cllc.2012.03.011; Klabatsa A, 2014, EUR J NUCL MED MOL I, V41, P276, DOI 10.1007/s00259-013-2561-1; Krug LM, 2009, J CLIN ONCOL, V27, P3007, DOI 10.1200/JCO.2008.20.3943; Lee ST, 2009, MOL IMAGING BIOL, V11, P473, DOI 10.1007/s11307-009-0203-6; Lim CH, 2019, CLIN RADIOL, V74, P207, DOI 10.1016/j.crad.2018.12.010; Lopci E, 2015, EUR J NUCL MED MOL I, V42, P667, DOI 10.1007/s00259-014-2960-y; Network NCC, 2019, NCCN MAL PLEUR MES G; Nowak AK, 2016, J THORAC ONCOL, V11, P2089, DOI 10.1016/j.jtho.2016.08.147; Scherpereel A, 2019, LANCET ONCOL, V20, P239, DOI 10.1016/S1470-2045(18)30765-4; Thieke C, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0575-5; Treasure T, 2011, LANCET ONCOL, V12, P763, DOI 10.1016/S1470-2045(11)70149-8; Tsutani Y, 2013, ANN ONCOL, V24, P1005, DOI 10.1093/annonc/mds537; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Wolf AS, 2016, THORAC SURG CLIN, V26, P359, DOI 10.1016/j.thorsurg.2016.04.003	25	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0229299	10.1371/journal.pone.0229299	http://dx.doi.org/10.1371/journal.pone.0229299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7XT	32069313	gold, Green Published			2022-12-26	WOS:000535212900031
J	Sdoia, S; Zivi, P; Ferlazzo, F				Sdoia, Stefano; Zivi, Pierpaolo; Ferlazzo, Fabio			Anodal tDCS over the right parietal but not frontal cortex enhances the ability to overcome task set inhibition during task switching	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; COGNITIVE CONTROL; PREFRONTAL CORTEX; BACKWARD INHIBITION; NEURAL MECHANISMS; EXECUTIVE CONTROL; ATTENTION; INTERFERENCE; COMPONENTS; SELECTION	Switching between tasks requires individuals to inhibit mental representations of the previous task demands and to activate representations of the new task demands. The inhibition of the executed task remains active for a while so that when the inhibited task set must be re-activated shortly after, the need to overcome residual task set inhibition leads to behavioral costs. In a sham-controlled balanced-order within-subjects experimental design we investigated whether applying right anodal/left cathodal transcranial direct current stimulation (tDCS) over the dorsolateral prefrontal or parietal cortex modulated the ability to overcome persistent task inhibition during task switching. Results showed that right anodal/left cathodal tDCS over the parietal cortex improves performance selectively when switching back to a recently inhibited task that requires previous inhibition to be overcome. Right Anodal/left cathodal tDCS over the prefrontal cortex improves performance during task switching in general, either when re-engaging in a inhibited task or when engaging in a noninhibited task. Results suggest a different contribution of prefrontal and parietal regions to task switching, with parietal cortex being selectively involved in overcoming persistent task inhibition and prefrontal cortex being more generally involved in the control of task set during task switching.	[Sdoia, Stefano; Zivi, Pierpaolo; Ferlazzo, Fabio] Sapienza Univ, Dept Psychol, Rome, Italy	Sapienza University Rome	Sdoia, S (corresponding author), Sapienza Univ, Dept Psychol, Rome, Italy.	stefano.sdoia@uniroma1.it		SDOIA, STEFANO/0000-0001-9275-8350; ZIVI, Pierpaolo/0000-0002-6063-1678	Sapienza University of Rome [RM1181643660189A]	Sapienza University of Rome	This study was supported by GRANT n. RM1181643660189A Sapienza University of Rome to SS.	ALLPORT A, 1994, ATTENTION PERFORM, V15, P421; Allport A, 1999, ATTENTION SPACE ACTI, P273; Altmann EM, 2008, PSYCHOL REV, V115, P602, DOI 10.1037/0033-295X.115.3.602; Arbuthnott K, 2000, CAN J EXP PSYCHOL, V54, P33, DOI 10.1037/h0087328; Arbuthnott KD, 2002, CAN J EXP PSYCHOL, V56, P18, DOI 10.1037/h0087382; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Dreher JC, 2002, P NATL ACAD SCI USA, V99, P14595, DOI 10.1073/pnas.222193299; Esterman M, 2009, P NATL ACAD SCI USA, V106, P17974, DOI 10.1073/pnas.0903593106; Gade M, 2007, MEM COGNITION, V35, P603, DOI 10.3758/BF03193298; Goschke T., 2000, ATTENTION PERFORM, V18, P333; Hubner M, 2003, J EXP PSYCHOL LEARN, V29, P289, DOI 10.1037/0278-7393.29.2.289; Kiesel A, 2010, PSYCHOL BULL, V136, P849, DOI 10.1037/a0019842; Kim C, 2012, HUM BRAIN MAPP, V33, P130, DOI 10.1002/hbm.21199; Koch I, 2010, PSYCHON B REV, V17, P1, DOI 10.3758/PBR.17.1.1; Le TH, 1998, J NEUROPHYSIOL, V79, P1535, DOI 10.1152/jn.1998.79.3.1535; Liston C, 2006, NEURON, V50, P643, DOI 10.1016/j.neuron.2006.04.015; Logan Gordon D., 1994, P189; Mayr U, 2000, J EXP PSYCHOL GEN, V129, P4, DOI 10.1037/0096-3445.129.1.4; Mayr U, 2006, J COGNITIVE NEUROSCI, V18, P14, DOI 10.1162/089892906775250085; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Philipp AM, 2013, HUM BRAIN MAPP, V34, P1910, DOI 10.1002/hbm.22036; Priori A, 1998, NEUROREPORT, V9, P2257, DOI 10.1097/00001756-199807130-00020; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rubinstein JS, 2001, J EXP PSYCHOL HUMAN, V27, P763, DOI 10.1037//0096-1523.27.4.763; Rushworth MFS, 2001, J NEUROSCI, V21, P5262, DOI 10.1523/JNEUROSCI.21-14-05262.2001; Schuch S, 2003, J EXP PSYCHOL HUMAN, V29, P92, DOI 10.1037/0096-1523.29.1.92; Sdoia S, 2008, EXP PSYCHOL, V55, P322, DOI 10.1027/1618-3169.55.5.322; Sinai M, 2007, PSYCHOPHYSIOLOGY, V44, P596, DOI 10.1111/j.1469-8986.2007.00527.x; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Sohn MH, 2001, J EXP PSYCHOL GEN, V130, P764, DOI 10.1037//0096-3445.130.4.764; Sylvester CYC, 2003, NEUROPSYCHOLOGIA, V41, P357, DOI 10.1016/S0028-3932(02)00167-7; Tipper SP, 2001, Q J EXP PSYCHOL-A, V54, P321, DOI 10.1080/02724980042000183; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Vandierendonck A, 2010, PSYCHOL BULL, V136, P601, DOI 10.1037/a0019791; Wassermann EM, 2005, TRENDS COGN SCI, V9, P503, DOI 10.1016/j.tics.2005.09.001; Whitmer AJ, 2012, COGN AFFECT BEHAV NE, V12, P661, DOI 10.3758/s13415-012-0118-6; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; Worringer B, 2019, BRAIN STRUCT FUNCT, V224, P1845, DOI 10.1007/s00429-019-01870-4; Yeung N, 2006, J NEUROSCI, V26, P1429, DOI 10.1523/JNEUROSCI.3109-05.2006; Yeung N, 2003, J EXP PSYCHOL HUMAN, V29, P919, DOI 10.1037/0096-1523.29.5.919; Zhang R, 2016, BRAIN STRUCT FUNCT, V221, P4575, DOI 10.1007/s00429-016-1186-0; 2018, QUANT LINGUIST, V72, P1	51	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0228541	10.1371/journal.pone.0228541	http://dx.doi.org/10.1371/journal.pone.0228541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7XT	32069294	Green Published, gold			2022-12-26	WOS:000535212900010
J	Kateete, DP; Asiimwe, BB; Mayanja, R; Najjuka, CF; Rutebemberwa, E				Kateete, David Patrick; Asiimwe, Benon B.; Mayanja, Raymond; Najjuka, Christine Florence; Rutebemberwa, Elizeus			Species and drug susceptibility profiles of staphylococci isolated from healthy children in Eastern Uganda	PLOS ONE			English	Article							NASAL COLONIZATION; AUREUS; IDENTIFICATION; EPIDERMIDIS; RESISTANCE; VANCOMYCIN; PREVALENCE; STRAINS; GENES	Staphylococci are a key component of the human microbiota, and they mainly colonize the skin and anterior nares. However, they can cause infection in hospitalized patients and healthy individuals in the community. Although majority of the Staphylococcus aureus strains are coagulase-positive, some do not produce coagulase, and the isolation of coagulase-positive non-S. aureus isolates in humans is increasingly being reported. Therefore, sound knowledge of the species and characteristics of staphylococci in a given setting is important, especially isolates from children and immunocompromised individuals. The spectrum of Staphylococcus species colonizing children in Uganda is poorly understood; here, we aimed to determine the species and characteristics of staphylococci isolated from children in Eastern Uganda. Seven hundred and sixty four healthy children less than 5 years residing in Iganga and Mayuge districts in Eastern Uganda were enrolled. A total of 513 staphylococci belonging to 13 species were isolated from 485 children (63.5%, 485/764), with S. aureus being the dominant species (37.6%, 193/513) followed by S. epidermidis (25.5%, 131/513), S. haemolyticus (2.3%, 12/513), S. hominis (0.8%, 4/513) and S. haemolyticus/lugdunensis (0.58%, 3/513). Twenty four (4.95%, 24/485) children were co-colonized by two or more Staphylococcus species. With the exception of penicillin, antimicrobial resistance (AMR) rates were low; all isolates were susceptible to vancomycin, teicoplanin, linezolid and daptomycin. The prevalence of methicillin resistance was 23.8% (122/513) and it was highest in S. haemolyticus (66.7%, 8/12) followed by S. aureus (28.5%, 55/193) and S. epidermidis (23.7%, 31/131). The prevalence of multidrug resistance was 20.3% (104/513), and 59% (72/122) of methicillin resistant staphylococci were multidrug resistant. Four methicillin susceptible S. aureus isolates and a methicillin resistant S. scuiri isolate were mupirocin resistant (high-level). The most frequent AMR genes were mecA, vanA, ant(4')-Ia, and aac(6')-Ie- aph(2 '')-Ia, pointing to presence of AMR drivers in the community.	[Kateete, David Patrick] Makerere Univ, Sch Biomed Sci, Dept Immunol & Mol Biol, Coll Hlth Sci, Kampala, Uganda; [Kateete, David Patrick; Asiimwe, Benon B.; Mayanja, Raymond; Najjuka, Christine Florence] Makerere Univ, Sch Biomed Sci, Dept Med Microbiol, Coll Hlth Sci, Kampala, Uganda; [Mayanja, Raymond] Makerere Univ, Walter Reed Project, Kampala, Uganda; [Rutebemberwa, Elizeus] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	Makerere University; Makerere University; Makerere University; Makerere University	Kateete, DP (corresponding author), Makerere Univ, Sch Biomed Sci, Dept Immunol & Mol Biol, Coll Hlth Sci, Kampala, Uganda.; Kateete, DP (corresponding author), Makerere Univ, Sch Biomed Sci, Dept Med Microbiol, Coll Hlth Sci, Kampala, Uganda.	dkateete@chs.mak.ac.ug	Kateete, David Patrick/HCH-5603-2022	Kateete, David Patrick/0000-0001-8075-3069; Rutebemberwa, Elizeus/0000-0001-8363-7928				Becker K, 2014, CLIN MICROBIOL REV, V27, P870, DOI 10.1128/CMR.00109-13; Boye K, 2007, CLIN MICROBIOL INFEC, V13, P725, DOI 10.1111/j.1469-0691.2007.01720.x; Budri PE, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020391; Carroll KC, 2006, J CLIN MICROBIOL, V44, P2072, DOI 10.1128/JCM.02636-05; Chessa D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146668; Courvalin P, 2006, CLIN INFECT DIS, V42, pS25, DOI 10.1086/491711; de Benito S, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0318-0; Depardieu F, 2004, J CLIN MICROBIOL, V42, P5857, DOI 10.1128/JCM.42.12.5857-5860.2004; Faria NA, 2014, MICROB DRUG RESIST, V20, P108, DOI 10.1089/mdr.2013.0197; Gagnon S, 2011, J ANTIMICROB CHEMOTH, V66, P2758, DOI 10.1093/jac/dkr379; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Ida T, 2001, J CLIN MICROBIOL, V39, P3115, DOI 10.1128/JCM.39.9.3115-3121.2001; Jain A, 1999, Pediatr Rev, V20, P183, DOI 10.1542/pir.20-6-183; Kalyango JN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-340; Kateete DP, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4136-7; Kateete David P, 2011, BMC Res Notes, V4, P326, DOI 10.1186/1756-0500-4-326; Kateete DP, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-23; Kateete DP, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0551-1; Kateete DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063413; Kates AE, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0331-3; Koneman E., 2006, KONEMANS COLOR ATLAS, V6; Koneman EW., 1997, NONFERMENTATIVE GRAM, P253; de Almeida GCM, 2014, ACTA PAUL ENFERM, V27, P273, DOI 10.1590/1982-0194201400046; Matthews KR, 1997, J FOOD PROTECT, V60, P686, DOI 10.4315/0362-028X-60.6.686; Montanaro L, 2007, J BIOMED MATER RES A, V83A, P813, DOI 10.1002/jbm.a.31399; Morgenstern M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148437; Okee MS, 2012, J INFECT DEV COUNTR, V6, P242, DOI 10.3855/jidc.2007; Omuse G, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0669-y; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Pereira EM, 2010, MICROBIOL RES, V165, P243, DOI 10.1016/j.micres.2009.03.003; Post V, 2017, J CLIN MICROBIOL, V55, P3089, DOI [10.1128/JCM.00881-17, 10.1128/jcm.00881-17]; Rutebemberwa E, 2015, UPSALA J MED SCI, V120, P249, DOI 10.3109/03009734.2015.1072606; Seni J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066153; Seni Jeremiah, 2013, BMC Res Notes, V6, P298, DOI 10.1186/1756-0500-6-298; Shittu AO, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0382-5; Sivertsen A, 2016, ANTIMICROB AGENTS CH, V60, P4119, DOI 10.1128/AAC.00286-16; Sundareshan S., 2017, Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases, V38, P66, DOI 10.5958/0974-0147.2017.00011.3; Sundsfjord A, 2004, APMIS, V112, P815, DOI 10.1111/j.1600-0463.2004.apm11211-1208.x; Tavares AL., 2014, COMMUNITY ASS METHIC; Wang LJ, 2012, J MED MICROBIOL, V61, P1240, DOI 10.1099/jmm.0.042663-0; Wangai FK, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4245-3; Widerstrom M, 2011, APMIS, V119, P505, DOI 10.1111/j.1600-0463.2011.02757.x; Woo PCY, 2001, J CLIN PATHOL-MOL PA, V54, P244, DOI 10.1136/mp.54.4.244; Xu Z, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0367-4; Zipperer A, 2016, NATURE, V535, P511, DOI 10.1038/nature18634	45	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0229026	10.1371/journal.pone.0229026	http://dx.doi.org/10.1371/journal.pone.0229026			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053668	Green Published, gold			2022-12-26	WOS:000535198700093
J	Faria, M; Domingues, R; Paixao, F; Bugalho, MJ; Matos, P; Silva, AL				Faria, Marcia; Domingues, Rita; Paixao, Francisca; Bugalho, Maria Joao; Matos, Paulo; Silva, Ana Luisa			TNF alpha-mediated activation of NF-kappa B downregulates sodium-iodide symporter expression in thyroid cells	PLOS ONE			English	Article							GENE-EXPRESSION; DEPENDENT TRANSCRIPTION; BRAF(V600E) MUTATION; CANCER; NIS; PAPILLARY; KINASE; MODULATION; INHIBITORS; RAC1B	The sodium-iodide symporter (NIS) mediates transport of iodide across the basolateral membrane of thyroid cells. NIS expression in thyroid cancer (TC) cells allows the use of radioactive iodine (RAI) as a diagnostic and therapeutic tool, being RAI therapy the systemic treatment of choice for metastatic disease. Still, a significant proportion of patients with advanced TC lose the ability to respond to RAI therapy and no effective alternative therapies are available. Defective NIS expression is the main reason for impaired iodide uptake in TC and NIS downregulation has been associated with several pathways linked to malignant transformation. NF-kappa B signaling is one of the pathways associated with TC. Interestingly, NIS expression can be negatively regulated by TNF-alpha, a bona fide activator of NF-kappa B with a central role in thyroid autoimmunity. This prompted us to clarify NF-kappa B's role in this process. We confirmed that TNF-alpha leads to downregulation of TSH-induced NIS expression in non-neoplastic thyroid follicular cell-derived models. Notably, a similar effect was observed when NF-kappa B activation was triggered independently of ligand-receptor specificity, using phorbol-myristate-acetate (PMA). TNF-alpha and PMA downregulation of NIS expression was reverted when NF-kappa B-dependent transcription was blocked, demonstrating the requirement for NF-kappa B activity. Additionally, TNF-alpha and PMA were shown to have a negative impact on TSH-induced iodide uptake, consistent with the observed transcriptional downregulation of NIS. Our data support the involvement of NF-kappa B-directed transcription in the modulation of NIS expression, where up-or down-regulation of NIS depends on the combined output to NF-kappa B of several converging pathways. A better understanding of the mechanisms underlying NIS expression in the context of normal thyroid physiology may guide the development of pharmacological strategies to increase the efficiency of iodide uptake. Such strategies would be extremely useful in improving the response to RAI therapy in refractory-TC.	[Faria, Marcia; Domingues, Rita; Paixao, Francisca; Bugalho, Maria Joao; Silva, Ana Luisa] Hosp Santa Maria, Serv Endocrinol Diabet & Metab CHULN, Lisbon, Portugal; [Faria, Marcia; Matos, Paulo] Univ Lisbon, BioISI Biosyst & Integrat Sci Inst, Fac Ciencias, Lisbon, Portugal; [Faria, Marcia; Matos, Paulo] Inst Nacl Saude Doutor Ricardo Jorge, Dept Genet Humana, Lisbon, Portugal; [Domingues, Rita; Paixao, Francisca; Silva, Ana Luisa] Univ Lisbon, ISAMB Inst Saude Ambiental, Fac Med, Lisbon, Portugal; [Bugalho, Maria Joao] Univ Lisbon, Fac Med, Lisbon, Portugal	Universidade de Lisboa; Hospital Santa Maria; BIOISI; Universidade de Lisboa; Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade de Lisboa; Universidade de Lisboa	Silva, AL (corresponding author), Hosp Santa Maria, Serv Endocrinol Diabet & Metab CHULN, Lisbon, Portugal.; Silva, AL (corresponding author), Univ Lisbon, ISAMB Inst Saude Ambiental, Fac Med, Lisbon, Portugal.	silva.r.analuisa@gmail.com		Domingues, Rita/0000-0001-7130-3795; Silva, Ana Luisa/0000-0002-4839-8279	Fundacao para a Ciencia e a Tecnologia from Portugal [PTDC/BIAMOL/31787/2017]; FCT fellowship [PD/BD/114388/2016]	Fundacao para a Ciencia e a Tecnologia from Portugal(Portuguese Foundation for Science and Technology); FCT fellowship(Portuguese Foundation for Science and Technology)	This work was supported by the Fundacao para a Ciencia e a Tecnologia, grant [PTDC/BIAMOL/31787/2017] from Portugal. MF is recipient of FCT fellowship PD/BD/114388/2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bommarito A, 2011, ENDOCR-RELAT CANCER, V18, P669, DOI 10.1530/ERC-11-0076; Bottero Virginie, 2003, Mol Diagn, V7, P187, DOI 10.2165/00066982-200307030-00008; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Cianchetta S, 2010, TOXICOL APPL PHARM, V243, P372, DOI 10.1016/j.taap.2009.12.004; D'Agostino M, 2014, J MOL ENDOCRINOL, V52, P121, DOI 10.1530/JME-13-0160; Dohan O, 2003, MOL CELL ENDOCRINOL, V213, P59, DOI 10.1016/j.mce.2003.10.059; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Dralle H, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.77; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; Espadinha C, 2009, CLIN ENDOCRINOL, V70, P629, DOI 10.1111/j.1365-2265.2008.03376.x; Faria Marcia, 2019, J Mol Endocrinol, V63, P309, DOI 10.1530/JME-19-0195; Faria M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172689; Fiegen D, 2004, J BIOL CHEM, V279, P4743, DOI 10.1074/jbc.M310281200; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Giuliani C, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00471; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hinzpeter A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001153; Holden NS, 2008, CELL SIGNAL, V20, P1338, DOI 10.1016/j.cellsig.2008.03.001; Jung KH, 2008, J NUCL MED, V49, P1966, DOI 10.2967/jnumed.108.055764; Kogai T, 1997, ENDOCRINOLOGY, V138, P2227, DOI 10.1210/en.138.6.2227; Kogai T, 2008, J ENDOCRINOL, V199, P243, DOI [10.1677/JOE-08-0333, 10.1677/JOE-08-0333e]; Kogai T, 2012, PHARMACOL THERAPEUT, V135, P355, DOI 10.1016/j.pharmthera.2012.06.007; Lakshmanan A, 2015, ONCOTARGET, V6, P31792, DOI 10.18632/oncotarget.5172; Lakshmanan A, 2014, HORM CANCER-US, V5, P363, DOI 10.1007/s12672-014-0203-0; Lazar V, 1999, J CLIN ENDOCR METAB, V84, P3228, DOI 10.1210/jc.84.9.3228; Lim ES, 2019, ENDOCR CONNECT, V8, P571, DOI 10.1530/EC-19-0053; Liu JR, 2019, ENDOCRINOL METAB, V34, P215, DOI 10.3803/EnM.2019.34.3.215; Loureiro CA, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1580; Matos P, 2003, J BIOL CHEM, V278, P50442, DOI 10.1074/jbc.M308215200; Nicola JP, 2010, MOL ENDOCRINOL, V24, P1846, DOI 10.1210/me.2010-0102; Pacifico F, 2010, MOL CELL ENDOCRINOL, V321, P29, DOI 10.1016/j.mce.2009.10.010; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Palona I, 2006, ENDOCRINOLOGY, V147, P5699, DOI 10.1210/en.2006-0400; Pilli T, 2009, THYROID, V19, P1333, DOI 10.1089/thy.2009.0195; Ravera S, 2017, ANNU REV PHYSIOL, V79, P261, DOI 10.1146/annurev-physiol-022516-034125; Reale C, 2018, VITAM HORM, V106, P195, DOI 10.1016/bs.vh.2017.05.003; Rhoden KJ, 2008, ANAL BIOCHEM, V373, P239, DOI 10.1016/j.ab.2007.10.020; Rhoden KJ, 2007, AM J PHYSIOL-CELL PH, V292, pC814, DOI 10.1152/ajpcell.00291.2006; Schmidt A, 2017, ARCH ENDOCRIN METAB, V61, P81, DOI 10.1590/2359-3997000000245; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Spitzweg C, 1999, THYROID, V9, P821, DOI 10.1089/thy.1999.9.821; Spitzweg C, 2014, LANCET DIABETES ENDO, V2, P830, DOI 10.1016/S2213-8587(14)70051-8; Taki K, 2002, MOL ENDOCRINOL, V16, P2266, DOI 10.1210/me.2002-0109; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189	45	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228794	10.1371/journal.pone.0228794	http://dx.doi.org/10.1371/journal.pone.0228794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32049985	Green Published, gold			2022-12-26	WOS:000535192300025
J	Gorecki, K; McEvoy, MM				Gorecki, Kamil; McEvoy, Megan M.			Phylogenetic analysis reveals an ancient gene duplication as the origin of the MdtABC efflux pump	PLOS ONE			English	Article							ENZYMOLOGY WEB TOOLS; MULTIDRUG; RESISTANCE; FAMILY	The efflux pumps from the Resistance-Nodulation-Division family, RND, are main contributors to intrinsic antibiotic resistance in Gram-negative bacteria. Among this family, the MdtABC pump is unusual by having two inner membrane components. The two components, MdtB and MdtC are homologs, therefore it is evident that the two components arose by gene duplication. In this paper, we describe the results obtained from a phylogenetic analysis of the MdtBC pumps in the context of other RNDs. We show that the individual inner membrane components (MdtB and MdtC) are conserved throughout the Proteobacterial species and that their existence is a result of a single gene duplication. We argue that this gene duplication was an ancient event which occurred before the split of Proteobacteria into Alpha-, Beta- and Gamma- classes. Moreover, we find that the MdtABC pumps and the MexMN pump from Pseudomonas aeruginosa share a close common ancestor, suggesting the MexMN pump arose by another gene duplication event of the original Mdt ancestor. Taken together, these results shed light on the evolution of the RND efflux pumps and demonstrate the ancient origin of the Mdt pumps and suggest that the core bacterial efflux pump repertoires have been generally stable throughout the course of evolution.	[Gorecki, Kamil; McEvoy, Megan M.] Univ Calif Los Angeles, Inst Soc & Genet, Los Angeles, CA 90024 USA; [McEvoy, Megan M.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA; [McEvoy, Megan M.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	McEvoy, MM (corresponding author), Univ Calif Los Angeles, Inst Soc & Genet, Los Angeles, CA 90024 USA.; McEvoy, MM (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA.; McEvoy, MM (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90024 USA.	mcevoymm@ucla.edu		Gorecki, Kamil/0000-0002-9672-2408; McEvoy, Megan/0000-0002-4132-7355				Alvarez-Ortega C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00007; Anes J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00587; Battistuzzi FU, 2009, MOL BIOL EVOL, V26, P335, DOI 10.1093/molbev/msn247; Begic S, 2008, CAN J MICROBIOL, V54, P411, DOI [10.1139/W08-019, 10.1139/w08-019]; Dou Y, 2017, MOL MED REP, V15, P4061, DOI 10.3892/mmr.2017.6528; Du DJ, 2014, NATURE, V509, P512, DOI 10.1038/nature13205; Frawley ER, 2013, P NATL ACAD SCI USA, V110, P12054, DOI 10.1073/pnas.1218274110; Gerlt JA, 2017, BIOCHEMISTRY-US, V56, P4293, DOI 10.1021/acs.biochem.7b00614; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Godoy P, 2010, MICROB BIOTECHNOL, V3, P691, DOI 10.1111/j.1751-7915.2010.00189.x; Henriquez T, 2019, ENV MICROBIOL REP, V11, P98, DOI 10.1111/1758-2229.12708; Horiyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108642; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Khattar ZA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212077; Kim HS, 2010, J BACTERIOL, V192, P1377, DOI 10.1128/JB.01448-09; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Mima T, 2009, MICROBIOL-SGM, V155, P3509, DOI 10.1099/mic.0.031260-0; Nikaido H, 2018, RES MICROBIOL, V169, P363, DOI 10.1016/j.resmic.2018.03.001; Nishino K, 2007, J BACTERIOL, V189, P9066, DOI 10.1128/JB.01045-07; Pletzer D, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-185; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Salinero KK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-351; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Wang D, 2013, METALLOMICS, V5, P372, DOI 10.1039/c3mt20217h; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Yang LA, 2011, J MICROBIOL, V49, P107, DOI 10.1007/s12275-011-0186-2; Zallot R, 2019, BIOCHEMISTRY-US, V58, P4169, DOI 10.1021/acs.biochem.9b00735; Zallot R, 2018, CURR OPIN CHEM BIOL, V47, P77, DOI 10.1016/j.cbpa.2018.09.009	28	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228877	10.1371/journal.pone.0228877	http://dx.doi.org/10.1371/journal.pone.0228877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32050009	Green Submitted, gold, Green Published			2022-12-26	WOS:000535192300033
J	Perez-Ruiz, ER; Vivoni, ER; Templeton, NP				Perez-Ruiz, Eli R.; Vivoni, Enrique R.; Templeton, Nicole P.			Urban land cover type determines the sensitivity of carbon dioxide fluxes to precipitation in Phoenix, Arizona	PLOS ONE			English	Article							EDDY COVARIANCE MEASUREMENTS; FREQUENCY-RESPONSE CORRECTIONS; CO2 FLUX; ENERGY FLUXES; WATER-VAPOR; TEMPORAL VARIABILITY; SPATIAL VARIABILITY; DENSE URBAN; HEAT; VEGETATION	Urbanization modifies land surface characteristics with consequent impacts on local energy, water, and carbon dioxide (CO2) fluxes. Despite the disproportionate impact of cities on CO2 emissions, few studies have directly quantified CO2 conditions for different urban land cover patches, in particular for arid and semiarid regions. Here, we present a comparison of eddy covariance measurements of CO2 fluxes (FC) and CO2 concentrations ([CO2]) in four distinct urban patches in Phoenix, Arizona: a xeric landscaping, a parking lot, a mesic landscaping, and a suburban neighborhood. Analyses of diurnal, daily, and seasonal variations of FC and [CO2] were related to vegetation activity, vehicular traffic counts, and precipitation events to quantify differences among sites in relation to their urban land cover characteristics. We found that the mesic landscaping with irrigated turf grass was primarily controlled by plant photosynthetic activity, while the parking lot in close proximity to roads mainly exhibited the signature of vehicular emissions. The other two sites that had mixtures of irrigated vegetation and urban surfaces displayed an intermediate behavior in terms of CO2 fluxes. Precipitation events only impacted FC in urban patches without outdoor water use, indicating that urban irrigation decouples CO2 fluxes from the effects of infrequent storms in an arid climate. These findings suggest that the proportion of irrigated vegetation and urban surfaces fractions within urban patches could be used to scale up CO2 fluxes to a broader city footprint.	[Perez-Ruiz, Eli R.; Vivoni, Enrique R.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85281 USA; [Perez-Ruiz, Eli R.] Univ Autonoma Ciudad Juarez, Inst Ingn & Tecnol, Dept Ingn Civil & Ambiental, Ciudad Juarez, Chihuahua, Mexico; [Vivoni, Enrique R.; Templeton, Nicole P.] Arizona State Univ, Sch Sustainable Engn & Built Environm, Tempe, AZ 85281 USA; [Templeton, Nicole P.] Holist Engn & Land Management, Phoenix, AZ USA	Arizona State University; Arizona State University-Tempe; Universidad Autonoma de Ciudad Juarez; Arizona State University; Arizona State University-Tempe	Vivoni, ER (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85281 USA.; Vivoni, ER (corresponding author), Arizona State Univ, Sch Sustainable Engn & Built Environm, Tempe, AZ 85281 USA.	vivoni@asu.edu	Vivoni, Enrique/E-1202-2012	Vivoni, Enrique/0000-0002-2659-9459; Perez Ruiz, Eli Rafael/0000-0003-4954-0238	U.S. Army Research Office [65962-EVII]; National Science Foundation [EF1049251, DEB-1637590]; Fulbright Foreign Student Program; Programa de Desarrollo Profesional Docente SES-SEP	U.S. Army Research Office; National Science Foundation(National Science Foundation (NSF)); Fulbright Foreign Student Program; Programa de Desarrollo Profesional Docente SES-SEP	E.R.V received U.S. Army Research Office (Grant 65962-EVII), National Science Foundation (Grant EF1049251 and Grant DEB-1637590) E.R.P-R. received Fulbright Foreign Student Program and the Programa de Desarrollo Profesional Docente SES-SEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DK, 1997, B AM METEOROL SOC, V78, P2197, DOI 10.1175/1520-0477(1997)078<2197:TNAM>2.0.CO;2; Anderson CA, 2016, WATER RESOUR RES, V52, P4785, DOI 10.1002/2015WR018016; Awal MA, 2010, URBAN FOR URBAN GREE, V9, P261, DOI 10.1016/j.ufug.2010.01.007; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Bergeron O, 2011, ATMOS ENVIRON, V45, P1564, DOI 10.1016/j.atmosenv.2010.12.043; Bjorkegren AB, 2015, ATMOS ENVIRON, V122, P775, DOI 10.1016/j.atmosenv.2015.10.012; Buckley SM, 2016, URBAN ECOSYST, V19, P1479, DOI 10.1007/s11252-013-0341-0; Chow WTL, 2014, INT J CLIMATOL, V34, P3863, DOI 10.1002/joc.3947; Chow WTL, 2014, ATMOS ENVIRON, V99, P64, DOI 10.1016/j.atmosenv.2014.09.053; Christen A, 2011, ATMOS ENVIRON, V45, P6057, DOI 10.1016/j.atmosenv.2011.07.040; Churkina G, 2008, ECOL MODEL, V216, P107, DOI 10.1016/j.ecolmodel.2008.03.006; Clement R., 1999, EDIRE DATA SOFTWARE; Coutts AM, 2007, ATMOS ENVIRON, V41, P51, DOI 10.1016/j.atmosenv.2006.08.030; Crawford B, 2016, J APPL METEOROL CLIM, V55, P507, DOI 10.1175/JAMC-D-15-0060.1; Crawford B, 2014, ATMOS ENVIRON, V98, P308, DOI 10.1016/j.atmosenv.2014.08.052; Crawford B, 2011, ATMOS ENVIRON, V45, P896, DOI 10.1016/j.atmosenv.2010.11.017; Davis KJ, 2017, ELEMENTA-SCI ANTHROP, V5, DOI 10.1525/elementa.188; Feigenwinter C, 2012, EDDY COVARIANCE SPRI; Foken T, 2006, BOUND-LAY METEOROL, V119, P431, DOI 10.1007/s10546-006-9048-6; Gately CK, 2015, P NATL ACAD SCI USA, V112, P4999, DOI 10.1073/pnas.1421723112; Gately CK, 2013, ENVIRON SCI TECHNOL, V47, P2423, DOI 10.1021/es304238v; Georgescu M, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034026; Grimmond C.S.B., 2012, FLUXNET NEWSL, V5, P1; Grimmond CSB, 2006, THEOR APPL CLIMATOL, V84, P3, DOI 10.1007/s00704-005-0140-5; Grimmond CSB, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004936; Grimmond CSB, 2002, ENVIRON POLLUT, V116, pS243, DOI 10.1016/S0269-7491(01)00256-1; Gurney KR, 2019, J GEOPHYS RES-ATMOS, V124, P2823, DOI 10.1029/2018JD028859; Hardiman BS, 2017, SCI TOTAL ENVIRON, V592, P366, DOI 10.1016/j.scitotenv.2017.03.028; Helfter C, 2016, ATMOS CHEM PHYS, V16, P10543, DOI 10.5194/acp-16-10543-2016; Hemond H. F., 2015, CHEM FATE TRANSPORT, P311, DOI [10.1016/B978-0-12-398256-8.00004-9, DOI 10.1016/B978-0-12-398256-8.00004-9, 10.1016/B978-0-12-340270-7.50008-4, DOI 10.1016/B978-0-12-340270-7.50008-4]; Hiller RV, 2011, BOUND-LAY METEOROL, V138, P215, DOI 10.1007/s10546-010-9558-0; Hirano T, 2015, SOLA, V11, P100, DOI 10.2151/sola.2015-024; Hutyra LR, 2014, EARTHS FUTURE, V2, P473, DOI 10.1002/2014EF000255; Idso SB, 2002, ATMOS ENVIRON, V36, P1655, DOI 10.1016/S1352-2310(02)00159-0; Jarvi L, 2012, ATMOS CHEM PHYS, V12, P8475, DOI 10.5194/acp-12-8475-2012; Jarvi L, 2019, J GEOPHYS RES-ATMOS, V124, P8363, DOI 10.1029/2018JD029576; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Koerner B, 2002, ENVIRON POLLUT, V116, pS45, DOI 10.1016/S0269-7491(01)00246-9; Koerner Brenda A., 2010, Urban Ecosystems, V13, P1, DOI 10.1007/s11252-009-0105-z; Kordowski K, 2010, ATMOS ENVIRON, V44, P2722, DOI 10.1016/j.atmosenv.2010.04.039; Kormann R, 2001, BOUND-LAY METEOROL, V99, P207, DOI 10.1023/A:1018991015119; Kotthaus S, 2012, ATMOS ENVIRON, V57, P301, DOI 10.1016/j.atmosenv.2012.04.024; Lauvaux T, 2016, J GEOPHYS RES-ATMOS, V121, P5213, DOI 10.1002/2015JD024473; Lazzarini M, 2015, GEOPHYS RES LETT, V42, P9980, DOI 10.1002/2015GL066534; Lietzke B, 2015, INT J CLIMATOL, V35, P3921, DOI 10.1002/joc.4255; Lietzke B, 2013, ATMOS ENVIRON, V74, P60, DOI 10.1016/j.atmosenv.2013.03.030; Liu HZ, 2012, ATMOS CHEM PHYS, V12, P7881, DOI 10.5194/acp-12-7881-2012; Massman WJ, 2001, AGR FOREST METEOROL, V107, P247, DOI 10.1016/S0168-1923(00)00237-9; McHale MR, 2017, ECOL APPL, V27, P644, DOI 10.1002/eap.1472; Mills G, 2007, INT J CLIMATOL, V27, P1849, DOI 10.1002/joc.1604; MOORE CJ, 1986, BOUND-LAY METEOROL, V37, P17, DOI 10.1007/BF00122754; Moriwaki R, 2004, J APPL METEOROL, V43, P1700, DOI 10.1175/JAM2153.1; Ng BJL, 2015, ENVIRON POLLUT, V203, P227, DOI 10.1016/j.envpol.2014.06.009; OKE TR, 1988, PROG PHYS GEOG, V12, P471, DOI 10.1177/030913338801200401; Park C, 2016, J ENVIRON QUAL, V45, P253, DOI 10.2134/jeq2015.02.0115; Pataki DE, 2006, GLOBAL CHANGE BIOL, V12, P2092, DOI 10.1111/j.1365-2486.2006.01242.x; Paw KT, 2000, BOUND-LAY METEOROL, V97, P487, DOI 10.1023/A:1002786702909; Pawlak W, 2011, INT J CLIMATOL, V31, P232, DOI 10.1002/joc.2247; Perez-Ruiz ER, 2010, J ARID ENVIRON, V74, P556, DOI 10.1016/j.jaridenv.2009.09.029; Peters EB, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001933; Ramamurthy P, 2015, BOUND-LAY METEOROL, V157, P461, DOI 10.1007/s10546-015-0074-0; Ramamurthy P, 2011, ATMOS ENVIRON, V45, P73, DOI 10.1016/j.atmosenv.2010.09.049; Richardson SJ, 2017, ELEMENTA-SCI ANTHROP, V5, DOI 10.1525/elementa.140; Roth M, 2017, INT J CLIMATOL, V37, P2679, DOI 10.1002/joc.4873; Sargent M, 2018, P NATL ACAD SCI USA, V115, P7491, DOI 10.1073/pnas.1803715115; Schmid HP, 2000, AGR FOREST METEOROL, V103, P357, DOI 10.1016/S0168-1923(00)00140-4; SCHMID HP, 1994, BOUND-LAY METEOROL, V67, P293, DOI 10.1007/BF00713146; Schmidli RJ, 1996, CLIMATE PHOENIX ARIZ; Schmutz M, 2016, J GEOPHYS RES-ATMOS, V121, P8649, DOI 10.1002/2016JD025063; Scott RL, 2004, AGR FOREST METEOROL, V122, P65, DOI 10.1016/j.agrformet.2003.09.001; Soegaard H, 2003, REMOTE SENS ENVIRON, V87, P283, DOI 10.1016/S0034-4257(03)00185-8; Song JY, 2017, J GEOPHYS RES-ATMOS, V122, P3317, DOI 10.1002/2016JD026267; Song T, 2012, ATMOS RES, V106, P139, DOI 10.1016/j.atmosres.2011.12.001; Stagakis S, 2019, ATMOS ENVIRON, V201, P278, DOI 10.1016/j.atmosenv.2019.01.009; Stewart ID, 2012, B AM METEOROL SOC, V93, P1879, DOI 10.1175/BAMS-D-11-00019.1; Templeton NP, 2018, J GEOPHYS RES-ATMOS, V123, P2111, DOI 10.1002/2017JD027845; U.S. Census Bureau, 2010, 2010 CENS DAT; Ueyama M, 2016, ATMOS CHEM PHYS, V16, P14727, DOI 10.5194/acp-16-14727-2016; van de Boer A, 2013, AGR FOREST METEOROL, V169, P1, DOI 10.1016/j.agrformet.2012.09.016; Velasco E, 2005, ATMOS ENVIRON, V39, P7433, DOI 10.1016/j.atmosenv.2005.08.038; Velasco E, 2014, ATMOS ENVIRON, V97, P226, DOI 10.1016/j.atmosenv.2014.08.018; Velasco E, 2013, ATMOS CHEM PHYS, V13, P10185, DOI 10.5194/acp-13-10185-2013; Velasco E, 2016, LANDSCAPE URBAN PLAN, V148, P99, DOI 10.1016/j.landurbplan.2015.12.003; Velasco E, 2010, GEOGR COMPASS, V4, P1238, DOI 10.1111/j.1749-8198.2010.00384.x; Verduzco VS, 2018, J GEOPHYS RES-BIOGEO, V123, P688, DOI 10.1002/2017JG004361; Verduzco VS, 2015, J GEOPHYS RES-BIOGEO, V120, P2081, DOI 10.1002/2015JG003119; Vermote E., 2015, MOD09GQ MODISTERRA S, DOI [10.5067/MODIS/MOD09GQ.006, DOI 10.5067/MODIS/MOD09GQ.006]; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Vivoni ER, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036001; Vogt R, 2006, THEOR APPL CLIMATOL, V84, P117, DOI 10.1007/s00704-005-0149-9; Vogt R, 2003, 5 INT C URB CLIM LOD; Volo TJ, 2015, LANDSCAPE URBAN PLAN, V133, P127, DOI 10.1016/j.landurbplan.2014.09.012; Volo TJ, 2014, ECOHYDROLOGY, V7, P1297, DOI 10.1002/eco.1457; Ward HC, 2015, ENVIRON POLLUT, V198, P186, DOI 10.1016/j.envpol.2014.12.031; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Weissert LF, 2016, ATMOS ENVIRON, V143, P164, DOI 10.1016/j.atmosenv.2016.08.044; White R. P., 2003, DRYLANDS PEOPLE ECOS; Wilczak JM, 2001, BOUND-LAY METEOROL, V99, P127, DOI 10.1023/A:1018966204465; Williams IN, 2015, GEOPHYS RES LETT, V42, P9416, DOI 10.1002/2015GL066305	99	9	9	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228537	10.1371/journal.pone.0228537	http://dx.doi.org/10.1371/journal.pone.0228537			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LG2SL	32049986	gold, Green Published			2022-12-26	WOS:000527957000001
J	Bekele, YA; Fekadu, GA				Bekele, Yibeltal Alemu; Fekadu, Gedefaw Abeje			Factors associated with HIV testing among young females; further analysis of the 2016 Ethiopian demographic and health survey data	PLOS ONE			English	Article								Background HIV counseling and testing are key to control and prevent the spread of the virus and improve the lives of people living with HIV. Although the risk of acquiring the virus is high, only 27% of young Ethiopian women age 15 to 24 years old were tested and counseled for HIV. This coverage is low to achieve the 90-90-90 goal. Identifying factors associated with low utilization of HIV testing and counseling services among young females (aged 15 to 24 years) is important to identify the barriers and improve uptake. Therefore, this analysis was done to identify factors associated with low utilization of HIV counseling and testing services among young Ethiopian women. Methods The study used the 2016 Ethiopian demographic and health survey data. The data was downloaded from The DHS program with permission. A total of 2661 young women (aged 15 to 24 years) were included in the final model. Data was weighted to consider disproportionate sampling and non-response. A Complex data management technique was applied to consider the complex sampling technique used in the DHS. Multivariable logistic regression was used to identify factors associated with HIV testing among young women. Result Among sexually active young women, 33.5% (95%CI; 30.1, 37.1) were tested for HIV. Young women who attended primary ((AOR 2.8; (95% CI; 2.0, 3.9)), secondary (AOR 4.7; (95% CI; 3.1, 7.3)) or higher education (AOR; 5.6; 95% CI; 2.6, 12.0), those who had multiple sexual partners (AOR 5.5; 95% (CI; 1.3, 23.3)), young women who ever used alcohol (AOR 1.46; 95% (CI; 1.1, 2.0)) and young women who visited health care facilities (AOR 1.8; (95% CI; 1.4, 2.3)) had higher odds of being tested for HIV. On the other hand, young women from the rural areas had lower odds (AOR 0.5; (95% CI; 0.3, 0.7)) of being tested for HIV. Conclusion HIV testing among sexually active young women in Ethiopia was low. Educational status, place of residence, alcohol intake, number of sexual partners and visiting health facility 12 months before the survey were found significant predictors of HIV testing. Therefore, the Ethiopian government should encourage girls to complete secondary education to improve HIV testing and counseling. Young women should be encouraged to visit health facilities to improve HIV testing service uptake.	[Bekele, Yibeltal Alemu; Fekadu, Gedefaw Abeje] Bahir Dar Univ, Sch Publ Hlth, Dept Reprod Hlth & Populat Studies, Bahir Dar, Ethiopia	Bahir Dar University	Bekele, YA (corresponding author), Bahir Dar Univ, Sch Publ Hlth, Dept Reprod Hlth & Populat Studies, Bahir Dar, Ethiopia.	yibeltalalemu6@gmail.com	Abeje, Gedefaw/AAL-1098-2021	Bekele, Yibeltal/0000-0003-1272-7824				[Anonymous], ALCOHOLS ROLE HIV TR; [Anonymous], 2018, WOM GIRLS HIV; [Anonymous], 2017, NATL GUIDELINES COMP; [Anonymous], 2015, SUST DEV GOAL; Asaolu IO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164052; Djibuti M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1760-z; Ethiopian Central Statistics Agency (ECSA), 2016, ETH DEM HLTH SURV ED; Ethiopian Ministry of Health, 2015, HLTH SECT TRANSF PLA; Girum T, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3214-6; Hibbett Kristen, 2018, ADDRESSING BARRIERS; Hopkins J., 2015, DRINKING RISKY SEXUA; Ibrahim M., 2013, INT J PREVENTION TRE, V2, P23, DOI DOI 10.5923/j.ijpt.20130203.01; Jamison EA, 2007, ECON EDUC REV, V26, P771, DOI 10.1016/j.econedurev.2007.07.001; Jeremia Damian, 2015, HIV PREVALENCE FACTO; Kennedy Caitlin E., 2014, PROVIDER INITIATED H, P17; Kyaddondo D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-966; MacPhail C, 2009, AIDS CARE, V21, P456, DOI 10.1080/09540120802282586; Mafigiri R, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4166-2; Mahande MJ, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0180-3; Menon AJ., 2017, AFRREV IJAH INT J AR, V6, P130; Molla G., 2015, J AIDS CLIN RES, V6; Musumari PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153452; National Council for Population and Development (NCPD), 2015, DEM HLTH SURV 2014; National Institute of Statistics of Rwanda (NISR) [Rwanda]; Ministry of Health (MOH) [Rwanda]; and ICF International, 2015, RWAND DEM HLTH SURV; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; Nwachukwu C. E., 2011, AFRICAN J REPROD HLT, V15; Oginni A., 2014, SOCIO DEMOGRAPHIC FA, V30; Peltzer K, 2013, AFR HEALTH SCI, V13, P1012, DOI 10.4314/ahs.v13i4.22; Ssebunya RN, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5544-0; Teklehaimanot HD, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2918-z; Uganda Bureau of Statistics (UBOS) and ICF, 2016, UG DEM HLTH SURV 201; UNAIDS, 2016, PRACT GUID MEAN FULL; UNAIDS, 2019, WOM HIV SPOTL AD GIR; UNAIDS State of the epidemic, 2018, NUMB AIDS REL DEATHS; UNICEF, 2018, AD HIV PREV; United Nations Programme on HIV/AIDS (UNAIDS), 2015, GAP REP 2014; WHO/UNAIDS, 2017, STAT HIV TEST SERV N; World Health Organization (WHO), 2019, MAT NEWB CHILD AD HL; World Health Organization (WHO), 2019, STAT HIV TEST SERV	39	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228783	10.1371/journal.pone.0228783	http://dx.doi.org/10.1371/journal.pone.0228783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045460	Green Published, gold			2022-12-26	WOS:000534633200039
J	Richter, AM; Woods, ML; Kuster, MM; Walesch, SK; Braun, T; Boettger, T; Dammann, RH				Richter, Antje M.; Woods, Michelle L.; Kuester, Miriam M.; Walesch, Sara K.; Braun, Thomas; Boettger, Thomas; Dammann, Reinhard H.			RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice	ONCOGENE			English	Article							TUMOR-SUPPRESSOR GENES; DNA METHYLATION; P53; MOUSE; EXPRESSION; FAMILY; HYPERMETHYLATION; SUSCEPTIBILITY; APOPTOSIS; MODEL	Kidney cancer incidences are rising globally, thereby fueling the demand for targeted therapies and precision medicine. In our previous work, we have identified and characterized the Ras-Association Domain Family encoding ten members that are often aberrantly expressed in human cancers. In this study, we created and analyzed the Rassf10 knockout mice. Here we show that Rassf10 haploinsufficiency promotes neoplasia formation in two established mouse cancer models (Rassf1A(-/-) and p53(-/-)). Haploinsufficient Rassf10 knockout mice were significantly prone to various diseases including lymphoma (Rassf1A(-/-) background) and thymoma (p53(-/-) background). Especially Rassf10(-/-) and p53-deficient mice exhibited threefold increased rates of kidney cysts compared with p53(-/-) controls. Moreover, we observed that in human kidney cancer, RASSF10 is frequently epigenetically inactivated by its CpG island promoter hypermethylation. Primary tumors of renal clear cell and papillary cell carcinoma confirmed that RASSF10 methylation is associated with decreased expression in comparison to normal kidney tissue. In independent data sets, we could validate that RASSF10 inactivation clinically correlated with decreased survival and with progressed disease state of kidney cancer patients and polycystic kidney size. Functionally, we revealed that the loss of Rassf10 was significantly associated with upregulation of KRAS signaling and MYC expression. In summary, we could show that Rassf10 functions as a haploinsufficient tumor suppressor. In combination with other markers, RASSF10 silencing can serve as diagnostic and prognostic cancer biomarker in kidney diseases.	[Richter, Antje M.; Woods, Michelle L.; Kuester, Miriam M.; Walesch, Sara K.; Dammann, Reinhard H.] Univ Giessen, Inst Genet, D-35392 Giessen, Germany; [Richter, Antje M.; Braun, Thomas; Boettger, Thomas] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Braun, Thomas; Dammann, Reinhard H.] Univ Giessen & Marburg Lung Ctr, German Ctr Lung Res DZL, D-35392 Giessen, Germany	Justus Liebig University Giessen; Max Planck Society	Richter, AM; Dammann, RH (corresponding author), Univ Giessen, Inst Genet, D-35392 Giessen, Germany.; Richter, AM (corresponding author), Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany.; Dammann, RH (corresponding author), Univ Giessen & Marburg Lung Ctr, German Ctr Lung Res DZL, D-35392 Giessen, Germany.	antje.m.richter@gen.bio.uni-giessen.de; reinhard.dammann@gen.bio.uni-giessen.de	Braun, Thomas/B-2310-2008; Boettger, Thomas/E-3406-2012	Boettger, Thomas/0000-0003-4280-8449; Braun, Thomas/0000-0002-6165-4804	Projekt DEAL	Projekt DEAL	We thank Sylvia Thomas at the MPI for performing the microarrays analysis, Richard Volckmann for his help with R2 data at AMC and Julia Weber and Helga Linder for cloning of the Rassf10 mouse knockout vector. Open access funding provided by Projekt DEAL.	Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen YJ, 2005, WORLD J GASTROENTERO, V11, P1333, DOI 10.3748/wjg.v11.i9.1333; Cheng YY, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/4987103; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Diez-Villanueva A, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0014-8; Doetschman Thomas, 2009, V530, P423, DOI 10.1007/978-1-59745-471-1_23; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Donehower LA, 1996, SEMIN CANCER BIOL, V7, P269, DOI 10.1006/scbi.1996.0035; Dudgeon C, 2014, GENE DEV, V28, P2613, DOI 10.1101/gad.252148.114; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fan C, 2017, CELL PHYSIOL BIOCHEM, V41, P1229, DOI 10.1159/000464386; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Goossens N, 2015, TRANSL CANCER RES, V4, P256, DOI 10.3978/j.issn.2218-676X.2015.06.04; Gostissa M, 2013, P NATL ACAD SCI USA, V110, P2934, DOI 10.1073/pnas.1222570110; GRANTHAM JJ, 1990, AM J KIDNEY DIS, V15, P110, DOI 10.1016/S0272-6386(12)80507-5; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Haag T, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2087-6; Haag Tanja, 2014, Genes Cancer, V5, P365; Han SM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37101-9; Helmbold P, 2012, J INVEST DERMATOL, V132, P687, DOI 10.1038/jid.2011.380; Henry NL, 2012, MOL ONCOL, V6, P140, DOI 10.1016/j.molonc.2012.01.010; Herman JG, 1999, SEMIN CANCER BIOL, V9, P359, DOI 10.1006/scbi.1999.0138; Hesson LB, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-42; Hill VK, 2011, ONCOGENE, V30, P978, DOI 10.1038/onc.2010.471; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Inoue Kazushi, 2017, Adv Med Biol, V118, P83; Issa IA, 2017, WORLD J GASTROENTERO, V23, P5086, DOI 10.3748/wjg.v23.i28.5086; Jimenez AP, 2017, ONCOTARGET, V8, P88437, DOI 10.18632/oncotarget.18177; Johansson J, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00003; Kiehl S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06899; Kirwan A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/490531; Klopstock N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005025; Kornberg Z, 2018, TRANSL ANDROL UROL, V7, P459, DOI 10.21037/tau.2018.06.02; Kuperwasser C, 2000, AM J PATHOL, V157, P2151, DOI 10.1016/S0002-9440(10)64853-5; Li X, 2016, ONCOGENE, V35, P2453, DOI 10.1038/onc.2015.300; Liu W, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.24; Loeb LA, 2016, CANCER RES, V76, P2057, DOI 10.1158/0008-5472.CAN-16-0794; Modhukur V, 2018, EPIGENOMICS-UK, V10, P277, DOI 10.2217/epi-2017-0118; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Morales JK, 2010, GENES IMMUN, V11, P599, DOI 10.1038/gene.2010.35; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Partin AW, 2014, J UROLOGY, V192, P1081, DOI 10.1016/j.juro.2014.04.013; Puccini J, 2013, CELL DEATH DIFFER, V20, P964, DOI 10.1038/cdd.2013.35; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Richter AM, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.18; Richter AM, 2019, CANCERS, V11, DOI 10.3390/cancers11121976; Richter AM, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0360-4; Richter AM, 2016, CANCERS, V8, DOI 10.3390/cancers8030026; Richter AM, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00021; Richter Antje M, 2013, Cancers (Basel), V5, P1566, DOI 10.3390/cancers5041566; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Rivera J, 2008, IMMUNITY, V28, P1, DOI 10.1016/j.immuni.2007.12.008; Santarosa M, 2004, BBA-REV CANCER, V1654, P105, DOI 10.1016/j.bbcan.2004.01.001; Sauter ER, 2017, EUR J BREAST HEALTH, V13, P162, DOI 10.5152/ejbh.2017.3635; Schagdarsurengin U, 2007, ONCOGENE, V26, P3089, DOI 10.1038/sj.onc.1210107; Schagdarsurengin U, 2009, EPIGENETICS-US, V4, P571, DOI 10.4161/epi.4.8.10056; Schonenberger D, 2016, CANCER RES, V76, P2025, DOI 10.1158/0008-5472.CAN-15-1859; Seeger-Nukpezah T, 2015, NAT REV NEPHROL, V11, P515, DOI 10.1038/nrneph.2015.46; Selleck MJ, 2017, BIOMARK INSIGHTS, V12, DOI 10.1177/1177271917715236; Sherwood V, 2010, BIOCHEM J, V425, P303, DOI 10.1042/BJ20091318; Steinmann Katrin, 2011, Genes Cancer, V2, P65, DOI 10.1177/1947601911405043; Stewart GD, 2013, J UROLOGY, V189, P1110, DOI 10.1016/j.juro.2012.08.219; Sweetman D, 2006, DEV DYNAM, V235, P2185, DOI 10.1002/dvdy.20881; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Tommasi S, 2005, CANCER RES, V65, P92; Van Bodegom D, 2006, J BIOL CHEM, V281, P31234, DOI 10.1074/jbc.M606510200; van der Weyden L, 2009, INT J EXP PATHOL, V90, P101, DOI 10.1111/j.1365-2613.2008.00635.x; Vaseva AV, 2018, CANCER CELL, V34, P807, DOI 10.1016/j.ccell.2018.10.001; Vavvas D, 1998, J BIOL CHEM, V273, P5439, DOI 10.1074/jbc.273.10.5439; Vogelmann R, 2005, J CELL SCI, V118, P4901, DOI 10.1242/jcs.02594; Volodko N, 2014, FEBS LETT, V588, P2671, DOI 10.1016/j.febslet.2014.02.041; Wang YF, 2014, BIOMED PHARMACOTHER, V68, P321, DOI 10.1016/j.biopha.2013.12.005; Wei ZR, 2013, BIOCHEM BIOPH RES CO, V432, P632, DOI 10.1016/j.bbrc.2013.02.033; Wystub K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003793; Xie NN, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/7834175; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Zamay TN, 2017, CANCERS, V9, DOI 10.3390/cancers9110155	79	10	10	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	15					3114	3127		10.1038/s41388-020-1195-6	http://dx.doi.org/10.1038/s41388-020-1195-6		FEB 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LB8NS	32047266	Green Published, hybrid			2022-12-26	WOS:000512843500001
J	Yilak, G; Gebretsadik, W; Tadesse, H; Debalkie, M; Bante, A				Yilak, Gizachew; Gebretsadik, Woiynshet; Tadesse, Hiwot; Debalkie, Megbaru; Bante, Agegnehu			Prevalence of ineffective breastfeeding technique and associated factors among lactating mothers attending public health facilities of South Ari district, Southern Ethiopia	PLOS ONE			English	Article							RISK	Introduction Improper positioning, attachment, and suckling are constructs for ineffective breastfeeding technique (IBT). IBT results in inadequate intake of breast milk, which leads to poor weight gain, stunting, and declines immunity. Besides, IBT increases the risk of postpartum breast problems. Despite its impact on maternal and child health, breastfeeding technique is not well studied in Ethiopia. Hence, the purpose of this study was to assess the prevalence of IBT and associated factors among lactating mothers attending public health facilities of South Ari district, Southern Ethiopia. Materials and methods An institution-based cross-sectional study was conducted among 415 lactating mothers attending public health facilities of South Ari district from March 1-29, 2019. A structured observational checklist and interviewer-administered questionnaires were used. Bivariable and multivariable analyses were carried out using binary logistic regression to assess the association between explanatory variables and IBT. Statistical significance was declared at p-value < 0.05. Results Overall, the prevalence of IBT was 63.5% [95% confidence interval (CI); 59.0%, 68.0%]. Having no formal education [adjusted odds ratio (AOR): 5.0, 95% CI: 2.3, 10.5], delivering at home [AOR: 4.5; 95% CI; 1.6, 13.1], having breast problems [AOR: 2.5, 95% CI: 1.1, 5.7], being primiparous [AOR: 1.8, 95% CI: 1.0, 3.2], not receiving counseling during pregnancy and postnatal period [AOR: 2.3, 95% CI: 1.4, 3.9 and AOR: 2.5, 95% CI: 1.3, 5.1 respectively] were significantly associated with IBT. Conclusion IBT was very high in the study area. Thus, empowering women, increasing institutional delivery, and providing continuous counseling about breastfeeding throughout the maternal continuum of care is invaluable to improve breastfeeding techniques.	[Yilak, Gizachew] Mizan Tepi Univ, Coll Med & Hlth Sci, Dept Nursing, Mizan, Ethiopia; [Gebretsadik, Woiynshet; Tadesse, Hiwot; Debalkie, Megbaru; Bante, Agegnehu] Arba Minch Univ, Coll Med & Hlth Sci, Dept Nursing, Arba Minch, Ethiopia	Arba Minch University	Bante, A (corresponding author), Arba Minch Univ, Coll Med & Hlth Sci, Dept Nursing, Arba Minch, Ethiopia.	agegnehubante@gmail.com		Bante, Agegnehu/0000-0003-0583-6635				[Anonymous], 2016, LANCET, V387, P404, DOI 10.1016/S0140-6736(16)00210-5; As' ad S, 2019, INDIAN J PUBLIC HLTH, V10, P838; Santos KJD, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0999-4; Dasgupta U, 2013, INDIAN J MATERNAL CH, V15, P10; Degefa N, 2019, INT J PEDIAT, V2019; Duan X, 2017, OSTEOPOROSIS INT, V28, P495, DOI 10.1007/s00198-016-3753-x; El-Khedr S. M., 2014, Journal of Biology, Agriculture and Healthcare, V4, P56; Ethiopian Public Health Institute (EPHI) [Ethiopia] and ICF, 2019, ETH MIN DEM HLTH SUR; Federal Democratic Republic of Ethiopia Ministry of Health, 2011, INT MAN NEWB CHILDH; Gonzalez-Jimenez E., 2018, SELECTED TOPICS BREA; Goyal RC, 2011, J FAM COMMUNITY MED, V18, P74, DOI 10.4103/2230-8229.83372; Joshi Harshdeep, 2016, J Family Med Prim Care, V5, P309, DOI 10.4103/2249-4863.192373; Kiranmai Tella, 2016, International Journal of Medical Science and Public Health, V5, P28; Kishore MSS, 2009, J TROP PEDIATRICS, V55, P183, DOI 10.1093/tropej/fmn110; Mamta Parashar, 2015, ICAN: Infant, Child & Adolescent Nutrition, V7, P317, DOI 10.1177/1941406415602528; Modugno F, 2019, GYNECOL ONCOL, V153, P116, DOI 10.1016/j.ygyno.2019.01.017; Nagendra K, 2017, SRI LANKA J CHILD HL, V46; Paudel D., 2014, J SCI SOC, V41, P108, DOI [10.4103/0974-5009.132851, DOI 10.4103/0974-5009.132851]; Radzewicz E., 2018, Progress in Health Sciences, V8, P70, DOI 10.5604/01.3001.0012.8324; Rajaei S, 2019, J WOMENS HEALTH, V28, P30, DOI 10.1089/jwh.2018.6970; Sankar MJ, 2015, ACTA PAEDIATR, V104, P3, DOI 10.1111/apa.13147; Singh S, 2013, BREASTFEEDING PRACTI, V11, P219; Thakre SB, 2012, J CLIN DIAGNOSTIC RE, V6; Tiruye G, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0147-z; United Nations Children's Fund (UNICEF) World Health Organization International Bank for Reconstruction and Development/The World Bank, 2019, ZAMB HLTH BUDG BRIEF; Wambach K., 2019, BREASTFEEDING HUMAN, V6th, P820; Westerfield KL, 2018, AM FAMILY PHYS, V98; WHO, 2009, INF YOUNG CHILD FEED; WHO & UNICEF (World Health Organization & UNICEF), 1993, BREASTF COUNS TRAIN; World Health Organization, 2014, BREASTF COUNS TRAIN; World Health Organization, 2018, WOM BREAST FEED PRAC; Yasmeen T, 2019, INT J MED SCI DIAGNO, V3, P44	32	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228863	10.1371/journal.pone.0228863	http://dx.doi.org/10.1371/journal.pone.0228863			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045451	Green Published, gold			2022-12-26	WOS:000534633200044
J	Lepa, C; Moeller-Kerutt, A; Stoelting, M; Picciotto, C; Eddy, ML; Butt, E; Kerjaschki, D; Korb-Pap, A; Vollenbroeker, B; Weide, T; George, B; Kremerskothen, J; Pavenstaedt, H				Lepa, Carolin; Moeller-Kerutt, Annika; Stoelting, Miriam; Picciotto, Cara; Eddy, Mee-Ling; Butt, Elke; Kerjaschki, Dontscho; Korb-Pap, Adelheid; Vollenbroeker, Beate; Weide, Thomas; George, Britta; Kremerskothen, Joachim; Pavenstaedt, Hermann			LIM and SH3 protein 1 (LASP-1): A novel link between the slit membrane and actin cytoskeleton dynamics in podocytes	FASEB JOURNAL			English	Article						actin cytoskeleton; angiotensin; CD2AP; nephrocyte; slit membrane	NUCLEAR-LOCALIZATION; DIAPHRAGM; CD2AP; PHOSPHORYLATION; OVEREXPRESSION; SYSTEM; BINDS; CELL	The foot processes of podocytes exhibit a dynamic actin cytoskeleton, which maintains their complex cell structure and antagonizes the elastic forces of the glomerular capillary. Interdigitating secondary foot processes form a highly selective filter for proteins in the kidney, the slit membrane. Knockdown of slit membrane components such as Nephrin or Neph1 and cytoskeletal adaptor proteins such as CD2AP in mice leads to breakdown of the filtration barrier with foot process effacement, proteinuria, and early death of the mice. Less is known about the crosstalk between the slit membrane-associated proteins and cytoskeletal components inside the podocyte foot processes. Our study shows that LASP-1, an actin-binding protein, is highly expressed in podocytes. Electron microscopy studies demonstrate that LASP-1 is found at the slit membrane suggesting a role in anchoring slit membrane components to the actin cytoskeleton. Live cell imaging experiments with transfected podocytes reveal that LASP-1 is either part of a highly dynamic granular complex or a static, actin cytoskeleton-bound protein. We identify CD2AP as a novel LASP-1 binding partner that regulates its association with the actin cytoskeleton. Activation of the renin-angiotensin-aldosterone system, which is crucial for podocyte function, leads to phosphorylation and altered localization of LASP-1. In vivo studies using the Drosophila nephrocyte model indicate that Lasp is necessary for the slit membrane integrity and functional filtration.	[Lepa, Carolin; Moeller-Kerutt, Annika; Stoelting, Miriam; Picciotto, Cara; Eddy, Mee-Ling; Vollenbroeker, Beate; Weide, Thomas; George, Britta; Kremerskothen, Joachim; Pavenstaedt, Hermann] Univ Klinikum Munster, Med Klin & Poliklin D, Munster, Germany; [Butt, Elke] Klinikum Julius Maximilians Univ Wurzburg, Inst Expt Biomed 2, Wurzburg, Germany; [Kerjaschki, Dontscho] Med Univ Wien, Klin Inst Pathol, Vienna, Austria; [Korb-Pap, Adelheid] Univ Klinikum Munster, Inst Expt Muskuloskelettale Med, Munster, Germany	University of Munster; University of Wurzburg; Medical University of Vienna; University of Munster	Kremerskothen, J (corresponding author), Univ Hosp Munster, Dept Mol Nephrol, Albert Schweitzer Campus 1, D-48149 Munster, Germany.	kremers@uni-muenster.de	George, Britta/AAL-2031-2021	George, Britta/0000-0001-5430-5086				Butt E, 2003, J BIOL CHEM, V278, P15601, DOI 10.1074/jbc.M209009200; Butt E, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00391; Chew CS, 2002, J CELL SCI, V115, P4787, DOI 10.1242/jcs.00174; Duvall-Noelle N, 2016, ONCOGENE, V35, P1122, DOI 10.1038/onc.2015.166; Frietsch JJ, 2010, BRIT J CANCER, V102, P1645, DOI 10.1038/sj.bjc.6605685; Fu YL, 2017, HUM MOL GENET, V26, P768, DOI 10.1093/hmg/ddw428; George B, 2012, SEMIN NEPHROL, V32, P307, DOI 10.1016/j.semnephrol.2012.06.002; Grahammer F, 2013, NAT REV NEPHROL, V9, P587, DOI 10.1038/nrneph.2013.169; Grunewald TGP, 2007, BRIT J CANCER, V96, P296, DOI 10.1038/sj.bjc.6603545; Grunewald TGP, 2007, BMC CANCER, V7, P1, DOI 10.1186/1471-2407-7-198; Helmstadter M, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00262; Hochapfel F, 2017, CELL MOL LIFE SCI, V74, P4573, DOI 10.1007/s00018-017-2593-y; Hsu HH, 2008, J MOL MED, V86, P1379, DOI 10.1007/s00109-008-0399-y; Marquez E, 2015, AM J PHYSIOL-RENAL, V308, P1; Mihlan S, 2013, ONCOGENE, V32, P2107, DOI 10.1038/onc.2012.216; Orth MF, 2015, ONCOTARGET, V6, P26, DOI 10.18632/oncotarget.3083; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Regele HM, 2000, J AM SOC NEPHROL, V11, P403, DOI 10.1681/ASN.V113403; Ruggieri V, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317705757; Schenk LK, 2017, FASEB J, V31, P5019, DOI 10.1096/fj.201700142R; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Tossidou I, 2007, J BIOL CHEM, V282, P7457, DOI 10.1074/jbc.M608519200; Viney RL, 2007, PROTEOMICS, V7, P804, DOI 10.1002/pmic.200600666; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526; Welsch T, 2005, AM J PHYSIOL-RENAL, V289, pF1134, DOI 10.1152/ajprenal.00178.2005; Wennmann DO, 2012, SEMIN NEPHROL, V32, P377, DOI 10.1016/j.semnephrol.2012.06.009; Yu SMW, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00221	29	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5453	5464		10.1096/fj.201901443R	http://dx.doi.org/10.1096/fj.201901443R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32086849	Green Published, hybrid			2022-12-26	WOS:000530242100041
J	Zhang, H; Shen, Z; Lin, YM; Zhang, J; Zhang, YW; Liu, PH; Zeng, H; Yu, ML; Chen, XY; Ning, LG; Mao, XL; Cen, L; Yu, CH; Xu, CF				Zhang, Hong; Shen, Zhe; Lin, Yiming; Zhang, Jie; Zhang, Yuwei; Liu, Peihao; Zeng, Hang; Yu, Mengli; Chen, Xueyang; Ning, Longgui; Mao, Xinli; Cen, Li; Yu, Chaohui; Xu, Chengfu			Vitamin D receptor targets hepatocyte nuclear factor 4? and mediates protective effects of vitamin D in nonalcoholic fatty liver disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vitamin D; nuclear receptor; liver metabolism; lipid metabolism; insulin resistance; gene regulation; hepatic steatosis; hepatocyte nuclear factor 4? (HNF4?); metabolic syndrome; nonalcoholic fatty liver disease (NAFLD)	TRANSCRIPTION FACTOR; GENE-EXPRESSION; D DEFICIENCY; OBESITY; STEATOHEPATITIS; PATHOGENESIS; METABOLISM; RESISTANCE; HISTOLOGY; FIBROSIS	Epidemiological studies have suggested a link between vitamin D deficiency and increased risk for nonalcoholic fatty liver disease (NAFLD); however, the underlying mechanisms have remained unclear. Here, using both clinical samples and experimental rodent models along with several biochemical approaches, we explored the specific effects and mechanisms of vitamin D deficiency in NAFLD pathology. Serum vitamin D levels were significantly lower in individuals with NAFLD and in high-fat diet (HFD)-fed mice than in healthy controls and chow-fed mice, respectively. Vitamin D supplementation ameliorated HFD-induced hepatic steatosis and insulin resistance in mice. Hepatic expression of vitamin D receptor (VDR) was up-regulated in three models of NAFLD, including HFD-fed mice, methionine/choline-deficient diet (MCD)-fed mice, and genetically obese (ob/ob) mice. Liver-specific VDR deletion significantly exacerbated HFD- or MCD-induced hepatic steatosis and insulin resistance and also diminished the protective effect of vitamin D supplementation on NAFLD. Mechanistic experiments revealed that VDR interacted with hepatocyte nuclear factor 4 ? (HNF4?) and that overexpression of HNF4? improved HFD-induced NAFLD and metabolic abnormalities in liver-specific VDR-knockout mice. These results suggest that vitamin D ameliorates NAFLD and metabolic abnormalities by activating hepatic VDR, leading to its interaction with HNF4?. Our findings highlight a potential value of using vitamin D for preventing and managing NAFLD by targeting VDR.	[Zhang, Hong; Shen, Zhe; Lin, Yiming; Zhang, Jie; Zhang, Yuwei; Liu, Peihao; Zeng, Hang; Yu, Mengli; Chen, Xueyang; Ning, Longgui; Mao, Xinli; Cen, Li; Yu, Chaohui; Xu, Chengfu] Zhejiang Univ, Coll Med, Dept Gastroenterol, Affiliated Hosp 1, Hangzhou 310003, Peoples R China; [Mao, Xinli] Taizhou Hosp Zhejiang Prov, Dept Gastroenterol, Linhai 317000, Peoples R China	Zhejiang University	Yu, CH; Xu, CF (corresponding author), Zhejiang Univ, Coll Med, Dept Gastroenterol, Affiliated Hosp 1, Hangzhou 310003, Peoples R China.	zyyyych@zju.edu.cn; xiaofu@zju.edu.cn	Xu, Cheng/GXH-4815-2022; Shen, Zhe/CVP-6409-2022	Xu, Cheng/0000-0003-1000-733X; 	National Key R&D Program of China [2017YFC0908900, 2018YFA0109800]; National Natural Science Foundation of China [81570523, 81700485, 81722009, 81770573, U180321]; Key Research and Development Program of Zhejiang Province Grant [2020C03033]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Program of Zhejiang Province Grant	This work was supported by National Key R&D Program of China Grants 2017YFC0908900 and 2018YFA0109800, National Natural Science Foundation of China Grants 81570523, 81700485, 81722009, 81770573, and U180321, and Key Research and Development Program of Zhejiang Province Grant 2020C03033. The authors declare that they have no conflicts of interest with the contents of this article.	Abramovitch S, 2011, GUT, V60, P1728, DOI 10.1136/gut.2010.234666; Anstee QM, 2019, NAT REV GASTRO HEPAT, V16, P411, DOI 10.1038/s41575-019-0145-7; Baciu C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189223; Bagamasbad P, 2011, GEN COMP ENDOCR, V170, P3, DOI 10.1016/j.ygcen.2010.03.013; Barchetta I, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0638-y; Barchetta I, 2012, HEPATOLOGY, V56, P2180, DOI 10.1002/hep.25930; Bertrand L, 2008, CARDIOVASC RES, V79, P238, DOI 10.1093/cvr/cvn093; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Bozic M, 2016, J HEPATOL, V65, P748, DOI 10.1016/j.jhep.2016.05.031; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Cave MC, 2016, BBA-GENE REGUL MECH, V1859, P1083, DOI 10.1016/j.bbagrm.2016.03.002; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Dasarathy J, 2014, LIVER INT, V34, pE118, DOI 10.1111/liv.12312; Della Corte C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168216; Diehl AM, 2017, NEW ENGL J MED, V377, P2063, DOI 10.1056/NEJMra1503519; Dwivedi PP, 2000, J BIOL CHEM, V275, P47, DOI 10.1074/jbc.275.1.47; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Finck BN, 2018, DIABETES, V67, P2485, DOI 10.2337/dbi18-0024; Geldenhuys S, 2014, DIABETES, V63, P3759, DOI 10.2337/db13-1675; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Grammatiki M, 2019, HORM-INT J ENDOCRINO, V18, P37, DOI 10.1007/s42000-018-0063-z; Han SX, 2009, DRUG METAB DISPOS, V37, P469, DOI 10.1124/dmd.108.025155; HUGHES MR, 1988, SCIENCE, V242, P1702, DOI 10.1126/science.2849209; Jahn D, 2019, BBA-MOL BASIS DIS, V1865, P1567, DOI 10.1016/j.bbadis.2019.03.007; Jais A, 2017, J CLIN INVEST, V127, P24, DOI 10.1172/JCI88878; Kitson MT, 2016, GUT, V65, DOI 10.1136/gutjnl-2015-310417; Kousteni S, 2012, BONE, V50, P437, DOI 10.1016/j.bone.2011.06.034; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Lee MS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05721-4; Li J, 2015, J BIOL CHEM, V290, P24021, DOI 10.1074/jbc.M115.645200; Li M, 2018, GUT, V67, P2169, DOI 10.1136/gutjnl-2017-313778; Li YY, 2016, HEPATOLOGY, V63, P1860, DOI 10.1002/hep.28472; Moore DD, 2006, PHARMACOL REV, V58, P742, DOI 10.1124/pr.58.4.6; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Nelson JE, 2016, AM J GASTROENTEROL, V111, P852, DOI 10.1038/ajg.2016.51; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Nobili V, 2015, GUT, V64, P698, DOI 10.1136/gutjnl-2014-308175; Pedigo NG, 2005, ONCOGENE, V24, P2654, DOI 10.1038/sj.onc.1208336; ROSS TK, 1993, P NATL ACAD SCI USA, V90, P9257, DOI 10.1073/pnas.90.20.9257; Roth CL, 2012, HEPATOLOGY, V55, P1103, DOI 10.1002/hep.24737; Shaffer PL, 2002, EMBO J, V21, P2242, DOI 10.1093/emboj/21.9.2242; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Targher G, 2007, NUTR METAB CARDIOVAS, V17, P517, DOI 10.1016/j.numecd.2006.04.002; Tilg H, 2017, NAT REV GASTRO HEPAT, V14, P32, DOI 10.1038/nrgastro.2016.147; Wan LY, 2015, MOLECULES, V20, P12389, DOI 10.3390/molecules200712389; Wang SY, 2012, CELL METAB, V16, P473, DOI 10.1016/j.cmet.2012.09.003; Watt MJ, 2019, ENDOCR REV, V40, P1367, DOI 10.1210/er.2019-00034; Wei Z, 2018, CELL, V173, P1135, DOI 10.1016/j.cell.2018.04.013; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Wong VWS, 2016, LANCET GASTROENTEROL, V1, P56, DOI 10.1016/S2468-1253(16)30011-5; Xiao L, 2010, ADV DRUG DELIVER REV, V62, P1316, DOI 10.1016/j.addr.2010.07.006; Xie LF, 2016, J HEPATOL, V65, P113, DOI 10.1016/j.jhep.2016.03.008; Xu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8466; Yin LY, 2011, ARTERIOSCL THROM VAS, V31, P328, DOI 10.1161/ATVBAHA.110.217828; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zhou F, 2019, HEPATOLOGY, V70, P1119, DOI 10.1002/hep.30702	57	25	26	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3891	3905		10.1074/jbc.RA119.011487	http://dx.doi.org/10.1074/jbc.RA119.011487			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32051143	hybrid, Green Published			2022-12-26	WOS:000527704400014
J	Brom, P; Anderson, P; Channing, A; Underhill, LG				Brom, Peta; Anderson, Pippin; Channing, Alan; Underhill, Leslie G.			The role of cultural norms in shaping attitudes towards amphibians in Cape Town, South Africa	PLOS ONE			English	Article							CONSERVATION; BIODIVERSITY; WETLANDS; CONNECTEDNESS; PERCEPTIONS; MOTIVATIONS; TOLERANCE; BELIEFS; DISGUST; VALUES	Urban ecosystems are increasingly viewed as an important component within strategies for wildlife conservation but are shaped as much by natural systems as they are by social and political processes. At the garden scale, attitudes and preferences govern design and maintenance choices including the decision to encourage or discourage specific faunal presence. At the global scale, charismatic taxa that are well-liked attract more conservation funding and volunteer stewardship. Amphibians are a class of animals that are both loved and loathed making them a suitable subject for comparing and unpacking the drivers of preference and attitudes towards animals. We conducted a mixed methods survey of 192 participants in three adjacent neighbourhoods in Cape Town, South Africa. The survey included both quantitative and qualitative questions which were analysed thematically and used to explain the quantitative results. The results revealed that attitudes formed during childhood tended to be retained into adulthood, were shaped by cultural norms, childhood experiences and the attitudes of primary care-givers. The findings are significant for environmental education programmes aimed at building connectedness to nature and biophilic values.	[Brom, Peta; Anderson, Pippin] Univ Cape Town, Dept Environm & Geog Sci, Rondebosch, South Africa; [Channing, Alan] North West Univ, Unit Environm Sci & Management, Potchefstroom, South Africa; [Underhill, Leslie G.] Univ Cape Town, Dept Biol Sci, Rondebosch, South Africa	University of Cape Town; North West University - South Africa; University of Cape Town	Brom, P (corresponding author), Univ Cape Town, Dept Environm & Geog Sci, Rondebosch, South Africa.	brompeta@gmail.com	Brom, Peta/AAD-5669-2021	Brom, Peta/0000-0002-9183-438X; Anderson, Pippin/0000-0003-3716-1206				[Anonymous], 2011, EURASIA J MATH SCI T, DOI [10.12973/ejmste/75207, DOI 10.12973/EJMSTE/75207]; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Belaire JA, 2016, LANDSCAPE ECOL, V31, P401, DOI 10.1007/s10980-015-0256-7; CARRUTHERS V. C., 2009, COMPLETE GUIDE FROGS; Ceriaco LMP, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-8; Clayton S, 2007, J ENVIRON PSYCHOL, V27, P215, DOI 10.1016/j.jenvp.2007.06.001; de Groot JM, 2010, J ENVIRON PSYCHOL, V30, P368, DOI 10.1016/j.jenvp.2010.04.002; de Groot WT, 2003, LANDSCAPE URBAN PLAN, V63, P127, DOI 10.1016/S0169-2046(02)00184-6; Duerden MD, 2010, J ENVIRON PSYCHOL, V30, P379, DOI 10.1016/j.jenvp.2010.03.007; Freeman C, 2012, J ENVIRON PSYCHOL, V32, P135, DOI 10.1016/j.jenvp.2012.01.005; Goddard MA, 2013, ECOL ECON, V86, P258, DOI 10.1016/j.ecolecon.2012.07.016; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Hammond-Tooke WD, 1999, S AFR ARCHAEOL BULL, V54, P128, DOI 10.2307/3889291; Hassall C, 2015, HYDROBIOLOGIA, V745, P137, DOI 10.1007/s10750-014-2100-5; Hocking DJ, 2014, HERPETOL CONSERV BIO, V9, P1; Hunter LM, 2004, HUM ECOL REV, V11, P13; Ives CD, 2016, GLOBAL ECOL BIOGEOGR, V25, P117, DOI 10.1111/geb.12404; Kiesling FM, 2010, J ENVIRON PSYCHOL, V30, P315, DOI 10.1016/j.jenvp.2010.02.004; Klassen MJ, 2010, CLEAN COMBUSTION LIQ, P1; Knight AJ, 2008, J ENVIRON PSYCHOL, V28, P94, DOI 10.1016/j.jenvp.2007.10.001; Kruger DJD, 2015, URBAN ECOSYST, V18, P1333, DOI 10.1007/s11252-015-0443-y; Larson KL, 2009, ENVIRON MANAGE, V44, P921, DOI 10.1007/s00267-009-9353-1; Le Viol I, 2012, ECOL ENG, V47, P146, DOI 10.1016/j.ecoleng.2012.06.031; Macbeth Shakespeare W., 1989, NINTH; Magle SB, 2012, BIOL CONSERV, V155, P23, DOI 10.1016/j.biocon.2012.06.018; Martin C, 2017, J ENVIRON PSYCHOL, V52, P56, DOI 10.1016/j.jenvp.2017.04.009; Mayer FS, 2004, J ENVIRON PSYCHOL, V24, P503, DOI 10.1016/j.jenvp.2004.10.001; Measey GJ, 2011, SANBI BIODIVERS SER, P1; Merckelbach H, 1997, BEHAV RES THER, V35, P1031, DOI 10.1016/S0005-7967(97)00054-5; Mokhatla MM, 2015, S AFR J SCI, V111, P171, DOI 10.17159/sajs.2015/20140389; Nassauer JI, 2009, LANDSCAPE URBAN PLAN, V92, P282, DOI 10.1016/j.landurbplan.2009.05.010; Ownby CarolanPostma., 1981, S AFRICAN J AFRICAN, V1, P60, DOI [10.1080/02572117.1981.10586450, DOI 10.1080/02572117.1981.10586450]; Palmer J.A., 1999, ENVIRON EDUC RES, V5, P181, DOI [10.1080/1350462980040408, DOI 10.1080/1350462980040408, https://doi.org/10.1080/1350462990050205, DOI 10.1080/1350462990050205]; Pooley JA, 2000, ENVIRON BEHAV, V32, P711, DOI 10.1177/0013916500325007; Prokop P., 2018, Ethnozoology: animals in our lives, P447; Prokop P, 2013, ANIM CONSERV, V16, P458, DOI 10.1111/acv.12014; Prokop P, 2016, EURASIA J MATH SCI T, V12, P1499, DOI 10.12973/eurasia.2016.1241a; Prokop P, 2012, ANTHROZOOS, V25, P277, DOI 10.2752/175303712X13403555186136; Randler C, 2012, SOC ANIM, V20, P61, DOI 10.1163/156853012X614369; Rose W., 1929, ACCOUNT S AFRICAN FR; Scheffers BR, 2013, LANDSCAPE URBAN PLAN, V113, P139, DOI 10.1016/j.landurbplan.2013.01.001; Scheffers BR, 2012, URBAN ECOSYST, V15, P133, DOI 10.1007/s11252-011-0199-y; Schlegel J, 2010, J NAT CONSERV, V18, P278, DOI 10.1016/j.jnc.2009.12.002; Simon JA, 2009, LANDSCAPE ECOL, V24, P361, DOI 10.1007/s10980-008-9311-y; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tarrant J, 2016, AFR ZOOL, V51, P13, DOI 10.1080/15627020.2015.1122554; Tomazic I, 2011, SOC ANIM, V19, P225, DOI [10.1163/156853011X578901, 10.1163/156853011x578901]; United Nations, 2018, WORLD URB PROSP 2018, P1; Wells N.M., 2006, J ENVIRON PSYCHOL, V16, P1, DOI DOI 10.1016/j.jenvp.2010.10.001; Westgate MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140973	50	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0219331	10.1371/journal.pone.0219331	http://dx.doi.org/10.1371/journal.pone.0219331			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8DW	32092067	Green Published, gold, Green Submitted			2022-12-26	WOS:000535229300003
J	Denesyuk, A; Dimitriou, PS; Johnson, MS; Nakayama, T; Denessiouk, K				Denesyuk, Alexander; Dimitriou, Polytimi S.; Johnson, Mark S.; Nakayama, Toru; Denessiouk, Konstantin			The acid-base-nucleophile catalytic triad in ABH-fold enzymes is coordinated by a set of structural elements	PLOS ONE			English	Article							PALMITOYL-PROTEIN THIOESTERASE; HALOALKANE DEHALOGENASE LINB; C-BOND HYDROLASE; CRYSTAL-STRUCTURE; BACILLUS-SUBTILIS; MOLECULAR-BASIS; PROLYL OLIGOPEPTIDASE; RESOLUTION STRUCTURE; DIRECTED EVOLUTION; SUBSTRATE-BINDING	The alpha/beta-Hydrolases (ABH) are a structural class of proteins that are found widespread in nature and includes enzymes that can catalyze various reactions in different substrates. The catalytic versatility of the ABH fold enzymes, which has been a valuable property in protein engineering applications, is based on a similar acid-base-nucleophile catalytic mechanism. In our research, we are concerned with the structure that surrounds the key units of the catalytic machinery, and we have previously found conserved structural organizations that coordinate the catalytic acid, the catalytic nucleophile and the residues of the oxyanion hole. Here, we explore the architecture that surrounds the catalytic histidine at the active sites of enzymes from 40 ABH fold families, where we have identified six conserved interactions that coordinate the catalytic histidine next to the catalytic acid and the catalytic nucleophile. Specifically, the catalytic nucleophile is coordinated next to the catalytic histidine by two weak hydrogen bonds, while the catalytic acid is directly involved in the coordination of the catalytic histidine through by two weak hydrogen bonds. The imidazole ring of the catalytic histidine is coordinated by a CH-p contact and a hydrophobic interaction. Moreover, the catalytic triad residues are connected with a residue that is located at the core of the active site of ABH fold, which is suggested to be the fourth member of a "structural catalytic tetrad". Besides their role in the stability of the catalytic mechanism, the conserved elements of the catalytic site are actively involved in ligand binding and affect other properties of the catalytic activity, such as substrate specificity, enantioselectivity, pH optimum and thermostability of ABH fold enzymes. These properties are regularly targeted in protein engineering applications, and thus, the identified conserved structural elements can serve as potential modification sites in order to develop ABH fold enzymes with altered activities.	[Denesyuk, Alexander; Dimitriou, Polytimi S.; Johnson, Mark S.; Denessiouk, Konstantin] Abo Akad Univ, Fac Sci & Engn, Struct Bioinformat Lab, Biochem, Turku, Finland; [Denesyuk, Alexander] Russian Acad Sci, Inst Biol Instrumentat, Fed Res Ctr, Pushchino Sci Ctr Biol Res, Pushchino, Russia; [Nakayama, Toru] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi, Japan	Abo Akademi University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Tohoku University	Denesyuk, A (corresponding author), Abo Akad Univ, Fac Sci & Engn, Struct Bioinformat Lab, Biochem, Turku, Finland.; Denesyuk, A (corresponding author), Russian Acad Sci, Inst Biol Instrumentat, Fed Res Ctr, Pushchino Sci Ctr Biol Res, Pushchino, Russia.	adenesyu@abo.fi		Denesyuk, Alexander/0000-0002-5461-2294	Sigrid Juselius Foundation; Joe, Pentti and Tor Borg Memorial Fund; Magnus Ehrnrooth foundation; Finnish Cultural Foundation; Abo Akademi Doctoral Network of Informational and Structural Biology	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Joe, Pentti and Tor Borg Memorial Fund; Magnus Ehrnrooth foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Abo Akademi Doctoral Network of Informational and Structural Biology	This work is supported by a grant from the Sigrid Juselius Foundation to MSJ and Joe, Pentti and Tor Borg Memorial Fund to KD. PSD is funded by the Abo Akademi Doctoral Network of Informational and Structural Biology, the Magnus Ehrnrooth foundation and the Finnish Cultural Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Biocenter Finland Bioinformatics Network (Dr. Jukka Lehtonen) and CSC IT Center for Science for computational support for the project. The Structural Bioinformatics Laboratory is part of the Drug Development and Diagnostics Platform of Abo Akademi University.	Agarwal V, 2012, P NATL ACAD SCI USA, V109, P17406, DOI 10.1073/pnas.1207028109; Alcaide M, 2013, BIOCHEM J, V454, P157, DOI 10.1042/BJ20130552; Alvarez Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092257; [Anonymous], 2017, DISCOVERY STUDIO MOD; Arndt JW, 2005, PROTEINS, V58, P755, DOI 10.1002/prot.20336; Auldridge ME, 2012, PLANT CELL, V24, P1596, DOI 10.1105/tpc.111.093997; Austin HP, 2018, P NATL ACAD SCI USA, V115, pE4350, DOI 10.1073/pnas.1718804115; Baath JA, 2019, J BIOL CHEM, V294, P6635, DOI 10.1074/jbc.RA119.007831; Bartlam M, 2004, STRUCTURE, V12, P1481, DOI 10.1016/j.str.2004.05.019; Bastard K, 2017, NAT CHEM BIOL, V13, P858, DOI 10.1038/nchembio.2397; Bellizzi JJ, 2000, P NATL ACAD SCI USA, V97, P4573, DOI 10.1073/pnas.080508097; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhowmik S, 2007, J BIOL CHEM, V282, P36377, DOI 10.1074/jbc.M707035200; Bordes F, 2009, CHEMBIOCHEM, V10, P1705, DOI 10.1002/cbic.200900215; Boublik Y, 2002, PROTEIN ENG, V15, P43, DOI 10.1093/protein/15.1.43; Bourne PC, 2000, STRUCTURE, V8, P143, DOI 10.1016/S0969-2126(00)00090-3; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; Brezovsky J, 2016, ACS CATAL, V6, P7597, DOI 10.1021/acscatal.6b02081; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Bythell-Douglas R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054758; Czekster CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00862-4; Das AK, 2000, J BIOL CHEM, V275, P23847, DOI 10.1074/jbc.M002758200; De Simone G, 2001, J MOL BIOL, V314, P507, DOI 10.1006/jmbi.2001.5152; DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492; DEREWENDA ZS, 1994, J MOL BIOL, V241, P83, DOI 10.1006/jmbi.1994.1475; Devedjiev Y, 2000, STRUCTURE, V8, P1137, DOI 10.1016/S0969-2126(00)00529-3; Dimitriou PS, 2019, PROTEIN SCI, V28, P344, DOI 10.1002/pro.3527; Dimitriou PS, 2017, PROTEINS, V85, P1845, DOI 10.1002/prot.25338; Dou S, 2014, BIOCHEM BIOPH RES CO, V446, P1145, DOI 10.1016/j.bbrc.2014.03.072; Droge MJ, 2006, CHEMBIOCHEM, V7, P149, DOI 10.1002/cbic.200500308; EGLOFF MP, 1995, BIOCHEMISTRY-US, V34, P2751, DOI 10.1021/bi00009a003; Elmi F, 2002, J BACTERIOL, V187, P8470; Engel M, 2006, J MOL BIOL, V355, P768, DOI 10.1016/j.jmb.2005.11.014; Engel M, 2003, P NATL ACAD SCI USA, V100, P5063, DOI 10.1073/pnas.0230620100; Fournier D, 2005, CHEM-BIOL INTERACT, V157, P257, DOI 10.1016/j.cbi.2005.10.040; Fu J, 2013, APPL MICROBIOL BIOT, V97, P3965, DOI 10.1007/s00253-012-4276-9; Fulop V, 2001, J BIOL CHEM, V276, P1262, DOI 10.1074/jbc.M007003200; Ghosh D, 1999, ACTA CRYSTALLOGR D, V55, P779, DOI 10.1107/S0907444999000244; Ghosh D, 2001, J BIOL CHEM, V276, P11159, DOI 10.1074/jbc.M008831200; Goettig P, 2002, EMBO J, V21, P5343, DOI 10.1093/emboj/cdf552; Gorman J, STRUCTURAL GENOMICS; Gruninger RJ, 2016, BIOCHEM J, V473, P839, DOI 10.1042/BJ20151153; Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063; Heikinheimo P, 1999, STRUCTURE, V7, pR141, DOI 10.1016/S0969-2126(99)80079-3; Hisano T, 2006, J MOL BIOL, V356, P993, DOI 10.1016/j.jmb.2005.12.028; Hofmann B, 1998, J MOL BIOL, V279, P889, DOI 10.1006/jmbi.1998.1802; Horsman GP, 2006, BIOCHEMISTRY-US, V45, P11071, DOI 10.1021/bi0611098; Janda I, 2004, ACTA CRYSTALLOGR D, V60, P1101, DOI 10.1107/S0907444904007188; Jansson A, 2003, J BIOL CHEM, V278, P39006, DOI 10.1074/jbc.M304008200; Jochens H, 2011, CHEMBIOCHEM, V12, P1508, DOI 10.1002/cbic.201000771; Johnston JM, 2010, ACTA CRYSTALLOGR D, V66, P909, DOI 10.1107/S0907444910025771; Joo S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02881-1; Kanamaru S, 2005, J MOL BIOL, V346, P1013, DOI 10.1016/j.jmb.2004.12.042; Kawasaki K, 2002, ACTA CRYSTALLOGR D, V58, P1168, DOI 10.1107/S090744490200714X; Kim HK, 2005, ACTA CRYSTALLOGR D, V61, P920, DOI 10.1107/S0907444905009042; Kitadokoro K, 2019, FEBS J, V286, P2087, DOI 10.1111/febs.14781; Kitadokoro K, 2012, POLYM DEGRAD STABIL, V97, P771, DOI 10.1016/j.polymdegradstab.2012.02.003; Klvana M, 2009, J MOL BIOL, V392, P1339, DOI 10.1016/j.jmb.2009.06.076; Knapik AA, 2012, PROTEINS, V80, P2359, DOI 10.1002/prot.24122; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krem MM, 2001, EMBO J, V20, P3036, DOI 10.1093/emboj/20.12.3036; Krooshof GH, 1998, BIOCHEMISTRY-US, V37, P15013, DOI 10.1021/bi9815187; Lai KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023269; Larsen NA, 2006, BIOCHEMISTRY-US, V45, P10184, DOI 10.1021/bi060950i; Legler PM, 2008, BIOCHEMISTRY-US, V47, P9592, DOI 10.1021/bi8010016; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Lemak S, 2012, BIOCHEM J, V445, P193, DOI 10.1042/BJ20112113; Lenfant N, 2013, NUCLEIC ACIDS RES, V41, pD423, DOI 10.1093/nar/gks1154; LIAO DI, 1992, BIOCHEMISTRY-US, V31, P9796, DOI 10.1021/bi00155a037; Liu P, 2004, J MOL BIOL, V342, P551, DOI 10.1016/j.jmb.2004.06.069; Liu P, 2007, J MOL BIOL, V367, P212, DOI 10.1016/j.jmb.2006.12.067; McAuley KE, 2004, ACTA CRYSTALLOGR D, V60, P878, DOI 10.1107/S0907444904004937; McKary MG, 2016, BIOCHEMISTRY-US, V55, P7099, DOI 10.1021/acs.biochem.6b01057; Menyhard DK, 2015, ACTA CRYSTALLOGR D, V71, P461, DOI 10.1107/S1399004714026819; Mindrebo JT, 2016, CURR OPIN STRUC BIOL, V41, P233, DOI 10.1016/j.sbi.2016.08.005; Mirza IA, 2005, BIOCHEMISTRY-US, V44, P15768, DOI 10.1021/bi051951y; Monincova M, 2007, APPL ENVIRON MICROB, V73, P2005, DOI 10.1128/AEM.02416-06; Murayama K, 2005, PROTEINS, V58, P982, DOI 10.1002/prot.20361; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Naffin-Olivos JL, 2017, BIOCHEMISTRY-US, V56, P2304, DOI 10.1021/acs.biochem.6b01066; Nakajima Y, 2006, J BACTERIOL, V188, P1599, DOI 10.1128/JB.188.4.1599-1606.2006; Narasimhan D, 2011, MOL PHARMACOL, V80, P1056, DOI 10.1124/mol.111.074997; Narasimhan D, 2010, PROTEIN ENG DES SEL, V23, P537, DOI 10.1093/protein/gzq025; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Truongvan N, 2016, EXTREMOPHILES, V20, P187, DOI 10.1007/s00792-016-0812-3; Nishio M, 2014, PHYS CHEM CHEM PHYS, V16, P12648, DOI 10.1039/c4cp00099d; Oakley AJ, 2004, BIOCHEMISTRY-US, V43, P870, DOI 10.1021/bi034748g; Ohara K, 2014, J BIOL CHEM, V289, P24499, DOI 10.1074/jbc.M113.521856; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Osipiuk J, CRYSTAL STRUCTURE HY; Padmanabhan B, 2004, J BIOL CHEM, V279, P9615, DOI 10.1074/jbc.M312165200; Palm GJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09326-3; Park SY, 2008, J MOL BIOL, V376, P1426, DOI 10.1016/j.jmb.2007.12.062; Pathak D, 1990, REFINED STRUCTURE DI, DOI [10.1016/0022-2836(90)90196-s, DOI 10.1016/0022-2836(90)90196-S]; Payne K, 2009, MOL MICROBIOL, V73, P367, DOI 10.1111/j.1365-2958.2009.06775.x; Perz V, 2016, BIOTECHNOL BIOENG, V113, P1024, DOI 10.1002/bit.25874; Porter JL, 2015, ACS CHEM BIOL, V10, P611, DOI 10.1021/cb500809f; Racys DT, 2010, BIOORGAN MED CHEM, V18, P4775, DOI 10.1016/j.bmc.2010.05.012; Rathi PC, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004754; Rauwerdink A, 2015, ACS CATAL, V5, P6153, DOI 10.1021/acscatal.5b01539; Reetz MT, 2009, J AM CHEM SOC, V131, P7334, DOI 10.1021/ja809673d; Ren B, 2013, J MOL BIOL, V425, P2737, DOI 10.1016/j.jmb.2013.04.032; Rengachari S, 2012, BBA-MOL CELL BIOL L, V1821, P1012, DOI 10.1016/j.bbalip.2012.04.006; Ridder IS, 1999, ACTA CRYSTALLOGR D, V55, P1273, DOI 10.1107/S090744499900534X; Rigolet P, 2002, STRUCTURE, V10, P1383, DOI 10.1016/S0969-2126(02)00851-1; Robinson A, 2000, ACTA CRYSTALLOGR D, V56, P1376, DOI 10.1107/S0907444900010647; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Roussel A, 1998, J BIOL CHEM, V273, P32121, DOI 10.1074/jbc.273.48.32121; Roussel A, 1999, J BIOL CHEM, V274, P16995, DOI 10.1074/jbc.274.24.16995; Rozeboom HJ, 2014, BBA-PROTEINS PROTEOM, V1844, P567, DOI 10.1016/j.bbapap.2014.01.003; Sanishvili R, 2003, J BIOL CHEM, V278, P26039, DOI 10.1074/jbc.M303867200; Schleberger C, 2007, J MOL BIOL, V367, P409, DOI 10.1016/j.jmb.2006.12.068; Schmidt A, 2008, J BIOL CHEM, V283, P21827, DOI 10.1074/jbc.M801056200; Seetharaman J, OR94 NE STRUCT GEN C; Sherlin D, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2630-4; Skoczinski P, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0772-z; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Spiller B, 1999, P NATL ACAD SCI USA, V96, P12305, DOI 10.1073/pnas.96.22.12305; Stauch B, 2015, J LIPID RES, V56, P2348, DOI 10.1194/jlr.M063388; Sun YR, 2014, J BIOL CHEM, V289, P15867, DOI 10.1074/jbc.M113.535641; Szeltner Z, 2002, J BIOL CHEM, V277, P42613, DOI 10.1074/jbc.M208043200; Turner JM, 2002, BIOCHEMISTRY-US, V41, P12297, DOI 10.1021/bi026131p; UPPENBERG J, 1994, STRUCTURE, V2, P293, DOI 10.1016/S0969-2126(00)00031-9; VERSCHUEREN KHG, 1993, NATURE, V363, P693, DOI 10.1038/363693a0; Vincent F, 2003, J MOL BIOL, V330, P593, DOI 10.1016/S0022-2836(03)00632-6; Wallace AC, 1996, PROTEIN SCI, V5, P1001; Wan WY, 1999, J MOL BIOL, V286, P1633, DOI 10.1006/jmbi.1999.2552; Wei YY, 1998, STRUCTURE, V6, P511, DOI 10.1016/S0969-2126(98)00052-5; Won SJ, 2016, ACS CHEM BIOL, V11, P3374, DOI 10.1021/acschembio.6b00720; Xie Y, 2007, ACTA CRYSTALLOGR F, V63, P993, DOI 10.1107/S1744309107061106; Yadav P, 2019, J BIOL CHEM, V294, P89, DOI 10.1074/jbc.RA118.004254; Zhang R, 1 5 STRUCTURE CEPHAL; Zhu XY, 2003, J BIOL CHEM, V278, P2008, DOI 10.1074/jbc.M210103200; Zou JY, 2000, STRUCTURE, V8, P111, DOI 10.1016/S0969-2126(00)00087-3	134	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229376	10.1371/journal.pone.0229376	http://dx.doi.org/10.1371/journal.pone.0229376			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084230	Green Published, gold			2022-12-26	WOS:000535227900101
J	Lee, TH; Choi, JY; Park, JM; Kang, TH				Lee, Tae-Hee; Choi, Ji Ye; Park, Jeong-Min; Kang, Tae-Hong			Posttranscriptional control of the replication stress response via TTP-mediated Claspin mRNA stabilization	ONCOGENE			English	Article							DNA-DAMAGE CHECKPOINT; FORK STABILITY; CELL-CYCLE; TNF-ALPHA; TRISTETRAPROLIN; ATR; CHK1; EXPRESSION; DEGRADATION; ACTIVATION	ATR and CHK1 play key roles in the protection and recovery of the stalled replication forks. Claspin, an adaptor for CHK1 activation, is essential for DNA damage signaling and efficient replication fork progression. Here, we show that tristetraprolin (TTP), an mRNA-binding protein, can modulate the replication stress response via stabilization of Claspin mRNA. TTP depletion compromised specifically in the phosphorylation of CHK1, but not p53 or H2AX among other ATR substrates, and produced CHK1-defective replication phenotypes including accumulation of stalled replication forks. Importantly, the expression of siRNA-resistant TTP in TTP-deficient cells restored CHK1 phosphorylation and reduced the number of stalled replication forks as close to the control cells. Besides, we found that TTP was required for efficient replication fork progression even in the absence of exogenous DNA damage in a Claspin-dependent manner. Mechanistically, TTP was able to bind to the 3 '-untranslated region of Claspin mRNA to increase the stability of Claspin mRNA which eventually contributed to the subsequent ATR-CHK1 activation upon DNA damage. Taken together, our results revealed an intimate link between TTP-dependent Claspin mRNA stability and ATR-CHK1-dependent replication fork stability to maintain replication fork integrity and chromosomal stability.	[Lee, Tae-Hee; Choi, Ji Ye; Park, Jeong-Min; Kang, Tae-Hong] Dong A Univ, Dept Biol Sci, Busan 49315, South Korea	Dong A University	Kang, TH (corresponding author), Dong A Univ, Dept Biol Sci, Busan 49315, South Korea.	thkang@dau.ac.kr	Kang, Tae-Hong/Y-8294-2019	Kang, Tae-Hong/0000-0002-6013-900X; Lee, Tae-Hee/0000-0002-6263-6499	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [NRF-2018R1D1A3B07043817, NRF-2015R1D1A1A01056994]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education	We would like to thank Dr Sang-Eun Lee (UT Health San Antonio) for the insightful discussion and comments. We also thank JWP (University of Ulsan) for generous sharing of reagents. This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (NRF-2018R1D1A3B07043817 and NRF-2015R1D1A1A01056994).	Berglund AE, 2016, ONCOTARGET, V7, P83462, DOI 10.18632/oncotarget.13128; Bertoli C, 2016, CELL REP, V15, P1412, DOI 10.1016/j.celrep.2016.04.036; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Bianco JN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08886-8; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Bye-A-Jee H, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0183-9; Carrick DM, 2007, ARCH BIOCHEM BIOPHYS, V462, P278, DOI 10.1016/j.abb.2007.04.011; Choi JY, 2016, ONCOTARGET, V7, P32980, DOI 10.18632/oncotarget.9087; Choi JY, 2015, ONCOTARGET, V6, P22575, DOI 10.18632/oncotarget.4610; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Ciais D, 2013, CELL MOL LIFE SCI, V70, P2031, DOI 10.1007/s00018-012-1150-y; Faustrup H, 2009, J CELL BIOL, V184, P13, DOI 10.1083/jcb.200807137; Freire R, 2006, CELL CYCLE, V5, P2831, DOI 10.4161/cc.5.24.3559; Gao DM, 2009, MOL BIOL CELL, V20, P3305, DOI 10.1091/mbc.E09-01-0092; Izawa N, 2011, CANCER RES, V71, P5621, DOI 10.1158/0008-5472.CAN-11-0385; Jeong SY, 2003, J BIOL CHEM, V278, P46782, DOI 10.1074/jbc.M304551200; Kang TH, 2014, NUCLEIC ACIDS RES, V42, P4427, DOI 10.1093/nar/gku094; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Lee JM, 2016, BMB REP, V49, P566, DOI 10.5483/BMBRep.2016.49.10.097; Lee JY, 2013, NUCLEIC ACIDS RES, V41, P5614, DOI 10.1093/nar/gkt222; Lee TH, 2014, ONCOGENE, V33, P19, DOI 10.1038/onc.2012.539; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Lindsey-Boltz LA, 2009, J BIOL CHEM, V284, P33107, DOI 10.1074/jbc.M109.064485; Ma XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179852; Macheret M, 2015, ANNU REV PATHOL-MECH, V10, P425, DOI 10.1146/annurev-pathol-012414-040424; Martin Y, 2015, ONCOGENE, V34, P1058, DOI 10.1038/onc.2014.38; McGarry E, 2016, CANCER RES, V76, P2384, DOI 10.1158/0008-5472.CAN-15-2890; Oakes V, 2014, CELL CYCLE, V13, P3302, DOI 10.4161/15384101.2014.949111; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Park JM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113384; Park JM, 2015, BIOCHEM BIOPH RES CO, V461, P543, DOI 10.1016/j.bbrc.2015.04.071; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Petermann E, 2008, MOL BIOL CELL, V19, P2373, DOI 10.1091/mbc.E07-10-1035; Pfeiffer JR, 2012, J IMMUNOL, V188, P1828, DOI 10.4049/jimmunol.1102837; Rounbehler RJ, 2012, CELL, V150, P563, DOI 10.1016/j.cell.2012.06.033; Scorah J, 2009, CELL CYCLE, V8, P1036, DOI 10.4161/cc.8.7.8040; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Sercin O, 2011, CELL CYCLE, V10, P1599, DOI 10.4161/cc.10.10.15562; Shaltiel IA, 2015, J CELL SCI, V128, P607, DOI 10.1242/jcs.163766; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Vesela E, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010019; Wei ZR, 2016, ONCOTARGET, V7, P17737, DOI 10.18632/oncotarget.7397; Yang CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12135; Yazinski SA, 2016, ANNU REV GENET, V50, P155, DOI 10.1146/annurev-genet-121415-121658; Yuan J, 2014, NUCLEIC ACIDS RES, V42, P13110, DOI 10.1093/nar/gku1034; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhu M, 2014, NUCLEIC ACIDS RES, V42, P13074, DOI 10.1093/nar/gku978	50	7	7	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2020	39	16					3245	3257		10.1038/s41388-020-1220-9	http://dx.doi.org/10.1038/s41388-020-1220-9		FEB 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QF9OJ	32086441				2022-12-26	WOS:000514942300001
J	Ruijsink, B; Zugaj, K; Wong, J; Pushparajah, K; Hussain, T; Moireau, P; Razavi, R; Chapelle, D; Chabiniok, R				Ruijsink, Bram; Zugaj, Konrad; Wong, James; Pushparajah, Kuberan; Hussain, Tarique; Moireau, Philippe; Razavi, Reza; Chapelle, Dominique; Chabiniok, Radomir			Dobutamine stress testing in patients with Fontan circulation augmented by biomechanical modeling	PLOS ONE			English	Article							LEFT-VENTRICLE; HEART; PREDICTORS; MORTALITY	Understanding (patho)physiological phenomena and mechanisms of failure in patients with Fontan circulation-a surgically established circulation for patients born with a functionally single ventricle-remains challenging due to the complex hemodynamics and high interpatient variations in anatomy and function. In this work, we present a biomechanical model of the heart and circulation to augment the diagnostic evaluation of Fontan patients with early-stage heart failure. The proposed framework employs a reduced-order model of heart coupled with a simplified circulation including venous return, creating a closed-loop system. We deploy this framework to augment the information from data obtained during combined cardiac catheterization and magnetic resonance exams (XMR), performed at rest and during dobutamine stress in 9 children with Fontan circulation and 2 biventricular controls. We demonstrate that our modeling framework enables patient-specific investigation of myocardial stiffness, contractility at rest, contractile reserve during stress and changes in vascular resistance. Hereby, the model allows to identify key factors underlying the pathophysiological response to stress in these patients. In addition, the rapid personalization of the model to patient data and fast simulation of cardiac cycles make our framework directly applicable in a clinical workflow. We conclude that the proposed modeling framework is a valuable addition to the current clinical diagnostic XMR exam that helps to explain patient-specific stress hemodynamics and can identify potential mechanisms of failure in patients with Fontan circulation.	[Ruijsink, Bram; Zugaj, Konrad; Wong, James; Pushparajah, Kuberan; Hussain, Tarique; Razavi, Reza; Chabiniok, Radomir] St Thomas Hosp, Kings Coll London, Sch Biomed Engn & Imaging Sci, London, England; [Hussain, Tarique] UT Southwestern Med Ctr, Dept Pediat, Dallas, TX USA; [Moireau, Philippe; Chapelle, Dominique; Chabiniok, Radomir] Inria Ctr Rech Saclay Ile de France, Palaiseau, France; [Moireau, Philippe; Chapelle, Dominique; Chabiniok, Radomir] Inst Polytech Paris, CNRS, Ecole Polytech, LMS, Paris, France	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Texas System; University of Texas Southwestern Medical Center Dallas; Centre National de la Recherche Scientifique (CNRS)	Chabiniok, R (corresponding author), St Thomas Hosp, Kings Coll London, Sch Biomed Engn & Imaging Sci, London, England.; Chabiniok, R (corresponding author), Inria Ctr Rech Saclay Ile de France, Palaiseau, France.; Chabiniok, R (corresponding author), Inst Polytech Paris, CNRS, Ecole Polytech, LMS, Paris, France.	radomir.chabiniok@inria.fr	Chabiniok, Radomir/AAO-9829-2020; Pushparajah, Kuberan/ABA-5484-2020	Chabiniok, Radomir/0000-0002-7527-2751; Pushparajah, Kuberan/0000-0003-1541-1155; Zugaj, Konrad/0000-0003-4097-0629; Hussain, Tariq/0000-0002-1332-2418; Ruijsink, Bram/0000-0001-8313-5709; Razavi, Reza/0000-0003-1065-3008; Hussain, Tarique/0000-0003-4091-992X	Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; King's College London; NIHR Cardiovascular MedTech Co-operative; Wellcome/EPSRC Centre for Medical Engineering [WT 203148/Z/16/Z]; Inria-UTSW Medical Center Dallas Associated Team TOFMOD	Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London; NIHR Cardiovascular MedTech Co-operative; Wellcome/EPSRC Centre for Medical Engineering; Inria-UTSW Medical Center Dallas Associated Team TOFMOD	The authors (all except for TH, PM and DC) acknowledge financial support from the Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and the NIHR Cardiovascular MedTech Co-operative (previously existing as the Cardiovascular Healthcare Technology Co-operative 2012-2017). The authors also acknowledge the support of Wellcome/EPSRC Centre for Medical Engineering [WT 203148/Z/16/Z] and of Inria-UTSW Medical Center Dallas Associated Team TOFMOD. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; BUSSMANN WD, 1977, Z KARDIOL, V66, P690; Caremani M, 2016, P NATL ACAD SCI USA, V113, P3675, DOI 10.1073/pnas.1525057113; Caruel M, 2014, BIOMECH MODEL MECHAN, V13, P897, DOI 10.1007/s10237-013-0544-6; Chabiniok R, 2017, LECT NOTES COMPUT SC, V10263, P401, DOI 10.1007/978-3-319-59448-4_38; Chabiniok R, 2012, BIOMECH MODEL MECHAN, V11, P609, DOI 10.1007/s10237-011-0337-8; Chabiniok R, P ISMRM; Chabiniok R, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2015.0083; Chapelle D, 2015, LECT NOTES COMPUT SC, V9126, P295, DOI 10.1007/978-3-319-20309-6_34; Chapelle D, 2012, INT J MULTISCALE COM, V10, P189, DOI 10.1615/IntJMultCompEng.2011002360; Cordina R, 2017, JACC-CARDIOVASC IMAG, V10, P212, DOI 10.1016/j.jcmg.2016.03.006; Corsini C, 2014, COMPUT METHOD BIOMEC, V17, P1572, DOI 10.1080/10255842.2012.758254; de Vecchi A, 2012, ANN THORAC SURG, V94, P1562, DOI 10.1016/j.athoracsur.2012.05.122; Esmaily MM, 2012, J BIOMECHANICAL ENG, V134, P1; Guyton AC, 1973, CIRCULATORY PHYSL CA; Hadjicharalambous M, 2017, ANN BIOMED ENG, V45, P605, DOI 10.1007/s10439-016-1721-4; Hadjicharalambous M, 2015, BIOMECH MODEL MECHAN, V14, P807, DOI 10.1007/s10237-014-0638-9; Holzapfel GA, 2009, PHILOS T R SOC A, V367, P3445, DOI 10.1098/rsta.2009.0091; Khairy P, 2008, CIRCULATION, V117, P85, DOI 10.1161/CIRCULATIONAHA.107.738559; Khairy P, 2007, CIRCULATION, V115, P800, DOI 10.1161/CIRCULATIONAHA.105.592378; Klotz S, 2006, AM J PHYSIOL-HEART C, V291, pH403, DOI 10.1152/ajpheart.01240.2005; Koeken Y, 2012, IEEE ENG MED BIO, P6673, DOI 10.1109/EMBC.2012.6347525; Kung E, 2015, ANN BIOMED ENG, V43, P1335, DOI 10.1007/s10439-014-1131-4; Le Gall A, 2018, P VIRT PHYS HUM C; Le Gall A, 2019, LECT NOTES COMPUT SC, V11504, P266, DOI 10.1007/978-3-030-21949-9_29; Le Tallec P., 1994, HDB NUMERICAL ANAL, V3; Mace L, 2000, AM J PHYSIOL-HEART C, V279, pH2335, DOI 10.1152/ajpheart.2000.279.5.H2335; Masutani S, 2017, J THORAC CARDIOV SUR, V153, P912, DOI 10.1016/j.jtcvs.2016.11.061; Moller S, 2013, EUR HEART J, V34, P2804, DOI 10.1093/eurheartj/eht246; Muller LO, 2019, IEEE T BIO-MED ENG, V66, P1269, DOI 10.1109/TBME.2018.2872323; Pennati G, 2013, FRONT PEDIATR, V1, DOI 10.3389/fped.2013.00004; Puelz C, 2017, COMPUT BIOL MED, V89, P405, DOI 10.1016/j.compbiomed.2017.08.024; Pushparajah K, 2016, EUR HEART J-CARD IMG, V17, P644, DOI 10.1093/ehjci/jev178; RUFFOLO RR, 1984, ANN INTERN MED, V100, P313, DOI 10.7326/0003-4819-100-2-313; RUFFOLO RR, 1985, EUR J PHARMACOL, V109, P173, DOI 10.1016/0014-2999(85)90418-2; Ruijsink B, 2019, LECT NOTES COMPUT SC, V11504, P379, DOI 10.1007/978-3-030-21949-9_41; Ruijsink B, 2017, LECT NOTES COMPUT SC, V10555, P86, DOI 10.1007/978-3-319-67564-0_9; Sainte-Marie J, 2006, COMPUT STRUCT, V84, P1743, DOI 10.1016/j.compstruc.2006.05.003; Sermesant M, 2012, MED IMAGE ANAL, V16, P201, DOI 10.1016/j.media.2011.07.003; SUGA H, 1973, CIRC RES, V32, P314, DOI 10.1161/01.RES.32.3.314; van Bakel TMJ, 2018, J CARDIOVASC TRANSL, V11, P145, DOI 10.1007/s12265-017-9781-x; Veldtman GR, 2017, CONGENIT HEART DIS, V12, P699, DOI 10.1111/chd.12526; Vennin S, 2015, AM J PHYSIOL-HEART C, V309, pH969, DOI 10.1152/ajpheart.00152.2015; Walmsley J, 2017, CARDIOVASC RES, V113, P1486, DOI 10.1093/cvr/cvx154; Wang VY, 2015, ANNU REV BIOMED ENG, V17, P351, DOI 10.1146/annurev-bioeng-071114-040609; Watrous RL, 2014, WORLD J PEDIATR CONG, V5, P372, DOI 10.1177/2150135114529450; WESTERHOF N, 1969, J BIOMECH, V2, P121, DOI 10.1016/0021-9290(69)90024-4; Wong J, 2018, J APPL PHYSIOL, V125, P889, DOI 10.1152/japplphysiol.00580.2017; Wong J, 2017, INT J CARDIOL, V230, P439, DOI 10.1016/j.ijcard.2016.12.087	49	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229015	10.1371/journal.pone.0229015	http://dx.doi.org/10.1371/journal.pone.0229015			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084180	Green Submitted, Green Published, gold			2022-12-26	WOS:000535227900042
J	Wang, QH; Luo, Q; Yang, ZX; Zhao, YH; Li, JQ; Wang, J; Piao, JM; Chen, X				Wang, Qunhui; Luo, Qi; Yang, Zhongxi; Zhao, Yu-Hao; Li, Jiaqi; Wang, Jian; Piao, Jianmin; Chen, Xuan			Weighted gene co-expression network analysis identified six hub genes associated with rupture of intracranial aneurysms	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSM; CEREBRAL ANEURYSM; GRANZYME K; BASP1; MANAGEMENT; CARCINOMA; SUGGESTS; SCORE; RISK	Intracranial aneurysms (IAs) are characterized by localized dilation or ballooning of a cerebral artery. When IAs rupture, blood leaks into the space around the brain to create a subarachnoid hemorrhage. The latter is associated with a higher risk of disability and mortality. The aims of this study were to gain greater insight into the pathogenesis of ruptured IAs, and to clarify whether identified hub genes represent potential biological markers for assessing the likelihood of IA progression and rupture. Briefly, the GSE36791 and GSE73378 datasets from the National Center of Biotechnology Information Gene Expression Omnibus database were reanalyzed and subjected to a weighted gene co-expression network analysis to test the association between gene sets and clinical features. The clinical significance of these genes as potential biomarkers was also examined, with their expression validated by quantitative real-time PCR. A total of 14 co-expression modules and 238 hub genes were identified. In particular, three modules (labeled turquoise, blue, and brown) were found to highly correlate with IA rupture events. Additionally, six potential biomarkers were identified (BASP1, CEBPB, ECHDC2, GZMK, KLHL3, and SLC2A3), which are strongly associated with the progression and rupture of IAs. Taken together, these findings provide novel insights into potential molecular mechanisms responsible for IAs and they highlight the potential for these particular genes to serve as biomarkers for monitoring IA rupture.	[Wang, Qunhui; Luo, Qi; Yang, Zhongxi; Zhao, Yu-Hao; Li, Jiaqi; Wang, Jian; Piao, Jianmin; Chen, Xuan] First Hosp Jilin Univ, Dept Neurosurg, Changchun, Jilin, Peoples R China	Jilin University	Piao, JM (corresponding author), First Hosp Jilin Univ, Dept Neurosurg, Changchun, Jilin, Peoples R China.	piaojm@jlu.edu.cn; 83823095@qq.com	LUO, QI/GQH-7209-2022		Young Scientists Fund, National Natural Science Foundation of China [81701124]	Young Scientists Fund, National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Young Scientists Fund, National Natural Science Foundation of China (Grant no. 81701124).	Ahmad J, 2014, BIOL CHEM, V395, P1253, DOI 10.1515/hsz-2014-0174; Alg VS, 2013, NEUROLOGY, V80, P2154, DOI 10.1212/WNL.0b013e318295d751; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brinjikji W, 2017, J NEUROINTERV SURG, V9, P376, DOI 10.1136/neurintsurg-2016-012327; Brisman JL, 2006, NEW ENGL J MED, V355, P928, DOI 10.1056/NEJMra052760; Brown RD, 2014, LANCET NEUROL, V13, P393, DOI 10.1016/S1474-4422(14)70015-8; Can A, 2016, NEUROSURGERY, V78, P510, DOI 10.1227/NEU.0000000000001083; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chalouhi N, 2013, STROKE, V44, P3613, DOI 10.1161/STROKEAHA.113.002390; Cooper DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021484; Deng Yan, 2018, Open Rheumatol J, V12, P123, DOI [10.2174/1874312901812010070, 10.2174/1874312901812010123]; Sanchez-Nino MD, 2010, J AM SOC NEPHROL, V21, P610, DOI 10.1681/ASN.2009020227; Du CH, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0997-z; Du JH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000233; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Etminan N, 2016, NAT REV NEUROL, V12, P699, DOI 10.1038/nrneurol.2016.150; Etminan N, 2015, NEUROLOGY, V85, P881, DOI 10.1212/WNL.0000000000001891; Ferdaus MZ, 2016, AM J PHYSIOL-RENAL, V310, pF1389, DOI 10.1152/ajprenal.00132.2016; Gabriel RA, 2010, STROKE, V41, P21, DOI 10.1161/STROKEAHA.109.566018; Giordan E, 2018, ACTA NEUROCHIR, V160, P2419, DOI 10.1007/s00701-018-3729-z; Green LM, 2009, NUCLEIC ACIDS RES, V37, P431, DOI 10.1093/nar/gkn955; Greving JP, 2014, LANCET NEUROL, V13, P59, DOI 10.1016/S1474-4422(13)70263-1; Hasan D, 2012, STROKE, V43, P3258, DOI 10.1161/STROKEAHA.112.673400; Joeckel LT, 2011, CELL DEATH DIFFER, V18, P1112, DOI 10.1038/cdd.2011.5; Joeckel LT, 2017, IMMUNOL CELL BIOL, V95, P676, DOI 10.1038/icb.2017.35; Johnston SC, 1998, NEUROLOGY, V50, P1413, DOI 10.1212/WNL.50.5.1413; Kolde R, 2012, PHEATMAP PRETTY HEAT, DOI [10.1186/s12935-017-0452-4, DOI 10.1186/S12935-017-0452-4]; Korshunova I, 2008, J NEUROSCI RES, V86, P2201, DOI 10.1002/jnr.21678; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li PX, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000972; Luedi MM, 2017, J NEUROSURG ANESTH, V29, P46, DOI 10.1097/ANA.0000000000000368; Moribe T, 2008, INT J ONCOL, V33, P949, DOI 10.3892/ijo_00000082; Pera J, 2013, J CEREBR BLOOD F MET, V33, P1025, DOI 10.1038/jcbfm.2013.37; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rivero-Arias Oliver, 2010, Cost Eff Resour Alloc, V8, P6, DOI 10.1186/1478-7547-8-6; Skodvin TO, 2019, NEUROSURGERY, V84, P132, DOI 10.1093/neuros/nyy010; Tang HR, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0452-4; Tsuruda T, 2012, ARTERIOSCL THROM VAS, V32, P1410, DOI 10.1161/ATVBAHA.111.237065; Van 't Hof FNG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139352; Wang QH, 2018, BIOCHEM BIOPH RES CO, V506, P548, DOI 10.1016/j.bbrc.2018.10.117; Wilson WRW, 2006, CIRCULATION, V113, P438, DOI 10.1161/CIRCULATIONAHA.105.551572; Yan N, 2017, J MOL BIOL, V429, P2710, DOI 10.1016/j.jmb.2017.07.009; Yoshida S, 2018, CLIN EXP NEPHROL, V22, P1251, DOI 10.1007/s10157-018-1593-z; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yuan LS, 2017, GENOM DATA, V14, P132, DOI 10.1016/j.gdata.2017.10.006; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhou L, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0067-4	48	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229308	10.1371/journal.pone.0229308	http://dx.doi.org/10.1371/journal.pone.0229308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084215	Green Published, gold			2022-12-26	WOS:000535227900087
J	Bowers, SJ; Vargas, F; Gonzalez, A; He, SN; Jiang, P; Dorrestein, PC; Knight, R; Wright, KP; Lowry, CA; Fleshner, M; Vitaterna, MH; Turek, FW				Bowers, Samuel J.; Vargas, Fernando; Gonzalez, Antonio; He, Shannon; Jiang, Peng; Dorrestein, Pieter C.; Knight, Rob; Wright, Kenneth P., Jr.; Lowry, Christopher A.; Fleshner, Monika; Vitaterna, Martha H.; Turek, Fred W.			Repeated sleep disruption in mice leads to persistent shifts in the fecal microbiome and metabolome	PLOS ONE			English	Article							GUT MICROBIOTA; TRITERPENE ACIDS; BRAIN; RESTRICTION; DEPRIVATION; RECOVERY; DIFFERENTIATION; PERFORMANCE; DISTURBANCE; CLASSIFIER	It has been established in recent years that the gut microbiome plays a role in health and disease, potentially via alterations in metabolites that influence host physiology. Although sleep disruption and gut dysbiosis have been associated with many of the same diseases, studies investigating the gut microbiome in the context of sleep disruption have yielded inconsistent results, and have not assessed the fecal metabolome. We exposed mice to five days of sleep disruption followed by four days of ad libitum recovery sleep, and assessed the fecal microbiome and fecal metabolome at multiple timepoints using 16S rRNA gene amplicons and untargeted LC-MS/MS mass spectrometry. We found global shifts in both the microbiome and metabolome in the sleep-disrupted group on the second day of recovery sleep, when most sleep parameters had recovered to baseline levels. We observed an increase in the Firmicutes:Bacteroidetes ratio, along with decreases in the genus Lactobacillus, phylum Actinobacteria, and genus Bifidobacterium in sleep-disrupted mice compared to control mice. The latter two taxa remained low at the fourth day post-sleep disruption. We also identified multiple classes of fecal metabolites that were differentially abundant in sleep-disrupted mice, some of which are physiologically relevant and commonly influenced by the microbiome. This included bile acids, and inference of microbial functional gene content suggested reduced levels of the microbial bile salt hydrolase gene in sleep-disrupted mice. Overall, this study adds to the evidence base linking disrupted sleep to the gut microbiome and expands it to the fecal metabolome, identifying sleep disruption-sensitive bacterial taxa and classes of metabolites that may serve as therapeutic targets to improve health after poor sleep.	[Bowers, Samuel J.; He, Shannon; Jiang, Peng; Vitaterna, Martha H.; Turek, Fred W.] Northwestern Univ, Ctr Sleep & Circadian Biol, Evanston, IL 60208 USA; [Bowers, Samuel J.; He, Shannon; Jiang, Peng; Vitaterna, Martha H.; Turek, Fred W.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Vargas, Fernando; Dorrestein, Pieter C.] Univ Calif San Diego, Collaborat Mass Spectrometry Innovat Ctr, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Gonzalez, Antonio; Knight, Rob] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.; Knight, Rob] Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [Wright, Kenneth P., Jr.; Lowry, Christopher A.; Fleshner, Monika] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Wright, Kenneth P., Jr.; Lowry, Christopher A.; Fleshner, Monika] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA; [Wright, Kenneth P., Jr.] Univ Colorado, Sleep & Chronobiol Lab, Boulder, CO 80309 USA; [Turek, Fred W.] Northwestern Univ, Feinberg Sch Med, Ken & Ruth Davee Dept Neurol, Chicago, IL 60611 USA; [Turek, Fred W.] Northwestern Univ, Dept Psychiat & Behav Sci, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Northwestern University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Bowers, SJ (corresponding author), Northwestern Univ, Ctr Sleep & Circadian Biol, Evanston, IL 60208 USA.; Bowers, SJ (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	samuel.bowers@northwestern.edu	Gonzalez, Antonio/A-6421-2018; Dorrestein, Pieter/ABF-2930-2020	Bowers, Samuel/0000-0002-4821-699X; Knight, Rob/0000-0002-0975-9019; Lowry, Christopher/0000-0003-3920-5575	Office of Naval Research [N00014-15-1-2809]; National Institutes of Health Training Grant [T32HL007909]	Office of Naval Research(Office of Naval Research); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by the Office of Naval Research Grant #N00014-15-1-2809 (SJB, FV, AG, SH, PJ, PCD, RK, KPW, CAL, MF, MHV, FWT), https://www.onr.navy.mil/.Also with support from National Institutes of Health Training Grant T32HL007909 (SJB, MHV, FWT) https://researchtraining.nih.gov/programs/training-grants.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077184; Amir A., 2017, MSYSTEMS, V2, DOI [DOI 10.1128/MSYSTEMS.00191-16, 10.1128/mSystems.00191-16]; Antalis TM, 2007, NAT CLIN PRACT GASTR, V4, P393, DOI 10.1038/ncpgasthep0846; Apprill A, 2015, AQUAT MICROB ECOL, V75, P129, DOI 10.3354/ame01753; Banno N, 2005, BIOL PHARM BULL, V28, P1995, DOI 10.1248/bpb.28.1995; Banno N, 2004, BIOSCI BIOTECH BIOCH, V68, P85, DOI 10.1271/bbb.68.85; Bassett SM, 2015, STRESS, V18, P638, DOI 10.3109/10253890.2015.1087503; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Benedict C, 2016, MOL METAB, V5, P1175, DOI 10.1016/j.molmet.2016.10.003; Bercik P, 2011, NEUROGASTROENT MOTIL, V23, P1132, DOI 10.1111/j.1365-2982.2011.01796.x; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bryant RA, 2010, SLEEP, V33, P69, DOI 10.1093/sleep/33.1.69; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen L, 2016, ONCOTARGET, V7, P31226, DOI 10.18632/oncotarget.8886; Codling C, 2010, DIGEST DIS SCI, V55, P392, DOI 10.1007/s10620-009-0934-x; Colpitts SL, 2017, GUT MICROBES, DOI [10.1080/19490976.2017.1398871, DOI 10.1080/19490976.2017.1398871]; Crumeyrolle-Arias M, 2014, PSYCHONEUROENDOCRINO, V42, P207, DOI 10.1016/j.psyneuen.2014.01.014; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Daniels JK, 2017, CURRENT OPINION PSYC; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; El Aidy S, 2020, J SLEEP RES, V29, DOI 10.1111/jsr.12920; Foley MH, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007581; Franklin CL, 2017, LAB ANIMAL, V46, P114, DOI 10.1038/laban.1222; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gao V, 2016, J NEUROSCI METH, V264, P33, DOI 10.1016/j.jneumeth.2016.02.016; Gautam A, 2018, J NEUROSCI RES, V96, P1311, DOI 10.1002/jnr.24229; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Genuer R, 2015, R J, V7, P19; Gloor GB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02224; Gonzalez A, 2018, NAT METHODS, V15, P796, DOI 10.1038/s41592-018-0141-9; Govindarajan K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167319; Guo CJ, 2017, CELL, V168, P517, DOI 10.1016/j.cell.2016.12.021; Guyon A, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx064; Haack M, 2007, SLEEP, V30, P1145, DOI 10.1093/sleep/30.9.1145; Hemmings SMJ, 2017, PSYCHOSOM MED; Irwin MR, 2015, ANNU REV PSYCHOL, V66, P143, DOI 10.1146/annurev-psych-010213-115205; Joyce SA, 2014, P NATL ACAD SCI USA, V111, P7421, DOI 10.1073/pnas.1323599111; Karl JP, 2017, AM J PHYSIOL-GASTR L, V312, pG559, DOI 10.1152/ajpgi.00066.2017; Koliada A, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1027-1; Krause AJ, 2017, NAT REV NEUROSCI, V18, P404, DOI 10.1038/nrn.2017.55; Kuipers F, 2014, NAT REV ENDOCRINOL, V10, P488, DOI 10.1038/nrendo.2014.60; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384; Li F, 2013, BIOMED CHROMATOGR, V27, P1767, DOI 10.1002/bmc.2991; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Lowry Christopher A, 2016, Curr Environ Health Rep, V3, P270, DOI 10.1007/s40572-016-0100-5; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Ma BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047416; Ma WN, 2019, LIFE SCI, V225, P88, DOI 10.1016/j.lfs.2019.04.006; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mertens KL, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00617; Messaoudi M, 2011, GUT MICROBES, V2, P256, DOI 10.4161/gmic.2.4.16108; Mirarab S, 2012, BIOCOMPUT-PAC SYM, P247; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Parseus A, 2017, GUT, V66, P429, DOI 10.1136/gutjnl-2015-310283; Pejovic S, 2013, AM J PHYSIOL-ENDOC M, V305, pE890, DOI 10.1152/ajpendo.00301.2013; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; PIELOU E C, 1969, P286; Poroyko VA, 2016, SCI REP-UK, V6, DOI 10.1038/srep35405; Protsyuk I, 2018, NAT PROTOC, V13, P134, DOI 10.1038/nprot.2017.122; Ray Katrina, 2015, Nat Rev Gastroenterol Hepatol, V12, P311, DOI 10.1038/nrgastro.2015.69; Reber SO, 2016, P NATL ACAD SCI USA, V113, pE3130, DOI 10.1073/pnas.1600324113; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; Schrimpe-Rutledge AC, 2016, J AM SOC MASS SPECTR, V27, P1897, DOI 10.1007/s13361-016-1469-y; Sessenwein JL, 2017, J NEUROSCI, V37, P11758, DOI 10.1523/JNEUROSCI.1672-17.2017; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Steenbergen L, 2015, BRAIN BEHAV IMMUN, V48, P258, DOI 10.1016/j.bbi.2015.04.003; Stilling RM, 2016, NEUROCHEM INT, V99, P110, DOI 10.1016/j.neuint.2016.06.011; Suchecki D, 2002, NEUROSCI LETT, V320, P45, DOI 10.1016/S0304-3940(02)00024-1; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Tang YM, 2009, SLEEP MED, V10, P597, DOI 10.1016/j.sleep.2008.12.009; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wali SO, 2013, ANN THORAC MED, V8, P22, DOI 10.4103/1817-1737.105715; Wang F, 2006, J NAT PROD, V69, P807, DOI 10.1021/np050371z; Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; Yanguas-Casas N, 2017, J CELL PHYSIOL, V232, P2231, DOI 10.1002/jcp.25742; Yun Y, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1052-0; Zhang SL, 2017, P NATL ACAD SCI USA, V114, pE1564, DOI 10.1073/pnas.1620673114; Zierer J, 2018, NAT GENET, V50, P790, DOI 10.1038/s41588-018-0135-7	92	21	23	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0229001	10.1371/journal.pone.0229001	http://dx.doi.org/10.1371/journal.pone.0229001			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8CF	32078624	gold, Green Published, Green Submitted			2022-12-26	WOS:000535224600013
J	Nguyen, DV; Roret, T; Fernandez-Gonzalez, A; Kohler, A; Morel-Rouhier, M; Gelhaye, E; Sormani, R				Duy Vuong Nguyen; Roret, Thomas; Fernandez-Gonzalez, Antonio; Kohler, Annegret; Morel-Rouhier, Melanie; Gelhaye, Eric; Sormani, Rodnay			Target Of Rapamycin pathway in the white-rot fungus Phanerochaete chrysosporium	PLOS ONE			English	Article							TOR; COMPLEXES; SEQUENCE; NITROGEN; GROWTH; YEAST	The Target Of Rapamycin (TOR) signaling pathway is known to regulate growth in response to nutrient availability and stress in eukaryotic cells. In the present study, we have investigated the TOR pathway in the white-rot fungus Phanerochaete chrysosporium. Inhibition of TOR activity by rapamycin affects conidia germination and hyphal growth highlighting the conserved mechanism of susceptibility to rapamycin. Interestingly, the secreted protein content is also affected by the rapamycin treatment. Finally, homologs of the components of TOR pathway can be identified in P. chrysosporium. Altogether, those results indicate that the TOR pathway of P. chrysosporium plays a central role in this fungus.	[Duy Vuong Nguyen; Roret, Thomas; Fernandez-Gonzalez, Antonio; Kohler, Annegret; Morel-Rouhier, Melanie; Gelhaye, Eric; Sormani, Rodnay] Univ Lorraine, IAM, INRA, Nancy, France; [Roret, Thomas] Sorbonne Univ, LBI2M, CNRS, Roscoff, France	INRAE; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Sormani, R (corresponding author), Univ Lorraine, IAM, INRA, Nancy, France.	rodnay.sormani@univ-lorraine.fr	Fernández-González, Antonio J/AAG-8125-2020	Fernández-González, Antonio J/0000-0002-1938-5436; Fernandez-Gonzalez, Antonio Jose/0000-0002-8781-8133; sormani, rodnay/0000-0002-0939-8639; Morel-Rouhier, Melanie/0000-0001-5149-0474	French National Research Agency (ANR) as part of the "Investissements d'Avenir" program (Lab of Excellence ARBRE) [ANR-11-LABX-0002-01]; Ministry of Agriculture and Rural Development, Vietnam (Agricultural and Fisheries Biotechnology Program); French ministry of foreign affair (program Campus France); Region Grand Est	French National Research Agency (ANR) as part of the "Investissements d'Avenir" program (Lab of Excellence ARBRE)(French National Research Agency (ANR)); Ministry of Agriculture and Rural Development, Vietnam (Agricultural and Fisheries Biotechnology Program); French ministry of foreign affair (program Campus France); Region Grand Est(Region Grand-Est)	This work was supported by a grant overseen by the French National Research Agency (ANR) as part of the "Investissements d'Avenir" program (ANR-11-LABX-0002-01, Lab of Excellence ARBRE). DVN was supported by a Doctoral Fellowship from the Ministry of Agriculture and Rural Development, Vietnam (Agricultural and Fisheries Biotechnology Program) and support from French ministry of foreign affair (program Campus France). AFG was supported by a postdoctoral grant from Region Grand Est. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastidas RJ, 2012, EUKARYOT CELL, V11, P270, DOI 10.1128/EC.05284-11; Bertram PG, 2002, MOL CELL BIOL, V22, P1246, DOI 10.1128/MCB.22.4.1246-1252.2002; Chen DD, 2019, FUNGAL GENET BIOL, V123, P70, DOI 10.1016/j.fgb.2018.12.005; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Crespo JL, 2001, J BIOL CHEM, V276, P34441, DOI 10.1074/jbc.M103601200; Cruz MC, 1999, MOL CELL BIOL, V19, P4101; Dementhon K, 2003, EUKARYOT CELL, V2, P238, DOI 10.1128/EC.2.2.238-246.2003; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Falloon K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137869; Fernandez-Gonzalez AJ, 2018, ENVIRON MICROBIOL, V20, P3890, DOI 10.1111/1462-2920.14409; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Gonzalez A, 2017, EMBO J, V36, P397, DOI 10.15252/embj.201696010; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Joubert A, 2010, BIOTECHNIQUES, V48, P399, DOI 10.2144/000113399; Kersten P, 2014, FUNGAL GENET BIOL, V72, P124, DOI 10.1016/j.fgb.2014.05.011; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Morel M, 2013, MICROB BIOTECHNOL, V6, P248, DOI 10.1111/1751-7915.12015; Nagy LG, 2017, MOL BIOL EVOL, V34, P35, DOI 10.1093/molbev/msw238; Niles BJ, 2014, CELL REP, V6, P541, DOI 10.1016/j.celrep.2013.12.040; Roelants FM, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030066; SEHGAL SN, 1975, J ANTIBIOT, V28, P727, DOI 10.7164/antibiotics.28.727; Shertz CA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-510; Stracka D, 2014, J BIOL CHEM, V289, P25010, DOI 10.1074/jbc.M114.574335; TIEN M, 1983, SCIENCE, V221, P661, DOI 10.1126/science.221.4611.661; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Valette N, 2017, FUNGAL BIOL REV, V31, P113, DOI 10.1016/j.fbr.2017.01.002; Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yu FW, 2014, NEW PHYTOL, V203, P219, DOI 10.1111/nph.12776; ZHENG XF, 1995, CELL, V82, P121, DOI 10.1016/0092-8674(95)90058-6	33	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0224776	10.1371/journal.pone.0224776	http://dx.doi.org/10.1371/journal.pone.0224776			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8CF	32078630	Green Published, gold, Green Submitted			2022-12-26	WOS:000535224600002
J	Skutschas, P; Kolchanov, V; Krasnolutskii, S; Averianov, A; Schellhorn, R; Schultz, J; Martin, T				Skutschas, Pavel; Kolchanov, Veniamin; Krasnolutskii, Sergey; Averianov, Alexander; Schellhorn, Rico; Schultz, Julia; Martin, Thomas			A new small-sized stem salamander from the Middle Jurassic of Western Siberia, Russia	PLOS ONE			English	Article							CROWN-GROUP SALAMANDER; AMPHIBIA; CAUDATA	Salamanders (Caudata) are one of the three modern groups of amphibians known from the Middle Jurassic. The early stages of evolution of these amphibians are still poorly known, especially for stem taxa of Jurassic age. A new small-sized stem salamander, Egoria malashichevi gen. et sp. nov., from the Middle Jurassic (Bathonian) Itat Formation of the Berezovsk Quarry locality in Western Siberia, Russia, is described on the basis of isolated vertebrae, including an atlas centrum and a fragmentary trunk vertebra centrum previously referred to an undescribed salamander taxon ("Berezovsk salamander A"). The new taxon is diagnosed by the following unique combination of vertebral characters: atlantal anterior cotyles with elliptical anterior outline, located at an angle of approximately 135-137 degrees to each other; wide posterior portion of the atlantal centrum; ossified portion of the intercotylar tubercle represented by dorsal and ventral lips; absence of a deep depression on the ventral surface of the atlantal centrum; absence of pronounced ventrolateral ridges on the atlas; absence of spinal nerve foramina; presence of a pitted texture on the ventral and lateral surfaces of the centra and lateral surfaces neural arch pedicels; presence of a short atlantal neural arch with its anterior border situated behind the level of the anterior cotyles; short trunk vertebrae; and upper transverse process (= diapophysis) larger than lower transverse process (= parapophysis) on the trunk vertebrae; notochordal canal opens in the upper half of the cotyle (= the lower portion of the centrum is more massive and less compact than the upper portion). The microanatomical organization of the atlas and trunk vertebrae is characterized by the presence of inner cancellous endochondral bone. The small body size (about 180-215 mm) of Egoria malashichevi gen. et sp. nov. indicates that that not all stem salamanders were large neotenic forms (up to 550-600 mm in Urupia and Marmorerpeton) and hints at a broader ecological role for stem salamanders.	[Skutschas, Pavel; Kolchanov, Veniamin] St Petersburg State Univ, Vertebrate Zool Dept, St Petersburg, Russia; [Krasnolutskii, Sergey] Sharypovo Reg Museum, Sharypovo, Krasnoyarsk Ter, Russia; [Averianov, Alexander] Russian Acad Sci, Zool Inst, St Petersburg, Russia; [Averianov, Alexander] Russian Acad Sci, Borissiak Paleontol Inst, Moscow, Russia; [Averianov, Alexander] Kazan Fed Univ, Inst Geol & Petr Technol, Kazan, Russia; [Averianov, Alexander; Schellhorn, Rico; Schultz, Julia; Martin, Thomas] Rhein Friedrich Wilhelms Univ Bonn, Inst Geosci, Sect Paleontol, Bonn, Germany	Saint Petersburg State University; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Russian Academy of Sciences; Paleontological Institute of the Russian Academy of Sciences; Kazan Federal University; University of Bonn	Skutschas, P (corresponding author), St Petersburg State Univ, Vertebrate Zool Dept, St Petersburg, Russia.	skutchas@mail.ru	Skutschas, Pavel/D-5143-2013; Kolchanov, Veniamin/AGG-6111-2022; Skutschas, Pavel/AAK-1811-2021	Skutschas, Pavel/0000-0001-8093-2905; Kolchanov, Veniamin/0000-0001-6644-3486; Skutschas, Pavel/0000-0001-8093-2905; Schellhorn, Rico/0000-0003-4890-3025	Russian Foundation for Basic Research (RFBR) [19-0400060]; Russian Foundation for Basic Research (RFBR)) [11-04-91331-NNIO]; Deutsche Forschungsgemeinschaft (DFG) [MA 1643/14-1]	Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Russian Foundation for Basic Research (RFBR))(Russian Foundation for Basic Research (RFBR)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study is funded by the Russian Foundation for Basic Research (RFBR; https://kias.rfbr.ru/) according to the research project 19-0400060 received by Pavel P. Skutschas and Veniamin V. Kolchanov. The fieldwork in the Berezovsk Quarry locality was supported by the Russian Foundation for Basic Research (RFBR; https://kias.rfbr.ru/) according to the research project 11-04-91331-NNIO received by Dr. Alexander Averianov and the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de/) according to the research project MA 1643/14-1, 3 received by Prof. Thomas Martin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averianov Alexander, 2016, Global Geology - English Edition, V19, P187; Averianov AO, 2008, PALAEONTOLOGY, V51, P471, DOI 10.1111/j.1475-4983.2007.00748.x; de Buffrenil V, 2015, HIST BIOL, V27, P109, DOI 10.1080/08912963.2013.869800; EVANS SE, 1994, IN THE SHADOW OF THE DINOSAURS, P303; EVANS SE, 1988, GEOBIOS-LYON, V21, P539, DOI 10.1016/S0016-6995(88)80069-X; Evans Susan E., 1996, Museum of Northern Arizona Bulletin, V60, P219; Ivakhnenko MF, 1978, PALEONTOL ZH, V3, P84; Linnaeus C., 1758, SYSTEMA NATURAE REGN, DOI [10.5962/bhl.title.542, DOI 10.5962/BHL.TITLE.542]; Milner Andrew R., 2000, Amphibian Biology, V4, P1412; NESSOV L A, 1988, Acta Zoologica Cracoviensia, V31, P475; Scopoli G.A., 1777, INTRO HIST NATURALEM; Skutschas P. P., 2011, Trudy Zoologicheskogo Instituta, V315, P167; Skutschas P, 2011, ZOOL J LINN SOC-LOND, V161, P816, DOI 10.1111/j.1096-3642.2010.00663.x; Skutschas PP, 2018, ACTA PALAEONTOL POL, V63, P519, DOI 10.4202/app.00498.2018; Skutschas PP, 2016, PALAEOBIO PALAEOENV, V96, P41, DOI 10.1007/s12549-015-0216-x; Skutschas PP, 2016, ACTA PALAEONTOL POL, V61, P119, DOI 10.4202/app.00124.2014; Skutschas PP, 2014, CRETACEOUS RES, V51, P88, DOI 10.1016/j.cretres.2014.05.014; Skutschas PP, 2013, PALAEOBIO PALAEOENV, V93, P441, DOI 10.1007/s12549-013-0126-8	18	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228610	10.1371/journal.pone.0228610	http://dx.doi.org/10.1371/journal.pone.0228610			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074114	gold, Green Published			2022-12-26	WOS:000535220600021
J	Lee, RH; Kim, JM; Cheong, JH; Ryu, JI; Kim, YS; Han, MH				Lee, Ryang-Hun; Kim, Jae Min; Cheong, Jin Hwan; Ryu, Je Il; Kim, Young Soo; Han, Myung-Hoon			Significance of skull osteoporosis to the development of peritumoral brain edema after LINAC-based radiation treatment in patients with intracranial meningioma	PLOS ONE			English	Article							STEREOTACTIC RADIOSURGERY	Background and purpose Disruption of the tumor-brain barrier in meningioma plays a critical role in the development of peritumoral brain edema (PTBE). We hypothesized that osteoporotic conditions may be associated with PTBE occurrence after radiation in patients with intracranial meningioma. Methods We measured Hounsfield units (HU) of the frontal skull on simulation brain CT in patients who underwent linear accelerator (LINAC)-based radiation treatment for intracranial meningioma. Receiver operating characteristic curve analysis was performed to determine the optimal cut-off values for several predictive factors. The cumulative hazard for PTBE was estimated and classified according to these factors. Hazard ratios were then estimated to identify independent predictive factors associated with the development of PTBE after radiation in intracranial meningioma patients. Results A total of 83 intracranial meningiomas in 76 patients who received LINAC-based radiation treatment in our hospital over an approximate 5-year period were included for the study. We found mean frontal skull HU.630.625 and gross tumor volume >7.194 cc to be independent predictors of PTBE after radiation treatment in patients with meningioma (hazard ratio, 8.41; P = 0.019; hazard ratio, 5.92; P = 0.032, respectively). In addition, patients who were >= 65 years showed a marginally significant association with PTBE. Conclusions Our study suggests that possible osteoporotic conditions, large tumor volume, and older age may be associated with PTBE occurrence after LINAC-based radiation treatment for intracranial meningioma. In the future we anticipate that these findings may enhance the understanding of the underlying mechanisms of PTBE after radiation in meningioma patients.	[Lee, Ryang-Hun; Kim, Jae Min; Cheong, Jin Hwan; Ryu, Je Il; Han, Myung-Hoon] Hanyang Univ, Dept Neurosurg, Guri Hosp, Guri, Gyonggi Do, South Korea; [Kim, Young Soo] Hanyang Univ, Dept Neurosurg, Med Ctr, Seoul, South Korea	Hanyang University; Hanyang University	Han, MH (corresponding author), Hanyang Univ, Dept Neurosurg, Guri Hosp, Guri, Gyonggi Do, South Korea.	gksmh80@gmail.com			Hanyang University (KR) [HY-201900000003370]	Hanyang University (KR)	This study was funded by Hanyang University (KR) (HY-201900000003370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae IS, 2019, AGING-US, V11, P8217, DOI 10.18632/aging.102316; Birnbaum BA, 2007, RADIOLOGY, V242, P109, DOI 10.1148/radiol.2421052066; Cai RS, 2010, NEUROSURGERY, V66, P513, DOI 10.1227/01.NEU.0000365366.53337.88; CHARNAS LR, 1993, NEUROLOGY, V43, P2603, DOI 10.1212/WNL.43.12.2603; Conti A, 2016, CUREUS, V8, DOI 10.7759/cureus.605; Gunning-Dixon FM, 2009, INT J GERIATR PSYCH, V24, P109, DOI 10.1002/gps.2087; Han MH, 2018, STROKE, V49, P1850, DOI 10.1161/STROKEAHA.118.021063; Hanna A, 2016, J NEURO-ONCOL, V127, P303, DOI 10.1007/s11060-015-2034-4; Hou J, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.8.FOCUS13301; Kirkpatrick JP, 2017, NEURO-ONCOLOGY, V19, P38, DOI 10.1093/neuonc/now301; Maslennikova A, 2015, INT J RADIAT BIOL, V91, P240, DOI 10.3109/09553002.2014.969848; Meniai-Merzouki F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32124-8; Milano MT, 2018, INT J RADIAT ONCOL, V101, P344, DOI 10.1016/j.ijrobp.2018.03.026; Miller JP, 2018, APL BIOENG, V2, DOI 10.1063/1.5018327; Na MK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197336; Nakasu Satoshi, 2005, Brain Tumor Pathol, V22, P53, DOI 10.1007/s10014-005-0187-0; Patil CG, 2008, NEUROSURGERY, V63, P435, DOI 10.1227/01.NEU.0000325257.58684.92; Pinzi V, 2018, INT J RADIAT BIOL, V94, P621, DOI 10.1080/09553002.2018.1478157; Saboori Parisa, 2015, Anat Res Int, V2015, P279814, DOI 10.1155/2015/279814; Singh VP, 2000, J NEUROSURG, V93, P57, DOI 10.3171/jns.2000.93.supplement_3.0057; Tuan NT, 2008, J NUTR, V138, P1377, DOI 10.1093/jn/138.7.1377; Weller R. O., 2005, Morphologie, V89, P22, DOI 10.1016/S1286-0115(05)83235-7; Whittle IR, 2004, LANCET, V363, P1535, DOI 10.1016/S0140-6736(04)16153-9; Wiemels J, 2010, J NEURO-ONCOL, V99, P307, DOI 10.1007/s11060-010-0386-3; Yamashima T, 2009, MENINGIOMAS, P15, DOI DOI 10.1007/978-1-84628-784-8_3	25	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0226312	10.1371/journal.pone.0226312	http://dx.doi.org/10.1371/journal.pone.0226312			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7XT	32069308	Green Published, Green Submitted, gold			2022-12-26	WOS:000535212900005
J	Desta, DM; Nedi, T; Hailu, A; Atey, TM; Tsadik, AG; Asgedom, SW; Kasahun, GG; Ayalew, E				Desta, Desilu Mahari; Nedi, Teshome; Hailu, Abraha; Atey, Tesfay Mehari; Tsadik, Afewerki Gebremeskel; Asgedom, Solomon Weldegebriel; Kasahun, Gebremicheal Gebereslassie; Ayalew, Eskinder			Treatment outcome of acute coronary syndrome patients admitted to Ayder Comprehensive Specialized Hospital, Mekelle, Ethiopia; A retrospective cross-sectional study	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; ASSOCIATION TASK-FORCE; ST-SEGMENT ELEVATION; EPIDEMIOLOGIC CHARACTERISTICS; AMERICAN-COLLEGE; MANAGEMENT; MORTALITY; REGISTRY; GUIDELINES; NAIROBI	Background Acute coronary syndrome (ACS) is increasingly becoming a common cause of cardiovascular mortality in developing countries. Even though, there is an introduction of limited percutaneous coronary intervention and thrombolytic therapies, in-hospital mortality due to ACS still remains high in sub-Saharan countries. Objective The aim of the study was to assess treatment outcome of ACS patients admitted to Ayder Comprehensive Specialized Hospital, Mekelle, Ethiopia. Methods A retrospective cross-sectional study was done by collecting data from patients' medical records using a data abstraction tool. Data were analyzed using logistic regression to determine crude and adjusted odds ratio. At 95% confidence interval, p-value<0.05 was considered as statistically significant. Results Of the total 151 patients, in-hospital mortality was found to be 24.5%, and hypertension was the most frequent (46.4%) risk factor of ACS. Concerning the management practice, catheterization and primary percutaneous coronary intervention were done in 27.1%, and 3.9% respectively. Additionally, in emergency setting loading dose of aspirin and clopidogrel were used in about 63.8% and 62.8%, respectively. The other frequently used medications were beta-blockers (86.9%), angiotensin converting enzymes/angiotensin receptor blockers (84.1%) and statins (84.1%). Streptokinase was administered in 6.3% of patients with ST-elevated myocardial infarction and heparins in 78.1% of them. The commonly prescribed discharge medications were aspirin (98.2%), statins (94.7%) and clopidogrel (92%). Non-use of beta-blockers (p = 0.014), in-hospital complication of cardiogenic shock (p = 0.001) and left ventricular ejection fraction of <= 30% (p = 0.032) were independent predictors of in-hospital mortality. Conclusion The proportion of in-hospital mortality due to ACS was found to be high. Therefore, timely evidence based therapy should be implemented in the setup.	[Desta, Desilu Mahari; Atey, Tesfay Mehari; Tsadik, Afewerki Gebremeskel; Asgedom, Solomon Weldegebriel] Mekelle Univ, Coll Hlth Sci, Sch Pharm, Clin Pharm Unit, Mekelle, Tigray, Ethiopia; [Nedi, Teshome; Ayalew, Eskinder] Addis Ababa Univ, Coll Hlth Sci, Sch Pharm, Dept Pharmacol & Clin Pharm, Addis Ababa, Ethiopia; [Hailu, Abraha] Mekelle Univ, Coll Hlth Sci, Sch Med, Dept Internal Med, Mekelle, Tigray, Ethiopia; [Kasahun, Gebremicheal Gebereslassie] Aksum Univ, Coll Hlth Sci, Dept Pharm, Aksum, Tigray, Ethiopia	Mekelle University; Addis Ababa University; Mekelle University	Ayalew, E (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Sch Pharm, Dept Pharmacol & Clin Pharm, Addis Ababa, Ethiopia.	eskipharma@gmail.com	Kasahun, Gebremicheal Gebreslassie/AAI-9900-2020; Sisay, Eskinder Ayalew/AAB-8251-2022	Kasahun, Gebremicheal Gebreslassie/0000-0002-8981-1832; Sisay, Eskinder Ayalew/0000-0002-2837-2602; Gebremeskel, Afewerki/0000-0001-5818-3434; Atey, Tesfay Mehari/0000-0002-6483-2258				Marino BCA, 2016, ARQ BRAS CARDIOL, V107, P106, DOI 10.5935/abc.20160095; Andrikopoulos G, 2016, HELL J CARDIOL, V57, P157, DOI 10.1016/j.hjc.2016.06.003; Andrikpoulos G, 2012, HELL J CARDIOL, V53, P33; Arslan F, 2017, NETH HEART J, V25, P170, DOI 10.1007/s12471-016-0944-1; Bahiru E, 2018, CARDIOVASC J AFR, V29, P177, DOI [10.5830/CVJA-2018-013, 10.5830/CVJA-2018-017, 10.5830/cvja-2018-013]; Bedetti G, 2010, AM J CARDIOL, V106, P1709, DOI 10.1016/j.amjcard.2010.08.024; Bekele Alemayehu Shashu, 2014, Ethiopian Journal of Health Development, V28, P11; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Bogale K, 2017, THESIS; Brezinov OP, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006226; Cretu Diana E, 2015, Maedica (Bucur), V10, P295; Dziewierz Artur, 2010, Acute Card Care, V12, P3, DOI 10.3109/17482941003637106; Erne Paul, 2003, HeartDrug, V3, P134, DOI 10.1159/000073838; Eyuboglu M, 2017, INT J CARDIOL, V234, P137, DOI 10.1016/j.ijcard.2017.02.036; FIKREYESUS Y, 1989, ETHIOPIAN MED J, V27, P55; Firdous S, 2017, JCPSP-J COLL PHYSICI, V27, P597, DOI 2716; Fox KAA, 2010, HEART, V96, P1095, DOI 10.1136/hrt.2009.190827; Fox KAA, 2002, EUR HEART J, V23, P1177, DOI 10.1053/euhj.2001.3081; Ghazawy ER, 2015, ADV PREVENTIVE MED, V2015; Guo Jeff J, 2016, Value Health Reg Issues, V9, P93, DOI 10.1016/j.vhri.2016.01.001; Hashmi Kashif Ali, 2018, BMC Res Notes, V11, P721, DOI 10.1186/s13104-018-3830-7; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Iqbal Farhin, 2016, Indian Heart J, V68, P128, DOI 10.1016/j.ihj.2015.07.040; Islam Mohammad S, 2016, Oman Med J, V31, P46, DOI 10.5001/omj.2016.09; Iyalomhe G. B. S., 2010, Journal of Public Health and Epidemiology, V2, P71; Jneid H, 2017, J AM COLL CARDIOL, V70, P2048, DOI 10.1016/j.jacc.2017.06.032; Kassaian SE, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007786; Kataja A, 2017, CONTIN CARDIOL ED, V3, P121, DOI DOI 10.1002/CCE2.62; Khatri P, 2015, J UNIVERSAL COLL MED, V3, P1, DOI DOI 10.3126/JUCMS.V3I2.14282; Kimeu R, 2016, CARDIOVASC J AFR, V27, P218, DOI 10.5830/CVJA-2015-091; Kolo P M, 2013, Niger Postgrad Med J, V20, P5; Kosaraju A, 2017, LEFT VENTRICULAR EJE; Kumar A, 2009, MAYO CLIN PROC, V84, P917, DOI 10.1016/S0025-6196(11)60509-0; Kurtul A, 2017, CORONARY ARTERY DIS, V28, P406, DOI 10.1097/MCA.0000000000000500; Manfrini O, 2014, EUR HEART J SUPPL, V16, pA87, DOI 10.1093/eurheartj/sut019; Martinez-Sanchez C, 2017, ACUTE CORONARY SYNDR, V54, P726; Mohan H., 2005, TXB PATHOLOGY; Mohanan PP, 2013, EUR HEART J, V34, P121, DOI 10.1093/eurheartj/ehs219; N'Guetta R, 2016, ANN CARDIOLOGIE ANGE; O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1161/CIR.0b013e3182742c84, 10.1016/j.jacc.2012.11.018]; Pathak V, 2015, J INDIAN COLL CARDIO, V5, P112; Polonski L, 2007, KARDIOL POL, V65, P861; Posnenkova OM, 2014, COR VASA, V56, pE217, DOI 10.1016/j.crvasa.2014.03.004; Qanitha A, 2018, BMJ-BRIT MED J, V5; Raposeiras-Roubin S, 2012, JACC-CARDIOVASC INTE, V5, P1117, DOI 10.1016/j.jcin.2012.06.023; Salarifar M, 2009, IRAN J PUBLIC HEALTH, V38, P97; Sarr M, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-118; Schamroth C, 2012, CARDIOVASC J AFR, V23, P365, DOI 10.5830/CVJA-2012-017; Seck M, 2007, Med Trop (Mars), V67, P569; Shavadia J, 2012, CARDIOVASC J AFR, V23, P318, DOI 10.5830/CVJA-2012-002; Singh Shiv Shankar, 2017, J Family Med Prim Care, V6, P502, DOI 10.4103/2249-4863.222033; Smith JN, 2015, J AM BOARD FAM MED, V28, P283, DOI 10.3122/jabfm.2015.02.140189; Soeiro AD, 2016, CLINICS, V71, P635, DOI 10.6061/clinics/2016(11)03; Thiele H, 2015, EUR HEART J, V36, P1223, DOI 10.1093/eurheartj/ehv051; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Tousek P, 2014, INT J CARDIOL, V173, P204, DOI 10.1016/j.ijcard.2014.02.013; Wachira BW, 2014, AFR J EMERG MED, V4, P104, DOI 10.1016/j.afjem.2013.12.003; World Health Organization, 2008, PROJ MORT BURD DIS 2; Xavier D, 2008, LANCET, V371, P1435, DOI 10.1016/S0140-6736(08)60623-6; Yadeta D, 2017, HEART ASIA, V9, DOI 10.1136/heartasia-2016-010829	60	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228953	10.1371/journal.pone.0228953	http://dx.doi.org/10.1371/journal.pone.0228953			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053702	gold, Green Published			2022-12-26	WOS:000535198700077
J	Diaz-Rivera, A; Meza-Rios, A; de Sanchez, VC; Velasco-Loyden, G; Garcia-Benavides, L; Jave-Suarez, LF; Monroy-Ramirez, HC; Santos-Garcia, A; Armendariz-Borunda, J; Sandoval-Rodriguez, A				Diaz-Rivera, Adriana; Meza-Rios, Alejandra; Chagoya de Sanchez, Victoria; Velasco-Loyden, Gabriela; Garcia-Benavides, Leonel; Jave-Suarez, Luis F.; Christian Monroy-Ramirez, Hugo; Santos-Garcia, Arturo; Armendariz-Borunda, Juan; Sandoval-Rodriguez, Ana			Hydrodynamics-based liver transfection achieves gene silencing of CB1 using short hairpin RNA plasmid in cirrhotic rats	PLOS ONE			English	Article							CANNABINOID RECEPTOR ANTAGONISM; HEPATIC STELLATE CELLS; NAKED DNA; EXPRESSION; GROWTH; ENDOCANNABINOIDS; HEPATOCYTES; REPLICATION; INHIBITION; ACTIVATION	Background There is a correlation between the endocannabinoid system and hepatic fibrosis based on the activation of CB1 and CB2 receptors; where CB1 has profibrogenic effects. Gene therapy with a plasmid carrying a shRNA for CB1 delivered by hydrodynamic injection has the advantage of hepatic tropism, avoiding possible undesirable effects of CB1 pharmacological inhibition. Objective To evaluate hydrodynamics-based liver transfection in an experimental model of liver cirrhosis of a plasmid with the sequence of a shRNA for CB1 and its antifibrogenic effects Methods Three shRNA (21pb) were designed for blocking CB1 mRNA at positions 877, 1232 and 1501 (pshCB1-A, B, C). Sequences were cloned in the pENTRT/U6. Safety was evaluated monitoring CB1 expression in brain tissue. The silencing effect was determined in rat HSC primary culture and CCl4 cirrhosis model. Hydrodynamic injection in cirrhotic liver was through iliac vein and with a dose of 3mg/kg plasmid. Serum levels of liver enzymes, mRNA levels of TGF-beta 1, Col IA1 and alpha-SMA and the percentage of fibrotic tissue were analyzed. Results Hydrodynamic injection allows efficient CB1 silencing in cirrhotic livers and pshCB1-B (position 1232) demonstrated the main CB1-silencing. Using this plasmid, mRNA level of fibrogenic molecules and fibrotic tissue considerably decrease in cirrhotic animals. Brain expression of CB1 remained unaltered. Conclusion Hydrodynamics allows a hepatotropic and secure transfection in cirrhotic animals. The sequence of the shCB1-B carried in a plasmid or any other vector has the potential to be used as therapeutic strategy for liver fibrosis.	[Diaz-Rivera, Adriana; Christian Monroy-Ramirez, Hugo; Armendariz-Borunda, Juan; Sandoval-Rodriguez, Ana] Univ Guadalajara, Ctr Univ Ciencias Salud, Inst Mol Biol Med, Guadalajara, Jalisco, Mexico; [Meza-Rios, Alejandra; Santos-Garcia, Arturo; Armendariz-Borunda, Juan] Tecnol Monterrey, Campus Guadalajara, Guadalajara, Jalisco, Mexico; [Chagoya de Sanchez, Victoria; Velasco-Loyden, Gabriela] Univ Nacl Autonoma Mexico, Cellular Physiol Inst, Mexico City, DF, Mexico; [Garcia-Benavides, Leonel] Univ Guadalajara, Ctr Univ Tonala, Biomed Sci Dept, Tonala, Mexico; [Jave-Suarez, Luis F.] Inst Mexicano Seguro Social, Ctr Invest Biomed Occidente, Immunol Div, Mexico City, DF, Mexico	Universidad de Guadalajara; Tecnologico de Monterrey; Universidad Nacional Autonoma de Mexico; Universidad de Guadalajara; Instituto Mexicano del Seguro Social	Armendariz-Borunda, J; Sandoval-Rodriguez, A (corresponding author), Univ Guadalajara, Ctr Univ Ciencias Salud, Inst Mol Biol Med, Guadalajara, Jalisco, Mexico.; Armendariz-Borunda, J (corresponding author), Tecnol Monterrey, Campus Guadalajara, Guadalajara, Jalisco, Mexico.	armdbo@gmail.com; anasol44@hotmail.com	garcia, leonel/V-9040-2017; Garcia Benavides, Leonel/GPP-7463-2022; Armendáriz-Borunda, Juan/AAU-1471-2021; Jave-Suarez, Luis Felipe/T-7036-2018	garcia, leonel/0000-0001-8087-3597; Garcia Benavides, Leonel/0000-0001-8087-3597; Jave-Suarez, Luis Felipe/0000-0001-6209-5031; Sandoval-Rodriguez, Ana/0000-0003-1708-1495; Monroy-Ramirez, Hugo Christian/0000-0001-8891-5317	CONACYT [103772]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	CONACYT grant number 103772 awarded to ASR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.conacyt.gob.mx/index.php/fondos-y-apoyos.	Bonamassa B, 2011, PHARM RES-DORDR, V28, P694, DOI 10.1007/s11095-010-0338-9; Budker V, 1996, GENE THER, V3, P593; Carmona S, 2006, MOL THER, V13, P411, DOI 10.1016/j.ymthe.2005.10.013; Chang JH, 2001, J VIROL, V75, P3469, DOI 10.1128/JVI.75.7.3469-3473.2001; Chen SW, 2008, GENE THER, V15, P1424, DOI 10.1038/gt.2008.93; Chen SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050850; Cheng K, 2009, MOL PHARMACEUT, V6, P772, DOI 10.1021/mp9000469; Cui F, 2001, GENE THERAPY, V8; Domenicali M, 2009, GASTROENTEROLOGY, V137, P341, DOI 10.1053/j.gastro.2009.01.004; Hezode C, 2005, HEPATOLOGY, V42, P63, DOI 10.1002/hep.20733; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Jones D, 2008, NAT REV DRUG DISCOV, V7, P961, DOI 10.1038/nrd2775; Kirn JW, 2007, BIOCHEM BIOPH RES CO, V359, P292, DOI 10.1016/j.bbrc.2007.05.080; Kobayashi N, 2001, J PHARMACOL EXP THER, V297, P853; Lewis DL, 2002, NATURE GENETICS, V32; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Mallat A, 2008, AM J PHYSIOL-GASTR L, V294, pG9, DOI 10.1152/ajpgi.00467.2007; Maruyama H, 2002, J GENE MED, V4, P333, DOI 10.1002/jgm.281; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Rockey DC, 2007, HEPATIC FIBROSIS CIR, P87; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; Siegmund SV, 2007, FASEB J, V21, P2798, DOI 10.1096/fj.06-7717com; Tam J, 2011, HEPATOLOGY, V53, P346, DOI 10.1002/hep.24077; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Yang YY, 2007, CLIN SCI, V112, P533, DOI 10.1042/CS20060260; Yazawa H, 2006, CANCER GENE THER, V13, P993, DOI 10.1038/sj.cgt.7700970; Yeikilis R, 2006, WORLD J GASTROENTERO, V12, P6149, DOI 10.3748/wjg.v12.i38.6149; Zhang GF, 1997, HUM GENE THER, V8, P1763, DOI 10.1089/hum.1997.8.15-1763; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	31	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228729	10.1371/journal.pone.0228729	http://dx.doi.org/10.1371/journal.pone.0228729			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053633	gold, Green Published			2022-12-26	WOS:000535198700049
J	Fikire, A; Ayele, G; Haftu, D				Fikire, Alemayehu; Ayele, Gistane; Haftu, Desta			Determinants of delay in care seeking for diarrheal diseases among mothers/caregivers with under-five children in public health facilities of Arba Minch town, southern Ethiopia; 2019	PLOS ONE			English	Article								Background Timely and appropriate health care seeking for diarrhea of under-five children is important to reduce severe and life-threatening complications. However, different findings indicate that mothers of under-five children often delay in seeking care which in turn contributes to the death of large number of children without ever reaching a health facility. Therefore, a proper pinpointing of determinants of delay in seeking care informs intervention strategies for health service planners. Objectives Of this study was to identify the determinants of delay in care seeking for diarrheal disease among mothers/caregivers of under-five children in public health facilities of Arba Minch town, South Ethiopia, 2019. Methods Facility based case control study was conducted from March 4 to April 30, 2019. Total sample size was 400. Cases were selected by systematic random sampling technique while controls were mothers of under-five children with signs and symptoms of diarrhea who came to the same health facility within 24 hours following cases. Data was collected by using pretested structured questionnaire by three data collectors and entered into EpiData V4 and exported to SPSS V23 for further analysis. Bivariable logistic regression was done to identify variables candidate for Multivariable LR at p-value<0.25. Multivariable logistic regression was done and p-value <0.05 and 95%CI of AOR was used to declare statistical significance. Result Female sex[AOR = 1.93, (95%CI: 1.11,3.36)], child age <24 months[AOR = 4.47,95% CI:2.51,7.97)], mothers'/caregivers without formal education[AOR = 6.90, (95% CI:3.10,15.37)], and attended primary school [AOR = 3.12,(95%CI:1.44,6.73)], poorest household wealth index category[AOR = 2.81, (95%CI:1.20,6.58) and poor household wealth index category [AOR = 2.61,(95%CI: 1.12, 6.09)], mothers/caregivers who did not visit health facility to first episode diarrhea [AOR = 4.55, (95%CI:2.41,8.59)], mothers/caregivers who were satisfied in the last six month visit [AOR = 0.29, (95%CI:0.15,0.55)], and poor perceived health care professionals respect[AOR = 4.91, (95%CI:2.64,9.15)] were important determinants of delay in seeking care. Conclusions Sex and age of the child, educational status of the mother/caregiver, poor wealth index category, not visiting health facility at first response, satisfaction with the care and examination, and respect of health care professionals were important determinants of delay in seeking care among mothers/caregivers of under-five children with diarrhea illness. All concerned body should focus interventions on poor and less educated mothers/caregivers with emphasis on female children and <24 months. Health workers are needed to provide respectful service to promote satisfaction level of clients.	[Fikire, Alemayehu] Hawassa Coll Hlth Sci, Publ Hlth Team, Hawassa, Ethiopia; [Ayele, Gistane; Haftu, Desta] Arba Minch Univ, Sch Publ Hlth, Arba Minch, Ethiopia	Arba Minch University	Fikire, A (corresponding author), Hawassa Coll Hlth Sci, Publ Hlth Team, Hawassa, Ethiopia.	fikirualemu@gmail.com		Shobe, Alemayehu/0000-0001-7187-917X				Adam B, 2015, DHS WORKING PAPERS; Adane M, 2017, J HEALTH POPUL NUTR, V36, P1, DOI 10.1186/s41043-017-0085-1; Assefa T., 2008, ETHIOPIAN J HLTH SCI, V18, P87; Azage M, 2015, RURAL REMOTE HEALTH, V15; Begashaw B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161014; Berhe H, 2017, STATUS CARING RESPEC, V10, P1119; Bezatu M, 2012, BMC PUBLIC HLTH, V12; Bilal N. K, 2011, YES AFRICA CAN SUCCE, V2011, P433; Chilambwe M, 2015, J INFECT DIS THER, V3, P227; Chistian Umuhuza, 2018, PAN AFRICAN MED J, V30; Degefa G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193035; Dengia T, 2014, GLOBAL J MED PUBLIC; Diaz T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-157; Ethiopian Public Health Institute (EPHI); ICF, 2016, ETH DEM HLTH SURV 20; Fissehaye Tedros, 2018, BMC Res Notes, V11, P749, DOI 10.1186/s13104-018-3850-3; Gamo Zone Health Department, 2010, ANN PERF REP; Gebrehiwot E.M., 2015, SCI J CLIN MED, V4, P4; Gebretsadik A, 2015, INT J FAMILY MED; Geldsetzer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093427; Gidudu J, 2011, VACCINE, V29, P1053, DOI 10.1016/j.vaccine.2010.11.065; Girma T, PAEDIAT CHILD UNPUB, P219; Group WB, 2016, HLTH EXT PROGR ETH I; Kefale AT, 2016, INTEGR PHARM RES PRA, V5, P85, DOI 10.2147/IPRP.S118657; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Malhotra N, 2013, ACTA PAEDIATR, V102, pE413, DOI 10.1111/apa.12304; Muhumuza J., 2017, SCI J PUBLIC HLTH, V5, P246, DOI [10.11648/j.sjph.20170503.23, DOI 10.11648/J.SJPH.20170503.23]; Nilanjana Ghosh, 2013, International Journal of Medicine and Public Health, V3, P12; Page AL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-389; Sisay S, 2014, GLOBAL J LIFE SCI BI, V1, P20; Sreeramareddy Chandrashekhar T, 2006, BMC Int Health Hum Rights, V6, P7, DOI 10.1186/1472-698X-6-7; Tee GH, 2011, S E ASIAN J TROP MED, V42; Tufa K, 2016, PLOS ONE, V11; UNICEF WHO World Bank Group UN, 2018, LEV TRENDS CHILD MOR, P6; World Health Organization, 2017, CHRONIC OBSTRUCTIVE, P2	34	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228558	10.1371/journal.pone.0228558	http://dx.doi.org/10.1371/journal.pone.0228558			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053615	Green Published, gold			2022-12-26	WOS:000535198700032
J	Reps, JM; Cepeda, MS; Ryan, PB				Reps, Jenna Marie; Cepeda, M. Soledad; Ryan, Patrick B.			Wisdom of the CROUD: Development and validation of a patient-level prediction model for opioid use disorder using population-level claims data	PLOS ONE			English	Article							COMMON DATA MODEL; ABUSE; DEPENDENCE; STATES; DRUG; RISK; TOOL	Objective Some patients who are given opioids for pain could develop opioid use disorder. If it was possible to identify patients who are at a higher risk of opioid use disorder, then clinicians could spend more time educating these patients about the risks. We develop and validate a model to predict a person's future risk of opioid use disorder at the point before being dispensed their first opioid. Methods A cohort study patient-level prediction using four US claims databases with target populations ranging between 343,552 and 384,424 patients. The outcome was recorded diagnosis of opioid abuse, dependency or unspecified drug abuse as a proxy for opioid use disorder from 1 day until 365 days after the first opioid is dispensed. We trained a regularized logistic regression using candidate predictors consisting of demographics and any conditions, drugs, procedures or visits prior to the first opioid. We then selected the top predictors and created a simple 8 variable score model. Results We estimated the percentage of new users of opioids with reported opioid use disorder within a year to range between 0.04%-0.26% across US claims data. We developed an 8 variable Calculator of Risk for Opioid Use Disorder (CROUD) score, derived from the prediction models to stratify patients into higher and lower risk groups. The 8 baseline variables were age 15-29, medical history of substance abuse, mood disorder, anxiety disorder, low back pain, renal impairment, painful neuropathy and recent ER visit. 1.8% of people were in the high risk group for opioid use disorder and had a score > = 23 with the model obtaining a sensitivity of 13%, specificity of 98% and PPV of 1.14% for predicting opioid use disorder. Conclusions CROUD could be used by clinicians to obtain personalized risk scores. CROUD could be used to further educate those at higher risk and to personalize new opioid dispensing guidelines such as urine testing. Due to the high false positive rate, it should not be used for contraindication or to restrict utilization.	[Reps, Jenna Marie; Cepeda, M. Soledad; Ryan, Patrick B.] Janssen Res & Dev Titusville, Titusville, NJ 08560 USA		Reps, JM (corresponding author), Janssen Res & Dev Titusville, Titusville, NJ 08560 USA.	jreps@its.jnj.com	Ryan, Patrick/HDO-1133-2022					CDC, 2019, GUID PRESCR OP CHRON; Ciesielski T, 2016, AM J MED, V129, P699, DOI 10.1016/j.amjmed.2016.02.014; Dufour R, 2014, AM J PHARM BENEFIST, V6, P208; Edlund MJ, 2010, DRUG ALCOHOL DEPEN, V112, P90, DOI 10.1016/j.drugalcdep.2010.05.017; Goyal H, 2017, AM J MED, V130, pE113, DOI 10.1016/j.amjmed.2016.09.022; Hakkinen M, 2014, FORENSIC SCI INT, V245, P121, DOI 10.1016/j.forsciint.2014.10.028; Health IW, 2019, IBM MARKETSCAN RES D; Heron Melonie, 2017, Natl Vital Stat Rep, V66, P1; Hripcsak G, 2016, P NATL ACAD SCI USA, V113, P7329, DOI 10.1073/pnas.1510502113; Lipari R.N., 2016, PRESCRIPTION DRUG US; Meier L, 2008, J R STAT SOC B, V70, P53, DOI 10.1111/j.1467-9868.2007.00627.x; OPTUM, 2019, REAL WORLD DAT; Overhage JM, 2012, J AM MED INFORM ASSN, V19, P54, DOI 10.1136/amiajnl-2011-000376; Reps JM, 2018, J AM MED INFORM ASSN, V25, P969, DOI 10.1093/jamia/ocy032; Rudd RA, 2016, AM J TRANSPLANT, V16, P1323, DOI 10.1111/ajt.13776; Scholl L, 2019, MMWR-MORBID MORTAL W, V67, P1419; Suchard MA, 2013, ACM T MODEL COMPUT S, V23, DOI 10.1145/2414416.2414791; United States Food and Drug Administration, 2018, FDA ED BLUEPR HLTH C; Voss EA, 2015, J AM MED INFORM ASSN, V22, P553, DOI 10.1093/jamia/ocu023; White AG, 2009, AM J MANAG CARE, V15, P897	20	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228632	10.1371/journal.pone.0228632	http://dx.doi.org/10.1371/journal.pone.0228632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7SH	32053653	Green Published, gold			2022-12-26	WOS:000535198700039
J	Seifert, AM; Reiche, C; Heiduk, M; Tannert, A; Meinecke, AC; Baier, S; von Renesse, J; Kahlert, C; Distler, M; Welsch, T; Reissfelder, C; Aust, DE; Miller, G; Weitz, J; Seifert, L				Seifert, Adrian M.; Reiche, Charlotte; Heiduk, Max; Tannert, Anna; Meinecke, Ann-Christin; Baier, Stephanie; von Renesse, Janusz; Kahlert, Christoph; Distler, Marius; Welsch, Thilo; Reissfelder, Christoph; Aust, Daniela E.; Miller, George; Weitz, Juergen; Seifert, Lena			Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels	ONCOGENE			English	Article							T-CELLS; CANCER; EXPRESSION; ONCOGENESIS; SURVIVAL; IMMUNITY	Pancreatic ductal adenocarcinoma (PDAC) responds poorly to checkpoint blockade, such as anti-CTLA-4 and anti-PD-1. Galectin-9, a beta-galactoside-binding lectin, promotes immune suppression through T-cell inhibition, and programming of tolerogenic macrophages. Of all cancers tested, PDAC showed the highest expression of LGALS9 (galectin-9) mRNA. We analyzed formalin-fixed and paraffin-embedded specimens from 83 patients with PDAC stained for galectin-9. Using flow cytometry, we determined galectin-9 expression on immune cells from tumor and matched blood samples from 12 patients with resectable PDAC. Furthermore, we analyzed galectin-9 serum levels by enzyme-linked immunosorbent assay using serum samples from 70 patients with PDAC, from 36 individuals with benign pancreatic disease, and from 28 healthy controls. Galectin-9 was highly expressed in human PDAC compared with normal pancreas and present on both tumor and immune cells. Tumor-infiltrating immune cells, especially CD3(+) T cells, showed upregulation of galectin-9 compared with immune cells from matched blood. Blood gamma delta T cells from PDAC patients had higher galectin-9 expression than gamma delta T cells from healthy individuals. Galectin-9 polarized macrophages toward a protumoral M2 phenotype leading to suppressed T-cell cytokine secretion. Furthermore, serum concentration of galectin-9 was able to discriminate PDAC from benign pancreatic disease and healthy individuals, and was prognostic for stage IV patients. Galectin-9 is a new biomarker for the detection of PDAC.	[Seifert, Adrian M.; Reiche, Charlotte; Heiduk, Max; Tannert, Anna; Meinecke, Ann-Christin; Baier, Stephanie; von Renesse, Janusz; Kahlert, Christoph; Distler, Marius; Welsch, Thilo; Weitz, Juergen; Seifert, Lena] Univ Dresden, Fac Med, Univ Hosp Carl Gustav Carus, Dept Visceral Thorac & Vasc Surg, Dresden, Germany; [Seifert, Adrian M.; Heiduk, Max; Kahlert, Christoph; Welsch, Thilo; Weitz, Juergen; Seifert, Lena] German Canc Consortium DKTK, Partner Site Dresden, Heidelberg, Germany; [Seifert, Adrian M.; Heiduk, Max; Kahlert, Christoph; Welsch, Thilo; Weitz, Juergen; Seifert, Lena] German Canc Res Ctr, Heidelberg, Germany; [Heiduk, Max] Natl Ctr Tumor Dis NCT, Partner Site Dresden, Dresden, Germany; [Reissfelder, Christoph] Heidelberg Univ, Univ Med Mannheim, Med Fac Mannheim, Dept Surg, Mannheim, Germany; [Aust, Daniela E.] Univ Dresden, Univ Hosp Carl Gustav Carus, Fac Med, Dept Pathol, Dresden, Germany; [Aust, Daniela E.] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, NCT Biobank Dresden, Dresden, Germany; [Miller, George] NYU, Sch Med, Dept Surg, SA Localio Lab, New York, NY USA; [Miller, George] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; New York University; New York University	Seifert, L (corresponding author), Univ Dresden, Fac Med, Univ Hosp Carl Gustav Carus, Dept Visceral Thorac & Vasc Surg, Dresden, Germany.; Seifert, L (corresponding author), German Canc Consortium DKTK, Partner Site Dresden, Heidelberg, Germany.; Seifert, L (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	lena.seifert@ukdd.de	Seifert, Adrian M./AAL-3453-2021	Seifert, Adrian M./0000-0002-5329-3164; Reissfelder, Christoph/0000-0003-4591-1046; Heiduk, Max/0000-0002-7907-4162; Seifert, Lena/0000-0003-4763-8127	Ernst-Jung Stiftung; Monika Kutzner Stiftung; German Research Foundation (DFG); German Cancer Consortium (DKTK); Medical Faculty Carl Gustav Carus TU Dresden; CMCB Light Microscopy Facility of TU Dresden; Projekt DEAL	Ernst-Jung Stiftung; Monika Kutzner Stiftung; German Research Foundation (DFG)(German Research Foundation (DFG)); German Cancer Consortium (DKTK); Medical Faculty Carl Gustav Carus TU Dresden; CMCB Light Microscopy Facility of TU Dresden; Projekt DEAL	This work was supported by the Ernst-Jung Stiftung (LS), the Monika Kutzner Stiftung (LS), the German Research Foundation (DFG; LS), the German Cancer Consortium (DKTK; AMS) and the Medical Faculty Carl Gustav Carus TU Dresden (AMS, LS). We thank the CMCB Light Microscopy Facility of TU Dresden for their support. Open access funding provided by Projekt DEAL.	Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Balli D, 2017, CLIN CANCER RES, V23, P3129, DOI 10.1158/1078-0432.CCR-16-2128; Belo AI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065957; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan A, 2014, CLIN CANCER RES, V20, P5787, DOI 10.1158/1078-0432.CCR-14-0289; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Daley D, 2017, NAT MED, V23, P556, DOI 10.1038/nm.4314; Daley D, 2016, CELL, V166, P1485, DOI 10.1016/j.cell.2016.07.046; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Irie A, 2005, CLIN CANCER RES, V11, P2962, DOI 10.1158/1078-0432.CCR-04-0861; Jiang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081799; Kim J, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5583; Li H, 2012, HEPATOLOGY, V56, P1342, DOI 10.1002/hep.25777; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Madireddi S, 2014, J EXP MED, V211, P1425, DOI 10.1084/jem.20132687; Maftouh M, 2014, ONCOTARGET, V5, P5335, DOI 10.18632/oncotarget.2104; Martinez-Bosch Neus, 2018, Oncotarget, V9, P32984, DOI 10.18632/oncotarget.26034; Nagahara K, 2008, J IMMUNOL, V181, P7660, DOI 10.4049/jimmunol.181.11.7660; Ohue Y, 2016, CANCER IMMUNOL RES, V4, P1049, DOI 10.1158/2326-6066.CIR-15-0266; Okura R, 2018, ONCOL LETT, V15, P407, DOI 10.3892/ol.2017.7316; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Radon TP, 2015, CLIN CANCER RES, V21, P3512, DOI 10.1158/1078-0432.CCR-14-2467; Roda O, 2009, GASTROENTEROLOGY, V136, P1379, DOI 10.1053/j.gastro.2008.12.039; Royal RE, 2010, J IMMUNOTHER, V33, P828, DOI 10.1097/CJI.0b013e3181eec14c; Seifert AM, 2017, CLIN CANCER RES, V23, P454, DOI 10.1158/1078-0432.CCR-16-1163; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; Shimamura T, 2002, CLIN CANCER RES, V8, P2570; Sideras K, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1273309; Song SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042699; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152599; Wu C, 2014, IMMUNITY, V41, P270, DOI 10.1016/j.immuni.2014.06.011; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yang KS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3226; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	36	32	33	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	15					3102	3113		10.1038/s41388-020-1186-7	http://dx.doi.org/10.1038/s41388-020-1186-7		FEB 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LB8NS	32055023	Green Published, hybrid			2022-12-26	WOS:000513314100001
J	Shibabaw, A; Gelaw, B; Gebreyes, W; Robinson, R; Wang, SH; Tessema, B				Shibabaw, Agumas; Gelaw, Baye; Gebreyes, Wondwossen; Robinson, Richard; Wang, Shu-Hua; Tessema, Belay			The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia	PLOS ONE			English	Article							TERTIARY CARE CENTER; MYCOBACTERIUM-TUBERCULOSIS; SPATIAL-ANALYSIS; RISK-FACTORS; XDR-TB; PREVALENCE; MECHANISMS; OUTCOMES; PEOPLE	Background The emergence of pre-extensively and extensively drug-resistant tuberculosis (Pre-XDR/XDR-TB) is the major hurdle for TB prevention and care programs especially in developing countries like Ethiopia. The less emphasis on universal access to laboratory techniques for the rapid diagnosis of TB and drug susceptibility testing (DST) makes the management of MDR-TB a challenge. Early detection of second line anti-TB drugs resistance is essential to reduce transmission of Pre-XDR/XDR-TB strains and adjusting the treatment regimen in MDR-TB. Objective To determine the prevalence and resistance pattern of Pre-XDR- and XDR-TB among MDR-TB patients in the Amhara region, Ethiopia. Methods A cross sectional study was carried out in nine MDR-TB treatment centers in the Amhara region. Sputum samples were collected from all pulmonary rifampicin resistant (RR) or MDR-TB patients prior to anti-TB treatment. Lowenstein-Jensen (LJ) culture, Ziehl Neelsen (ZN) smear, MTBDRplus and MTBDRsl assays were performed according to the standard procedures. Data were analyzed using SPSS 20 software. Chi-square and/or Fishers exact test was employed. Results Overall, 6.3% of MDR-TB isolates were resistant to at least one second line drugs. Pre-XDR-TB and XDR-TB isolates accounted 5.7% and 0.6% respectively. Moreover, 3.4% were resistant to FQs and 3.4% were resistant to second line injectable drugs. All isolates were susceptible for low level kanamycin. Almost all pre-XDR-TB strains (90%) were previously treated with anti-TB drugs. Drug resistant Mycobacterium tuberculosis isolates were disproportionately distributed in districts of the Amhara region and the majorities were concentrated in urban areas. Conclusions The high proportion of MDR-TB patients resistant to at least one second line drug is alarming. Strengthening the laboratory facilities to monitor pre-XDR and XDR-TB patients is crucial. The TB programs need to give emphasis on the effective and rational use of second line drugs for newly diagnosed MDR-TB patients to prevent the emergence of pre-XDR/XDR-TB strains.	[Shibabaw, Agumas; Gelaw, Baye; Tessema, Belay] Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Med Microbiol, Gondar, Ethiopia; [Shibabaw, Agumas; Gebreyes, Wondwossen; Wang, Shu-Hua] Ohio State Univ, Global One Hlth Initiat GOHi, Columbus, OH 43210 USA; [Shibabaw, Agumas; Robinson, Richard] Ohio State Univ, Coll Med, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Gebreyes, Wondwossen] Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Wang, Shu-Hua] Ohio State Univ, Coll Med, Dept Internal Med, Div Infect Dis, Columbus, OH 43210 USA	University of Gondar; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Shibabaw, A (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Med Microbiol, Gondar, Ethiopia.; Shibabaw, A (corresponding author), Ohio State Univ, Global One Hlth Initiat GOHi, Columbus, OH 43210 USA.; Shibabaw, A (corresponding author), Ohio State Univ, Coll Med, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.	agumas2000@gmail.com	SHIBABAW, AGUMAS/GLV-0652-2022	SHIBABAW, AGUMAS/0000-0001-6286-7564	University of Gondar Mega project grant	University of Gondar Mega project grant	This work was funded by University of Gondar Mega project grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdella K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1955-3; Adwani S, 2016, J KRISHNA INST MED S, V5, P13; Agonafir M, 2010, INT J TUBERC LUNG D, V14, P1259; Agrawal D, 2009, INT J TUBERC LUNG D, V13, P79; Ajbani K, 2011, J CLIN MICROBIOL, V49, P2546, DOI 10.1128/JCM.02511-10; Chen Y, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2628913; Dalal A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116798; Dalton T, 2012, LANCET, V380, P1406, DOI 10.1016/S0140-6736(12)60734-X; Daniel O., 2013, GLOB ADV RES J MICRO, V2; Dooley KE, 2002, CLIN INFECT DIS, V34, P1607, DOI 10.1086/340618; Emmerson AM, 2003, J ANTIMICROB CHEMOTH, V51, P13, DOI 10.1093/jac/dkg208; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gelaw YA, 2019, J GLOB INFECT DIS, V11, P63, DOI 10.4103/jgid.jgid_95_18; Glaziou P, 2015, CSH PERSPECT MED, V5, DOI [10.1101/cshperspect.a017798, 10.1055/s-0038-1651492]; Hogan Catherine A, 2017, J Clin Tuberc Other Mycobact Dis, V6, P1, DOI 10.1016/j.jctube.2016.12.001; HSE National Drug Treatment Centre, 2016, CERV SMEAR GUID; Kempker RR, 2015, EMERG INFECT DIS, V21, P992, DOI 10.3201/eid2106.141873; Kliiman K, 2009, EUR RESPIR J, V33, P1085, DOI 10.1183/09031936.00155708; Kozinska M, 2016, POL ARCH MED WEWN, V126, P32; Kozinska Monika, 2011, Pneumonol Alergol Pol, V79, P278; Lan YB, 2019, INFECT DRUG RESIST, V12, P211, DOI 10.2147/IDR.S188538; Law DCG, 2004, SEX TRANSM INFECT, V80, P294, DOI 10.1136/sti.2003.006700; Li XX, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.23620; Nguyen L, 2016, ARCH TOXICOL, V90, P1585, DOI 10.1007/s00204-016-1727-6; lqbal R, 2012, PAK J MED RES, V51, P1; Malik S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039754; Manson AL, 2017, CLIN INFECT DIS, V64, P1494, DOI 10.1093/cid/cix169; Mesfin EA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197737; Mirza IA, 2015, JCPSP-J COLL PHYSICI, V25, P337, DOI 05.2015/JCPSP.337341; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; Nguyen HB, 2016, WPSAR, V7, DOI [10.5365/WPSAR.2016.7.1.008, DOI 10.5365/WPSAR.2016.7.1.008]; Palmero Domingo, 2015, Arch Bronconeumol, V51, pe49, DOI 10.1016/j.arbres.2015.03.012; Porwal C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055299; Ramachandran R, 2009, INT J TUBERC LUNG D, V13, P1154; Rao NA, 2010, JCPSP-J COLL PHYSICI, V20, P262, DOI 04.2010/JCPSP.262265; Reechaipichitkul W, 2011, SE ASIAN J TROP MED, V42, P1154; Sagonda T, 2014, TUBERCULOSIS RES TRE, V2014, P349; Sharma SK, 2009, INDIAN J MED RES, V130, P392; Shen GH, 2009, INT J TUBERC LUNG D, V13, P371; Smith SE, 2015, EMERG INFECT DIS, V21, P1002, DOI 10.3201/eid2106.141907; Tasbiti Alireza Hadizadeh, 2017, Osong Public Health Res Perspect, V8, P116, DOI 10.24171/j.phrp.2017.8.2.03; Tasnim T., 2018, J TUBERC RES, V6, P199, DOI 10.4236/jtr.2018.63018; Touray K, 2010, TROP MED INT HEALTH, V15, P664, DOI 10.1111/j.1365-3156.2010.02533.x; WHO, 2019, GLOB TUB REP; Williamson DA, 2012, DIAGN MICR INFEC DIS, V74, P207, DOI 10.1016/j.diagmicrobio.2012.06.013; World Health Organization, 2018, GLOB TURB REP 2018; World Health Organization, 1998, LAB SERV TUB CONTR 3; World Health Organization, 2013, DEFINITIONS REPORTIN; Yuan XL, 2012, J CLIN MICROBIOL, V50, P2404, DOI 10.1128/JCM.06860-11; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320	50	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0229040	10.1371/journal.pone.0229040	http://dx.doi.org/10.1371/journal.pone.0229040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053661	gold, Green Published			2022-12-26	WOS:000535198700094
J	Zheng, XH; Arias, EB; Qi, NR; Saunders, TL; Cartee, GD				Zheng, Xiaohua; Arias, Edward B.; Qi, Nathan R.; Saunders, Thomas L.; Cartee, Gregory D.			In vivo glucoregulation and tissue-specific glucose uptake in female Akt substrate 160 kDa knockout rats	PLOS ONE			English	Article							RAB GAP AS160; GLUT4 TRANSLOCATION; INSULIN-RESISTANCE; SKELETAL-MUSCLES; TRANSPORT; TBC1D1; PHOSPHORYLATION; DELETION; METABOLISM; MUTATION	The Rab GTPase activating protein known as Akt substrate of 160 kDa (AS160 or TBC1D4) regulates insulin-stimulated glucose uptake in skeletal muscle, the heart, and white adipose tissue (WAT). A novel rat AS160-knockout (AS160-KO) was created with CRISPR/Cas9 technology. Because female AS160-KO versus wild type (WT) rats had not been previously evaluated, the primary objective of this study was to compare female AS160-KO rats with WT controls for multiple, important metabolism-related endpoints. Body mass and composition, physical activity, and energy expenditure were not different between genotypes. AS160-KO versus WT rats were glucose intolerant based on an oral glucose tolerance test (P<0.001) and insulin resistant based on a hyperinsulinemic-euglycemic clamp (HEC; P<0.001). Tissue glucose uptake during the HEC of female AS160-KO versus WT rats was: 1) significantly lower in epitrochlearis (P<0.05) and extensor digitorum longus (EDL; P<0.01) muscles of AS160-KO compared to WT rats; 2) not different in soleus, gastrocnemius or WAT; and 3) similar to 3-fold greater in the heart (P<0.05). GLUT4 protein content was reduced in AS160-KO versus WT rats in the epitrochlearis (P<0.05), EDL (P<0.05), gastrocnemius (P<0.05), soleus (P<0.05), WAT (P<0.05), and the heart (P<0.005). Insulin-stimulated glucose uptake by isolated epitrochlearis and soleus muscles was lower (P<0.001) in AS160-KO versus WT rats. Akt phosphorylation of insulin-stimulated tissues was not different between the genotypes. A secondary objective was to probe processes that might account for the genotype-related increase in myocardial glucose uptake, including glucose transporter protein abundance (GLUT1, GLUT4, GLUT8, SGLT1), hexokinase II protein abundance, and stimulation of the AMP-activated protein kinase (AMPK) pathway. None of these parameters differed between genotypes. Metabolic phenotyping in the current study revealed AS160 deficiency produced a profound glucoregulatory phenotype in female AS160-KO rats that was strikingly similar to the results previously reported in male AS160-KO rats.	[Zheng, Xiaohua; Arias, Edward B.; Cartee, Gregory D.] Univ Michigan, Sch Kinesiol, Muscle Biol Lab, Ann Arbor, MI 48109 USA; [Qi, Nathan R.; Cartee, Gregory D.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Saunders, Thomas L.] Univ Michigan, Med Sch, Transgen Anim Model Core, Ann Arbor, MI 48109 USA; [Cartee, Gregory D.] Univ Michigan, Div Genet Med Genet, Dept Internal Med, Med Sch, Ann Arbor, MI 48109 USA; [Cartee, Gregory D.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Cartee, GD (corresponding author), Univ Michigan, Sch Kinesiol, Muscle Biol Lab, Ann Arbor, MI 48109 USA.; Cartee, GD (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.; Cartee, GD (corresponding author), Univ Michigan, Div Genet Med Genet, Dept Internal Med, Med Sch, Ann Arbor, MI 48109 USA.; Cartee, GD (corresponding author), Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA.	gcartee@umich.edu		Saunders, Thom/0000-0003-2015-101X	National Institutes of Health (University of Michigan Animal Phenotyping Core) [DK71771, AG010026, DK020572, DK089503]	National Institutes of Health (University of Michigan Animal Phenotyping Core)	This research was supported by grants from the National Institutes of Health (DK71771 and AG010026 to G.D.C.; DK020572 and DK089503 supported services provided by the University of Michigan Animal Phenotyping Core).	Abel ED, 2004, FRONT BIOSCI-LANDMRK, V9, P201, DOI 10.2741/1216; Abel ED, 1999, J CLIN INVEST, V104, P1703, DOI 10.1172/JCI7605; Aerni-Flessner L, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-63; ALLISON DB, 1995, DIABETES CARE, V18, P245, DOI 10.2337/diacare.18.2.245; Arias EB, 2007, AM J PHYSIOL-ENDOC M, V292, pE1191, DOI 10.1152/ajpendo.00602.2006; Arias EB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216236; Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; CARTEE GD, 1995, AM J PHYSIOL-ENDOC M, V268, pE902, DOI 10.1152/ajpendo.1995.268.5.E902; Cartee G, 2015, DIABETOLOGIA, V58, P19, DOI 10.1007/s00125-014-3395-5; Castorena CM, 2014, DIABETES, V63, P2297, DOI 10.2337/db13-1686; Castorena CM, 2011, J APPL PHYSIOL, V111, P1106, DOI 10.1152/japplphysiol.00631.2011; Chadt A, 2015, DIABETES, V64, P746, DOI 10.2337/db14-0368; Chen QL, 2017, DIABETOLOGIA, V60, P336, DOI 10.1007/s00125-016-4151-9; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DeBosch B, 2006, J BIOL CHEM, V281, P32841, DOI 10.1074/jbc.M513087200; Ducommun S, 2012, AM J PHYSIOL-ENDOC M, V302, pE1036, DOI 10.1152/ajpendo.00379.2011; Ellenbroek B, 2016, DIS MODEL MECH, V9, P1079, DOI 10.1242/dmm.026120; Filipiak WE, 2006, TRANSGENIC RES, V15, P673, DOI 10.1007/s11248-006-9002-x; Galic S, 2018, ELIFE, V7, DOI 10.7554/eLife.32656; HANSEN PA, 1994, J APPL PHYSIOL, V76, P979, DOI 10.1152/jappl.1994.76.2.979; Hardie D. G., 2018, J ROYAL SOC INTERFAC, V15, P1; Hargett SR, 2016, AM J PHYSIOL-ENDOC M, V310, pE276, DOI 10.1152/ajpendo.00342.2015; Henriksen EJ, 1998, AM J PHYSIOL-REG I, V275, pR40, DOI 10.1152/ajpregu.1998.275.1.R40; Lansey MN, 2012, AM J PHYSIOL-ENDOC M, V303, pE1273, DOI 10.1152/ajpendo.00316.2012; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Luiken JJFP, 2015, TRENDS ENDOCRIN MET, V26, P404, DOI 10.1016/j.tem.2015.06.002; MacKrell JG, 2012, DIABETES, V61, P995, DOI 10.2337/db11-1299; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Moltke I, 2014, NATURE, V512, P190, DOI 10.1038/nature13425; Pataky MW, 2019, METHODS MOL BIOL, V1889, P283, DOI 10.1007/978-1-4939-8897-6_17; Popp MW, 2016, CELL, V165, P1319, DOI 10.1016/j.cell.2016.05.053; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; RUSSELL RR, 1999, AM J PHYSIOL, V277, pH64, DOI DOI 10.1152/AJPHEART.1999.277.2.H643; Sakurai T, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-69; Samovski D, 2012, J LIPID RES, V53, P709, DOI 10.1194/jlr.M023424; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Sharma N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038835; Sharma N, 2011, AM J PHYSIOL-ENDOC M, V300, pE966, DOI 10.1152/ajpendo.00659.2010; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Szablewski L, 2017, INT J CARDIOL, V230, P70, DOI 10.1016/j.ijcard.2016.12.083; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Treebak JT, 2010, AM J PHYSIOL-CELL PH, V298, pC377, DOI 10.1152/ajpcell.00297.2009; Waller AP, 2015, BBA-MOL BASIS DIS, V1852, P873, DOI 10.1016/j.bbadis.2015.01.009; Wang HY, 2019, AM J PHYSIOL-ENDOC M, V316, pE837, DOI 10.1152/ajpendo.00528.2018; Wang HY, 2013, BIOCHEM J, V449, P479, DOI 10.1042/BJ20120702; Wright DC, 2005, AM J PHYSIOL-ENDOC M, V288, pE1062, DOI 10.1152/ajpendo.00561.2004; Wright DC, 2004, DIABETES, V53, P330, DOI 10.2337/diabetes.53.2.330; Xie BX, 2016, DIABETES, V65, P3327, DOI 10.2337/db16-0416	50	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0223340	10.1371/journal.pone.0223340	http://dx.doi.org/10.1371/journal.pone.0223340			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053588	Green Submitted, gold, Green Published			2022-12-26	WOS:000535198700006
J	Pitto, L; van Rossom, S; Desloovere, K; Molenaers, G; Huenaerts, C; De Groote, F; Jonkers, I				Pitto, Lorenzo; van Rossom, Sam; Desloovere, Kaat; Molenaers, Guy; Huenaerts, Catherine; De Groote, Friedl; Jonkers, Ilse			Pre-treatment EMG can be used to model post-treatment muscle coordination during walking in children with cerebral palsy	PLOS ONE			English	Article							RECTUS FEMORIS TRANSFER; TYPICALLY DEVELOPING-CHILDREN; ACTIVATION PATTERNS; GAIT ANALYSIS; SPINAL-CORD; SYNERGIES; MODULES; REPEATABILITY; COMPLEXITY	When treating children with Cerebral Palsy (CP), computational simulations based on musculoskeletal models have a great potential in assisting the clinical decision-making process towards the most promising treatments. In particular, predictive simulations could be used to predict and compare the functional outcome of a series of candidate interventions. In order to be able to benefit from these predictive simulations however, it is important to know how much information about the post-treatment patient's motor control could be gathered from data available before the intervention. Within this paper, we quantified how much of the muscle activity measured after a treatment could be explained by subject-specific muscle synergies computed from EMG data collected before the intervention. We also investigated whether generic synergies could be used, in case no EMG data is available when running predictive simulations, to reproduce both pre- and post-treatment muscle activity in children with CP. Subject-specific synergies proved to be a good indicator of the patient's post-treatment motor control, explaining on average more than 85% of the post-treatment muscle activity, compared to an average of 94% when applied to the original pre-treatment data. Generic synergies explained 84% of the pre-treatment and 83% of the post-treatment muscle activity on average, but performed relatively well for patients with low selective motor control and poorly in patients with more selectivity. Our results suggest that subject-specific muscle synergies computed from pre-treatment EMG data could be used with confidence to represent the post-treatment motor control of children with CP during walking. In addition, when performing simulations involving patients with a low selective motor control, generic synergies could be a valid alternative.	[Pitto, Lorenzo; van Rossom, Sam; De Groote, Friedl; Jonkers, Ilse] Katholieke Univ Leuven, Dept Movement Sci, Leuven, Belgium; [Desloovere, Kaat; Huenaerts, Catherine] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium; [Desloovere, Kaat; Huenaerts, Catherine] Univ Hosp Leuven, Clin Mot Anal Lab, Leuven, Belgium; [Molenaers, Guy] Univ Hosp Leuven, Dept Dev & Regenerat, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Pitto, L (corresponding author), Katholieke Univ Leuven, Dept Movement Sci, Leuven, Belgium.	lorenzo.pitto@kuleuven.be		Pitto, Lorenzo/0000-0003-3044-5011; De Groote, Friedl/0000-0002-4255-8673	IWT-TBM [140184]	IWT-TBM(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	Project was funded with IWT-TBM Grant Number: 140184.	Ackermann M, 2010, J BIOMECH, V43, P1055, DOI 10.1016/j.jbiomech.2009.12.012; Baker R, 2009, GAIT POSTURE, V30, P265, DOI 10.1016/j.gaitpost.2009.05.020; Berger DJ, 2013, J NEUROSCI, V33, P12384, DOI 10.1523/JNEUROSCI.0122-13.2013; Bianco NA, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038199; Bizzi E, 2008, BRAIN RES REV, V57, P125, DOI 10.1016/j.brainresrev.2007.08.004; Cheung VCK, 2012, P NATL ACAD SCI USA, V109, P14652, DOI 10.1073/pnas.1212056109; Cheung VCK, 2009, J NEUROPHYSIOL, V101, P1235, DOI 10.1152/jn.01387.2007; Clark DJ, 2010, J NEUROPHYSIOL, V103, P844, DOI 10.1152/jn.00825.2009; Colver A, 2014, LANCET, V383, P1240, DOI 10.1016/S0140-6736(13)61835-8; de Morais MC, 2008, GAIT POSTURE, V28, P316, DOI 10.1016/j.gaitpost.2008.01.013; Desloovere K, 2006, GAIT POSTURE, V24, P302, DOI 10.1016/j.gaitpost.2005.10.008; Fairhurst C, 2012, ARCH DIS CHILDHOOD-E, V97, P122, DOI 10.1136/edpract-2011-300593; Falisse A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208811; Fox MD, 2009, J BIOMECH, V42, P614, DOI 10.1016/j.jbiomech.2008.12.007; Graham HK, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2015.82; Hanna SE, 2009, DEV MED CHILD NEUROL, V51, P295, DOI 10.1111/j.1469-8749.2008.03196.x; Hicks JL, 2011, GAIT POSTURE, V34, P197, DOI 10.1016/j.gaitpost.2011.04.009; Ivanenko YP, 2004, J PHYSIOL-LONDON, V556, P267, DOI 10.1113/jphysiol.2003.057174; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Lee S, 2019, ACM T GRAPHIC, DOI [10.1145/3306346.3322944, DOI 10.1145/3306346.3322944]; Mansouri M, 2016, GAIT POSTURE, V43, P24, DOI 10.1016/j.gaitpost.2015.08.016; Meyer AJ, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00077; Muthusamy K, 2008, J PEDIATR ORTHOPED, V28, P674, DOI 10.1097/BPO.0b013e3181804c04; Narayanan Unni G, 2012, J Pediatr Orthop, V32 Suppl 2, pS172, DOI 10.1097/BPO.0b013e31825eb2a6; Nieuwenhuys A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152697; Patikas D, 2007, GAIT POSTURE, V26, P362, DOI 10.1016/j.gaitpost.2006.10.012; Roh J, 2011, J NEUROPHYSIOL, V106, P1363, DOI 10.1152/jn.00842.2010; Rozumalski A, 2017, J BIOMECH, V64, P112, DOI 10.1016/j.jbiomech.2017.09.002; Safavynia Seyed A, 2011, Top Spinal Cord Inj Rehabil, V17, P16; Saltiel P, 2001, J NEUROPHYSIOL, V85, P605, DOI 10.1152/jn.2001.85.2.605; Sartori M, 2017, WIRES SYST BIOL MED, V9, DOI 10.1002/wsbm.1368; Schwartz MH, 2016, DEV MED CHILD NEUROL, V58, P1139, DOI 10.1111/dmcn.13126; Shuman B, 2016, GAIT POSTURE, V45, P127, DOI 10.1016/j.gaitpost.2016.01.011; Shuman BR, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0502-3; Steele KM, 2019, GAIT POSTURE, V67, P290, DOI 10.1016/j.gaitpost.2018.10.009; Steele KM, 2015, DEV MED CHILD NEUROL, V57, P1176, DOI 10.1111/dmcn.12826; Ting L.H., 2010, MOT CONTROL THEOR EX, DOI DOI 10.1093/ACPROF:OSO/9780195395273.003.0005; Ting LH, 2012, INT J NUMER METH BIO, V28, P1003, DOI 10.1002/cnm.2485; Ting LH, 2010, PROGR MOTOR CONTROL; Wren TAL, 2009, J PEDIATR ORTHOPED, V29, P558, DOI 10.1097/BPO.0b013e3181b2f8c2	40	5	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228851	10.1371/journal.pone.0228851	http://dx.doi.org/10.1371/journal.pone.0228851			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32050002	Green Published, gold			2022-12-26	WOS:000535192300029
J	Yasmin, R; Shoaib, MH; Ahmed, FR; Qazi, F; Ali, H; Zafar, F				Yasmin, Riffat; Shoaib, Muhammad Harris; Ahmed, Farrukh Rafiq; Qazi, Faaiza; Ali, Huma; Zafar, Farya			Aceclofenac fast dispersible tablet formulations: Effect of different concentration levels of Avicel PH102 on the compactional, mechanical and drug release characteristics	PLOS ONE			English	Article							COMPRESSION; STRENGTH	The objective of this study was based on the formulation development of fast dispersible Aceclofenac tablets (100 mg) and to evaluate the influence of pharmaceutical mixtures of directly compressible Avicel PH102 with Mannitol and Ac-di-sol on the compressional, mechanical characteristics and drug release properties. Fast dispersible Aceclofenac formulations were developed by central composite design (CCD). Among them the best possible formulation was selected on the basis of micromeritic properties, appropriate tablet weight and disintegration time for further study. Tablets were directly compressed using manual hydraulic press with a compressional force ranging from 7.2 to 77.2 MN/m(2). Pre and post compression studies were performed and the compressed formulations (FA-FF) were assessed for different quality tests. The Heckel and Kawakita equations were applied for determination of compressional behavior of formulations. The quality attributes suggested that formulation (FB) containing avicel PH 102 (20%), mannitol (25%) and ac-di-sol (3%) as best optimized formulation showing better mechanical strength i.e. hardness 35.40 +/- 6.93N, tensile strength 0.963 MN/m(2), and friability 0.68%. Furthermore, compressional analysis of FB showed lowest P-Y value 59.520 MN/m(2) and P-k value 1.040 MN/m(2) indicating plasticity of the material. Formulation FB disintegrated rapidly within 21 seconds and released 99.92% drug after 45 min in phosphate buffer pH 6.8. Results of drug release kinetics showed that all formulations followed Weibull and First-order models in three different dissolution media. Avicel PH102 based formulation mixture exhibit excellent compactional strength with rapid disintegration and quick drug release.	[Yasmin, Riffat; Shoaib, Muhammad Harris; Ahmed, Farrukh Rafiq; Qazi, Faaiza; Ali, Huma; Zafar, Farya] Univ Karachi, Fac Pharm & Pharmaceut Sci, Dept Pharmaceut, Karachi, Pakistan; [Yasmin, Riffat] DUHS, Dow Coll Pharm, Karachi, Pakistan; [Ali, Huma] Jinnah Sindh Med Univ, Karachi, Pakistan	University of Karachi; Jinnah Sindh Medical University - Pakistan	Shoaib, MH (corresponding author), Univ Karachi, Fac Pharm & Pharmaceut Sci, Dept Pharmaceut, Karachi, Pakistan.	harrisshoaib2000@yahoo.com	Shoaib, Muhammad/AAR-8933-2020	Shoaib, Muhammad/0000-0002-3639-0026; ahmed, farrukh rafiq/0000-0002-5696-3426				Adetunji O. A., 2006, Tropical Journal of Pharmaceutical Research, V5, P589; Adetunji OA, 2007, TROPICAL J PHARM RES, V5, P589; Amin MCIM, 2012, TROP J PHARM RES, V11, P585, DOI 10.4314/tjpr.v11i4.9; [Anonymous], 2001, EUROPEAN PHARMACOPOE; Bala R, 2013, J ADV PHARM TECHNOL, V4, P151, DOI 10.4103/2231-4040.116785; Chang RK, 2002, PHARM TECHNOL, V24, P52; Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1; Dash S, 2010, ACTA POL PHARM, V67, P217; Denny PJ, 2002, POWDER TECHNOL, V127, P162, DOI 10.1016/S0032-5910(02)00111-0; FELL JT, 1970, J PHARM SCI, V59, P688, DOI 10.1002/jps.2600590523; Fukami J, 2006, INT J PHARMACEUT, V310, P101, DOI 10.1016/j.ijpharm.2005.11.041; HIGUCHI T, 1961, J PHARM SCI, V50, P874, DOI 10.1002/jps.2600501018; KAWAKITA K, 1971, POWDER TECHNOL, V4, P61, DOI 10.1016/0032-5910(71)80001-3; KIDWAI M, 2010, INT J DRUG DELIVERY, V6, DOI DOI 10.3762/BJOC.6.35; Kumar V., 2016, INT J PHARM SCI SCI, V2, P1; LIN CW, 1995, INT J PHARM, V118, P169, DOI 10.1016/0378-5173(94)00343-4; Mahmoodi F, 2012, EUR J PHARM SCI, V46, P49, DOI 10.1016/j.ejps.2012.02.006; Martin Trudi P., 1993, Australian Journal of Hospital Pharmacy, V23, P378; Mohammed B B, 2009, NIGERIAN J PHARM SCI, V8, P80; Mor J, 2016, CELLULOSE, V100, P100; Mor J, 2016, J PHARM INNOV, V5, P1; Mustapha MA, 2013, MED J ISLAMIC WORLD, V109, P1; Nicklasson F, 2000, PHARMACEUT RES, V17, P949, DOI 10.1023/A:1007575120817; Odeku O., 2005, PHARM TECHNOL, V29, P82; Panigrahi R, 2010, REV FAST DISSOLVING; Parfitt K, 2009, MARTINDALE COMPLETE; Schiermeier S, 2002, EUR J PHARM SCI, V15, P295, DOI 10.1016/S0928-0987(02)00011-8; Setty CM, 2008, INDIAN J PHARM SCI, V70, P180, DOI 10.4103/0250-474X.41452; Sharma AJ A, 2011, INT J PHARM LIFE SCI, V4, P681; Shoaib MH, 2010, AAPS PHARMSCITECH, V11, P708, DOI 10.1208/s12249-010-9427-7; Thoorens G, 2014, INT J PHARMACEUT, V473, P64, DOI 10.1016/j.ijpharm.2014.06.055; VUDATHALA GK, 1992, J PHARM SCI-US, V81, P282, DOI 10.1002/jps.2600810318	32	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0223201	10.1371/journal.pone.0223201	http://dx.doi.org/10.1371/journal.pone.0223201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32050259	Green Submitted, Green Published, gold			2022-12-26	WOS:000535192300001
J	Hernandez, J; Escallon, C; Medina, D; Vernasco, B; Walke, JB; Belden, LK; Moore, IT				Hernandez, Jessica; Escallon, Camilo; Medina, Daniel; Vernasco, Ben J.; Walke, Jenifer B.; Belden, Lisa K.; Moore, Ignacio T.			Cloacal bacterial communities of tree swallows (Tachycineta bicolor): Similarity within a population, but not between pair-bonded social partners	PLOS ONE			English	Article							ANIMAL BEHAVIOR; DIVERSITY; SEQUENCES; PATERNITY; MICROBES; QUALITY; DIET	Host-associated microbial communities can influence the overall health of their animal hosts, and many factors, including behavior and physiology, can impact the formation of these complex communities. Bacteria within these communities can be transmitted socially between individuals via indirect (e.g., shared environments) or direct (e.g., physical contact) pathways. Limited research has been done to investigate how social interactions that occur in the context of mating shape host-associated microbial communities. To gain a better understanding of these interactions and, more specifically, to assess how mating behavior shapes an animal's microbiome, we studied the cloacal bacterial communities of a socially monogamous yet genetically polygynous songbird, the North American tree swallow (Tachycineta bicolor). We address two questions: (1) do the cloacal bacterial communities differ between female and male tree swallows within a population? and (2) do pair-bonded social partners exhibit more similar cloacal bacterial communities than expected by chance? To answer these questions, we sampled the cloacal microbiome of adults during the breeding season and then used culture-independent, 16S rRNA gene amplicon sequencing to assess bacterial communities. Overall, we found that the cloacal bacterial communities of females and males were similar, and that the communities of pair-bonded social partners were not more similar than expected by chance. Our results suggest that social monogamy does not correlate with an increased similarity in cloacal bacterial community diversity or structure. As social partners were not assessed at the same time, it is possible that breeding stage differences masked social effects on bacterial community diversity and structure. Further, given that tree swallows exhibit high variation in rates of extra-pair activity, considering extra-pair activity when assessing cloacal microbial communities may be important for understanding how these bacterial communities are shaped. Further insight into how bacterial communities are shaped will ultimately shed light on potential tradeoffs associated with alternative behavioral strategies and socially-transmitted microbes.	[Hernandez, Jessica; Escallon, Camilo; Medina, Daniel; Vernasco, Ben J.; Walke, Jenifer B.; Belden, Lisa K.; Moore, Ignacio T.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Escallon, Camilo] Univ La Salle, Dept Ciencias Basicas, Bogota, Colombia; [Medina, Daniel] Univ Estadual Campinas, Dept Biol Anim, Campinas, Brazil; [Vernasco, Ben J.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Walke, Jenifer B.] Eastern Washington Univ, Dept Biol, Cheney, WA 99004 USA	Virginia Polytechnic Institute & State University; Universidad de La Salle; Universidade Estadual de Campinas; Washington State University; Eastern Washington University	Hernandez, J (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	jess228@vt.edu	Medina, Daniel/AAI-2357-2020	Moore, Ignacio/0000-0001-8875-8913; Hernandez, Jessica/0000-0001-7385-6174; Walke, Jenifer/0000-0002-5943-5506; Belden, Lisa/0000-0002-3514-3920	Global Change Center at Virginia Tech; Virginia Society of Ornithology; Bill & Melinda Gates Millennium Fellowship; NSF GRFP	Global Change Center at Virginia Tech; Virginia Society of Ornithology; Bill & Melinda Gates Millennium Fellowship; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD))	ITM received funding from the Global Change Center at Virginia Tech. JH received funding from the Virginia Society of Ornithology. JH was supported by the Bill & Melinda Gates Millennium Fellowship and an NSF GRFP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair KL, 2017, CURR OPIN MICROBIOL, V35, P23, DOI 10.1016/j.mib.2016.11.002; Adkins-Regan E., 2005, HORMONES ANIMAL SOCI; Ambrosini R, 2019, FEMS MICROBIOL ECOL, V95, DOI 10.1093/femsec/fiz061; [Anonymous], 2017, R LANG ENV STAT COMP, V55, P275; Archie EA, 2015, CURR OPIN BEHAV SCI, V6, P28, DOI 10.1016/j.cobeha.2015.07.008; Archie EA, 2011, ANIM BEHAV, V82, P425, DOI 10.1016/j.anbehav.2011.05.029; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Banning JL, 2008, OECOLOGIA, V156, P423, DOI 10.1007/s00442-008-1002-5; Bech C, 1999, P ROY SOC B-BIOL SCI, V266, P2161, DOI 10.1098/rspb.1999.0903; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dunn PO, 2009, BEHAV ECOL SOCIOBIOL, V63, P911, DOI 10.1007/s00265-009-0734-5; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Escallon C, 2017, FUNCT ECOL, V31, P192, DOI 10.1111/1365-2435.12696; Ezenwa VO, 2012, SCIENCE, V338, P198, DOI 10.1126/science.1227412; Fraune S, 2010, BIOESSAYS, V32, P571, DOI 10.1002/bies.200900192; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Kreisinger J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137401; Kulkarni S, 2007, BEHAV PROCESS, V74, P88, DOI 10.1016/j.beproc.2006.10.005; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; LIFJELD JT, 1993, ANIM BEHAV, V45, P213, DOI 10.1006/anbe.1993.1028; Lombardo MP, 1996, CONDOR, V98, P167, DOI 10.2307/1369521; Maul JD, 2005, MICROB ECOL, V50, P19, DOI 10.1007/s00248-004-0076-9; McCarty JP, 1999, CONDOR, V101, P246, DOI 10.2307/1369987; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; McGraw KJ, 2005, EVOL ECOL RES, V7, P251; Nelson RJ, 2015, INTRO BEHAV ENDOCRIN; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Poole, 2011, BIRDS N AM; Stewart R, 2000, CONDOR, V102, P679, DOI 10.1650/0010-5422(2000)102[0679:CMIHS]2.0.CO;2; Tung J, 2015, ELIFE, V4, DOI 10.7554/eLife.05224; van Veelen HPJ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0371-6; Waite DW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00223; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; Westneat DF, 2000, J AVIAN BIOL, V31, P1, DOI 10.1034/j.1600-048X.2000.310101.x; White J, 2010, ECOL LETT, V13, P1515, DOI 10.1111/j.1461-0248.2010.01542.x; Williams T., 2012, PHYSL ADAPTATIONS BR	43	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228982	10.1371/journal.pone.0228982	http://dx.doi.org/10.1371/journal.pone.0228982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045456	gold, Green Published			2022-12-26	WOS:000534633200050
J	Opanda, S; Bulimo, W; Gachara, G; Ekuttan, C; Amukoye, E				Opanda, Silvanos; Bulimo, Wallace; Gachara, George; Ekuttan, Christopher; Amukoye, Evans			Assessing antigenic drift and phylogeny of influenza A (H1N1) pdm09 virus in Kenya using HA1 sub-unit of the hemagglutinin gene	PLOS ONE			English	Article							VACCINE EFFECTIVENESS; ORIGIN; EVOLUTION; SITES	Influenza A (H1N1) pdm09 virus emerged in North America in 2009 and has been established as a seasonal strain in humans. After an antigenic stasis of about six years, new antigenically distinct variants of the virus emerged globally in 2016 necessitating a change in the vaccine formulation for the first time in 2017. Herein, we analyzed thirty-eight HA sequences of influenza A (H1N1) pdm09 strains isolated in Kenya during 2015-2018 seasons, to evaluate their antigenic and molecular properties based on the HA1 sub-unit. Our analyses revealed that the A (H1N1) pdm09 strains that circulated in Kenya during this period belonged to genetic clade 6B, subclade 6B.1 and 6B.2. The Kenyan 2015 and 2016 isolates differed from the vaccine strain A/California/07/2009 at nine and fourteen antigenic sites in the HA1 respectively. Further, those isolated in 2017 and 2018 correspondingly varied from A/Michigan/45/2015 vaccine strain at three and fifteen antigenic sites. The predicted vaccine efficacy of A/California/07/2009 against Kenyan 2015/2016 was estimated to be 32.4% while A/Michigan/45/2015 showed estimated vaccine efficacies of 39.6% - 41.8% and 32.4% - 42.1% against Kenyan 2017 and 2018 strains, respectively. Hemagglutinationinhibition (HAI) assay using ferret post-infection reference antiserum showed that the titers for the Kenyan 2015/2016 isolates were 2-8-fold lower compared to the vaccine strain. Overall, our results suggest the A (H1N1) pdm09 viruses that circulated in Kenya during 2015/2016 influenza seasons were antigenic variants of the recommended vaccine strains, denoting sub-optimal vaccine efficacy. Additionally, data generated point to a swiftly evolving influenza A (H1N1) pdm09 virus in recent post pandemic era, underscoring the need for sustained surveillance coupled with molecular and antigenic analyses, to inform appropriate and timely influenza vaccine update.	[Opanda, Silvanos; Bulimo, Wallace] US Army Med Res Directorate Africa USAMRD A, Dept Emerging Infect Dis DEID, Nairobi, Kenya; [Bulimo, Wallace] Univ Nairobi UoN, Dept Biochem, Nairobi, Kenya; [Gachara, George] Kenyatta Univ KU, Dept Med Lab Sci, Nairobi, Kenya; [Ekuttan, Christopher] Def Forces Mem Hosp, Kenya Def Forces KDF, Nairobi, Kenya; [Amukoye, Evans] Kenya Med Res Inst KEMRI, Ctr Resp Dis Res, Nairobi, Kenya	University of Nairobi; Kenyatta University; Kenya Medical Research Institute	Bulimo, W (corresponding author), US Army Med Res Directorate Africa USAMRD A, Dept Emerging Infect Dis DEID, Nairobi, Kenya.; Bulimo, W (corresponding author), Univ Nairobi UoN, Dept Biochem, Nairobi, Kenya.	Wallace.Bulimo@usamru-k.org	; Bulimo, Wallace/B-1982-2014	Opanda, Silvanos/0000-0002-6783-251X; amukoye, Evans/0000-0003-0683-0585; Gachara, George/0000-0001-5428-9565; Bulimo, Wallace/0000-0001-8475-0586	US Department of Defense through the Global Emerging Infections Surveillance and Response System (DoD GEIS) [17_KY_1.1.9]	US Department of Defense through the Global Emerging Infections Surveillance and Response System (DoD GEIS)(United States Department of Defense)	This work was supported by the US Department of Defense through the Global Emerging Infections Surveillance and Response System (DoD GEIS) for funding the project through Professor Wallace Bulimo, Promis ID 17_KY_1.1.9. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Hajjar S, 2010, ANN SAUDI MED, V30, P1, DOI 10.4103/0256-4947.59365; BioSoft H, 2014, DNABASER; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Bulimo WD, 2012, AFRICAN J PHARM THER, V1; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P435; Clark AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188267; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Deem MW, 2009, PROTEIN ENG DES SEL, V22, P543, DOI 10.1093/protein/gzp027; Deng YM, 2015, J CLIN VIROL, V68, P43, DOI 10.1016/j.jcv.2015.04.019; Ebranati E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137099; ECDC, 2018, INFL VIR CHAR SUMM E; ECDC, 2017, INFL VIR CHAR SUMM E; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El Moussi A, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-150; Friedman N, 2017, ONCOTARGET, V8, P32856, DOI 10.18632/oncotarget.16459; Gachara G, 2016, INFECT GENET EVOL, V40, P98, DOI 10.1016/j.meegid.2016.02.029; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gupta R, 2017, PREDICTION N GLYCOSY; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hsieh YC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34077-4; Huang KYA, 2015, J CLIN INVEST, V125, P2631, DOI 10.1172/JCI81104; Koel BF, 2015, J VIROL, V89, P3763, DOI 10.1128/JVI.02962-14; Korsun N, 2017, INFECT GENET EVOL, V49, P241, DOI 10.1016/j.meegid.2017.01.027; Li X, 2016, PROTEIN ENG DES SEL, V29, P309, DOI 10.1093/protein/gzw017; Matsuzaki Y, 2014, J VIROL, V88, P12364, DOI 10.1128/JVI.01381-14; Mohebbi A, 2019, VIRUS RES, V259, P38, DOI 10.1016/j.virusres.2018.10.001; Monamele CG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210119; Mostafa A, 2016, ARCH VIROL, V161, P1505, DOI 10.1007/s00705-016-2815-x; Mugosa B, 2016, J MED VIROL, V88, P1905, DOI 10.1002/jmv.24552; Opanda SM, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1834-0; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Puig-Barbera J, 2017, VACCINE, V35, P7331, DOI 10.1016/j.vaccine.2017.10.100; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Skowronski DM, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.3.30112; Skowronski DM, 2019, EUROSURVEILLANCE, V24, P32, DOI 10.2807/1560-7917.ES.2019.24.15.1900104; Suwannakarn K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009717; Tabu C., 2009, Morbidity and Mortality Weekly Report, V58, P1143; Tewawong N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175655; Tewawong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139958; UNDERWOOD PA, 1987, J VIROL, V61, P206, DOI 10.1128/JVI.61.1.206-208.1987; WHO, REC COMP INFL VIR VA; WHO, REC COMP INF L VIR V; WHO, 2014, WHO SURV CAS DEF ILI; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; World Health Organization (WHO), 2015, REC COMP INFL VIR VA; Yasuhara A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17986-8	51	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228029	10.1371/journal.pone.0228029	http://dx.doi.org/10.1371/journal.pone.0228029			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045419	gold, Green Published			2022-12-26	WOS:000534633200006
J	Han, XJ; Chen, HH; Gong, H; Tang, XQ; Huang, N; Xu, WT; Tai, HR; Zhang, GC; Zhao, TT; Gong, CH; Wang, S; Yang, Y; Xiao, HY				Han, Xiaojuan; Chen, Honghan; Gong, Hui; Tang, Xiaoqiang; Huang, Ning; Xu, Weitong; Tai, Haoran; Zhang, Gongchang; Zhao, Tingting; Gong, Chuhui; Wang, Shuang; Yang, Yu; Xiao, Hengyi			Autolysosomal degradation of cytosolic chromatin fragments antagonizes oxidative stress?induced senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oxidative stress; senescence; DNA damage; autophagy; NF-kappaB (NF-KB); autolysosome; cGAS-STING pathway; cytosolic chromatin fragment (CCF); senescence-associated secretory phenotype (SASP)	CYCLIC GMP-AMP; SECRETORY PHENOTYPE; DNASE-II; CGAS; 2ND-MESSENGER; INFLAMMATION; EXPRESSION	Oxidative stress-induced DNA damage, the senescence-associated secretory phenotype (SASP), and impaired autophagy all are general features of senescent cells. However, the cross-talk among these events and processes is not fully understood. Here, using NIH3T3 cells exposed to hydrogen peroxide stress, we show that stress-induced DNA damage provokes the SASP largely via cytosolic chromatin fragment (CCF) formation, which activates a cascade comprising cGMP-AMP synthase (cGAS), stimulator of interferon genes protein (STING), NF-?B, and SASP, and that autolysosomal function inhibits this cascade. We found that CCFs accumulate in senescent cells with activated cGAS-STING-NF-?B signaling, promoting SASP and cellular senescence. We also present evidence that the persistent accumulation of CCFs in prematurely senescent cells is partially associated with a defect in DNA-degrading activity in autolysosomes and reduced abundance of activated DNase 2?. Intriguingly, we found that metformin- or rapamycin-induced activation of autophagy significantly lessened the size and levels of CCFs and repressed the activation of the cGAS-STING-NF-?B-SASP cascade and cellular senescence. These effects of autophagy activators indicated that autolysosomal function contributes to CCF clearance and SASP suppression, further supported by the fact that the lysosome inhibitor bafilomycin A1 blocked the role of autophagy-mediated CCF clearance and senescence repression.	[Han, Xiaojuan; Chen, Honghan; Gong, Hui; Huang, Ning; Xu, Weitong; Tai, Haoran; Zhang, Gongchang; Zhao, Tingting; Gong, Chuhui; Wang, Shuang; Yang, Yu; Xiao, Hengyi] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Lab Aging Res,Natl Clin Res Ctr Geriatr, 1 Keyuan 4 Rd,Gaopeng Ave, Chengdu 610041, Peoples R China; [Han, Xiaojuan] Xian Med Univ, Shaanxi Key Lab Brain Disorders, Xian 710049, Peoples R China; [Han, Xiaojuan] Xian Med Univ, Inst Basic & Translat Med, Xian 710049, Peoples R China; [Tang, Xiaoqiang] Sichuan Univ, West China Univ Hosp 2, Key Lab Birth Defects & Related Dis Women & Child, MOE,State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Tai, Haoran] Chengdu Med Coll, Dept Anat & Histol & Embryol, Dev & Regenerat Key Lab Sichuan Prov, Chengdu 610031, Peoples R China	Sichuan University; Xi'an Medical University; Xi'an Medical University; Sichuan University; Chengdu Medical College	Xiao, HY (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Lab Aging Res,Natl Clin Res Ctr Geriatr, 1 Keyuan 4 Rd,Gaopeng Ave, Chengdu 610041, Peoples R China.	hengyix@scu.edu.cn	Tang, Xiaoqiang/G-4319-2013	Tang, Xiaoqiang/0000-0003-1314-3417	National Natural Science Foundation of China [81771511]; National Key R&D Program of China [2018YFC2000400]; National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University [Z2018B04]; Young Talent Found of the University Association for Science and technology in Shaanxi, China [20190308]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University; Young Talent Found of the University Association for Science and technology in Shaanxi, China	This work is supported by National Natural Science Foundation of China Grant 81771511; National Key R&D Program of China Grant 2018YFC2000400; National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Grant Z2018B04, and the Young Talent Found of the University Association for Science and technology in Shaanxi, China 20190308. The authors declare that they have no conflicts of interest with the contents of this article.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Dou ZX, 2015, NATURE, V527, P105, DOI 10.1038/nature15548; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Fujiwara Y, 2013, AUTOPHAGY, V9, P1167, DOI 10.4161/auto.24880; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005; Han XJ, 2016, AGING CELL, V15, P416, DOI 10.1111/acel.12446; Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ivanov A, 2013, J CELL BIOL, V202, P129, DOI 10.1083/jcb.201212110; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kang HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023367; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kliosnky D, 2016, AUTOPHAGY, V12, P443, DOI 10.1080/15548627.2016.1147886; Lan YY, 2014, CELL REP, V9, P180, DOI 10.1016/j.celrep.2014.08.074; Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139; Ohkouchi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059148; Park YE, 2009, AUTOPHAGY, V5, P795, DOI 10.4161/auto.8901; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tai HR, 2017, AUTOPHAGY, V13, P99, DOI 10.1080/15548627.2016.1247143; Takahashi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03555-8; Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	37	28	28	4	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4451	4463		10.1074/jbc.RA119.010734	http://dx.doi.org/10.1074/jbc.RA119.010734			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32047109	Green Published, hybrid			2022-12-26	WOS:000524499700008
J	Zweifel, ME; Courtemanche, N				Zweifel, Mark E.; Courtemanche, Naomi			Competition for delivery of profilin?actin to barbed ends limits the rate of formin-mediated actin filament elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						formin; actin; profilin; fluorescence; microscopy; polyproline tract	FH1 DOMAIN; NUCLEATION; POLYMERIZATION; MECHANISM; PROLINE; MODEL; DROSOPHILA; PROTEINS; MONOMERS; COMPLEX	Formins direct the elongation of unbranched actin filaments by binding their barbed ends and processively stepping onto incoming actin monomers to incorporate them into the filament. Binding of profilin to actin monomers creates profilin?actin complexes, which then bind polyproline tracts located in formin homology 1 (FH1) domains. Diffusion of these natively disordered domains enables direct delivery of profilin?actin to the barbed end, speeding the rate of filament elongation. In this study, we investigated the mechanism of coordinated actin delivery from the multiple polyproline tracts in formin FH1 domains. We found that each polyproline tract can efficiently mediate polymerization, but that all tracts do not generate the same rate of elongation. In WT FH1 domains, the multiple polyproline tracts compete to deliver profilin?actin to the barbed end. This competition ultimately limits the rate of formin-mediated elongation. We propose that intrinsic properties of the filament-binding FH2 domain tune the efficiency of FH1-mediated elongation by directly regulating the rate of monomer incorporation at the barbed end. A strong correlation between competitive FH1-mediated profilin?actin delivery and FH2-regulated gating of the barbed end effectively limits the elongation rate, thereby obviating the need for evolutionary optimization of FH1 domain sequences.	[Zweifel, Mark E.; Courtemanche, Naomi] Univ Minnesota, Dept Genet Cell Biol & Dev, 6-130 MCB,420 Washington Ave SE, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Courtemanche, N (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 6-130 MCB,420 Washington Ave SE, Minneapolis, MN 55455 USA.	ncourtem@umn.edu		Courtemanche, Naomi/0000-0003-4374-4782	National Institutes of Health [GM122787, AR007612]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Research Grant GM122787 (to N. C.) and National Institutes of Health Training Grant AR007612 (to M. E. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahuja R, 2007, CELL, V131, P337, DOI 10.1016/j.cell.2007.08.030; An LL, 2005, LEUKEMIA RES, V29, P535, DOI 10.1016/j.leukres.2004.11.009; Aydin F, 2018, ELIFE, V7, DOI 10.7554/eLife.37342; Breitsprecher D, 2011, EMBO J, V30, P456, DOI 10.1038/emboj.2010.348; Bruhmann S, 2017, P NATL ACAD SCI USA, V114, pE5815, DOI 10.1073/pnas.1703145114; Bryant D, 2017, CYTOSKELETON, V74, P29, DOI 10.1002/cm.21344; Byrnes AE, 2017, J CELL BIOL, V216, P1641, DOI 10.1083/jcb.201610090; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; Courtemanche Naomi, 2018, Biophys Rev, V10, P1553, DOI 10.1007/s12551-018-0468-6; Courtemanche N, 2013, P NATL ACAD SCI USA, V110, P9752, DOI 10.1073/pnas.1308257110; Courtemanche N, 2012, J BIOL CHEM, V287, P7812, DOI 10.1074/jbc.M111.322958; Eads JC, 1998, BIOCHEMISTRY-US, V37, P11171, DOI 10.1021/bi9720033; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Geyer EA, 2018, ELIFE, V7, DOI [10.7554/eLife.34574, 10.7554/elife.34574]; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Heimsath EG, 2012, J BIOL CHEM, V287, P3087, DOI 10.1074/jbc.M111.312207; Horan BG, 2018, FEBS LETT, V592, P1804, DOI 10.1002/1873-3468.13088; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Kursula P, 2008, J MOL BIOL, V375, P270, DOI 10.1016/j.jmb.2007.10.050; Lapidus LJ, 2000, P NATL ACAD SCI USA, V97, P7220, DOI 10.1073/pnas.97.13.7220; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Neidt EM, 2008, J BIOL CHEM, V283, P23872, DOI 10.1074/jbc.M803734200; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Patel AA, 2018, J BIOL CHEM, V293, P532, DOI 10.1074/jbc.M117.800888; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Petrella EC, 1996, BIOCHEMISTRY-US, V35, P16535, DOI 10.1021/bi961498d; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Pruyne D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164067; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Ramabhadran V, 2012, J BIOL CHEM, V287, P34234, DOI 10.1074/jbc.M112.365122; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Scott BJ, 2011, MOL BIOL CELL, V22, P3826, DOI 10.1091/mbc.E11-06-0492; Sherer LA, 2018, J BIOL CHEM, V293, P17917, DOI 10.1074/jbc.RA118.004845; Slep KC, 2009, BIOCHEM SOC T, V37, P1002, DOI 10.1042/BST0371002; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Winkelman JD, 2014, P NATL ACAD SCI USA, V111, P4121, DOI 10.1073/pnas.1322093111; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zhao C, 2014, FEBS LETT, V588, P2288, DOI 10.1016/j.febslet.2014.05.016; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	51	9	9	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4513	4525		10.1074/jbc.RA119.012000	http://dx.doi.org/10.1074/jbc.RA119.012000			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32075907	Green Published, hybrid			2022-12-26	WOS:000524499700013
J	Kabra, A; Rumpa, E; Li, Y				Kabra, Ashish; Rumpa, Efsita; Li Ying			Modulation of conformational equilibrium by phosphorylation underlies the activation of deubiquitinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); deubiquitylation (deubiquitination); protein conformation; post-translational modification (PTM); enzyme kinetics; conformational dynamics; deubiquitinase A (DUBA); enzyme activation; protein homeostasis	CHEMICAL-SHIFTS; EXCHANGE RATES; UBIQUITIN; MOTIONS; SPECIFICITY; MECHANISMS; SOFTWARE; ENZYMES; SYSTEM; FAMILY	Deubiquitinases deconjugate ubiquitin modifications from target proteins and are involved in many cellular processes in eukaryotes. The functions of deubiquitinases are regulated by post-translational modifications, mainly phosphorylation and ubiquitination. Post-translational modifications can result in subtle changes in structural and dynamic properties, which are difficult to identify but functionally important. In this work, we used NMR spectroscopy to characterize the conformational properties of the human deubiquitinase A (DUBA), a negative regulator of type I interferon. DUBA activity is regulated by phosphorylation at a single serine residue, Ser-177. We found that the catalytic rate constant of DUBA is enhanced by phosphorylation. By comparing NMR and enzyme kinetics data among different forms of DUBA with low and high activities, we concluded that a two-state equilibrium that was present only in phosphorylated DUBA is important for DUBA activity. Our results highlight the importance of defining conformational dynamics in understanding the mechanism of DUBA activation.	[Kabra, Ashish; Rumpa, Efsita; Li Ying] Univ Louisville, Dept Chem, 2320 South Brook St, Louisville, KY 40208 USA	University of Louisville	Li, Y (corresponding author), Univ Louisville, Dept Chem, 2320 South Brook St, Louisville, KY 40208 USA.	ying.li.1@louisville.edu	Kabra, Ashish/AGV-0844-2022; Li, Ying/D-1758-2011; Kabra, Ashish/ABD-2125-2020	Kabra, Ashish/0000-0002-5291-5398; Li, Ying/0000-0001-7678-9405; Kabra, Ashish/0000-0002-5291-5398	National Institutes of Health [R15GM123391]; University of Louisville	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Louisville	This work was supported by National Institutes of Health Grant R15GM123391 (to Y. L.) and by startup funds from University of Louisville. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahlner A, 2013, J BIOMOL NMR, V56, P191, DOI 10.1007/s10858-013-9737-7; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; BICKNELL R, 1985, BIOCHEM J, V231, P83, DOI 10.1042/bj2310083; Bienkiewicz EA, 1999, J BIOMOL NMR, V15, P203, DOI 10.1023/A:1008375029746; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Coleman KE, 2018, MOL CELL, V70, P1, DOI 10.1016/j.molcel.2018.03.022; de Vivo A, 2019, NUCLEIC ACIDS RES, V47, P729, DOI 10.1093/nar/gky1219; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Findeisen M, 2007, MAGN RESON CHEM, V45, P175, DOI 10.1002/mrc.1941; Gardino AK, 2009, CELL, V139, P1109, DOI 10.1016/j.cell.2009.11.022; Goddard T. D., 2004, SPARKY 3 NMR ASSIGNM; Gonzalez-Navajas JM, 2010, J EXP MED, V207, P2799, DOI 10.1084/jem.20101326; Harrigan JA, 2018, NAT REV DRUG DISCOV, V17, P57, DOI 10.1038/nrd.2017.152; HOFFMANN R, 1994, INT J PEPT PROT RES, V44, P193; Huang OW, 2012, NAT STRUCT MOL BIOL, V19, P171, DOI 10.1038/nsmb.2206; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Kabra A, 2019, BIOMOL NMR ASSIGN, V13, P37, DOI 10.1007/s12104-018-9847-y; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kessler BM, 2011, CELL BIOCHEM BIOPHYS, V60, P21, DOI 10.1007/s12013-011-9176-6; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kumar P, 2012, J BIOL CHEM, V287, P17050, DOI 10.1074/jbc.M111.316661; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Leznicki P, 2017, J CELL SCI, V130, P1997, DOI 10.1242/jcs.201855; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Li Y, 2013, P NATL ACAD SCI USA, V110, P16462, DOI 10.1073/pnas.1314303110; Loria JP, 2008, ACCOUNTS CHEM RES, V41, P214, DOI 10.1021/ar700132n; Mevissen TET, 2017, ANNU REV BIOCHEM, V86, P159, DOI 10.1146/annurev-biochem-061516-044916; Mevissen TET, 2016, NATURE, V538, P402, DOI 10.1038/nature19836; Neu A, 2015, NAT CHEM BIOL, V11, P697, DOI [10.1038/nchembio.1866, 10.1038/NCHEMBIO.1866]; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Rehman SAA, 2016, MOL CELL, V63, P146, DOI 10.1016/j.molcel.2016.05.009; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rutz S, 2015, NATURE, V518, P417, DOI 10.1038/nature13979; Sahtoe DD, 2015, TRENDS BIOCHEM SCI, V40, P456, DOI 10.1016/j.tibs.2015.05.002; Saleh- T, 2017, NAT STRUCT MOL BIOL, V24, P893, DOI 10.1038/nsmb.3470; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; VOGEL HJ, 1982, BIOCHEMISTRY-US, V21, P5825, DOI 10.1021/bi00266a016; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104; Wertz IE, 2015, NATURE, V528, P370, DOI 10.1038/nature16165; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; Zhao Y, 2018, MOL CELL, V69, P505, DOI 10.1016/j.molcel.2018.01.009; Zhu Guang, 2004, Methods Mol Biol, V278, P57	47	3	3	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3945	3951		10.1074/jbc.AC119.010808	http://dx.doi.org/10.1074/jbc.AC119.010808			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32071088	Green Published, hybrid			2022-12-26	WOS:000527704400019
J	Cargill, KR; Chibe, T; Murali, A; Mukherjee, E; Crinzi, E; Sims-Lucas, S				Cargill, Kasey R.; Chibe, Takuto; Murali, Anjana; Mukherjee, Elina; Crinzi, Elizabeth; Sims-Lucas, Sunder			Prenatal hypoxia increases susceptibility to kidney injury	PLOS ONE			English	Article							HEART SUSCEPTIBILITY; REPERFUSION INJURY; RENAL DYSFUNCTION; PATHOPHYSIOLOGY; RESTRICTION; ISCHEMIA; IMPAIRS; RATS	Prenatal hypoxia is a gestational stressor that can result in developmental abnormalities or physiological reprogramming, and often decreases cellular capacity against secondary stress. When a developing fetus is exposed to hypoxia, blood flow is preferentially redirected to vital organs including the brain and heart over other organs including the kidney. Hypoxia-induced injury can lead to structural malformations in the kidney; however, even in the absence of structural lesions, hypoxia can physiologically reprogram the kidney leading to decreased function or increased susceptibility to injury. Our investigation in mice reveals that while prenatal hypoxia does not affect normal development of the kidneys, it primes the kidneys to have an increased susceptibility to kidney injury later in life. We found that our model does not develop structural abnormalities when prenatally exposed to modest 12% O-2 as evident by normal histological characterization and gene expression analysis. Further, adult renal structure and function is comparable to mice exposed to ambient oxygen throughout nephrogenesis. However, after induction of kidney injury with a nephrotoxin (cisplatin), the offspring of mice housed in hypoxia exhibit significantly reduced renal function and proximal tubule damage following injury. We conclude that exposure to prenatal hypoxia in utero physiologically reprograms the kidneys leading to increased susceptibility to injury later in life.	[Cargill, Kasey R.; Chibe, Takuto; Murali, Anjana; Mukherjee, Elina; Crinzi, Elizabeth; Sims-Lucas, Sunder] Univ Pittsburgh, Dept Pediat, Div Nephrol, UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sims-Lucas, S (corresponding author), Univ Pittsburgh, Dept Pediat, Div Nephrol, UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA.	simslucas@upmc.edu		Cargill, Kasey/0000-0003-3082-1937; Sims-Lucas, Sunder/0000-0003-1908-4809	National Institutes of Health NIDDK [DK116370]; UPMC Children's Hospital of Pittsburgh Research Advisory Committee; American Heart Association [17POST33670685]; Richard King Mellon Institute for Pediatric Research; National Institutes of Health NIDDK K01 [DK096996]; National Institutes of Health NIDDK R03 [DK110503]	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); UPMC Children's Hospital of Pittsburgh Research Advisory Committee; American Heart Association(American Heart Association); Richard King Mellon Institute for Pediatric Research; National Institutes of Health NIDDK K01; National Institutes of Health NIDDK R03	Dr. Cargill (KRC) was supported by the National Institutes of Health NIDDK (DK116370) and by the UPMC Children's Hospital of Pittsburgh Research Advisory Committee. Dr. Chiba (TC) was supported by the American Heart Association (17POST33670685) and the Richard King Mellon Institute for Pediatric Research. Dr. Sims-Lucas (SSL) was supported by the National Institutes of Health NIDDK K01 (DK096996) and R03 (DK110503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagby SP, 2009, CLIN J AM SOC NEPHRO, V4, P10, DOI 10.2215/CJN.06101108; Barnett LMA, 2018, TOXICOL SCI, V164, P379, DOI 10.1093/toxsci/kfy159; Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Battista MC, 2002, AM J PHYSIOL-ENDOC M, V283, pE124, DOI 10.1152/ajpendo.00004.2001; BAUD L, 1986, AM J PHYSIOL, V251, pF765, DOI 10.1152/ajprenal.1986.251.5.F765; Boubred F, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1086-3; Coca SG, 2010, AM J KIDNEY DIS, V56, P122, DOI 10.1053/j.ajkd.2009.12.034; Cosmi E, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/364381; Ducsay CA, 2018, PHYSIOL REV, V98, P1241, DOI 10.1152/physrev.00043.2017; Golan H, 2006, DEVELOPMENTAL SCI, V9, P338, DOI 10.1111/j.1467-7687.2006.00498.x; Gonzalez-Rodriguez P, 2013, INT J MED SCI, V10, P532, DOI 10.7150/ijms.5566; Hagen T., 2012, OXYGEN VERSUS REACTI; He LY, 2017, KIDNEY INT, V92, P1071, DOI 10.1016/j.kint.2017.06.030; Hemker SL, 2016, PEDIATR NEPHROL, V31, P1571, DOI 10.1007/s00467-016-3333-5; Heyman SN, 2009, EXPERT OPIN DRUG DIS, V4, P629, DOI 10.1517/17460440902946389; Ho J, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00128; Hsu RK, 2016, SEMIN NEPHROL, V36, P283, DOI 10.1016/j.semnephrol.2016.05.005; Jensen GM, 1997, AM J PUBLIC HEALTH, V87, P1003, DOI 10.2105/AJPH.87.6.1003; Li GH, 2003, J SOC GYNECOL INVEST, V10, P265, DOI 10.1016/S1071-5576(03)00074-1; Li HS, 2019, REDOX BIOL, V25, DOI 10.1016/j.redox.2019.101109; Li Q, 2009, AM J PATHOL, V175, P2133, DOI 10.2353/ajpath.2009.090354; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Meng XM, 2018, LAB INVEST, V98, P63, DOI 10.1038/labinvest.2017.120; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Nalivaeva NN, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00825; Newsome A.D., 2017, FASEB J, V31, P305, DOI [10.1016/j.bpa.2017.09.001, DOI 10.1016/J.BPA.2017.09.001]; Nishinakamura R, 2016, NAT REV NEPHROL, V12, P67, DOI 10.1038/nrneph.2015.203; Nojiri T, 2016, PEPTIDES, V82, P85, DOI 10.1016/j.peptides.2016.06.003; O'Brien LL, 2014, SEMIN CELL DEV BIOL, V36, P31, DOI 10.1016/j.semcdb.2014.08.014; Oh Gi-Su, 2014, Electrolyte Blood Press, V12, P55, DOI 10.5049/EBP.2014.12.2.55; Ostermann M, 2017, BEST PRACT RES-CLIN, V31, P305, DOI 10.1016/j.bpa.2017.09.001; Ozkok A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/967826; Patterson AJ, 2010, CURR MOL MED, V10, P653; Patterson AJ, 2010, CIRC RES, V107, P365, DOI 10.1161/CIRCRESAHA.110.221259; Peyronnet J, 2000, J PHYSIOL-LONDON, V524, P525, DOI 10.1111/j.1469-7793.2000.00525.x; Ratliff B.B., 2016, ANTIOXIDANTS REDOX S, V25; Takasato M, 2015, DEVELOPMENT, V142, P1937, DOI 10.1242/dev.104802; Walton SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08365-4; Walton SL, 2018, J PHYSIOL-LONDON, V596, P5873, DOI 10.1113/JP275918; Wilkinson LJ, 2015, KIDNEY INT, V87, P975, DOI 10.1038/ki.2014.394; Xia SX, 2015, REPROD SCI, V22, P156, DOI 10.1177/1933719114536474; Xu Y, 2006, FASEB J, V20, P1251, DOI 10.1096/fj.05-4917fje; Xue Q, 2009, J PHARMACOL EXP THER, V330, P624, DOI 10.1124/jpet.109.153239; Zlotos L, 2015, AM J PHARM EDUC, V79, DOI 10.5688/ajpe79337; Zwemer CF, 2007, J APPL PHYSIOL, V102, P286, DOI 10.1152/japplphysiol.00536.2006	45	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229618	10.1371/journal.pone.0229618	http://dx.doi.org/10.1371/journal.pone.0229618			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084244	Green Published, gold			2022-12-26	WOS:000535227900117
J	Zhang, DH; Wang, YF; He, K; Yang, QG; Gong, MQ; Ji, MJ; Chen, L				Zhang, Donghui; Wang, Yingfan; He, Kun; Yang, Qinggui; Gong, Maoqing; Ji, Minjun; Chen, Lin			Wolbachia limits pathogen infections through induction of host innate immune responses	PLOS ONE			English	Article							NF-KAPPA-B; CYTOPLASMIC INCOMPATIBILITY; MOSQUITO VECTOR; TOLL PATHWAY; DENGUE VIRUS; AEDES; ACTIVATION; POPULATIONS; RICKETTSIACEAE; RECOGNITION	Background Wolbachia has been reported to suppress a variety of pathogen infections in mosquitoes, but the mechanism is undefined. Two possibilities have been proposed. One is that Wolbachia activates host immune responses, and the other one is that Wolbachia competes with pathogens for limited nutrients. Methodology/Principal findings In this study, we compared host immune responses and the densities of two different strains of Wolbachia in naturally occurring parental and artificially created hybrid host genetic backgrounds. No significant difference in Wolbachia density was found between these hosts. We found that Wolbachia could activate host innate immune responses when the host genetic profile was different from that of its natural host. When these hosts were challenged with pathogenic bacteria, mosquitoes in new host-Wolbachia symbioses had a higher survival rate than in old host-Wolbachia symbioses. Conclusions/Significance The presence of Wolbachia per se does not necessarily affect pathogen infections, suggesting that a competition for limited nutrients is not the main reason for Wolbachia-mediated pathogen suppression. Instead, host immune responses are responsible for it. The elucidation of an immunity nature of PI is important to guide future practice: Wolbachia may be genetically engineered to be more immunogenic, it is desired to search and isolate more strains of Wolbachia, and test more host-Wolbachia symbioses for future applications. Our results also suggest Wolbachia-based PI may be applied to naturally Wolbachia-infected mosquito populations, and extend to the control of a broader range of mosquito-borne diseases.	[Zhang, Donghui] Nanjing Med Univ, Sch Int Educ, Nanjing, Jiangsu, Peoples R China; [Zhang, Donghui; Ji, Minjun; Chen, Lin] Nanjing Med Univ, Jiangsu Prov Key Lab Modern Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Wang, Yingfan] Nanjing Med Univ, Sch Basic Med Sci, Program Integrat Clin Med 5 3, Nanjing, Jiangsu, Peoples R China; [He, Kun] Nanjing Med Univ, Sch Med Imaging, Program Med Imaging, Nanjing, Jiangsu, Peoples R China; [Yang, Qinggui] Jiangsu Int Travel Healthcare Ctr, Nanjing, Jiangsu, Peoples R China; [Gong, Maoqing] Shandong Acad Med Sci, Shandong Inst Parasit Dis Prevent & Control, Jining, Shandong, Peoples R China; [Ji, Minjun; Chen, Lin] Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Ji, Minjun; Chen, Lin] Nanjing Med Univ, Sch Publ Hlth, Key Lab Infect Dis, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Nanjing Medical University; Nanjing Medical University	Chen, L (corresponding author), Nanjing Med Univ, Jiangsu Prov Key Lab Modern Pathogen Biol, Nanjing, Jiangsu, Peoples R China.; Chen, L (corresponding author), Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China.; Chen, L (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Key Lab Infect Dis, Nanjing, Jiangsu, Peoples R China.	linchen@njmu.edu.cn						Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bian G, 2005, P NATL ACAD SCI USA, V102, P13568, DOI 10.1073/pnas.0502815102; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Bourtzis K, 2000, INSECT MOL BIOL, V9, P635, DOI 10.1046/j.1365-2583.2000.00224.x; Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636; Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011; Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021; Chen L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002030; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Martinez FDB, 2012, ARCH ENVIRON CON TOX, V62, P351, DOI 10.1007/s00244-011-9700-0; Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hoey J, 2000, CAN MED ASSOC J, V162, P1036; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Kleino A, 2005, EMBO J, V24, P3423, DOI 10.1038/sj.emboj.7600807; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin MQ, 2003, INFECT IMMUN, V71, P5324, DOI 10.1128/IAI.71.9.5324-5331.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Micieli MV, 2014, J MED ENTOMOL, V51, P189, DOI 10.1603/ME13152; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Pan X., 2012, P NATL ACAD SCI USA, V109, pE23, DOI DOI 10.1073/pnas.1116932108; Pan XL, 2018, ISME J, V12, P277, DOI 10.1038/ismej.2017.174; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Rances E, 2013, J VIROL, V87, P11945, DOI 10.1128/JVI.01522-13; Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548; Ricci I, 2002, J MED ENTOMOL, V39, P562, DOI 10.1603/0022-2585-39.4.562; Ritchie SA, 2018, TRENDS PARASITOL, V34, P217, DOI 10.1016/j.pt.2017.11.011; Schultz MJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00339-17; Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354; Shin SW, 2003, P NATL ACAD SCI USA, V100, P2616, DOI 10.1073/pnas.0537347100; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Sinkins SP, 2004, INSECT BIOCHEM MOLEC, V34, P723, DOI 10.1016/j.ibmb.2004.03.025; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Sudeep AB, 2014, J VECTOR DIS, V51, P251; Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x; van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892; Wassie F, 2012, J EXPO SCI ENV EPID, V22, P549, DOI 10.1038/jes.2012.45; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; YEN JH, 1973, J INVERTEBR PATHOL, V22, P242, DOI 10.1016/0022-2011(73)90141-9; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102	52	8	9	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0226736	10.1371/journal.pone.0226736	http://dx.doi.org/10.1371/journal.pone.0226736			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8CF	32078642	Green Published, gold			2022-12-26	WOS:000535224600004
J	Sinha, A; Israeli, R; Cirigliano, A; Gihaz, S; Trabelcy, B; Braus, GH; Gerchman, Y; Fishman, A; Negri, R; Rinaldi, T; Pick, E				Sinha, Abhishek; Israeli, Ran; Cirigliano, Angela; Gihaz, Shalev; Trabelcy, Beny; Braus, Gerhard H.; Gerchman, Yoram; Fishman, Ayelet; Negri, Rodolfo; Rinaldi, Teresa; Pick, Elah			The COP9 signalosome mediates the Spt23 regulated fatty acid desaturation and ergosterol biosynthesis	FASEB JOURNAL			English	Article						Csn5; COP9 signalosome; Ergosterol; NEDD8; Ole1; Rub1; Spt23; S; cerevisiae	UNFOLDED PROTEIN RESPONSE; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; UBIQUITIN LIGASE; PCI COMPLEXES; GTPASE YPT7; YEAST; PROTEASOME; STRESS	The COP9 signalosome (CSN) is a conserved eukaryotic complex, essential for vitality in all multicellular organisms and critical for the turnover of key cellular proteins through catalytic and non-catalytic activities. Saccharomyces cerevisiae is a powerful model organism for studying fundamental aspects of the CSN complex, since it includes a conserved enzymatic core but lacks non-catalytic activities, probably explaining its non-essentiality for life. A previous transcriptomic analysis of an S. cerevisiae strain deleted in the CSN5/RRI1 gene, encoding to the CSN catalytic subunit, revealed a downregulation of genes involved in lipid metabolism. We now show that the S. cerevisiae CSN holocomplex is essential for cellular lipid homeostasis. Defects in CSN assembly or activity lead to decreased quantities of ergosterol and unsaturated fatty acids (UFA); vacuole defects; diminished lipid droplets (LDs) size; and to accumulation of endoplasmic reticulum (ER) stress. The molecular mechanism behind these findings depends on CSN involvement in upregulating mRNA expression of SPT23. Spt23 is a novel activator of lipid desaturation and ergosterol biosynthesis. Our data reveal for the first time a functional link between the CSN holocomplex and Spt23. Moreover, CSN-dependent upregulation of SPT23 transcription is necessary for the fine-tuning of lipid homeostasis and for cellular health.	[Sinha, Abhishek; Israeli, Ran; Trabelcy, Beny; Gerchman, Yoram; Pick, Elah] Univ Haifa, Dept Biol & Environm, Fac Nat Sci, IL-3600600 Oranim, Tivon, Israel; [Cirigliano, Angela; Negri, Rodolfo; Rinaldi, Teresa] Sapienza Univ Rome, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Gihaz, Shalev; Fishman, Ayelet] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, Haifa, Israel; [Braus, Gerhard H.] Univ Goettingen, Dept Mol Microbiol & Genet, Inst Microbiol & Genet, Goettingen Ctr Mol Biosci GZMB, Gottingen, Germany	University of Haifa; Sapienza University Rome; Technion Israel Institute of Technology; University of Gottingen	Pick, E (corresponding author), Univ Haifa, Dept Biol & Environm, Fac Nat Sci, IL-3600600 Oranim, Tivon, Israel.	elahpic@research.haifa.ac.il	Braus, Gerhard H/G-3999-2012; Gerchman, Yoram/F-5226-2015; Rinaldi, Teresa/AAC-9710-2020	Braus, Gerhard H/0000-0002-3117-5626; Gerchman, Yoram/0000-0002-8637-9589; Rinaldi, Teresa/0000-0001-6291-245X; Gihaz, Shalev/0000-0001-7292-0808; Sinha, Abhishek/0000-0003-1831-5513	Ministry of Science and Technology [3-9022]; Ministry of Foreign Affairs; Israel Science Foundation [162/17]; Council for Higher Education	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Foreign Affairs(Ministry of Foreign Affairs and International Cooperation (Italy)); Israel Science Foundation(Israel Science Foundation); Council for Higher Education	Ministry of Science and Technology, Grant/Award Number: 3-9022; Ministry of Foreign Affairs; Israel Science Foundation 162/17; Council for Higher Education	Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Auld KL, 2006, CELL CYCLE, V5, P1503, DOI 10.4161/cc.5.14.2979; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Balderhaar HJK, 2010, J CELL SCI, V123, P4085, DOI 10.1242/jcs.071977; Ballweg S, 2017, BIOL CHEM, V398, P215, DOI 10.1515/hsz-2016-0277; BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Brachmann CB, 1998, YEAST, V14, P115; Bramasole L, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9090449; BREIVIK ON, 1957, J AGR FOOD CHEM, V5, P360, DOI 10.1021/jf60075a005; Busch S, 2003, MOL MICROBIOL, V49, P717, DOI 10.1046/j.1365-2958.2003.03612.x; Busch S, 2007, P NATL ACAD SCI USA, V104, P8089, DOI 10.1073/pnas.0702108104; Catlett NL, 2000, J CELL BIOL, V150, P513, DOI 10.1083/jcb.150.3.513; Cavadini S, 2016, NATURE, V531, P598, DOI 10.1038/nature17416; Chamovitz DA, 2009, EMBO REP, V10, P352, DOI 10.1038/embor.2009.33; Chemler JA, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-20; Christmann M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003275; Cirigliano A, 2019, BBA-MOL CELL BIOL L, V1864, P290, DOI 10.1016/j.bbalip.2018.12.002; Cirigliano A, 2016, J ENZYM INHIB MED CH, V31, P1632, DOI 10.3109/14756366.2016.1160901; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Covino R, 2016, MOL CELL, V63, P49, DOI 10.1016/j.molcel.2016.05.015; Davies BSJ, 2006, GENETICS, V174, P191, DOI 10.1534/genetics.106.059964; De Angelis L, 2016, MICROBIOL-SGM, V162, P1435, DOI 10.1099/mic.0.000315; Deguil J, 2011, TRAFFIC, V12, P349, DOI 10.1111/j.1600-0854.2010.01150.x; Di Mambro T, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00080; Dror A, 2014, APPL ENVIRON MICROB, V80, P1515, DOI 10.1128/AEM.03371-13; Dubiel D, 2017, BBA-MOL CELL RES, V1864, P1405, DOI 10.1016/j.bbamcr.2017.05.009; Dubiel D, 2015, FEBS LETT, V589, P2507, DOI 10.1016/j.febslet.2015.06.007; Eisenberg-Bord M, 2018, J CELL BIOL, V217, P269, DOI 10.1083/jcb.201704122; ENCHEV RI, 2012, CELL REP, V16, P30; Fabris M, 2014, NEW PHYTOL, V204, P521, DOI 10.1111/nph.12917; Grillitsch K, 2011, BBA-MOL CELL BIOL L, V1811, P1165, DOI 10.1016/j.bbalip.2011.07.015; Halbleib K, 2017, MOL CELL, V67, P673, DOI 10.1016/j.molcel.2017.06.012; He Q, 2005, GENE DEV, V19, P1518, DOI 10.1101/gad.1322205; Heese-Peck A, 2002, MOL BIOL CELL, V13, P2664, DOI 10.1091/mbc.E02-04-0186; Hickman MJ, 2007, MOL CELL BIOL, V27, P7414, DOI 10.1128/MCB.00887-07; Higa A, 2014, MOL CELL BIOL, V34, P1839, DOI 10.1128/MCB.01484-13; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Jiang YD, 2001, MOL CELL BIOL, V21, P6161, DOI 10.1128/MCB.21.18.6161-6169.2001; Jin H, 2008, J CELL BIOL, V180, P813, DOI 10.1083/jcb.200705076; Kaliszewski P, 2008, BBA-MOL CELL BIOL L, V1781, P627, DOI 10.1016/j.bbalip.2008.07.011; Kato JY, 2009, GENES CELLS, V14, P1209, DOI 10.1111/j.1365-2443.2009.01349.x; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Klionsky DJ, 2005, CURR BIOL, V15, pR282, DOI 10.1016/j.cub.2005.04.013; KNITTELFELDER OL, 2017, COLD SPRING HARB PRO; Kolawa N, 2013, MOL CELL PROTEOMICS, V12, P2791, DOI 10.1074/mcp.M113.030163; Krogerus K, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0679-8; KUPKE IR, 1978, J CHROMATOGR, V146, P261, DOI 10.1016/S0378-4347(00)81892-7; Lee MH, 2011, CELL CYCLE, V10; Licursi V, 2014, FEBS J, V281, P175, DOI 10.1111/febs.12584; Lingaraju GM, 2014, NATURE, V512, P161, DOI 10.1038/nature13566; Liu C, 2003, GENE DEV, V17, P1130, DOI 10.1101/gad.1090803; Liu C, 2013, J BIOL CHEM, V288, P20443, DOI 10.1074/jbc.M113.468959; Liu SF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147991; Luke-Glaser S, 2007, MOL CELL BIOL, V27, P4526, DOI 10.1128/MCB.01724-06; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Matheson K, 2017, G3-GENES GENOM GENET, V7, P2219, DOI 10.1534/g3.117.040022; Maytal-Kivity V, 2002, EMBO REP, V3, P1215, DOI 10.1093/embo-reports/kvf235; Maytal-Kivity V, 2003, INT J BIOCHEM CELL B, V35, P706, DOI 10.1016/S1357-2725(02)00378-3; Menon Suchithra, 2008, BMC Biochemistry, V9, P1, DOI 10.1186/1471-2091-9-1; Michaillat L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054160; Mosadeghi R, 2016, ELIFE, V5, DOI 10.7554/eLife.12102; Muller O, 2000, J CELL BIOL, V151, P519, DOI 10.1083/jcb.151.3.519; Mundt KE, 1999, CURR BIOL, V9, P1427, DOI 10.1016/S0960-9822(00)80091-3; Munn AL, 1999, MOL BIOL CELL, V10, P3943, DOI 10.1091/mbc.10.11.3943; Nahlik K, 2010, MOL MICROBIOL, V78, P964, DOI 10.1111/j.1365-2958.2010.07384.x; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; Nezames CD, 2012, PLANT PHYSIOL, V160, P38, DOI 10.1104/pp.112.198879; Numrich J, 2015, J CELL SCI, V128, P2278, DOI 10.1242/jcs.164905; Oh CS, 2006, J BIOL CHEM, V281, P7030, DOI 10.1074/jbc.M510746200; Oron E, 2002, DEVELOPMENT, V129, P4399; Oron E, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100150; Ottaviano D, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov028; PEREIRA L, 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/93195622291708; Pick E, 2014, BIOCHEM SOC T, V42, P1786, DOI 10.1042/BST20140227; Pick E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043980; Pick E, 2009, MOL CELL, V35, P260, DOI 10.1016/j.molcel.2009.07.009; Rabut G, 2011, MOL CELL, V43, P488, DOI 10.1016/j.molcel.2011.05.032; Ralser M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120093; Rape M, 2004, BBA-MOL CELL RES, V1695, P209, DOI 10.1016/j.bbamcr.2004.09.022; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Rice C, 2010, BIOCHEM BIOPH RES CO, V403, P293, DOI 10.1016/j.bbrc.2010.11.020; Rispal D, 2011, RNA, V17, P1213, DOI 10.1261/rna.2697111; Rosel D, 2006, EUR J CELL BIOL, V85, P1023, DOI 10.1016/j.ejcb.2006.04.006; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Scheel H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-71; Schlierf A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13166; Schmaler T, 2010, SUBCELL BIOCHEM, V54, P57, DOI 10.1007/978-1-4419-6676-6_5; Schwechheimer C, 2010, EUR J CELL BIOL, V89, P157, DOI 10.1016/j.ejcb.2009.11.021; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Schweitzer K, 2010, BIOCHEM SOC T, V38, P156, DOI 10.1042/BST0380156; Serratore ND, 2018, GENETICS, V208, P1037, DOI 10.1534/genetics.117.300554; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Siepe D, 2009, NAT CELL BIOL, V11, P967, DOI 10.1038/ncb1908; Soares JR, 2017, BBA-GEN SUBJECTS, V1861, P3429, DOI 10.1016/j.bbagen.2016.09.005; STUKEY JE, 1989, J BIOL CHEM, V264, P16537; Su HB, 2013, CIRC-HEART FAIL, V6, P1049, DOI 10.1161/CIRCHEARTFAILURE.113.000338; Surma MA, 2013, MOL CELL, V51, P519, DOI 10.1016/j.molcel.2013.06.014; Tamura KI, 2004, J BIOSCI BIOENG, V98, P159, DOI 10.1016/S1389-1723(04)00260-9; Tsuge T, 2001, J MOL BIOL, V305, P1, DOI 10.1006/jmbi.2000.4288; WADA Y, 1992, J BIOL CHEM, V267, P18665; Wang JY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001232; Wang RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048020; Wee S, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-15; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; WEI N, 1992, PLANT CELL, V4, P1507, DOI 10.1105/tpc.4.12.1507; Wei N, 1998, PHOTOCHEM PHOTOBIOL, V68, P237; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Weindling E, 2015, BIOCHEM BIOPH RES CO, V457, P473, DOI 10.1016/j.bbrc.2015.01.021; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; YOSHIDA A, 2013, SCI REP UK, V3; Yu ZL, 2011, MOL BIOL CELL, V22, P911, DOI 10.1091/mbc.E10-08-0655; Zemla A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2628; Zhang SR, 1999, GENETICS, V151, P473; Zhang SR, 1997, MOL CELL BIOL, V17, P4718, DOI 10.1128/MCB.17.8.4718; Zhou ZP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002712; Zuleta IA, 2014, NAT METHODS, V11, P443, DOI 10.1038/nmeth.2879	123	6	6	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4870	4889		10.1096/fj.201902487R	http://dx.doi.org/10.1096/fj.201902487R		FEB 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32077151				2022-12-26	WOS:000515255600001
J	Price, BL; Morley, R; Bowling, FL; Lovering, AM; Dobson, CB				Price, Bianca L.; Morley, Robert; Bowling, Frank L.; Lovering, Andrew M.; Dobson, Curtis B.			Susceptibility of monomicrobial or polymicrobial biofilms derived from infected diabetic foot ulcers to topical or systemic antibiotics in vitro	PLOS ONE			English	Article							SOFT-TISSUE; PENETRATION; WOUNDS; PHARMACOKINETICS; BACTERIOLOGY; VANCOMYCIN; MANAGEMENT; RESISTANCE; DIAGNOSIS; ADHESION	Diabetic foot ulcers can become chronic and non-healing despite systemic antibiotic treatment. The penetration of systematically-administered antibiotics to the site of infection is uncertain, as is the effectiveness of such levels against polymicrobial biofilms. We have developed an in vitro model to study the effectiveness of different treatments for infected diabetic foot ulcers in a wound-like environment and compared the activity of systemic levels of antibiotics with that for topically applied antibiotics released from calcium sulfate beads. This is the first study that has harvested bacteria from diabetic foot infections and recreated similar polymicrobial biofilms to those present in vivo for individual subjects. After treatment with levels of gentamicin attained in serum after systemic administration (higher than corresponding tissues concentrations) we measured a 0-2 log reduction in bacterial viability of P. aeruginosa, S. aureus or a polymicrobial biofilm. Conversely, addition of gentamicin loaded calcium sulfate beads resulted in 5-9 log reductions in P. aeruginosa, S aureus and polymicrobial biofilms derived from three subjects. We conclude that systemically administered antibiotics are likely to be inadequate for successfully treating these infections, especially given the vastly increased concentrations required to inhibit cells in a biofilm, and that topical antibiotics provide a more effective alternative.	[Price, Bianca L.] Univ Manchester, Fac Biol Med & Hlth, Lydia Becker Inst Immunol & Inflammat, Div Pharm & Optometry, Manchester, Lancs, England; [Morley, Robert] Derbyshire Community Hlth Serv NHS Fdn Trust, Podiatr Surg Dept, Buxton Hosp, Bakewell, England; [Bowling, Frank L.] Univ Manchester, Fac Biol Med & Hlth, Div Diabet Endocrinol & Gastroenterol, Manchester, Lancs, England; [Lovering, Andrew M.] Antimicrobial Reference Lab, Microbiol Dept, Bristol, Avon, England; [Dobson, Curtis B.] Univ Manchester, Fac Biol Med & Hlth FBMH, Div Pharm & Optometry, Med Device Biol Grp, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Price, BL (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Lydia Becker Inst Immunol & Inflammat, Div Pharm & Optometry, Manchester, Lancs, England.	Bianca.price@manchester.ac.uk	Price, Bianca/AAG-7399-2021	Price, Bianca/0000-0003-1843-618X; Dobson, Curtis/0000-0002-6483-4608	Biocomposited Ltd	Biocomposited Ltd	BP and CD received funding from Biocomposited Ltd for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; Armstrong DG, 2017, NEW ENGL J MED, V376, P2367, DOI 10.1056/NEJMra1615439; Banu A, 2015, AUSTRALAS MED J, V8, P280, DOI 10.4066/AMJ.2015.2422; Barwell ND, 2017, INT J CLIN PRACT, V71, DOI 10.1111/ijcp.13006; Birkenhauer E, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-191; Bjarnsholt T, 2013, NAT REV DRUG DISCOV, V12, P791, DOI 10.1038/nrd4000; Blondeau J M, 2004, J Chemother, V16 Suppl 3, P1; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Bowling FL, 2012, CURR DIABETES REV, V8, P195, DOI 10.2174/157339912800563990; Brownrigg JRW, 2013, EUR J VASC ENDOVASC, V45, P673, DOI 10.1016/j.ejvs.2013.02.014; Centre for Clinical Practice at NICE (UK), 2011, DIAB FOOT PROBL INP; Citron DM, 2007, J CLIN MICROBIOL, V45, P2819, DOI 10.1128/JCM.00551-07; Dalton T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027317; Dumville JC, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011038.pub2; Forbes S, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.03054-16; Gardiner M, 2017, PEERJ, V5, DOI 10.7717/peerj.3543; Gardner SE, 2013, DIABETES, V62, P923, DOI 10.2337/db12-0771; Garrett TR, 2008, PROG NAT SCI-MATER, V18, P1049, DOI 10.1016/j.pnsc.2008.04.001; Gauland C, 2011, ADV SKIN WOUND CARE, V24, P515, DOI 10.1097/01.ASW.0000407647.12832.6c; Goldstein EJC, 1996, DIABETES CARE, V19, P638, DOI 10.2337/diacare.19.6.638; Gottrup F., 2014, J WOUND CARE, V23, DOI [10.12968/jowc.2014.23.10, DOI 10.12968/JOWC.2014.23.10]; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Harrison F, 2017, ISME J, V11, P2492, DOI 10.1038/ismej.2017.103; Hobizal Kimberlee B, 2012, Diabet Foot Ankle, V3, DOI 10.3402/dfa.v3i0.18409; Howell-Jones RS, 2005, J ANTIMICROB CHEMOTH, V55, P143, DOI 10.1093/jac/dkh513; Howlin RP, 2015, ANTIMICROB AGENTS CH, V59, P111, DOI 10.1128/AAC.03676-14; Huang YC, 2016, INT J POLYM SCI, V2016, DOI 10.1155/2016/6545362; Jacobs MR, 2001, CLIN MICROBIOL INFEC, V7, P589, DOI 10.1046/j.1198-743x.2001.00295.x; Kiang TKL, 2014, CLIN PHARMACOKINET, V53, P695, DOI 10.1007/s40262-014-0152-3; Kim SH, 2002, BIOMATERIALS, V23, P1657, DOI 10.1016/S0142-9612(01)00292-7; Kottler J, 2011, DUPED: LIES AND DECEPTION IN PSYCHOTHERAPY, P9; Lamont P, 2013, INT J LOW EXTR WOUND, V12, P71, DOI 10.1177/1534734613476519; Lebeaux D, 2013, PATHOGENS, V2, P288, DOI 10.3390/pathogens2020288; Legat FJ, 2005, ANTIMICROB AGENTS CH, V49, P4368, DOI 10.1128/AAC.49.10.4368-4371.2005; Liddy H., 2002, Journal of Antimicrobial Chemotherapy, V50, P142, DOI 10.1093/jac/dkf090; Lipsky BA, 2016, DIABETES-METAB RES, V32, P246, DOI 10.1002/dmrr.2739; Lipsky BA, 2016, DIABETES-METAB RES, V32, P45, DOI 10.1002/dmrr.2699; Lipsky BA, 2012, CLIN INFECT DIS, V54, pE132, DOI [10.1093/cid/cis460, 10.1093/cid/cis346]; Loesche M, 2017, J INVEST DERMATOL, V137, P237, DOI 10.1016/j.jid.2016.08.009; Malone M, 2017, J WOUND CARE, V26, P20, DOI 10.12968/jowc.2017.26.1.20; Morley R., 2015, FOOT EDINB; Mottola C, 2016, FOLIA MICROBIOL, V61, P35, DOI 10.1007/s12223-015-0401-3; MULLER M, 1995, CLIN PHARMACOL THER, V57, P371, DOI 10.1016/0009-9236(95)90205-8; Noor S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01792; Oates A, 2012, J CLIN MICROBIOL, V50, P2263, DOI 10.1128/JCM.06599-11; Oliver RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136514; Omar A, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5010009; Paisey RB, 2018, DIABETIC MED, V35, P53, DOI 10.1111/dme.13512; Patel JB, 2011, MANUAL CLIN MICROBIO, P1122, DOI DOI 10.1128/9781555816728.CH68; Price BL, 2016, ANTIMICROB AGENTS CH, V60, P6880, DOI 10.1128/AAC.01064-16; Reed EE, 2014, ANN PHARMACOTHER, V48, P962, DOI 10.1177/1060028014535360; Olid AS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009061.pub2; Sendi P, 2016, ANTIMICROB AGENTS CH, V60, P1702, DOI 10.1128/AAC.01933-15; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Skhirtladze K, 2006, ANTIMICROB AGENTS CH, V50, P1372, DOI 10.1128/AAC.50.4.1372-1375.2006; Stewart PS, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0010-2014; Sun Y, 2008, WOUND REPAIR REGEN, V16, P805, DOI 10.1111/j.1524-475X.2008.00434.x; Suryaletha K., 2018, INT WOUND J, V27, P128; Tan T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1280; Traunmuller F, 2010, J ANTIMICROB CHEMOTH, V65, P1252, DOI 10.1093/jac/dkq109; Wagner F W Jr, 1981, Foot Ankle, V2, P64; Werthen M, 2010, APMIS, V118, P156, DOI 10.1111/j.1600-0463.2009.02580.x; Wu S, 2015, PODIATRY MANAGEMENT, P79; Zeitlinger MA, 2011, ANTIMICROB AGENTS CH, V55, P3067, DOI 10.1128/AAC.01433-10	64	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0228704	10.1371/journal.pone.0228704	http://dx.doi.org/10.1371/journal.pone.0228704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7XT	32069293	Green Published, gold			2022-12-26	WOS:000535212900012
J	Bessou, M; Lopez, J; Gadet, R; Deygas, M; Popgeorgiev, N; Poncet, D; Nougarede, A; Billard, P; Mikaelian, I; Gonzalo, P; Rimokh, R; Gillet, G				Bessou, Margaux; Lopez, Jonathan; Gadet, Rudy; Deygas, Mathieu; Popgeorgiev, Nikolay; Poncet, Delphine; Nougarede, Adrien; Billard, Pauline; Mikaelian, Ivan; Gonzalo, Philippe; Rimokh, Ruth; Gillet, Germain			The apoptosis inhibitor Bcl-xL controls breast cancer cell migration through mitochondria-dependent reactive oxygen species production	ONCOGENE			English	Article							ANION CHANNEL; ENDOPLASMIC-RETICULUM; CYTOCHROME-C; BH4 DOMAIN; BCL-X(L); FAMILY; CALCIUM; VDAC; METASTASIS; RELEASE	The Bcl-xL apoptosis inhibitor plays a major role in vertebrate development. In addition to its effect on apoptosis, Bcl-xL is also involved in cell migration and mitochondrial metabolism. These effects may favour the onset and dissemination of metastasis. However, the underlying molecular mechanisms remain to be fully understood. Here we focus on the control of cell migration by Bcl-xL in the context of breast cancer cells. We show that Bcl-xL silencing led to migration defects in Hs578T and MDA-MB231 cells. These defects were rescued by re-expressing mitochondria-addressed, but not endoplasmic reticulum-addressed, Bcl-xL. The use of BH3 mimetics, such as ABT-737 and WEHI-539 confirmed that the effect of Bcl-xL on migration did not depend on interactions with BH3-containing death accelerators such as Bax or BH3-only proteins. In contrast, the use of a BH4 peptide that disrupts the Bcl-xL/VDAC1 complex supports that Bcl-xL by acting on VDAC1 permeability contributes to cell migration through the promotion of reactive oxygen species production by the electron transport chain. Collectively our data highlight the key role of Bcl-xL at the interface between cell metabolism, cell death, and cell migration, thus exposing the VDAC1/Bcl-xL interaction as a promising target for anti-tumour therapy in the context of metastatic breast cancer.	[Bessou, Margaux; Lopez, Jonathan; Gadet, Rudy; Deygas, Mathieu; Popgeorgiev, Nikolay; Poncet, Delphine; Nougarede, Adrien; Billard, Pauline; Mikaelian, Ivan; Gonzalo, Philippe; Rimokh, Ruth; Gillet, Germain] Univ Claude Bernard Lyon 1, Univ Lyon, Ctr Rech Cancerol Lyon, Ctr Leon Berard,INSERM 1052,CNRS 5286, F-69008 Lyon, France; [Lopez, Jonathan; Poncet, Delphine] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Ctr Biol Sud, Chemin Grand Revoyet, F-69495 Pierre Benite, France; [Gonzalo, Philippe] CHU St Etienne, Lab Biochim, F-42000 St Etienne, France; [Gillet, Germain] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Lab Anat & Cytol Pathol, Chemin Grand Revoyet, F-69495 Pierre Benite, France; [Deygas, Mathieu] Inst Curie, CNRS, UMR144, 6 Rue Jean Calvin, F-75005 Paris, France; [Nougarede, Adrien] CEA LETI, 17 Ave Martyrs, F-38000 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; CHU Lyon; CHU de St Etienne; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; CEA	Rimokh, R; Gillet, G (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, Ctr Rech Cancerol Lyon, Ctr Leon Berard,INSERM 1052,CNRS 5286, F-69008 Lyon, France.; Gillet, G (corresponding author), Hosp Civils Lyon, Ctr Hosp Lyon Sud, Lab Anat & Cytol Pathol, Chemin Grand Revoyet, F-69495 Pierre Benite, France.	ruth.rimokh@inserm.fr; germain.gillet@univ-lyon1.fr	gillet, germain/A-9095-2013; Billard, Pauline/AAS-5731-2020; Poncet, Delphine A/A-7190-2016	Billard, Pauline/0000-0002-3255-0192; Poncet, Delphine A/0000-0003-0446-5262; LOPEZ, Jonathan/0000-0003-3768-2378; Popgeorgiev, Nikolay/0000-0002-4835-5201; GILLET, Germain/0000-0002-1514-327X	AFM telethon [20269]; Fondation ARC [PGA1 RF20180206799, PJA 20161204606]	AFM telethon(Association Francaise contre les Myopathies); Fondation ARC	We would like to thank Stephane Borel for technical assistance, Julien Prudent for critical reading of the manuscript, Brigitte Manship for manuscript editing, Isabelle Goddard for skilful technical assistance regarding studies in mice (LMT, Lyon), and CIQLE core facility (SFR Sante Lyon-Est) for videomicroscopy. This work was supported by AFM telethon (to GG, grant #20269) and Fondation ARC to GG (grant #PGA1 RF20180206799) and JL (grant #PJA 20161204606).	Angelova PR, 2016, FREE RADICAL BIO MED, V100, P81, DOI 10.1016/j.freeradbiomed.2016.06.005; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Ben-Hail D, 2016, BBA-MOL CELL RES, V1863, P1612, DOI 10.1016/j.bbamcr.2016.04.002; Bonneau B, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004480; Bonneau B, 2013, BBA-MOL CELL RES, V1833, P1755, DOI 10.1016/j.bbamcr.2013.01.021; Chen YB, 2011, J CELL BIOL, V195, P263, DOI 10.1083/jcb.201108059; Choi SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10384; Dogterom M, 2019, NAT REV MOL CELL BIO, V20, P38, DOI 10.1038/s41580-018-0067-1; Du YCN, 2007, PLOS BIOL, V5, P2255, DOI 10.1371/journal.pbio.0050276; Eno CO, 2012, MOL BIOL CELL, V23, P2605, DOI 10.1091/mbc.E12-02-0090; Fernandez Y, 2000, CELL DEATH DIFFER, V7, P350, DOI 10.1038/sj.cdd.4400662; Fouque A, 2016, CELL DEATH DIFFER, V23, P1702, DOI 10.1038/cdd.2016.61; GONZALEZGARCIA M, 1994, DEVELOPMENT, V120, P3033; Griffiths EJ, 2009, BBA-BIOENERGETICS, V1787, P1324, DOI 10.1016/j.bbabio.2009.01.019; Hager JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004455; Hardwick JM, 2012, TRENDS CELL BIOL, V22, P318, DOI 10.1016/j.tcb.2012.03.005; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Huang HY, 2013, J BIOL CHEM, V288, P19870, DOI 10.1074/jbc.M112.448290; Hwang KT, 2012, INT J CANCER, V131, pE1109, DOI 10.1002/ijc.27539; Johnson BW, 2000, J BIOL CHEM, V275, P31546, DOI 10.1074/jbc.M001363200; Karczmarek-Borowska B, 2006, LUNG CANCER, V51, P61, DOI 10.1016/j.lungcan.2005.08.010; Kastl L, 2014, FEBS LETT, V588, P175, DOI 10.1016/j.febslet.2013.11.033; Keitel U, 2014, ONCOTARGET, V5, P11778, DOI 10.18632/oncotarget.2634; Lessene G, 2013, NAT CHEM BIOL, V9, P390, DOI [10.1038/NCHEMBIO.1246, 10.1038/nchembio.1246]; Li C, 2007, P NATL ACAD SCI USA, V104, P12565, DOI 10.1073/pnas.0702489104; Lim SK, 2012, CLIN EXP METASTAS, V29, P901, DOI 10.1007/s10585-012-9479-z; Lopez J, 2015, BRIT J CANCER, V112, P957, DOI 10.1038/bjc.2015.85; Ludin A, 2014, ANTIOXID REDOX SIGN, V21, P1605, DOI 10.1089/ars.2014.5941; Martin SS, 2004, ONCOGENE, V23, P4641, DOI 10.1038/sj.onc.1207595; Monaco G, 2015, J BIOL CHEM, V290, P9150, DOI 10.1074/jbc.M114.622514; Mookerjee SA, 2017, J BIOL CHEM, V292, P7189, DOI 10.1074/jbc.M116.774471; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nguyen MHT, 2005, ANN NY ACAD SCI, V1047, P127, DOI 10.1196/annals.1341.012; Olopade OI, 1997, CANCER J SCI AM, V3, P230; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Paupe V, 2018, BIOCHEM BIOPH RES CO, V500, P75, DOI 10.1016/j.bbrc.2017.05.039; Popgeorgiev N, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00013; Popgeorgiev N, 2011, DEV CELL, V20, P663, DOI 10.1016/j.devcel.2011.03.016; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Prudent J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3330; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rostovtseva TK, 2005, J BIOENERG BIOMEMBR, V37, P129, DOI 10.1007/s10863-005-6566-8; Schmitt E, 2007, ONCOGENE, V26, P5851, DOI 10.1038/sj.onc.1210396; Senju Y, 2019, CURR OPIN CELL BIOL, V56, P7, DOI 10.1016/j.ceb.2018.08.003; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Suzuki J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5153; Tan WZ, 2007, BBA-BIOMEMBRANES, V1768, P2510, DOI 10.1016/j.bbamem.2007.06.002; Teng Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-453; Tsujimoto Y, 2000, CELL DEATH DIFFER, V7, P1174, DOI 10.1038/sj.cdd.4400780; Vander Heiden MG, 1999, MOL CELL, V3, P159; Vervliet T, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00075; Vogler M, 2011, BLOOD, V117, P7145, DOI 10.1182/blood-2011-03-344812; Watanabe J, 2002, INT J ONCOL, V21, P515; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Yang J, 2016, P NATL ACAD SCI USA, V113, pE1953, DOI 10.1073/pnas.1517935113; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	58	26	26	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	15					3056	3074		10.1038/s41388-020-1212-9	http://dx.doi.org/10.1038/s41388-020-1212-9		FEB 2020	19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LB8NS	32066881	Green Submitted			2022-12-26	WOS:000514052700002
J	Hernandez, DM; Kang, JH; Choudhury, M; Andrianifahanana, M; Yin, XQ; Limper, AH; Leof, EB				Hernandez, Danielle M.; Kang, Jeong-Han; Choudhury, Malay; Andrianifahanana, Mahefatiana; Yin, Xueqian; Limper, Andrew H.; Leof, Edward B.			IPF pathogenesis is dependent upon TGF beta induction of IGF-1	FASEB JOURNAL			English	Article						fibroblast; promoter; signaling; transcription	GROWTH-FACTOR-I; IDIOPATHIC PULMONARY-FIBROSIS; INDUCED LUNG INJURY; MAMMALIAN TARGET; GENE-EXPRESSION; INSULIN; RECEPTOR; MECHANISMS; ACTIVATION; BLEOMYCIN	Pathogenic fibrotic diseases, including idiopathic pulmonary fibrosis (IPF), have some of the worst prognoses and affect millions of people worldwide. With unclear etiology and minimally effective therapies, two-thirds of IPF patients die within 2-5 years from this progressive interstitial lung disease. Transforming Growth Factor Beta (TGF beta) and insulin-like growth factor-1 (IGF-1) are known to promote fibrosis; however, myofibroblast specific upregulation of IGF-1 in the initiation and progression of TGF beta-induced fibrogenesis and IPF have remained unexplored. To address this, the current study (1) documents the upregulation of IGF-1 via TGF beta in myofibroblasts and fibrotic lung tissue, as well as its correlation with decreased pulmonary function in advanced IPF; (2) identifies IGF-1's C1 promoter as mediating the increase in IGF-1 transcription by TGF beta in pulmonary fibroblasts; (3) determines that SMAD2 and mTOR signaling are required for TGF beta-dependent Igf-1 expression in myofibroblasts; (4) demonstrates IGF-1R activation is essential to support TGF beta-driven profibrotic myofibroblast functions and excessive wound healing; and (5) establishes the effectiveness of slowing the progression of murine lung fibrosis with the IGF-1R inhibitor OSI-906. These findings expand our knowledge of IGF-1's role as a novel fibrotic-switch, bringing us one step closer to understanding the complex biological mechanisms responsible for fibrotic diseases and developing effective therapies.	[Hernandez, Danielle M.] Mayo Clin, Coll Med & Sci, Grad Sch Biomed Sci, Biochem & Mol Biol Dept, Rochester, MN USA; [Hernandez, Danielle M.; Kang, Jeong-Han; Choudhury, Malay; Andrianifahanana, Mahefatiana; Yin, Xueqian; Limper, Andrew H.; Leof, Edward B.] Mayo Clin, Div Pulm & Crit Care Med, Thorac Dis Res Unit, Dept Med,Coll Med, 200 Second St SW, Rochester, MN 55905 USA; [Hernandez, Danielle M.] Univ Minnesota Twin Cities, Masonic Canc Ctr, Dept Neurosurg, Minneapolis, MN USA; [Kang, Jeong-Han] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA; [Yin, Xueqian] Mayo Clin, Coll Med, Dept Mol Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Mayo Clinic	Limper, AH; Leof, EB (corresponding author), Mayo Clin, Div Pulm & Crit Care Med, Thorac Dis Res Unit, Dept Med,Coll Med, 200 Second St SW, Rochester, MN 55905 USA.	limper.andrew@mayo.edu; leof.edward@mayo.edu	Kang, Jeong-Han/J-3541-2019	Kang, Jeong-Han/0000-0002-9693-0696; Hernandez, Danielle M./0000-0003-0867-4950; Choudhury, Malay/0000-0003-3051-9084	HHS | NIH | National Institute of General Medical Sciences (NIGMS) [R01-GM054200, R37-GM055816]; Caerus Foundation [91736058]; Hurvis Accelerate the Cure for IPF [91736063]	HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Caerus Foundation; Hurvis Accelerate the Cure for IPF	HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: R01-GM054200 and R37-GM055816; Caerus Foundation, Grant/Award Number: 91736058; Hurvis Accelerate the Cure for IPF, Grant/Award Number: 91736063	Ahamed K, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-31; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Allen JT, 2000, NEUROPEPTIDES, V34, P98, DOI 10.1054/npep.2000.0802; Andonegui G, 2012, AM J PHYSIOL-LUNG C, V303, pL788, DOI 10.1152/ajplung.00008.2012; Andrianifahanana M, 2016, FASEB J, V30, P3733, DOI 10.1096/fj.201600428R; Andrianifahanana M, 2013, FASEB J, V27, P4444, DOI 10.1096/fj.12-224907; Andrianifahanana M, 2010, CANCER RES, V70, P7421, DOI 10.1158/0008-5472.CAN-10-0232; Antoniou KM, 2010, CONNECT TISSUE RES, V51, P71, DOI 10.3109/03008200903056150; ATKISON PR, 1980, ENDOCRINOLOGY, V106, P2006, DOI 10.1210/endo-106-6-2006; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bartholmai B, 2006, INSIGHT J; Bauer Y, 2015, AM J RESP CELL MOL, V52, P217, DOI 10.1165/rcmb.2013-0310OC; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloor CA, 2001, AM J RESP CRIT CARE, V164, P265, DOI 10.1164/ajrccm.164.2.2003114; Brisson Becky K, 2013, Front Endocrinol (Lausanne), V4, P42, DOI 10.3389/fendo.2013.00042; Brown GC, 2015, EMBO REP, V16, P137, DOI 10.15252/embr.201439518; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; Cai WK, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-00417-7, 10.1038/ncomms14892]; Camelo A, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00173; Chetty A, 1999, EXP LUNG RES, V25, P701; Chetty A, 2006, PEDIATR RES, V60, P389, DOI 10.1203/01.pdr.0000238257.15502.f4; Choi JE, 2009, AM J RESP CRIT CARE, V179, P212, DOI 10.1164/rccm.200802-228OC; CLEMMONS DR, 1981, J CLIN INVEST, V67, P10, DOI 10.1172/JCI110001; Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046; Della Latta V, 2015, PHARMACOL RES, V97, P122, DOI 10.1016/j.phrs.2015.04.012; Divo MJ, 2014, EUR RESPIR J, V44, P1055, DOI 10.1183/09031936.00059814; Dudakovic A, 2014, J CELL BIOCHEM, V115, P1816, DOI 10.1002/jcb.24852; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esnault S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170207; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Frankel SK, 2005, AM J PHYSIOL-LUNG C, V288, pL805, DOI 10.1152/ajplung.00420.2004; George PM, 2019, LANCET RESP MED, V7, P271, DOI 10.1016/S2213-2600(18)30502-2; GOLDSTEIN RH, 1989, ENDOCRINOLOGY, V124, P964, DOI 10.1210/endo-124-2-964; Gyorfi AH, 2018, MATRIX BIOL, V68-69, P8, DOI 10.1016/j.matbio.2017.12.016; Hecker L, 2018, AM J PHYSIOL-LUNG C, V314, P1642, DOI 10.1152/ajplung.00275.2017; Hewlett JC, 2018, MATRIX BIOL, V71-72, P112, DOI 10.1016/j.matbio.2018.03.021; Honeyman L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-16; Hsu E, 2011, ARTHRITIS RHEUM-US, V63, P783, DOI 10.1002/art.30159; Hung CF, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-102; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Jung MY, 2018, FASEB J, V32, P3803, DOI 10.1096/fj.201701187R; Kalari KR, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-224; Kang JH, 2017, J CLIN INVEST, V127, P2541, DOI 10.1172/JCI88696; Kasprzak A, 2013, INT J ONCOL, V42, P305, DOI 10.3892/ijo.2012.1706; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; KIAMINSKI N, 2015, LUNG DIS WEEK ATS PU; Kim KK, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a022293; Kim TH, 2012, AM J RESP CELL MOL, V47, P372, DOI 10.1165/rcmb.2012-0085OC; Koczorowska MM, 2011, EXP THER MED, V2, P149, DOI 10.3892/etm.2010.174; Kotarkonda LK, 2017, EXP MOL PATHOL, V102, P86, DOI 10.1016/j.yexmp.2017.01.004; Kottmann RM, 2009, RESPIROLOGY, V14, P917, DOI 10.1111/j.1440-1843.2009.01624.x; Laron Zvi, 2004, Novartis Found Symp, V262, P56; Leger C, 2010, AM J PHYSIOL-LUNG C, V298, pL492, DOI 10.1152/ajplung.00310.2009; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacNee W, 2014, EUR RESPIR J, V44, P1332, DOI 10.1183/09031936.00134014; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Morikawa M, 2013, ONCOGENE, V32, P1609, DOI 10.1038/onc.2012.191; Mukhopadhyay S, 2016, MOL CANCER THER, V15, P347, DOI 10.1158/1535-7163.MCT-15-0720; Mulvihill MJ, 2009, FUTURE MED CHEM, V1, P1153, DOI 10.4155/FMC.09.89; NATIONS U, 2019, WORLD POP PROSP 2019; O'Dwyer DN, 2017, SCI REP-UK, V7, DOI 10.1038/srep46560; Oberbauer A M, 2013, Front Endocrinol (Lausanne), V4, P39, DOI 10.3389/fendo.2013.00039; Pala L, 2001, J ENDOCRINOL INVEST, V24, P856, DOI 10.1007/BF03343942; Pilewski JM, 2005, AM J PATHOL, V166, P399, DOI 10.1016/S0002-9440(10)62263-8; Pineiro-Hermida S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04561-4; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Puche JE, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-224; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Rahimi RA, 2009, CANCER RES, V69, P84, DOI 10.1158/0008-5472.CAN-08-2146; REISER KM, 1986, EXP LUNG RES, V10, P331, DOI 10.3109/01902148609058286; Ryu JH, 2014, MAYO CLIN PROC, V89, P1130, DOI 10.1016/j.mayocp.2014.03.016; Selman M, 2008, PLOS MED, V5, P373, DOI 10.1371/journal.pmed.0050062; Sime PJ, 2001, CLIN IMMUNOL, V99, P308, DOI 10.1006/clim.2001.5008; Steele MP, 2013, ANNU REV MED, V64, P265, DOI 10.1146/annurev-med-042711-142004; STILES AD, 1989, AM J RESP CELL MOL, V1, P21, DOI 10.1165/ajrcmb/1.1.21; STILES AD, 1990, AM J RESP CELL MOL, V3, P93, DOI 10.1165/ajrcmb/3.2.93; Tao Y, 2007, NAT CLIN PRACT ONCOL, V4, P591, DOI 10.1038/ncponc0934; TORRY DJ, 1994, J CLIN INVEST, V93, P1525, DOI 10.1172/JCI117131; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; UN, 2013, ESAPWP228 UN; Valentinis B, 1999, ONCOGENE, V18, P1827, DOI 10.1038/sj.onc.1202471; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vassilakos G, 2014, HORM-INT J ENDOCRINO, V13, P182, DOI 10.1007/BF03401333; Walton KL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00461; Wang Z, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6057589; Warnken M, 2010, N-S ARCH PHARMACOL, V382, P511, DOI 10.1007/s00210-010-0561-2; Wu YL, 1996, J CELL PHYSIOL, V168, P499, DOI 10.1002/(SICI)1097-4652(199609)168:3<499::AID-JCP2>3.0.CO;2-K; Zank DC, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00010; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	94	18	20	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5363	5388		10.1096/fj.201901719RR	http://dx.doi.org/10.1096/fj.201901719RR		FEB 2020	26	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32067272	Green Accepted			2022-12-26	WOS:000515249700001
J	Chen, L; Xiong, Y; Yan, CC; Zhou, W; Endo, Y; Xue, H; Hu, YQ; Hu, LC; Leng, XZ; Liu, J; Lin, Z; Mi, BB; Liu, GH				Chen, Lang; Xiong, Yuan; Yan, Chenchen; Zhou, Wu; Endo, Yori; Xue, Hang; Hu, Yiqiang; Hu, Liangcong; Leng, Xingzhu; Liu, Jing; Lin, Ze; Mi, Bobin; Liu, Guohui			LncRNA KCNQ1OT1 accelerates fracture healing via modulating miR-701-3p/FGFR3 axis	FASEB JOURNAL			English	Article						apoptosis; FGFR3; lncRNA; migration; miRNA; osteoblast proliferation	ENDOCHONDRAL OSSIFICATION; FGFR3; RNA; MOUSE	Emerging evidence highlights the role of the long noncoding RNA (lncRNA) KCNQ1OT1 in fracture healing. Osteoblast proliferation, migration, and survival are pivotal during this process. In this study, we aimed to improve our understanding of the regulatory role of lncRNA KCNQ1OT1 during osteoblast proliferation, migration, and survival. We searched the gene expression omnibus databases and LncBase Experimental V.2 to identify key microRNAs (miRNAs) targets of KCNQ1OT1. MiR-701-3p was selected as a differentially expressed miRNA and RNA immunoprecipitation assays were performed to verify its interaction with KCNQ1OT1. Fibroblast growth factor receptor 3 (FGFR3) was also identified as a target of miR-701-3p. We further identified KCNQ1OT1 as a competing endogenous RNA of miR-701-3p that could influence osteoblast proliferation, migration, and apoptosis in vitro and in vivo. Taken together, our results indicate that the KCNQ1OT1/miR-701-3p/FGFR3 axis is an important regulator of osteoblast proliferation, migration, and apoptosis, and provide a new therapeutic avenue for fracture healing.	[Chen, Lang; Xiong, Yuan; Yan, Chenchen; Zhou, Wu; Xue, Hang; Hu, Yiqiang; Hu, Liangcong; Liu, Jing; Lin, Ze; Mi, Bobin; Liu, Guohui] Huazhong Univ Sci & Technol, Union Hosp, Dept Orthoped, Tongji Med Coll, Wuhan, Peoples R China; [Endo, Yori] Harvard Med Sch, Brigham & Womens Hosp, Div Plast Surg, Boston, MA 02115 USA; [Leng, Xingzhu] Univ Utrecht, Dept Biomed Sci, UMC Utrecht, Utrecht, Netherlands	Huazhong University of Science & Technology; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Utrecht University	Mi, BB; Liu, GH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthopaed, 1277 Jiefang Ave, Wuhan 430022, Peoples R China.	mibobin@hust.edu.cn; liuguohui@hust.edu.cn	Endo, Yori/AAY-8962-2020; Xiong, Yuan/AAQ-3642-2021	Endo, Yori/0000-0002-9282-8811; Xiong, Yuan/0000-0003-1090-9288	National Natural Science Foundation of China [81772345, 81606934]; Health and Family Planning Commission of Hubei Province [WJ2019Z009]; Department of Science and Technology, Hubei Provincial People's Government [2016CFB424]; National Health and Family Planning Commission of the People's Republic of China [ZX-01-C2016024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health and Family Planning Commission of Hubei Province; Department of Science and Technology, Hubei Provincial People's Government(Department of Science & Technology (DOST), Philippines); National Health and Family Planning Commission of the People's Republic of China	National Natural Science Foundation of China, Grant/Award Number: 81772345 and 81606934; Health and Family Planning Commission of Hubei Province, Grant/Award Number: WJ2019Z009; Department of Science and Technology, Hubei Provincial People's Government, Grant/Award Number: 2016CFB424; National Health and Family Planning Commission of the People's Republic of China, Grant/Award Number: ZX-01-C2016024	Chen GH, 2019, PRION, V13, P106, DOI 10.1080/19336896.2019.1607464; Dong HF, 2013, CHEM REV, V113, P6207, DOI 10.1021/cr300362f; Dong ZW, 2019, J CELL PHYSIOL, V234, P11304, DOI 10.1002/jcp.27788; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Foldynova-Trantirkova S, 2012, HUM MUTAT, V33, P29, DOI 10.1002/humu.21636; Gao XR, 2018, CELL BIOSCI, V8, DOI 10.1186/s13578-018-0216-4; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Giganti MG, 2014, FRONT BIOSCI-LANDMRK, V19, P1162, DOI 10.2741/4273; Huang YH, 2015, 2015 12TH WEB INFORMATION SYSTEM AND APPLICATION CONFERENCE (WISA), P3, DOI [10.1109/WISA.2015.16, 10.1109/PPC.2015.7296864]; Huch K, 2003, HISTOCHEM CELL BIOL, V119, P281, DOI 10.1007/s00418-003-0519-2; Jing PY, 2018, CANCER LETT, V427, P38, DOI 10.1016/j.canlet.2018.04.019; Liang TT, 2018, FASEB J, V32, P377, DOI 10.1096/fj.201700560RR; Lin P, 2018, CELL PHYSIOL BIOCHEM, V48, P1953, DOI 10.1159/000492519; Liu XY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0677-8; Mao WP, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1136-9; Niyibizi C, 2000, EXPERT OPIN INV DRUG, V9, P1573, DOI 10.1517/13543784.9.7.1573; Osawa Y, 2017, BONE, V105, P42, DOI 10.1016/j.bone.2017.05.016; Rashid F, 2016, GENOM PROTEOM BIOINF, V14, P73, DOI 10.1016/j.gpb.2016.03.005; Schmitz SU, 2016, CELL MOL LIFE SCI, V73, P2491, DOI 10.1007/s00018-016-2174-5; Shao J, 2019, J CELL PHYSIOL, V234, P17269, DOI 10.1002/jcp.28344; Shi ZJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168691; Wang CG, 2019, EXP MOL PATHOL, V107, P77, DOI 10.1016/j.yexmp.2019.01.012; Wang XN, 2017, EUR REV MED PHARMACO, V21, P4771; Wang XF, 2015, AUTOPHAGY, V11, P1998, DOI 10.1080/15548627.2015.1091551; Wei JW, 2012, J CELL BIOL, V197, P509, DOI 10.1083/jcb.201201057; Weksberg R, 2001, HUM MOL GENET, V10, P2989, DOI 10.1093/hmg/10.26.2989; Wu Q., 2019, J CELL PHYSL; Xian D, 2019, J CELL MOL MED, V23, P3808, DOI 10.1111/jcmm.14071; Xiong Y, 2019, MOL THER-NUCL ACIDS, V17, P223, DOI 10.1016/j.omtn.2019.06.001; Xu HJ, 2019, FASEB J, V33, P8055, DOI 10.1096/fj.201801618RRR; Yang CL, 2019, FASEB J, V33, P10490, DOI 10.1096/fj.201802543RR; Yu SJ, 2019, AGING CELL, V18, DOI 10.1111/acel.12940	32	15	17	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5208	5222		10.1096/fj.201901864RR	http://dx.doi.org/10.1096/fj.201901864RR		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32060985				2022-12-26	WOS:000515245500001
J	Moon, J; Choi, SH; Yoon, CH; Kim, MK				Moon, Jayoon; Choi, Se Hyun; Yoon, Chang Ho; Kim, Mee Kum			Gut dysbiosis is prevailing in Sjogren's syndrome and is related to dry eye severity	PLOS ONE			English	Article							TH17 CELLS; MICROBIOTA; MANAGEMENT; CORNEAL	Objective To investigate gut dysbiosis in patients with Sjogren's syndrome (SS) or dry eye syndrome (DES) compared to normal subjects and to evaluate the association of dysbiosis with dry eye severity. Methods 10 subjects with SS, 14 subjects with DES and 12 controls were enrolled. Corneal staining, tear break up time (TBUT) and tear secretion were evaluated. Bacterial genomic 16s rRNA from stool samples were analyzed. Main outcomes were microbiome compositional differences among groups and their correlation to dry eye signs. Results Gut microbiome analysis revealed significant compositional differences in SS compared to controls and DES. In phylum, Bacteriodetes increased, while Firmicutes/Bacteroidetes ratio and Actinobacteria decreased (p<0.05). In genus, Bifidobacterium was reduced (vs controls; p = 0.025, vs DES; p = 0.026). Beta diversity of SS also showed significant distances from controls and DES (p = 0.007 and 0.019, respectively). SS showed decreased genus of Blautia (p = 0.041), Dorea (p = 0.025) and Agathobacter (p = 0.035) compared to controls and increased genus of Prevotella (p = 0.026), Odoribacter (p = 0.028) and Alistipes (p = 0.46) compared to DES. On the other hand, DES only had increased genus Veillonella (p = 0.045) and reduced Subdoligranulum (p = 0.035) compared to controls. Bacteroidetes, Actinobacteria and Bifidobacterium were significantly related with dry eye signs (p<0.05). After adjustment of age, gender and group classification, multivariate linear regression analysis revealed tear secretion was strongly affected by Prevotella (p = 0.025). With additional adjustment of hydroxychloroquine use, TBUT was markedly affected by Prevotella (p = 0.037) and Actinobacteria (p = 0.001). Conclusions Sjogren's syndrome showed significant gut dysbiosis compared to controls and environmental dry eye syndrome, while dry eye patients showed compositional changes of gut microbiome somewhere in between Sjogren's syndrome and controls. Dysbiosis of the gut microbiota was partly correlated to dry eye severity.	[Moon, Jayoon; Choi, Se Hyun; Yoon, Chang Ho; Kim, Mee Kum] Seoul Natl Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea; [Moon, Jayoon; Yoon, Chang Ho; Kim, Mee Kum] Seoul Natl Univ Hosp, Seoul Artificial Eye Ctr, Lab Ocular Regenerat Med & Immunol, Biomed Res Inst, Seoul, South Korea; [Choi, Se Hyun] Hallym Univ, Dept Ophthalmol, Sacred Heart Hosp, Anyang Si, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Hallym University	Kim, MK (corresponding author), Seoul Natl Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea.; Kim, MK (corresponding author), Seoul Natl Univ Hosp, Seoul Artificial Eye Ctr, Lab Ocular Regenerat Med & Immunol, Biomed Res Inst, Seoul, South Korea.	kmk9@snu.ac.kr	Choi, Se Hyun/AAE-4705-2022	Choi, Se Hyun/0000-0002-9916-0332; Kim, Mee Kum/0000-0001-7850-6894	Ministry of Science, ICT & Future Planning [2017R1A2B2007209]	Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	Mee Kum Kim, this study was supported by the Ministry of Science, ICT & Future Planning (grant number: 2017R1A2B2007209, URL: https://www.msit.go.kr/web/main/main.do).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Akpek EK, 2015, OPHTHALMOLOGY, V122, P56, DOI 10.1016/j.ophtha.2014.07.026; Both T, 2017, INT J MED SCI, V14, P191, DOI 10.7150/ijms.17718; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Cavuoto KM, 2019, OCUL SURF, V17, P384, DOI 10.1016/j.jtos.2019.05.006; Chen YH, 2017, J IMMUNOL, V199, P1163, DOI 10.4049/jimmunol.1602144; Consolandi C, 2015, AUTOIMMUN REV, V14, P269, DOI 10.1016/j.autrev.2014.11.009; Gomez ALC, 2012, REV PENSAM AM, V5, P7; Craig JP, 2017, OCUL SURF, V15, P802, DOI 10.1016/j.jtos.2017.08.003; de Paiva CS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23561; Depommier C, 2019, NAT MED, V25, P1096, DOI 10.1038/s41591-019-0495-2; Foulks GN, 2015, OCUL SURF, V13, P118, DOI 10.1016/j.jtos.2014.12.001; Gentile CL, 2018, SCIENCE, V362, P776, DOI 10.1126/science.aau5812; Horai R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00232; Hyon Joon Young, 2014, Korean J Ophthalmol, V28, P197, DOI 10.3341/kjo.2014.28.3.197; Jeong Y, 2019, J CLIN MED, V8, DOI 10.3390/jcm8050693; Johnson EL, 2017, J MOL MED, V95, P1, DOI 10.1007/s00109-016-1492-2; JONES LT, 1966, AM J OPHTHALMOL, V62, P47, DOI 10.1016/0002-9394(66)91676-X; Jones L, 2017, OCUL SURF, V15, P575, DOI 10.1016/j.jtos.2017.05.006; Kim J, 2017, NUTRIENTS, V9; Kuklinski E, 2017, CLIN IMMUNOL, V182, P55, DOI 10.1016/j.clim.2017.04.017; Li Z, 2018, ANIM MODEL EXP MED, V1, P180, DOI 10.1002/ame2.12033; Litvak Y, 2018, SCIENCE, V362, P1017, DOI 10.1126/science.aat9076; Liu YH, 2019, AM J CLIN NUTR, V110, P701, DOI 10.1093/ajcn/nqz139; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Luo XM, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02288-17; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Mandl T, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1446-2; Mao KR, 2018, NATURE, V554, P255, DOI 10.1038/nature25437; NORN MS, 1969, ACTA OPHTHALMOL, V47, P865; Opazo MC, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00432; Pascal V, 2017, GUT, V66, P813, DOI 10.1136/gutjnl-2016-313235; Pflugfelder SC, 2013, EXP EYE RES, V117, P118, DOI 10.1016/j.exer.2013.08.013; Relman DA, 2011, NEW ENGL J MED, V365, P347, DOI 10.1056/NEJMra1003071; Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Segre JA, 2015, SCIENCE, V349, P1058, DOI 10.1126/science.aad0781; Shiboski CH, 2017, ARTHRITIS RHEUMATOL, V69, P35, DOI 10.1002/art.39859; Silverman GJ, 2019, NAT REV RHEUMATOL, V15, P72, DOI 10.1038/s41584-018-0152-z; Subbarayal B, 2016, J IMMUNOL, V197, P3464, DOI 10.4049/jimmunol.1502641; Tap J, 2017, GASTROENTEROLOGY, V152, P111, DOI 10.1053/j.gastro.2016.09.049; Verstappen GM, 2018, J AUTOIMMUN, V87, P16, DOI 10.1016/j.jaut.2017.11.003; Wei YR, 2020, GUT, V69, P569, DOI 10.1136/gutjnl-2018-317836; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zarate-Blades CR, 2017, GUT MICROBES, V8, P59, DOI 10.1080/19490976.2016.1273996; Zhong DL, 2018, CLIN RHEUMATOL, V37, P25, DOI 10.1007/s10067-017-3821-4; Zmora N, 2018, CELL, V174, P1388, DOI 10.1016/j.cell.2018.08.041	47	52	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0229029	10.1371/journal.pone.0229029	http://dx.doi.org/10.1371/journal.pone.0229029			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7VI	32059038	Green Published, gold			2022-12-26	WOS:000535206600028
J	Castro, CM; Corciulo, C; Solesio, ME; Liang, FX; Pavlov, EV; Cronstein, BN				Castro, Cristina M.; Corciulo, Carmen; Solesio, Maria E.; Liang, Fengxia; Pavlov, Evgeny V.; Cronstein, Bruce N.			Adenosine A2A receptor (A2AR) stimulation enhances mitochondrial metabolism and mitigates reactive oxygen species-mediated mitochondrial injury	FASEB JOURNAL			English	Article						adenosine receptor; ATP; chondrocytes; mitochondria; osteoarthritis	PHOSPHORYLATION; DYSFUNCTION; CARTILAGE; RESPONSES; STRESS; ALPHA; A(2A); SHAPE; OPA1	In OA chondrocytes, there is diminished mitochondrial production of ATP and diminished extracellular adenosine resulting in diminished adenosine A2A receptor (A2AR) stimulation and altered chondrocyte homeostasis which contributes to the pathogenesis of OA. We tested the hypothesis that A2AR stimulation maintains or enhances mitochondrial function in chondrocytes. The effect of A2AR signaling on mitochondrial health and function was determined in primary murine chondrocytes, a human chondrocytic cell line (T/C-28a2), primary human chondrocytes, and a murine model of OA by transmission electron microscopy analysis, mitochondrial stress testing, confocal live imaging for mitochondrial inner membrane polarity, and immunohistochemistry. In primary murine chondrocytes from A2AR(-/-) null mice, which develop spontaneous OA by 16 weeks, there is mitochondrial swelling, dysfunction, and reduced mitochondrial content with increased reactive oxygen species (ROS) burden and diminished mitophagy, as compared to chondrocytes from WT animals. IL-1-stimulated T/C-28a2 cells treated with an A2AR agonist had reduced ROS burden with increased mitochondrial dynamic stability and function, findings which were recapitulated in primary human chondrocytes. In an obesity-induced OA mouse model, there was a marked increase in mitochondrial oxidized material which was markedly improved after intraarticular injections of liposomal A2AR agonist. These results are consistent with the hypothesis that A2AR ligation is mitoprotective in OA.	[Castro, Cristina M.] NYU, Grossman Sch Med, Skirball Inst Grad Biomol Sci, Immunol & Inflammat Training Program, New York, NY USA; [Castro, Cristina M.; Corciulo, Carmen; Cronstein, Bruce N.] NYU, Grossman Sch Med, Div Translat Med, 550 First Ave, New York, NY 10016 USA; [Solesio, Maria E.; Pavlov, Evgeny V.] NYU, Coll Dent, New York, NY USA; [Liang, Fengxia] NYU Langone Hlth, DART Microscopy Lab, New York, NY USA; [Cronstein, Bruce N.] NYU, Dept Med, Grossman Sch Med, Div Rheumatol, 550 1St Ave, New York, NY 10016 USA; [Solesio, Maria E.] Rutgers State Univ, Dept Biol, New Brunswick, NJ USA	New York University; New York University; New York University; NYU Langone Medical Center; New York University; Rutgers State University New Brunswick	Cronstein, BN (corresponding author), NYU, Grossman Sch Med, Div Translat Med, 550 First Ave, New York, NY 10016 USA.	bruce.cronstein@nyulangone.org		Liang, Fengxia/0000-0003-0037-4590; Solesio Torregrosa, Maria de la Encarnacion/0000-0002-8105-1701; CORCIULO, CARMEN/0000-0002-1865-3494; Cronstein, Bruce/0000-0002-4295-7383	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [RO1-AR054897, RO1-AR056672]; Arthritis Foundation (AF); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [T32GM007308]; NYU-HHC Clinical and Translational Science Institute [UL1-TR000038]	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Arthritis Foundation (AF); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); NYU-HHC Clinical and Translational Science Institute	HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: RO1-AR054897 and RO1-AR056672; Arthritis Foundation (AF); HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: T32GM007308; NYU-HHC Clinical and Translational Science Institute, Grant/Award Number: UL1-TR000038	Ahmad Aamir, 2009, Curr Aging Sci, V2, P174; Al-Mehdi AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002712; Ansari MY, 2018, OSTEOARTHR CARTILAGE, V26, P1087, DOI 10.1016/j.joca.2017.07.020; Anson RM, 2000, J AM AGING ASSOC, V23, P199, DOI 10.1007/s11357-000-0020-y; Bitton Ryan, 2009, Am J Manag Care, V15, pS230; Blanco FJ, 2004, MITOCHONDRION, V4, P715, DOI 10.1016/j.mito.2004.07.022; Blanco FJ, 2011, NAT REV RHEUMATOL, V7, P161, DOI 10.1038/nrrheum.2010.213; Chandel NS, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-34; Chen JF, 2001, P NATL ACAD SCI USA, V98, P1970, DOI 10.1073/pnas.98.4.1970; Cillero-Pastor B, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-235; Cillero-Pastor B, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-42; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; CORCIULO C, 2019, OSTEOARTHR CARTIL S1, V27, pS174; Corciulo C, 2017, AM COLL RHEUM ANN M, V69; Corciulo C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15019; Corciulo C, 2016, PURINERG SIGNAL, V12, P537, DOI 10.1007/s11302-016-9519-2; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Cronstein BN, 2017, NAT REV RHEUMATOL, V13, P41, DOI 10.1038/nrrheum.2016.178; D'Lima D, 2006, ARTHRITIS RHEUM-US, V54, P1814, DOI 10.1002/art.21874; Dagda RK, 2011, CELL DEATH DIFFER, V18, P1914, DOI 10.1038/cdd.2011.74; Delco ML, 2018, J ORTHOP RES, V36, P739, DOI 10.1002/jor.23651; Demontiero O, 2012, THER ADV MUSCULOSKEL, V4, P61, DOI 10.1177/1759720X11430858; Gibon E, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0300-9; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Goutas A, 2018, FREE RADICAL BIO MED, V126, P122, DOI 10.1016/j.freeradbiomed.2018.08.003; Griffin TM, 2012, ARTHRITIS RHEUM-US, V64, P443, DOI 10.1002/art.33332; Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112; Guasti L, 2012, STEM CELL TRANSL MED, V1, P384, DOI 10.5966/sctm.2012-0009; Guillery O, 2008, BIOL CELL, V100, P315, DOI 10.1042/BC20070110; Higuchi-Sanabria R, 2018, DEV CELL, V44, P139, DOI 10.1016/j.devcel.2017.12.020; Inoue K, 2001, Tanpakushitsu Kakusan Koso, V46, P829; Johnson K, 2000, ARTHRITIS RHEUM-US, V43, P1560, DOI 10.1002/1529-0131(200007)43:7<1560::AID-ANR21>3.3.CO;2-J; Khoa ND, 2006, MOL PHARMACOL, V69, P1311, DOI 10.1124/mol.105.016857; Khoa ND, 2003, J IMMUNOL, V171, P3991, DOI 10.4049/jimmunol.171.8.3991; Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026; Kurz B, 2004, ARTHRITIS RHEUM, V50, P123, DOI 10.1002/art.11438; Laforge M, 2016, CELL DEATH DIFFER, V23, P89, DOI 10.1038/cdd.2015.42; Lizana L, 2008, P NATL ACAD SCI USA, V105, P4099, DOI 10.1073/pnas.0709932105; Loeser Richard F, 2017, Trans Am Clin Climatol Assoc, V128, P44; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P1011, DOI 10.1016/j.joca.2006.03.008; Maneiro E, 2003, ARTHRITIS RHEUM, V48, P700, DOI 10.1002/art.10837; McElroy GS, 2017, EXP CELL RES, V356, P217, DOI 10.1016/j.yexcr.2017.03.034; Mediero A, 2012, AM J PATHOL, V180, P775, DOI 10.1016/j.ajpath.2011.10.017; Mendez AS, 2015, ELIFE, V4, DOI 10.7554/eLife.05434; Oh CK, 2017, CELL REP, V21, P2171, DOI 10.1016/j.celrep.2017.10.068; Quintana-Cabrera R, 2018, BIOCHEM BIOPH RES CO, V500, P94, DOI 10.1016/j.bbrc.2017.04.088; Quintana-Cabrera R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05655-x; Rampelt H, 2017, BBA-MOL CELL RES, V1864, P737, DOI 10.1016/j.bbamcr.2016.05.020; Ren ZL, 2019, ACTA PHARMACOL SIN, V40, P441, DOI 10.1038/s41401-018-0077-8; Soto-Hermida A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112735; Terkeltaub R, 2002, MITOCHONDRION, V1, P301, DOI 10.1016/S1567-7249(01)00037-X; Thomas WD, 2000, J IMMUNOL, V165, P5612, DOI 10.4049/jimmunol.165.10.5612; Wallace Douglas C, 2002, Methods Mol Biol, V197, P3, DOI 10.1385/1-59259-284-8:003	53	20	20	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5027	5045		10.1096/fj.201902459R	http://dx.doi.org/10.1096/fj.201902459R		FEB 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32052890	Green Accepted			2022-12-26	WOS:000513850200001
J	Cilleros-Mane, V; Just-Borras, L; Tomas, M; Garcia, N; Tomas, JM; Lanuza, MA				Cilleros-Mane, Victor; Just-Borras, Laia; Tomas, Marta; Garcia, Neus; Tomas, Josep Maria; Lanuza, Maria Angel			The M-2 muscarinic receptor, in association to M-1, regulates the neuromuscular PKA molecular dynamics	FASEB JOURNAL			English	Article						muscarinic receptors; neuromuscular junction; PKA; SNAP-25	PROTEIN-KINASE-C; SPONTANEOUS ACETYLCHOLINE-RELEASE; SYNAPTOSOME-ASSOCIATED PROTEIN; MODULATE TRANSMITTER RELEASE; ADENYLATE-CYCLASE ACTIVITY; LONG-TERM POTENTIATION; HIGH-AFFINITY BINDING; CATALYTIC SUBUNIT; NEUROTRANSMITTER RELEASE; GENE-EXPRESSION	Muscarinic acetylcholine receptor 1 subtype (M-1) and muscarinic acetylcholine receptor 2 subtype (M-2) presynaptic muscarinic receptor subtypes increase and decrease, respectively, neurotransmitter release at neuromuscular junctions. M-2 involves protein kinase A (PKA), although the muscarinic regulation to form and inactivate the PKA holoenzyme is unknown. Here, we show that M-2 signaling inhibits PKA by downregulating C beta subunit, upregulating RII alpha/beta and liberating RI beta and RII alpha to the cytosol. This promotes PKA holoenzyme formation and reduces the phosphorylation of the transmitter release target synaptosome-associated protein 25 and the gene regulator cAMP response element binding. Instead, M-1 signaling, which is downregulated by M-2, opposes to M-2 by recruiting R subunits to the membrane. The M-1 and M-2 reciprocal actions are performed through the anchoring protein A kinase anchor protein 150 as a common node. Interestingly, M-2 modulation on protein expression needs M-1 signaling. Altogether, these results describe the dynamics of PKA subunits upon M-2 muscarinic signaling in basal and under presynaptic nerve activity, uncover a specific involvement of the M-1 receptor and reveal the M-1/M-2 balance to activate PKA to regulate neurotransmission. This provides a molecular mechanism to the PKA holoenzyme formation and inactivation which could be general to other synapses and cellular models.	[Cilleros-Mane, Victor; Just-Borras, Laia; Tomas, Marta; Garcia, Neus; Tomas, Josep Maria; Lanuza, Maria Angel] Univ Rovira & Virgili, Dept Ciencies Med Basiques, Unitat Histol & Neurobiol UHNEUROB, C St Llorenc 21, E-43201 Reus, Spain	Universitat Rovira i Virgili	Tomas, JM; Lanuza, MA (corresponding author), Univ Rovira & Virgili, Dept Ciencies Med Basiques, Unitat Histol & Neurobiol UHNEUROB, C St Llorenc 21, E-43201 Reus, Spain.	josepmaria.tomas@urv.cat; mariaangel.lanuza@urv.cat	Lanuza, Maria A/I-3236-2017; Cilleros-Mañé, Víctor/G-5251-2018	Lanuza, Maria A/0000-0003-4795-4103; Cilleros-Mañé, Víctor/0000-0001-5690-9932; Just Borras, Laia/0000-0003-0473-3730; Tomas, Josep/0000-0002-0406-0006	Universitat Rovira i Virgili (ES) [2014PFR-URV-B2-83, 2017PFRURV-B2-85]; European Social Fund (ESF); Iniciativa de Empleo Juvenil (IEJ) [LE1511314-2014PEJ-04]; Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (ES) [SAF2015-67143-P]; Generalitat de Catalunya (ES) [2014SGR344, 2017SGR704]; Sistema Nacional de Garantia Juvenil (ES)	Universitat Rovira i Virgili (ES); European Social Fund (ESF)(European Social Fund (ESF)); Iniciativa de Empleo Juvenil (IEJ); Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (ES); Generalitat de Catalunya (ES)(Generalitat de Catalunya); Sistema Nacional de Garantia Juvenil (ES)	Universitat Rovira i Virgili (ES), Grant/Award Number: 2014PFR-URV-B2-83 and 2017PFRURV-B2-85; Sistema Nacional de Garantia Juvenil (ES), the European Social Fund (ESF) and the Iniciativa de Empleo Juvenil (IEJ), Grant/Award Number: LE1511314-2014PEJ-04; Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (ES), Grant/Award Number: SAF2015-67143-P; Generalitat de Catalunya (ES), Grant/Award Number: 2014SGR344 and 2017SGR704	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; BARNES SJ, 1993, ENDOCRINOLOGY, V133, P2756, DOI 10.1210/en.133.6.2756; Beavo J A, 1975, Adv Cyclic Nucleotide Res, V5, P241; BEEBE SJ, 1990, MOL ENDOCRINOL, V4, P465, DOI 10.1210/mend-4-3-465; Beguin P, 1996, AM J PHYSIOL-CELL PH, V270, pC131, DOI 10.1152/ajpcell.1996.270.1.C131; Besalduch N, 2010, J COMP NEUROL, V518, P211, DOI 10.1002/cne.22220; Boczan J, 2004, J BIOL CHEM, V279, P18911, DOI 10.1074/jbc.M400496200; Brandon EP, 1997, CURR OPIN NEUROBIOL, V7, P397, DOI 10.1016/S0959-4388(97)80069-4; Brazhnik E, 2004, J NEUROSCI, V24, P9313, DOI 10.1523/JNEUROSCI.1618-04.2004; Burford NT, 1996, BIOCHEM J, V315, P883, DOI 10.1042/bj3150883; CADD G, 1989, NEURON, V3, P71, DOI 10.1016/0896-6273(89)90116-5; CADD GG, 1990, J BIOL CHEM, V265, P19502; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; CHOI EJ, 1992, BIOCHEMISTRY-US, V31, P6492, DOI 10.1021/bi00143a019; Choi RCY, 2013, CHEM-BIOL INTERACT, V203, P282, DOI 10.1016/j.cbi.2012.10.025; Chou WH, 2010, J NEUROSCI, V30, P13955, DOI 10.1523/JNEUROSCI.0270-10.2010; Constantinescu A, 2002, J BIOL CHEM, V277, P18810, DOI 10.1074/jbc.M112107200; CRONIN MJ, 1986, PEPTIDES, V7, P935, DOI 10.1016/0196-9781(86)90114-2; Curia G, 2007, BRIT J PHARMACOL, V150, P792, DOI 10.1038/sj.bjp.0707144; de Jong APH, 2016, P NATL ACAD SCI USA, V113, P5095, DOI 10.1073/pnas.1522927113; Dell Ralph B, 2002, ILAR J, V43, P207; DIXON D, 1989, J NEUROSCI, V9, P4246; Enns LC, 2009, J GERONTOL A-BIOL, V64, P1221, DOI 10.1093/gerona/glp133; Nguyen E, 2013, MOL PHARMACOL, V83, P1057, DOI 10.1124/mol.112.081034; Evans GJO, 2001, J BIOL CHEM, V276, P47877, DOI 10.1074/jbc.M108186200; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Favreau P, 1999, Acta Physiol Pharmacol Ther Latinoam, V49, P257; Funderud A, 2009, CELL SIGNAL, V21, P274, DOI 10.1016/j.cellsig.2008.10.013; Furlan I, 2005, BRIT J PHARMACOL, V146, P389, DOI 10.1038/sj.bjp.0706329; Garcia N, 2005, HISTOL HISTOPATHOL, V20, P733, DOI 10.14670/HH-20.733; GARREL G, 1995, NEUROENDOCRINOLOGY, V62, P514, DOI 10.1159/000127042; GARREL G, 1993, ENDOCRINOLOGY, V133, P1010, DOI 10.1210/en.133.3.1010; Gervasi N, 2007, J NEUROSCI, V27, P2744, DOI 10.1523/JNEUROSCI.5352-06.2007; Guthrie CR, 1997, J BIOL CHEM, V272, P29560, DOI 10.1074/jbc.272.47.29560; Hao W, 2005, NEUROSCI LETT, V383, P121, DOI 10.1016/j.neulet.2005.03.062; HEGDE AN, 1993, P NATL ACAD SCI USA, V90, P7436, DOI 10.1073/pnas.90.16.7436; Hepp R, 2002, FEBS LETT, V532, P52, DOI 10.1016/S0014-5793(02)03629-3; Hirling H, 1996, P NATL ACAD SCI USA, V93, P11945, DOI 10.1073/pnas.93.21.11945; Hoover F, 2002, MOL CELL NEUROSCI, V19, P125, DOI 10.1006/mcne.2001.1053; Hurtado E, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00147; Jovanovic JN, 2001, J NEUROSCI, V21, P7944, DOI 10.1523/JNEUROSCI.21-20-07944.2001; Kaplan AP, 2017, ACS CHEM NEUROSCI, V8, P2746, DOI 10.1021/acschemneuro.7b00282; KELLAR KJ, 1985, J NEUROSCI, V5, P1577, DOI 10.1523/jneurosci.05-06-01577.1985; Keryer G, 1999, EXP CELL RES, V249, P131, DOI 10.1006/excr.1999.4447; KLEIN M, 1994, NEURON, V13, P159, DOI 10.1016/0896-6273(94)90466-9; Krasel C, 2001, J BIOL CHEM, V276, P1911, DOI 10.1074/jbc.M008773200; Lanuza MA, 2006, J NEUROSCI RES, V83, P1407, DOI 10.1002/jnr.20848; Lanuza MA, 2007, J NEUROSCI RES, V85, P748, DOI 10.1002/jnr.21192; Lanuza MA, 2010, EXP NEUROL, V225, P183, DOI 10.1016/j.expneurol.2010.06.014; Leenders AGM, 2005, PHARMACOL THERAPEUT, V105, P69, DOI 10.1016/j.pharmthera.2004.10.012; Li L, 2017, CARDIOVASC RES, V113, P147, DOI 10.1093/cvr/cvw221; Li MX, 2002, J NEUROBIOL, V52, P241, DOI 10.1002/neu.10089; Li MX, 2001, NAT NEUROSCI, V4, P871, DOI 10.1038/nn0901-871; Liu TP, 2002, AUTON NEUROSCI-BASIC, V96, P113, DOI 10.1016/S1566-0702(01)00396-4; LOHMANN SM, 1984, P NATL ACAD SCI-BIOL, V81, P6723, DOI 10.1073/pnas.81.21.6723; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Lonart G, 1998, J NEUROSCI, V18, P634; Losavio A, 1997, AM J PHYSIOL-CELL PH, V273, pC1835, DOI 10.1152/ajpcell.1997.273.6.C1835; Losavio A, 2000, LIFE SCI, V66, P2543, DOI 10.1016/S0024-3205(00)00588-9; Mantilla CB, 2014, J APPL PHYSIOL, V117, P910, DOI 10.1152/japplphysiol.01386.2013; Matveeva EA, 2001, J BIOL CHEM, V276, P12174, DOI 10.1074/jbc.M007394200; Minic J, 2002, EUR J NEUROSCI, V15, P439, DOI 10.1046/j.0953-816x.2001.01875.x; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Nadal L, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00024; Nadal L, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0248-9; Nagy G, 2004, NEURON, V41, P417, DOI 10.1016/S0896-6273(04)00038-8; Nagy G, 2002, J NEUROSCI, V22, P9278; Navedo MF, 2008, CIRC RES, V102, pE1, DOI 10.1161/CIRCRESAHA.107.167809; Nguyen PV, 2003, PROG NEUROBIOL, V71, P401, DOI 10.1016/j.pneurobio.2003.12.003; Nomura S, 2002, BIOCHEM BIOPH RES CO, V295, P236, DOI 10.1016/S0006-291X(02)00664-2; Obis T, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0171-5; Obis T, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0098-x; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Perkins GA, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-17; Perrino C, 2017, CARDIOVASC RES, V113, P115, DOI 10.1093/cvr/cvw254; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Pontier SM, 2006, EMBO J, V25, P2698, DOI 10.1038/sj.emboj.7601157; Poppinga WJ, 2015, AM J PHYSIOL-LUNG C, V308, pL766, DOI 10.1152/ajplung.00301.2014; Prinz A, 2006, CELL SIGNAL, V18, P1616, DOI 10.1016/j.cellsig.2006.01.013; Reinitz CA, 1997, ARCH BIOCHEM BIOPHYS, V348, P391, DOI 10.1006/abbi.1997.0401; Reinton N, 1998, GENOMICS, V49, P290, DOI 10.1006/geno.1998.5240; Reyes R, 1996, ARCH BIOCHEM BIOPHYS, V331, P41, DOI 10.1006/abbi.1996.0280; Risinger C, 1999, J NEUROCHEM, V72, P614, DOI 10.1046/j.1471-4159.1999.0720614.x; Roder IV, 2010, P NATL ACAD SCI USA, V107, P2031, DOI 10.1073/pnas.0914087107; Rudolf R, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00290; Santafe MM, 2007, NEUROSCIENCE, V148, P432, DOI 10.1016/j.neuroscience.2007.06.017; Santafe MM, 2009, J NEUROSCI RES, V87, P683, DOI 10.1002/jnr.21885; Santafe MM, 2006, EUR J NEUROSCI, V23, P2048, DOI 10.1111/j.1460-9568.2006.04753.x; Santafe MM, 2004, NEUROSCIENCE, V123, P61, DOI 10.1016/j.neuroscience.2003.09.012; Santafe MM, 2003, EUR J NEUROSCI, V17, P119, DOI 10.1046/j.1460-9568.2003.02428.x; Santafe MM, 2001, NEUROSCIENCE, V102, P697, DOI 10.1016/S0306-4522(00)00507-8; SCHERER NM, 1990, BIOCHEMISTRY-US, V29, P8475, DOI 10.1021/bi00488a039; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Simo A, 2019, MOL NEUROBIOL, V56, P5346, DOI 10.1007/s12035-018-1462-5; Simo A, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00207; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; Slutsky I, 1999, J PHYSIOL-LONDON, V514, P769, DOI 10.1111/j.1469-7793.1999.769ad.x; Slutsky I, 2001, J PHYSIOL-LONDON, V536, P717, DOI 10.1111/j.1469-7793.2001.00717.x; Snyder DA, 2006, CELL BIOCHEM BIOPHYS, V45, P111, DOI 10.1385/CBB:45:1:111; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SPAULDING SW, 1993, ENDOCR REV, V14, P632, DOI 10.1210/er.14.5.632; SPENCER DG, 1986, BRAIN RES, V380, P59, DOI 10.1016/0006-8993(86)91429-0; Stakkestad O, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-7; Stefan E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1605; SUMMERS ST, 1986, BIOCHEM BIOPH RES CO, V135, P276, DOI 10.1016/0006-291X(86)90973-3; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Tan ZY, 2014, FEBS LETT, V588, P3964, DOI 10.1016/j.febslet.2014.09.011; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Tillo SE, 2017, CELL REP, V19, P617, DOI 10.1016/j.celrep.2017.03.070; Tomas J, 2018, PATHWAYS, V9, P1, DOI DOI 10.3389/fphar.2018.00397; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Vigil D, 2004, BIOCHEMISTRY-US, V43, P5629, DOI 10.1021/bi0499157; Vogler O, 1999, J BIOL CHEM, V274, P12333, DOI 10.1074/jbc.274.18.12333; WALSH DA, 1968, J BIOL CHEM, V243, P3763; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wright MC, 2009, J NEUROSCI, V29, P14942, DOI 10.1523/JNEUROSCI.2276-09.2009; Xu ZR, 2017, J CACHEXIA SARCOPENI, V8, P808, DOI 10.1002/jcsm.12204; YAN C, 1994, J NEUROSCI, V14, P973; Zeng C, 2014, AM J PHYSIOL-ENDOC M, V307, pE384, DOI 10.1152/ajpendo.00175.2014	125	6	6	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4934	4955		10.1096/fj.201902113R	http://dx.doi.org/10.1096/fj.201902113R		FEB 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32052889				2022-12-26	WOS:000513849800001
J	Forrest, ME; Pinkard, O; Martin, S; Sweet, TJ; Hanson, G; Coller, J				Forrest, Megan E.; Pinkard, Otis; Martin, Sophie; Sweet, Thomas J.; Hanson, Gavin; Coller, Jeff			Codon and amino acid content are associated with mRNA stability in mammalian cells	PLOS ONE			English	Article							CAP-BINDING PROTEIN; GENE-EXPRESSION; CANCER METABOLISM; DECAPPING ENZYME; RETT-SYNDROME; BOX PROTEIN; TRANSLATION; DEADENYLATION; OPTIMALITY; EFFICIENCY	Messenger RNA (mRNA) degradation plays a critical role in regulating transcript levels in the cell and is a major control point for modulating gene expression. In yeast and other model organisms, codon identity is a powerful determinant of transcript stability, contributing broadly to impact half-lives. General principles governing mRNA stability are poorly understood in mammalian systems. Importantly, however, the degradation machinery is highly conserved, thus it seems logical that mammalian transcript half-lives would also be strongly influenced by coding determinants. Herein we characterize the contribution of coding sequence towards mRNA decay in human and Chinese Hamster Ovary cells. In agreement with previous studies, we observed that synonymous codon usage impacts mRNA stability in mammalian cells. Surprisingly, however, we also observe that the amino acid content of a gene is an additional determinant correlating with transcript stability. The impact of codon and amino acid identity on mRNA decay appears to be associated with underlying tRNA and intracellular amino acid concentrations. Accordingly, genes of similar physiological function appear to coordinate their mRNA stabilities in part through codon and amino acid content. Together, these results raise the possibility that intracellular tRNA and amino acid levels interplay to mediate coupling between translational elongation and mRNA degradation rate in mammals.	[Forrest, Megan E.; Pinkard, Otis; Martin, Sophie; Sweet, Thomas J.; Hanson, Gavin; Coller, Jeff] Case Western Reserve Univ, Ctr RNA Sci & Therapeut, Cleveland, OH 44106 USA; [Forrest, Megan E.; Pinkard, Otis; Coller, Jeff] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Coller, J (corresponding author), Case Western Reserve Univ, Ctr RNA Sci & Therapeut, Cleveland, OH 44106 USA.; Coller, J (corresponding author), Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.	jmc71@case.edu		Pinkard, Otis/0000-0003-2661-4820; Forrest, Megan/0000-0003-1126-2738; Coller, Jeff/0000-0001-5662-8110; Martin, Sophie/0000-0002-4458-7582	National Institutes of Health [GM125086, GM118018, T32GM136570]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grants (GM125086 and GM118018 to JC) and (T32GM136570 to JC and MEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agris PF, 2004, NUCLEIC ACIDS RES, V32, P223, DOI 10.1093/nar/gkh185; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Arango D, 2018, CELL, V175, P1872, DOI 10.1016/j.cell.2018.10.030; Artieri CG, 2014, GENOME RES, V24, P2011, DOI 10.1101/gr.175893.114; Bazzini AA, 2016, EMBO J, V35, P2087, DOI 10.15252/embj.201694699; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030; Burow DA, 2018, CELL REP, V24, P1704, DOI 10.1016/j.celrep.2018.07.039; CAPONIGRO G, 1995, GENE DEV, V9, P2421, DOI 10.1101/gad.9.19.2421; Charneski CA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001508; Chen CYA, 2017, TRENDS BIOCHEM SCI, V42, P16, DOI 10.1016/j.tibs.2016.08.014; Chen SY, 2017, MOL BIOL EVOL, V34, P2944, DOI 10.1093/molbev/msx229; Chen Y, 2014, MOL CELL, V54, P737, DOI 10.1016/j.molcel.2014.03.034; Colombo SL, 2011, P NATL ACAD SCI USA, V108, P21069, DOI 10.1073/pnas.1117500108; Dana A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002755; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Endres L, 2015, RNA BIOL, V12, P603, DOI 10.1080/15476286.2015.1031947; Espinar L, 2018, GENOME RES, V28, P509, DOI 10.1101/gr.230458.117; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Fafournoux P, 2000, BIOCHEM J, V351, P1, DOI 10.1042/0264-6021:3510001; Ferec C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009480; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gingold H, 2014, CELL, V158, P1281, DOI 10.1016/j.cell.2014.08.011; Goldschmidt-Reisin S, 1998, J BIOL CHEM, V273, P34828, DOI 10.1074/jbc.273.52.34828; Goodarzi H, 2016, CELL, V165, P1416, DOI 10.1016/j.cell.2016.05.046; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gossmann TI, 2012, GENOME BIOL EVOL, V4, P658, DOI 10.1093/gbe/evs027; Han P, GENOME WIDE SURVEY R; Hanson G, 2018, RNA, V24, P1377, DOI 10.1261/rna.066787.118; Hanson G, 2018, NAT REV MOL CELL BIO, V19, P20, DOI 10.1038/nrm.2017.91; Harigaya Y, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3237-6; Hia F, 2019, EMBO REP, P1; Ibrahim F, 2018, NAT STRUCT MOL BIOL, V25, P302, DOI 10.1038/s41594-018-0042-8; Imamachi N, 2014, METHODS, V67, P55, DOI 10.1016/j.ymeth.2013.07.014; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Komi D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203708; Kumar AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166854; Kuzuoglu-Ozturk D, 2016, EMBO J, V35, P1186, DOI 10.15252/embj.201592901; Labella AL, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008304; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Leung-Pineda V, 2004, BIOCHEM J, V379, P79, DOI 10.1042/BJ20031383; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Liyanage VRB, 2014, NEUROMOL MED, V16, P231, DOI 10.1007/s12017-014-8295-9; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Lu H, 2016, NEURON, V91, P739, DOI 10.1016/j.neuron.2016.07.018; Lu WQ, 2010, CANCER CELL, V18, P199, DOI 10.1016/j.ccr.2010.08.017; Mattijssen S, 2017, ELIFE, V6, DOI 10.7554/eLife.28889; Mayr C, 2017, ANNU REV GENET, V51, P171, DOI 10.1146/annurev-genet-120116-024704; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Mishima Y, 2016, MOL CELL, V61, P874, DOI 10.1016/j.molcel.2016.02.027; Mugridge JS, 2018, NAT STRUCT MOL BIOL, V25, P1077, DOI 10.1038/s41594-018-0164-z; Muhlrad D, 1994, GENES DEV; Narula A, 2019, RNA; Nascimento JD, 2018, ELIFE, V7, DOI 10.7554/eLife.32467; Nishihara T, 2013, NUCLEIC ACIDS RES, V41, P8692, DOI 10.1093/nar/gkt619; O'Brien TW, 1999, J BIOL CHEM, V274, P36043, DOI 10.1074/jbc.274.51.36043; Ontiveros RJ, 2019, BIOCHEM J, V476, P1227, DOI 10.1042/BCJ20180445; Pages H., 2018, BIOSTRINGS EFFICIENT; Pan T, 2018, CELL RES, V28, P395, DOI 10.1038/s41422-018-0013-y; Pavon-Eternod M, 2009, NUCLEIC ACIDS RES, V37, P7268, DOI 10.1093/nar/gkp787; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Radhakrishnan A, 2016, CELL, V167, P122, DOI 10.1016/j.cell.2016.08.053; Ramocki MB, 2010, AM J MED GENET A, V152A, P1079, DOI 10.1002/ajmg.a.33184; Rezgui VAN, 2013, P NATL ACAD SCI USA, V110, P12289, DOI 10.1073/pnas.1300781110; Richter JD, 2015, CELL, V163, P292, DOI 10.1016/j.cell.2015.09.041; Rio DC, 2010, COLD SPRING HARB PRO, V2010, P1, DOI DOI 10.1101/PDB.PROT5439; Rissland OS, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1330-z; RISSLAND OS, 2017, WILEY INTERDISCIP RE, V8, P1; Rouya C, 2014, RNA, V20, P1398, DOI 10.1261/rna.045302.114; Sabi R, 2014, DNA RES, V21, P511, DOI 10.1093/dnares/dsu017; Schaffer AE, 2019, ANNU REV GENOM HUM G, V20, P359, DOI 10.1146/annurev-genom-083118-015334; Schaffer AE, 2014, CELL, V157, P651, DOI 10.1016/j.cell.2014.03.049; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwartz DC, 2000, MOL CELL BIOL, V20, P7933, DOI 10.1128/MCB.20.21.7933-7942.2000; Shigematsu M, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx005; Spies N, 2013, GENOME RES, V23, P2078, DOI 10.1101/gr.156919.113; Tani H, 2012, RNA BIOL, V9, P1233, DOI 10.4161/rna.22036; Team,R.C, 2018, R LANG ENV STAT COMP; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; Wang XC, 2019, ELIFE, V8, DOI 10.7554/eLife.42265; Wang ZR, 2001, CELL, V107, P751, DOI 10.1016/S0092-8674(01)00592-X; Webster MW, 2018, MOL CELL, V70, P1089, DOI 10.1016/j.molcel.2018.05.033; Wilusz CJ, 2001, RNA, V7, P1416; Wolf J, 2014, BIOCHEM SOC T, V42, P184, DOI 10.1042/BST20130211; Wu CCC, 2019, MOL CELL, V73, P959, DOI 10.1016/j.molcel.2018.12.009; Xu NH, 1997, MOL CELL BIOL, V17, P4611, DOI 10.1128/MCB.17.8.4611; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Yan XW, 2016, CELL, V165, P976, DOI 10.1016/j.cell.2016.04.034; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Zhang Z, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0239-8; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zheng GQ, 2015, NAT METHODS, V12, P835, DOI [10.1038/NMETH.3478, 10.1038/nmeth.3478]	100	25	25	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228730	10.1371/journal.pone.0228730	http://dx.doi.org/10.1371/journal.pone.0228730			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053646	Green Submitted, gold, Green Published			2022-12-26	WOS:000535198700050
J	de Magalhaes, MC; Sanchez-Arcila, JC; Lyra, ACD; Long, LFB; de Souza, IV; Ferry, FRD; de Almeida, AJ; Alves-Leon, SV				de Magalhaes, Marilza Campos; Sanchez-Arcila, Juan Camilo; de Brito Lyra, Ana Carolina; Boufleur Long, Luiz Felipe; de Souza, Isabelle Vasconcellos; de Almeida Ferry, Fernando Raphael; de Almeida, Adilson Jose; Alves-Leon, Soniza Vieira			Hemostasis in elderly patients with human immunodeficiency virus (HIV) infection-Cross-sectional study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; D-DIMER; CEREBROVASCULAR EVENTS; COAGULATION PARAMETERS; CARDIOVASCULAR RISK; POSITIVE ADULTS; ISCHEMIC-STROKE; INFLAMMATION; AGE; BIOMARKERS	Introduction: Aging and chronic HIV infection are clinical conditions that share the states of inflammation and hypercoagulability. The life expectancy of the world population has increased in the last decades, bringing as complications the occurrence of diseases that undergoing metabolic, bone, cardiological, vascular and neurological alterations. HIV-infected patients experience these changes early and are living longer due to the success of antiretroviral therapy. The objectives of this study was to evaluate some changes in the plasma hemostatic profile of 115 HIV-reactive elderly individuals over 60 years old in the chronic phase of infection, and compare with 88 healthy uninfected elderly individuals. Plasma determinations of D-dimers, Fibrinogen, von Willebrand Factor, Antithrombin, Prothrombin Time, Activated Partial Thromboplastin Time, and platelet count were performed. In the HIV-reactive group, these variables were analyzed according to viral load, protease inhibitor use and CD4(+) T lymphocyte values. After adjusted values for age and sex, the results showed higher levels of Antithrombin (103%; 88%, p = 0.0001) and Prothrombin Time activities (92.4%; 88.2%, p = 0.019) in the HIV group compared to the control group. We observed higher values of Fibrinogen in protease inhibitor users in both the male (p = 0.043) and female (p = 0.004) groups, and in the female HIV group with detected viral load (p = 0.015). The male HIV group with a CD4(+) count>400 cells / mm(3) presented higher von Willebrand Factor values (p = 0.036). D-Dimers had higher values in the older age groups (p = 0.003; p = 0.042, respectively). Conclusion: Our results suggest that the elderly with chronic HIV infection with few comorbidities had a better hemostatic profile than negative control group, reflecting the success of treatment. Protease inhibitor use and age punctually altered this profile.	[de Magalhaes, Marilza Campos; de Brito Lyra, Ana Carolina; Boufleur Long, Luiz Felipe; de Souza, Isabelle Vasconcellos; de Almeida Ferry, Fernando Raphael; de Almeida, Adilson Jose; Alves-Leon, Soniza Vieira] Fed Univ Rio de Janeiro State UNIRIO, Gaffree & Guinle Univ Hosp, Postgrad Program Neurosci Neurol, Rio De Janeiro, RJ, Brazil; [Sanchez-Arcila, Juan Camilo; de Almeida, Adilson Jose] Oswaldo Cruz Inst FIOCRUZ, Viral Immunol Lab, Rio De Janeiro, RJ, Brazil	Universidade Federal do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz	Alves-Leon, SV (corresponding author), Fed Univ Rio de Janeiro State UNIRIO, Gaffree & Guinle Univ Hosp, Postgrad Program Neurosci Neurol, Rio De Janeiro, RJ, Brazil.	sonizavieiraalvesleon@gmail.com	Vasconcellos, Isabelle/AFV-3411-2022	Vasconcellos, Isabelle/0000-0002-2984-7526; Campos de Magalhaes, Marilza/0000-0003-0438-258X; Sanchez-Arcila, Juan Camilo/0000-0002-6879-4439				ABBATE R, 1993, INT J CLIN LAB RES, V23, P1, DOI 10.1007/BF02592271; Amin H, 2012, BLOOD COAGUL FIBRIN, V23, P745, DOI 10.1097/MBC.0b013e328358e913; Ances BM, 2010, J INFECT DIS, V201, P336, DOI 10.1086/649899; Arentzen M, 2015, INT J NEUROSCI, V125, P601, DOI 10.3109/00207454.2014.956870; Ariens RAS, 2011, BLOOD, V117, P4687, DOI 10.1182/blood-2011-03-340422; Arildsen H, 2013, HIV MED, V14, P1, DOI 10.1111/j.1468-1293.2012.01027.x; Asmal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048234; Aukrust P, 2000, THROMB HAEMOSTASIS, V84, P183; Baker JV, 2013, THROMB RES, V132, P495, DOI 10.1016/j.thromres.2013.08.016; Bozzette SA, 2003, NEW ENGL J MED, V348, P702, DOI 10.1056/NEJMoa022048; Brothers TD, 2014, CURR OPIN HIV AIDS, V9, P412, DOI 10.1097/COH.0000000000000070; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Bucciarelli P, 2009, CLIMACTERIC, V12, P47, DOI 10.1080/13697130903006365; Bull Lauren, 2018, Post Reprod Health, V24, P19, DOI 10.1177/2053369117748794; Cao W, 2009, JAIDS-J ACQ IMM DEF, V50, P137, DOI 10.1097/QAI.0b013e3181926c28; Centers for Disease Control and Prevention, 2014, HIV SURV REP; Chan YJ, 2011, J CHIN MED ASSOC, V74, P195, DOI 10.1016/j.jcma.2011.03.001; Chow FC, 2018, AIDS, V32, P59, DOI [10.1097/QAD.0000000000001650, 10.1097/qad.0000000000001650]; Cini M, 2014, INT J LAB HEMATOL, V36, P541, DOI 10.1111/ijlh.12184; CONLON MG, 1994, THROMB HAEMOSTASIS, V72, P551; CURRIE MS, 1994, J AM GERIATR SOC, V42, P738, DOI 10.1111/j.1532-5415.1994.tb06534.x; de Larranaga GF, 2003, BLOOD COAGUL FIBRIN, V14, P15, DOI 10.1097/00001721-200301000-00004; Desai Seema, 2010, Curr HIV/AIDS Rep, V7, P4, DOI 10.1007/s11904-009-0038-4; Duro M, 2018, INT J STD AIDS, V29, P1089, DOI 10.1177/0956462418775188; Elmaleh DR, 2005, INT J MOL MED, V16, P191; Favaloro EJ, 2014, SEMIN THROMB HEMOST, V40, P621, DOI 10.1055/s-0034-1384631; Fitch KV, 2017, INTERD T GERONT GERI, V42, P47, DOI 10.1159/000448543; Franchini M, 2006, CRIT REV ONCOL HEMAT, V60, P144, DOI 10.1016/j.critrevonc.2006.06.004; Funderburg NT, 2014, CURR OPIN HIV AIDS, V9, P80, DOI 10.1097/COH.0000000000000019; Gameiro CM, 2010, MATURITAS, V67, P316, DOI 10.1016/j.maturitas.2010.08.003; Gebo Kelly A, 2009, Curr Infect Dis Rep, V11, P246, DOI 10.1007/s11908-009-0036-0; Grabar S, 2004, AIDS, V18, P2029, DOI 10.1097/00002030-200410210-00007; Greig J., 2012, AIDS, V26, P31, DOI DOI 10.1097/QAD.0B013E3283558446; Grund B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155100; Guaraldi G, 2017, VIRULENCE, V8, P504, DOI 10.1080/21505594.2017.1306622; HAGER K, 1995, GERONTOLOGY, V41, P159; Hsue PY, 2012, CLIN INFECT DIS, V54, P1196, DOI 10.1093/cid/cis014; Imai K, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/340309; Jong E, 2009, AIDS PATIENT CARE ST, V23, P1001, DOI 10.1089/apc.2009.0173; Kanapathipillai R, 2013, MENOPAUSE, V20, P983, DOI [10.1097/gme.0b013e318282aa57, 10.1097/GME.0b013e318282aa57]; Kattula S, 2017, ARTERIOSCL THROM VAS, V37, pE13, DOI 10.1161/ATVBAHA.117.308564; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lagathu C, 2017, AIDS, V31, pS105, DOI [10.1097/QAD.0000000000001441, 10.1097/qad.0000000000001441]; Leng SX, 2015, CURR HIV-AIDS REP, V12, P25, DOI 10.1007/s11904-014-0247-3; Lijfering WM, 2008, CLIN CHEM, V54, P1226, DOI 10.1373/clinchem.2008.103614; Lippi G, 2014, SEMIN THROMB HEMOST, V40, P634, DOI 10.1055/s-0034-1384630; Lowe GDO, 2007, J THROMB HAEMOST, V5, P1125, DOI 10.1111/j.1538-7836.2007.02529.x; Madden E, 2008, AIDS, V22, P707, DOI 10.1097/QAD.0b013e3282f560d9; Mari D, 2008, EXP GERONTOL, V43, P66, DOI 10.1016/j.exger.2007.06.014; Matinella A, 2015, J NEUROL, V262, P1317, DOI 10.1007/s00415-015-7713-8; Misson J, 1997, J CLIN PHARM THER, V22, P109, DOI 10.1111/j.1365-2710.1997.tb00004.x; Montoya JL, 2017, AIDS, V31, P787, DOI 10.1097/QAD.0000000000001404; Mooney S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144312; Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886; Nasi M, 2017, CLIN EXP IMMUNOL, V187, P44, DOI 10.1111/cei.12814; Nasi M, 2014, IMMUNOL LETT, V162, P329, DOI 10.1016/j.imlet.2014.06.012; Nasir IA, 2016, MALAYS J PATHOL, V38, P103; Nordell AD, 2014, J AM HEART ASSOC, V3, P1; Omoregie R, 2009, W INDIAN MED J, V58, P437; Omoregie R, 2009, W INDIAN MED J, V201, P336, DOI [10.1080/13697130903006365, DOI 10.1080/13697130903006365]; Pathai S, 2014, J GERONTOL A-BIOL, V69, P833, DOI 10.1093/gerona/glt168; Pawelec G, 2009, REV MED VIROL, V19, P47, DOI 10.1002/rmv.598; Penzak Scott R, 2002, Am J Cardiovasc Drugs, V2, P91, DOI 10.2165/00129784-200202020-00003; Pontrelli G, 2010, AIDS, V24, P1145, DOI 10.1097/QAD.0b013e328337b9a0; Raman RT, 2016, J CLIN DIAGN RES, V10, pEC4, DOI 10.7860/JCDR/2016/17459.7718; Roemisch J, 2002, BLOOD COAGUL FIBRIN, V13, P657, DOI 10.1097/00001721-200212000-00001; Seyoum M, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5320827; Sico JJ, 2015, NEUROLOGY, V84, P1933, DOI 10.1212/WNL.0000000000001560; Sinha A, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004243; Strukova S, 2006, FRONT BIOSCI-LANDMRK, V11, P59, DOI 10.2741/1780; Teer E, 2019, AM J PHYSIOL-HEART C, V316, pH1146, DOI 10.1152/ajpheart.00797.2018; Tita-Nwa F, 2010, AGING CLIN EXP RES, V22, P20, DOI 10.1007/BF03324810; Torres B, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19246; Wandeler G, 2016, CURR OPIN HIV AIDS, V11, P492, DOI 10.1097/COH.0000000000000298; Whitney JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018589; Williams MS, 2016, J WOMENS HEALTH, V25, P166, DOI 10.1089/jwh.2015.5465; Wing E.J., 2017, T AM CLIN CLIMATOL A, V128, P131, DOI DOI 10.1016/J.IJID.2016.10.004; Younas M, 2016, HIV MED, V17, P89, DOI 10.1111/hiv.12310; Young J, 2005, ANTIVIR THER, V10, P585; Zakai NA, 2007, J THROMB HAEMOST, V5, P1128, DOI 10.1111/j.1538-7836.2007.02528.x; Zamudio-Rodriguez A, 2017, GAC MED MEX, V153, P598, DOI 10.24875/GMM.17002875	81	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0227763	10.1371/journal.pone.0227763	http://dx.doi.org/10.1371/journal.pone.0227763			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7PV	32049963	Green Published, gold			2022-12-26	WOS:000535192300005
J	Lee, KS; Quintiliani, L; Heinz, A; Johnson, NL; Xuan, ZM; Truong, V; Lasser, KE				Lee, Kristen S.; Quintiliani, Lisa; Heinz, Alexandra; Johnson, Natrina L.; Xuan, Ziming; Ve Truong; Lasser, Karen E.			A financial incentive program to improve appointment attendance at a safety-net hospital-based primary care hepatitis C treatment program	PLOS ONE			English	Article							VIRUS-INFECTION; INCREASES; LINKAGE	Introduction Hepatitis C (HCV) infection is a significant health threat, with increasing incidence rates in the setting of the opioid crisis. Many patients miss appointments and cannot initiate treatment. We implemented financial incentives to improve appointment attendance in a primary care-based HCV treatment setting. Methods We conducted a systems-level financial incentives intervention at the Adult Primary Care HCV Treatment Program at Boston Medical Center which provides care to many patients with substance use disorders. From April 1 to June 30, 2017, we provided a $15 gift card to patients who attended appointments with an HCV treatment provider. We evaluated the effectiveness of the incentives by 1) conducting a monthly interrupted time series analysis to assess trends in attendance January 2016-September 2017; and 2) comparing the proportion of attended appointments during the intervention to a historical comparison group in the previous year, April 1 to June 30, 2016. Results 327 visits were scheduled over the study period; 198 during the intervention and 129 during the control period. Of patient visits in the intervention group, 72.7% were attended relative to 61.2% of comparison group visits (p = 0.03). Appointments in the intervention group were more likely to be attended (adjusted odds ratio 1.94, 95% confidence interval 1.16-3.24). Interrupted time series analysis showed that the intervention was associated with an average increase of 15.4 attended visits per 100 appointments scheduled, compared to the period prior to the intervention (p = 0.01). Conclusions Implementation of a financial incentive program was associated with improved appointment attendance at a safety-net hospital-based primary care HCV treatment program. A randomized trial to establish efficacy and broader implementation potential is warranted.	[Lee, Kristen S.; Quintiliani, Lisa; Lasser, Karen E.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Lee, Kristen S.; Ve Truong; Lasser, Karen E.] Boston Med Ctr, Sect Gen Internal Med, Boston, MA 02118 USA; [Quintiliani, Lisa; Johnson, Natrina L.; Xuan, Ziming; Lasser, Karen E.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Heinz, Alexandra] Boston Med Ctr, Clin Addict Res & Educ Unit, Boston, MA USA	Boston University; Boston Medical Center; Boston University; Boston Medical Center	Lee, KS (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.; Lee, KS (corresponding author), Boston Med Ctr, Sect Gen Internal Med, Boston, MA 02118 USA.	Kristen.Lee@bmc.org			Boston University Evans Center for Implementation and Implementation Sciences Pilot Grant	Boston University Evans Center for Implementation and Implementation Sciences Pilot Grant	Boston University Evans Center for Implementation and Implementation Sciences Pilot Grant funded our study (http://sites.bu.edu/ciis/pilotgrants/).Authors KSL and KEL were the coprincipal investigators of this grant. There is no grant number for this pilot grant. The funder had role in guiding us with the study analysis. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Centers for Disease Control and Prevention, 2016, VIR HEP SURV US 2016; Coyle C, 2015, MMWR-MORBID MORTAL W, V64, P459; Edlin BR, 2015, HEPATOLOGY, V62, P1353, DOI 10.1002/hep.27978; Federal Register, 2016, MED STAT HLTH CAR PR; Ho SB, 2015, CLIN GASTROENTEROL H, V13, P2005, DOI 10.1016/j.cgh.2015.02.022; Kropp F, 2017, J SUBST ABUSE TREAT, V72, P111, DOI 10.1016/j.jsat.2016.06.012; Lasser KE, 2017, ANN FAM MED, V15, P258, DOI 10.1370/afm.2069; Lasser KE, 2005, J HEALTH CARE POOR U, V16, P475, DOI 10.1353/hpu.2005.0054; Manns MP, 2013, J VIRAL HEPATITIS, V20, P524, DOI 10.1111/jvh.12074; Mitchell GK, 2008, MED J AUSTRALIA, V188, pS61; Pace CA, 2018, ANN FAM MED, V16, P346, DOI 10.1370/afm.2263; Promberger M, 2013, HEALTH PSYCHOL, V32, P950, DOI 10.1037/a0032727; Trooskin SB, 2015, J GEN INTERN MED, V30, P950, DOI 10.1007/s11606-015-3209-6; Wohl DA, 2017, OPEN FORUM INFECT DI; Yehia BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101554; Yoshida EM, 2015, HEPATOLOGY, V61, P41, DOI 10.1002/hep.27366; Zibbell JE, 2018, AM J PUBLIC HEALTH, V108, P175, DOI 10.2105/AJPH.2017.304132	17	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228767	10.1371/journal.pone.0228767	http://dx.doi.org/10.1371/journal.pone.0228767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP9KA	32045447	Green Published, gold			2022-12-26	WOS:000534633200038
J	Sevrieva, IR; Brandmeier, B; Ponnam, S; Gautel, M; Irving, M; Campbell, KS; Sun, YB; Kampourakis, T				Sevrieva, Ivanka R.; Brandmeier, Birgit; Ponnam, Saraswathi; Gautel, Mathias; Irving, Malcom; Campbell, Kenneth S.; Sun, Yin-Biao; Kampourakis, Thomas			Cardiac myosin regulatory light chain kinase modulates cardiac contractility by phosphorylating both myosin regulatory light chain and troponin I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiomyocyte; posttranslational modification (PTM); myosin; troponin; contractile protein; calcium signalling; cardiac muscle regulation; cardiac myosin light chain kinase; heart function; troponin I phosphorylation	HUMAN HEART; CONSTITUTIVE PHOSPHORYLATION; VENTRICULAR MYOCARDIUM; MUSCLE; DEPHOSPHORYLATION; KINETICS; AFFINITY; STRETCH	Heart muscle contractility and performance are controlled by posttranslational modifications of sarcomeric proteins. Although myosin regulatory light chain (RLC) phosphorylation has been studied extensively in vitro and in vivo, the precise role of cardiac myosin light chain kinase (cMLCK), the primary kinase acting upon RLC, in the regulation of cardiomyocyte contractility remains poorly understood. In this study, using recombinantly expressed and purified proteins, various analytical methods, in vitro and in situ kinase assays, and mechanical measurements in isolated ventricular trabeculae, we demonstrate that human cMLCK is not a dedicated kinase for RLC but can phosphorylate other sarcomeric proteins with well-characterized regulatory functions. We show that cMLCK specifically monophosphorylates Ser(23) of human cardiac troponin I (cTnI) in isolation and in the trimeric troponin complex in vitro and in situ in the native environment of the muscle myofilament lattice. Moreover, we observed that human cMLCK phosphorylates rodent cTnI to a much smaller extent in vitro and in situ, suggesting species-specific adaptation of cMLCK. Although cMLCK treatment of ventricular trabeculae exchanged with rat or human troponin increased their cross-bridge kinetics, the increase in sensitivity of myofilaments to calcium was significantly blunted by human TnI, suggesting that human cTnI phosphorylation by cMLCK modifies the functional consequences of RLC phosphorylation. We propose that cMLCK-mediated phosphorylation of TnI is functionally significant and represents a critical signaling pathway that coordinates the regulatory states of thick and thin filaments in both physiological and potentially pathophysiological conditions of the heart.	[Sevrieva, Ivanka R.; Brandmeier, Birgit; Ponnam, Saraswathi; Gautel, Mathias; Irving, Malcom; Sun, Yin-Biao; Kampourakis, Thomas] Kings Coll London, Randall Ctr Cell & Mol Biophys, London SE1 1UL, England; [Sevrieva, Ivanka R.; Brandmeier, Birgit; Ponnam, Saraswathi; Gautel, Mathias; Irving, Malcom; Sun, Yin-Biao; Kampourakis, Thomas] Kings Coll London, British Heart Fdn, Ctr Res Excellence, London SE1 1UL, England; [Campbell, Kenneth S.] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40536 USA	University of London; King's College London; University of London; King's College London; University College London; University of Kentucky	Kampourakis, T (corresponding author), Kings Coll London, Randall Ctr Cell & Mol Biophys, London SE1 1UL, England.; Kampourakis, T (corresponding author), Kings Coll London, British Heart Fdn, Ctr Res Excellence, London SE1 1UL, England.	thomas.kampourakis@kcl.ac.uk	; Sun, Yin-Biao/F-9988-2018	Ponnam, Saraswathi/0000-0002-5592-3684; Kampourakis, Thomas/0000-0002-8269-1567; Sun, Yin-Biao/0000-0002-4992-8198; Sevrieva, Ivanka/0000-0001-8471-6484	British Heart Foundation [FS/16/3/31887, FS/15/1/31071]; British Heart Foundation Chair of Molecular Cardiology [CH/08/001]	British Heart Foundation(British Heart Foundation); British Heart Foundation Chair of Molecular Cardiology	This study was supported by British Heart Foundation Basic Science Intermediate Fellowship FS/16/3/31887 (to T. K.), Senior Basic Science Fellowship FS/15/1/31071 (to Y.-B. S.), and British Heart Foundation Chair of Molecular Cardiology CH/08/001 (to M. G. and B. B.) The authors declare that they have no conflicts of interest with the contents of this article.	Al Madhoun AS, 2011, EMBO J, V30, P2477, DOI 10.1038/emboj.2011.153; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; Bunch TA, 2018, J MOL CELL CARDIOL, V125, P140, DOI 10.1016/j.yjmcc.2018.10.009; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Chang AN, 2015, J BIOL CHEM, V290, P10703, DOI 10.1074/jbc.M115.642165; Chung JH, 2018, J MOL CELL CARDIOL, V121, P81, DOI 10.1016/j.yjmcc.2018.07.005; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; Ding PG, 2010, J BIOL CHEM, V285, P40819, DOI 10.1074/jbc.M110.160499; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; HERRING BP, 1992, J BIOL CHEM, V267, P25945; Hodatsu A, 2019, ESC HEART FAIL, V6, P406, DOI 10.1002/ehf2.12410; Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200; IKEBE M, 1994, J BIOL CHEM, V269, P28173; Isobe K, 2020, AM J PHYSIOL-RENAL, V318, pF600, DOI 10.1152/ajprenal.00431.2019; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kampourakis T, 2018, J PHYSIOL-LONDON, V596, P31, DOI 10.1113/JP275050; Kampourakis T, 2016, P NATL ACAD SCI USA, V113, pE3039, DOI 10.1073/pnas.1602776113; Kampourakis T, 2015, J MOL CELL CARDIOL, V85, P199, DOI 10.1016/j.yjmcc.2015.06.002; Keane NE, 1997, EUR J BIOCHEM, V248, P329, DOI 10.1111/j.1432-1033.1997.00329.x; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Kockskamper J, 2008, PROG BIOPHYS MOL BIO, V97, P250, DOI 10.1016/j.pbiomolbio.2008.02.026; Martin-Garrido A, 2018, J BIOL CHEM, V293, P8588, DOI 10.1074/jbc.RA117.001292; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; Messer AE, 2009, PROTEOM CLIN APPL, V3, P1371, DOI 10.1002/prca.200900071; Monasky MM, 2010, J MOL CELL CARDIOL, V48, P1023, DOI 10.1016/j.yjmcc.2010.03.004; Perino A, 2012, CIRC RES, V111, P482, DOI 10.1161/CIRCRESAHA.111.262899; Pulcastro HC, 2016, ARCH BIOCHEM BIOPHYS, V601, P56, DOI 10.1016/j.abb.2015.12.014; Riise J, 2008, CARDIOVASC RES, V80, P407, DOI 10.1093/cvr/cvn216; Saad NS, 2018, LIFE SCI, V215, P119, DOI 10.1016/j.lfs.2018.10.065; Sanbe A, 1999, J BIOL CHEM, V274, P21085, DOI 10.1074/jbc.274.30.21085; Scruggs SB, 2011, ARCH BIOCHEM BIOPHYS, V510, P129, DOI 10.1016/j.abb.2011.02.013; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; Seguchi O, 2007, J CLIN INVEST, V117, P2812, DOI 10.1172/JCI30804; Sheikh F, 2012, J CLIN INVEST, V122, P1209, DOI 10.1172/JCI61134; Solaro RJ, 2013, CIRC RES, V112, P355, DOI 10.1161/CIRCRESAHA.112.268672; Sun YB, 2009, J PHYSIOL-LONDON, V587, P155, DOI 10.1113/jphysiol.2008.164707; Tobita T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17769-1; van der Velden J, 2003, CARDIOVASC RES, V57, P37, DOI 10.1016/S0008-6363(02)00606-5; Varian KD, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/290971; Warren SA, 2012, CIRCULATION, V126, P2575, DOI 10.1161/CIRCULATIONAHA.112.116202; Yuan CC, 2015, P NATL ACAD SCI USA, V112, pE4138, DOI 10.1073/pnas.1505819112; ZHANG R, 1995, CIRC RES, V76, P1028, DOI 10.1161/01.RES.76.6.1028; Zhang R, 1995, J BIOL CHEM, V270, P30773, DOI 10.1074/jbc.270.51.30773; ZHI G, 1994, J BIOL CHEM, V269, P24723	44	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4398	4410		10.1074/jbc.RA119.011945	http://dx.doi.org/10.1074/jbc.RA119.011945			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32086378	Green Published, hybrid			2022-12-26	WOS:000524499700004
J	Wortham, AM; Goldman, DC; Chen, JX; Fleming, WH; Zhang, AS; Enns, CA				Wortham, Aaron M.; Goldman, Devorah C.; Chen Juxing; Fleming, William H.; Zhang An-Sheng; Enns, Caroline A.			Extrahepatic deficiency of transferrin receptor 2 is associated with increased erythropoiesis independent of iron overload	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						iron metabolism; iron; erythropoiesis; erythropoietin; transferrin; metal homeostasis; metabolic regulation; erythropoiesis; erythropoietin; hereditary hemochromatosis; iron overload; transferrin receptor-2	PROGENITORS BFU-E; ERYTHROID-DIFFERENTIATION; HEPCIDIN EXPRESSION; DEPENDENT INDUCTION; DISTINCT STAGES; MICE LEADS; GENE; ERYTHROFERRONE; TFR2; HFE	Transferrin receptor 2 (TFR2) is a transmembrane protein expressed mainly in hepatocytes and in developing erythroid cells and is an important focal point in systemic iron regulation. Loss of TFR2 function results in a rare form of the iron-overload disease hereditary hemochromatosis. Although TFR2 in the liver has been shown to be important for regulating iron homeostasis in the body, TFR2's function in erythroid progenitors remains controversial. In this report, we analyzed TFR2-deficient mice in the presence or absence of iron overload to distinguish between the effects caused by a high iron load and those caused by loss of TFR2 function. Analysis of bone marrow from TFR2-deficient mice revealed a reduction in the early burst-forming unit?erythroid and an expansion of late-stage erythroblasts that was independent of iron overload. Spleens of TFR2-deficient mice displayed an increase in colony-forming unit?erythroid progenitors and in all erythroblast populations regardless of iron overload. This expansion of the erythroid compartment coincided with increased erythroferrone (ERFE) expression and serum erythropoietin (EPO) levels. Rescue of hepatic TFR2 expression normalized hepcidin expression and the total cell count of the bone marrow and spleen, but it had no effect on erythroid progenitor frequency. On the basis of these results, we propose a model of TFR2's function in murine erythropoiesis, indicating that deficiency in this receptor is associated with increased erythroid development and expression of EPO and ERFE in extrahepatic tissues independent of TFR's role in the liver.	[Wortham, Aaron M.; Chen Juxing; Zhang An-Sheng; Enns, Caroline A.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, L215,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Goldman, Devorah C.; Fleming, William H.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA; [Chen Juxing] Novus Int Inc, St Charles, MO 63304 USA	Oregon Health & Science University; Oregon Health & Science University	Enns, CA (corresponding author), Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, L215,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	ennsca@ohsu.edu		Enns, Caroline/0000-0002-5852-3766	National Institutes of Health [R01DK072166, R37-DK054488, R01DK109694, R01DK102791]; American Heart Association [11POST5250029]; Collins Medical Trust	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Collins Medical Trust	This work was supported by National Institutes of Health Grants R01DK072166, R37-DK054488, R01DK109694, and R01DK102791, American Heart Association Grant 11POST5250029, and a Collins Medical Trust grant (to J. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson SA, 2013, CELL METAB, V17, P282, DOI 10.1016/j.cmet.2013.01.007; BESSMAN JD, 1983, AM J CLIN PATHOL, V80, P322, DOI 10.1093/ajcp/80.3.322; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Chen JX, 2007, J BIOL CHEM, V282, P6201, DOI 10.1074/jbc.M610127200; Chen JX, 2009, TRAFFIC, V10, P1488, DOI 10.1111/j.1600-0854.2009.00961.x; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Chloupkova M, 2010, BLOOD CELL MOL DIS, V44, P28, DOI 10.1016/j.bcmd.2009.09.004; Crownover BK, 2013, AM FAM PHYSICIAN, V87, P183; Doty RT, 2015, J CLIN INVEST, V125, P4681, DOI 10.1172/JCI83054; Drake SF, 2007, AM J PHYSIOL-GASTR L, V292, pG323, DOI 10.1152/ajpgi.00278.2006; Fillebeen C, 2019, BLOOD, V133, P344, DOI 10.1182/blood-2018-05-850404; Fleming RE, 2002, P NATL ACAD SCI USA, V99, P10653, DOI 10.1073/pnas.162360699; Fleming RE, 2000, P NATL ACAD SCI USA, V97, P2214, DOI 10.1073/pnas.040548097; Fleming RE, 2001, P NATL ACAD SCI USA, V98, P2707, DOI 10.1073/pnas.051630898; Forejtnikova H, 2010, BLOOD, V116, P5357, DOI 10.1182/blood-2010-04-281360; Gao JW, 2010, BLOOD, V115, P3374, DOI 10.1182/blood-2009-09-245209; Ghosh MC, 2013, CELL METAB, V17, P271, DOI 10.1016/j.cmet.2012.12.016; Grover A, 2014, J EXP MED, V211, P181, DOI 10.1084/jem.20131189; HEATH DS, 1976, BLOOD, V47, P777; Hirano I, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00451-16; Hu JP, 2013, BLOOD, V121, P3246, DOI 10.1182/blood-2013-01-476390; Jiang XK, 2016, BLOOD CELL MOL DIS, V58, P45, DOI 10.1016/j.bcmd.2016.02.005; JOHNSON CS, 1983, AM J CLIN PATHOL, V80, P31, DOI 10.1093/ajcp/80.1.31; Johnson MB, 2007, MOL BIOL CELL, V18, P743, DOI 10.1091/mbc.E06-09-0798; Johnson MB, 2004, BLOOD, V104, P4287, DOI 10.1182/blood-2004-06-2477; Joshi R, 2015, MOL GENET GENOM MED, V3, P221, DOI 10.1002/mgg3.136; Kautz L, 2014, BLOOD, V124, P2569, DOI 10.1182/blood-2014-06-584607; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Kawabata H, 2005, BLOOD, V105, P376, DOI 10.1182/blood-2004-04-1416; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; Kawabata H, 2001, BLOOD, V98, P1949, DOI 10.1182/blood.V98.6.1949; Kile BT, 2003, MAMM GENOME, V14, P81, DOI 10.1007/s00335-002-2160-0; Kim A, 2015, CURR OPIN HEMATOL, V22, P199, DOI 10.1097/MOH.0000000000000132; Kleven MD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194728; Koulnis M, 2014, ADV EXP MED BIOL, V844, P37, DOI 10.1007/978-1-4939-2095-2_3; LANDSCHULZ KT, 1992, BLOOD, V79, P2749; LEONARD JP, 1988, BLOOD, V72, P1492; Li J, 2014, BLOOD, V124, P3636, DOI 10.1182/blood-2014-07-588806; Liu J, 2013, BLOOD, V121, pE43, DOI 10.1182/blood-2012-09-456079; Nai A, 2015, BLOOD, V125, P1170, DOI 10.1182/blood-2014-08-596254; Nai A, 2014, HAEMATOLOGICA, V99, P1016, DOI 10.3324/haematol.2013.103143; Nestorowa S, 2016, BLOOD, V128, pE20, DOI 10.1182/blood-2016-05-716480; Oshima K, 2017, LAB INVEST, V97, P555, DOI 10.1038/labinvest.2017.11; Pagani A, 2015, HAEMATOLOGICA, V100, P461, DOI 10.3324/haematol.2014.118521; Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Rauner M, 2019, NAT METAB, V1, P111, DOI 10.1038/s42255-018-0005-8; Rishi G, 2016, AM J HEMATOL, V91, P812, DOI 10.1002/ajh.24417; Roetto A, 2010, BLOOD, V115, P3382, DOI 10.1182/blood-2009-09-240960; Salgia RJ, 2015, CLIN LIVER DIS, V19, P187, DOI 10.1016/j.cld.2014.09.011; Santos PCJL, 2012, INT J MOL SCI, V13, P1497, DOI 10.3390/ijms13021497; Schmidt PJ, 2012, AM J HEMATOL, V87, P588, DOI 10.1002/ajh.23173; Socolovsky M, 1998, BLOOD, V92, P1491, DOI 10.1182/blood.V92.5.1491.417k40_1491_1496; Storti F, 2014, HAEMATOLOGICA, V99, pE45, DOI 10.3324/haematol.2013.102707; Terszowski G, 2005, BLOOD, V105, P1937, DOI 10.1182/blood-2004-09-3459; Vogt TM, 2003, BLOOD, V101, P2008, DOI 10.1182/blood-2002-09-2742; Wahedi M, 2017, J BIOL CHEM, V292, P18354, DOI 10.1074/jbc.M117.801795; Wallace DF, 2007, GASTROENTEROLOGY, V132, P301, DOI 10.1053/j.gastro.2006.11.028; Wallace DF, 2015, BRIT J HAEMATOL, V168, P891, DOI 10.1111/bjh.13225; WALLERSTEIN RO, 1987, WESTERN J MED, V146, P443	60	6	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3906	3917		10.1074/jbc.RA119.010535	http://dx.doi.org/10.1074/jbc.RA119.010535			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32054685	hybrid, Green Published			2022-12-26	WOS:000527704400015
J	Kawashima, H; Ozawa, Y; Toda, E; Homma, K; Osada, H; Narimatsu, T; Nagai, N; Tsubota, K				Kawashima, Hirohiko; Ozawa, Yoko; Toda, Eriko; Homma, Kohei; Osada, Hideto; Narimatsu, Toshio; Nagai, Norihiro; Tsubota, Kazuo			Neuroprotective and vision-protective effect of preserving ATP levels by AMPK activator	FASEB JOURNAL			English	Article						AMPK; ATP; Neurodegeneration; photostress; retina	RETINAL-PIGMENT EPITHELIUM; STRAND BREAK REPAIR; OXIDATIVE-METABOLISM; PROTEIN-KINASE; LIGHT; RHODOPSIN; DNA; OVEREXPRESSION; DEGENERATION; RETINOPATHY	Progression of blinding diseases, such as age-related macular degeneration, is accelerated by light exposure. However, no particular intervention is applied to the photostress. Here, we report neuroprotective effects of the adenosine monophosphate (AMP)-activated protein kinase (AMPK) activator, 5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR), on light-induced visual function impairment, photoreceptor disorders and death in mice. Increase in retinal ATP levels in response to photostress was transient, because oxygen consumption rate (OCR) and cytochrome c oxidase (CcO) activity were reduced under photostress. However, AICAR treatment preserved OCR, CcO activity, and high levels of retinal ATP after light exposure. AMPK knockdown in the photoreceptor-derived cell line revealed that AMPK targeted CcO activity. Further, our data indicated that photostress reduced mitochondrial respiratory function and ATP levels, while AICAR treatment promoted neuronal survival and retained visual function, stabilizing ATP levels through preserved CcO activity. The current study has provided proof of concept for providing cells with sufficient energy to promote cell survival in the presence of cellular stress. This is in contrast to the previous reports which primarily investigated therapeutic approaches to suppress stress signals. Hence, stabilization of the ATP supply may serve as a novel therapeutic approach to support tissue survival under stress and prevent neurodegeneration.	[Kawashima, Hirohiko; Ozawa, Yoko; Toda, Eriko; Homma, Kohei; Osada, Hideto; Narimatsu, Toshio; Nagai, Norihiro] Keio Univ, Lab Retinal Cell Biol, Sch Med, Tokyo, Japan; [Kawashima, Hirohiko; Ozawa, Yoko; Narimatsu, Toshio; Nagai, Norihiro; Tsubota, Kazuo] Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan	Keio University; Keio University	Ozawa, Y (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Lab Retinal Cell Biol,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	ozawa@a5.keio.jp	Ozawa, Yoko/AAH-9888-2020; Homma, Kohei/AAF-6716-2021; Tsubota, Kazuo/M-1915-2013	Homma, Kohei/0000-0002-6253-8047; Tsubota, Kazuo/0000-0002-8874-7111; Osada, Hideto/0000-0001-9971-8992; Ozawa, Yoko/0000-0003-4797-5705	Japan Society of the Promotion of Science [18K09422]; Keio | School of Medicine, Keio University (School of Medicine, Keio University)	Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Keio | School of Medicine, Keio University (School of Medicine, Keio University)	Japan Society of the Promotion of Science, Grant/Award Number: 18K09422; Keio | School of Medicine, Keio University (School of Medicine, Keio University)	Ban N, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0017-8; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Cai ZY, 2012, NEUROMOL MED, V14, P1, DOI 10.1007/s12017-012-8173-2; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005; Choi SU, 2019, EYE, V33, P1540, DOI 10.1038/s41433-019-0439-6; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hopfner KP, 2014, BIOESSAYS, V36, P1170, DOI 10.1002/bies.201400102; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Hurley JB, 2015, J NEUROSCI RES, V93, P1079, DOI 10.1002/jnr.23583; Iacovelli J, 2016, INVEST OPHTH VIS SCI, V57, P1038, DOI 10.1167/iovs.15-17758; Kamoshita M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30226; Kanow MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28899; Kim J, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.16; Kooragayala K, 2015, INVEST OPHTH VIS SCI, V56, P8428, DOI 10.1167/iovs.15-17901; Kubota S, 2010, AM J PATHOL, V177, P1725, DOI 10.2353/ajpath.2010.100098; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; McCarty CA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1455; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Narimatsu T, 2015, EXP EYE RES, V132, P48, DOI 10.1016/j.exer.2015.01.003; Narimatsu T, 2014, CLIN EXP OPHTHALMOL, V42, P555, DOI 10.1111/ceo.12253; Narimatsu T, 2014, FREE RADICAL BIO MED, V71, P176, DOI 10.1016/j.freeradbiomed.2014.03.020; Narimatsu T, 2013, INVEST OPHTH VIS SCI, V54, P4555, DOI 10.1167/iovs.12-11572; Okamoto T, 2019, TRANSL VIS SCI TECHN, V8, DOI 10.1167/tvst.8.6.20; Okamoto T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146517; Osada H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178627; Ozawa Y, 2012, CURR PHARM DESIGN, V18, P51, DOI 10.2174/138161212798919101; Ozawa Y, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/506137; Ozawa Y, 2008, J BIOL CHEM, V283, P24561, DOI 10.1074/jbc.M802238200; Pobre KFR, 2019, J BIOL CHEM, V294, P2098, DOI 10.1074/jbc.REV118.002804; Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707; Reme CE, 1999, INVEST OPHTH VIS SCI, V40, P2398; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Rojowska A, 2014, EMBO J, V33, P2847, DOI 10.15252/embj.201488889; Sasaki M, 2012, J NUTR BIOCHEM, V23, P423, DOI 10.1016/j.jnutbio.2011.01.006; Satish S, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9248640; Saydah S, 2019, MMWR-MORBID MORTAL W, V68, P453, DOI 10.15585/mmwr.mm6820a2; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Sung CH, 2010, J CELL BIOL, V190, P953, DOI 10.1083/jcb.201006020; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Wen XH, 2009, BIOPHYS J, V96, P939, DOI 10.1016/j.bpj.2008.10.016; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Xu L, 2018, P NATL ACAD SCI USA, V115, P10475, DOI 10.1073/pnas.1802724115; Zhang C, 2015, J ALZHEIMERS DIS, V44, P375, DOI 10.3233/JAD-141890	49	9	9	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5016	5026		10.1096/fj.201902387RR	http://dx.doi.org/10.1096/fj.201902387RR		FEB 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32090372	hybrid			2022-12-26	WOS:000515260900001
J	Vaidya, M; Sugaya, K				Vaidya, Manjusha; Sugaya, Kiminobu			Differential sequences and single nucleotide polymorphism of exosomal SOX2 DNA in cancer	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; STRANDED GENOMIC DNA; GLIOBLASTOMA; TRANSCRIPTION; NEUROBLASTOMA; GENE; SUSCEPTIBILITY; IDENTIFICATION; ASSOCIATION; EXPRESSION	Glioblastoma multiforme (GBM) is the most common form of brain cancer, with an average life expectancy of fewer than two years post-diagnosis. We have previously reported that cancer cell originated exosomes, including GBM, have NANOG and NANOGP8 DNA associated with them. The exosomal NANOG DNA has certain differences as compared to its normal counterpart that are of immense importance as a potential cancer biomarker. NANOG has been demonstrated to play an essential role in the maintenance of embryonic stem cells, and its pseudogene, NANOGP8, is suggested to promote the cancer stem cell phenotype. Similarly, SOX2 is another stemness gene highly expressed in cancer stem cells with an intimate involvement in GBM progression and metastasis as well as promotion of tumorigenicity in Neuroblastoma (NB). Since exosomes are critical in intercellular communication with a role in dissipating hallmark biomolecules responsible for cancer, we conducted a detailed analysis of the association of the SOX2 gene with exosomes whose sequence modulations with further research and appropriate sample size can help to identify diagnostic markers for cancer. We have detected SOX2 DNA associated with exosomes and have identified some of the SNPs and nucleotide variations in the sequences from a GBM and SH-SY5Y sample. Although a further systematic investigation of exosomal DNA from GBM and NB patient's blood is needed, finding of SOX2 DNA in exosomes in the current study may have value in clinical research. SOX2 is known to be misregulated in cancer cells by changes in miRNA function, such as SNPs in the binding sites. Our finding of cancer-specific SNPs in exosomal SOX2 DNA sequence may reflect those changes in the cancer stem cells as well as cancer cells. A series of our study on embryonic stem cell gene analysis in exosomal DNA may lead to a minimally invasive exosome-based diagnosis, and give us a key in understanding the mechanisms of cancer formation, progression, and metastasis.	[Vaidya, Manjusha; Sugaya, Kiminobu] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Sugaya, K (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA.	ksugaya@ucf.edu			Wrenn Trust [2210-4202]; Florida Department of Health Ed and Ethel Moore Alzheimer's Disease Research [6901-7005]	Wrenn Trust; Florida Department of Health Ed and Ethel Moore Alzheimer's Disease Research	This work was supported by The Wrenn Trust (grant number 2210-4202), preclinical test of Alzheimer's disease treatment in human 3D brain in vitro model, Principal Investigator (KS); The Florida Department of Health Ed and Ethel Moore Alzheimer's Disease Research (grant number 6901-7005), Antibody targeting of IL1RAP and studying their therapeutic effects in mouse models of Alzheimer's disease, Principal Investigator (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de la Rocha AMA, 2014, AM J CANCER RES, V4, P312; Andreu Z, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00442; Annovazzi L, 2011, CANCER GENOM PROTEOM, V8, P139; Aravindan N, 2019, CANCER DRUG RESIST, V2, P1086, DOI 10.20517/cdr.2019.68; Aravindan N, 2019, CANCER DRUG RESIST, V2, P948, DOI 10.20517/cdr.2019.72; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Berezovsky AD, 2014, NEOPLASIA, V16, DOI 10.1016/j.neo.2014.03.006; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Buzas EI, 2018, SEMIN IMMUNOPATHOL, V40, P453, DOI 10.1007/s00281-018-0682-0; Cheng JL, 2012, P NATL ACAD SCI USA, V109, P10827, DOI 10.1073/pnas.1208716109; Chyr Jacqueline, 2018, Oncotarget, V9, P22340, DOI 10.18632/oncotarget.24918; Cox JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015486; Gomez-Mateo MD, 2011, GENE CHROMOSOME CANC, V50, P374, DOI 10.1002/gcc.20859; Edgar JR, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0268-z; Fang XF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-11; Field Melvin, 2010, Clin Neurosurg, V57, P151; Fischer S, 2016, PLOS ONE, V11; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Garcia-Romero N, 2017, ONCOTARGET, V8, P1416, DOI 10.18632/oncotarget.13635; Han IB, 2016, ANTICANCER RES, V36, P6691, DOI 10.21873/anticanres.11280; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Kahlert C, 2014, J BIOL CHEM, V289, P3869, DOI 10.1074/jbc.C113.532267; Kalluri R, 2016, COLD SH Q B, V81, P275, DOI 10.1101/sqb.2016.81.030932; Kawamura Y, 2017, CANCER SCI, V108, P824, DOI 10.1111/cas.13222; Khushman M, 2017, PANCREAS, V46, P782, DOI 10.1097/MPA.0000000000000847; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Li YZ, 2015, P NATL ACAD SCI USA, V112, P1839, DOI 10.1073/pnas.1424171112; Liou GY, 2019, INT J BIOCHEM CELL B, V106, P1, DOI 10.1016/j.biocel.2018.10.013; Luo WZ, 2019, LIFE SCI, V226, P98, DOI 10.1016/j.lfs.2019.04.023; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Nowling TK, 2000, J BIOL CHEM, V275, P3810, DOI 10.1074/jbc.275.6.3810; Oksvold MP, 2015, METHODS MOL BIOL, V1218, P465, DOI 10.1007/978-1-4939-1538-5_27; Otsubo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016617; Pandian V, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0002-8; Rider MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep23978; Schiapparelli P, 2010, ONCOL REP, V24, P1355, DOI 10.3892/or_00000993; Skeeles LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058609; Song WS, 2016, J CHIN MED ASSOC, V79, P538, DOI 10.1016/j.jcma.2016.03.010; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Takahashi A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15287; Takenobu H, 2011, ONCOGENE, V30, P97, DOI 10.1038/onc.2010.383; Toschi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095303; Tulsyan S, 2014, CANCER CHEMOTH PHARM, V74, P1065, DOI 10.1007/s00280-014-2588-4; Vaidya M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197782; Weina K, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-19; Whiteside TL, 2016, ADV CLIN CHEM, V74, P103, DOI 10.1016/bs.acc.2015.12.005; Williams C, 2014, CELL RES, V24, P766, DOI 10.1038/cr.2014.44; Wuebben EL, 2017, ONCOTARGET, V8, P44917, DOI 10.18632/oncotarget.16570; Wurtele H, 2003, GENE THER, V10, P1791, DOI 10.1038/sj.gt.3302074; Yadav A, 2016, TUMOR BIOL, V37, P1835, DOI 10.1007/s13277-015-3929-6; Yang SB, 2012, ONCOL REP, V28, P186, DOI 10.3892/or.2012.1765; Zhang YS, 2012, J BIOL CHEM, V287, P41514, DOI 10.1074/jbc.M112.404871	53	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229309	10.1371/journal.pone.0229309	http://dx.doi.org/10.1371/journal.pone.0229309			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092088	Green Published, gold			2022-12-26	WOS:000535229300044
J	Behler, O; Uppenkamp, S				Behler, Oliver; Uppenkamp, Stefan			Activation in human auditory cortex in relation to the loudness and unpleasantness of low-frequency and infrasound stimuli	PLOS ONE			English	Article							SOUND-LEVEL; ACOUSTIC FEATURES; FMRI ACTIVATION; INTENSITY; THRESHOLDS; REPRESENTATION; AUDIBILITY; ANNOYANCE; NOISE; TONES	Low frequency noise (LFS) and infrasound (IS) are controversially discussed as potential causes of annoyance and distress experienced by many people. However, the perception mechanisms for IS in the human auditory system are not completely understood yet. In the present study, sinusoids at 32 Hz (at the lower limit of melodic pitch for tonal stimulation), as well as 8 Hz (IS range) were presented to a group of 20 normal hearing subjects, using monaural stimulation via a loudspeaker sound source coupled to the ear canal by a long silicone rubber tube. Each participant attended two experimental sessions. In the first session, participants performed a categorical loudness scaling procedure as well as an unpleasantness rating task in a sound booth. In the second session, the loudness scaling procedure was repeated while brain activation was measured using functional magnetic resonance imaging (fMRI). Subsequently, activation data were collected for the respective stimuli presented at fixed levels adjusted to the individual loudness judgments. Silent trials were included as a baseline condition. Our results indicate that the brain regions involved in processing LFS and IS are similar to those for sounds in the typical audio frequency range, i.e., mainly primary and secondary auditory cortex (AC). In spite of large variation across listeners with respect to judgments of loudness and unpleasantness, neural correlates of these interindividual differences could not yet be identified. Still, for individual listeners, fMRI activation in the AC was more closely related to individual perception than to the physical stimulus level.	[Behler, Oliver; Uppenkamp, Stefan] Carl von Ossietzky Univ Oldenburg, Med Phys, Oldenburg, Germany; [Uppenkamp, Stefan] Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4All, Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Behler, O (corresponding author), Carl von Ossietzky Univ Oldenburg, Med Phys, Oldenburg, Germany.	oliver.behler@uni-oldenburg.de			European Metrology Programme for Innovation and Research (EMPIR - EURAMET) [15HLT03 Ears II]	European Metrology Programme for Innovation and Research (EMPIR - EURAMET)	OB and SU received funding from the European Metrology Programme for Innovation and Research (EMPIR - EURAMET), grant number 15HLT03 Ears II, https://www.euramet.org/research-innovation/research-empir/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JB, 1990, J ACOUST SOC AM, V88, P745, DOI 10.1121/1.399778; [Anonymous], 2262003 ISO; ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; Behler O, 2016, NEUROIMAGE, V139, P176, DOI 10.1016/j.neuroimage.2016.06.025; Boyen K, 2014, HEARING RES, V312, P48, DOI 10.1016/j.heares.2014.03.001; Brand T, 2002, J ACOUST SOC AM, V112, P1597, DOI 10.1121/1.1502902; Brechmann A, 2002, J NEUROPHYSIOL, V87, P423, DOI 10.1152/jn.00187.2001; Broner N., 1985, Journal of Low Frequency Noise & Vibration, V4, P1; Broner N., 1978, Acoustics Letters, V2, P22; CORSO JF, 1958, AM J PSYCHOL, V71, P367, DOI 10.2307/1420081; Cox RM, 1997, EAR HEARING, V18, P388, DOI 10.1097/00003446-199710000-00004; Dommes E, 2009, BRAIN RES, V1304, P129, DOI 10.1016/j.brainres.2009.09.089; Edmister WB, 1999, HUM BRAIN MAPP, V7, P89, DOI 10.1002/(SICI)1097-0193(1999)7:2<89::AID-HBM2>3.3.CO;2-E; Grosso A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9886; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Hall DA, 2001, J ACOUST SOC AM, V109, P1559, DOI 10.1121/1.1345697; Hart HC, 2002, HEARING RES, V171, P177, DOI 10.1016/S0378-5955(02)00498-7; HELLER O, 1985, PSYCHOL BEITR, V27, P478; Hensel J, 2007, HEARING RES, V233, P67, DOI 10.1016/j.heares.2007.07.004; Inukai Y, 2005, J LOW FREQ NOISE V A, V24, P163, DOI 10.1260/026309205775374433; Inukai Y, 2000, J LOW FREQ NOISE V A, V19, P135, DOI 10.1260/0263092001492895; Jancke L, 2002, HEARING RES, V170, P166, DOI 10.1016/S0378-5955(02)00488-4; Kuehler R, 2015, J ACOUST SOC AM, V137, pEL347, DOI 10.1121/1.4916795; Kuhler R, 2015, P EURONOISE 2015 JUN; Kumar S, 2012, J NEUROSCI, V32, P14184, DOI 10.1523/JNEUROSCI.1759-12.2012; Langers DRM, 2007, NEUROIMAGE, V35, P709, DOI 10.1016/j.neuroimage.2006.12.013; Leventhall H G, 2004, Noise Health, V6, P59; Lichtenhan J, 2013, P M ACOUST, V19; Marquardt T, 2007, J ACOUST SOC AM, V121, P3628, DOI 10.1121/1.2722506; Marquardt T, 2018, ACTA ACUST UNITED AC, V104, P825, DOI 10.3813/AAA.919232; Mohr CM, 1999, J ACOUST SOC AM, V105, P2738, DOI 10.1121/1.426942; Moller H., 1987, Journal of Low Frequency Noise & Vibration, V6, P1; Moller H, 2004, Noise Health, V6, P37; Moller H., 1984, Journal of Low Frequency Noise & Vibration, V3, P78; Moore BC., 1995, PERCEPTUAL CONSEQUEN, DOI 10.1093/acprof:oso/9780198523307.001.0001; PERSSON K, 1988, J SOUND VIB, V127, P491, DOI 10.1016/0022-460X(88)90374-4; Persson K., 1990, Journal of Low Frequency Noise & Vibration, V9, P32; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rohl M, 2012, JARO-J ASSOC RES OTO, V13, P369, DOI 10.1007/s10162-012-0315-6; Rohl M, 2011, HUM BRAIN MAPP, V32, P1483, DOI 10.1002/hbm.21123; Sigalovsky IS, 2006, HEARING RES, V215, P67, DOI 10.1016/j.heares.2006.03.002; Staib M, 2020, HUM BRAIN MAPP, V41, P882, DOI 10.1002/hbm.24846; Suzuki M, 2002, HEARING RES, V163, P37, DOI 10.1016/S0378-5955(01)00367-7; TEMPEST W, 1973, ACUSTICA, V29, P205; Uppenkamp S, 2014, HEARING RES, V307, P65, DOI 10.1016/j.heares.2013.08.005; Weichenberger M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174420; Weichenberger M, 2015, HEARING RES, V328, P87, DOI 10.1016/j.heares.2015.08.001; WHITTLE LS, 1972, J SOUND VIB, V21, P431, DOI 10.1016/0022-460X(72)90828-0; Woods DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005183; YEOWART NS, 1974, J ACOUST SOC AM, V55, P814, DOI 10.1121/1.1914605; Zald DH, 2002, NEUROIMAGE, V16, P746, DOI 10.1006/nimg.2002.1115	51	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229088	10.1371/journal.pone.0229088	http://dx.doi.org/10.1371/journal.pone.0229088			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084171	Green Submitted, Green Published, gold			2022-12-26	WOS:000535227900049
J	Djebbari, F; Sharpley, FA; McLain-Smith, S; Vallance, G; Eyre, TA; Kothari, J; Moore, S; Ramasamy, K				Djebbari, Faouzi; Sharpley, Faye A.; McLain-Smith, Susan; Vallance, Grant; Eyre, Toby A.; Kothari, Jaimal; Moore, Sally; Ramasamy, Karthik			Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients	PLOS ONE			English	Article							QUALITY-OF-LIFE; MULTIPLE-MYELOMA; ELDERLY-PATIENTS; LENALIDOMIDE; DEXAMETHASONE; PREDNISONE; MELPHALAN; BORTEZOMIB	Treatment of transplant-ineligible (TNE) newly diagnosed multiple myeloma (NDMM) requires a balance between disease control and maintaining quality of life (QoL). Patients value treatment-free remission periods in this incurable condition, as they are associated with better QoL. We set out to study clinical outcomes of consecutive TNE NDMM patients in routine care treated in Thames Valley Cancer Network between 2009 and 2017. The primary outcome was the evaluation of the treatment-free interval (TFI) after 1st and subsequent lines of therapy in the total cohort and in individual subgroups, according to age (<= 75 vs. >75 years), and co-morbidities using Charlson Co-morbidity Index (CCI): mild: 0-2 vs. moderate: 3-4 vs. severe: >= 5). Secondary outcomes include response rates, overall survival (OS) and progression-free survival (PFS) between subgroups: according to age and according to co-morbidities. In a total cohort of 292 patients, median TFI (IQR) was longest after first-line therapy 6.9 months (1.4-16.9), reducing after second line therapy to 1.8 months (.7-6.9), and after third line therapy to 0.6 months (0.2-1.5). Median TFI followed the same trend across the different subgroups, by age (<= 75, >75 years) and by CCI (0-2, 3-4, >= 5). Overall response rate (ORR) to first line therapy for total cohort was 67%, with responses categorised as complete response (CR): 21%, very good partial response: 16%, partial response: 30%, stable disease: 18%, and progressive disease: 8%. ORR in individual subgroups by age were (<= 75: 70% vs. > 75: 63%), and by CCI (0-2: 65% vs. 3-4: 71% vs. >= 5: 77%). Median OS and PFS for the total cohort were (30.2 months, 95% CI: 23.8-36.9), and (9 months, 95% CI: 7.9-9.8), respectively. Patients aged > 75 years showed a significant reduction in OS and PFS compared to those <= 75 years of age: OS (49.0 vs. 22.4 months, p<0.0001, HR: 2.08, 95% CI: 1.5-2.8), PFS (9.7 vs. 8.0 months, p<0.01, HR: 1.47, 95% CI: 1.1-1.9). Median OS was significantly reduced with worsening co-morbidities: (CCI 0-2: 52.4 months vs. CCI 3-4: 33.0 months vs. CCI >= 5: 24.0 months, p = 0.01, HR: 1.43, 95% CI: 1.1-1.9). Median PFS was significantly reduced in the severely co-morbid subgroup (CCI 0-2: 9.4 months vs. CCI 3-4: 9.6 months vs. CCI >= 5: 7.1 months, p = 0.025, HR: 1.3, 95% CI: 1.0-1.6). This study demonstrated that first line therapy in the TNE NDMM setting resulted in the longest TFI which was modest at a median of 6.9 months, and decreased significantly following subsequent lines of therapy and across the different subgroups by age and by co-morbidities. Therapy objective should be to maximise the benefit of first line treatment. We envisage that the recent shift towards a continuous therapeutic approach will benefit TNE patients in view of improved survival data demonstrated by a number phase 3 trials. When continuous therapy is not appropriate due to patient choice or toxicities, an efficacious (not limited to thalidomide and bortezomib) but tolerable first line FDT strategy, which can maximise TFI and maintain a good QoL, remains a reasonable alternative approach.	[Djebbari, Faouzi; Sharpley, Faye A.; Vallance, Grant; Eyre, Toby A.; Kothari, Jaimal; Moore, Sally; Ramasamy, Karthik] Oxford Univ Hosp NHS Fdn Trust, Dept Clin Haematol, Oxford, England; [McLain-Smith, Susan] PH Associates, Marlow, Bucks, England	Oxford University Hospitals NHS Foundation Trust	Djebbari, F (corresponding author), Oxford Univ Hosp NHS Fdn Trust, Dept Clin Haematol, Oxford, England.	faouzi.djebbari@ouh.nhs.uk		Vallance, Grant/0000-0001-6539-4002; DJEBBARI, Faouzi/0000-0001-9578-7632; Ramasamy, Karthik/0000-0003-3385-3707				Acaster S, 2013, SUPPORT CARE CANCER, V21, P599, DOI 10.1007/s00520-012-1548-y; Benboubker L, 2014, NEW ENGL J MED, V371, P906, DOI 10.1056/NEJMoa1402551; Cancer Research UK, CANC STAT MYEL INC S; Delforge M, 2015, HAEMATOLOGICA, V100, P826, DOI 10.3324/haematol.2014.120121; Dimopoulos M.A, 2014, BLOOD; Facon T, 2019, NEW ENGL J MED, V380, P2104, DOI 10.1056/NEJMoa1817249; Mateos MV, 2018, NEW ENGL J MED, V378, P518, DOI 10.1056/NEJMoa1714678; Mateosi MV, 2017, HEMATOL-AM SOC HEMAT, P498, DOI 10.1182/asheducation-2017.1.498; Matsue K, 2016, LEUKEMIA LYMPHOMA, V57, P110, DOI 10.3109/10428194.2015.1041386; Muhlbacher A.C, 2018, PSYCHOSOCIAL MED, V5, P1; National Institute for Health and Care Excellence, LEN PLUS DEX PREV UN; Palumbo A, 2012, NEW ENGL J MED, V366, P1759, DOI 10.1056/NEJMoa1112704; Richardson P, 2017, EXPERT REV HEMATOL, V10, P933, DOI 10.1080/17474086.2017.1369399; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Yong K, 2016, BRIT J HAEMATOL, V175, P252, DOI 10.1111/bjh.14213; Zweegman S, 2017, CURR OPIN ONCOL, V29, P315, DOI 10.1097/CCO.0000000000000395	16	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229469	10.1371/journal.pone.0229469	http://dx.doi.org/10.1371/journal.pone.0229469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084254	Green Published, gold			2022-12-26	WOS:000535227900110
J	Panahi, B; Farhadian, M; Hejazi, MA				Panahi, Bahman; Farhadian, Mohammad; Hejazi, Mohammad Amin			Systems biology approach identifies functional modules and regulatory hubs related to secondary metabolites accumulation after transition from autotrophic to heterotrophic growth condition in microalgae	PLOS ONE			English	Article							SERINE HYDROXYMETHYLTRANSFERASE; ARABIDOPSIS; NETWORK; OVEREXPRESSION; PROTEIN; ACID; PATHWAY; BIOMASS	Heterotrophic growth mode is among the most promising strategies put forth to overcome the low biomass and secondary metabolites productivity challenge. To shedding light on the underlying molecular mechanisms, transcriptome meta-analysis was integrated with weighted gene co-expression network analysis (WGCNA), connectivity analysis, functional enrichment, and hubs identification. Meta-analysis and Functional enrichment analysis demonstrated that most of the biological processes are up-regulated at heterotrophic growth condition, which leads to change of genetic architectures and phenotypic outcomes. WGNCA analysis of meta-genes also resulted four significant functional modules across logarithmic (LG), transition (TR), and production peak (PR) phases. The expression pattern and connectivity characteristics of the brown module as a non-preserved module vary across LG, TR, and PR phases. Functional analysis identified Carotenoid biosynthesis, Fatty acid metabolism and Methane metabolism as enriched pathways in the non-preserved module. Our integrated approach was applied here, identified some hubs, such as a serine hydroxymethyltransferase (SHMT1), which is the best candidate for development of metabolites accumulating strains in microalgae. Current study provided a new insight into underlying metabolite accumulation mechanisms and opens new avenue for the future applied studies in the microalgae field.	[Panahi, Bahman] Agr Res Educ & Extens Org AREEO, Agr Biotechnol Res Inst Iran ABRII, Branch Northwest & West Reg, Dept Genom, Tabriz, Iran; [Farhadian, Mohammad] Univ Tabriz, Fac Agr, Dept Anim Sci, Tabriz, Iran; [Hejazi, Mohammad Amin] Agr Res Educ & Extens Org AREEO, Agr Biotechnol Res Inst Iran ABRII, Branch Northwest & West Reg, Dept Food Biotechnol, Tabriz, Iran	University of Tabriz	Panahi, B (corresponding author), Agr Res Educ & Extens Org AREEO, Agr Biotechnol Res Inst Iran ABRII, Branch Northwest & West Reg, Dept Genom, Tabriz, Iran.	b.panahi@abrii.ac.ir	Panahi, Bahman/HHN-6671-2022; Farhadian, Mohammad/AAC-7726-2022; Farhadina, Mohammad/AEX-0922-2022	Panahi, Bahman/0000-0001-8523-994X; 	Agricultural Biotechnology Research Institute of Iran (ABRII)	Agricultural Biotechnology Research Institute of Iran (ABRII)	The work was supported by the Agricultural Biotechnology Research Institute of Iran (ABRII). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akubude V. C., 2019, Materials Science for Energy Technologies, V2, P216, DOI 10.1016/j.mset.2018.12.006; Bakhtiarizadeh MR, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00453; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Botia JA, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0420-6; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Cecchin M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24979-8; Cho Dae-Hyun, 2017, Sci Rep, V7, P1979, DOI 10.1038/s41598-017-02139-8; Choi CI, 2019, MAR DRUGS, V17, DOI 10.3390/md17040242; de Lomana ALG, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0391-z; Fulda M, 2002, PLANT J, V32, P93, DOI 10.1046/j.1365-313X.2002.01405.x; Gao CF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-582; Gargouri M, 2015, J EXP BOT, V66, P4551, DOI 10.1093/jxb/erv217; GLADUE RM, 1994, J APPL PHYCOL, V6, P131, DOI 10.1007/BF02186067; Harun R, 2010, RENEW SUST ENERG REV, V14, P1037, DOI 10.1016/j.rser.2009.11.004; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karlsen J, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00126-18; Ke SW, 2018, BOT STUD, V59, DOI 10.1186/s40529-018-0226-x; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li L, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0839-8; Li T, 2020, ALGAL RES, V45, DOI 10.1016/j.algal.2019.101753; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MARTINEZ F, 1991, ANN BOT-LONDON, V67, P239, DOI 10.1093/oxfordjournals.aob.a088128; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Medina IR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156006; Moreno JI, 2005, PLANT J, V41, P451, DOI 10.1111/j.1365-313X.2004.02311.x; Mullner D, 2013, J STAT SOFTW, V53, P1; Ogbonna JC, 1998, J APPL PHYCOL, V10, P67, DOI 10.1023/A:1008011201437; Panahi B, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00752; Panahi B, 2019, PHYSIOL MOL BIOL PLA, V25, P485, DOI 10.1007/s12298-018-00637-1; Panahi B, 2015, FEBS LETT, V589, P3564, DOI 10.1016/j.febslet.2015.09.023; Panahi Bahman, 2013, Biotechnologia (Poznan), V94, P285; Perez-Garcia O., 2015, ALGAL BIOREFINERIES, P61, DOI DOI 10.1007/978-3-319-20200-6_3; Pulz O, 2004, APPL MICROBIOL BIOT, V65, P635, DOI 10.1007/s00253-004-1647-x; Pulz O, 2001, APPL MICROBIOL BIOT, V57, P287, DOI 10.1007/s002530100702; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Rengel R, 2018, ALGAL RES, V31, P183, DOI 10.1016/j.algal.2018.02.009; Saito K, 2008, TRENDS PLANT SCI, V13, P36, DOI 10.1016/j.tplants.2007.10.006; Subrahmanian N, 2016, BBA-BIOENERGETICS, V1857, P1001, DOI 10.1016/j.bbabio.2016.01.009; Sun JM, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4155-y; Tahmasebi A, 2019, PROG BIOPHYS MOL BIO, V146, P112, DOI 10.1016/j.pbiomolbio.2019.02.005; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; Wei HR, 2006, PLANT PHYSIOL, V142, P762, DOI 10.1104/pp.106.080358; Xiao YB, 2018, MAR DRUGS, V16, DOI 10.3390/md16080283; Xiong W, 2008, APPL MICROBIOL BIOT, V78, P29, DOI 10.1007/s00253-007-1285-1; Xu YH, 2012, J EXP BOT, V63, P1095, DOI 10.1093/jxb/err315; Yan JF, 2013, APPL MICROBIOL BIOT, V97, P1933, DOI 10.1007/s00253-012-4481-6; Yang Z, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/7364216; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang J, 2019, SUSTAIN ENERG FUELS, V3, P195, DOI 10.1039/c8se00471d; Zheng Y, 2016, MOL PLANT, V9, P1667, DOI 10.1016/j.molp.2016.09.014; Zijffers JWF, 2008, MAR BIOTECHNOL, V10, P404, DOI 10.1007/s10126-007-9077-2; Zinta G, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00700	57	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0225677	10.1371/journal.pone.0225677	http://dx.doi.org/10.1371/journal.pone.0225677			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084664	Green Published, Green Submitted, gold			2022-12-26	WOS:000535227900007
J	Xia, Y; Li, JD; Zhang, ZJ; Luo, S; Liu, SX; Ma, CH; Li, W				Xia, Yu; Li, Jingdu; Zhang, Zhijun; Luo, Sha; Liu, Shouxin; Ma, Chunhui; Li, Wei			Decoding biomass recalcitrance: Dispersion of ionic liquid in aqueous solution and efficient extraction of lignans with microwave magnetic field	PLOS ONE			English	Article							BIPHENYL CYCLOOCTENE LIGNANS; SCHISANDRA-CHINENSIS; ASSISTED EXTRACTION; MACROPOROUS RESIN; EXCHANGE-RESIN; PRETREATMENT; WATER; ORGANIZATION; PYROLYSIS; LIGNIN	Alkaline ionic liquid aqueous solutions were used to extract biphenyl cyclooctene lignans derivatives, and hydrolyze to the free-state biphenyl cyclooctene lignans simultaneously from Schisandra chinensis by microwave-assisted heating. The hydrogen bonds formatted between ionic liquid and water molecular attacks the amorphous region of cellulose. Selective heating by microwave produce the more polar regions, which results in swelling and fragmentation of raw materials near the hot spots. Therefore, ionic liquid-microwave-assisted extraction method of free-state biphenyl cyclooctene lignans was set up. The solid residue after treatment was characterized by infrared spectroscopy and scanning electron microscopy, which showed that cellulose, hemicellulose, and lignin were removed partially. The water content of ionic liquid solution affected its viscosity and diffusivity, and in turns the extraction efficiency of lignans. The IL solutions with different mole fractions of IL were detected by FTIR and Raman spectroscopy, the result shows that IL solutions with higher water contents (> 0.6) won't form clusters. The optimum hydrolysis conditions were 0.2 g of ionic liquid catalyst per 5.0 g of S. chinensis fruits, a microwave irradiation power of 600 W, and heating time of 12 min, which gave a yield of free-state biphenyl cyclooctene lignans of 4.12 +/- 0.37 mg g(-1). Besides, a hydrolysis mechanism of ester-bond biphenyl cyclooctene lignans and decreasing "biomass recalcitrance effect" by ionic liquid microwave-assisted method was proposed.	[Xia, Yu; Li, Jingdu; Zhang, Zhijun; Luo, Sha; Liu, Shouxin; Ma, Chunhui; Li, Wei] Northeast Forestry Univ, Coll Mat Sci & Engn, Harbin, Peoples R China; [Xia, Yu; Li, Jingdu; Zhang, Zhijun; Luo, Sha; Liu, Shouxin; Ma, Chunhui; Li, Wei] Northeast Forestry Univ, Key Lab Biobased Mat Sci & Technol, Minist Educ, Harbin, Peoples R China; [Xia, Yu] Chinese Acad Agr Sci, Inst Urban Agr, Chengdu, Peoples R China	Northeast Forestry University - China; Northeast Forestry University - China; Chinese Academy of Agricultural Sciences; Institute of Urban Agriculture, CAAS	Ma, CH; Li, W (corresponding author), Northeast Forestry Univ, Coll Mat Sci & Engn, Harbin, Peoples R China.; Ma, CH; Li, W (corresponding author), Northeast Forestry Univ, Key Lab Biobased Mat Sci & Technol, Minist Educ, Harbin, Peoples R China.	mchmchmchmch@163.com; liwei19820927@126.com			National Natural Science Foundation of China [31890773]; Fundamental Research Funds for the Central Universities [2572019BB02]; postdoctoral scientific research developmental fund of Heilongjiang Province [LBH-Q16001]; Research Start-up Funding of Introduce Talents in Northeast Forestry University [YQ2015-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); postdoctoral scientific research developmental fund of Heilongjiang Province; Research Start-up Funding of Introduce Talents in Northeast Forestry University	The authors thank the National Natural Science Foundation of China (31890773), the Fundamental Research Funds for the Central Universities (2572019BB02), the postdoctoral scientific research developmental fund of Heilongjiang Province in 2016 (LBH-Q16001), and the Research Start-up Funding of Introduce Talents in Northeast Forestry University (YQ2015-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ GA, 2014, J CHEM PHYS, V140, DOI DOI 10.1063/1.4879660; Blesic M, 2007, GREEN CHEM, V9, P481, DOI 10.1039/b615406a; Boonmanumsin P, 2012, BIORESOURCE TECHNOL, V103, P425, DOI 10.1016/j.biortech.2011.09.136; Cammarata L, 2001, PHYS CHEM CHEM PHYS, V3, P5192, DOI 10.1039/b106900d; Chang GT, 2005, J ETHNOPHARMACOL, V102, P430, DOI 10.1016/j.jep.2005.07.003; Chen SM, 2014, PHYS CHEM CHEM PHYS, V16, P5893, DOI 10.1039/c3cp53116c; Choi YW, 2006, J NAT PROD, V69, P356, DOI 10.1021/np0503707; Desai RK, 2012, GREEN CHEM, V18, P1; Dong K, 2017, CHEM REV, V117, P6636, DOI 10.1021/acs.chemrev.6b00776; El Seoud OA, 2007, J COLLOID INTERF SCI, V313, P296, DOI 10.1016/j.jcis.2007.04.028; Fazio B, 2008, J RAMAN SPECTROSC, V39, P233, DOI 10.1002/jrs.1825; Ferraz R, 2011, CHEMMEDCHEM, V6, P975, DOI 10.1002/cmdc.201100082; Gomez LD, 2008, NEW PHYTOL, V178, P473, DOI 10.1111/j.1469-8137.2008.02422.x; Hallett JP, 2011, CHEM REV, V111, P3508, DOI 10.1021/cr1003248; Harris D, 2010, PLANT BIOTECHNOL J, V8, P244, DOI 10.1111/j.1467-7652.2009.00481.x; Hassan HMA, 2017, J MOL LIQ, V236, P385, DOI 10.1016/j.molliq.2017.04.034; Hayouni S, 2017, MOL CATAL, V437, P121, DOI 10.1016/j.mcat.2017.05.007; Jiang N, 2010, CHEMSUSCHEM, V3, P1285, DOI 10.1002/cssc.201000120; Jiang X, 2016, J CO2 UTIL, V16, P264, DOI 10.1016/j.jcou.2016.08.003; Kaparaju P, 2010, BIORESOURCE TECHNOL, V101, P3175, DOI 10.1016/j.biortech.2009.12.008; Katayanagi H, 2004, J PHYS CHEM B, V108, P19451, DOI 10.1021/jp0477607; Kostas ET, 2017, RENEW SUST ENERG REV, V77, P12, DOI 10.1016/j.rser.2017.03.135; Lee HJ, 2010, FOOD CHEM, V120, P1224, DOI 10.1016/j.foodchem.2009.11.068; Li CL, 2011, BIORESOURCE TECHNOL, V102, P6928, DOI 10.1016/j.biortech.2011.04.005; Li CL, 2010, BIORESOURCE TECHNOL, V101, P4900, DOI 10.1016/j.biortech.2009.10.066; Lu Y, 2009, J CHROMATOGR A, V1216, P1980, DOI 10.1016/j.chroma.2008.09.070; Ma CH, 2015, J CHROMATOGR B, V976, P1, DOI 10.1016/j.jchromb.2014.11.003; Ma CH, 2011, J CHROMATOGR A, V1218, P8573, DOI 10.1016/j.chroma.2011.09.075; Ma CH, 2011, J CHROMATOGR B, V879, P3444, DOI 10.1016/j.jchromb.2011.09.022; Ma CH, 2011, ANAL CHIM ACTA, V689, P110, DOI 10.1016/j.aca.2011.01.012; MacFarlane DR, 2006, CHEM COMMUN, P1905, DOI 10.1039/b516961p; Macquarrie DJ, 2012, BIOFUEL BIOPROD BIOR, V6, P549, DOI 10.1002/bbb.1344; Matharu AS, 2018, CHEMSUSCHEM, V11, P1344, DOI 10.1002/cssc.201702456; Mele A, 2003, ANGEW CHEM INT EDIT, V42, P4364, DOI 10.1002/anie.200351783; Miki K, 2005, J PHYS CHEM B, V109, P9014, DOI 10.1021/jp046309c; Sahraoui N, 2008, J CHROMATOGR A, V1210, P229, DOI 10.1016/j.chroma.2008.09.078; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Vinatoru M, 2017, TRAC-TREND ANAL CHEM, V97, P159, DOI 10.1016/j.trac.2017.09.002; Watanabe M, 2017, CHEM REV, V117, P7190, DOI 10.1021/acs.chemrev.6b00504; Yang QW, 2018, CHEM SOC REV, V47, P2020, DOI 10.1039/c7cs00464h; Zhang LH, 2017, CHEM ENG J, V328, P445, DOI 10.1016/j.cej.2017.07.060; Zheng AQ, 2015, GREEN CHEM, V17, P1167, DOI 10.1039/c4gc01724b	42	1	1	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0226901	10.1371/journal.pone.0226901	http://dx.doi.org/10.1371/journal.pone.0226901			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084140	Green Published, gold			2022-12-26	WOS:000535227900008
J	Tankpa, V; Wang, L; Atanga, RA; Awotwi, A; Guo, XM				Tankpa, Vitus; Wang, Li; Atanga, Raphael Ane; Awotwi, Alfred; Guo, Xiaomeng			Evidence and impact of map error on land use and land cover dynamics in Ashi River watershed using intensity analysis	PLOS ONE			English	Article							COASTAL ZONE; URBANIZATION; CLASSIFICATION; TRAJECTORIES; TRANSITIONS; SEDIMENT; COUNTY; AREAS; BASIN; SOIL	Previously, applications of intensity analysis (IA) on land use and land cover change (LULCC) studies have focused on deviations from uniform intensity (UI) and failed to quantify the reasons behind these deviations. This study presents the application of IA with hypothetical errors that could explain non-uniform LULCC in the context of IA at four-time points. LULCC in the Ashi watershed was examined using Landsat images from 1990, 2000, 2010 and 2014 showing the classes: Urban, water, agriculture, close canopy, open canopy and other vegetation. Matrices were created to statistically examine LULCC using IA. The results reveal that the seeming LULCC intensities are not uniform with respect to the interval, category and transition levels of IA. Error analysis indicates that, hypothetical errors in 13%, 19% and 11.2% of the 2000, 2010 and 2014 maps respectively could account for all differences between the observed gain intensities and the UI; while errors in 12%, 21%, and 11% of the 1990, 2000 and 2010 maps respectively could account for all differences between the observed loss intensities and the UI. A hypothetical error in 0.6% and 1.6% of the 1990 map; 1.5% and 4% of the 2000 map; 1.2% and 2.1% of the 2010 map could explain divergences from uniform transitions given URB gain and AGR gain during 1990-2000, 2000-2010 and 2010-2014 respectively. Evidence for a specific deviation from the relevant hypothesized UI is either strong or weak depending on the size of these errors. We recommend that users of IA concept consider assessing their map errors, since limited ground information on past time point data exist. These errors will indicate strength of evidence for deviations and reveals patterns that increase researcher's insight on LULCC processes.	[Tankpa, Vitus; Wang, Li; Guo, Xiaomeng] Harbin Inst Technol, Sch Environm, State Key Lab Urban Water Resource & Environm, Harbin, Peoples R China; [Atanga, Raphael Ane] Univ Johannesburg, Sch Tourism & Hospitality, Dept Tourism, Johannesburg, South Africa; [Awotwi, Alfred] UDS, Dept Environm Sci, Navrongo, Ghana	Harbin Institute of Technology; University of Johannesburg	Wang, L (corresponding author), Harbin Inst Technol, Sch Environm, State Key Lab Urban Water Resource & Environm, Harbin, Peoples R China.	wli@hit.edu.cn	Tankpa, Vitus/AAS-5950-2021; Wang, Li/AAU-2092-2020; Wang, LI/ABF-2909-2020	Wang, Li/0000-0003-0661-9149; 	National Key Research and Development Program of China; Major Science and Technology Program for Water Pollution Control and Treatment [2012 ZX07201003]	National Key Research and Development Program of China; Major Science and Technology Program for Water Pollution Control and Treatment	This research was supported by the National Key Research and Development Program of China (Project No. 2016YFC0401105), and the Major Science and Technology Program for Water Pollution Control and Treatment (2012 ZX07201003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful for the support provided by the National Key Research and Development Program of China. We also, appreciates the critical comments of the anonymous reviewers of the manuscript,which helped to improve the quality of this paper greatly.	Abd El-Kawy OR, 2011, APPL GEOGR, V31, P483, DOI 10.1016/j.apgeog.2010.10.012; Akinyemi FO, 2017, J SPAT SCI, V62, P69, DOI 10.1080/14498596.2016.1196624; Aldwaik SZ, 2013, INT J GEOGR INF SCI, V27, P1717, DOI 10.1080/13658816.2013.787618; Aldwaik SZ, 2012, LANDSCAPE URBAN PLAN, V106, P103, DOI 10.1016/j.landurbplan.2012.02.010; Alkharabsheh MM, 2013, PROCEDIA ENVIRON SCI, V19, P912, DOI 10.1016/j.proenv.2013.06.101; Alo CA, 2008, ENVIRON PLANN B, V35, P280, DOI 10.1068/b32091; Anteneh Y, 2018, ENVIRON MONIT ASSESS, V190, DOI 10.1007/s10661-018-6688-1; Aspinall R, 2004, J ENVIRON MANAGE, V72, P91, DOI 10.1016/j.jenvman.2004.02.009; Awotwi A, 2015, WATER ENVIRON J, V29, P259, DOI 10.1111/wej.12100; Benefoh DT, 2018, APPL GEOGR, V99, P109, DOI 10.1016/j.apgeog.2018.07.027; Carmona A, 2012, APPL GEOGR, V32, P904, DOI 10.1016/j.apgeog.2011.09.006; [陈竹 Chen Zhu], 2013, [生态学报, Acta Ecologica Sinica], V33, P3213; Creutzig F, 2015, P NATL ACAD SCI USA, V112, P6283, DOI 10.1073/pnas.1315545112; Ding J, 2015, WATER-SUI, V7, P4427, DOI 10.3390/w7084427; Dubovyk O, 2011, ISPRS J PHOTOGRAMM, V66, P235, DOI 10.1016/j.isprsjprs.2010.10.002; Enaruvbe GO, 2015, INT J REMOTE SENS, V36, P244, DOI 10.1080/01431161.2014.994721; Gergel S.E., 2017, LEARNING LANDSCAPE E; Gitau M, 2012, LAND-BASEL, V1, P5, DOI 10.3390/land1010005; Gu CL, 2017, CHINESE GEOGR SCI, V27, P847, DOI 10.1007/s11769-017-0911-9; Han J, 2009, J URBAN PLAN DEV, V135, P166, DOI 10.1061/(ASCE)0733-9488(2009)135:4(166); Huang BQ, 2018, ECOL INDIC, V89, P336, DOI 10.1016/j.ecolind.2017.12.057; Huang JL, 2013, OCEAN COAST MANAGE, V81, P14, DOI 10.1016/j.ocecoaman.2012.07.011; Huang L, 2016, LANDSCAPE URBAN PLAN, V145, P57, DOI 10.1016/j.landurbplan.2015.09.005; Li N, 2017, ENVIRON SCI POLLUT R, V24, P3214, DOI 10.1007/s11356-016-7132-0; Li XM, 2013, APPL GEOGR, V38, P1, DOI 10.1016/j.apgeog.2012.11.004; Li YY, 2016, WATER-SUI, V8, DOI 10.3390/w8060220; LIM L., 2016, J JSCE, V4, P227, DOI [10.2208/journalofjsce.4.1_227, DOI 10.2208/JOURNALOFJSCE.4.1_227]; Liu SW, 2014, HABITAT INT, V42, P103, DOI 10.1016/j.habitatint.2013.11.003; Lu M., 2014, COMP EC SOCIAL SYSTE, P1; Ma GW, 2015, ENVIRON EARTH SCI, V73, P4831, DOI 10.1007/s12665-014-3786-4; Ma WL, 2013, ENVIRON MONIT ASSESS, V185, P8399, DOI 10.1007/s10661-013-3182-7; Macleod RD, 1998, PHOTOGRAMM ENG REM S, V64, P207; Manandhar R, 2010, AGR ECOSYST ENVIRON, V135, P336, DOI 10.1016/j.agee.2009.10.016; Mertens B, 2000, ANN ASSOC AM GEOGR, V90, P467, DOI 10.1111/0004-5608.00205; Muller K, 2010, LANDSCAPE URBAN PLAN, V98, P3, DOI 10.1016/j.landurbplan.2010.07.004; Munsi M, 2010, REG ENVIRON CHANGE, V10, P145, DOI 10.1007/s10113-009-0101-0; Pang C, 2013, FORESTS, V4, P968, DOI 10.3390/f4040968; Pontius RG, 2013, LAND-BASEL, V2, P351, DOI 10.3390/land2030351; Romero-Ruiz MH, 2012, APPL GEOGR, V32, P766, DOI 10.1016/j.apgeog.2011.08.010; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Shi KF, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8080790; Sun Y, 2015, ENVIRON EARTH SCI, V73, P7221, DOI 10.1007/s12665-014-3901-6; Takada T, 2010, LANDSCAPE ECOL, V25, P561, DOI 10.1007/s10980-009-9433-x; Tripathi R, 2014, APPL GEOGR, V46, P137, DOI 10.1016/j.apgeog.2013.11.007; Wang ZM, 2009, CHINESE GEOGR SCI, V19, P225, DOI 10.1007/s11769-009-0225-7; White MD, 2006, LANDSCAPE URBAN PLAN, V74, P125, DOI 10.1016/j.landurbplan.2004.11.015; Williams DL, 2006, PHOTOGRAMM ENG REM S, V72, P1171, DOI 10.14358/PERS.72.10.1171; Yan B, 2013, J HYDROL, V484, P26, DOI 10.1016/j.jhydrol.2013.01.008; Yang YY, 2017, CHINESE GEOGR SCI, V27, P441, DOI 10.1007/s11769-017-0876-8; Zhou P, 2014, SENSORS-BASEL, V14, P11640, DOI 10.3390/s140711640	50	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0229298	10.1371/journal.pone.0229298	http://dx.doi.org/10.1371/journal.pone.0229298			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8CF	32078648	Green Published, gold			2022-12-26	WOS:000535224600025
J	Arthuis, C; Diguisto, C; Lorphelin, H; Dochez, V; Simon, E; Perrotin, F; Winer, N				Arthuis, Chloe; Diguisto, Caroline; Lorphelin, Henri; Dochez, Vincent; Simon, Emmanuel; Perrotin, Franck; Winer, Norbert			Perinatal outcomes of intrahepatic cholestasis during pregnancy: An 8-year case-control study	PLOS ONE			English	Article							CHOLIC-ACID; EARLY-TERM; PATIENT	Introduction Previous studies of fetal effects have suggested that intrahepatic cholestasis of pregnancy is associated with a higher rate of adverse neonatal outcomes including preterm birth, neonatal respiratory distress syndrome, meconium-stained amniotic fluid, neonatal intensive care unit admission, and stillbirth. The objective was to compare the neonatal and maternal consequences in pregnancies affected by intrahepatic cholestasis and normal pregnancies. Material and methods This case-control study compares pregnancies affected by intrahepatic cholestasis (pruritus and bile acid. 10 mu mol/L) with low-risk pregnancies managed between December 2006 and December 2014 at a French university hospital center. Results There were 83 (59.3%) cases of mild cholestasis (10 <= BA <= 39 mu mol/L), 46 (32.8%) of moderate cholestasis (40 <= BA <= 99 mu mol/L), and 11 (7.9%) of severe cholestasis (BA >= 100 mu mol/L). No in utero fetal deaths occurred in the 140 women with cholestasis or the 560 controls analyzed. The rate of respiratory distress syndrome was higher in neonates of women with intrahepatic cholestasis (17.1% vs. 4.6%, P<0.001; crude OR 4.46 (CI95% 2.49-8.03)). This risk was also significant after adjustment for gestational age at birth and mode of delivery, adjusted OR 2.56 (CI95%1.26-5.18). The postpartum hemorrhage rate was twice as high among the case mothers (25% versus 14.1% for controls, P = 0.002). Conclusion After adjustment on the confounding factors we found a higher rate of respiratory distress syndrome and neonatal morbidity among neonates of the cholestasis group.	[Arthuis, Chloe; Diguisto, Caroline; Lorphelin, Henri; Simon, Emmanuel; Perrotin, Franck] Univ Hosp Reg Ctr Tours, Dept Gynecol & Obstet, Tours, France; [Arthuis, Chloe; Dochez, Vincent; Winer, Norbert] Univ Hosp Ctr Nantes, Dept Gynecol & Obstet, Nantes, France	Nantes Universite; CHU de Nantes	Arthuis, C (corresponding author), Univ Hosp Reg Ctr Tours, Dept Gynecol & Obstet, Tours, France.; Arthuis, C (corresponding author), Univ Hosp Ctr Nantes, Dept Gynecol & Obstet, Nantes, France.	chloearthuis@gmail.com	Perrotin, Franck/AAL-8833-2021	Perrotin, Franck/0000-0001-9694-6658; Arthuis, Chloe/0000-0002-7937-3648				[Anonymous], 2011, OBSTET CHOLESTASIS G; Bacq Y, 2012, GASTROENTEROLOGY, V143, P1492, DOI 10.1053/j.gastro.2012.08.004; Brouwers L, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.07.026; CHAPPELL LC, 2012, BMJ-BRIT MED J, V344, DOI DOI 10.1136/BMJ.E3799; Chappell LC, 2019, LANCET, V394, P849, DOI 10.1016/S0140-6736(19)31270-X; Estiu MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176504; Geenes V, 2014, HEPATOLOGY, V59, P1482, DOI 10.1002/hep.26617; Glantz A, 2004, HEPATOLOGY, V40, P467, DOI 10.1002/hep.20336; Gorelik J, 2004, BJOG-INT J OBSTET GY, V111, P867, DOI 10.1111/j.1471-0528.2004.00166.x; Henderson CE, 2014, AM J OBSTET GYNECOL, V211, P189, DOI 10.1016/j.ajog.2014.03.058; Kawakita T, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.06.021; Khireddine I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054858; Lo JO, 2015, J MATERN-FETAL NEO M, V28, P2254, DOI 10.3109/14767058.2014.984605; Ovadia C, 2019, LANCET, V393, P899, DOI 10.1016/S0140-6736(18)31877-4; PEREZ R, 1994, RES EXP MED, V194, P63, DOI 10.1007/BF02576367; Puljic A, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.02.012; Quigley MA, 2012, ARCH DIS CHILD-FETAL, V97, pF167, DOI 10.1136/archdischild-2011-300888; RIOSECO AJ, 1994, AM J OBSTET GYNECOL, V170, P890, DOI 10.1016/S0002-9378(94)70304-3; Sengupta S, 2013, JAMA PEDIATR, V167, P1053, DOI 10.1001/jamapediatrics.2013.2581; Sentilhes L, 2006, OBSTET GYNECOL, V107, P458, DOI 10.1097/01.AOG.0000187951.98401.f7; Shemer EW, 2013, BJOG-INT J OBSTET GY, V120, P717, DOI 10.1111/1471-0528.12174; Williamson C, 2004, BJOG-INT J OBSTET GY, V111, P676, DOI 10.1111/j.1471-0528.2004.00167.x; Zecca E, 2006, PEDIATRICS, V117, P1669, DOI 10.1542/peds.2005-1801; Zecca E, 2008, PEDIATRICS, V121, pE146, DOI 10.1542/peds.2007-1220	24	18	20	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0228213	10.1371/journal.pone.0228213	http://dx.doi.org/10.1371/journal.pone.0228213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8AS	32074108	Green Published, gold			2022-12-26	WOS:000535220600009
J	Nair, S; Trummell, HQ; Rajbhandari, R; Thudi, NK; Nozell, SE; Warram, JM; Willey, CD; Yang, ES; Placzek, WJ; Bonner, JA; Bredel, M				Nair, Sindhu; Trummell, Hoa Q.; Rajbhandari, Rajani; Thudi, Nanda K.; Nozell, Susan E.; Warram, Jason M.; Willey, Christopher D.; Yang, Eddy S.; Placzek, William J.; Bonner, James A.; Bredel, Markus			Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; EXTRACELLULAR DOMAIN MUTATIONS; SQUAMOUS-CELL CARCINOMA; FACTOR RECEPTOR; ANTIBODY MIXTURE; DOWN-REGULATION; PLUS CETUXIMAB; UBIQUITINATION; INHIBITION; MECHANISMS	Epidermal growth factor receptor (EGFR) is a pro-tumorigenic receptor tyrosine kinase that facilitates growth for cancer cells that overexpress the receptor. Monoclonal anti-EGFR antibody Cetuximab (CTX) provides significant clinical benefit in patients with head and neck squamous cell carcinoma (HNSCC). Missense mutations in the ectodomain (ECD) of EGFR can be acquired under CTX treatment and mimic the effect of large deletions on spontaneous untethering and activation of the receptor. Little is known about the contribution of EGFR ECD mutations to EGFR activation and CTX resistance in HNSCC. We identified two concurrent non-synonymous missense mutations (G33S and N56K) mapping to domain I in or near the EGF binding pocket of the EGFR ECD in patient-derived HNSCC cells that were selected for CTX resistance through repeated exposure to the agent in an effort to mimic what may occur clinically. Structural modeling predicted that the G33S and N56K mutants would restrict adoption of a fully closed (tethered) and inactive EGFR conformation while not permitting association of EGFR with the EGF ligand or CTX. Binding studies confirmed that the mutant, untethered receptor displayed reduced affinity for both EGF and CTX but demonstrated sustained activation and presence at the cell surface with diminished internalization and sorting for endosomal degradation, leading to persistent downstream AKT signaling. Our results demonstrate that HNSCC cells can select for EGFR ECD mutations under CTX exposure that converge to trap the receptor in an open, ligand-independent, constitutively activated state. These mutants impede the receptor's competence to bind CTX possibly explaining certain cases of CTX treatment-induced or de novo resistance to CTX.	[Nair, Sindhu; Trummell, Hoa Q.; Rajbhandari, Rajani; Thudi, Nanda K.; Nozell, Susan E.; Willey, Christopher D.; Yang, Eddy S.; Bonner, James A.; Bredel, Markus] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA; [Warram, Jason M.] Univ Alabama Birmingham, Dept Otolaryngol, Birmingham, AL USA; [Placzek, William J.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bonner, JA; Bredel, M (corresponding author), Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA.	jabonner@uabma.edu; mbredel@uab.edu	Placzek, William/AAG-1172-2020	Placzek, William/0000-0003-4096-8617; Nair, Sindhu/0000-0002-5350-1664; Willey, Christopher/0000-0001-9953-0279; Bonner, James/0000-0002-8413-3788	O'Neal Comprehensive Cancer Center [CA013148]	O'Neal Comprehensive Cancer Center	We thank Dr. Michael R. Crowley, Heflin Center for Genomic Sciences at UAB (supported by O'Neal Comprehensive Cancer Center core grant CA013148), for sequencing services and the UAB High Resolution Imaging Facility (HRIF) for access to imaging equipment.	Ahsan A, 2010, CANCER RES, V70, P2862, DOI 10.1158/0008-5472.CAN-09-4294; Arena S, 2015, CLIN CANCER RES, V21, P2157, DOI 10.1158/1078-0432.CCR-14-2821; Bakker J, 2017, J CELL SCI, V130, P4087, DOI 10.1242/jcs.209197; Bessman NJ, 2014, CELL REP, V9, P1306, DOI 10.1016/j.celrep.2014.10.010; Binder ZA, 2018, CANCER CELL, V34, P163, DOI 10.1016/j.ccell.2018.06.006; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Braig F, 2017, CANCER RES, V77, P1188, DOI 10.1158/0008-5472.CAN-16-0754; Brand TM, 2014, CANCER RES, V74, P5152, DOI 10.1158/0008-5472.CAN-14-0294; Brand TM, 2011, CANCER BIOL THER, V11, P777, DOI 10.4161/cbt.11.9.15050; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Capuani F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8999; Dienstmann R, 2015, CANCER DISCOV, V5, P598, DOI 10.1158/2159-8290.CD-14-1432; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Haglund K, 2005, EMBO REP, V6, P635, DOI 10.1038/sj.embor.7400453; Harari PM, 2004, ENDOCR-RELAT CANCER, V11, P689, DOI 10.1677/erc.1.00600; Herbst RS, 2002, CANCER-AM CANCER SOC, V94, P1593, DOI 10.1002/cncr.10372; Keller J, 2016, MOL CANCER RES, V14, P740, DOI 10.1158/1541-7786.MCR-15-0477; Khattri A, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.e18061; Klein P, 2004, P NATL ACAD SCI USA, V101, P929, DOI 10.1073/pnas.0307285101; Kojima T, 2018, CANCER SCI, V109, P3253, DOI 10.1111/cas.13767; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lee JC, 2006, PLOS MED, V3, P2264, DOI 10.1371/journal.pmed.0030485; Leemans CR, 2018, NAT REV CANCER, V18, P269, DOI 10.1038/nrc.2018.11; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Liao HW, 2015, J CLIN INVEST, V125, P4529, DOI 10.1172/JCI82826; Licitra L, 2013, EUR J CANCER, V49, P1161, DOI 10.1016/j.ejca.2012.11.018; Mellman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016949; Mohapatra B, 2013, BBA-MOL CELL RES, V1833, P122, DOI 10.1016/j.bbamcr.2012.10.010; Montagut C, 2018, JAMA ONCOL, V4, DOI 10.1001/jamaoncol.2017.5245; Needham SR, 2014, BIOCHEM SOC T, V42, P114, DOI 10.1042/BST20130236; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Okada Y, 2017, MOL CANCER RES, V15, P1445, DOI 10.1158/1541-7786.MCR-16-0383; Orellana L, 2019, P NATL ACAD SCI USA, V116, P10009, DOI 10.1073/pnas.1821442116; Pines G, 2010, FEBS LETT, V584, P2699, DOI 10.1016/j.febslet.2010.04.019; Piper RC, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016808; Polo S, 2014, CELL CYCLE, V13, P681, DOI 10.4161/cc.27855; Purba ER, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6020013; Rampias T, 2014, CLIN CANCER RES, V20, P2933, DOI 10.1158/1078-0432.CCR-13-2721; Ravid T, 2004, J BIOL CHEM, V279, P37153, DOI 10.1074/jbc.M403210200; Rebucci M, 2011, INT J ONCOL, V38, P189, DOI 10.3892/ijo_00000838; Roepstorff K, 2002, J BIOL CHEM, V277, P18954, DOI 10.1074/jbc.M201422200; Sanchez-Martin FJ, 2016, CLIN CANCER RES, V22, P3260, DOI 10.1158/1078-0432.CCR-15-2400; Schmid SL, 2017, J CELL BIOL, V216, P2623, DOI 10.1083/jcb.201705017; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Sigismund S, 2013, EMBO J, V32, P2140, DOI 10.1038/emboj.2013.149; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stang E, 2004, MOL BIOL CELL, V15, P3591, DOI 10.1091/mbc.E04-01-0041; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Umebayashi K, 2008, MOL BIOL CELL, V19, P3454, DOI 10.1091/mbc.E07-10-0988; Wee P, 2017, CANCERS, V9, DOI 10.3390/cancers9050052; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Wheeler SE, 2010, ONCOGENE, V29, P5135, DOI 10.1038/onc.2009.279; Willey CD, 2019, BIOCHEM BIOPH RES CO, V517, P36, DOI 10.1016/j.bbrc.2019.06.159; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; Yu S, 2017, ONCOTARGETS THER, V10, P4507, DOI 10.2147/OTT.S131999	58	10	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0229077	10.1371/journal.pone.0229077	http://dx.doi.org/10.1371/journal.pone.0229077			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7XT	32069320	Green Published, gold			2022-12-26	WOS:000535212900021
J	Shin, JH; Lee, G; Jeong, MG; Kim, HK; Won, HY; Choi, Y; Lee, JH; Nam, M; Choi, CS; Hwang, GS; Hwang, ES				Shin, Ji Hyun; Lee, Gibbeum; Jeong, Mi Gyeong; Kim, Hyo Kyeong; Won, Hee Yeon; Choi, Yujeong; Lee, Ji-Hyeok; Nam, Miso; Choi, Cheol Soo; Hwang, Geum-Sook; Hwang, Eun Sook			Transcriptional coactivator with PDZ-binding motif suppresses the expression of steroidogenic enzymes by nuclear receptor 4 A1 in Leydig cells	FASEB JOURNAL			English	Article						Leydig cell; mitochondrial dysfunction; steroidogenesis; TAZ; testosterone	3-BETA-HYDROXYSTEROID DEHYDROGENASE-DEFICIENCY; MYOGENIC DIFFERENTIATION; TAZ; CHOLESTEROL; GENE; BIOSYNTHESIS; ACTIVATION; TISSUE; RAT; PROLIFERATION	Transcriptional coactivator with PDZ-binding motif (TAZ) plays crucial role in maintaining testicular structure and function via regulation of senescence of spermatogenic cells. However, it remains unclear whether TAZ is involved in testosterone biosynthesis in testicular Leydig cells. We found that TAZ deficiency caused aberrant Leydig cell expansion and increased lipid droplet formation, which was significantly associated with increased lipogenic enzyme expression. Additionally, the expression of key steroidogenic enzymes, including steroidogenic acute regulatory protein, cytochrome P450 (CYP) 11A1, CYP17A1, and 3 beta-hydroxysteroid dehydrogenase, was greatly increased in TAZ-deficient testes and primary Leydig cells. Interestingly, the transcriptional activity of nuclear receptor 4 A1 (NR4A1) was dramatically suppressed by TAZ; however, the protein expression and the subcellular localization of NR4A1 were not affected by TAZ. TAZ directly associated with the N-terminal region of NR4A1 and substantially suppressed its DNA-binding and transcriptional activities. Stable expression of TAZ in the mouse Leydig TM3 cell line decreased the expression of key steroidogenic enzymes, whereas knockdown of endogenous TAZ in TM3 cells increased transcripts of steroidogenic genes induced by NR4A1. Consistently, testosterone production was enhanced within TAZ-deficient Leydig cells. However, TAZ deficiency resulted in decreased testosterone secretion caused by dysfunctional mitochondria and lysosomes. Therefore, TAZ plays essential role in NR4A1-induced steroidogenic enzyme expression and testosterone production in Leydig cells.	[Shin, Ji Hyun; Lee, Gibbeum; Jeong, Mi Gyeong; Kim, Hyo Kyeong; Won, Hee Yeon; Choi, Yujeong; Hwang, Eun Sook] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Coll Pharm, Seoul, South Korea; [Lee, Ji-Hyeok; Choi, Cheol Soo] Gachon Univ, Sch Med, Lee Gil Ya Canc & Diabet Inst, Korea Mouse Metab Phenotyping Ctr, Incheon, South Korea; [Nam, Miso; Hwang, Geum-Sook] Korea Basic Sci Inst, Western Seoul Ctr, Integrated Metabol Res Grp, Seoul, South Korea	Ewha Womans University; Gachon University; Korea Basic Science Institute (KBSI)	Hwang, ES (corresponding author), Ewha Womans Univ, Coll Pharm, C206 Sci Bldg,52 Ewhayeodae Gil, Seoul 03760, South Korea.; Hwang, ES (corresponding author), Ewha Womans Univ, Grad Sch Pharmaceut Sci, C206 Sci Bldg,52 Ewhayeodae Gil, Seoul 03760, South Korea.	eshwang@ewha.ac.kr			National Research Foundation of Korea [2016R1D1A1B03935951, 2018R1A5A2025286, 2014M3A9D5A01073886]; Korea Basic Science Institute [C39531]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Basic Science Institute	National Research Foundation of Korea, Grant/Award Number: 2016R1D1A1B03935951, 2018R1A5A2025286 and 2014M3A9D5A01073886; Korea Basic Science Institute, Grant/Award Number: C39531	AZZIZ R, 1993, AM J OBSTET GYNECOL, V168, P889, DOI 10.1016/S0002-9378(12)90840-6; Di Palma T, 2009, EXP CELL RES, V315, P162, DOI 10.1016/j.yexcr.2008.10.016; DiMarino AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00201; Doran E, 2004, CHEM-BIOL INTERACT, V147, P141, DOI 10.1016/j.cbi.2003.12.002; Fan JJ, 2018, ENDOCRINOLOGY, V159, P1130, DOI 10.1210/en.2017-03065; Fukuda H, 1999, EUR J BIOCHEM, V260, P505, DOI 10.1046/j.1432-1327.1999.00183.x; HALL PF, 1991, J STEROID BIOCHEM, V40, P527, DOI 10.1016/0960-0760(91)90272-7; Hammond GL, 2011, BIOL REPROD, V85, P431, DOI 10.1095/biolreprod.111.092593; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; HOU JW, 1990, ENDOCRINOLOGY, V127, P2047; Hwang JH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08287-x; Iida KT, 2002, FEBS LETT, V520, P177, DOI 10.1016/S0014-5793(02)02811-9; Jang EJ, 2012, MOL CELL BIOL, V32, P4925, DOI 10.1128/MCB.00392-12; Jeong H, 2010, FASEB J, V24, P3310, DOI 10.1096/fj.09-151324; Jeong MG, 2017, AGING CELL, V16, P1035, DOI 10.1111/acel.12631; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kim AR, 2019, FASEB J, V33, P5914, DOI 10.1096/fj.201801256RR; Kim AR, 2017, BIOCHEM BIOPH RES CO, V486, P378, DOI 10.1016/j.bbrc.2017.03.049; Kim TH, 2017, ARCH PHARM RES, V40, P1336, DOI 10.1007/s12272-017-0965-3; Konishi T, 2018, AM J PHYSIOL-GASTR L, V314, pG471, DOI 10.1152/ajpgi.00153.2017; Lala DS, 1997, P NATL ACAD SCI USA, V94, P4895, DOI 10.1073/pnas.94.10.4895; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li F, 2019, ARTERIOSCL THROM VAS, V39, P850, DOI 10.1161/ATVBAHA.119.312136; Lu L, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.205; Martin LJ, 2005, ENDOCRINOLOGY, V146, P861, DOI 10.1210/en.2004-0859; Martin LJ, 2010, BIOL REPROD, V83, P3, DOI 10.1095/biolreprod.110.083824; Miller WL, 2007, MOL ENDOCRINOL, V21, P589, DOI 10.1210/me.2006-0303; Miller WL, 2011, J LIPID RES, V52, P2111, DOI 10.1194/jlr.R016675; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; O'Donnell L, 2000, BIOL REPROD, V63, P99, DOI 10.1095/biolreprod63.1.99; Papadopoulos V, 2012, BEST PRACT RES CL EN, V26, P771, DOI 10.1016/j.beem.2012.05.002; PARDRIDGE WM, 1986, CLIN ENDOCRINOL META, V15, P259, DOI 10.1016/S0300-595X(86)80024-X; Park GH, 2014, BRIT J PHARMACOL, V171, P4051, DOI 10.1111/bph.12755; PAULA FJA, 1994, BRAZ J MED BIOL RES, V27, P1149; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; PIGNATARO OP, 1983, MOL CELL ENDOCRINOL, V33, P53, DOI 10.1016/0303-7207(83)90056-4; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; SCHUMACHER M, 1978, FEBS LETT, V91, P333, DOI 10.1016/0014-5793(78)81204-6; Shea-Eaton WK, 2001, ENDOCRINOLOGY, V142, P1525, DOI 10.1210/en.142.4.1525; Sun J, 2011, J REPROD DEVELOP, V57, P433, DOI 10.1262/jrd.10-123N; TANABE Y, 1983, GEN COMP ENDOCR, V49, P144, DOI 10.1016/0016-6480(83)90018-7; Thelen AM, 2017, TRENDS CELL BIOL, V27, P843, DOI 10.1016/j.tcb.2017.07.006; Traish AM, 2011, HORM MOL BIOL CLIN I, V8, P431, DOI 10.1515/HMBCI.2011.132; van Rensburg HJJ, 2018, CANCER RES, V78, P1457, DOI 10.1158/0008-5472.CAN-17-3139; Wang ZJ, 2001, P NATL ACAD SCI USA, V98, P7988, DOI 10.1073/pnas.141543298; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wilhelm D, 2013, CURR TOP DEV BIOL, V106, P89, DOI 10.1016/B978-0-12-416021-7.00003-1; Won HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17073-y; Yui S, 2018, CELL STEM CELL, V22, P35, DOI 10.1016/j.stem.2017.11.001; Zhang PL, 1996, MOL ENDOCRINOL, V10, P147, DOI 10.1210/me.10.2.147; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zirkin BR, 2018, BIOL REPROD, V99, P101, DOI 10.1093/biolre/ioy059; ZIRKIN BR, 1980, ENDOCRINOLOGY, V107, P1867, DOI 10.1210/endo-107-6-1867	57	5	5	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5332	5347		10.1096/fj.201900695RRRR	http://dx.doi.org/10.1096/fj.201900695RRRR		FEB 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32067268				2022-12-26	WOS:000515248800001
J	Chen, SN; Liu, D; Qian, M; Xu, L; Li, Y; Sun, HZ; Wang, X; Zhou, HY; Bao, J; Xu, CY				Chen, Sainan; Liu, Di; Qian, Min; Xu, Li; Li, Ying; Sun, Haozhong; Wang, Xi; Zhou, Haiyun; Bao, Jian; Xu, Changyan			Preparation of cyanobacteria-enhanced poly (vinyl)alcohol-based films with resistance to blue-violet light / red light and water	PLOS ONE			English	Article							POLYVINYL-ALCOHOL; CARBON-DIOXIDE; EUTROPHICATION; NANOCRYSTALS; NANOFIBERS; FIBERS; STARCH; BLOOMS; ACID	The harmful cyanobacteria blooms which usually form in spring and summer, cause global eutrophication of freshwater and coastal marine ecosystems. This study tried to utilize cyanobacteria as a raw material to produce biological poly(vinyl)alcohol-based films. Cyanobacteria was firstly modified with poly(ethylene glycol), guanidine hydrochloride, carboxymethyl cellulose and 3-glycidoxypropyltrimethoxysilane as plasticizer, modifier, toughening agent and coupling agent, respectively. And then the modified cyanobacteria was introduced to poly(vinyl)alcohol and cellulose nanofibers/poly(vinyl)alcohol matrix to improve the barrier properties of poly(vinyl)alcohol to light and water. Compared with poly(vinyl)alcohol and cellulose nanofibers/poly(vinyl)alcohol films, the obtained cyanobacteria/poly(vinyl) alcohol and the cyanobacteria/cellulose nanofibers/poly(vinyl)alcohol composites exhibit better resistance to light and water. More interestingly, we found that after adding cyanobacteria, the poly(vinyl)alcohol-based films present better barrier properties to blue-violet light and red light. In adddition, introducing cyanobacteria into poly(vinyl)alcohol or cellulose nanofibers/poly(vinyl)alcohol matrix increases the surface roughness and contact angle to water of the composites.	[Chen, Sainan; Zhou, Haiyun; Bao, Jian] Jiangsu Acad Environm Sci, Jiangsu Prov Key Lab Environm Engn, Nanjing, Jiangsu, Peoples R China; [Liu, Di; Qian, Min; Xu, Li; Li, Ying; Sun, Haozhong; Wang, Xi; Xu, Changyan] Nanjing Forestry Univ, Coll Mat Sci & Engn, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University	Chen, SN (corresponding author), Jiangsu Acad Environm Sci, Jiangsu Prov Key Lab Environm Engn, Nanjing, Jiangsu, Peoples R China.; Xu, CY (corresponding author), Nanjing Forestry Univ, Coll Mat Sci & Engn, Nanjing, Jiangsu, Peoples R China.	csn@jshb.gov.cn; changyanxu1999@163.com		Xu, Changyan/0000-0003-4370-9784	Postgraduate Research & Practice Innovation Program of Jiangsu Province [SJKY19_0868]; Key Laboratory of Jiangsu Province Environmental Engineering for Open Project Foundation [ZX2017009]; SNC	Postgraduate Research & Practice Innovation Program of Jiangsu Province; Key Laboratory of Jiangsu Province Environmental Engineering for Open Project Foundation; SNC	This research was funded by the Postgraduate Research & Practice Innovation Program of Jiangsu Province (grant number SJKY19_0868) and Key Laboratory of Jiangsu Province Environmental Engineering for Open Project Foundation (grant number ZX2017009). Initials of author: SNC	Andrade-Pizarro Ricardo David, 2015, Dyna rev.fac.nac.minas, V82, P219, DOI 10.15446/dyna.v82n191.45296; Angermayr SA, 2012, APPL ENVIRON MICROB, V78, P7098, DOI 10.1128/AEM.01587-12; [Anonymous], 2017, GLOB BIOPL PACK FOR; Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; Benson D, 2014, J CLEAN PROD, V72, P4, DOI 10.1016/j.jclepro.2014.02.060; Bonilla J, 2014, FOOD HYDROCOLLOID, V35, P463, DOI 10.1016/j.foodhyd.2013.07.002; Chen CC, 2017, CELLULOSE, V24, P5487, DOI 10.1007/s10570-017-1512-6; Chen X, 2019, MAT SCI ENG C-MATER, V102, P289, DOI 10.1016/j.msec.2019.04.059; Chen YW, 2016, CARBOHYD POLYM, V151, P1210, DOI 10.1016/j.carbpol.2016.06.083; Chen Y, 2008, CARBOHYD POLYM, V73, P8, DOI 10.1016/j.carbpol.2007.10.015; Cho MJ, 2011, J IND ENG CHEM, V17, P36, DOI 10.1016/j.jiec.2010.10.006; Constante A, 2015, ALGAL RES, V12, P412, DOI 10.1016/j.algal.2015.10.005; Duan J, 2016, J ENVIRON CHEM ENG, V4, P440, DOI 10.1016/j.jece.2015.11.029; El Achaby M, 2018, INT J BIOL MACROMOL, V106, P681, DOI 10.1016/j.ijbiomac.2017.08.067; El-Badry YA, 2019, SPECTROCHIM ACTA A, V219, P307, DOI 10.1016/j.saa.2019.04.050; Ghaderi J, 2019, FOOD HYDROCOLLOID, V95, P122, DOI 10.1016/j.foodhyd.2019.04.021; Giteru SG, 2019, FOOD HYDROCOLLOID, V87, P270, DOI 10.1016/j.foodhyd.2018.08.006; Gupta B, 2013, J APPL POLYM SCI, V127, P1301, DOI 10.1002/app.37665; Jayasekara R, 2004, POLYM TEST, V23, P17, DOI 10.1016/S0142-9418(03)00049-7; Jing X, 2019, SENSOR ACTUAT B-CHEM, V295, P159, DOI 10.1016/j.snb.2019.05.082; Kanatt SR, 2012, FOOD HYDROCOLLOID, V29, P290, DOI 10.1016/j.foodhyd.2012.03.005; Lan EI, 2013, ENERG ENVIRON SCI, V6, P2672, DOI 10.1039/c3ee41405a; Larkum AWD, 2018, PHOTOSYNTHETICA, V56, P11, DOI 10.1007/s11099-018-0792-x; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6899, DOI 10.1073/pnas.1103014108; Mandal A, 2014, J IND ENG CHEM, V20, P462, DOI 10.1016/j.jiec.2013.05.003; Monshupanee T, 2016, SCI REP-UK, V6, DOI 10.1038/srep37121; Ni J, ADV EXPT MED BIOL, P239; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Oliver JWK, 2013, P NATL ACAD SCI USA, V110, P1249, DOI 10.1073/pnas.1213024110; Rowe AA, 2016, J THERM ANAL CALORIM, V126, P1371, DOI 10.1007/s10973-016-5791-1; Singh AK, 2017, J APPL PHYCOL, V29, P1213, DOI 10.1007/s10811-016-1006-1; Singh JS, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00529; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; Wang HY, 2019, POLYMERS-BASEL, V11, DOI 10.3390/polym11010153; Wang RF, 2015, J CO2 UTIL, V11, P67, DOI 10.1016/j.jcou.2015.01.007; Wu G, 2019, J POLYM SCI POL CHEM, V57, P1216, DOI 10.1002/pola.29378; Yang SY, 2019, ENZYME MICROB TECH, V128, P72, DOI 10.1016/j.enzmictec.2019.05.003; Yoon SD, 2007, J APPL POLYM SCI, V106, P2485, DOI 10.1002/app.26755; Yue YY, 2015, IND CROP PROD, V76, P355, DOI 10.1016/j.indcrop.2015.07.006	39	6	6	9	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228814	10.1371/journal.pone.0228814	http://dx.doi.org/10.1371/journal.pone.0228814			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053641	Green Published, gold			2022-12-26	WOS:000535198700059
J	Frison, S; Angood, C; Khara, T; Bahwere, P; Black, RE; Briend, A; Connell, N; Fenn, B; Isanaka, S; James, P; Kerac, M; Mayberry, A; Myatt, M; Dolan, C				Frison, Severine; Angood, Chloe; Khara, Tanya; Bahwere, Paluku; Black, Robert E.; Briend, Andre; Connell, Nicki; Fenn, Bridget; Isanaka, Sheila; James, Philip; Kerac, Marko; Mayberry, Amy; Myatt, Mark; Dolan, Carmel		Wasting Prevention Working Grp Col	Prevention of child wasting: Results of a Child Health & Nutrition Research Initiative (CHNRI) prioritisation exercise	PLOS ONE			English	Article							MALNUTRITION; RISK; UNDERNUTRITION; MORTALITY; DISEASE	Background An estimated 49.5 million children under five years of age are wasted. There is a lack of robust studies on effective interventions to prevent wasting. The aim of this study was to identify and prioritise the main outstanding research questions in relation to wasting prevention to inform future research agendas. Method A research prioritisation exercise was conducted following the Child Health and Nutrition Research Initiative method. Identified research gaps were compiled from multiple sources, categorised into themes and streamlined into forty research questions by an expert group. A survey was then widely circulated to assess research questions according to four criteria. An overall research priority score was calculated to rank questions. Findings The prioritised questions have a strong focus on interventions. The importance of the early stages of life in determining later experiences of wasting was highlighted. Other important themes included the identification of at-risk infants and young children early in the progression of wasting and the roles of existing interventions and the health system in prevention. Discussion These results indicate consensus to support more research on the pathways to wasting encompassing the in-utero environment, on the early period of infancy and on the process of wasting and its early identification. They also reinforce how little is known about impactful interventions for the prevention of wasting. Conclusion This exercise provides a five-year investment case for research that could most effectively improve on-the-ground programmes to prevent child wasting and inform supportive policy change.	[Frison, Severine; Angood, Chloe; Khara, Tanya; Fenn, Bridget; Dolan, Carmel] Emergency Nutr Network, Oxford, England; [Frison, Severine] London Sch Hyg & Trop Med, Dept Infect Dis & Epidemiol, London, England; [Bahwere, Paluku] Valid Int, Oxford, England; [Black, Robert E.] Johns Hopkins Univ, Bloomsbury Sch Publ Hlth, Inst Int Programs, Baltimore, MD USA; [Briend, Andre] Tampere Univ, Ctr Child Hlth Res, Tampere, Finland; [Connell, Nicki] Eleanor Crook Fdn, Washington, DC USA; [Isanaka, Sheila] Harvard Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Isanaka, Sheila] Harvard Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Isanaka, Sheila] Epicentre, Dept Res, Paris, France; [James, Philip; Kerac, Marko] London Sch Hyg & Trop Med, Dept Populat Hlth, London, England; [Mayberry, Amy] Wasted Lives & Act Hunger UK, London, England; [Myatt, Mark] Brixton Hlth, Llwyngwril Gwynedd, Wales	University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Tampere University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine	Frison, S (corresponding author), Emergency Nutr Network, Oxford, England.; Frison, S (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis & Epidemiol, London, England.	severine.frison@ennonline.net	Isanaka, Sheila/AAQ-9056-2020; Poluru, Ramesh/K-8093-2013; James, Philip/AAG-4618-2020; Kerac, Marko/G-1777-2010; Kerac, Marko/GQR-1136-2022	Poluru, Ramesh/0000-0002-7693-418X; James, Philip/0000-0001-5448-8193; Kerac, Marko/0000-0002-3745-7317; Fenn, Bridget/0000-0002-8424-4664; Frison, Severine/0000-0002-1586-9564; McGrath, Marie/0000-0002-0660-1873; Khara, Tanya/0000-0002-6251-0052; van der Kam, Saskia/0000-0002-3608-8054; Mayberry, Amy/0000-0003-1113-2706	UK aid; UK Government; PATH by UK Aid from the UK government [DFI.2118-01629955-CRT]	UK aid(CGIAR); UK Government; PATH by UK Aid from the UK government	This paper was produced through the Maximising the Quality of Scaling Up Nutrition Plus (MQSUN+) project supported by UK aid and the UK Government; however, the views expressed do not necessarily reflect the UK Government's official views or policies. This paper was also funded by PATH through contract DFI.2118-01629955-CRT by UK Aid from the UK government. The funders had no role in study design, in the data collection, the analysis, interpretation of data, and in the decision to submit the paper for publication.	Angood C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153221; Angood C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001812; [Anonymous], 2017, SUMM CHNRI SURV; [Anonymous], 2018, RESR AG ACT; [Anonymous], 2018, GLOBAL NUTR REPORT C; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bourke CD, 2016, TRENDS IMMUNOL, V37, P386, DOI 10.1016/j.it.2016.04.003; Christian P, 2013, INT J EPIDEMIOL, V42, P1340, DOI 10.1093/ije/dyt109; Debes AK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S19; Emergency Nutrition Network (ENN), 2018, CURR STAT EV THINK W; ENN, 2018, AET WAST; Grantham-McGregor S, 2005, PUBLIC HEALTH NUTR, V8, P1191, DOI 10.1079/PHN2005805; Hossain M, 2017, J PAEDIATR CHILD H, V53, P474, DOI 10.1111/jpc.13443; Isanaka S, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12817; Johnson MJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017727; Kerac M, 2011, ARCH DIS CHILD, V96, P1008, DOI 10.1136/adc.2010.191882; Maitland K, 2006, PLOS MED, V3, P2431, DOI 10.1371/journal.pmed.0030500; McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639; Moore SE, 2017, ANN NUTR METAB, V70, P179, DOI 10.1159/000456555; Mwangome M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213523; Myatt M, 2018, ARCH PUBLIC HEALTH, V76, DOI 10.1186/s13690-018-0277-1; Olofin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064636; Richard SA, 2012, J NUTR, V142, P1291, DOI 10.3945/jn.111.154922; Rudan I, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010501; Rudan I, 2008, CROAT MED J, V49, P720, DOI 10.3325/cmj.2008.49.720; Shekar M, 2017, ANN NUTR METAB, V71, P111; Stobaugh HC, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12702; Stobaugh HC, 2018, J NUTR, V148, P974, DOI 10.1093/jn/nxy033; Trehan I, 2018, J TROP PEDIATRICS, V64, P169, DOI 10.1093/tropej/fmx103; United Nations, 2018, SUST DEV GOALS REP; Victora C, 2012, ARCH ARGENT PEDIATR, V110, P311, DOI 10.5546/aap.2012.311; Wells JCK, 2018, EUR J CLIN NUTR, V72, P688, DOI 10.1038/s41430-018-0142-x; WHO, 2019, LEV TRENDS CHILD MAL; Yoshida S, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010508; Young H., 2018, PERSISTENT GLOBAL AC	35	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228151	10.1371/journal.pone.0228151	http://dx.doi.org/10.1371/journal.pone.0228151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32049994	Green Published, gold			2022-12-26	WOS:000535192300009
J	Park, JW; Hong, SP; Lee, JH; Moon, SH; Cho, YS; Jung, KH; Lee, J; Lee, KH				Park, Jin Won; Hong, Sun-pyo; Lee, Jin Hee; Moon, Seung Hwan; Cho, Young Seok; Jung, Kyung-Ho; Lee, Jeeyun; Lee, Kyung-Han			Tc-99m-MIBI uptake as a marker of mitochondrial membrane potential in cancer cells and effects of MDR1 and verapamil	PLOS ONE			English	Article							P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; CHANNEL MODULATORS; IN-VITRO; TC-99M-SESTAMIBI; DOXORUBICIN; CHEMOTHERAPY; EXPRESSION; RETENTION; APOPTOSIS	We investigated the relation of Tc-99m-MIBI uptake to mitochondrial membrane potential (MMP) in cancer cell lines and patient-derived tumor cells (PDCs). In T47D and HT29 cells with low MDR1 expression, FCCP dose-dependently reduced MMP and Tc-99m-MIBI accumulation in similar patterns with nearly perfect linear relationships. T47D and HT29 cells with high MDR1 expression had low Tc-99m-MIBI accumulation that was minimally affected by FCCP dose. In these cells, verapamil markedly increased Tc-99m-MIBI accumulation to magnitudes that were excessive compared to MMP increase. Decreased plasma membrane potential by verapamil and its recovery by FCCP suggested that enhanced Tc-99m-MIBI transport through modified plasma membranes contributed to the excess accumulation. Evaluation of three different colon cancer PDCs with low to modest MDR1 expression verified that FCCP significantly suppressed MMP and similarly reduced Tc-99m-MIBI accumulation. Verapamil partially recovered both MMP and Tc-99m-MIBI accumulation that was lowered by FCCP. Importantly, a high linear correlation was found (r = 0.865) between Tc-99m-MIBI accumulation and MMP in these cells. These findings indicate that low baseline Tc-99m-MIBI uptake that is markedly increased by verapamil represents cancer cells with high levels of MDR1 expression. However, in cancer cells with low or modest levels of MDR1 expression that do not markedly increase Tc-99m-MIBI uptake by verapamil, the magnitude of uptake is largely dependent on cellular MMP.	[Park, Jin Won; Hong, Sun-pyo; Lee, Jin Hee; Moon, Seung Hwan; Cho, Young Seok; Jung, Kyung-Ho; Lee, Kyung-Han] Sungkyunkwan Univ, Samsung Med Ctr, Dept Nucl Med, Sch Med, Seoul, South Korea; [Park, Jin Won; Lee, Jin Hee; Jung, Kyung-Ho; Lee, Kyung-Han] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea; [Lee, Jeeyun] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Jung, KH; Lee, KH (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Nucl Med, Sch Med, Seoul, South Korea.; Jung, KH; Lee, KH (corresponding author), Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea.	kyungho.jung@sbri.co.kr; khnm.lee@samsung.com		Lee, Kyung-Han/0000-0003-3565-5536	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2019R1A2C2007455, NRF-2018R1C1B6001250]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (KH Lee, NRF-2019R1A2C2007455 and JW Park, NRF-2018R1C1B6001250).	Arbab AS, 1996, J NUCL MED, V37, P1551; Arbab AS, 2003, NUCL MED COMMUN, V24, P155, DOI 10.1097/00006231-200302000-00008; Arbab AS, 1999, ANN NUCL MED, V13, P27, DOI 10.1007/BF03165424; Ballinger JR, 2008, NUCL MED COMMUN, V29, P303, DOI 10.1097/MNM.0b013e32812906b1; BALLINGER JR, 1995, NUCL MED COMMUN, V16, P253, DOI 10.1097/00006231-199504000-00156; Brenner C, 2000, SCIENCE, V289, P1150, DOI 10.1126/science.289.5482.1150; Burak Z, 2001, EUR J NUCL MED, V28, P1341, DOI 10.1007/s002590100588; Cayre A, 1999, J NUCL MED, V40, P672; CHIU ML, 1990, J NUCL MED, V31, P1646; Chopineaux-Courtois V, 1999, J AM CHEM SOC, V121, P1743, DOI 10.1021/ja9836139; Del Vecchio S, 1999, Q J NUCL MED, V43, P125; Del Vecchio S, 2004, EUR J NUCL MED MOL I, V31, pS88, DOI 10.1007/s00259-004-1530-0; Elefantova K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071985; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Hockenbery DM, 2002, CANCER CELL, V2, P1, DOI 10.1016/S1535-6108(02)00087-9; Lee JY, 2015, ONCOTARGET, V6, P25619, DOI 10.18632/oncotarget.4627; Lorke DE, 2001, J NUCL MED, V42, P646; Lu PH, 2001, EUR J BIOCHEM, V268, P1687, DOI 10.1046/j.1432-1033.2001.02041.x; Modica-Napolitano JS, 2001, ADV DRUG DELIVER REV, V49, P63, DOI 10.1016/S0169-409X(01)00125-9; Muzzammil T, 2001, BRIT J CANCER, V84, P367, DOI 10.1054/bjoc.2000.1621; Pajeva I, 2004, EUR J PHARM SCI, V21, P243, DOI 10.1016/j.ejps.2003.10.013; Park JW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42954-9; PIWNICAWORMS D, 1990, CIRCULATION, V82, P1826, DOI 10.1161/01.CIR.82.5.1826; Robey RW, 2018, NAT REV CANCER, V18, P452, DOI 10.1038/s41568-018-0005-8; Schuldes H, 1998, INT J CLIN PHARM TH, V36, P71; Solaini G, 2007, BIOSCIENCE REP, V27, P11, DOI 10.1007/s10540-007-9033-4; SUMMERHAYES IC, 1982, P NATL ACAD SCI-BIOL, V79, P5292, DOI 10.1073/pnas.79.17.5292; Yajima T, 2009, INT J ONCOL, V35, P273, DOI 10.3892/ijo_00000337; Ye XQ, 2011, INT J CANCER, V129, P820, DOI 10.1002/ijc.25944; Yokogami K, 1998, EUR J NUCL MED, V25, P401, DOI 10.1007/s002590050238	30	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228848	10.1371/journal.pone.0228848	http://dx.doi.org/10.1371/journal.pone.0228848			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32050000	gold, Green Published			2022-12-26	WOS:000535192300028
J	Verma, MV; de Vreede, L; Achterbosch, T; Rutten, MM				Verma, Monika van den Bos; de Vreede, Linda; Achterbosch, Thom; Rutten, Martine M.			Consumers discard a lot more food than widely believed: Estimates of global food waste using an energy gap approach and affluence elasticity of food waste	PLOS ONE			English	Article								This work provides an internationally comparable consumer food waste dataset based on food availability, energy gap and consumer affluence. Such data can be used for constructing meaningful and internationally comparable metrics on food waste, such as those for Sustainable Development Goal 12. The data suggests that consumer food waste follows a linear-log relationship with consumer affluence and starts to emerge when consumers reach a threshold of approximately $6.70/day/capita level of expenditure. These findings also imply that most empirical models overestimate consumption by not accounting for the possibility of food waste in their analysis. The results also show that the most widely cited global estimate of food waste is underestimated by a factor greater than 2 (214 Kcal/day/capita versus 527 Kcal/day/capita). Comparison with estimates of US consumer food waste based on national survey data shows this approach can reasonably reproduce the results without needing extensive data from national surveys.	[Verma, Monika van den Bos; de Vreede, Linda; Achterbosch, Thom; Rutten, Martine M.] Wageningen Univ & Res, Wageningen Econ Res, The Hague, Netherlands; [de Vreede, Linda] Erasmus Univ, Rotterdam, Netherlands; [Rutten, Martine M.] Dutch Minist Foreign Affairs, The Hague, Netherlands	Wageningen University & Research; Erasmus University Rotterdam	Verma, MV (corresponding author), Wageningen Univ & Res, Wageningen Econ Res, The Hague, Netherlands.	monika05@gmail.com		Achterbosch, Thom/0000-0002-2608-1131; van den Bos-Verma, Monika/0000-0001-9393-6171	Dutch Ministry of Economic Affairs [KB-22-002-005, KB-1-1C-1]	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	MV, TA and MR received funding from Dutch Ministry of Economic Affairs (project grant#KB-22-002-005) and grant number KB-1-1C-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT M. K., 1941, Wheat Studies of the Food Res. Inst., Stanford Univ., California, V18, P37; Bouet A, 2014, 17 ANN C GLOB EC AN; Buchner B., 2012, FOOD WASTE CAUSES IM; Buzby J. C., 2014, Economic Information Bulletin - USDA Economic Research Service; Cederberg C, 2013, 857 FAO SIK; Dawson PJ, 1998, AM J AGR ECON, V80, P474, DOI 10.2307/1244550; Dou ZX, 2016, GLOB FOOD SECUR-AGR, V8, P19, DOI 10.1016/j.gfs.2016.02.001; Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x; Dumith SC, 2011, PREV MED, V53, P24, DOI 10.1016/j.ypmed.2011.02.017; FAO, 2001, FOOD BAL SHEETS HDB; FAO, 2001, FOOD NUTR TECHN REP, P96; Food and Agriculture Organization of the United Nations, 2011, GLOBAL FOOD LOSSES F; Gouel C, 2019, AM J AGR ECON, V101, P383, DOI 10.1093/ajae/aay030; Gupta MD, 2014, POWER 1 8 BILLION AD, P136; Hall KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007940; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hawkesworth S, 2010, PHILOS T R SOC B, V365, P3083, DOI 10.1098/rstb.2010.0122; Hic C, 2016, ENVIRON SCI TECHNOL, V50, P4269, DOI 10.1021/acs.est.5b05088; ICP, 2011, PURCH POW PANT REAL, P328; ICP, 2005, GLOB PURCH POW PAR R, P231; Kehlbacher A, 2011, ESTIMATING FOOD DRIN; Kong A, 2013, J NUTR EDUC BEHAV, V45, P39, DOI 10.1016/j.jneb.2012.04.014; Kummu M, 2012, SCI TOTAL ENVIRON, V438, P477, DOI 10.1016/j.scitotenv.2012.08.092; Lallukka T, 2007, EUR J CLIN NUTR, V61, P701, DOI 10.1038/sj.ejcn.1602583; Mendoza A, 2017, J EPIDEMIOL COMMUN H, V71, P713, DOI 10.1136/jech-2016-207781; Neff RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127881; Osner R., 1982, NUTR FOOD SCI, V82, P13, DOI [DOI 10.1108/EB058904, 10.1108/eb058904]; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Popkin BM, COMPARISON DIETARY T; Portner H.-O., 2019, SPEC REP OC CRYOSPH; Stefan V, 2013, FOOD QUAL PREFER, V28, P375, DOI 10.1016/j.foodqual.2012.11.001; Svedberg P, 1999, WORLD DEV, V27, P2081, DOI 10.1016/S0305-750X(99)00102-3; Verma M, 2016, UNPUB; World Health Organization, WORLD HLTH SURV WHS; Zhou D, 2015, APPL ECON PERSPECT P, V37, P575, DOI 10.1093/aepp/ppu043	35	29	29	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228369	10.1371/journal.pone.0228369	http://dx.doi.org/10.1371/journal.pone.0228369			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7PV	32049964	Green Published, gold			2022-12-26	WOS:000535192300013
J	Janmohammadi, A; Sheikhi, N; Nazarpak, HH; Brujeni, GN				Janmohammadi, Arash; Sheikhi, Nariman; Nazarpak, Hadi Haghbin; Brujeni, Gholamreza Nikbakht			Effects of vaccination on acute-phase protein response in broiler chicken	PLOS ONE			English	Article							PERFORMANCE; STRESS	Broiler chickens experience an acute-phase response (APR) through vaccination, which reflects the innate immunity and stress related to immunization. It is also considered that APR can modulate adaptive immunity and response to infection. As biomarkers for APR, assessing the acute-phase proteins (APPs) function and their levels in response to immunization is of great value for vaccine design, development and administration. In this study, the heterophils/lymphocyte (H/L) ratio and the level of APPs was evaluated in broilers with three different Newcastle disease (ND) vaccination regimens. Inactivated ND vaccine (IND) was administered by the intramuscular route. Live attenuated strains, Lasota and Vitapest, was administered by ocular routes. H/L ratio, serum amyloid A ( SAA) and alpha-1 acid glycoprotein (AGP) were measured before and after two rounds of vaccination on days 10 and 21. In a comparison between the three vaccines, H/L ratio in IND group significantly increased to 3 fold (1.48 +/- 0.41) after the first vaccination while the Lasota and Vitapest showed a milder response. The concentration of SAA increased after 24h by 1.8-fold in IND group (0.116 +/- 0.015 mg/L) and 2-fold in Lasota group (0.14 +/- 0.002 mg/L). Significant changes were found in Vitapest group after 48h post vaccination (0.113 +/- 0.016 mg/L). Elevation pattern of AGP, 24 hours after first vaccination in IND (3.5-fold) and Vitapest (2.5-fold) was different from Lasota in which the peak was reached after 48 hours (2.9-fold). Except for IND group, no significant changes in SAA and AGP concentrations were detected after the second vaccination. A significant positive correlation between SAA values at day 22 and HI titers at day 28 (r = 0.998, P <= 0.0.005) was found. According to these results, different types of ND vaccines can cause different patterns of acute phase responses. Assessment of stress and level of acute-phase proteins can be used for prediction of immune response outcomes in vaccine design and development.	[Janmohammadi, Arash; Sheikhi, Nariman] Islamic Azad Univ, Fac Vet Med, Dept Clin Sci, Sci & Res Branch, Tehran, Iran; [Nazarpak, Hadi Haghbin] Islamic Azad Univ, Fac Vet Med, Dept Clin Sci, Garmsar Branch, Tehran, Iran; [Brujeni, Gholamreza Nikbakht] Univ Tehran, Fac Vet Med, Dept Microbiol & Immunol, Tehran, Iran	Islamic Azad University; Islamic Azad University; University of Tehran	Brujeni, GN (corresponding author), Univ Tehran, Fac Vet Med, Dept Microbiol & Immunol, Tehran, Iran.	nikbakht@ut.ac.ir	Brujeni, Gholamreza Nikbakht/F-6057-2017	Brujeni, Gholamreza Nikbakht/0000-0002-2970-5827				Andersen SA, 2012, VET J, V191, P199, DOI 10.1016/j.tvjl.2011.01.019; Arthington JD, 2013, J ANIM SCI, V91, P1831, DOI 10.2527/jas.2012-5724; Caipang CMA, 2008, FISH SHELLFISH IMMUN, V24, P314, DOI 10.1016/j.fsi.2007.11.018; Carty CL, 2006, ARTERIOSCL THROM VAS, V26, P2738, DOI 10.1161/01.ATV.0000248534.30057.b5; Cotter PF, 2015, POULTRY SCI, V94, P512, DOI 10.3382/ps/peu009; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P941, DOI 10.1631/jzus.2005.B0941; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Hernandez-Caravaca I, 2017, RES VET SCI, V114, P69, DOI 10.1016/j.rvsc.2017.03.006; Kaab H, 2018, POULTRY SCI, V97, P463, DOI 10.3382/ps/pex340; Najafi P, 2016, POULTRY SCI, V95, P760, DOI 10.3382/ps/pew001; Najafi P, 2015, INT J BIOMETEOROL, V59, P1577, DOI 10.1007/s00484-015-0964-3; Nazifi S, 2011, Comp Clin Path, V20, P69, DOI 10.1007/s00580-009-0939-z; O'Reilly EL, 2014, WORLD POULTRY SCI J, V70, P27, DOI 10.1017/S0043933914000038; Sevimli A, 2012, VET QUART, V32, P17, DOI 10.1080/01652176.2012.689117	14	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0229009	10.1371/journal.pone.0229009	http://dx.doi.org/10.1371/journal.pone.0229009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045459	Green Published, gold			2022-12-26	WOS:000534633200051
J	de Andrade, LGM; Tedesco-Silva, H				Modelli de Andrade, Luis Gustavo; Tedesco-Silva, Helio			Recycling of predictors used to estimate glomerular filtration rate: Insight into lateral collinearity	PLOS ONE			English	Article							EQUATION	Background One overlooked problem in statistical analysis is lateral collinearity, a phenomenon that may occur when the outcome variable derives from the predictors. In nephrology this issue is seen with the use of estimated glomerular filtration rate (eGFR) as an outcome and age, sex, and ethnicity as predictors. In this study with simulated data, we aim to illustrate this problem. Methods We randomly generated unrelated data to estimate eGFR by common equations. Results Using simulated data, we show that age, gender, and ethnicity (recycled predictors variables) are statistically significantly correlated with eGFR in linear regression analysis. Whereas the initial obvious conclusion is that age, sex, and ethnicity are strong predictors of eGFR, more rigorous interpretation suggests that this is a byproduct of the mathematical model produced when deriving new predictors from another. Conclusion While statistical models have the ability to identify vertical collinearity (predictor-predictor), lateral collinearity (predictor-outcome) is seldom identified and discussed in statistical analysis. Therefore, caution is needed when interpreting the correlation between age, gender, and ethnicity with eGFR derived from regression analyses.	[Modelli de Andrade, Luis Gustavo] Univ Estadual Paulista, Dept Internal Med, UNESP, Botucatu, SP, Brazil; [Tedesco-Silva, Helio] Univ Fed Sao Paulo, Hosp Rim, So Paulo, Brazil; [Modelli de Andrade, Luis Gustavo] Univ Estadual Paulista, Botucatu, SP, Brazil; [Tedesco-Silva, Helio] Univ Fed Sao Paulo, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP)	de Andrade, LGM (corresponding author), Univ Estadual Paulista, Dept Internal Med, UNESP, Botucatu, SP, Brazil.; de Andrade, LGM (corresponding author), Univ Estadual Paulista, Botucatu, SP, Brazil.	Gustavo.modeli@unesp.br	de Andrade, Luis Gustavo Modelli/I-4146-2013	Modelli de Andrade, Luis Gustavo/0000-0002-0230-0766				Chen YF, 2019, LIPIDS HLTH DIS, V18, P1, DOI DOI 10.1186/S12943-019-1053-86; Das SK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214568; Delanaye P, 2016, CLIN KIDNEY J, V9, P700, DOI 10.1093/ckj/sfw071; Fisher RA, 1934, STAT METHODS RES WOR, V5th; Kock N., 2012, J ASS INFO SYS, V13, P7; Levey AS, 2014, AM J KIDNEY DIS, V63, P820, DOI 10.1053/j.ajkd.2013.12.006; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Matsushita K, 2010, AM J KIDNEY DIS, V55, P648, DOI 10.1053/j.ajkd.2009.12.016; Pottel H, 2016, NEPHROL DIAL TRANSPL, V31, P798, DOI 10.1093/ndt/gfv454; Shinoda K, 2019, TRANSPL P, V51, P1306, DOI 10.1016/j.transproceed.2019.01.142; Stapleton CP, 2019, AM J TRANSPLANT, V19, P2262, DOI 10.1111/ajt.15326; Vatcheva Kristina P, 2016, Epidemiology (Sunnyvale), V6	13	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228842	10.1371/journal.pone.0228842	http://dx.doi.org/10.1371/journal.pone.0228842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045449	Green Published, gold			2022-12-26	WOS:000534633200041
J	Ozer, I; Carle, T				Ozer, Ismet; Carle, Thomas			Back to the light, coevolution between vision and olfaction in the "Dark-flies" (Drosophila melanogaster)	PLOS ONE			English	Article							BRAIN SIZE; EVOLUTION; LOBE; EYE	Trade-off between vision and olfaction, the fact that investment in one correlates with decreased investment in the other, has been demonstrated by a wealth of comparative studies. However, there is still no empirical evidence suggesting how these two sensory systems coevolve, i.e. simultaneously or alternatively. The "Dark-flies" (Drosophila melanogaster) constitute a unique model to investigate such relation since they have been reared in the dark since 1954, approximately 60 years (similar to 1500 generations). To observe how vision and olfaction evolve, populations of Dark-flies were reared in normal lighting conditions for 1 (DF1G) and 65 (DF65G) generations. We measured the sizes of the visual (optic lobes, OLs) and olfactory (antennal lobes, ALs) primary centres, as well as the rest of the brain, and compared the results with the original and its genetically most similar strain (Oregon flies). We found that, whereas the ALs decreased in size, the OLs (together with the brain) increased in size in the Dark-flies returned back to the light, both in the DF1G and DF65G. These results experimentally show that trade-off between vision and olfaction occurs simultaneously, and suggests that there are possible genetic and epigenetic processes regulating the size of both optic and antennal lobes. Furthermore, although the Dark-flies were able to mate and survive in the dark with a reduced neural investment, individuals being returned to the light seem to have been selected with reinvestment in visual capabilities despite a potential higher energetic cost.	[Ozer, Ismet; Carle, Thomas] Newcastle Univ, Inst Neurosci, Framlington Pl, Newcastle Upon Tyne, Tyne & Wear, England; [Carle, Thomas] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka, Japan	Newcastle University - UK; Kyushu University	Carle, T (corresponding author), Newcastle Univ, Inst Neurosci, Framlington Pl, Newcastle Upon Tyne, Tyne & Wear, England.; Carle, T (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka, Japan.	th.carle@gmail.com		Carle, Thomas/0000-0002-6851-0600	European Commission [H2020-MSCA-IF-2015-706699]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission (H2020-MSCA-IF-2015-706699). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Aldaz S, 2010, CURR BIOL, V20, pR429, DOI 10.1016/j.cub.2010.03.010; Balkenius A, 2006, J COMP PHYSIOL A, V192, P431, DOI 10.1007/s00359-005-0081-6; Barth M, 1997, J NEUROSCI, V17, P1493; Barth M, 1997, LEARN MEMORY, V4, P219, DOI 10.1101/lm.4.2.219; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; BARTON RA, 1995, PHILOS T ROY SOC B, V348, P381, DOI 10.1098/rstb.1995.0076; Barton RA, 1998, P ROY SOC B-BIOL SCI, V265, P1933, DOI 10.1098/rspb.1998.0523; Barton RA, 2001, BEHAV BRAIN SCI, V24, P281, DOI 10.1017/S0140525X01253953; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bulova S, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1353-4; Catania KC, 2002, P NATL ACAD SCI USA, V99, P5692, DOI 10.1073/pnas.072097999; Catania KC, 1996, BIOSCIENCE, V46, P578, DOI 10.2307/1312987; Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; Corral-Lopez A, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2408-z; DECASIEN AR, 2017, NAT ECOL EVOL, V1, P24741, DOI DOI 10.1038/S41559-016-0001; DERUNTZ P, 1994, J EXP ZOOL, V268, P421, DOI 10.1002/jez.1402680602; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Fuse N, 2014, SPRINGERBRIEF BIOL, P1, DOI 10.1007/978-4-431-54147-9; Garamszegi LZ, 2002, P ROY SOC B-BIOL SCI, V269, P961, DOI 10.1098/rspb.2002.1967; Gaynor KM, 2018, SCIENCE, V360, P1232, DOI 10.1126/science.aar7121; Guillet A, 2019, BRAIN BEHAV EVOL; HEALY S, 1990, EVOLUTION, V44, P339, DOI 10.1111/j.1558-5646.1990.tb05203.x; Healy SD, 2013, ANIM BEHAV, V86, pE1, DOI 10.1016/j.anbehav.2013.05.017; IMAIZUMI T, 1979, JPN J GENET, V54, P55, DOI 10.1266/jjg.54.55; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Izutsu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033288; Keesey IW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09087-z; Kotrschal A, 2013, ANIM BEHAV, V86, pE4, DOI 10.1016/j.anbehav.2013.07.011; Kotrschal K, 1998, REV FISH BIOL FISHER, V8, P373, DOI 10.1023/A:1008839605380; Montgomery SH, 2015, J COMP NEUROL, V523, P869, DOI 10.1002/cne.23711; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; O zer I, 2019, J COMP NEUROL; O'Carroll DC, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0062; O'Donnell S, 2013, BRAIN BEHAV EVOLUT, V82, P177, DOI 10.1159/000354968; Pearl R, 1926, J GEN PHYSIOL, V9, P513, DOI 10.1085/jgp.9.4.513; Posnien N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037346; Ramaekers A, 2019, DEV CELL, V50, P780, DOI 10.1016/j.devcel.2019.07.027; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Reichert H, 2010, ADV EXP MED BIOL, V689, P145; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sheehan ZB V., 2019, J COMP NEUROL, P1; Soares D, 2013, BIOSCIENCE, V63, P274, DOI 10.1525/bio.2013.63.4.7; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Stieb SM, 2011, BRAIN BEHAV EVOLUT, V77, P136, DOI 10.1159/000326211; Stockl AL, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00121; Tan SJ, 2005, CURR BIOL, V15, pR540, DOI 10.1016/j.cub.2005.07.019; Tierney SM, 2017, AUSTRAL ENTOMOL, V56, P23, DOI 10.1111/aen.12264; Warrant EJ, 2004, BIOL REV, V79, P671, DOI 10.1017/S1464793103006420; Zhu J, DROSOPHILA PAX6 PROM, DOI [10.1073/pnas.1610614114, DOI 10.1073/PNAS.1610614114]	50	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228939	10.1371/journal.pone.0228939	http://dx.doi.org/10.1371/journal.pone.0228939			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045466	gold, Green Published			2022-12-26	WOS:000534633200047
J	Alogaili, F; Chinnarasu, S; Jaeschke, A; Kranias, EG; Hui, DY				Alogaili, Fawzi; Chinnarasu, Sivaprakasam; Jaeschke, Anja; Kranias, Evangelia G.; Hui, David Y.			Hepatic HAX-1 inactivation prevents metabolic diseases by enhancing mitochondrial activity and bile salt export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						liver metabolism; pyruvate dehydrogenase complex (PDC); calcium; bile acid; inositol trisphosphate receptor (InsP3R)	FATTY LIVER-DISEASE; Y GASTRIC BYPASS; GLUCOSE-HOMEOSTASIS; ACID SYNTHESIS; RECEPTOR; PROTEIN; RETICULUM; OVEREXPRESSION; CHOLESTEROL; DYSFUNCTION	Increasing hepatic mitochondrial activity through pyruvate dehydrogenase and elevating enterohepatic bile acid recirculation are promising new approaches for metabolic disease therapy, but neither approach alone can completely ameliorate disease phenotype in high-fat diet?fed mice. This study showed that diet-induced hepatosteatosis, hyperlipidemia, and insulin resistance can be completely prevented in mice with liver-specific HCLS1-associated protein X-1 (HAX-1) inactivation. Mechanistically, we showed that HAX-1 interacts with inositol 1,4,5-trisphosphate receptor-1 (InsP3R1) in the liver, and its absence reduces InsP3R1 levels, thereby improving endoplasmic reticulum?mitochondria calcium homeostasis to prevent excess calcium overload and mitochondrial dysfunction. As a result, HAX-1 ablation activates pyruvate dehydrogenase and increases mitochondria utilization of glucose and fatty acids to prevent hepatosteatosis, hyperlipidemia, and insulin resistance. In contrast to the reduction of InsP3R1 levels, hepatic HAX-1 deficiency increases bile salt exporter protein levels, thereby promoting enterohepatic bile acid recirculation, leading to activation of bile acid?responsive genes in the intestinal ileum to augment insulin sensitivity and of cholesterol transport genes in the liver to suppress hyperlipidemia. The dual mechanisms of increased mitochondrial respiration and enterohepatic bile acid recirculation due to improvement of endoplasmic reticulum?mitochondria calcium homeostasis with hepatic HAX-1 inactivation suggest that this may be a potential therapeutic target for metabolic disease intervention.	[Alogaili, Fawzi; Chinnarasu, Sivaprakasam; Jaeschke, Anja; Hui, David Y.] Univ Cincinnati, Metab Dis Res Ctr, Dept Pathol & Lab Med, Coll Med, Cincinnati, OH 45237 USA; [Alogaili, Fawzi; Kranias, Evangelia G.] Univ Cincinnati, Dept Pharmacol & Syst Physiol, Coll Med, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Hui, DY (corresponding author), Univ Cincinnati, Dept Pathol, Coll Med, 2120 E Galbraith Rd, Cincinnati, OH 45237 USA.	huidy@ucmail.uc.edu	Chinnarasu, Sivaprakasam/AAU-4373-2020	COJANDARAJ, Dr LOUIS/0000-0002-5264-6546; ALOGAILI, FAWZI/0000-0003-3702-7138	National Institutes of Health [RO1 DK074932]; Higher Committee for Education Development in Iraq	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Higher Committee for Education Development in Iraq	This work was supported by National Institutes of Health Grant RO1 DK074932 (to D. Y. H.). This work was also supported by a scholarship from the Higher Committee for Education Development in Iraq (to F. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad NN, 2013, INT J OBESITY, V37, P1553, DOI 10.1038/ijo.2013.38; Ahmadian M, 2010, INT J BIOCHEM CELL B, V42, P555, DOI 10.1016/j.biocel.2009.12.009; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Arruda AP, 2015, CELL METAB, V22, P381, DOI 10.1016/j.cmet.2015.06.010; Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735; Bain SC, 2008, EXPERT OPIN DRUG SAF, V7, P643, DOI 10.1517/14740330802432003 ; Bidwell PA, 2018, J MOL CELL CARDIOL, V114, P220, DOI 10.1016/j.yjmcc.2017.11.014; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Chen SJ, 2013, HUM GENE THER CL DEV, V24, P154, DOI 10.1089/humc.2013.082; Day CP, 2011, CLIN MED, V11, P176, DOI 10.7861/clinmedicine.11-2-176; Delea TE, 2003, DIABETES CARE, V26, P2983, DOI 10.2337/diacare.26.11.2983; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Djouadi F, 2003, MOL GENET METAB, V78, P112, DOI 10.1016/S1096-7192(03)00017-9; Egnatchik RA, 2014, MOL METAB, V3, P544, DOI 10.1016/j.molmet.2014.05.004; Fadeel B, 2009, BBA-GEN SUBJECTS, V1790, P1139, DOI 10.1016/j.bbagen.2009.06.004; Feriod CN, 2017, HEPATOL COMMUN, V1, P23, DOI 10.1002/hep4.1012; Feriod CN, 2014, AM J PHYSIOL-ENDOC M, V307, pE1057, DOI 10.1152/ajpendo.00236.2014; Figge A, 2004, J BIOL CHEM, V279, P2790, DOI 10.1074/jbc.M307363200; Go Y, 2016, DIABETES, V65, P2876, DOI 10.2337/db16-0223; Goh GBB, 2015, BBA CLIN, V3, P141, DOI 10.1016/j.bbacli.2014.09.001; Hamlin AN, 2016, J BIOL CHEM, V291, P16610, DOI 10.1074/jbc.M116.717744; Han J, 2010, J BIOL CHEM, V285, P22461, DOI 10.1074/jbc.M109.086587; Henkel AS, 2013, AM J PHYSIOL-GASTR L, V304, pG221, DOI 10.1152/ajpgi.00322.2012; Hippe A, 2006, GENE, V379, P116, DOI 10.1016/j.gene.2006.04.027; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jeoung NH, 2008, AM J PHYSIOL-ENDOC M, V295, pE46, DOI 10.1152/ajpendo.00536.2007; Kaushal S, 2014, N AM J MED SCI, V6, P107, DOI 10.4103/1947-2714.128471; Khan AU, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10339-5; Kneeman JM, 2012, THER ADV GASTROENTER, V5, P199, DOI 10.1177/1756283X11430859; Kohli R, 2013, J CLIN ENDOCR METAB, V98, pE708, DOI 10.1210/jc.2012-3736; Krishnan KC, 2018, CELL SYST, V6, P103, DOI 10.1016/j.cels.2017.12.006; Kruglov EA, 2011, HEPATOLOGY, V54, P1790, DOI 10.1002/hep.24548; Labonte ED, 2006, DIABETES, V55, P935, DOI 10.2337/diabetes.55.04.06.db05-1286; Lam CK, 2013, CIRC RES, V112, P79, DOI 10.1161/CIRCRESAHA.112.279935; Li TG, 2011, HEPATOLOGY, V53, P996, DOI 10.1002/hep.24107; MEIER PJ, 1990, METHOD ENZYMOL, V192, P534; Miller WL, 2007, BBA-MOL CELL BIOL L, V1771, P663, DOI 10.1016/j.bbalip.2007.02.012; Myronovych A, 2014, OBESITY, V22, P390, DOI 10.1002/oby.20548; Nakatani H, 2009, METABOLISM, V58, P1400, DOI 10.1016/j.metabol.2009.05.006; Ortiz DF, 2004, J BIOL CHEM, V279, P32761, DOI 10.1074/jbc.M404337200; Owen BM, 2015, TRENDS ENDOCRIN MET, V26, P22, DOI 10.1016/j.tem.2014.10.002; Pandak WM, 2002, J BIOL CHEM, V277, P48158, DOI 10.1074/jbc.M205244200; Park SW, 2010, P NATL ACAD SCI USA, V107, P19320, DOI 10.1073/pnas.1012044107; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Polonsky KS, 2008, NAT CLIN PRACT ENDOC, V4, P421, DOI 10.1038/ncpendmet0889; Rieusset J, 2017, BBA-MOL CELL RES, V1864, P865, DOI 10.1016/j.bbamcr.2017.01.001; Schumacher JD, 2017, TOXICOL APPL PHARM, V330, P1, DOI 10.1016/j.taap.2017.06.023; Simmen T, 2011, EXPERT OPIN THER TAR, V15, P741, DOI 10.1517/14728222.2011.561787; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Torra IP, 2003, MOL ENDOCRINOL, V17, P259, DOI 10.1210/me.2002-0120; Triplitt C, 2007, J MANAGE CARE PHARM, V13, pS2; Vafiadaki E, 2009, MOL BIOL CELL, V20, P306, DOI 10.1091/mbc.E08-06-0587; Wang HH, 2010, EUR J CLIN INVEST, V40, P541, DOI 10.1111/j.1365-2362.2010.02300.x; Wang YG, 2012, NATURE, V485, P128, DOI 10.1038/nature10988; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Wu CY, 2018, MOL METAB, V12, P12, DOI 10.1016/j.molmet.2018.03.014; Yap SV, 2010, J MOL CELL CARDIOL, V48, P1266, DOI 10.1016/j.yjmcc.2009.10.028; Zhao W, 2009, P NATL ACAD SCI USA, V106, P20776, DOI 10.1073/pnas.0906998106	60	6	6	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4631	4646		10.1074/jbc.RA119.012361	http://dx.doi.org/10.1074/jbc.RA119.012361			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32079675	Green Published, hybrid			2022-12-26	WOS:000524499700022
J	Cheung, K; Barter, MJ; Falk, J; Proctor, CJ; Reynard, LN; Young, DA				Cheung, Kathleen; Barter, Matthew J.; Falk, Julia; Proctor, Carole J.; Reynard, Louise N.; Young, David A.			Histone ChIP-Seq identifies differential enhancer usage during chondrogenesis as critical for defining cell-type specificity	FASEB JOURNAL			English	Article						cartilage; chondrocyte development; chromatin	IN-VITRO CHONDROGENESIS; MARROW STEM-CELLS; DNA METHYLATION; TRANSCRIPTION FACTORS; CHONDROCYTE HYPERTROPHY; GENOME-WIDE; FUNCTIONAL-CHARACTERIZATION; ARTICULAR CHONDROCYTES; EPIGENETIC REGULATION; GENE-REGULATION	Epigenetic mechanisms are known to regulate gene expression during chondrogenesis. In this study, we have characterized the epigenome during the in vitro differentiation of human mesenchymal stem cells (hMSCs) into chondrocytes. Chromatin immunoprecipitation followed by next-generation sequencing (ChIP-seq) was used to assess a range of N-terminal posttranscriptional modifications (marks) to histone H3 lysines (H3K4me3, H3K4me1, H3K27ac, H3K27me3, and H3K36me3) in both hMSCs and differentiated chondrocytes. Chromatin states were characterized using histone ChIP-seq and cis-regulatory elements were identified in chondrocytes. Chondrocyte enhancers were associated with chondrogenesis-related gene ontology (GO) terms. In silico analysis and integration of DNA methylation data with chondrogenesis chromatin states revealed that enhancers marked by histone marks H3K4me1 and H3K27ac were de-methylated during in vitro chondrogenesis. Similarity analysis between hMSC and chondrocyte chromatin states defined in this study with epigenomes of cell-types defined by the Roadmap Epigenomics project revealed that enhancers are more distinct between cell-types compared to other chromatin states. Motif analysis revealed that the transcription factor SOX9 is enriched in chondrocyte enhancers. Luciferase reporter assays confirmed that chondrocyte enhancers characterized in this study exhibited enhancer activity which may be modulated by DNA methylation and SOX9 overexpression. Altogether, these integrated data illustrate the cross-talk between different epigenetic mechanisms during chondrocyte differentiation.	[Cheung, Kathleen; Barter, Matthew J.; Falk, Julia; Proctor, Carole J.; Reynard, Louise N.; Young, David A.] Newcastle Univ, Inst Med Genet, Skeletal Res Grp, Cent Pkwy, Newcastle Upon Tyne, Tyne & Wear, England; [Cheung, Kathleen] Newcastle Univ, Fac Med Sci, Bioinformat Support Unit, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Cheung, K; Young, DA (corresponding author), Newcastle Univ, Inst Med Genet, Skeletal Res Grp, Cent Pkwy, Newcastle Upon Tyne, Tyne & Wear, England.	kat.cheung@ncl.ac.uk; david.young@ncl.ac.uk	Young, David/GOV-5677-2022	Young, David/0000-0002-7078-6745; Cheung, Kathleen/0000-0002-6449-7517; Reynard, Louise/0000-0002-6613-1797	MRC [MR/P020941/1] Funding Source: UKRI; Arthritis Research UK [19424, 18746] Funding Source: Medline; Medical Research Council [MR/P020941/1] Funding Source: Medline; The Dunhill Medical Trust [R476/0516] Funding Source: Medline; Versus Arthritis [18746, 19424] Funding Source: Medline; Department of Health Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Dunhill Medical Trust(Dunhill Medical Trust); Versus Arthritis(Versus Arthritis); Department of Health		Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x; Alvarez-Garcia O, 2016, ARTHRITIS RHEUMATOL, V68, P1876, DOI 10.1002/art.39643; Baker M, 2011, NAT METHODS, V2011, P89; Barter MJ, 2017, DEVELOPMENT, V144, P4510, DOI 10.1242/dev.152504; Barter MJ, 2015, STEM CELLS, V33, P3266, DOI 10.1002/stem.2093; Barter MJ, 2020, SCI REP, P625954; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bell RE, 2016, GENOME RES, V26, P601, DOI 10.1101/gr.197194.115; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Capellini TD, 2017, NAT GENET, V49, P1202, DOI 10.1038/ng.3911; Cayami FK, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.823; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Cotney J, 2013, CELL, V154, P185, DOI 10.1016/j.cell.2013.05.056; Cremazy F, 1998, FEBS LETT, V438, P311, DOI 10.1016/S0014-5793(98)01294-0; Dixon JR, 2016, MOL CELL, V62, P668, DOI 10.1016/j.molcel.2016.05.018; Ealy M, 2008, HEARING RES, V240, P80, DOI 10.1016/j.heares.2008.03.001; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Ferguson GB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05573-y; Furumatsu T, 2010, ACTA MED OKAYAMA, V64, P155; Grossman SR, 2018, P NATL ACAD SCI USA, V115, pE7222, DOI 10.1073/pnas.1804663115; Haller R, 2012, CELL DEATH DIFFER, V19, P461, DOI 10.1038/cdd.2011.114; Hata K, 2015, JPN DENT SCI REV, V51, P105, DOI 10.1016/j.jdsr.2015.05.001; He XJ, 2016, DEVELOPMENT, V143, P3012, DOI 10.1242/dev.134502; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Herlofsen SR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-105; Heyn H, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0879-2; Hissnauer TN, 2010, OSTEOARTHR CARTILAGE, V18, P1630, DOI 10.1016/j.joca.2010.10.002; Huynh NPT, 2019, FASEB J, V33, P358, DOI 10.1096/fj.201800534R; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kanai Y, 1999, HUM MOL GENET, V8, P691, DOI 10.1093/hmg/8.4.691; Keller RB, 2018, GENET MED, V20, P411, DOI 10.1038/gim.2017.115; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kokabu S, 2014, FEBS LETT, V588, P614, DOI 10.1016/j.febslet.2013.12.031; Kozhemyakina E, 2015, ARTHRITIS RHEUMATOL, V67, P1261, DOI 10.1002/art.39030; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee WJ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8932583; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Leung VYL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002356; Li CR, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0039-9; Li FF, 2011, J BONE MINER RES, V26, P2899, DOI 10.1002/jbmr.504; Li IMH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19186-4; Lian CJ, 2019, BONE RES, V7, DOI 10.1038/s41413-019-0046-y; Liu CF, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.164459; Liu CF, 2015, NUCLEIC ACIDS RES, V43, P8183, DOI 10.1093/nar/gkv688; Liu Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33779-z; Liu Y, 2017, ENGINEERING-PRC, V3, P28, DOI 10.1016/J.ENG.2017.01.010; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Lovkvist C, 2016, NUCLEIC ACIDS RES, V44, P5123, DOI 10.1093/nar/gkw124; Ma WX, 2014, NAT PROTOC, V9, P1428, DOI 10.1038/nprot.2014.083; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Malfait F, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-78; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Mokuda S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10177-1; Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370; Mueller MB, 2010, CELLS TISSUES ORGANS, V192, P158, DOI 10.1159/000313399; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374; Murdoch AD, 2016, MATRIX BIOL, V50, P16, DOI 10.1016/j.matbio.2015.10.003; Nolis IK, 2009, P NATL ACAD SCI USA, V106, P20222, DOI 10.1073/pnas.0902454106; Oh CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010113; Ohba S, 2015, CELL REP, V12, P229, DOI 10.1016/j.celrep.2015.06.013; Otero M, 2017, CONNECT TISSUE RES, V58, P15, DOI 10.1080/03008207.2016.1200566; Otero M, 2012, J BIOL CHEM, V287, P3559, DOI 10.1074/jbc.M111.265744; Palstra Robert-Jan, 2012, Frontiers in Genetics, V3, DOI 10.3389/fgene.2012.00195; Pask AJ, 2002, GENESIS, V33, P131, DOI 10.1002/gene.10096; Pasumarthy KK, 2017, STEM CELL REP, V9, P999, DOI 10.1016/j.stemcr.2017.07.018; Petell CJ, 2016, NUCLEIC ACIDS RES, V44, P7605, DOI 10.1093/nar/gkw426; Qu Y, 2017, BLOOD, V129, pE13, DOI [10.1182/blood-2016-07726877, 10.1182/blood-2016-07-726877]; Reynard LN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159024; Rutkowski TP, 2016, J CELL SCI, V129, P2145, DOI 10.1242/jcs.181271; Sebastian A, 2014, BIOINFORMATICS, V30, P258, DOI 10.1093/bioinformatics/btt663; Sharifi-Zarchi A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4353-7; Sheaffer KL, 2014, GENE DEV, V28, P652, DOI 10.1101/gad.230318.113; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shin Y, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4466; Smith EM, 2016, AM J HUM GENET, V98, P185, DOI 10.1016/j.ajhg.2015.12.002; Tchetina EV, 2005, J RHEUMATOL, V32, P876; Tew SR, 2011, OSTEOARTHR CARTILAGE, V19, P1036, DOI 10.1016/j.joca.2011.04.015; Tew SR, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2311; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tian Y, 2016, LIFE SCI, V148, P220, DOI 10.1016/j.lfs.2016.02.031; van der Kraan PM, 2012, OSTEOARTHR CARTILAGE, V20, P223, DOI 10.1016/j.joca.2011.12.003; Vandel J, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-018-5408-0; Watts AE, 2013, TISSUE ENG PT A, V19, P2275, DOI [10.1089/ten.tea.2012.0479, 10.1089/ten.TEA.2012.0479]; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Whitney GA, 2012, BIORESEARCH OPEN ACC, V1, P157, DOI 10.1089/biores.2012.0231; Wondimu EB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24695-3; Wunderle VM, 1998, P NATL ACAD SCI USA, V95, P10649, DOI 10.1073/pnas.95.18.10649; Yamasaki S, 2014, CARTILAGE, V5, P196, DOI 10.1177/1947603514534681; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679; Yang J, 2011, FEBS LETT, V585, P2992, DOI 10.1016/j.febslet.2011.08.013; Yasuda H, 2017, J BIOL CHEM, V292, P528, DOI 10.1074/jbc.M116.758425; Zeybel M, 2012, NAT MED, V18, P1369, DOI 10.1038/nm.2893; Zhang LM, 2010, BIOTECHNOL LETT, V32, P1339, DOI 10.1007/s10529-010-0293-x; Zhang Y, 2016, OSTEOARTHR CARTILAGE, V24, P835, DOI 10.1016/j.joca.2015.12.013; Zhou SH, 2004, J BONE MINER RES, V19, P463, DOI 10.1359/JBMR.0301239	103	6	6	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5317	5331		10.1096/fj.201902061RR	http://dx.doi.org/10.1096/fj.201902061RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32058623	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000530242100033
J	Hosseini, SAH; Zhang, C; Weingartner, S; Moeller, S; Stuber, M; Ugurbil, K; Akcakaya, M				Hosseini, Seyed Amir Hossein; Zhang, Chi; Weingaertner, Sebastian; Moeller, Steen; Stuber, Matthias; Ugurbil, Kamil; Akcakaya, Mehmet			Accelerated coronary MRI with sRAKI: A database-free self-consistent neural network k-space reconstruction for arbitrary undersampling	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; ARTERIES	Purpose To accelerate coronary MRI acquisitions with arbitrary undersampling patterns by using a novel reconstruction algorithm that applies coil self-consistency using subject-specific neural networks. Methods Self-consistent robust artificial-neural-networks for k-space interpolation (sRAKI) performs iterative parallel imaging reconstruction by enforcing self-consistency among coils. The approach bears similarity to SPIRiT, but extends the linear convolutions in SPIRiT to nonlinear interpolation using convolutional neural networks (CNNs). These CNNs are trained individually for each scan using the scan-specific autocalibrating signal (ACS) data. Reconstruction is performed by imposing the learned self-consistency and data-consistency, which enables sRAKI to support random undersampling patterns. Fully-sampled targeted right coronary artery MRI was acquired in six healthy subjects. The data were retrospectively undersampled, and reconstructed using SPIRiT, l(1)-SPIRiT and sRAKI for acceleration rates of 2 to 5. Additionally, prospectively undersampled whole-heart coronary MRI was acquired to further evaluate reconstruction performance. Results sRAKI reduces noise amplification and blurring artifacts compared with SPIRiT and l(1)-SPIRiT, especially at high acceleration rates in targeted coronary MRI. Quantitative analysis shows that sRAKI outperforms these techniques in terms of normalized mean-squared-error (similar to 44% and similar to 21% over SPIRiT and l(1)-SPIRiT at rate 5) and vessel sharpness (similar to 10% and similar to 20% over SPIRiT and l(1)-SPIRiT at rate 5). Whole-heart data shows the sharpest coronary arteries when resolved using sRAKI, with 11% and 15% improvement in vessel sharpness over SPIRiT and l(1)-SPIRiT, respectively. Conclusion sRAKI is a database-free neural network-based reconstruction technique that may further accelerate coronary MRI with arbitrary undersampling patterns, while improving noise resilience over linear parallel imaging and image sharpness over l(1) regularization techniques.	[Hosseini, Seyed Amir Hossein; Zhang, Chi; Weingaertner, Sebastian; Akcakaya, Mehmet] Univ Minnesota, Elect & Comp Engn, Minneapolis, MN 55455 USA; [Hosseini, Seyed Amir Hossein; Zhang, Chi; Weingaertner, Sebastian; Moeller, Steen; Ugurbil, Kamil; Akcakaya, Mehmet] Univ Minnesota, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Weingaertner, Sebastian] Delft Univ Technol, Dept Imaging Phys, Delft, Netherlands; [Stuber, Matthias] Univ Hosp CHUV, Dept Radiol, Lausanne, Switzerland; [Stuber, Matthias] Univ Lausanne UNIL, Lausanne, Switzerland; [Stuber, Matthias] Ctr Biomed Imaging CIBM, Lausanne, Switzerland	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Delft University of Technology; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Akcakaya, M (corresponding author), Univ Minnesota, Elect & Comp Engn, Minneapolis, MN 55455 USA.; Akcakaya, M (corresponding author), Univ Minnesota, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA.	akcakaya@umn.edu	Ugurbil, Kamil/AAD-6058-2022	Akcakaya, Mehmet/0000-0001-6400-7736; Weingartner, Sebastian/0000-0002-0739-6306	National Institutes of Health (NIH) [R00HL111410]; National Science Foundation (NSF) [CCF-1651825]; NIH [P41EB015894, U01EB025144, P41EB027061]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Author M. A. has received the following grants: National Institutes of Health (NIH) R00HL111410, National Science Foundation (NSF) CCF-1651825. Author K.U. has received the following grants: NIH P41EB015894, NIH U01EB025144, NIH P41EB027061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal HK, 2020, IEEE T MED IMAGING, V39, P1268, DOI 10.1109/TMI.2019.2946501; Aggarwal HK, 2019, IEEE T MED IMAGING, V38, P394, DOI 10.1109/TMI.2018.2865356; Aitken AP, 2015, MAGN RESON MED, V74, P756, DOI 10.1002/mrm.25460; Akcakaya M, 2019, MAGN RESON MED, V81, P439, DOI 10.1002/mrm.27420; Akcakaya M, 2014, MAGN RESON MED, V71, P815, DOI 10.1002/mrm.24683; Akcakaya M, 2012, MAGN RESON MED, V67, P1434, DOI 10.1002/mrm.24242; Akcakaya M, 2011, MAGN RESON MED, V66, P756, DOI 10.1002/mrm.22841; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Bi XM, 2007, MAGN RESON MED, V58, P1, DOI 10.1002/mrm.21224; Chang YC, 2012, MAGN RESON MED, V68, P730, DOI 10.1002/mrm.23279; Cheng JY, 2018, ANN M INT SOC MAGN R; Correia T, 2018, MAGN RESON MED, V80, P2618, DOI 10.1002/mrm.27208; Cruz G, 2017, MAGN RESON MED, V77, P1894, DOI 10.1002/mrm.26274; DERICHE R, 1990, IEEE T PATTERN ANAL, V12, P78, DOI 10.1109/34.41386; EDELMAN RR, 1991, RADIOLOGY, V181, P641, DOI 10.1148/radiology.181.3.1947074; Eldar YC, 2017, IEEE SIGNAL PROC MAG, V34, P8, DOI 10.1109/MSP.2017.2743842; Eo T, 2018, MAGN RESON MED, V80, P2188, DOI 10.1002/mrm.27201; Etienne A, 2002, MAGNET RESON MED, V48, P658, DOI 10.1002/mrm.10253; Feng L, 2018, MAGN RESON MED, V79, P826, DOI 10.1002/mrm.26745; Forman C, 2014, MAGN RESON MATER PHY, V27, P435, DOI 10.1007/s10334-013-0428-x; Fuin N, 2019, SCMR 22 ANN SCI SESS; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Hammernik K, 2018, MAGN RESON MED, V79, P3055, DOI 10.1002/mrm.26977; Han Y, 2020, IEEE T MED IMAGING, V39, P377, DOI 10.1109/TMI.2019.2927101; Han Y, 2018, MAGN RESON MED, V80, P1189, DOI 10.1002/mrm.27106; Hassan Dar SU, 2018, ANN M INT SOC MAGN R; Hosseini S a. H, 2019, SCMR ISMRM COPR WORK; Hosseini S a. H, 2018, ISMRM WORKSH MACH 2; Hosseini S a. H, 2019, ANN M INT SOC MAG RE; Hosseini SAH, 2019, I S BIOMED IMAGING, P1692, DOI 10.1109/ISBI.2019.8759459; Hu P, 2011, MAGN RESON MED, V65, P392, DOI 10.1002/mrm.22706; Hyun CM, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aac71a; Kim TH., 2019, P 27 ANN M ISMRM; Kim WY, 2001, NEW ENGL J MED, V345, P1863, DOI 10.1056/NEJMoa010866; Kingma D.P., 2015, ICLR; Kwon K, 2017, MED PHYS, V44, P6209, DOI 10.1002/mp.12600; Lee DW, 2018, IEEE T BIO-MED ENG, V65, P1985, DOI 10.1109/TBME.2018.2821699; Li DB, 1996, RADIOLOGY, V201, P857, DOI 10.1148/radiology.201.3.8939242; Liou CY, 2014, NEUROCOMPUTING, V139, P84, DOI 10.1016/j.neucom.2013.09.055; Lustig M, 2010, MAGN RESON MED, V64, P457, DOI 10.1002/mrm.22428; Mao XJ, 2016, IRAN J RADIOL, V13, DOI 10.5812/iranjradiol.29402; McConnell MV, 1997, MAGN RESON MED, V37, P148, DOI 10.1002/mrm.1910370121; Munoz C, 2019, MAGN RESON MED, V82, P732, DOI 10.1002/mrm.27732; Murphy M, 2012, IEEE T MED IMAGING, V31, P1250, DOI 10.1109/TMI.2012.2188039; Niendorf T, 2006, MAGN RESON MED, V56, P167, DOI 10.1002/mrm.20923; Oshinski JN, 1996, RADIOLOGY, V201, P737, DOI 10.1148/radiology.201.3.8939224; Piccini D, 2017, MAGN RESON MED, V77, P1473, DOI 10.1002/mrm.26221; Pruessmann KP, 2001, MAGNET RESON MED, V46, P638, DOI 10.1002/mrm.1241; Qin C, 2019, IEEE T MED IMAGING, V38, P280, DOI 10.1109/TMI.2018.2863670; Schlemper J, 2018, IEEE T MED IMAGING, V37, P491, DOI 10.1109/TMI.2017.2760978; Stuber M, 1999, J AM COLL CARDIOL, V34, P524, DOI 10.1016/S0735-1097(99)00223-5; Weber OM, 2003, MAGNET RESON MED, V50, P1223, DOI 10.1002/mrm.10653; Wielopolski PA, 1998, RADIOLOGY, V209, P209, DOI 10.1148/radiology.209.1.9769834; Yang G, 2018, IEEE T MED IMAGING, V37, P1310, DOI 10.1109/TMI.2017.2785879	54	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229418	10.1371/journal.pone.0229418	http://dx.doi.org/10.1371/journal.pone.0229418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084235	Green Published, gold, Green Submitted			2022-12-26	WOS:000535227900107
J	Luan, HA; Gao, W; Huang, SW; Tang, JW; Li, MY; Zhang, HZ; Chen, XP; Masiliunas, D				Luan, Haoan; Gao, Wei; Huang, Shaowen; Tang, Jiwei; Li, Mingyue; Zhang, Huaizhi; Chen, Xinping; Masiliunas, Dainius			Substitution of manure for chemical fertilizer affects soil microbial community diversity, structure and function in greenhouse vegetable production systems	PLOS ONE			English	Article							ORGANIC-CARBON FRACTIONS; ENZYME-ACTIVITIES; INORGANIC FERTILIZERS; PADDY SOILS; NITROGEN; BIOMASS; AGGREGATION; AMENDMENTS; BACTERIAL; RESIDUES	Soil microbial communities and enzyme activities together affect various ecosystem functions of soils. Fertilization, an important agricultural management practice, is known to modify soil microbial characteristics; however, inconsistent results have been reported. The aim of this research was to make a comparative study of the effects of different nitrogen (N) fertilizer rates and types (organic and inorganic) on soil physicochemical properties, enzyme activities and microbial attributes in a greenhouse vegetable production (GVP) system of Tianjin, China. Results showed that manure substitution of chemical fertilizer, especially at a higher substitution rate, improved soil physicochemical properties (higher soil organic C (SOC) and nutrient (available N and P) contents; lower bulk densities), promoted microbial growth (higher total phospholipid fatty acids and microbial biomass C contents) and activity (higher soil hydrolase activities). Manure application induced a higher fungi/bacteria ratio due to a lower response in bacterial than fungal growth. Also, manure application greatly increased bacterial stress indices, as well as microbial communities and functional diversity. The principal component analysis showed that the impact of manure on microbial communities and enzyme activities were more significant than those of chemical fertilizer. Furthermore, redundancy analysis indicated that SOC and total N strongly influenced the microbial composition, while SOC and ammonium-N strongly influenced the microbial activity. In conclusion, manure substitution of inorganic fertilizer, especially at a higher substitution rate, was more efficient for improving soil quality and biological functions.	[Luan, Haoan; Huang, Shaowen; Tang, Jiwei; Zhang, Huaizhi] Chinese Acad Agr Sci, Minist Agr, Key Lab Plant Nutr & Fertilizer, Inst Agr Resources & Reg Planning, Beijing, Peoples R China; [Luan, Haoan; Chen, Xinping] China Agr Univ, Ctr Resources Environm & Food Secur, Beijing, Peoples R China; [Gao, Wei; Li, Mingyue] Tianjin Inst Agr Resources & Environm, Tianjin, Peoples R China; [Masiliunas, Dainius] Wageningen Univ, Lab Geoinformat Sci & Remote Sensing, Wageningen, Netherlands	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; China Agricultural University; Wageningen University & Research	Luan, HA; Huang, SW (corresponding author), Chinese Acad Agr Sci, Minist Agr, Key Lab Plant Nutr & Fertilizer, Inst Agr Resources & Reg Planning, Beijing, Peoples R China.; Luan, HA (corresponding author), China Agr Univ, Ctr Resources Environm & Food Secur, Beijing, Peoples R China.; Gao, W (corresponding author), Tianjin Inst Agr Resources & Environm, Tianjin, Peoples R China.	luanhaoan@163.com; vivigao2002@163.com; huangshaowen@caas.cn	Masiliūnas, Dainius/AAP-6770-2021	Masiliūnas, Dainius/0000-0001-5654-1277; Huang, Shao-Wen/0000-0002-9760-864X	National Key Research and Development Program of China [2016YFD0201001]; China Agriculture Research System [CARS-23-B02]; Key Research and Development Program of Shandong Province, China [2017CXGC0206]	National Key Research and Development Program of China; China Agriculture Research System; Key Research and Development Program of Shandong Province, China	This research was supported by the National Key Research and Development Program of China (2016YFD0201001), China Agriculture Research System (CARS-23-B02), and the Key Research and Development Program of Shandong Province, China (2017CXGC0206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREMNER J. M., 1960, JOUR AGRIC SCI, V55, P11, DOI 10.1017/S0021859600021572; Burns RG, 2013, SOIL BIOL BIOCHEM, V58, P216, DOI 10.1016/j.soilbio.2012.11.009; Chantigny MH, 2002, SOIL BIOL BIOCHEM, V34, P509, DOI 10.1016/S0038-0717(01)00209-7; Chen S, 2017, NUTR CYCL AGROECOSYS, V107, P265, DOI 10.1007/s10705-017-9835-0; Cusack DF, 2011, ECOLOGY, V92, P621, DOI 10.1890/10-0459.1; DeForest JL, 2009, SOIL BIOL BIOCHEM, V41, P1180, DOI 10.1016/j.soilbio.2009.02.029; Dong WY, 2014, APPL SOIL ECOL, V84, P140, DOI 10.1016/j.apsoil.2014.06.007; Fan Y, 2017, ECOL ENG, V102, P367, DOI 10.1016/j.ecoleng.2017.02.032; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Gai XP, 2016, APPL SOIL ECOL, V107, P170, DOI 10.1016/j.apsoil.2016.06.001; Gallo M, 2004, MICROB ECOL, V48, P218, DOI 10.1007/s00248-003-9001-x; Gamalero E, 2012, SCI TOTAL ENVIRON, V425, P262, DOI 10.1016/j.scitotenv.2012.03.012; Ge Y, 2008, J SOIL SEDIMENT, V8, P43, DOI 10.1065/jss2008.01.270; Gleeson D, 2016, SCI TOTAL ENVIRON, V571, P1407, DOI 10.1016/j.scitotenv.2016.05.185; Hu WY, 2017, CHEMOSPHERE, V170, P183, DOI 10.1016/j.chemosphere.2016.12.047; Jian SY, 2016, SOIL BIOL BIOCHEM, V101, P32, DOI 10.1016/j.soilbio.2016.07.003; Jiao Y, 2006, GEODERMA, V134, P24, DOI 10.1016/j.geoderma.2005.08.012; Kaschuk G, 2010, SOIL BIOL BIOCHEM, V42, P1, DOI 10.1016/j.soilbio.2009.08.020; Koranda M, 2014, FEMS MICROBIOL ECOL, V87, P142, DOI 10.1111/1574-6941.12214; Kumar U, 2017, ECOL INDIC, V73, P536, DOI 10.1016/j.ecolind.2016.10.014; Lagomarsino A, 2011, BIOL FERT SOILS, V47, P283, DOI 10.1007/s00374-010-0530-4; Lazcano C, 2013, BIOL FERT SOILS, V49, P723, DOI 10.1007/s00374-012-0761-7; Leifheit EF, 2014, PLANT SOIL, V374, P523, DOI 10.1007/s11104-013-1899-2; Li J, 2015, APPL SOIL ECOL, V96, P75, DOI 10.1016/j.apsoil.2015.07.001; Li S, 2016, SOIL TILL RES, V155, P289, DOI 10.1016/j.still.2015.07.019; Liang C, 2012, APPL SOIL ECOL, V54, P24, DOI 10.1016/j.apsoil.2011.11.015; Liang H, 2018, ECOL MODEL, V367, P24, DOI 10.1016/j.ecolmodel.2017.10.016; Liu EK, 2010, GEODERMA, V158, P173, DOI 10.1016/j.geoderma.2010.04.029; Liu YR, 2018, SOIL BIOL BIOCHEM, V118, P35, DOI 10.1016/j.soilbio.2017.12.003; Luo SS, 2017, APPL SOIL ECOL, V117, P10, DOI 10.1016/j.apsoil.2017.04.024; Ma XY, 2016, BIOL FERT SOILS, V52, P775, DOI 10.1007/s00374-016-1118-4; MEBIUS LJ, 1960, ANAL CHIM ACTA, V22, P120, DOI 10.1016/S0003-2670(00)88254-9; Mi WH, 2016, SOIL TILL RES, V163, P64, DOI 10.1016/j.still.2016.05.009; Mokolobate MS, 2002, BIOL FERT SOILS, V35, P79, DOI 10.1007/s00374-001-0439-z; National Bureau of Statistics of China (NBSC), 2015, CHIN STAT YB 2015; Ni W, 2011, PEDOSPHERE, V1, P77, DOI [10.1007/s11769-001-0054-9, DOI 10.1007/S11769-001-0054-9]; Ning CC, 2017, J INTEGR AGR, V16, P1819, DOI [10.1016/S2095-3119(16)61476-4, 10.1016/s2095-3119(16)61476-4]; Olsen S.R., 1982, AGRON MONGR, V9; Qi RM, 2016, APPL SOIL ECOL, V102, P36, DOI 10.1016/j.apsoil.2016.02.004; Rahman MT, 2017, APPL SOIL ECOL, V111, P84, DOI 10.1016/j.apsoil.2016.11.018; Schroder JL, 2011, SOIL SCI SOC AM J, V75, P957, DOI 10.2136/sssaj2010.0187; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; Smith AP, 2014, SOIL BIOL BIOCHEM, V77, P292, DOI 10.1016/j.soilbio.2014.05.030; Streit K, 2014, GLOBAL CHANGE BIOL, V20, P1327, DOI 10.1111/gcb.12396; Strickland MS, 2010, SOIL BIOL BIOCHEM, V42, P1385, DOI 10.1016/j.soilbio.2010.05.007; Sun DS, 2017, SCI TOTAL ENVIRON, V574, P735, DOI 10.1016/j.scitotenv.2016.09.112; Sun HY, 2016, APPL SOIL ECOL, V108, P16, DOI 10.1016/j.apsoil.2016.07.014; Sun JT, 2016, SCI TOTAL ENVIRON, V544, P670, DOI 10.1016/j.scitotenv.2015.12.012; Udom BE, 2016, APPL SOIL ECOL, V101, P5, DOI 10.1016/j.apsoil.2016.01.007; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang C, 2018, SOIL BIOL BIOCHEM, V121, P103, DOI 10.1016/j.soilbio.2018.03.009; Wang CY, 2010, ECOL RES, V25, P1121, DOI 10.1007/s11284-010-0737-8; Wei M, 2017, EUR J SOIL BIOL, V82, P27, DOI 10.1016/j.ejsobi.2017.08.002; Wei WL, 2016, AGR ECOSYST ENVIRON, V225, P86, DOI 10.1016/j.agee.2016.04.004; Wixon DL, 2013, SOIL BIOL BIOCHEM, V57, P769, DOI 10.1016/j.soilbio.2012.08.016; Wu YP, 2013, EUR J SOIL BIOL, V54, P32, DOI 10.1016/j.ejsobi.2012.10.006; Xiao Y, 2015, ECOL ENG, V82, P381, DOI 10.1016/j.ecoleng.2015.05.015; Yanardag IH, 2017, GEODERMA, V295, P1, DOI 10.1016/j.geoderma.2017.02.008; Yu HL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151622; Yu L, 2018, SCI TOTAL ENVIRON, V640, P1221, DOI 10.1016/j.scitotenv.2018.06.018; Yu WT, 2013, CATENA, V107, P89, DOI 10.1016/j.catena.2013.02.010; Yue XL, 2016, EUR J SOIL BIOL, V77, P34, DOI 10.1016/j.ejsobi.2016.10.002; Zak DR, 2008, ECOL APPL, V18, P2016, DOI 10.1890/07-1743.1; Zhang B, 2014, BIOL FERT SOILS, V50, P1077, DOI 10.1007/s00374-014-0929-4; Zhang HY, 2019, AGR WATER MANAGE, V212, P273, DOI 10.1016/j.agwat.2018.09.018; Zhang HJ, 2013, SOIL BIOL BIOCHEM, V57, P228, DOI 10.1016/j.soilbio.2012.08.024; Zhang QC, 2012, APPL SOIL ECOL, V57, P1, DOI 10.1016/j.apsoil.2012.02.012; Zhang YL, 2016, SOIL TILL RES, V155, P85, DOI 10.1016/j.still.2015.08.006; Zhou JZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12083; Zhou XB, 2012, SOIL BIOL BIOCHEM, V47, P67, DOI 10.1016/j.soilbio.2011.05.012	71	20	20	12	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0214041	10.1371/journal.pone.0214041	http://dx.doi.org/10.1371/journal.pone.0214041			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084129	Green Submitted, Green Published, gold			2022-12-26	WOS:000535227900001
J	Tabak, YP; Sung, A; Ye, G; Vankeepuram, L; Gupta, V; McCann, E				Tabak, Ying P.; Sung, Anita; Ye, Gang; Vankeepuram, Latha; Gupta, Vikas; McCann, Eilish			Attributable burden in patients with carbapenem-nonsusceptible gram-negative respiratory infections	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; CLOSTRIDIUM-DIFFICILE INFECTION; SURVEILLANCE PROGRAM; DISEASES-SOCIETY; US; ENTEROBACTERIACEAE; RATES; RISK; SUSCEPTIBILITY; GUIDELINES	Objective We aimed to describe the clinical and economic burden attributable to carbapenem-nonsusceptible (C-NS) respiratory infections. Methods This retrospective matched cohort study assessed clinical and economic outcomes of adult patients (aged >= 18 years) who were admitted to one of 78 acute care hospitals in the United States with nonduplicate C-NS and carbapenem-susceptible (C-S) isolates from a respiratory source. A subset analysis of patients with principal diagnosis codes denoting bacterial pneumonia or other diagnoses was also conducted. Isolates were classified as community- or hospital-onset based on collection time. A generalized linear mixed model method was used to estimate the attributable burden for mortality, 30-day readmission, length of stay (LOS), cost, and net gain/loss (payment minus cost) using propensity score-matched C-NS versus C-S cohorts. Results For C-NS cases, mortality (25.7%), LOS (29.4 days), and costs ($81,574) were highest in the other principal diagnosis, hospital-onset subgroup; readmissions (19.4%) and net loss (-$9522) were greatest in the bacterial pneumonia, hospital-onset subgroup. Mortality and readmissions were not significantly higher for C-NS cases in any propensity score-matched subgroup. Significant C-NS-attributable burden was found for both other principal diagnosis subgroups for LOS (hospital-onset: 3.7 days, P = 0.006; community-onset: 1.5 days, P<0.001) and cost (hospital-onset: $12,777, P<0.01; community-onset: $2681, P<0.001). Conclusions Increased LOS and cost burden were observed in propensity score-matched patients with C-NS compared with C-S respiratory infections; the C-NS-attributable burden was significant only for patients with other principal diagnoses.	[Tabak, Ying P.; Ye, Gang; Vankeepuram, Latha; Gupta, Vikas] Dickinson & Co, Becton, Med Affairs, Digital Hlth, Franklin Lakes, NJ USA; [Sung, Anita; McCann, Eilish] Merck & Co Inc, Ctr Observat & Real World Evidence CORE, Kenilworth, NJ 07033 USA	Becton Dickinson; Merck & Company	McCann, E (corresponding author), Merck & Co Inc, Ctr Observat & Real World Evidence CORE, Kenilworth, NJ 07033 USA.	Eilish.mccann@merck.com	Sung, Anita/ABC-9885-2021		Merck Sharp Dohme Corp.	Merck Sharp Dohme Corp.(Merck & Company)	This study and editorial assistance for the development of the manuscript were funded by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. The funder provided support in the form of salaries for authors [EM, AS] and funding for contract data mining and analysis with Digital Health, Medical Affairs, Becton, Dickinson and Company, Franklin Lakes, NJ, USA [YPT, GY, LV, VG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	[Anonymous], 2013, UNTREATABLE REPORT C; [Anonymous], 2017, CLIN CLASS SOFTW CCS; [Anonymous], 2014, ANT RES GLOB REP SUR; Biehle LR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143845; Djordjevic ZM, 2017, J INFECT PUBLIC HEAL, V10, P740, DOI 10.1016/j.jiph.2016.11.016; Eber MR, 2010, ARCH INTERN MED, V170, P347, DOI 10.1001/archinternmed.2009.509; Gross AE, 2017, CLIN INFECT DIS, V65, P613, DOI 10.1093/cid/cix379; Gutierrez-Gutierrez B, 2017, LANCET INFECT DIS, V17, P726, DOI 10.1016/S1473-3099(17)30228-1; Jones RN, 2010, CLIN INFECT DIS, V51, pS81, DOI 10.1086/653053; Kalil AC, 2016, CLIN INFECT DIS, V63, P575, DOI 10.1093/cid/ciw504; Kochanek Kenneth D, 2016, Natl Vital Stat Rep, V65, P1; Kollef MH, 2012, INFECT CONT HOSP EP, V33, P250, DOI 10.1086/664049; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mataseje LF, 2016, ANTIMICROB AGENTS CH, V60, P6787, DOI 10.1128/AAC.01359-16; Muggeo A, 2017, J ANTIMICROB CHEMOTH, V72, P1496, DOI 10.1093/jac/dkw590; Parsons LS, 2001, SAS SUGI, P214; Sader HS, 2014, INT J ANTIMICROB AG, V43, P328, DOI 10.1016/j.ijantimicag.2014.01.007; Tabak YP, 2014, J AM MED INFORM ASSN, V21, P455, DOI 10.1136/amiajnl-2013-001790; Tabak YP, 2013, INFECT CONT HOSP EP, V34, P588, DOI 10.1086/670621; Thaden JT, 2014, INFECT CONT HOSP EP, V35, P978, DOI 10.1086/677157; Wu PF, 2016, SCI REP-UK, V6, DOI 10.1038/srep32665; Wuerth BA, 2016, EMERG INFECT DIS, V22, P1624, DOI 10.3201/eid2209.150680; Zilberberg MD, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2383-z; Zilberberg MD, 2011, INFECT CONT HOSP EP, V32, P649, DOI 10.1086/660360; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	25	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229393	10.1371/journal.pone.0229393	http://dx.doi.org/10.1371/journal.pone.0229393			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084236	Green Published, gold			2022-12-26	WOS:000535227900105
J	Brown, TP; Bhattacharjee, P; Ramachandran, S; Sivaprakasam, S; Ristic, B; Sikder, MOF; Ganapathy, V				Brown, Timothy P.; Bhattacharjee, Pushpak; Ramachandran, Sabarish; Sivaprakasam, Sathish; Ristic, Bojana; Sikder, Mohd Omar F.; Ganapathy, Vadivel			The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment	ONCOGENE			English	Article							MURINE DENDRITIC CELLS; UP-REGULATION; LACTIC-ACID; METABOLISM; INFLAMMATION; GENERATION; EXPRESSION; GPR109A; PROTEIN; ACTIVATION	GPR81 is a G-protein-coupled receptor for lactate, which is upregulated in breast cancer and plays an autocrine role to promote tumor growth by tumor cell-derived lactate. Here we asked whether lactate has any paracrine role via activation of GPR81 in cells present in tumor microenvironment to help tumor growth. First, we showed that deletion of Gpr81 suppresses breast cancer growth in a constitutive breast cancer mouse model (MMTV-PyMT-Tg). We then used a syngeneic transplant model by monitoring tumor growth from a mouse breast cancer cell line (AT-3, Gpr81-negative) implanted in mammary fat pad of wild-type mice and Gpr81-null mice. Tumor growth was suppressed in Gpr81-null mice compared with wild-type mice. There were more tumor-infiltrating T cells and MHCIIhi-immune cells in tumors from Gpr81-null mice compared with tumors from wild-type mice. RNA-seq analysis of tumors indicated involvement of immune cells and antigen presentation in Gpr81-dependent tumor growth. Antigen-presenting dendritic cells expressed Gpr81 and activation of this receptor by lactate suppressed cell-surface presentation of MHCII. Activation of Gpr81 in dendritic cells was associated with decreased cAMP, IL-6 and IL-12. These findings suggest that tumor cell-derived lactate activates GPR81 in dendritic cells and prevents presentation of tumor-specific antigens to other immune cells. This paracrine mechanism is complementary to the recently discovered autocrine mechanism in which lactate induces PD-L1 in tumor cells via activation of GPR81 in tumor cells, thus providing an effective means for tumor cells to evade immune system. As such, blockade of GPR81 signaling could boost cancer immunotherapy.	[Brown, Timothy P.; Bhattacharjee, Pushpak; Ramachandran, Sabarish; Sivaprakasam, Sathish; Ristic, Bojana; Sikder, Mohd Omar F.; Ganapathy, Vadivel] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Ganapathy, V (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA.	vadivel.ganapathy@ttuhsc.edu	Bhattacharjee, Pushpak/AFV-4590-2022; Sivaprakasam, Sathish/E-9367-2018	Sivaprakasam, Sathish/0000-0002-9230-0144	Welch Endowed Chair in Biochemistry at Texas Tech University Health Sciences Center [BI-0028]; South Plains Foundation	Welch Endowed Chair in Biochemistry at Texas Tech University Health Sciences Center; South Plains Foundation	This work was supported by the Welch Endowed Chair in Biochemistry, Grant no. BI-0028, at Texas Tech University Health Sciences Center (VG) and a grant from the South Plains Foundation (SR).	Ahmed K, 2010, CELL METAB, V11, P311, DOI 10.1016/j.cmet.2010.02.012; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Dvorak CA, 2012, ACS MED CHEM LETT, V3, P637, DOI 10.1021/ml3000676; Elangovan S, 2014, CANCER RES, V74, P1166, DOI 10.1158/0008-5472.CAN-13-1451; Feng J, 2017, ONCOGENE, V36, P5829, DOI 10.1038/onc.2017.188; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Fisel P, 2018, CTS-CLIN TRANSL SCI, V11, P352, DOI 10.1111/cts.12551; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Ge H, 2008, J LIPID RES, V49, P797, DOI 10.1194/jlr.M700513-JLR200; GOLDMAN RD, 1964, CANCER RES, V24, P389; Gottfried E, 2006, BLOOD, V107, P2013, DOI 10.1182/blood-2005-05-1795; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Halestrap AP, 2013, MOL ASPECTS MED, V34, P337, DOI 10.1016/j.mam.2012.05.003; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hoque R, 2014, GASTROENTEROLOGY, V146, P1763, DOI 10.1053/j.gastro.2014.03.014; Husain Z, 2013, J IMMUNOL, V191, P1486, DOI 10.4049/jimmunol.1202702; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lee YJ, 2016, ONCOTARGET, V7, P70898, DOI 10.18632/oncotarget.12286; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Offermanns S, 2017, TRENDS ENDOCRIN MET, V28, P227, DOI [10.1016/J.tem.2016.11.007, 10.1016/j.tem.2016.11.007]; Ranganathan P, 2018, J IMMUNOL, V200, P1781, DOI 10.4049/jimmunol.1700604; Raychaudhuri D, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01878; Roland CL, 2014, CANCER RES, V74, P5301, DOI 10.1158/0008-5472.CAN-14-0319; Romero-Garcia S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00052; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; STANISLAUS D, 1994, ENDOCRINOLOGY, V135, P2220, DOI 10.1210/en.135.5.2220; Stewart TJ, 2009, J IMMUNOL, V183, P117, DOI 10.4049/jimmunol.0804132; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Wagner W, 2017, J PHYSIOL PHARMACOL, V68, P555; Wagner W, 2017, DNA REPAIR, V52, P49, DOI 10.1016/j.dnarep.2017.02.007; Wagner W, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0114-x; Walenta S, 2000, CANCER RES, V60, P916; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577	47	73	76	3	30	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2020	39	16					3292	3304		10.1038/s41388-020-1216-5	http://dx.doi.org/10.1038/s41388-020-1216-5		FEB 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QF9OJ	32071396				2022-12-26	WOS:000514262700001
J	Li, JJ; Pu, TJ; Yin, LJ; Li, QL; Liao, CP; Wu, BJ				Li, Jingjing; Pu, Tianjie; Yin, Lijuan; Li, Qinlong; Liao, Chun-Peng; Wu, Boyang Jason			MAOA-mediated reprogramming of stromal fibroblasts promotes prostate tumorigenesis and cancer stemness	ONCOGENE			English	Article							MONOAMINE-OXIDASE; TUMOR PROGRESSION; SIGNALING PATHWAY; OXIDATIVE STRESS; CELLS; STAT3; INTERLEUKIN-6; INFLAMMATION; METASTASIS; MICROENVIRONMENT	The tumor microenvironment plays a critical role in prostate cancer (PC) development and progression. Inappropriate activation of the stroma potentiates the growth and transformation of epithelial tumor cells. Here, we show that upregulation of monoamine oxidase A (MAOA), a mitochondrial enzyme that degrades monoamine neurotransmitters and dietary amines, in stromal cells elevates production of reactive oxygen species, triggers an inflammatory response including activation of IL-6, and promotes tumorigenesis in vitro and in vivo. Mechanistically, MAOA enhances IL-6 transcription through direct Twist1 binding to a conserved E-box element at the IL-6 promoter. MAOA in stromal fibroblasts provides tumor cell growth advantages through paracrine IL-6/STAT3 signaling. Tissue microarray analysis revealed co-expression correlations between individual pairs of proteins of the stromal MAOA-induced Twist1/IL-6/STAT3 pathway in clinical specimens. Downstream of stromal MAOA, STAT3 also promotes cell stemness and transcriptionally activates expression of cancer stem cell marker CD44 in PC cells. MAOA inhibitor treatment effectively suppressed prostate tumor growth in mice in a stroma-specific targeted manner. Collectively, these findings characterize the contribution of MAOA to stromal activation in PC pathogenesis and provide a rationale for targeting MAOA in stromal cells to treat PC.	[Li, Jingjing; Pu, Tianjie; Wu, Boyang Jason] Washington State Univ, Coll Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, 205 E Spokane Falls Blvd,PBS 421, Spokane, WA 99202 USA; [Li, Jingjing] Shanghai Jiao Tong Univ, Sch Pharm, Lab Regener, Shanghai 200240, Peoples R China; [Pu, Tianjie; Yin, Lijuan] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu 610041, Sichuan, Peoples R China; [Yin, Lijuan] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Med, Urooncol Res Program, Los Angeles, CA 90048 USA; [Li, Qinlong] Med Univ Air Force, Xijing Hosp, Dept Pathol, Xian 710032, Shaanxi, Peoples R China; [Liao, Chun-Peng] Univ Southern Calif, Keck Sch Med, Lawrence J Ellison Inst Transformat Med, Los Angeles, CA 90089 USA	Washington State University; Shanghai Jiao Tong University; Sichuan University; Cedars Sinai Medical Center; Air Force Military Medical University; University of Southern California	Wu, BJ (corresponding author), Washington State Univ, Coll Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, 205 E Spokane Falls Blvd,PBS 421, Spokane, WA 99202 USA.	boyang.wu@wsu.edu	Li, Jing/GYU-5036-2022; Pu, Tianjie/AAE-9454-2022; Pu, Tianjie/AFD-8574-2022	Liao, Chun-Peng/0000-0001-8920-4322	Concern Foundation CONquer canCER Now Award; Department of Defense Prostate Cancer Research Program [W81XWH-15-1-0493]; NIH/NCI [R37CA233658]; WSU start-up fund	Concern Foundation CONquer canCER Now Award; Department of Defense Prostate Cancer Research Program(United States Department of Defense); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); WSU start-up fund	We thank Yang Li (University of Southern California), Yanping Wang (CSMC), and Yidi Xu (Washington State University) for technical help, Leland W.K. Chung (CSMC) for comprehensive support of this study, and Gary Mawyer for editorial assistance. This work was supported by a Concern Foundation CONquer canCER Now Award, the Department of Defense Prostate Cancer Research Program grant W81XWH-15-1-0493, the NIH/NCI grant R37CA233658, and the WSU start-up fund to B.J.W.	Acharya A, 2010, OXID MED CELL LONGEV, V3, P23, DOI 10.4161/oxim.3.1.10095; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Azevedo A, 2011, WORLD J CLIN ONCOL, V2, P384, DOI 10.5306/wjco.v2.i12.384; Barron DA, 2012, ENDOCR-RELAT CANCER, V19, pR187, DOI 10.1530/ERC-12-0085; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Cheng N, 2011, JOVE-J VIS EXP, DOI 10.3791/2716; Culig Z, 2018, MOL CELL ENDOCRINOL, V462, P25, DOI 10.1016/j.mce.2017.03.012; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Dobrian Anca D, 2012, Front Endocrinol (Lausanne), V3, P108, DOI 10.3389/fendo.2012.00108; Dumont N, 2013, NEOPLASIA, V15, P249, DOI 10.1593/neo.121950; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Flamand V, 2010, J CANCER RES CLIN, V136, P1761, DOI 10.1007/s00432-010-0835-6; Franco OE, 2012, ADV PHARMACOL, V65, P267, DOI 10.1016/B978-0-12-397927-8.00009-9; Galoczova M, 2018, CELL MOL BIOL LETT, V23, DOI 10.1186/s11658-018-0078-0; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Ishihara K, 2002, BBA-MOL CELL RES, V1592, P281, DOI 10.1016/S0167-4889(02)00321-X; Kawada M, 2006, CANCER RES, V66, P4419, DOI 10.1158/0008-5472.CAN-05-4239; Kumari N, 2016, TUMOR BIOL, V37, P11553, DOI 10.1007/s13277-016-5098-7; Policastro LL, 2013, ANTIOXID REDOX SIGN, V19, P854, DOI 10.1089/ars.2011.4367; Leach DA, 2017, CANCERS, V9, DOI 10.3390/cancers9010010; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Lee KW, 2015, CANCER RES, V75, P73, DOI 10.1158/0008-5472.CAN-14-0350; Li Y, 2013, J BIOL CHEM, V288, P25007, DOI 10.1074/jbc.M113.450353; Lin L, 2016, INT J ONCOL, V49, P2265, DOI 10.3892/ijo.2016.3728; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Mathy-Hartert M, 2008, OSTEOARTHR CARTILAGE, V16, P756, DOI 10.1016/j.joca.2007.10.009; Meng E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107142; Moreira MP, 2018, EXP CELL RES, V363, P283, DOI 10.1016/j.yexcr.2018.01.018; Olumi AF, 1999, CANCER RES, V59, P5002; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654; Studebaker AW, 2008, CANCER RES, V68, P9087, DOI 10.1158/0008-5472.CAN-08-0400; Sun XJ, 2010, IN VITRO CELL DEV-AN, V46, P538, DOI 10.1007/s11626-010-9309-z; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Tanner MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016027; THALMANN GN, 1994, CANCER RES, V54, P2577; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; True L, 2006, P NATL ACAD SCI USA, V103, P10991, DOI 10.1073/pnas.0603678103; Valencia T, 2014, CANCER CELL, V26, P121, DOI 10.1016/j.ccr.2014.05.004; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wassmann S, 2004, CIRC RES, V94, P534, DOI 10.1161/01.RES.0000115557.25127.8D; Wu JB, 2009, J BIOL CHEM, V284, P16723, DOI 10.1074/jbc.M901779200; Wu JB, 2017, CANCER CELL, V31, P368, DOI 10.1016/j.ccell.2017.02.003; Wu JB, 2014, J CLIN INVEST, V124, P2891, DOI 10.1172/JCI70982; Yan YM, 2015, STEM CELL TRANSL MED, V4, P1033, DOI 10.5966/sctm.2015-0048; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhang G, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/782581; Zhau HYE, 1996, P NATL ACAD SCI USA, V93, P15152, DOI 10.1073/pnas.93.26.15152; Zhu YZ, 2014, PROSTATE, V74, P1086, DOI 10.1002/pros.22819	56	13	13	5	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2020	39	16					3305	3321		10.1038/s41388-020-1217-4	http://dx.doi.org/10.1038/s41388-020-1217-4		FEB 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QF9OJ	32066880				2022-12-26	WOS:000514052700004
J	Pelletier, VH; Girard, S; Lemoyne, J				Pelletier, Vincent Huard; Girard, Stephanie; Lemoyne, Jean			Adolescent hockey players' predispositions to adopt sport and exercise behaviours: An ecological perspective	PLOS ONE			English	Article							PHYSICAL-ACTIVITY PROMOTION; SAMPLE-SIZE; MODEL; CHILDREN; COACH; FIT; MOTIVATION; EDUCATION; CRITERIA; MOTIVES	Organized sport yields many cognitive, social and physical benefits and is one of the most popular types of physical activity for children and adolescents. Despite the benefits of sports participation, a substantial proportion of adolescents fail to meet Canadian guidelines regarding physical activity. In this regard, it is relevant to understand the mechanisms underlying the adoption of various active behaviours. This study aims to identify the predisposing, enabling and reinforcing factors that potentially influence 4 categories of active behaviours using the Youth Physical Activity Promotion model (YPAP). Data was drawn from 416 male adolescent hockey players (M-age = 15.4; SD = 2) who completed a pre-validated questionnaire. Structural equation modeling and interaction analyses were performed to explain the contribution of each determinant. Findings reveal that there are different behavioural patterns based on the type of activity. The interaction between attitudes and environmental factors was a key predictor for each type of behaviour. Perceived competence was associated with more recreational activities, whereas the support of parents and coaches determined involvement in ice hockey. This study refined our understanding of physical activity participation among adolescents already involved in organized sports and emphasized the importance of considering multiple factors surrounding their environment. Several practical recommendations are made to improve young athletes' predisposition to practice physical activity in an organized sports setting.	[Pelletier, Vincent Huard; Girard, Stephanie; Lemoyne, Jean] Univ Quebec Trois Rivieres, Dept Human Kinet, Trois Rivieres, PQ, Canada	University of Quebec; University of Quebec Trois Rivieres	Lemoyne, J (corresponding author), Univ Quebec Trois Rivieres, Dept Human Kinet, Trois Rivieres, PQ, Canada.	jean.lemoyne@uqtr.ca	Girard, Stéphanie/AHE-6834-2022; Pelletier, Vincent Huard/AAT-5602-2021	Lemoyne, Jean/0000-0002-5766-2203				Ahn SJ, 2015, J HEALTH COMMUN, V20, P807, DOI 10.1080/10810730.2015.1018597; Amorose AJ, 2016, PSYCHOL SPORT EXERC, V26, P1, DOI 10.1016/j.psychsport.2016.05.005; Asparouhov T., 2005, P FEDERAL COMMITTEE, P14; Bailey R, 2009, RES PAP EDUC, V24, P1, DOI 10.1080/02671520701809817; Barnes JD, 2018, J PHYS ACT HEALTH, V15, pS328, DOI 10.1123/jpah.2018-0454; Barnes JD, 2016, J PHYS ACT HEALTH, V13, pS110, DOI 10.1123/jpah.2016-0300; Chanal JP, 2007, J SPORT EXERCISE PSY, V27, P53; Chen SL, 2014, MEAS PHYS EDUC EXERC, V18, P227, DOI 10.1080/1091367X.2014.936017; Clavel F., ADV TOPICS PLOTTING; Cote J., 2009, PHYS HLTH ED, V74, P6; Downs SJ, 2014, EUR J SPEC NEEDS EDU, V29, P402, DOI 10.1080/08856257.2014.906979; Ede S., 2012, Journal of Sport Behavior, V35, P3; Fan XT, 1999, STRUCT EQU MODELING, V6, P56, DOI 10.1080/10705519909540119; Girard S, 2017, REV SCI EDUC, V43, P28, DOI 10.7202/1050972ar; Hills AP, 2015, PROG CARDIOVASC DIS, V57, P368, DOI 10.1016/j.pcad.2014.09.010; Hockey Quebec, RAPP ANN 2017 18; Hockey Quebec, PLAN STRAT 2017 2022; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hynynen ST, 2016, INT REV SPORT EXER P, V9, P22, DOI 10.1080/1750984X.2015.1081706; Johnson P. O., 1936, STAT RES MEMOIRS; Juntumaa B, 2007, ED PSYCHOL RES FOCUS, P121; Keegan RJ, 2009, PSYCHOL SPORT EXERC, V10, P361, DOI 10.1016/j.psychsport.2008.12.003; Kilpatrick M, 2005, J AM COLL HEALTH, V54, P87, DOI 10.3200/JACH.54.2.87-94; Kirk R., 2014, EXPT DESIGN PROCEDUR, DOI [10.4135/9781483384733, DOI 10.4135/9781483384733]; Klein A, 2000, PSYCHOMETRIKA, V65, P457, DOI 10.1007/BF02296338; Lorah JA, 2018, J COUNS PSYCHOL, V65, P629, DOI 10.1037/cou0000290; Mageau GA, 2003, J SPORT SCI, V21, P883, DOI 10.1080/0264041031000140374; Marsh H.W., 2012, HDB STRUCTURAL EQUAT, P436; Marsh HW, 2010, J SPORT EXERCISE PSY, V32, P438, DOI 10.1123/jsep.32.4.438; Marsh HW, 2005, J SPORT EXERCISE PSY, V27, P71, DOI 10.1123/jsep.27.1.71; Martins JS, 2018, PSYCHOL ADDICT BEHAV, V32, P16, DOI 10.1037/adb0000324; McCreary DR., 2004, PSYCHOL MEN MASC, V5, P49, DOI [10.1037/1524-9220.5.1.49, DOI 10.1037/1524-9220.5.1.49]; Moesch K, 2011, SCAND J MED SCI SPOR, V21, pE282, DOI 10.1111/j.1600-0838.2010.01280.x; Mollerlokken NE, 2015, PERCEPT MOTOR SKILL, V121, P913, DOI 10.2466/10.PMS.121c23x0; Morin P, 2013, PHENEX J, V5, P1; Rowe DA, 2007, PEDIATR EXERC SCI, V19, P420, DOI 10.1123/pes.19.4.420; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sallis JF, 2002, HLTH BEHAV HLTH ED T, V3, P462; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Seabra AC, 2013, J PHYS ACT HEALTH, V10, P1159, DOI 10.1123/jpah.10.8.1159; Sirard JR, 2001, SPORTS MED, V31, P439, DOI 10.2165/00007256-200131060-00004; Standage M, 2007, INTRINSIC MOTIVATION; TANAKA JS, 1987, CHILD DEV, V58, P134, DOI 10.1111/j.1467-8624.1987.tb03495.x; Wall M., 2007, Physical Education and Sport Pedagogy, V12, P77, DOI 10.1080/17408980601060358; Welk GJ, 1999, QUEST, V51, P5, DOI 10.1080/00336297.1999.10484297; Yan Z, 2015, J SPORT HEALTH SCI, V4, P203, DOI 10.1016/j.jshs.2013.07.002	47	3	3	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2020	15	2							e0228352	10.1371/journal.pone.0228352	http://dx.doi.org/10.1371/journal.pone.0228352			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ7VI	32059019	Green Published, gold			2022-12-26	WOS:000535206600009
J	Gwak, DS; Kim, BK; Chung, I; Han, MK				Gwak, Dong-Seok; Kim, Baik-Kyun; Chung, Inyoung; Han, Moon-Ku			The usefulness of Time-of-Flight MR angiography in detection of intraplaque hemorrhage in patients with acute ischemic stroke with symptomatic carotid stenosis	PLOS ONE			English	Article							PREPARED RAPID ACQUISITION; ARTERY; INFARCTION; PLAQUES; EVENTS; SIGNAL; RISK	Objective Carotid intraplaque hemorrhage (IPH) is a well-known risk indicator of thromboembolism, but it is not easy to rapidly detect IPH in acute symptomatic carotid disease. The aim of this study was to assess the utility of time-of-flight (TOF) magnetic resonance angiography (MRA) in the detection of IPH and evaluate the degree of stenosis and stroke patterns in patients with acute symptomatic carotid disease. Methods We retrospectively identified consecutive patients with acute symptomatic carotid disease who were admitted within 12 h after stroke onset. Fifty-nine patients underwent TOF MRA at admission and were categorized according to the presence or absence of intraplaque high signal intensity (HSI). The severity of carotid stenosis and diffusion-weighted magnetic resonance imaging lesion patterns were evaluated. Results Intraplaque HSI was detected in 28.8% of the enrolled patients (17/59). Mild-to-moderate symptomatic carotid stenosis was more frequent in the intraplaque HSI-positive group (70.6%) than in the intraplaque HSI-negative group (42.8%) (p = 0.015). The patients with intraplaque HSI more frequently exhibited a disseminated small infarction pattern (76.5% in the intraplaque HSI-positive group, 47.6% in the -negative group), and did not exhibit a border-zone infarction pattern (0% in the positive group, 16.7% in the negative group). Conclusions TOF MRA may be a useful noninvasive and rapid tool to detect IPH in patients with acute symptomatic carotid disease. IPH was common in those with a lower degree of carotid stenosis and manifested as a disseminated small infarction pattern. Intraplaque HSI on TOF MRA in acute symptomatic carotid disease may help to determine the mechanism of stroke and establish early treatment plans.	[Gwak, Dong-Seok] Kyungpook Natl Univ Hosp, Dept Neurol, Daegu, South Korea; [Kim, Baik-Kyun] Chungbuk Natl Univ Hosp, Dept Neurol, Cheongju, Chungcheongbuk, South Korea; [Chung, Inyoung] Seoul Natl Univ, Bundang Hosp, Dept Medicare Syst, Seongnam Si, Gyeonggi Do, South Korea; [Han, Moon-Ku] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Neurol, Seongnam Si, Gyeonggi Do, South Korea	Kyungpook National University; Kyungpook National University Hospital; Chungbuk National University; Chungbuk National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Han, MK (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Neurol, Seongnam Si, Gyeonggi Do, South Korea.	mkhan@snu.ac.kr		Chung, Inyoung/0000-0002-3586-4162				Ahn Ji-eun, 2018, Investigative Magnetic Resonance Imaging, V22, P94, DOI 10.13104/imri.2018.22.2.94; Altaf N, 2007, STROKE, V38, P1633, DOI 10.1161/STROKEAHA.106.473066; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Bluth EI, 2000, JAMA-J AM MED ASSOC, V284, P177, DOI 10.1001/jama.284.2.177; BOGOUSSLAVSKY J, 1986, ANN NEUROL, V20, P346, DOI 10.1002/ana.410200312; Del Sette M, 2000, STROKE, V31, P631, DOI 10.1161/01.STR.31.3.631; FALK E, 1989, AM J CARDIOL, V63, pE114, DOI 10.1016/0002-9149(89)90242-7; Kolodgie FD, 2003, NEW ENGL J MED, V349, P2316, DOI 10.1056/NEJMoa035655; Mathiesen EB, 2001, CIRCULATION, V103, P2171; McNally JS, 2012, CIRC-CARDIOVASC IMAG, V5, P376, DOI 10.1161/CIRCIMAGING.111.967398; Michel JB, 2011, EUR HEART J, V32, P1977, DOI 10.1093/eurheartj/ehr054; Park JS, 2015, J KOREAN NEUROSURG S, V57, P94, DOI 10.3340/jkns.2015.57.2.94; Polak JF, 1998, RADIOLOGY, V208, P649, DOI 10.1148/radiology.208.3.9722841; Roh JK, 2000, STROKE, V31, P688, DOI 10.1161/01.STR.31.3.688; Sacco RL, 2001, NEW ENGL J MED, V345, P1113, DOI 10.1056/NEJMcp011227; Yamada K, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-81; Yim YJ, 2008, J MAGN RESON IMAGING, V27, P1341, DOI 10.1002/jmri.21284	17	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0229024	10.1371/journal.pone.0229024	http://dx.doi.org/10.1371/journal.pone.0229024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053703	Green Published, gold			2022-12-26	WOS:000535198700092
J	Jia, YL; Liao, Z; Chew, HF; Wang, LF; Lin, BS; Chen, CQ; Lu, GD; Lin, ZX				Jia, Yulei; Liao, Zhen; Chew, Huifang; Wang, Lifang; Lin, Biaosheng; Chen, Chaoqian; Lu, Guodong; Lin, Zhanxi			Effect of Pennisetum giganteum z.x.lin mixed nitrogen-fixing bacterial fertilizer on the growth, quality, soil fertility and bacterial community of pakchoi (Brassica chinensis L.)	PLOS ONE			English	Article							PARTICLE-SIZE FRACTIONS; LONG-TERM FERTILIZATION; MICROBIAL COMMUNITY; DIVERSITY; INOCULATION; SUCCESSION; MANAGEMENT; YIELD	Biofertilizer plays a significant role in crop cultivation that had reduced its inorganic fertilizer use. The effects of inorganic fertilizer reduction combined with Pennisetum giganteum z.x. lin mixed nitrogen-fixing biofertilizer on the growth, quality, soil nutrients and diversity of the soil bacterial community in the rhizosphere soil of pakchoi were studied. The experiment composed of 6 treatments, including CK (no fertilization), DL (10% inorganic fertilizer reduction combined with Pennisetum giganteum z.x.lin mixed nitrogen-fixing biofertilizer), ZL (25% inorganic fertilizer reduction combined with Pennisetum giganteum z.x.lin mixed nitrogen-fixing biofertilizer), SL (50% inorganic fertilizer reduction combined with Pennisetum giganteum z.x.lin mixed nitrogen-fixing biofertilizer), FHF (100% inorganic fertilizer) and JZ (100% inorganic fertilizer combined with sterilized Pennisetum giganteum z.x.lin mixed nitrogen-fixing biofertilizer). Compared with conventional fertilization, the 25% reduction in chemical fertilizer applied with the Pennisetum giganteum mixed nitrogen-fixing biofertilizer resulted in higher plant height, plant weight, chlorophyll content, soluble protein content, soluble sugar content, vitamin C content, alkali hydrolyzed nitrogen content, available phosphorus content, available potassium content and organic matter content in pakchoi, and these variables increased by 11.81%, 8.54%, 7.37%, 16.88%, 17.05%, 23.70%, 24.24%, 36.56%, 21.09% and 19.72%, respectively. In addition, the 25% reduction in chemical fertilizer applied with the Pennisetum giganteum mixed nitrogen-fixing biofertilizer also had the lowest nitrate content, which was 53.86% lower than that with conventional fertilization. Different fertilizer treatments had a significant effect on the soil bacterial community structure. Compared with conventional fertilization, the coapplication of Pennisetum giganteum z.x.lin mixed nitrogen-fixing biofertilizer and inorganic fertilizer significantly increased the relative abundance of Proteobacteria and Actinobacteria in the soil. The results of the redundancy analysis (RDA) showed that soil organic matter, alkali-hydrolyzed nitrogen, available phosphorus, available potassium, pH and water content had a specific impact on the soil bacterial community. Among the factors, soil water content was the main factor affecting the soil bacterial community, followed by soil organic matter, soil pH, available potassium, soil available phosphorus and soil alkali-hydrolyzed nitrogen.	[Jia, Yulei; Liao, Zhen; Chew, Huifang; Wang, Lifang; Lin, Biaosheng; Chen, Chaoqian; Lu, Guodong; Lin, Zhanxi] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Peoples R China; [Jia, Yulei; Liao, Zhen; Chew, Huifang; Wang, Lifang; Lin, Biaosheng; Chen, Chaoqian; Lu, Guodong; Lin, Zhanxi] Natl Engn Res Ctr Juncao Technol, Fuzhou, Peoples R China; [Lin, Biaosheng] Longyan Univ, Coll Life Sci, Longyan, Peoples R China	Fujian Agriculture & Forestry University; Longyan University	Lin, ZX (corresponding author), Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Peoples R China.; Lin, ZX (corresponding author), Natl Engn Res Ctr Juncao Technol, Fuzhou, Peoples R China.	lzxjuncao@163.com		Jia, Yulei/0000-0003-4398-0048	Central Leading Local Science and Technology Development Special Fund Project of China [2018L3003]; Ministry of Agriculture, Grass and Ecology Industry [[2018]126]; Ministry of Construction and Collaborative Innovation Center, China [[2018]126]	Central Leading Local Science and Technology Development Special Fund Project of China; Ministry of Agriculture, Grass and Ecology Industry; Ministry of Construction and Collaborative Innovation Center, China	This work was supported by the Central Leading Local Science and Technology Development Special Fund Project of China under grant number 2018L3003 and the Ministry of Agriculture, Grass and Ecology Industry and the Ministry of Construction and Collaborative Innovation Center, China under grant number [2018]126.	ABBASS Z, 1993, SOIL BIOL BIOCHEM, V25, P1075, DOI 10.1016/0038-0717(93)90156-6; Angeloni NL, 2010, FEMS MICROBIOLOGY LE, V263, P86; Averill C, 2016, ECOL LETT, V19, P937, DOI 10.1111/ele.12631; Bakry M. A. A., 2009, Research Journal of Agriculture and Biological Sciences, V5, P16; Bao SD., 2000, SOIL AGR CHEM ANAL, P45; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carini P, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.242; Cavigelli MA, 2000, ECOLOGY, V81, P1402; [陈建明 Chen Jianming], 2017, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V23, P1296; Chen XF, 2015, J SOIL SEDIMENT, V15, P292, DOI 10.1007/s11368-014-0981-6; Chu HY, 2016, ENVIRON MICROBIOL, V18, P1523, DOI 10.1111/1462-2920.13236; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Coolon JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067884; Felske A, 2000, APPL ENVIRON MICROB, V66, P3998, DOI 10.1128/AEM.66.9.3998-4003.2000; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fischer G, 2009, AGR ECOSYSTEMS ENV, V136; Govindarajan M, 2006, PLANT SOIL, V280, P239, DOI 10.1007/s11104-005-3223-2; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Han Guang, 2011, Acta Pedologica Sinica, V48, P405; Han XiaoLing, 2005, Soils and Fertilizers (Beijing), P51; Hedlund K, 2002, SOIL BIOL BIOCHEM, V34, P1299, DOI 10.1016/S0038-0717(02)00073-1; Huang JK, 2008, J SOIL WATER CONSERV, V63, p165A, DOI 10.2489/jswc.63.5.165A; KENNEDY AC, 1995, PLANT SOIL, V170, P75, DOI 10.1007/BF02183056; Kogel-Knabner I., 2010, CHEMINFORM, V33; Kuramae EE, 2010, ISME J, V4, P711, DOI 10.1038/ismej.2010.11; [李欢 LI Huan], 2011, [土壤通报, Journal of Soil Science], V42, P1179; Lin BS, 2018, JIANGSU AGR SCI, V46, P281; [林兴生 Lin Xingsheng], 2018, [草地学报, Acta Agrestia Sinica], V26, P1525; [林兴生 Lin Xingsheng], 2014, [生态学报, Acta Ecologica Sinica], V34, P4304; Liu GuangYe, 2001, Chinese Journal of Applied and Environmental Biology, V7, P66; Liu JJ, 2014, SOIL BIOL BIOCH, V70; Ma QX, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1006-6; Maestre FT, 2015, P NATL ACAD SCI USA, V112, P15684, DOI 10.1073/pnas.1516684112; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Morugan-Coronado A, 2019, SCI TOTAL ENVIRON, V655, P158, DOI 10.1016/j.scitotenv.2018.11.174; Munyaka PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142536; [逄焕成 PANG Huan-cheng], 2009, [农业环境科学学报, Journal of Agro-Environment Science], V28, P951; Pankhurst CE, 1996, BIODIVERS CONSERV, V5, P197, DOI 10.1007/BF00055830; Peng SB, 2002, AGRON J, V94, P925, DOI 10.2134/agronj2002.9250; Qin LP, 2005, CHINESE AGR SCI B, P150; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Redillas MCFR, 2012, PLANT BIOTECHNOL REP, V6, P89, DOI 10.1007/s11816-011-0210-3; Ren BH, 2018, SCI REP, V8, P1, DOI DOI 10.1038/S41598-018-24040-; Sarathchandra S.U, 2001, SOIL BIOL BIOCH, V33; Shi P, 2015, ARCH AGRONOMY SOIL S, V61; Spain AM, 2009, ISME J, V3, P992, DOI 10.1038/ismej.2009.43; Tedersoo L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15572; Trivedi P, 2017, SOIL BIOL BIOCHEM, V111, P10, DOI 10.1016/j.soilbio.2017.03.013; Velthof GL, 2009, J ENV QUALITY, V38; Venieraki A, 2011, J MICROBIOL, V49, P525, DOI 10.1007/s12275-011-0457-y; Wang FuWei, 2015, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V23, P1302; Wang HuiYing, 2018, Scientia Agricultura Sinica, V51, P914; Wang J, 2015, SOIL BIOL BIOCH, V88; Wang L, 2019, CHIN COMP LAW SER, V7, P1, DOI 10.1163/9789004380578; [王孝涛 Wang Xiaotao], 2012, [东北农业大学学报, Journal of Northeast Agricultural University], V43, P96; Wang XK., 2006, PRINCIPLES TECHNIQUE, V122, P186; Wu SC, 2005, GEODERMA, V125, P155, DOI 10.1016/j.geoderma.2004.07.003; Wu SL, 2012, NO HORTICULTURE, P26; [肖佳雷 Xiao Jialei], 2013, [作物杂志, Crops], P83; Xu YongSheng, 2015, Southwest China Journal of Agricultural Sciences, V28, P2586; Xun WB, 2016, ENVIRON MICROBIOL, V18, P1907, DOI 10.1111/1462-2920.13098; Yang YD, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9010014; [张凯煜 Zhang Kaiyu], 2019, [中国环境科学, China Environmental Science], V39, P1245; Zhang Q, 2017, SOIL BIOL BIOCHEM, V105, P25, DOI 10.1016/j.soilbio.2016.11.005; Zhang Q, 2015, APPL SOIL ECOL, V94, P59, DOI 10.1016/j.apsoil.2015.05.005; [赵秉强 Zhao Bingqiang], 2004, [植物营养与肥料学报, Plant nutrition and fertitizer science], V10, P536; Zhong WH, 2010, PLANT SOIL, V326, P511, DOI 10.1007/s11104-009-9988-y; Zhong YQW, 2015, SOIL BIOL BIOCH, V91	69	10	12	7	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2020	15	2							e0228709	10.1371/journal.pone.0228709	http://dx.doi.org/10.1371/journal.pone.0228709			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7PV	32049972	Green Published, gold			2022-12-26	WOS:000535192300021
J	Lin, MH; Huang, YC; Chen, WK; Wang, JY				Lin, Ming-Hung; Huang, Yin-Chun; Chen, Wei-Kung; Wang, Jong-Yi			Sleepiness and injury risk in emergency medical service workers in Taiwan	PLOS ONE			English	Article							EXCESSIVE DAYTIME SLEEPINESS; HEALTH-STATUS; FATIGUE; DEPRIVATION; PERFORMANCE; SAFETY; ALERTNESS; ASSOCIATION; POPULATION; VALIDATION	Background Insufficient sleep is a common health and safety risk factor in high-impact workplaces where workers are required to take rotating shifts. However, studies on sleepiness-related risks and incidents, particularly among emergency medical services (EMS) workers are limited. Objective This study sought to investigate the prevalence of sleepiness and related workplace incidents among EMS workers. Methods This study utilized a cross-sectional survey design on a convenient sample of 500 EMS workers from 41 EMS squads across Taiwan. Data were collected using structured online questionnaires on workplace sleepiness and related safety incidents based on the Epworth Sleepiness Scale (ESS) and a modified 25-item EMS Safety Inventory respectively. Results With a response rate of 79.8% (n = 399), 36.9% of the respondents were identified as having mild daytime sleepiness, while 39.2% of the respondents were identified as having excessive daytime sleepiness. Multivariate analysis indicated that not only was working on rotating shifts the main cause of the high ESS scores among EMS workers, but also that higher ESS scores increased their risk of sustaining a workplace injury. Furthermore, ill-at-work incidents were associated with an increased risk of workplace-related injuries. Conclusion Overall, the findings indicated a correlation among working on rotation shifts, the prevalence of sleepiness, and a higher risk of workplace injury among EMS workers.	[Lin, Ming-Hung] Tajen Univ, Dept Pharm & Master Program, Pingtung, Taiwan; [Lin, Ming-Hung] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Huang, Yin-Chun] Nantou Cty Fire Bur, Nantou, Taiwan; [Chen, Wei-Kung] China Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan; [Wang, Jong-Yi] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Wang, JY (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.	ericwang@mail.cmu.edu.tw	Lin, Ming Hung/ABH-4835-2020	Lin, Ming Hung/0000-0002-3128-7468; Wang, Jong-Yi/0000-0002-7798-826X	Ministry of Science and Technology, Taiwan [MOST104-2410-H-039-006]; China Medical University, Taiwan [CMU107-S-18]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); China Medical University, Taiwan(China Medical University)	This study was supported by Ministry of Science and Technology, Taiwan (Grant No. MOST104-2410-H-039-006) and China Medical University, Taiwan (Grant No. CMU107-S-18).	Akerstedt T, 2011, IND HEALTH, V49, P141, DOI 10.2486/indhealth.MS4902ED; Avalle M, 2016, IEEE ACM T NETWORK, V24, P1704, DOI 10.1109/TNET.2015.2429918; Campbell D, 2009, PAEDIAT CHILD HLTH, V14, p30A, DOI [10.1093/pch/14.suppl_a.30a, DOI 10.1093/PCH/14.SUPPL_A.30A]; Caruso CC, 2004, DHHS NIOSH PUBLICATI, DOI 10.26616/NIOSHPUB2004143; Caruso CC, 2014, REHABIL NURS, V39, P16, DOI 10.1002/rnj.107; Chen NH, 2002, QUAL LIFE RES, V11, P817, DOI 10.1023/A:1020818417949; Chen YY, 2010, INJURY PREV, V16, P172, DOI 10.1136/ip.2009.021840; Chiang WC, 2009, RESUSCITATION, V80, P9, DOI 10.1016/j.resuscitation.2008.10.010; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Copin N, 2016, PRESSE MED, V45, pE145, DOI 10.1016/j.lpm.2015.12.014; Cunningham R, 2010, NEW ZEAL MED J, V123, P35; Czeisler CA, 2005, NEW ENGL J MED, V353, P1078; Geiger-Brown J, 2012, CHRONOBIOL INT, V29, P211, DOI 10.3109/07420528.2011.645752; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Hardin K, 2013, ENCY SLEEP, P297, DOI [10.1016/b978-0-12-378610-4.00067-x, DOI 10.1016/B978-0-12-378610-4.00067-X]; Huang C, 2008, CHIA NAN ANNU B HUMA, V34, P742; Ingre M, 2006, J SLEEP RES, V15, P142, DOI 10.1111/j.1365-2869.2006.00517.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johnson AL, 2014, J NURS ADMIN, V44, P17, DOI 10.1097/NNA.0000000000000016; Kaur G, 2017, SLEEP MED, V29, P23, DOI 10.1016/j.sleep.2016.08.020; Kling RN, 2010, SLEEP, V33, P611, DOI 10.1093/sleep/33.5.611; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Kum RO, 2015, EUR ARCH OTO-RHINO-L, V272, P247, DOI 10.1007/s00405-014-3242-9; Lim DK, 2014, ANN OCCUP ENVIRON ME, V26, DOI 10.1186/2052-4374-26-11; Liviya W, 2014, J OCCUP ENVIRON MED, V56, P935, DOI 10.1097/JOM.0000000000000150; Lockley SW, 2007, JT COMM J QUAL PATIE, V33, P7, DOI 10.1016/S1553-7250(07)33109-7; Maddox WT, 2009, SLEEP, V32, P1439, DOI 10.1093/sleep/32.11.1439; de Magalhaes AMM, 2013, REV LAT-AM ENFERM, V21, P146, DOI 10.1590/S0104-11692013000700019; Olson EJ, 2009, CHEST, V136, P1389, DOI 10.1378/chest.08-1952; Ozer C, 2014, INT J CLIN EXP MED, V7, P268; Papp KK, 2004, ACAD MED, V79, P394, DOI 10.1097/00001888-200405000-00007; Patterson PD, 2015, PREHOSP EMERG CARE, V19, P365, DOI 10.3109/10903127.2014.995847; Patterson PD, 2014, ACCIDENT ANAL PREV, V73, P399, DOI 10.1016/j.aap.2014.09.028; Patterson PD, 2012, PREHOSP EMERG CARE, V16, P572, DOI 10.3109/10903127.2012.704491; Patterson PD, 2012, PREHOSP EMERG CARE, V16, P86, DOI 10.3109/10903127.2011.616261; Peters M, 2015, AMBULANCE SERVICES L; PETERSON RA, 1994, J CONSUM RES, V21, P381, DOI 10.1086/209405; Philibert I, 2005, SLEEP, V28, P1392, DOI 10.1093/sleep/28.11.1392; Polit DF, 2007, RES NURS HEALTH, V30, P459, DOI 10.1002/nur.20199; Reichard AA, 2017, PREHOSP EMERG CARE, V21, P420, DOI 10.1080/10903127.2016.1274350; Reinke L, 2015, INTENS CARE MED, V41, P657, DOI 10.1007/s00134-015-3667-7; Rosenthal LD, 2008, J NERV MENT DIS, V196, P429, DOI 10.1097/NMD.0b013e31816ff3bf; Sallinen M, 1998, J SLEEP RES, V7, P240, DOI 10.1046/j.1365-2869.1998.00121.x; Shen JH, 2006, SLEEP MED REV, V10, P63, DOI 10.1016/j.smrv.2005.05.004; Sofianopoulos S, 2012, EMERG MED J, V29, P152, DOI 10.1136/emj.2010.094342; Tietzel AJ, 2001, SLEEP, V24, P293, DOI 10.1093/sleep/24.3.293; Wada K, 2007, J OCCUP HEALTH, V49, P523, DOI 10.1539/joh.49.523; Wang PC, 2014, WORK, V49, P705, DOI 10.3233/WOR-131696; Weaver MD, 2012, PREHOSP EMERG CARE, V16, P43, DOI 10.3109/10903127.2011.614048; Wehrens SMT, 2012, CHRONOBIOL INT, V29, P537, DOI 10.3109/07420528.2012.675258; Weinger MB, 2002, JAMA-J AM MED ASSOC, V287, P955, DOI 10.1001/jama.287.8.955; Wesensten NJ, 2005, J SLEEP RES, V14, P255, DOI 10.1111/j.1365-2869.2005.00468.x	52	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229202	10.1371/journal.pone.0229202	http://dx.doi.org/10.1371/journal.pone.0229202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8DW	32092086	Green Published, gold			2022-12-26	WOS:000535229300030
J	Hayat, M; Kerr, R; Bentley, AR; Rotimi, CN; Raal, FJ; Ramsay, M				Hayat, Mahtaab; Kerr, Robyn; Bentley, Amy R.; Rotimi, Charles N.; Raal, Frederick J.; Ramsay, Michele			Genetic associations between serum low LDL-cholesterol levels and variants in LDLR, APOB, PCSK9 and LDLRAP1 in African populations	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; GENOME-WIDE ASSOCIATION; FAMILIAL HYPERCHOLESTEROLEMIA; CARDIOVASCULAR-DISEASE; SUSCEPTIBILITY GENES; COMMON VARIANTS; RISK-FACTOR; LOCI; MUTATIONS; PREVALENCE	Non-communicable diseases, including cardiovascular diseases (CVDs), are increasing in African populations. High serum low density lipoprotein cholesterol (LDL-cholesterol) levels are a known risk factor for CVDs in European populations, but the link remains poorly understood among Africans. This study investigated the associations between serum LDL-cholesterol levels and selected variants in the low density lipoprotein receptor (LDLR), apolipoprotein B (APOB), proprotein convertase subtilisin/kexin type 9 (PCSK9) and low density lipoprotein receptor adaptor protein 1 (LDLRAP1) genes in some selected African populations. Nineteen SNPs were selected from publicly available African whole genome sequence data based on functional prediction and allele frequency. SNPs were genotyped in 1000 participants from the AWI-Gen, study selected from the extremes of LDL-cholesterol level distribution (500 with LDL-cholesterol>3.5 mmol/L and 500 with LDL-cholesterol<1.1 mmol/L). The minor alleles at five of the six associated SNPs were significantly associated (P<0.05) with lower LDL-cholesterol levels: LDLRAP1 rs12071264 (OR 0.56, 95% CI: 0.39-0.75, P = 2.73x10(-4)) and rs35910270 (OR 0.78, 95% CI: 0.64-0.94, P = 0.008); APOB rs6752026 (OR 0. 55, 95% CI: 0.41-0.72, P = 2.82x10(-5)); LDLR: rs72568855 (OR 0.47, 95% CI: 0.27-0.82, P = 0.008); and PCSK9 rs45613943 (OR = 0.72, 95% CI: 0.58-0.88, P = 0.001). The minor allele of the sixth variant was associated with higher LDL-cholesterol levels: APOB rs679899 (OR 1.41, 95% CI: 1.06-1.86, P = 0.016). A replication analysis in the Africa America Diabetes Mellitus (AADM) study found the PCSK9 variant to be significantly associated with low LDL-cholesterol levels (Beta = -0.10). Since Africans generally have lower LDL-cholesterol levels, these LDL-cholesterol associated variants may be involved in adaptation due to unique gene-environment interactions. In conclusion, using a limited number of potentially functional variants in four genes, we identified significant associations with lower LDL-cholesterol levels in sub-Saharan Africans.	[Hayat, Mahtaab; Ramsay, Michele] Univ Witwatersrand, Fac Hlth Sci, Sydney Brenner Inst Mol Biosci, Johannesburg, South Africa; [Hayat, Mahtaab; Kerr, Robyn; Ramsay, Michele] Univ Witwatersrand, Fac Hlth Sci, Natl Hlth Lab Serv, Div Human Genet, Johannesburg, South Africa; [Hayat, Mahtaab; Kerr, Robyn; Ramsay, Michele] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa; [Bentley, Amy R.; Rotimi, Charles N.] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA; [Raal, Frederick J.] Univ Witwatersrand, Fac Hlth Sci, Carbohydrate & Lipid Metab Res Unit, Johannesburg, South Africa	University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Witwatersrand	Hayat, M (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sydney Brenner Inst Mol Biosci, Johannesburg, South Africa.; Hayat, M (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Natl Hlth Lab Serv, Div Human Genet, Johannesburg, South Africa.; Hayat, M (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa.	mahtaab.hayat@gmail.com	Raal, FJ/ABD-5111-2021	Raal, FJ/0000-0002-9170-7938; Hayat, Mahtaab/0000-0003-4723-1407; Ramsay, Michele/0000-0002-4156-4801; Kerr, Robyn/0000-0001-9297-6091	National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) [U54HG006938]; Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) of the National Institutes of Health [U54HG006938]; National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health [U54HG006938]; Office of AIDS research (OAR) of the National Institutes of Health [U54HG006938]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) [U54HG006938]; Department of Science and Technology, South Africa [DST/CON 0056/2014]; National Human Genome Research Institute (NHGRI) at the National Institutes of Health [1ZIAHG200362]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health [1ZIAHG200362]; Center for Information Technology at the National Institutes of Health [1ZIAHG200362]; Office of the Director at the National Institutes of Health [1ZIAHG200362]; Office of Research on Minority Health [3T37TW00041-03S2]; Department of Science and Technology; Intramural Research Program of the National Human Genome Research Institute in the Center for Research on Genomics and Global Health (CRGGH); Office of the Director (OD) of the National Institutes of Health (NIH) [U54HG006938]	National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) of the National Institutes of Health; National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health; Office of AIDS research (OAR) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Science and Technology, South Africa(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines); National Human Genome Research Institute (NHGRI) at the National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Information Technology at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Director at the National Institutes of Health; Office of Research on Minority Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Department of Science and Technology(Department of Science & Technology (India)); Intramural Research Program of the National Human Genome Research Institute in the Center for Research on Genomics and Global Health (CRGGH); Office of the Director (OD) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	MR Grant number U54HG006938. Funder: National Human Genome Research Institute (NHGRI), Office of the Director (OD), Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), the National Institute of Environmental Health Sciences (NIEHS), the Office of AIDS research (OAR) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), of the National Institutes of Health (NIH) https://www.genome.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MR Grant number DST/CON 0056/2014 Funder: the Department of Science and Technology, South Africa https://www.dst.gov.za/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CNR Grant number 1ZIAHG200362 Funder: National Human Genome Research Institute (NHGRI), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the Center for Information Technology, and the Office of the Director at the National Institutes of Health https://www.genome.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CNR Grant number 3T37TW00041-03S2 Funder: Office of Research on Minority Health https://www.minorityhealth.hhs.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MR is a South African Research Chair in Genomics and Bioinformatics of African populations hosted by the University of the Witwatersrand, funded by the Department of Science and Technology, and administered by National Research Foundation of South Africa (NRF). This study would not have been possible without the generosity of the AWI-Gen participants and we wish to acknowledge the sterling contributions of the AWI-Gen field workers, phlebotomists, laboratory scientists, administrators, data personnel and other staff who contributed to the project.; The authors acknowledge with thanks the participants in the AADM project, their families and their physicians. The study was supported in part by the Intramural Research Program of the National Human Genome Research Institute in the Center for Research on Genomics and Global Health (CRGGH).	Adeyemo A, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-88; Adeyemo AA, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00335; Agyepong IA, 2017, LANCET, V390, P2803, DOI 10.1016/S0140-6736(17)31509-X; Ali SA, 2018, GLOBAL HEALTH ACTION, V11, P4, DOI 10.1080/16549716.2018.1507133; American Diabetes Association, 2018, Diabetes Care, V41, pS13, DOI 10.2337/dc18-S002; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Austin MA, 2004, AM J EPIDEMIOL, V160, P407, DOI 10.1093/aje/kwh236; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bastien M, 2014, PROG CARDIOVASC DIS, V56, P369, DOI 10.1016/j.pcad.2013.10.016; Benn M, 2016, EUR HEART J, V37, P1384, DOI 10.1093/eurheartj/ehw028; Bonora E, 2001, DIABETOLOGIA, V44, P2107, DOI 10.1007/s001250100020; Brautbar A, 2015, CURR ATHEROSCLER REP, V17, DOI 10.1007/s11883-015-0491-z; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; De Filippo C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01979; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a; Dumitrescu L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002138; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Garcia-Giustiniani D, 2016, ARQ BRAS CARDIOL, V106, P434, DOI 10.5935/abc.20160074; Hoffmann TJ, 2018, NAT GENET, V50, P401, DOI 10.1038/s41588-018-0064-5; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Kang HM, 2016, STATGEN EPACTS; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kim DS, 2013, J LIPID RES, V54, P1512, DOI 10.1194/jlr.P035238; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Kromberg JGR, 2013, J COMMUN GENET, V4, P413, DOI 10.1007/s12687-012-0101-5; Loughrey CM, 2000, ATHEROSCLEROSIS, V148, P57, DOI 10.1016/S0021-9150(99)00238-5; Marees AT, 2018, INT J METH PSYCH RES, V27, DOI 10.1002/mpr.1608; Martin-Morales R, 2013, GENE, V531, P92, DOI 10.1016/j.gene.2013.08.049; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Noubiap JJ, 2018, LANCET GLOB HEALTH, V6, pE998, DOI 10.1016/S2214-109X(18)30275-4; Ramsay M, 2016, GLOB HEALTH EPIDEM G, V1, DOI 10.1017/gheg.2016.17; Rasmussen-Torvik LJ, 2012, CTS-CLIN TRANSL SCI, V5, P394, DOI 10.1111/j.1752-8062.2012.00446.x; Rimbert A, 2016, ATHEROSCLEROSIS, V250, P52, DOI 10.1016/j.atherosclerosis.2016.04.010; Rotimi CN, 2004, DIABETES, V53, P838, DOI 10.2337/diabetes.53.3.838; Rotimi CN, 2001, ANN EPIDEMIOL, V11, P51, DOI 10.1016/S1047-2797(00)00180-0; Saavedra YGL, 2014, ARTERIOSCL THROM VAS, V34, P2700, DOI 10.1161/ATVBAHA.114.304406; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Shen HQ, 2010, ARCH INTERN MED, V170, P1850, DOI 10.1001/archinternmed.2010.384; Shetty PB, 2015, CIRC-CARDIOVASC GENE, V8, P106, DOI 10.1161/CIRCGENETICS.114.000481; StataCorp, 2015, STAT STAT SOFTW REL; Talmud PJ, 2014, CURR OPIN LIPIDOL, V25, P274, DOI 10.1097/MOL.0000000000000090; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; WHO, 2019, DIS BURDEN MORTALITY, DOI DOI 10.1111/1467-9876.00280; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wu Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003379; Zubair N, 2016, HUM MOL GENET, V25, P5500, DOI 10.1093/hmg/ddw358	56	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229098	10.1371/journal.pone.0229098	http://dx.doi.org/10.1371/journal.pone.0229098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084179	gold, Green Published			2022-12-26	WOS:000535227900051
J	Kurahashi, M; Kito, Y; Baker, SA; Jennings, LK; Dowers, JGR; Koh, SD; Sanders, KM				Kurahashi, Masaaki; Kito, Yoshihiko; Baker, Salah A.; Jennings, Libby K.; Dowers, James G. R.; Koh, Sang Don; Sanders, Kenton M.			A novel postsynaptic signal pathway of sympathetic neural regulation of murine colonic motility	FASEB JOURNAL			English	Article						colonic motility; PDGFR alpha(+) cells; sympathetic neural regulation; alpha 1 adrenoceptor	ALPHA-POSITIVE CELLS; IRRITABLE-BOWEL-SYNDROME; SMOOTH-MUSCLE-CELLS; INTERSTITIAL-CELLS; GASTROINTESTINAL MOTILITY; NERVOUS-SYSTEM; RECEPTOR; INNERVATION; INSIGHTS; MECHANISMS	Transcriptome data revealed alpha 1 adrenoceptors (ARs) expression in platelet-derived growth factor receptor alpha(+) cells (PDGFR alpha(+) cells) in murine colonic musculature. The role of PDGFR alpha(+) cells in sympathetic neural regulation of murine colonic motility was investigated. Norepinephrine (NE), via alpha 1A ARs, activated a small conductance Ca2+-activated K+ (SK) conductance, evoked outward currents and hyperpolarized PDGFR alpha(+) cells (the alpha 1A AR-SK channel signal pathway). alpha 1 AR agonists increased intracellular Ca2+ transients in PDGFR alpha(+) cells and inhibited spontaneous phasic contractions (SPCs) of colonic muscle through activation of a SK conductance. Sympathetic nerve stimulation inhibited both contractions of distal colon and propulsive contractions represented by the colonic migrating motor complexes (CMMCs) via the alpha 1A AR-SK channel signal pathway. Postsynaptic signaling through alpha 1A ARs in PDGFR alpha(+) cells is a novel mechanism that conveys part of stress responses in the colon. PDGFR alpha(+) cells appear to be a primary effector of sympathetic neural regulation of murine colonic motility.	[Kurahashi, Masaaki; Baker, Salah A.; Jennings, Libby K.; Dowers, James G. R.; Koh, Sang Don; Sanders, Kenton M.] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Anderson Med Bldg MS352, Reno, NV 89557 USA; [Kito, Yoshihiko] Saga Univ, Dept Pharmacol, Saga, Japan	Nevada System of Higher Education (NSHE); University of Nevada Reno; Saga University	Kurahashi, M (corresponding author), Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Anderson Med Bldg MS352, Reno, NV 89557 USA.	mkurahashi@med.unr.edu	Dowers, James/GYU-7830-2022	BAKER, SAL/0000-0002-1514-6876	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01-DK-091336]	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	HHS vertical bar NIH vertical bar National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: R01-DK-091336	AGGARWAL A, 1994, GASTROENTEROLOGY, V106, P945, DOI 10.1016/0016-5085(94)90753-6; Anderson G, 2007, EXP NEUROL, V207, P4, DOI 10.1016/j.expneurol.2007.05.010; Baker SA, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0080-18.2018; Baker SA, 2016, J PHYSIOL-LONDON, V594, P3317, DOI 10.1113/JP271699; Baker SA, 2015, J PHYSIOL-LONDON, V593, P1945, DOI 10.1113/jphysiol.2014.287599; Baker SA, 2013, J PHYSIOL-LONDON, V591, P6193, DOI 10.1113/jphysiol.2013.264747; Berman S, 2012, NEUROIMAGE, V63, P1854, DOI 10.1016/j.neuroimage.2012.08.028; BURNSTOCK G, 1973, GASTROENTEROLOGY, V64, P141; Chhatriwala M, 2004, J PHARMACOL EXP THER, V311, P1038, DOI 10.1124/jpet.104.068650; DePonti F, 1996, PHARMACOL THERAPEUT, V69, P59, DOI 10.1016/0163-7258(95)02031-4; Ford AC, 2017, NEW ENGL J MED, V376, P2566, DOI 10.1056/NEJMra1607547; Furness JB, 2014, ADV EXP MED BIOL, V817, P39, DOI 10.1007/978-1-4939-0897-4_3; GAGNON DJ, 1972, GUT, V13, P654, DOI 10.1136/gut.13.8.654; Gallego D, 2006, AM J PHYSIOL-GASTR L, V291, pG584, DOI 10.1152/ajpgi.00474.2005; GONELLA J, 1987, PHYSIOL REV, V67, P902, DOI 10.1152/physrev.1987.67.3.902; Ha SE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182265; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Hwang SJ, 2012, J PHYSIOL-LONDON, V590, P1957, DOI 10.1113/jphysiol.2011.224634; Iino S, 2009, HISTOCHEM CELL BIOL, V131, P691, DOI 10.1007/s00418-009-0580-6; KOH SD, 1997, AM J PHYSIOL-CELL PH, V273; Komuro T, 1999, ARCH HISTOL CYTOL, V62, P295, DOI 10.1679/aohc.62.295; Kurahashi M, 2014, AM J PHYSIOL-CELL PH, V307, pC561, DOI 10.1152/ajpcell.00080.2014; Kurahashi M, 2012, J CELL MOL MED, V16, P1397, DOI 10.1111/j.1582-4934.2011.01510.x; Kurahashi M, 2011, J PHYSIOL-LONDON, V589, P697, DOI 10.1113/jphysiol.2010.201129; Lee MY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176031; Lee MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133751; Lomax AE, 2010, NEUROGASTROENT MOTIL, V22, P7, DOI 10.1111/j.1365-2982.2009.01381.x; MANBER L, 1979, AM J PHYSIOL, V236, pE738, DOI 10.1152/ajpendo.1979.236.6.E738; McAllen RM, 1997, CLIN EXP PHARMACOL P, V24, P791, DOI 10.1111/j.1440-1681.1997.tb02693.x; NORBERG K, 1966, PHARMACOL REV, V18, P743; Peri LE, 2013, NEUROGASTROENT MOTIL, V25, pE609, DOI 10.1111/nmo.12174; Piascik MT, 2001, J PHARMACOL EXP THER, V298, P403; Posserud I, 2004, GUT, V53, P1102, DOI 10.1136/gut.2003.017962; Pradidarcheep W, 2009, N-S ARCH PHARMACOL, V379, P397, DOI 10.1007/s00210-009-0393-0; Sanders KM, 2016, PHYSIOLOGY, V31, P316, DOI 10.1152/physiol.00006.2016; Sanders KM, 2012, NAT REV GASTRO HEPAT, V9, P633, DOI 10.1038/nrgastro.2012.168; Smith TK, 2017, AM J PHYSIOL-GASTR L, V312, pG1, DOI 10.1152/ajpgi.00337.2016; Spencer NJ, 2016, J PHYSIOL-LONDON, V594, P4099, DOI 10.1113/JP271919; Spencer NJ, 1998, NEUROGASTROENT MOTIL, V10, P543; Walter GC, 2016, J COMP NEUROL, V524, P2577, DOI 10.1002/cne.23978; Williams TJ, 1999, BRIT J PHARMACOL, V127, P252, DOI 10.1038/sj.bjp.0702541	41	6	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5563	5577		10.1096/fj.201903134R	http://dx.doi.org/10.1096/fj.201903134R		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32086857	Bronze, Green Accepted			2022-12-26	WOS:000515258400001
J	Peng, ZY; Peralta, MDR; Cox, DL; Toney, MD				Peng, Zeyu; Peralta, Maria D. R.; Cox, Daniel L.; Toney, Michael D.			Bottom-up synthesis of protein-based nanomaterials from engineered beta-solenoid proteins	PLOS ONE			English	Article							THIOFLAVIN-T-BINDING; AMYLOID FIBRILS; MOLECULAR BIOMIMETICS; NANOCOMPONENT ARRAYS; GOLD NANOPARTICLES; DNA; PEPTIDE; DESIGN; NANOWIRES; MECHANISM	Biomolecular self-assembly is an emerging bottom-up approach for the synthesis of novel nanomaterials. DNA and viruses have both been used to create scaffolds but the former lacks chemical diversity and the latter lack spatial control. To date, the use of protein scaffolds to template materials on the nanoscale has focused on amyloidogenic proteins that are known to form fibrils or two-protein systems where a second protein acts as a crosslinker. We previously developed a unique approach for self-assembly of nanomaterials based on engineering beta-solenoid proteins (BSPs) to polymerize into micrometer-length fibrils. BSPs have highly regular geometries, tunable lengths, and flat surfaces that are amenable to engineering and functionalization. Here, we present a newly engineered BSP based on the antifreeze protein of the beetle Rhagium inquisitor (RiAFP-m9), which polymerizes into stable fibrils under benign conditions. Gold nanoparticles were used to functionalize the RiAFP-m9 fibrils as well as those assembled from the previously described SBAFP-m1 protein. Cysteines incorporated into the sequences provide site-specific gold attachment. Additionally, silver was deposited on the gold-labelled fibrils by electroless plating to create nanowires. These results bolster prospects for programable self-assembly of BSPs to create scaffolds for functional nanomaterials.	[Peng, Zeyu; Peralta, Maria D. R.; Toney, Michael D.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Cox, Daniel L.] Univ Calif Davis, Dept Phys, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Peng, ZY (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	zpeng1119@hotmail.com			Research Investments in the Sciences and Engineering (RISE) program from the UC Davis Office of Research	Research Investments in the Sciences and Engineering (RISE) program from the UC Davis Office of Research	This work was supported by Research Investments in the Sciences and Engineering (RISE) program from the UC Davis Office of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler-Abramovich L, 2006, LANGMUIR, V22, P1313, DOI 10.1021/la052409d; An BL, 2017, ACS NANO, V11, P6985, DOI 10.1021/acsnano.7b02298; Arora A, 2004, PROTEIN SCI, V13, P2429, DOI 10.1110/ps.04823504; Aryal S, 2006, SPECTROCHIM ACTA A, V63, P160, DOI 10.1016/j.saa.2005.04.048; Bailey JB, 2016, METHOD ENZYMOL, V580, P223, DOI 10.1016/bs.mie.2016.05.009; Baxa U, 2004, J MOL BIOL, V339, P259, DOI 10.1016/j.jmb.2004.03.033; Bhardwaj A, 2008, PROTEIN SCI, V17, P1475, DOI 10.1110/ps.036111.108; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bolisetty S, 2016, NAT NANOTECHNOL, V11, P365, DOI [10.1038/NNANO.2015.310, 10.1038/nnano.2015.310]; Bruning M, 2010, NANO LETT, V10, P4533, DOI 10.1021/nl1024886; Buell AK, 2011, J AM CHEM SOC, V133, P7737, DOI 10.1021/ja109620d; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; Chen AY, 2014, NAT MATER, V13, P515, DOI [10.1038/nmat3912, 10.1038/NMAT3912]; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; DeFrates KG, 2018, NANOMATERIALS-BASEL, V8, DOI 10.3390/nano8070457; Estephan E, 2009, BIOTECHNOL BIOENG, V104, P1121, DOI 10.1002/bit.22478; Flynn CE, 2003, ACTA MATER, V51, P5867, DOI 10.1016/j.actamat.2003.08.031; Flynn CE, 2003, J MATER CHEM, V13, P2414, DOI 10.1039/b307593a; Galzitskaya OV, 2018, J BIOENERG BIOMEMBR, V50, P504; Galzitskaya O, 2019, CURR PROTEIN PEPT SC, V20, P630, DOI 10.2174/1389203720666190125160937; Galzitskaya OV, 2017, J ALZHEIMERS DIS, V59, P785, DOI 10.3233/JAD-170230; Getz EB, 1999, ANAL BIOCHEM, V273, P73, DOI 10.1006/abio.1999.4203; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Glover DJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11771; Gonen S, 2015, SCIENCE, V348, P1365, DOI 10.1126/science.aaa9897; Gottlieb D, 2008, J MATER CHEM, V18, P3865, DOI 10.1039/b807150k; Hakim A, 2013, J BIOL CHEM, V288, P12295, DOI 10.1074/jbc.M113.450973; Hakim A, 2012, ACTA CRYSTALLOGR F, V68, P547, DOI 10.1107/S1744309112010421; Hernandez-Garcia A, 2014, NAT NANOTECHNOL, V9, P698, DOI [10.1038/NNANO.2014.169, 10.1038/nnano.2014.169]; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kim H, 2014, CHEM MATER, V26, P5265, DOI 10.1021/cm5019663; Le JD, 2004, NANO LETT, V4, P2343, DOI 10.1021/nl048635+; Lee YJ, 2009, SCIENCE, V324, P1051, DOI [10.1126/science.1171541, 10.1126/science.1169041]; Li CX, 2013, ADV MATER, V25, P3694, DOI 10.1002/adma.201300904; Liang C, 2018, ACS APPL MATER INTER, V10, P25017, DOI 10.1021/acsami.8b04752; Liu Y, 2006, NUCLEIC ACIDS RES, V34, pW235, DOI 10.1093/nar/gkl163; Majzik A, 2010, COLLOID SURFACE B, V81, P235, DOI 10.1016/j.colsurfb.2010.07.011; Mao CB, 2004, SCIENCE, V303, P213, DOI 10.1126/science.1092740; Mocanu A, 2009, COLLOID SURFACE A, V338, P93, DOI 10.1016/j.colsurfa.2008.12.041; Moore AN, 2017, ACCOUNTS CHEM RES, V50, P714, DOI 10.1021/acs.accounts.6b00553; Nam KT, 2006, SCIENCE, V312, P885, DOI 10.1126/science.1122716; Nystrom G, 2016, ADV MATER, V28, P472, DOI 10.1002/adma.201503465; Patolsky F, 2002, ANGEW CHEM INT EDIT, V41, P2323, DOI 10.1002/1521-3773(20020703)41:13<2323::AID-ANIE2323>3.0.CO;2-H; Peelle BR, 2005, ACTA BIOMATER, V1, P145, DOI 10.1016/j.actbio.2004.11.004; Peng ZY, 2017, BIOCHEMISTRY-US, V56, P6041, DOI 10.1021/acs.biochem.7b00364; Peng ZY, 2017, BIOPHYS J, V113, P1945, DOI 10.1016/j.bpj.2017.09.003; Peralta MDR, 2015, ACS NANO, V9, P449, DOI 10.1021/nn5056089; Petean I, 2008, J OPTOELECTRON ADV M, V10, P2289; Pinto YY, 2005, NANO LETT, V5, P2399, DOI 10.1021/nl0515495; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Ryu J, 2010, BIOTECHNOL BIOENG, V105, P221, DOI 10.1002/bit.22544; Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964; Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Selivanova OM, 2018, LANGMUIR, V34, P2332, DOI 10.1021/acs.langmuir.7b03393; Selivanova OM, 2016, CURR PROTEIN PEPT SC, V18, P57, DOI 10.2174/1389203717666160526122421; Selivanova OM, 2016, BBA-PROTEINS PROTEOM, V1864, P1489, DOI 10.1016/j.bbapap.2016.08.002; Tamerler C, 2009, PHILOS T R SOC A, V367, P1705, DOI 10.1098/rsta.2009.0018; Udomprasert A, 2014, NAT NANOTECHNOL, V9, P537, DOI [10.1038/NNANO.2014.102, 10.1038/nnano.2014.102]; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Zheng JW, 2006, NANO LETT, V6, P1502, DOI 10.1021/nl060994c; Zhong C, 2014, NAT NANOTECHNOL, V9, P858, DOI 10.1038/nnano.2014.199; Zhou F, 2016, ACS NANO, V10, P3069, DOI 10.1021/acsnano.5b05159	66	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229319	10.1371/journal.pone.0229319	http://dx.doi.org/10.1371/journal.pone.0229319			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084222	Green Published, gold			2022-12-26	WOS:000535227900090
J	Stipek, C; Santos, R; Babcock, E; Lirman, D				Stipek, Clinton; Santos, Rolando; Babcock, Elizabeth; Lirman, Diego			Modelling the resilience of seagrass communities exposed to pulsed freshwater discharges: A seascape approach	PLOS ONE			English	Article							BISCAYNE BAY; THALASSIA-TESTUDINUM; POPULATION-DYNAMICS; FLORIDA BAY; SIZE; SALINITY; GROWTH; AGE	Submerged aquatic vegetation (SAV) communities display complex patch dynamics at seascape scales that are presently poorly understood as most studies of disturbance on SAV habitats have focused on changes in biomass at small, quadrat-level scales. In this study, analyses of remote sensing imagery and population modelling were applied to understand SAV patch dynamics and forecast the fate of these important communities in Biscayne Bay, Miami, Florida, US. We evaluated how the proximity of freshwater canals influences seagrass-dominated SAV patch dynamics and, in turn, how patch-size structure influences the stability of seagrass seascapes under different salinity scenarios. Seagrass fragmentation rates were higher in sites adjacent to freshwater canals compared to sites distant from the influences of freshwater deliveries. Furthermore, we documented a clear trend in patch mortality rates with respect to patch size, with the smallest patches (50 m(2)) undergoing 57% annual mortality on average. The combination of higher fragmentation rates and the higher mortality of smaller seagrass patches in habitats exposed to pulses of low salinity raises concern for the long-term persistence of seagrass meadows in nearshore urban habitats of Biscayne Bay that are presently targets of Everglades restoration. Our model scenarios that simulated high fragmentation rates resulted in SAV population collapses, regardless of SAV recruitment rates. The combined remote sensing and population modelling approach used here provides evaluation and predictive tools that can be used by managers to track seagrass status and stress-response at seascape levels not available previously for the seagrasses of South Florida.	[Stipek, Clinton; Babcock, Elizabeth; Lirman, Diego] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Marine Biol & Ecol Dept, 4600 Rickenbacker Causeway, Miami, FL 33149 USA; [Santos, Rolando] Florida Int Univ, Coll Arts Sci & Educ, Miami, FL 33199 USA	University of Miami; State University System of Florida; Florida International University	Stipek, C (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Marine Biol & Ecol Dept, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	Clinton.stipek@rsmas.miami.edu		Stipek, Clinton/0000-0002-8050-1096	US Army Corps of Engineers; National Park Service through the Integrated Biscayne Bay Ecological Assessment and Monitoring (IBBEAM)	US Army Corps of Engineers(United States Department of DefenseUnited States Army); National Park Service through the Integrated Biscayne Bay Ecological Assessment and Monitoring (IBBEAM)	This work received support from the US Army Corps of Engineers and the National Park Service through the Integrated Biscayne Bay Ecological Assessment and Monitoring (IBBEAM).	Abadie A, 2018, ECOL INDIC, V87, P1, DOI 10.1016/j.ecolind.2017.12.029; Browder Joan A., 2000, Urban Ecosystems, V3, P245, DOI 10.1023/A:1009504601357; Cropper WP, 2001, ESTUAR COAST SHELF S, V53, P13, DOI 10.1006/ecss.2001.0787; CUFF WR, 1980, ECOL MODEL, V9, P281, DOI 10.1016/0304-3800(80)90022-8; Cunha AH, 2009, ESTUAR COAST SHELF S, V84, P584, DOI 10.1016/j.ecss.2009.07.030; Cuvillier A, 2017, ESTUAR COAST SHELF S, V184, P90, DOI 10.1016/j.ecss.2016.10.046; Davis SE, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P9, DOI 10.1007/978-90-481-2406-0_2; Duarte CM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P271; Duarte Carlos M., 2008, P281, DOI 10.1017/CBO9780511751790.025; ERFTEMEIJER PLA, 1994, OECOLOGIA, V99, P45, DOI 10.1007/BF00317082; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Gillanders BM, 2003, MAR ECOL PROG SER, V247, P281, DOI 10.3354/meps247281; Grech A, 2018, GLOBAL CHANGE BIOL, V24, P3093, DOI 10.1111/gcb.14127; Hall MO, 2016, MAR ECOL PROG SER, V560, P243, DOI 10.3354/meps11923; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; HUGHES TP, 1984, AM NAT, V123, P778, DOI 10.1086/284239; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Jankowska E, J EXPT MARINE BIOL E, V510, P54; Kendrick GA, 2005, MAR ECOL PROG SER, V290, P291, DOI 10.3354/meps290291; Liao JB, 2013, ECOL MODEL, V268, P9, DOI 10.1016/j.ecolmodel.2013.07.021; Lirman D, 2014, ESTUAR COAST, V37, P1243, DOI 10.1007/s12237-014-9769-6; Lirman D, 2003, ESTUARIES, V26, P131, DOI 10.1007/BF02691700; Livernois MC, 2017, AQUAT BOT, V142, P1, DOI 10.1016/j.aquabot.2017.05.006; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Montefalcone M, 2010, ESTUAR COAST SHELF S, V86, P292, DOI 10.1016/j.ecss.2009.11.018; Montefalcone M, 2009, ECOL INDIC, V9, P595, DOI 10.1016/j.ecolind.2008.09.013; O'Brien KR, 2018, MAR POLLUT BULL, V134, P166, DOI 10.1016/j.marpolbul.2017.09.006; Ondiviela B, 2014, COAST ENG, V87, P158, DOI 10.1016/j.coastaleng.2013.11.005; Orth RJ, 2016, SEAGRASSES BIOL ECOL, P111; ROBBLEE MB, 1991, MAR ECOL PROG SER, V71, P297, DOI 10.3354/meps071297; Santos R, 2014, MARINE ECOLOGY, P1; Santos RO, 2012, CAN J FISH AQUAT SCI, V69, P1380, DOI [10.1139/f2012-018, 10.1139/F2012-018]; Santos RO, 2011, MAR ECOL PROG SER, V427, P233, DOI 10.3354/meps08996; Sklar Fred, 2002, P39; Stubben C, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i11; Vidondo B, 1997, MAR ECOL PROG SER, V158, P131, DOI 10.3354/meps158131; Wang JD, 2003, B MAR SCI, V72, P695; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Williams JA, 2016, J EXP MAR BIOL ECOL, V479, P97, DOI 10.1016/j.jembe.2016.03.008; Zink IC, 2017, ECOL INDIC, V81, P1, DOI 10.1016/j.ecolind.2017.05.046	40	5	5	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2020	15	2							e0229147	10.1371/journal.pone.0229147	http://dx.doi.org/10.1371/journal.pone.0229147			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DJ	32084176	Green Published, gold			2022-12-26	WOS:000535227900063
J	Lu, YF; Wang, JC; Zeng, R; Nagata, T; Katz, R; Mukai, S; Miller, JB				Lu, Yifan; Wang, Jay C.; Zeng, Rebecca; Nagata, Tatsuo; Katz, Raviv; Mukai, Shizuo; Miller, John B.			Detection of retinal microvascular changes in von Hippel-Lindau disease using optical coherence tomography angiography	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; HEMANGIOBLASTOMAS; DIAGNOSIS; GENE; IDENTIFICATION; ANGIOMATOSIS; FEATURES; FUNDUS	Purpose Von Hippel-Lindau (VHL) disease is a hereditary disorder that can lead to ophthalmic manifestations, including retinal capillary hemangioma (RCH). The diagnosis of RCH is often guided by wide-field fluorescein angiography. In some cases, optical coherence tomography angiography (OCT-A) serves as a non-invasive alternative to FA. Herein, we used OCT-A to examine the macular microvasculature in patients with VHL disease. Subjects Subjects were selected from patients with a diagnosis of VHL. The control group included eyes without retinal diagnosis from patients with an episode of unilateral retinal detachment or trauma and age <= 50 years old. Methods Subjects were scanned on the Optovue RTVue-XR device to acquire 3mm x 3mm OCT-A images of the superficial (SCP) and deep capillary plexus (DCP). SCP and DCP vessel density (VD) were calculated after the images were binarized. Furthermore, for subjects with RCH, each OCT-A image was divided equally into four quadrants. SCP and DCP VD of quadrants with RCH were compared to those without RCH. T-tests were performed for statistical analysis. Results 67 eyes with a history of VHL disease were included as study subjects, while 16 eyes were included as controls. Significant increases in VD were found in patients with VHL disease for both the SCP (p = 0.0441) and DCP (p = 0.0344). When comparing quadrants with associated RCH development to those without, we found no significant difference in SCP VD (p = 0.160) or DCP VD (p = 0.484). Conclusions OCT-A can detect changes in the retinal microvasculature in the macula of patients with VHL disease. OCT-A imaging may be an additional tool for screening and early detection of patients at risk of developing ocular complications of VHL disease. Future studies should explore subtle progression on OCT-A associated with the pathogenesis and development of RCH, particularly with larger scan patterns.	[Lu, Yifan; Mukai, Shizuo; Miller, John B.] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA; [Lu, Yifan; Wang, Jay C.; Zeng, Rebecca; Katz, Raviv; Miller, John B.] Massachusetts Eye & Ear, Harvard Retinal Imaging Lab, Boston, MA 02114 USA; [Wang, Jay C.; Nagata, Tatsuo; Mukai, Shizuo; Miller, John B.] Massachusetts Eye & Ear, Retina Serv, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Eye & Ear Infirmary	Miller, JB (corresponding author), Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA.; Miller, JB (corresponding author), Massachusetts Eye & Ear, Harvard Retinal Imaging Lab, Boston, MA 02114 USA.; Miller, JB (corresponding author), Massachusetts Eye & Ear, Retina Serv, Boston, MA 02114 USA.	john_miller@meei.harvard.edu	Miller, John J/GZG-5663-2022	Katz, Raviv/0000-0002-5305-8551	Mukai Fund of Massachusetts Eye and Ear, Boston, Massachusetts	Mukai Fund of Massachusetts Eye and Ear, Boston, Massachusetts	All the funding received for this study is the Mukai Fund of Massachusetts Eye and Ear, Boston, Massachusetts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	AMOILS SP, 1969, ARCH OPHTHALMOL-CHIC, V81, P689; Blasi MA, 2006, RETINA-J RET VIT DIS, V26, P404, DOI 10.1097/00006982-200604000-00004; BLODI CF, 1990, OPHTHALMOLOGY, V97, P791; CARR RE, 1980, OPHTHALMOLOGY, V87, P956; Chou Brian W, 2018, Am J Ophthalmol Case Rep, V10, P59, DOI 10.1016/j.ajoc.2018.01.036; Falavarjani KG, 2018, J OPHTHAL VIS RES, V13, P260, DOI 10.4103/jovr.jovr_173_17; Gaudric A, 2011, OPHTHALMOLOGY, V118, P142, DOI 10.1016/j.ophtha.2010.04.031; GROSSNIKLAUS HE, 1992, OPHTHALMOLOGY, V99, P140; HARDWIG P, 1984, OPHTHALMOLOGY, V91, P263; Kaelin William G Jr, 2017, Trans Am Clin Climatol Assoc, V128, P298; Kashani AH, 2015, RETINA-J RET VIT DIS, V35, P2323, DOI 10.1097/IAE.0000000000000811; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; LANE CM, 1989, EYE, V3, P33, DOI 10.1038/eye.1989.5; Lang SJ, 2017, KLIN MONATSBL AUGENH, V234, P1146, DOI 10.1055/s-0043-102574; Lang SJ, 2016, OSLI RETINA, V47, P935, DOI 10.3928/23258160-20161004-07; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; MAHER ER, 1994, EUR J CANCER, V30A, P1987, DOI 10.1016/0959-8049(94)00391-H; MAHER ER, 1990, Q J MED, V77, P1151, DOI 10.1093/qjmed/77.2.1151; Matsunaga DR, 2015, OSLI RETINA, V46, P796, DOI 10.3928/23258160-20150909-03; Minnella Angelo Maria, 2018, J Med Case Rep, V12, P248, DOI 10.1186/s13256-018-1787-8; MOORE A T, 1991, Eye (London), V5, P723; Munk MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177059; Na X, 2003, J UROLOGY, V170, P588, DOI 10.1097/01.ju.0000074870.54671.98; Niemela M, 2000, INVEST OPHTH VIS SCI, V41, P1909; Pierro L, 2019, OSLI RETINA, V50, pE81, DOI 10.3928/23258160-20190301-17; Russo V, 2012, INT OPHTHALMOL, V32, P71, DOI DOI 10.1007/s10792-011-9513-1; Sachdeva R, 2010, ACTA OPHTHALMOL, V88, pe334, DOI 10.1111/j.1755-3768.2010.02008.x; Sagar P, 2019, INDIAN J OPHTHALMOL, V67, P701, DOI 10.4103/ijo.IJO_1429_18; Sagar P, 2018, INDIAN J OPHTHALMOL, V66, P872, DOI 10.4103/ijo.IJO_1199_17; SALAZAR FG, 1980, AM J OPHTHALMOL, V89, P540, DOI 10.1016/0002-9394(80)90063-X; Schmidt D, 2000, Eur J Med Res, V5, P47; SHIELDS JA, 1993, ARCH OPHTHALMOL-CHIC, V111, P551, DOI 10.1001/archopht.1993.01090040143049; Smith J, 2011, OPHTHALMOLOGICA, V226, P42, DOI 10.1159/000328209; Spaide RF, 2015, OPHTHALMOLOGY, V122, P2261, DOI 10.1016/j.ophtha.2015.07.025; Toy BC, 2012, OPHTHALMOLOGY, V119, P2622, DOI 10.1016/j.ophtha.2012.06.026; Turell ME, 2010, MIDDLE EAST AFR J OP, V17, P191, DOI 10.4103/0974-9233.65486; Vishal Raval, 2018, Am J Ophthalmol Case Rep, V11, P98, DOI 10.1016/j.ajoc.2018.06.018; Waheed NK, 2016, DEV OPHTHALMOL, V56, P91, DOI 10.1159/000442784; Wang HR, 2018, CANCER RES, V78, P1266, DOI 10.1158/0008-5472.CAN-17-1718; Wang JL, 2018, PREGNANCY HYPERTENS, V13, P95, DOI 10.1016/j.preghy.2018.04.016; Webster AR, 1999, ARCH OPHTHALMOL-CHIC, V117, P371, DOI 10.1001/archopht.117.3.371; WHITSON JT, 1986, RETINA-J RET VIT DIS, V6, P253, DOI 10.1097/00006982-198606040-00010	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0229213	10.1371/journal.pone.0229213	http://dx.doi.org/10.1371/journal.pone.0229213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8CF	32078656	gold, Green Published			2022-12-26	WOS:000535224600023
J	Raina, P; Gilsing, A; Mayhew, AJ; Sohel, N; van den Heuvel, E; Griffith, LE				Raina, Parminder; Gilsing, Anne; Mayhew, Alexandra J.; Sohel, Nazmul; van den Heuvel, Edwin; Griffith, Lauren E.			Individual and population level impact of chronic conditions on functional disability in older adults	PLOS ONE			English	Article							ATTRIBUTABLE RISK; ELDERLY POPULATION; MULTIMORBIDITY; HEALTH; DISEASE; BURDEN	Background It is unknown if the relationship between multimorbidity and disability differs by combinations of chronic conditions. The objective of our study was to elucidate how joint effect of different combinations of chronic conditions impact the five year risk of functional disability at the population level. Methods Participants >= 65 years from the Canadian Study of Health and Aging were assessed for functional disability measured using activities of daily living (ADL) and instrumental ADL (IADL), and the presence of conditions in five disease domains; cardiometabolic, neurological, sensory, musculoskeletal, and respiratory. Logistic regression was used to assess the relationship between each disease domain and incident ADL and IADL measured at five years of follow up and population attributable risk (PAR) was modeled for diseases domains that were significantly associated with disability. Results were stratified by sex and age (6574 years, >= 75 years). Results There were 6272 participants free of ADL disability and 4571 participants free from IADL disability at baseline. For incident ADL, the greatest PAR values were 21.3 (9.8-32.8) for the cardiometabolic domain in males 65-74 years, 22.7 (4.7-40.8) for the musculoskeletal domain for females aged 65-74 years, and 11.2 (2.8-19.7) for the musculoskeletal domain in males >= 75 years. The PAR for the musculoskeletal, sensory, and neurological domains were similar in females >= 75 years(9.3-9.9). PAR values were lower but followed similar patterns for IADL disability. Conclusion The chronic disease domains which most strongly predicted incident ADLs and IADLs did not account for the greatest amount of disability at the population level.	[Raina, Parminder; Gilsing, Anne; Mayhew, Alexandra J.; Sohel, Nazmul; Griffith, Lauren E.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Raina, Parminder; Gilsing, Anne; Mayhew, Alexandra J.; Sohel, Nazmul; Griffith, Lauren E.] McMaster Univ, Labarge Ctr Mobil Aging, Hamilton, ON, Canada; [Raina, Parminder; Gilsing, Anne; Mayhew, Alexandra J.; Sohel, Nazmul; Griffith, Lauren E.] McMaster Univ, McMaster Inst Res Aging, Hamilton, ON, Canada; [van den Heuvel, Edwin] Eindhoven Univ Technol, Dept Math & Comp Sci, Eindhoven, Netherlands	McMaster University; McMaster University; McMaster University; Eindhoven University of Technology	Raina, P (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.; Raina, P (corresponding author), McMaster Univ, Labarge Ctr Mobil Aging, Hamilton, ON, Canada.; Raina, P (corresponding author), McMaster Univ, McMaster Inst Res Aging, Hamilton, ON, Canada.	praina@mcmaster.ca		Griffith, Lauren/0000-0002-2794-9692; Mayhew, Alexandra/0000-0001-6700-9497				American Lung Association Epidemiology and Statistics Unit, 2015, TRENDS PNEUM INFL MO; Arokiasamy P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0402-8; Australian Institute of Health and Welfare, 2012, PHE, P157; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Basu S, 1995, AM J EPIDEMIOL, V142, P1338, DOI 10.1093/oxfordjournals.aje.a117602; Basu S, 2013, AM J EPIDEMIOL, V178, P1620, DOI 10.1093/aje/kwt191; Boots-van der Wiel A, 2005, EUR J PUBLIC HEALTH, V15, P494, DOI 10.1093/eurpub/cki015; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Cacciatore F, 2004, AGING CLIN EXP RES, V16, P382; Cacciatore F, 1999, GERONTOLOGY, V45, P323, DOI 10.1159/000022113; Deeg DJH, 1993, CHANGE AUTONOMY WELL; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Fried LP, 2010, PUBLIC HEALTH REV, V32, P351, DOI 10.1007/BF03391606; Fultz NH, 2003, J AGING HEALTH, V15, P465, DOI 10.1177/0898264303253502; Griffith L, 2010, AGE AGEING, V39, P738, DOI 10.1093/ageing/afq105; Griffith LE, 2019, J AM GERIATR SOC, V67, P1632, DOI 10.1111/jgs.15921; Griffith LE, 2017, J EPIDEMIOL COMMUN H, V71, P381, DOI 10.1136/jech-2016-207982; Horne DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-258; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Martinez FJ, 2006, AM J RESP CRIT CARE, V173, P1326, DOI 10.1164/rccm.200510-1677OC; McDaid O, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002571; McDowell I, 2001, INT PSYCHOGERIATR, V13, P7, DOI 10.1017/S1041610202007949; Modig K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064928; Picavet HSJ, 1997, AM J PUBLIC HEALTH, V87, P1680, DOI 10.2105/AJPH.87.10.1680; Quinones AR, 2016, J GERONTOL A-BIOL, V71, P823, DOI 10.1093/gerona/glw035; Salive ME, 2013, EPIDEMIOL REV, V35, P75, DOI 10.1093/epirev/mxs009; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Verbrugge LM, 2007, ARTHRIT CARE RES, P212; World Health Organization, 2018, AG HLTH	30	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0229160	10.1371/journal.pone.0229160	http://dx.doi.org/10.1371/journal.pone.0229160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8CF	32078637	gold, Green Published			2022-12-26	WOS:000535224600019
J	Zouk, AN; Gulati, S; Xing, DQ; Wille, KM; Rowe, SM; Wells, JM				Zouk, Aline N.; Gulati, Swati; Xing, Dongqi; Wille, Keith M.; Rowe, Steven M.; Wells, J. Michael			Pulmonary artery enlargement is associated with pulmonary hypertension and decreased survival in severe cystic fibrosis: A cohort study	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; MAGNETIC-RESONANCE; AORTA RATIO; ECHOCARDIOGRAPHY; EXACERBATIONS; PREDICTOR; MORTALITY; MANAGEMENT; DIAGNOSIS; PRESSURE	Background Pulmonary artery (PA) enlargement, defined as pulmonary artery to ascending aorta diameter ratio (PA:A)>1 on computed tomography (CT), is a marker of pulmonary vascular disease in chronic lung diseases. PA enlargement is prevalent in cystic fibrosis (CF), but its relationship to hemodynamics and prognostic utility in severe CF are unknown. We hypothesized that the PA:A would have utility in identifying pulmonary hypertension (PH) in severe CF and that PA enlargement would be associated with reduced transplant-free survival. Methods We conducted a retrospective study of adults with CF undergoing lung transplant evaluation at a single center between 2000 and 2015. CT, right heart catheterization (RHC), and clinical data were collected. The PA:A was measured from a single CT slice. We measured associations between PA:A and invasive hemodynamic parameters including PH defined as a mPAP >= 25mmHg using adjusted linear and logistic regression models. Kaplan-Meier and adjusted Cox regression models were used to measure associations between PA:A>1, RHC-defined PH, and transplant-free survival in severe CF. Results We analyzed 78 adults with CF that had CT scans available for review, including 44 that also had RHC. RHC-defined PH defined as a mPAP >= 25mmHg was present in 36% of patients with CF undergoing transplant evaluation. The PA:A correlated with mPAP (r = 0.73; 95% CI 3.87-7.80; p<0.001) and PVR (r = 0.42, p = 0.005) and the PA:A>1 was an independent predictor of PH (aOR 4.50; 95% CI 1.05-19.2; p = 0.042). PA:A>1 was independently associated with increased hazards for death or transplant (aHR 2.69; 95% CI 1.41-5.14; P = 0.003). The presence of mPAP >= 25mmHg was independently associated with decreased survival in this cohort. Conclusions PA enlargement is associated with pulmonary hemodynamics and PH in severe CF. PA enlargement is an independent prognostic indicator of PH and decreased survival in this population.	[Zouk, Aline N.; Gulati, Swati; Xing, Dongqi; Wille, Keith M.; Rowe, Steven M.; Wells, J. Michael] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Xing, Dongqi; Rowe, Steven M.; Wells, J. Michael] Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; [Xing, Dongqi; Rowe, Steven M.; Wells, J. Michael] UAB Lung Hlth Ctr, Birmingham, AL 35294 USA; [Wells, J. Michael] Birmingham VA Med Ctr, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Wells, JM (corresponding author), Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA.; Wells, JM (corresponding author), Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA.; Wells, JM (corresponding author), UAB Lung Hlth Ctr, Birmingham, AL 35294 USA.; Wells, JM (corresponding author), Birmingham VA Med Ctr, Birmingham, AL 35233 USA.	jmwells@uabmc.edu	Wells, James Michael/ABA-2755-2021	Wells, James Michael/0000-0001-9612-5454	National Institutes of Health [K08HL123940]; Cystic Fibrosis Foundation [SORSCH15RO]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This study was supported by grants from the National Institutes of Health [K08HL123940 to JMW] and the Cystic Fibrosis Foundation [SORSCH15RO to JMW].	Arcasoy SM, 2003, AM J RESP CRIT CARE, V167, P735, DOI 10.1164/rccm.200210-1130OC; Belkin RA, 2006, AM J RESP CRIT CARE, V173, P659, DOI 10.1164/rccm.200410-1369OC; Belle-van Meerkerk G, 2013, J HEART LUNG TRANSPL, V32, P609, DOI 10.1016/j.healun.2013.03.006; Benza R, 2008, J AM COLL CARDIOL, V52, P1683, DOI 10.1016/j.jacc.2008.08.033; D'Alto M, 2013, INT J CARDIOL, V168, P4058, DOI 10.1016/j.ijcard.2013.07.005; Estepar RSJ, 2013, AM J RESP CRIT CARE, V188, P231, DOI 10.1164/rccm.201301-0162OC; Fisher MR, 2007, EUR RESPIR J, V30, P914, DOI 10.1183/09031936.00033007; Fraser KL, 1999, CHEST, V115, P1321, DOI 10.1378/chest.115.5.1321; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Giacchi V, 2015, HEART LUNG CIRC, V24, P1002, DOI 10.1016/j.hlc.2015.03.006; Hayes D, 2016, ANN THORAC SURG, V101, P1104, DOI 10.1016/j.athoracsur.2015.09.086; Hayes D, 2014, AM J RESP CRIT CARE, V190, P898, DOI 10.1164/rccm.201407-1382OC; Hayes D, 2014, J CYST FIBROS, V13, P416, DOI 10.1016/j.jcf.2013.12.004; Iyer AS, 2014, CHEST, V145, P824, DOI 10.1378/chest.13-1422; Janda S, 2011, HEART, V97, P612, DOI 10.1136/hrt.2010.212084; Karakus G, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0184-3; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; Kovacs G, 2008, RESPIRATION, V76, P458, DOI 10.1159/000158548; Manika K, 2012, PULM MED, V2012, DOI 10.1155/2012/252345; Mayer-Hamblett N, 2002, AM J RESP CRIT CARE, V166, P1550, DOI 10.1164/rccm.200202-087OC; Nakanishi R, 2013, AM J CARDIOL, V111, P1259, DOI 10.1016/j.amjcard.2013.01.266; Ramos KJ, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0367-9; Robert R, 2007, EUR RESPIR J, V30, P857, DOI 10.1183/09031936.00060007; Robert R, 2004, J BIOL CHEM, V279, P21160, DOI 10.1074/jbc.M312199200; Scarsini R, 2016, INT J CARDIOL, V202, P221, DOI 10.1016/j.ijcard.2015.09.009; Shin S, 2016, EUR RESPIR J, V47, P1445, DOI 10.1183/13993003.01532-2015; Shin S, 2014, RESP MED, V108, P1626, DOI 10.1016/j.rmed.2014.08.009; Tabeling C, 2015, P NATL ACAD SCI USA, V112, pE1614, DOI 10.1073/pnas.1421190112; Tonelli AR, 2010, J HEART LUNG TRANSPL, V29, P865, DOI 10.1016/j.healun.2010.04.006; Venuta F, 2012, J CARDIOVASC SURG, V53, P817; Wells JM, 2016, LANCET RESP MED, V4, P636, DOI 10.1016/S2213-2600(16)30105-9; Wells JM, 2016, CHEST, V149, P1197, DOI 10.1378/chest.15-1504; Wells JM, 2012, NEW ENGL J MED, V367, P913, DOI 10.1056/NEJMoa1203830; Yagi M, 2017, RESPIROLOGY, V22, P1393, DOI 10.1111/resp.13066	34	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2020	15	2							e0229173	10.1371/journal.pone.0229173	http://dx.doi.org/10.1371/journal.pone.0229173			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8CF	32078644	Green Published, gold			2022-12-26	WOS:000535224600020
J	Meira, KC; Silva, GWD; dos Santos, J; Guimaraes, RM; de Souza, DLB; Ribeiro, GPC; Dantas, ESO; de Carvalho, JBL; Jomar, RT; Simoes, TC				Meira, Karina Cardoso; dos Santos Silva, Glauber Weder; dos Santos, Juliano; Guimaraes, Raphael Mendonca; Bezerra de Souza, Dyego Leandro; Cani Ribeiro, Gilcilene Pretta; Oliveira Dantas, Eder Samuel; Leite de Carvalho, Jovanka Bittencourt; Jomar, Rafael Tavares; Simoes, Taynana Cesar			Analysis of the effects of the age-period-birth cohort on cervical cancer mortality in the Brazilian Northeast	PLOS ONE			English	Article							BREAST-CANCER; TRENDS; HEALTH; DISEASE; MODELS; RATES; OVERDIAGNOSIS; PROJECTIONS	Cervical cancer (CC) is a public health problem with a high disease burden and mortality in developing countries. In Brazil, areas with low human development index have the highest incidence rates of Brazil and upward temporal trend for this disease. The Northeast region has the second highest incidence of cervical cancer (20.47 new cases / 100,000 women). In this region, the mortality rates are similar to rates in countries that do not have a health system with a universal access screening program, as in Brazil. Thus, this study aimed to analyze the effects of age, period and birth cohorts on mortality from cervical cancer in the Northeast region of Brazil. Estimable functions predicted the effects of age, period and birth cohort. The average mortality rate was 10.35 deaths per 100,000 women during the period analyzed (1980-2014). The highest mortality rate per 100,000 women was observed in Maranhao (24.39 deaths), and the lowest mortality rate was observed in Bahia (11.24 deaths). According to the period effects, only the state of Rio Grande do Norte showed a reduction in mortality risk in the five years of the 2000s. There was a reduction in mortality risk for birth cohorts of women after the 1950s, except in Maranhao State, which showed an increasing trend in mortality risk for younger generations. We found that the high rates of cervical cancer mortality in the states of northeastern Brazil remain constant over time. Even after an increase in access to health services in the 2000s, associated with increased access to the cancer care network, which includes early detection (Pap Test), cervical cancer treatment and palliative care. However, it is important to note that the decreased risk of death and the mortality rates from CC among women born after the 1960s may be correlated with increased screening coverage, as well as increased access to health services for cancer treatment observed in younger women.	[Meira, Karina Cardoso; Leite de Carvalho, Jovanka Bittencourt] Univ Fed Rio Grande do Norte, Hlth Sch, Natal, RN, Brazil; [dos Santos Silva, Glauber Weder] Univ Fed Rio Grande do Norte, Dept Nursing, Natal, RN, Brazil; [dos Santos, Juliano] Canc Hosp III, Natl Canc Inst, Rio De Janeiro, Brazil; [Guimaraes, Raphael Mendonca] Fundacao Oswaldo Cruz, Joaquim Venancio Polytech Sch, Rio De Janeiro, Brazil; [Bezerra de Souza, Dyego Leandro; Oliveira Dantas, Eder Samuel] Univ Fed Rio Grande do Norte, Collect Hlth Dept, Natal, RN, Brazil; [Cani Ribeiro, Gilcilene Pretta] State Secretariat Espirito Santo, Management Hlth Syst & Serv, Vitoria, ES, Brazil; [Jomar, Rafael Tavares] Natl Canc Inst, Rio De Janeiro, Brazil; [Simoes, Taynana Cesar] Fundacao Oswaldo Cruz, Rene Rachou Inst, Belo Horizonte, MG, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; National Cancer Institute (Inca); Fundacao Oswaldo Cruz; Universidade Federal do Rio Grande do Norte; National Cancer Institute (Inca); Fundacao Oswaldo Cruz	Meira, KC (corresponding author), Univ Fed Rio Grande do Norte, Hlth Sch, Natal, RN, Brazil.	cardosomeira@yahoo.com.br	Silva, Glauber Weder dos Santos/B-2553-2017; Jomar, Rafael T/G-4478-2014; Dantas, Eder/ABA-5815-2021; dos Santos, Juliano/G-4523-2012; GUIMARAES, RAPHAEL/ABH-8745-2020; Giunta, Diego Hernan/AAJ-6928-2021; Simões, Taynãna César/ABE-8964-2021	Silva, Glauber Weder dos Santos/0000-0002-0570-1944; Jomar, Rafael T/0000-0002-4101-7138; Dantas, Eder/0000-0002-6595-6105; dos Santos, Juliano/0000-0001-9961-3576; Giunta, Diego Hernan/0000-0002-8427-6033; Cardoso Meira, Karina/0000-0002-1722-5703	National Scientific and Technological Development (CNPQ); Coordination for the Improvement of Higher Education (CAPES) [001]	National Scientific and Technological Development (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This article is a product of a project coordinated by the main author, Meira KC, and funded by the National Scientific and Technological Development (CNPQ) (http://www.cnpq.br/) and Coordination for the Improvement of Higher Education, for promoting this research (CAPES-Financing Code 001). The funders had no role in study design, data collection.	Costa RFA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138945; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Arbyn M, 2009, EUR J CANCER, V45, P2671, DOI 10.1016/j.ejca.2009.07.016; Arbyn M, 2009, EUR J CANCER, V45, P2640, DOI 10.1016/j.ejca.2009.07.018; Silva GAE, 2010, CAD SAUDE PUBLICA, V26, P2398; Barbosa IR, 2016, CIENC SAUDE COLETIVA, V21, P253, DOI 10.1590/1413-81232015211.03662015; Brasil. Ministerio da Saude. Departamento de Informatica do Sistema Unico de Saude, 2014, SIST MORT; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bray F, 2013, VACCINE, V31, pH32, DOI 10.1016/j.vaccine.2013.02.071; Carmo CCD, 2011, REV SAUDE PUBL, V45, DOI [10.1590/s0034, DOI 10.1590/S0034]; Carneiro SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187579; CLAYTON D, 1987, STAT MED, V6, P469, DOI 10.1002/sim.4780060406; da Silva JB, 2013, LANCET ONCOL, V14, P385, DOI 10.1016/S1470-2045(13)70094-9; Decarli A, 1987, RIV STATISTICA APPLI, V20, P397; Dickinson JA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-992; do Nascimento MI, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005953; Doll R, 1966, CANC INCIDENCE 5 COU; dos Santos J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193135; Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Girianelli VR, 2014, REV SAUDE PUBL, V48, P459, DOI 10.1590/S0034-8910.2014048005214; Granato L., 2018, CAD PROLAM USP, V16, P5, DOI [10.11606/issn.1676-6288.prolam.2017.133966, DOI 10.11606/ISSN.1676-6288.PROLAM.2017.133966, 10.11606/issn.1676-6288.pro-lam.2017.133966, DOI 10.11606/ISSN.1676-6288.PRO-LAM.2017.133966]; Guimaraes R.M., 2016, R POL PUBL, V20, P33, DOI [10.18764/2178-2865.v20n1p35-50, DOI 10.18764/2178-2865.V20N1P35-50]; Holford TR, 2006, STAT MED, V25, P977, DOI 10.1002/sim.2253; HOLFORD TR, 1983, BIOMETRICS, V39, P311, DOI 10.2307/2531004; Instituto Brasileiro de Geografi a e Estatistica, 2011, AC UT UT SERV SAUD; Instituto Brasileiro de Geografia e Estatistica, SUPL SAUD; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2019, SIST IBGE REC NET; Instituto Nacional de Cancer (INCA), 2018, EST 2018 2019 CANC B; Gamarra CJ, 2010, REV PANAM SALUD PUBL, V28, P100, DOI 10.1590/S1020-49892010000800005; Kienen N, 2018, PROG COMM HLTH PARTN, V12, P111, DOI 10.1353/cpr.2018.0026; Dias MBK, 2010, EPIDEMIOL SERV SAUDE, V19, P293; Lee WC, 1996, STAT MED, V15, P273, DOI 10.1002/(SICI)1097-0258(19960215)15:3<273::AID-SIM172>3.0.CO;2-R; Li HQ, 2000, INT J EPIDEMIOL, V29, P398, DOI 10.1093/ije/29.3.398; Llorca J, 1999, J EPIDEMIOL COMMUN H, V53, P408, DOI 10.1136/jech.53.7.408; Malta DC, 2014, E CULTURA, V66, P25, DOI [10.21800/S0009-67252014000100012, DOI 10.21800/S0009-67252014000100012]; Mathers C., 2008, GLOBAL BURDEN DIS 20; Meira K.C., 2012, CAD SAUDE COLET, V20, P381; Meira KC, 2013, REV SAUDE PUBL, V47, P274, DOI 10.1590/S0034-8910.2013047004253; Mello JMH, 2002, EPIDEMIOLOGY, V5, P197, DOI DOI 10.1590/S1415-790X2002000200007; Moon EK, 2017, CANCER RES TREAT, V49, P526, DOI 10.4143/crt.2016.316; Ojamaa K, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-5006-1; Oliveira Max Moura de, 2018, Rev. bras. epidemiol., V21, pe180014, DOI 10.1590/1980-549720180014; Osmond C, 1982, Stat Med, V1, P245, DOI 10.1002/sim.4780010306; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Peroni FDA, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-0938-x; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Queiroz Bernardo Lanza, 2017, Rev. bras. epidemiol., V20, P21, DOI 10.1590/1980-5497201700050003; Renna NL, 2018, EPIDEMIOL SERV SAUDE, V27, DOI [10.5123/S1679-49742018000200003, 10.5123/s1679-49742018000200003]; Ribeiro CM, 2018, EPIDEMIOL SERV SAUDE, V27, DOI 10.5123/S1679-49742018000100004; Robertson C, 1998, STAT MED, V17, P1305, DOI 10.1002/(SICI)1097-0258(19980630)17:12<1305::AID-SIM853>3.0.CO;2-W; ROBERTSON C, 1986, STAT MED, V5, P527, DOI 10.1002/sim.4780050517; Sales L., 2015, MULHERES COM CANC CO; Thuler LCS, 2014, REV BRAS GINECOL OBS, V36, P237, DOI 10.1590/S0100-720320140005010; Small W, 2017, CANCER-AM CANCER SOC, V123, P2404, DOI 10.1002/cncr.30667; Srivastava S, 2019, NAT REV CANCER, V19, P349, DOI 10.1038/s41568-019-0142-8; Szwarcwald CL, 2011, NUCL COMUNICAC SAUDE, P79; Teixeira LA, 2011, SOC STUD SCI, V41, P585, DOI 10.1177/0306312711408380; Theme Filha Mariza Miranda, 2016, Int J Equity Health, V15, P136; Vaccarella S, 2013, EUR J CANCER, V49, P3262, DOI 10.1016/j.ejca.2013.04.024; van Luijt PA, 2016, J MED SCREEN, V23, P210, DOI 10.1177/0969141316629505; Viacava F, 2016, CIENC SAUDE COLETIVA, V21, P351, DOI 10.1590/1413-81232015212.19422015; de Sousa AMV, 2016, EPIDEMIOL SERV SAUDE, V25, P311, DOI [10.5123/s1679-49742016000200010, 10.5123/S1679-49742016000200010]; Wang JY, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5307459; Wang JY, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111148; Warenius H, 2009, ANTICANCER RES, V29, P1933; Yang Y, INTERDISCIPLINARY ST	66	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2020	15	2							e0226258	10.1371/journal.pone.0226258	http://dx.doi.org/10.1371/journal.pone.0226258			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8AS	32074101	Green Published, gold			2022-12-26	WOS:000535220600003
J	Baba, M; Kojima, K; Nishimura, T; Sugiura, T; Takita, T; Uehara, R; Crouch, RJ; Yasukawa, K				Baba, Misato; Kojima, Kenji; Nishimura, Takuto; Sugiura, Takuya; Takita, Teisuke; Uehara, Ryo; Crouch, Robert J.; Yasukawa, Kiyoshi			Val143 of human ribonuclease H2 is not critical for, but plays a role in determining catalytic activity and substrate specificity	PLOS ONE			English	Article							RNASE H2; DNA; REVEAL; COMPLEX; MECHANISM	Ribonuclease H2 (RNase H2) exhibits both single ribonucleotide excision activity (activity A) and RNA strand degrading activity (activity B). Val143 of human RNase H2 is located at the active site and is conserved in eukaryotic RNase H2. In this study, we explored the role of Val143 in catalytic activity and substrate specificity. Nineteen single variants at amino acid position 143 were expressed in E. coli, and all variants except for V143C and V143M were purified from the cells. When the activity of the wild-type human RNase H2 (WT) was set as 100%, the relative activities A and B of the 17 variants were in the range of 0.05-130 and 0.02-42%, respectively. When the ratio of the relative activity A to the relative activity B of WT was set as 1, the ratios of the 17 variants were in the range of 0.2-5.7. This indicates that valine is optimal for balancing the two activities. The ratios for V143Y and V143W were relatively high (5.6 and 5.5, respectively), suggesting that the bulky residues like tyrosine and tryptophan at position 143 caused steric hindrance with the 2'-OH of the sugar moiety of the ribonucleotide at the 5' side of the scissile phosphodiester bond. The ratio for V143Q was relatively low (0.2). These results suggested that Val143 is not critical for, but plays a role in determining catalytic activity and substrate specificity.	[Baba, Misato; Kojima, Kenji; Nishimura, Takuto; Sugiura, Takuya; Takita, Teisuke; Yasukawa, Kiyoshi] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto, Japan; [Uehara, Ryo; Crouch, Robert J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Format RNA, Intramural Res Program, NIH, Bethesda, MD USA; [Uehara, Ryo] Ritsumeikan Univ, Ritsumeikan Global Innovat Res Org, Noji Higashi, Shiga, Japan	Kyoto University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Ritsumeikan University	Yasukawa, K (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto, Japan.	yasukawa@kais.kyoto-u.ac.jp		Yasukawa, Kiyoshi/0000-0001-7748-6043	Japan Society for the Promotion of Science [21580110, 18KK0285, 18K19839, 18J14339]; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH	This study was supported in part by Grants-in-Aid for Scientific Research (no. 21580110 for K.K., K.Y., no. 18KK0285 for K.K., T. T., and K.Y., 18K19839 for K. Y., and no. 18J14339 for M.B.) from the Japan Society for the Promotion of Science. R.J.C. and R.U. were supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH. There was no additional external funding received for this study	Aden K, 2019, GASTROENTEROLOGY, V156, P145, DOI 10.1053/j.gastro.2018.09.047; Baba M, 2017, J BIOCHEM, V162, P211, DOI 10.1093/jb/mvx021; Bartsch K, 2017, HUM MOL GENET, V26, P3960, DOI 10.1093/hmg/ddx283; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Champoux JJ, 2009, FEBS J, V276, P1506, DOI 10.1111/j.1742-4658.2009.06909.x; Chon H, 2013, NUCLEIC ACIDS RES, V41, P3130, DOI 10.1093/nar/gkt027; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Coffin SR, 2011, J BIOL CHEM, V286, P16984, DOI 10.1074/jbc.M111.228833; Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887; Figiel M, 2011, J BIOL CHEM, V286, P10540, DOI 10.1074/jbc.M110.181974; Gunther C, 2015, J CLIN INVEST, V125, P413, DOI 10.1172/JCI78001; Hiller B, 2018, CANCER RES, V78, P5917, DOI 10.1158/0008-5472.CAN-18-1099; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; Hyjek M, 2019, DNA REPAIR, V84, DOI 10.1016/j.dnarep.2019.102672; Jeong HS, 2004, NUCLEIC ACIDS RES, V32, P407, DOI 10.1093/nar/gkh209; Nishimura T, 2019, J BIOCHEM, V166, P537, DOI 10.1093/jb/mvz073; Parniak MA, 2003, ANAL BIOCHEM, V322, P33, DOI 10.1016/j.ab.2003.06.001; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Reijns MAM, 2011, J BIOL CHEM, V286, P10530, DOI 10.1074/jbc.M110.177394; Rychlik MP, 2010, MOL CELL, V40, P658, DOI 10.1016/j.molcel.2010.11.001; Shaban NM, 2010, J BIOL CHEM, V285, P3617, DOI 10.1074/jbc.M109.059048; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Tadokoro T, 2009, FEBS J, V276, P1482, DOI 10.1111/j.1742-4658.2009.06907.x; Tsukiashi M, 2019, J BIOCHEM, V165, P249, DOI 10.1093/jb/mvy101; Uehara R, 2018, CELL REP, V25, P1135, DOI 10.1016/j.celrep.2018.10.019; Wang C, 2019, ONCOGENE, V38, P2451, DOI 10.1038/s41388-018-0606-4; Zhang L, 2015, AM J HUM GENET, V96, P597, DOI 10.1016/j.ajhg.2015.02.017; Zimmermann M, 2018, NATURE, V559, P285, DOI 10.1038/s41586-018-0291-z	28	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2020	15	2							e0228774	10.1371/journal.pone.0228774	http://dx.doi.org/10.1371/journal.pone.0228774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7XT	32069311	gold, Green Published, Green Submitted			2022-12-26	WOS:000535212900013
J	Rogala, MM; Lewandowski, D; Detyna, J; Antonczyk, A; Danielewska, ME				Rogala, Maja M.; Lewandowski, Daniel; Detyna, Jerzy; Antonczyk, Agnieszka; Danielewska, Monika E.			Corneal pulsation and biomechanics during induced ocular pulse. An ex-vivo pilot study	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE; POSTERIOR SCLERA; BLOOD-FLOW; AIR-PUFF; AMPLITUDE; PORCINE; DEFORMATION; EYE; APPLANATION; MICROSCOPY	The purpose of this study was to ascertain the relationships between the amplitude of the corneal pulse (CP) signal and the parameters of corneal biomechanics during ex-vivo intraocular pressure (IOP) elevation experiments on porcine eyes with artificially induced ocular pulse cycles. Two experiments were carried out using porcine eyes. In the first one, a selected eye globe was subjected to three IOP levels (15, 30 and 45 mmHg), where changes in physical ocular pulse amplitude were controlled by infusion/withdrawal volumes (Delta V). In the second experiment, six eyes were subjected to IOP from 15 mmHg to 45 mmHg in steps of 5 mmHg with a constant Delta V, where corneal deformation parameters were measured using Corvis ST. In both experiments, at each IOP, the CP and IOP signals were acquired synchronically using a non-contact ultrasonic distance sensor and a pressure transmitter, respectively. Based on the amplitudes of the CP and IOP signals ocular pulse based corneal rigidity index (OPCRI) was calculated. Results indicate positive correlations between Delta V and the physical ocular pulse amplitude, and between.V and the corneal pulse amplitude (both p < 0.001). OPCRI was found to increase with elevated IOP. Furthermore, IOP statistically significantly differentiated changes in OPCRI, the amplitudes of CP and IOP signals and in most of the corneal deformation parameters (p < 0.05). The partial correlation analysis, with IOP as a control variable, revealed a significant correlation between the length of the flattened cornea during the first applanation (A1L) and the corneal pulse amplitude (p = 0.002), and between A1L and OPCRI (p = 0.003). In conclusion, this study proved that natural corneal pulsations, detected with a non-contact ultrasonic technique, reflect pressure-volume dynamics and can potentially be utilized to assess stiffness of the cornea. The proposed new rigidity index could be a simple approach to estimating corneal rigidity.	[Rogala, Maja M.; Lewandowski, Daniel; Detyna, Jerzy] Wroclaw Univ Sci & Technol, Dept Mech Mat Sci & Engn, Wroclaw, Poland; [Antonczyk, Agnieszka] Wroclaw Univ Environm & Life Sci, Dept Surg, Wroclaw, Poland; [Danielewska, Monika E.] Wroclaw Univ Sci & Technol, Dept Biomed Engn, Wroclaw, Poland	Wroclaw University of Science & Technology; Wroclaw University of Environmental & Life Sciences; Wroclaw University of Science & Technology	Danielewska, ME (corresponding author), Wroclaw Univ Sci & Technol, Dept Biomed Engn, Wroclaw, Poland.	monika.danielewska@pwr.edu.pl	Lewandowski, Daniel/A-4324-2016; Antończyk, Agnieszka/A-2707-2017; Lewandowski, Daniel/AGY-1726-2022; Detyna, Jerzy/D-2026-2012	Lewandowski, Daniel/0000-0002-5169-9021; Antończyk, Agnieszka/0000-0003-2065-4223; Detyna, Jerzy/0000-0001-5750-2085	Wroclaw University of Science and Technology	Wroclaw University of Science and Technology	M. E. D. acknowledges support from the statutory funds of Wroclaw University of Science and Technology.	Alonso-Caneiro D, 2011, OPT EXPRESS, V19, P14188, DOI 10.1364/OE.19.014188; Ambrosio R, 2013, REV BRAS OFTALMOL, V72, P99, DOI 10.1590/S0034-72802013000200005; Anderson K, 2004, J R SOC INTERFACE, V1, P3, DOI 10.1098/rsif.2004.0002; Bao F., 2012, Journal of Medical Engineering & Technology, V36, P17, DOI 10.3109/03091902.2011.629276; Bao FJ, 2015, EXP EYE RES, V137, P11, DOI 10.1016/j.exer.2015.05.018; Bell JS, 2018, ACTA BIOMATER, V65, P216, DOI 10.1016/j.actbio.2017.11.015; Clayson K, 2017, EXP EYE RES, V165, P29, DOI 10.1016/j.exer.2017.08.015; Coudrillier B, 2012, INVEST OPHTH VIS SCI, V53, P1714, DOI 10.1167/iovs.11-8009; Danielewska ME, 2012, CLIN EXP OPTOM, V95, P631, DOI 10.1111/j.1444-0938.2012.00775.x; Danielewska ME, 2015, INVEST OPHTH VIS SCI, V56; Dastiridou AI, 2009, INVEST OPHTH VIS SCI, V50, P5718, DOI 10.1167/iovs.09-3760; Dorronsoro C, 2012, BIOMED OPT EXPRESS, V3, P473, DOI 10.1364/BOE.3.000473; Eisenberg DL, 1998, OPHTHALMOLOGY, V105, P1173, DOI 10.1016/S0161-6420(98)97016-6; Eliasy A, 2018, EXP EYE RES, V175, P98, DOI 10.1016/j.exer.2018.06.013; Elsheikh A, 2008, EXP EYE RES, V86, P783, DOI 10.1016/j.exer.2008.02.006; Elsheikh A, 2011, ACTA BIOENG BIOMECH, V13, P25; Frings A, 2015, CLIN OPHTHALMOL, V9, P305, DOI 10.2147/OPTH.S76491; Fung Y.C., 1993, BIOMECHANICS MECH PR; Galin M A, 1969, Headache, V9, P112, DOI 10.1111/j.1526-4610.1969.hed0902112.x; Gelatt K.N., 2012, VET OPHTHALMOLOGY; Girard MJA, 2015, CURR EYE RES, V40, P1, DOI 10.3109/02713683.2014.914543; Gora M, 2009, OPT EXPRESS, V17, P14880, DOI 10.1364/OE.17.014880; Hatami-Marbini H, 2014, EXP EYE RES, V120, P103, DOI 10.1016/j.exer.2013.11.017; Hatami-Marbini H, 2014, J BIOMECH, V47, P723, DOI 10.1016/j.jbiomech.2013.11.019; Hoffmann Esther M, 2004, BMC Ophthalmol, V4, P4; Holzapfel G.A., 2001, HDB MAT BEHAV MODELS, V3, P1049, DOI 10.1007/978-0-387-21787-1_11; Hon Y, 2013, OPTOMETRY VISION SCI, V90, pE1, DOI 10.1097/OPX.0b013e318279eb87; Iskander DR, 2006, OPHTHAL PHYSL OPT, V26, P572, DOI 10.1111/j.1475-1313.2006.00415.x; Jedzierowska M, 2019, IOP SER MED BIOL IM, DOI 10.1088/2053-2563/aafee5ch1; Johnson RD, 2011, CORNEA, V30, P516, DOI 10.1097/ICO.0b013e3181f0579e; Kasprzak HT, 2007, EYE, V21, P1212, DOI 10.1038/sj.eye.6702578; Kaufmann C, 2004, INVEST OPHTHALMOL, P3118; Kaufmann C, 2006, ARCH OPHTHALMOL-CHIC, V124, P1104, DOI 10.1001/archopht.124.8.1104; Kling S, 2017, OPHTHAL PHYSL OPT, V37, P240, DOI 10.1111/opo.12345; Kling S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104904; Knecht PB, 2011, ACTA OPHTHALMOL, V89, pE466, DOI 10.1111/j.1755-3768.2011.02141.x; Kotecha A, 2006, INVEST OPHTH VIS SCI, V47, P5337, DOI 10.1167/iovs.06-0557; Kowalska MA, 2008, BIOCYBERN BIOMED ENG, V28, P35; Kowalska MA, 2011, IEEE T BIO-MED ENG, V58, P674, DOI 10.1109/TBME.2010.2100819; LAWRENCE CARTERET, 1966, INVEST OPHTHALMOL, V5, P515; Leung CKS, 2013, INVEST OPHTH VIS SCI, V54, P2885, DOI 10.1167/iovs.12-11563; Licznerski TJ, 2011, ULTRASONICS, V51, P960, DOI 10.1016/j.ultras.2011.05.011; Liu J, 2005, J CATARACT REFR SURG, V31, P146, DOI 10.1016/j.jcrs.2004.09.031; Liu J, 2017, IOVS; Medeiros FA, 2006, J GLAUCOMA, V15, P364, DOI 10.1097/01.ijg.0000212268.42606.97; Morris HJ, 2013, INVEST OPHTH VIS SCI, V54, P7215, DOI 10.1167/iovs.13-12441; NORTHROP RB, 1977, IEEE T BIO-MED ENG, V24, P139, DOI 10.1109/TBME.1977.326118; Pallikaris IG, 2005, INVEST OPHTH VIS SCI, V46, P409, DOI 10.1167/iovs.04-0162; Pavlatos E, 2018, IEEE T MED IMAGING, V37, P663, DOI 10.1109/TMI.2017.2775146; Perez-Merino P, 2019, IOP SER MED BIOL IM, DOI 10.1088/2053-2563/aafee5ch5; Ramos RF, 2008, INVEST OPHTH VIS SCI, V49, P275, DOI 10.1167/iovs.07-0863; Reisdorf S., 2016, CORNEAL BIOMECHANICS, P106; Rogala MM, 2017, EXP EYE RES, V162, P27, DOI 10.1016/j.exer.2017.07.003; Roy AS, 2014, J CATARACT REFR SURG, V40, P971, DOI 10.1016/j.jcrs.2013.08.065; Ruiz-Ederra J, 2005, EXP EYE RES, V81, P561, DOI 10.1016/j.exer.2005.03.014; Sanchez I, 2011, GRAEF ARCH CLIN EXP, V249, P475, DOI 10.1007/s00417-011-1617-9; Scarcelli G, 2013, INVEST OPHTH VIS SCI, V54, P1418, DOI 10.1167/iovs.12-11387; Scarcelli G, 2012, INVEST OPHTH VIS SCI, V53, P185, DOI 10.1167/iovs.11-8281; Schwenn O, 2002, BRIT J OPHTHALMOL, V86, P981, DOI 10.1136/bjo.86.9.981; Shah S, 2007, INVEST OPHTH VIS SCI, V48, P3026, DOI 10.1167/iovs.04-0694; SILVER DM, 1989, ACTA OPHTHALMOL, V67, P25; Srodka W, 2009, OPT APPL, V39, P401; Touboul D, 2008, J CATARACT REFR SURG, V34, P616, DOI 10.1016/j.jcrs.2007.11.051; Wang S, 2013, LASER PHYS LETT, V10, DOI 10.1088/1612-2011/10/7/075605; WHITACRE MM, 1993, AM J OPHTHALMOL, V115, P592, DOI 10.1016/S0002-9394(14)71455-2; Wolffsohn JS, 2012, CORNEA, V31, P849, DOI 10.1097/ICO.0b013e318243e42d; Zeng YJ, 2001, J BIOMECH, V34, P533, DOI 10.1016/S0021-9290(00)00219-0	67	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228920	10.1371/journal.pone.0228920	http://dx.doi.org/10.1371/journal.pone.0228920			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053692	Green Published, gold			2022-12-26	WOS:000535198700070
J	Singh, D; Mathimaran, N; Boller, T; Kahmen, A				Singh, Devesh; Mathimaran, Natarajan; Boller, Thomas; Kahmen, Ansgar			Deep-rooted pigeon pea promotes the water relations and survival of shallow-rooted finger millet during drought-Despite strong competitive interactions at ambient water availability	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; HYDRAULIC LIFT; PLANT; GROWTH; TREES; MAIZE; FACILITATION; INOCULATION; DIVERSITY; GRASSES	Bioirrigation has been defined as the transfer of hydraulically lifted water by a deep-rooted plant to a neighbouring shallow-rooted plant which cannot access deep soil moisture. In this study, we tested if facilitative effects of bioirrigation or the competition for water dominate the interaction of two intercropped plants-deep-rooted pigeon pea (PP) and shallow-rooted finger millet (FM) before and during a drought. Additionally, we tested how the presence of a common mycorrhizal network (CMN) affects the balance between facilitative (i.e. bioirrigation) and competitive interactions between two intercropping species. Our results show that PP can indeed promote the water relations of FM during a drought event. Specifically, stomatal conductance in FM controls dropped to low values of 27.1 to 33.6 mmol m(-2)s(-1), while FM in intercropping treatments were able to maintain its stomatal conductance at 60 mmol m(-2)s(-1). In addition, the presence of PP reduced the drought-induced foliar damage and mortality of FM. The observed facilitative effects of PP on FM were partially enhanced by the presence of a CMN. In contrast to the facilitative effects under drought, PP exerted strong competitive effects on FM before the onset of drought. This hindered growth and biomass production of FM when intercropped with PP, an effect that was even enhanced in the presence of a CMN. The results from our study thus indicate that in intercropping, deep-rooted plants may act as "bioirrigators" for shallow-rooted crops and that a CMN can promote these facilitative effects. However, the interspecific competition between the intercropped plants under conditions of abundant moisture supply can be strong and are enhanced by the presence of a CMN. In more general terms, our study shows that the extent by which the antagonistic effects of facilitation and competition are expressed in an intercropping system strongly depends on the availability of resources, which in the case of the present study was water and the presence of biotic interactions (i.e. the presence of a CMN).	[Singh, Devesh; Mathimaran, Natarajan; Boller, Thomas; Kahmen, Ansgar] Univ Basel, Dept Environm Sci, Bot, Basel, Switzerland; [Singh, Devesh] Yale NUS Coll, Singapore, Singapore; [Mathimaran, Natarajan] MS Swaminathan Res Fdn, Chennai, Tamil Nadu, India	University of Basel; Yale NUS College	Singh, D (corresponding author), Univ Basel, Dept Environm Sci, Bot, Basel, Switzerland.; Singh, D (corresponding author), Yale NUS Coll, Singapore, Singapore.	singhdevesh@outlook.com	Natarajan, Mathimaran/AAM-7839-2020; Singh, Devesh/AAF-2853-2020	Natarajan, Mathimaran/0000-0002-4109-1581; Singh, Devesh/0000-0002-0894-0852	Indo-Swiss Collaboration in Biotechnology programme of the Swiss SDC (Swiss Agency for Development and Cooperation); Indian DBT (Department of Biotechnology)	Indo-Swiss Collaboration in Biotechnology programme of the Swiss SDC (Swiss Agency for Development and Cooperation); Indian DBT (Department of Biotechnology)	This research resulted from work in the project "Biofertilization and bioirrigation for sustainable mixed cropping of pigeon pea and finger millet (BIOFI)" funded by the Indo-Swiss Collaboration in Biotechnology programme of the Swiss SDC (Swiss Agency for Development and Cooperation) and the Indian DBT (Department of Biotechnology).	Allen MF, 2007, VADOSE ZONE J, V6, P291, DOI 10.2136/vzj2006.0068; Barea JM, 1991, ROLE VESICULA RARBUS; Beggi F, 2016, J PLANT NUTR SOIL SC, V179, P466, DOI 10.1002/jpln.201500501; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bogie NA, 2018, FRONT ENV SCI-SWITZ, V6, DOI 10.3389/fenvs.2018.00098; Booth MG, 2010, ECOLOGY, V91, P2294, DOI 10.1890/09-1139.1; Brundrett MC, 2009, PLANT SOIL, V320, P37, DOI 10.1007/s11104-008-9877-9; Burgess SSO, 2011, PLANT SOIL, V341, P25, DOI 10.1007/s11104-010-0638-1; CALDWELL MM, 1990, ISRAEL J BOT, V39, P395; CALDWELL MM, 1989, OECOLOGIA, V79, P1, DOI 10.1007/BF00378231; Carminati A, 2010, PLANT SOIL, V332, P163, DOI 10.1007/s11104-010-0283-8; CORAK SJ, 1987, PLANT PHYSIOL, V84, P582, DOI 10.1104/pp.84.3.582; DAWSON TE, 1993, OECOLOGIA, V95, P565, DOI 10.1007/BF00317442; Duchene O, 2017, AGR ECOSYST ENVIRON, V240, P148, DOI 10.1016/j.agee.2017.02.019; Egerton-Warburton LM, 2007, J EXP BOT, V58, P1473, DOI 10.1093/jxb/erm009; Fernandez ME, 2008, AGROFOREST SYST, V74, P185, DOI 10.1007/s10457-008-9119-4; Govinda RYS, 1983, ZENTRALBL MIKROBIOL, V138, P415, DOI [10.1016/S0232-4393(83)80039-0, DOI 10.1016/S0232-4393(83)80039-0]; Hart MM, 2003, TRENDS ECOL EVOL, V18, P418, DOI 10.1016/S0169-5347(03)00127-7; Hauggaard-Nielsen' H, 2008, RENEW AGR FOOD SYST, V23, P3, DOI 10.1017/S1742170507002025; Hetrick BAD, 1996, CAN J BOT, V74, P19, DOI 10.1139/b96-003; Hirota I, 2004, AGROFOREST SYST, V60, P181, DOI 10.1023/B:AGFO.0000013293.77907.64; Jahansooz MR, 2007, EUR J AGRON, V26, P275, DOI 10.1016/j.eja.2006.10.008; Ludwig F, 2004, ECOL LETT, V7, P623, DOI 10.1111/j.1461-0248.2004.00615.x; Ludwig F, 2003, OECOLOGIA, V134, P293, DOI 10.1007/s00442-002-1119-x; Mao LL, 2012, FIELD CROP RES, V138, P11, DOI 10.1016/j.fcr.2012.09.019; Mathimaran N, 2012, J BACTERIOL, V194, P3272, DOI 10.1128/JB.00349-12; Moustakas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057025; Murali K., 2014, Journal of Food Legumes, V27, P28; Poorter H, 2012, FUNCT PLANT BIOL, V39, P839, DOI 10.1071/FP12049; Prieto I, 2012, NEW PHYTOL, V193, P830, DOI 10.1111/j.1469-8137.2011.04039.x; Prieto I, 2011, PERSPECT PLANT ECOL, V13, P181, DOI 10.1016/j.ppees.2011.05.002; Querejeta J, 2003, OECOLOGIA, P134, DOI [10.1007/s00442-002-1111-5, DOI 10.1007/S00442-002-1111-5]; Rao MR, 1997, AGROFOREST SYST, V38, P3, DOI 10.1023/A:1005971525590; REDDY MS, 1981, FIELD CROP RES, V4, P13, DOI 10.1016/0378-4290(81)90050-2; REDDY MSB, 1991, BIOL AGRIC HORTIC, V8, P177; Saharan K, 2018, FRONT ENV SCI-SWITZ, V6, DOI 10.3389/fenvs.2018.00046; SAUER DB, 1986, PHYTOPATHOLOGY, V76, P745, DOI 10.1094/Phyto-76-745; SCHENCK NC, 1982, NEW PHYTOL, V92, P193, DOI 10.1111/j.1469-8137.1982.tb03376.x; Sekiya N, 2004, FIELD CROP RES, V86, P167, DOI 10.1016/j.fcr.2003.08.007; Sekiya N, 2011, PLANT SOIL, V341, P39, DOI 10.1007/s11104-010-0581-1; Singh D, 2019, PLANT SOIL, V440, P277, DOI 10.1007/s11104-019-04082-1; Sorensen JN, 2005, PLANT SOIL, V273, P101, DOI 10.1007/s11104-004-6960-8; Vessey JK, 2003, PLANT SOIL, V255, P571, DOI 10.1023/A:1026037216893; Walder F, 2012, PLANT PHYSIOL, V159, P789, DOI 10.1104/pp.112.195727; Wang GZ, 2019, J PLANT INTERACT, V14, P10, DOI 10.1080/17429145.2018.1550218; Weremijewicz J, 2013, NEW PHYTOL, V198, P203, DOI 10.1111/nph.12125; WILLEY RW, 1972, J AGR SCI-CAMBRIDGE, V79, P517, DOI 10.1017/S0021859600025909; YUNUSA IAM, 1989, J AGR SCI, V112, P1, DOI 10.1017/S0021859600084045; Zarebanadkouki M, 2013, NEW PHYTOL, V199, P1034, DOI 10.1111/nph.12330; Zegada-Lizarazu W, 2006, PLANT PROD SCI, V9, P123, DOI 10.1626/pps.9.123	50	12	15	7	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228993	10.1371/journal.pone.0228993	http://dx.doi.org/10.1371/journal.pone.0228993			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	32053664	Green Published, gold			2022-12-26	WOS:000535198700085
J	Kwon, EH; Musema, GMA; Boelter, J; Townsend, S; Tshala-Katumbay, D; Kayembe, PK; West, J; Wood, C				Kwon, Eun Hee; Musema, Godefroid M. A.; Boelter, Jessica; Townsend, Sydney; Tshala-Katumbay, Desire; Kayembe, Patrick K.; West, John; Wood, Charles			HIV-1 subtypes and drug resistance mutations among female sex workers varied in different cities and regions of the Democratic Republic of Congo	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GENETIC DIVERSITY; GENOMES; SUPERINFECTION; KINSHASA; SUGGESTS	Background Complex mosaic structures of HIV-1 were found in the Democratic Republic of Congo (DRC). Currently, there is limited information on the circulating HIV-1 strains, the distribution of these strains and antiretroviral (ART) resistant viruses in different regions of the country, and the HIV-1 strains harbored by the high-risk groups like female sex workers (FSW) reported to be the source of recombinant and ART resistant viruses. Methods Dried Blood Spots (DBS), collected from 325 infected FSWs in ten cities from 2012 DRC HIV/STI Integrated Biological and Behavioral Surveillance Survey, were tested for HIV-1 genotypes and antiretroviral resistance mutations. Regional segregation of HIV-1 clades was detected using phylogenetics. The significance for differences in HIV-1 subtype and drug resistance mutations were evaluated using Chi-square tests. Results There were 145 (env) and 93 (pol) sequences analyzed. Based on env sequences, the predominant subtype was A1 (44%), and recombinants as defined pol sequences comprised 35% of the total sample. Paired sequences of pol and env from DRC FSW revealed mosaic recombinant in 54% of the sequences. Distinct geographic distributions of different HIV-1 subtypes and recombinants were observed. Subtype A1 was prevalent (40%) in Goma located in the East and significantly higher than in Mbuji-Mayi (p<0.05) in the South-central region, or in Lubumbashi in the South. Antiretroviral resistance was detected in 21.5% of 93 pol sequences analyzed, with the M184I/V and K103N mutations that confer high-level resistance to NRTI and NNRTI, respectively, being the most frequent mutations. However, the K103N mutant viruses were found only in the East. Conclusion HIV-1 variants found in DRC FSW reflect those reported to circulate in the general population from the corresponding geographical locations. HIV-1 mosaic genetics were readily detected in FSW. Importantly, ART resistance mutations to NNRTI and NRTI were common in the DRC sex workers.	[Kwon, Eun Hee; Boelter, Jessica; Townsend, Sydney; West, John; Wood, Charles] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68588 USA; [Wood, Charles] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [West, John; Wood, Charles] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Musema, Godefroid M. A.; Kayembe, Patrick K.] Univ Kinshasa, Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Tshala-Katumbay, Desire] Oregon Hlth & Sci Univ, Dept Neurol, Sch Med, Portland, OR 97201 USA; [Tshala-Katumbay, Desire] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA; [Tshala-Katumbay, Desire] Univ Kinshasa, Dept Neurol, Kinshasa, DEM REP CONGO; [Tshala-Katumbay, Desire] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Universite de Kinshasa; Oregon Health & Science University; Oregon Health & Science University; Universite de Kinshasa; Institute Nacional de Recherche Biomedical	Wood, C (corresponding author), Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68588 USA.; Wood, C (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.; Wood, C (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA.	cwood1@unl.edu	Wood, Charles/AAH-4536-2021	Wood, Charles/0000-0002-4256-1530	PHS grants from the National Institute of Health; Fogarty International grant [D43 TW010354]; National Cancer Institute grants [RO1 CA75903, U54 CA190155, U54 CA221204]; National Institute of General Medical Science grant [P30 GM103509]	PHS grants from the National Institute of Health; Fogarty International grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Cancer Institute grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science grant	This study was supported in part of PHS grants from the National Institute of Health; Fogarty International grant (D43 TW010354), National Cancer Institute grants (RO1 CA75903, U54 CA190155 and U54 CA221204), and National Institute of General Medical Science grant (P30 GM103509) to CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ENQUETE INTEGREE SUR; Arenas CJV, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex032; Boillot F, 2016, JAIDS-J ACQ IMM DEF, V71, pE9, DOI 10.1097/QAI.0000000000000844; CASSOL S, 1991, J CLIN MICROBIOL, V29, P667, DOI 10.1128/JCM.29.4.667-671.1991; Djoko CF, 2011, AIDS RES HUM RETROV, V27, P323, DOI 10.1089/aid.2010.0201; Fang GW, 2004, AIDS, V18, P153, DOI 10.1097/00002030-200401230-00003; Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739; Hemelaar J, 2012, TRENDS MOL MED, V18, P182, DOI 10.1016/j.molmed.2011.12.001; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Kamangu EN, 2015, J HIV AIDS, DOI [10.16966/2380-5536.114, DOI 10.16966/2380-5536.114]; Kamangu EN., 2018, OPEN ACCESS LIB JOUR, V5, P1, DOI [10.4236/oalib.1104560, DOI 10.4236/OALIB.1104560]; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Kita K, 2004, AIDS RES HUM RETROV, V20, P1352, DOI 10.1089/aid.2004.20.1352; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Manigart O, 2004, AIDS, V18, P1645, DOI 10.1097/01.aids.0000131333.30548.db; Muwonga J, 2011, JAIDS-J ACQ IMM DEF, V57, pS27, DOI 10.1097/QAI.0b013e31821f596c; Niama FR, 2006, INFECT GENET EVOL, V6, P337, DOI 10.1016/j.meegid.2005.12.001; Niama Fabien Roch, 2017, BMC Res Notes, V10, P243, DOI 10.1186/s13104-017-2550-8; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; RAPPORT SUR L'ETAT D'AVANCEMENT DE LA REPONSE A L'EPIDEMIE DU VIH/Sida, 2014, REP DEM C PRES REP N; Redd AD, 2014, AIDS, V28, P2147, DOI 10.1097/QAD.0000000000000365; Rodgers MA, 2017, J VIROL, V91, DOI [10.1128/JVI.01841-16, 10.1128/jvi.01841-16]; Rusine J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042557; Schultz AK, 2012, NUCLEIC ACIDS RES, V40, pW193, DOI 10.1093/nar/gks414; Steain Megan C, 2004, Sex Health, V1, P239, DOI 10.1071/SH04024; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000; Vidal N, 2006, AIDS RES HUM RETROV, V22, P202, DOI 10.1089/aid.2006.22.202; Vidal N, 2005, JAIDS-J ACQ IMM DEF, V40, P456, DOI 10.1097/01.qai.0000159670.18326.94; Vidal N, 2007, AIDS RES HUM RETROV, V23, P175, DOI 10.1089/aid.2006.0126; Vidal N, 2009, AIDS RES HUM RETROV, V25, P823, DOI 10.1089/aid.2008.0283; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004; Zhang H, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-73	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2020	15	2							e0228670	10.1371/journal.pone.0228670	http://dx.doi.org/10.1371/journal.pone.0228670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9KA	32045455	gold, Green Submitted, Green Published			2022-12-26	WOS:000534633200030
J	Viallard, C; Audiger, C; Popovic, N; Akla, N; Lanthier, K; Legault-Navarrete, I; Melichar, H; Costantino, S; Lesage, S; Larrivee, B				Viallard, Claire; Audiger, Cindy; Popovic, Natalija; Akla, Naoufal; Lanthier, Kevin; Legault-Navarrete, Isaac; Melichar, Heather; Costantino, Santiago; Lesage, Sylvie; Larrivee, Bruno			BMP9 signaling promotes the normalization of tumor blood vessels	ONCOGENE			English	Article							BONE MORPHOGENETIC PROTEIN-9; ENDOTHELIAL-CELL-ADHESION; RECEPTOR-LIKE KINASE-1; VASCULAR NORMALIZATION; ANTIANGIOGENIC THERAPY; INHIBITS ANGIOGENESIS; IN-VIVO; CANCER; HYPOXIA; GROWTH	The presence of an immature tumor vascular network contributes to cancer dissemination and the development of resistance to therapies. Strategies to normalize the tumor vasculature are therefore of significant therapeutic interest for cancer treatments. VEGF inhibitors are used clinically to normalize tumor blood vessels. However, the time frame and dosage of these inhibitors required to achieve normalization is rather narrow, and there is a need to identify additional signaling targets to attain vascular normalization. In addition to VEGF, the endothelial-specific receptor Alk1 plays a critical role in vascular development and promotes vascular remodeling and maturation. Therefore, we sought to evaluate the effects of the Alk1 ligand BMP9 on tumor vascular formation. BMP9 overexpression in Lewis Lung Carcinoma (LLC) tumors significantly delayed tumor growth. Blood vessels in BMP9-overexpressing LLC tumors displayed markers of vascular maturation and were characterized by increased perivascular cell coverage. Tumor vasculature normalization was associated with decreased permeability and increased perfusion. These changes in vascular function in BMP9-overexpressing LLC tumors resulted in significant alterations of the tumor microenvironment, characterized by a decrease in hypoxia and an increase in immune infiltration. In conclusion, we show that BMP9 promotes vascular normalization in LLC tumors that leads to changes in the microenvironment.	[Viallard, Claire; Audiger, Cindy; Popovic, Natalija; Akla, Naoufal; Lanthier, Kevin; Legault-Navarrete, Isaac; Melichar, Heather; Costantino, Santiago; Lesage, Sylvie; Larrivee, Bruno] Ctr Rech Hop Maisonneuve Rosemt, Montreal, PQ, Canada; [Viallard, Claire; Popovic, Natalija; Lanthier, Kevin; Larrivee, Bruno] Univ Montreal, Dept Biol Mol, Montreal, PQ, Canada; [Audiger, Cindy; Lesage, Sylvie] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Akla, Naoufal] Univ Montreal, Dept Biochim, Montreal, PQ, Canada; [Melichar, Heather] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Costantino, Santiago; Larrivee, Bruno] Univ Montreal, Dept Ophtalmol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Larrivee, B (corresponding author), Ctr Rech Hop Maisonneuve Rosemt, Montreal, PQ, Canada.; Larrivee, B (corresponding author), Univ Montreal, Dept Biol Mol, Montreal, PQ, Canada.; Larrivee, B (corresponding author), Univ Montreal, Dept Ophtalmol, Montreal, PQ, Canada.	bruno.larrivee@umontreal.ca	Costantino, Santiago/ABD-5472-2020	Costantino, Santiago/0000-0002-2454-2635; Popovic, Natalija/0000-0002-8324-4099; Larrivee, Bruno/0000-0003-1388-3108; Lesage, Sylvie/0000-0002-0968-2795	Cancer Research Society; Canadian Institutes of Health Research [363450]; Fonds de recherche -Sante (FRQS); Department of Ophthalmology of Universite de Montreal Research Fund Award (FROUM); Suzanne-Veronneau-Troutmann Award (SVT); FRQS scholarship; Montreal Diabetes Research Center PhD Award; Heart and Stroke Foundation of Canada	Cancer Research Society; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche -Sante (FRQS); Department of Ophthalmology of Universite de Montreal Research Fund Award (FROUM); Suzanne-Veronneau-Troutmann Award (SVT); FRQS scholarship; Montreal Diabetes Research Center PhD Award; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	We thank Dr. Paul S. Oh for kindly providing the Alk1.EC mice and Manuel Buscarlet for assistance with data analysis. This work was supported by an operating grant from the Cancer Research Society, and an operating grant from the Canadian Institutes of Health Research (363450). CV was supported by a post-doctoral research award from Fonds de recherche -Sante (FRQS). NA was supported by the Department of Ophthalmology of Universite de Montreal Research Fund Award (FROUM), Suzanne-Veronneau-Troutmann Award (SVT) and a FRQS scholarship. CA is recipient of a Montreal Diabetes Research Center PhD Award. SL is an FRQS Research Scholar Emeritus. BL is recipient of a New Investigator Award from the Heart and Stroke Foundation of Canada.	Abou-Alfa GK, 2019, ONCOLOGIST, V24, P161, DOI 10.1634/theoncologist.2018-0654; Akla N, 2018, ARTERIOSCL THROM VAS, V38, P1821, DOI 10.1161/ATVBAHA.118.310733; Appleby SL, 2016, J IMMUNOL, V197, P3302, DOI 10.4049/jimmunol.1601219; Arndt H, 1996, GUT, V38, P911, DOI 10.1136/gut.38.6.911; Azzi S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00211; Baeyens N, 2016, J CELL BIOL, V214, P807, DOI 10.1083/jcb.201603106; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Benn A, 2016, J CELL SCI, V129, P206, DOI 10.1242/jcs.179960; Berman ME, 1996, J IMMUNOL, V156, P1515; Brand V, 2016, MOL ONCOL, V10, P1603, DOI 10.1016/j.molonc.2016.10.002; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cerani A, 2013, CELL METAB, V18, P505, DOI 10.1016/j.cmet.2013.09.003; Chabot C, 2009, MOL CELL BIOL, V29, P241, DOI 10.1128/MCB.01374-08; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; de Vinuesa AG, 2016, BIOCHEM SOC T, V44, P1142, DOI 10.1042/BST20160093; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; Douaisi M, 2017, J IMMUNOL, V198, P2310, DOI 10.4049/jimmunol.1500350; Duriez PJ, 2000, J BIOL CHEM, V275, P18099, DOI 10.1074/jbc.M908925199; Eales KL, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.50; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Friedl J, 2002, BLOOD, V100, P1334, DOI 10.1182/blood.V100.4.1334.h81602001334_1334_1339; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Greenberg JI, 2009, EXPERT OPIN BIOL TH, V9, P1347, DOI 10.1517/14712590903208883; Gupta S, 2015, CURR ONCOL REP, V17, DOI 10.1007/s11912-015-0441-5; Hawinkels LJAC, 2016, CLIN CANCER RES, V22, P96, DOI 10.1158/1078-0432.CCR-15-0743; Hawinkels LJAC, 2013, EXPERT OPIN INV DRUG, V22, P1371, DOI 10.1517/13543784.2013.837884; Hu-Lowe DD, 2011, CANCER RES, V71, P1362, DOI 10.1158/0008-5472.CAN-10-1451; Huang YH, 2013, CANCER RES, V73, P2943, DOI 10.1158/0008-5472.CAN-12-4354; Huang YH, 2012, P NATL ACAD SCI USA, V109, P17561, DOI 10.1073/pnas.1215397109; Inai T, 2004, AM J PATHOL, V165, P35, DOI 10.1016/S0002-9440(10)63273-7; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jayson GC, 2016, LANCET, V388, P518, DOI 10.1016/S0140-6736(15)01088-0; Jerkic M, 2015, FASEB J, V29, P3678, DOI 10.1096/fj.14-269258; Keane MP, 2004, J IMMUNOL, V172, P2853, DOI 10.4049/jimmunol.172.5.2853; Kim JH, 2012, ANGIOGENESIS, V15, P497, DOI 10.1007/s10456-012-9277-x; Kim R, 2007, IMMUNOLOGY, V121, P1, DOI 10.1111/j.1365-2567.2007.02587.x; Koch AW, 2011, DEV CELL, V20, P33, DOI 10.1016/j.devcel.2010.12.001; Kumar V, 2014, IMMUNOLOGY, V143, P512, DOI 10.1111/imm.12380; Lamouille S, 2002, BLOOD, V100, P4495, DOI 10.1182/blood.V100.13.4495; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Lechner MG, 2013, J IMMUNOTHER, V36, P477, DOI 10.1097/01.cji.0000436722.46675.4a; Liu T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04833; Long L, 2015, NAT MED, V21, P777, DOI 10.1038/nm.3877; Lu TY, 2011, J CLIN INVEST, V121, P4015, DOI 10.1172/JCI45862; McKenney JK, 2001, AM J SURG PATHOL, V25, P1167, DOI 10.1097/00000478-200109000-00007; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Mitrofan CG, 2017, J BIOL CHEM, V292, P13714, DOI 10.1074/jbc.M117.778506; Moya IM, 2012, DEV CELL, V22, P501, DOI 10.1016/j.devcel.2012.01.007; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Nakahara T, 2006, CANCER RES, V66, P1434, DOI 10.1158/0008-5472.CAN-05-0923; Noman MZ, 2015, AM J PHYSIOL-CELL PH, V309, pC569, DOI 10.1152/ajpcell.00207.2015; Nouvion AL, 2010, J CELL SCI, V123, P4221, DOI 10.1242/jcs.073635; Ntumba K, 2016, ONCOTARGET, V7, P55957, DOI 10.18632/oncotarget.11182; Ochoa-Callejero L, 2016, SCI REP-UK, V6, DOI 10.1038/srep33495; Ola R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13650; Oladipupo SS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33037-2; Ouarne M, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0885-1; Oubaha M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9440; Park JS, 2016, CANCER CELL, V30, P953, DOI 10.1016/j.ccell.2016.10.018; Qin RS, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4738-2; Renier N, 2016, CELL, V165, P1789, DOI 10.1016/j.cell.2016.05.007; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; Rostama B, 2015, ARTERIOSCL THROM VAS, V35, P2626, DOI 10.1161/ATVBAHA.115.306541; Sceneay J, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22355; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Shrimali RK, 2010, CANCER RES, V70, P6171, DOI 10.1158/0008-5472.CAN-10-0153; Sitkovsky MV, 2008, CLIN CANCER RES, V14, P5947, DOI 10.1158/1078-0432.CCR-08-0229; Stacchini A, 2003, J BIOL REG HOMEOS AG, V17, P308; Sun ZY, 2012, J EXP MED, V209, P1363, DOI 10.1084/jem.20111343; Taguchi K, 2019, J IMMUNOL METHODS, V464, P105, DOI 10.1016/j.jim.2018.11.005; Tian HY, 2018, FASEB J, V32, P2934, DOI 10.1096/fj.201700867RR; Tolaney SM, 2015, P NATL ACAD SCI USA, V112, P14325, DOI 10.1073/pnas.1518808112; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; Varadaraj A, 2015, NEOPLASIA, V17, P826, DOI 10.1016/j.neo.2015.11.003; Vaupel P, 2004, ONCOLOGIST, V9, P10, DOI 10.1634/theoncologist.9-90005-10; Viallard C, 2017, ANGIOGENESIS, V20, P409, DOI 10.1007/s10456-017-9562-9; Voss MH, 2019, CANCER-AM CANCER SOC, V125, P2400, DOI 10.1002/cncr.32061; Wang XE, 2016, ONCOTARGET, V7, P41857, DOI 10.18632/oncotarget.9621; Ye L, 2008, MOL CANCER RES, V6, P1594, DOI 10.1158/1541-7786.MCR-08-0171; Yi M, 2009, P NATL ACAD SCI USA, V106, P17886, DOI 10.1073/pnas.0901324106; Yoong KF, 1998, J IMMUNOL, V160, P3978	84	17	18	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	14					2996	3014		10.1038/s41388-020-1200-0	http://dx.doi.org/10.1038/s41388-020-1200-0		FEB 2020	19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KZ2VB	32042114				2022-12-26	WOS:000512528200004
